PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Yoshida, Y; Izumi, Y				Yoshida, Yusuke; Izumi, Yasuo			Binary metal (Ti, Cu) oxyhydroxy-organic (terephthalate) framework: An interface model nanocatalyst for hydrogen purification	JOURNAL OF CATALYSIS			English	Article						Copper; Titanium oxide; Metal-support interface; Metal-organic frameworks; EXAFS spectroscopy; Rietveld refinement; Preferential oxidation	TITANIUM-OXIDE; CUO/TIO2 CATALYSTS; RAMAN-SPECTROSCOPY; CO OXIDATION; SITES; PHOTOCATALYSTS; STORAGE; LIGHT; SIZE; TPD	The importance of metal-support interfaces is widely known in commercial and fundamental heterogeneous catalysis; however, it is difficult to characterize the active interface sites. In this study, we synthesize a new class of compound comprising tetragonal [Ti8O8(OH)(4)](12+) clusters interlinked by terephthalates (bdc) and [Cu-2(OH)(6)](2-) linkers {Ti8O8(OH)(4)center dot(bdc)(2)center dot[Cu-2(OH)(6)](4)}. The crystalline structure was refined for X-ray diffraction and direct links between [Cu-2(OH)(6)](2-) and [Ti8O8(OH)(4)](12+) are confirmed by extended X-ray absorption fine structure. This compound functions very well (k = 0.117 min(-1) in CO 63 Pa + O-2 76 Pa at 323 K) as a catalytic model of interface Cu sites on ultra-dispersed Ti [hydro]oxide for preferential oxidation of CO in predominantly H-2 gas, that is important for the purification of hydrogen used in fuel cells. In comparison, mean 1.7-nm CuO nanoparticles embedded inside the pores of MIL125 were inert (k = 0.0035 min(-1)) because of the absence of links between Cu and [Ti8O8(OH)(4)](12+) clusters. In CO 0.51 kPa + O-2 0.51 kPa at 323 K, the conversion to CO2 and CO PROX selectivity using Ti8O8(OH)(4)center dot(bdc)(2)center dot[Cu-2(OH)(6)](4) (76% and 99%) was significantly higher than that using CuO/CeO2 (28% and 96%, respectively) for 24 h. (C) 2015 Elsevier Inc. All rights reserved.	[Yoshida, Yusuke; Izumi, Yasuo] Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, Chiba 2638522, Japan	Izumi, Y (reprint author), Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, Yayoi 1-33, Chiba 2638522, Japan.	aata3481@chiba-u.jp; yizumi@faculty.chiba-u.jp			Japan Society for the Promotion of Science [26410204, 22550117, 25.489]	The authors are grateful for the financial supports from the Grant-in-Aid for Scientific Research C (26410204, 22550117) and Research Fellowship for Young Scientists (25.489; Y.Y.) from Japan Society for the Promotion of Science and approval of the Photon Factory Proposal Review Committee for X-ray measurements (2013G159, 2011G083).	Aika K., 1995, AMMONIA CATALYSIS MA, P103; Fujishima Y, 2015, J MATER CHEM A, V3, P8389, DOI 10.1039/C4TA06824F; BEARDEN JA, 1967, REV MOD PHYS, V39, P78, DOI 10.1103/RevModPhys.39.78; Jentys A, 1999, PHYS CHEM CHEM PHYS, V1, P4059, DOI 10.1039/a904654b; Bennici S, 2006, APPL CATAL B-ENVIRON, V62, P336, DOI 10.1016/j.apcatb.2005.09.001; Avgouropoulos G, 2008, J MOL CATAL A-CHEM, V296, P47, DOI 10.1016/j.molcata.2008.09.013; CHIEN SH, 1982, J CATAL, V77, P301, DOI 10.1016/0021-9517(82)90172-5; Kumar DP, 2013, CHEM COMMUN, V49, P9443, DOI 10.1039/c3cc44742a; Il'ichev AN, 2015, KINET CATAL+, V56, P115, DOI 10.1134/S002315841501005X; DuBois JL, 2000, J AM CHEM SOC, V122, P5775, DOI 10.1021/ja993134p; Choi YM, 2006, CHEMPHYSCHEM, V7, P1957, DOI 10.1002/cphc.200600190; Masoomi MY, 2012, COORDIN CHEM REV, V256, P2921, DOI 10.1016/j.ccr.2012.05.032; Izumi Y, 2009, J PHYS CHEM C, V113, P6706, DOI 10.1021/jp810817y; Rui ZB, 2013, J MOL CATAL A-CHEM, V372, P128, DOI 10.1016/j.molcata.2013.02.026; Jiang Z, 2013, NANOSCALE, V5, P11770, DOI 10.1039/c3nr03829g; KLIER K, 1982, ADV CATAL, V31, P243, DOI 10.1016/S0360-0564(08)60455-1; Loiseau T, 2006, J AM CHEM SOC, V128, P10223, DOI 10.1021/ja0621086; Dan-Hardi M, 2009, J AM CHEM SOC, V131, P10857, DOI 10.1021/ja903726m; Tellez CA, 2001, SPECTROCHIM ACTA A, V57, P993, DOI 10.1016/S1386-1425(00)00428-5; Lee HC, 2008, CATAL TODAY, V132, P109, DOI 10.1016/j.cattod.2007.12.028; Suh MP, 2012, CHEM REV, V112, P782, DOI 10.1021/cr200274s; Li R, 2014, ADV MATER, V26, P4783, DOI 10.1002/adma.201400428; Lu JQ, 2013, APPL SURF SCI, V287, P124, DOI 10.1016/j.apsusc.2013.09.091; Ankudinov AL, 1998, PHYS REV B, V58, P7565, DOI 10.1103/PhysRevB.58.7565; Ohtani B, 2010, J PHOTOCH PHOTOBIO A, V216, P179, DOI 10.1016/j.jphotochem.2010.07.024; Polster CS, 2009, J CATAL, V266, P308, DOI 10.1016/j.jcat.2009.06.021; Izumi Y, 2005, ANAL CHEM, V77, P6969, DOI 10.1021/ac0512453; Cho A, 2003, SCIENCE, V299, P1684, DOI 10.1126/science.299.5613.1684; Yoshida Y, 2012, J CATAL, V287, P190, DOI 10.1016/j.jcat.2011.12.022; Chavan S, 2012, PHYS CHEM CHEM PHYS, V14, P1614, DOI 10.1039/c1cp23434j; Wu ZL, 2010, LANGMUIR, V26, P16595, DOI 10.1021/la101723w; Brandenburg K., DIAMOND CRYSTAL MOL; Hyde B. G., 1989, INORGANIC CRYSTAL ST, P12; Kang M. Y., 2013, J MOL CATAL A-CHEM, V268, P72; Vaarkamp M., 2006, XDAP VERSION 2 2 7; Zschomack G., 2007, HDB XRAY DATA, P233	36	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0021-9517	1090-2694		J CATAL	J. Catal.	DEC	2015	332						1	12		10.1016/j.jcat.2015.09.007		12	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CY0CI	WOS:000366073500001		
J	Kako, K; Nakamura, A; Nagashima, Y; Ishida, J; Fukamizu, A				Kako, Koichiro; Nakamura, Ayumi; Nagashima, Yusuke; Ishida, Junji; Fukamizu, Akiyoshi			Detection of ethanolamine altering in fetuses of pregnancy-associated hypertensive mice treated with vasodepressors by using UPLC and MALDI-TOF/MS	JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES			English	Article						Amines; Ethanolamine; Pregnancy-associated hypertension; Anti-hypertensive drugs; UPLC; MALDI-TOF/MS	PLASMA; PREECLAMPSIA; SEROTONIN; RECEPTOR	Since serotonin, homocysteine and oxytocin are known to fluctuate during mammalian gestation, we screened amines altered in pregnant-associated hypertensive (PAH) mice by tagging their amino groups with 6-aminoquinoline carbamoyl (AQC) group in concert with ultra high-performance liquid chromatography (UPLC). Interestingly, a candidate amine significantly increased in PAH mice was recovered to the basal level, when treated with antihypertensive drugs. Mass spectrometric analyses indicated that the molecular mass of this amine was 61.2, which was identified as ethanolamine. (C) 2015 Elsevier B.V. All rights reserved.	[Kako, Koichiro; Ishida, Junji; Fukamizu, Akiyoshi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Kako, Koichiro; Nakamura, Ayumi; Nagashima, Yusuke; Ishida, Junji; Fukamizu, Akiyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Ishida, Junji; Fukamizu, Akiyoshi] Univ Tsukuba, Life Sci Ctr, TARA, Tsukuba, Ibaraki 3058577, Japan	Fukamizu, A (reprint author), Univ Tsukuba, Life Sci Ctr, TARA, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	akif@tara.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, Sports and Technology of Japan [21510222]; University of Tsukuba	The authors are grateful to Daiichi-Sankyo Co., Ltd., Tokyo, Japan, for the gift of olmesartan. This study was supported by a Grant-in-Aid for Scientific Research (C) (to KK, Grant No. 21510222) from the Ministry of Education, Culture, Sports, Science, Sports and Technology of Japan and the TARA Project (to AF) from University of Tsukuba.	DEGEEST K, 1985, J PERINAT MED, V13, P3, DOI 10.1515/jpme.1985.13.1.3; COHEN SA, 1993, ANAL BIOCHEM, V211, P279, DOI 10.1006/abio.1993.1270; Powers RW, 1998, AM J OBSTET GYNECOL, V179, P1605, DOI 10.1016/S0002-9378(98)70033-X; Carrasco G, 1998, LIFE SCI, V62, P1323, DOI 10.1016/S0024-3205(98)00066-6; Shirakawa T, 2011, MOL MED REP, V4, P615, DOI 10.3892/mmr.2011.488; Cikot RJLM, 2001, BRIT J NUTR, V85, P49, DOI 10.1079/BJN2000209; Takimoto E, 1996, SCIENCE, V274, P995, DOI 10.1126/science.274.5289.995; de Escobar GM, 2004, BEST PRACT RES CL EN, V18, P225, DOI 10.1016/j.beem.2004.03.012; MILLS JL, 1995, LANCET, V345, P149, DOI 10.1016/S0140-6736(95)90165-5; Sakairi A, 2008, HYPERTENS RES, V31, P2165, DOI 10.1291/hypres.31.2165; Nagashima Y., 2012, MOL MED REP, V5, P944; Saito Tomoko, 2004, FASEB Journal, V18, P388; WEINER CP, 1987, AM J OBSTET GYNECOL, V156, P885	13	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-0232	1873-376X		J CHROMATOGR B	J. Chromatogr. B	DEC 1	2015	1006						93	98		10.1016/j.jchromb.2015.10.018		6	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CY0EA	WOS:000366077900011		
J	Hamanishi, J; Mandai, M; Ikeda, T; Minami, M; Kawaguchi, A; Murayama, T; Kanai, M; Mori, Y; Matsumoto, S; Chikuma, S; Matsumura, N; Abiko, K; Baba, T; Yamaguchi, K; Ueda, A; Hosoe, Y; Morita, S; Yokode, M; Shimizu, A; Honjo, T; Konishi, I				Hamanishi, Junzo; Mandai, Masaki; Ikeda, Takafumi; Minami, Manabu; Kawaguchi, Atsushi; Murayama, Toshinori; Kanai, Masashi; Mori, Yukiko; Matsumoto, Shigemi; Chikuma, Shunsuke; Matsumura, Noriomi; Abiko, Kaoru; Baba, Tsukasa; Yamaguchi, Ken; Ueda, Akihiko; Hosoe, Yuko; Morita, Satoshi; Yokode, Masayuki; Shimizu, Akira; Honjo, Tasuku; Konishi, Ikuo			Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer	JOURNAL OF CLINICAL ONCOLOGY			English	Article							PEGYLATED LIPOSOMAL DOXORUBICIN; RANDOMIZED PHASE-III; TUMOR-CELLS; T-CELLS; CARCINOMA; EXPRESSION; IMMUNOTHERAPY; LYMPHOCYTES; TOPOTECAN; MELANOMA	Purpose Programmed death-1 (PD-1), a coinhibitory immune signal receptor expressed in T cells, binds to PD-1 ligand and regulates antitumor immunity. Nivolumab is an anti-PD-1 antibody that blocks PD-1 signaling. We assessed the safety and antitumor activity of nivolumab in patients with platinum-resistant ovarian cancer. Patients and Methods Twenty patients with platinum-resistant ovarian cancer were treated with an intravenous infusion of nivolumab every 2 weeks at a dose of 1 or 3 mg/kg (constituting two 10-patient cohorts) from October 21, 2011. This phase II trial defined the primary end point as the best overall response. Patients received up to six cycles (four doses per cycle) of nivolumab treatment or received doses until disease progression occurred. Twenty nivolumab-treated patients were evaluated at the end of the trial on December 7, 2014. Results Grade 3 or 4 treatment-related adverse events occurred in eight (40%) of 20 patients. Two patients had severe adverse events. In the 20 patients in whom responses could be evaluated, the best overall response was 15%, which included two patients who had a durable complete response (in the 3-mg/kg cohort). The disease control rate in all 20 patients was 45%. The median progression-free survival time was 3.5 months (95% CI, 1.7 to 3.9 months), and the median overall survival time was 20.0 months (95% CI, 7.0 months to not reached) at study termination. Conclusion This study, to our knowledge, is the first to explore the effects of nivolumab against ovarian cancer. The encouraging safety and clinical efficacy of nivolumab in patients with platinum-resistant ovarian cancer indicate the merit of additional large-scale investigations. (C) 2015 by American Society of Clinical Oncology	[Hamanishi, Junzo; Mandai, Masaki; Mori, Yukiko; Matsumoto, Shigemi; Chikuma, Shunsuke; Matsumura, Noriomi; Abiko, Kaoru; Baba, Tsukasa; Yamaguchi, Ken; Ueda, Akihiko; Hosoe, Yuko; Honjo, Tasuku; Konishi, Ikuo] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Mandai, Masaki] Kinki Univ, Fac Med, Osaka, Japan; [Ikeda, Takafumi; Minami, Manabu; Kawaguchi, Atsushi; Murayama, Toshinori; Morita, Satoshi; Yokode, Masayuki; Shimizu, Akira] Kyoto Univ Hosp, Kyoto 606, Japan	Hamanishi, J (reprint author), Kyoto Univ, Grad Sch Med, Dept Gynecol & Obstet, Sakyo Ku, 54 Kawahara Cho, Kyoto, Kyoto 6068507, Japan.	jnkhmns@kuhp.kyoto-u.ac.jp			Health and Labour Sciences Research Grant [11104959]; Translational Research Network Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan [2013037]; Kyoto University	Supported by research funds from Health and Labour Sciences Research Grant No. 11104959 (to J.H. and I.K.); by Translational Research Network Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan Grant No. 2013037 (to J.H. and I.K.); and by Kyoto University grants.	Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Hamanishi J, 2011, CLIN IMMUNOL, V141, P338, DOI 10.1016/j.clim.2011.08.013; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Kooi S, 1996, CELL IMMUNOL, V174, P116, DOI 10.1006/cimm.1996.0301; Crotzer DR, 2007, GYNECOL ONCOL, V105, P404, DOI 10.1016/j.ygyno.2006.12.024; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326; Mutch DG, 2007, J CLIN ONCOL, V25, P2811, DOI 10.1200/JCO.2006.09.6735; Zorn KK, 2005, CLIN CANCER RES, V11, P6422, DOI 10.1158/1078-0432.CCR-05.0508; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Abiko K, 2013, CLIN CANCER RES, V19, P1363, DOI 10.1158/1078-0432.CCR-12-2199; Hoskins P, 2010, J NATL CANCER I, V102, P1547, DOI 10.1093/jnci/djq362; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Hwang WT, 2012, GYNECOL ONCOL, V124, P192, DOI 10.1016/j.ygyno.2011.09.039; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Cannistra SA, 2007, J CLIN ONCOL, V25, P5180, DOI 10.1200/JCO.2007.12.0782; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hino R, 2010, CANCER-AM CANCER SOC, V116, P1757, DOI 10.1002/cncr.24899; Gordon AN, 2001, J CLIN ONCOL, V19, P3312; Naumann RW, 2011, DRUGS, V71, P1397, DOI 10.2165/11591720-000000000-00000; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Kandalaft LE, 2011, J CLIN ONCOL, V29, P925, DOI 10.1200/JCO.2009.27.2369; IOANNIDES CG, 1991, J IMMUNOL, V146, P1700; Morgan RJ, 2013, J NATL COMPR CANC NE, V11, P1199; Cancer Genome Atlas Research Network, 2011, NATURE, V474, P609, DOI DOI 10.1038/NATURE10166; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271	32	1	1	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	DEC 1	2015	33	34					4015	+		10.1200/JCO.2015.62.3397		13	Oncology	Oncology	CX9JE	WOS:000366021000009		
J	Wayama, MT; Yoshimura, H; Ohba, S; Yoshida, H; Matsuda, S; Kobayashi, J; Kobayashi, M; Gomes, JE; Sano, K				Wayama, Marcelo Tadahiro; Yoshimura, Hitoshi; Ohba, Seigo; Yoshida, Hisato; Matsuda, Shinpei; Kobayashi, Junichi; Kobayashi, Motohiro; Gomes Filho, Joao Eduardo; Sano, Kazuo			Diminished Progression of Periapical Lesions with Zoledronic Acid in Ovariectomized Rats	JOURNAL OF ENDODONTICS			English	Article						Bisphosphonate; estrogen deficiency; osteonecrosis	BISPHOSPHONATE-RELATED OSTEONECROSIS; INDUCE OSTEONECROSIS; TOOTH EXTRACTION; DISEASE; JAW; PERIODONTITIS; ALENDRONATE; RESORPTION; MICE; ANGIOGENESIS	Introduction: The aim of this study was to investigate the effects of systemically administered zoledronic acid (ZOL) on the progression of periapical lesions in estrogen-deficient rats. Methods: Female Wistar rats were divided into the following groups: SHAM-veh, sham surgery treated with vehicle (physiological saline); OVX-veh, ovariectomy treated with vehicle; SHAM-ZOL, sham surgery treated with ZOL; and OVX-ZOL, ovariectomy treated with ZOL. Vehicle or ZOL was administered intravenously once a week for 4 weeks. The pulp of the mandibular first molar of all rats was exposed to the oral environment to induce a periapical lesion, and the lesions were analyzed after 7 and 30 days. The mandibles were examined by micro-computed tomographic imaging and histopathologic, histometric, and immunohistochemical analyses. Results: Histopathologically, the OVX-veh group had more severe inflammation and bone loss and a larger number of cells that were positive for tartrate-resistant acid phosphatase compared with the SHAM-veh and OVX-ZOL groups; the SHAM-veh and OVX-ZOL groups were similar to each other. The SHAM-ZOL group had the lowest magnitude of these conditions. Tomographically, the OVX-veh group had greater bone loss than the other groups at both time points. The SHAM-veh, SHAM-ZOL, and OVX-ZOL groups had similar bone loss at both time points. In the sagittal section on day 30, the SHAM-ZOL group had lower bone loss compared with the SHAM-veh and OVX-ZOL groups. Conclusions: The hypoestrogenic condition aggravates the progression of periapical lesions. ZOL therapy may help contain bone destruction of periapical lesions.	[Wayama, Marcelo Tadahiro; Yoshimura, Hitoshi; Yoshida, Hisato; Matsuda, Shinpei; Kobayashi, Junichi; Sano, Kazuo] Univ Fukui, Div Dent & Oral Surg, Dept Sensory & Locomotor Med, Fac Med Sci, Fukui 9101193, Japan; [Kobayashi, Motohiro] Univ Fukui, Div Tumor Pathol, Dept Pathol Sci, Fac Med Sci, Fukui 9101193, Japan; [Wayama, Marcelo Tadahiro; Gomes Filho, Joao Eduardo] Univ Estadual Paulista, Aracatuba Sch Dent, Dept Endodont, Sao Paulo, Brazil; [Ohba, Seigo] Nagasaki Univ, Grad Sch Biomed Sci, Dept Regenerat Oral Surg, Nagasaki 852, Japan	Sano, K (reprint author), Univ Fukui, Div Dent & Oral Surg, Dept Sensory & Locomotor Med, Fac Med Sci, 23-3 Matsuokashimoaizuki, Fukui 9101193, Japan.	sano@u-fukui.ac.jp			Fukui Prefectural Dental Association	The authors thank the Fukui Prefectural Dental Association for supporting this study and Drs Aiki, Furuhashi, Ichikawa, and Yasui, University of Pukui, for their help in the experiments.	Ahn SG, 2014, J BREAST CANCER, V17, P350, DOI 10.4048/jbc.2014.17.4.350; Troeltzsch M, 2014, J ENDODONT, V40, P1260, DOI 10.1016/j.joen.2013.12.030; Evans HM, 1922, P NATL ACAD SCI USA, V8, P38, DOI 10.1073/pnas.8.3.38; Gomes-Filho JE, 2015, INT ENDOD J, V48, P1059, DOI 10.1111/iej.12403; Drake MT, 2010, MOL INTERV, V10, P141, DOI 10.1124/mi.10.3.5; Said F, 2012, J PERIODONTOL, V83, P1063, DOI 10.1902/jop.2011.110242; Gomes JE, 2015, J ENDODONT, V41, P671, DOI 10.1016/j.joen.2014.11.027; Aghaloo TL, 2011, J BONE MINER RES, V26, P1871, DOI 10.1002/jbmr.379; Scardina GA, 2012, GERODONTOLOGY, V29, pE1045, DOI 10.1111/j.1741-2358.2011.00608.x; Liu SB, 2010, J ENDODONT, V36, P658, DOI 10.1016/j.joen.2010.01.011; Silva PGD, 2015, ARCH ORAL BIOL, V60, P1237, DOI 10.1016/j.archoralbio.2015.05.015; Hsiao A, 2009, J ENDODONT, V35, P1525, DOI 10.1016/j.joen.2009.07.020; Xiong H, 2010, INT ENDOD J, V43, P485, DOI 10.1111/j.1365-2591.2010.01703.x; Aghaloo TL, 2014, J BONE MINER RES, V29, P843, DOI 10.1002/jbmr.2097; Garcia VG, 2013, LASER MED SCI, V28, P143, DOI 10.1007/s10103-012-1099-y; Shintani T, 2015, INT J ORAL MAX SURG, V44, P840, DOI 10.1016/j.ijom.2015.03.013; Ricucci D, 2014, J ENDODONT, V40, P1268, DOI 10.1016/j.joen.2014.01.008; Newcomb PA, 2015, J CLIN ONCOL, V33, P1186, DOI 10.1200/JCO.2014.58.6842; Xiong HF, 2007, J ENDODONT, V33, P1304, DOI 10.1016/j.joen.2007.07.011; Kang B, 2013, J BONE MINER RES, V28, P1631, DOI 10.1002/jbmr.1894; Bodem JP, 2015, J CRANIO MAXILL SURG, V43, P510, DOI 10.1016/j.jcms.2015.02.018; Borm Jan M, 2013, Schweiz Monatsschr Zahnmed, V123, P985; Cheong S, 2014, J ORAL MAXIL SURG, V72, P2461, DOI 10.1016/j.joms.2014.07.004; de Molon RS, 2014, BONE, V68, P11, DOI 10.1016/j.bone.2014.07.027; Di Nisio C, 2015, Eur J Histochem, V59, P2455, DOI 10.4081/ejh.2015.2455; Estrela Carlos, 2014, Braz Dent J, V25, P404, DOI 10.1590/0103-6440201302432; Gil-Montoya José Antonio, 2015, Clin Interv Aging, V10, P461, DOI 10.2147/CIA.S54630; Li CL, 2014, CLIN ORAL IMPLANTS R; Martins CA, 2015, J ENDODONT, V41, P45, DOI 10.1016/j.joen.2014.07.010; Nuti Ranuccio, 2014, Clin Cases Miner Bone Metab, V11, P208; Raj DV, 2014, GERODONTOLOGY; Santosh Patil, 2013, J Clin Exp Dent, V5, pe8, DOI 10.4317/jced.50928; Suri Vanita, 2014, J Midlife Health, V5, P115, DOI 10.4103/0976-7800.141187	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0099-2399	1878-3554		J ENDODONT	J. Endod.	DEC	2015	41	12					2002	2007		10.1016/j.joen.2015.08.029		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CY1DF	WOS:000366146200009		
J	Adachi, M; Kiho, K; Sekine, G; Ohta, T; Matsubara, M; Yoshida, T; Katsumata, A; Tanuma, J; Sumitomo, S				Adachi, Makoto; Kiho, Kazuki; Sekine, Genta; Ohta, Takahisa; Matsubara, Makoto; Yoshida, Takakazu; Katsumata, Akitoshi; Tanuma, Jun-ichi; Sumitomo, Shinichiro			Inflammatory Myofibroblastic Tumor Mimicking Apical Periodontitis	JOURNAL OF ENDODONTICS			English	Article						Apical periodontitis; inflammatory myofibroblastic tumor; jaw tumor; mandible	PROGNOSTIC FEATURES; PSEUDOTUMOR; EXPRESSION; LIVER; ALK1; HEAD; P80	Inflammatory myofibroblastic tumors (IMTs) are rare. IMTs of the head and neck occur in all age groups, from neonates to old age, with the highest incidence occurring in childhood and early adulthood. An IMT has been defined as a histologically distinctive lesion of uncertain behavior. This article describes an unusual case of IMT mimicking apical periodontitis in the mandible of a 42-year-old man. At first presentation, the patient showed spontaneous pain and percussion pain at teeth #28 to 30, which continued after initial endodontic treatment. Panoramic radiography revealed a radiolucent lesion at the site. Cone-beam computed tomographic imaging showed osteolytic lesions, suggesting an aggressive neoplasm requiring incisional biopsy. Histopathological examination indicated an IMT. The lesion was removed en bloc under general anesthesia, and the patient manifested no clinical evidence of recurrence for 24 months. Lesions of nonendodontic origin should be included in the differential diagnosis of apical periodontitis. Every available diagnostic tool should be used to confirm the diagnosis. Cone-beam computed tomographic imaging is very helpful for differential diagnosis in IMTs mimicking apical periodontitis.	[Adachi, Makoto; Ohta, Takahisa; Matsubara, Makoto; Sumitomo, Shinichiro] Asahi Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Mizuho, Gifu 5010296, Japan; [Kiho, Kazuki; Sekine, Genta; Yoshida, Takakazu] Asahi Univ, Sch Dent, Dept Endodont, Mizuho, Gifu 5010296, Japan; [Katsumata, Akitoshi] Asahi Univ, Sch Dent, Dept Oral Radiol, Mizuho, Gifu 5010296, Japan; [Tanuma, Jun-ichi] Asahi Univ, Sch Dent, Dept Oral Pathol, Mizuho, Gifu 5010296, Japan	Adachi, M (reprint author), Asahi Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Hozumi 1851, Mizuho, Gifu 5010296, Japan.	madachi_dds_phd@yahoo.co.jp					Faitaroni LA, 2008, J ENDODONT, V34, P216, DOI 10.1016/j.joen.2007.11.010; Cessna MH, 2002, MODERN PATHOL, V15, P931, DOI 10.1097/01.MP.000002615.04130.1F; Gomez-Roman JJ, 2001, AM J SURG PATHOL, V25, P624, DOI 10.1097/00000478-200105000-00009; ABEHSERA M, 1995, J COMPUT ASSIST TOMO, V19, P80, DOI 10.1097/00004728-199501000-00015; Nam KJ, 1996, AM J ROENTGENOL, V167, P485; Rodrigues CD, 2011, J ENDODONT, V37, P91, DOI 10.1016/j.joen.2010.08.002; Poh CF, 2005, ORAL SURG ORAL MED O, V100, P460, DOI 10.1016/j.tripleo.2004.07.005; Debiec-Rychter M, 2003, AM J PATHOL, V163, P913, DOI 10.1016/S0002-9440(10)63451-7; Pontes FSC, 2014, J ENDODONT, V40, P16, DOI 10.1016/j.joen.2013.08.021; Coffin CM, 2001, MODERN PATHOL, V14, P569, DOI 10.1038/modpathol.3880352; Ong HS, 2012, ORAL ONCOL, V48, P141, DOI 10.1016/j.oraloncology.2011.09.004; Devaney KO, 2012, EUR ARCH OTO-RHINO-L, V269, P2461, DOI 10.1007/s00405-012-2026-3; Chan JKC, 2001, AM J SURG PATHOL, V25, P761, DOI 10.1097/00000478-200106000-00007; Brooks JK, 2005, ORAL SURG ORAL MED O, V99, P716, DOI 10.1016/j.tripleo.2004.11.023; Kim SY, 2011, ORAL SURG ORAL MED O, V112, P684, DOI 10.1016/j.tripleo.2011.05.004; Binmadi Nada O, 2011, Open Dent J, V5, P66, DOI 10.2174/1874210601105010066; Coindre J M, 1994, Ann Pathol, V14, P426; Sah Parul, 2013, Head Neck Pathol, V7, P393, DOI 10.1007/s12105-013-0474-8; Salehinejad Jahanshah, 2013, J Oral Maxillofac Pathol, V17, P306, DOI 10.4103/0973-029X.119754	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0099-2399	1878-3554		J ENDODONT	J. Endod.	DEC	2015	41	12					2079	2082		10.1016/j.joen.2015.09.006		4	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CY1DF	WOS:000366146200022		
J	Nozu, T; Kumei, S; Miyagishi, S; Takakusaki, K; Okumura, T				Nozu, Tsukasa; Kumei, Shima; Miyagishi, Saori; Takakusaki, Kaoru; Okumura, Toshikatsu			Colorectal distention induces acute and delayed visceral hypersensitivity: role of peripheral corticotropin-releasing factor and interleukin-1 in rats	JOURNAL OF GASTROENTEROLOGY			English	Article						Colorectal distention; Visceral sensitization; IL-1; Corticotropin-releasing factor	IRRITABLE-BOWEL-SYNDROME; WATER AVOIDANCE STRESS; COLONIC HYPERSENSITIVITY; RECEPTOR ANTAGONIST; SIGNALING PATHWAYS; ISCHEMIA; MODEL; PATHOPHYSIOLOGY; HYPERALGESIA; SENSITIVITY	Background Most studies evaluating visceral sensation measure visceromotor response (VMR) to colorectal distention (CRD). However, CRD itself induces visceral sensitization, and little is known about the detailed characteristics of this response. The present study tried to clarify this question. Methods VMR was determined by measuring abdominal muscle contractions as a response to CRD in rats. The CRD set consisted of two isobaric distentions (60 mmHg for 10 min twice, with a 30-min rest), and the CRD set was performed on two separate days, i.e., days 1 and 3, 8. Results On day 1, VMR to the second CRD was increased as compared with that to the first CRD, which is the acute sensitization. VMR to the first CRD on day 3 returned to the same level as that to the first CRD on day 1, and total VMR, i.e., the whole response to the CRD set, was not different between day 1 and day 3. However, total VMR was significantly increased on day 8 as compared with that on day 1, suggesting CRD induced the delayed sensitization. Intraperitoneally administered astressin (200 A mu g/kg), a corticotropin-releasing factor receptor antagonist, at the end of the first CRD blocked the acute sensitization, but anakinra (20 mg/kg, intraperitoneally), an interleukin-1 receptor antagonist, did not modify it. Astressin (200 A mu g/kg, twice before CRD on day 8) did not alter the delayed sensitization, but anakinra (20 mg/kg, twice) abolished it. Conclusions CRD induced both acute sensitization and delayed sensitization, which were mediated through peripheral corticotropin-releasing factor and interleukin-1 pathways, respectively.	[Nozu, Tsukasa] Asahikawa Med Univ, Dept Reg Med & Educ, Asahikawa, Hokkaido 0788510, Japan; [Kumei, Shima; Miyagishi, Saori; Okumura, Toshikatsu] Asahikawa Med Univ, Dept Gen Med, Asahikawa, Hokkaido 0788510, Japan; [Takakusaki, Kaoru] Asahikawa Med Univ, Res Ctr Brain Funct & Med Engn, Asahikawa, Hokkaido 0788510, Japan	Nozu, T (reprint author), Asahikawa Med Univ, Dept Reg Med & Educ, Midorigaoka Higashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan.	tnozu@sea.plala.or.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [C-23590252, C-22590753]	This work was supported in part by Grants-inAid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [C-23590252 (TN), and C-22590753 (TO)].	Coelho AM, 2000, BRAIN RES BULL, V52, P223, DOI 10.1016/S0361-9230(00)00269-0; Tsuchiya Y, 2012, DIGEST DIS SCI, V57, P2555, DOI 10.1007/s10620-012-2210-8; SCHULTZBERG M, 1987, J NEUROSCI RES, V18, P184, DOI 10.1002/jnr.490180126; Larauche M, 2009, J PHYSIOL PHARMACOL, V60, P33; Coelho AM, 2000, AM J PHYSIOL-GASTR L, V279, pG781; Vlachakis IK, 2011, INT ANGIOL, V30, P35; Bradesi S, 2005, AM J PHYSIOL-GASTR L, V289, pG42, DOI 10.1152/ajpgi.00500.2004; Million M, 2006, GUT, V55, P172, DOI 10.1136/gut.2005.051391; Santos J, 1999, AM J PHYSIOL-GASTR L, V277, pG391; Liebregts T, 2007, GASTROENTEROLOGY, V132, P913, DOI 10.1053/j.gastro.2007.01.046; Larauche M, 2009, AM J PHYSIOL-GASTR L, V297, pG215, DOI 10.1152/ajpgi.00072.2009; Lee YJ, 2014, WORLD J GASTROENTERO, V20, P2456, DOI 10.3748/wjg.v20.i10.2456; Saito-Nakaya K, 2008, NEUROGASTROENT MOTIL, V20, P1147, DOI 10.1111/j.1365-2982.2008.01151.x; Tache Y, 2004, BRIT J PHARMACOL, V141, P1321, DOI 10.1038/sj.bjp.0705760; Gaudreau GA, 2004, BEHAV BRAIN RES, V150, P185, DOI 10.1016/j.bbr.2003.07.004; Wu SV, 2011, ENDOCRINOLOGY, V152, P126, DOI 10.1210/en.2010-0997; Chaloner A, 2013, AGE, V35, P1, DOI 10.1007/s11357-011-9323-4; Sloots CEJ, 2000, NEUROGASTROENT MOTIL, V12, P361; OWENS MJ, 1991, PHARMACOL REV, V43, P425; Beatty JK, 2014, WORLD J GASTROENTERO, V20, P3976, DOI 10.3748/wjg.v20.i14.3976; Galea J, 2011, J CEREBR BLOOD F MET, V31, P439, DOI 10.1038/jcbfm.2010.103; Tanaka Y, 2011, J NEUROGASTROENTEROL, V17, P131, DOI 10.5056/jnm.2011.17.2.131; Greenhalgh AD, 2010, BRIT J PHARMACOL, V160, P153, DOI 10.1111/j.1476-5381.2010.00684.x; Zhai QZ, 1999, PAIN, V83, P321, DOI 10.1016/S0304-3959(99)00116-5; Schwetz I, 2004, AM J PHYSIOL-GASTR L, V286, pG683, DOI 10.1152/ajpgi.00358.2003; Stengel A, 2009, ANNU REV PHYSIOL, V71, P219, DOI 10.1146/annurev.physiol.010908.163221; Fu LW, 1999, J PHYSIOL-LONDON, V521, P249, DOI 10.1111/j.1469-7793.1999.00249.x; Kindt S, 2009, NEUROGASTROENT MOTIL, V21, P389, DOI 10.1111/j.1365-2982.2008.01220.x; Girard S, 2010, J IMMUNOL, V184, P3997, DOI 10.4049/jimmunol.0903349; Million M, 2005, PEPTIDES, V26, P1188, DOI 10.1016/j.peptides.2005.02.004; Ait-Belgnaoui A, 2005, PAIN, V113, P141, DOI 10.1016/j.pain.2004.10.002; De Giorgio Roberto, 2008, Curr Gastroenterol Rep, V10, P385, DOI 10.1007/s11894-008-0073-0; Gage G.J., 2012, JOVE-J VIS EXP, V65, P3564, DOI DOI 10.3791/3564; Larauche M, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2012.01980.x; Million M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073749; Nozu T, 2014, ENDOCRINOLOGY, V155, P4655, DOI 10.1210/en.2014-1421; Overman EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039935	37	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	DEC	2015	50	12					1153	1161		10.1007/s00535-015-1070-3		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CY1GZ	WOS:000366156000001		
J	Nagata, N; Niikura, R; Aoki, T; Moriyasu, S; Sakurai, T; Shimbo, T; Shinozaki, M; Sekine, K; Okubo, H; Watanabe, K; Yokoi, C; Yanase, M; Akiyama, J; Uemura, N				Nagata, Naoyoshi; Niikura, Ryota; Aoki, Tomonori; Moriyasu, Shiori; Sakurai, Toshiyuki; Shimbo, Takuro; Shinozaki, Masafumi; Sekine, Katsunori; Okubo, Hidetaka; Watanabe, Kazuhiro; Yokoi, Chizu; Yanase, Mikio; Akiyama, Junichi; Uemura, Naomi			Role of urgent contrast-enhanced multidetector computed tomography for acute lower gastrointestinal bleeding in patients undergoing early colonoscopy	JOURNAL OF GASTROENTEROLOGY			English	Article						Multidetector computed tomography (MDCT) angiography; Urgent colonoscopy; Acute lower gastrointestinal hemorrhage; Colonic diverticular bleeding	ROW HELICAL CT; DIAGNOSIS; LOCALIZATION; HEMORRHAGE; PREDICTORS; MANAGEMENT; TRIAL	Background The clinical significance of performing computed tomography (CT) for acute lower gastrointestinal bleeding (LGIB) remains unknown. This study aimed to evaluate the role of urgent CT in acute LGIB settings. Methods The cohort comprised 223 patients emergently hospitalized for LGIB who underwent early colonoscopy within 24 h of arriving at the hospital, including 126 who underwent CT within 3 h of arrival. We compared the bleeding source rate between two strategies: early colonoscopy following urgent CT or early colonoscopy alone. Results No significant differences in age, sex, comorbidities, vital signs, or laboratory data were observed between the strategies. The detection rate was higher with colonoscopy following CT for vascular lesions (35.7 vs. 20.6 %, p = 0.01), leading to more endoscopic therapies (34.9 vs. 13.4 %, p < 0.01). Of the 126 who underwent colonoscopy following CT, 26 (20.6 %) had extravasation and 34 (27.0 %) had nonvascular findings. The sensitivity and specificity of CT extravasation and nonvascular findings for predicting vascular lesions and inflammation or tumors were 37.8 and 88.9 and 81.3 and 80.9 %, respectively. A high kappa agreement (0.83, p < 0.01) for active bleeding locations was found between CT and subsequent colonoscopy. There were no cases of contrast-induced nephropathy after 1 week of CT. Conclusions Urgent CT before colonoscopy had about 15 % additional value for detecting vascular lesion compared to colonoscopy alone and thus enabled subsequent endoscopic therapies. Contrast-enhanced CT in acute LGIB settings was safe and correctly identified the presence and location of active bleeding, as well as severe inflammation or tumor stenosis, facilitating decision making.	[Nagata, Naoyoshi; Niikura, Ryota; Aoki, Tomonori; Moriyasu, Shiori; Sakurai, Toshiyuki; Sekine, Katsunori; Okubo, Hidetaka; Watanabe, Kazuhiro; Yokoi, Chizu; Yanase, Mikio; Akiyama, Junichi] Natl Ctr Global Hlth & Med NCGM, Dept Gastroenterol & Hepatol, Shinjuku Ku, Tokyo 1628655, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Res Inst, Int Clin Res Ctr, Dept Clin Res & Informat, Tokyo, Japan; [Shinozaki, Masafumi] Natl Ctr Global Hlth & Med, Dept Diagnost Radiol, Tokyo, Japan; [Uemura, Naomi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Chiba, Japan	Nagata, N (reprint author), Natl Ctr Global Hlth & Med NCGM, Dept Gastroenterol & Hepatol, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	nnagata_ncgm@yahoo.co.jp			National Center for Global Health and Medicine [26A-201]	We thank the clinical research coordinators Ms. Hisae Kawashiro, Sawako Iijima, Yoko Tanigawa, Aiko Gotannda, and Yaeko Sawada for help with data collection. This study was partly supported by a grant for research and development from the National Center for Global Health and Medicine (26A-201).	Barrett BJ, 2006, NEW ENGL J MED, V354, P379, DOI 10.1056/NEJMcp050801; Green BT, 2005, AM J GASTROENTEROL, V100, P2395, DOI 10.1111/j.1572-0241.2005.00306.x; Kaltenbach T, 2012, CLIN GASTROENTEROL H, V10, P131, DOI 10.1016/j.cgh.2011.10.029; JENSEN DM, 1988, GASTROENTEROLOGY, V95, P1569; Zuckerman GR, 1999, GASTROINTEST ENDOSC, V49, P228, DOI 10.1016/S0016-5107(99)70491-8; Strate LL, 2005, GASTROENTEROL CLIN N, V34, P643, DOI 10.1016/j.gtc.2005.08.007; Amarteifio E, 2008, CLIN IMAG, V32, P1, DOI 10.1016/j.clinimag.2007.08.018; Jaeckle T, 2008, EUR RADIOL, V18, P1406, DOI 10.1007/s00330-008-0907-z; Tan KK, 2010, J GASTROINTEST SURG, V14, P112, DOI 10.1007/s11605-009-1069-2; Yoon W, 2006, RADIOLOGY, V239, P160, DOI 10.1148/radiol.2383050175; Strate LL, 2005, GASTROINTEST ENDOSC, V61, P46, DOI 10.1016/S0016-5107(04)02227-8; Ell C, 2008, AM J GASTROENTEROL, V103, P883, DOI 10.1111/j.1572-0241.2007.01708.x; Chua AE, 2008, J MED IMAG RADIAT ON, V52, P333, DOI 10.1111/j.1440-1673.2008.01964.x; Strate LL, 2003, ARCH INTERN MED, V163, P838, DOI 10.1001/archinte.163.7.838; Obana T, 2013, DIGEST DIS SCI, V58, P1985, DOI 10.1007/s10620-013-2629-6; Pasha SF, 2014, GASTROINTEST ENDOSC, V79, P875, DOI 10.1016/j.gie.2013.10.039; Hur S, 2014, J VASC INTERV RADIOL, V25, P10, DOI 10.1016/j.jvir.2013.09.012; Yamaguchi T, 2003, ABDOM IMAGING, V28, P634, DOI 10.1007/s00261-002-0099-y; Jensen DM, 2000, NEW ENGL J MED, V342, P78, DOI 10.1056/NEJM200001133420202; Lhewa DY, 2012, WORLD J GASTROENTERO, V18, P1185, DOI 10.3748/wjg.v18.i11.1185; FOUTCH PG, 1995, AM J GASTROENTEROL, V90, P1779; Gady Joshua S, 2003, Curr Surg, V60, P344, DOI 10.1016/S0149-7944(02)00749-3; Nagata N, 2014, ENDOSC GASTROINTEST; Niikura R, 2014, GASTROENTEROL J CLIN; Sim J, 2005, PHYS THER, V85, P257	25	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	DEC	2015	50	12					1162	1172		10.1007/s00535-015-1069-9		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CY1GZ	WOS:000366156000002		
J	Matsuhashi, N; Kudo, M; Yoshida, N; Murakami, K; Kato, M; Sanuki, T; Oshio, A; Joh, T; Higuchi, K; Haruma, K; Nakada, K				Matsuhashi, Nobuyuki; Kudo, Mineo; Yoshida, Norimasa; Murakami, Kazunari; Kato, Mototsugu; Sanuki, Tsuyoshi; Oshio, Atsushi; Joh, Takashi; Higuchi, Kazuhide; Haruma, Ken; Nakada, Koji			Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multicenter prospective observational study	JOURNAL OF GASTROENTEROLOGY			English	Article						Gastroesophageal reflux disease; Dyspeptic symptoms; Depression; Anxiety; Therapeutic response to proton pump inhibitor therapy	QUALITY-OF-LIFE; IBS PATIENTS; SYMPTOM; RELIEF; PREDICTION; GUIDELINES; MANAGEMENT; FREQUENCY; DIAGNOSIS; CONSENSUS	Background Proton pump inhibitor (PPI) therapy, the first-line treatment for gastroesophageal reflux disease (GERD), is not always effective. This study aimed to examine the effect of pretreatment patient characteristics on response to PPI therapy. Methods Japanese outpatients with symptomatic GERD scheduled to receive endoscopy and PPI therapy were enrolled in this multicenter prospective observational study. The patients' characteristics, including GERD and dyspeptic symptoms, anxiety, depression, and quality of life, were assessed using questionnaires before and 2 and 4 weeks after the start of PPI therapy. Factors affecting therapeutic response were examined by simple and multiple regression analyses using three patient-reported outcome measures as objective variables. Results Data from 182 patients were analyzed. In multiple regression analysis using the residual symptom rate as an objective variable, lower GERD symptom score (p < 0.05), absence of erosive esophagitis (p < 0.05), higher epigastric pain/burning symptom score (p < 0.05), and higher depression subscale score (p < 0.05) accompanied poorer therapeutic response. In analyses using the patient's impression of therapy, lower GERD symptom score (p < 0.05) and absence of erosive esophagitis (p < 0.05) accompanied poorer therapeutic response. In analyses using the relative GERD symptom intensity evaluated using a numeric rating scale, lower GERD symptom score (p < 0.05), higher epigastric pain/burning symptom score (p < 0.1), and lower body mass index (p < 0.05) accompanied poorer therapeutic response. Conclusions Patients who complained of milder GERD symptoms before treatment were likely to have poorer response to PPI therapy. Association of absence of erosive esophagitis, severer epigastric pain/burning symptoms, lower body mass index, and severer depression with poorer therapeutic response was also suggested.	[Matsuhashi, Nobuyuki] NTT Med Ctr Tokyo, Dept Gastroenterol, Shinagawa Ku, Tokyo 1418625, Japan; [Kudo, Mineo] Sapporo Hokuyu Hosp, Dept Gastroenterol, Shiroishi Ku, Sapporo, Hokkaido 0030006, Japan; [Yoshida, Norimasa] Japanese Red Cross Kyoto Daiichi Hosp, Dept Gastroenterol, Higashiyama Ku, Kyoto 6050981, Japan; [Murakami, Kazunari] Oita Univ Hosp, Dept Gastroenterol, Oita 8795593, Japan; [Kato, Mototsugu] Hokkaido Univ Hosp, Div Endoscopy, Kita Ku, Sapporo, Hokkaido 0608648, Japan; [Sanuki, Tsuyoshi] Kita Harima Med Ctr, Dept Gastroenterol, Ono, Hyogo 6751392, Japan; [Oshio, Atsushi] Waseda Univ, Fac Letters Arts & Sci, Shinjuku Ku, Tokyo 1628644, Japan; [Joh, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Joh, Takashi; Higuchi, Kazuhide; Haruma, Ken; Nakada, Koji] GERD Soc Study Comm, Kita Ku, Osaka 5300005, Japan; [Higuchi, Kazuhide] Osaka Med Coll, Dept Internal Med 2, Takatsuki, Osaka 5698686, Japan; [Haruma, Ken] Kawasaki Med Univ, Dept Internal Med, Div Gastroenterol, Kurashiki, Okayama 7010192, Japan; [Nakada, Koji] Jikei Univ, Sch Med, Dept Surg, Minato Ku, Tokyo 1058461, Japan	Nakada, K (reprint author), GERD Soc Study Comm, Kita Ku, 2-2-2 Nakanoshima, Osaka 5300005, Japan.	nakada@jikei.ac.jp			AstraZeneca (Osaka, Japan)	We are grateful to the GERD Society for support of publication of this work. Assistance in statistical analyses and writing was funded by AstraZeneca (Osaka, Japan).	Hongo M, 2006, J GASTROENTEROL, V41, P95, DOI 10.1007/s00535-006-1775-4; Modlin IM, 2009, DIGESTION, V80, P74, DOI 10.1159/000219365; Katz PO, 2013, AM J GASTROENTEROL, V108, P308, DOI 10.1038/ajg.2012.444; Furuta T, 2011, J GASTROENTEROL, V46, P1273, DOI 10.1007/s00535-011-0446-2; Passos MCF, 2009, AM J GASTROENTEROL, V104, P912, DOI 10.1038/ajg.2009.13; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Chiba N, 1997, GASTROENTEROLOGY, V112, P1798, DOI 10.1053/gast.1997.v112.pm9178669; KLAUSER AG, 1990, LANCET, V335, P205, DOI 10.1016/0140-6736(90)90287-F; Zerbib F, 2012, GUT, V61, P501, DOI 10.1136/gutjnl-2011-300798; Mearin F, 2012, EUR J GASTROEN HEPAT, V24, P665, DOI 10.1097/MEG.0b013e3283512139; Spiegel B, 2009, GASTROENTEROLOGY, V137, P1944, DOI 10.1053/j.gastro.2009.08.047; Oh JH, 2009, GUT LIVER, V3, P259, DOI 10.5009/gnl.2009.3.4.259; Niu XP, 2013, WORLD J GASTROENTERO, V19, P3124, DOI 10.3748/wjg.v19.i20.3124; Ang D, 2011, ALIMENT PHARM THER, V33, P634, DOI 10.1111/j.1365-2036.2010.04566.x; Bytzer P, 2003, AM J GASTROENTEROL, V98, pS31, DOI 10.1016/S0002-9270(03)00013-3; Heading RC, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-52; Miyamoto M, 2010, INTERNAL MED, V49, P1469, DOI 10.2169/internalmedicine.49.3615; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Whitehead WE, 2006, AM J GASTROENTEROL, V101, P1057, DOI 10.1111/j.1572-0241.2006.00535.x; Dean BB, 2004, CLIN GASTROENTEROL H, V2, P656, DOI 10.1053/S1542-3565(04)00288-5; Wu JCY, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01627.x; Fukuhara S, 2004, MANUAL SF 8 JAPANESE; Hershcovici T, 2010, NEUROGASTROENT MOTIL, V16, P8; Hoshihara Y, 1996, RINSHO SHOKAKI NAIKA, V11, P1563; Nakada K, 2013, GASTROENTEROLOGY, V144, pS683; Nakada K, 2013, GASTROENTEROLOGY, V144, pS856; The Japanese Society of Gastroenterology, 2009, GERD MAN GUID; US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2012, GUID IND IRR BOW SYN; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	29	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	DEC	2015	50	12					1173	1183		10.1007/s00535-015-1073-0		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CY1GZ	WOS:000366156000003		
J	Sekiguchi, M; Sekine, S; Sakamoto, T; Otake, Y; Nakajima, T; Matsuda, T; Taniguchi, H; Kushima, R; Ohe, Y; Saito, Y				Sekiguchi, Masau; Sekine, Shigeki; Sakamoto, Taku; Otake, Yosuke; Nakajima, Takeshi; Matsuda, Takahisa; Taniguchi, Hirokazu; Kushima, Ryoji; Ohe, Yuichiro; Saito, Yutaka			Excellent prognosis following endoscopic resection of patients with rectal neuroendocrine tumors despite the frequent presence of lymphovascular invasion	JOURNAL OF GASTROENTEROLOGY			English	Article						Rectal neuroendocrine tumor; Endoscopic resection; Lymphovascular invasion	GASTROINTESTINAL CARCINOID-TUMORS; SUBMUCOSAL DISSECTION; MUCOSAL RESECTION; LIGATION DEVICE; CLINICOPATHOLOGICAL CHARACTERISTICS; CONSENSUS GUIDELINES; METASTASIS; MANAGEMENT; D2-40; EXPRESSION	Background Endoscopic resection (ER) has been increasingly used for the treatment of rectal neuroendocrine tumors (NETs); however, only limited data are available on its long-term outcomes. This study analyzed the long-term outcomes of rectal NETs treated by ER and characterized potential risk factors for metastasis in these cases, with emphasis on lymphovascular invasion. Methods We retrospectively analyzed the clinicopathological features and outcomes of 86 patients with 90 rectal NETs who had been treated by ER. Lymphovascular invasion was reevaluated using elastic-staining and double-staining immunohistochemistry. Results En bloc resection with tumor-free margins was achieved in 87 lesions (96.7 %). The median tumor size was 5 mm (range 2-13), and all the lesions were confined to the submucosal layer. The Ki-67 index was less than 3 % in all the lesions, which were therefore classified as NET G1. Elastic-staining and double-staining immunohistochemistry revealed the presence of lymphatic and venous invasion in 23 (25.6 %) and 35 lesions (36.7 %), respectively. Collectively, lymphatic and/or vascular invasion was identified in 42 lesions (46.7 %). All cases were followed up without additional surgery, and no metastasis or recurrence was detected during the median follow-up period of 67.5 months. Conclusions This study showed an excellent long-term prognosis following ER of patients with rectal NETs, confirming that ER is a valid treatment option for small rectal NETs. The present study also revealed highly prevalent lymphovascular invasion even in minute rectal NETs; this observation raises a question regarding its significance as a risk factor for metastasis.	[Sekiguchi, Masau; Sakamoto, Taku; Otake, Yosuke; Nakajima, Takeshi; Matsuda, Takahisa; Saito, Yutaka] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan; [Sekiguchi, Masau; Ohe, Yuichiro] Juntendo Univ, Grad Sch Med, Adv Clin Res Canc, Tokyo, Japan; [Sekine, Shigeki; Taniguchi, Hirokazu; Kushima, Ryoji] Natl Canc Ctr, Pathol & Clin Lab Div, Chuo Ku, Tokyo 1040045, Japan	Sekine, S (reprint author), Natl Canc Ctr, Pathol & Clin Lab Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	masekigu@ncc.go.jp; ssekine@ncc.go.jp			National Cancer Center Research and Development Fund [23-A-11]	The authors thank Ms. Sachiko Miura for the skillful technical assistance. This work was supported by the National Cancer Center Research and Development Fund (23-A-11).	Suzuki S, 2012, SURG ENDOSC, V26, P759, DOI 10.1007/s00464-011-1948-y; INOUE T, 1992, DIS COLON RECTUM, V35, P34, DOI 10.1007/BF02053336; [Anonymous], 2002, LAB INVEST, V82, P1255; Lee DS, 2010, ENDOSCOPY, V42, P647, DOI 10.1055/s-0030-1255591; Modlin IM, 2003, CANCER, V97, P934, DOI 10.1002/cncr.11105; Sekine S, 2011, CARCINOGENESIS, V32, P622, DOI 10.1093/carcin/bgr002; Anthony LB, 2010, PANCREAS, V39, P767, DOI 10.1097/MPA.0b013e3181ec1261; Kim KM, 2013, CLIN RES HEPATOL GAS, V37, P275, DOI 10.1016/j.clinre.2012.07.007; Saito Y, 2014, DIGEST ENDOSC, V26, P52, DOI 10.1111/den.12196; WIEDENMANN B, 1991, ACTA ONCOL, V30, P435; Ono A, 2003, GASTROINTEST ENDOSC, V57, P583, DOI 10.1067/mge.2003.142; Fahy BN, 2007, ANN SURG ONCOL, V14, P1735, DOI 10.1245/s10434-006-9311-6; Park CH, 2011, ENDOSCOPY, V43, P790, DOI 10.1055/s-0030-1256414; Shigeta K, 2014, J GASTROINTEST SURG, V18, P768, DOI 10.1007/s11605-014-2468-6; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Kim HH, 2012, DIGEST ENDOSC, V24, P159, DOI 10.1111/j.1443-1661.2011.01190.x; Hotta K, 2006, PATHOL INT, V56, P591, DOI 10.1111/j.1440-1827.2006.02013.x; Soga J, 2005, CANCER-AM CANCER SOC, V103, P1587, DOI 10.1002/cncr.20939; Caplin M, 2012, NEUROENDOCRINOLOGY, V95, P88, DOI 10.1159/000335594; Fujimoto Y, 2010, LANGENBECK ARCH SURG, V395, P139, DOI 10.1007/s00423-008-0438-8; Vass DG, 2004, J CLIN PATHOL, V57, P769, DOI 10.1136/jcp.2003.015826; Konishi T, 2007, GUT, V56, P863, DOI 10.1136/gut.2006.109157; Kasuga A, 2012, J GASTROEN HEPATOL, V27, P1801, DOI 10.1111/j.1440-1746.2012.07218.x; Scherubl H, 2009, ENDOSCOPY, V41, P162, DOI 10.1055/s-0028-1119456; Yamagishi D, 2012, ONCOL LETT, V4, P910, DOI 10.3892/ol.2012.868; Kwaan MR, 2008, ARCH SURG-CHICAGO, V143, P471, DOI 10.1001/archsurg.143.5.471; Kim GU, 2013, ENDOSCOPY, V45, P1018, DOI 10.1055/s-0033-1344860; Shields CJ, 2010, ANN SURG, V252, P750, DOI 10.1097/SLA.0b013e3181fb8df6; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Kawahara M, 2002, EUR J SURG ONCOL, V28, P140, DOI 10.1053/ejso.2001.1229; Shim KN, 2004, ENDOSCOPY, V36, P313, DOI 10.1055/s-2004-814202; de Mestier L, 2013, ENDOSCOPY, V45, P1039, DOI 10.1055/s-0033-1344794; Yoon SN, 2010, INT J COLORECTAL DIS, V25, P1087, DOI 10.1007/s00384-010-0949-y; Fogt F, 2004, ONCOL REP, V11, P47; Fukunaga M, 2005, HISTOPATHOLOGY, V46, P396, DOI 10.1111/j.1365-2559.2005.02098.x; TOMODA H, 1990, JPN J SURG, V20, P468, DOI 10.1007/BF02470834; Kim BN, 2008, SURG ENDOSC, V22, P1992, DOI 10.1007/s00464-008-0006-x; Mashimo Y, 2008, J GASTROEN HEPATOL, V23, P218, DOI 10.1111/j.1440-1746.2008.05313.x; Edge SB, 2010, AJCC CANC STAGING MA; Ito T, 2014, J GASTROENTEROL; Klimstra DS, 2010, WHO CLASSIFICATION T, P174; Shinohara T, 2008, Endoscopy, V40 Suppl 2, pE40, DOI 10.1055/s-2007-966849	42	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	DEC	2015	50	12					1184	1189		10.1007/s00535-015-1079-7		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CY1GZ	WOS:000366156000004		
J	Takada, K; Toyoda, H; Tada, T; Ito, T; Hasegawa, R; Gotoh, T; Ichikawa, H; Sone, Y; Kumada, T				Takada, Ken; Toyoda, Hidenori; Tada, Toshifumi; Ito, Takanori; Hasegawa, Ryohei; Gotoh, Tatsuya; Ichikawa, Hironori; Sone, Yasuhiro; Kumada, Takashi			Accurate and rapid identification of feeding arteries with multidetector-row angiography-assisted computed tomography for transarterial chemoembolization for hepatocellular carcinoma	JOURNAL OF GASTROENTEROLOGY			English	Article						Hepatocellular carcinoma; Transarterial chemoembolization; Angiography; Multidetector-row computed tomography; Three-dimensional vascular image	C-ARM CT; UNIFIED CT; HELICAL CT; SYSTEM; ARTERIOGRAPHY; EMBOLIZATION; PORTOGRAPHY; CANCER; IMPACT	Background Transarterial chemoembolization (TACE) is an important treatment modality for hepatocellular carcinoma (HCC). Accurate identification of feeding arteries and catheterization are necessary for achieving treatment efficacy, especially with selective TACE. However, this often requires multiple imaging studies. We evaluated the utility of a newly developed apparatus that combines multidetector-row computed tomography (MDCT) and angiography (angio-MDCT) to facilitate TACE for treatment of HCC. Methods A total of 73 patients who underwent selective TACE with angio-MDCT were compared with 57 patients who had undergone selective TACE with single-row computed tomography assisted by angiography (angio-CT) in terms of the number of imaging studies needed to complete TACE. Results The mean number of digital subtraction arteriography (DSA) and CT studies required for characterization of feeding arteries before embolization was 3.53 (range 1-8) and 5.16 (range 2-11), respectively, with single-row angio-CT, and 1.67 (range 1-5) and 2.90 (range 1-5), respectively, with angio-MDCT. Fewer studies were needed in patients who underwent TACE with angio-MDCT (p < 0.0001 for both DSA and CT). Whereas single-row angio-CT failed to identify extrahepatic feeders in three patients (37.5 %), all extrahepatic feeders could be identified with angio-MDCT. Conclusions Angio-MDCT facilitates rapid and accurate identification of feeding arteries in patients undergoing TACE through the three-dimensional image analyses by the reconstruction with the workstation.	[Takada, Ken; Gotoh, Tatsuya; Ichikawa, Hironori] Ogaki Municipal Hosp, Dept Med Technol, Ogaki, Gifu 5038502, Japan; [Toyoda, Hidenori; Tada, Toshifumi; Ito, Takanori; Hasegawa, Ryohei; Kumada, Takashi] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Gifu 5038502, Japan; [Sone, Yasuhiro] Ogaki Municipal Hosp, Dept Radiol, Ogaki, Gifu 5038502, Japan	Toyoda, H (reprint author), Ogaki Municipal Hosp, Dept Gastroenterol, 4-86 Minaminokawa, Ogaki, Gifu 5038502, Japan.	hmtoyoda@spice.ocn.ne.jp					Minamiguchi H, 2013, JPN J RADIOL, V31, P428, DOI 10.1007/s11604-013-0205-9; Eide KR, 2009, EUR J VASC ENDOVASC, V37, P23, DOI 10.1016/j.ejvs.2008.09.017; Kakeda S, 2007, J VASC INTERV RADIOL, V18, P1508, DOI 10.1016/j.jvir.2007.08.003; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; MATSUI O, 1983, RADIOLOGY, V146, P721; Fishman EK, 2006, RADIOGRAPHICS, V26, P905, DOI 10.1148/rg.263055186; Takayasu K, 2001, AM J ROENTGENOL, V176, P681; Iwazawa J, 2009, AM J ROENTGENOL, V192, P1057, DOI 10.2214/AJR.08.1285; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Toyoda H, 2009, AM J ROENTGENOL, V192, P766, DOI 10.2214/AJR.08.1368; Kothary N, 2011, J VASC INTERV RADIOL, V22, P1535, DOI 10.1016/j.jvir.2011.07.008; Lee KH, 2002, RADIOGRAPHICS, V22, P1077; Miyayama S, 2006, CARDIOVASC INTER RAD, V29, P39, DOI 10.1007/s00270-004-0287-y; Kim HC, 2005, RADIOGRAPHICS, V25, pS25, DOI 10.1148/rg.25si055508; Inaba Y, 2000, AM J ROENTGENOL, V174, P955; FREENY PC, 1983, RADIOLOGY, V148, P193; Gwon Dong Il, 2007, Radiographics, V27, P687, DOI 10.1148/rg.273065036; Hirota S, 2006, CARDIOVASC INTER RAD, V29, P39; Kokudo N., 2009, J GASTROENTEROL, V44, pS119	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	DEC	2015	50	12					1190	1196		10.1007/s00535-015-1065-0		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CY1GZ	WOS:000366156000005		
J	Beppu, T; Nitta, H; Hayashi, H; Imai, K; Okabe, H; Nakagawa, S; Hashimoto, D; Chikamoto, A; Ishiko, T; Yoshida, M; Yamashita, Y; Baba, H				Beppu, Toru; Nitta, Hidetoshi; Hayashi, Hiromitsu; Imai, Katsunori; Okabe, Hirohisa; Nakagawa, Shigeki; Hashimoto, Daisuke; Chikamoto, Akira; Ishiko, Takatoshi; Yoshida, Morikatsu; Yamashita, Yasuyuki; Baba, Hideo			Effect of branched-chain amino acid supplementation on functional liver regeneration in patients undergoing portal vein embolization and sequential hepatectomy: a randomized controlled trial	JOURNAL OF GASTROENTEROLOGY			English	Article						Branched-chain amino acids; Portal vein embolization; Major hepatectomy; Functional liver regeneration; Liver uptake value	LATE EVENING SNACK; HEPATOCELLULAR-CARCINOMA; ORAL SUPPLEMENTATION; PREOPERATIVE EVALUATION; COMPUTED-TOMOGRAPHY; TC-99M-GSA SCINTIGRAPHY; HEPATIC RESECTION; MAJOR HEPATECTOMY; CLINICAL-TRIAL; REMNANT LIVER	Portal vein embolization (PVE) can decrease the resection ratio for major hepatectomy. Tc-99m-galactosyl human serum albumin (GSA) scintigraphy is useful for evaluating quantitative functional liver volume. Branched chain amino acids (BCAAs) modulate liver function and regeneration. We analyzed the effects of BCAAs, in terms of liver function and regeneration after PVE, in combination with major hepatectomy. This randomized controlled trial was conducted for patients receiving PVE through to complete hepatectomy from September, 2011 to June, 2013. BCAA granules were added two times a day to a conventional diet in the BCAA administration group (BCAA group). The primary end point was functional liver regeneration of the future remnant liver after PVE followed by hepatic resection. Functional liver regeneration was assessed by the liver uptake value obtained from Tc-99m-GSA scintigraphy single-photon-emission computed tomography/computed tomography fusion images. The secondary end points were volumetric liver regeneration and changes in liver function and laboratory data. A BCAA group (n = 13) and a non-BCAA group (control group; n = 15) were included. The primary end point was partially met: the liver uptake value significantly increased in the BCAA group compared with the control group 6 months after hepatic resection (266.7 % vs 77.6 %, P = 0.04) and marginally increased after PVE (43.8 % vs 17.4 %, P = 0.079). Following PVE, the increment of the uptake ratio of the liver to the liver plus heart at 15 min was significantly less in the BCAA group than in the control group (0.0 and 0.01, P = 0.023). BCAA supplementation improved functional liver regeneration and function in patients undergoing PVE followed by major hepatic resection.	[Beppu, Toru; Nitta, Hidetoshi; Hayashi, Hiromitsu; Imai, Katsunori; Okabe, Hirohisa; Nakagawa, Shigeki; Hashimoto, Daisuke; Chikamoto, Akira; Ishiko, Takatoshi; Baba, Hideo] Kumamoto Univ, Dept Surg Gastroenterol, Grad Sch Life Sci, Chuo Ku, Kumamoto 8608556, Japan; [Beppu, Toru] Kumamoto Univ Hosp, Dept Multidisciplinary Treatment Gastroenterol Ca, Kumamoto 8608556, Japan; [Yoshida, Morikatsu; Yamashita, Yasuyuki] Kumamoto Univ, Dept Diagnost Radiol, Grad Sch Life Sci, Chuo Ku, Kumamoto 8608556, Japan	Baba, H (reprint author), Kumamoto Univ, Dept Surg Gastroenterol, Grad Sch Life Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hdobaba@kumamoto-u.ac.jp					Arakawa M, 2011, ENDOCR J, V58, P161, DOI 10.1507/endocrj.K10E-221; Kwon AH, 2001, AM J GASTROENTEROL, V96, P541; Ninomiya S, 2011, CANCER PREV RES, V4, P2092, DOI 10.1158/1940-6207.CAPR-11-0340; Cho JY, 2006, SURGERY, V139, P508, DOI 10.1016/j.surg.2005.09.007; Okabe H, 2011, J SURG ONCOL, V104, P641, DOI 10.1002/jso.21928; van den Esschert JW, 2009, J GASTROINTEST SURG, V13, P1464, DOI 10.1007/s11605-009-0929-0; CHEN MF, 1991, ANN SURG, V213, P227, DOI 10.1097/00000658-199103000-00008; Okabayashi T, 2011, AMINO ACIDS, V40, P1213, DOI 10.1007/s00726-010-0748-3; Mizuguchi T, 2011, J GASTROINTEST SURG, V15, P1433, DOI 10.1007/s11605-011-1566-y; Okabayashi T, 2010, AMINO ACIDS, V38, P901, DOI 10.1007/s00726-009-0297-9; Olthoff KM, 2003, LIVER TRANSPLANT, V9, pS35, DOI 10.1053/jlts.2003.50229; Nagino M, 2006, ANN SURG, V243, P364, DOI 10.1097/01.sla.0000201482.11876.14; Beppu T, 2011, J GASTROENTEROL, V46, P938, DOI 10.1007/s00535-011-0406-x; Aoyama K, 2007, HEPATOL RES, V37, P608, DOI 10.1111/j.1872-034X.2007.00036; Meng WCS, 1999, AUST NZ J SURG, V69, P811, DOI 10.1046/j.1440-1622.1999.01701.x; Beppu T, 2012, HEPATO-GASTROENTEROL, V59, P542, DOI 10.5754/hge09737; Mitsumori A, 1998, EUR J NUCL MED, V25, P1377, DOI 10.1007/s002590050311; Tsien CD, 2012, J GASTROEN HEPATOL, V27, P430, DOI 10.1111/j.1440-1746.2011.06951.x; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Kim SJ, 2011, HEPATO-GASTROENTEROL, V58, P1280, DOI 10.5754/hge10389; Okabe H, 2014, INT J CLIN ONCOL, V19, P614, DOI 10.1007/s10147-013-0591-0; Azoulay D, 2000, ANN SURG, V232, P665, DOI 10.1097/00000658-200011000-00008; Yoshiji H, 2009, J GASTROENTEROL, V44, P483, DOI 10.1007/s00535-009-0031-0; Yoshida M, 2012, JPN J RADIOL, V30, P255, DOI 10.1007/s11604-011-0041-8; Farges O, 2003, ANN SURG, V237, P208, DOI 10.1097/00000658-200302000-00010; de Graaf W, 2008, J NUCL MED, V49, P122, DOI 10.2967/jnumed.107.044255; Muto Y, 2006, HEPATOL RES, V35, P204, DOI 10.1016/j.hepres.2006.04.007; Yoshida M, 2012, JPN J RADIOL, V30, P435, DOI 10.1007/s11604-012-0072-9; Fujioka H, 1999, J CLIN GASTROENTEROL, V28, P329, DOI 10.1097/00004836-199906000-00009; HOLECEK M, 1985, PHYSIOL BOHEMOSLOV, V34, P359; Tajiri K, 2013, WORLD J GASTROENTERO, V19, P7620, DOI 10.3748/wjg.v19.i43.7620; Yoshida R, 2012, J HEPATO-BIL-PAN SCI, V19, P438, DOI 10.1007/s00534-011-0459-5; Okabe H, 2013, J GASTROINTEST SURG, V17, P1447, DOI 10.1007/s11605-013-2237-y; Tomiya T, 2004, BIOCHEM BIOPH RES CO, V313, P411, DOI 10.1016/j.bbrc.2003.07.017; de Graaf W, 2011, BRIT J SURG, V98, P825, DOI 10.1002/bjs.7456; Kawamura H, 2008, J GASTROEN HEPATOL, V23, P1235, DOI 10.1111/j.1440-1746.2008.05389.x; Ichikawa K, 2013, SURG TODAY, V43, P720, DOI 10.1007/s00595-012-0288-4; Beppu T, 2009, J GASTROENTEROL, V45, P211; Hayashi H, 2015, SURGERY, V157, P20, DOI 10.1016/j.surg.2014.06.013; Katsuragawa H, 2007, JPN J MED PHARM SCI, V57, P121; Kishi Y, 2009, ANN SURG, V25, P540; Yoshida M, 2014, ANN NUCL MED, V28, P780, DOI 10.1007/s12149-014-0872-3	42	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	DEC	2015	50	12					1197	1205		10.1007/s00535-015-1067-y		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CY1GZ	WOS:000366156000006		
J	Hiraoka, A; Aibiki, T; Okudaira, T; Toshimori, A; Kawamura, T; Nakahara, H; Suga, Y; Azemoto, N; Miyata, H; Miyamoto, Y; Ninomiya, T; Hirooka, M; Abe, M; Matsuura, B; Hiasa, Y; Michitaka, K				Hiraoka, Atsushi; Aibiki, Toshihiko; Okudaira, Tomonari; Toshimori, Akiko; Kawamura, Tomoe; Nakahara, Hiromasa; Suga, Yoshifumi; Azemoto, Nobuaki; Miyata, Hideki; Miyamoto, Yasunao; Ninomiya, Tomoyuki; Hirooka, Masashi; Abe, Masanori; Matsuura, Bunzo; Hiasa, Yoichi; Michitaka, Kojiro			Muscle atrophy as pre-sarcopenia in Japanese patients with chronic liver disease: computed tomography is useful for evaluation	JOURNAL OF GASTROENTEROLOGY			English	Article						Chronic liver disease; Liver cirrhosis; Chronic hepatitis; Muscle atrophy; Sarcopenia	MASS; TRANSPLANTATION; ASSOCIATION; CIRRHOSIS; MEXICO; ADULTS; TRIAL	The definition of muscle atrophy (pre-sarcopenia) and its diagnostic criteria have not been well reported. To elucidate the frequency of pre-sarcopenia in chronic liver disease (CLD), we examined clinical features of Japanese CLD patients using abdominal computed tomography (CT) findings. We enrolled 988 CLD (736 with na < ve hepatocellular carcinoma) and 372 normal control subjects (NCs). The psoas muscle area index [PI, psoas muscle area at the mid-L3 level in CT (cm(2))/height (m)(2)] was calculated using personal computer software. The cut-off level for pre-sarcopenia was defined as less than two standard deviations (SDs) below the mean PI value in the NCs under 55 years old [males, 45.6 +/- A 5.7 years (n = 61), 4.24 cm(2)/m(2); females, 47.0 +/- A 6.1 years (n = 49), 2.50 cm(2)/m(2)]. Elderly was defined as 65 years or older. Clinical features were retrospectively evaluated. In the CLD group (HCV:HBV:HBV and HCV:alcohol:non-HBV and HCV = 652:88:7:82:159), pre-sarcopenia was observed in 15.3 % of patients with chronic hepatitis (CH), 24.4 % of those with liver cirrhosis (LC) Child-Pugh A, 37.7 % of those with LC Child-Pugh B, and 37.1 % of those with LC Child-Pugh C. A comparison between NC and CH by age (< 55, 55-64, 65-74, a parts per thousand yen75 years) showed that the frequency of pre-sarcopenia was higher in CH regardless of age (1.8 vs. 3.6 %, 3.2 vs. 15.9 %, 4.9 vs. 13.4 %, 14.3 vs. 20.2 %, respectively). PI values showed correlations with BMI (r = 0.361), age (r = -0.167), albumin (r = 0.115), and branched-chain amino acids (r = 0.199) (P < 0.01). Retrospective evaluate for pre-sarcopenia was easy to perform with CT findings. Nutrition and exercise instruction should be considered for early stage and even non-elderly CLD as well as LC.	[Hiraoka, Atsushi; Aibiki, Toshihiko; Okudaira, Tomonari; Toshimori, Akiko; Kawamura, Tomoe; Nakahara, Hiromasa; Suga, Yoshifumi; Azemoto, Nobuaki; Miyata, Hideki; Miyamoto, Yasunao; Ninomiya, Tomoyuki; Michitaka, Kojiro] Ehime Prefectural Cent Hosp, Gastroenterol Ctr, Matsuyama, Ehime 7900024, Japan; [Hirooka, Masashi; Abe, Masanori; Matsuura, Bunzo; Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan	Hiraoka, A (reprint author), Ehime Prefectural Cent Hosp, Gastroenterol Ctr, Kasuga Cho 83, Matsuyama, Ehime 7900024, Japan.	hirage@m.ehime-u.ac.jp					Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Kim HK, 2012, J AM GERIATR SOC, V60, P16, DOI 10.1111/j.1532-5415.2011.03776.x; Krell RW, 2013, LIVER TRANSPLANT, V19, P1396, DOI 10.1002/lt.23752; Hayashi F, 2013, HEPATOL RES, V43, P1264, DOI 10.1111/hepr.12085; Sanada K, 2010, EUR J APPL PHYSIOL, V110, P57, DOI 10.1007/s00421-010-1473-z; Montano-Loza AJ, 2012, CLIN GASTROENTEROL H, V10, P166, DOI 10.1016/j.cgh.2011.08.028; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Bjorkman MP, 2011, J NUTR HEALTH AGING, V15, P462, DOI 10.1007/s12603-010-0276-6; [Anonymous], 2014, JAMDA, V15, P95; Masuda T, 2014, LIVER TRANSPLANT, V20, P401, DOI 10.1002/lt.23811; Michitaka K, 2010, HEPATOL RES, V40, P393, DOI 10.1111/j.1872-034X.2009.00614.x; Harimoto N, 2013, BRIT J SURG, V100, P1523, DOI 10.1002/bjs.9258; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Janssen I, 2000, J APPL PHYSIOL, V89, P465; Tanimoto Y, 2012, ARCH GERONTOL GERIAT, V54, pE230, DOI 10.1016/j.archger.2011.06.015; Durand F, 2014, J HEPATOL, V60, P1151, DOI 10.1016/j.jhep.2014.02.026; Fujita S, 2006, J NUTR, V136, P277; ROSENBERG IH, 1989, AM J CLIN NUTR, V50, P1231; Yoshizumi T, 2014, HEPATOL RES, V44, P313, DOI 10.1111/hepr.12119	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	DEC	2015	50	12					1206	1213		10.1007/s00535-015-1068-x		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CY1GZ	WOS:000366156000007		
J	Montagnoli, A; Nagayasu, J				Montagnoli, Alberto; Nagayasu, Jun			UK house price convergence clubs and spillovers	JOURNAL OF HOUSING ECONOMICS			English	Article						Regional house prices; Heterogeneity; Convergence; Spillovers	BEHAVIOR; MARKETS; TESTS	Using a number of advanced statistical methods, this paper analyses the convergence and spillover effects of house prices across UK regions. In contrast to the single steady state often assumed in modern macroeconomic analyses, we find that house prices across UK regions can be grouped into four clusters, confirming the heterogeneity and complexity of the UK housing market. Moreover we document the dynamics of house price spillovers across regions. (C) 2015 Elsevier Inc. All rights reserved.	[Montagnoli, Alberto] Univ Sheffield, Dept Econ, Sheffield S10 2TN, S Yorkshire, England; [Nagayasu, Jun] Tohoku Univ, Grad Sch Econ & Management, Sendai, Miyagi 980, Japan	Nagayasu, J (reprint author), Tohoku Univ, Grad Sch Econ & Management, Sendai, Miyagi 980, Japan.	alberto.montagnoli@sheffield.ac.uk; jun.nagayasu.d8@tohoku.ac.jp					Abelson P, 2005, ECON REC, V81, pS96, DOI 10.1111/j.1475-4932.2005.00243.x; Chen PF, 2011, J HOUS ECON, V20, P315, DOI 10.1016/j.jhe.2011.09.002; Phillips PCB, 2007, J MACROECON, V29, P455, DOI 10.1016/j.jmacro.2007.03.002; Cook S, 2006, URBAN STUD, V43, P2067, DOI 10.1080/00420980600897735; Cook S, 2003, APPL ECON LETT, V10, P849, DOI 10.1080/1350485032000143119; Phillips PCB, 2007, ECONOMETRICA, V75, P1771, DOI 10.1111/j.1468-0262.2007.00811.x; [Anonymous], 1997, J POLIT ECON; ALEXANDER C, 1994, URBAN STUD, V31, P1667, DOI 10.1080/00420989420081571; Levin A, 2002, J ECONOMETRICS, V108, P1, DOI 10.1016/S0304-4076(01)00098-7; Gupta R, 2012, J REAL ESTATE FINANC, V44, P339, DOI 10.1007/s11146-010-9234-7; Iacoviello M, 2010, HOUSING MARKETS IN EUROPE: A MACROECONOMIC PERSPECTIVE, P3, DOI 10.1007/978-3-642-15340-2_1; [Anonymous], 2010, INT REV APPL EC, DOI DOI 10.1080/02692171.2010.483785; Im KS, 2003, J ECONOMETRICS, V115, P53, DOI 10.1016/S0304-4076(03)00092-7; Phillips PCB, 2009, J APPL ECONOM, V24, P1153, DOI 10.1002/jae.1080; Muellbauer J, 2008, OXFORD REV ECON POL, V24, P1, DOI 10.1093/oxrep/grn011; Black A, 2006, J BUS FINAN ACCOUNT, V33, P1535, DOI 10.1111/j.1468-5957.2006.00638.x; Meen G, 1999, HOUSING STUD, V14, P733, DOI 10.1080/02673039982524; Cook S, 2005, PHYSICA A, V345, P611, DOI 10.1016/j.physa.2004.07.031; Iacoviello M, 2010, AM ECON J-MACROECON, V2, P125, DOI 10.1257/mac.2.2.125; Diebold FX, 2009, ECON J, V119, P158, DOI 10.1111/j.1468-0297.2008.02208.x; Cameron G., 2006, CEPR DISCUSSION PAPE, V5619; Girouard N., 2006, OECD EC DEP WORKING, V475; Gregoriou A., 2014, URBAN STUD, V51, P339; Holmes M.J., 2008, URBAN STUD, V40, P1531; Iacoviello M., 2011, INT FINANCE DISCUSSI, V1027; Koop G, 1996, J ECONOMETRICS, V74, P119, DOI 10.1016/0304-4076(95)01753-4; MACDONALD R, 1993, SCOT J POLIT ECON, V40, P43, DOI 10.1111/j.1467-9485.1993.tb00636.x; Stevenson S., 2008, REAL ESTATE ECON, V36, P129	28	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1051-1377	1096-0791		J HOUS ECON	J. Hous. Econ.	DEC	2015	30						50	58		10.1016/j.jhe.2015.10.003		9	Economics; Urban Studies	Business & Economics; Urban Studies	CY1CX	WOS:000366145400004		
J	Nomura, T; Higuchi, Y; Kubota, H; Miyawaki, D; Urata, R; Sugimoto, T; Kato, T; Keira, N; Tatsumi, T				Nomura, Tetsuya; Higuchi, Yusuke; Kubota, Hiroshi; Miyawaki, Daisuke; Urata, Ryota; Sugimoto, Takeshi; Kato, Taku; Keira, Natsuya; Tatsumi, Tetsuya			Practical Usefulness of Dual Lumen Catheter-Facilitated Reverse Wire Technique for Markedly Angulated Bifurcated Lesions	JOURNAL OF INTERVENTIONAL CARDIOLOGY			English	Article							IN-VITRO; SIDE BRANCHES; INSIGHTS	Objectives: This study aimed to investigate the practical usefulness of dual lumen catheter-facilitated reverse wire technique. Background: We sometimes encounter difficulty in introducing a guidewire to the highly angulated side branch. In those cases, the reverse wire technique is considered as a last resort to overcome the situation. Methods: Between January 2013 and June 2015, we performed the reverse wire technique for guidewire crossing into an extremely angulated side branch in consecutive seven cases with true bifurcated lesions. We retrospectively evaluated patients' backgrounds, lesion characteristics, and details of the percutaneous coronary intervention (PCI) procedures. Results: Three interventional cardiologists with various levels of experience in coronary intervention performed this technique. A polymer-jacket hydrophilic-coated guidewire was used for the reverse wire system excluding in one case, and we adopted a sharp curve for the tip shape in all cases. After crossing the reverse wire into a highly angulated side branch, we usually deliver a flexible micro catheter over the guidewire for the purpose of guidewire exchange. We deployed a stent in the side branch in three cases. We successfully performed all PCI procedures without any complications and no major adverse cardiac event was observed during hospitalization. Conclusions: We could safely and effectively perform the reverse wire technique for guidewire crossing into a markedly angulated side branch. We recommend a polymer-jacket hydrophilic-coated guidewire with a sharp curve in the tip shape for this technique. All interventional cardiologists should acquire knowledge and skills regarding this guidewire manipulation technique.	[Nomura, Tetsuya; Higuchi, Yusuke; Kubota, Hiroshi; Miyawaki, Daisuke; Urata, Ryota; Sugimoto, Takeshi; Kato, Taku; Keira, Natsuya; Tatsumi, Tetsuya] Nantan Gen Hosp, Dept Cardiovasc Med, Nantan City, Kyoto 6290197, Japan	Nomura, T (reprint author), Nantan Gen Hosp, Dept Cardiovasc Med, 25 Yagi Ueno,Yagi Cho, Nantan City, Kyoto 6290197, Japan.	t2-ya@nike.eonet.ne.jp					Foin N, 2013, CIRC J, V77, P73, DOI 10.1253/circj.CJ-12-0272; Kawasaki T, 2008, CATHETER CARDIO INTE, V71, P73, DOI 10.1002/ccd.21297; Tamura T, 2011, EUROINTERVENTION, V7, P588, DOI 10.4244/EIJV7I5A95; Ojeda S, 2010, REV ESP CARDIOL, V63, P1487, DOI 10.1016/S0300-8932(10)70279-7; Burzotta F, 2010, EUROINTERVENTION, V6, pJ72, DOI 10.4244/EIJV6SUPJA12; FISCHMAN DL, 1993, J AM COLL CARDIOL, V22, P1641; Mortier P, 2010, EUROINTERVENTION, V6, pJ53, DOI 10.4244/EIJV6SUPJA9; Jensen Jan S, 2008, EuroIntervention, V4, P229, DOI 10.4244/EIJV4I2A41; Watanabe S, 2013, EUROINTERVENTION, V9, P870, DOI 10.4244/EIJV9I7A141	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0896-4327	1540-8183		J INTERV CARDIOL	J. Interv. Cardiol.	DEC	2015	28	6					544	550		10.1111/joic.12253		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CY4SI	WOS:000366398100005		
J	Kobayashi, N; Ito, Y; Nakano, M; Araki, M; Hirano, K; Yamawaki, M; Takimura, H; Sakamoto, Y; Tsukahara, R; Muramatsu, T				Kobayashi, Norihiro; Ito, Yoshiaki; Nakano, Masatsugu; Araki, Motoharu; Hirano, Keisuke; Yamawaki, Masahiro; Takimura, Hideyuki; Sakamoto, Yasunari; Tsukahara, Reiko; Muramatsu, Toshiya			Incidence and Characteristics of Late Catch-Up Phenomenon Between Sirolimus-Eluting Stent and Everolimus-Eluting Stent: A Propensity Matched Study	JOURNAL OF INTERVENTIONAL CARDIOLOGY			English	Article							INTRAVASCULAR ULTRASOUND ANALYSIS; CLINICAL CHARACTERISTICS; CORONARY-ARTERY; FOLLOW-UP; IMPLANTATION; FRACTURE; IMPACT; RESTENOSIS; THROMBOSIS; CLASSIFICATION	ObjectivesWe evaluated and compared the incidence and characteristics of late catch-up phenomenon (LCU) between everolimus-eluting stent (EES) and sirolimus-eluting stent (SES) implantations. BackgroundLate catch-up phenomenon after everolimus-eluting stent (EES) implantation has not yet been evaluated sufficiently. MethodsBetween April 2007 and May 2011, 1,234 patients with coronary artery disease were treated with SES and 502 patients with EES. Following propensity score matching, we evaluated 495 SES-treated patients and 495 ESS-treated patients. The incidences of LCU (i.e., late target lesion revascularization [TLR] [1-3 years]) were compared. ResultsThe cumulative incidence of TLR at 3 years was 11.9% in the SES group and 6.1% in the EES group (P=0.001). The incidence of late TLR was 7.5% in the SES group and 3.4% in the EES group (P=0.004). Even though not statistically significant, intravascular ultrasound showed a higher tendency of stent fracture (SF) in late restenosis lesions in the SES group than in the EES group (37.0% vs 7.7%; P=0.052). Moreover, the SF rate tended to increase in late restenosis compared with early restenosis (within 1 year) in the SES group compared with the EES group (SES: 37.0% vs 22.2%; P=0.293, EES: 7.7% vs 10.0%; P=0.846), although the increase was not significantly different. ConclusionsEES was superior to SES in terms of LCU. SF may be associated with LCU after SES implantation. (J Interven Cardiol 2015;28:551-562)	[Kobayashi, Norihiro; Ito, Yoshiaki; Araki, Motoharu; Hirano, Keisuke; Yamawaki, Masahiro; Takimura, Hideyuki; Sakamoto, Yasunari; Muramatsu, Toshiya] Saiseikai Yokohama City Eastern Hosp, Dept Cardiol, Yokohama, Kanagawa 2308765, Japan; [Nakano, Masatsugu; Tsukahara, Reiko] Gen Tokyo Hosp, Dept Cardiol, Tokyo, Japan	Kobayashi, N (reprint author), Saiseikai Yokohama City Eastern Hosp, Dept Cardiol, Tsurumi Ku, 3-6-1 Shimosueyoshi, Yokohama, Kanagawa 2308765, Japan.	ovation17@gmail.com					Park KW, 2010, AM HEART J, V159, P446, DOI 10.1016/j.ahj.2010.01.001; Aoki J, 2007, CATHETER CARDIO INTE, V69, P380, DOI 10.1002/ccd.20950; Lee MS, 2007, CATHETER CARDIO INTE, V69, P387, DOI 10.1002/ccd.20942; Lee SE, 2009, J CARDIOL, V53, P422, DOI 10.1016/j.jjcc.2009.02.010; Chakravarty T, 2010, AM J CARDIOL, V106, P1075, DOI 10.1016/j.amjcard.2010.06.010; Cook S, 2007, CIRCULATION, V115, P2426, DOI 10.1161/CIRCULATIONAHA.106.658237; Teeuwen K, 2013, EUROINTERVENTION, V9, P212, DOI 10.4244/EIJV9I2A36; Yang TH, 2012, INT J CARDIOL, V160, P48, DOI 10.1016/j.ijcard.2011.03.024; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Kuramitsu S, 2012, CIRC-CARDIOVASC INTE, V5, P663, DOI 10.1161/CIRCINTERVENTIONS.112.969238; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Fujii K, 2005, J AM COLL CARDIOL, V45, P995, DOI 10.1016/j.jacc.2004.12.066; Imai M, 2011, CIRCULATION, V123, P2382, DOI 10.1161/CIRCULATIONAHA.110.003459; Cosgrave J, 2007, AM J CARDIOL, V100, P41, DOI 10.1016/j.amjcard.2007.01.070; Nakagawa Y, 2010, AM J CARDIOL, V106, P329, DOI 10.1016/j.amjcard.2010.03.031; Mehran R, 1999, CIRCULATION, V100, P1872; Kang SJ, 2011, CIRC-CARDIOVASC INTE, V4, P9, DOI 10.1161/CIRCINTERVENTIONS.110.940320; Sonoda S, 2004, J AM COLL CARDIOL, V43, P1959, DOI 10.1016/j./jacc.2004.01.044; Park SJ, 2012, J AM COLL CARDIOL, V59, P2051, DOI 10.1016/j.jacc.2011.10.909; Popma JJ, 2009, AM J CARDIOL, V103, P923, DOI 10.1016/j.amjcard.2008.12.022; Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028; Park DW, 2006, J AM COLL CARDIOL, V48, P2432, DOI 10.1016/j.jacc.2006.08.033; Nakazawa G, 2009, J AM COLL CARDIOL, V54, P1924, DOI 10.1016/j.jacc.2009.05.075; Umeda H, 2011, CIRC-CARDIOVASC INTE, V4, P349, DOI 10.1161/CIRCINTERVENTIONS.110.958306; Hong MK, 2006, CIRCULATION, V113, P414, DOI 10.1161/CIRCULATIONAHA.105.563403; Doi H, 2009, AM J CARDIOL, V103, P818, DOI 10.1016/j.amjcard.2008.11.051	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0896-4327	1540-8183		J INTERV CARDIOL	J. Interv. Cardiol.	DEC	2015	28	6					551	562		10.1111/joic.12247		12	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CY4SI	WOS:000366398100006		
J	Kise, H; Suzuki, S; Hoshiai, M; Toda, T; Koizumi, K; Hasebe, Y; Kono, Y; Honda, Y; Kaga, S; Sugita, K				Kise, Hiroaki; Suzuki, Shoji; Hoshiai, Minako; Toda, Takako; Koizumi, Keiichi; Hasebe, Yohei; Kono, Yosuke; Honda, Yoshihiro; Kaga, Shigeaki; Sugita, Kanji			Benefits of Balloon-Dilatable Bilateral Pulmonary Artery Banding in Patients With Hypoplastic Left Heart Syndrome and Other Complex Cardiac Anomalies	JOURNAL OF INTERVENTIONAL CARDIOLOGY			English	Article							HIGH-RISK; NORWOOD; PALLIATION; VARIANTS; STRATEGY; INJURY; ARREST	ObjectivesThe purpose of this study was to evaluate the potential of balloon-dilatable bilateral pulmonary artery banding (b-PAB) and its impact on the configuration of the pulmonary artery (PA). BackgroundWe have previously used balloon-dilatable b-PAB as first-stage palliation for patients with hypoplastic left heart syndrome (HLHS) and other complex cardiac anomalies. MethodsTwo pliable tapes were placed around each branch of the PA and tightened with 7-0 polypropylene sutures in a manner that allowed for the subsequent adjustment of PA diameters. We retrospectively examined the adjustability of PA diameters by balloon dilation and the need for surgical PA angioplasty at later stages. ResultsFrom January 2010 to October 2013, we performed b-PAB in 8 patients, including 3 borderline cases between biventricular repair (BVR) and univentricular repair (UVR). The b-PAB procedures were performed at a median age of 6.5 days (range, 2-10 days). Balloon dilations were performed in 10 lesions in 4 patients. All of the procedures were performed safely. Two patients reached definite BVR. The remaining 6 patients underwent open palliative procedures with univentricular physiologies that resulted in 2 deaths unrelated to the initial b-PAB. In all but 1 of the patients, the PA configuration was properly maintained and did not require surgical pulmonary angioplasty. ConclusionsBalloon-dilatable b-PAB can be performed safely and prevents PA distortion at later stages. This technique should be considered for patients with complex cardiac anomalies if uncertainty exists regarding the optimal surgical strategy (BVR or UVR) in early infancy. (J Interven Cardiol 2015;28:594-599)	[Kise, Hiroaki; Hoshiai, Minako; Toda, Takako; Koizumi, Keiichi; Hasebe, Yohei; Kono, Yosuke; Sugita, Kanji] Univ Yamanashi Hosp, Dept Pediat, Chuo City, Yamanashi, Japan; [Suzuki, Shoji; Honda, Yoshihiro; Kaga, Shigeaki] Univ Yamanashi Hosp, Dept Surg, Chuo City, Yamanashi, Japan	Kise, H (reprint author), Univ Yamanashi Hosp, Dept Pediat, Chuo City, Yamanashi, Japan.	hrkks24@gmail.com					Bacha EA, 2006, J THORAC CARDIOV SUR, V131, P163, DOI 10.1016/j.jtcvs.2005.07.053; Guleserian KJ, 2013, J THORAC CARDIOV SUR, V145, P206, DOI 10.1016/j.jtcvs.2012.09.063; Photiadis J, 2012, THORAC CARDIOV SURG, V60, P181, DOI 10.1055/s-0031-1295569; Hoshino S, 2015, CATHETER CARDIO INTE, V85, pE197, DOI 10.1002/ccd.25868; Wernovsky G, 2000, CIRCULATION, V102, P883; Hickey EJ, 2007, EUR J CARDIO-THORAC, V31, P906, DOI 10.1016/j.ejcts.2007.01.006; Tsui SSL, 2004, ANN THORAC SURG, V78, P188, DOI 10.1016/j.athorcsur.2003.11.048; Kitahori K, 2010, J THORAC CARDIOV SUR, V140, P1084, DOI 10.1016/j.jtcvs.2010.07.084; Mahle WT, 2006, PEDIATRICS, V117, pE90, DOI 10.1542/peds.2005-0575; Gomide M, 2013, J THORAC CARDIOV SUR, V146, P1146, DOI 10.1016/j.jtcvs.2013.01.051; Brown S, 2010, EUR J CARDIO-THORAC, V37, P296, DOI 10.1016/j.ejcts.2009.06.056; Dave H, 2014, EUR J CARDIO-THORAC, V46, P14, DOI 10.1093/ejcts/ezt604; Davies RR, 2014, J THORAC CARDIOV SUR, V147, P706, DOI 10.1016/j.jtcvs.2013.10.038; Harada Yorikazu, 2014, Gen Thorac Cardiovasc Surg, V62, P334, DOI 10.1007/s11748-013-0347-9; Hsia TY, 2006, ANN THORAC SURG, V81, P2381; Nakano Toshihide, 2014, Kyobu Geka, V67, P299; Ota N, 2014, J THORAC CARDIOV SUR, V148, P1519, DOI 10.1016/j.jtcvs.2013.11.053; Sakamoto Takahiko, 2014, Kyobu Geka, V67, P278	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0896-4327	1540-8183		J INTERV CARDIOL	J. Interv. Cardiol.	DEC	2015	28	6					594	599		10.1111/joic.12250		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CY4SI	WOS:000366398100010		
J	Phan, HP; Dao, DV; Nakamura, K; Dimitrijev, S; Nguyen, NT				Hoang-Phuong Phan; Dzung Viet Dao; Nakamura, Koichi; Dimitrijev, Sima; Nam-Trung Nguyen			The Piezoresistive Effect of SiC for MEMS Sensors at High Temperatures: A Review	JOURNAL OF MICROELECTROMECHANICAL SYSTEMS			English	Review						Silicon carbide; piezoresistive effect; piezoresistance; harsh environments; microelectromechanical systems (MEMS)	HARSH-ENVIRONMENT APPLICATIONS; CHEMICAL-VAPOR-DEPOSITION; CUBIC SILICON-CARBIDE; GROUP-III-NITRIDE; PRESSURE SENSOR; SINGLE-CRYSTALLINE; POLYCRYSTALLINE SILICON; BIOMEDICAL APPLICATIONS; GIANT PIEZORESISTANCE; ELECTRONIC-PROPERTIES	Silicon carbide (SiC) is one of the most promising materials for applications in harsh environments thanks to its excellent electrical, mechanical, and chemical properties. The piezoresistive effect of SiC has recently attracted a great deal of interest for sensing devices in hostile conditions. This paper reviews the piezoresistive effect of SiC for mechanical sensors used at elevated temperatures. We present experimental results of the gauge factors obtained for various poly-types of SiC films and SiC nanowires, the related theoretical analysis, and an overview on the development of SiC piezoresistive transducers. The review also discusses the current issues and the potential applications of the piezoresistive effect in SiC. [2015-0092]	[Hoang-Phuong Phan; Dzung Viet Dao; Dimitrijev, Sima; Nam-Trung Nguyen] Griffith Univ, Queensland Micro & Nanotechnol Ctr, Nathan, Qld 4111, Australia; [Nakamura, Koichi] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Kyoto 6068501, Japan; [Nakamura, Koichi] Egypt Japan Univ Sci & Technol, Dept Mat Sci & Engn, Alexandria 21934, Egypt	Phan, HP (reprint author), Griffith Univ, Queensland Micro & Nanotechnol Ctr, Nathan, Qld 4111, Australia.	hoangphuong.phan@griffithuni.edu.au; d.dao@griffith.edu.au; koichi@cpier.kyoto-u.ac.jp; s.dimitrijev@griffith.edu.au; nam-trung.nguyen@griffith.edu.au	Nguyen, Nam-Trung/A-4180-2008	Nguyen, Nam-Trung/0000-0003-3626-5361			Amano H, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.050001; Wright NG, 2008, MATER TODAY, V11, P16, DOI 10.1016/S1369-7021(07)70348-6; Zeng HJ, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/30/305501; Zetterling CM, 2015, MRS BULL, V40, P431, DOI 10.1557/mrs.2015.90; MOSSER V, 1991, SENSOR ACTUAT A-PHYS, V28, P113, DOI 10.1016/0924-4247(91)85020-O; LONG D, 1961, J APPL PHYS, V32, P2050, DOI 10.1063/1.1728326; Okojie RS, 1998, IEEE T ELECTRON DEV, V45, P785, DOI 10.1109/16.662776; Neuzil P, 2010, NANO LETT, V10, P1248, DOI 10.1021/nl9037856; Kermany AR, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4866268; Li M, 2007, NAT NANOTECHNOL, V2, P114, DOI 10.1038/nnano.2006.208; Spearing SM, 2000, ACTA MATER, V48, P179, DOI 10.1016/S1359-6454(99)00294-3; Yang YL, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/1/015501; Rowe ACH, 2008, NAT NANOTECHNOL, V3, P311, DOI 10.1038/nnano.2008.108; Barlian AA, 2009, P IEEE, V97, P513, DOI 10.1109/JPROC.2009.2013612; SMITH CS, 1954, PHYS REV, V94, P42, DOI 10.1103/PhysRev.94.42; Vetter WM, 2004, J CRYST GROWTH, V260, P201, DOI 10.1016/j.jcrysgro.2003.08.043; Neudeck PG, 2002, P IEEE, V90, P1065, DOI 10.1109/JPROC.2002.1021571; Toriyama T, 2002, APPL PHYS LETT, V81, P2797, DOI 10.1063/1.1513652; BARDEEN J, 1950, PHYS REV, V80, P72, DOI 10.1103/PhysRev.80.72; Eickhoff M, 2004, J APPL PHYS, V95, P7908, DOI 10.1063/1.1728311; Forster C, 2006, PHYS STATUS SOLIDI A, V203, P1829, DOI 10.1002/pssa.200565232; Kinoshita T, 1999, J APPL PHYS, V85, P8193, DOI 10.1063/1.370659; Toriyama T, 2004, J MICROMECH MICROENG, V14, P1445, DOI 10.1088/0960-1317/14/11/002; Milne JS, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.256801; Kishimoto A, 2006, MAT SCI ENG B-SOLID, V135, P145, DOI 10.1016/j.mseb.2006.08.050; HERRING C, 1956, PHYS REV, V101, P944, DOI 10.1103/PhysRev.101.944; Nakamura K, 2008, JPN J APPL PHYS, V47, P5132, DOI 10.1143/JJAP.47.5132; Rowe ACH, 2014, J MATER RES, V29, P731, DOI 10.1557/jmr.2014.52; Phan HP, 2015, RSC ADV, V5, P56377, DOI 10.1039/c5ra10144a; Dao DV, 2002, PROC IEEE MICR ELECT, P312; HOMMA T, 1994, SENSOR ACTUAT A-PHYS, V40, P93, DOI 10.1016/0924-4247(94)85011-9; Strass J, 1997, TRANSDUCERS 97 - 1997 INTERNATIONAL CONFERENCE ON SOLID-STATE SENSORS AND ACTUATORS, DIGEST OF TECHNICAL PAPERS, VOLS 1 AND 2, P1439, DOI 10.1109/SENSOR.1997.635735; PARK CH, 1994, PHYS REV B, V49, P4485, DOI 10.1103/PhysRevB.49.4485; Eickhoff M, 2004, J APPL PHYS, V96, P2878, DOI 10.1063/1.1775043; Polesel-Maris J, 2007, J PHYS CONF SER, V61, P955, DOI 10.1088/1742-6596/61/1/189; Kumar SS, 2014, MICROSYST TECHNOL, V20, P1213, DOI 10.1007/s00542-014-2215-7; Atwell AR, 2003, SENSOR ACTUAT A-PHYS, V104, P11, DOI 10.1016/S0924-4247(02)00436-3; Akiyama T, 2011, 2011 IEEE SENSORS, P222; Friedrichs P, 2014, MATER SCI FORUM, V778-780, P1104, DOI 10.4028/www.scientific.net/MSF.778-780.1104; Ma SJ, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4813843; Wu CH, 2006, IEEE SENS J, V6, P316, DOI 10.1109/JSEN.2006.870145; Tilak V, 2006, PHYS STATUS SOLIDI C, V3, P2307, DOI 10.1002/pssc.200565217; Saddow SE, 2011, MATER SCI FORUM, V679-680, P824, DOI 10.4028/www.scientific.net/MSF.679-680.824; Bi JH, 2013, J MATER CHEM C, V1, P4514, DOI 10.1039/c3tc30655k; Gong SB, 2012, J MICROELECTROMECH S, V21, P253, DOI 10.1109/JMEMS.2011.2179017; Shekhawat G, 2006, SCIENCE, V311, P1592, DOI 10.1126/science.1122588; Tanaka S, 2001, J VAC SCI TECHNOL B, V19, P2173, DOI 10.1116/1.1418401; He RR, 2006, NAT NANOTECHNOL, V1, P42, DOI 10.1038/nnano.2006.53; Cimalla V, 2007, J PHYS D APPL PHYS, V40, P6386, DOI 10.1088/0022-3727/40/20/S19; KANDA Y, 1991, SENSOR ACTUAT A-PHYS, V28, P83, DOI 10.1016/0924-4247(91)85017-I; Wang L, 2011, THIN SOLID FILMS, V519, P6443, DOI 10.1016/j.tsf.2011.04.224; Sandhu A, 2000, ELECTRON LETT, V36, P497, DOI 10.1049/el:20000463; Chung GS, 2010, J KOREAN PHYS SOC, V56, P1759, DOI 10.3938/jkps.56.1759; Lugstein A, 2010, NANO LETT, V10, P3204, DOI 10.1021/nl102179c; TERMAN LM, 1962, SOLID STATE ELECTRON, V5, P285, DOI 10.1016/0038-1101(62)90111-9; Kumar Madhav, 2015, Nano Lett, V15, P2562, DOI 10.1021/acs.nanolett.5b00129; Zekentes K, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/13/133001; Kang TK, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4704564; Chung GS, 2010, MICROELECTRON ENG, V87, P2348, DOI 10.1016/j.mee.2010.04.005; Casady JB, 1996, SOLID STATE ELECTRON, V39, P1409, DOI 10.1016/0038-1101(96)00045-7; Gabriel G, 2007, MICROELECTRON J, V38, P406, DOI 10.1016/j.mejo.2006.11.008; Reichert W, 1997, DIAM RELAT MATER, V6, P1448, DOI 10.1016/S0925-9635(97)00078-2; [Anonymous], 2013, MICROWAVE J; Oliveros A, 2013, BIOMED MICRODEVICES, V15, P353, DOI 10.1007/s10544-013-9742-3; Fraga MA, 2011, MICROSYST TECHNOL, V17, P477, DOI 10.1007/s00542-011-1244-8; Senesky DG, 2009, IEEE SENS J, V9, P1472, DOI 10.1109/JSEN.2009.2026996; Fujita S, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.030101; Yasui K, 2008, THIN SOLID FILMS, V516, P644, DOI 10.1016/j.tsf.2007.06.187; Okojie RS, 2010, IEEE SENSOR, P2269, DOI 10.1109/ICSENS.2010.5690714; GUK GN, 1976, SOV PHYS SEMICOND+, V10, P83; [Anonymous], 1997, P INT C SOL STAT SEN; Eickhoff M, 2004, J APPL PHYS, V96, P2872, DOI 10.1063/1.1775052; Wright NG, 2007, J PHYS D APPL PHYS, V40, P6345, DOI 10.1088/0022-3727/40/20/S17; Nakamura K, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.045205; SHOR JS, 1993, IEEE T ELECTRON DEV, V40, P1093, DOI 10.1109/16.214734; Shao RW, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4769217; SUZUKI K, 1984, JPN J APPL PHYS 2, V23, pL871, DOI 10.1143/JJAP.23.L871; Chung GS, 2005, SENSOR ACTUAT A-PHYS, V119, P599, DOI 10.1016/j.sna.2004.10.004; Werner MR, 2001, IEEE T IND ELECTRON, V48, P249, DOI 10.1109/41.915402; SHOR JS, 1994, IEEE T ELECTRON DEV, V41, P661, DOI 10.1109/16.285013; Gungor VC, 2009, IEEE T IND ELECTRON, V56, P4258, DOI 10.1109/TIE.2009.2015754; EDWARDS WD, 1969, J PHYS E SCI INSTRUM, V2, P613, DOI 10.1088/0022-3735/2/7/314; Bykhovski AD, 1996, APPL PHYS LETT, V68, P818, DOI 10.1063/1.116543; Mehregany M, 1998, P IEEE, V86, P1594, DOI 10.1109/5.704265; Kishimoto A, 2008, CERAM INT, V34, P845, DOI 10.1016/j.ceramint.2007.09.033; Fahrner WR, 2001, MICROSYST TECHNOL, V7, P138, DOI 10.1007/s005420100089; [Anonymous], 2014, CREE MAT CAT SIL CAR; Zhang QC, 2010, IEEE T POWER ELECTR, V25, P2889, DOI 10.1109/TPEL.2010.2079956; Dinh T, 2015, APPL PHYS EXPRESS, V8, DOI 10.7567/APEX.8.061303; Fraga MA, 2012, MICROSYST TECHNOL, V18, P1027, DOI 10.1007/s00542-012-1435-y; Qamar A, 2015, IEEE ELECTR DEVICE L, V36, P708, DOI 10.1109/LED.2015.2435153; SETO JYW, 1976, J APPL PHYS, V47, P4780, DOI 10.1063/1.322515; Hossain TK, 2006, J MICROMECH MICROENG, V16, P751, DOI 10.1088/0960-1317/16/4/011; Laermer F, 2003, MICROELECTRON ENG, V67-8, P349, DOI 10.1016/S0167-9317(03)00089-3; Akiyama T, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/8/085034; Phan HP, 2014, J MATER CHEM C, V2, P7176, DOI 10.1039/c4tc01054j; Yousef H, 2011, SENSOR ACTUAT A-PHYS, V167, P171, DOI 10.1016/j.sna.2011.02.038; Gao FM, 2011, CHEM COMMUN, V47, P11993, DOI 10.1039/c1cc14343c; Willander M, 2006, J MATER SCI-MATER EL, V17, P1, DOI 10.1007/s10854-005-5137-4; Cheng GM, 2014, NANO LETT, V14, P754, DOI 10.1021/nl404058r; Zorman CA, 2008, PHYS STATUS SOLIDI B, V245, P1404, DOI 10.1002/pssb.200844135; HERRING C, 1955, AT&T TECH J, V34, P237; Wu RB, 2015, PROG MATER SCI, V72, P1, DOI 10.1016/j.pmatsci.2015.01.003; Okojie RS, 2015, IEEE ELECTR DEVICE L, V36, P174, DOI 10.1109/LED.2014.2379262; Bir G, 1974, SYMMETRY STRAIN INDU; Choyke W. J., 2004, SILICON CARBIDE RECE, P441; Dao Dzung Viet, 2010, Advances in Natural Sciences: Nanoscience & Nanotechnology, V1, DOI 10.1088/2043-6254/1/1/013001; Doll J. C., 2013, PIEZORESISTOR DESIGN; Eaton WP, 1997, P SOC PHOTO-OPT INS, V3046, P30, DOI 10.1117/12.276606; Eickhoff M, 1999, SENSOR ACTUAT A-PHYS, V74, P56, DOI 10.1016/S0924-4247(98)00302-1; Elwenspoek M., 2004, SILICON MICROMACHINI; Fraga M. A., 2010, P IEEE INT C IND TEC, P513; Guk G. N., 1974, SOV PHYS SEMICOND, V9, P104; Kanda Y., 1982, ELECT DEVICES IEEE T, V29, P64; Kroetz GH, 1999, SENSOR ACTUAT A-PHYS, V74, P182, DOI 10.1016/S0924-4247(98)00296-9; Kuo H.-I., 2003, P 12 INT C SOL STAT, P742; Lee Jigong, 2009, [Journal of Sensor Science and Technology, 센서학회지], V18, P147; Liu X., 2010, POLYCRYSTALLINE SILI; Maboudian R, 2013, J VAC SCI TECHNOL A, V31, DOI 10.1116/1.4807902; Minh-Dung N., 2013, P IEEE 26 INT C MICR, P617; Nakamura K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.06GE05; Nakamura K., 2010, P 11 THERM MECH MULT, P1; Okojie RS, 1998, SENSOR ACTUAT A-PHYS, V66, P200, DOI 10.1016/S0924-4247(98)00009-0; Phan HP, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4869151; Phan HP, 2014, IEEE ELECTR DEVICE L, V35, P399, DOI 10.1109/LED.2014.2301673; Phan HP, 2015, J MATER CHEM C, V3, P1172, DOI 10.1039/c4tc02679a; Rapatskaya I. V., 1968, FIZ TVERD TELA+, V9, P2833; Saddow SE, 2012, SILICON CARBIDE BIOTECHNOLOGY: A BIOCOMPATIBLE SEMICONDUCTOR FOR ADVANCED BIOMEDICAL DEVICES AND APPLICATIONS, 1ST EDITION, P1; Sarro PM, 2000, SENSOR ACTUAT A-PHYS, V82, P210, DOI 10.1016/S0924-4247(99)00335-0; Sun Y, 2010, STRAIN EFFECT IN SEMICONDUCTORS: THEORY AND DEVICE APPLICATIONS, P1, DOI 10.1007/978-1-4419-0552-9_1; Toriyama T., 2000, P INT S MICR HUM SCI, P175; Toriyama T., 2003, P 12 INT C SOL STAT, P758; Tsai NC, 2007, SENSOR ACTUAT A-PHYS, V134, P555, DOI 10.1016/j.sna.2006.06.014; von Berg J., 1998, P 4 INT HIGH TEMP EL, P245; Wang ZH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6158; Werner M., 1999, SENSORS UPDATE, V5, P141, DOI 10.1002/1616-8984(199904)5:1<141::AID-SEUP141>3.0.CO;2-J; Wieczorek G., 2007, P IEEE SENS C, P748; Wijesundara MBJ, 2011, MEMS REF SHELF, P1, DOI 10.1007/978-1-4419-7121-0; Ziermann R, 1999, MAT SCI ENG B-SOLID, V61-2, P576, DOI 10.1016/S0921-5107(98)00477-2	139	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1057-7157	1941-0158		J MICROELECTROMECH S	J. Microelectromech. Syst.	DEC	2015	24	6					1663	1677		10.1109/JMEMS.2015.2470132		15	Engineering, Electrical & Electronic; Engineering, Mechanical	Engineering	CX8XB	WOS:000365987000001		
J	Ma, XX; Kato, Y; van Kempen, F; Hirai, Y; Tsuchiya, T; van Keulen, F; Tabata, O				Ma, Xiaoxu; Kato, Yoshiki; van Kempen, Floris; Hirai, Yoshikazu; Tsuchiya, Toshiyuki; van Keulen, Fred; Tabata, Osamu			Experimental Study of Numerical Optimization for 3-D Microstructuring Using DMD-Based Grayscale Lithography	JOURNAL OF MICROELECTROMECHANICAL SYSTEMS			English	Article						3-D microstructuring; 3-D photolithography; digital micromirror device (DMD)-based grayscale lithography; optimization; lithography simulation; thick photoresist; fast marching method	THICK PHOTORESIST LITHOGRAPHY; GRAY-SCALE LITHOGRAPHY; MASKLESS LITHOGRAPHY; PROJECTION LITHOGRAPHY; FABRICATION; EXPOSURE; PHOTOLITHOGRAPHY; SIMULATION; ARRAYS; DEVICE	Digital micromirror device (DMD)-based grayscale lithography is a promising tool for 3-D photolithography of thick photoresists, because this technique provides a patterning solution for free-form 3-D microstructures. Among the numerous process parameters in DMD-based grayscale lithography, the exposure dose pattern corresponding to the grayscale mask pattern, the focal position in the photoresist, and the development time most strongly influence the final profile of the 3-D microstructure. However, finding the best combination of the three process parameters is a difficult and time-consuming task. In this paper, we propose a process optimization method for DMD-based grayscale lithography that is based on the 3-D photolithography simulation and sensitivity analysis. This optimization tool provides not only automatic process optimization for all three process parameters, i.e., the exposure dose pattern, the focal position, and the development time, but also a solution to improve fabrication accuracy for critical features by adopting a variable weight factor. Through a series of experiments, using a 20-mu m-thick positive photoresist, the validity and effectiveness of the proposed optimization method and the improvement of the fabrication accuracy were successfully demonstrated. [2015-0055]	[Ma, Xiaoxu; Kato, Yoshiki; Hirai, Yoshikazu; Tsuchiya, Toshiyuki; Tabata, Osamu] Kyoto Univ, Dept Micro Engn, Kyoto 6168540, Japan; [van Kempen, Floris; van Keulen, Fred] Delft Univ Technol, Dept Precis & Microsyst Engn, NL-2628 CC Delft, Netherlands	Hirai, Y (reprint author), Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6068501, Japan.	x_ma@nms.me.kyoto-u.ac.jp; y_kato@nms.me.kyoto-u.ac.jp; f.c.m.vankempen@tudelft.nl; hirai@me.kyoto-u.ac.jp; tutti@me.kyoto-u.ac.jp; a.vankeulen@tudelft.nl; tabata@me.kyoto-u.ac.jp			Japan Science and Technology Agency through the Adaptable and Seamless Technology Transfer Program within the Target-Driven Research and Development Exploratory Research [AS242Z03743K]; NanoNextNL, a micro and nanotechnology consortium of the Government of The Netherlands; Nanotechnology Platform Project within the Ministry of Education, Culture, Sports, Science, and Technology, Japan, through Kyoto University Nano Technology Hub	This work was supported in part by the Japan Science and Technology Agency through the Adaptable and Seamless Technology Transfer Program within the Target-Driven Research and Development Exploratory Research under Grant AS242Z03743K; in part by NanoNextNL, a micro and nanotechnology consortium of the Government of The Netherlands and 130 partners; and in part by the Nanotechnology Platform Project within the Ministry of Education, Culture, Sports, Science, and Technology, Japan, through Kyoto University Nano Technology Hub. Subject Editor J. Brugger. (Corresponding author: Yoshikazu Hirai.)	Ding XY, 2014, APPL OPTICS, V53, P5307, DOI 10.1364/AO.53.005307; Liu C, 2005, P SOC PHOTO-OPT INS, V5645, P307, DOI 10.1117/12.577352; Kwon KY, 2014, J MICROELECTROMECH S, V23, P1272, DOI 10.1109/JMEMS.2014.2352412; Chung J, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/3/035014; Suzuki T, 2006, PROC IEEE MICR ELECT, P346; Huang YH, 2012, J OPT SOC KOREA, V16, P127, DOI 10.3807/JOSK.2012.16.2.127; Lu YT, 2004, OPT ENG, V43, P2666, DOI 10.1117/1.1801411; Morgan B, 2004, J MICROELECTROMECH S, V13, P113, DOI 10.1109/JMEMS.2003.823220; Ryoo H, 2011, MICROELECTRON ENG, V88, P235, DOI 10.1016/j.mee.2010.10.039; Bianchi S, 2013, OPT LETT, V38, P4935, DOI 10.1364/OL.38.004935; Sato H, 2006, J MICROMECH MICROENG, V16, P2318, DOI 10.1088/0960-1317/16/11/010; Choi A, 2009, CURR APPL PHYS, V9, pE294, DOI 10.1016/j.cap.2009.06.029; Flack WW, 1997, P SOC PHOTO-OPT INS, V3049, P789, DOI 10.1117/12.275881; Waits CM, 2003, J MICROMECH MICROENG, V13, P170, DOI 10.1088/0960-1317/13/2/302; Chung J, 2007, J VAC SCI TECHNOL B, V25, P1671, DOI 10.1116/1.2781527; Wu MH, 2002, LANGMUIR, V18, P9312, DOI 10.1021/la015735b; Sensu Y, 2004, P SOC PHOTO-OPT INS, V5376, P1040, DOI 10.1117/12.533904; Erdmann A, 2015, MICROELECTRON ENG, V132, P21, DOI 10.1016/j.mee.2014.09.011; Totsu K, 2006, SENSOR ACTUAT A-PHYS, V130, P387, DOI 10.1016/j.sna.2005.12.008; Zhong KJ, 2014, OPTIK, V125, P2413, DOI 10.1016/j.ijleo.2013.10.082; Huang H, 2007, J MICROMECH MICROENG, V17, P393, DOI 10.1088/0960-1317/17/2/027; Liu SJ, 2005, MICROELECTRON ENG, V78-79, P490, DOI 10.1016/j.mee.2005.01.014; Zhong KJ, 2014, OPT LASER TECHNOL, V56, P367, DOI 10.1016/j.optlastec.2013.08.027; Lee HS, 2005, J MICROMECH MICROENG, V15, P2136, DOI 10.1088/0960-1317/15/11/020; Hur J, 2012, J OPT SOC KOREA, V16, P221, DOI 10.3807/JOSK.2012.16.3.221; Toepke MW, 2005, J AM CHEM SOC, V127, P7674, DOI 10.1021/ja050660+; Hirai Y, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/6/065005; Yoon YK, 2005, J MICROELECTROMECH S, V14, P886, DOI 10.1109/JMEMS.2005.851804; Hirai Y, 2015, SENSOR ACTUAT B-CHEM, V213, P547, DOI 10.1016/j.snb.2015.01.118; Mosher L, 2009, J MICROELECTROMECH S, V18, P308, DOI 10.1109/JMEMS.2008.2011703; Gao YQ, 2010, OPTIK, V121, P1164, DOI 10.1016/j.ijleo.2008.12.037; Kewitsch AS, 1996, APPL PHYS LETT, V68, P455, DOI 10.1063/1.116411; Hirai Y, 2010, J MICROELECTROMECH S, V19, P1058, DOI 10.1109/JMEMS.2010.2067202; Hung KY, 2008, MICROSYST TECHNOL, V14, P1217, DOI 10.1007/s00542-007-0545-4; Seo M, 2012, MICROELECTRON ENG, V98, P125, DOI 10.1016/j.mee.2012.07.075; OPPLIGER Y, 1994, MICROELECTRON ENG, V23, P449, DOI 10.1016/0167-9317(94)90193-7; Sato H, 2007, J MICROMECH MICROENG, V17, P909, DOI 10.1088/0960-1317/17/5/009; Arfken G. B., 2005, MATH METHODS PHYS; Born M., 1999, PRINCIPLES OPTICS EL; He Yong, 2010, Journal of Northeast Forestry University, V38, P37; Iwasaki W, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.06FB05; Mack C., 2007, FUNDAMENTAL PRINCIPL; Mack CA, 2005, P SOC PHOTO-OPT INS, V5754, P1, DOI 10.1117/12.601590; Rammohan A, 2011, SENSOR ACTUAT B-CHEM, V153, P125, DOI 10.1016/j.snb.2010.10.021; Schleunitz A., 2014, NANO CONVERGENCE, V1, P1; Sethian J. A., 1999, LEVEL SET METHODS FA; van Kempen F. C. M., 2013, P TRANSDUCERS EUROSE, P1625; van Keulen F., 2009, P EUROSIME APR, P1	48	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1057-7157	1941-0158		J MICROELECTROMECH S	J. Microelectromech. Syst.	DEC	2015	24	6					1856	1867		10.1109/JMEMS.2015.2447548		12	Engineering, Electrical & Electronic; Engineering, Mechanical	Engineering	CX8XB	WOS:000365987000023		
J	Minh, LV; Hara, M; Kuwano, H				Le Van Minh; Hara, Motoaki; Kuwano, Hiroki			Lead-Free (K,Na)NbO3 Impact-Induced-Oscillation Microenergy Harvester	JOURNAL OF MICROELECTROMECHANICAL SYSTEMS			English	Article						Energy harvesting; lead-free piezoelectric; MEMS; piezoelectric energy harvester; piezoelectric devices	ENERGY; CONSTANTS; DEVICES	We developed microenergy harvesters using impact-induced oscillation to scavenge electrical power from low frequency (<200 Hz) and random environmental vibrations. The microharvesters comprised a (K,Na)NbO3/Si composite cantilever and a cylindrical cavity to guide a metal ball to perpendicularly strike the cantilever. Through ball impact, oscillation of the cantilever was induced, generating electrical power at ambient vibration frequencies from 20 to 150 Hz. The contact time of ball impact was identified as a key parameter for power enhancement and was effectively tuned by adjusting the impact position on the triangular cantilever. The experimental output power when the impact position was at the base of the cantilever was 34.6 nW. This value is tenfold higher than that from conventional devices in which the ball strikes the tip of the cantilever. [2015-0063]	[Le Van Minh; Hara, Motoaki; Kuwano, Hiroki] Tohoku Univ, Dept Nanomech, Grad Sch Engn, Sendai, Miyagi 9808579, Japan	Minh, LV (reprint author), Tohoku Univ, Dept Nanomech, Grad Sch Engn, Sendai, Miyagi 9808579, Japan.	minhlv@nanosys.mech.tohoku.ac.jp; hara@nanosys.mech.tohoku.ac.jp; hiroki.kuwano@nanosys.mech.tohoku.ac.jp			Project Research of a Nano-Energy System Creation through the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [18GS0203]; Center of Innovation Science and Technology-Based Radical Innovation and Entrepreneurship Program, Tohoku University, Sendai, Japan, through MEXT; Tohoku University Research and Development Center of Excellence for Integrated Microsystems through MEXT	This work was supported in part by the Project Research of a Nano-Energy System Creation through the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), under Grant 18GS0203; in part by the Center of Innovation Science and Technology-Based Radical Innovation and Entrepreneurship Program, Tohoku University, Sendai, Japan, through MEXT; and in part by the Tohoku University Research and Development Center of Excellence for Integrated Microsystems through MEXT. Subject Editor A. Zhang.	Roundy S, 2003, COMPUT COMMUN, V26, P1131; Renaud M, 2007, SMART MATER STRUCT, V16, P1125, DOI 10.1088/0964-1726/16/4/022; Fang HB, 2006, MICROELECTRON J, V37, P1280, DOI 10.1016/j.mejo.2006.07.023; Roundy S, 2005, IEEE PERVAS COMPUT, V4, P28, DOI 10.1109/MPRV.2005.14; BRANTLEY WA, 1973, J APPL PHYS, V44, P534, DOI 10.1063/1.1661935; Umeda M, 1996, JPN J APPL PHYS 1, V35, P3267, DOI 10.1143/JJAP.35.3267; Gu L, 2011, MICROELECTRON J, V42, P277, DOI 10.1016/j.mejo.2010.10.007; PETERSEN KE, 1978, IEEE T ELECTRON DEV, V25, P1241, DOI 10.1109/T-ED.1978.19259; ZGONIK M, 1993, J APPL PHYS, V74, P1287, DOI 10.1063/1.354934; Kim MT, 1996, THIN SOLID FILMS, V283, P12, DOI 10.1016/0040-6090(95)08498-3; Christoforou AP, 1998, J SOUND VIB, V217, P563, DOI 10.1006/jsvi.1998.1807; Cottone F, 2014, 2014 IEEE 27TH INTERNATIONAL CONFERENCE ON MICRO ELECTRO MECHANICAL SYSTEMS (MEMS), P385, DOI 10.1109/MEMSYS.2014.6765657; Elfrink R., 2011, P IEEE INT EL DEV M; Elfrink R., 2009, J MICROMECH MICROENG, V19; Gilbert James M, 2008, International Journal of Automation and Computing, V5, DOI 10.1007/s11633-008-0334-2; Goldschmidtboeing F., 2008, J MICROMECH MICROENG, V18; Gu L., 2011, POWERMEMS2011 WORKSH, P15; Halg B., 1990, Proceedings. IEEE Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Robots (Cat. No.90CH2832-4), DOI 10.1109/MEMSYS.1990.110271; Lee B. S., 2009, J MICROMECH MICROENG, V19; Mo C., 2009, SMART MATER STRUCT, V18; Paradiso A., 2005, IEEE PERVAS COMPUT, V4, P18; Renaud M, 2005, Transducers '05, Digest of Technical Papers, Vols 1 and 2, P784; Schwieger H., 1965, EXPT MECHANICS, V5, P378, DOI 10.1007/BF02326086; Shackelford J.F., 2001, CRC MAT SCI ENG HDB; Shen D., 2008, J MICROMECH MICROENG, V18; Shibata K., 2011, JPN J APPL PHYS, V50; Simon E., 2010, P POW MEMS, P33; Starner T, 2004, LOW POWER ELECT DESI, P1; Van Minh L., 2013, P IEEE 26 INT C MICR, P833; Van Minh L., 2013, J MICROMECH MICROENG, V23	30	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1057-7157	1941-0158		J MICROELECTROMECH S	J. Microelectromech. Syst.	DEC	2015	24	6					1887	1895		10.1109/JMEMS.2015.2451141		9	Engineering, Electrical & Electronic; Engineering, Mechanical	Engineering	CX8XB	WOS:000365987000026		
J	Froemel, J; Baum, M; Wiemer, M; Gessner, T				Froemel, Joerg; Baum, Mario; Wiemer, Maik; Gessner, Thomas			Low-Temperature Wafer Bonding Using Solid-Liquid Inter-Diffusion Mechanism	JOURNAL OF MICROELECTROMECHANICAL SYSTEMS			English	Article						Wafer bonding; intermetallic; gallium alloys; solid liquid interdiffusion (SLID); transient liquid phase (TLP)	AU-IN; ROOM-TEMPERATURE; SYSTEMS; GALLIUM; VACUUM; INDIUM; GOLD	The low temperature joining of semiconductor substrates on wafer level by solid-liquid inter-diffusion bonding using the Cu/Ga and Au/In systems is investigated regarding the bonding parameters and their influence on bond interface properties. The focus is on temperature dependence and composition of interface. In the case of Cu/Ga bonding, a phase transition from CuGa2 to Cu9Ga4 was found to be primarily responsible for an increase in bonding strength. After the temperature treatment of 90 degrees C, a shear strength of up to 90 MPa could be achieved. Furthermore, the combination of Au and In with composition ratios suitable for AuI(n)2 and AuIn intermetallic phase formation was investigated. In the case of AuIn shear strength, 96 MPa was achieved using a bonding temperature of 200 degrees C. [2014-0325]	[Froemel, Joerg; Baum, Mario; Wiemer, Maik; Gessner, Thomas] Fraunhofer Inst Elect Nano Syst, D-09126 Chemnitz, Germany; [Froemel, Joerg; Gessner, Thomas] Tohoku Univ, World Premier Int Res Ctr, Fraunhofer Project Ctr NEMS MEMS Devices & Mfg Te, Initiat Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan	Froemel, J (reprint author), Fraunhofer Inst Elect Nano Syst, D-09126 Chemnitz, Germany.	joerg.froemel@enas.fraunhofer.de; mario.baum@enas.fraunhofer.de; maik.wiemer@enas.fraunhofer.de; thomas.gessner@enas.fraunhofer.de			European Union through the European Regional Development Fund; Free State of Saxony, Germany, within the Research Project Delta-Alpha through Sachsische Aufbaubank (SAB); World Premier International Research Center Initiative within the Ministry of Education, Culture, Sports, Science, and Technology, Japan	This work was supported in part by the European Union through the European Regional Development Fund; in part by the Free State of Saxony, Germany, within the Research Project Delta-Alpha through Sachsische Aufbaubank (SAB); and in part by the World Premier International Research Center Initiative within the Ministry of Education, Culture, Sports, Science, and Technology, Japan. Subject Editor C.-J. Kim.	Aksu S., 2011, U.S. Patent, Patent No. [7 892 413, 7892413]; Ancharov A, 2008, Russian Metallurgy, V2008, DOI 10.1134/S0036029508060049; KISSINGER G, 1993, SENSOR ACTUAT A-PHYS, V36, P149, DOI 10.1016/0924-4247(93)85009-5; Welch WC, 2008, PROC IEEE MICR ELECT, P806; LASKY JB, 1986, APPL PHYS LETT, V48, P78, DOI 10.1063/1.96768; SHIMBO M, 1986, J APPL PHYS, V60, P2987, DOI 10.1063/1.337750; LEE CC, 1993, IEEE T COMPON HYBR, V16, P311, DOI 10.1109/33.232058; Krondorfer RH, 2007, IEEE T COMPON PACK T, V30, P285, DOI 10.1109/TCAPT.2007.898360; Knechtel R, 2006, MICROSYST TECHNOL, V12, P468, DOI 10.1007/s00542-005-0036-4; Sohn YC, 2007, ELEC COMP C, P633; Taklo MMV, 2004, J MICROMECH MICROENG, V14, P884, DOI 10.1088/0960-1317/14/7/007; DORIN R, 1988, J APPL ELECTROCHEM, V18, P134, DOI 10.1007/BF01016217; Petzold M, 2001, P SOC PHOTO-OPT INS, V4558, P133, DOI 10.1117/12.442994; WALLIS G, 1969, J APPL PHYS, V40, P3946, DOI 10.1063/1.1657121; L'vov BV, 2000, THERMOCHIM ACTA, V360, P85, DOI 10.1016/S0040-6031(00)00558-X; Grummel B, 2011, PROC INT SYMP POWER, P260, DOI 10.1109/ISPSD.2011.5890840; ROYCE BSH, 1988, IEEE T COMPON HYBR, V11, P454, DOI 10.1109/33.16683; DUVALL DS, 1974, WELD J, V53, P203; GOSELE U, 1995, APPL PHYS LETT, V67, P3614; Zhang W, 2008, J ELECTRON MATER, V37, P1095, DOI 10.1007/s11664-008-0487-3; MARINKOVIC Z, 1992, THIN SOLID FILMS, V217, P26, DOI 10.1016/0040-6090(92)90601-7; Zank J, 1996, THIN SOLID FILMS, V286, P259, DOI 10.1016/S0040-6090(95)08214-X; Braeuer J, 2012, SENSOR ACTUAT A-PHYS, V188, P212, DOI 10.1016/j.sna.2012.01.015; Grummel BJ, 2013, IEEE T COMP PACK MAN, V3, P716, DOI 10.1109/TCPMT.2013.2239702; Zhang X, 2007, J MICROELECTROMECH S, V16, P639, DOI 10.1109/JMEMS.2007.897088; Higurashi E, 2009, IEEE J SEL TOP QUANT, V15, P1500, DOI 10.1109/JSTQE.2009.2020812; Baum M., 2014, P SMART SYST INT C S, P45; BERNSTEI.L, 1966, T METALL SOC AIME, V236, P405; BERNSTEI.L, 1966, J ELECTROCHEM SOC, V113, P1282, DOI 10.1149/1.2423806; Berwian P., 2005, THESIS; Desaguliers J. T., 1745, COURSE EXPT PHILOS; Froemel J., 2011, TRANSDUCERS 2011 - 2011 16th International Solid-State Sensors, Actuators and Microsystems Conference, DOI 10.1109/TRANSDUCERS.2011.5969495; Froemel J., 2014, IEEE INT WORKSH 4 LO; Froemel J., 2013, P C WAF BOND MICR 3D, P97; Fromel J., 2012, P 3 IEEE INT WORKSH, P163; Jezequel J., 1977, J PHYS F MET PHYS, V7, P1613; Kon H., 2013, P C WAF BOND MICR 3D, P18; Ramm P., 2012, HDB WAFER BONDING; Rayleigh L., 1936, P PHYS SOC A, V156, P326, DOI 10.1098/rspa.1936.0151; Wang Q., 2006, P 7 INT C EL PACK TE, P1; Yu D. Q., 2010, P 3 EL SYST INT TECH, P1	41	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1057-7157	1941-0158		J MICROELECTROMECH S	J. Microelectromech. Syst.	DEC	2015	24	6					1973	1980		10.1109/JMEMS.2015.2455340		8	Engineering, Electrical & Electronic; Engineering, Mechanical	Engineering	CX8XB	WOS:000365987000035		
J	Sato, M; Sakurai, N; Suzuki, H; Shibata, D; Kino, K				Sato, Masaru; Sakurai, Nozomu; Suzuki, Hideyuki; Shibata, Daisuke; Kino, Kuniki			Enzymatic carboxylation of hydroxystilbenes by the gamma-resorcylic acid decarboxylase from Rhizobium radiobacter WU-0108 under reverse reaction conditions	JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC			English	Article						Enzymatic carboxylation; gamma-Resorcylic acid decarboxylase; Hydroxystilbene; Resveratrol; Gnetol	KOLBE-SCHMITT REACTION; SP STRAIN MTP-10005; EADOCK DSS; PHENOLS	We examined 66 aromatics for carboxylation by the gamma-resorcylic acid decarboxylase from Rhizobium radiobacter WU-0108 under reverse reaction conditions. The enzyme carboxylated resorcinol, catechol, 5-methylresorcinol and three hydroxystilbenes (resveratrol, gnetol, and piceatannol) with high yields. Except for catechol, the structures of these substrates include a 1,3-dihydroxybenzene moiety. Other compounds gave no reaction products. The reaction products from resveratrol and gnetol were 2,6-dihydroxy-4-[(E)-2-(4-hydroxyphenyl)ethenyl]benzoic acid and 2,6-dihydroxy-4-[(E)-2-(2,6-dihydroxyphenyl)ethenyl]benzoic acid, respectively, as determined by mass spectrometry and nuclear magnetic resonance analyses. Kinetic analyses of the carboxylation reactions indicated that resveratrol and gnetol are better substrates than resorcinol or catechol. (C) 2015 Elsevier B.V. All rights reserved.	[Sato, Masaru; Suzuki, Hideyuki; Shibata, Daisuke] Kazusa DNA Res Inst, Dept Biotechnol Res & Dev, Kisarazu, Chiba 2920818, Japan; [Sakurai, Nozomu] Kazusa DNA Res Inst, Dev Technol Dept, Kisarazu, Chiba 2920818, Japan; [Kino, Kuniki] Waseda Univ, Fac Sci & Engn, Dept Appl Chem, Shinjuku Ku, Tokyo 1698555, Japan	Shibata, D (reprint author), Kazusa DNA Res Inst, Dept Biotechnol Res & Dev, 2-6-7 Kazusakamatari, Kisarazu, Chiba 2920818, Japan.	shibata@kazusa.or.jp			Natsuhiko Sugimura of Materials Characterization Central Laboratory of Waseda University; Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (Tokyo, Japan); Kazusa DNA Research Institute Foundation	The gene encoding the decarboxylase was a kind gift from Prof. Kohtaro Kirimura of Waseda University. NMR analyses were kindly supported by Natsuhiko Sugimura of Materials Characterization Central Laboratory of Waseda University. The authors are also grateful to Miyuki Inde for technical assistance. This study was supported in part by the Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (Tokyo, Japan) and by the Kazusa DNA Research Institute Foundation.	Goto M, 2006, J BIOL CHEM, V281, P34365, DOI 10.1074/jbc.M607270200; Ishii Y, 2004, BIOCHEM BIOPH RES CO, V324, P611, DOI 10.1016/j.bbrc.2004.09.091; Grosdidier A, 2011, J COMPUT CHEM, V32, P2149, DOI 10.1002/jcc.21797; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Yoshida T, 2002, BIOSCI BIOTECH BIOCH, V66, P2388; Omura H, 1998, EUR J BIOCHEM, V253, P480, DOI 10.1046/j.1432-1327.1998.2530480.x; Kirimura K, 2011, CHEM LETT, V40, P206, DOI 10.1246/cl.2011.206; Glueck SM, 2010, CHEM SOC REV, V39, P313, DOI 10.1039/b807875k; LINDSEY AS, 1957, CHEM REV, V57, P583, DOI 10.1021/cr50016a001; Kirimura K, 2010, BIOCHEM BIOPH RES CO, V394, P279, DOI 10.1016/j.bbrc.2010.02.154; Yoshida M, 2004, J BACTERIOL, V186, P6855, DOI 10.1128/JB.186.20.6855-6863.2004; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Wuensch C, 2012, ORG LETT, V14, P1974, DOI 10.1021/ol300385k; Yoshida T, 2010, BIOTECHNOL LETT, V32, P701, DOI 10.1007/s10529-010-0210-3; Wuensch C, 2014, RSC ADV, V4, P9673, DOI 10.1039/c3ra47719c	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-1177	1873-3158		J MOL CATAL B-ENZYM	J. Mol. Catal. B-Enzym.	DEC	2015	122						348	352		10.1016/j.molcatb.2015.10.006		5	Biochemistry & Molecular Biology; Chemistry, Physical	Biochemistry & Molecular Biology; Chemistry	CY0EI	WOS:000366078800043		
J	Shimizu, S; Osawa, S; Sekiguchi, T; Mochizuki, T; Oka, H; Kumabe, T				Shimizu, Satoru; Osawa, Shigeyuki; Sekiguchi, Tomoko; Mochizuki, Takahiro; Oka, Hidehiro; Kumabe, Toshihiro			Modified One-piece Supraorbital Approach for Orbital Tumors: Widely Preserved Orbital Roof in a Self-fitting Flap	JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE			English	Article						orbital roof; orbital tumor; osteotomy; supraorbital approach; threadwire saw	TECHNICAL NOTE; ORBITOZYGOMATIC CRANIOTOMY; BONE FLAPS; CRANIOPLASTY; FIXATION; FISSURE	ObjectivesThe one-piece supraorbital approach is a rational approach for the removal of orbital tumors. However, cutting the roof through the orbit is often difficult. We modified the technique to facilitate the osteotomy and improve the cosmetic effect. DesignThree burr holes are made: the first, the MacCarty keyhole (burr hole 1), exposes the anterior cranial fossa and orbit; the second is placed above the supraorbital nerve (burr hole 2); and the third on the superior temporal line. Through burr hole 2, a small hole is created on the roof, 10mm in depth. Next the roof is rongeured through burr hole 1 toward the preexisting small hole. Seamless osteotomies using a diamond-coated threadwire saw and the preexisting four holes are performed. Lastly the flap is removed. On closure, sutures are passed through holes in the cuts made with the threadwire saw, and tied. ResultsWe applied our technique to address orbital tumors in two adult patients. The osteotomies in the roof were easy, and most parts of the roof were repositioned. ConclusionsOur modification results in orbital osteotomies with greater preservation of the roof. Because the self-fitting flap does not require the use of fixation devices, the reconstruction is cosmetically satisfactory.	[Shimizu, Satoru; Osawa, Shigeyuki; Sekiguchi, Tomoko; Mochizuki, Takahiro] Yokohama Stroke & Brain Ctr, Dept Neurosurg, Yokohama, Kanagawa 2350012, Japan; [Oka, Hidehiro; Kumabe, Toshihiro] Kitasato Univ, Dept Neurosurg, Sch Med, Sagamihara, Kanagawa 228, Japan	Shimizu, S (reprint author), Yokohama Stroke & Brain Ctr, Dept Neurosurg, Isogo Ku, I-2-1 Takigashira, Yokohama, Kanagawa 2350012, Japan.	Satoru4756@aol.com					JANE JA, 1982, NEUROSURGERY, V11, P537; Lemole GM, 2003, J NEUROSURG, V99, P924, DOI 10.3171/jns.2003.99.5.0924; MAROON JC, 1984, J NEUROSURG, V60, P1226, DOI 10.3171/jns.1984.60.6.1226; Balasingam V, 2005, J NEUROSURG, V102, P940, DOI 10.3171/jns.2005.102.5.0940; Winston KR, 2003, J NEUROSURG, V99, P484, DOI 10.3171/jns.2003.99.3.0484; DELASHAW JB, 1993, J NEUROSURG, V79, P615, DOI 10.3171/jns.1993.79.4.0615; Aziz KMA, 2002, ACTA NEUROCHIR, V144, P15, DOI 10.1007/s701-002-8270-1; Frazier CH, 1913, ANN SURG, V57, P145, DOI 10.1097/00000658-191302000-00001; MacCarty C S, 1964, Clin Neurosurg, V11, P76; MacCarty C S, 1961, SURG TREATMENT INTRA, P57; MacCarty C S, 1961, CLIN NEUROSURG, V7, P100; Hayashi N, 2002, NEUROSURGERY, V51, P1520, DOI 10.1227/01.NEU.0000036592.54039.1A; N Hayashi, 2002, NEUROSURGERY, V51, P1523; Tanriover N, 2006, NEUROSURGERY, V58, P229, DOI 10.1227/01.NEU.0000210010.46680.B4; Shimizu S, 2005, NEUROSURGERY, V57, P152, DOI 10.1227/01.NEU.0000163600.31460.D8; S Shimizu, 2005, NEUROSURGERY S, V57, P158; Seçkin Hakan, 2008, Neurosurg Focus, V25, pE4, DOI 10.3171/FOC.2008.25.12.E4; Shimizu S, 2011, SKULL BASE-INTERD AP, V21, P322, DOI 10.1055/s-0031-1284214; T Iwama, 2003, NEUROSURGERY, V52, P595; Iwama T, 2003, NEUROSURGERY, V52, P591, DOI 10.1227/01.NEU.0000047891.86938.46	20	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6331	2193-634X		J NEUROL SURG PART B	Journal of Neurol. Surg. Part B	DEC	2015	76	6					459	463		10.1055/s-0035-1554903		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CY2BI	WOS:000366213400008		
J	Takahashi, A; Shimizu, H; Okazaki, Y; Sakaguchi, H; Taira, T; Suzuki, T; Chiji, H				Takahashi, Azusa; Shimizu, Hisae; Okazaki, Yukako; Sakaguchi, Hirohide; Taira, Toshio; Suzuki, Takashi; Chiji, Hideyuki			Anthocyanin-rich Phytochemicals from Aronia Fruits Inhibit Visceral Fat Accumulation and Hyperglycemia in High-fat Diet-induced Dietary Obese Rats	JOURNAL OF OLEO SCIENCE			English	Article						Aronia; phytochemicals; anthocyanin; visceral fat accumulation; postprandial hyperlipidemia	E-DEFICIENT MICE; ALPHA-GLUCOSIDASE; AMELIORATES HYPERGLYCEMIA; CHLOROGENIC ACID; ADIPOSE-TISSUE; MELANOCARPA; EXTRACT; INSULIN; SUPPLEMENTATION; METABOLISM	Aronia fruits (chokeberry: Aronia melanocarpa E.) containing phenolic phytochemicals, such as cyanidin 3-glycosides and chlorogenic acid, have attracted considerable attention because of their potential human health benefits in humans including antioxidant activities and ability to improved vision. In the present study, the effects of anthocyanin-rich phytochemicals from aronia fruits (aronia phytochemicals) on visceral fat accumulation and fasting hyperglycemia were examined in rats fed a high-fat diet (Experiment 1). Total visceral fat mass was significantly lower in rats fed aronia phytochemicals than that in both the control group and bilberry phytochemicals-supplemented rats (p < 0.05). Moreover, perirenal and epididymal adipose tissue mass in rats fed aronia phytochemicals was significantly lower than that in both the control and bilberry phytochemicals group. Additionally, the mesenteric adipose tissue mass in aronia phytochemicals-fed rats was significantly low (p < 0.05). Furthermore, the fasting blood glucose levels significantly decreased in rats fed aronia phytochemicals for 4 weeks compared to that in the control rats (p <0.05). Therefore, we investigated the effects of phytochemicals on postprandial hyperlipidemia after corn oil loading in rats, pancreatic lipase activity in vitro, and the plasma glycemic response after sucrose loading in order to elucidate the preventive factor of aronia phytochemical on visceral fat accumulation. In the oral corn oil tolerance tests (Experiment 2), aronia phytochemicals significantly inhibited the increases in plasma triglyceride levels, with a half-maximal inhibitory concentration (IC50) of 1.50 mg/mL. However, the inhibitory activity was similar to that of bilberry and tea catechins. In the sucrose tolerance tests (Experiment 3), aronia phytochemicals also significantly inhibited the increases in blood glucose levels that were observed in the control animals (p < 0.05). These results suggest that anthocyanin-rich phytochemicals in aronia fruits suppress visceral fat accumulation and hyperglycemia by inhibiting pancreatic lipase activity and/or intestinal lipid absorption.	[Takahashi, Azusa; Suzuki, Takashi] Hokkaido Univ, Grad Sch Agr, Div Agrobiol, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Shimizu, Hisae; Chiji, Hideyuki] Fuji Womens Univ, Fac Human Life Sci, Dept Food Sci & Human Nutr, Ishikari, Hokkaido 0613204, Japan; [Okazaki, Yukako] Fuji Womens Univ, Fac Human Life Sci, Deprtment Human Life Sci, Ishikari, Hokkaido 0613204, Japan; [Sakaguchi, Hirohide] Nihonshinyaku Co Ltd, Minami Ku, Kyoto, Kyoto 6018550, Japan; [Taira, Toshio] COSMO BIO Co Ltd, Nishi Ku, Sapporo, Hokkaido 0630061, Japan	Chiji, H (reprint author), Fuji Womens Univ, Fac Human Life Sci, Dept Food Sci & Human Nutr, 4-5-7 Hanakawa Minami, Ishikari, Hokkaido 0613204, Japan.	hchiji@fujijoshi.ac.jp			 [25292017]	Some parts of this study were conducted with the grant of the Grant-in-Aid for Scientific Research B (Grant number 25292017).	Karthikesan K, 2010, GEN PHYSIOL BIOPHYS, V29, P23, DOI 10.4149/gpb_2010_01_23; REEVES PG, 1993, J NUTR, V123, P1939; Ardevol A, 2013, FOOD CHEM, V141, P160, DOI 10.1016/j.foodchem.2013.02.104; Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046; McDougall GJ, 2005, J AGR FOOD CHEM, V53, P2760, DOI 10.1021/jf0489926; Sasaki Rie, 2007, Biochem Pharmacol, V74, P1619, DOI 10.1016/j.bcp.2007.08.008; Tamura A, 2004, J NUTR SCI VITAMINOL, V50, P13; Takikawa M, 2010, J NUTR, V140, P527, DOI 10.3945/jn.109.118216; Qin Y, 2009, AM J CLIN NUTR, V90, P485, DOI 10.3945/ajcn.2009.27814; Rodriguez de Sotillo Delcy V., 2002, Journal of Nutritional Biochemistry, V13, P717, DOI 10.1016/S0955-2863(02)00231-0; Kawasaki K, 2009, J JPN SOC FOOD SCI, V56, P545; Matsumoto M, 2004, J AGR FOOD CHEM, V52, P2226, DOI 10.1021/jf034818q; Basu A, 2010, J NUTR, V140, P1582, DOI 10.3945/jn.110.124701; Takahashi A, 2014, J OLEO SCI, V63, P201, DOI 10.5650/jos.ess13196; Valcheva-Kuzmanova S, 2004, EXP TOXICOL PATHOL, V56, P195, DOI 10.1016/j.etp.2004.04.012; Johnston KL, 2003, AM J CLIN NUTR, V78, P728; Han LK, 2005, YAKUGAKU ZASSHI, V125, P213, DOI 10.1248/yakushi.125.213; Qin BL, 2012, BRIT J NUTR, V108, P581, DOI 10.1017/S000711451100599X; You Q, 2011, J AGR FOOD CHEM, V59, P9506, DOI 10.1021/jf201452v; Seeram NP, 2006, J AGR FOOD CHEM, V54, P9329, DOI 10.1021/jf061750g; Tsuda T, 2003, J NUTR, V133, P2125; Xia XD, 2006, J NUTR, V136, P2220; Krajka-Kuzniak V, 2009, J AGR FOOD CHEM, V57, P5071, DOI 10.1021/jf803973y; Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003; Chandra A, 2001, J AGR FOOD CHEM, V49, P3515, DOI 10.1021/jf010389p; [Anonymous], 2011, NIPPON EIYO SHOKURYO; Ohta Y, 2007, J JPN SOC FOOD SCI, V54, P287; Wang Y, 2012, J NUTR, V142, P1033, DOI 10.3945/jn.112.157701; Dam R. M., 2004, DIABETOLOGIA, V47, P2152, DOI 10.1007/s00125-004-1573-6; Matsiu T, 2002, J AGR FOOD CHEM, V50, P7244, DOI 10.1021/jf025913m; McDougall G. J., 2009, FOOD CHEM, V115, P191; Taira T., 2015, J CLIN BIOCHEM NUTR, V57, P1; Takahashi A., 2015, Nippon Shokuhin Kagaku Kogaku Kaishi = Journal of the Japanese Society for Food Science and Technology, V62, P235; Tosca L., 2003, J NUTR, V133, P2268	34	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	DEC	2015	64	12					1243	1250		10.5650/jos.ess15181		8	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CY2LQ	WOS:000366240600001		
J	Sasaki, R; Umezawa, M; Tsukahara, S; Ishiguro, T; Sato, S; Watanabe, Y				Sasaki, Ryo; Umezawa, Masatoshi; Tsukahara, Satoru; Ishiguro, Takashi; Sato, Shinichi; Watanabe, Yomi			Assignment of Milk Fat Fatty Acid Propyl Esters by GC-FID Analysis with the Aid of Ag-ion Solid-phase Extraction	JOURNAL OF OLEO SCIENCE			English	Article						milk fat; fatty acid composition; Ag-ion solid phase extraction; fatty acid propyl ester; DB-23	GAS-CHROMATOGRAPHY; COLUMNS; ISOMERS; FRACTIONATION; METHYL; CIS; CLA	The recovery of short-chain fatty acids (FAs) in milk fat (MF) is improved when the analysis of the FA composition of MF by gas chromatography (GC) is conducted with the propyl or butyl ester derivatives, instead of the methyl esters. However, this approach complicates the detection of minor FAs, such as the minor positional isomers of 16:1, which represent <0.2% of the total content. In addition, the standards of these minor esters are not commercially available. In this study, with the aim to identify minor FAs, the fatty acid propyl esters (FAPEs) of MF were fractionated by Ag-ion solid phase extraction (Ag+-SPE) and analyzed by GC using a DB-23 capillary column. FAPEs were successfully fractionated mainly according to the degree of unsaturation by adjusting the elution conditions of the Ag+-SPE, and the minor FAPEs were easily determined without the aid of standard compounds. For example, by comparison of the GC profile of the saturated Ag+-SPE fraction with that of the original MF, minor FAs, such as iso-, anteiso-, and saturated FAs of 15:0 and 17:0, were expected to be eluted in this order. In addition, 16:1 propyl ester was co-eluted with iso 17:0 propyl ester under the GC conditions used in this study, as confirmed by the detection of the corresponding molecular ions (296 and 312, respectively) by GC-MS. Moreover, 9c,11t-conjugated linoleic acid was found to elute between 18:3 and 20:0. To the best of our knowledge, this is the first report suggesting that the peak observed before that of cis-12:1 corresponds to trans-12:1. In conclusion, Ag+-SPE fractionation of FAPEs contributed to the identification of minor FAs in MF without the use of standard compounds.	[Sasaki, Ryo; Umezawa, Masatoshi; Tsukahara, Satoru; Ishiguro, Takashi] Miyoshi Oil & Fat Co Ltd, Katsushika Ku, Tokyo 1248510, Japan; [Sato, Shinichi] Japan Food Res Labs, Tama Ku, Tokyo 2060025, Japan; [Watanabe, Yomi] Osaka Municipal Tech Res Inst, Joto Ku, Osaka 5368553, Japan	Sasaki, R (reprint author), Miyoshi Oil & Fat Co Ltd, Katsushika Ku, 4-66-1 Horikiri, Tokyo 1248510, Japan.	sasakir@so.miyoshi-yushi.co.jp					Kramer JKG, 2008, LIPIDS, V43, P259, DOI 10.1007/s11745-007-3143-4; Schroder M, 2013, J AM OIL CHEM SOC, V90, P771, DOI 10.1007/s11746-013-2218-z; Kramer JKG, 2002, LIPIDS, V37, P823, DOI 10.1007/s11745-002-0967-2; Goto H, 2012, J OLEO SCI, V61, P49, DOI 10.5650/jos.61.49; Yoshinaga K, 2014, FOOD CHEM, V160, P39, DOI 10.1016/j.foodchem.2014.03.069; Vingering N, 2009, EUR J LIPID SCI TECH, V111, P669, DOI 10.1002/ejlt.200800289; CHRISTIE WW, 1989, J LIPID RES, V30, P1471; Ulberth F, 1999, J AM OIL CHEM SOC, V76, P263, DOI 10.1007/s11746-999-0228-7	8	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	DEC	2015	64	12					1251	1258		10.5650/jos.ess15125		8	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CY2LQ	WOS:000366240600002		
J	Choi, YS; Lee, KH; Jeong, YH; Koba, K; Sugano, M				Choi, Yong-Soon; Lee, Koung-Hee; Jeong, Yeon-Ho; Koba, Kazunori; Sugano, Michihiro			Effects of Aster scaber Seed Oil Containing trans-Delta 3 Fatty Acids on Lipid Profiles of Hamsters and Rats	JOURNAL OF OLEO SCIENCE			English	Article						Aster scaber seed oil; cholesterol; trans-Delta 3fatty acids; hamsters; rats	LIPOPROTEIN CHOLESTEROL LEVELS; PLASMA; TRANS; PEROXIDATION; METABOLISM; NUTRITION; ANIMALS; LIVER; DIETS; FOODS	The effects of Aster scaber seed oil (ASO) on lipid profiles were studied in rats and hamsters. ASO contained considerable amounts of Delta 3t-16:1 (11.4%), Delta 3t, 9c-18:2 (4.6%), and Delta 3t, 9c, 12c-18:3 (11.3%). Young rats and hamsters were fed diets containing ASO, soybean oil (SBO), or olive oil (OLO) as fat sources for 4 weeks in separate experiments with or without cholesterol. In the rat study, there were no significant differences in the concentrations of serum total cholesterol, high-density lipoprotein (HDL)-cholesterol, and triacylglycerol among the groups. The serum but not liver malondialdehyde (MDA) level was significantly lower in the ASO-fed group than it was in the other groups. The biochemical and growth parameters revealed no significant biological damages in the ASO-fed animals. In the hamster study, dietary cholesterol-dependent effects were evident in the serum lipids profiles, whereas the fat-induced effect was only observed in the ratio of serum low-density lipoprotein (LDL)-/HDL-cholesterol. Furthermore, fat- and cholesterol-induced effects were evident in the ratio of serum LDL-/HDL-cholesterol. Significant interactions between dietary fat and cholesterol were observed as evident from the concentration of serum cholesterol and triacylglycerol, as well as the activity of serum cholesterol ester transfer protein. These results suggest that dietary ASO containing trans-Delta 3 fatty acids appeared to improve the serum LDL-/HDL-cholesterol ratio more than the SBO did, especially when hamsters were simultaneously fed cholesterol-supplemented diet.	[Choi, Yong-Soon; Lee, Koung-Hee; Jeong, Yeon-Ho] Kangwon Natl Univ, Dept Med Biotechnol, Chunchon 24341, South Korea; [Choi, Yong-Soon; Jeong, Yeon-Ho] Kangwon Natl Univ, Inst Biosci & Biotechnol, Chunchon 24341, South Korea; [Koba, Kazunori] Nagasaki Univ, Dept Nutr Sci, Nagasaki 8512195, Japan; [Sugano, Michihiro] Kyushu Univ, Fukuoka 8130043, Japan	Koba, K (reprint author), Nagasaki Univ, Fac Nursing & Nutr, Dept Nutr Sci, 1-1-1 Manabino, Nagasaki 8512195, Japan.	koba@sun.ac.jp			Kangwon National University	This study was in part supported by 2012 Research Grant from Kangwon National University.	Tsutsumi K, 2001, BIOL PHARM BULL, V24, P579, DOI 10.1248/bpb.24.579; Poudyal H, 2015, PROG LIPID RES, V59, P172, DOI 10.1016/j.plipres.2015.07.002; REEVES PG, 1993, J NUTR, V123, P1939; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Petrovic M, 2010, FOOD CHEM, V122, P285, DOI 10.1016/j.foodchem.2010.02.018; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; CHUNG TY, 1993, J AGR FOOD CHEM, V41, P1693, DOI 10.1021/jf00034a033; AITZETMULLER K, 1994, J PLANT PHYSIOL, V143, P538; SCACCINI C, 1992, J LIPID RES, V33, P627; Zhang ZS, 2009, MOL NUTR FOOD RES, V53, P921, DOI 10.1002/mnfr.200800517; SOMMERFELD M, 1983, PROG LIPID RES, V22, P221, DOI 10.1016/0163-7827(83)90010-3; ZHOU J, 1993, J CLIN BIOCHEM NUTR, V15, P119; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ryu MH, 2003, J BIOCHEM MOL BIOL, V36, P312; Gurr MI, 1996, NUTR RES REV, V9, P259, DOI 10.1079/NRR19960014; Destaillats F, 2000, LIPIDS, V35, P1027, DOI 10.1007/s11745-000-0614-y; Tsevegsuren N, 2003, LIPIDS, V38, P573, DOI 10.1007/s11745-003-1498-6; IKEDA I, 1992, LIPIDS, V27, P500, DOI 10.1007/BF02536130; PAYNEWAHL K, 1981, J NAT PROD, V44, P190, DOI 10.1021/np50014a008; STEIN Y, 1990, BIOCHIM BIOPHYS ACTA, V1042, P138, DOI 10.1016/0005-2760(90)90068-9; Nicolosi RJ, 1998, J LIPID RES, V39, P1972; Sargis RM, 2003, BIOCHEMISTRY-US, V42, P11533, DOI 10.1021/bi034927y; SUGANO M, 1994, BRIT J NUTR, V72, P775, DOI 10.1079/BJN19940079; MATSUZAWA T, 1993, J VET MED SCI, V55, P351; MOORE CE, 1980, J NUTR, V110, P2284; Klerkx AHEM, 2006, ARTERIOSCL THROM VAS, V26, P706, DOI 10.1161/01.ATV.0000205595.19612.c9; Damude HG, 2008, PLANT PHYSIOL, V147, P962, DOI 10.1104/pp.108.121681; LOWRY OH, 1951, J BIOL CHEM, V193, P265	28	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	DEC	2015	64	12					1321	1327		10.5650/jos.ess15196		7	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CY2LQ	WOS:000366240600010		
J	Miyazawa, M; Nakahashi, H; Kashima, Y; Motooka, R; Hara, N; Nakagawa, H; Yoshii, T; Usami, A; Marumoto, S				Miyazawa, Mitsuo; Nakahashi, Hiroshi; Kashima, Yusei; Motooka, Ryota; Hara, Nobuyuki; Nakagawa, Hiroki; Yoshii, Takashi; Usami, Atsushi; Marumoto, Shinsuke			Chemical Composition and Aroma Evaluation of Essential Oils from Skunk Cabbage (Symplocarpus foetidus)	JOURNAL OF OLEO SCIENCE			English	Article						Symplocarpus foetidus; essential oil; aroma evaluation; AEDA; OAV		Two sample preparation methods, namely hydrodistillation (HD) and solvent-assisted flavor evaporation (SAFE), have been used to investigate the essential oils of the aerial parts (leaves and stems) of Symplocarpus foetidus, a plant with a characteristic odor, by gas chromatography mass spectrometry (GC-MS). Characteristic aroma-active compounds in the oils were detected by GC-Olfactometry (GC-O) and aroma extract dilution analysis (AEDA). From the HD method, the main compounds in the oil were found to be p-vinyl-guaiacol (15.5%), 2-pentyl-furan (13.4%), and (2)-ligustilide (9.5%). From the SAFE method, the main compounds were 2-butoxy-ethanol (49.6%), ethyl-pentanoate (4.5%), and mesitylene (4.0%). In HD oil, the most intense aroma-active compounds were 2-pentyl-furan (flavor dilution factor (FD) = 32, odor activity value (OAV) = 57), p-vinyl-guaiacol (FD = 16, OAV = 41), and dimethyl disulfide (FD = 16, OAV = 41). In SAFE oil, the main aroma-active compounds were 2-butoxy ethanol (FD = 32, OAV = 16), and 2-methoxy thiazole (FD = 32, OAV = 25).	[Miyazawa, Mitsuo; Nakahashi, Hiroshi; Kashima, Yusei; Motooka, Ryota; Hara, Nobuyuki; Nakagawa, Hiroki; Yoshii, Takashi; Usami, Atsushi] Kindai Univ, Kinki Univ, Fac Sci & Engn, Dept Appl Chem, Higashiosaka, Osaka 5778502, Japan; [Marumoto, Shinsuke] Kindai Univ, Kinki Univ, Joint Res Ctr, Higashiosaka, Osaka 5778502, Japan	Miyazawa, M (reprint author), Kindai Univ, Kinki Univ, Fac Sci & Engn, Dept Appl Chem, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	miyazawa@apch.kindai.ac.jp					Adams R. P., 2007, IDENTIFICATION ESSEN; Pongsuwan W, 2007, J AGR FOOD CHEM, V55, P231, DOI 10.1021/jf062330u; Namgung HJ, 2010, J SCI FOOD AGR, V90, P1926, DOI 10.1002/jsfa.4036; Nejia H, 2013, NAT PROD RES, V27, P1795, DOI 10.1080/14786419.2012.755680; Cho IH, 2006, J AGR FOOD CHEM, V54, P4820, DOI 10.1021/jf0601416; Ko BK, 2009, J AGR FOOD CHEM, V57, P6862, DOI 10.1021/jf901454j; Beleggia R, 2009, J CEREAL SCI, V49, P301, DOI 10.1016/j.jcs.2008.12.002; Grosch Werner, 1994, Flavour and Fragrance Journal, V9, P147, DOI 10.1002/ffj.2730090403; Fiehn O, 2006, OMICS, V10, P158, DOI 10.1089/omi.2006.10.158; Engel W, 1999, EUR FOOD RES TECHNOL, V209, P237, DOI 10.1007/s002170050486; Kim MY, 2003, J AGR FOOD CHEM, V51, P6173, DOI 10.1021/jf034647p; Cao J., 2005, YAOWU FENXI ZAZHI, V25, P1211; Castioni P., 1996, SCI PHARM, V64, P83; Ito Kikukatsu, 2012, Seikagaku, V84, P853; Knutson R., 2014, NAT PROD RES, V25, P1504; Kurihara T., 1997, ANN REP TOHOKU COLL, V24, P123; Majcher H. H. J., 2009, J FOOD COMPOS ANAL, V22, P606; Mega J. A., 1981, J AGR FOOD CHEM, V29, P1; Pino JA, 2006, FLAVOUR FRAG J, V21, P207, DOI 10.1002/ffj.1703; Schieberle P., 1995, CHARACTERIZATION FOO, P403, DOI 10.1016/B978-044481499-9/50018-4; Seitz E. W., 1994, FERMENTATION PRODUCT, P95; Takahashi K., 2007, NAT PROD RES, V76, P15; WANG P L, 1972, Hortscience, V7, P87; Werkhoff P., 2002, FLAVOR FRAGRANCE ODO, P139	24	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	DEC	2015	64	12					1329	1336		10.5650/jos.ess15161		8	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CY2LQ	WOS:000366240600011		
J	Tominaga, M; Nishino, K; Morisaki, Y; Chujo, Y				Tominaga, Masato; Nishino, Kenta; Morisaki, Yasuhiro; Chujo, Yoshiki			Synthesis, characterization, and optoelectronic study of three biaryl-fused closo-o-carboranes and their nido-[C2B9](-) species	JOURNAL OF ORGANOMETALLIC CHEMISTRY			English	Article						Biaryl; o-Carborane; nido-Carborane; Charge transfer emission	3-COORDINATE GOLD(I) COMPLEXES; AGGREGATION-INDUCED EMISSION; LUMINESCENCE PROPERTIES; POLYMERS; BORON; DERIVATIVES; CHEMISTRY; SUBSTITUTION; COPOLYMERS; BEHAVIORS	A biaryl-fused closo-o-carborane with a phenylthiophene moiety was synthesized and reacted with fluoride to obtain its nido-[C2B9](-) species; the reaction with fluoride to obtain nido-[C2B9](-) species was also performed for biphenyl- and bithiophene-fused o-carboranes, the synthesis of which we have previously reported. The structures and optoelectronic properties of the three carboranes and their nido-[C2B9](-) species were experimentally and theoretically characterized. The nido-[C2B9](-) species possessed high HOMO and LUMO energy levels because of the electron-rich anion species. They also displayed charge transfer (CT) transition bands, and efficient CT emissions were observed in the crystalline as well as solution state because of the shorter carbon carbon bond length in the nido-carborane cage and suppression of the carbon-carbon bond vibration. (C) 2015 Elsevier B.V. All rights reserved.	[Tominaga, Masato; Nishino, Kenta; Morisaki, Yasuhiro; Chujo, Yoshiki] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan	Morisaki, Y (reprint author), Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan.	ymo@chujo.synchem.kyoto-u.ac.jp; chujo@chujo.synchem.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24102013]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "New Polymeric Materials Based on Element-Blocks" (No. 24102013) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Altomare A, 1999, J APPL CRYSTALLOGR, V32, P115, DOI 10.1107/S0021889898007717; BREGADZE VI, 1992, CHEM REV, V92, P209, DOI 10.1021/cr00010a002; Fox MA, 1996, POLYHEDRON, V15, P565, DOI 10.1016/0277-5387(95)00297-6; Visbal R, 2013, J AM CHEM SOC, V135, P4712, DOI 10.1021/ja401523x; Weber L, 2013, DALTON T, V42, P2266, DOI 10.1039/c2dt32378h; Tominaga M, 2014, ASIAN J ORG CHEM, V3, P624, DOI 10.1002/ajoc.201300280; Yasuike S, 1997, HETEROCYCLES, V45, P1899; Wee KR, 2012, ANGEW CHEM INT EDIT, V51, P2677, DOI 10.1002/anie.201109069; PAPETTI S, 1966, J POLYM SCI A1, V4, P1623, DOI 10.1002/pol.1966.150040624; Morisaki Y, 2014, CHEM-ASIAN J, V9, P1247, DOI 10.1002/asia.201400067; Dash BP, 2011, NEW J CHEM, V35, P1955, DOI 10.1039/c1nj20228f; Bae HJ, 2014, DALTON T, V43, P4978, DOI 10.1039/c3dt52465e; Gonzalez-Campo A, 2008, MACROMOLECULES, V41, P8458, DOI 10.1021/ma801483c; Kokado K, 2009, MACROMOLECULES, V42, P1418, DOI 10.1021/ma8027358; Dash BP, 2011, INORG CHEM, V50, P5485, DOI 10.1021/ic200010q; Wee KR, 2012, J AM CHEM SOC, V134, P17982, DOI 10.1021/ja3066623; Lu SY, 2002, PROG POLYM SCI, V27, P1661, DOI 10.1016/S0079-6700(02)00018-7; McKay D, 2015, CHEM SCI, V6, P3117, DOI 10.1039/c5sc00726g; Grimes RN, 2011, CARBORANES, 2ND EDITION, P301, DOI 10.1016/B978-0-12-374170-7.00009-4; Simon YC, 2007, MACROMOLECULES, V40, P5628, DOI 10.1021/ma0709093; Tominaga M, 2014, NEW J CHEM, V38, P5686, DOI 10.1039/c4nj00955j; Colquhoun HM, 1997, POLYMER, V38, P2447, DOI 10.1016/S0032-3861(96)00811-7; Toppino A, 2013, INORG CHEM, V52, P8743, DOI 10.1021/ic400928v; Weber L, 2012, CHEM-EUR J, V18, P8347, DOI 10.1002/chem.201200390; Jelliss PA, 2012, BORON SCIENCE: NEW TECHNOLOGIES AND APPLICATIONS, P355; Sundar RA, 1997, J POLYM SCI POL CHEM, V35, P2387, DOI 10.1002/(SICI)1099-0518(19970915)35:12<2387::AID-POLA8>3.0.CO;2-S; SON DY, 1995, J POLYM SCI POL CHEM, V33, P2969, DOI 10.1002/pola.1995.080331715; PLESEK J, 1992, CHEM REV, V92, P269, DOI 10.1021/cr00010a005; Peterson JJ, 2009, MACROMOLECULES, V42, P8594, DOI 10.1021/ma901703r; Issa F, 2011, CHEM REV, V111, P5701, DOI 10.1021/cr2000866; Crespo O, 2003, INORG CHEM, V42, P2061, DOI 10.1021/ic0259843; Naito H, 2015, ANGEW CHEM INT EDIT, V54, P5084, DOI 10.1002/anie.201500129; Morisaki Y, 2012, CHEM-EUR J, V18, P11251, DOI 10.1002/chem.201201513; Davis AR, 2012, ACS MACRO LETT, V1, P469, DOI 10.1021/mz300037u; HAWTHORNE MF, 1993, ANGEW CHEM INT EDIT, V32, P950, DOI 10.1002/anie.199309501; Shi C, 2013, ANGEW CHEM INT EDIT, V52, P13434, DOI 10.1002/anie.201307333; Dash B.P., 2011, BORON SCI NEW TECHNO, P675, DOI DOI 10.1201/B11199-34; Grimes RN, 2011, CARBORANES, 2ND EDITION, P1; Grimes RN, 2011, CARBORANES, 2ND EDITION, P1053, DOI 10.1016/B978-0-12-374170-7.00002-1; Grimes RN, 2011, CARBORANES, 2ND EDITION, P187, DOI 10.1016/B978-0-12-374170-7.00011-2; Kokado K., 2010, J ORG CHEM, V76, P316; Lerouge F, 2007, DALTON T, P1898, DOI 10.1039/b618771d; Luo JD, 2001, CHEM COMMUN, P1740, DOI 10.1039/b105159h; Parrott M.C., 2005, J AM CHEM SOC, V127, P127; Qin A., 2013, AGGREGATION INDUCED; Sheldrick G.M., 1997, SHELX 97 PROGRAMS CR; Stibr B., 1992, CHEM REV, V92, P225; Lerouge F, 2011, DALTON T, V40, P7541, DOI 10.1039/c1dt10309a	48	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-328X	1872-8561		J ORGANOMET CHEM	J. Organomet. Chem.	DEC 1	2015	798		1				165	170		10.1016/j.jorganchem.2015.06.002		6	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CY1GT	WOS:000366155400026		
J	Li, GZ; Azuma, S; Minegishi, H; Nakamura, H				Li, Guangzhe; Azuma, Soyoko; Minegishi, Hidemitsu; Nakamura, Hiroyuki			Synthesis and biological evaluation of meta-carborane-containing phenoxyacetanilides as inhibitors of hypoxia-inducible factor (HIF)-1 transcriptional activity	JOURNAL OF ORGANOMETALLIC CHEMISTRY			English	Article						meta-Carborane; Hypoxia inducible factor; Transcription; Inhibitor	NEUTRON-CAPTURE THERAPY; DERIVATIVES; CANCER; PHARMACOPHORES; FACTOR-1-ALPHA; CHEMISTRY; DISCOVERY; CLUSTERS; HIF-1	meta-Carboranylphenoxyacetanilides were synthesized by copper catalyzed coupling reaction of meta-carborane and phenyl iodides. The synthesized compounds were evaluated for their ability to inhibit hypoxia-induced HIF-1 transcriptional activity using a cell-based reporter gene assay. Among the compounds synthesized, meta-carborane containing phenoxyanilides 2d and 2h, which have an isobutyl group on meta-carborane, exhibited significant inhibition of hypoxia-induced HIF-1 transcriptional activity toward HeLa cell-based reporter gene assay with the IC50 values of 0.73 and 0.55 mu M, respectively. (C) 2015 Elsevier B.V. All rights reserved.	[Li, Guangzhe; Minegishi, Hidemitsu; Nakamura, Hiroyuki] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Azuma, Soyoko; Minegishi, Hidemitsu] Gakushuin Univ, Fac Sci, Dept Chem, Toshima Ku, Tokyo 1718588, Japan	Nakamura, H (reprint author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	hiro@res.titech.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [26102721]	This work was partially supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Chemical Biology of Natural Products" (26102721) from The Ministry of Education, Culture, Sports, Science and Technology, Japan.	Lee K, 2007, J MED CHEM, V50, P1675, DOI 10.1021/jm0610292; Nakamura H, 2013, BIOORG MED CHEM LETT, V23, P806, DOI 10.1016/j.bmcl.2012.11.081; Shimizu K, 2010, BIOORG MED CHEM LETT, V20, P1453, DOI 10.1016/j.bmcl.2009.12.037; Ban HS, 2010, J AM CHEM SOC, V132, P11870, DOI 10.1021/ja104739t; Nakamura H, 2014, DALTON T, V43, P4941, DOI 10.1039/c3dt52828f; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Minegishi H, 2013, CHEMMEDCHEM, V8, P265, DOI 10.1002/cmdc.201200502; Lunato AJ, 1999, J MED CHEM, V42, P3378, DOI 10.1021/jm990125i; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Scholz M, 2011, CHEM REV, V111, P7035, DOI 10.1021/cr200038x; Soloway AH, 1998, CHEM REV, V98, P1515, DOI 10.1021/cr941195u; Won MS, 2009, BIOCHEM BIOPH RES CO, V385, P16, DOI 10.1016/j.bbrc.2009.05.022; Tiwari R, 2009, J CHEM INF MODEL, V49, P1581, DOI 10.1021/ci900031y; Scholz M, 2011, EUR J MED CHEM, V46, P1131, DOI 10.1016/j.ejmech.2011.01.030; COULT R, 1993, J ORGANOMET CHEM, V462, P19, DOI 10.1016/0022-328X(93)83337-U; Grimes RN, 2011, CARBORANES, 2ND EDITION, P301, DOI 10.1016/B978-0-12-374170-7.00009-4; Endo Y, 2001, CHEM BIOL, V8, P341, DOI 10.1016/S1074-5521(01)00016-3; Endo Y, 1999, J MED CHEM, V42, P1501, DOI 10.1021/jm9900725; Scholz M, 2011, BIOORGAN MED CHEM, V19, P3242, DOI 10.1016/j.bmc.2011.03.054; Julius RL, 2007, P NATL ACAD SCI USA, V104, P4808, DOI 10.1073/pnas.0700316104; Ban HS, 2011, EXPERT OPIN THER PAT, V21, P131, DOI 10.1517/13543776.2011.547477; Bos R, 2001, J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Reynolds RC, 2007, J MED CHEM, V50, P3283, DOI 10.1021/jm0701977; Moss RL, 2014, APPL RADIAT ISOTOPES, V88, P2, DOI 10.1016/j.apradiso.2013.11.109; Wilkinson SM, 2014, ACS CHEM NEUROSCI, V5, P335, DOI 10.1021/cn500054n; Lee MW, 2012, J MED CHEM, V55, P7290, DOI 10.1021/jm300740t; Minegishi H, 2013, ACS MED CHEM LETT, V4, P297, DOI 10.1021/ml3004632; Calabrese G, 2012, DRUG DISCOV TODAY, V17, P153, DOI 10.1016/j.drudis.2011.09.014; Brynda J, 2013, ANGEW CHEM INT EDIT, V52, P13760, DOI 10.1002/anie.201307583; Armstrong AF, 2007, DALTON T, P4240, DOI 10.1039/b709843j	32	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-328X	1872-8561		J ORGANOMET CHEM	J. Organomet. Chem.	DEC 1	2015	798		1				189	195		10.1016/j.jorganchem.2015.05.029		7	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CY1GT	WOS:000366155400029		
J	Nomura, K; Fukuda, H; Matsuda, H; Katao, S; Patamma, S				Nomura, Kotohiro; Fukuda, Hiroya; Matsuda, Hideshi; Katao, Shohei; Patamma, Srisuda			Synthesis and structural analysis of half-titanocenes containing 1,3-imidazolidin-2-iminato ligands: Effect of ligand substituents in ethylene (co)polymerization	JOURNAL OF ORGANOMETALLIC CHEMISTRY			English	Article						Titanium; Imidazolidin-2-iminato; Ethylene polymerization; Polymerization catalysts	MAO CATALYST SYSTEMS; EFFICIENT ETHYLENE/NORBORNENE COPOLYMERIZATION; SYNDIOSPECIFIC STYRENE POLYMERIZATION; PRECISE OLEFIN POLYMERIZATION; TITANIUM COMPLEXES; IMIDAZOLIN-2-IMINATO LIGANDS; CYCLOPENTADIENYL FRAGMENT; LIVING COPOLYMERIZATION; PHOSPHINIMIDE COMPLEXES; ALKENE POLYMERIZATION	A series of half-titanocenes containing 1,3-imidazolidin-2-iminato ligands of type, (tert-BuC5H4)TiCl2[1,3-R-2(CH2N)(2)C=N] [R = Bu-t (2a), cyclohexyl (Cy, 2b), C6H5 (2c), 2,6-Me2C6H3 (2d), 2,6-(Pr2C6H3)-Pr-i (2e)] have been prepared and structures of 2a-d have been determined by X-ray crystallography. Complex 2a showed higher catalytic activity than the Cp analogue (1a) for ethylene polymerization but showed low catalytic activity in ethylene/1-hexene copolymerization under the similar conditions; the 2,6-Me2C6H3 analogue (2d) showed moderate catalytic activity for the ethylene/1-hexene copolymerization. The copolymerization with styrene proceeded in a living manner under certain conditions, whereas the other complexes (2a-c) including the Cp analogues, CpTiCl2[1,3-R-2(CH2N)(2)C=N] (1a-d), showed low catalytic activities and/or afforded a mixture of polymers (copolymer, and homopolymers) under the similar conditions. (C) 2015 Elsevier B.V. All rights reserved.	[Nomura, Kotohiro; Matsuda, Hideshi; Patamma, Srisuda] Tokyo Metropolitan Univ, Dept Chem, Grad Sch Sci & Engn, Hachioji, Tokyo 1920397, Japan; [Nomura, Kotohiro; Fukuda, Hiroya; Katao, Shohei] Nara Inst Sci & Technol, Grad Sch Mat Sci, Ikoma, Nara 6300101, Japan	Nomura, K (reprint author), Tokyo Metropolitan Univ, Dept Chem, Grad Sch Sci & Engn, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.	ktnomura@tmu.ac.jp			Japan Society for the Promotion of Science (JSPS) [24350049]; Tokyo Metropolitan government; priority research program by TMG	The present research is partly supported by Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (JSPS, No. 24350049). S.P. expresses her thanks to Tokyo Metropolitan government (Asian Human Resources Fund) for predoctoral fellowship, and the project is also supported partially by priority research program by TMG. The authors also express their thanks to Tosoh Finechem Co. for donating MAO (TMAO).	Alt HG, 2006, COORDIN CHEM REV, V250, P1, DOI 10.1016/j.ccr.2005.05.022; Wang W, 2005, ADV SYNTH CATAL, V347, P433, DOI 10.1002/adsc.200404275; Apisuk W, 2013, J POLYM SCI POL CHEM, V51, P2575, DOI 10.1002/pola.26638; Kinjo R, 2010, ANGEW CHEM INT EDIT, V49, P5930, DOI 10.1002/anie.201002889; Dias AR, 2004, J ORGANOMET CHEM, V689, P203, DOI 10.1016/j.jorganchem.2003.10.005; Nomura K, 2003, MACROMOLECULES, V36, P3797, DOI 10.1021/ma034215f; Nomura K, 2002, MACROMOLECULES, V35, P5388, DOI 10.1021/ma0200773; Nomura K, 2000, MACROMOLECULES, V33, P8122, DOI 10.1021/ma0011284; [Anonymous], 2000, CRYSTALSTRUCTURE 3 8; Nomura K, 2007, J MOL CATAL A-CHEM, V267, P1, DOI 10.1016/j.molcata.2006.11.006; Nomura K, 2004, J MOL CATAL A-CHEM, V220, P133, DOI 10.1016/j.molcata.2004.06.010; Nomura K, 2011, CHEM REV, V111, P2342, DOI 10.1021/cr100207h; Nomura K, 2010, CATAL SURV ASIA, V14, P33, DOI 10.1007/s10563-010-9086-4; Nomura K, 2011, DALTON T, V40, P7666, DOI 10.1039/c1dt10086f; ALTOMARE A, 1994, J APPL CRYSTALLOGR, V27, P435, DOI 10.1107/S002188989400021X; Liu J, 2007, ADV SYNTH CATAL, V349, P2235, DOI 10.1002/adsc.200700247; Nomura K, 2002, ORGANOMETALLICS, V21, P3042, DOI 10.1021/om020179h; Domski GJ, 2007, PROG POLYM SCI, V32, P30, DOI 10.1016/j.progpolymsci.2006.11.001; Zhang H, 2005, J AM CHEM SOC, V127, P9364, DOI 10.1021/ja052198z; Wang W, 2005, J AM CHEM SOC, V127, P4582, DOI 10.1021/ja050274s; Nomura K, 2000, MACROMOLECULES, V33, P3187, DOI 10.1021/ma000317j; [Anonymous], 2000, CRYSTALSTRUCTURE 4 0, P196; Makio H, 2011, CHEM REV, V111, P2363, DOI 10.1021/cr100294r; [Anonymous], 2013, INT S REL HOM HET CA; Nomura K, 2011, DALTON T, V40, P7842, DOI 10.1039/c1dt10467e; Bolton PD, 2005, ADV SYNTH CATAL, V347, P355, DOI 10.1002/adsc.200404267; [Anonymous], 2012, CHEM INT POL S CIPS2; Suhm J, 1998, J MOL CATAL A-CHEM, V128, P215, DOI 10.1016/S1381-1169(97)00175-1; Stephan DW, 2003, ORGANOMETALLICS, V22, P1937, DOI 10.1021/om020954t; Nomura K, 2011, MACROMOLECULES, V44, P1986, DOI 10.1021/ma200018z; Nomura K, 2007, J ORGANOMET CHEM, V692, P4675, DOI 10.1016/j.jorganchem.2007.04.043; Nomura K, 2012, J MOL CATAL A-CHEM, V363, P501, DOI 10.1016/j.molcata.2012.08.001; Nomura K, 1998, MACROMOLECULES, V31, P7588, DOI 10.1021/ma980690f; Beddie C, 2004, ORGANOMETALLICS, V23, P5240, DOI 10.1021/om049545i; Stephan DW, 1999, ORGANOMETALLICS, V18, P1116, DOI 10.1021/om980955e; Zhang H, 2006, MACROMOLECULES, V39, P5266, DOI 10.1021/ma060503a; Nomura K, 2000, J MOL CATAL A-CHEM, V159, P127, DOI 10.1016/S1381-1169(00)00181-3; Nomura K, 1998, ORGANOMETALLICS, V17, P2152, DOI 10.1021/om980106r; Nomura K, 2003, MACROMOLECULES, V36, P2633, DOI 10.1021/ma030053b; Beurskens P.T., 1999, DIRDIF 99 PROGRAM SY; Delferro M., 2000, CHEM REV, V100, P1167; Delferro M., 2011, CHEM REV, V111, P2450; Gibson VC, 2003, CHEM REV, V103, P283, DOI 10.1021/cr980461r; Ijpeij E. G., 2005, [No title captured], Patent No. [WO 2005090418, 2005090418]; Ijpeij E. G., 2007, [No title captured], Patent No. [WO 2007031295, 2007031295]; Ishino H., 2004, ORGANOMETALLICS, V23, P454; Kretschmer WP, 2002, CHEM COMMUN, P608, DOI 10.1039/b111343g; Mason A.F., 2007, MACROMOLECULAR ENG, P217; McMeeking J., 2000, [No title captured], Patent No. [USP 6114481, 6114481]; Milani B., 2009, DALTON T, P8769; Nomura K, 2009, DALTON T, P8811, DOI 10.1039/b910407k; Nomura K., 2014, LECT NOTES CHEM SERI, P51; Nomura K, 2006, CHEM COMMUN, P2659, DOI 10.1039/b605005k; Nomura K., 2010, SYNDIOTACTIC POLYSTY, P60; Schellenberg J., 2009, J PROG POLYM SCI, V34, P688; Schellenberg J., 2010, SYNDIOTACTIC POLYSTY; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stehan D.W., 1998, [No title captured], Patent No. [EP 881233 A1, 881233]; Stephan W., 2005, ORGANOMETALLICS, V24, P2548; Tamm M, 2006, DALTON T, P459, DOI 10.1039/b511752f; Tamm M, 2004, CHEM COMMUN, P876, DOI 10.1039/b401041h; Toldy L., 1979, Ger. Pat., Patent No. [DE 2916140, 2916140]; Zhang H, 2007, DALTON T, P1802, DOI 10.1039/b701003f	63	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-328X	1872-8561		J ORGANOMET CHEM	J. Organomet. Chem.	DEC 1	2015	798		2				375	383		10.1016/j.jorganchem.2015.04.028		9	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CY1GV	WOS:000366155600012		
J	Okada, M; Nakayama, Y; Shiono, T				Okada, Mitsuhiro; Nakayama, Yuushou; Shiono, Takeshi			Highly soluble polynorbornene prepared by an anilinonaphthoquinone-ligated nickel complex via coordination-insertion polymerization	JOURNAL OF ORGANOMETALLIC CHEMISTRY			English	Article						Polynorbornene; Vinyl-addition; Nickel; Single-site catalyst	VINYL ADDITION POLYMERIZATION; CARBOXYLIC-ACID ESTERS; IN-SITU FORMATION; NORBORNENE POLYMERIZATION; PALLADIUM(II) COMPLEXES; VINYL/ADDITION POLYMERIZATION; ALUMINOXANE CATALYSTS; MECHANISTIC INSIGHTS; MOLECULAR-STRUCTURES; METAL-CATALYSTS	Norbornene polymerization was conducted with 2-(2,6-diisopropylanilino)-1,4-naphthoquinone-ligated nickel complex (1) activated by B(C6F5)(3) and dried modified methylaluminoxane (dMMAO) in toluene at 40 degrees C. The 1-B(C6F5)(3) system showed higher activity than the 1-dMMAO system and gave higher molecular-weight polynorbornene via coordination-insertion polymerization. The solubility of the polymer obtained by 1-B(C6F5)(3) was also higher than that obtained by 1-dMMAO, and dissolved in cyclohexane even at room temperature. The self-standing films of the polynorbornene obtained by the B(C6F5)(3) system were prepared by the solution casting method with cyclohexane. The films thus prepared showed good transparency in the UV-visible region. The C-13 NMR spectra of the polymers indicated that the microstructures of the polynorbornenes were dependent on the activator used. The heat decomposition temperature, i.e., 10% weight loss, determined by TGA was 386 degrees C for the polymer obtained by 1-B(C6F5)(3) and 402 degrees C for that obtained by 1-dMMAO, respectively. (C) 2015 Elsevier B.V. All rights reserved.	[Okada, Mitsuhiro; Nakayama, Yuushou; Shiono, Takeshi] Hiroshima Univ, Grad Sch Engn, Dept Appl Chem, Higashihiroshima 7398527, Japan	Shiono, T (reprint author), Hiroshima Univ, Grad Sch Engn, Dept Appl Chem, 1-4-1 Kagamiyama, Higashihiroshima 7398527, Japan.	tshiono@hiroshima-u.ac.jp					Jang Y, 2006, EUR POLYM J, V42, P1250, DOI 10.1016/j.eurpolymj.2005.11.028; GOODALL BL, 1995, MACROMOL SYMP, V89, P421, DOI 10.1002/masy.19950890139; Lozan V, 2003, Z NATURFORSCH B, V58, P1152; Yamazaki M, 2004, J MOL CATAL A-CHEM, V213, P81, DOI 10.1016/j.molcata.2003.10.058; Zhang JK, 2011, J ORGANOMET CHEM, V696, P3697, DOI 10.1016/j.jorganchem.2011.08.017; Saito T, 2012, POLYMER, V53, P308, DOI 10.1016/j.polymer.2011.12.004; Blank F, 2010, DALTON T, V39, P3609, DOI 10.1039/b925674a; Mathew JP, 1996, MACROMOLECULES, V29, P2755, DOI 10.1021/ma9515285; Nishizawa O, 2008, J POLYM SCI POL CHEM, V46, P1185, DOI 10.1002/pola.22458; Kaita S, 2006, MACROMOL RAPID COMM, V27, P1752, DOI 10.1002/marc.200600464; Wu Q, 2002, J POLYM SCI POL CHEM, V40, P1421, DOI 10.1002/pola.10227; Okada M, 2007, J ORGANOMET CHEM, V692, P5183, DOI 10.1016/j.jorganchem.2007.07.049; Karafilidis C, 2007, ANGEW CHEM INT EDIT, V46, P3745, DOI 10.1002/anie.200604264; Zhang D, 2013, DALTON T, V42, P12020, DOI 10.1039/c3dt50957e; Sacchi MC, 2001, MACROMOL CHEM PHYSIC, V202, P2052, DOI 10.1002/1521-3935(20010601)202:10<2052::AID-MACP2052>3.0.CO;2-P; Blank F, 2010, J MOL CATAL A-CHEM, V330, P1, DOI 10.1016/j.molcata.2010.07.009; MEHLER C, 1992, MACROMOLECULES, V25, P4226, DOI 10.1021/ma00042a030; Patil AO, 2003, J POLYM SCI POL CHEM, V41, P2095, DOI 10.1002/pola.10725; Karafilidis C, 2004, ANGEW CHEM INT EDIT, V43, P2444, DOI 10.1002/anie.200353454; Hasan T, 2002, MACROMOLECULES, V35, P8933, DOI 10.1021/ma025586j; Arndt M, 1998, POLYM BULL, V41, P433, DOI 10.1007/s002890050384; Saraev VV, 2012, KINET CATAL+, V53, P456, DOI 10.1134/S002315841204009X; Yamashita M, 2006, ORGANOMETALLICS, V25, P4588, DOI 10.1021/om060347w; Wang HY, 2006, J ORGANOMET CHEM, V691, P1275, DOI 10.1016/j.jorganchem.2005.12.001; Mi X, 2003, MACROMOL CHEM PHYSIC, V204, P868, DOI 10.1002/macp.200390057; Lassahn PG, 2002, MACROMOL RAPID COMM, V23, P16, DOI 10.1002/1521-3927(20020101)23:1<16::AID-MARC16>3.0.CO;2-K; Sachse A, 2010, DALTON T, V39, P3903, DOI 10.1039/b925535d; Walter MD, 2009, J AM CHEM SOC, V131, P9055, DOI 10.1021/ja9025598; Heinz BS, 1998, MACROMOL RAPID COMM, V19, P251, DOI 10.1002/(SICI)1521-3927(19980501)19:5<251::AID-MARC251>3.0.CO;2-#; Barnes DA, 2003, MACROMOLECULES, V36, P2623, DOI 10.1021/ma030001m; Walter MD, 2009, J POLYM SCI POL CHEM, V47, P2560, DOI 10.1002/pola.23340; Sun WH, 2003, ORGANOMETALLICS, V22, P3678, DOI 10.1021/om030018t; KAMINSKY W, 1991, MAKROMOL CHEM-M SYMP, V47, P83, DOI 10.1002/masy.19910470108; Abu-Surrah AS, 2000, POLYHEDRON, V19, P1601, DOI 10.1016/S0277-5387(00)00436-8; ARNDT M, 1995, J MOL CATAL A-CHEM, V101, P171, DOI 10.1016/1381-1169(95)00083-6; Funk JK, 2004, ORGANOMETALLICS, V23, P1680, DOI 10.1021/om049943l; Okada M, 2006, MACROMOL RAPID COMM, V27, P1418, DOI 10.1002/marc.200600335; Nelkenbaum E, 2005, ORGANOMETALLICS, V24, P2645, DOI 10.1021/om0490379; Qiao YL, 2013, ORGANOMETALLICS, V32, P1932, DOI 10.1021/om400033n; Janiak C, 2001, J MOL CATAL A-CHEM, V166, P193, DOI 10.1016/S1381-1169(00)00475-1; Zhang D, 2004, ORGANOMETALLICS, V23, P3270, DOI 10.1021/om0499658; Berchtold B, 2002, J POLYM SCI POL CHEM, V40, P3604, DOI 10.1002/pola.10450; Li XF, 2002, J POLYM SCI POL CHEM, V40, P2680, DOI 10.1002/pola.10358; Abu-Surrah AS, 2001, MACROMOL CHEM PHYSIC, V202, P599, DOI 10.1002/1521-3935(20010301)202:5<599::AID-MACP599>3.0.CO;2-1; He XH, 2007, J POLYM SCI POL CHEM, V45, P4733, DOI 10.1002/pola.22221; Haselwander TFA, 1997, MACROMOLECULES, V30, P5345, DOI 10.1021/ma970306z; Massa W, 1997, ACTA POLYM, V48, P432, DOI 10.1002/actp.1997.010481003; Benade LL, 2011, POLYHEDRON, V30, P2878, DOI 10.1016/j.poly.2011.08.021; Long YY, 2011, DALTON T, V40, P1610, DOI 10.1039/c0dt01225d; Lejeune M, 2006, MACROMOL RAPID COMM, V27, P865, DOI 10.1002/marc.200600055; KAMINSKY W, 1992, POLYM INT, V28, P251, DOI 10.1002/pi.4990280312; Mast C, 1999, MACROMOL RAPID COMM, V20, P232, DOI 10.1002/(SICI)1521-3927(19990401)20:4<232::AID-MARC232>3.0.CO;2-A; Deng JA, 2013, ORGANOMETALLICS, V32, P4507, DOI 10.1021/om400268y; Dang L, 2014, ORGANOMETALLICS, V33, P6812, DOI 10.1021/om500839w; TSUJINO T, 1965, MAKROMOLEKUL CHEM, V85, P71; Janiak C, 2001, MACROMOL RAPID COMM, V22, P479, DOI 10.1002/1521-3927(20010401)22:7<479::AID-MARC479>3.0.CO;2-C; Hasan T, 2004, MACROMOLECULES, V37, P7432, DOI 10.1021/ma049455p; Makovetskii KL, 2006, KINET CATAL+, V47, P241, DOI 10.1134/S0023158406020133; Kohara T, 1996, MACROMOL SYMP, V101, P571, DOI 10.1002/masy.19961010163; KAMINSKY W, 1992, J MOL CATAL, V74, P109, DOI 10.1016/0304-5102(92)80228-9; Blank F, 2009, COORDIN CHEM REV, V253, P827, DOI 10.1016/j.ccr.2008.05.010; Blank F., 2012, J ORGANOMET CHEM, V696, P473; Ivin K.J., 1987, ENCY POLYM SCI ENG, V9, P634; Ivin K.J., 1997, OLEFIN METATHESIS ME, P496; Lassahn PG, 2003, DALTON T, P927, DOI 10.1039/b209633a; Lassahn PG, 2003, DALTON T, P4437, DOI 10.1039/b302937a; Siedle G, 2007, DALTON T, P52, DOI 10.1039/b613789j; Wang HY, 2005, EUR J INORG CHEM, P1665, DOI 10.1002/ejic.200400856; Wu Q., 2000, ACS SYM SER, V760, P165	69	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-328X	1872-8561		J ORGANOMET CHEM	J. Organomet. Chem.	DEC 1	2015	798		2				384	387		10.1016/j.jorganchem.2015.06.028		4	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CY1GV	WOS:000366155600013		
J	Bessho, K				Bessho, Kazuhiko			Complications and Quality of Life in Long-Term Survivors of Biliary Atresia with Their Native Livers	JOURNAL OF PEDIATRICS			English	Editorial Material							KASAI OPERATION; HEPATOCELLULAR-CARCINOMA; PORTOPULMONARY HYPERTENSION; PULMONARY-HYPERTENSION; SPLENIC EMBOLIZATION; ESOPHAGEAL-VARICES; PEDIATRIC-PATIENTS; ANTIREFLUX VALVE; TRANSPLANTATION; CHOLANGITIS		[Bessho, Kazuhiko] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka 5650871, Japan	Bessho, K (reprint author), Osaka Univ, Grad Sch Med, Dept Pediat, Yamada Oka 2-2-D5, Suita, Osaka 5650871, Japan.	bessho@ped.med.osaka-u.ac.jp					Wu ET, 2001, PEDIATR SURG INT, V17, P390; Tomita H, 2014, J HEPATOL, V60, P1242, DOI 10.1016/j.jhep.2014.01.028; Shimaoka S, 2001, J PEDIATR SURG, V36, P349, DOI 10.1053/jpsu.2001.20713; Bijl EJ, 2013, NETH J MED, V71, P170; Hol L, 2008, EUR J GASTROEN HEPAT, V20, P227, DOI 10.1097/MEG.0b013e3282cfb716; Squires RH, 2014, HEPATOLOGY, V60, P362, DOI 10.1002/hep.27191; Sasaki H, 2007, J PEDIATR SURG, V42, P1329, DOI 10.1016/j.jpedsurg.2007.03.027; Taat F, 2004, PEDIATR BLOOD CANCER, V43, P603, DOI 10.1002/pbc.20115; Nio M, 2003, J PEDIATR SURG, V38, P997, DOI 10.1016/S0022-3468(03)00178-7; Vera A, 2012, J PEDIATR GASTR NUTR, V55, P336, DOI 10.1097/MPG.0b013e318233ff17; Abbasi A, 2010, JCPSP-J COLL PHYSICI, V20, P369, DOI 06.2010/JCPSP.369372; Hadzic N, 2011, J PEDIATR-US, V159, P617, DOI 10.1016/j.jpeds.2011.03.004; Lien TH, 2015, J PEDIATR GASTR NUTR, V60, P654, DOI 10.1097/MPG.0000000000000676; Bu LN, 2003, J PEDIATR SURG, V38, P590, DOI 10.1053/jpsu.2003.50128; Kumagi T, 2012, LIVER INT, V32, P510, DOI 10.1111/j.1478-3231.2011.02668.x; SAEKI M, 1991, J PEDIATR SURG, V26, P800, DOI 10.1016/0022-3468(91)90142-G; Potgieser ARE, 2012, J ADOLESCENT HEALTH, V50, P641, DOI 10.1016/j.jadohealth.2011.10.007; Kuroda T, 2007, J PEDIATR SURG, V42, P2106, DOI 10.1016/j.jpedsurg.2007.08.037; DeRusso PA, 2003, PEDIATRICS, V112, P185, DOI 10.1542/peds.112.1.185; Ayoub T, 2011, CURR OPIN ORGAN TRAN, V16, P331, DOI 10.1097/MOT.0b013e328346e138; Klein GL, 2002, PEDIATR TRANSPLANT, V6, P136, DOI 10.1034/j.1399-3046.2002.01060.x; Ogasawara Y, 2003, J PEDIATR SURG, V38, P1826, DOI 10.1016/S0022-3468(0-i)00623-7; Krowka MJ, 2013, J HEPATOL, V59, P367, DOI 10.1016/j.jhep.2013.03.026; Hogler W, 2012, J PEDIATR GASTR NUTR, V54, P313, DOI 10.1097/MPG.0b013e31823e9412; Vajro P, 2014, DIGEST LIVER DIS, V46, P295, DOI 10.1016/j.dld.2013.10.018; Brunati A, 2007, PEDIATR TRANSPLANT, V11, P117, DOI 10.1111/j.1399-3046.2006.00623.x; KUMPE DA, 1985, RADIOLOGY, V155, P357; Yonemura T, 1999, BRIT J SURG, V86, P1139, DOI 10.1046/j.1365-2168.1999.01207.x; Ng VL, 2014, J PEDIATR-US, V165, P539, DOI 10.1016/j.jpeds.2014.05.038; Kyoden Y, 2008, LIVER TRANSPLANT, V14, P186, DOI 10.1002/lt.21344; Cartin-Ceba R, 2014, CLIN LIVER DIS, V18, P421, DOI 10.1016/j.cld.2014.01.004; Luo Y, 2008, WORLD J PEDIATR, V4, P14, DOI 10.1007/s12519-008-0003-0; KULKARNI PB, 1977, AM J DIS CHILD, V131, P442; Shinkai M, 2009, J PEDIATR GASTR NUTR, V48, P443; Condino AA, 2005, J PEDIATR-US, V147, P20, DOI 10.1016/j.jpeds.2005.02.019; Sundaram SS, 2013, J PEDIATR-US, V163, P1052, DOI 10.1016/j.jpeds.2013.04.037; Uchida Y, 2006, AM J TRANSPLANT, V6, P2443, DOI 10.1111/j.1600-6143.2006.01487.x; LILLY JR, 1979, J PEDIATR SURG, V14, P301, DOI 10.1016/S0022-3468(79)80487-X; Karrer FM, 1996, ARCH SURG-CHICAGO, V131, P493; Davenport Mark, 2006, Indian Journal of Pediatrics, V73, P825, DOI 10.1007/BF02790394; Goda T, 2013, J PEDIATR SURG, V48, P2373, DOI 10.1016/j.jpedsurg.2013.08.009; Umeshita K, 2003, LANCET, V362, P687, DOI 10.1016/S0140-6736(03)14230-4; Shirouzu Y, 2006, LIVER TRANSPLANT, V12, P870, DOI 10.1002/lt.20758; Shneider BL, 2007, LIVER TRANSPLANT, V13, P1482, DOI 10.1002/lt.21303; Lykavieris P, 2005, HEPATOLOGY, V41, P366, DOI 10.1002/hep.20547; Adami MR, 2013, WORLD J GASTROENTERO, V19, P2053, DOI 10.3748/wjg.v19.i13.2053; Lee S, 2013, PEDIATR SURG INT, V29, P1297, DOI 10.1007/s00383-013-3366-9; Tatekawa Y, 2001, J PEDIATR SURG, V36, P436, DOI 10.1053/jpsu.2001.21600; Valayer J, 1996, J PEDIATR SURG, V31, P1546, DOI 10.1016/S0022-3468(96)90174-8; Shneider BL, 2006, J PEDIATR-US, V148, P467, DOI 10.1016/j.jpeds.2005; Miga D, 2001, J PEDIATR-US, V139, P291, DOI 10.1067/mpd.2001.115967; Nio M, 1996, J PEDIATR SURG, V31, P381, DOI 10.1016/S0022-3468(96)90742-3; Nio M, 2004, J PEDIATR SURG, V39, P1797, DOI 10.1016/j.jpedsurg.2004.08.021; de Vries W, 2011, CLIN GASTROENTEROL H, V9, P1086, DOI 10.1016/j.cgh.2011.07.024; Nio M, 2012, J PEDIATR SURG, V47, P2179, DOI 10.1016/j.jpedsurg.2012.09.003; BRANDT CT, 1989, J PEDIATR SURG, V24, P642, DOI 10.1016/S0022-3468(89)80710-9; Brandt CT, 1989, J PEDIATR SURG, V24, P4; Kasai M, 1959, SHUJUTSU OPERATION, V13, P733; Lind RC, 2015, EUR J PEDIATR SURG, V25, P60, DOI 10.1055/s-0034-1387941; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Rook Michelle, 2009, Curr Gastroenterol Rep, V11, P83; Saing H, 2003, J PEDIAT, V142, P566; Trotter JF, 2002, CURR TREAT OPTIONS G, V5, P491, DOI 10.1007/s11938-002-0037-7; Wildhaber BE, 2012, ISRN SURG, V2012	64	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	DEC	2015	167	6					1202	1206		10.1016/j.jpeds.2015.08.041		5	Pediatrics	Pediatrics	CY1CI	WOS:000366143900009		
J	Kato, S; Yoshimura, K; Kimata, T; Mine, K; Uchiyama, T; Kaneko, K				Kato, Shogo; Yoshimura, Ken; Kimata, Takahisa; Mine, Kenji; Uchiyama, Takamichi; Kaneko, Kazunari			Urinary 8-Hydroxy-2 '-Deoxyguanosine: A Biomarker for Radiation-Induced Oxidative DNA Damage in Pediatric Cardiac Catheterization	JOURNAL OF PEDIATRICS			English	Article							CONGENITAL HEART-DISEASE; IONIZING-RADIATION; MEDICAL RADIATION; CANCER-RISKS; CHILDREN; EXPOSURE; STRESS	Objective To determine the utility of urinary 8-hydroxy-20-deoxyguanosine (8-OHdG) as a sensitive biomarker for radiation-induced cellular DNA damage in children undergoing cardiac catheterization. Study design We enrolled pediatric patients with congenital heart diseases requiring cardiac catheterization in conjunction with healthy children and children under sedation as control. Demographic, clinical, laboratory and invasive hemodynamic data, urinary 8-OHdG levels, and radiation exposure measurements were collected prospectively. Results Nineteen patients, 10 healthy children and 9 children under sedation, were studied. In 19 patients who underwent cardiac catheterization, the median level of 8-OHdG in urine obtained at 24-48 hours after the procedure was significantly higher than at baseline (44.0 vs 17.3 ng/mg creatinine, P = .0001). Furthermore, the urinary 8-OHdG level after the procedure increased in 18 of the 19 study subjects. In contrast, there was no significant difference in 8-OHdG levels between the 2 spot urine samples obtained at arbitrary intervals of 24-48 hours in 10 healthy children (P = .7213), and at baseline and 24-48 hours following echocardiography in 9 children under sedation (P = .1097). Stepwise multiple regression analysis revealed that the cumulative air kerma during the cardiac catheterization was the variable which was strongly and significantly associated with the ratio of post-to precardiac catheterization urinary 8-OHdG levels among the evaluated variables (R-2 = 0.7179, F = 11.0256, P = .0007). Conclusions Urinary 8-OHdG could be a useful biomarker for radiation-induced cellular DNA damage in children undergoing diagnostic cardiac catheterization.	[Kato, Shogo; Yoshimura, Ken; Kimata, Takahisa; Mine, Kenji; Uchiyama, Takamichi; Kaneko, Kazunari] Kansai Med Univ, Dept Pediat, Hirakata, Osaka 5731010, Japan	Kaneko, K (reprint author), Kansai Med Univ, Dept Pediat, 2-5-1 Shin Machi, Hirakata, Osaka 5731010, Japan.	kanekok@hirakata.kmu.ac.jp			Mami Mizutani Foundation	Funded by the Mami Mizutani Foundation. The authors declare no conflicts of interest.	Hall EJ, 2009, PEDIATR RADIOL, V39, pS57, DOI 10.1007/s00247-008-1027-2; Ogino K, 2011, FREE RADICAL RES, V45, P147, DOI 10.3109/10715762.2010.520318; Bianchi P, 2013, ANESTH ANALG, V117, P455, DOI 10.1213/ANE.0b013e318299a7da; Evans MD, 2010, FASEB J, V24, P1249, DOI 10.1096/fj.09-147124; Glatz AC, 2014, J PEDIATR-US, V164, P789, DOI 10.1016/j.jpeds.2013.10.074; Kaneko K, 2012, CLIN CHIM ACTA, V413, P1822, DOI 10.1016/j.cca.2012.07.009; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Eisenberg MJ, 2011, CAN MED ASSOC J, V183, P430, DOI 10.1503/cmaj.100463; Ait-Ali L, 2010, HEART, V96, P269, DOI 10.1136/hrt.2008.160309; Rosello-Lleti E, 2012, AM J HYPERTENS, V25, P236, DOI 10.1038/ajh.2011.202; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Hornhardt S, 2014, DNA REPAIR, V16, P54, DOI 10.1016/j.dnarep.2014.02.001; Hamaoka A, 2010, J CARDIOL, V56, P245, DOI 10.1016/j.jjcc.2010.06.006; LOFT S, 1993, J TOXICOL ENV HEALTH, V40, P391; Beels L, 2009, CIRCULATION, V120, P1903, DOI 10.1161/CIRCULATIONAHA.109.880385; Justino H, 2006, PEDIATR RADIOL, V36, P146, DOI 10.1007/s00247-006-0194-2; Ron E, 2003, HEALTH PHYS, V85, P47, DOI 10.1097/00004032-200307000-00011; Johnson JN, 2014, CIRCULATION, V130, P161, DOI 10.1161/CIRCULATIONAHA.113.005425; Brasch RC, 2008, PEDIATR RADIOL, V38, pS281, DOI 10.1007/s00247-008-0773-5; SCHUELER BA, 1994, AM J ROENTGENOL, V162, P173; Balter S, 2007, CATHETER CARDIO INTE, V70, P244, DOI 10.1002/ccd.21141; Richter B, 2012, CLIN RES CARDIOL, V101, P217, DOI 10.1007/s00392-011-0383-3; Kobayashi J, 2004, DNA REPAIR, V3, P855, DOI 10.1016/j.dnarep.2004.03.023; Little MP, 2009, RADIOLOGY, V251, P6, DOI [10.1148/radiol.2511081686, 10.1148/radiol.1.2511081686]; Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5; Mayne ST, 2003, J NUTR, V133, P933; UNSCEAR 2000, 2000, HEALTH PHYS, V79, P314, DOI DOI 10.1097/00004032-200009000-00017	27	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	DEC	2015	167	6					1369	+		10.1016/j.jpeds.2015.07.042		7	Pediatrics	Pediatrics	CY1CI	WOS:000366143900038		
J	Haney, S; Fox-Kemper, B; Julien, K; Webb, A				Haney, Sean; Fox-Kemper, Baylor; Julien, Keith; Webb, Adrean			Symmetric and Geostrophic Instabilities in the Wave-Forced Ocean Mixed Layer	JOURNAL OF PHYSICAL OCEANOGRAPHY			English	Article						Circulation; Dynamics; Ageostrophic circulations; Baroclinic flows; Eddies; Fronts; Instability; Waves; oceanic	LARGE-EDDY-SIMULATION; LANGMUIR CIRCULATIONS; BAROCLINIC STABILITY; CLIMATE SIMULATIONS; POTENTIAL VORTICITY; TURBULENCE; MODEL; RESTRATIFICATION; CURRENTS; ENERGY	Here, the effects of surface waves on submesoscale instabilities are studied through analytical and linear analyses as well as nonlinear large-eddy simulations of the wave-averaged Boussinesq equations. The wave averaging yields a surface-intensified current (Stokes drift) that advects momentum, adds to the total Coriolis force, and induces a Stokes shear force. The Stokes-Coriolis force alters the geostrophically balanced flow by reducing the burden on the Eulerian-Coriolis force to prop up the front, thereby potentially inciting an anti-Stokes Eulerian shear, while maintaining the Lagrangian (Eulerian plus Stokes) shear. Since the Lagrangian shear is maintained, the Charney-Stern-Pedlosky criteria for quasigeostrophic (QG) baroclinic instability are unchanged with the appropriate Lagrangian interpretation of the shear and QG potential vorticity. While the Stokes drift does not directly affect vorticity, the anti-Stokes Eulerian shear contributes to the Ertel potential vorticity (PV). When the Stokes shear and geostrophic shear are aligned (antialigned), the PV is more (less) cyclonic. If the Stokes-modified PV is anticyclonic, the flow is unstable to symmetric instabilities (SI). Stokes drift also weakly impacts SI through the Stokes shear force. When the Stokes and Eulerian shears are the same (opposite) sign, the Stokes shear force does positive (negative) work on the flow associated with SI. Stokes drift also allows SI to extract more potential energy from the front, providing an indirect mechanism for Stokes-induced restratification.	[Haney, Sean] Univ Colorado, Dept Atmospher & Ocean Sci, Boulder, CO 80309 USA; [Haney, Sean] CIRES, Boulder, CO USA; [Fox-Kemper, Baylor] Brown Univ, Dept Earth Environm & Planetary Sci, Providence, RI 02912 USA; [Julien, Keith] Univ Colorado, Dept Appl Math, Boulder, CO 80309 USA; [Webb, Adrean] Univ Tokyo, Dept Ocean Technol Policy & Environm, Kashiwa, Chiba, Japan	Haney, S (reprint author), Univ Calif San Diego, Scripps Inst Oceanog, 9500 Gilman Dr 0213, La Jolla, CA 92093 USA.	shaney@ucsd.edu			NASA [NNX09AF38G]; NSF [OCE 0934737, 1258907]; National Science Foundation [CNS-0821794]; University of Colorado Boulder	The authors thank Prof. Gregory Chini for insightful discussions of interactions between symmetric instability and Langmuir circulations, Prof. Eric D'Asaro for suggesting that the submesoscale instabilities of the boundary layer including Stokes forces be explored, and Dr. Peter Sullivan for help with the NCAR LES model. BFK, KJ, AW, and SH were partially supported by NASA NNX09AF38G and NSF OCE 0934737 and 1258907. This work utilized the Janus supercomputer, which is supported by the National Science Foundation (Award Number CNS-0821794) and the University of Colorado Boulder. The Janus supercomputer is a joint effort of the University of Colorado Boulder, the University of Colorado Denver, and the National Center for Atmospheric Research.	CRAIK ADD, 1977, J FLUID MECH, V81, P209, DOI 10.1017/S0022112077001980; Thomas LN, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044680; HUANG NE, 1979, J FLUID MECH, V91, P191, DOI 10.1017/S0022112079000112; STONE PH, 1970, J ATMOS SCI, V27, P721, DOI 10.1175/1520-0469(1970)027<0721:ONGBSP>2.0.CO;2; Lentz SJ, 2012, ANNU REV MAR SCI, V4, P317, DOI 10.1146/annurev-marine-120709-142745; McWilliams JC, 2004, J FLUID MECH, V511, P135, DOI 10.1017/S0022112004009358; MCWILLIAMS JC, 1985, J ATMOS SCI, V42, P1773, DOI 10.1175/1520-0469(1985)042<1773:AUVMST>2.0.CO;2; Fox-Kemper B, 2011, OCEAN MODEL, V39, P61, DOI 10.1016/j.ocemod.2010.09.002; VANNESTE J, 1993, MATH COMPUT MODEL, V17, P149, DOI 10.1016/0895-7177(93)90099-K; Thomas LN, 2013, DEEP-SEA RES PT II, V91, P96, DOI 10.1016/j.dsr2.2013.02.025; Molemaker MJ, 2010, J FLUID MECH, V654, P35, DOI 10.1017/S0022112009993272; McWilliams JC, 2013, J FLUID MECH, V730, P464, DOI 10.1017/jfm.2013.348; NAKAMURA N, 1988, J ATMOS SCI, V45, P3253, DOI 10.1175/1520-0469(1988)045<3253:SSOBIO>2.0.CO;2; Holm DD, 1996, PHYSICA D, V98, P415, DOI 10.1016/0167-2789(96)00105-4; Thomas LN, 2005, J PHYS OCEANOGR, V35, P2457, DOI 10.1175/JPO2830.1; MOENG CH, 1984, J ATMOS SCI, V41, P2052, DOI 10.1175/1520-0469(1984)041<2052:ALESMF>2.0.CO;2; Hamlington PE, 2014, J PHYS OCEANOGR, V44, P2249, DOI 10.1175/JPO-D-13-0139.1; Brostrom G, 2014, OCEAN DYNAM, V64, P1039, DOI 10.1007/s10236-014-0723-8; Haine TWN, 1998, J PHYS OCEANOGR, V28, P634, DOI 10.1175/1520-0485(1998)028<0634:GSABIO>2.0.CO;2; Mahadevan A, 2012, SCIENCE, V337, P54, DOI 10.1126/science.1218740; CHARNEY JG, 1962, J ATMOS SCI, V19, P159, DOI 10.1175/1520-0469(1962)019<0159:OTSOIB>2.0.CO;2; D'Asaro E, 2011, SCIENCE, V332, P318, DOI 10.1126/science.1201515; CRAIK ADD, 1976, J FLUID MECH, V73, P401, DOI 10.1017/S0022112076001420; EADY ET, 1949, TELLUS, V1, P33; McWilliams JC, 2014, J PHYS OCEANOGR, V44, P870, DOI 10.1175/JPO-D-13-0122.1; HOSKINS BJ, 1974, Q J ROY METEOR SOC, V100, P480, DOI 10.1002/qj.49710042520; Lentz SJ, 2008, J PHYS OCEANOGR, V38, P2341, DOI 10.1175/2008JPO3986.1; Webb A, 2011, OCEAN MODEL, V40, P273, DOI 10.1016/j.ocemod.2011.08.007; Fan YL, 2014, J CLIMATE, V27, P4752, DOI 10.1175/JCLI-D-13-00583.1; TANDON A, 1994, J PHYS OCEANOGR, V24, P1419, DOI 10.1175/1520-0485(1994)024<1419:MLRDTA>2.0.CO;2; LEIBOVICH S, 1981, J FLUID MECH, V102, P141, DOI 10.1017/S0022112081002589; Li K, 2012, J PHYS OCEANOGR, V42, P1945, DOI 10.1175/JPO-D-11-0225.1; Large WG, 2009, CLIM DYNAM, V33, P341, DOI 10.1007/s00382-008-0441-3; STONE PH, 1971, J FLUID MECH, V45, P659, DOI 10.1017/S0022112071000260; Thomson J, 2013, J GEOPHYS RES-OCEANS, V118, P5951, DOI 10.1002/2013JC008837; Polton JA, 2005, J PHYS OCEANOGR, V35, P444, DOI 10.1175/JPO2701.1; Sullivan PP, 2011, J ATMOS SCI, V68, P2395, DOI 10.1175/JAS-D-10-05010.1; McWilliams JC, 2000, SPILL SCI TECHNOL B, V6, P225; McWilliams JC, 1997, J FLUID MECH, V334, P1, DOI 10.1017/S0022112096004375; Capet X, 2008, J PHYS OCEANOGR, V38, P2256, DOI 10.1175/2008JPO3810.1; Boccaletti G, 2007, J PHYS OCEANOGR, V37, P2228, DOI 10.1175/JPO3101.1; Smyth WD, 2002, OCEAN DYNAM, V52, P104, DOI 10.1007/s10236-002-0012-9; Van Roekel LP, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007516; Taylor JR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049312; Gnanadesikan A, 1995, J PHYS OCEANOGR, V25, P3148, DOI 10.1175/1520-0485(1995)025<3148:SAIOTE>2.0.CO;2; PEDLOSKY J, 1964, J ATMOS SCI, V21, P201, DOI 10.1175/1520-0469(1964)021<0201:TSOCIT>2.0.CO;2; McWilliams JC, 2012, J PHYS OCEANOGR, V42, P1793, DOI 10.1175/JPO-D-12-07.1; STONE PH, 1966, J ATMOS SCI, V23, P390, DOI 10.1175/1520-0469(1966)023<0390:ONGBS>2.0.CO;2; Boyd J.P., 2001, CHEBYSHEV FOURIER SP; Haney S., 2015, THESIS; Li Q., 2015, OCEAN MODEL IN PRESS, DOI [10.1016/j.ocemod.2015.07.020, DOI 10.1016/J.OCEMOD.2015.07.020]; Pedlosky J., 1982, GEOPHYS FLUID DYNAMI; Tolman H. L., 2009, MAB CONTRIBUTION, V276; Ursell F., 1950, GEOPHYS            S, V6, P1, DOI [10.1111/j.1365-246X.1950.tb02968.x, DOI 10.1111/J.1365-246X.1950.TB02968.X]; Webb A, 2015, OCEAN MODEL, V96, P49, DOI 10.1016/j.ocemod.2014.12.007	55	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-3670	1520-0485		J PHYS OCEANOGR	J. Phys. Oceanogr.	DEC	2015	45	12					3033	3056		10.1175/JPO-D-15-0044.1		24	Oceanography	Oceanography	CY4RC	WOS:000366394900002		
J	Samata, H; Kobayashi, K; Hanioka, M; Ozawa, TC				Samata, Hiroaki; Kobayashi, Katsutoshi; Hanioka, Masashi; Ozawa, Tadashi C.			Fluorescence quantum yield of Gd0.9-xRxEu0.1OOH (R=Y, La) crystals	JOURNAL OF RARE EARTHS			English	Article						rare-earth oxyhydroxide; phosphor; elemental substitution; fluorescence quantum yield	RARE-EARTH OXYHYDROXIDES; LUMINESCENCE PROPERTIES; EUROPIUM; EU3+	Gd0.9-xRxEu0.1OOH (R=Y, La) crystals were synthesized by a flux method using a mixture of NaOH and KOH as the flux. X-ray diffraction data were well refined using the Rietveld method assuming that the crystals had a monoclinic structure belonging to the P2(1)/m space group. The unit cell volumes of the Gd0.9-xLaxEu0.1OOH crystals increased with increasing x, whereas those of Gd0.9-xYxEu0.1OOH decreased with increasing x. The Commission Internationale de I'Eclairage (CIE) chromaticity coordinates of Gd0.9-xRxEu0.1OOH (R=Y, La) crystals were located in the red region and were nearly constant over the range of x values considered. The fluorescence quantum yield Phi(f) monotonically decreased with increasing x regardless of the ionic radii of the substitute ions. The fact that the Phi(f) value of La0.9Eu0.1OOH was greater than that of Gd0.9Eu0.1OOH indicated that the observed decrease in the Phi(f) values of the Gd0.9-xLaxEu0.1OOH crystals up to x=0.3 could not be attributed to an increase in the distance between Eu3+ ions or to a decrease in the Gd3+ content. The decrease might be due to an increase of killer centers introduced by elemental substitutions with the larger ion.	[Samata, Hiroaki; Kobayashi, Katsutoshi; Hanioka, Masashi] Kobe Univ, Grad Sch Maritime Sci, Higashinada Ku, Kobe, Hyogo 6580022, Japan; [Ozawa, Tadashi C.] Natl Inst Mat Sci, Superconducting Properties Unit, Mat Dev Grp, Tsukuba, Ibaraki 3050047, Japan	Samata, H (reprint author), Kobe Univ, Grad Sch Maritime Sci, Higashinada Ku, Kobe, Hyogo 6580022, Japan.	samata@maritime.kobe-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [21560696, 24560827]	Project supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants (21560696, 24560827)	Adachi G., 1999, SCI RARE EARTHS, P775; Izumi F, 2000, MATER SCI FORUM, V321-3, P198; VYSSOTSKY V, 1961, PHYS REV, V123, P1566, DOI 10.1103/PhysRev.123.1566; Chang C, 2006, NANOTECHNOLOGY, V17, P1981, DOI 10.1088/0957-4484/17/8/031; Samata H, 2015, J RARE EARTH, V33, P712, DOI 10.1016/S1002-0721(14)60475-0; Xia ZG, 2010, J PHYS CHEM SOLIDS, V71, P175, DOI 10.1016/j.jpcs.2009.10.016; Suzuki K, 2009, PHYS CHEM CHEM PHYS, V11, P9850, DOI 10.1039/b912178a; Malchukova E, 2014, J RARE EARTH, V32, P217, DOI 10.1016/S1002-0721(14)60055-7; Ma Q, 2012, J RARE EARTH, V30, P426, DOI 10.1016/S1002-0721(12)60066-0; Samata H, 2007, J CRYST GROWTH, V304, P448, DOI 10.1016/j.jcrysgro.2007.03.025; HOLSA J, 1985, INORG CHEM, V24, P1539, DOI 10.1021/ic00204a026; Zhang LX, 2013, J RARE EARTH, V31, P449, DOI 10.1016/S1002-0721(12)60302-0; Samata H, 2009, J ALLOY COMPD, V468, P566, DOI 10.1016/j.jallcom.2008.01.056; Zhong JM, 2014, J RARE EARTH, V32, P5, DOI 10.1016/S1002-0721(14)60026-0; Honma T, 1998, J PHYS CHEM SOLIDS, V59, P1187, DOI 10.1016/S0022-3697(98)00056-0; Cotton S., 2006, LANTHANIDE ACTINIDE, P61; HOLSA J, 1990, J PHYS CHEM-US, V94, P4835, DOI 10.1021/j100375a016; Pratt S, 1979, CHEM PHYS LETT, V65, P100; Samata H, 2014, J MAT SCI CHEM ENG, V2, P23; Samata H, 2015, J RARE EARTH, V33, P177, DOI 10.1016/S1002-0721(14)60399-9; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Sheina LP, 1965, IAN SSSR NEORG MATER, V1, P2219; Sinha SP, 1983, SYSTEMATICS PROPERTI, P311; Young RA, 1995, RIETVELD METHOD, P1	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1002-0721			J RARE EARTH	J. Rare Earths	DEC	2015	33	12					1256	1260		10.1016/S1002-0721(14)60554-8		5	Chemistry, Applied	Chemistry	CY3JA	WOS:000366304200004		
J	Yoshida, K; Radner, H; Mjaavatten, MD; Greenberg, JD; Kavanaugh, A; Kishimoto, M; Matsui, K; Okada, M; Reed, G; Saeki, Y; Tohma, S; Kremer, J; Solomon, DH				Yoshida, Kazuki; Radner, Helga; Mjaavatten, Maria D.; Greenberg, Jeffrey D.; Kavanaugh, Arthur; Kishimoto, Mitsumasa; Matsui, Kazuo; Okada, Masato; Reed, George; Saeki, Yukihiko; Tohma, Shigeto; Kremer, Joel; Solomon, Daniel H.			Incidence and Predictors of Biological Antirheumatic Drug Discontinuation Attempts among Patients with Rheumatoid Arthritis in Remission: A CORRONA and NinJa Collaborative Cohort Study	JOURNAL OF RHEUMATOLOGY			English	Article						RHEUMATOID ARTHRITIS; ANTIRHEUMATIC AGENTS; AFFILIATIONS; BIOLOGICAL ANTIRHEUMATIC AGENTS; REMISSION; DISCONTINUATION	LOW-DISEASE-ACTIVITY; ADALIMUMAB PLUS METHOTREXATE; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; INFLIXIMAB; THERAPY; MONOTHERAPY; ETANERCEPT; CHALLENGES; WITHDRAWAL	Objective. We conducted a longitudinal observational study of biological disease-modifying antirheumatic drugs (bDMARD) to describe the proportions of patients with rheumatoid arthritis in remission who discontinued these agents, and to assess the potential predictors of the decision to discontinue. Methods. We used data from the US COnsortium of Rheumatology Researchers Of North America (CORRONA) and the Japanese National Database of Rheumatic Diseases by iR-net in Japan (NinJa) registries, and ran parallel analyses. Patients treated with bDMARD who experienced remission (defined by the Clinical Disease Activity Index <= 2.8) were included. The outcome of interest was the occurrence of bDMARD discontinuation while in remission. The predictors of discontinuation were assessed in the Cox regression models. Frailty models were also used to examine the effects of individual physicians in the discontinuation decision. Results. The numbers of eligible patients who were initially in remission were 6263 in the CORRONA and 744 in the NinJa. Among these patients, 10.0% of patients in CORRONA and 11.8% of patients in NinJa discontinued bDMARD while in remission over 5 years, whereas many of the remaining patients lost remission before discontinuing bDMARD. Shorter disease duration was associated with higher rates of discontinuation in both cohorts. In CORRONA, methotrexate use and lower disease activity were also associated with discontinuation. In frailty models, physician random effects were significant in both cohorts. Conclusion. Among patients who initially experienced remission while receiving bDMARD, around 10% remained in remission and then discontinued bDMARD in both registries. Several factors were associated with more frequent discontinuation while in remission. Physician preference likely is also an important correlate of bDMARD discontinuation, indicating the need for standardization of practice.	[Yoshida, Kazuki; Radner, Helga; Mjaavatten, Maria D.; Solomon, Daniel H.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Yoshida, Kazuki] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Reed, George] Univ Massachusetts, Sch Med, Worcester, MA USA; [Greenberg, Jeffrey D.] New York Univ Hosp Joint Dis, New York, NY USA; [Kremer, Joel] Albany Med Coll, Ctr Rheumatol, Albany, NY 12208 USA; [Kavanaugh, Arthur] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA; [Radner, Helga] Med Univ Vienna, Div Rheumatol, Dept Internal Med 3, Vienna, Austria; [Mjaavatten, Maria D.] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway; [Kishimoto, Mitsumasa; Okada, Masato] St Lukes Int Hosp, Immunorheumatol Ctr, Tokyo, Japan; [Matsui, Kazuo] Kameda Med Ctr, Dept Rheumatol, Kamogawa, Japan; [Saeki, Yukihiko] Natl Hosp Org Osaka Minami Med Ctr, Dept Clin Res, Kawachi Nagano, Osaka, Japan; [Tohma, Shigeto] Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Dept Rheumatol, Sagamihara, Kanagawa, Japan	Yoshida, K (reprint author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	kazukiyoshida@mail.harvard.edu			Abbvie; Amgen; AstraZeneca; Genentech; Horizon Pharma; Eli Lilly; Novartis; Pfizer; Vertex; UCB; Ministry of Health, Labor, and Welfare of Japan; Japan Student Services Organization and Harvard T.H. Chan School of Public Health; Takeda; Bayer; PhRMA; Pfizer Japan Inc.; CORRONA;  [NIH-K24AR055989]	The CORRONA Rheumatoid Arthritis registry has been supported through contracted subscriptions in the last 2 years by Abbvie, Amgen, AstraZeneca, Genentech, Horizon Pharma, Eli Lilly, Novartis, Pfizer, Vertex, and UCB. This study was conducted entirely independently of any pharmaceutical company input. NinJa has been supported in part by a Health and Labor Sciences Research Grant from the Ministry of Health, Labor, and Welfare of Japan. KY receives tuition support jointly from Japan Student Services Organization and Harvard T.H. Chan School of Public Health (partially supported by training grants from Pfizer, Takeda, Bayer, and PhRMA). JDG is an employee and shareholder of CORRONA. He has received consulting fees from AstraZeneca and Pfizer. AK has conducted sponsored clinical research for Amgen and UCB. MK received speaking fees and/or honoraria from Pfizer. MO received speaking fees and/or honoraria from Pfizer. GR is an employee of CORRONA. ST received research grants from Pfizer Japan Inc. JK received research grants from Amgen, Genentech, Pfizer, and UCB. He owns shares in CORRONA and derives salary support. DHS receives salary support from institutional research grants from Eli Lilly, Amgen, and CORRONA. He also serves in unpaid roles in studies funded by Pfizer and Eli Lilly, and receives salary support from NIH-K24AR055989.	Smolen JS, 2013, LANCET, V381, P918, DOI 10.1016/S0140-6736(12)61811-X; Nishimoto N, 2014, MOD RHEUMATOL, V24, P17, DOI 10.3109/14397595.2013.854079; Yoshida K, 2014, ANN RHEUM DIS, V73, P595, DOI 10.1136/annrheumdis-2013-203302; Brocq O, 2009, JOINT BONE SPINE, V76, P350, DOI 10.1016/j.jbspin.2008.11.009; Navarro-Millan I, 2013, CLIN THER, V35, P1850, DOI 10.1016/j.clinthera.2013.09.015; Fortier I, 2011, AM J EPIDEMIOL, V174, P261, DOI 10.1093/aje/kwr194; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Nawata M, 2008, MOD RHEUMATOL, V18, P460, DOI 10.1007/s10165-008-0089-1; Tanaka Y, 2010, ANN RHEUM DIS, V69, P1286, DOI 10.1136/ard.2009.121491; Kavanaugh A, 2015, ANN RHEUM DIS, V74, P1150, DOI 10.1136/annrheumdis-2014-206435; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Tanaka Y, 2015, ANN RHEUM DIS, V74, P389, DOI 10.1136/annrheumdis-2013-204016; van der Maas A, 2012, ANN RHEUM DIS, V71, P1849, DOI 10.1136/annrheumdis-2011-200945; Tanaka Y, 2012, CURR OPIN RHEUMATOL, V24, P319, DOI 10.1097/BOR.0b013e3283524e4c; van den Broek M, 2011, ANN RHEUM DIS, V70, P1389, DOI 10.1136/ard.2010.147751; Harigai M, 2012, MOD RHEUMATOL, V22, P814, DOI 10.1007/s10165-011-0586-5; Varadhan R, 2010, MED CARE, V48, pS96, DOI 10.1097/MLR.0b013e3181d99107; Yoshida K, 2013, CLIN EXP RHEUMATOL, V31, pS28; Curtis JR, 2010, ARTHRIT CARE RES, V62, P101, DOI 10.1002/acr.20020; Takeuchi T, 2015, RHEUMATOLOGY, V54, P683, DOI 10.1093/rheumatology/keu338; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Quinn MA, 2005, ARTHRITIS RHEUM, V52, P27, DOI 10.1002/art.20712; Detert J, 2013, ANN RHEUM DIS, V72, P844, DOI 10.1136/annrheumdis-2012-201612; Emery P, 2014, NEW ENGL J MED, V371, P1781, DOI 10.1056/NEJMoa1316133; Jacobs W, 2014, COCHRANE DB SYST REV, V9; Kremer JM, 2005, CLIN EXP RHEUMATOL, V23, pS172; Polinski JM, 2009, ARTHRIT RHEUM-ARTHR, V61, P745, DOI 10.1002/art.24560; Smolen JS, 2014, LANCET, V383, P321, DOI 10.1016/S0140-6736(13)61751-1; Smolen JS, 2015, ANN RHEUM DIS, V74, P843, DOI 10.1136/annrheumdis-2013-204632; Tanaka Y, 2013, CLIN THER, V35, P2028, DOI 10.1016/j.clinthera.2013.10.008; van Vollenhoven RF, 2015, ANN RHEUM DIS; Yamanaka H, 2006, MOD RHEUMATOL, V16, P75; Yoshida K, 2015, RHEUMATOLOGY	33	0	0	J RHEUMATOL PUBL CO	TORONTO	365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA	0315-162X	1499-2752		J RHEUMATOL	J. Rheumatol.	DEC	2015	42	12					2238	2246		10.3899/jrheum.150240		9	Rheumatology	Rheumatology	CX7VB	WOS:000365909900005		
J	Asai, S; Takahashi, N; Funahashi, K; Yoshioka, Y; Takemoto, T; Terabe, K; Asai, N; Ishiguro, N; Kojima, T				Asai, Shuji; Takahashi, Nobunori; Funahashi, Koji; Yoshioka, Yutaka; Takemoto, Toki; Terabe, Kenya; Asai, Nobuyuki; Ishiguro, Naoki; Kojima, Toshihisa			Concomitant Methotrexate Protects Against Total Knee Arthroplasty in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors	JOURNAL OF RHEUMATOLOGY			English	Article						RHEUMATOID ARTHRITIS; TUMOR NECROSIS FACTOR INHIBITOR; METHOTREXATE; KNEE JOINT; LONGTERM EFFECT; TOTAL KNEE ARTHROPLASTY	MODIFYING ANTIRHEUMATIC DRUGS; DISEASE-ACTIVITY SCORE; DOUBLE-BLIND; RADIOGRAPHIC DAMAGE; ORTHOPEDIC-SURGERY; PREDICTIVE FACTORS; PLUS METHOTREXATE; JOINT REPLACEMENT; CLINICAL-TRIAL; COMBINATION	Objective. To determine the effects of concomitant methotrexate (MTX) on the incidence of total knee arthroplasty (TKA) resulting from the progression of joint destruction in patients with rheumatoid arthritis (RA) during longterm treatment with tumor necrosis factor (TNF) inhibitors. Methods. A total of 155 patients with RA (310 knee joints) received TNF inhibitors at our institute between May 1, 2001, and May 31, 2008. A total of 111 symptomatic (tender and/or swollen) knee joints in 68 patients were retrospectively studied over the course of a minimum of 5 years of followup. The median (interquartile range) followup period was 8.1 (7.0-9.3) years. All data were analyzed using the knee joint as the statistical unit of analysis. TKA during treatment with TNF inhibitors was used as the outcome variable in predictive analyses. The cumulative incidence of TKA was compared by concomitant or no MTX use (MTX +/-). Results. There were 79 subjects (71%) who received concomitant MTX. According to Kaplan-Meier estimates, the cumulative incidence of TKA for the MTX+ group was significantly lower than that for the MTX-group (24% vs 45% at 5 yrs, respectively, p = 0.035). Multivariate analysis using the Cox proportional hazards model revealed that concomitant MTX (HR 0.44, 95% CI 0.22-0.89), Larsen grade (HR 2.93, 95% CI 1.94-4.41), and older age at baseline (HR 1.04, 95% CI 1.01-1.08) were independent predictors of TKA. Conclusion. Concomitant MTX reduces the incidence of TKA by 56% in patients with RA during longterm treatment with TNF inhibitors.	[Asai, Shuji; Takahashi, Nobunori; Funahashi, Koji; Yoshioka, Yutaka; Takemoto, Toki; Terabe, Kenya; Asai, Nobuyuki; Ishiguro, Naoki; Kojima, Toshihisa] Nagoya Univ, Grad Sch Med, Dept Orthoped Surg, Nagoya, Aichi 4668550, Japan	Asai, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Orthoped Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	asai@med.nagoya-u.ac.jp					Breedveld FC, 2004, ANN RHEUM DIS, V63, P627, DOI 10.1136/ard.2003.011395; Himanen AK, 2007, J BONE JOINT SURG BR, V89B, P609, DOI 10.1302/0301-620X.89D5.17950; Leon L, 2013, J RHEUMATOL, V40, P1850, DOI 10.3899/jrheum.130118; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Emery P, 2011, ARTHRITIS RHEUM-US, V63, P1200, DOI 10.1002/art.30263; James D, 2004, RHEUMATOLOGY, V43, P369, DOI 10.1093/rheumatology/keh059; Jamsen E, 2009, J BONE JOINT SURG AM, V91A, P38, DOI 10.2106/JBJS.G.01686; Wolfe F, 1998, ARTHRITIS RHEUM, V41, P1072, DOI 10.1002/1529-0131(199806)41:6<1072::AID-ART14>3.0.CO;2-G; Eckstein F, 2013, ANN RHEUM DIS, V72, P707, DOI 10.1136/annrheumdis-2011-201164; Breedveld FC, 2006, ARTHRITIS RHEUM, V54, P26, DOI 10.1002/art.21519; Drossaers-Bakker KW, 2000, RHEUMATOLOGY, V39, P998, DOI 10.1093/rheumatology/39.9.998; Kameda H, 2013, ANN RHEUM DIS, V72, P310, DOI 10.1136/annrheumdis-2012-201804; Imagama T, 2013, CLIN RHEUMATOL, V32, P823, DOI 10.1007/s10067-013-2181-y; Burmester GR, 2015, ANN RHEUM DIS, V74, P1037, DOI 10.1136/annrheumdis-2013-204769; Koike T, 2014, MOD RHEUMATOL, V24, P390, DOI 10.3109/14397595.2013.843760; Aletaha D, 2011, ARTHRITIS RHEUM-US, V63, P3702, DOI 10.1002/art.30634; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Visser K, 2009, ANN RHEUM DIS, V68, P1086, DOI 10.1136/ard.2008.094474; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Kapetanovic MC, 2008, ANN RHEUM DIS, V67, P1412, DOI 10.1136/ard.2007.086710; Kameda H, 2011, J RHEUMATOL, V38, P1585, DOI 10.3899/jrheum.110014; Seki E, 2009, CLIN RHEUMATOL, V28, P453, DOI 10.1007/s10067-008-1076-9; Wells G, 2009, ANN RHEUM DIS, V68, P954, DOI 10.1136/ard.2007.084459; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; GUTH A, 1995, INVEST RADIOL, V30, P181, DOI 10.1097/00004424-199503000-00008; LARSEN A, 1977, ACTA RADIOL DIAGN, V18, P481; Keystone E, 2008, ARTHRITIS RHEUM, V58, P3319, DOI 10.1002/art.23964; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Choy EHS, 2001, NEW ENGL J MED, V344, P907; Jacobs JW, 2012, RHEUMATOLOGY OXFO S4, V51, piv27; Kuper HH, 1997, BRIT J RHEUMATOL, V36, P855	32	1	1	J RHEUMATOL PUBL CO	TORONTO	365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA	0315-162X	1499-2752		J RHEUMATOL	J. Rheumatol.	DEC	2015	42	12					2255	2260		10.3899/jrheum.150410		6	Rheumatology	Rheumatology	CX7VB	WOS:000365909900007		
J	Kobayashi, N; Kobayashi, I; Mori, M; Sato, S; Iwata, N; Shigemura, T; Agematsu, K; Yokota, S; Koike, K				Kobayashi, Norimoto; Kobayashi, Ichiro; Mori, Masaaki; Sato, Shinji; Iwata, Naomi; Shigemura, Tomonari; Agematsu, Kazunaga; Yokota, Shumpei; Koike, Kenichi			Increased Serum B Cell Activating Factor and a Proliferation-inducing Ligand Are Associated with Interstitial Lung Disease in Patients with Juvenile Dermatomyositis	JOURNAL OF RHEUMATOLOGY			English	Article						B CELL ACTIVATING FACTOR; PROLIFERATION-INDUCING LIGAND; ANTI-MDA5; JUVENILE DERMATOMYOSITIS; INTERSTITIAL LUNG DISEASE	CLINICALLY AMYOPATHIC DERMATOMYOSITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; IDIOPATHIC INFLAMMATORY MYOPATHIES; JAPANESE PATIENTS; SJOGRENS-SYNDROME; GENE 5; BAFF; AUTOANTIBODIES; EXPRESSION; RITUXIMAB	Objective. Rapidly progressive interstitial lung disease (RP-ILD) is an intractable and fatal complication of juvenile dermatomyositis (JDM). This study evaluated serum levels of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in JDM patients with complicating ILD, and their association with ILD phenotypes, clinical variables, and anti-melanoma differentiation-associated gene 5 (MDA5). Methods. We measured the levels of BAFF, APRIL, and anti-MDA5 in the sera of 23 JDM patients with ILD [8 in the RP-ILD group and 15 in the chronic ILD (C-ILD) group], 17 JDM patients without ILD (non-ILD group), and 10 age-matched controls, using the ELISA method. ILD was identified by high-resolution computed tomography. Results. Serum BAFF titers were significantly higher in the JDM patients with RP-ILD versus those with C-ILD (p = 0.011) and in healthy controls (p = 0.0004). The C-ILD group had significantly higher levels of BAFF versus controls (p = 0.0001). Serum APRIL was markedly elevated in the RP-ILD group as compared with the C-ILD group (p = 0.003) and controls (p = 0.006). In patients with ILD, both BAFF and APRIL levels were correlated with serum Krebs von den Lungen-6 and interleukin 18. Subjects with high titer anti-MDA5 (> 200 U) had higher levels of BAFF and APRIL than those with low titer anti-MDA5 (< 100 U; p = 0.019 and p = 0.0029, respectively), which may have been due to a relationship between RP-ILD and high anti-MDA5 titer. Conclusion. Our findings of markedly elevated levels of BAFF and APRIL in patients with RP-ILD JDM suggest the potential importance of these cytokines in the diagnosis and treatment of RP-ILD accompanying JDM.	Shinshu Univ, Sch Med, Dept Pediat, Grad Sch Med, Matsumoto, Nagano 3908621, Japan; Shinshu Univ, Sch Med, Dept Infect & Host Def, Grad Sch Med, Matsumoto, Nagano 3908621, Japan; [Kobayashi, Ichiro] Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido, Japan; [Mori, Masaaki; Yokota, Shumpei] Yokohama City Univ, Grad Sch Med, Dept Pediat, Yokohama, Kanagawa 232, Japan; [Sato, Shinji] Tokai Univ, Sch Med, Dept Rheumatol, Isehara, Kanagawa 25911, Japan; [Iwata, Naomi] Aichi Childrens Hlth & Med Ctr, Dept Immunol & Infect Dis, Obu, Japan	Kobayashi, N (reprint author), Shinshu Univ, Sch Med, Dept Pediat, Asahi 3-1-1, Matsumoto, Nagano 3908621, Japan.	norimoto@shinshu-u.ac.jp			Ministry of Health, Labor, and Welfare of Japan	Supported by a Health Labor Sciences Research Grant from The Ministry of Health, Labor, and Welfare of Japan.	Baek A, 2012, J NEUROIMMUNOL, V249, P96, DOI 10.1016/j.jneuroim.2012.04.006; Bielecki M, 2010, J RHEUMATOL, V37, P2286, DOI 10.3899/jrheum.100454; GUZMAN J, 1994, J RHEUMATOL, V21, P739; Nakashima R, 2010, RHEUMATOLOGY, V49, P433, DOI 10.1093/rheumatology/kep375; Ravelli A, 2010, ARTHRIT CARE RES, V62, P63, DOI 10.1002/acr.20015; Hamaguchi Y, 2011, ARCH DERMATOL, V147, P391, DOI 10.1001/archdermatol.2011.52; Kobayashi N, 2015, RHEUMATOLOGY, V54, P784, DOI 10.1093/rheumatology/keu385; Koga T, 2012, RHEUMATOLOGY, V51, P1278, DOI 10.1093/rheumatology/ker518; Gono T, 2010, RHEUMATOLOGY, V49, P1878, DOI 10.1093/rheumatology/keq196; Kobayashi I, 2001, J PEDIATR-US, V138, P274, DOI 10.1067/mpd.2001.110324; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; McCann LJ, 2006, RHEUMATOLOGY, V45, P1255, DOI 10.1093/rheumatology/kel099; Kaneko T, 2014, MOD RHEUMATOL, V24, P310, DOI 10.3109/14397595.2013.843748; Mariette X, 2003, ANN RHEUM DIS, V62, P168, DOI 10.1136/ard.62.2.168; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; KOBAYASHI J, 1995, CHEST, V108, P311, DOI 10.1378/chest.108.2.311; Sato S, 2013, MOD RHEUMATOL, V23, P496, DOI 10.1007/s10165-012-0663-4; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; Vosters JL, 2012, RHEUMATOLOGY, V51, P1557, DOI 10.1093/rheumatology/kes080; Keir GJ, 2012, EUR RESPIR J, V40, P641, DOI 10.1183/09031936.00163911; Stohl W, 2004, ANN RHEUM DIS, V63, P1096, DOI 10.1136/ard.2003.018663; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Arai S, 2013, MOD RHEUMATOL, V23, P872, DOI 10.1007/s10165-012-0756-0; Vincent FB, 2012, IMMUNOL CELL BIOL, V90, P293, DOI 10.1038/icb.2011.111; Sato S, 2005, ARTHRITIS RHEUM, V52, P1571, DOI 10.1002/art.21023; Krystufkova O, 2009, ANN RHEUM DIS, V68, P836, DOI 10.1136/ard.2008.091405; Matsushita T, 2006, ARTHRITIS RHEUM, V54, P192, DOI 10.1002/art.21526; Kobayashi I, 2011, J PEDIATR-US, V158, P675, DOI 10.1016/j.jpeds.2010.11.033; Gunawardena H, 2009, RHEUMATOLOGY, V48, P607, DOI 10.1093/rheumatology/kep078; Clottu A, 2012, DERMATOLOGY, V225, P376, DOI 10.1159/000346573; Nakajima H, 2000, J RHEUMATOL, V27, P1164; Wedderburn LR, 2009, BEST PRACT RES CL RH, V23, P665, DOI 10.1016/j.berh.2009.07.007; Sem M, 2009, RHEUMATOLOGY, V48, P968, DOI 10.1093/rheumatology/kep157; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2007, CURR OPIN IMMUNOL, V19, P327, DOI 10.1016/j.coi.2007.04.008; Marie I, 2012, RESP MED, V106, P581, DOI 10.1016/j.rmed.2012.01.001; Furie R, 2011, ARTHRITIS RHEUM-US, V63, P3918, DOI 10.1002/art.30613; Stohl W, 2012, ARTHRITIS RHEUM-US, V64, P2328, DOI 10.1002/art.34400; Gerami P, 2006, J AM ACAD DERMATOL, V54, P597, DOI 10.1016/j.jaad.2005.10.041; BITNUM S, 1964, J PEDIATR-US, V64, P101, DOI 10.1016/S0022-3476(64)80325-5; De Padilla CML, 2013, J RHEUMATOL, V40, P294, DOI 10.3899/jrheum.120555; Huber AM, 2013, ARTHRIT CARE RES, V66, P732; Rider LG, 2011, ARTHRIT CARE RES, V63, pS118, DOI 10.1002/acr.20532; Tansley SL, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4600	44	0	0	J RHEUMATOL PUBL CO	TORONTO	365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA	0315-162X	1499-2752		J RHEUMATOL	J. Rheumatol.	DEC	2015	42	12					2412	2418		10.3899/jrheum.140977		7	Rheumatology	Rheumatology	CX7VB	WOS:000365909900028		
J	Nakamura, K; Ohira, M; Yokokawa, Y; Nagasawa, Y				Nakamura, Keisuke; Ohira, Masayoshi; Yokokawa, Yoshiharu; Nagasawa, Yuya			Validity and Reproducibility of an Incremental Sit-To-Stand Exercise Test for Evaluating Anaerobic Threshold in Young, Healthy Individuals	JOURNAL OF SPORTS SCIENCE AND MEDICINE			English	Article						Sit-to-stand; cycle ergometer; anaerobic threshold; correlations; reproducibility; validity	6-MINUTE WALK TEST; OXYGEN-UPTAKE; CARDIAC REHABILITATION; PERCEIVED EXERTION; ARM; RELIABILITY; MUSCLE; ADULTS; PERFORMANCE; CONSUMPTION	Sit-to-stand exercise (STS) is a common activity of daily living. The objectives of the present study were: 1) to assess the validity of aerobic fitness measurements based on anaerobic thresholds (ATs), during incremental sit-to-stand exercise (ISTS) with and without arm support compared with an incremental cycle-ergometer (CE) test; and 2) to examine the reproducibility of the AT measured during the ISTSs. Twenty-six healthy individuals randomly performed the ISTS and CE test. Oxygen uptakes at the AT (AT-VO2) and heart rate at the AT (AT-HR) were determined during the ISTSs and CE test, and repeated-measures analyses of variance and Tukey's post-hoc test were used to evaluate the differences between these variables. Pearson correlation coefficients were used to assess the strength of the relationship between AT-VO2 and AT-HR during the ISTSs and CE test. Data analysis yielded the following correlations: AT-VO2 during the ISTS with arm support and the CE test, r = 0.77 (p < 0.05); AT-VO2 during the ISTS without arm support and the CE test, r = 0.70 (p < 0.05); AT-HR during the ISTS with arm support and the CE test, r = 0.80 (p < 0.05); and AT-HR during the ISTS without arm support and the CE test, r = 0.66 (p < 0.05). The AT-VO2 values during the ISTS with arm support (18.5 +/- 1.9 mL.min(-1).kg(-1)) and the CE test (18.4 +/- 1.8 mL.min(-1).kg(-1)) were significantly higher than those during the ISTS without arm support (16.6 +/- 1.8 mL.min(-1).kg(-1); p < 0.05). The AT-HR values during the ISTS with arm support (126 +/- 10 bpm) and the CE test (126 +/- 13 bpm) were significantly higher than those during the ISTS without arm support (119 +/- 9 bpm; p < 0.05). The ISTS with arm support may provide a cardiopulmonary function load equivalent to the CE test; therefore, it is a potentially valid test for evaluating AT-VO2 and AT-HR in healthy, young adults.	[Nakamura, Keisuke; Nagasawa, Yuya] Matsumoto City Hosp, Dept Rehabil, Matsumoto, Nagano 3901401, Japan; [Nakamura, Keisuke] Shinshu Univ, Grad Sch Med, Dept Hlth Sci, Matsumoto, Nagano 390, Japan; [Ohira, Masayoshi; Yokokawa, Yoshiharu] Shinshu Univ, Sch Hlth Sci, Dept Phys Therapy, Matsumoto, Nagano 390, Japan	Nakamura, K (reprint author), Matsumoto City Hosp, Dept Rehabil, 4417-180 Hata, Matsumoto, Nagano 3901401, Japan.	keipons55@yahoo.co.jp; mohira@shinshu-u.ac.jp; fhakuba@shinshu-u.ac.jp; shinn_yu_ra@yahoo.co.jp					SICONOLFI SF, 1982, MED SCI SPORT EXER, V14, P335; Kamimura S, 2011, J PHYS THER SCI, V23, P53; Billinger SA, 2008, J STRENGTH COND RES, V22, P1556, DOI 10.1519/JSC.0b013e3181739dd7; Goto Y, 2007, CIRC J, V71, P173, DOI 10.1253/circj.71.173; Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113; Muraki S, 2004, EUR J APPL PHYSIOL, V91, P246, DOI 10.1007/s00421-003-0962-8; GLESER MA, 1974, MED SCI SPORT EXER, V6, P104; Green JM, 2003, EUR J APPL PHYSIOL, V89, P445, DOI 10.1007/s00421-003-0869-4; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020; AHLQUIST LE, 1992, EUR J APPL PHYSIOL O, V65, P360, DOI 10.1007/BF00868141; O'Meara DM, 2006, HUM MOVEMENT SCI, V25, P257, DOI 10.1016/j.humov.2005.11.003; Orr JL, 2013, ANAESTHESIA, V68, P497, DOI 10.1111/anae.12195; Bellet RN, 2012, PHYSIOTHERAPY, V98, P277, DOI 10.1016/j.physio.2011.11.003; NAGLE FJ, 1984, MED SCI SPORT EXER, V16, P563; Bohannon RW, 2011, J STRENGTH COND RES, V25, P3205, DOI 10.1519/JSC.0b013e318234e59f; SINGH SJ, 1994, EUR RESPIR J, V7, P2016; GOBEL FL, 1978, CIRCULATION, V57, P549; Nakamura K, 2014, J PHYS THER SCI, V26, P1631, DOI 10.1589/jpts.26.1631; Hill DW, 2014, J SPORT MED PHYS FIT, V54, P255; Kervio G, 2003, MED SCI SPORT EXER, V35, P169, DOI 10.1249/01.MSS.0000043545.02712.A7; DAVIS JA, 1976, J APPL PHYSIOL, V41, P544; ARBORELIUS UP, 1992, ERGONOMICS, V35, P1377, DOI 10.1080/00140139208967399; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; GLASSFOR.RG, 1965, J APPL PHYSIOL, V20, P509; Hulley SB, 2013, DESIGNING CLIN RES; Ito H., 2013, J CARDIOL, V61, P71; KUSHMERICK MJ, 1992, AM J PHYSIOL, V263, pC598; Moudgil V.K., 2007, MED SCI SPORTS EXERC, V39, P822; Pescatello L.S., 2013, ACSMS GUIDELINES EXE, P87; Sugiyama K, 2013, J PHYSIOL ANTHROPOL, V32, DOI 10.1186/1880-6805-32-2; WASSERMAN K, 1984, AM REV RESPIR DIS, V129, pS35; Wasserman K., 2012, PRINCIPLES EXERCISE, P129; Yoshioka S, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-27	33	0	0	JOURNAL SPORTS SCIENCE & MEDICINE	BURSA	MEDICAL FACULTY ULUDAG UNIV, DEPT SPORTS MEDICINE, BURSA, 16059, TURKEY	1303-2968			J SPORT SCI MED	J. Sport. Sci. Med.	DEC	2015	14	4					708	715				8	Sport Sciences	Sport Sciences	CY4VE	WOS:000366406100004		
J	Gouttebarge, V; Backx, FJG; Aoki, H; Kerkhoffs, GMMJ				Gouttebarge, Vincent; Backx, Frank J. G.; Aoki, Haruhito; Kerkhoffs, Gino M. M. J.			Symptoms of Common Mental Disorders in Professional Football (Soccer) Across Five European Countries	JOURNAL OF SPORTS SCIENCE AND MEDICINE			English	Article						Professional football; mental disorders; life events; career dissatisfaction	HEALTH; POPULATION; PREVALENCE; DISTRESS; INJURY; SPORT	Evidence on the prevalence of symptoms related to distress, anxiety/depression or substance abuse/dependence, - typically referred to as symptoms of common mental disorders (CMD) - is lacking in European professional football (soccer). The aims of the present study were to investigate the prevalence of symptoms related to CMD (distress, anxiety/depression, sleeping disturbance, adverse alcohol behaviour, and adverse nutrition behaviour) in professional footballers from five European countries, and to explore associations of the outcome measures under study with life events and career dissatisfaction. A cross-sectional design was used. Questionnaires were distributed among professional footballers by the national players' unions in Finland, France, Norway, Spain and Sweden. The highest prevalence of symptoms related to common mental disorders were 18% for distress (Sweden), 43% for anxiety/depression (Norway), 33% for sleeping disturbance (Spain), 17% for adverse alcohol behaviour (Finland), and 74% for adverse nutrition behaviour (Norway). In Finland, France and Sweden, both life events and career dissatisfaction were associated with distress, anxiety/depression, adverse alcohol behaviour, and adverse nutrition behaviour. Results suggest the need for self-awareness in professional football about common mental disorders and a multidisciplinary approach by the medical team.	[Gouttebarge, Vincent] World Players Union FIFPro, NL-2132 LR Hoofddorp, Netherlands; [Gouttebarge, Vincent; Kerkhoffs, Gino M. M. J.] Univ Amsterdam, Acad Med Ctr, Acad Ctr Evidence based Sports Med ACES, NL-1105 AZ Amsterdam, Netherlands; [Gouttebarge, Vincent; Kerkhoffs, Gino M. M. J.] Vrije Univ Amsterdam, Acad Med Ctr, Amsterdam Collaborat Hlth & Safety Sports ACHSS, Med Ctr, Amsterdam, Netherlands; [Gouttebarge, Vincent; Kerkhoffs, Gino M. M. J.] Univ Amsterdam, Acad Med Ctr, Dept Orthopaed Surg, NL-1105 AZ Amsterdam, Netherlands; [Backx, Frank J. G.] Univ Med Ctr, Dept Rehabil Nursing Sci & Sports, Utrecht, Netherlands; [Aoki, Haruhito] St Marianna Univ, Sch Med, Kawasaki, Kanagawa, Japan	Gouttebarge, V (reprint author), World Players Union FIFPro, Players Serv, Scorpius 161, NL-2132 LR Hoofddorp, Netherlands.	v.gouttebarge@fifpro.org; f.j.g.backx@umcutrecht.nl; haruhito@pj8.so-net.ne.jp; g.m.kerkhoffs@amc.nl			Finland (Jalkapallon Pelaajayhdistys Ry JPY); France (Union Nationale des Footballeurs Professionels UNFP); Norway (Norske Idrettsutoveres Sentralorganisasjon NISO); Spain (Asociacion de Futbolistas Espanoles AFE); Sweden (Spelarforeningen Fotboll I Sverige SFS)	The authors would like to thank the players' unions from Finland (Jalkapallon Pelaajayhdistys Ry JPY), France (Union Nationale des Footballeurs Professionels UNFP), Norway (Norske Idrettsutoveres Sentralorganisasjon NISO), Spain (Asociacion de Futbolistas Espanoles AFE) and Sweden (Spelarforeningen Fotboll I Sverige SFS) for their support in the study. We are grateful to all the professional footballers who participated in the study. The authors declare that they have no competing financial, professional or personal interests that might have influenced the performance or presentation of the work described. This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.	King M, 2008, BRIT J PSYCHIAT, V192, P362, DOI 10.1192/bjp.bp.107.039966; Braam C, 2009, J OCCUP REHABIL, V19, P231, DOI 10.1007/s10926-009-9178-z; Bultmann U, 2002, J PSYCHOSOM RES, V52, P445, DOI 10.1016/S0022-3999(01)00228-8; Gouttebarge V, 2015, OCCUP MED-OXFORD, V65, P190, DOI 10.1093/occmed/kqu202; Arnold R, 2012, J SPORT EXERCISE PSY, V34, P397; Dawson DA, 2005, ALCOHOL CLIN EXP RES, V29, P844, DOI 10.1097/01.ALC.0000164374.32229.A2; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Korten A, 2000, BRIT J PSYCHIAT, V177, P325, DOI 10.1192/bjp.177.4.325; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Gulliver A, 2015, J SCI MED SPORT, V18, P255, DOI 10.1016/j.jsams.2014.04.006; Shuer ML, 1997, WESTERN J MED, V166, P104; Krueger RF, 1998, J ABNORM PSYCHOL, V107, P216, DOI 10.1037/0021-843X.107.2.216; Walker N, 2007, J R SOC PROMO HEALTH, V127, P174, DOI 10.1177/1466424007079494; Bramwell S T, 1975, J Human Stress, V1, P6; Cohen J., 1988, STAT POWER ANAL BEHA; Gouttebarge V., 2015, KNEE SURG SPORTS TRA; Gouttebarge V., 2014, ASIAN J SPORTS MED, V5; Gouttebarge V., 2015, 24 INT C SPORTS REH, P179; GREENHAUS JH, 1990, ACAD MANAGE J, V33, P64, DOI 10.2307/256352; Gulliver Amelia, 2012, J Med Internet Res, V14, pe69, DOI 10.2196/jmir.1864; Gulliver A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-157; Junge A., 2015, 24 INT C SPORTS REH, P181; Lahelma E, 2015, OCCUP ENVIRON MED, V72, P181, DOI 10.1136/oemed-2014-102432; Lynge Inge, 2004, Int J Circumpolar Health, V63 Suppl 2, P377; Portney L.G., 2008, FDN CLIN RES APPL PR; Schaal K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019007; Terluin B, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-34; Van der Veer T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028038; Verhaak P.F., 2005, BRIT J GEN PRACT, V519, P770; Woodward M., 2013, EPIDEMIOLOGY STUDY D; Yu L., 2011, BEHAV SLEEP MED, V28, P6; Meneses-Gaya Carolina de, 2009, Psychol. Neurosci., V2, P83, DOI 10.3922/j.psns.2009.1.12	32	0	0	JOURNAL SPORTS SCIENCE & MEDICINE	BURSA	MEDICAL FACULTY ULUDAG UNIV, DEPT SPORTS MEDICINE, BURSA, 16059, TURKEY	1303-2968			J SPORT SCI MED	J. Sport. Sci. Med.	DEC	2015	14	4					811	818				8	Sport Sciences	Sport Sciences	CY4VE	WOS:000366406100016		
J	Kuba, N; Suzuki, K; Hashino, T; Seiki, T; Satoh, M				Kuba, Naomi; Suzuki, Kentaroh; Hashino, Tempei; Seiki, Tatsuya; Satoh, Masaki			Numerical Experiments to Analyze Cloud Microphysical Processes Depicted in Vertical Profiles of Radar Reflectivity of Warm Clouds	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article						Physical Meteorology and Climatology; Aerosols; Cloud droplets; Cloud microphysics; Cloud radiative effects; Clouds; Condensation	PART II; EFFECTIVE RADIUS; MODEL; EVOLUTION; FRAMEWORK; RAIN; EQUATION; BREAKUP; IMPACT; GROWTH	Information about microphysical processes in warm clouds embedded in satellite measurements must be untangled to be used to improve the parameterization in global models. In this paper, the relationship between vertical profiles of horizontally averaged radar reflectivity Z(m) and cloud optical depth from cloud top (d) was investigated using a hybrid cloud microphysical model and a forward simulator of satellite measurements. The particle size distributions were explicitly simulated using a bin method in a kinematic framework. In contrast to previous interpretations of satellite-observed data, three patterns of the Z(m)-(d) relationship related to microphysical processes were identified. The first is related to the autoconversion process, which causes Z(m) to increase upward with decreasing (d). Before the initiation of surface precipitation, Z(m) increases downward with (d) in the upper part of the cloud, which is considered to be a second characteristic pattern and is caused by the accretion process. The appearance of this pattern corresponds to the initiation of efficient production of raindrops in the cloud. The third is related to the sedimentation and evaporation of raindrops causing Z(m) to decrease downward with (d) in the lower part of the Z(m)-(d) relationship. It was also found that the bulk collection efficiency has a partially positive correlation with the slope factor of Z(m) with regard to (d) and that the slope factor could be a gross measure of the collection efficiency in partial cases. This study also shows that differences in the aerosol concentration modulate the duration of these three patterns and change the slope factor of Z(m).	[Kuba, Naomi; Suzuki, Kentaroh; Satoh, Masaki] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778568, Japan; [Hashino, Tempei] Kyushu Univ, Appl Mech Res Inst, Fukuoka 812, Japan; [Seiki, Tatsuya; Satoh, Masaki] Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Yokohama, Japan	Kuba, N (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, 5-1-5 Kashiwano Ha, Kashiwa, Chiba 2778568, Japan.	kuba@aori.u-tokyo.ac.jp			Earth Clouds, Aerosols and Radiation Explorer (Earth-CARE) project of the Japan Aerospace Exploration Agency (JAXA)	This study was conducted under the patronage of the Strategic Programs for Innovative Research (SPIRE) Field 3 Projection of Planet Earth Variations for Mitigating Natural Disasters. The development of the Joint Simulator used in this study was supported by the Earth Clouds, Aerosols and Radiation Explorer (Earth-CARE) project of the Japan Aerospace Exploration Agency (JAXA). The authors sincerely thank Ryohei Misumi of the National Research Institute for Earth Science and Disaster Prevention (NIED), who supplied Fortran code for the breakup process. This study used the Fortran code supplied in Bott (1998) for calculating terminal velocity. This study can be replicated by using input data (Table 1) for the microphysical model and using a Joint Simulator (Hashino et al. 2013; http://www.eorc.jaxa.jp/EARTHCARE/about/jointsimulator.html).	Suzuki K, 2006, SOLA, V2, P116, DOI 10.2151/sola.2006-030; Kuba N, 2006, ATMOS CHEM PHYS, V6, P2793; Kuba N, 2010, ATMOS CHEM PHYS, V10, P3335; FEINGOLD G, 1988, J ATMOS SCI, V45, P3387, DOI 10.1175/1520-0469(1988)045<3387:EORSPI>2.0.CO;2; Sato Y, 2012, J ATMOS SCI, V69, P2012, DOI 10.1175/JAS-D-11-0244.1; Hashino T, 2013, J GEOPHYS RES-ATMOS, V118, P7273, DOI 10.1002/jgrd.50564; CHEN JP, 1994, J ATMOS SCI, V51, P2613, DOI 10.1175/1520-0469(1994)051<2613:SOCMAC>2.0.CO;2; Bott A, 1998, J ATMOS SCI, V55, P2284, DOI 10.1175/1520-0469(1998)055<2284:AFMFTN>2.0.CO;2; HALL WD, 1980, J ATMOS SCI, V37, P2486, DOI 10.1175/1520-0469(1980)037<2486:ADMMWA>2.0.CO;2; Seifert A, 2005, J ATMOS SCI, V62, P1917, DOI 10.1175/JAS3432.1; Suzuki K, 2010, J ATMOS SCI, V67, P3019, DOI 10.1175/2010JAS3463.1; Rosenfeld D, 1998, B AM METEOROL SOC, V79, P2457, DOI 10.1175/1520-0477(1998)079<2457:SBIIPF>2.0.CO;2; Matsui T, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019287; Bony S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023851; Masunaga H, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001269; Noda AT, 2010, ATMOS RES, V96, P208, DOI 10.1016/j.atmosres.2009.05.007; Masunaga H, 2005, J ATMOS OCEAN TECH, V22, P909, DOI 10.1175/JTECH1751.1; Szumowski MJ, 1998, ATMOS RES, V45, P299, DOI 10.1016/S0169-8095(97)00082-3; Wang HL, 2009, J ATMOS SCI, V66, P3237, DOI 10.1175/2009JAS3022.1; Grabowski WW, 1998, J ATMOS SCI, V55, P3264, DOI 10.1175/1520-0469(1998)055<3264:CRMOCS>2.0.CO;2; NAKAJIMA T, 1988, J QUANT SPECTROSC RA, V40, P51, DOI 10.1016/0022-4073(88)90031-3; Reisin TG, 1998, ATMOS RES, V45, P275, DOI 10.1016/S0169-8095(97)00081-1; Suzuki K, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033590; Kuba N, 2014, J GEOPHYS RES-ATMOS, V119, P3281, DOI 10.1002/2013JD020276; Szumowski MJ, 1998, J ATMOS SCI, V55, P208, DOI 10.1175/1520-0469(1998)055<0208:TMSAEO>2.0.CO;2; Nakajima TY, 2010, J ATMOS SCI, V67, P1897, DOI 10.1175/2010JAS3276.1; NAKAJIMA T, 1986, J QUANT SPECTROSC RA, V35, P13, DOI 10.1016/0022-4073(86)90088-9; Klett J. D., 1997, ATMOSPHERIC OCEANOGR, V18; Rogers R. R., 1989, SHORT COURSE CLOUD P	29	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	DEC	2015	72	12					4509	4528		10.1175/JAS-D-15-0053.1		20	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CY3TI	WOS:000366332400001		
J	Weerahandi, S; Kawai, N				Weerahandi, Samaradasa; Kawai, Norisuke			Small response estimation when parameter sign is known	JOURNAL OF THE KOREAN STATISTICAL SOCIETY			English	Article						Generalized estimates; Generalized Bayes estimates; Stein identity; Inadmissibility	CONFIDENCE-INTERVALS	This article addresses the problem of estimating a small parameter of a regression model when the sign of the parameter is known. The parameter of interest is considered to be small relative to the error variance. A variety of applications where the problem arises are discussed. By taking an approach similar to that of Stein (1961), a substantial improvement over the LSE is obtained. The superiority of the proposed estimator is shown via a simulation study and illustrated in an application. Given the importance of the problem in applications, a discussion of much needed further research in related problems is included. (C) 2015 The Korean Statistical Society. Published by Elsevier B.V. All rights reserved.	[Weerahandi, Samaradasa] Pfizer, New York, NY 10017 USA; [Kawai, Norisuke] Pfizer Japan, Shibuya Ku, Tokyo, Japan	Weerahandi, S (reprint author), Pfizer, 235 East 42nd St, New York, NY 10017 USA.	sweeraha@hotmail.com					Kim HJ, 2008, J KOREAN STAT SOC, V37, P81, DOI 10.1016/j.jkss.2007.06.001; van Eeden C, 2001, STAT PROBABIL LETT, V51, P277, DOI 10.1016/S0167-7152(00)00159-0; Weerahandi S, 2012, COMMUN STAT-THEOR M, V41, P4069, DOI 10.1080/03610926.2010.533233; Mandelkern M, 2002, STAT SCI, V17, P149; Shao PYS, 1996, STAT SINICA, V6, P259; KATZ MW, 1961, ANN MATH STAT, V32, P136, DOI 10.1214/aoms/1177705146; Leone RP, 1995, MARKET SCI, V14, P141; STEIN C, 1964, ANN I STAT MATH, V16, P155, DOI 10.1007/BF02868569; WEERAHANDI S, 1993, J AM STAT ASSOC, V88, P899, DOI 10.2307/2290779; Weerahandi S., 2004, GEN INFERENCE REPEAT; Weerahandi S., 2014, METRIKA	11	0	0	KOREAN STATISTICAL SOC	SEOUL	SCIENCE & TECHNOLOGY, BLDG RM 709, 635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL, 135-703, SOUTH KOREA	1226-3192	1876-4231		J KOREAN STAT SOC	J. Korean Stat. Soc.	DEC	2015	44	4					546	554		10.1016/j.jkss.2015.02.003		9	Statistics & Probability	Mathematics	CY0AE	WOS:000366067200006		
J	Murakami, H; Ha, HT				Murakami, Hidetoshi; Ha, Hyung-Tae			The modified Mood test for the scale alternative and its numerical comparisons	JOURNAL OF THE KOREAN STATISTICAL SOCIETY			English	Article						Approximation; Critical values; Asymptotic efficiency; Modified Mood test; Power comparison	NONPARAMETRIC STATISTICS; APPROXIMATIONS; DISPERSION; ORDER; SUM	On statistical hypotheses testing in two-sample problems, the Mood test is popular as one of the most efficient nonparametric tests for dispersion differences. In this paper, we show that a modification of the Mood test proposed by Tamura (1963) can gain even more efficiency and power under various distributional assumptions. The accuracy of the proposed approximations to the tail probabilities and critical values of the modified Mood test, namely M-p, were investigated. Our results showed that the Edgeworth expansion was more accurate than the other approximations. Asymptotic efficiencies and the optimal value p of the modified Mood test under various distributional assumptions were examined, with the results revealing that the large (small) value of p was useful for light (heavy) tail distributions. Additionally, the power of the modified Mood test for the one-sided alternative with various population distributions for small sample sizes was investigated via Monte Carlo simulations. Finally, the proposed method was demonstrated using real data. (C) 2015 The Korean Statistical Society. Published by Elsevier B.V. All rights reserved.	[Murakami, Hidetoshi] Tokyo Univ Sci, Dept Math Informat Sci, Shinjuku Ku, Tokyo 1628601, Japan; [Ha, Hyung-Tae] Gachon Univ, Dept Appl Stat, Sungnam Ci 461701, Kyunggi Do, South Korea	Ha, HT (reprint author), Gachon Univ, Dept Appl Stat, Sungnam Ci 461701, Kyunggi Do, South Korea.	murakami@gug.math.chuo-u.ac.jp; htha@gachon.ac.kr			JSPS, KAKENHI [26730025]; National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2013R1A1A2059794]	The authors wish to express sincere thanks to the editor and two anonymous referees, whose comments significantly improve the overall quality of the manuscript. The research of Hidetoshi Murakami is supported by the Grant-in-Aid for Young Scientists B of JSPS, KAKENHI Number 26730025. And the research of Hyung-Tae Ha is supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A2059794).	Murakami H, 2010, INT J ADV MANUF TECH, V49, P757, DOI 10.1007/s00170-009-2439-3; TAMURA R, 1963, ANN MATH STAT, V34, P1101, DOI 10.1214/aoms/1177704035; LEHMANN EL, 1951, ANN MATH STAT, V22, P165, DOI 10.1214/aoms/1177729639; SIEGEL S, 1960, J AM STAT ASSOC, V55, P429, DOI 10.2307/2281906; McGrath RN, 2002, J NONPARAMETR STAT, V14, P699, DOI 10.1080/1048525021000008518; MOOD AM, 1954, ANN MATH STAT, V25, P514, DOI 10.1214/aoms/1177728719; Yuan Y, 2008, STAT SINICA, V18, P1185; BICKEL PJ, 1974, ANN STAT, V2, P1, DOI 10.1214/aos/1176342609; Ha HT, 2007, COMMUN STAT-SIMUL C, V36, P1135, DOI 10.1080/03610910701569671; Provost SB, 2009, COMMUN STAT-THEOR M, V38, P1969, DOI 10.1080/03610920902835052; DAVIS TP, 1989, SCAND J STAT, V16, P23; Abd-Elfattah EF, 2013, COMPUTATION STAT, V28, P289, DOI 10.1007/s00180-011-0299-4; ANSARI AR, 1960, ANN MATH STAT, V31, P1174, DOI 10.1214/aoms/1177705688; SMITH PJ, 1995, AM STAT, V49, P217, DOI 10.2307/2684642; Chakraborti S, 2008, IMS COLLECTIONS PARA, V1, P156; Freund J. E., 1957, 34 VIRG POL I NAT SC; HOEFFDING W, 1948, ANN MATH STAT, V19, P293, DOI 10.1214/aoms/1177730196; JURECKOVA J, 1975, ANN PROBAB, V3, P526, DOI 10.1214/aop/1176996358; Lehmann E. L, 2006, NONPARAMETRICS STAT; Murakami H., 2007, J JAPAN STAT SOC, V37, P299; Murakami H., 2014, STATISTICS	21	0	0	KOREAN STATISTICAL SOC	SEOUL	SCIENCE & TECHNOLOGY, BLDG RM 709, 635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL, 135-703, SOUTH KOREA	1226-3192	1876-4231		J KOREAN STAT SOC	J. Korean Stat. Soc.	DEC	2015	44	4					592	605		10.1016/j.jkss.2015.03.005		14	Statistics & Probability	Mathematics	CY0AE	WOS:000366067200010		
J	Yonezawa, Y; Ohsumi, T; Miyashita, T; Kataoka, A; Hashimoto, K; Nejishima, H; Ogawa, H				Yonezawa, Yutaka; Ohsumi, Tomoka; Miyashita, Taishi; Kataoka, Akira; Hashimoto, Kazuto; Nejishima, Hiroaki; Ogawa, Haruko			Evaluation of skin phototoxicity study using SD rats by transdermal and oral administration	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Phototoxicity; Guinea pig; Sprague-Dawley rats; Minimum erythema dose	PHARMACEUTICAL SUBSTANCES; IN-VITRO; PHARMACOKINETICS; KETOPROFEN; PHOTOSENSITIVITY; CHLORPROMAZINE; PREDICTION; FUROSEMIDE; ABSORPTION; OXYGEN	Guinea pigs are the most frequently used animals in phototoxicity studies. However, general toxicity studies most often use Sprague-Dawley (SD) rats. To reduce the number of animals needed for drug development, we examined whether skin phototoxicity studies could be performed using SD rats. A total of 19 drugs that had previously been shown to have phototoxic potential and 3 known phototoxic compounds were administered transdermally to guinea pigs and SD rats. Eleven of the potentially phototoxic drugs and 2 of the known phototoxic compounds were also administered orally to guinea pigs and SD rats. After administration, the animals were irradiated with UV-A (10 J/cm(2)) and UV-B (0.25 J/cm(2) in guinea pigs and 0.031 J/cm(2) in SD rats) with doses based on standard phototoxicity study guidelines and the results of a minimum erythema dose test, respectively. In the transderrnal administration study, all of the known phototoxic compounds and 7 of the drugs induced phototoxic reactions. In the oral administration study, both known phototoxic compounds and 5 drugs induced phototoxic reactions in both species; one compound each was found to be toxic only in SD rats or guinea pigs. The concordance rate of guinea pigs and SD rats was 100% in the transdermal administration study and 85% in the oral administration study. This study demonstrated that phototoxicity studies using SD rats have the same potential to detect phototoxic compounds as studies using guinea pigs.	[Yonezawa, Yutaka; Ohsumi, Tomoka; Miyashita, Taishi; Kataoka, Akira; Hashimoto, Kazuto; Nejishima, Hiroaki] Kaken Pharmaceut Co Ltd, Pharmacokinet & Safety Dept, Drug Res Ctr, Fujieda, Shizuoka 4268646, Japan; [Yonezawa, Yutaka] Gifu Univ, United Grad Sch Vet Sci, Gifu 5011193, Japan; [Ogawa, Haruko] Obihiro Univ Agr & Vet Med, Diagnost Ctr Anim Hlth & Food Safety, Obihiro, Hokkaido 0808555, Japan	Yonezawa, Y (reprint author), Kaken Pharmaceut Co Ltd, Pharmacokinet & Safety Dept, Drug Res Ctr, 301 Gensuke, Fujieda, Shizuoka 4268646, Japan.	yonezawa_yutaka@kaken.co.jp					Bagheri H, 2000, DRUG SAFETY, V22, P339, DOI 10.2165/00002018-200022050-00002; SATTARI S, 1994, CHIRALITY, V6, P435, DOI 10.1002/chir.530060512; Onoue S, 2006, PHARM RES, V23, P156, DOI 10.1007/s11095-005-8497-9; YEUNG PKF, 1993, EUR J CLIN PHARMACOL, V45, P563, DOI 10.1007/BF00315316; Kokki H, 2001, EUR J CLIN PHARMACOL, V57, P643, DOI 10.1007/s002280100339; Igarashi Y, 2015, NUCLEIC ACIDS RES, V43, pD921, DOI 10.1093/nar/gku955; Nielsen LH, 2013, EUR J PHARM BIOPHARM, V85, P942, DOI 10.1016/j.ejpb.2013.09.002; Wolf R, 1998, CLIN DERMATOL, V16, P41, DOI 10.1016/S0738-081X(97)00169-7; Vargas F, 1998, J PHOTOCH PHOTOBIO B, V42, P219, DOI 10.1016/S1011-1344(98)00074-8; LOVELL WW, 1992, FOOD CHEM TOXICOL, V30, P155, DOI 10.1016/0278-6915(92)90151-A; Seto Y, 2011, AAPS J, V13, P482, DOI 10.1208/s12248-011-9292-7; [Anonymous], 1995, KET; PARRISH JA, 1974, NEW ENGL J MED, V291, P1207, DOI 10.1056/NEJM197412052912301; Onoue S, 2008, J PHARMACEUT BIOMED, V46, P187, DOI 10.1016/j.jpba.2007.09.003; Shayeganpour A, 2008, BIOPHARM DRUG DISPOS, V29, P159, DOI 10.1002/bdd.599; CURRY SH, 1971, BRIT J PHARMACOL, V42, P403; JEANMOUGIN M, 1988, ARCH DERMATOL RES, V280, pS90; Nakazawa T, 2006, ARCH TOXICOL, V80, P442, DOI 10.1007/s00204-006-0063-7; Seto Y, 2013, J PHOTOCH PHOTOBIO B, V120, P44, DOI 10.1016/j.jphotobiol.2013.01.010; ALLEN JE, 1993, CLIN PHARMACY, V12, P580; MODICA R, 1983, TOXICOL LETT, V18, P103, DOI 10.1016/0378-4274(83)90078-4; Neumann NJ, 2005, J PHOTOCH PHOTOBIO B, V79, P25, DOI 10.1016/j.jphotobiol.2004.11.014; Draize J.H., 1959, APPRAISAL SAFETY CHE, P46; Kuninishi YM, 1998, JPN PHARMACOL THER, V26, P1651; Morikawa F., 1974, SUNLIGHT MAN, P529; Morimura T., 2010, ANN REP HATANO RES I, V33, P32; Okumura Yutaka, 2005, Journal of Toxicological Sciences, V30, P19, DOI 10.2131/jts.30.19; Shionogi & Co. Ltd, 2008, PROD EV REP PIRF; Tazura Y., 2009, 36 ANN M JAP SOC TOX; Utsunomiya S., 2011, 38 ANN M JAP SOC TOX	30	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2015	40	6					667	683				17	Toxicology	Toxicology	CY2LF	WOS:000366239500001		
J	Tsuji, S; Kuwahara, Y; Takagi, H; Sugiura, M; Nakanishi, Y; Wakamatsu, M; Tsuritani, K; Sato, Y				Tsuji, Satoshi; Kuwahara, Yusuke; Takagi, Hironori; Sugiura, Masayuki; Nakanishi, Yutaka; Wakamatsu, Masaki; Tsuritani, Katsuki; Sato, Yasushi			Gene expression analysis in the lung of the rasH2 transgenic mouse at week 4 prior to induction of malignant tumor formation by urethane and N-methylolacrylamide	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						RasH2 transgenic mice; Carcinogenicity study; Lung; Urethane; N-methylolacrylamide	B KINASE INHIBITOR; AURORA-B; CYCLIN B1; CARCINOEMBRYONIC ANTIGEN; PROSTATE-CANCER; VINYL CARBAMATE; MESSENGER-RNA; MICE; EPIREGULIN; CARCINOGENICITY	The rasH2 transgenic (Tg) mice are susceptible to genotoxic and some non-genotoxic carcinogens. In carcinogenicity studies carried out using rasH2 Tg mice, the carcinogenic potential of chemicals are evaluated over a 26-week experimental period. In the present study, we examined the comprehensive gene expressions in the lungs of Tg and non-Tg mice prior to the induction of malignant tumors. Urethane (UP.), a mutagenic carcinogen, was administered for 4 weeks, and thereafter withdrawn for 22 weeks. N-methylolacrylamide (NMA), a non-mutagenic carcinogen, was administered for 26 weeks. At week 4, gene expression analysis of non-neoplastic part of the lungs demonstrated changes in the expressions of the cell-cycle and inflammation related genes following UR and NMA treatment, respectively, in both the Tg and non-Tg mice. The gene expressions of epireguline, aurora kinase B, and cyclin B1 increased in the HR-treated Tg mice. We also found an increase in the plasma carcinoembryonic antigen level in the HR-treated Tg mice. Although UR treatment induced the formation of adenomas or adenocarcinomas in the lungs in all mice, earlier induction was apparent in the Tg mice. NMA treatment was found to induce the formation of adenomas and adenocarcinomas at week 26 in the Tg mice, but not in the non-Tg mice, and no expressions of specific genes were apparent in either genotype of mice. Our results indicate that analysis of cancer-related gene expressions in the lungs and plasma biomarkers at week 4 in rasH2 Tg mice could be a screening tool for carcinogenicity, especially of mutagenic carcinogens.	[Tsuji, Satoshi; Takagi, Hironori; Sugiura, Masayuki; Nakanishi, Yutaka; Wakamatsu, Masaki; Sato, Yasushi] Taisho Pharmaceut Co Ltd, Drug Safety & Pharmacokinet Labs, Kita Ku, Saitama 3319530, Japan; [Kuwahara, Yusuke; Tsuritani, Katsuki] Taisho Pharmaceut Co Ltd, Chem Labs, Kita Ku, Saitama 3319530, Japan	Tsuji, S (reprint author), Taisho Pharmaceut Co Ltd, Drug Safety & Pharmacokinet Labs, Kita Ku, 1-403 Yoshino Cho, Saitama 3319530, Japan.	sa-tsuji@so.taisho.co.jp					Alyacloub FS, 2008, MOL CARCINOGEN, V47, P165, DOI 10.1002/mc.20383; Jin ML, 2008, ARCH TOXICOL, V82, P771, DOI 10.1007/s00204-008-0293-y; Sak A, 2012, INT J RADIAT ONCOL, V84, P492, DOI 10.1016/j.ijrobp.2011.12.021; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Park HJ, 2011, ARCH TOXICOL, V85, P1627, DOI 10.1007/s00204-011-0715-0; Ozaki M, 2005, TOXICOL PATHOL, V33, P267, DOI 10.1080/01926230590908231; Carvajal RD, 2006, CLIN CANCER RES, V12, P6869, DOI 10.1158/1078-0432.CCR-06-1405; Soria JC, 2000, CANCER RES, V60, P4000; Storer RD, 2001, TOXICOL PATHOL, V29, P30, DOI 10.1080/019262301753178465; Kawai M, 2008, TOXICOL PATHOL, V36, P950, DOI 10.1177/0192623308327118; Kawamoto H, 1997, AM J PATHOL, V150, P15; Nesfield SR, 2005, INT J TOXICOL, V24, P301, DOI 10.1080/10915810500210278; Wang AJ, 1997, J CANCER RES CLIN, V123, P124, DOI 10.1007/BF01269891; Kamaraj S, 2009, INVEST NEW DRUG, V27, P214, DOI 10.1007/s10637-008-9159-7; Paulsson B, 2002, MUTAT RES-GEN TOX EN, V516, P101, DOI 10.1016/S1383-5718(02)00027-X; Zhang J, 2008, CANCER PREV RES, V1, P201, DOI 10.1158/1940-6207.CAPR-08-0014; Sos ML, 2012, P NATL ACAD SCI USA, V109, P17034, DOI 10.1073/pnas.1207310109; Forkert PG, 2010, DRUG METAB REV, V42, P355, DOI 10.3109/03602531003611915; Okamura M, 2006, TOXICOLOGY, V217, P129, DOI 10.1016/j.tox.2005.09.021; Sauer L, 2010, ONCOGENE, V29, P2628, DOI 10.1038/onc.2010.24; TENNANT RW, 1995, ENVIRON HEALTH PERSP, V103, P942, DOI 10.2307/3432740; Amsterdam A, 2011, INT J ONCOL, V39, P1165, DOI 10.3892/ijo.2011.1123; Lin WC, 2007, EUR RESPIR J, V30, P1227, DOI 10.1183/09031936.00141706; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Naruszewicz M, 2009, AM J CLIN NUTR, V89, P773, DOI 10.3945/ajcn.2008.26647; Mori I, 2000, CANCER LETT, V153, P199, DOI 10.1016/S0304-3835(00)00372-4; BONHAM K, 1989, MOL CARCINOGEN, V2, P34, DOI 10.1002/mc.2940020106; Toyoda H, 1997, BIOCHEM J, V326, P69; Bonet C, 2012, J BIOL CHEM, V287, P29887, DOI 10.1074/jbc.M112.371682; Aihara A, 2010, J HEPATOL, V52, P63, DOI 10.1016/j.jhep.2009.10.013; Evans RP, 2008, BRIT J HAEMATOL, V140, P295, DOI 10.1111/j.1365-2141.2007.06913.x; Veronesi G, 2005, LUNG CANCER-J IASLC, V48, P233, DOI 10.1016/j.lungcan.2004.10.018; Mashal RD, 1996, CANCER RES, V56, P4159; Mitsumori K, 1998, TOXICOL PATHOL, V26, P520; Sistare FD, 2011, TOXICOL PATHOL, V39, P716, DOI 10.1177/0192623311406935; Kim Y, 2003, ANN CLIN LAB SCI, V33, P32; SAITOH A, 1990, ONCOGENE, V5, P1195; Okamura M, 2004, ARCH TOXICOL, V78, P688, DOI 10.1007/s00204-004-0589-5; Tomisawa M, 2003, TOXICOL LETT, V142, P111, DOI 10.1016/S0378-4274(03)00018-3; Yamamoto S, 1996, CARCINOGENESIS, V17, P2455, DOI 10.1093/carcin/17.11.2455; Sunaga N, 2013, ONCOGENE, V32, P4034, DOI 10.1038/onc.2012.402; Toyosawa K, 2001, TOXICOL PATHOL, V29, P458, DOI 10.1080/01926230152499944; Bauer AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026590; Gully CP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-42; IARC, 1974, IARC MON EV CARC RIS, V7, P111; IARC, 1994, IARC MON EV CARC RIS, V60, P435; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; National Toxicology Program, 1989, NAT TOX PROGR TECHN, V352; Priya D. K. D., 2011, Asian Journal of Biochemistry, V6, P395, DOI 10.3923/ajb.2011.395.405; Rieke R.M., 2011, J CELL BIOL, V193, P1049; Yano Tomohiro, 1999, Life Sciences, V64, P229	51	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2015	40	6					685	700				16	Toxicology	Toxicology	CY2LF	WOS:000366239500002		
J	Kobayashi, T; Namekawa, J; Shimomoto, T; Yasui, M; Iijima, T; Itano, Y; Miura, D; Kasahara, Y				Kobayashi, Taiki; Namekawa, Junichi; Shimomoto, Takasumi; Yasui, Mari; Iijima, Takeshi; Itano, Yasuhiro; Miura, Daishiro; Kasahara, Yoshinori			The effects of long-lasting hypoglycemia on male reproductive organs in rats	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Hypoglycemia; Insulin; Testis; Sperm; Germ cell; Reproductive organs	ZINC-DEFICIENCY; SERTOLI CELLS; NPH INSULIN; GERM-CELLS; VITAMIN-A; METABOLISM; LACTATE; SPERMATOGENESIS; SPERMATOCYTES; THERAPY	Glucose has an important role in spermatogenesis. Nevertheless there are few reports in which the effects of long-lasting hypoglycemia on male reproductive organs have been evaluated. Therefore, insulin was administered subcutaneously at 100, 200, and 400 IU/kg to male rats twice a day for one month. This treatment regimen produced plasma glucose levels that rapidly decreased after treatment, with decreased glucose levels lasting for several hours after each administration on the first and final treatment days. During the treatment period, no abnormalities in clinical signs or body weight were observed. No statistically significant differences were noted in the weights of testes, epididymides, prostates and seminal vesicles, or pituitary glands. Histopathological examination revealed that the insulin-treated animals exhibited degeneration of seminiferous tubules in the testes and exfoliation of germ cells in the lumens of epididymides as a secondary change related to the testicular lesions. The incidences of the histopathological findings were found to be proportional to insulin dose. Sperm analysis of the group receiving the highest dosage indicated that the sperm concentration tended to decrease and the incidences of sperm malformations tended to increase. Our results suggest that long-lasting hypoglycemia affects male reproductive organs in rats.	[Kobayashi, Taiki; Namekawa, Junichi; Shimomoto, Takasumi; Yasui, Mari; Iijima, Takeshi; Itano, Yasuhiro; Miura, Daishiro; Kasahara, Yoshinori] Teijin Pharma Ltd, Pharmaceut Dev Res Labs, Hino, Tokyo 1918512, Japan	Kobayashi, T (reprint author), Teijin Pharma Ltd, Pharmaceut Dev Res Labs, 4-3-2 Asahigaoka, Hino, Tokyo 1918512, Japan.	tai.kobayashi@teijin.co.jp					MASON KE, 1982, J NUTR, V112, P1019; Merker HJ, 1997, J TRACE ELEM MED BIO, V11, P19; ROBINSON R, 1981, BIOL REPROD, V24, P1032, DOI 10.1095/biolreprod24.5.1032; AXELSON J, 1987, SCAND J GASTROENTERO, V22, P737, DOI 10.3109/00365528709011152; JUTTE NHPM, 1982, J REPROD FERTIL, V65, P431; Bajpai M, 1998, EUR J ENDOCRINOL, V138, P322, DOI 10.1530/eje.0.1380322; SOBHON P, 1979, ACTA ANAT, V103, P169; Rato L, 2012, NAT REV UROL, V9, P330, DOI 10.1038/nrurol.2012.77; Boussouar F, 2004, TRENDS ENDOCRIN MET, V15, P345, DOI 10.1016/j.tem.2004.07.003; Bensoussan K, 1998, J ANDROL, V19, P266; Livera G, 2002, REPRODUCTION, V124, P173, DOI 10.1530/rep.0.1240173; Rosenstock J, 2001, DIABETES CARE, V24, P631, DOI 10.2337/diacare.24.4.631; Creasy DM, 2001, TOXICOL PATHOL, V29, P64, DOI 10.1080/019262301301418865; MANCINE RE, 1960, P SOC EXP BIOL MED, V104, P699; Yki-Jarvinen H, 2000, DIABETES CARE, V23, P1130, DOI 10.2337/diacare.23.8.1130; JUTTE NHPM, 1981, J REPROD FERTIL, V62, P399; Bonds DE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b4909; Greaves P., 2007, HISTOPATHOLOGY PRECL, P661, DOI 10.1016/B978-044452771-4/50012-2; Haschek W.M., 1998, FUNDAMENTALS TOXICOL, P443; ICH, 2005, HARM TRIP GUID S5 R2; OECD, 2008, OECD GUID TEST CHEM; OECD, 2009, SER TEST ASS, V106, P11	22	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2015	40	6					719	725				7	Toxicology	Toxicology	CY2LF	WOS:000366239500005		
J	Shirota, M; Kawashima, J; Nakamura, T; Kamiie, J; Shirota, K; Yoshida, M				Shirota, Mariko; Kawashima, Jun; Nakamura, Tomohiro; Kamiie, Junichi; Shirota, Kinji; Yoshida, Midori			Dose-dependent acceleration in the delayed effects of neonatal oral exposure to low-dose 17 alpha-ethynylestradiol on reproductive functions in female Sprague-Dawley rats	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						17 alpha-ethynylestradiol; Internal dose level; Critical period; Sexual differentiation; Estrous cycle	ESTROGEN-RECEPTOR-ALPHA; GENE-EXPRESSION PROFILE; IN-UTERO EXPOSURE; PRIMORDIAL FOLLICLES; SINGLE INJECTIONS; MAMMARY-GLAND; ASSAY; DIETHYLSTILBESTROL; CHEMICALS; CYCLE	Xenoestrogen exposure during the critical period of sexual differentiation of the brain causes delayed effects on female reproduction. We investigated the internal dose of orally administered ethynylestradiol (EE) during the critical period and its delayed effects by administering 0 (vehicle control), 0.4, or 2 mu g/kg EE to female Sprague-Dawley rats for 5 days from postnatal day (PND) 1. Determination of serum EE level 24 hr after the initial dosing and 6 and 24 hr after the final dosing of 2 mu g/kg indicated that the administered EE entered the circulation and cleared after every administration. Although the treatment did not affect physical development, including growth, eyelid opening, and vaginal opening, the estrous cycle was arrested from postnatal week (PNW) 12 even with 0.4 mu g/kg EE, with an inverse correlation between doses and arresting ages. Although ovarian morphology at PNW 22-23 indicated that the treatment caused long-term anovulation and cystic follicle formation, the number of primordial follicles at PNW 22-23 was similar among the groups. Because this number was lower than that at PND 10 in all groups, primordial follicles may have been consumed under long-term anovulation. The treatment also caused other abnormalities, including mammary gland hyperplasia, increase in pituitary and liver weights, and decrease in the uterine weight. Because the highest circulating EE level in the 2 mu g/kg-treated neonates is considered to be comparable to the physiological range of estradiol-17 beta, we concluded that a slight increase in the circulating estrogens during the neonatal period exerts irreversible delayed effects.	[Shirota, Mariko; Kawashima, Jun; Nakamura, Tomohiro] Sch Vet Med, Lab Comparat Toxicol, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan; [Kamiie, Junichi; Shirota, Kinji] Azabu Univ, Lab Vet Pathol, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan; [Shirota, Kinji] Azabu Univ, Res Inst Biosci, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan; [Yoshida, Midori] Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, Tokyo 1588501, Japan	Shirota, M (reprint author), Sch Vet Med, Lab Comparat Toxicol, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan.	m-shirota@azabu-u.ac.jp			 [H22-Kagaku-Ippan-003];  [H25-Kagaku-Ippan-003]	The authors gratefully thank Dr. Yoko Kakinuma for her help in preparing histological specimens. This study was partly supported by a grant-in-aid for research on risk of chemical compounds origin from the Minister of Health, Labor and Welfare (H22-Kagaku-Ippan-003 and H25-Kagaku-Ippan-003). No conflicts of interest, financial or otherwise, are declared by the authors.	SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.2307/3432519; Hong HX, 2012, CHEM RES TOXICOL, V25, P2553, DOI 10.1021/tx3003406; Nishihara T, 2000, J HEALTH SCI, V46, P282; Chen Y, 2009, J ENDOCRINOL, V202, P407, DOI 10.1677/JOE-09-0109; GORSKI RA, 1968, ENDOCRINOLOGY, V82, P1001; Rodriguez HA, 2010, REPROD TOXICOL, V30, P550, DOI 10.1016/j.reprotox.2010.07.008; Betancourt AM, 2010, ENVIRON HEALTH PERSP, V118, P1614, DOI 10.1289/ehp.1002148; IGUCHI T, 1990, BIOL REPROD, V43, P478, DOI 10.1095/biolreprod43.3.478; Usuda K, 2014, J VET MED SCI, V76, P1105, DOI 10.1292/jvms.14-0148; BARRACLOUGH C, 1961, ENDOCRINOLOGY, V68, P62; GITLIN D, 1967, J CLIN INVEST, V46, P1010, DOI 10.1172/JCI105590; Frye CA, 2012, J NEUROENDOCRINOL, V24, P144, DOI 10.1111/j.1365-2826.2011.02229.x; Yasuno K, 2013, J VET MED SCI, V75, P1095, DOI 10.1292/jvms.13-0016; Fang H, 2000, ENVIRON HEALTH PERSP, V108, P723, DOI 10.1289/ehp.00108723; Cimafranca MA, 2010, BIOL REPROD, V83, P114, DOI 10.1095/biolreprod.109.080549; Sanseverino J, 2009, TOXICOL SCI, V107, P122, DOI 10.1093/toxsci/kfn229; Burdick HO, 1941, AM J PHYSIOL, V132, P0405; Coldham NG, 1997, ENVIRON HEALTH PERSP, V105, P734, DOI 10.1289/ehp.97105734; Nozawa K, 2014, REPROD TOXICOL, V46, P77, DOI 10.1016/j.reprotox.2014.03.001; Shirota M, 2003, REPRODUCTION, V125, P85, DOI 10.1530/rep.0.1250085; Prins GS, 2011, REPROD TOXICOL, V31, P1, DOI 10.1016/j.reprotox.2010.09.009; Barkhem T, 1998, MOL PHARMACOL, V54, P105; Bukovsky A, 2000, STEROIDS, V65, P190, DOI 10.1016/S0039-128X(99)00101-4; Ohta R, 2012, REPROD TOXICOL, V34, P323, DOI 10.1016/j.reprotox.2012.04.014; Ayyanan A, 2011, MOL ENDOCRINOL, V25, P1915, DOI 10.1210/me.2011-1129; Ichimura R, 2015, REPROD TOXICOL, V51, P145, DOI 10.1016/j.reprotox.2015.01.004; SMITH MS, 1975, ENDOCRINOLOGY, V96, P219; Jefferson WN, 2012, REPRODUCTION, V143, P247, DOI 10.1530/REP-11-0369; McLachlan JA, 2012, MOL CELL ENDOCRINOL, V354, P60, DOI 10.1016/j.mce.2011.11.028; Asai S, 2002, ENDOCRINE, V18, P161, DOI 10.1385/ENDO:18:2:161; Borges NC, 2009, J CHROMATOGR B, V877, P3601, DOI 10.1016/j.jchromb.2009.08.048; Chung WCJ, 2013, PFLUG ARCH EUR J PHY, V465, P573, DOI 10.1007/s00424-013-1258-4; Takahashi M, 2013, REPROD TOXICOL, V40, P16, DOI 10.1016/j.reprotox.2013.05.005; Umekita Y, 2011, TOXICOL LETT, V205, P15, DOI 10.1016/j.toxlet.2011.04.031; Downs JL, 2009, MOL CELL ENDOCRINOL, V299, P32, DOI 10.1016/j.mce.2008.11.012; Freyberger A, 2010, REPROD TOXICOL, V30, P50, DOI 10.1016/j.reprotox.2010.01.001; Gore AC, 2014, ENDOCR REV, V35, P961, DOI 10.1210/er.2013-1122; Mogi K, 2015, NEUROSCI LETT, V584, P88, DOI 10.1016/j.neulet.2014.10.028; Moral R, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-5; Nakamuro K., 2002, J JPN SOC WATER ENV, V125, P355, DOI 10.2965/jswe.25.355; Safe SH, 2000, ENVIRON HEALTH PERSP, V108, P487, DOI 10.2307/3454608; Shiorta M, 2012, J TOXICOL SCI, V37, P681; Walker DM, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102798; Watanabe Chiaki, 2003, Congenital Anomalies, V43, P177, DOI 10.1111/j.1741-4520.2003.tb01041.x	44	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2015	40	6					727	738				12	Toxicology	Toxicology	CY2LF	WOS:000366239500006		
J	Takeda, S; Hirota, R; Teradaira, S; Takeda-Imoto, M; Watanabe, K; Toda, A; Aramaki, H				Takeda, Shuso; Hirota, Rena; Teradaira, Sari; Takeda-Imoto, Masumi; Watanabe, Kazuhito; Toda, Akihisa; Aramaki, Hironori			Cannabidiol-2 ',6 '-dimethyl ether stimulates body weight gain in apolipoprotein E-deficient BALB/c. KOR/Stm Slc-Apoe(shl) mice	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Cannabidiol-2',6'-dimethyl ether; Apolipoprotein E; Cannabidiol; Fiber-type cannabis plant	LOW-DENSITY-LIPOPROTEIN; FOOD-INTAKE; IN-VITRO; CANNABIDIOL; METABOLITE; RECEPTORS	The biological activities of cannabidiol (CBD), a major non-psychotropic constituent of the fiber-type cannabis plant, have been examined in detail (e.g., CBD modulation of body weight in mice and rats). However, few studies have investigated the biological activities of cannabidiol-2',6'-dimethyl ether (CBDD), a dimethyl ether derivative of the parent CBD. We herein focused on the effects of CBDD on body weight changes in mice, and demonstrated that it stimulated body weight gain in apolipoprotein E (ApoE)-deficient BALB/c. KOR/Stm Slc-Apoe(shl) mice, especially between 10 and 20 weeks of age.	[Takeda, Shuso; Aramaki, Hironori] Daiichi Univ Pharm, Dept Mol Biol, Minami Ku, Fukuoka 8158511, Japan; [Takeda, Shuso] Hiroshima Int Univ, Fac Pharmaceut Sci, Lab Xenobiot Metab & Environm Toxicol, Hiroshima 7370112, Japan; [Hirota, Rena; Teradaira, Sari; Takeda-Imoto, Masumi; Toda, Akihisa] Daiichi Univ Pharm, Dept Hyg Chem, Minami Ku, Fukuoka 8158511, Japan; [Watanabe, Kazuhito] Hokuriku Univ, Fac Pharmaceut Sci, Dept Hyg Chem, Kanazawa, Ishikawa 9201181, Japan; [Aramaki, Hironori] Daiichi Univ Pharm, Drug Innovat Res Ctr, Minami Ku, Fukuoka 8158511, Japan	Toda, A (reprint author), Daiichi Univ Pharm, Dept Hyg Chem, Minami Ku, 22-1 Tamagawa Cho, Fukuoka 8158511, Japan.	toda@daiichi-cps.ac.jp; haramaki@daiichi-cps.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [25460182]	This study was supported in part by a Grant-in-Aid for Scientific Research (C) [25460182, (to S.T.)] from the Japan Society for the Promotion of Science (JSPS) KAKENHI.	Takeda S, 2011, BIOL PHARM BULL, V34, P1252; Mahley RW, 2006, J CLIN INVEST, V116, P1226, DOI 10.1172/JCI28632; Takeda S, 2013, YAKUGAKU ZASSHI, V133, P1093, DOI 10.1248/yakushi.13-00196; BORNHEIM LM, 1989, MOL PHARMACOL, V36, P377; GOHDA H, 1990, CHEM PHARM BULL, V38, P1697; Verty ANA, 2004, ENDOCRINOLOGY, V145, P3224, DOI 10.1210/en.2004-0059; OMURA T, 1964, J BIOL CHEM, V239, P2370; Vasankari T, 2001, INT J OBESITY, V25, P205, DOI 10.1038/sj.ijo.0801533; Shen L, 2008, DIABETES, V57, P2092, DOI 10.2337/db08-0291; Suzuki K, 2004, CANCER EPIDEM BIOMAR, V13, P1781; Schreyer SA, 2002, AM J PHYSIOL-ENDOC M, V282, pE207; Izzo AA, 2009, TRENDS PHARMACOL SCI, V30, P515, DOI 10.1016/j.tips.2009.07.006; Wiley JL, 2005, BRIT J PHARMACOL, V145, P293, DOI 10.1038/sj.bjp.0706157; Scopinho AA, 2011, PHARMACOL BIOCHEM BE, V98, P268, DOI 10.1016/j.pbb.2011.01.007; Takeda S, 2009, DRUG METAB DISPOS, V37, P1733, DOI 10.1124/dmd.109.026930; Ignatowska-Jankowska B, 2011, NEUROSCI LETT, V490, P82, DOI 10.1016/j.neulet.2010.12.031; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsushima Y, 2001, J Atheroscler Thromb, V8, P71; NISHIBAY.H, 1968, J BIOCHEM-TOKYO, V63, P766; Takeda S, 2011, J PHARM SCI-US, V100, P1206, DOI 10.1002/jps.22354; Zanelati TV, 2010, BRIT J PHARMACOL, V159, P122, DOI 10.1111/j.1476-5381.2009.00521.x	21	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2015	40	6					739	743				5	Toxicology	Toxicology	CY2LF	WOS:000366239500007		
J	Matsunaga, K; Kuroda, Y; Sakai, S; Adachi, R; Teshima, R; Yagami, A; Itagaki, H				Matsunaga, Kayoko; Kuroda, Yasutaka; Sakai, Shinobu; Adachi, Reiko; Teshima, Reiko; Yagami, Akiko; Itagaki, Hiroshi			Anaphylactic augmentation by epicutaneous sensitization to acid-hydrolyzed wheat protein in a guinea pig model	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Acid-hydrolyzed wheat protein; Cross-reactivity; Epicutaneous sensitization; Guinea pig; Passive cutaneous anaphylaxis	EXERCISE-INDUCED ANAPHYLAXIS; 7S ANTIBODIES; BALB/C MICE; ALLERGENICITY; SKIN; IDENTIFICATION; COSMETICS; ANTIGEN; GLUTEN; SOAP	Recent reports suggest that hydrolyzed wheat protein (HWP) variants such as Glupear (R) 19S (GP19S) induce immediate-type hypersensitivity via epicutaneous (EC) sensitization. The identification of strong allergens is a key step in product assessment before commercial launch. However, few reports have described the estimation of actual and potential anaphylactic sensitizing capacity. In this study we assessed the strength of both the actual and potential anaphylactic sensitizing capacity by investigating the immediate-type hypersensitivity inducing potential of HWP compared with gluten. We assessed these strengths via the EC route using an EC or intradermal (ID) sensitization method. We quantified the strength of immediate-type hypersensitivity by evaluating the titer of serum antibodies isolated from sensitized subjects using passive cutaneous anaphylaxis (PCA) reactions. We also evaluated the cross-reactivity between GP19S and gluten. GP19S and gluten applied by both the sensitization methods induced obvious IgG1-mediated PCA reactions. GP19S had stronger sensitizing potential than gluten, according to the serum titers and dye spot diameters. The difference in antibody titers between GP19S and gluten was 16-fold for the EC method versus 2-fold for the ID method. GP19S cross-reacted with gluten. Acid hydrolysis of gluten increased anaphylactic sensitizing capacity in the EC method. To our knowledge, our study is the first to quantitatively confirm that HWP and gluten can induce immediate-type hypersensitivity through an intact skin. These findings suggest that acid-HWP imposes a higher risk of EC sensitization than gluten because of the ease with which the former confers a sensitizing effect through the intact skin.	[Matsunaga, Kayoko; Yagami, Akiko] Fujita Hlth Univ, Sch Med, Dept Dermatol, Toyoake, Aichi 4701192, Japan; [Kuroda, Yasutaka; Itagaki, Hiroshi] Yokohama Natl Univ, Fac Engn, Dept Mat Sci & Engn, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Sakai, Shinobu; Adachi, Reiko] Natl Inst Hlth Sci, Div Biochem, Setagaya Ku, Tokyo 1588501, Japan; [Teshima, Reiko] Natl Inst Hlth Sci, Div Foods, Setagaya Ku, Tokyo 1588501, Japan	Kuroda, Y (reprint author), Yokohama Natl Univ, Fac Engn, Dept Mat Sci & Engn, Hodogaya Ku, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	kuroda-yasutaka-bt@ynu.jp					Stremnitzer C, 2014, ALLERGY, V69, P741, DOI 10.1111/all.12399; OVARY Z, 1963, J EXP MED, V117, P951, DOI 10.1084/jem.117.6.951; WOLFF K, 1967, J INVEST DERMATOL, V48, P504; Dearman RJ, 2009, CLIN EXP ALLERGY, V39, P458, DOI 10.1111/j.1365-2222.2008.03194.x; Chinuki Y, 2013, CONTACT DERMATITIS, V68, P86, DOI 10.1111/j.1600-0536.2012.02168.x; Barbero AM, 2009, TOXICOL IN VITRO, V23, P1, DOI 10.1016/j.tiv.2008.10.008; Bartnikas LM, 2013, J ALLERGY CLIN IMMUN, V131, P451, DOI 10.1016/j.jaci.2012.11.032; BERKEN A, 1966, J EXP MED, V123, P119, DOI 10.1084/jem.123.1.119; CHEN H, 1985, BRIT J DERMATOL, V113, P707, DOI 10.1111/j.1365-2133.1985.tb02406.x; Nakamura R, 2013, INT ARCH ALLERGY IMM, V160, P259, DOI 10.1159/000341671; VERDIER F, 1994, TOXICOLOGY, V93, P55, DOI 10.1016/0300-483X(94)90196-1; Gourbeyre P, 2012, MOL NUTR FOOD RES, V56, P336, DOI 10.1002/mnfr.201100353; Chinuki Y, 2011, CONTACT DERMATITIS, V65, P55, DOI 10.1111/j.1600-0536.2011.01917.x; Palosuo K, 1999, J ALLERGY CLIN IMMUN, V103, P912, DOI 10.1016/S0091-6749(99)70438-0; BLOCH KJ, 1963, J EXP MED, V117, P965, DOI 10.1084/jem.117.6.965; Adachi R, 2012, ALLERGY, V67, P1392, DOI 10.1111/all.12018; Lauriere M, 2006, CONTACT DERMATITIS, V54, P283, DOI 10.1111/j.0105-1873.2006.00830.x; BUEHLER EV, 1965, ARCH DERMATOL, V91, P171; Amaro C, 2008, CONTACT DERMATITIS, V58, P67, DOI 10.1111/j.1600-0536.2007.01267.x; WATANABE N, 1977, J IMMUNOL METHODS, V14, P381, DOI 10.1016/0022-1759(77)90149-1; OVARY Z, 1958, PROG ALLERGY, V5, P459, DOI 10.1159/000277653; Nakamura R, 2013, J ALLERGY CLIN IMMUN, V132, P1436, DOI 10.1016/j.jaci.2013.07.017; Fukutomi Y, 2011, J ALLERGY CLIN IMMUN, V127, P531, DOI 10.1016/j.jaci.2010.09.035; Chinuki Y, 2012, ALLERGOL INT, V61, P529, DOI 10.2332/allergolint.12-RAI-0494; NEVEU PJ, 1978, IMMUNOLOGY, V35, P129; Kroghsbo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107137	26	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2015	40	6					745	752				8	Toxicology	Toxicology	CY2LF	WOS:000366239500008		
J	Kanno, Y; Zhao, S; Yamashita, N; Yanai, K; Nemoto, K; Inouye, Y				Kanno, Yuichiro; Zhao, Shuai; Yamashita, Naoya; Yanai, Kazuyuki; Nemoto, Kiyomitsu; Inouye, Yoshio			Androgen receptor functions as a negative transcriptional regulator of DEPTOR, mTOR inhibitor	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Androgen receptor; mTOR; DEPTOR; Prostate cancer	PROSTATE-CANCER; BETA-TRCP; GENETIC MODELS; DEGRADATION; ACTIVATION; EXPRESSION	It has been noticed that crosstalk between androgen receptor (AR) and mammalian target of rapamycin (mTOR) signaling pathways plays a crucial role in the proliferation of prostate cancer cells. To clarify this mechanism, we focused on DEPTOR, a naturally occurring inhibitor of mTOR. The treatment of a human AR-positive prostate cancer cell line, LNCaP, with the AR-agonist dihydrotestosterone (DHT) repressed DEPTOR mRNA expression in a time-dependent manner. This repression was abrogated by treatment with the AR-antagonist bicalutamide. Knockdown of DEPTOR mRNA by siRNA resulted in the increased phosphorylation of 70 kDa ribosomal protein S6 kinase 1 (S6K), a substrate of mTORC1, accompanied by the elevated expression of cyclin D1, a positive regulator of cell proliferation. Furthermore, the ChIP assay demonstrated that AR could bind to AR-responsible element-like region within the 4th intron of the DEPTOR gene. The amount of acetylated histone H3 (Lys9, Lys14) was reduced by the DHT treatment in this region. Taken together, these results propose that AR-dependent prostate cancer cell proliferation requires decreased DEPTOR transcription directly controlled by AR.	[Kanno, Yuichiro; Zhao, Shuai; Yamashita, Naoya; Nemoto, Kiyomitsu; Inouye, Yoshio] Toho Univ, Fac Pharmaceut Sci, Dept Mol Toxicol, Chiba 2748510, Japan; [Yanai, Kazuyuki] Toho Univ, Fac Sci, Dept Biomol Sci, Chiba 2748510, Japan	Kanno, Y (reprint author), Toho Univ, Fac Pharmaceut Sci, Dept Mol Toxicol, Chiba 2748510, Japan.	ykanno@phar.toho-u.ac.jp			MEXT KAKENHI [23790104, 25460175]	This work was partly supported by MEXT KAKENHI [Grants 23790104 and 25460175].	Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Zhao YC, 2011, MOL CELL, V44, P304, DOI 10.1016/j.molcel.2011.08.029; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Lee DK, 2003, J CLIN ENDOCR METAB, V88, P4043, DOI 10.1210/jc.2003-030261; Dehm SM, 2007, MOL ENDOCRINOL, V21, P2855, DOI 10.1210/me.2007-0223; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Gao DM, 2011, MOL CELL, V44, P290, DOI 10.1016/j.molcel.2011.08.030; Bennett NC, 2010, INT J BIOCHEM CELL B, V42, P813, DOI 10.1016/j.biocel.2009.11.013; Li H, 2014, ONCOTARGET, V5, P12811; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Matsumoto T, 2005, J BIOCHEM, V138, P105, DOI 10.1093/jb/mvi118; Matsumoto T, 2008, J STEROID BIOCHEM, V109, P236, DOI 10.1016/j.jsbmb.2008.03.023; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Liu YN, 2008, MOL CELL BIOL, V28, P7096, DOI 10.1128/MCB.00449-08; Matsumoto T, 2003, J STEROID BIOCHEM, V85, P95, DOI 10.1016/S0960-0760(03)00231-0; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; van Duin M, 2005, GENE CHROMOSOME CANC, V44, P438, DOI 10.1002/gcc.20259	18	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2015	40	6					753	758				6	Toxicology	Toxicology	CY2LF	WOS:000366239500009		
J	Takahashi, S; Morita, K; Kinoshita, M; Fujimori, S; Ishikawa, T				Takahashi, Satoshi; Morita, Koji; Kinoshita, Makoto; Fujimori, Shin; Ishikawa, Toshio			Effects of scorched food leachates with or without activated charcoal pretreatment on AhR activation in cultured cells	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Aryl hydrocarbon receptor; Overcooked food; Activated charcoal; CYP1A1; Polycyclic aromatic hydrocarbons	ARYL-HYDROCARBON RECEPTOR; POLYCYCLIC AROMATIC-HYDROCARBONS; DIET	Aryl hydrocarbon receptor (AhR) is a transcription factor activated by xenobiotics, including dioxins and polycyclic aromatic hydrocarbons (PAHs). Although AhR is also activated by some dietary constituents, it has not been completely clarified in what circumstances AhR ligands are ingested in our daily life. Because PAHs are formed by the incomplete combustion of organic materials, we hypothesized that scorched foods might contain and leach out AhR ligands sufficient to stimulate AhR in vitro. To test this hypothesis, scorched foods (bread, cheese, etc.) were mixed vigorously with water, and the supernatants were retrieved as samples. The samples were added to HepG2 cells stably expressing an AhR-responsive reporter gene. Also, expression of CYP1A1, an endogenous AhR-responsive gene, was analyzed by RT-PCR in different cell lines treated with the samples. We further tested whether pretreatment of the samples with activated charcoal would alter their AhR-stimulating activity. All the supernatant samples tested induced AhR-dependent reporter gene activity and CYP1A1 mRNA expression. In some samples, these inductions were inhibited by pretreatment with activated charcoal. Our findings indicate that scorched food leachates stimulate AhR in cultured cells and that activated charcoal adsorbs the AhR-stimulating substances in some leachates. Thus, people who habitually eat scorched foods are exposed to AhR ligands on a regular basis. Further studies are needed to elucidate whether burnt foods actually exert biological effects on our health.	[Takahashi, Satoshi; Morita, Koji; Kinoshita, Makoto; Fujimori, Shin; Ishikawa, Toshio] Teikyo Univ, Sch Med, Dept Internal Med, Itabashi Ku, Tokyo 1738605, Japan	Ishikawa, T (reprint author), Teikyo Univ, Sch Med, Dept Internal Med, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	tishi-tky@umin.ac.jp					Fang ZZ, 2014, BRIT J PHARMACOL, V171, P1735, DOI 10.1111/bph.12576; Ishikawa T, 2012, THYROID, V22, P769, DOI 10.1089/thy.2012.0057; Tilg H, 2012, NEW ENGL J MED, V366, P181, DOI 10.1056/NEJMcibr1113158; Grover IS, 2013, ENVIRON MONIT ASSESS, V185, P6459, DOI 10.1007/s10661-012-3037-7; Shibamoto T, 2007, REV ENVIRON CONTAM T, V190, P1, DOI 10.1007/978-0-387-36903-7_1; Kalthoff S, 2010, GASTROENTEROLOGY, V139, P1699, DOI 10.1053/j.gastro.2010.06.048; Backlund M, 2005, CELL SIGNAL, V17, P39, DOI 10.1016/j.cellsig.2004.05.010; Ishikawa T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102152; Kim S.Y., 2006, BMC BIOINFORMATICS, V7, P1; Leu Tzeng-Horng, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P357, DOI 10.2174/1568011024606370; National Cancer Institute, 2010, CHEM MEAT COOK HIGH; Oberg M, 2005, TOXICOL SCI, V85, P935, DOI 10.1093/toxsci/kfi154; Okey Allan B, 2005, Toxicol Appl Pharmacol, V207, P43, DOI 10.1016/j.taap.2004.12.028; Phillips DH, 1999, MUTAT RES-GEN TOX EN, V443, P139, DOI 10.1016/S1383-5742(99)00016-2; Rose M, 2015, FOOD CHEM TOXICOL, V78, P1, DOI 10.1016/j.fct.2014.12.018; Shertzer H G, 2000, Drug Metabol Drug Interact, V17, P159	16	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2015	40	6					777	786				10	Toxicology	Toxicology	CY2LF	WOS:000366239500011		
J	Sakamoto, Y; Yoshida, M; Tamura, K; Takahashi, M; Kodama, Y; Inoue, K				Sakamoto, Yohei; Yoshida, Midori; Tamura, Kei; Takahashi, Miwa; Kodama, Yukio; Inoue, Kaoru			Dose-dependent difference of nuclear receptors involved in murine liver hypertrophy by piperonyl butoxide	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Constitutive androstane receptor; Pregnane X receptor; Liver hypertrophy; Mouse model; Piperonyl butoxide	CONSTITUTIVE ANDROSTANE RECEPTOR; PREGNANE-X RECEPTOR; HEPATOCELLULAR-CARCINOMA; CHRONIC TOXICITY; TUMOR PROMOTION; RISK-ASSESSMENT; CANCER-RISK; MOUSE-LIVER; MICE; INDUCTION	Nuclear receptors play important roles in chemically induced liver hypertrophy in rodents. To clarify the involvement of constitutive androstane receptor (CAR) and other nuclear receptors in mouse liver hypertrophy induced by different doses of piperonyl butoxide (PBO), wild-type and CAR-knockout mice were administered PBO (200, 1,000, or 5,000 ppm) in the basal diet for 1 week. Increased liver weight and diffuse hepatocellular hypertrophy were observed at 5,000 ppm for both genotypes, accompanied by increased Cyp3all mRNA and CYP3A protein expression, suggesting that CAR-independent pathway, possibly pregnane X receptor (PXR), plays a major role in the induction of hypertrophy. Moreover, wild-type mice at 5,000 ppm showed enhanced hepatocellular hypertrophy and strong positive staining for CYP2B in the centrilobular area, suggesting the localized contribution of CAR. At 1,000 ppm, only wild-type mice showed liver weight increase and centrilobular hepatocellular hypertrophy concurrent with elevated Cyp2b10 mRNA expression and strong CYP2B staining, indicating that CAR was essential at 1,000 ppm. We concluded that high-dose PBO induced hypertrophy via CAR and another pathway, while lower dose of PBO induced a pathway mediated predominantly by CAR. The dose-responsiveness on liver hypertrophy is important for understanding the involvement of nuclear receptors.	[Sakamoto, Yohei; Yoshida, Midori; Tamura, Kei; Takahashi, Miwa; Inoue, Kaoru] Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, Tokyo 1588501, Japan; [Kodama, Yukio] Natl Inst Hlth Sci, Div Toxicol, Setagaya Ku, Tokyo 1588501, Japan; [Sakamoto, Yohei; Tamura, Kei] Teijin Pharma Ltd, Toxicol Res Dept, Pharmaceut Dev Res Labs, Tokyo 1918512, Japan	Inoue, K (reprint author), Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, Kamiyoga 1-18-1, Tokyo 1588501, Japan.	k-inoue@nihs.go.jp			Food Safety Commission, Japan [1303]	We thank Tomomi Morikawa, Yoshimi Komatsu, and Ayako Kaneko for expert technical assistance in performing the animal experiments and processing of histological materials. This study was supported in part by a Grant-in-Aid for the Research Program for Risk Assessment Study on Food Safety from the Food Safety Commission, Japan (No.1303)	Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; Okamiya H, 1998, ARCH TOXICOL, V72, P744, DOI 10.1007/s002040050569; Ryu DY, 1996, MOL PHARMACOL, V50, P443; Tasaki M, 2010, CANCER SCI, V101, P2525, DOI 10.1111/j.1349-7006.2010.01705.x; Holsapple MP, 2006, TOXICOL SCI, V89, P51, DOI 10.1093/toxsci/kfj001; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931.7940.2004; Quattrochi LC, 2001, DRUG METAB DISPOS, V29, P615; Tamasi V, 2009, MOL PHARMACEUT, V6, P1573, DOI 10.1021/mp9001552; ADAMS NH, 1993, CHEM-BIOL INTERACT, V86, P255, DOI 10.1016/0009-2797(93)90101-4; Sakamoto Y, 2013, TOXICOL PATHOL, V41, P1078, DOI 10.1177/0192623313482055; Goetz AK, 2011, REGUL TOXICOL PHARM, V61, P141, DOI 10.1016/j.yrtph.2011.07.012; Tamura K, 2013, TOXICOL LETT, V221, P47, DOI 10.1016/j.toxlet.2013.05.011; Xie W, 2000, GENE DEV, V14, P3014, DOI 10.1101/gad.846800; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; FUJITANI T, 1993, TOXICOLOGY, V83, P93, DOI 10.1016/0300-483X(93)90094-9; Boobis AR, 2009, CRIT REV FOOD SCI, V49, P690, DOI 10.1080/10408390903098673; Whysner J, 1996, PHARMACOL THERAPEUT, V71, P153, DOI 10.1016/0163-7258(96)00067-8; Morita R, 2013, J TOXICOL SCI, V38, P679; Muguruma M, 2006, TOXICOLOGY, V228, P178, DOI 10.1016/j.tox.2006.08.029; Bercu JP, 2010, REGUL TOXICOL PHARM, V58, P369, DOI 10.1016/j.yrtph.2010.08.002; TAKAHASHI O, 1994, FUND APPL TOXICOL, V22, P293, DOI 10.1006/faat.1994.1033; LeCluyse EL, 2001, CHEM-BIOL INTERACT, V134, P283, DOI 10.1016/S0009-2797(01)00163-6; Takahashi O, 1997, TOXICOLOGY, V124, P95, DOI 10.1016/S0300-483X(97)00136-4; Watanabe T., 1998, J TOXICOL PATHOL, V11, P1, DOI 10.1293/tox.11.1	25	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2015	40	6					787	796				10	Toxicology	Toxicology	CY2LF	WOS:000366239500012		
J	Matsumoto, H; Saito, F; Takeyoshi, M				Matsumoto, Hiroshi; Saito, Fumiyo; Takeyoshi, Masahiro			Applicability of a gene expression based prediction method to SD and Wistar rats: an example of CARCINOscreen (R)	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Carcinogenicity; Liver; Prediction; Microarray; Gene expression; SD rat; Wistar rat	HEPATOTOXICITY	Recently, the development of several gene expression-based prediction methods has been attempted in the fields of toxicology. CARCINOscreen (R) is a gene expression-based screening method to predict carcinogenicity of chemicals which target the liver with high accuracy. In this study, we investigated the applicability of the gene expression-based screening method to SD and Wistar rats by using CARCINOscreen (R), originally developed with F344 rats, with two carcinogens, 2,4-diaminotoluen and thioacetamide, and two non-carcinogens, 2,6-diaminotoluen and sodium benzoate. After the 28-day repeated dose test was conducted with each chemical in SD and Wistar rats, microarray analysis was performed using total RNA extracted from each liver. Obtained gene expression data were applied to CARCINOscreen (R). Predictive scores obtained by the CARCINOscreen (R) for known carcinogens were > 2 in all strains of rats, while non-carcinogens gave prediction scores below 0.5. These results suggested that the gene expression based screening method, CARCINOscreen (R), can be applied to SD and Wistar rats, widely used strains in toxicological studies, by setting of an appropriate boundary line of prediction score to classify the chemicals into carcinogens and non-carcinogens.	[Matsumoto, Hiroshi; Saito, Fumiyo; Takeyoshi, Masahiro] CERI, Chem Assessment & Res Ctr, Sugito, Saitama 3450043, Japan	Matsumoto, H (reprint author), CERI, Chem Assessment & Res Ctr, 1600 Shimo Takano, Sugito, Saitama 3450043, Japan.	matsumoto-hiroshi@ceri.jp					BOORMAN GA, 1994, TOXICOL PATHOL, V22, P105; Zidek N, 2007, TOXICOL SCI, V99, P289, DOI 10.1093/toxsci/kfm131; Wild CP, 1996, CANCER EPIDEM BIOMAR, V5, P179; Kuester RK, 2002, TOXICOL SCI, V65, P151, DOI 10.1093/toxsci/65.1.151; Matsumoto H, 2014, J TOXICOL SCI, V39, P725; Ellinger-Ziegelbauer H, 2008, MUTAT RES-FUND MOL M, V637, P23, DOI 10.1016/j.mrfmmm.2007.06.010	6	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2015	40	6					805	807				3	Toxicology	Toxicology	CY2LF	WOS:000366239500014		
J	Yamashita, K; Matsumoto, H; Saito, F; Takeyoshi, M				Yamashita, Kyosuke; Matsumoto, Hiroshi; Saito, Fumiyo; Takeyoshi, Masahiro			Differences in gene expression profiles in liver caused by different types of anesthesia: cases of CO2-O-2 and isoflurane	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Anesthesia; DNA microarray; Gene expression; Liver		Anesthesia is used for pain control and is necessary in toxicological studies. In this study, we examined the effects of anesthesia on gene expression profiles caused by different types of anesthesia. To elucidate the effects of anesthesia on gene expression profiles, DNA microarray analysis was performed with CO2-O-2 anesthesia and isoflurane anesthesia, and gene expression profiles in the liver were analyzed. Consequently, a total of 209 probes out of 61,573 showed higher or lower expression levels in the isoflurane anesthesia group compared with CO2-O-2 anesthesia. This is less than 0.34% of all probes, indicating that the effects of different types of anesthesia on gene expression profiles are limited. However, careful consideration should be taken in the cases of handling the disturbed genes using DNA microarray, especially in case of research on glutathione-related pathway under isoflurane anesthesia.	[Yamashita, Kyosuke; Matsumoto, Hiroshi; Saito, Fumiyo; Takeyoshi, Masahiro] CERI, Chem Assessment & Res Ctr, Sugito, Saitama 3450043, Japan	Yamashita, K (reprint author), CERI, Chem Assessment & Res Ctr, 1600 Shimo Takano, Sugito, Saitama 3450043, Japan.	yamashita-kyosuke@ceri.jp					Nakazato K, 2009, BIOMED RES-TOKYO, V30, P17; Nagate T, 2007, J VET MED SCI, V69, P1137, DOI 10.1292/jvms.69.1137; Edmands SD, 2013, ANESTH ANALG, V116, P589, DOI 10.1213/ANE.0b013e31827b27b0; Matsumoto H, 2014, J TOXICOL SCI, V39, P725; Matsumoto Hiroshi, 2009, Cancer Inform, V7, P253	5	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2015	40	6					829	836				8	Toxicology	Toxicology	CY2LF	WOS:000366239500017		
J	Ishii, I; Kamata, S; Hagiya, Y; Abiko, Y; Kasahara, T; Kumagai, Y				Ishii, Isao; Kamata, Shotaro; Hagiya, Yoshifumi; Abiko, Yumi; Kasahara, Tadashi; Kumagai, Yoshito			Protective effects of hydrogen sulfide anions against acetaminophen-induced hepatotoxicity in mice	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Acetaminophen; N-acetyl-p-benzoquinone imine; Glutathione; Hydrogen sulfide; Hepatotoxicity	CYSTATHIONINE GAMMA-LYASE; PERSULFIDES; METABOLITE; CYSTEINE; STRESS; INJURY	The key mechanism for hepatotoxicity resulting from acetaminophen (APAP) overdose is cytochrome P450-dependent formation of N-acetyl-p-benzoquinone imine (NAPQI), a potent electrophilic metabolite that forms protein adducts. The fundamental roles of glutathione in the effective conjugation/clearance of NAPQI have been established, giving a molecular basis for the clinical use of N-acetylcysteine as a sole antidote. Recent evidence from in vitro experiments suggested that sulfide anions (S2-) to yield hydrogen sulfide anions (HS-) under physiological pH could effectively react with NAPQI. This study evaluated the protective roles of HS- against APAP-induced hepatotoxicity in mice. We utilized cystathionine gamma-lyase-deficient (Cth(-/-)) mice that are highly sensitive to acetaminophen toxicity. Intraperitoneal injection of acetaminophen (150 mg/kg) into Cth(-/-) mice resulted in highly elevated levels of serum alanine/aspartate aminotransferases and lactate dehydrogenase associated with marked increases in oncotic hepatocytes; all of which were significantly inhibited by intraperitoneal preadministration of sodium hydrosulfide (NaHS). NaHS preadministration significantly suppressed APAP-induced serum malondialdehyde level increases without abrogating APAP-induced rapid depletion of hepatic glutathione. These results suggest that exogenous HS- protects hepatocytes by directly scavenging reactive NAPQI rather than by increasing cystine uptake and thereby elevating intracellular glutathione levels, which provides a novel therapeutic approach against acute APAP poisoning.	[Ishii, Isao; Kamata, Shotaro; Hagiya, Yoshifumi; Kasahara, Tadashi] Keio Univ, Grad Sch Pharmaceut Sci, Dept Biochem, Minato Ku, Tokyo 1058512, Japan; [Abiko, Yumi; Kumagai, Yoshito] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan	Ishii, I (reprint author), Keio Univ, Grad Sch Pharmaceut Sci, Dept Biochem, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	isao-ishii@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25460072, 25220103, S1101003]; Program for Advancement of Next Generation Research Projects from Keio University; Fukuzawa Memorial Fund for the Advancement of Education and Research from Keio University	This work was supported in part by the Grants-in-Aid for Scientific Research (25460072 to I.I. and 25220103 to Y.K.) and the Program for Strategic Research Foundation at Private Universities (S1101003 to I.I.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Program for Advancement of Next Generation Research Projects and Fukuzawa Memorial Fund for the Advancement of Education and Research from Keio University (to I.I.).	Abiko Y, 2015, CHEM RES TOXICOL, V28, P1796, DOI 10.1021/acs.chemrestox.5b00245; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P211; Kimura H, 2015, P JPN ACAD B-PHYS, V91, P131, DOI 10.2183/pjab.91.131; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Hagiya YF, 2015, TOXICOL APPL PHARM, V282, P195, DOI 10.1016/j.taap.2014.11.015; Yamada H, 2012, FREE RADICAL BIO MED, V52, P1716, DOI 10.1016/j.freeradbiomed.2012.02.033; Morsy MA, 2010, LIFE SCI, V87, P692, DOI 10.1016/j.lfs.2010.10.004; Lee WM, 2008, HEPATOL RES, V38, pS3, DOI 10.1111/j.1872-034X.2008.00419.x; Ono K, 2014, FREE RADICAL BIO MED, V77, P82, DOI 10.1016/j.freeradbiomed.2014.09.007; Trettin A, 2014, J CHROMATOGR B, V963, P99, DOI 10.1016/j.jchromb.2014.05.050; Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439; Bromer Matthew Q, 2003, Clin Liver Dis, V7, P351, DOI 10.1016/S1089-3261(03)00025-4; Hinson JA, 2010, HDB EXP PHARM, V196, P369, DOI DOI 10.1007/978-3-642-00663-0_12	15	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2015	40	6					837	841				5	Toxicology	Toxicology	CY2LF	WOS:000366239500018		
J	Yamashita, K; Shinoda, S; Hagiwara, S; Miyazaki, H; Itagaki, H				Yamashita, Kunihiko; Shinoda, Shinsuke; Hagiwara, Saori; Miyazaki, Hiroshi; Itagaki, Hiroshi			Unsaturated fatty acids show clear elicitation responses in a modified local lymph node assay with an elicitation phase, and test positive in the direct peptide reactivity assay	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Fatty acid; LLNA:DAE; Skin	THYMIC STROMAL LYMPHOPOIETIN; PIG MAXIMIZATION TEST; ALLERGIC INFLAMMATION; CONTACT ALLERGENS; IN-VIVO; SENSITIZATION; MICE; EXACERBATION; INDUCTION; CHEMICALS	The Organisation for Economic Co-operation and Development (OECD) Test Guidelines (TG) adopted the murine local lymph node assay (LLNA) and guinea pig maximization test (GPMT) as stand-alone skin sensitization test methods. However, unsaturated carbon-carbon double-bond and/or lipid acids afforded false-positive results more frequently in the LLNA compared to those in the GPMT and/or in human subjects. In the current study, oleic, linoleic, linolenic, undecylenic, fumaric, maleic, and succinic acid and squalene were tested in a modified LLNA with an elicitation phase (LLNA:DAE), and in a direct peptide reactivity assay (DPRA) to evaluate their skin-sensitizing potential. Oleic, linoleic, linolenic, undecylenic and maleic acid were positive in the LLNA:DAE, of which three, linoleic, linolenic, and maleic acid were positive in the DPRA. Furthermore, the results of the cross-sensitizing tests using four LLNA:DAE-positive chemicals were negative, indicating a chemical-specific elicitation response. In a previous report, the estimated concentration needed to produce a stimulation index of 3 (EC3) of linolenic acid, squalene, and maleic acid in the LLNA was < 10%. Therefore, these chemicals were classified as moderate skin sensitizers in the LLNA. However, the skin-sensitizing potential of all LLNA:DAE-positive chemicals was estimated as weak. These results suggested that oleic, linoleic, linolenic, undecylenic, and maleic acid had skin-sensitizing potential, and that the LLNA overestimated the skin-sensitizing potential compared to that estimated by the LLNA:DAE.	[Yamashita, Kunihiko; Miyazaki, Hiroshi] Daicel Corp, Corp Res Ctr, Aboshi Ku, Himeji, Hyogo 6711283, Japan; [Shinoda, Shinsuke; Hagiwara, Saori] Drug Safety Testing Ctr Co Ltd, Yoshimi Labs, Yoshimi, Saitama 3550166, Japan; [Yamashita, Kunihiko; Itagaki, Hiroshi] Yokohama Natl Univ, Dept Mat Sci & Engn, Fac Engn, Yokohama, Kanagawa 2408501, Japan	Yamashita, K (reprint author), Daicel Corp, Corp Res Ctr, Aboshi Ku, 1239 Shinzaike, Himeji, Hyogo 6711283, Japan.	ku_yamashita@jp.daicel.com					Pappinen S, 2005, TOXICOL APPL PHARM, V208, P233, DOI 10.1016/j.taap.2005.02.014; Sims JE, 2000, J EXP MED, V192, P671, DOI 10.1084/jem.192.5.671; Cumberbatch M, 2002, TOXICOL APPL PHARM, V182, P126, DOI 10.1006/taap.2002.9442; Yamashita S, 2013, ALLERGOL INT, V62, P463, DOI 10.2332/allergolint.13-OA-0552; Boelsma E, 1996, TOXICOL IN VITRO, V10, P729, DOI 10.1016/S0887-2333(96)00053-7; Montelius J, 1998, ACTA DERM-VENEREOL, V78, P433; Idehara Kenji, 2008, Journal of Pharmacological and Toxicological Methods, V58, P1, DOI 10.1016/j.vascn.2008.03.003; Angelova-Fischer I, 2010, J INVEST DERMATOL, V130, P2505, DOI 10.1038/jid.2010.143; KIMBER I, 1992, FOOD CHEM TOXICOL, V30, P165, DOI 10.1016/0278-6915(92)90153-C; Basketter DA, 1996, FOOD CHEM TOXICOL, V34, P985, DOI 10.1016/S0278-6915(96)00059-2; Kreiling R, 2008, FOOD CHEM TOXICOL, V46, P1896, DOI 10.1016/j.fct.2008.01.019; Yamashita K, 2014, J TOXICOL SCI, V39, P147; Omori Takashi, 2008, Journal of Pharmacological and Toxicological Methods, V58, P11, DOI 10.1016/j.vascn.2008.05.001; Anzai T, 2010, EXP ANIM TOKYO, V59, P245; Satou N, 2012, INT ARCH ALLERGY IMM, V157, P194, DOI 10.1159/000327545; Dean JH, 2001, REGUL TOXICOL PHARM, V34, P258, DOI 10.1006/rtph.2001.1497; Masamoto Y, 2001, YAKUGAKU ZASSHI, V121, P97, DOI 10.1248/yakushi.121.97; Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213; ICCVAM, 2010, NIH PUBLICATION; MAGNUSSO.B, 1969, J INVEST DERMATOL, V52, P268; OECD, 1992, OECD GUID TEST CHEM; OECD, 2010, OECD GUID TEST CHEM; OECD, 2002, OECD GUID TEST CHEM; Urbisch D, 2015, REGUL TOXICOL PHARM, V71, P337, DOI 10.1016/j.yrtph.2014.12.008; Yamashita K., 2005, AATEX, V11, P136, DOI DOI 10.1016/J.VASCN.2008.03.003; Yamashita K, 2015, J TOXICOL SCI, V40, P137, DOI 10.2131/jts.40.137	26	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2015	40	6					843	853				11	Toxicology	Toxicology	CY2LF	WOS:000366239500019		
J	Kimura, M; Mizukami, S; Watanabe, Y; Hasegawa-Baba, Y; Onda, N; Yoshida, T; Shibutani, M				Kimura, Masayuki; Mizukami, Sayaka; Watanabe, Yousuke; Hasegawa-Baba, Yasuko; Onda, Nobuhiko; Yoshida, Toshinori; Shibutani, Makoto			Disruption of spindle checkpoint function ahead of facilitation of cell proliferation by repeated administration of hepatocarcinogens in rats	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Cell proliferation; Hepatocarcinogen; Hepatocarcinogenic promoter; Spindle checkpoint; Ubiquitin D; Apoptosis	BETA-NAPHTHOFLAVONE; ABERRANT ACTIVATION; UBIQUITIN LIGASE; MDM2; LIVER; CARCINOGENS; PROTEINS; PHOSPHORYLATION; ONCOPROTEIN; P53	We aimed to clarify the hepatocarcinogen-specific disruption of cell cycle checkpoint functions and its time course after repeated administration of hepatocarcinogens. Thus, rats were repeatedly administered with hepatocarcinogens (methapyrilene, carbadox and thioacetamide), a marginal hepatocarcinogen (leucomalachite green), hepatocarcinogenic promoters (oxfendazole and P-naphthoflavone) or non-carcinogenic hepatotoxicants (promethazine and acetaminophen) for 7, 28 or 90 days, and the temporal changes in cell proliferation, expression of G(1)/S and spindle checkpoint-related molecules, and apoptosis were examined using immunohistochemistry and/or real-time RT-PCR analysis. Hepatocarcinogens facilitating cell proliferation at day 28 of administration also facilitated cell proliferation and apoptosis at day 90. Hepatocarcinogen- or hepatocarcinogenic promoter-specific cellular responses were riot detected by immunohistochemical single molecule analysis even after 90 days. Expression of Cdkn1a, Mad2l1, Chekl1 and Rbl2 mRNA also lacked specificity to hepatocarcinogens or hepatocarcinogenic promoters. In contrast, all hepatocarcinogens and the marginally hepatocarcinogenic leucomalachite green induced Mdm2 upregulation or increase in the number of phosphorylated MDM2(+) cells from day 28, irrespective of the lack of cell proliferation facilitation by some compounds. However, different Tp53 expression levels suggest different mechanisms of induction or activation of MDM2 among hepatocarcinogens. On the other hand, hepatocarcinogenic methapyrilene and carbadox downregulated the number of both ubiquitin D+ cells and proliferating cells remaining in M phase at day 28 and/or day 90, irrespective of the lack of cell proliferation facilitation in the latter. These results suggest that hepatocarcinogens disrupt spindle checkpoint function after 28 or 90 days of administration, which may be induced ahead of cell proliferation facilitation.	[Kimura, Masayuki; Mizukami, Sayaka; Watanabe, Yousuke; Hasegawa-Baba, Yasuko; Onda, Nobuhiko; Yoshida, Toshinori; Shibutani, Makoto] Tokyo Univ Agr & Technol, Lab Vet Pathol, Fuchu, Tokyo 1838509, Japan; [Kimura, Masayuki; Mizukami, Sayaka; Watanabe, Yousuke] Gifu Univ, United Grad Sch Vet Sci, Pathogenet Vet Sci, Gifu 5011193, Japan	Shibutani, M (reprint author), Tokyo Univ Agr & Technol, Lab Vet Pathol, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	mshibuta@cc.tuat.ac.jp			Ministry of Health, Labour and Welfare of Japan [H25-shokuhin-ippan-005]	The authors thank Mrs. Shigeko Suzuki for her technical assistance in preparing the histological specimens. This work was supported by Health and Labour Sciences Research Grants (Research on Food Safety) from the Ministry of Health, Labour and Welfare of Japan (Grant No. H25-shokuhin-ippan-005). All authors disclose that there are no conflicts of interest that could inappropriately influence the outcome of the present study. M.K. is a Research Fellow of the Japan Society for the Promotion of Science.	MCKILLOP D, 1991, BIOCHEM PHARMACOL, V41, P1, DOI 10.1016/0006-2952(91)90003-N; Theng SS, 2014, P NATL ACAD SCI USA, V111, pE5282, DOI 10.1073/pnas.1403383111; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Yafune A, 2013, ARCH TOXICOL, V87, P1141, DOI 10.1007/s00204-013-1011-y; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; GOTZ C, 1995, INT J ONCOL, V6, P1129; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; JEDING I, 1995, BIOCHEM PHARMACOL, V49, P359, DOI 10.1016/0006-2952(94)00424-K; Taniai E, 2012, ARCH TOXICOL, V86, P1453, DOI 10.1007/s00204-012-0829-z; Jonker MJ, 2009, CARCINOGENESIS, V30, P1805, DOI 10.1093/carcin/bgp190; Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Mitsumori K, 1997, FOOD CHEM TOXICOL, V35, P799, DOI 10.1016/S0278-6915(97)00051-3; BECKER FF, 1983, J NATL CANCER I, V71, P553; Mattila R, 2007, ARCH DERMATOL RES, V298, P381, DOI 10.1007/s00403-006-0711-z; FERNANDEZ G, 1981, BRIT J EXP PATHOL, V62, P440; Malmlof M, 2007, J BIOL CHEM, V282, P2288, DOI 10.1074/jbc.M604953200; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Uehara T, 2011, TOXICOL APPL PHARM, V255, P297, DOI 10.1016/j.taap.2011.07.001; Eastin WC, 1998, ENVIRON HEALTH PERSP, V106, P81, DOI 10.2307/3433914; Yafune A, 2013, TOXICOL LETT, V219, P203, DOI 10.1016/j.toxlet.2013.03.012; Hayashi H, 2012, J TOXICOL SCI, V37, P969; Eckle VS, 2004, TOXICOL PATHOL, V32, P9, DOI 10.1080/01926230490260673; Shoda T, 2000, TOXICOL PATHOL, V28, P540, DOI 10.1177/019262330002800406; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; BEUTIN L, 1981, ANTIMICROB AGENTS CH, V20, P336; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Zhao YH, 2014, ACTA BIOCH BIOPH SIN, V46, P180, DOI 10.1093/abbs/gmt147; Gorospe M, 1999, GENE EXPRESSION, V7, P377; Patil M, 2013, CELL MOL LIFE SCI, V70, P4009, DOI 10.1007/s00018-013-1307-3; Bhattacharya S, 2014, FEBS J, V281, P3061, DOI 10.1111/febs.12843; Taniai E, 2012, J TOXICOL SCI, V37, P1093; El-Shafey Mostafa M, 2015, Pathophysiology, V22, P49, DOI 10.1016/j.pathophys.2014.12.002; Kimura M., 2015, J APPL TOXICOL, DOI [10.1002/jat.3163, DOI 10.1002/JAT.3163]; King T.O., 1976, TARGET ORGAN T UNPUB; Lim CB, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-20; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; NTP, 2005, NATL TOXICOL PROGRAM, V527, P1; NTP, 2000, TOXIC REP SER, V46, P1; NTP, 1993, NATL TOXICOL PROGRAM, V394, P1; NTP, 1993, NTP SER, V425, P1; O'Neil N., 2006, WORMBOOK, V13, P1; Tamano Seiko, 2010, Asian Pac J Cancer Prev, V11, P4; WHO, 1991, WHO TECH REP SER, V815, P1	49	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2015	40	6					855	871				17	Toxicology	Toxicology	CY2LF	WOS:000366239500020		
J	Abiko, Y; Puga, A; Kumagai, Y				Abiko, Yumi; Puga, Alvaro; Kumagai, Yoshito			Covalent binding of quinones activates the Ah receptor in Hepa1c1c7 cells	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Electrophile; Aryl hydrocarbon receptor; Quinone; CYP1A1	ARYL-HYDROCARBON RECEPTOR; TRANSCRIPTIONAL ACTIVATION; BUTYLATED HYDROXYANISOLE; RESPONSIVE ELEMENTS; OXIDATIVE STRESS; DIOXIN RECEPTOR; LIGAND-BINDING; GENE BATTERY; PHASE-I; PROTEIN	Highly reactive quinone species produced by photooxidation and/or metabolic activation of mono- or bi-aromatic hydrocarbons modulate cellular homeostasis and electrophilic signal transduction pathways through the covalent modification of proteins. Polycyclic aromatic hydrocarbons, but not mono- or bi-aromatic hydrocarbons, are well recognized as ligands for the aryl hydrocarbon receptor (AhR). However, quinone species produced from mono- and bi-aromatic hydrocarbons could potentially cause AhR activation. To clarify the AhR response to mono- and bi-aromatic hydrocarbon quinones, we studied Cyp1a1 (cytochrome P450 1A1) induction and AhR activation by these quinones. We detected Cyp1a1 induction during treatment with quinones in Hepa1c1c7 cells, but not their parent compounds. Nine of the twelve quinones with covalent binding capability for proteins induced Cyp1a1. Cyp1a1 induction mediated by 1,2-naphthoquinone (1,2-NQ), 1,4-NQ, 1,4-benzoquinone (1,4-BQ) and tert-butyl-1,4-BQ was suppressed by a specific AhR inhibitor and was not observed in c35 cells, which do not have a functional AhR. These quinones stimulated AhR nuclear translocation and interaction with the AhR nuclear translocator. Interestingly, 1,2-NQ covalently modified AhR, which was detected by an immunoprecipitation assay using a specific antibody against 1,2-NQ, resulting in enhancement of xenobiotic responsive element (XRE)-derived luciferase activity and binding of AhR to the Cyp1a1 promoter region. While mono- and bi-aromatic hydrocarbons are generally believed to be poor ligands for AhR and hence unable to induce Cyp1a1, our study suggests that the quinones of these molecules are able to modify AhR and activate the AhR/XRE pathway, thereby inducing Cyp1a1. Since we previously reported that 1,2-NQ and tert-butyl-1,4-BQ also activate NF-E2-related factor 2, it seems likely that some of quinones are bi-functional inducers for phase-I and phase-II reaction of xenobiotics.	[Abiko, Yumi; Kumagai, Yoshito] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Puga, Alvaro] Univ Cincinnati, Coll Med, Dept Environm Hlth, Ctr Environm Genet, Cincinnati, OH 45267 USA	Kumagai, Y (reprint author), Univ Tsukuba, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.	yk-em-tu@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25220103]; NIH [R01 ES006273, R01 ES010807]	This work was supported by a Grant-in-Aid (#25220103 to Y.K.) for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Work done at the University of Cincinnati was supported by NIH grants R01 ES006273 and R01 ES010807.	Denison MS, 1998, TOXICOL APPL PHARM, V152, P406, DOI 10.1006/taap.1998.9999; Chang CY, 1998, MOL CELL BIOL, V18, P525; Snyder R, 1996, ENVIRON HEALTH PERSP, V104, P1165, DOI 10.2307/3433158; Nioi P, 2004, MUTAT RES-FUND MOL M, V555, P149, DOI 10.1016/j.mrfmmm.2004.05.023; Abiko Y, 2015, J TOXICOL SCI, V40, P405, DOI 10.2131/jts.40.405; VERHAGEN H, 1989, CARCINOGENESIS, V10, P1947, DOI 10.1093/carcin/10.10.1947; BUETLER TM, 1995, TOXICOL APPL PHARM, V135, P45, DOI 10.1006/taap.1995.1207; HARPER PA, 1991, ARCH BIOCHEM BIOPHYS, V290, P27, DOI 10.1016/0003-9861(91)90587-9; PROCHASKA HJ, 1988, CANCER RES, V48, P4776; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Li F, 2011, ENVIRON TOXICOL PHAR, V32, P478, DOI 10.1016/j.etap.2011.09.001; Maher JM, 2007, HEPATOLOGY, V46, P1597, DOI 10.1002/hep.21831; LIU RM, 1994, CARCINOGENESIS, V15, P2347, DOI 10.1093/carcin/15.10.2347; WALLER CL, 1995, CHEM RES TOXICOL, V8, P847, DOI 10.1021/tx00048a005; Henry EC, 2003, MOL PHARMACOL, V63, P392, DOI 10.1124/mol.63.2.392; Soshilov A, 2008, J BIOL CHEM, V283, P32995, DOI 10.1074/jbc.M802414200; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Marlowe JL, 2008, MOL BIOL CELL, V19, P3263, DOI 10.1091/mbc.E08-04-0359; Wilson AS, 1996, TOXICOLOGY, V114, P233, DOI 10.1016/S0300-483X(96)03515-9; Toyama T, 2013, J TOXICOL SCI, V38, P477; Miura T, 2010, J TOXICOL SCI, V35, P843, DOI 10.2131/jts.35.843; Parr RG, 1999, J AM CHEM SOC, V121, P1922, DOI 10.1021/ja983494x; QUATTROCHI LC, 1993, MOL PHARMACOL, V43, P504; Genter MB, 2006, BIOCHEM BIOPH RES CO, V348, P120, DOI 10.1016/j.bbrc.2006.07.025; Pandini A, 2007, BIOCHEMISTRY-US, V46, P696, DOI 10.1021/bi061460t; Abiko Y, 2011, TOXICOL APPL PHARM, V255, P32, DOI 10.1016/j.taap.2011.05.013; NEBERT DW, 1993, ANN NY ACAD SCI, V685, P624, DOI 10.1111/j.1749-6632.1993.tb35928.x; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; WALLACE LA, 1989, CELL BIOL TOXICOL, V5, P297, DOI 10.1007/BF01795358; Denison MS, 2002, CHEM-BIOL INTERACT, V141, P3, DOI 10.1016/S0009-2797(02)00063-7; Sun WM, 1997, J BIOL CHEM, V272, P31845, DOI 10.1074/jbc.272.50.31845; Iwamoto N, 2007, J BIOL CHEM, V282, P33396, DOI 10.1074/jbc.M705224200; Kumagai Y, 2012, ANNU REV PHARMACOL, V52, P221, DOI 10.1146/annurev-pharmtox-010611-134517; POLAND A, 1976, J BIOL CHEM, V251, P4936; Miura T, 2011, CHEM RES TOXICOL, V24, P559, DOI 10.1021/tx100427p; Schnekenburger M, 2007, MOL CELL BIOL, V27, P7089, DOI 10.1128/MCB.00838-07; Batterman S, 2012, INDOOR AIR, V22, P266, DOI 10.1111/j.1600-0668.2011.00760.x; FUJISAWASEHARA A, 1987, NUCLEIC ACIDS RES, V15, P4179, DOI 10.1093/nar/15.10.4179; OLLINGER K, 1991, J BIOL CHEM, V266, P21496; Badham HJ, 2007, TOXICOLOGY, V229, P177, DOI 10.1016/j.tox.2006.10.021; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Miao WM, 2003, MOL PHARMACOL, V64, P346, DOI 10.1124/mol.64.2.346; Khan NM, 2011, FREE RADICAL BIO MED, V51, P115, DOI 10.1016/j.freeradbiomed.2011.03.037; Ciolino HP, 1998, BIOCHEM PHARMACOL, V56, P197, DOI 10.1016/S0006-2952(98)00143-9; BARFORD D, 1995, NAT STRUCT BIOL, V2, P1043, DOI 10.1038/nsb1295-1043; Eiguren-Fernandez A, 2010, ENVIRON RES, V110, P207, DOI 10.1016/j.envres.2010.01.009; Motahari P, 2015, DARU, V23, DOI 10.1186/s40199-015-0122-9	47	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2015	40	6					873	886				14	Toxicology	Toxicology	CY2LF	WOS:000366239500021		
J	Toyama, T; Abiko, Y; Katayama, Y; Kaji, T; Kumagai, Y				Toyama, Takashi; Abiko, Yumi; Katayama, Yuko; Kaji, Toshiyuki; Kumagai, Yoshito			S-Mercuration of ubiquitin carboxyl-terminal hydrolase L1 through Cys152 by methylmercury causes inhibition of its catalytic activity and reduction of monoubiquitin levels in SH-SY5Y cells	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Electrophile; Methylmercury; S-Mercuration; UCH-L1	OXYGEN-REGULATED PROTEIN; PARKINSONS-DISEASE; MINAMATA DISEASE; UCH-L1; AGGREGATION; GENE; 1,2-NAPHTHOQUINONE; GLUTATHIONE; MECHANISM; CHAPERONE	Methylmercury (MeHg) is an environmental electrophile that covalently modifies cellular proteins. In this study, we identified proteins that undergo S-mercuration by MeHg. By combining two-dimensional SDS-PAGE, atomic absorption spectrometry and ultra performance liquid chromatography mass spectrometry (UPLC/MS/MS), we revealed that ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) is a target for S-mercuration in human neuroblastoma SH-SY5Y cells exposed to MeHg (1 mu M 9 hr). The modification site of UCH-L1 by MeHg was Cys152, as determined by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. MeHg was shown to inhibit the catalytic activity of recombinant human UCH-L1 in a concentration-dependent manner. Knockdown of UCH-L1 indicated that this enzyme plays a critical role in regulating mono-ubiquitin (monoUb) levels in SH-SY5Y cells and exposure of SH-SY5Y cells to MeHg caused a reduction in the level of monoUb in these cells. These observations suggest that UCH-L1 readily undergoes S-mercuration by MeHg through Cys152 and this covalent modification inhibits UCH-L1, leading to the potential disruption of the maintenance of cellular monoUb levels.	[Toyama, Takashi; Abiko, Yumi; Kumagai, Yoshito] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Katayama, Yuko; Kumagai, Yoshito] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Kaji, Toshiyuki] Tokyo Univ Sci, Fac Pharmaceut Sci, Noda, Chiba 278, Japan	Katayama, Y (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.	yk-em-tu@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25220103]	This work was supported by a Grant-in-Aid (#25220103 to Y.K.) for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Koharudin LMI, 2010, P NATL ACAD SCI USA, V107, P6835, DOI 10.1073/pnas.1002295107; Toyama T, 2007, BIOCHEM BIOPH RES CO, V363, P645, DOI 10.1016/j.bbrc.2007.09.017; Kanda H, 2012, ARCH TOXICOL, V86, P1693, DOI 10.1007/s00204-012-0893-4; Ballatori N, 2002, ENVIRON HEALTH PERSP, V110, P689; Abiko Y, 2015, J TOXICOL SCI, V40, P405, DOI 10.2131/jts.40.405; GARCIA JD, 1974, P SOC EXP BIOL MED, V146, P66; IMURA N, 1980, TOXICOLOGY, V17, P241, DOI 10.1016/0300-483X(80)90101-8; Ikeda J, 1997, BIOCHEM BIOPH RES CO, V230, P94, DOI 10.1006/bbrc.1996.5890; Shinyashiki M, 1998, BRAIN RES, V798, P147, DOI 10.1016/S0006-8993(98)00400-4; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; ANNAU Z, 1988, TOXICOLOGY, V49, P219, DOI 10.1016/0300-483X(88)90002-9; Sinsimer KS, 2008, MOL CELL BIOL, V28, P5223, DOI 10.1128/MCB.00431-08; Kurihara LJ, 2001, HUM MOL GENET, V10, P1963, DOI 10.1093/hmg/10.18.1963; Li ZM, 2004, BIOCHEM BIOPH RES CO, V319, P1171, DOI 10.1016/j.bbrc.2004.05.098; Tamm C, 2008, NEUROREPORT, V19, P339, DOI 10.1097/WNR.0b013e3282f50ca4; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; WASTENEYS GO, 1988, CELL BIOL TOXICOL, V4, P41, DOI 10.1007/BF00141286; Kanda H, 2008, ARCH TOXICOL, V82, P803, DOI 10.1007/s00204-008-0307-9; Toyama T, 2013, J TOXICOL SCI, V38, P477; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; HARADA M, 1978, TERATOLOGY, V18, P285, DOI 10.1002/tera.1420180216; SRIVASTAVA M, 1989, FEBS LETT, V250, P99, DOI 10.1016/0014-5793(89)80692-1; Petersen MS, 2008, NEUROTOXICOLOGY, V29, P584, DOI 10.1016/j.neuro.2008.03.001; RABENSTEIN DL, 1977, ANAL CHEM, V49, P1036, DOI 10.1021/ac50015a042; Saigoh K, 1999, NAT GENET, V23, P47; Contu VR, 2014, J NEUROCHEM, V130, P826, DOI 10.1111/jnc.12762; Zheng J, 1996, CHEM RES TOXICOL, V9, P904, DOI 10.1021/tx960014b; Grandjean P, 2010, ENVIRON HEALTH PERSP, V118, P1137, DOI 10.1289/ehp.0901757; HENDERSHOT LM, 1994, GENOMICS, V20, P281, DOI 10.1006/geno.1994.1166; Larsen CN, 1996, BIOCHEMISTRY-US, V35, P6735, DOI 10.1021/bi960099f; Vollrath V, 2006, BIOCHEM J, V395, P599, DOI 10.1042/BJ20051518; Madejczyk MS, 2007, J PHARMACOL EXP THER, V322, P378, DOI 10.1124/jpet.107.122812; Toyama T, 2011, ENVIRON HEALTH PERSP, V119, P1117, DOI 10.1289/ehp.1003123; Kabuta T, 2008, HUM MOL GENET, V17, P1482, DOI 10.1093/hmg/ddn037; Bando Y, 2000, AM J PHYSIOL-CELL PH, V278, pC1172; HARADA M, 1995, CRIT REV TOXICOL, V25, P1, DOI 10.3109/10408449509089885; Kumagai Y., 2013, OXID MED CELL LONGEV, V2013; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Toyama T, 2014, CHEM-BIOL INTERACT, V214, P41, DOI 10.1016/j.cbi.2014.02.008; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625	42	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2015	40	6					887	893				7	Toxicology	Toxicology	CY2LF	WOS:000366239500022		
J	Lee, JY; Tokumoto, M; Fujiwara, Y; Satoh, M				Lee, Jin-Yong; Tokumoto, Maki; Fujiwara, Yasuyuki; Satoh, Masahiko			Involvement of ubiquitin-coding genes in cadmium-induced protein ubiquitination in human proximal tubular cells	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Cadmium; HK-2 cells; Renal toxicity; Ubiquitinated protein; Ubiquitin-coding genes	DOWN-REGULATION; DEUBIQUITINATING ENZYMES; PROTEASOME SYSTEM; MESSENGER-RNA; UBC LEADS; IN-VIVO; TOXICITY; STRESS; DISRUPTION; APOPTOSIS	Cadmium (Cd) is a toxic heavy metal with a long half-life in humans. It causes disorders of various tissue systems, including the kidney, and is associated with protein aggregation. Our previous study demonstrated Cd-induced suppression of the UBE2D gene family, one of the ubiquitin-conjugating enzyme families. However, the precise role of ubiquitin-coding genes in Cd toxicity remains to be understood. In this study, we investigated the effect of Cd on expression of the ubiquitin-coding genes UBB, UBC, UBA80, and UBA52 in HK-2 human proximal tubular cells. Prior to the appearance of Cd toxicity, the UBB, UBC, and UBA80 expression levels increased following Cd treatment. Knockdown of UBB by siRNA transfection significantly decreased Cd cytotoxicity. Notably, Cd induces ubiquitinated protein levels in HK-2 cells, and knockdown of UBB blocked this process. These results suggest that UBB is involved in Cd-induced increase of protein ubiquitination, and that accumulation of ubiquitinated proteins through increased UBB expression may contribute to Cd toxicity in HK-2 cells.	[Lee, Jin-Yong; Tokumoto, Maki; Fujiwara, Yasuyuki; Satoh, Masahiko] Aichi Gakuin Univ, Sch Pharm, Lab Pharmaceut Hlth Sci, Chikusa Ku, Nagoya, Aichi 4648650, Japan; [Fujiwara, Yasuyuki] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Environm Hlth, Hachioji, Tokyo 1920392, Japan	Satoh, M (reprint author), Aichi Gakuin Univ, Sch Pharm, Lab Pharmaceut Hlth Sci, Chikusa Ku, 1-100 Kusumoto Cho, Nagoya, Aichi 4648650, Japan.	masahiko@dpc.agu.ac.jp					Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Hamer G, 2010, NAT METHODS, V7, P473, DOI [10.1038/nmeth.1460, 10.1038/NMETH.1460]; Klaassen CD, 2009, TOXICOL APPL PHARM, V238, P215, DOI 10.1016/j.taap.2009.03.026; Ryu KY, 2008, MOL CELL BIOL, V28, P1136, DOI 10.1128/MCB.01566-07; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Vabulas RM, 2007, CURR OPIN CLIN NUTR, V10, P24, DOI 10.1097/MCO.0b013e328011645b; Salomons FA, 2010, EXP CELL RES, V316, P1289, DOI 10.1016/j.yexcr.2010.02.003; FORNACE AJ, 1989, NUCLEIC ACIDS RES, V17, P1215, DOI 10.1093/nar/17.3.1215; Tokumoto M, 2011, J TOXICOL SCI, V36, P191; Yu XZ, 2011, TOXICOL SCI, V120, P403, DOI 10.1093/toxsci/kfr010; Song CC, 2008, TOXICOL APPL PHARM, V228, P351, DOI 10.1016/j.taap.2007.12.026; BOND U, 1986, MOL CELL BIOL, V6, P4602; Lee JY, 2013, J TOXICOL SCI, V38, P959; BAKER RT, 1991, NUCLEIC ACIDS RES, V19, P1035, DOI 10.1093/nar/19.5.1035; Lee JY, 2015, FEBS LETT, V589, P2720, DOI 10.1016/j.febslet.2015.08.016; Ryu KY, 2007, EMBO J, V26, P2693, DOI 10.1038/sj.emboj.7601722; Fujiwara Y, 2012, BIOL PHARM BULL, V35, P1892; BAKER RT, 1987, NUCLEIC ACIDS RES, V15, P443, DOI 10.1093/nar/15.2.443; Jarup L, 2002, NEPHROL DIAL TRANSPL, V17, P35; Yu XZ, 2008, TOXICOL SCI, V104, P385, DOI 10.1093/toxsci/kfn087; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337; Park H, 2013, BIOCHEM BIOPH RES CO, V435, P434, DOI 10.1016/j.bbrc.2013.05.003; Tokumoto M, 2013, J TOXICOL SCI, V38, P815; Wilkinson KD, 1997, FASEB J, V11, P1245; Du K, 2014, J TOXICOL SCI, V39, P861; Figueiredo-Pereira ME, 2002, J BIOL CHEM, V277, P25283, DOI 10.1074/jbc.M109145200; Han XJ, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.142; Jarup Lars, 1998, Scandinavian Journal of Work Environment and Health, V24, P1; Kim MN, 2015, BBA-MOL CELL RES, V1853, P996, DOI 10.1016/j.bbamcr.2015.02.010; Oh C, 2013, SCI REP-UK, V3, DOI 10.1038/srep02623; Ryu HW, 2014, SCI REP-UK, V4, DOI 10.1038/srep07026	32	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2015	40	6					901	908				8	Toxicology	Toxicology	CY2LF	WOS:000366239500024		
J	Kariyazono, Y; Taura, J; Hattori, Y; Ishii, Y; Narimatsu, S; Fujimura, M; Takeda, T; Yamada, H				Kariyazono, Yudai; Taura, Junki; Hattori, Yukiko; Ishii, Yuji; Narimatsu, Shizuo; Fujimura, Masatake; Takeda, Tomoki; Yamada, Hideyuki			Effect of in utero exposure to endocrine disruptors on fetal steroidogenesis governed by the pituitary-gonad axis: a study in rats using different ways of administration	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Endocrine disruptor; Steroidogenic acute-regulatory protein; Luteinizing hormone; Maternal exposure; Fetus; Rats	TESTICULAR STEROIDOGENESIS; NEUROENDOCRINE SYSTEMS; METHYLMERCURY EXPOSURE; MATERNAL EXPOSURE; CADMIUM EXPOSURE; SEXUAL-BEHAVIOR; GENE-EXPRESSION; LEYDIG-CELLS; LEAD; DIOXIN	The effects of endocrine disruptors on testicular steroidogenesis in fetal rats were investigated in a study involving in utero exposure. In the major part of this study, pregnant rats at gestational day (GD) 15 were given a single oral administration of the test substance, and then the expression of the following mRNAs in GD20 fetuses was determined: testicular steroidogenic acute-regulatory protein (StAR), a cholesterol transporter mediating the rate-limiting step of steroidogenesis, a beta-subunit of pituitary luteinizing hormone (LH), and a regulator of gonadal steroidogenesis. Among the substances tested, only di(2-ethylhexyl)phthalate (DEHP) reduced the expression of fetal testicular StAR. The others listed below exhibited little effect on fetal StAR: 2,2',4,4'-tetrabromodiphenylether, tributyltin chloride, atrazine, permethrin, cadmium chloride (Cd), lead acetate (Pb) and methylmercury (CH3HgOH). None of them, including DEHP, lacked the ability to reduce the expression of pituitary LH beta mRNA. The present study also examined the potential of metals as modifiers of fetal steroidogenesis by giving them to pregnant dams in drinking water during GD1 and GD20. Under these conditions, Cd and Pb at a low concentration (0.01 ppm) significantly attenuated the fetal testicular expression of StAR mRNA without a concomitant reduction in LH beta. No such effect was detected with CH3HgOH even at 1 ppm. These results suggest that: 1) DEHP, Cd and Pb attenuate the fetal production of sex steroids by directly acting on the testis, and 2) chronic treatment during the entire gestational period is more useful than a single administration for determining the hazardous effect of a suspected endocrine disruptor on fetal steroidogenesis.	[Kariyazono, Yudai; Taura, Junki; Hattori, Yukiko; Ishii, Yuji; Takeda, Tomoki; Yamada, Hideyuki] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 8128582, Japan; [Narimatsu, Shizuo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008530, Japan; [Fujimura, Masatake] Natl Inst Minaniata Dis, Dept Basic Med Sci, Minamata 8670008, Japan	Yamada, H (reprint author), Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hyamada@phar.kyushu-u.ac.jp			Japan Society for the Promotion of Science;  [24221004]	This study was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science; Scientific Research (S) (Project No.: 24221004).	Adeeko A, 2003, TOXICOL SCI, V74, P407, DOI 10.1093/toxsci/kfg131; Batra N, 1998, REPROD TOXICOL, V12, P535, DOI 10.1016/S0890-6238(98)00030-6; Talsness CE, 2008, ENVIRON HEALTH PERSP, V116, P308, DOI 10.1289/ehp.10536; Foradori CD, 2009, BIOL REPROD, V81, P40, DOI 10.1095/biolreprod.108.075713; Takeda T, 2014, MOL PHARMACOL, V85, P74, DOI 10.1124/mol.113.088575; Batra N, 2001, J APPL TOXICOL, V21, P507, DOI 10.1002/jat.796; Bolin CM, 2006, FASEB J, V20, P788, DOI 10.1096/fj.05-5091fje; Amzal B, 2009, ENVIRON HEALTH PERSP, V117, P1293, DOI 10.1289/ehp.0800317; Schug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007; Kishta O, 2007, REPROD TOXICOL, V23, P1, DOI 10.1016/j.reprotox.2006.08.014; Suvorov A, 2009, NEONATOLOGY, V95, P203, DOI 10.1159/000155651; RICE DC, 1989, J TOXICOL ENV HEALTH, V27, P189; Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015; Siu ER, 2009, TOXICOL APPL PHARM, V238, P240, DOI 10.1016/j.taap.2009.01.028; EL-Maraghy SA, 2011, J BIOCHEM MOL TOXIC, V25, P15, DOI 10.1002/jbt.20354; Frye CA, 2012, J NEUROENDOCRINOL, V24, P144, DOI 10.1111/j.1365-2826.2011.02229.x; Kikuchi Y, 2002, J OCCUP HEALTH, V44, P240, DOI 10.1539/joh.44.240; Ji YL, 2010, REPROD TOXICOL, V29, P176, DOI 10.1016/j.reprotox.2009.10.014; Mutoh J, 2006, ENDOCRINOLOGY, V147, P927, DOI 10.1210/en.2005-1125; Yadav N, 2008, FOOD CHEM TOXICOL, V46, P494, DOI 10.1016/j.fct.2007.08.035; Zhang SY, 2007, ENDOCRINOLOGY, V148, P3941, DOI 10.1210/en.2006-1497; Storelli MM, 2001, FOOD ADDIT CONTAM, V18, P303, DOI 10.1080/02652030010021413; Zhao Y, 2012, TOXICOL IN VITRO, V26, P950, DOI 10.1016/j.tiv.2012.04.003; Ji YL, 2011, TOXICOL LETT, V205, P69, DOI 10.1016/j.toxlet.2011.05.233; Takeda T, 2012, J BIOL CHEM, V287, P18440, DOI 10.1074/jbc.M111.335158; LEE JH, 1995, J TOXICOL ENV HEALTH, V45, P415; Gunnarsson D, 2004, TOXICOLOGY, V200, P49, DOI 10.1016/j.tox.2004.03.003; Kippler M, 2010, TOXICOL LETT, V192, P162, DOI 10.1016/j.toxlet.2009.10.018; Gore AC, 2008, FRONT NEUROENDOCRIN, V29, P358, DOI 10.1016/j.yfrne.2008.02.002; Takeda T, 2009, J PHARMACOL EXP THER, V329, P1091, DOI 10.1124/jpet.109.151282; Kuriwaki J, 2005, TOXICOL LETT, V156, P369, DOI 10.1016/j.toxlet.2004.12.009; Hamdi SA, 1997, ARCH ANDROLOGY, V38, P243; Fudvoye J, 2014, VITAM HORM, V94, P1, DOI 10.1016/B978-0-12-800095-3.00001-8; Matsumoto Y, 2010, J TOXICOL SCI, V35, P365; BOADI WY, 1991, ARCH TOXICOL, V65, P318, DOI 10.1007/BF01968966; Satarug S, 2004, ENVIRON HEALTH PERSP, V112, P1099, DOI 10.1289/ehp.6751; Foradori CD, 2009, BIOL REPROD, V81, P1099, DOI 10.1095/biolreprod.109.077453; Stroheker T, 2006, FOOD CHEM TOXICOL, V44, P2064, DOI 10.1016/j.fct.2006.07.007; Sant'Ana MG, 2001, NEUROTOXICOL TERATOL, V23, P203, DOI 10.1016/S0892-0362(01)00118-0; Carlson N.R, 2007, PHYSIOL BEHAV, P329; GOYER RA, 1990, ENVIRON HEALTH PERSP, V89, P101, DOI 10.2307/3430905; Hattori Y, 2014, ENDOCRINE, V47, P572, DOI 10.1007/s12020-014-0257-3; Patrick Lyn, 2003, Altern Med Rev, V8, P106; STOLTENBURGDIDINGER G, 1990, NEUROTOXICOL TERATOL, V12, P573, DOI 10.1016/0892-0362(90)90064-J; Taura J, 2014, TOXICOL APPL PHARM, V281, P48, DOI 10.1016/j.taap.2014.09.001; Vo TTB, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-104; WHO, 1993, WHO TECHN REP SER, V837; Yu M.-H., 2011, ENV TOXICOLOGY BIOL, P195	48	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	DEC	2015	40	6					909	916				8	Toxicology	Toxicology	CY2LF	WOS:000366239500025		
J	AboEllail, MAM; Hanaoka, U; Numoto, A; Hata, T				AboEllail, Mohamed Ahmed Mostafa; Hanaoka, Uiko; Numoto, Atsuo; Hata, Toshiyuki			HDlive Imaging of a Giant Fetal Hemangioma	JOURNAL OF ULTRASOUND IN MEDICINE			English	Letter							PRENATAL-DIAGNOSIS; NECK		[AboEllail, Mohamed Ahmed Mostafa; Hanaoka, Uiko; Hata, Toshiyuki] Kagawa Univ, Grad Sch Med, Dept Perinatol & Gynecol, Takamatsu, Kagawa 760, Japan; [Numoto, Atsuo] Numoto Ladies Clin, Dept Obstet & Gynecol, Toshiyuki, Kagawa, Japan	AboEllail, MAM (reprint author), Kagawa Univ, Grad Sch Med, Dept Perinatol & Gynecol, Takamatsu, Kagawa 760, Japan.						Kaplan MC, 2013, J ULTRAS MED, V32, P873, DOI 10.7863/ultra.32.5.873; Goncalves LF, 1997, ULTRASOUND OBST GYN, V9, P128, DOI 10.1046/j.1469-0705.1997.09020128.x; Rotas M, 2006, J ULTRAS MED, V25, P527; Tseng JJ, 1999, ULTRASOUND OBST GYN, V13, P363, DOI 10.1046/j.1469-0705.1999.13050363.x; Kagan KO, 2011, ULTRASOUND OBST GYN, V38, P607, DOI 10.1002/uog.10112; Yoshida S, 2006, J OBSTET GYNAECOL RE, V32, P47, DOI 10.1111/j.1447-0756.2006.00350.x; Mulliken JB, 2004, J AM ACAD DERMATOL, V50, P875, DOI 10.1016/j.jaad.2003.10.670; Shiraishi H, 2000, PRENATAL DIAG, V20, P1004, DOI 10.1002/1097-0223(200012)20:12<1004::AID-PD953>3.0.CO;2-Z; Kasbach RH, 1940, AM J DIS CHILD, V59, P1063; Tanaka K, 2014, J MED ULTRASON, V42, P109	10	0	0	AMER INST ULTRASOUND MEDICINE	LAUREL	SUBSCRIPTION DEPT, 14750 SWEITZER LANE, STE 100, LAUREL, MD 20707-5906 USA	0278-4297	1550-9613		J ULTRAS MED	J. Ultrasound Med.	DEC	2015	34	12					2315	2318		10.7863/ultra.15.01070		4	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	CY0CB	WOS:000366072700026		
J	Enomoto, Y; Takagi, T; Matsubara, H; Tsujimoto, M; Yamauchi, K; Yoshimura, S; Iwama, T				Enomoto, Yukiko; Takagi, Toshinori; Matsubara, Hirofumi; Tsujimoto, Masanori; Yamauchi, Keita; Yoshimura, Shinichi; Iwama, Toru			Delayed Stenosis in the Intracranial Vessels following Endovascular Treatment for Acute Stroke	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article							ACUTE ISCHEMIC-STROKE; IN-STENT RESTENOSIS; MECHANICAL THROMBECTOMY; ARTERIAL-STENOSIS; RANDOMIZED-TRIAL; RETRIEVER; REVASCULARIZATION; MANAGEMENT; THROMBOSIS; DEVICE	Purpose: To evaluate delayed stenosis of the vessels after endovascular thrombectomy using magnetic resonance (MR) angiography. Materials and Methods: Of 82 consecutive patients who underwent successful endovasoular treatment for acute intracranial large vessel occlusion between October 2010 and October 2014 at a single institution, 57 patients for whom 3-month radiologic follow-up examinations using MR angiography were available were included in the analysis. MR angiography images were assessed to detect delayed stenosis, which was defined as a decrease in the diameter of treated vessels > 50% compared with MR angiography images obtained 24 hours after endovascular treatment. Results: MR angiography images obtained 3 months after endovascular treatment revealed delayed stenosis of treated vessels in five (8.8%) of 57 patients. All cases of delayed stenosis were asymptomatic and occurred in the middle cerebral artery (MCA). Further serial radiologic follow-up showed gradual improvement of all delayed stenosis over 12 months. Conclusions: Endovascular treatment poses a risk of delayed stenosis of treated vessels, especially in the MCA. MR angiography is a useful modality in long-term follow-up to evaluate delayed stenosis after endovascular treatment.	[Enomoto, Yukiko; Takagi, Toshinori; Matsubara, Hirofumi; Tsujimoto, Masanori; Yamauchi, Keita; Iwama, Toru] Gifu Univ, Grad Sch Med, Dept Neurosurg, Gifu 5011194, Japan; [Yoshimura, Shinichi] Hyogo Med Univ, Grad Sch Med, Dept Neurosurg, Nishinomiya, Hyogo, Japan	Enomoto, Y (reprint author), Gifu Univ, Grad Sch Med, Dept Neurosurg, 1-1 Yanagido, Gifu 5011194, Japan.	enomoto@gifu-u.ac.jp					Adams Jr HP, 1993, ARTERIOSCLER THROMB, V24, P35, DOI DOI 10.1161/01.STR.24.1.35; Langer D, 2009, STROKE, V40, P2761, DOI 10.1161/STROKEAHA.108.544957; Kwon SU, 2005, STROKE, V36, P782, DOI 10.1161/01.STR.0000157667.06542.b7; Smith WS, 2008, STROKE, V39, P1205, DOI 10.1161/STROKEAHA.107.497115; Tomsick T, 2008, AM J NEURORADIOL, V29, P582, DOI 10.3174/ajnr.A0843; Levy EI, 2007, NEUROSURGERY, V61, P644, DOI 10.1227/01.NEU.0000280023.69511.3A; Albuquerque FC, 2008, NEUROSURGERY, V63, P23, DOI [10.1227/01.NEU.0000335067.53190.A2, 10.1227/01.NEU.0000316428.68824.23]; Asakura M, 1998, CIRCULATION, V97, P2003; Yu SCH, 2011, AM J NEURORADIOL, V32, P753, DOI 10.3174/ajnr.A2363; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; ROGERS C, 1993, CIRCULATION, V88, P1215; Kurre W, 2013, CARDIOVASC INTER RAD, V36, P629, DOI 10.1007/s00270-012-0496-8; Zaidat OO, 2008, NEUROLOGY, V70, P1518, DOI 10.1212/01.wnl.0000306308.08229.a3; Turk AS, 2008, AM J NEURORADIOL, V29, P23, DOI 10.3174/ajnr.A0869; Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Eugene F, 2015, AM J NEURORADIOL, V36, P126, DOI 10.3174/ajnr.A4071; Kai Yutaka, 2011, Surg Neurol Int, V2, P8, DOI 10.4103/2152-7806.76145; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Teng DY, 2015, STROKE, V46, P1099, DOI 10.1161/STROKEAHA.114.007494; Yuki I, 2014, AM J NEURORADIOL, V34, pE87	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	DEC	2015	26	12					1814	1819		10.1016/j.jvir.2015.08.014		6	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	CY2HX	WOS:000366230500010		
J	Imamine, R; Shibata, T; Yabuta, M; Shinozuka, K; Kataoka, M; Isoda, H; Yoshizawa, A; Uemoto, S; Togashi, K				Imamine, Rinpei; Shibata, Toshiya; Yabuta, Minoru; Shinozuka, Ken; Kataoka, Masako; Isoda, Hiroyoshi; Yoshizawa, Atsushi; Uemoto, Shinji; Togashi, Kaori			Long-Term Outcome of Percutaneous Biliary Interventions for Biliary Anastomotic Stricture in Pediatric Patients after Living Donor Liver Transplantation with Roux-en-Y Hepaticojejunostomy	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article							TRANSHEPATIC BALLOON DILATION; SINGLE-CENTER EXPERIENCE; TRACT COMPLICATIONS; 2 DECADES; MANAGEMENT; RECIPIENTS; STENT	Purpose: To retrospectively evaluate long-term outcomes of percutaneous transhepatic biliary drainage (PTBD) followed by; balloon dilation and placement of an internal drainage tube for anastomotic stricture in pediatric patients who underwent living donor liver transplantation (LDLT) with Roux-en-Y hepaticojejunostomy (RYHJ). Materials and Methods: Fifty-two patients (23 male, 29 female; median age, 5 y) with anastomotic biliary stricture were treated with PTBD followed by balloon catheter dilation and long-term placement of an internal drainage tube, which was removed upon cholangiographic confirmation of free flow of bile into the small bowel. Clinical success, tube independence rate, risk factors of recurrent biliary stricture, and patency rates were evaluated. Results: Thirty-nine patients (75%) had no stricture recurrence. Of 13 patients (25%) with recurrence, six were treated again with the same percutaneous biliary interventions and showed no further recurrence. Clinical success was noted in 43 of 52 patients (83%). Drainage tubes were removed from 49 patients (94%). Mtiltivariate logistic regression analysis indicated that serum alanine aminotransferase level > 53 IU/L at discharge after the initial series of percutaneous biliary interventions was a significant risk factor for recurrent biliary stricture (P = .002). Kaplan-Meier analysis showed 1-, 3-, 5-, and 10-year primary and primary assisted patency rates of 75%, 70%; 70%, and 68%, and 94%, 92%, 88%, and 88%, respectively. Conclusions: PTBD followed by balloon dilation and internal drainage may be an effective treatment for anastomotic biliary stricture after pediatric LDLT with RYHJ.	[Imamine, Rinpei; Shibata, Toshiya; Yabuta, Minoru; Shinozuka, Ken; Kataoka, Masako; Isoda, Hiroyoshi; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Radiol, Sakyo Ku, Kyoto 6068507, Japan; [Yoshizawa, Atsushi; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Surg, Sakyo Ku, Kyoto 6068507, Japan	Shibata, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Radiol, Sakyo Ku, 54 Kawaharacho, Kyoto 6068507, Japan.	ksj@kuhp.kyoto-u.ac.jp					Yamamoto K, 2011, CARDIOVASC INTER RAD, V34, P601, DOI 10.1007/s00270-010-0045-2; Seo JK, 2009, LIVER TRANSPLANT, V15, P369, DOI 10.1002/lt.21700; Koivusalo A, 1996, SCAND J GASTROENTERO, V31, P506, DOI 10.3109/00365529609006773; Egawa H, 2001, WORLD J SURG, V25, P1300; TANAKA K, 1993, ANN SURG, V217, P82, DOI 10.1097/00000658-199301000-00014; Saad WEA, 2006, J VASC INTERV RADIOL, V17, P837, DOI 10.1097/01.RVI.0000209343.80105.B4; Azeem N, 2013, GASTROINTEST ENDOSC, V77, P568, DOI 10.1016/j.gie.2012.11.031; Kochhar G, 2013, WORLD J GASTROENTERO, V19, P2841, DOI 10.3748/wjg.v19.i19.2841; Moreira AM, 2010, CARDIOVASC INTER RAD, V33, P90, DOI 10.1007/s00270-009-9619-2; Roumilhac D, 2003, LIVER TRANSPLANT, V9, P394, DOI 10.1053/jlts.2003.50052; Jeffrey GP, 1999, AUST NZ J SURG, V69, P717, DOI 10.1046/j.1440-1622.1999.01671.x; GREIF F, 1994, ANN SURG, V219, P40, DOI 10.1097/00000658-199401000-00007; Hwang S, 2006, LIVER TRANSPLANT, V12, P831, DOI 10.1002/lt.20693; ZAJKO AB, 1995, J VASC INTERV RADIOL, V6, P79, DOI 10.1016/S1051-0443(95)71063-6; Culp WC, 1996, RADIOLOGY, V199, P339; STARZL TE, 1989, NEW ENGL J MED, V321, P1014, DOI 10.1056/NEJM198910123211505; Kasahara M, 2013, AM J TRANSPLANT, V13, P1830, DOI 10.1111/ajt.12276; Petersen BD, 1996, J VASC INTERV RADIOL, V7, P221, DOI 10.1016/S1051-0443(96)70765-0; Op den Dries S, 2014, J HEPATOL, V60, P1172, DOI 10.1016/j.jhep.2014.02.010; Kurita A, 2013, J GASTROENTEROL, V48, P1097, DOI 10.1007/s00535-012-0705-x; Miraglia R, 2008, CARDIOVASC INTER RAD, V31, P993, DOI 10.1007/s00270-008-9378-5; Saad WEA, 2005, J VASC INTERV RADIOL, V16, P1221, DOI 10.1097/01.RVI.0000173281.69988.57; Brun N, 2010, Cir Pediatr, V23, P3; Howard RJ, 2005, ANN SURG, V241, P916; Busuttil RW, 2005, ANN SURG, V241, P905, DOI 10.1097/01.sla.0000164077.77912.98; Fonio P, 2015, RADIOL MED, V120, P289, DOI 10.1007/s11547-014-0432-x; lida T, 2014, CLIN TRANSPLANT, V28, P1025; Moreels Tom G, 2010, World J Gastrointest Endosc, V2, P314, DOI 10.4253/wjge.v2.i9.314; Qian Ye Ben, 2004, Arch Surg, V139, P1101, DOI 10.1001/archsurg.139.10.1101; Sunku Bhanu, 2006, Liver Transpl, V12, P821, DOI 10.1002/lt.20712; Trotter JF, 2002, NEW ENGL J MED, V346, P1074, DOI 10.1056/NEJMra011629	31	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	DEC	2015	26	12					1852	1859		10.1016/j.jvir.2015.07.029		8	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	CY2HX	WOS:000366230500017		
J	Imagawa, J; Tanaka, H; Okada, M; Nakamae, H; Hino, M; Murai, K; Ishida, Y; Kumagai, T; Sato, S; Ohashi, K; Sakamaki, H; Wakita, H; Uoshima, N; Nakagawa, Y; Minami, Y; Ogasawara, M; Takeoka, T; Akasaka, H; Utsumi, T; Uike, N; Sato, T; Ando, S; Usuki, K; Morita, S; Sakamoto, J; Kimura, S				Imagawa, Jun; Tanaka, Hideo; Okada, Masaya; Nakamae, Hirohisa; Hino, Masayuki; Murai, Kazunori; Ishida, Yoji; Kumagai, Takashi; Sato, Seiichi; Ohashi, Kazuteru; Sakamaki, Hisashi; Wakita, Hisashi; Uoshima, Nobuhiko; Nakagawa, Yasunori; Minami, Yosuke; Ogasawara, Masahiro; Takeoka, Tomoharu; Akasaka, Hiroshi; Utsumi, Takahiko; Uike, Naokuni; Sato, Tsutomu; Ando, Sachiko; Usuki, Kensuke; Morita, Satoshi; Sakamoto, Junichi; Kimura, Shinya		DADI Trial Grp	Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial	LANCET HAEMATOLOGY			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; EUROPEAN-LEUKEMIANET; CML PATIENTS; FOLLOW-UP; IMATINIB; THERAPY; MANAGEMENT; REMISSION; DISEASE; CELLS	Background First-line imatinib treatment can be successfully discontinued in patients with chronic myeloid leukaemia after deep molecular response has been sustained for at least 2 years. We investigated the safety and efficacy of discontinuing second-line or subsequent dasatinib after at least 1 year of deep molecular response. Methods The Dasatinib Discontinuation trial was a prospective multicentre trial done in Japan. Eligible patients taking dasatinib and with confirmed stable deep molecular response were enrolled between April 1, 2011, and March 31, 2012. All patients received dasatinib consolidation therapy for at least 1 year. In those with sustained deep molecular response, dasatinib was discontinued. Patients were followed up every month in year 1 (clinical cutoff), every 3 months in year 2, and every 6 months in year 3 for deep molecular response and immunological profiles. The primary endpoint was the proportion of patients with treatment-free remission at 6 months after discontinuation. Molecular relapse was defined as loss of deep molecular response at any assessment. This study is registered, number UMIN000005130. Findings 88 patients were enrolled in the consolidation phase, 24 were excluded from the discontinuation phase due to fluctuations in BCR-ABL1 transcript levels. One patient was excluded because of positive expression of major and minor BCR-ABL1 transcripts in chronic myeloid leukaemia cells and the detection of minor BCR-ABL1 transcripts during consolidation. Thus, 63 patients discontinued dasatinib treatment. The 25 patients who were excluded from discontinuation continued to receive dasatinib and none showed disease progression. Median follow-up was 20.0 months (IQR 16.5-24.0). Of the 63 patients who discontinued and were not excluded, 30 patients maintained deep molecular response while 33 patients had molecular relapses, all within the first 7 months after discontinuation. The estimated overall treatment-free remission was 49% (95% CI 36-61) at 6 months. No severe treatment-related toxic effects were seen. Treatment was restarted in the 33 patients with relapse; rapid molecular responses were seen in all 33 patients, of whom 29 (88%) regained deep molecular response within 3 months, as did the remaining four by 6 months. Interpretation Dasatinib discontinuation after sustained deep molecular response for more than 1 year is feasible.	[Imagawa, Jun] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Haematol & Oncol, Hiroshima, Japan; [Tanaka, Hideo] Hiroshima City Asa Hosp, Dept Haematol, Hiroshima, Japan; [Okada, Masaya] Hyogo Coll Med, Dept Internal Med, Div Haematol, Nishinomiya, Hyogo 6638501, Japan; [Nakamae, Hirohisa] Osaka City Univ, Grad Sch Med, Dept Haematol, Osaka 558, Japan; [Hino, Masayuki; Murai, Kazunori; Ishida, Yoji] Iwate Med Univ, Dept Haematol & Oncol, Morioka, Iwate 020, Japan; [Kumagai, Takashi] Hme Municipal Gen Hosp, Dept Haematol, Tokyo, Japan; [Sato, Seiichi] Fujimoto Sogo Hosp, Dept Internal Med, Miyakonojo, Japan; [Ohashi, Kazuteru; Sakamaki, Hisashi] Ctr Komagome Hosp, Div Metropolitan Canc & Infect Dis, Div Haematol, Tokyo, Japan; [Wakita, Hisashi] Japanese Red Cross Narita Hosp, Div Haematol & Oncol, Narita, Japan; [Uoshima, Nobuhiko] Matsushita Mem Hosp, Dept Haematol, Moriguchi, Osaka, Japan; [Nakagawa, Yasunori] Japanese Red Cross Med Ctr, Dept Haematol, Tokyo, Japan; [Minami, Yosuke] Kobe Univ Hosp, Div Blood Transfus, Kobe, Hyogo, Japan; [Minami, Yosuke] Kobe Univ Hosp, Div Med Oncol & Haematol, Kobe, Hyogo, Japan; [Ogasawara, Masahiro] Sapporo Hokuyu Hosp, Dept Haematol, Sapporo, Hokkaido, Japan; [Takeoka, Tomoharu] Otsu Red Cross Hosp, Div Haematol & Immunol, Otsu, Shiga, Japan; [Akasaka, Hiroshi] Shinko Hosp, Dept Haematol, Kobe, Hyogo, Japan; [Utsumi, Takahiko] Shiga Med Ctr Adults, Dept Haematol, Moriyama, Japan; [Uike, Naokuni] Natl Hosp Org, Kyushu Natl Canc Ctr, Div Haematol, Fukuoka, Japan; [Sato, Tsutomu] Sapporo Med Univ, Sch Med, Dept Internal Med 4, Sapporo, Hokkaido, Japan; [Ando, Sachiko] Teine Keijinkai Hosp, Dept Haematol, Sapporo, Hokkaido, Japan; [Usuki, Kensuke] NTT Med Ctr Tokyo, Div Haematol, Tokyo, Japan; [Morita, Satoshi] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan; [Sakamoto, Junichi] ECRIN, Okazaki, Aichi, Japan; [Kimura, Shinya] Saga Univ, Fac Med, Dept Internal Med, Div Haematol Resp Med & Oncol, Saga 840, Japan	Kimura, S (reprint author), Saga Univ, Fac Med, Dept Internal Med, Div Haematol Resp Med & Oncol, 5-1-1 Nabeshima, Saga 8498501, Japan.	shkimu@cc.saga-u.ac.jp			Epidemiological and Clinical Research Information Network (ECRIN)	Epidemiological and Clinical Research Information Network (ECRIN).	Yoshida C, 2012, INT J CLIN ONCOL, V17, P584, DOI 10.1007/s10147-011-0328-x; Kimura S, 2014, INT J CLIN ONCOL, V19, P3, DOI 10.1007/s10147-013-0641-7; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Mori S, 2015, AM J HEMATOL, V90, P910, DOI 10.1002/ajh.24120; Kumagai T, 2014, INT J HEMATOL, V99, P41, DOI 10.1007/s12185-013-1483-9; Cross NCP, 2015, LEUKEMIA, V29, P999, DOI 10.1038/leu.2015.29; Hochhaus A, 2007, BLOOD, V109, P2303, DOI 10.1182/blood-2006-09-047266; Branford S, 2012, BLOOD, V119, P4264, DOI 10.1182/blood-2011-11-393041; Kantarjian HM, 2012, BLOOD, V119, P1123, DOI 10.1182/blood-2011-08-376087; Dusetzina SB, 2014, J CLIN ONCOL, V32, P306, DOI 10.1200/JCO.2013.52.9123; McCormack PL, 2012, BIODRUGS, V26, P61, DOI 10.2165/11207640-000000000-00000; Tanaka H, 2012, INT J HEMATOL, V96, P308, DOI 10.1007/s12185-012-1132-8; Rousselot P, 2014, J CLIN ONCOL, V32, P424, DOI 10.1200/JCO.2012.48.5797; Ross DM, 2014, BRIT J HAEMATOL, V166, P3, DOI 10.1111/bjh.12892; Cortes JE, 2003, BLOOD, V101, P3794, DOI 10.1182/blood-2002-09-2790; Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Baccarani M, 2006, BLOOD, V108, P1809, DOI 10.1182/blood-2006-02-005686; Shah NP, 2014, BLOOD, V123, P2317, DOI 10.1182/blood-2013-10-532341; Ross DM, 2013, BLOOD, V122, P515, DOI 10.1182/blood-2013-02-483750; Mustjoki S, 2009, LEUKEMIA, V23, P1398, DOI 10.1038/leu.2009.46; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Deininger M, 2009, 51 ASH ANN M EXP NEW; Fisher JPH, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27572; Ilander MM, 2013, BLOOD, V122; Rea D, 2013, BLOOD, V122; Rea D RP, 2012, 54 ASH ANN M EXP ATL; Ross DM, 2011, HAEMATOL-HEMATOL J, V96, P1720, DOI 10.3324/haematol.2011.048165	29	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2352-3026			LANCET HAEMATOL	Lancet Haematol.	DEC	2015	2	12					E528	E535		10.1016/S2352-3026(15)00196-9		8	Hematology	Hematology	CX9OB	WOS:000366033900011		
J	Izutsu, T; Tsutsumi, A; Minas, H; Thornicroft, G; Patel, V; Ito, A				Izutsu, Takashi; Tsutsumi, Atsuro; Minas, Harry; Thornicroft, Graham; Patel, Vikram; Ito, Akiko			Mental health and wellbeing in the Sustainable Development Goals	LANCET PSYCHIATRY			English	Editorial Material									[Izutsu, Takashi] Univ Tokyo, Komaba Org Educ Excellence, Tokyo, Japan; [Tsutsumi, Atsuro] United Nations Univ, Int Inst Global Hlth, Kuala Lumpur 56000, Malaysia; [Minas, Harry] Univ Melbourne, Ctr Mental Hlth, Global & Cultural Mental Hlth Unit, Melbourne, Vic, Australia; [Thornicroft, Graham] Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Global Mental Hlth, London WC2R 2LS, England; [Patel, Vikram] London Sch Hyg & Trop Med, London WC1, England; [Ito, Akiko] UN, Dept Econ & Social Affairs, New York, NY 10017 USA	Tsutsumi, A (reprint author), United Nations Univ, Int Inst Global Hlth, Kuala Lumpur 56000, Malaysia.	tsutsumi@gakushikai.jp	Thornicroft, Graham/B-4027-2010				[Anonymous], 2013, MENT HLTH ACT PLAN 2; OECD, 2014, MAK MENT HLTH COUNT; UN, 2015, SEND FRAM DIS RISK R; UN UNU, 2013, UN EXP GROUP M MENT; UN UNU, 2015, MENT HLTH WELL BEING; UN WHO, 2010, POL AN MENT HLTH DEV; United Nations, 2015, ADD AB ACT AG 3 INT; United Nations, 2015, TRANSF OUR WORLD 203; WHO, 2001, WORLD HLTH REP 2001; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Health Organization, 2010, MHGAP INT GUID MENT; World Health Organization, 2014, PREV SUIC GLOB IMP	12	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2215-0374			LANCET PSYCHIAT	Lancet Psychiatry	DEC	2015	2	12					1052	1054				4	Psychiatry	Psychiatry	CY0JY	WOS:000366093600014		
J	Hu, W; Xu, Q; Wang, GH; van Asch, TWJ; Hicher, PY				Hu, W.; Xu, Q.; Wang, G. H.; van Asch, T. W. J.; Hicher, P. -Y.			Sensitivity of the initiation of debris flow to initial soil moisture	LANDSLIDES			English	Article						Debris flow; Initial moisture; Runoff; Internal erosion	SHALLOW LANDSLIDES; MOBILIZATION; BEHAVIOR; COLLAPSE; SAND	The initiation of debris flows is commonly attributed either to fluidization as a result of rainfall-induced landslides or to gully erosion induced by concentrated runoffs. A series of flume tests have been performed to show how the initial soil moisture influences the initiation of debris flows. At the start of each experiment, surface runoff was generated over loose granular deposits, triggering debris flows. These experimental debris flows enacted different scenarios according to the small variations among the initial soil moistures. In the loose granular deposits with initial soil moistures ranging from 1 to 5 %, most runoff water could infiltrate and trigger a landslide, which accelerated within 1 s to speed over 1 ms(-1) and then transformed into a debris flow. In the same soil deposits with initial moistures > 5 or < 1 %, the debris flow was initiated by slow gully erosion with episodic events of damming and breaching due to small-scale landslides occurring on the side-slopes of the erosion valley. The slope failures were not triggered by positive pore pressure but by a decrease in suction due to the wetting of the soil. This suction decrease in initially unsaturated slopes explains why the transformation of these slope failures into debris flows are due not only to an increase of pore pressure leading to soil liquefaction, which is one of the expected triggering mechanisms, but also to a loss of the cohesive strength of the soil.	[Hu, W.; Xu, Q.; van Asch, T. W. J.] Chengdu Univ Technol, State Key Lab Geohazard Prevent & Geoenvironm Pro, Chengdu 650023, Peoples R China; [Wang, G. H.] Kyoto Univ, Disaster Prevent Res Inst, Kyoto, Japan; [van Asch, T. W. J.] Univ Utrecht, Fac Geosci, NL-3584 CS Utrecht, Netherlands; [Hicher, P. -Y.] LUNAM Univ, Ecole Cent Nantes, CNRS UMR 6183, Nantes, France	Xu, Q (reprint author), Chengdu Univ Technol, State Key Lab Geohazard Prevent & Geoenvironm Pro, Chengdu 650023, Peoples R China.	xuqiang_68@126.com			National fundamental scientific research grant of China [41102188]; public welfare project from the Ministry of Land and Resources of People's Republic of China [2013-11122]; National Science Found for Distinguished Young Scholars of China [41225011]	This research is financially supported by National fundamental scientific research grant of China (No. 41102188); public welfare project from the Ministry of Land and Resources of People's Republic of China (2013-11122); and the National Science Found for Distinguished Young Scholars of China (Grant No. 41225011).	SASITHARAN S, 1993, CAN GEOTECH J, V30, P569; Hicher PY, 2013, GEOTECHNIQUE, V63, P118, DOI 10.1680/geot.11.P.020; Guzzetti F, 2008, LANDSLIDES, V5, P3, DOI 10.1007/s10346-007-0112-1; Daouadji A, 2011, INT J NUMER ANAL MET, V35, P1731, DOI 10.1002/nag.975; van Asch TWJ, 2009, NAT HAZARD EARTH SYS, V9, P1703; Klubertanz G, 2009, ENG GEOL, V109, P114, DOI 10.1016/j.enggeo.2009.06.007; FREDLUND DG, 1978, CAN GEOTECH J, V15, P313, DOI 10.1139/t78-029; Hicher PY, 2007, INT J SOLIDS STRUCT, V44, P2304, DOI 10.1016/j.ijsolstr.2006.07.007; Marchi L, 2002, GEOMORPHOLOGY, V46, P1, DOI 10.1016/S0169-555X(01)00162-3; Berti M, 2005, LANDSLIDES, V2, P171, DOI 10.1007/s10346-005-0062-4; Wang GH, 2003, ENG GEOL, V69, P109, DOI 10.1016/S0013-7952(02)00268-5; Gabet EJ, 2006, GEOMORPHOLOGY, V74, P207, DOI 10.1016/j.geomorph.2005.08.013; Berti M, 1999, GEOMORPHOLOGY, V29, P265, DOI 10.1016/S0169-555X(99)00018-5; Malet JP, 2005, GEOMORPHOLOGY, V66, P215, DOI 10.1016/j.geomorph.2004.09.014; ECKERSLEY D, 1990, GEOTECHNIQUE, V40, P489; Gajo A, 2004, CAN GEOTECH J, V41, P257, DOI 10.1139/T03-078; Cascini L, 2014, LANDSLIDES, V11, P779, DOI 10.1007/s10346-013-0395-3; Chang DS, 2013, J GEOTECH GEOENVIRON, V139, P1454, DOI 10.1061/(ASCE)GT.1943-5606.0000871; DAI F.C., 1999, ENG GEOL, V51, P279; Iverson RM, 2000, SCIENCE, V290, P513, DOI 10.1126/science.290.5491.513; Iverson RM, 1997, ANNU REV EARTH PL SC, V25, P85, DOI 10.1146/annurev.earth.25.1.85; LADE PV, 1992, J GEOTECH ENG-ASCE, V118, P51, DOI 10.1061/(ASCE)0733-9410(1992)118:1(51); Olivares L, 2001, TC11 LANDSL C TRANS; Papa M.N., 2012, HYDROL EARTH SYST SC, V9, P12797, DOI DOI 10.5194/HESSD-9-12797-2012; Staley D.M., 2012, LANDSLIDES, V10, P547, DOI DOI 10.1007/S10346-012-0341-9; Takahashi T, 1978, HYDRAUL DIV P AM SOC, V104, P1153; Xu Q, 2012, NAT HAZARD EARTH SYS, V18, P596	27	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1612-510X	1612-5118		LANDSLIDES	Landslides	DEC	2015	12	6					1139	1145		10.1007/s10346-014-0529-2		7	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CY0VE	WOS:000366124000008		
J	Moriishi, M; Kitayama, Y; Ooya, T; Takeuchi, T				Moriishi, Masako; Kitayama, Yukiya; Ooya, Tooru; Takeuchi, Toshifumi			Amphiphilic Polymerizable Porphyrins Conjugated to a Polyglycerol Dendron Moiety as Functional Surfactants for Multifunctional Polymer Particles	LANGMUIR			English	Article							RADICAL EMULSION POLYMERIZATION; DRUG-DELIVERY; MINIEMULSION POLYMERIZATION; METHYL-METHACRYLATE; SUSPENSION POLYMERIZATION; SWITCHABLE SURFACTANTS; PHOTODYNAMIC THERAPY; CONTROL AGENT; STYRENE; NANOPARTICLES	An amphiphilic polyglycerol dendron (PGD) conjugated porphyrin (PGP) bearing a polymerizable group was successfully synthesized. The PGP was used as an effective surfactant in emulsion and microsuspension polymerization systems to prepare styrene and methacrylate polymer particles, and the use of PGP provided the simple polymer particles with fluorescence derived from the metalloporphyrin and high colloidal stability due to the PGD. Furthermore, based on confocal laser scanning microscopy, we observed that the particles spontaneously formed a coreshell morphology with the PGP localized in the shell region during the polymerization and demonstrated drug loading in the shell region using rhodamine B as a model drug. The results indicate that the use of the functional surfactant PGP led to the preparation of multifunctional polymer particles from simple monomer species, and the resulting particles possessed high colloidal stability, fluorescence, and drug loading capability.	[Moriishi, Masako; Kitayama, Yukiya; Ooya, Tooru; Takeuchi, Toshifumi] Kobe Univ, Grad Sch Engn, Nada Ku, Kobe, Hyogo 6578501, Japan	Takeuchi, T (reprint author), Kobe Univ, Grad Sch Engn, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	takeuchi@gold.kobe-u.ac.jp			Japan Society for the Promotion of Science (JSPS); JSPS [25288054]; SYSTEM INSTRUMENTS Co., Ltd. (Tokyo, Japan)	This work was partially supported by a Grant-in-Aid for Young Scientific Research (B) from the Japan Society for the Promotion of Science (JSPS) (given to Y.K.) and also partially supported by the Support Program from a Grant-in-Aid for Scientific Research (Grant 25288054) from JSPS. This work was performed in part under the Cooperative Research Program of "Network Joint Research Center for Materials and Devices" with Prof. Takehiko Wada at Tohoku University, Japan. The authors thank SYSTEM INSTRUMENTS Co., Ltd. (Tokyo, Japan) for their financial support.	Kitayama Y, 2010, LANGMUIR, V26, P7029, DOI 10.1021/la904296h; Minkenberg CB, 2009, J AM CHEM SOC, V131, P11274, DOI 10.1021/ja902808q; Tonnar J, 2008, ANGEW CHEM INT EDIT, V47, P1294, DOI 10.1002/anie.200704146; Zheng YC, 2015, CHEM SOC REV, V44, P4091, DOI 10.1039/c4cs00528g; Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1; Yang SK, 2011, J AM CHEM SOC, V133, P9964, DOI 10.1021/ja2009136; Asua JM, 2002, PROG POLYM SCI, V27, P1283, DOI 10.1016/S0079-6700(02)00010-2; Veiseh O, 2010, ADV DRUG DELIVER REV, V62, P284, DOI 10.1016/j.addr.2009.11.002; Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/nmat2614, 10.1038/NMAT2614]; Fowler CI, 2012, MACROMOLECULES, V45, P2955, DOI 10.1021/ma2027484; Herold M, 2003, MACROMOL CHEM PHYSIC, V204, P770, DOI 10.1002/macp.200390049; Sakai H, 1999, J PHYS CHEM B, V103, P10737, DOI 10.1021/jp9927505; Cao NN, 2007, J POLYM SCI POL CHEM, V45, P5800, DOI 10.1002/pola.22330; Hill JS, 1995, P NATL ACAD SCI USA, V92, P12126, DOI 10.1073/pnas.92.26.12126; Bae Y, 2009, ADV DRUG DELIVER REV, V61, P768, DOI 10.1016/j.addr.2009.04.016; GREENE BW, 1970, J COLLOID INTERF SCI, V32, P90, DOI 10.1016/0021-9797(70)90105-0; Colver PJ, 2008, J AM CHEM SOC, V130, P16850, DOI 10.1021/ja807242k; SAJI T, 1985, J AM CHEM SOC, V107, P6865, DOI 10.1021/ja00310a020; Li WW, 2010, J AM CHEM SOC, V132, P7823, DOI 10.1021/ja100685s; OTTEWILL RH, 1987, COLLOID POLYM SCI, V265, P845, DOI 10.1007/BF01418462; Yang SK, 2013, NAT CHEM, V5, P692, DOI [10.1038/nchem.1706, 10.1038/NCHEM.1706]; Klinger D, 2012, POLYMER, V53, P5209, DOI 10.1016/j.polymer.2012.08.053; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Kitayama Y, 2012, MACROMOLECULES, V45, P2286, DOI 10.1021/ma3000829; O'Connor AE, 2009, PHOTOCHEM PHOTOBIOL, V85, P1053, DOI 10.1111/j.1751-1097.2009.00585.x; Dexter AF, 2006, NAT MATER, V5, P502, DOI 10.1038/nmat1653; Ma GH, 2004, MACROMOLECULES, V37, P2954, DOI 10.1021/ma035316g; Haag R, 2000, J AM CHEM SOC, V122, P2954, DOI 10.1021/ja994363e; Zetterlund PB, 2005, MACROMOL RAPID COMM, V26, P955, DOI 10.1002/marc.200500100; Oh JK, 2008, PROG POLYM SCI, V33, P448, DOI 10.1016/j.progpolymsci.2008.01.002; Horcajada P, 2010, NAT MATER, V9, P172, DOI [10.1038/nmat2608, 10.1038/NMAT2608, 10.1038/NMAT260B]; Kitayama Y, 2012, POLYM CHEM-UK, V3, P1555, DOI 10.1039/c2py20105d; Rieger J, 2008, MACROMOLECULES, V41, P4065, DOI 10.1021/ma800544v; Ryu JH, 2010, J AM CHEM SOC, V132, P17227, DOI 10.1021/ja1069932; Guyot A, 1997, J APPL POLYM SCI, V65, P2289, DOI 10.1002/(SICI)1097-4628(19970919)65:12<2289::AID-APP4>3.0.CO;2-5; Ferguson CJ, 2005, MACROMOLECULES, V38, P2191, DOI 10.1021/ma048787r; Liu YX, 2006, SCIENCE, V313, P958, DOI 10.1126/science.1128142; Landfester K, 2009, ANGEW CHEM INT EDIT, V48, P4488, DOI 10.1002/anie.200900723; Kitayama Y, 2011, POLYMER, V52, P2729, DOI 10.1016/j.polymer.2011.04.027; Takimoto K, 2015, LANGMUIR, V31, P4981, DOI 10.1021/acs.langmuir.5b00769; Ethirajan M, 2011, CHEM SOC REV, V40, P340, DOI 10.1039/b915149b; Wyszogrodzka M, 2009, BIOMACROMOLECULES, V10, P1043, DOI 10.1021/bm801093t; Biju V, 2014, CHEM SOC REV, V43, P744, DOI 10.1039/c3cs60273g; Gilbert R. G., 1995, EMULSION POLYM MECH; Langer R, 1998, NATURE, V392, P5; Okubo M., 1984, MACROMOLECULES, V42, P1979	46	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0743-7463			LANGMUIR	Langmuir	DEC 1	2015	31	47					12903	12910		10.1021/acs.langmuir.5b02865		8	Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	CX8CT	WOS:000365930900008		
J	Hirose, M; Ishigami, T; Suga, K; Umakoshi, H				Hirose, Masanori; Ishigami, Takaaki; Suga, Keishi; Umakoshi, Hiroshi			Liposome Membrane as a Platform for the L-Pro-Catalyzed Michael Addition of trans-beta-Nitrostyrene and Acetone	LANGMUIR			English	Article							AMINO-ACID ESTERS; ALDOL REACTION; SUPEROXIDE-DISMUTASE; PROLINE; ORGANOCATALYSIS; HYDROLYSIS; ALDEHYDES; MICELLE; SYSTEMS; KETONES	Herein, we show that the L-proline (L-Pro)-catalyzed Michael addition of trans-beta-nitrostyrene and acetone can proceed in water using liposome membranes and that the membrane fluidity and polarity are major controlling factors for this reaction. The highest conversion and rate constant of the reaction within the liposomes was achieved with the 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC)/1,2-dipalmitoyl-3-trimethylammoniumpropane (DPTAP) system. The catalytic activity of L-Pro in the liposome suspension was found to be comparable to that in a DMSO system. The reaction rate constant was found to be controlled by both the phase state of the liposome membrane and the surface charge on the membrane. Greater enantioselectivity was achieved in the presence of the liposomes than in DMSO solution, with corresponding enantiomeric excess values of 97.6% for the DOPC/DPTAP liposome system and 10% in DMSO. The hydrophobic region of the liposome membrane, which is a relatively stable self-organizing system, can serve as an effective platform for molecular recognition and selective conversion in aqueous media.	[Hirose, Masanori; Ishigami, Takaaki; Suga, Keishi; Umakoshi, Hiroshi] Osaka Univ, Grad Sch Engn Sci, Div Chem Engn, Toyonaka, Osaka 5608531, Japan	Umakoshi, H (reprint author), 1-3 Machikaneyamacho, Toyonaka, Osaka 5608531, Japan.	b-ice@cheng.es.osaka-u.ac.jp			Funding Program for Next Generation World-Leading Researchers of the Council for Science and Technology Policy (CSTP) [GR066]; Japan Society for the Promotion of Science (JSPS) [13J03878]; JSPS [26249116, 25889039, T15K142040]	We thank Dr. Yukihiro Okamoto (Graduate School of Engineering Science, Osaka University) and Dr. Toshinori Shimanouchi (Graduate School of Environmental Science, Okayama University) for their constructive comments and technical support. This work was supported by the Funding Program for Next Generation World-Leading Researchers of the Council for Science and Technology Policy (CSTP) (GR066), Japan Society for the Promotion of Science (JSPS) Grant-in-aid for JSPS Fellow (13J03878), JSPS Grant-in-Aid for Scientific Research A (26249116), JSPS Grant-in-Aid for Research Activity Start-up (25889039), and JSPS Grant-in-Aid for Challenging Exploratory Research (T15K142040). One of the authors (T.I.) also ex-presses his gratitude for the Japan Society for the Promotion of Science (JSPS) scholarships.	Zayas HA, 2013, ACS MACRO LETT, V2, P327, DOI 10.1021/mz4000943; Ishikawa H, 2009, ANGEW CHEM INT EDIT, V48, P1304, DOI 10.1002/anie.200804883; Hitz T, 2001, MACROMOLECULES, V34, P2443, DOI 10.1021/ma001946w; Hayashi Y, 2006, ANGEW CHEM INT EDIT, V45, P5527, DOI 10.1002/anie.200601156; Zandvoort E, 2012, ANGEW CHEM INT EDIT, V51, P1240, DOI 10.1002/anie.201107404; Mase N, 2006, J AM CHEM SOC, V128, P4966, DOI 10.1021/ja060338e; Zhang HF, 2009, CHIRALITY, V21, P492, DOI 10.1002/chir.20621; JACOB SW, 1986, CRYOBIOLOGY, V23, P14, DOI 10.1016/0011-2240(86)90014-3; List B, 2002, J AM CHEM SOC, V124, P827, DOI 10.1021/ja0174231; Blocher M, 1999, MACROMOLECULES, V32, P7332, DOI 10.1021/ma990917m; Suga K, 2015, ANAL CHEM, V87, P4772, DOI 10.1021/ac5048532; Lu A, 2012, CHEM COMMUN, V48, P9699, DOI 10.1039/c2cc35170f; Suga K, 2013, LANGMUIR, V29, P4830, DOI 10.1021/la304768f; Ishigami T, 2015, ACS APPL MATER INTER, V7, P21065, DOI 10.1021/acsami.5b07198; Iwasaki F, 2015, J PHYS CHEM B, V119, P9772, DOI 10.1021/acs.jpcb.5b03762; List B, 2000, J AM CHEM SOC, V122, P2395, DOI 10.1021/ja994280y; Umakoshi H, 2008, LANGMUIR, V24, P4451, DOI 10.1021/la800174n; Walde P, 2014, CHEM COMMUN, V50, P10177, DOI 10.1039/c4cc02812k; Dwars T, 2005, ANGEW CHEM INT EDIT, V44, P7174, DOI 10.1002/anie.200501365; Tuan LQ, 2008, LANGMUIR, V24, P350, DOI 10.1021/la702690a; Mukherjee S, 2007, CHEM REV, V107, P5471, DOI 10.1021/cr0684016; MacMillan DWC, 2008, NATURE, V455, P304, DOI 10.1038/nature07367; Gu Q, 2009, TETRAHEDRON, V65, P5265, DOI 10.1016/j.tet.2009.04.087; Yoshimoto M, 2007, LANGMUIR, V23, P9416, DOI 10.1021/la701277f; List B, 2001, ORG LETT, V3, P2423, DOI 10.1021/ol015799d; Ohkubo K, 1996, MACROMOL RAPID COMM, V17, P109, DOI 10.1002/marc.1996.030170206; Raj M, 2009, CHEM COMMUN, P6687, DOI 10.1039/b910861k; Rodriguez-Llansola F, 2010, CHEM-EUR J, V16, P8480, DOI 10.1002/chem.201000654; UEOKA R, 1988, J AM CHEM SOC, V110, P1588, DOI 10.1021/ja00213a035; Yeagle P., 2011, STRUCTURE BIOL MEMBR, P19	30	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0743-7463			LANGMUIR	Langmuir	DEC 1	2015	31	47					12968	12974		10.1021/acs.langmuir.5b03439		7	Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	CX8CT	WOS:000365930900016		
J	Beaune, G; Winnik, FM; Brochard-Wyart, F				Beaune, Gregory; Winnik, Francoise M.; Brochard-Wyart, Francoise			Formation of Tethers from Spreading Cellular Aggregates	LANGMUIR			English	Article							LIQUID-OVERLAY CULTURE; PROSTATE-CANCER CELLS; MEMBRANE NANOTUBES; GIANT VESICLES; EXTRUSION; DYNAMICS; TISSUES; TUBES; FLOW; SPHEROIDS	Membrane tubes are commonly extruded from cells and vesicles when a point-like force is applied on the membrane. We report here the unexpected formation of membrane tubes from lymph node cancer prostate (LNCaP) cell aggregates in the absence of external applied forces. The spreading of LNCaP aggregates deposited on adhesive glass substrates coated with fibronectin is very limited because cell-cell adhesion is stronger than cell-substrate adhesion. Some cells on the aggregate periphery are very motile and try to escape from the aggregate, leading to the formation of membrane tubes. Tethered networks and exchange of cargos between cells were observed as well. Growth of the tubes is followed by either tube retraction or tube rupture. Hence, even very cohesive cells are successful in escaping aggregates, which may lead to epithelial mesenchymal transition and tumor metastasis. We interpret the dynamics of formation and retraction of tubes in the framework of membrane mechanics.	[Beaune, Gregory; Winnik, Francoise M.] Natl Inst Mat Sci NIMS, WPI Int Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan; [Winnik, Francoise M.] Univ Montreal, Dept Chem, Montreal, PQ H3C 3J7, Canada; [Winnik, Francoise M.] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [Brochard-Wyart, Francoise] PSL Res Univ, CNRS, Inst Curie, UMR 168, F-75005 Paris, France; [Brochard-Wyart, Francoise] Univ Paris 06, Univ Paris 04, CNRS, UMR 168, F-75005 Paris, France	Brochard-Wyart, F (reprint author), PSL Res Univ, CNRS, Inst Curie, UMR 168, F-75005 Paris, France.	francoise.brochard@curie.fr			NIMS Molecule & Material Synthesis Platform in "Nanotechnology Platform Project"	LNCaP cells were a generous gift from Dr. Xia Li (WPI International Center for Materials Nanoarchitectonics (MANA) National Institute for Materials Science (NIMS), Japan). This study was supported by NIMS Molecule & Material Synthesis Platform in "Nanotechnology Platform Project" operated by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Pontes B, 2008, EUR BIOPHYS J BIOPHY, V37, P121, DOI 10.1007/s00249-007-0184-9; Meng S, 2007, CARBOHYD POLYM, V70, P82, DOI 10.1016/j.carbpol.2007.03.006; Borghi N, 2003, EUROPHYS LETT, V64, P837, DOI 10.1209/epl/i2003-00321-x; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Alessandri K, 2013, P NATL ACAD SCI USA, V110, P14843, DOI 10.1073/pnas.1309482110; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; Dimova R, 2002, EUR PHYS J E, V7, P241, DOI 10.1140/epje/i200101032; Onfelt B, 2006, J IMMUNOL, V177, P8476; Hwang WC, 1997, BIOPHYS J, V72, P2669; Marmottant P, 2009, P NATL ACAD SCI USA, V106, P17271, DOI 10.1073/pnas.0902085106; Guevorkian K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218101; Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7; Dopheide SM, 2002, BLOOD, V99, P159, DOI 10.1182/blood.V99.1.159; Beaune G, 2014, P NATL ACAD SCI USA, V111, P8055, DOI 10.1073/pnas.1323788111; Song H, 2003, BIOTECHNOL PROGR, V19, P1742, DOI 10.1021/bp034061n; Bernard AB, 2012, TISSUE ENG PART C-ME, V18, P583, DOI [10.1089/ten.TEC.2011.0504, 10.1089/ten.tec.2011.0504]; Rossier O, 2003, LANGMUIR, V19, P575, DOI 10.1021/la026236t; Foty RA, 1996, DEVELOPMENT, V122, P1611; Cuvelier D, 2005, BIOPHYS J, V88, P2714, DOI 10.1529/biophysj.104.056473; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; LaBarbera DV, 2012, EXPERT OPIN DRUG DIS, V7, P819, DOI 10.1517/17460441.2012.708334; Tabdanov E, 2009, BIOPHYS J, V96, P2457, DOI 10.1016/j.bpj.2008.11.059; Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398; Carre A, 1996, NATURE, V379, P432, DOI 10.1038/379432a0; Douezan S, 2011, P NATL ACAD SCI USA, V108, P7315, DOI 10.1073/pnas.1018057108; Brochard-Wyart F, 2006, P NATL ACAD SCI USA, V103, P7660, DOI 10.1073/pnas.0602012103; HOCHMUTH RM, 1982, BIOPHYS J, V39, P83; Cavallari G, 2007, TRANSPL P, V39, P2018, DOI 10.1016/j.transproceed.2007.05.016; Enmon RM, 2001, BIOTECHNOL BIOENG, V72, P579, DOI 10.1002/1097-0290(20010320)72:6<579::AID-BIT1023>3.0.CO;2-L; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Hsu SH, 2012, J MED BIOL ENG, V32, P85, DOI 10.5405/jmbe.864; Xu X, 2012, BIOMATERIALS, V33, P9049, DOI 10.1016/j.biomaterials.2012.08.061; Douezan S, 2012, SOFT MATTER, V8, P784, DOI 10.1039/c1sm06399e; Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Enmon RM, 2002, BIOTECHNOL BIOENG, V80, P580, DOI 10.1002/bit.10394; Dai JW, 1999, BIOPHYS J, V77, P3363; Hickman JA, 2014, BIOTECHNOL J, V9, P1115, DOI 10.1002/biot.201300492; HOCHMUTH RM, 1973, BIOPHYS J, V13, P747; du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102; Schmidtke DW, 2000, J CELL BIOL, V149, P719, DOI 10.1083/jcb.149.3.719; Lieber AD, 2013, CURR BIOL, V23, P1409, DOI 10.1016/j.cub.2013.05.063; Dommersnes PG, 2005, EUROPHYS LETT, V70, P271, DOI 10.1209/epl/i2004-10477-9; Cuvelier D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.228101; De Gennes P.-G., 2004, CAPILLARY WETTING PH; Gonzalez-Rodriguez D, 2012, SCIENCE, V338, P910, DOI 10.1126/science.1226418; Hochmuth F M, 1996, Biophys J, V70, P358; Stirbat TV, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13084-1	48	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0743-7463			LANGMUIR	Langmuir	DEC 1	2015	31	47					12984	12992		10.1021/acs.langmuir.5b02785		9	Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	CX8CT	WOS:000365930900018		
J	Wakabayashi, A; Goto, T; Dobashi, T; Maki, Y				Wakabayashi, Atsumi; Goto, Tatsuhiko; Dobashi, Toshiaki; Maki, Yasuyuki			Glassy Behavior of a Tin Dioxide Nanoparticle Suspension	LANGMUIR			English	Article							DYNAMIC LIGHT-SCATTERING; ATTRACTIVE PARTICLES; PHASE-DIAGRAM; TRANSITION; GELS; GELATION	Dilute suspensions of charged colloidal particles with a short-range attraction and long-range repulsion can exhibit a variety of arrested states. In many applications using suspensions of charged nanoparticles, the optimization of the process requires the understanding of the mechanism underlying the stability and the rheological properties of the suspensions. In an attempt to clarify the solidification mechanism for dilute suspensions of tin dioxide (SnO2) nanoparticles, we present dynamic viscoelasticity, dynamic and static light scattering, and small-angle X-ray scattering experiments on a SnO2 nanoparticle suspension with a nanoparticle concentration of 25.0 wt % (volume fraction phi = 0.045). The behaviors of the observed dynamic and static structure factors reveal that the aging of SnO2 nanoparticles is Wigner glassy rather than gel-like.	[Wakabayashi, Atsumi] Sumitomo Osaka Cement Co Ltd, Adv Mat Div, Funabashi, Chiba 2748601, Japan; [Goto, Tatsuhiko; Dobashi, Toshiaki; Maki, Yasuyuki] Gunma Univ, Fac Sci & Technol, Div Mol Sci, Kiryu, Gumma 3768515, Japan	Maki, Y (reprint author), Gunma Univ, Fac Sci & Technol, Div Mol Sci, Kiryu, Gumma 3768515, Japan.	maki@gunma-u.ac.jp					Abou B, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.021510; Zaccarelli E, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/32/323101; Cipelletti L, 2000, PHYS REV LETT, V84, P2275, DOI 10.1103/PhysRevLett.84.2275; Sciortino F, 2005, ADV PHYS, V54, P471, DOI 10.1080/00018730500414570; ADOLF D, 1990, MACROMOLECULES, V23, P3700, DOI 10.1021/ma00217a026; VANMEGEN W, 1994, PHYS REV E, V49, P4206, DOI 10.1103/PhysRevE.49.4206; Segre PN, 2001, PHYS REV LETT, V86, P6042, DOI 10.1103/PhysRevLett.86.6042; Poon WCK, 2004, MRS BULL, V29, P96, DOI 10.1557/mrs2004.35; Li CP, 2005, J AM CERAM SOC, V88, P1448, DOI 10.1111/j.1551-2916.2005.00339.x; Norisuye T, 2000, MACROMOLECULES, V33, P900, DOI 10.1021/ma991496b; Bonn D, 1999, LANGMUIR, V15, P7534, DOI 10.1021/la990167+; SIROTA EB, 1989, PHYS REV LETT, V62, P1524, DOI 10.1103/PhysRevLett.62.1524; Trappe V, 2000, PHYS REV LETT, V85, P449, DOI 10.1103/PhysRevLett.85.449; Ito K, 2005, JPN J APPL PHYS 1, V44, P8684, DOI 10.1143/JJAP.44.8684; Kanao M, 2003, MACROMOLECULES, V36, P2093, DOI 10.1021/ma0213899; Ruzicka B, 2011, SOFT MATTER, V7, P1268, DOI 10.1039/c0sm00590h; Lu PJ, 2013, ANNU REV CONDEN MA P, V4, P217, DOI 10.1146/annurev-conmatphys-030212-184213; Chiu HC, 2007, J PHYS CHEM C, V111, P7256, DOI 10.1021/jp0688355; Hunter GL, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/6/066501; Sciortino F, 2002, NAT MATER, V1, P145, DOI 10.1038/nmat752; HIRATSUKA RS, 1990, J NON-CRYST SOLIDS, V121, P76; Trappe V, 2001, NATURE, V411, P772, DOI 10.1038/35081021; Winter HH, 2013, MACROMOLECULES, V46, P2425, DOI 10.1021/ma400086v; Bellour M, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031405; Glatter O, 1982, SMALL ANGLE XRAY SCA; Jabbari-Farouji S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061405; Katzel U, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031402; Klix CL, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.165702; Russel W. B., 1989, COLLOIDAL DISPERSION; Ruzicka B, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.258301; Santos L. R. B., 2000, J APPL CRYSTALLORG, V33, P609; Simeonova NB, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041401; Tanaka H, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.031404; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627	34	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0743-7463			LANGMUIR	Langmuir	DEC 1	2015	31	47					13022	13028		10.1021/acs.langmuir.5b03310		7	Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	CX8CT	WOS:000365930900022		
J	Sagisaka, M; Fujita, Y; Nakanishi, Y; Takahashi, H; Tsuyoshi, N; James, C; Yoshizawa, A; Mohamed, A; Guittard, F; Eastoe, J				Sagisaka, Masanobu; Fujita, Yayoi; Nakanishi, Yusuke; Takahashi, Hisayuki; Tsuyoshi, Narumi; James, Craig; Yoshizawa, Atsushi; Mohamed, Azmi; Guittard, Frederic; Eastoe, Julian			Periodic Formation/Breakdown of Lamellar Aggregates with Anionic Cyanobiphenyl Surfactants	LANGMUIR			English	Article							HYDROCARBON HYBRID SURFACTANT; DILUTE AQUEOUS-SOLUTION; TUMOR-SPECIFIC CHEMOTHERAPY; CALCIUM HYDROXYAPATITE; CONCENTRATED-SOLUTIONS; AMMONIUM AMPHIPHILES; BILAYER-MEMBRANE; PHASE-TRANSITION; BLOCK-COPOLYMER; LIPOSOMES	This study reports unusual behavior of aqueous-phase lamellar aggregates with a new class of hybrid surfactant, CB-B2ES, having mesogenic units {6-[4-(4-cyanophenyl)phenyloxy]hexyl} and temperature-sensitive oxyethylated (butoxyethoxyethyl) tails. These tails are poorly miscible and likely to microsegregate if the surfactant molecules assemble. Lamellar aggregates appear at CB-B2ES concentrations higher than 5 wt % and were found to undergo repeat formation/breakdown periodically at 30 degrees C, with an average domain lifetime of similar to 10 s. To investigate effects of the temperature-sensitive oxyethylene units on the hydrophilic/lipophilic balance (HLB) of the CB-B2ES bilayers, a fluorescence probe 1-pyrene-carboxaldehide was solubilized in the mixtures to sense the micro-environmental polarities. Fluorimetric measurements suggested that the polarity of CB-B2ES bilayers is very similar to that of the non-ethoxylated CB-B2ES analogue at high temperatures (>= 65 degrees C). However, for CB-B2ES, polarity increased with a decreasing temperature, in contrast with the small decrease in polarity observed for analogous non-ethoxylated bilayers. This is consistent with increased hydration of the oxyethylene units in CB-B2ES bilayers at low temperatures. The periodic formation/breakdown and cooling-induced hydrophilicity of the CB-B2ES lamellar aggregates did not appear in the non-hybrid and/or non-ethoxylated surfactant systems. Therefore, the combination of two unsymmetrical tails, one containing oxyethylene units and the other containing cyanobiphenyl terminal tips, must play an important role promoting this unusual behavior.	[Sagisaka, Masanobu; Fujita, Yayoi; Nakanishi, Yusuke; Takahashi, Hisayuki; Tsuyoshi, Narumi; James, Craig; Yoshizawa, Atsushi] Hirosaki Univ, Grad Sch Sci & Technol, Dept Frontier Mat Chem, Hirosaki, Aomori 0368561, Japan; [Mohamed, Azmi] Univ Pendidikan Sultan Idris, Fac Sci & Math, Dept Chem, Tanjong Malim 35900, Perak, Malaysia; [Mohamed, Azmi] Univ Pendidikan Sultan Idris, Fac Sci & Math, Nanotechnol Res Ctr, Tanjong Malim 35900, Perak, Malaysia; [Guittard, Frederic] Univ Nice Sophia Antipolis, CNRS, Equipe Surfaces & Interfaces, F-06100 Nice, France; [Eastoe, Julian] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	Sagisaka, M (reprint author), Hirosaki Univ, Grad Sch Sci & Technol, Dept Frontier Mat Chem, 3 Bunkyo Cho, Hirosaki, Aomori 0368561, Japan.	sagisaka@hirosaki-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [KAKENHI] [23685034]; Research Councils of the United Kingdom (RCUK) under the G8 Research Councils Initiative for Multilateral Research Funding [EPSRC EP/I018301/1, G8-2012]; Agence Nationale de la Recherche (ANR) under the G8 Research Councils Initiative for Multilateral Research Funding [G8-2012, 13-G8ME-0003]; JSPS; Engineering and Physical Sciences Research Council (EPSRC) [EP/I018301, EP/I018212/1]	This project was supported by the Japan Society for the Promotion of Science (JSPS) [KAKENHI, Grant-in-Aid for Young Scientists (A), 23685034], and leading research organizations [Research Councils of the United Kingdom (RCUK, through EPSRC EP/I018301/1) and Agence Nationale de la Recherche (ANR, 13-G8ME-0003)] under the G8 Research Councils Initiative for Multilateral Research Funding, G8-2012. Craig James thanks the JSPS for an 18 month fellowship (JSPS Postdoctoral Fellowship for Foreign Researchers) and the Engineering and Physical Sciences Research Council (EPSRC, Grants EP/I018301 and EP/I018212/1).	Abe M., 2000, SHIKIZAI KYOKAISHI, V73, P53; Feitosa E, 2010, LANGMUIR, V26, P17852, DOI 10.1021/la102603a; Sagisaka M, 2001, COLLOID SURFACE A, V183, P749, DOI 10.1016/S0927-7757(01)00501-5; Tobita K, 1998, LANGMUIR, V14, P4753, DOI 10.1021/la9801007; Kondo Y, 2005, CURR OPIN COLLOID IN, V10, P88, DOI 10.1016/j.cocis.2005.06.003; Sagisaka M, 2011, J COLLOID INTERF SCI, V357, P400, DOI 10.1016/j.jcis.2011.02.024; Miyazawa H, 2003, J FLUORINE CHEM, V124, P189, DOI 10.1016/j.jfluchem.2003.08.007; Kono K, 2010, BIOMATERIALS, V31, P7096, DOI 10.1016/j.biomaterials.2010.05.045; Wells J, 2003, INT J PHARM, V261, P105, DOI 10.1016/S0378-5173(03)00290-4; Ohno A, 2008, J FLUORINE CHEM, V129, P577, DOI 10.1016/j.jfluchem.2008.03.007; RICCHELLI F, 1988, J PHOTOCH PHOTOBIO B, V2, P475, DOI 10.1016/1011-1344(88)85076-0; YATVIN MB, 1978, SCIENCE, V202, P1290, DOI 10.1126/science.364652; Bartucci R, 1996, COLLOID SURFACE A, V115, P63, DOI 10.1016/0927-7757(96)03665-5; Takahashi Y, 2010, J PHYS CHEM B, V114, P13319, DOI 10.1021/jp1028273; Abe M, 1997, LANGMUIR, V13, P2932, DOI 10.1021/la961023n; Aydogan N, 2003, LANGMUIR, V19, P10726, DOI 10.1021/la0351921; STOIMENOVA M, 1992, J COLLOID INTERF SCI, V151, P591, DOI 10.1016/0021-9797(92)90507-I; Kondo Y, 2002, J AM CHEM SOC, V124, P6516, DOI 10.1021/ja0178564; Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017; Kono K, 2011, BIOMATERIALS, V32, P1387, DOI 10.1016/j.biomaterials.2010.10.050; Ito A, 1996, LANGMUIR, V12, P5768, DOI 10.1021/la960240l; Banerjee P, 2007, COLLOID SURFACE A, V302, P44, DOI 10.1016/j.colsurfa.2007.01.038; Matsuoka K, 2003, CURR OPIN COLLOID IN, V8, P227, DOI 10.1016/S1359-0294(03)00056-6; Abe M, 2000, COLLOID SURFACE A, V167, P47, DOI 10.1016/S0927-7757(99)00482-3; HIGASHI N, 1986, MACROMOLECULES, V19, P1362, DOI 10.1021/ma00159a014; Miyazawa H, 2005, J FLUORINE CHEM, V126, P301, DOI 10.1016/j.fluchem.2004.10.016; OKAHATA Y, 1979, J AM CHEM SOC, V101, P5231, DOI 10.1021/ja00512a020; KUNITAKE T, 1980, J AM CHEM SOC, V102, P549, DOI 10.1021/ja00522a019; Abe M, 2000, IND ENG CHEM RES, V39, P2697, DOI 10.1021/ie990832+; ALEXANDRIDIS P, 1995, COLLOID SURFACE A, V96, P1, DOI 10.1016/0927-7757(94)03028-X; Miyazawa H, 2004, J FLUORINE CHEM, V125, P1485, DOI 10.1016/j.fluchem.2004.05.015; Nieh MP, 2004, LANGMUIR, V20, P7893, DOI 10.1021/la0486411; KUNITAKE T, 1977, J AM CHEM SOC, V99, P3860, DOI 10.1021/ja00453a066; Aydogan N, 2006, LANGMUIR, V22, P2028, DOI 10.1021/la052786q; Saeki A, 2000, LANGMUIR, V16, P9991, DOI 10.1021/la000356o; Kondo Y, 2007, LANGMUIR, V23, P5857, DOI 10.1021/la700522e; Kawaguchi T, 2007, JPN J APPL PHYS 1, V46, P5911, DOI 10.1143/JJAP.46.5911; Sagisaka M, 2009, LANGMUIR, V25, P10230, DOI 10.1021/la901032c; Hayashi H, 1996, BBA-BIOMEMBRANES, V1280, P127, DOI 10.1016/0005-2736(95)00273-1; Harroun TA, 2005, LANGMUIR, V21, P5356, DOI 10.1021/la050018t; Demus H., 1998, HDB LIQUID CRYSTAL; FENDLER JH, 1980, ACCOUNTS CHEM RES, V13, P7, DOI 10.1021/ar50145a002; Guo V., 1992, J PHYS CHEM-US, V96, P6738; KUNITAKE T, 1977, CHEM LETT, P387, DOI 10.1246/cl.1977.387; OKAHATA Y, 1980, BER BUNSEN PHYS CHEM, V84, P550; Sagisaka M., 2001, SHIKIZAI KYOKAISHI, V74, P63; Zana R., 2005, DYNAMICS SURFACTANT	47	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0743-7463			LANGMUIR	Langmuir	DEC 1	2015	31	47					13040	13047		10.1021/acs.langmuir.5b03564		8	Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	CX8CT	WOS:000365930900024		
J	Hosokawa, H; Mochida, T				Hosokawa, Hitoshi; Mochida, Tomoyuki			Colorimetric Humidity and Solvent Recognition Based on a Cation-Exchange Clay Mineral Incorporating Nickel(II)-Chelate Complexes	LANGMUIR			English	Article							METAL-CHELATE COMPLEXES; RELATIVE-HUMIDITY; ORGANIC-COMPOUNDS; COMPOSITE FILM; SENSOR; MONTMORILLONITE; POLYMER; COLOR; INTERCALATION; MECHANISM	Solvatochromic nickel(II) complexes with diketonato and diamine ligands were incorporated into a saponite clay by ion exchange, and their colorimetric humidity- and solvent-recognition properties were investigated. These powders exhibit color change from red to blue-green depending on humidity, and the detection range can be controlled by modifying the metal complex. The humidity response takes advantage of the humidity-dependent water content in clay and the coordination of water molecules to the metal complex in equilibrium. The addition of organic solvents to the powders causes a color change to occur, varying from red to blue-green depending on the donor number of the solvent, thereby enabling solvent recognition. In the clay, the affinity of less sterically hindered complexes to water or solvent molecules is decreased compared with that in solution because the cationic complexes interact with the anionic layers in the clay. Incorporating diethylene glycol into the materials produced thermochromic powders.	[Hosokawa, Hitoshi; Mochida, Tomoyuki] Kobe Univ, Grad Sch Sci, Dept Chem, Nada Ku, Kobe, Hyogo 6578501, Japan	Mochida, T (reprint author), Kobe Univ, Grad Sch Sci, Dept Chem, Nada Ku, Kobe, Hyogo 6578501, Japan.	tmochida@platinum.kobe-u.ac.jp			KAKENHI from Japan Society of Promotion of Science [24350073]	This work was supported financially by KAKENHI (Grant No. 24350073) from Japan Society of Promotion of Science. We thank Dr. Y. Funasako (Tokyo University of Science, Yamaguchi) for helpful discussions.	FUKUDA Y, 1975, J INORG NUCL CHEM, V37, P455, DOI 10.1016/0022-1902(75)80355-1; FUKUDA Y, 1972, J INORG NUCL CHEM, V34, P2315, DOI 10.1016/0022-1902(72)80168-4; Chi H, 2015, ACS APPL MATER INTER, V7, P19882, DOI 10.1021/acsami.5b06883; Herzer N, 2012, J AM CHEM SOC, V134, P7608, DOI 10.1021/ja301845n; TAHA A, 1991, MONATSH CHEM, V122, P327, DOI 10.1007/BF00809654; BOLTINGHOUSE F, 1989, ANAL CHEM, V61, P1863, DOI 10.1021/ac00192a016; Gao DY, 2001, J MATER SCI, V36, P4567, DOI 10.1023/A:1017971811942; Usami H, 1998, J CHEM SOC FARADAY T, V94, P83, DOI 10.1039/a704446a; Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/nmat2614, 10.1038/NMAT2614]; Hosokawa H, 2014, CHEM-EUR J, V20, P15014, DOI 10.1002/chem.201403996; Takagi S, 2010, LANGMUIR, V26, P4639, DOI 10.1021/la1007928; KUDO A, 1989, J CATAL, V120, P337, DOI 10.1016/0021-9517(89)90274-1; Tsuyumoto I, 2011, INT J APPL CERAM TEC, V8, P793, DOI 10.1111/j.1744-7402.2010.02506.x; DONER HE, 1969, SCIENCE, V166, P1406, DOI 10.1126/science.166.3911.1406; Wang ZH, 2010, ADV FUNCT MATER, V20, P3784, DOI 10.1002/adfm.201001195; Wang H, 2013, SENSORS-BASEL, V13, P4192, DOI 10.3390/s130404192; Yui T, 2002, LANGMUIR, V18, P891, DOI 10.1021/la011297x; Wang XN, 2013, ADV FUNCT MATER, V23, P6044, DOI 10.1002/adfm.201301044; Luechinger NA, 2007, LANGMUIR, V23, P3473, DOI 10.1021/la062424y; RUSSELL AP, 1985, ANAL CHIM ACTA, V170, P209, DOI 10.1016/S0003-2670(00)81744-4; Sohrabnezhad S, 2007, MATER LETT, V61, P2311, DOI 10.1016/j.matlet.2006.09.006; Khijwania SK, 2005, SENSOR ACTUAT B-CHEM, V104, P217, DOI 10.1016/j.snb.2004.05.012; Do J, 2009, LANGMUIR, V25, P9405, DOI 10.1021/la901476q; Su PG, 2008, SENSOR ACTUAT B-CHEM, V129, P380, DOI 10.1016/j.snb.2007.08.032; Dacres H, 2006, TALANTA, V69, P631, DOI 10.1016/j.talanta.2005.10.037; Hawkeye MM, 2011, ADV FUNCT MATER, V21, P3652, DOI 10.1002/adfm.201100893; TAKAGI K, 1993, J AM CHEM SOC, V115, P4339, DOI 10.1021/ja00063a060; SANGSTER J, 1989, J PHYS CHEM REF DATA, V18, P1111; Rakow NA, 2000, NATURE, V406, P710, DOI 10.1038/35021028; Gupta BD, 2001, SENSOR ACTUAT B-CHEM, V80, P132, DOI 10.1016/S0925-4005(01)00899-1; SEKI T, 1990, MACROMOLECULES, V23, P31, DOI 10.1021/ma00203a007; Kshirsagar VS, 2009, APPL CATAL A-GEN, V370, P16, DOI 10.1016/j.apcata.2009.09.003; Ishihara S, 2013, ACS APPL MATER INTER, V5, P5927, DOI 10.1021/am401956s; Funasako Y, 2013, CHEM COMMUN, V49, P4688, DOI 10.1039/c3cc41399c; Hatch CD, 2012, LANGMUIR, V28, P1790, DOI 10.1021/la2042873; Kohno Y, 2009, APPL CLAY SCI, V42, P519, DOI 10.1016/j.clay.2008.06.012; Yu Y, 2014, CHEM COMMUN, V50, P1444, DOI 10.1039/c3cc47723a; ROCKLAND LB, 1960, ANAL CHEM, V32, P1375, DOI 10.1021/ac60166a055; Funasako Y, 2012, CHEM-EUR J, V18, P11929, DOI 10.1002/chem.201201778; Itagaki Y, 2009, SENSOR ACTUAT B-CHEM, V142, P44, DOI 10.1016/j.snb.2009.07.033; Nakato T, 2012, J PHYS CHEM C, V116, P8562, DOI 10.1021/jp2118899; El-Ayaan U, 2001, MONATSH CHEM, V132, P1279, DOI 10.1007/s007060170018; Bridgeman D, 2014, LANGMUIR, V30, P10785, DOI 10.1021/la502593g; NGA NT, 1977, B CHEM SOC JPN, V50, P154; Tellis JC, 2011, ANAL CHEM, V83, P928, DOI 10.1021/ac102616w; Kaushik A, 2015, CHEM REV, V115, P4571, DOI 10.1021/cr400659h; Kim E, 2012, ACS APPL MATER INTER, V4, P5179, DOI 10.1021/am3011115; Pimchan P, 2014, APPL CLAY SCI, V101, P223, DOI 10.1016/j.clay.2014.08.004; Ishida Y, 2012, J PHYS CHEM A, V116, P12065, DOI 10.1021/jp309502j; Farahani H, 2014, SENSORS-BASEL, V14, P7881, DOI 10.3390/s140507881; Fukuda Y., 2007, INORGANIC CHROMOTROP; Gutmann V., 1978, DONOR ACCEPTOR APPRO; Kolpakov SA, 2014, SENSORS-BASEL, V14, P3986, DOI 10.3390/s140303986; Lee J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3461; Moreno-Bondi M. C., 2004, FIBRE OPTIC SENSORS; Sadaoka Y., 1991, SENSOR ACTUAT A-PHYS, V25-27, P489; Shichi T., 2000, J PHOTOCH PHOTOBIO C, V1, P113, DOI 10.1016/S1389-5567(00)00008-3; Kubelka P., 1931, Zeitschrift fur Technische Physik, V12	58	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0743-7463			LANGMUIR	Langmuir	DEC 1	2015	31	47					13048	13053		10.1021/acs.langmuir.5b03709		6	Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	CX8CT	WOS:000365930900025		
J	Terse-Thakoor, T; Komori, K; Ramnani, P; Lee, I; Muchandani, A				Terse-Thakoor, Trupti; Komori, Kikuo; Ramnani, Pankaj; Lee, Ilkeun; Muchandani, Ashok			Electrochemically Functionalized Seamless Three-Dimensional Graphene-Carbon Nanotube Hybrid for Direct Electron Transfer of Glucose Oxidase and Bioelectrocatalysis	LANGMUIR			English	Article							LAYER GRAPHENE; SINGLE-LAYER; BIOSENSOR; OXIDATION; STORAGE; GROWTH; ENERGY; SENSOR	Three-dimensional seamless chemical vapor deposition (CVD) grown graphene-carbon nanotubes (G-CNT) hybrid film has been studied for its potential in achieving direct electron transfer (DET) of glucose oxidase (GOx) and its bioelectrocatalytic activity in glucose detection. A two-step CVD method was employed for the synthesis of seamless G-CNT hybrid film where CNTs are grown on already grown graphene film on copper foil using iron as a catalyst. Physical characterization using SEM and TEM show uniform dense coverage of multiwall carbon nanotubes (MWCNT) grown directly on graphene with seamless contacts. The G-CNT hybrid film was electrochemically modified to introduce oxygenated functional groups for DET favorable immobilization of GOx. Pristine and electrochemically functionalized G-CNT film was characterized by electrochemical impedance spectroscopy (EIS), cyclic voltammetry, X-ray photoelectron-spectroscopy, and Raman spectroscopy. The DET between GOx and electrochemically oxidized G-CNT electrode was studied using cyclic voltammetry which showed a pair of well-defined and quasi-reversible redox peaks with a formal potential of -459 mV at pH 7 corresponding to the redox site of GOx. The constructed electrode detected glucose concentration over the clinically relevant range of 2-8 mM with the highest sensitivity of 19.31 mu A/mM/cm(2) compared to reported composite hybrid electrodes of graphene oxide and CNTs. Electrochemically functionalized CVD grown seamless G-CNT structure used in this work has potential to be used for development of artificial mediatorless redox enzyme based biosensors and biofuel cells.	[Terse-Thakoor, Trupti] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [Komori, Kikuo; Ramnani, Pankaj; Muchandani, Ashok] Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA; [Lee, Ilkeun] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Komori, Kikuo] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan	Muchandani, A (reprint author), Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA.	adani@engr.ucr.edu			National Science Foundation [1307671]; U.S. Department of Agriculture [2014-67021-21589]; W. Ruel Johnson Chair in Environmental Engineering; U.S. National Science Foundation [DMR-0958796]	The authors acknowledge the National Science Foundation (1307671) and U.S. Department of Agriculture (2014-67021-21589) and W. Ruel Johnson Chair in Environmental Engineering for the financial support and the UCR Central Facility for Advanced Microscopy and Microanalysis for scanning microscopy and transmission electron microscopy and Center for Nanoscale Science and Engineering for nanofabrication cleanroom facilities. The XPS instrument used in this research was acquired with funds from the U.S. National Science Foundation, Grant DMR-0958796.	Palanisamy S, 2014, MAT SCI ENG C-MATER, V34, P207, DOI 10.1016/j.msec.2013.09.011; Liu Q, 2007, BIOSENS BIOELECTRON, V22, P3203, DOI 10.1016/j.bios.2007.02.013; Graf D, 2007, NANO LETT, V7, P238, DOI 10.1021/nl061702a; Pumera M, 2011, ENERG ENVIRON SCI, V4, P668, DOI 10.1039/c0ee00295j; Ko S, 2014, PHYS CHEM CHEM PHYS, V16, P12209, DOI 10.1039/c4cp01278j; Rajesh, 2013, J POWER SOURCES, V223, P23, DOI 10.1016/j.jpowsour.2012.08.088; Wu P, 2010, ELECTROCHIM ACTA, V55, P8606, DOI 10.1016/j.electacta.2010.07.079; Doepke A, 2012, ELECTROANAL, V24, P1501, DOI 10.1002/elan.201200105; Wang ZJ, 2009, J PHYS CHEM C, V113, P14071, DOI 10.1021/jp906348x; Wang J, 2005, ELECTROANAL, V17, P7, DOI 10.1002/elan.200403113; Li QY, 2013, NANO LETT, V13, P486, DOI 10.1021/nl303879k; Datsyuk V, 2008, CARBON, V46, P833, DOI 10.1016/j.carbon.2008.02.012; Guiseppi-Elie A, 2002, NANOTECHNOLOGY, V13, P559, DOI 10.1088/0957-4484/13/5/303; Moumene M, 2013, INT J ELECTROCHEM SC, V8, P2009; Nguyen DD, 2012, NANOSCALE, V4, P632, DOI 10.1039/c1nr11328c; Xu JZ, 2003, CHINESE J CHEM, V21, P1088; Ji XB, 2006, CHEMPHYSCHEM, V7, P1337, DOI 10.1002/cphc.200600098; Paul RK, 2010, SMALL, V6, P2309, DOI 10.1002/smll.201000525; Deng CY, 2010, BIOSENS BIOELECTRON, V26, P213, DOI 10.1016/j.bios.2010.06.013; Jacobs CB, 2010, ANAL CHIM ACTA, V662, P105, DOI 10.1016/j.aca.2010.01.009; Cai CX, 2004, ANAL BIOCHEM, V332, P75, DOI 10.1016/j.ab.2004.05.057; Liang B, 2013, BIOSENS BIOELECTRON, V43, P131, DOI 10.1016/j.bios.2012.11.040; Frackowiak E, 2001, CARBON, V39, P937, DOI 10.1016/S0008-6223(00)00183-4; Chen JL, 2012, J APPL ELECTROCHEM, V42, P875, DOI 10.1007/s10800-012-0461-x; Komori K, 2015, ACS APPL MATER INTER, V7, P3647, DOI 10.1021/am508032p; Badhulika S, 2014, ELECTROANAL, V26, P103, DOI 10.1002/elan.201300286; Wang J, 2008, CHEM REV, V108, P814, DOI 10.1021/cr068123a; Kang XH, 2009, BIOSENS BIOELECTRON, V25, P901, DOI 10.1016/j.bios.2009.09.004; Dong XC, 2012, J MATER CHEM, V22, P17044, DOI 10.1039/c2jm33286h; Han Z, 2014, ADV FUNCT MATER, V24, P964, DOI 10.1002/adfm.201301732; Mani V, 2013, BIOSENS BIOELECTRON, V41, P309, DOI 10.1016/j.bios.2012.08.045; Alwarappan S, 2012, ANAL LETT, V45, P746, DOI 10.1080/00032719.2011.653900; Shan CS, 2009, ANAL CHEM, V81, P2378, DOI 10.1021/ac802193c; Palanisamy S, 2012, INT J ELECTROCHEM SC, V7, P2153; Chen PH, 1996, ANAL CHEM, V68, P3958, DOI 10.1021/ac960492r; Fu CL, 2009, ELECTROCHEM COMMUN, V11, P997, DOI 10.1016/j.elecom.2009.02.042; Pumera M, 2010, TRAC-TREND ANAL CHEM, V29, P954, DOI 10.1016/j.trac.2010.05.011; Okpalugo TIT, 2005, CARBON, V43, P153, DOI 10.1016/j.carbon.2004.08.033; Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368; Badhulika Sushmee, 2015, Front Chem, V3, P38, DOI 10.3389/fchem.2015.00038; Eswaraiah V, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-137; Zhu Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2234	42	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0743-7463			LANGMUIR	Langmuir	DEC 1	2015	31	47					13054	13061		10.1021/acs.langmuir.5b03273		8	Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	CX8CT	WOS:000365930900026		
J	Matsuda, H; Hosono, K; Tsuru, S; Kurashige, C; Sekiguchi, K; Akira, S; Uematsu, S; Okamoto, H; Majima, M				Matsuda, Hiromi; Hosono, Kanako; Tsuru, Seri; Kurashige, Chie; Sekiguchi, Kazuki; Akira, Shizuo; Uematsu, Satoshi; Okamoto, Hirotsugu; Majima, Masataka			Roles of mPGES-1, an inducible prostaglandin E synthase, in enhancement of LPS-induced lymphangiogenesis in a mouse peritonitis model	LIFE SCIENCES			English	Article						Lymphangiogenesis; Inflammation; Prostaglandin; Synthase; Cyclooxygenase-2; mPGES-1; Peritonitis	TUMOR-GROWTH; ANGIOGENESIS; COX-2	Aims: Lymphangiogenesis is frequently observed during inflammation, and this inflammation-induced lymphangiogenesis (IL) is a phenomenon actively involved in the pathophysiology of inflammation. We explored the roles of an inducible prostaglandin E synthase, mAGES-1, in IL elicited by lipopolysaccharide (LPS). Main methods: Peritonitis was induced in mice by intraperitoneal injection of LPS (E. coli 0111-B4; 25 mu g/mouse every 2 days), and IL was evaluated by LYVE-1 immunostaining of whole-mount diaphragm tissues. Key findings: Compared to vehicle-treated wild-type (WT) mice, lymphatics in the diaphragms of mice injected with LPS were widened and the number of LYVE-1-positive ladder-structured lymphatics increased temporally. This increase in lymphangiogenesis was accompanied by increased expression of vascular endothelial growth factor (VEGF)-C/D in the diaphragms. In mice treated with celecoxib, a cyclooxygenase-2 inhibitor, IL was suppressed with reduced expression of VEGF-C/D. This was also observed in mPGES-1 knockout mice (KO). Immunoreactive COX-2 and mPGES-1 were detected in both CD11b-positive and CD3 epsilon-positivecells in the diaphragm. When FITC-dextran was injected into the peritoneal cavities, the amount of residual FITC-dextran was reduced significantly in WI mice injected with LPS, and this reduction was significantly decreased in mPGES-1 KO mice. Significance: The present results suggest that mPGES-1 plays a significant role in lymphangiogenesis during inflammation, and represents a novel target for controlling IL. (C) 2015 Elsevier Inc. All rights reserved.	[Matsuda, Hiromi; Hosono, Kanako; Tsuru, Seri; Kurashige, Chie; Sekiguchi, Kazuki; Majima, Masataka] Kitasato Univ, Dept Pharmacol, Sch Med, Sagamihara, Kanagawa 2520374, Japan; [Matsuda, Hiromi; Tsuru, Seri; Kurashige, Chie; Okamoto, Hirotsugu] Kitasato Univ, Dept Anesthesiol, Sch Med, Sagamihara, Kanagawa 2520374, Japan; [Matsuda, Hiromi; Hosono, Kanako; Tsuru, Seri; Kurashige, Chie; Sekiguchi, Kazuki; Majima, Masataka] Grad Sch Med Sci, Dept Mol Pharmacol, Sagamihara, Kanagawa 2520374, Japan; [Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Uematsu, Satoshi] Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccine, Tokyo 1088639, Japan	Majima, M (reprint author), Grad Sch Med Sci, Dept Mol Pharmacol, Sagamihara, Kanagawa 2520374, Japan.	mmajima@med.kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [15K15056, 15K08241, 80532556, 23116102, 24659119, 26462132, 26293055]; Takeda Science Foundation; Uehara Memorial Foundation	We thank Michiko Ogino, Kyoko Yoshikawa, and Mieko Hamano for their technical assistance. This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), #15K15056, #15K08241, #80532556, #23116102, #24659119, #26462132, and #26293055, and from the Takeda Science Foundation and Uehara Memorial Foundation.	Katagiri H, 2004, HEPATOLOGY, V39, P139, DOI 10.1002/hep.20000; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Kashiwagi S, 2011, LAB INVEST, V91, P1314, DOI 10.1038/labinvest.2011.84; Kamei D, 2010, BIOCHEM J, V425, P361, DOI 10.1042/BJ20090045; Majima M, 2003, TRENDS PHARMACOL SCI, V24, P524, DOI 10.1016/j.tips.2003.08.005; Katoh H, 2010, AM J PATHOL, V176, P1469, DOI 10.2353/ajpath.2010.090607; Katori M, 2000, INFLAMM RES, V49, P367, DOI 10.1007/s000110050605; Isono M, 2011, LIFE SCI, V88, P693, DOI 10.1016/j.lfs.2011.02.008; Hosono K, 2011, ARTERIOSCL THROM VAS, V31, P1049, DOI 10.1161/ATVBAHA.110.222356; Kim H, 2012, TRENDS IMMUNOL, V33, P350, DOI 10.1016/j.it.2012.03.006; Kamata H, 2010, BIOMED PHARMACOTHER, V64, P409, DOI 10.1016/j.biopha.2010.01.017; Amano H, 2003, J EXP MED, V197, P221, DOI 10.1084/jem.20021408; Asari Y, 1996, SHOCK, V5, P208, DOI 10.1097/00024382-199603000-00007; Kim H, 2014, J CLIN INVEST, V124, P936, DOI 10.1172/JCI71607; Amano H, 2001, JPN J PHARMACOL, V87, P181, DOI 10.1254/jjp.87.181; Sherwood L, 2015, CENGAGE LEARNING	17	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	DEC 1	2015	142						1	7		10.1016/j.lfs.2015.10.008		7	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CY1FU	WOS:000366152900001		
J	Tobita, H				Tobita, Hidetaka			Continuous Tanks-in-Series Process for Free-Radical Polymerization with Long-Chain Branching and Scission: Effect of the Order of a Large Tank	MACROMOLECULAR REACTION ENGINEERING			English	Article						branched; Monte Carlo simulation; polyethylene (PE); radical polymerization; reactor design	MOLECULAR-WEIGHT DISTRIBUTION; LOW-DENSITY POLYETHYLENE; MODEL; POLYMERS; DIMENSIONS; SIMULATION; DYNAMICS; PREDICT	Tanks-in-series model for free-radical polymerization that involves the polymer transfer reactions, leading to both long-chain branching and scission, is extended to account for different xi(i) k(p,i) [R-center dot](i)(t) over bar (i) for each tank, where the subscript i represents each value for the ith tank. Illustrative calculations are conducted for the cases with one large xi(n) for the nth tank and the same xi(i) for all i's with i not equal n. The effect of the order of a large xi(n) was investigated, by keeping the final conversion chi(N), average branch density (rho) over bar (N), and scission density (eta) over bar (N) the same, to find that the largest weight-average degree of polymerization, (P) over bar (w) is obtained for n = 1. The full distributions of MW, the branching density, and the radii of gyration are also investigated to propose a novel reactor design strategy for the tower-type multi-zone reactors.	[Tobita, Hidetaka] Univ Fukui, Dept Mat Sci & Engn, Fukui 9108507, Japan	Tobita, H (reprint author), Univ Fukui, Dept Mat Sci & Engn, 3-9-1 Bunkyo, Fukui 9108507, Japan.	tobita@matse.u-fukui.ac.jp			Japan Polyethylene Corporation	I appreciate useful discussion with Dr. S. Kitade and Dr. K. Yokomizo, Japan Polychem Corporation, and Dr. T. Hattori, Japan Polyethylene Corporation. Financial support from Japan Polyethylene Corporation is deeply appreciated.	Tobita H, 1996, MACROMOLECULES, V29, P3010, DOI 10.1021/ma9509725; van Boxtel MHCM, 2001, MACROMOL THEOR SIMUL, V10, P25, DOI 10.1002/1521-3919(20010101)10:1<25::AID-MATS25>3.0.CO;2-L; Tobita H, 2015, MACROMOL REACT ENG, V9, P245, DOI 10.1002/mren.201400042; Tobita H, 2013, MACROMOL REACT ENG, V7, P181, DOI 10.1002/mren.201200070; Read DJ, 2011, SCIENCE, V333, P1871, DOI 10.1126/science.1207060; ZABISKY RCM, 1992, POLYMER, V33, P2243, DOI 10.1016/0032-3861(92)90514-W; NITTA KH, 1994, J CHEM PHYS, V101, P4222, DOI 10.1063/1.467472; Kim DM, 2004, CHEM ENG SCI, V59, P699, DOI 10.1016/j.ces.2003.11.008; ZIMM BH, 1949, J CHEM PHYS, V17, P1301, DOI 10.1063/1.1747157; Iedema PD, 2000, MACROMOLECULES, V33, P7173, DOI 10.1021/ma991711o; Giudici R, 1996, POLYM REACT ENG, V4, P73; Ehrlich P., 1970, ADV POLYM SCI, V7, P386; Goto S., 1981, J APPL POLYM SCI APP, V36, P21; Hutchinson RA, 2001, MACROMOL THEOR SIMUL, V10, P144, DOI 10.1002/1521-3919(20010301)10:3<144::AID-MATS144>3.0.CO;2-A; Iedema PD, 2012, MACROMOL THEOR SIMUL, V21, P166, DOI 10.1002/mats.201100094; Levenspiel O., 1972, CHEM REACTION ENG; Meimaroglou D, 2010, MACROMOLECULES, V43, P5820, DOI 10.1021/ma1005233; Pladis P, 1998, CHEM ENG SCI, V53, P3315, DOI 10.1016/S0009-2509(98)00133-X; Tobita H, 1996, MACROMOL THEOR SIMUL, V5, P1167; Tobita H, 2014, MACROMOL THEOR SIMUL, V23, P477, DOI 10.1002/mats.201400024; Tobita H, 2014, MACROMOL THEOR SIMUL, V23, P182, DOI 10.1002/mats.201300148; Tobita H, 2001, J POLYM SCI POL PHYS, V39, P2960, DOI 10.1002/polb.10052; Tobita H., 2002, E-POLYMERS, V2, P688; Tobita H, 2001, J POLYM SCI POL PHYS, V39, P391, DOI 10.1002/1099-0488(20010115)39:4<391::AID-POLB1011>3.0.CO;2-3	24	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1862-832X	1862-8338		MACROMOL REACT ENG	Macromol. React. Eng.	DEC	2015	9	6					556	569		10.1002/mren.201500031		14	Engineering, Chemical; Polymer Science	Engineering; Polymer Science	CX9XS	WOS:000366060700003		
J	Gadallah, R; Tsutsumi, S; Hiraoka, K; Murakawa, H				Gadallah, Ramy; Tsutsumi, Seiichiro; Hiraoka, Kazuo; Murakawa, Hidekazu			Prediction of residual stresses induced by low transformation temperature weld wires and its validation using the contour method	MARINE STRUCTURES			English	Article						Contour method; Simulated contour method; LTT weld wires; Compressive residual stresses; Martensitic transformation start temperature; FEM	FATIGUE; STEEL; METAL; CONSUMABLES; JOINTS	Welding residual stresses are one of the main factors influencing the engineering properties of welded structures, and should be taken into account during designing and manufacturing products such as ships, bridges, etc. Recently, both computational and experimental methods play a significant role for providing residual stresses. The contour method (CM) became one of the most powerful techniques that can provide measurement of residual stresses normal to a plane of interest. In this method a component is cut at any plane of interest. Displacements normal to the cut surface are measured and then processed. Using the Thermal -Elastic-Plastic Finite Element Method (TEP-FEM), residual stresses after welding can be predicted. As well as, the elastic FEM can be used to reproduce residual stresses from measured longitudinal displacements in the CM. The main objective of this paper is to evaluate the effectiveness of different low transformation temperature (LTT) weld wires using TEP-FEM and the CM. In the simulation part, a computational approach is developed to numerically simulate both of welding and the CM. In the TEP-FEM, phase transformation is considered for LTT welds, additionally volume change and variation of mechanical properties with temperature are considered. In the simulated CM, welded specimens to be measured are replaced by TEP-FE models. Then the procedure of the CM is examined before applying it to real measurements. The simulated CM successfully predicted how the CM would reconstruct the residual stresses if applied experimentally. In the experimental part, welding is conducted using conventional and various LTT. weld wires. Longitudinal residual stresses produced due to welding are measured using the CM. The results of TEP-FE simulation and the CM show the effectiveness of the different LTT weld wires in introducing compressive stresses in the weld. It is also observed that the applied LTT weld wires, which have almost the same martensitic transformation start temperatures, do not show big difference in the induced compressive residual stresses in the weld metal. (C) 2015 Elsevier Ltd. All rights reserved.	[Gadallah, Ramy] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Tsutsumi, Seiichiro; Hiraoka, Kazuo; Murakawa, Hidekazu] Osaka Univ, Joining & Welding Res Inst, Osaka 5670047, Japan	Gadallah, R (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	gadallah@jwri.osaka-u.ac.jp			ClassNK as a part of the ClassNK Joint R&D for Industry Program	Authors gratefully thank Prof. Sherif Rashed for the helpful comments and discussions. This research work was developed with the support of ClassNK as a part of the ClassNK Joint R&D for Industry Program.	Prime MB, 2013, PRACTICAL RESIDUAL STRESS MEASUREMENT METHODS, P109; Murakawa H, 2010, SCI TECHNOL WELD JOI, V15, P393, DOI 10.1179/136217110X12714217309614; Bhatti AA, 2013, PROCEDIA ENGINEER, V66, P192, DOI 10.1016/j.proeng.2013.12.074; Prime MB, 2001, J ENG MATER-T ASME, V123, P162, DOI 10.1115/1.1345526; Prime MB, 2004, EXP MECH, V44, P176, DOI 10.1177/00144851039762; Toparli MB, 2013, EXP MECH, V53, P1705, DOI 10.1007/s11340-013-9766-x; Yadav V, 2002, INT J MACH TOOL MANU, V42, P877, DOI 10.1016/S0890-6955(02)00029-9; Darcis PHP, 2008, FATIGUE FRACT ENG M, V31, P125, DOI 10.1111/J.1460-2695.2007.01205.x; Deng D, 2013, COMP MATER SCI, V78, P55, DOI 10.1016/j.commatsci.2013.05.023; ISHIDA K, 1995, J ALLOY COMPD, V220, P126, DOI 10.1016/0925-8388(94)06002-9; Thomas SH, 2014, SCI TECHNOL WELD JOI, V19, P392, DOI 10.1179/1362171814Y.0000000199; Hacini L, 2009, EXP MECH, V49, P775, DOI 10.1007/s11340-008-9205-6; Zhang Y, 2004, ACTA MATER, V52, P5225, DOI 10.1016/j.actamat.2004.07.045; Liu CA, 2013, MATER DESIGN, V46, P366, DOI 10.1016/j.matdes.2012.10.030; Altenkirch J, 2011, MAT SCI ENG A-STRUCT, V528, P5566, DOI 10.1016/j.msea.2011.03.091; Murugan N, 2009, MATER DESIGN, V30, P2067, DOI 10.1016/j.matdes.2008.08.041; Barsoum Z, 2009, ENG FAIL ANAL, V16, P2186, DOI 10.1016/j.engfailanal.2009.02.013; Braga DFO, 2013, J MATER PROCESS TECH, V213, P2323, DOI 10.1016/j.jmatprotec.2013.07.004; Devarajan K, 2012, BONFRING INT J IND E, V2, P35, DOI [http://dx.doi.org/10.9756/BIJIEMS.1022, DOI 10.9756/BIJIEMS.1022]; Gadallah R, 2014, PREPR NATL M JPN WEL, V94, P226; Hosseinzadeh F, 2014, J ENG, P1, DOI [http://dx.doi.Org/10.1049/joe.2014:0134, DOI 10.1049/J0E.2014:0134]; Kannengiesser T, 2009, JCPDS INT CTR DIFFR, P755; Kasuya T, 2014, WELD WORLD, V58, P477, DOI 10.1007/s40194-014-0131-1; Miki C., 2001, STEEL STRUCTURES, V1, P25; Murakawa H, 2015, WELD WORLD, V59, P53, DOI 10.1007/s40194-014-0178-z; Murakawa H, 2014, T JOIN WELD RES I, V43, P53; Murakawa H., 2008, T JWRI, V37, P75; Ohta A, 2003, WELD J, V82, P78; Ota A, 2002, WELD INT, V16, P44, DOI [http://dx.doi.Org/10.1080/09507110209549487, DOI 10.1080/09507110209549487]; Prime MB, 2002, RESIDUAL STRESSES, P521, DOI [http://dx.doi.org/10.4028/www.scientific.net/MSF.404-407.521, DOI 10.4028/WWW.SCIENTIFIC.NET/MSF.404-407.521]; Prime MB, 2011, C P SOC EXPT MECH SE, V6, P233; Rossini NS, 2012, MATER DESIGN, V35, P572, DOI 10.1016/j.matdes.2011.08.022; Zhang Y, 2002, RESIDUAL STRESSES, P527, DOI [http://dx.doi.org/10.4028/www.scientific.net/MSF.404-407.527, DOI 10.4028/WWW.SCIENTIFLC.NETFMSF.404-407.527]	33	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0951-8339	1873-4170		MAR STRUCT	Mar. Struct.	DEC	2015	44						232	253		10.1016/j.marstruc.2015.10.002		22	Engineering, Marine; Engineering, Civil	Engineering	CY0CP	WOS:000366074200013		
J	Hosono, S; Ito, H; Oze, I; Higaki, Y; Morita, E; Takashima, N; Suzuki, S; Shimatani, K; Mikami, H; Ohnaka, K; Ozaki, E; Katsuura-Kamano, S; Kubo, M; Nagata, C; Naito, M; Hamajima, N; Tanaka, H				Hosono, Satoyo; Ito, Hidemi; Oze, Isao; Higaki, Yasuki; Morita, Emi; Takashima, Naoyuki; Suzuki, Sadao; Shimatani, Keiichi; Mikami, Haruo; Ohnaka, Keizo; Ozaki, Etsuko; Katsuura-Kamano, Sakurako; Kubo, Michiaki; Nagata, Chisato; Naito, Mariko; Hamajima, Nobuyuki; Tanaka, Hideo		J-MICC Study Grp	Polymorphisms in CYP19A1, HSD17B1 and HSD17B2 genes and serum. sex hormone level among postmenopausal Japanese women	MATURITAS			English	Article						Cross-sectional study; Polymorphisms in CYP19A1, HSD17B1 and HSD17B2; Sex hormone concentration	MULTIINSTITUTIONAL COLLABORATIVE COHORT; INTERNATIONAL HAPMAP PROJECT; ENDOMETRIAL CANCER-RISK; BREAST-CANCER; ASSOCIATION; VARIANTS; POPULATION; NUTRITION; GENOTYPES	Objective: Extraovarian sex hormone production plays an important role in estrogen biosynthesis in postmenopausal women. We examined possible associations between serum sex hormone level and polymorphisms in CYP19A1,HSD17B1, and HSD17B2. We also assessed possible interaction between these polymorphisms and current overweight. Methods: We conducted a cross-sectional study. 785 Japanese natural postmenopausal women were randomly selected from the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study database. Information on lifestyle factors was obtained from a self-administered questionnaire. Serum estrogens and androgens levels were measured by liquid chromatography-tandem mass spectrometry. Four tag SNPs (single nucleotide polymorphisms) of CYP19A1, one missense SNP of HSD17B1 and three tag SNPs of HSD17B2 were examined by Invader assay. A trend test was conducted using linear regression. Results: After adjustment for multiple comparisons, we found that rs4441215 and rs936306 in CYP19A1 and rs4888202 and rs2955160 in HSD17B2 were associated with differences in serum estrone level. Further, rs4441215 and rs936306 were associated with differences in serum estradiol level. None of these polymorphisms showed a significant interaction with current body mass index (BMI). Conclusions: Our findings suggested that CYP19A1 and HSD17B2 polymorphisms might be associated with circulating sex hormone levels in Japanese postmenopausal women, independent of current BMI. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Hosono, Satoyo; Ito, Hidemi; Oze, Isao; Tanaka, Hideo] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Higaki, Yasuki] Fukuoka Univ, Fac Sports & Hlth Sci, Exercise Physiol Lab, Jonan Ku, Fukuoka 8140180, Japan; [Morita, Emi; Naito, Mariko] Nagoya Univ, Dept Prevent Med, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; [Morita, Emi] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Takashima, Naoyuki] Shiga Univ Med Sci, Dept Hlth Sci, Otsu, Shiga 5202192, Japan; [Suzuki, Sadao] Nagoya City Univ, Dept Publ Hlth, Grad Sch Med Sci, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Shimatani, Keiichi] Kagoshima Univ, Dept Int Isl & Community Med, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan; [Mikami, Haruo] Chiba Canc Ctr Res Inst, Div Canc Registry Prevent & Epidemiol, Chuo Ku, Chiba 2600801, Japan; [Ohnaka, Keizo] Kyushu Univ, Dept Geriatr Med, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan; [Ozaki, Etsuko] Kyoto Prefectural Univ Med, Dept Epidemiol Community Hlth & Med, Kamigyo Ku, Kyoto 6028566, Japan; [Katsuura-Kamano, Sakurako] Univ Tokushima, Inst Hlth Biosci, Dept Prevent Med, Grad Sch, Tokushima 7708503, Japan; [Kubo, Michiaki] RIKEN, Lab Genotyping Dev, Ctr Genom Med, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Nagata, Chisato] Gifu Univ, Dept Epidemiol & Prevent Med, Grad Sch Med, Gifu 5011194, Japan; [Hamajima, Nobuyuki] Nagoya Univ, Dept Healthcare Adm, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan	Hosono, S (reprint author), Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	shosono@aichi-cc.jp			Japanese Ministry of Education, Science, Sports, Culture and Technology [17015018, 221S0001]	This study was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas of Cancer (No. 17015018) and on Innovative Areas (No. 221S0001) from the Japanese Ministry of Education, Science, Sports, Culture and Technology.	Lukanova A, 2005, CANCER EPIDEM BIOMAR, V14, P98; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; Iwasaki M, 2010, NUTR CANCER, V62, P466, DOI 10.1080/01635580903441279; Kaaks R, 2005, ENDOCR-RELAT CANCER, V12, P1071, DOI 10.1677/erc.1.01038; Wakai K, 2011, J EPIDEMIOL, V21, P223, DOI 10.2188/jea.JE20100139; Tworoger SS, 2004, CANCER EPIDEM BIOMAR, V13, P94, DOI 10.1158/1055-9965.EPI-03-0026; Vihko P, 2001, MOL CELL ENDOCRINOL, V171, P71, DOI 10.1016/S0303-7207(00)00389-0; Rebbeck TR, 2010, MENOPAUSE, V17, P1026, DOI 10.1097/gme.0b013e3181db61a1; Latil AG, 2001, CANCER, V92, P1130, DOI 10.1002/1097-0142(20010901)92:5<1130::AID-CNCR1430>3.0.CO;2-B; Ma XY, 2010, BREAST CANCER RES TR, V122, P495, DOI 10.1007/s10549-009-0693-6; Travis RC, 2004, CANCER EPIDEM BIOMAR, V13, P2282; Travis RC, 2009, CANCER EPIDEM BIOMAR, V18, P2734, DOI 10.1158/1055-9965.EPI-09-0496; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Zhang J, 1997, CONTROL CLIN TRIALS, V18, P204, DOI 10.1016/S0197-2456(96)00129-8; Al-Azzawi F, 2009, MATURITAS, V63, P135, DOI 10.1016/j.maturitas.2009.03.009; Sangrajrang S, 2009, INT J CANCER, V125, P837, DOI 10.1002/ijc.24434; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Henderson BE, 2000, CARCINOGENESIS, V21, P427, DOI 10.1093/carcin/21.3.427; Kidokoro K, 2009, J HUM GENET, V54, P78, DOI 10.1038/jhg.2008.11; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hamajima N, 2007, ASIAN PAC J CANCER P, V8, P317; Allen NE, 2008, ENDOCR-RELAT CANCER, V15, P485, DOI 10.1677/ERC-07-0064; Grundberg E, 2013, AM J HUM GENET, V93, P876, DOI 10.1016/j.ajhg.2013.10.004; Uemura H, 2012, MATURITAS, V71, P369, DOI 10.1016/j.maturitas.2011.12.021; Hosono S, 2011, ASIAN PAC J CANCER P, V12, P2747; Dunning AM, 2004, J NATL CANCER I, V96, P936, DOI 10.1093/jnci/djh167; Cai H, 2008, PHARMACOGENET GENOM, V18, P657, DOI 10.1097/FPC.0b013e3282fe3326; Key T, 2002, J Natl Cancer Inst, V94, P606; Nishiyama T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035000	30	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-5122	1873-4111		MATURITAS	Maturitas	DEC	2015	82	4					394	401		10.1016/j.maturitas.2015.08.003		8	Geriatrics & Gerontology; Obstetrics & Gynecology	Geriatrics & Gerontology; Obstetrics & Gynecology	CY0DI	WOS:000366076100012		
J	Katsura, M				Katsura, M.			Nonlinearity error reduction in signal ratiometry by ratio-to-phase conversion	MEASUREMENT SCIENCE AND TECHNOLOGY			English	Article						nonlinearity error; voltage measurement; optical measurement; ratiometry	SCINTILLATION SPECTROMETERS; LINEARITY MEASUREMENTS; LIGHT-SOURCE; APERTURE; SYSTEM	Signal ratiometry plays a crucial role in many measurement fields. Its achievable accuracy is not restricted by the stability of the available signal standard within its linearity limit because the ratio calculations cancel the resultant gain error in the measured signal intensities. However, when there is a significant non-linear response, the multi-point calibration used to reduce the non-linearity error requires one or more stable signal sources. This study describes two progressive methods which reduce the non-linearity error using a ratio-to-phase conversion without a calibrator. We validated our methods' performance using a dc voltage ratiometry experiment.	[Katsura, M.] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan	Katsura, M (reprint author), Osaka Univ, Grad Sch Sci, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	mhirai@ess.sci.osaka-u.ac.jp			Japan Society for the Promotion of Science [24656062]	This study was supported by a Japan Society for the Promotion of Science Grant-in-Aid for Challenging Exploratory Research (No. 24656062). The author has a competing interest with an international patent application No. PCT/JP2015/069026 relative to this study. The authors would like to thank Enago (www.enago.jp) for the English language review.	Harmon SR, 2013, 2013 IEEE INTERNATIONAL TOPICAL MEETING ON MICROWAVE PHOTONICS (MWP), P17, DOI 10.1109/MWP.2013.6724008; Early MD, 2013, IEEE T INSTRUM MEAS, V62, P1600, DOI 10.1109/TIM.2012.2230734; Salzberg BM, 2005, J NEUROSCI METH, V141, P165, DOI 10.1016/j.jneumeth.2004.06.009; Theocharous E, 2004, APPL OPTICS, V43, P4182, DOI 10.1364/AO.43.004182; [Anonymous], 2001, 12412000 IEEE; Vargha B, 2002, MEASUREMENT, V31, P201, DOI 10.1016/S0263-2241(01)00026-4; Yamamori H, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2167789; Hanaoka Y, 2011, APPL OPTICS, V50, P2401, DOI 10.1364/AO.50.002401; ZWINKELS JC, 1991, APPL OPTICS, V30, P1678, DOI 10.1364/AO.30.001678; MIELENZ KD, 1972, APPL OPTICS, V11, P2294, DOI 10.1364/AO.11.002294; CLARKE FJJ, 1972, J RES NBS A PHYS CH, VA 76, P375, DOI 10.6028/jres.076A.036; REITER WL, 1980, NUCL INSTRUM METHODS, V169, P469, DOI 10.1016/0029-554X(80)90944-1; Monteiro F, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4817390; van den Brom HE, 2007, MEAS SCI TECHNOL, V18, P3316, DOI 10.1088/0957-0233/18/11/008; REITER WL, 1980, NUCL INSTRUM METHODS, V173, P275, DOI 10.1016/0029-554X(80)90780-6; CUTKOSKY RD, 1978, IEEE T INSTRUM MEAS, V27, P421, DOI 10.1109/TIM.1978.4314728; Francis R, 1993, UV62; Kester W, 2005, DATA CONVERSION HDB, P303, DOI 10.1016/B978-075067841-4/50022-1; Lee C P, 2007, IEEE T CIRCUITS SYST, V54, P2733; Maxim integrated products, 1996, MAX4526MAX4527; Ozturk T C, 2012, 20 IMEKO WORLD C MET; SymPy development team, 2014, SYMPY PYTH LIB SYMB; Travis J C, 2011, TN1715 NAT I STAND T; Upstone S L, 2012, VALIDATING UV VISIBL; Upstone S L, 2006, ULTRAVIOLET VISIBLE	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0957-0233	1361-6501		MEAS SCI TECHNOL	Meas. Sci. Technol.	DEC	2015	26	12							125011	10.1088/0957-0233/26/12/125011		12	Engineering, Multidisciplinary; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CY5LD	WOS:000366448200011		
J	Park, HJ; Tasaka, Y; Murai, Y				Park, Hyun Jin; Tasaka, Yuji; Murai, Yuichi			Ultrasonic pulse echography for bubbles traveling in the proximity of a wall	MEASUREMENT SCIENCE AND TECHNOLOGY			English	Article						multiphase flow; echography; bubble; boundary layer; ultrasound	DRAG REDUCTION; FILM THICKNESS; FLOW STRUCTURE; 2-PHASE FLOW; INJECTION; CONDENSATION; TOMOGRAPHY; TRANSDUCER; SYSTEM; MEDIA	The behavior of a bubbly two-phase flow in the vicinity of a wall affects heat, mass, and momentum transfer; therefore, there is great interest in developing a quantitative technique to monitor this behavior. Herein we propose a new method based on ultrasound echo signal processing that it feasible for industrial applications where the boundary layer is modified by traveling bubbles. By introducing time-resolved direct waveform analysis at 100 MHz, we have succeeded in the spatio-temporal detection of bubble surfaces at echographic profiling frequencies in the range of 15-20 kHz. Unlike conventional approaches, which use short pulses, a relatively long pulse length is applied to allow ultrasound Doppler velocimetry in the liquid phase. Examination of the horizontal bubbly two-phase turbulent channel flows demonstrated the feasibility of this method; spatio-temporal echography of moving bubble surfaces is successfully achieved as the bubbles travel on length scales smaller than the spatial ultrasonic pulse length near the wall. The applicable range of parameters (e.g. bubble size and shape, and flow speed) was determined by 3D numerical analysis of the wave equation and its application to bubbles flowing beneath a flat-bottom model ship.	[Park, Hyun Jin; Tasaka, Yuji; Murai, Yuichi] Hokkaido Univ, Grad Sch Engn, Div Energy & Environm Syst, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Park, HJ (reprint author), Hokkaido Univ, Grad Sch Engn, Div Energy & Environm Syst, Kita Ku, N13 W8, Sapporo, Hokkaido 0608628, Japan.	hyun-jin@ring-me.eng.hokudai.ac.jp			Fundamental Research Developing Association for Shipbuilding and Offshore (REDAS) [15J00147]; JSPS KAKENHI Grant [24246033, 23760143]	This work was supported by the Fundamental Research Developing Association for Shipbuilding and Offshore (REDAS), Grant-in-Aid for JSPS Fellows No. 15J00147, JSPS KAKENHI Grant Nos. 24246033 and 23760143. The authors would like to express their appreciation for this support.	Kitagawa A, 2005, EXP FLUIDS, V38, P466, DOI 10.1007/s00348-004-0926-8; Pedersen PC, 2000, ULTRASONICS, V38, P486, DOI 10.1016/S0041-624X(99)00214-0; HIGDON RL, 1992, J COMPUT PHYS, V101, P386, DOI 10.1016/0021-9991(92)90016-R; Ceccio SL, 2010, ANNU REV FLUID MECH, V42, P183, DOI 10.1146/annurev-fluid-121108-145504; Kumagai I, 2015, OCEAN ENG, V95, P183, DOI 10.1016/j.oceaneng.2014.11.019; Fiedler S, 2003, INT J ENERG RES, V27, P315, DOI 10.1002/er.877; Karpiouk AB, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2937478; LU Q, 1993, EXP THERM FLUID SCI, V7, P354, DOI 10.1016/0894-1777(93)90058-Q; Kumar SB, 1997, AICHE J, V43, P1414, DOI 10.1002/aic.690430605; MATIKAINEN L, 1986, REV SCI INSTRUM, V57, P1661, DOI 10.1063/1.1138546; Murakawa H, 2008, FLOW MEAS INSTRUM, V19, P205, DOI 10.1016/j.flowmeasinst.2007.06.010; Kamei T, 1998, NUCL ENG DES, V184, P349, DOI 10.1016/S0029-5493(98)00208-8; Hunter A, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/10/105605; GLOVER GH, 1977, IEEE T SON ULTRASON, V24, P229; Prasser HM, 2005, FLOW MEAS INSTRUM, V16, P73, DOI [10.1016/j.flowmeasinst.2005.02.003, 10.1016/j.flowmeasurement.2005.02.003]; Wada S, 2006, FLOW MEAS INSTRUM, V17, P207, DOI 10.1016/j.flowmeasinst.2005.11.006; Olerni C, 2013, MEAS SCI TECHNOL, V24, DOI 10.1088/0957-0233/24/3/035403; Park HJ, 2015, INT J MULTIPHAS FLOW, V75, P12, DOI 10.1016/j.ijmultiphaseflow.2015.05.003; Sathe MJ, 2010, CHEM ENG SCI, V65, P2431, DOI 10.1016/j.ces.2009.11.014; Murai Y, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/11/114003; Murai Y, 2010, FLOW MEAS INSTRUM, V21, P356, DOI 10.1016/j.flowmeasinst.2010.03.007; Prasser HM, 2001, FLOW MEAS INSTRUM, V12, P299, DOI 10.1016/S0955-5986(00)00046-7; Oishi Y, 2014, EXP THERM FLUID SCI, V55, P128, DOI 10.1016/j.expthermflusci.2014.02.022; Park HJ, 2014, CHEM ENG SCI, V116, P486, DOI 10.1016/j.ces.2014.05.026; Johansen JP, 2010, INT J MULTIPHAS FLOW, V36, P720, DOI 10.1016/j.ijmultiphaseflow.2010.05.002; Tisne P, 2003, INT J MULTIPHAS FLOW, V29, P841, DOI 10.1016/S0301-9322(03)00038-7; Schroder CT, 2002, IEEE T GEOSCI REMOTE, V40, P474, DOI 10.1109/36.992813; Dines D A, 1979, ULTRASONIC IMAGING, V1, P16; Kodama Y, 2008, JAPAN SOC NAV ARCHIT, V6, P163; Makiharju SA, 2013, EXP FLUIDS, V54, DOI 10.1007/s00348-013-1561-z; MCCORMIC.ME, 1973, NAV ENG J, V85, P11; Mizokami S, 2013, MHI TECH REV, V50, P44; Mizokami S., 2010, MITSUBISHI HEAVY IND, V47, P41; Murai Y, 2014, EXP FLUIDS, V55, DOI 10.1007/s00348-014-1773-x; Oishi Yoshihiko, 2009, Journal of Physics: Conference Series, V147, DOI 10.1088/1742-6596/147/1/012020; Reddyhoff R, 2006, SEALING TECHNOL, V2006, P7; Saito T, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/11/114002; Ymashita T, 2012, JRC REV, V63, P34	38	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0957-0233	1361-6501		MEAS SCI TECHNOL	Meas. Sci. Technol.	DEC	2015	26	12							125301	10.1088/0957-0233/26/12/125301		14	Engineering, Multidisciplinary; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CY5LD	WOS:000366448200026		
J	Subacius, L; Jarasiunas, K; Scajev, P; Kato, M				Subacius, L.; Jarasiunas, K.; Scajev, P.; Kato, M.			Development of a microwave photoconductance measurement technique for the study of carrier dynamics in highly-excited 4H-SiC	MEASUREMENT SCIENCE AND TECHNOLOGY			English	Article						carrier dynamics; microwave conductivity; free carrier absorption; silicon carbide	CONDUCTIVITY MEASUREMENTS; SEMICONDUCTORS; KINETICS	The microwave conductance decay (MCD) technique combining an initially matched transmission line setup and picosecond optical excitation was developed and applied for the monitoring of transmitted and reflected microwave power transients in a 4H-SiC epilayer in a wide excitation range, from 2 x 10(14) to 10(18) cm(-3). The excitation-dependent decrease in measurement sensitivity in the power-law relations of the transients was observed at excess carrier densities above 10(16) cm(-3) due to the line mismatches and decrease in the internal microwave field in the illuminated sample. The calibration procedure of MCD data on excess carrier density was applied for the correction of the MCD transients and resulted in nearly identical MCD kinetics in the reflection and transmission. In a 35 mu m-thick n-type 4H-SiC epilayer, the tendencies of the gradual decrease of the initial decay time with an excitation increase and the excitation-enhanced carrier recombination rate in MCD tails were analyzed numerically. These tendencies were attributed to the excitation dependent surface recombination rate and the enhanced trap-related bulk recombination, correspondingly.	[Subacius, L.; Jarasiunas, K.; Scajev, P.] Vilnius Univ, Inst Appl Res, LT-10222 Vilnius, Lithuania; [Subacius, L.] Ctr Phys Sci & Technol, Inst Semicond Phys, LT-01108 Vilnius, Lithuania; [Kato, M.] Nagoya Inst Technol, Dept Engn Phys Elect & Mech, Nagoya, Aichi 4668555, Japan	Subacius, L (reprint author), Vilnius Univ, Inst Appl Res, Sauletekio Al 9-3, LT-10222 Vilnius, Lithuania.	kestutis.jarasiunas@ff.vu.lt					Grivickas P, 2001, J MATER RES, V16, P524, DOI 10.1557/JMR.2001.0075; Klein PB, 2008, J APPL PHYS, V103, DOI 10.1063/1.2837105; Schuler N, 2010, J APPL PHYS, V107, DOI 10.1063/1.3331628; Myers-Ward RL, 2010, J APPL PHYS, V108, DOI 10.1063/1.3475152; KUNST M, 1988, J APPL PHYS, V63, P1093, DOI 10.1063/1.340013; SPROUL AB, 1994, J APPL PHYS, V76, P2851, DOI 10.1063/1.357521; Schins JM, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2008978; Sridhara SG, 1999, MAT SCI ENG B-SOLID, V61-2, P229, DOI 10.1016/S0921-5107(98)00508-X; Lauer K, 2008, J APPL PHYS, V104, DOI 10.1063/1.3021459; Scajev P, 2010, J APPL PHYS, V108, DOI 10.1063/1.3459894; KUNST M, 1986, J APPL PHYS, V60, P3558, DOI 10.1063/1.337612; SWIATKOWSKI C, 1995, J APPL PHYS, V78, P1763, DOI 10.1063/1.360206; BOULOU M, 1977, J APPL PHYS, V48, P4713, DOI 10.1063/1.323537; Klein PB, 2010, J APPL PHYS, V108, DOI 10.1063/1.3466745; Chung BK, 2007, PROG ELECTROMAGN RES, V75, P239, DOI 10.2528/PIER07052801; Mori Y, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/33/335102; Kato M, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.02BP12; Kato M, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.04DP14; Ridley B K, 1999, QUANTUM PROCESSES SE; Scajev P, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/26/265304	20	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0957-0233	1361-6501		MEAS SCI TECHNOL	Meas. Sci. Technol.	DEC	2015	26	12							125014	10.1088/0957-0233/26/12/125014		8	Engineering, Multidisciplinary; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CY5LD	WOS:000366448200014		
J	Nobutoki, T; Ihara, T				Nobutoki, Tatsuro; Ihara, Toshiaki			Early disruption of neurovascular units and microcirculatory dysfunction in the spinal cord in spinal muscular atrophy type I	MEDICAL HYPOTHESES			English	Article							BLOOD-FLOW; NITRIC-OXIDE; DISEASE; BRAIN; SURVIVAL; ASTROCYTES; PROTEIN; SMN; IDENTIFICATION; ABNORMALITIES	Spinal muscular atrophy type I (SMA-I) is characterized by progressive muscle weakness with onset in early infancy, usually resulting in mortality before two years of age. However, the processes underlying the pathophysiological progression of the disease remain unclear. Prior to the onset of muscle weakness, a regression of local capillaries is observed along with motor neuron loss. Local populations of neurons, astrocytes, and vascular endothelial cells constitute a neurovascular unit (NVU), in which neuronal and synaptic metabolism is tightly coupled to capillary blood flow by astrocyte-mediated vasodilatory control. We hypothesize that survival motor neuron protein deficiency and initial neuronal dysfunction leads to the regression of vascular beds and the disruption of NVU function. As a result, local capillary blood flow becomes insufficient, leading to metabolic stress in neurons, endothelial cells, pericytes, and astrocytes, ultimately disrupting the astrocytic regulation of capillaries. This pathogenic process may accelerate the loss of anterior horn motor neurons, leading to the further regression of capillaries and astroglial dysfunction. Hypocapnia, resulting from dehydration and hyperventilation during therapeutic manual ventilation, might further damage the NVU. Moreover, disruption of the microcirculation may affect sympathetic and sensory neurons in the spinal cord, contributing to sympathetic hyperactivity and sensory nerve degeneration, respectively. These mutually reinforcing processes may underlie the progression of muscle weakness during infancy in SMA-I. Therefore, disruption of the NVU and a stressful neurovascular environment in the anterior horn may play important roles in disease initiation and/or progression in SMA-I. The NVU is therefore a critical therapeutic target for treating SMA-I. Our hypothetical model may provide insight into why most neuroprotective strategies that do not address astroglial and vascular cell dysfunction have limited efficacy. (C) 2015 Elsevier Ltd. All rights reserved.	[Nobutoki, Tatsuro; Ihara, Toshiaki] Natl Mie Hosp, Dept Pediat, Tsu, Mie 5140125, Japan	Nobutoki, T (reprint author), Natl Mie Hosp, Dept Pediat, 357 Osato Kubota, Tsu, Mie 5140125, Japan.	nbtk.kamakura.ped@tenor.ocn.ne.jp					Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Miyazaki K, 2011, J NEUROSCI RES, V89, P718, DOI 10.1002/jnr.22594; Rindt H, 2015, HUM MOL GENET, V24, P4094, DOI 10.1093/hmg/ddv148; CZINN EA, 1995, ANESTH ANALG, V80, P492, DOI 10.1097/00000539-199503000-00010; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Arnold WD, 2013, ANN NEUROL, V74, P348, DOI 10.1002/ana.23995; Hachiya Y, 2005, BRAIN DEV-JPN, V27, P574, DOI 10.1016/j.braindev.2005.02.009; Itoh Y, 2012, J CEREBR BLOOD F MET, V32, P1167, DOI 10.1038/jcbfm.2012.5; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Abe K, 2012, J CEREBR BLOOD F MET, V32, P1317, DOI 10.1038/jcbfm.2011.187; McGivern JV, 2013, GLIA, V61, P1418, DOI 10.1002/glia.22522; Winkler EA, 2012, J CEREBR BLOOD F MET, V32, P1841, DOI 10.1038/jcbfm.2012.113; Somers E, 2012, NEUROMUSCULAR DISORD, V22, P435, DOI 10.1016/j.nmd.2011.10.021; Wirth B, 1999, AM J HUM GENET, V64, P1340, DOI 10.1086/302369; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Duque SI, 2015, ANN NEUROL, V77, P399, DOI 10.1002/ana.24332; Koga N, 1999, NEUROSCI LETT, V267, P173, DOI 10.1016/S0304-3940(99)00358-4; Sanchez G, 2013, HUM MOL GENET, V22, P668, DOI 10.1093/hmg/dds474; Petzold GC, 2011, NEURON, V71, P782, DOI 10.1016/j.neuron.2011.08.009; Araujo APDC, 2009, J PEDIATR-US, V155, P292, DOI 10.1016/j.jpeds.2009.01.071; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Toribatake Y, 1997, SPINAL CORD, V35, P26, DOI 10.1038/sj.sc.3100348; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Zhou HH, 1998, ANESTH ANALG, V87, P407, DOI 10.1097/00000539-199808000-00033; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073; Nakagomi T, 2015, STEM CELLS, V33, P1962, DOI 10.1002/stem.1977; Ishikawa M, 2002, NEUROSURGERY, V50, P377; Ishikawa M, 2002, NEUROSURGERY, V50, P371, DOI 10.1097/00006123-200202000-00025; Kye MJ, 2014, HUM MOL GENET, V23, P6318, DOI 10.1093/hmg/ddu350; lida H, 1997, MASUI, V46, P2; Rudnik-Schoneborn S, 2010, MUSCLE NERVE, V42, P144, DOI 10.1002/mus.21654; Wang CH, 2012, SWAIMANS PEDIAT NEUR, V2, P1482; Wang S, 2015, MOL CELL BIOL, V35, P1299, DOI 10.1128/MCB.00306-14; Wang W, 2015, MED RES REV, V35, P225, DOI 10.1002/med.21327; Yonekawa T, 2013, BRAIN DEV-JPN, V35, P165, DOI 10.1016/j.braindev.2012.03.009	40	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	DEC	2015	85	6					842	845		10.1016/j.mehy.2015.09.028		4	Medicine, Research & Experimental	Research & Experimental Medicine	CY2IG	WOS:000366231400023		
J	Hashimoto, H; Kurata, A; Nashiro, T; Kuroda, M; Horiuchi, H				Hashimoto, Hirotsugu; Kurata, Atsushi; Nashiro, Tamaki; Kuroda, Masahiko; Horiuchi, Hajime			Does perineural invasion of the myenteric plexus have a key role in annular rectal invasion and digestive system symptoms of prostate carcinoma patients?	MEDICAL HYPOTHESES			English	Article							CANCER; ADENOCARCINOMA; INVOLVEMENT	Prostate carcinoma is one of the most common cancers globally. It relatively rarely invades the rectum, accounting for only about 4% of resected cases. About half of these cases of rectal invasion show an annular rectal stricture pattern. It has been hypothesized that anatomical structures, namely Denonvilliers fascia, may play an important role in annular rectal involvement of prostate carcinoma. Here, we propose another hypothesis: the reason for annular rectal invasion by prostate carcinoma is its extension along the myenteric plexus (Auerbach's plexus). We illustrate this using a case presentation and description of the symptoms of such cases. From a review of the literature, autonomic digestive system symptoms of rectal invasion of prostatic carcinoma, such as diarrhea, tenesmus, or fecal incontinence is seen in about half of cases, coinciding with the frequency of annular rectal invasion. Thus, by modifying the long-established hypothesis, our suggestion that prostate carcinoma spreads along the myenteric plexus when cancer cells invade beyond the Denonvilliers fascia to the rectum could explain the cause and frequency not only of the annular rectal invasion but also the digestive system symptoms related to this disease. The prognosis of prostate carcinoma invading the rectum is very poor; however, this new hypothesis might shed light on the digestive system symptoms associated with prostate carcinoma and might lead to recognition and treatment of these cases at a relatively early stage of rectal invasion. (C) 2015 Elsevier Ltd. All rights reserved.	[Hashimoto, Hirotsugu; Nashiro, Tamaki; Horiuchi, Hajime] NTT Med Ctr Tokyo, Dept Diagnost Pathol, Tokyo 1418625, Japan; [Hashimoto, Hirotsugu; Kurata, Atsushi; Kuroda, Masahiko] Tokyo Med Univ, Dept Mol Pathol, Tokyo 1608402, Japan	Hashimoto, H (reprint author), NTT Med Ctr Tokyo, Dept Diagnost Pathol, Shinagawa Ku, 5-9-22 Higashi Gotanda, Tokyo 1418625, Japan.	hhashimoto-tki@umin.ac.jp					LASSER A, 1978, DIS COLON RECTUM, V21, P23, DOI 10.1007/BF02586541; Yang G, 1996, CANCER, V78, P1267, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1267::AID-CNCR15>3.0.CO;2-Z; Hoffman JRH, 2009, AM SURGEON, V75, P434; Bowrey DJ, 2003, ANN ROY COLL SURG, V85, P382, DOI 10.1308/003588403322520726; WINTER CC, 1957, SURG GYNECOL OBSTET, V105, P136; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; GENGLER L, 1975, AM J ROENTGENOL, V125, P910; Ito K, 2014, NAT REV UROL, V11, P197, DOI 10.1038/nrurol.2014.42; BECKER JA, 1965, AMER J ROENTGENOL RA, V94, P421; Epstein JI, 2004, PATHOLOGY GENETICS T, P162; Lazarus JA, 1935, AM J SURG, V30, P502, DOI 10.1016/S0002-9610(35)91218-1; WINTER CHESTER C., 1955, CALIFORNIA MED, V82, P85	12	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	DEC	2015	85	6					854	857		10.1016/j.mehy.2015.09.024		4	Medicine, Research & Experimental	Research & Experimental Medicine	CY2IG	WOS:000366231400026		
J	Wang, CL; Saito, M; Tanaka, T; Amako, K; Yoshida, S				Wang, Changle; Saito, Mitsumasa; Tanaka, Tamami; Amako, Kazunobu; Yoshida, Shin-ichi			Comparative analysis of virulence traits between a Legionella feeleii strain implicated in Pontiac fever and a strain that caused Legionnaires' disease	MICROBIAL PATHOGENESIS			English	Article						Legionella feeleii; Pontiac fever; Legionnaires' disease; Bacterial infection; Host cell immune response	INTRACELLULAR MICROCOLONIES; EPITHELIAL-CELLS; VERO CELLS; PNEUMOPHILA; INFECTION; GROWTH; MACROPHAGES; FLAGELLUM; SEROGROUP; OUTBREAK	Legionella strains of the same species and serogroup are known to cause Legionnaires' disease (a potentially fatal atypical pneumonia) or Pontiac fever (a mild, flu-like disease), but the bacterial factors that define these dramatic differences in pathology have not been elucidated. To gain a better understanding of these factors, we compared the characteristics of Legionella feeleii strains that were isolated from either a sample of freshwater implicated in an outbreak of Pontiac fever (ATCC 35072, serogroup I, LfPF), or a patient with Legionnaires' disease (ATCC 38549, serogroup 2, LfLD). Growth of LfPF and LfLD in BYE broth was slower than the positive control, Legionella pneumophila strain JR32. However, LfLD grew faster than LfPF at 42 degrees C. After in vitro infection to J774 murine or U937 human macrophage cell lines and A549 human lung epithelial cell line, LfLD showed a higher cell infection rate, stronger internalization by host cells, and greater cytotoxicity than that of LfPF. Large amounts of IL-6 and IL-8 were secreted by human host cells after infection with LED, but not with LfPF. LfLD possessed mono-polar flagellum while LfPF was unflagellated. When LfLD was cultured at 25, 30 and 37 degrees C, the bacteria had higher motility rate at lower temperatures. Based on our results, this is the first study that showed distinct characteristics between LfPF and LfLD, which may give important leads in elucidating differences in their virulence. (C) 2015 Elsevier Ltd. All rights reserved.	[Wang, Changle; Amako, Kazunobu; Yoshida, Shin-ichi] Kyushu Univ, Grad Sch Med Sci, Dept Bacteriol, Fukuoka 8128582, Japan; [Tanaka, Tamami] Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka 8128582, Japan; [Saito, Mitsumasa] Univ Occupat & Environm Hlth, Sch Med, Dept Microbiol, Kitakyushu, Fukuoka 8078555, Japan	Wang, CL (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Bacteriol, Fukuoka 8128582, Japan.	wc11986@bact.med.kyushu-u.ac.jp			Ministry of Education, Sports, Culture, Science, and Technology, Japan [25460537]	This work was supported by grant-in-aid 25460537 for scientific research from the Ministry of Education, Sports, Culture, Science, and Technology, Japan.	Newton HJ, 2010, CLIN MICROBIOL REV, V23, P274, DOI 10.1128/CMR.00052-09; Antunes G, 2002, EUR RESPIR J, V20, P990, DOI 10.1183/09031936.02.00295102; Park DR, 1996, J IMMUNOL, V157, P2528; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Molofsky AB, 2005, INFECT IMMUN, V73, P5720, DOI 10.1128/IAI.73.9.5720-5734.2005; Muder RR, 2002, CLIN INFECT DIS, V35, P990, DOI 10.1086/342884; Heuner K, 2003, INT J MED MICROBIOL, V293, P133, DOI 10.1078/1438-4221-00259; FRASER DW, 1979, SCIENCE, V205, P690, DOI 10.1126/science.462175; THACKER WL, 1985, J CLIN MICROBIOL, V22, P1; Cramp GJ, 2010, EPIDEMIOL INFECT, V138, P15, DOI 10.1017/S0950268809990835; FIELDS BS, 1990, INFECT IMMUN, V58, P3139; ABUKWAIK Y, 1993, INFECT IMMUN, V61, P1320; Couper KN, 2008, J IMMUNOL, V180, P5771; McCoy-Simandle K, 2011, INFECT IMMUN, V79, P1984, DOI 10.1128/IAI.01077-10; Ohnishi H, 2004, INFECT IMMUN, V72, P3592, DOI 10.1128/IAI.72.6.3595-3603.2004; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; Takekawa Y, 2012, CAN J MICROBIOL, V58, P179, DOI [10.1139/w11-126, 10.1139/W11-126]; RISTROPH JD, 1980, J CLIN MICROBIOL, V11, P19; Higa F, 1998, J CLIN MICROBIOL, V36, P1392; Fernandez RC, 1996, INFECT IMMUN, V64, P1968; Palusinska-Szysz M, 2009, ARCH IMMUNOL THER EX, V57, P279, DOI 10.1007/s00005-009-0035-8; PEARLMAN E, 1988, MICROB PATHOGENESIS, V5, P87, DOI 10.1016/0882-4010(88)90011-3; Lorenz J, 2011, EUR RESPIR J, V37, P648, DOI 10.1183/09031936.00200009; HERWALDT LA, 1984, ANN INTERN MED, V100, P333; Maruta K, 1998, AM J RESP CRIT CARE, V157, P1967; Alli OAT, 2003, MICROBIOL-SGM, V149, P631, DOI 10.1099/mic.0.25980-0; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schmeck B, 2007, EUR RESPIR J, V29, P25, DOI 10.1183/09031936.00141005; MANGIONE EJ, 1985, JAMA-J AM MED ASSOC, V253, P535; Whitfield NN, 2010, INFECT IMMUN, V78, P423, DOI 10.1128/IAI.00070-09; YOSHIDA S, 1984, J GEN MICROBIOL, V130, P901; FALLON RJ, 1990, J CLIN PATHOL, V43, P479, DOI 10.1136/jcp.43.6.479; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; MARRA A, 1989, J BACTERIOL, V171, P2238; Mukaida N, 1998, CYTOKINE GROWTH F R, V9, P9, DOI 10.1016/S1359-6101(97)00022-1; HEUNER K, 1995, INFECT IMMUN, V63, P2499; Maruta K, 1998, MICROB PATHOGENESIS, V24, P65, DOI 10.1006/mpat.1997.0171; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Ogawa M, 2001, MICROBIOL IMMUNOL, V45, P557; Dietrich C, 2001, INFECT IMMUN, V69, P2116, DOI 10.1128/IAI.69.4.2116-2122.2001; Eisele N.A., 2011, J PATHOG, V2011, DOI [DOI 10.4061/2011/249802, 10.4061/2011/249802]; Fiumefreddo R., 2009, BMC PULM MED, V9, P1471; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967	44	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0882-4010			MICROB PATHOGENESIS	Microb. Pathog.	DEC	2015	89						79	86		10.1016/j.micpath.2015.09.004		8	Immunology; Microbiology	Immunology; Microbiology	CY2HR	WOS:000366229900010		
J	Yamagishi, Y; Abe, H				Yamagishi, Yuka; Abe, Hiroshi			Reorganization of actin filaments by ADF/cofilin is involved in formation of microtubule structures during Xenopus oocyte maturation	MOLECULAR BIOLOGY OF THE CELL			English	Article							LIM-KINASE; FUNCTIONAL INVOLVEMENT; SLINGSHOT PHOSPHATASE; GERMINAL VESICLE; F-ACTIN; COFILIN; SPINDLE; PHOSPHORYLATION; ORGANIZATION; PROTEINS	We examined the reorganization of actin filaments and microtubules during Xenopus oocyte maturation. Surrounding the germinal vesicle (GV) in immature oocytes, the cytoplasmic actin filaments reorganized to accumulate beneath the vegetal side of the GV, where the microtubule-organizing center and transient microtubule array (MTOC-TMA) assembled, just before GV breakdown (GVBD). Immediately after GVBD, both Xenopus ADF/cofilin (XAC) and its phosphatase Slingshot (XSSH) accumulated into the nuclei and intranuclear actin filaments disassembled from the vegetal side with the shrinkage of the GV. As the MTOC-TMA developed well, cytoplasmic actin filaments were retained at the MTOC-TMA base region. Suppression of XAC dephosphorylation by anti-XSSH antibody injection inhibited both actin filament reorganization and proper formation and localization of both the MTOC-TMA and meiotic spindles. Stabilization of actin filaments by phalloidin also inhibited formation of the MTOC-TMA and disassembly of intranuclear actin filaments without affecting nuclear shrinkage. Nocodazole also caused the MTOC-TMA and the cytoplasmic actin filaments at its base region to disappear, which further impeded disassembly of intranuclear actin filaments from the vegetal side. XAC appears to reorganize cytoplasmic actin filaments required for precise assembly of the MTOC and, together with the MTOC-TMA, regulate the intranuclear actin filament disassembly essential for meiotic spindle formation.	[Yamagishi, Yuka; Abe, Hiroshi] Chiba Univ, Grad Sch Adv Integrat Sci, Dept Nanobiol, Chiba 2638522, Japan	Abe, H (reprint author), Chiba Univ, Grad Sch Adv Integrat Sci, Dept Nanobiol, Chiba 2638522, Japan.	habe@faculty.chiba-u.jp			Japan Society for the Promotion of Science [15J05519]	We are grateful to Keita Ohsumi for providing anti-Xenopus lamin III antibody and Akira Matsuura for helpful suggestions. Y.Y. is a Research Fellow of the Japan Society for the Promotion of Science. This work was partly supported by Japan Society for the Promotion of Science Grant-in-Aid for Fellows 15J05519.	OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Nizami ZF, 2012, CHROMOSOME RES, V20, P953, DOI 10.1007/s10577-012-9320-1; ABE H, 1989, J BIOCHEM-TOKYO, V106, P696; Abe H, 1996, J CELL BIOL, V132, P871, DOI 10.1083/jcb.132.5.871; Tanaka K, 2005, ZOOL SCI, V22, P971, DOI 10.2108/zsj.22.971; Bohnsack MT, 2006, NAT CELL BIOL, V8, P257, DOI 10.1038/ncb1357; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Masui Y, 1979, Int Rev Cytol, V57, P185, DOI 10.1016/S0074-7696(08)61464-3; Takahashi T, 2001, DEV BIOL, V229, P554, DOI 10.1006/dbio.2000.9999; Gaillard J, 2011, MOL BIOL CELL, V22, P4575, DOI 10.1091/mbc.E11-07-0616; Arber S, 1998, NATURE, V393, P805; Samwer M, 2013, EMBO J, V32, P1886, DOI 10.1038/emboj.2013.108; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Almonacid M, 2014, J CELL SCI, V127, P477, DOI 10.1242/jcs.142711; Iwase S, 2013, MOL BIOL CELL, V24, P1933, DOI 10.1091/mbc.E12-12-0851; GARD DL, 1995, ZYGOTE, V3, P17; GARD DL, 1992, DEV BIOL, V151, P516, DOI 10.1016/0012-1606(92)90190-R; Okada I, 2012, CYTOSKELETON, V69, P312, DOI 10.1002/cm.21028; Yi KX, 2012, CYTOSKELETON, V69, P727, DOI 10.1002/cm.21048; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Okada K, 1999, J CELL SCI, V112, P1553; Becker BE, 2003, DEV BIOL, V261, P488, DOI 10.1016/S0012-1606(03)00330-0; Li R, 2013, NAT REV MOL CELL BIO, V14, P141, DOI 10.1038/nrm3531; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; JESSUS C, 1986, BIOL CELL, V56, P113; Tanaka K, 2005, ZOOL SCI, V22, P955, DOI 10.2108/zsj.22.955; Sandquist JC, 2011, DEV CELL, V21, P410, DOI 10.1016/j.devcel.2011.07.018; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Roth-Johnson EA, 2014, J BIOL CHEM, V289, P4395, DOI 10.1074/jbc.M113.499921; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Yang N, 1998, NATURE, V393, P809; Field CM, 2011, CURR BIOL, V21, P825; IIDA K, 1986, EXP CELL RES, V164, P492, DOI 10.1016/0014-4827(86)90047-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Loeder AD, 1994, ZYGOTE, V2, P111; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6	39	0	0	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	DEC 1	2015	26	24					4387	4400		10.1091/mbc.E15-01-0035		14	Cell Biology	Cell Biology	CY3RE	WOS:000366326500010		
J	Kai, K; Kondo, K; Wang, XP; Xie, XM; Pitner, MK; Reyes, ME; Torres-Adorno, AM; Masuda, H; Hortobagyi, GN; Bartholomeusz, C; Saya, H; Tripathy, D; Sen, S; Ueno, NT				Kai, Kazuharu; Kondo, Kimie; Wang, Xiaoping; Xie, Xuemei; Pitner, Mary K.; Reyes, Monica E.; Torres-Adorno, Angie M.; Masuda, Hiroko; Hortobagyi, Gabriel N.; Bartholomeusz, Chandra; Saya, Hideyuki; Tripathy, Debu; Sen, Subrata; Ueno, Naoto T.			Antitumor Activity of KW-2450 against Triple-Negative Breast Cancer by Inhibiting Aurora A and B Kinases	MOLECULAR CANCER THERAPEUTICS			English	Article							SPINDLE ASSEMBLY CHECKPOINT; SMALL-MOLECULE INHIBITOR; A KINASE; CELLS; APOPTOSIS; PATHWAYS; POTENT; SENSITIVITY; ARRY-142886; AZD6244	Currently, no targeted drug is available for triple-negative breast cancer (TNBC), an aggressive breast cancer that does not express estrogen receptor, progesterone receptor, or HER2. TNBC has high mitotic activity, and, because Aurora A and B mitotic kinases drive cell division and are overexpressed in tumors with a high mitotic index, we hypothesized that inhibiting Aurora A and B produces a significant antitumor effect in TNBC. We tested this hypothesis by determining the antitumor effects of KW-2450, a multikinase inhibitor of both Aurora A and B kinases. We observed significant inhibitory activities of KW-2450 on cell viability, apoptosis, colony formation in agar, and mammosphere formation in TNBC cells. The growth of TNBC xenografts was significantly inhibited with KW-2450. In cell-cycle analysis, KW-2450 induced tetraploid accumulation followed by apopto-sis or surviving octaploid (8N) cells, depending on dose. These phenotypes resembled those of Aurora B knockdown and complete pharmaceutical inhibition of Aurora A. We demonstrated that 8N cells resulting from KW-2450 treatment depended on the activation of mitogen-activated protein kinase kinase (MEK) for their survival. When treated with the MEK inhibitor selumetinib combined with KW-2450, compared with KW-2450 alone, the 8N cell population was significantly reduced and apoptosis was increased. Indeed, this combination showed synergistic antitumor effect in SUM149 TNBC xenografts. Collectively, Aurora A and B inhibition had a significant antitumor effect against TNBC, and this antitumor effect was maximized by the combination of selumetinib with Aurora A and B inhibition. (C)2015 AACR.	[Kai, Kazuharu; Kondo, Kimie; Wang, Xiaoping; Xie, Xuemei; Pitner, Mary K.; Reyes, Monica E.; Torres-Adorno, Angie M.; Masuda, Hiroko; Hortobagyi, Gabriel N.; Bartholomeusz, Chandra; Tripathy, Debu; Ueno, Naoto T.] Univ Texas MD Anderson Canc Ctr, Sect Translat Breast Canc Res, Houston, TX 77030 USA; [Kai, Kazuharu; Kondo, Kimie; Wang, Xiaoping; Xie, Xuemei; Pitner, Mary K.; Reyes, Monica E.; Torres-Adorno, Angie M.; Masuda, Hiroko; Hortobagyi, Gabriel N.; Bartholomeusz, Chandra; Tripathy, Debu; Ueno, Naoto T.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Saya, Hideyuki] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan; [Sen, Subrata] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA	Ueno, NT (reprint author), Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA.	kkai@mdanderson.org; nueno@mdanderson.org			Kyowa Hakko Kirin Co., Ltd. (Tokyo, Japan); U.S. NIH/National Cancer Institute [P30CA016672]; Nellie B. Connally Breast Cancer Research Fund; program "Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation" by the Ministry of Education, Culture, Sports, Science and Technology, Japan	This research was supported by Kyowa Hakko Kirin Co., Ltd. (Tokyo, Japan; to N.T. Ueno) and in part by the U.S. NIH/National Cancer Institute under award number P30CA016672 (to R.A. DePinho) and by the Nellie B. Connally Breast Cancer Research Fund (to D. Tripathy). K. Kai was supported by the program "Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation" by the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Litzenburger BC, 2011, CLIN CANCER RES, V17, P2314, DOI 10.1158/1078-0432.CCR-10-1903; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Kai K, 2009, CANCER SCI, V100, P2275, DOI 10.1111/j.1349-7006.2009.01318.x; Kitzen JJEM, 2010, CRIT REV ONCOL HEMAT, V73, P99, DOI 10.1016/j.critrevonc.2009.03.009; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Li ML, 2010, BIOCHEM PHARMACOL, V79, P122, DOI 10.1016/j.bcp.2009.08.011; Pal SK, 2011, BREAST CANCER RES TR, V125, P627, DOI 10.1007/s10549-010-1293-1; Stadheim TA, 2001, CANCER RES, V61, P1533; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Gizatullin F, 2006, CANCER RES, V66, P7668, DOI 10.1158/0008-5472.CAN-05-3353; Lee J, 2014, BREAST CANCER RES TR, V146, P259, DOI 10.1007/s10549-014-3014-7; Zhang DW, 2009, CLIN CANCER RES, V15, P6639, DOI 10.1158/1078-0432.CCR-09-0951; Creighton CJ, 2008, J CLIN ONCOL, V26, P4078, DOI 10.1200/JCO.2007.13.4429; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Adjei AA, 2008, J CLIN ONCOL, V26, P2139, DOI 10.1200/JCO.2007.14.4956; Soncini C, 2006, CLIN CANCER RES, V12, P4080, DOI 10.1158/1078-0432.CCR-05-1964; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Diamond JR, 2013, CLIN CANCER RES, V19, P291, DOI 10.1158/1078-0432.CCR-12-1611; Gorgun G, 2010, BLOOD, V115, P5202, DOI 10.1182/blood-2009-12-259523; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Katayama H, 2010, BBA-GENE REGUL MECH, V1799, P829, DOI 10.1016/j.bbagrm.2010.09.004; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Kai K, 2010, BREAST CANCER-TOKYO, V17, P80, DOI 10.1007/s12282-009-0176-y; Mates JM, 2012, ARCH TOXICOL, V86, P1649, DOI 10.1007/s00204-012-0906-3; Fan MY, 2001, DRUG RESIST UPDATE, V4, P253, DOI 10.1054/drup.2001.0214; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Sudo T, 2004, CANCER RES, V64, P2502, DOI 10.1158/0008-5472.CAN-03-2013; Zhang DW, 2004, ONCOGENE, V23, P8720, DOI 10.1038/sj.onc.1208153; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; Crosio C, 2002, MOL CELL BIOL, V22, P874; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Nitta M, 2004, ONCOGENE, V23, P6548, DOI 10.1038/sj.onc.1207873; Tentler JJ, 2015, MOL CANCER THER, V14, P1117, DOI 10.1158/1535-7163.MCT-14-0538-T; Dickson M, 2011, 2011 ASCO ANN M JUN; Kai K, 2014, ONCOGENE, V33, P440, DOI 10.1038/onc.2012.609; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Osuka S., 2012, STEM CELLS DAYTON OH, V31, P627; Umehara H, AACR 104 ANN M 2013	41	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	DEC	2015	14	12					2687	2699		10.1158/1535-7163.MCT-15-0096		13	Oncology	Oncology	CX9VZ	WOS:000366055100002		
J	Nakanishi, Y; Mizuno, H; Sase, H; Fujii, T; Sakata, K; Akiyama, N; Aoki, Y; Aoki, M; Ishii, N				Nakanishi, Yoshito; Mizuno, Hideaki; Sase, Hitoshi; Fujii, Toshihiko; Sakata, Kiyoaki; Akiyama, Nukinori; Aoki, Yuko; Aoki, Masahiro; Ishii, Nobuya			ERK Signal Suppression and Sensitivity to CH5183284/Debio 1347, a Selective FGFR Inhibitor	MOLECULAR CANCER THERAPEUTICS			English	Article							CELL LUNG-CANCER; POTENT ANTITUMOR-ACTIVITY; GROWTH-FACTOR RECEPTOR; BREAST-CANCER; END-POINTS; CLINICAL-TRIALS; GENE-EXPRESSION; B-RAF; RESISTANCE; MUTATIONS	Drugs that target specific gene alterations have proven beneficial in the treatment of cancer. Because cancer cells have multiple resistance mechanisms, it is important to understand the downstream pathways of the target genes and monitor the pharmacodynamic markers associated with therapeutic efficacy. We performed a transcriptome analysis to characterize the response of various cancer cell lines to a selective fibroblast growth factor receptor (FGFR) inhibitor (CH5183284/Debio 1347), a mitogen-activated protein kinase kinase (MEK) inhibitor, or a phosphoinositide 3-kinase (PI3K) inhibitor. FGFR and MEK inhibition produced similar expression patterns, and the extracellular signal-regulated kinase (ERK) gene signature was altered in several FGFR inhibitor-sensitive cell lines. Consistent with these findings, CH5183284/Debio 1347 suppressed phospho-ERK in every tested FGFR inhibitor-sensitive cell line. Because the mitogen-activated protein kinase (MAPK) pathway functions downstream of FGFR, we searched for a pharmacodynamic marker of FGFR inhibitor efficacy in a collection of cell lines with the ERK signature and identified dual-specificity phosphatase 6 (DUSP6) as a candidate marker. Although a MEK inhibitor suppressed the MAPK pathway, most FGFR inhibitor-sensitive cell lines are insensitive to MEK inhibitors and we found potent feedback activation of several pathways via FGFR. We therefore suggest that FGFR inhibitors exert their effect by suppressing ERK signaling without feedback activation. In addition, DUSP6 may be a pharmacodynamic marker of FGFR inhibitor efficacy in FGFR-addicted cancers. (C)2015 AACR.	[Nakanishi, Yoshito; Mizuno, Hideaki; Sase, Hitoshi; Fujii, Toshihiko; Sakata, Kiyoaki; Akiyama, Nukinori; Aoki, Yuko; Aoki, Masahiro; Ishii, Nobuya] Chugai Pharmaceut Co Ltd, Div Res, Kamakura, Kanagawa 2478530, Japan	Nakanishi, Y (reprint author), Chugai Pharmaceut Co Ltd, Div Res, 200 Kajiwara, Kamakura, Kanagawa 2478530, Japan.	nakanishiyst@chugai-pharm.co.jp			Chugai Pharmaceutical Co., Ltd.	This study was funded by the Chugai Pharmaceutical Co., Ltd.	Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Kashima K, 2012, CANCER SCI, V103, P2144, DOI 10.1111/cas.12010; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Dienstmann R, 2014, ANN ONCOL, V25, P552, DOI 10.1093/annonc/mdt419; Byron SA, 2013, NEOPLASIA, V15, P975, DOI 10.1593/neo.121106; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Kodama T, 2014, CANCER LETT, V351, P215, DOI 10.1016/j.canlet.2014.05.020; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; Isshiki Y, 2011, BIOORG MED CHEM LETT, V21, P1795, DOI 10.1016/j.bmcl.2011.01.062; Croonquist PA, 2003, BLOOD, V102, P2581, DOI 10.1182/blood-2003-04-1227; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Andre F, 2013, CLIN CANCER RES, V19, P3693, DOI 10.1158/1078-0432.CCR-13-0190; Ramnarain DB, 2006, CANCER RES, V66, P867, DOI 10.1158/0008-5472.CAN-05-2753; Tanaka H, 2011, CLIN CANCER RES, V17, P3272, DOI 10.1158/1078-0432.CCR-10-2882; Bloethner S, 2005, CARCINOGENESIS, V26, P1224, DOI 10.1093/carcin/bgi066; Byron SA, 2008, CANCER RES, V68, P6902, DOI 10.1158/0008-5472.CAN-08-0770; Ishii N, 2013, CANCER RES, V73, P4050, DOI 10.1158/0008-5472.CAN-12-3937; Yamnik RL, 2009, J BIOL CHEM, V284, P6361, DOI 10.1074/jbc.M807532200; Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Bonnas C, 2012, INT J CANCER, V131, P1621, DOI 10.1002/ijc.27422; Felip E, 2008, CLIN CANCER RES, V14, P3867, DOI 10.1158/1078-0432.CCR-07-5186; Punnoose EA, 2012, CLIN CANCER RES, V18, P2391, DOI 10.1158/1078-0432.CCR-11-3148; Sakamoto H, 2011, CANCER CELL, V19, P679, DOI 10.1016/j.ccr.2011.04.004; Furukawa T, 2005, MODERN PATHOL, V18, P1034, DOI 10.1038/modpathol.3800383; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Nakanishi Y, 2015, MOL CANCER THER, V14, P704, DOI 10.1158/1535-7163.MCT-14-0927-T; Dumesic PA, 2009, J CELL BIOL, V185, P409, DOI 10.1083/jcb.200804038; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Warmka JK, 2004, J BIOL CHEM, V279, P33085, DOI 10.1074/jbc.M403120200; Dickinson RJ, 2002, MECH DEVELOP, V113, P193, DOI 10.1016/S0925-4773(02)00024-2; Li CY, 2007, DEVELOPMENT, V134, P167, DOI 10.1242/dev.02701; Ang JE, 2012, CURR DRUG TARGETS, V13, P1525; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Elkabets M, 2013, SCI TRANSL MED, V5; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Herbert Corentin, 2014, Pharm Pat Anal, V3, P585, DOI 10.4155/ppa.14.45; Juric D, 2014, NATURE, V518, P240; Kodama T, 2014, MOL CANCER THER, V13, P2910, DOI 10.1158/1535-7163.MCT-14-0274; Kompier LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013821; Mizuno H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-137; Neal JW, 2015, NAT REV CLIN ONCOL, V12, P135, DOI 10.1038/nrclinonc.2014.222; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pinhel IF, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2719; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Nakanishi Y, 2014, MOL CANCER THER, V13, P2547, DOI 10.1158/1535-7163.MCT-14-0248	46	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	DEC	2015	14	12					2831	2839		10.1158/1535-7163.MCT-15-0497		9	Oncology	Oncology	CX9VZ	WOS:000366055100016		
J	Yasuzaki, Y; Yamada, Y; Ishikawa, T; Harashima, H				Yasuzaki, Yukari; Yamada, Yuma; Ishikawa, Takuya; Harashima, Hideyoshi			Validation of Mitochondrial Gene Delivery in Liver and Skeletal Muscle via Hydrodynamic Injection Using an Artificial Mitochondrial Reporter DNA Vector	MOLECULAR PHARMACEUTICS			English	Article						mitochondria; transgene expression; gene delivery; hydrodynamic injection; gene therapy	PLASMID DNA; SECONDARY STRUCTURE; VEIN INJECTIONS; INNER MEMBRANE; DISEASE; TRANSCRIPTION; EXPRESSION; PROMOTERS; PROTEINS; MUTATION	For successful mitochondrial transgene expression, two independent processes, i.e., developing a mitochondrial gene delivery system and construction of DNA vector to achieve mitochondrial gene expression, are required. To date, very few studies dealing with mitochondrial gene delivery have been reported and, in most cases, transgene expression was not validated, because the construction of a reporter DNA vector for mitochondrial gene expression is the bottleneck. In this study, mitochondrial transgene expression by the in vivo mitochondrial gene delivery of an artificial mitochondrial reporter DNA vector via hydrodynamic injection is demonstrated. In the procedure, a large volume of naked plasmid DNA (pDNA) is rapidly injected. We designed and constructed pHSP-mtLuc (CGG) as a mitochondrial reporter DNA vector that possesses a mitochondrial heavy strand promoter (HSP) and an artificial mitochondrial genome with the reporter NanoLuc (Nluc) luciferase gene that records adjustments to the mitochondrial codon system. We delivered the pDNA into mouse liver mitochondria by hydrodynamic injection, and detected exogenous mRNA in the liver using reverse transcription PCR analysis. The hydrodynamic injection of pHSP-mtLuc (CGG) resulted in the expression of the Nluc luciferase protein in liver and skeletal muscle. Our mitochondrial transgene expression reporter system would contribute to mitochondrial gene therapy and further studies directed at mitochondrial molecular biology.	[Yasuzaki, Yukari; Yamada, Yuma; Ishikawa, Takuya; Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Mol Design Pharmaceut, Sapporo, Hokkaido 060, Japan	Harashima, H (reprint author), Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.	harasima@pharm.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, the Japanese Government (MEXT) [23680053, 25560219, 26282131]	This work was supported, in part by, a Grant-in-Aid for Young Scientists (A) [Grant 23680053 to Y. Yamada], a Grant-in-Aid for Challenging Exploratory Research [Grant 25560219 to Y. Yamada], and a Grant-in-Aid for Scientific Research (B) [Grant 26282131 to Y. Yamada] from the Ministry of Education, Culture, Sports, Science and Technology, the Japanese Government (MEXT). We are grateful to Eriko Kawamura, Jiro Abe, Mai Tabata, and Yutaka Fukuda for their dedicated cooperation on purification of pDNA used in this experiment. We also thank Dr. Milton Feather for his helpful advice in writing the manuscript.	Yokoo T, 2013, GENE THER, V20, P816, DOI 10.1038/gt.2013.2; Hagstrom JE, 2004, MOL THER, V10, P386, DOI 10.1016/j.ymthe.2004.05.004; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Kamimura K, 2009, MOL THER, V17, P491, DOI 10.1038/mt.2008.294; Gagliardi D, 2004, TRENDS GENET, V20, P260, DOI 10.1016/j.tig.2004.04.006; D'Souza GGM, 2003, J CONTROL RELEASE, V92, P189, DOI 10.1016/S0168-3659(03)00297-9; Suda T, 2007, MOL THER, V15, P2063, DOI 10.1038/sj.mt.6300314; Cardoso AM, 2015, MOL PHARMACEUT, V12, P716, DOI 10.1021/mp5005349; Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Yasuzaki Y, 2013, J CONTROL RELEASE, V172, P805, DOI 10.1016/j.jconrel.2013.09.029; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Wooddell CI, 2011, HUM GENE THER, V22, P889, DOI 10.1089/hum.2010.160; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; CHANG DD, 1984, CELL, V36, P635, DOI 10.1016/0092-8674(84)90343-X; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Ott M, 2006, EMBO J, V25, P1603, DOI 10.1038/sj.emboj.7601070; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Bonamassa B, 2011, PHARM RES-DORDR, V28, P694, DOI 10.1007/s11095-010-0338-9; Jackson CB, 2014, MITOCHONDRION, V17, P67, DOI 10.1016/j.mito.2014.05.011; SHANSKE S, 1990, NEUROLOGY, V40, P24; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Herweijer H, 2007, GENE THER, V14, P99, DOI 10.1038/sj.gt.3302891; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Lyrawati D, 2011, PHARM RES-DORDR, V28, P2848, DOI 10.1007/s11095-011-0544-0; Kobayashi N, 2005, ADV DRUG DELIVER REV, V57, P713, DOI 10.1016/j.addr.2004.12.006; Jones CN, 2008, RNA, V14, P862, DOI 10.1261/rna.909208; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; Hegge JO, 2010, HUM GENE THER, V21, P829, DOI 10.1089/hum.2009.172; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Toumi H, 2006, MOL THER, V13, P229, DOI 10.1016/j.ymthe.2005.07.699; Vigen KK, 2007, HUM GENE THER, V18, P257, DOI 10.1089/hum.2006.115; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138; HOLT IJ, 1990, AM J HUM GENET, V46, P428; Yamada Y, 2012, METHOD ENZYMOL, V509, P301, DOI 10.1016/B978-0-12-391858-1.00015-0; Naithani S, 2003, MOL BIOL CELL, V14, P324, DOI 10.1091/mbc.E02-08-0490; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; Weissig V, 2011, PHARM RES-DORDR, V28, P2657, DOI 10.1007/s11095-011-0556-9; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Yu H, 2012, P NATL ACAD SCI USA, V109, pE1238, DOI 10.1073/pnas.1119577109; FISHER RP, 1985, J BIOL CHEM, V260, P1330; Yasuzaki Yukari, 2014, Pharmaceuticals (Basel), V7, P881, DOI 10.3390/ph7080881	44	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1543-8384			MOL PHARMACEUT	Mol. Pharm.	DEC	2015	12	12					4311	4320		10.1021/acs.molpharmaceut.5b00511		10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CY1FG	WOS:000366151500013		
J	Pan, YJ; Scanlon, MJ; Owada, Y; Yamamoto, Y; Porter, CJH; Nicolazzo, JA				Pan, Yijun; Scanlon, Martin J.; Owada, Yuji; Yamamoto, Yui; Porter, Christopher J. H.; Nicolazzo, Joseph A.			Fatty Acid-Binding Protein 5 Facilitates the Blood-Brain Barrier Transport of Docosahexaenoic Acid	MOLECULAR PHARMACEUTICS			English	Article						blood-brain barrier; docosahexaenoic acid; fatty acid-binding protein; hCMEC/D3 cells; intracellular trafficking	PHOSPHOLIPID-MEMBRANES; ALZHEIMERS-DISEASE; LYSINE RESIDUES; PERFUSION MODEL; HELICAL DOMAIN; EXPRESSION; DIFFUSION; GLUCOSE; CELLS	The brain has a limited ability to synthesize the essential polyunsaturated fatty acid (PUFA) docosahexaenoic acid (DHA) from its omega-3 fatty acid precursors. Therefore, to maintain brain concentrations of this PUPA at physiological levels, plasma-derived DHA must be transported across the blood brain barrier (BBB). While DHA is able to partition into the luminal membrane of brain endothelial cells, its low aqueous solubility likely limits its cytosolic transfer to the abluminal membrane, necessitating the requirement of an intracellular carrier protein to facilitate trafficking of this PUFA across the BBB. As the intracellular carrier protein fatty acid-binding protein 5 (FABPS) is expressed at the human BBB, the current study assessed the putative role of FABPS in the brain endothelial cell uptake and BBB transport of DHA in vitro and in vivo, respectively. hFAPB5 was recombinantly expressed and purified from Escherichia coli C41(DE3) cells and the binding affinity of DHA to hFABPS assessed using isothermal titration calorimetry. The impact of FABPS siRNA on uptake of C-14-DHA into immortalized human brain microvascular endothelial (hCMEC/D3) cells was assessed. An in situ transcardiac perfusion method was optimized in C57BL/6 mice and subsequently used to compare the BBB influx rate MO of C-14-DHA between FABPS-deficient (FABP5(-/-)) and wild-type (FABP5(+/+)) C57BL/6 mice. DHA bound to hFABPS with an equilibrium dissociation constant of 155 +/- 8 nM (mean +/- SEM). FABPS siRNA transfection decreased hCMEC/D3 mRNA and protein expression of FABPS by 53.2 +/- 5.5% and 44.8 +/- 13.7%, respectively, which was associated with a 14.1 +/- 2.7% reduction in C-14-DHA cellular uptake. By using optimized conditions for the in situ transcardiac perfusion (a 1 min preperfusion (10 mL/min) followed by perfusion of C-14-DHA (1 min)), the Kin of C-14-DHA was 0.04 +/- 0.01 mL/g/s. Relative to FABP5(+/+) mice, the K-in of C-14-DHA decreased 36.7 +/- 12.4% in FABP5(-/-)mice. This study demonstrates that FABPS binds to DHA and is involved in the brain endothelial cell uptake and subsequent BBB transport of DHA, confirming the importance of this cytoplasmic carrier protein in the CNS exposure of this PUFA essential for neuronal function.	[Pan, Yijun; Porter, Christopher J. H.; Nicolazzo, Joseph A.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Delivery Disposit & Dynam, Parkville, Vic 3052, Australia; [Scanlon, Martin J.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic 3052, Australia; [Owada, Yuji; Yamamoto, Yui] Yamaguchi Univ, Grad Sch Med, Dept Organ Anat, Ube, Yamaguchi 7558505, Japan; [Owada, Yuji] Tohoku Univ, Grad Sch Med, Dept Organ Anat, Aoba Ku, Sendai, Miyagi 9808575, Japan	Nicolazzo, JA (reprint author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Delivery Disposit & Dynam, 399 Royal Parade, Parkville, Vic 3052, Australia.	joseph.nicolazzo@monash.edu			William Buckland Foundation; Judith Jane Mason and Harold Stannett Williams Memorial Foundation	The Judith Jane Mason and Harold Stannett Williams Memorial Foundation and The William Buckland Foundation are acknowledged for their financial support of this project.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Rapoport SI, 2001, J LIPID RES, V42, P678; SODERBERG M, 1991, LIPIDS, V26, P421, DOI 10.1007/BF02536067; Rapoport SI, 2007, PROSTAG LEUKOTR ESS, V77, P251, DOI 10.1016/j.plefa.2007.10.023; Franchini GR, 2008, BBA-MOL CELL BIOL L, V1781, P192, DOI 10.1016/j.bbalip.2008.01.005; Dagenais C, 2000, J CEREBR BLOOD F MET, V20, P381; Liu JW, 2008, J NEUROCHEM, V106, P2015, DOI 10.1111/j.1471-4159.2008.05507.x; Afzal I, 2002, BIOCHEM J, V365, P707, DOI 10.1042/BJ20011624; Weisiger RA, 2007, J MOL NEUROSCI, V33, P42, DOI 10.1007/s12031-007-0047-y; LETCHER RL, 1981, AM J MED, V70, P1195, DOI 10.1016/0002-9343(81)90827-5; Fischer H, 1998, J MEMBRANE BIOL, V165, P201, DOI 10.1007/s002329900434; Mitchell RW, 2011, J NEUROCHEM, V117, P735, DOI 10.1111/j.1471-4159.2011.07245.x; Prasad MR, 1998, NEUROCHEM RES, V23, P81, DOI 10.1023/A:1022457605436; WHITE L, 1968, COMP BIOCHEM PHYSIOL, V27, P559, DOI 10.1016/0010-406X(68)90252-1; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Ouellet M, 2009, NEUROCHEM INT, V55, P476, DOI 10.1016/j.neuint.2009.04.018; TAKASATO Y, 1984, AM J PHYSIOL, V247, pH484; Corsico B, 1998, P NATL ACAD SCI USA, V95, P12174, DOI 10.1073/pnas.95.21.12174; Balendiran GK, 2000, J BIOL CHEM, V275, P27045; Mehta DC, 2013, PHARM RES-DORDR, V30, P2868, DOI 10.1007/s11095-013-1116-2; Cattelotte J, 2008, J CEREBR BLOOD F MET, V28, P1449, DOI 10.1038/jcbfm.2008.34; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Liou HL, 2001, BIOCHEMISTRY-US, V40, P6475, DOI 10.1021/bi0101042; Banks WA, 2004, BRAIN BEHAV IMMUN, V18, P434, DOI 10.1016/j.bbi.2003.09.013; Larque E, 2006, AM J CLIN NUTR, V84, P853; BUTT AM, 1990, J PHYSIOL-LONDON, V429, P47; Froger A., 2007, JOVE-J VIS EXP, V6, P253; Herr FM, 1996, BIOCHEMISTRY-US, V35, P1296, DOI 10.1021/bi952204b; Lee GS, 2015, PHARM RES-DORDR, V32, P3432, DOI 10.1007/s11095-015-1764-5; Pan Yijun, 2015, Curr Clin Pharmacol, V10, P222; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; VORUM H, 1992, BIOCHIM BIOPHYS ACTA, V1126, P135, DOI 10.1016/0005-2760(92)90283-2; Weksler Babette, 2013, Fluids Barriers CNS, V10, P16, DOI 10.1186/2045-8118-10-16; Yurko-Mauro K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120391	35	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1543-8384			MOL PHARMACEUT	Mol. Pharm.	DEC	2015	12	12					4375	4385		10.1021/acs.molpharmaceut.5b00580		11	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CY1FG	WOS:000366151500019		
J	Sugihara, M; Takeuchi, S; Sugita, M; Higaki, K; Kataoka, M; Yamashita, S				Sugihara, Masahisa; Takeuchi, Susumu; Sugita, Masaru; Higaki, Kazutaka; Kataoka, Makoto; Yamashita, Shinji			Analysis of Intra- and lntersubject Variability in Oral Drug Absorption in Human Bioequivalence Studies of 113 Generic Products	MOLECULAR PHARMACEUTICS			English	Article						bioequivalence; intrasubject variability; BCS; solubility-limited absorption; CYP3A4	HUMAN LIVER; CYTOCHROME-P450 ISOFORMS; KINETIC-PARAMETERS; DOSAGE FORMS; METABOLISM; INHIBITION; MICROSOMES; MODEL	In this study, the data of 113 human bioequivalence (BE). studies of immediate release (IR) formulations of 74 active pharmaceutical ingredients (APIs) conducted at Sawai Pharmaceutical Co., Ltd., was analyzed to understand the factors affecting intra- and intersubject variabilities in oral drug absorption. The ANOVA CV (%) calculated from area under the time concentration curve (AUC) in each BE study was used as an index of intrasubject variability (Vintra), and the relative standard deviation (%) in AUC was used as that of intersubject variability (Vinter). Although no significant correlation was observed between 20 Vintra and Vinter of all drugs, Vintra of class 3 drugs was found to increase in association with a decrease in drug permeability (P-eff). Since the absorption of class 3 drugs was rate-limited by the permeability, it was suggested that, for such drugs, the low P-eff might be a risk factor to cause a large intrasubject variability. To consider the impact of poor water solubility on the variability in BE study, a parameter of P-eef/DO (Do; dose number) was defined to discriminate the solubility-limited and dissolution-rate-limited absorption of class 2 drugs. It was found that the class 2 drugs with a solubility-limited absorption (P-eff/Do < 0.149 X 10(-4) cm/s) showed high intrasubject variability. Furthermore, as a reason for high intra- or intersubject variability in AUC for class 1 drugs, effects of drug metabolizing enzymes were investigated. It was demonstrated that intrasubject variability was high for drugs metabolized by CYP3A4 while intersubject variability was high for drugs metabolized by CYP2D6. For CYP3A4 substrate drugs, the Km value showed the significant relation with Vintra, indicating that the affinity to the enzyme can be a parameter to predict the risk of high intrasubject variability. In conclusion, by analyzing the in house data of human BE study, low permeability, solubility-limited absorption, and high affinity to CYP3A4 are identified as risk factors for high intrasubject variability in oral drug absorption. This information is of importance to design the human BE study for oral drug products containing APIs with a risk of large intrasubject variability in oral absorption.	[Sugihara, Masahisa; Takeuchi, Susumu; Sugita, Masaru] Sawai Pharmaceut Co Ltd, Yodogawa Ku, Osaka, Osaka 5320003, Japan; [Higaki, Kazutaka] Okayama Univ, Fac Pharmaceut Sci, Kita Ku, Okayama 7008530, Japan; [Kataoka, Makoto; Yamashita, Shinji] Setsunan Univ, Fac Pharmaceut Sci, Hirakata, Osaka 5730101, Japan	Sugihara, M (reprint author), Sawai Pharmaceut Co Ltd, Yodogawa Ku, 5-2-30 Miyahara, Osaka, Osaka 5320003, Japan.	m.sugihara@sawai.co.jp					Senda C, 1997, XENOBIOTICA, V27, P913; Schiller C, 2005, ALIMENT PHARM THERAP, V22, P971, DOI 10.1111/j.1365-2036.2005.02683.x; Johnson KC, 1996, PHARMACEUT RES, V13, P1795, DOI 10.1023/A:1016068705255; Kimura Y, 2010, FOOD CHEM TOXICOL, V48, P429, DOI 10.1016/j.fct.2009.10.041; Davit B, 2013, AAPS J, V15, P974, DOI 10.1208/s12248-013-9499-x; [Anonymous], 2014, GUID IND BIOAV BIOEQ; Sjogren E, 2014, EUR J PHARM SCI, V57, P99, DOI 10.1016/j.ejps.2014.02.010; Bu HZ, 2006, CURR DRUG METAB, V7, P231, DOI 10.2174/138920006776359329; Chen ML, 2007, PHARM RES, V24, P73, DOI 10.1007/s11095-006-9120-4; Sugano K, 2010, INT J PHARMACEUT, V398, P73, DOI 10.1016/j.ijpharm.2010.07.027; Sakuma S, 2011, MOL PHARMACEUT, V8, P1113, DOI 10.1021/mp100421j; Curatolo W, 1998, PHARM SCI TECHNOL TO, V1, P387, DOI 10.1016/S1461-5347(98)00097-2; Ho PC, 2001, J PHARM PHARM SCI, V4, P217; Yamashita S, 2009, MOL PHARMACEUT, V6, P48, DOI 10.1021/mp800140m; Davit BM, 2008, AAPS J, V10, P148, DOI 10.1208/s12248-008-9015-x; Misaka S, 2013, DRUG METAB PHARMACOK, V28, P244, DOI 10.2133/dmpk.DMPK-12-RG-101; Yoon YJ, 2007, DRUG METAB DISPOS, V35, P1518, DOI 10.1124/dmd.106.013607; Niwa T, 2005, BIOL PHARM BULL, V28, P1711, DOI 10.1248/bpb.28.1711; Yu LX, 1999, PHARMACEUT RES, V16, P1883, DOI 10.1023/A:1018911728161; Harris RZ, 2003, CLIN PHARMACOKINET, V42, P1071, DOI 10.2165/00003088-200342130-00001; Paine MF, 2006, DRUG METAB DISPOS, V34, P880, DOI 10.1124/dmd.105.008672; [Anonymous], 2012, NAT I HLTH SCI GUID; Dressman JB, 1998, PHARMACEUT RES, V15, P11, DOI 10.1023/A:1011984216775; HIRTZ J, 1985, BRIT J CLIN PHARMACO, V19, pS77; Tanaka Y, 2015, J PHARM SCI-US, V104, P3120, DOI 10.1002/jps.24433; Niwa T, 2008, CURR DRUG METAB, V9, P20	26	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1543-8384			MOL PHARMACEUT	Mol. Pharm.	DEC	2015	12	12					4405	4413		10.1021/acs.molpharmaceut.5b00602		9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CY1FG	WOS:000366151500022		
J	Ishibashi, T				Ishibashi, Toshiyuki			Tensor Formulation of Ensemble-Based Background Error Covariance Matrix Factorization	MONTHLY WEATHER REVIEW			English	Article						Models and modeling; Data assimilation; Numerical weather prediction; forecasting	VARIATIONAL DATA ASSIMILATION; KALMAN FILTER; PART II; OPERATIONAL IMPLEMENTATION; SYSTEM; SCHEME; STRATEGY; 4D-VAR; NWP	Factorization of a background error covariance matrix (B factorization) constructed from localization matrices and a small ensemble that obeys background error statistics is an efficient method for introducing flow-dependent background error statistics into variational form data assimilation systems. Although there are four types of matrix formulations of B factorization, their derivation processes and relationships are not clarified, and mathematical operability is limited because of their complex matrix forms. In this paper, B factorization in the tensor (component) form is formulated to overcome these shortcomings. The tensor formulation is very simple and directly connects the background error covariance matrix with its factorization. All existing matrix formulations are derived from the tensor formulation as their specific matrix form representations. Using the simplicity of the tensor formulation, the relationships between the strong-constraint four-dimensional variational data assimilation (4DVAR), 4DVAR with the four-dimensional background error covariance, and the weak-constraint 4DVAR are clarified.	[Ishibashi, Toshiyuki] Japan Meteorol Agcy, Meteorol Res Inst, Tsukuba, Ibaraki, Japan	Ishibashi, T (reprint author), Meteorol Res Inst, 1-1 Nagamine, Tsukuba, Ibaraki 3050052, Japan.	ishibasi@mri-jma.go.jp					Houtekamer PL, 2005, Q J ROY METEOR SOC, V131, P3269, DOI 10.1256/qj.05.135; Buehner M, 2005, Q J ROY METEOR SOC, V131, P1013, DOI 10.1256/qj.04.15; Desroziers G, 2014, Q J ROY METEOR SOC, V140, P2097, DOI 10.1002/qj.2325; Wang XG, 2014, MON WEATHER REV, V142, P3303, DOI 10.1175/MWR-D-13-00303.1; Buehner M, 2010, MON WEATHER REV, V138, P1567, DOI 10.1175/2009MWR3158.1; COURTIER P, 1994, Q J ROY METEOR SOC, V120, P1367, DOI 10.1002/qj.49712051912; Liu CS, 2013, MON WEATHER REV, V141, P2721, DOI 10.1175/MWR-D-12-00130.1; Bishop CH, 2009, TELLUS A, V61, P84, DOI 10.1111/j.1600-0870.2008.00371.x; Houtekamer PL, 2001, MON WEATHER REV, V129, P123, DOI 10.1175/1520-0493(2001)129<0123:ASEKFF>2.0.CO;2; Menetrier B, 2015, MON WEATHER REV, V143, P3925, DOI 10.1175/MWR-D-14-00404.1; Clayton AM, 2013, Q J ROY METEOR SOC, V139, P1445, DOI 10.1002/qj.2054; DERBER J, 1989, J PHYS OCEANOGR, V19, P1333, DOI 10.1175/1520-0485(1989)019<1333:AGODAS>2.0.CO;2; Liu CS, 2009, MON WEATHER REV, V137, P1687, DOI 10.1175/2008MWR2699.1; Bishop CH, 2011, MON WEATHER REV, V139, P1241, DOI 10.1175/2010MWR3403.1; Buehner M, 2013, NONLINEAR PROC GEOPH, V20, P669, DOI 10.5194/npg-20-669-2013; Wang XG, 2008, MON WEATHER REV, V136, P5116, DOI 10.1175/2008MWR2444.1; Aonashi K, 2011, J METEOROL SOC JPN, V89, P175, DOI 10.2151/jmsj.2011-301; Wang XG, 2007, MON WEATHER REV, V135, P222, DOI 10.1175/MWR3282.1; Kuhl DD, 2013, MON WEATHER REV, V141, P2740, DOI 10.1175/MWR-D-12-00182.1; El Akkraoui A, 2013, Q J ROY METEOR SOC, V139, P731, DOI 10.1002/qj.1997; Wang XG, 2013, MON WEATHER REV, V141, P4098, DOI 10.1175/MWR-D-12-00141.1; Bishop CH, 2007, Q J ROY METEOR SOC, V133, P2029, DOI 10.1002/qj.169; Gurol S, 2014, Q J ROY METEOR SOC, V140, P539, DOI 10.1002/qj.2150; Gaspari G, 1999, Q J ROY METEOR SOC, V125, P723, DOI 10.1256/smsqj.55416; Wang XG, 2008, MON WEATHER REV, V136, P5132, DOI 10.1175/2008MWR2445.1; Wang XG, 2010, MON WEATHER REV, V138, P2990, DOI 10.1175/2010MWR3245.1; Buehner M, 2010, MON WEATHER REV, V138, P1550, DOI 10.1175/2009MWR3157.1; Weaver A, 2001, Q J ROY METEOR SOC, V127, P1815, DOI 10.1256/smsqj.57517; Hamill TM, 2000, MON WEATHER REV, V128, P2905, DOI 10.1175/1520-0493(2000)128<2905:AHEKFV>2.0.CO;2; Bishop CH, 2011, MON WEATHER REV, V139, P573, DOI 10.1175/2010MWR3405.1; Purser RJ, 2003, MON WEATHER REV, V131, P1536, DOI 10.1175//2543.1; Lorenc AC, 2003, Q J ROY METEOR SOC, V129, P3183, DOI 10.1256/qj.02.132; Bishop CH, 2009, TELLUS A, V61, P97, DOI 10.1111/j.1600-0870.2008.00372.x; Arfken G. B., 2001, MATH METHOD PHYS; Dutton J. A., 2002, CAESELESS WIND INTRO; Fisher M., 2003, SEM REC DEV DAT ASS, P45; Kalnay E., 2003, ATMOSPHERIC MODELING; Lewis J., 2006, DYNAMIC DATA ASSIMIL; Liu C., 2013, P 6 WMO S DAT ASS CO, V1, P3; SASAKI Y, 1970, MON WEATHER REV, V98, P875, DOI 10.1175/1520-0493(1970)098<0875:SBFINV>2.3.CO;2	40	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0027-0644	1520-0493		MON WEATHER REV	Mon. Weather Rev.	DEC	2015	143	12					4963	4973		10.1175/MWR-D-15-0014.1		11	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CY4RY	WOS:000366397100003		
J	Kawase, S				Kawase, Satoshi			Relationships between performers' daily social skills, social behaviors in ensemble practice, and evaluations of ensemble performance	MUSICAE SCIENTIAE			English	Article						ensemble performance; interpersonal conflict; leadership; musical communication; social behaviors during ensemble practice; social skills	MUSICAL ENSEMBLES; COORDINATION; LEADERSHIP; SYNCHRONIZATION; METAANALYSIS; PERSONALITY; COMPETENCE; ORCHESTRA; VARIABLES; CONFLICT	Prior studies have demonstrated that appropriate social behaviors during ensemble practice enhance performance quality. Thus, do social behaviors during ensemble practice reflect performers' daily (i.e., non-musical) social skills? The purpose of the present study was to investigate correlations among daily social skills, social behaviors during ensemble practice, and the evaluation of ensemble music performance. A total of 68 female music majors responded to performance questionnaires created for this study and to five scales measuring daily social skills: two scales for social skills, one for the style of handling interpersonal conflict, one for nonverbal behavior, and one for leadership. To assess the causal model of the relationship among social skills, social behaviors during ensemble practice, and the evaluation of ensemble performance, this work employed structural equation modeling. With respect to the scores for social skills, styles of handling interpersonal conflicts, and leadership, the scores and social behaviors during ensemble practice revealed significant positive correlations. An analysis of the causal model suggested that a performer's daily social skills, an integrating style of handling interpersonal conflict (namely, the win-win style), and leadership in daily communication affect the evaluation of ensemble performance via social behaviors during ensemble practice. Overall, the main findings are as follows: (1) daily social skills are correlated with behaviors during ensemble practice; (2) performers with a high evaluation of their ensemble performance might employ two types of social behaviors during performance; (3) the causal sequence in which daily social skills influence the evaluation of ensemble performance via social behaviors during ensemble practice is likely to be valid; and (4) no correlation was observed between nonverbal skills in daily communication and the evaluation of ensemble performance.	[Kawase, Satoshi] Soai Univ, Osaka, Osaka 5590033, Japan	Kawase, S (reprint author), Soai Univ, Dept Mus, 4-4-1 Nankonaka Suminoe Ku, Osaka, Osaka 5590033, Japan.	satoshikawase.psy@gmail.com			JSPS KAKENHI [26870735]	This work was supported by JSPS KAKENHI Grant Number 26870735.	Biasutti M, 2013, MUSIC SCI, V17, P57, DOI 10.1177/1029864912467634; Kawase S, 2014, ECOL PSYCHOL, V26, P198, DOI 10.1080/10407413.2014.929477; Pitts SE, 2005, MUSIC LETT, V86, P257, DOI 10.1093/ml/gci035; Janssen O, 1996, INT J CONFL MANAGE, V7, P99, DOI 10.1108/eb022777; BUHRMESTER D, 1988, J PERS SOC PSYCHOL, V55, P991, DOI 10.1037/0022-3514.55.6.991; Keller PE, 2010, MUSIC PERCEPT, V28, P27, DOI 10.1525/MP.2010.28.1.27; ITO T, 1994, JPN PSYCHOL RES, V36, P74; EAGLY AH, 1990, PSYCHOL BULL, V108, P233, DOI 10.1037//0033-2909.108.2.233; Miksza P, 2007, J RES MUSIC EDUC, V55, P359, DOI 10.1177/0022429408317513; Marotto M, 2007, J MANAGE STUD, V44, P388, DOI 10.1111/j.1467-6486.2007.00682.x; Keller PE, 2007, CONSCIOUS COGN, V16, P102, DOI 10.1016/j.concog.2005.12.004; Boerner S, 2012, NONPROFIT MANAG LEAD, V22, P347, DOI 10.1002/nml.20058; Shimamoto K, 2006, JPN J EDUC PSYCHOL, V54, P211; SCHMIDT RC, 1994, ECOL PSYCHOL, V6, P159, DOI 10.1207/s15326969eco0603_1; Lumsden J, 2012, J EXP SOC PSYCHOL, V48, P746, DOI 10.1016/j.jesp.2011.12.007; Goebl W, 2009, MUSIC PERCEPT, V26, P427, DOI 10.1525/MP.2009.26.5.427; Ozer DJ, 2006, ANNU REV PSYCHOL, V57, P401, DOI 10.1146/annurev.psych.57.102904.190127; Ginsborg J, 2012, MUSIC SCI, V16, P148, DOI 10.1177/1029864911435733; Morgeson FP, 2005, PERS PSYCHOL, V58, P583, DOI 10.1111/j.1744-6570.2005.655.x; RoseKrasnor L, 1997, SOC DEV, V6, P111, DOI 10.1111/1467-9507.00029; Kawase S, 2014, ATTEN PERCEPT PSYCHO, V76, P527, DOI 10.3758/s13414-013-0568-0; Matthews WK, 2013, PSYCHOL MUSIC, V41, P630, DOI 10.1177/0305735612441738; Stewart GL, 2005, PERS PSYCHOL, V58, P343, DOI 10.1111/j.1744-6570.2005.00480.x; Goolsby TW, 1999, J RES MUSIC EDUC, V47, P174, DOI 10.2307/3345722; Bell ST, 2007, J APPL PSYCHOL, V92, P595, DOI 10.1037/0021-9010.92.3.595; Macnamara A, 2008, PSYCHOL MUSIC, V36, P335, DOI 10.1177/0305735607086041; Williamon A, 2002, MUSIC SCI, V6, P53; Lim MC, 2014, PSYCHOL MUSIC, V42, P307, DOI 10.1177/0305735612469674; RIGGIO RE, 1986, J PERS SOC PSYCHOL, V51, P649, DOI 10.1037//0022-3514.51.3.649; Blank M., 2007, PSYCHOL MUSIC, V35, P231, DOI DOI 10.1177/0305735607070306; Boerner S., 2005, J LEADERSH ORG STUD, V12, P31, DOI 10.1177/107179190501200203; Boerner S., 2004, HUMAN RESOURCE DEV I, V7, P465, DOI 10.1080/1367886042000246030; Braem PB, 2000, SIGNS OF LANGUAGE REVISITED, P143; Brooks D. K., 1984, THESIS; Davidson J. W., 2004, MUSICAL EXCELLENCE S, P105; Davidson J. W., 2005, MUSICAL COMMUNICATIO, P215; Davidson J. W., 1997, SOCIAL PSYCHOL MUSIC, P209; Dobson M. C., 2013, PSYCHOL MUSIC, V43, P24; Ginsborg J., 2006, PSYCHOL MUSIC, V34, P167, DOI DOI 10.1177/0305735606061851; Goldstein A. P., 1980, SKILL STREAMING ADOL; Kato T, 2003, JAPANESE J SOCIAL PS, V18, P78; Kawase S., 2015, PSYCHOL MUSIC, DOI [10.1177/0305735614568697, DOI 10.1177/0305735614568697]; Kawase S., 2014, INT J PSYCHOL STUDIE, V6, P49; Keller P. E., 2014, EXPRESSIVENESS MUSIC, P260, DOI DOI 10.1093/ACPROF:OSO/9780199659647.003.0015; Kikuchi A., 1988, OMOIYARI WO KAGAKU S; Kikuchi A., 2004, B FACULTY SOCIAL WEL, V6, P41; King E. C., 2006, PSYCHOL MUSIC, V34, P262, DOI DOI 10.1177/0305735606061855; King E. C., 2004, P ICMPC8, P11; Murnighan K. J., 1991, ADM SCI Q, V36, P165; Poggi I., 2002, LANGUAGE VISION MUSI, P271; RAHIM MA, 1983, ACAD MANAGE J, V26, P368, DOI 10.2307/255985; Takai J., 1994, JAPANESE J EXPT SOCI, V33, P224, DOI DOI 10.2130/JJESP.33.224; Van de Vliert E., 1997, COMPLEX INTERPERSONA; Wada M., 1992, B TOKYO GAKUGEI U, V43, P123; Williamson A, 2002, COGNITIVE PSYCHOL, V44, P1, DOI 10.1006/cogp.2001.0759; Young V. M., 1979, PSYCHOL MUSIC, V7, P12, DOI DOI 10.1177/030573567971002)	56	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1029-8649	2045-4147		MUSIC SCI	Music Sci.	DEC	2015	19	4					350	365		10.1177/1029864915590171		16	Music; Psychology, Experimental	Music; Psychology	CY0LD	WOS:000366096700002		
J	Sun, SY; Shi, GJ; Sha, HB; Ji, YW; Han, XM; Shu, X; Ma, HM; Inoue, T; Gao, BX; Kim, H; Bu, PC; Guber, RD; Shen, XL; Lee, AH; Iwawaki, T; Paton, AW; Paton, JC; Fang, DY; Tsai, B; Yates, JR; Wu, HQ; Kersten, S; Long, QM; Duhamel, GE; Simpson, KW; Qi, L				Sun, Shengyi; Shi, Guojun; Sha, Haibo; Ji, Yewei; Han, Xuemei; Shu, Xin; Ma, Hongming; Inoue, Takamasa; Gao, Beixue; Kim, Hana; Bu, Pengcheng; Guber, Robert D.; Shen, Xiling; Lee, Ann-Hwee; Iwawaki, Takao; Paton, Adrienne W.; Paton, James C.; Fang, Deyu; Tsai, Billy; Yates, John R., III; Wu, Haoquan; Kersten, Sander; Long, Qiaoming; Duhamel, Gerald E.; Simpson, Kenneth W.; Qi, Ling			IRE1 alpha is an endogenous substrate of endoplasmic-reticulum-associated degradation	NATURE CELL BIOLOGY			English	Article							UNFOLDED-PROTEIN RESPONSE; ER-ASSOCIATED DEGRADATION; MISFOLDED GLYCOPROTEINS; UBIQUITIN-LIGASE; INTESTINAL INFLAMMATION; TRANSMEMBRANE PROTEIN; CHAPERONE BIP; STRESS; PATHWAY; SEL1L	Endoplasmic reticulum (ER)-associated degradation (ERAD) represents a principle quality control mechanism to clear misfolded proteins in the ER; however, its physiological significance and the nature of endogenous ERAD substrates remain largely unexplored. Here we discover that IRE1 alpha, the sensor of the unfolded protein response (UPR), is a bona fide substrate of the Sel1L-Hrdl ERAD complex. ERAD-mediated IRE1 alpha degradation occurs under basal conditions in a BiP-dependent manner, requires both the intramembrane hydrophilic residues of IRE1 alpha and the lectin protein OS9, and is attenuated by ER stress. ERAD deficiency causes IRE1 alpha protein stabilization, accumulation and mild activation both in vitro and in vivo. Although enterocyte-specific Sel1L-knockout mice (Se/1L(Delta IEC)) are viable and seem normal, they are highly susceptible to experimental colitis and inflammation-associated dysbiosis, in an IRE1 alpha-dependent but CHOP-independent manner. Hence, Sel1L-Hrdl ERAD serves a distinct, essential function in restraint of IRE1 alpha signalling in vivo by managing its protein turnover.	[Sun, Shengyi; Qi, Ling] Cornell Univ, Grad Program Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Shi, Guojun; Sha, Haibo; Ji, Yewei; Shu, Xin; Kim, Hana; Guber, Robert D.; Qi, Ling] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Han, Xuemei; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Ma, Hongming; Wu, Haoquan] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci, El Paso, TX 79905 USA; [Inoue, Takamasa; Tsai, Billy] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Gao, Beixue; Fang, Deyu] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA; [Bu, Pengcheng; Shen, Xiling] Cornell Univ, Dept Elect & Comp Engn, Ithaca, NY 14853 USA; [Bu, Pengcheng; Shen, Xiling] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA; [Shen, Xiling] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [Lee, Ann-Hwee] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Iwawaki, Takao] Gunma Univ, Grad Sch Med, Educ & Res Support Ctr, Maebashi, Gunma 3718511, Japan; [Paton, Adrienne W.; Paton, James C.] Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA 5005, Australia; [Kersten, Sander] Wageningen Univ, Nutr Metab & Gen Grp, NL-6703 HD Wageningen, Netherlands; [Long, Qiaoming] Soochow Univ, Coll Med, Lab Anim Res Ctr, Suzhou 215006, Jiangsu, Peoples R China; [Duhamel, Gerald E.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Simpson, Kenneth W.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA	Long, QM (reprint author), Soochow Univ, Coll Med, Lab Anim Res Ctr, Suzhou 215006, Jiangsu, Peoples R China.	qmlong@suda.edu.cn; lq35@cornell.edu			American Diabetes Association; Chinese National Natural Science Foundation [31371391]; National Heart, Lung, and Blood Institute Proteomics Center [HHSN268201000035C, R01 MH067880, 8P41GM103533-17]; NIH of the Clinical and Translation Science Center at Weill Cornell Medical College [R01DK105393, R01GM113188, UL1TR000457]; ADA [1-12-CD-04]; Cornell VERG seed grant;  [59107338];  [R21AI085332];  [1R03AI114344]	We thank K.-L. Tung for help with the organoid culture; and other members of the Qi laboratory for comments and technical assistance. S.S. is an International Student Research Fellow of the Howard Hughes Medical Institute (59107338). L.Q. is the recipient of the Junior Faculty and Career Development Awards from American Diabetes Association (ADA). This work was supported by R21AI085332 (G.E.D.), 1R03AI114344 (H.W.), Chinese National Natural Science Foundation Grant 31371391 (Q.L.), National Heart, Lung, and Blood Institute Proteomics Center Award HHSN268201000035C, R01 MH067880 and 8P41GM103533-17 (J.R.Y. III), NIH R01DK105393, R01GM113188, UL1TR000457 of the Clinical and Translation Science Center at Weill Cornell Medical College, ADA 1-12-CD-04 and Cornell VERG seed grant (L.Q.).	Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Zhang T, 2014, DNA CELL BIOL, V33, P477, DOI 10.1089/dna.2014.2452; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103; Bertolotti A, 2000, NAT CELL BIOL, V2, P326; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Plemper RK, 1999, J CELL SCI, V112, P4123; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Hampton RY, 1996, MOL BIOL CELL, V7, P2029; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Qi L, 2011, METHOD ENZYMOL, V490, P137, DOI 10.1016/B978-0-12-385114-7.00008-8; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; MORI K, 1993, CELL, V74, P743; Xue Z, 2011, J BIOL CHEM, V286, P30859, DOI 10.1074/jbc.M111.273714; Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; He Y, 2010, GENE EXPRESSION, V15, P13, DOI 10.3727/105221610X12819686555051; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Sha HB, 2014, CELL METAB, V20, P458, DOI 10.1016/j.cmet.2014.06.015; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Dogan B, 2014, INFLAMM BOWEL DIS, V20, P1919, DOI 10.1097/MIB.0000000000000183; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Craven M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041594; Olzmann J.A., 2013, COLD SPRING HARB PER, V5, P5, DOI DOI 10.1101/CSHPERSPECT.A013185; Plemper R. K., 1997, NATURE, V388, P891; Redl H., 2013, CYTOKINES SEVERE SEP; Sun SY, 2014, P NATL ACAD SCI USA, V111, pE582, DOI 10.1073/pnas.1318114111; Ushroda R., 2013, MOL BIOL CELL, V24, P3155; Yang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011621; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008	41	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2015	17	12					1546	1555		10.1038/ncb3266		10	Cell Biology	Cell Biology	CX8DH	WOS:000365932300007		
J	Paternoster, L; Standl, M; Waage, J; Baurecht, H; Hotze, M; Strachan, DP; Curtin, JA; Bonnelykke, K; Tian, C; Takahashi, A; Esparza-Gordillo, J; Alves, AC; Thyssen, JP; den Dekker, HT; Ferreira, MA; Altmaier, E; Sleiman, PMA; Xiao, FL; Gonzalez, JR; Marenholz, I; Kalb, B; Pino-Yanes, M; Xu, CJ; Carstensen, L; Groen-Blokhuis, MM; Venturini, C; Pennell, CE; Barton, SJ; Levin, AM; Curjuric, I; Bustamante, M; Kreiner-Moller, E; Lockett, GA; Bacelis, J; Bunyavanich, S; Myers, RA; Matanovic, A; Kumar, A; Tung, JY; Hirota, T; Kubo, M; McArdle, WL; Henderson, AJ; Kemp, JP; Zheng, J; Smith, GD; Rueschendorf, F; Bauerfeind, A; Lee-Kirsch, MA; Arnold, A; Homuth, G; Schmidt, CO; Mangold, E; Cichon, S; Keil, T; Rodriguez, E; Peters, A; Franke, A; Lieb, W; Novak, N; Foelster-Holst, R; Horikoshi, M; Pekkanen, J; Sebert, S; Husemoen, LL; Grarup, N; De Jongste, JC; Rivadeneira, F; Hofman, A; Jaddoe, VWV; Pasmans, SGMA; Elbert, NJ; Uitterlinden, AG; Marks, GB; Thompson, PJ; Matheson, MC; Robertson, CF; Ried, JS; Li, J; Zuo, XB; Zheng, XD; Yin, XY; Sun, LD; McAleer, MA; O'Regan, GM; Fahy, CMR; Campbell, LE; Macek, M; Kurek, M; Hu, D; Eng, C; Postma, DS; Feenstra, B; Geller, F; Hottenga, JJ; Middeldorp, CM; Hysi, P; Bataille, V; Spector, T; Tiesler, CMT; Thiering, E; Pahukasahasram, B; Yang, JJ; Imboden, M; Huntsman, S; Vilor-Tejedor, N; Relton, CL; Myhre, R; Nystad, W; Custovic, A; Weiss, ST; Meyers, DA; Soederhaell, C; Melen, E; Ober, C; Raby, BA; Simpson, A; Jacobsson, B; Holloway, JW; Bisgaard, H; Sunyer, J; Probst-Hensch, NM; Williams, LK; Godfrey, KM; Wang, CA; Boomsma, DI; Melbye, M; Koppelman, GH; Jarvis, D; McLean, WHI; Irvine, AD; Zhang, XJ; Hakonarson, H; Gieger-, C; Burchard, EG; Martin, NG; Duijts, L; Linneberg, A; Jarvelin, MR; Noethen, MM; Lau, S; Huebner, N; Lee, YA; Tamari, M; Hinds, DA; Glass, D; Brown, SJ; Heinrich, J; Evans, DM; Weidinger, S				Paternoster, Lavinia; Standl, Marie; Waage, Johannes; Baurecht, Hansjoerg; Hotze, Melanie; Strachan, David P.; Curtin, John A.; Bonnelykke, Klaus; Tian, Chao; Takahashi, Atsushi; Esparza-Gordillo, Jorge; Alves, Alexessander Couto; Thyssen, Jacob P.; den Dekker, Herman T.; Ferreira, Manuel A.; Altmaier, Elisabeth; Sleiman, Patrick M. A.; Xiao, Feng Li; Gonzalez, Juan R.; Marenholz, Ingo; Kalb, Birgit; Pino-Yanes, Maria; Xu, Cheng-Jian; Carstensen, Lisbeth; Groen-Blokhuis, Maria M.; Venturini, Cristina; Pennell, Craig E.; Barton, Sheila J.; Levin, Albert M.; Curjuric, Ivan; Bustamante, Mariona; Kreiner-Moller, Eskil; Lockett, Gabrielle A.; Bacelis, Jonas; Bunyavanich, Supinda; Myers, Rachel A.; Matanovic, Anja; Kumar, Ashish; Tung, Joyce Y.; Hirota, Tomomitsu; Kubo, Michiaki; McArdle, Wendy L.; Henderson, A. John; Kemp, John P.; Zheng, Jie; Smith, George Davey; Rueschendorf, Franz; Bauerfeind, Anja; Lee-Kirsch, Min Ae; Arnold, Andreas; Homuth, Georg; Schmidt, Carsten O.; Mangold, Elisabeth; Cichon, Sven; Keil, Thomas; Rodriguez, Elke; Peters, Annette; Franke, Andre; Lieb, Wolfgang; Novak, Natalija; Foelster-Holst, Regina; Horikoshi, Momoko; Pekkanen, Juha; Sebert, Sylvain; Husemoen, Lise L.; Grarup, Niels; De Jongste, Johan C.; Rivadeneira, Fernando; Hofman, Albert; Jaddoe, Vincent W. V.; Pasmans, Suzanne G. M. A.; Elbert, Niels J.; Uitterlinden, Andre G.; Marks, Guy B.; Thompson, Philip J.; Matheson, Melanie C.; Robertson, Colin F.; Ried, Janina S.; Li, Jin; Zuo, Xian Bo; Zheng, Xiao Dong; Yin, Xian Yong; Sun, Liang Dan; McAleer, Maeve A.; O'Regan, Grainne M.; Fahy, Caoimhe M. R.; Campbell, Linda E.; Macek, Milan; Kurek, Michael; Hu, Donglei; Eng, Celeste; Postma, Dirkje S.; Feenstra, Bjarke; Geller, Frank; Hottenga, Jouke Jan; Middeldorp, Christel M.; Hysi, Pirro; Bataille, Veronique; Spector, Tim; Tiesler, Carla M. T.; Thiering, Elisabeth; Pahukasahasram, Badri; Yang, James J.; Imboden, Medea; Huntsman, Scott; Vilor-Tejedor, Natalia; Relton, Caroline L.; Myhre, Ronny; Nystad, Wenche; Custovic, Adnan; Weiss, Scott T.; Meyers, Deborah A.; Soederhaell, Cilla; Melen, Erik; Ober, Carole; Raby, Benjamin A.; Simpson, Angela; Jacobsson, Bo; Holloway, John W.; Bisgaard, Hans; Sunyer, Jordi; Probst-Hensch, Nicole M.; Williams, L. Keoki; Godfrey, Keith M.; Wang, Carol A.; Boomsma, Dorret I.; Melbye, Mads; Koppelman, Gerard H.; Jarvis, Deborah; McLean, W. H. Irwin; Irvine, Alan D.; Zhang, Xue Jun; Hakonarson, Hakon; Gieger-, Christian; Burchard, Esteban G.; Martin, Nicholas G.; Duijts, Liesbeth; Linneberg, Allan; Jarvelin, Marjo-Riitta; Noethen, Markus M.; Lau, Susanne; Huebner, Norbert; Lee, Young-Ae; Tamari, Mayumi; Hinds, David A.; Glass, Daniel; Brown, Sara J.; Heinrich, Joachim; Evans, David M.; Weidinger, Stephan		AAGC; EArly Genetics Lifecourse Epidemio	Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; SUSCEPTIBILITY LOCI; INTERLEUKIN-7 RECEPTOR; GENETIC ARCHITECTURE; JAPANESE POPULATION; VARIANTS; ASTHMA; METAANALYSIS; PSORIASIS; FILAGGRIN	Genetic association studies have identified 21 loci associated with atopic dermatitis risk predominantly in populations of European ancestry. To identify further susceptibility loci for this common, complex skin disease, we performed a meta-analysis of >15 million genetic variants in 21,399 cases and 95,464 controls from populations of European, African, Japanese and Latino ancestry, followed by replication in 32,059 cases and 228,628 controls from 18 studies. We identified ten new risk loci, bringing the total number of known atopic dermatitis risk loci to 31 (with new secondary signals at four of these loci). Notably, the new loci include candidate genes with roles in the regulation of innate host defenses and T cell function, underscoring the important contribution of (auto) immune mechanisms to atopic dermatitis pathogenesis.	[Paternoster, Lavinia] Univ Bristol, Med Res Council MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Paternoster, Lavinia; Kemp, John P.; Zheng, Jie; Smith, George Davey; Relton, Caroline L.; Evans, David M.] Univ Bristol, Med Res Council MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Paternoster, Lavinia; McArdle, Wendy L.; Henderson, A. John; Kemp, John P.; Zheng, Jie; Smith, George Davey; Evans, David M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Standl, Marie; Tiesler, Carla M. T.; Thiering, Elisabeth; Heinrich, Joachim] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Waage, Johannes; Bonnelykke, Klaus; Kreiner-Moller, Eskil; Bisgaard, Hans] Univ Copenhagen, Herlev & Gentofte Hosp, Copenhagen Prospect Studies Asthma Childhood COPS, Copenhagen, Denmark; [Baurecht, Hansjoerg; Hotze, Melanie; Rodriguez, Elke; Foelster-Holst, Regina; Weidinger, Stephan] Univ Hosp Schleswig Holstein, Dept Dermatol Allergol & Venereol, Kiel, Germany; [Strachan, David P.] Univ London, Populat Hlth Res Inst, St Georges, London, England; [Curtin, John A.; Custovic, Adnan; Simpson, Angela] Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Inflammat & Repair, Ctr Resp Med & Allergy, Manchester, Lancs, England; [Curtin, John A.; Custovic, Adnan; Simpson, Angela] Univ Hosp South Manchester Natl Hlth Serv NHS Fdn, Manchester, Lancs, England; [Tian, Chao; Tung, Joyce Y.; Hinds, David A.] 23andMe Inc, Mountain View, CA USA; [Takahashi, Atsushi] Inst Phys & Chem Res RIKEN, Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Esparza-Gordillo, Jorge; Marenholz, Ingo; Kalb, Birgit; Rueschendorf, Franz; Bauerfeind, Anja; Huebner, Norbert; Lee, Young-Ae] Max Delbruck Ctr Mol Med, Berlin, Germany; [Esparza-Gordillo, Jorge; Marenholz, Ingo; Matanovic, Anja; Lee, Young-Ae] Charite, Expt & Clin Res Ctr, Clin Pediat Allergy, D-13353 Berlin, Germany; [Alves, Alexessander Couto] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Thyssen, Jacob P.] Univ Copenhagen, Herlev & Gentofte Hosp, Dept Dermatol & Allergol, Natl Allergy Res Ctr, Copenhagen, Denmark; [den Dekker, Herman T.; De Jongste, Johan C.; Jaddoe, Vincent W. V.; Duijts, Liesbeth] Erasmus Univ, Med Ctr, Dept Pediat, Rotterdam, Netherlands; [den Dekker, Herman T.; Rivadeneira, Fernando; Hofman, Albert; Jaddoe, Vincent W. V.; Uitterlinden, Andre G.; Duijts, Liesbeth] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [den Dekker, Herman T.; Rivadeneira, Fernando; Jaddoe, Vincent W. V.; Elbert, Niels J.; Duijts, Liesbeth] Erasmus Univ, Med Ctr, Generat Study Grp R, Rotterdam, Netherlands; [Ferreira, Manuel A.; Martin, Nicholas G.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Altmaier, Elisabeth; Gieger-, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Altmaier, Elisabeth; Peters, Annette; Gieger-, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Altmaier, Elisabeth; Ried, Janina S.; Gieger-, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Sleiman, Patrick M. A.; Li, Jin; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Sleiman, Patrick M. A.; Hakonarson, Hakon] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Xiao, Feng Li; Zuo, Xian Bo; Zheng, Xiao Dong; Yin, Xian Yong; Sun, Liang Dan; Zhang, Xue Jun] Anhui Med Univ, Inst Dermatol, Hefei, Peoples R China; [Gonzalez, Juan R.; Bustamante, Mariona; Vilor-Tejedor, Natalia; Sunyer, Jordi] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Gonzalez, Juan R.; Bustamante, Mariona; Vilor-Tejedor, Natalia; Sunyer, Jordi] UPF, Barcelona, Spain; [Gonzalez, Juan R.; Bustamante, Mariona; Vilor-Tejedor, Natalia; Sunyer, Jordi] CIBERESP, Barcelona, Spain; [Kalb, Birgit; Lau, Susanne] Charite, Pediat Pneumol & Immunol, D-13353 Berlin, Germany; [Pino-Yanes, Maria; Hu, Donglei; Eng, Celeste; Huntsman, Scott; Burchard, Esteban G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Pino-Yanes, Maria] Inst Salud Carlos III, Ctr Invest Biomed Red CIBER Enfermedades Resp, Madrid, Spain; [Pino-Yanes, Maria] Hosp Univ Nuestra Senora de Candelaria, Res Unit, Santa Cruz De Tenerife, Spain; [Xu, Cheng-Jian; Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen Res Inst Asthma & COPD GRIAC, NL-9700 AB Groningen, Netherlands; [Xu, Cheng-Jian] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen Res Inst Asthma & COPD GRIAC, NL-9700 AB Groningen, Netherlands; [Carstensen, Lisbeth; Feenstra, Bjarke; Geller, Frank; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Groen-Blokhuis, Maria M.; Hottenga, Jouke Jan; Middeldorp, Christel M.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Netherlands Twin Register, Dept Biol Psychol, Amsterdam, Netherlands; [Venturini, Cristina; Hysi, Pirro; Bataille, Veronique; Spector, Tim; Glass, Daniel] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Pennell, Craig E.; Wang, Carol A.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Barton, Sheila J.; Godfrey, Keith M.] Univ Southampton, Lifecourse Epidemiol Unit, MRC, Southampton, Hants, England; [Levin, Albert M.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA; [Curjuric, Ivan; Kumar, Ashish; Imboden, Medea; Probst-Hensch, Nicole M.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Curjuric, Ivan; Kumar, Ashish; Imboden, Medea; Probst-Hensch, Nicole M.] Univ Basel, Basel, Switzerland; [Bustamante, Mariona] CRG, Barcelona, Spain; [Lockett, Gabrielle A.; Holloway, John W.] Univ Southampton, Fac Med, Human Dev & Hlth, Southampton SO9 5NH, Hants, England; [Bacelis, Jonas; Jacobsson, Bo] Sahlgrens Univ Hosp, Sahlgrenska Acad, Inst Clin Sci, Dept Obstet & Gynecol, Gothenburg, Sweden; [Bunyavanich, Supinda] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Myers, Rachel A.; Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Kumar, Ashish; Melen, Erik] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Kumar, Ashish; Horikoshi, Momoko] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Hirota, Tomomitsu; Tamari, Mayumi] Inst Phys & Chem Res RIKEN, Ctr Integrat Med Sci, Lab Resp & Allerg Dis, Yokohama, Kanagawa, Japan; [Kubo, Michiaki] Inst Phys & Chem Res RIKEN, Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Kemp, John P.; Evans, David M.] Univ Queensland, Translat Res Inst, Diamantina Inst, Brisbane, Qld, Australia; [Lee-Kirsch, Min Ae] Tech Univ Dresden, Klin Kinder & Jugendmed, D-01062 Dresden, Germany; [Arnold, Andreas] Univ Med Greifswald, Clin & Polyclin Dermatol, Greifswald, Germany; [Homuth, Georg] Med Univ Med, Interfac Inst Genet & Funct Genom, Dept Funct Genom, Greifswald, Germany; [Homuth, Georg] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany; [Schmidt, Carsten O.] Univ Med Greifswald, Study Hlth Pomerania KEF Klin Epidemiol Forsch, Inst Community Med, Greifswald, Germany; [Mangold, Elisabeth; Cichon, Sven; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Cichon, Sven; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Cichon, Sven] Univ Basel Hosp, Div Med Genet, CH-4031 Basel, Switzerland; [Cichon, Sven] Univ Basel, Dept Biomed, Basel, Switzerland; [Cichon, Sven] Res Ctr Julich, Struct & Funct Org Brain Genom Imaging, Inst Neurosci & Med INM 1, Julich, Germany; [Keil, Thomas] Charite, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany; [Keil, Thomas] Univ Wurzburg, Inst Clin Epidemiol & Biometry, D-97070 Wurzburg, Germany; [Peters, Annette] Munich Heart Alliance, DZHK German Res Ctr Cardiovasc Res, Munich, Germany; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Lieb, Wolfgang] Univ Kiel, Inst Epidemiol, Kiel, Germany; [Novak, Natalija] Univ Bonn, Dept Dermatol & Allergy, Bonn, Germany; [Pekkanen, Juha] Natl Inst Hlth & Welf, Unit Living Environm & Hlth, Kuopio, Finland; [Pekkanen, Juha] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Sebert, Sylvain; Jarvelin, Marjo-Riitta] Univ Oulu, Fac Med, Ctr Life Course Epidemiol & Syst Med, Oulu, Finland; [Sebert, Sylvain; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Husemoen, Lise L.; Linneberg, Allan] Capital Region Denmark, Res Ctr Prevent & Hlth, Copenhagen, Denmark; [Grarup, Niels] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Pasmans, Suzanne G. M. A.; Elbert, Niels J.] Erasmus Univ, Med Ctr, Dept Dermatol, Rotterdam, Netherlands; [Marks, Guy B.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; [Thompson, Philip J.] Queen Elizabeth II Med Ctr, Lung Inst Western Australia, Nedlands, WA, Australia; [Thompson, Philip J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Matheson, Melanie C.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Robertson, Colin F.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [McAleer, Maeve A.; Irvine, Alan D.] Natl Childrens Res Ctr, Dublin, Ireland; [McAleer, Maeve A.; O'Regan, Grainne M.; Irvine, Alan D.] Our Ladys Childrens Hosp, Dept Pediat Dermatol, Dublin, Ireland; [Fahy, Caoimhe M. R.; Irvine, Alan D.] Univ Dublin Trinity Coll, Clin Med, Dublin 2, Ireland; [Campbell, Linda E.; McLean, W. H. Irwin; Brown, Sara J.] Univ Dundee, Ctr Dermatol & Genet Med, Dundee, Scotland; [Macek, Milan] Univ Hosp Motol, Dept Biol & Med Genet, Prague, Czech Republic; [Macek, Milan] Charles Univ Prague, Fac Med 2, Prague, Czech Republic; [Kurek, Michael] Pomeranian Med Univ, Dept Clin Allergol, Szczecin, Poland; [Tiesler, Carla M. T.; Thiering, Elisabeth] Univ Munich, Dr von Hauner Childrens Hosp, Div Metab Dis & Nutr Med, Munich, Germany; [Pahukasahasram, Badri; Williams, L. Keoki] Henry Ford Hlth Syst, Ctr Hlth Policy & Hlth Serv Res, Detroit, MI USA; [Yang, James J.] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Relton, Caroline L.] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Myhre, Ronny; Nystad, Wenche; Jacobsson, Bo] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; [Raby, Benjamin A.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Weiss, Scott T.; Raby, Benjamin A.] Harvard Univ, Sch Med, Boston, MA USA; [Meyers, Deborah A.] Wake Forest Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC USA; Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Soederhaell, Cilla] Karolinska Inst, Ctr Innovat Med CIMED, Stockholm, Sweden; [Melen, Erik] Sachs Childrens Hosp, Stockholm, Sweden; [Holloway, John W.] Univ Southampton, Fac Med, Clin & Expt Sci, Southampton SO9 5NH, Hants, England; [Sunyer, Jordi] Hosp del Mar, Med Res Inst IMIM, Barcelona, Spain; [Williams, L. Keoki] Henry Ford Hlth Syst, Dept Internal Med, Detroit, MI USA; [Godfrey, Keith M.] Univ Southampton, Southampton Biomed Res Ctr, Natl Inst Hlth Res, Southampton, Hants, England; [Godfrey, Keith M.] Univ Hosp Southampton Natl Hlth Serv NHS Fdn Trus, Southampton, Hants, England; [Boomsma, Dorret I.] Vrije Univ Amsterdam, Inst Hlth & Care Res EMGO, Amsterdam, Netherlands; [Melbye, Mads; Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Melbye, Mads] Stanford Sch Med, Dept Med, Stanford, CA USA; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, Beatrix Childrens Hosp,Groningen Res Inst Asthma, Groningen, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, COPD GRIAC, Groningen, Netherlands; [Jarvis, Deborah] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Resp Epidemiol Occupat Med & Publ Hlth, London, England; [Jarvis, Deborah] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Med Res Council Publ Hlth England Ctr Environm &, Dept Epidemiol & Biostat, London, England; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Linneberg, Allan] Rigshosp, Dept Clin Expt Res, Glostrup, Denmark; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Med Res Council Publ Hlth England Ctr Environm &, Dept Epidemiol & Biostat, London, England; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Brown, Sara J.] Univ Dundee, Ninewells Hosp & Med Sch, Dept Dermatol, Dundee DD1 9SY, Scotland	Paternoster, L (reprint author), Univ Bristol, Med Res Council MRC Integrat Epidemiol Unit, Bristol, Avon, England.	l.paternoster@bristol.ac.uk	Holloway, John/B-5424-2009	Holloway, John/0000-0001-9998-0464	MRC Population Health Scientist Fellowship [MR/J012165/1]; Australian Research Council Future Fellowship [FT130101709]; Medical Research Council program grant [MC_UU_12013/4]	This publication is the work of the authors, and L.P. will serve as guarantor for the contents of this paper. This research was specifically funded by an MRC Population Health Scientist Fellowship awarded to L.P. (MR/J012165/1). D.M.E. is supported by an Australian Research Council Future Fellowship (FT130101709) and a Medical Research Council program grant (MC_UU_12013/4). Individual study acknowledgment and funding statements can be found in the Supplementary Note.	Kitabatake M, 2012, J IMMUNOL, V189, P1193, DOI 10.4049/jimmunol.1102774; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; Blair DR, 2013, CELL, V155, P70, DOI 10.1016/j.cell.2013.08.030; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Lundstrom W, 2012, SEMIN IMMUNOL, V24, P218, DOI 10.1016/j.smim.2012.02.005; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Wang X, 2013, HUM MOL GENET, V22, P2303, DOI 10.1093/hmg/ddt064; Lundstrom W, 2013, P NATL ACAD SCI USA, V110, pE1761, DOI 10.1073/pnas.1222303110; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Tang TS, 2012, J ALLERGY CLIN IMMUN, V129, P1209, DOI 10.1016/j.jaci.2012.02.002; Jakobsen C, 2013, J CROHNS COLITIS, V7, P79, DOI 10.1016/j.crohns.2012.05.024; Niwa Y, 2004, J INVEST DERMATOL, V123, P999, DOI 10.1111/j.0022-202X.2004.23462.x; Baker BS, 2006, CLIN EXP IMMUNOL, V144, P1, DOI 10.1111/j.1365-2249.2005.02980.x; Ferreira MAR, 2014, J ALLERGY CLIN IMMUN, V133, P1564, DOI 10.1016/j.jaci.2013.10.030; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Malissen B, 2014, NAT REV IMMUNOL, V14, P417, DOI 10.1038/nri3683; Bonnelykke K, 2013, NAT GENET, V45, P902, DOI 10.1038/ng.2694; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Nagarajan P, 2010, J CELL SCI, V123, P3566, DOI 10.1242/jcs.062240; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Baron S, 2005, GUT, V54, P357, DOI 10.1136/gut.2004.054353; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Bataille V, 2012, J EUR ACAD DERMATOL, V26, P1067, DOI 10.1111/j.1468-3083.2011.04444.x; Moisan J, 2007, J EXP MED, V204, P2825, DOI 10.1084/jem.20070994; Ellinghaus D, 2013, NAT GENET, V45, P808, DOI 10.1038/ng.2642; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Tintle S, 2011, J ALLERGY CLIN IMMUN, V128, P583, DOI 10.1016/j.jaci.2011.05.042; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Esparza-Gordillo J, 2013, J ALLERGY CLIN IMMUN, V132, P371, DOI 10.1016/j.jaci.2013.01.057; Cole C, 2014, J ALLERGY CLIN IMMUN, V134, P82, DOI 10.1016/j.jaci.2014.04.021; So HC, 2011, GENET EPIDEMIOL, V35, P447, DOI 10.1002/gepi.20593; Agarwala V, 2013, NAT GENET, V45, P1418, DOI 10.1038/ng.2804; Weidinger S, 2013, HUM MOL GENET, V22, P4841, DOI 10.1093/hmg/ddt317; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Rodriguez E, 2009, J ALLERGY CLIN IMMUN, V123, P1361, DOI 10.1016/j.jaci.2009.03.036; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Granada M, 2012, J ALLERGY CLIN IMMUN, V129, P840, DOI 10.1016/j.jaci.2011.09.029; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Uehira M, 1998, J INVEST DERMATOL, V110, P740, DOI 10.1046/j.1523-1747.1998.00179.x; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; de Jong MAWP, 2010, TRENDS IMMUNOL, V31, P452, DOI 10.1016/j.it.2010.08.002; Steward-Tharp SM, 2014, BLOOD, V123, P2978, DOI 10.1182/blood-2013-09-523167; Baurecht H, 2015, AM J HUM GENET, V96, P104, DOI 10.1016/j.ajhg.2014.12.004; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Giarnbartolomei C., 2014, PLOS GENET, V10; Noguchi E, 2011, PLOS GENET, V7, DOI [10.1371/journal.pgen.1002171, 10.1371/journal.pgen.1002170]; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Weidinger S., 2015, LANCET, DOI [10.1016/S0140-6736(15)00149-X, DOI 10.1016/S0140-6736(15)00149-X]; Wellcome Trust Case Control Consortium, 2012, NAT GENET, V44, P1294	69	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1449	+		10.1038/ng.3424		10	Genetics & Heredity	Genetics & Heredity	CX6LT	WOS:000365813200017		
J	Riley, JM; Meevasana, W; Bawden, L; Asakawa, M; Takayama, T; Eknapakul, T; Kim, TK; Hoesch, M; Mo, SK; Takagi, H; Sasagawa, T; Bahramy, MS; King, PDC				Riley, J. M.; Meevasana, W.; Bawden, L.; Asakawa, M.; Takayama, T.; Eknapakul, T.; Kim, T. K.; Hoesch, M.; Mo, S-K.; Takagi, H.; Sasagawa, T.; Bahramy, M. S.; King, P. D. C.			Negative electronic compressibility and tunable spin splitting in WSe2	NATURE NANOTECHNOLOGY			English	Article							TRANSITION-METAL DICHALCOGENIDES; 2-DIMENSIONAL ELECTRON; QUANTUM CAPACITANCE; BAND; SEMICONDUCTOR; RENORMALIZATION; INSULATOR; FIELD; MOS2; GAP	Tunable bandgaps(1), extraordinarily large exciton-binding energies(2,3), strong light-matter coupling(4) and a locking of the electron spin with layer and valley pseudospins(5-8) have established transition-metal dichalcogenides (TMDs) as a unique class of two-dimensional (2D) semiconductors with wide-ranging practical applications(9,10). Using angle-resolved photoemission (ARPES), we show here that doping electrons at the surface of the prototypical strong spin-orbit TMD WSe2, akin to applying a gate voltage in a transistor-type device, induces a counterintuitive lowering of the surface chemical potential concomitant with the formation of a multivalley 2D electron gas (2DEG). These measurements provide a direct spectroscopic signature of negative electronic compressibility (NEC), a result of electron-electron interactions, which we find persists to carrier densities approximately three orders of magnitude higher than in typical semiconductor 2DEGs that exhibit this effect(11,12). An accompanying tunable spin splitting of the valence bands further reveals a complex interplay between single-particle band-structure evolution and many-body interactions in electrostatically doped TMDs. Understanding and exploiting this will open up new opportunities for advanced electronic and quantum-logic devices.	[Riley, J. M.; Bawden, L.; King, P. D. C.] Univ St Andrews, Sch Phys & Astron, SUPA, St Andrews KY16 9SS, Fife, Scotland; [Riley, J. M.; Kim, T. K.; Hoesch, M.] Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Meevasana, W.; Eknapakul, T.] Suranaree Univ Technol, Sch Phys, Nakhon Ratchasima 30000, Thailand; [Meevasana, W.] Suranaree Univ Technol, NANOTEC SUT Ctr Excellence Adv Funct Nanomat, Nakhon Ratchasima 30000, Thailand; [Asakawa, M.; Sasagawa, T.] Tokyo Inst Technol, Mat & Struct Lab, Tokyo, Kanagawa 2268503, Japan; [Takayama, T.; Takagi, H.] Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; [Takayama, T.; Takagi, H.] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; [Mo, S-K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Bahramy, M. S.] Univ Tokyo, Quantum Phase Elect Ctr, Tokyo 1138656, Japan; [Bahramy, M. S.] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; [Bahramy, M. S.] RIKEN Ctr Emergent Matter Sci CEMS, Wako, Saitama 3510198, Japan	King, PDC (reprint author), Univ St Andrews, Sch Phys & Astron, SUPA, St Andrews KY16 9SS, Fife, Scotland.	philip.king@st-andrews.ac.uk			Engineering and Physical Sciences Research Council, UK [EP/I031014/1, EP/M023427/1, EP/L505079/1, EP/G03673X/1]; TRF-SUT Grant [RSA5680052]; NANOTEC, Thailand, through the Centres of Excellence Network; Royal Society through a University Research Fellowship; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24224009]; Office of Science, Office of Basic Energy Sciences, US Department of Energy [DE-AC02-05CH11231]	This work was supported by the Engineering and Physical Sciences Research Council, UK (Grant Nos EP/I031014/1, EP/M023427/1, EP/L505079/1 and EP/G03673X/1), TRF-SUT Grant RSA5680052 and NANOTEC, Thailand, through the Centres of Excellence Network. P.D.C.K. acknowledges support from the Royal Society through a University Research Fellowship. M.S.B. was supported by a Grant-in-Aid for Scientific Research (S) (No. 24224009) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, US Department of Energy, under Contract No. DE-AC02-05CH11231. We thank the Diamond Light Source for access to beamline I05 (proposal numbers SI9500 and SI11383) that contributed to the results presented here.	DASSARMA S, 1990, PHYS REV B, V41, P8288, DOI 10.1103/PhysRevB.41.8288; Xu XD, 2014, NAT PHYS, V10, P343, DOI 10.1038/NPHYS2942; Zhang YJ, 2014, SCIENCE, V344, P725, DOI 10.1126/science.1251329; EISENSTEIN JP, 1994, PHYS REV B, V50, P1760, DOI 10.1103/PhysRevB.50.1760; Nitta J, 1997, PHYS REV LETT, V78, P1335, DOI 10.1103/PhysRevLett.78.1335; Larentis S, 2014, NANO LETT, V14, P2039, DOI 10.1021/nl500212s; Ye ZL, 2014, NATURE, V513, P214, DOI 10.1038/nature13734; Zhang YJ, 2012, NANO LETT, V12, P1136, DOI 10.1021/nl2021575; Yuan HT, 2013, NAT PHYS, V9, P563, DOI 10.1038/NPHYS2691; Ugeda MM, 2014, NAT MATER, V13, P1091, DOI [10.1038/nmat4061, 10.1038/NMAT4061]; Zhang Y, 2014, NAT NANOTECHNOL, V9, P111, DOI [10.1038/nnano.2013.277, 10.1038/NNANO.2013.277]; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; VINTER B, 1976, PHYS REV B, V13, P4447, DOI 10.1103/PhysRevB.13.4447; King PDC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.096802; Ilani S, 2006, NAT PHYS, V2, P687, DOI 10.1038/nphys412; Finteis T, 1997, PHYS REV B, V55, P10400, DOI 10.1103/PhysRevB.55.10400; EISENSTEIN JP, 1992, PHYS REV LETT, V68, P674, DOI 10.1103/PhysRevLett.68.674; Li L, 2011, SCIENCE, V332, P825, DOI 10.1126/science.1204168; King PDC, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.125305; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Ye JT, 2012, SCIENCE, V338, P1193, DOI 10.1126/science.1228006; Mak KF, 2013, NAT MATER, V12, P207, DOI [10.1038/nmat3505, 10.1038/NMAT3505]; Bahramy MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2162; Blaha P., 2010, WIEN2K PACKAGE VERSI; Gong ZR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3053; He J., 2014, NAT MATER, V14, P577; King PDC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4414; Liang Y., 2014, PHYS REV LETT, V114; Liu XZ, 2015, NAT PHOTONICS, V9, P30, DOI 10.1038/NPHOTON.2014.304; Riley JM, 2014, NAT PHYS, V10, P835, DOI 10.1038/NPHYS3105; Souza I, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.035109; Yu GL, 2013, P NATL ACAD SCI USA, V110, P3282, DOI 10.1073/pnas.1300599110	33	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1748-3387	1748-3395		NAT NANOTECHNOL	Nat. Nanotechnol.	DEC	2015	10	12					1043	+		10.1038/NNANO.2015.217		6	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	CX9KE	WOS:000366023700012		
J	Parzefall, M; Bharadwaj, P; Jain, A; Taniguchi, T; Watanabe, K; Novotny, L				Parzefall, M.; Bharadwaj, P.; Jain, A.; Taniguchi, T.; Watanabe, K.; Novotny, L.			Antenna-coupled photon emission from hexagonal boron nitride tunnel junctions	NATURE NANOTECHNOLOGY			English	Article							LIGHT-EMISSION; OPTICAL ANTENNAS; PLASMONICS; METAMATERIALS; MICROSCOPE; METALS; ENHANCEMENT; NANOANTENNA; EXCITATION; CRYSTALS	The ultrafast conversion of electrical signals to optical signals at the nanoscale is of fundamental interest for data processing, telecommunication and optical interconnects. However, the modulation bandwidths of semiconductor light-emitting diodes are limited by the spontaneous recombination rate of electron-hole pairs, and the footprint of electrically driven ultrafast lasers is too large for practical on-chip integration. A metal-insulator-metal tunnel junction approaches the ultimate size limit of electronic devices and its operating speed is fundamentally limited only by the tunnelling time. Here, we study the conversion of electrons (localized in vertical gold-hexagonal boron nitride-gold tunnel junctions) to free-space photons, mediated by resonant slot antennas. Optical antennas efficiently bridge the size mismatch between nanoscale volumes and far-field radiation and strongly enhance the electron-photon conversion efficiency. We achieve polarized, directional and resonantly enhanced light emission from inelastic electron tunnelling and establish a novel platform for studying the interaction of electrons with strongly localized electromagnetic fields.	[Parzefall, M.; Bharadwaj, P.; Jain, A.; Novotny, L.] ETH, Photon Lab, CH-8093 Zurich, Switzerland; [Taniguchi, T.; Watanabe, K.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan	Novotny, L (reprint author), ETH, Photon Lab, CH-8093 Zurich, Switzerland.	lnovotny@ethz.ch			NCCR-QSIT programme [51NF40-160591]; Swiss National Science Foundation [200021_149433]; MEXT, Japan; JSPS [262480621, 25106006]	The authors thank Z.J. Lapin for sample fabrication by focused ion beam milling, K. Luszcz for support regarding the frequency modulation experiments, and M. Kasperczyk and D.W. Pohl for helpful discussions. Funding by the NCCR-QSIT programme (grant no. 51NF40-160591) and the Swiss National Science Foundation (grant no. 200021_149433) is appreciated. The authors also acknowledge the use of facilities at the FIRST Center for Micro-and Nanotechnology as well as the Scientific Center for Optical and Electron Microscopy (ScopeM) at ETH Zurich. K.W. and T.T. acknowledge support from the Elemental Strategy Initiative conducted by the MEXT, Japan. T.T. acknowledges support from a Grant-in-Aid for Scientific Research (grant no. 262480621) and on Innovative Areas 'Nano Informatics' (grant no. 25106006) from JSPS.	Alu A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.043901; LANDAUER R, 1994, REV MOD PHYS, V66, P217, DOI 10.1103/RevModPhys.66.217; JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Huang KCY, 2014, NAT PHOTONICS, V8, P244, DOI 10.1038/NPHOTON.2014.2; Coenen T, 2014, ACS NANO, V8, P7350, DOI 10.1021/nn502469r; Bharadwaj P, 2009, ADV OPT PHOTONICS, V1, P438, DOI 10.1364/AOP.1.000438; Kinkhabwala A, 2009, NAT PHOTONICS, V3, P654, DOI 10.1038/NPHOTON.2009.187; Bigourdan F, 2014, OPT EXPRESS, V22, P2337, DOI 10.1364/OE.22.002337; KIRTLEY J, 1981, PHYS REV B, V24, P5650, DOI 10.1103/PhysRevB.24.5650; Zhang Y, 2013, OPT EXPRESS, V21, P13938, DOI 10.1364/OE.21.013938; GIMZEWSKI JK, 1988, Z PHYS B CON MAT, V72, P497, DOI 10.1007/BF01314531; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Boltasseva A, 2011, SCIENCE, V331, P290, DOI 10.1126/science.1198258; SPARKS PD, 1992, PHYS REV LETT, V68, P2668, DOI 10.1103/PhysRevLett.68.2668; RENDELL RW, 1981, PHYS REV B, V24, P3276, DOI 10.1103/PhysRevB.24.3276; Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Novotny L, 2011, NAT PHOTONICS, V5, P83, DOI [10.1038/nphoton.2010.237, 10.1038/NPHOTON.2010.237]; Ward DR, 2010, NAT NANOTECHNOL, V5, P732, DOI 10.1038/nnano.2010.176; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Tang L, 2008, NAT PHOTONICS, V2, P226, DOI 10.1038/nphoton.2008.30; Nagpal P, 2009, SCIENCE, V325, P594, DOI 10.1126/science.1174655; Schneider NL, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.045409; Schuller JA, 2010, NAT MATER, V9, P193, DOI [10.1038/nmat2630, 10.1038/NMAT2630]; Watanabe K, 2004, NAT MATER, V3, P404, DOI 10.1038/nmat1134; Tassin P, 2012, NAT PHOTONICS, V6, P259, DOI 10.1038/nphoton.2012.27; JOHANSSON P, 1990, PHYS REV B, V42, P9210, DOI 10.1103/PhysRevB.42.9210; LAMBE J, 1976, PHYS REV LETT, V37, P923, DOI 10.1103/PhysRevLett.37.923; Schull G, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.057401; Knight MW, 2011, SCIENCE, V332, P702, DOI 10.1126/science.1203056; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Akselrod GM, 2014, NAT PHOTONICS, V8, P835, DOI 10.1038/NPHOTON.2014.228; Shafir D, 2012, NATURE, V485, P343, DOI 10.1038/nature11025; Gordon R, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.037401; Muhlschlegel P, 2005, SCIENCE, V308, P1607, DOI 10.1126/science.1111886; Bharadwaj P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.226802; DAVIS LC, 1977, PHYS REV B, V16, P2482, DOI 10.1103/PhysRevB.16.2482; Britnell L, 2012, NANO LETT, V12, P1707, DOI 10.1021/nl3002205; Yang HHU, 2014, ACS PHOTONICS, V1, P894, DOI 10.1021/ph5001988; Koerkamp KJK, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.183901; Taniguchi T, 2007, J CRYST GROWTH, V303, P525, DOI 10.1016/j.jcrysgro.2006.12.061; Aizpurua J, 2000, PHYS REV B, V62, P2065, DOI 10.1103/PhysRevB.62.2065; Khurgin JB, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3425890; Chen C, 2009, SCIENCE, V325, P981, DOI 10.1126/science.1174592; Curto AG, 2010, SCIENCE, V329, P930, DOI 10.1126/science.1191922; Biagioni P, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/2/024402; Chen XS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3361; Garcia-Vidal FJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.103901; Greffet JJ, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.117701; Huang JS, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1143; Lee GH, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3662043; Levinshtein M.E., 2001, PROPERTIES ADV SEMIC; Miyazaki HT, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.097401; Novotny L., 2012, PRINCIPLES NANOOPTIC; PERSSON BNJ, 1992, PHYS REV LETT, V68, P3224, DOI 10.1103/PhysRevLett.68.3224	54	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1748-3387	1748-3395		NAT NANOTECHNOL	Nat. Nanotechnol.	DEC	2015	10	12					1058	+		10.1038/NNANO.2015.203		7	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	CX9KE	WOS:000366023700015		
J	Bliokh, KY; Rodriguez-Fortuno, FJ; Nori, F; Zayats, AV				Bliokh, K. Y.; Rodriguez-Fortuno, F. J.; Nori, F.; Zayats, A. V.			Spin-orbit interactions of light	NATURE PHOTONICS			English	Review							INDEPENDENT TRANSVERSE SHIFT; BERRY TOPOLOGICAL PHASE; NANOPHOTONIC WAVE-GUIDE; IMBERT-FEDOROV SHIFTS; ANGULAR-MOMENTUM; CIRCULAR-POLARIZATION; OPTICAL-ELEMENTS; UNIAXIAL CRYSTALS; REFLECTED LIGHT; GOOS-HANCHEN	Light carries both spin and orbital angular momentum. These dynamical properties are determined by the polarization and spatial degrees of freedom of light. Nano-optics, photonics and plasmonics tend to explore subwavelength scales and additional degrees of freedom of structured - that is, spatially inhomogeneous - optical fields. In such fields, spin and orbital properties become strongly coupled with each other. In this Review we cover the fundamental origins and important applications of the main spin-orbit interaction phenomena in optics. These include: spin-Hall effects in inhomogeneous media and at optical interfaces, spin-dependent effects in nonparaxial (focused or scattered) fields, spin-controlled shaping of light using anisotropic structured interfaces (metasurfaces) and robust spin-directional coupling via evanescent near fields. We show that spin-orbit interactions are inherent in all basic optical processes, and that they play a crucial role in modern optics.	[Bliokh, K. Y.] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Bliokh, K. Y.; Nori, F.] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Bliokh, K. Y.] Australian Natl Univ, Nonlinear Phys Ctr, RSPhysE, Canberra, ACT, Australia; [Rodriguez-Fortuno, F. J.; Zayats, A. V.] Kings Coll London, Dept Phys, London WC2R 2LS, England; [Nori, F.] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA	Bliokh, KY (reprint author), RIKEN, Ctr Emergent Matter Sci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	k.bliokh@gmail.com			RIKEN iTHES Project; MURI Center for Dynamic Magneto-Optics (AFOSR) [FA9550-14-1-0040]; JSPS-RFBR [12-02-92100]; Australian Research Council; EPSRC (UK); ERC iPLASMM project [321268]; Royal Society; Wolfson Foundation	This work was partially supported by the RIKEN iTHES Project, MURI Center for Dynamic Magneto-Optics (AFOSR grant no. FA9550-14-1-0040), JSPS-RFBR (contract no. 12-02-92100), Grant-in-Aid for Scientific Research (A), the Australian Research Council, EPSRC (UK), and the ERC iPLASMM project (321268). A.V.Z. acknowledges support from the Royal Society and the Wolfson Foundation.	Aiello A, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.061801; Akhiezer A. I., 1965, QUANTUM ELECTRODYNAM; Allen L, 2003, OPTICAL ANGULAR MOME; Andrews D L, 2013, ANGULAR MOMENTUM LIG; Lee SY, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.213907; Bliokh KY, 2009, OPT LETT, V34, P389, DOI 10.1364/OL.34.000389; Dennis MR, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.183903; Bomzon Z, 2007, OPT LETT, V32, P3017, DOI 10.1364/OL.32.003017; Marrucci L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.163905; Slussarenko S, 2011, OPT EXPRESS, V19, P4085, DOI 10.1364/OE.19.004085; ZELDOVICH BY, 1994, JETP LETT+, V59, P766; Shitrit N, 2013, SCIENCE, V340, P724, DOI 10.1126/science.1234892; Yang SY, 2009, OPT LETT, V34, P3047, DOI 10.1364/OL.34.003047; Dasgupta R, 2006, OPT COMMUN, V257, P91, DOI 10.1016/j.optcom.2005.07.033; TOMITA A, 1986, PHYS REV LETT, V57, P937, DOI 10.1103/PhysRevLett.57.937; Sollner I, 2015, NAT NANOTECHNOL, V10, P775, DOI [10.1038/nnano.2015.159, 10.1038/NNANO.2015.159]; Berry MV, 2011, P ROY SOC A-MATH PHY, V467, P2500, DOI 10.1098/rspa.2011.0081; Bliokh KY, 2015, SCIENCE, V348, P1448, DOI 10.1126/science.aaa9519; Li GX, 2013, NANO LETT, V13, P4148, DOI 10.1021/nl401734r; Lu L, 2014, NAT PHOTONICS, V8, P821, DOI 10.1038/NPHOTON.2014.248; Alexeyev CN, 2006, J OPT A-PURE APPL OP, V8, P752, DOI 10.1088/1464-4258/8/9/008; Murakami S, 2003, SCIENCE, V301, P1348, DOI 10.1126/science.1087128; Xiao D, 2010, REV MOD PHYS, V82, P1959, DOI 10.1103/RevModPhys.82.1959; Berry MV, 2005, J OPT A-PURE APPL OP, V7, P685, DOI 10.1088/1464-4258/7/11/011; Lacoste D, 2004, OPT LETT, V29, P2040, DOI 10.1364/OL.29.002040; Shitrit N, 2011, NANO LETT, V11, P2038, DOI 10.1021/nl2004835; Fedoseyev VG, 2001, OPT COMMUN, V193, P9, DOI 10.1016/S0030-4018(01)01262-7; Bliokh KY, 2015, PHYS REP, V592, P1, DOI 10.1016/j.physrep.2015.06.003; Lin DM, 2014, SCIENCE, V345, P298, DOI 10.1126/science.1253213; Gorodetski Y, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.043903; LIBERMAN VS, 1992, PHYS REV A, V46, P5199, DOI 10.1103/PhysRevA.46.5199; Adachi H, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.063409; Zhou XX, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.043809; Bomzon Z, 2002, OPT LETT, V27, P1141, DOI 10.1364/OL.27.001141; Hasman E, 2005, PROG OPTICS, V47, P215, DOI 10.1016/S0079-6638(05)47004-3; PLAYER MA, 1987, J PHYS A-MATH GEN, V20, P3667, DOI 10.1088/0305-4470/20/12/020; Aiello A, 2008, OPT LETT, V33, P1437, DOI 10.1364/OL.33.001437; Hielscher AH, 1997, OPT EXPRESS, V1, P441; Luo HL, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.043806; Fedorov FI, 2013, J OPTICS-UK, V15, DOI 10.1088/2040-8978/15/1/014002; Haefner D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.123903; LIPSON SG, 1990, OPT LETT, V15, P154, DOI 10.1364/OL.15.000154; Garces-Chavez V, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.093602; Nagali E, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.013601; Gorodetski Y, 2009, NANO LETT, V9, P3016, DOI 10.1021/nl901437d; Schwartz C, 2006, OPT LETT, V31, P1121, DOI 10.1364/OL.31.001121; Kim H, 2010, NANO LETT, V10, P529, DOI 10.1021/nl903380j; Khilo NA, 2001, QUANTUM ELECTRON+, V31, P85, DOI 10.1070/QE2001v031n01ABEH001897; MASHHOON B, 1988, PHYS REV LETT, V61, P2639, DOI 10.1103/PhysRevLett.61.2639; Bokor N, 2005, OPT EXPRESS, V13, P10440, DOI 10.1364/OPEX.13.010440; Hasman E, 2002, OPT COMMUN, V209, P45, DOI 10.1016/S0030-4018(02)01598-5; VANENK SJ, 1994, J MOD OPTIC, V41, P963, DOI 10.1080/09500349414550911; Hosten O, 2008, SCIENCE, V319, P787, DOI 10.1126/science.1152697; Bliokh KY, 2008, NAT PHOTONICS, V2, P748, DOI 10.1038/nphoton.2008.229; Hakobyan D, 2014, NAT PHOTONICS, V8, P610, DOI [10.1038/nphoton.2014.142, 10.1038/NPHOTON.2014.142]; Zhao YQ, 2009, OPT EXPRESS, V17, P23316, DOI 10.1364/OE.17.023316; Brasselet E, 2009, OPT LETT, V34, P1021, DOI 10.1364/OL.34.001021; Beth RA, 1936, PHYS REV, V50, P115, DOI 10.1103/PhysRev.50.115; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Vuong LT, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.083903; Ling XH, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4898190; Merano M, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.023817; Lin J, 2013, SCIENCE, V340, P331, DOI 10.1126/science.1233746; Bliokh KY, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.063825; Onoda M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.083901; Garbin V, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/1/013046; Li CF, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.063814; Biener G, 2002, OPT LETT, V27, P1875, DOI 10.1364/OL.27.001875; Bliokh KY, 2011, OPT EXPRESS, V19, P26132, DOI 10.1364/OE.19.026132; MATHUR H, 1991, PHYS REV LETT, V67, P3325, DOI 10.1103/PhysRevLett.67.3325; Marrucci L, 2011, J OPTICS-UK, V13, DOI 10.1088/2040-8978/13/6/064001; Bliokh KY, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.043901; Kobayashi H, 2012, OPT EXPRESS, V20, P14064, DOI 10.1364/OE.20.014064; Bliokh KY, 2007, PHYS REV E, V75, DOI [10.1103/PhysRevE.75.066609, 10.1103/PhysRevE.75.06609]; Berard A, 2006, PHYS LETT A, V352, P190, DOI 10.1016/j.physleta.2005.11.071; Qin Y, 2010, OPT EXPRESS, V18, P16832, DOI 10.1364/OE.18.016832; Dennis MR, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/7/073013; GARETZ BA, 1979, OPT COMMUN, V31, P1, DOI 10.1016/0030-4018(79)90230-X; Gorodetski Y, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.125433; Bliokh KY, 2004, PHYS LETT A, V333, P181, DOI 10.1016/j.physleta.2004.10.035; Okuda H, 2006, OPT EXPRESS, V14, P8393, DOI 10.1364/OE.14.008393; Lefier Y, 2015, OPT LETT, V40, P2890, DOI 10.1364/OL.40.002890; Nieminen TA, 2008, J OPT A-PURE APPL OP, V10, DOI 10.1088/1464-4258/10/11/115005; BARANOVA NB, 1994, JETP LETT+, V59, P232; Litchinitser NM, 2012, SCIENCE, V337, P1054, DOI 10.1126/science.1226204; Yin XB, 2013, SCIENCE, V339, P1405, DOI 10.1126/science.1231758; Rashba EI, 2006, PHYSICA E, V34, P31, DOI 10.1016/j.physe.2006.02.014; Hermosa N, 2011, OPT LETT, V36, P3200, DOI 10.1364/OL.36.003200; Young AB, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.153901; GARETZ BA, 1981, J OPT SOC AM, V71, P609, DOI 10.1364/JOSA.71.000609; Bliokh KY, 2013, J OPTICS-UK, V15, DOI 10.1088/2040-8978/15/1/014001; Zhao YQ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.073901; Qin Y, 2009, OPT LETT, V34, P2551, DOI 10.1364/OL.34.002551; Curtis JE, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.133901; Kruk SS, 2014, ACS PHOTONICS, V1, P1218, DOI 10.1021/ph500288u; Veksler D, 2015, ACS PHOTONICS, V2, P661, DOI 10.1021/acsphotonic.5b00113; Monteiro PB, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.033830; Dahan N, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136402; Zhou XX, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4772502; Brasselet E, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.103903; IMBERT C, 1972, PHYS REV D, V5, P787, DOI 10.1103/PhysRevD.5.787; Qin Y, 2011, OPT EXPRESS, V19, P9636, DOI 10.1364/OE.19.009636; Gotte JB, 2013, OPT LETT, V38, P2295, DOI 10.1364/OL.38.002295; Bliokh KY, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.073903; CHIAO RY, 1986, PHYS REV LETT, V57, P933, DOI 10.1103/PhysRevLett.57.933; Menard JM, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.045303; Yu NF, 2014, NAT MATER, V13, P139, DOI 10.1038/nmat3839; RICHARDS B, 1959, PROC R SOC LON SER-A, V253, P358, DOI 10.1098/rspa.1959.0200; Bhandari R., 1997, Physics Reports, V281, DOI 10.1016/S0370-1573(96)00029-4; BIALYNICKIBIRULA I, 1987, PHYS REV D, V35, P2383, DOI 10.1103/PhysRevD.35.2383; Bliokh KY, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.061801; Bliokh KY, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.030404; Bliokh KY, 2009, J OPT A-PURE APPL OP, V11, DOI 10.1088/1464-4258/11/9/094009; Bliokh KY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4300; Bliokh K. Y., 2012, ANGULAR MOMENTUM LIG, P174; Born M., 2005, PRINCIPLES OPTICS; Ciattoni A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.036618; Darsht M. Y., 1995, SOV PHYS JETP, V80, P817; Schwartz C, 2006, OPT EXPRESS, V14, P8425, DOI 10.1364/OE.14.008425; Duval C, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.021701; FEDOSEYEV VG, 1988, J PHYS A-MATH GEN, V21, P2045, DOI 10.1088/0305-4470/21/9/019; Gorodetski Y, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.013901; Huang LL, 2013, LIGHT-SCI APPL, V2, DOI 10.1038/lsa.2013.26; Kapitanova PV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4226; Kravtsov Y. A., 1990, GEOMETRICAL OPTICS I; le Feber B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7695; Mitsch R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6713; Moe G., 2001, J PHYS B ATOM MOL PH, V10, P1191; O'Connor D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6327; O'Neil AT, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.053601; Petersen J, 2014, SCIENCE, V346, P67, DOI 10.1126/science.1257671; Pichler H, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.042116; Rodriguez-Fortuno FJ, 2014, ACS PHOTONICS, V1, P762, DOI 10.1021/ph500084b; Rodriguez-Fortuno FJ, 2013, SCIENCE, V340, P328, DOI 10.1126/science.1233739; Rodriguez-Herrera OG, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.253601; Roy B., 2013, NEW J PHYS, V16; Sayrin C., 2015, PREPRINT; Shitrit N, 2013, PHOTON NEWS      DEC, V53; Vinitskii S. I., 1990, USP FIZ NAUK, V33, P403; Wunderlich J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047204; Xiao SY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9360; Zambrana-Puyalto X, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5922	142	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-4885	1749-4893		NAT PHOTONICS	Nat. Photonics	DEC	2015	9	12					796	808		10.1038/NPHOTON.2010.201		13	Optics; Physics, Applied	Optics; Physics	CY1ES	WOS:000366150100011		
J	Takesue, H; Sasaki, T; Tamaki, K; Koashi, M				Takesue, Hiroki; Sasaki, Toshihiko; Tamaki, Kiyoshi; Koashi, Masato			Experimental quantum key distribution without monitoring signal disturbance	NATURE PHOTONICS			English	Article							SINGLE-PHOTON DETECTORS; CRYPTOGRAPHY; SECURITY; CIRCUIT; SWITCH; STATES; LIGHT; FIBER	Quantum key distribution (QKD) is a method of realizing private communication securely against an adversary with unlimited power. The QKD protocols proposed and demonstrated over the past 30 years relied on the monitoring of signal disturbance to set an upper limit to the amount of leaked information. Here, we report an experimental realization of the recently proposed round-robin differential-phase-shift protocol. We used a receiver set-up in which photons are randomly routed to one of four interferometers with different delays so that the phase difference is measured uniformly over all pair combinations among five pulses comprising the quantum signal. The amount of leak can be bounded from this randomness alone, and a secure key was extracted even when a finite communication time and the threshold nature of photon detectors were taken into account. This demonstrates the first QKD experiment without signal disturbance monitoring, thus opening up a new direction towards secure communication.	[Takesue, Hiroki; Tamaki, Kiyoshi] NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan; [Sasaki, Toshihiko; Koashi, Masato] Univ Tokyo, Grad Sch Engn, Photon Sci Ctr, Bunkyo Ku, Tokyo 1138656, Japan	Takesue, H (reprint author), NTT Corp, NTT Basic Res Labs, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan.	takesue.hiroki@lab.ntt.co.jp; sasaki@qi.t.u-tokyo.ac.jp			ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan); Photon Frontier Network Program (MEXT)	The authors thank Y. Yamamoto, T. Yamada and M. Oguma for discussions. This work was funded in part by the ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan) and the Photon Frontier Network Program (MEXT).	EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; Wen K, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.170503; HUTTNER B, 1995, PHYS REV A, V51, P1863, DOI 10.1103/PhysRevA.51.1863; Sasaki T, 2014, NATURE, V509, P475, DOI 10.1038/nature13303; Goh T, 1998, IEEE PHOTONIC TECH L, V10, P810, DOI 10.1109/68.681492; Korzh B, 2015, NAT PHOTONICS, V9, P163, DOI 10.1038/NPHOTON.2014.327; Dixon AR, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3385293; Yamazaki H, 2010, IEEE PHOTONIC TECH L, V22, P344, DOI 10.1109/LPT.2009.2039748; Tanaka A, 2012, IEEE J QUANTUM ELECT, V48, P542, DOI 10.1109/JQE.2012.2187327; Dixon AR, 2008, OPT EXPRESS, V16, P18790, DOI 10.1364/OE.16.018790; Lucamarini M, 2013, OPT EXPRESS, V21, P24550, DOI 10.1364/OE.21.024550; Peev M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/7/075001; Stucki D, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2126792; Scarani V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.057901; Honjo T, 2006, OPT LETT, V31, P522, DOI 10.1364/OL.31.000522; Honjo T, 2004, OPT LETT, V29, P2797, DOI 10.1364/OL.29.002797; Inoue K, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.037902; Zhang Q, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/4/045010; Scarani V, 2009, REV MOD PHYS, V81, P1301, DOI 10.1103/RevModPhys.81.1301; Sasaki M, 2011, OPT EXPRESS, V19, P10387, DOI 10.1364/OE.19.010387; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; Gobby C, 2004, APPL PHYS LETT, V84, P3762, DOI 10.1063/1.1738173; BENNETT CH, 1992, PHYS REV LETT, V68, P3121, DOI 10.1103/PhysRevLett.68.3121; Bennett C H, 1984, P IEEE INT C COMP SY, V175, P175; Jouguet P., 2013, NATURE PHOTON, V14, P378; Kwack MJ, 2013, IEICE T ELECTRON, VE96C, P738, DOI 10.1587/transele.E96.C.738; Lo HK, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.230504; Najafi F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6873; Takesue H, 2007, NAT PHOTONICS, V1, P343, DOI 10.1038/nphoton.2007.75; Tamaki K., 2012, PREPRINT; Waks E, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.012344	31	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-4885	1749-4893		NAT PHOTONICS	Nat. Photonics	DEC	2015	9	12					827	831		10.1038/NPHOTON.2015.173		5	Optics; Physics, Applied	Optics; Physics	CY1ES	WOS:000366150100016		
J	Sui, MQ; Chen, GR; Ma, LG; Shan, WY; Tian, D; Watanabe, K; Taniguchi, T; Jin, XF; Yao, W; Xiao, D; Zhang, YB				Sui, Mengqiao; Chen, Guorui; Ma, Liguo; Shan, Wen-Yu; Tian, Dai; Watanabe, Kenji; Taniguchi, Takashi; Jin, Xiaofeng; Yao, Wang; Xiao, Di; Zhang, Yuanbo			Gate-tunable topological valley transport in bilayer graphene	NATURE PHYSICS			English	Article							SCANNING-TUNNELING-MICROSCOPY; HGTE QUANTUM-WELLS; ELECTRONIC-PROPERTIES; HALL; DEFECTS; STATE; MOS2	Valley pseudospin, the quantum degree of freedom characterizing the degenerate valleys in energy bands(1), is a distinct feature of two-dimensional Dirac materials(1-5). Similar to spin, the valley pseudospin is spanned by a time-reversal pair of states, although the two valley pseudospin states transform to each other under spatial inversion. The breaking of inversion symmetry induces various valley-contrasted physical properties; for instance, valley-dependent topological transport is of both scientific and technological interest(2-5). Bilayer graphene is a unique system whose intrinsic inversion symmetry can be controllably broken by a perpendicular electric field, offering a rare possibility for continuously tunable topological valley transport. We used a perpendicular gate electric field to break the inversion symmetry in bilayer graphene, and a giant nonlocal response was observed as a result of the topological transport of the valley pseudospin. We further showed that the valley transport is fully tunable by external gates, and that the nonlocal signal persists up to room temperature and over long distances. These observations challenge the current understanding of topological valley transport in a gapped system, and the robust topological transport may lead to future valleytronic applications.	[Sui, Mengqiao; Chen, Guorui; Ma, Liguo; Tian, Dai; Jin, Xiaofeng; Zhang, Yuanbo] Fudan Univ, State Key Lab Surface Phys, Shanghai 200433, Peoples R China; [Sui, Mengqiao; Chen, Guorui; Ma, Liguo; Tian, Dai; Jin, Xiaofeng; Zhang, Yuanbo] Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China; [Sui, Mengqiao; Chen, Guorui; Ma, Liguo; Tian, Dai; Jin, Xiaofeng; Zhang, Yuanbo] Collaborat Innovat Ctr Adv Microstruct, Shanghai 200433, Peoples R China; [Shan, Wen-Yu; Xiao, Di] Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Adv Mat Lab, Tsukuba, Ibaraki 3050044, Japan; [Yao, Wang] Univ Hong Kong, Dept Phys, Hong Kong, Hong Kong, Peoples R China; [Yao, Wang] Univ Hong Kong, Ctr Theoret & Computat Phys, Hong Kong, Hong Kong, Peoples R China	Zhang, YB (reprint author), Fudan Univ, State Key Lab Surface Phys, Shanghai 200433, Peoples R China.	zhyb@fudan.edu.cn			National Basic Research Program of China (973 Program) [2013CB921902, 2011CB921802]; NSF of China [11034001, 11425415, 11374057, 11434003, 11421404]; University of Hong Kong (OYRA); RGC of Hong Kong SAR [HKU706412P]; US Department of Energy, Office of Science, Office of Basic Energy Science [DE-SC0012509]; MOST [2011CB921802, 2015CB921400]; MEXT, Japan; JSPS [262480621, 25106006]	We thank Q. Niu, D.-H. Lee, F. Wang, J. Shi, J. Xiao, P. Kim and J. Zhu for helpful discussions. Part of the sample fabrication was performed at the Fudan Nano-fabrication Lab. M.S., G.C., L.M. and Y.Z. acknowledge the financial support of the National Basic Research Program of China (973 Program) under grant nos 2013CB921902 and 2011CB921802, and NSF of China under grant nos 11034001 and 11425415. W.Y. acknowledges support from the University of Hong Kong (OYRA), and the RGC of Hong Kong SAR (HKU706412P). W.-Y.S. and D.X. acknowledge support from the US Department of Energy, Office of Science, Office of Basic Energy Science, under award no. DE-SC0012509. D.T. and X.J. are supported by MOST (grants no. 2015CB921400 and no. 2011CB921802) and NSF of China (grants no. 11374057, no. 11434003 and no. 11421404). K.W. and T.T. acknowledge support from the Elemental Strategy Initiative conducted by the MEXT, Japan. T.T. acknowledges support from Grant-in-Aid for Scientific Research (Grant 262480621) and Innovative Areas 'Nano Informatics' (Grant 25106006) from JSPS.	Alden JS, 2013, P NATL ACAD SCI USA, V110, P11256, DOI 10.1073/pnas.1309394110; Yao W, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096801; Lensky YD, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.256601; Xiao D, 2010, REV MOD PHYS, V82, P1959, DOI 10.1103/RevModPhys.82.1959; Lyanda-Geller Y, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.184426; Burkov AA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.057202; Lindvall N, 2012, J APPL PHYS, V111, DOI 10.1063/1.3695451; Xue JM, 2011, NAT MATER, V10, P282, DOI [10.1038/nmat2968, 10.1038/NMAT2968]; Wang ZY, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.016603; Roth A, 2009, SCIENCE, V325, P294, DOI 10.1126/science.1174736; Hoffmann A, 2013, IEEE T MAGN, V49, P5172, DOI 10.1109/TMAG.2013.2262947; Nagaosa N, 2010, REV MOD PHYS, V82, P1539, DOI 10.1103/RevModPhys.82.1539; Wu SF, 2013, NAT PHYS, V9, P149; Abanin DA, 2011, SCIENCE, V332, P328, DOI 10.1126/science.1199595; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Yao W, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235406; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Mak KF, 2014, SCIENCE, V344, P1489, DOI 10.1126/science.1250140; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Zou K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.081407; Balakrishnan J, 2013, NAT PHYS, V9, P284, DOI 10.1038/nphys2576; Wu S, 2012, NANOSCALE, V4, P2005, DOI 10.1039/c2nr11707j; Xiao D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.236809; Decker R, 2011, NANO LETT, V11, P2291, DOI 10.1021/nl2005115; Liu XJ, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.165304; Li JA, 2011, NAT PHYS, V7, P38, DOI 10.1038/NPHYS1822; Abanin DA, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.035304; Taychatanapat T, 2011, NAT PHYS, V7, P621, DOI [10.1038/nphys2008, 10.1038/NPHYS2008]; Xu XD, 2014, 2014 IEEE PHOTONICS SOCIETY SUMMER TOPICAL MEETING SERIES, P1, DOI 10.1109/SUM.2014.8; Cai JP, 2009, SHANGHAI NURS, V9, P5; Couto NJG, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041019; Engels S, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.126801; Gorbachev RV, 2014, SCIENCE, V346, P448, DOI 10.1126/science.1254966; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Shimazaki Y., 2015, GENERATION DETECTION; Taychatanapat T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.166601	36	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-2473	1745-2481		NAT PHYS	Nat. Phys.	DEC	2015	11	12					1027	+		10.1038/NPHYS3485		6	Physics, Multidisciplinary	Physics	CX7QZ	WOS:000365898400018		
J	Shimazaki, Y; Yamamoto, M; Borzenets, IV; Watanabe, K; Taniguchi, T; Tarucha, S				Shimazaki, Y.; Yamamoto, M.; Borzenets, I. V.; Watanabe, K.; Taniguchi, T.; Tarucha, S.			Generation and detection of pure valley current by electrically induced Berry curvature in bilayer graphene	NATURE PHYSICS			English	Article							MONOLAYER WSE2; MOS2; POLARIZATION; TRANSPORT; DEVICES	The field of 'Valleytronics' has recently been attracting growing interest as a promising concept for the next generation electronics, because non-dissipative pure valley currents with no accompanying net charge flow can be manipulated for computational use, akin to pure spin currents(1). Valley is a quantum number defined in an electronic system whose energy bands contain energetically degenerate but non-equivalent local minima (conduction band) or maxima (valence band) due to a certain crystal structure. Specifically, spatial inversion symmetry broken two-dimensional honeycomb lattice systems exhibiting Berry curvature is a subset of possible systems that enable optical(2-5), magnetic(6-9) and electrical control of the valley degree of freedom(10-12). Here we use dual-gated bilayer graphene to electrically induce and control broken inversion symmetry (or Berry curvature) as well as the carrier density for generating and detecting the pure valley current. In the insulating regime, at zero-magnetic field, we observe a large nonlocal resistance that scales cubically with the local resistivity, which is evidence of pure valley current.	[Shimazaki, Y.; Yamamoto, M.; Borzenets, I. V.; Tarucha, S.] Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; [Yamamoto, M.] JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Watanabe, K.; Taniguchi, T.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Tarucha, S.] RIKEN, CEMS, Wako, Saitama 3510198, Japan	Yamamoto, M (reprint author), Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan.	yamamoto@ap.t.u-tokyo.ac.jp; tarucha@ap.t.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) Research Fellowship; JSPS Program for Leading Graduate Schools (MERIT); JSPS [26248061, 25106006, 26220710]; Canon Foundation; JSPS International Research Fellowship; MEXT, Japan; DFG-JST	We acknowledge fruitful discussion with L. S. Levitov, J. C. W. Song, M. Koshino, M. Ezawa and N. Nagaosa. Y. S. acknowledges support from Japan Society for the Promotion of Science (JSPS) Research Fellowship for Young Scientists and JSPS Program for Leading Graduate Schools (MERIT). M.Y., K.W. and T.T. acknowledge support from JSPS Grant-in-Aid for Scientific Research on Innovative Areas 'Science of Atomic Layers'. M.Y. acknowledges support from Canon Foundation. I.V.B. acknowledges support from JSPS International Research Fellowship. K.W. and T.T. acknowledge support from the Elemental Strategy Initiative conducted by the MEXT, Japan. T.T. acknowledges support from JSPS Grant-in-Aid for Scientific Research A (No. 26248061) and JSPS Innovative Areas 'Nano Informatics' (No. 25106006). S.T. acknowledges support from DFG-JST joint research project 'Topological Electronics' and JSPS Grant-in-Aid for Scientific Research S (No. 26220710).	Aivazian G, 2015, NAT PHYS, V11, P148, DOI 10.1038/NPHYS3201; Brune C, 2010, NAT PHYS, V6, P448, DOI 10.1038/NPHYS1655; Lensky YD, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.256601; Xiao D, 2010, REV MOD PHYS, V82, P1959, DOI 10.1103/RevModPhys.82.1959; Jungwirth T, 2012, NAT MATER, V11, P382, DOI [10.1038/nmat3279, 10.1038/NMAT3279]; Lindvall N, 2012, J APPL PHYS, V111, DOI 10.1063/1.3695451; Nagaosa N, 2010, REV MOD PHYS, V82, P1539, DOI 10.1103/RevModPhys.82.1539; Abanin DA, 2011, SCIENCE, V332, P328, DOI 10.1126/science.1199595; Yao W, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235406; Li YL, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.266804; Mak KF, 2012, NAT NANOTECHNOL, V7, P494, DOI [10.1038/nnano.2012.96, 10.1038/NNANO.2012.96]; Goossens AM, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3685504; MacNeill D, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.037401; Koshino M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/095010; Mak KF, 2014, SCIENCE, V344, P1489, DOI 10.1126/science.1250140; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Zhang F, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.156801; Yan J, 2010, NANO LETT, V10, P4521, DOI 10.1021/nl102459t; Tikhonenko FV, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.056802; Valenzuela SO, 2006, NATURE, V442, P176, DOI 10.1038/nature04937; Zou K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.081407; Balakrishnan J, 2013, NAT PHYS, V9, P284, DOI 10.1038/nphys2576; Xiao D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.236809; Jalilian R, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/29/295705; Abanin DA, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.035304; Taychatanapat T, 2011, NAT PHYS, V7, P621, DOI [10.1038/nphys2008, 10.1038/NPHYS2008]; Zeng HL, 2012, NAT NANOTECHNOL, V7, P490, DOI [10.1038/nnano.2012.95, 10.1038/NNANO.2012.95]; Ohta T, 2006, SCIENCE, V313, P951, DOI 10.1126/science.1130681; Ju L, 2015, NATURE, V520, P650, DOI 10.1038/nature14364; Cai JP, 2009, SHANGHAI NURS, V9, P5; Cao T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1882; Gorbachev RV, 2014, SCIENCE, V346, P448, DOI 10.1126/science.1254966; Li J., 2010, NAT PHYS, V7, P38; Oostinga JB, 2008, NAT MATER, V7, P151, DOI 10.1038/nmat2082; Srivastava A, 2015, NAT PHYS, V11, P141, DOI 10.1038/NPHYS3203; Sui MQ, 2015, NAT PHYS, V11, P1027, DOI 10.1038/NPHYS3485; Taychatanapat T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.166601	37	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-2473	1745-2481		NAT PHYS	Nat. Phys.	DEC	2015	11	12					1032	+		10.1038/NPHYS3551		6	Physics, Multidisciplinary	Physics	CX7QZ	WOS:000365898400019		
J	Hoi, IC; Kockum, AF; Tornberg, L; Pourkabirian, A; Johansson, G; Delsing, P; Wilson, CM				Hoi, I. -C.; Kockum, A. F.; Tornberg, L.; Pourkabirian, A.; Johansson, G.; Delsing, P.; Wilson, C. M.			Probing the quantum vacuum with an artificial atom in front of a mirror	NATURE PHYSICS			English	Article							SPONTANEOUS EMISSION; SINGLE ATOMS; CAVITY	Quantum fluctuations of the vacuum are both a surprising and fundamental phenomenon of nature. Understood as virtual photons, they still have a very real impact, for instance, in the Casimir effects and the lifetimes of atoms. Engineering vacuum fluctuations is therefore becoming increasingly important to emerging technologies. Here, we shape vacuum fluctuations using a superconducting circuit analogue of a mirror, creating regions in space where they are suppressed. Moving an artificial atom through these regions and measuring the spontaneous emission lifetime of the atom provides us with the spectral density of the vacuum fluctuations. Using the paradigm of waveguide quantum electrodynamics, we significantly improve over previous studies of the interaction of an atom with its mirror image, observing a spectral density as low as 0.02 quanta, a factor of 50 below the mirrorless result. This demonstrates that we can hide the atom from the vacuum, even though it is exposed in free space.	[Hoi, I. -C.; Kockum, A. F.; Tornberg, L.; Pourkabirian, A.; Johansson, G.; Delsing, P.] Chalmers, Dept Microtechnol & Nanosci MC2, SE-41296 Gothenburg, Sweden; [Hoi, I. -C.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Hoi, I. -C.] Natl Tsing Hua Univ, Dept Phys, Hsinchu 30013, Taiwan; [Kockum, A. F.] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Wilson, C. M.] Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada; [Wilson, C. M.] Univ Waterloo, Dept Elect & Comp Engn, Waterloo, ON N2L 3G1, Canada	Delsing, P (reprint author), Chalmers, Dept Microtechnol & Nanosci MC2, SE-41296 Gothenburg, Sweden.	per.delsing@chalmers.se; chris.wilson@uwaterloo.ca			STINT; Swedish Research Council; European Union; EU; NSERC of Canada,; Industry Canada; Government of Ontario	We acknowledge financial support from STINT, the Swedish Research Council, the European Union represented by the ERC and the EU project PROMISCE, NSERC of Canada, Industry Canada, and the Government of Ontario. We would also like to acknowledge J. Kimble, G. Milburn, T. Stace, J. M. Martinis, C. P. Sun and H. Dong for fruitful discussions.	Shen JT, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.213001; Chan HB, 2001, SCIENCE, V291, P1941, DOI 10.1126/science.1057984; Makhlin Y, 2001, REV MOD PHYS, V73, P357, DOI 10.1103/RevModPhys.73.357; Astafiev O, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.267007; MOORE GT, 1970, J MATH PHYS, V11, P2679, DOI 10.1063/1.1665432; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; DEMARTINI F, 1987, PHYS REV LETT, V59, P2955; Lamoreaux SK, 2007, PHYS TODAY, V60, P40, DOI 10.1063/1.2711635; Hoi IC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.073601; van Loo AF, 2013, SCIENCE, V342, P1494, DOI 10.1126/science.1244324; Glaetzle AW, 2010, OPT COMMUN, V283, P758, DOI 10.1016/j.optcom.2009.10.063; SCHWINGER J, 1948, PHYS REV, V73, P416, DOI 10.1103/PhysRev.73.416; Peropadre B, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/3/035009; UNRUH WG, 1976, PHYS REV D, V14, P870, DOI 10.1103/PhysRevD.14.870; Hoi IC, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/2/025011; Chang DE, 2007, NAT PHYS, V3, P807, DOI 10.1038/nphys708; Dubin F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.183003; Wilson CM, 2011, NATURE, V479, P376, DOI 10.1038/nature10561; Abdumalikov AA, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.193601; Wendin G, 2007, LOW TEMP PHYS+, V33, P724, DOI 10.1063/1.2780165; WELTON TA, 1948, PHYS REV, V74, P1157, DOI 10.1103/PhysRev.74.1157; Astafiev O, 2010, SCIENCE, V327, P840, DOI 10.1126/science.1181918; PURCELL EM, 1946, PHYS REV, V69, P681; Koshino K, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/4/043005; Hoi IC, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.263601; Bushev P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.223602; Eschner J, 2001, NATURE, V413, P495, DOI 10.1038/35097017; Clerk AA, 2010, REV MOD PHYS, V82, P1155, DOI 10.1103/RevModPhys.82.1155; Reed MD, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3435463; Dorner U, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.023816; Kockum AF, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.013837; LAMB WE, 1947, PHYS REV, V72, P241, DOI 10.1103/PhysRev.72.241; Zheng HX, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.090502; Hoi IC, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.053601; Betbe H. A., 1947, PHYS REV, V72, P339; Casimir H.B.G., 1948, Proceedings Koninklijke Akademie van Wetenschappen te Amsterdam, V51; Dirac PAM, 1927, P R SOC LOND A-CONTA, V114, P243, DOI 10.1098/rspa.1927.0039; Harris D., 2012, NEW SCI, V2852, P34; HAWKING SW, 1974, NATURE, V248, P30, DOI 10.1038/248030a0; Houck AA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.080502; KLEPPNER D, 1981, PHYS REV LETT, V47, P233, DOI 10.1103/PhysRevLett.47.233; Lalumiere K, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.043806; Lee M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4441	43	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-2473	1745-2481		NAT PHYS	Nat. Phys.	DEC	2015	11	12					1045	1049		10.1038/NPHYS3484		5	Physics, Multidisciplinary	Physics	CX7QZ	WOS:000365898400022		
J	Kaminishi, E; Mori, T; Ikeda, TN; Ueda, M				Kaminishi, Eriko; Mori, Takashi; Ikeda, Tatsuhiko N.; Ueda, Masahito			Entanglement pre-thermalization in a one-dimensional Bose gas	NATURE PHYSICS			English	Article							WAVE-FUNCTIONS; QUANTUM; SYSTEM; RELAXATION; DYNAMICS	An isolated quantum system often shows relaxation to a quasi-stationary state before reaching thermal equilibrium. Such a pre-thermalized state was observed in recent experiments in a one-dimensional Bose gas after it had been coherently split into two. Although the existence of local conserved quantities is usually considered to be the key ingredient of pre-thermalization, the question of whether non-local correlations between the subsystems can influence pre-thermalization of the entire system has remained unanswered. Here we study the dynamics of coherently split one-dimensional Bose gases and find that the initial entanglement combined with energy degeneracy due to parity and translation invariance strongly affects the long-term behaviour of the system. The mechanism of this entanglement prethermalization is quite general and not restricted to one-dimensional Bose gases. In view of recent experiments with a small and well-defined number of ultracold atoms, our predictions based on exact few-body calculations could be tested in experiments.	[Kaminishi, Eriko; Mori, Takashi; Ikeda, Tatsuhiko N.; Ueda, Masahito] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Ikeda, Tatsuhiko N.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Ueda, Masahito] RIKEN Ctr Emergent Matter Sci CEMS, Wako, Saitama 3510198, Japan	Kaminishi, E (reprint author), Univ Tokyo, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kaminishi@cat.phys.s.u-tokyo.ac.jp			Japan Society for the Promotion of Science [26287088, 15H05855, 248408]; Photon Frontier Network Program from MEXT of Japan; Mitsubishi Foundation; Institute for Photon Science and Technology; JSPS Core-to-Core Program; Postdoctoral Fellowship for Research Abroad	We thank T. Deguchi, S. Furukawa and N. Sakumichi for discussions. This work was supported by KAKENHI Grant No. 26287088 from the Japan Society for the Promotion of Science, a Grant-in-Aid for Scientific Research on Innovative Areas 'Topological Materials Science' (KAKENHI Grant No. 15H05855), the Photon Frontier Network Program from MEXT of Japan, and the Mitsubishi Foundation. E.K. acknowledges support from the Institute for Photon Science and Technology. T.M. acknowledges the JSPS Core-to-Core Program 'Non-equilibrium dynamics of soft matter and information' for financial support. T.N.I. acknowledges the JSPS for financial support (Grant No. 248408) and Postdoctoral Fellowship for Research Abroad.	Eckstein M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.056403; Gring M, 2012, SCIENCE, V337, P1318, DOI 10.1126/science.1224953; Kitagawa T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.255302; Rigol M, 2008, NATURE, V452, P854, DOI 10.1038/nature06838; SLAVNOV NA, 1990, THEOR MATH PHYS+, V82, P273, DOI 10.1007/BF01029221; Kormos M, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.205131; LIEB EH, 1963, PHYS REV, V130, P1605, DOI 10.1103/PhysRev.130.1605; SLAVNOV NA, 1989, THEOR MATH PHYS+, V79, P502, DOI 10.1007/BF01016531; Serwane F, 2011, SCIENCE, V332, P336, DOI 10.1126/science.1201351; Linden N, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061103; Caux JS, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.257203; Trotzky S, 2012, NAT PHYS, V8, P325, DOI [10.1038/nphys2232, 10.1038/NPHYS2232]; Zurn G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.075303; Hofferberth S, 2007, NATURE, V449, P324, DOI 10.1038/nature06149; Iyer D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.115304; Kitagawa T, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/7/073018; Sato J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.110401; Kollar M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.054304; Goldstein S, 2010, P ROY SOC A-MATH PHY, V466, P3203, DOI 10.1098/rspa.2009.0635; Reimann P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.190403; Popescu S, 2006, NAT PHYS, V2, P754, DOI 10.1038/nphys444; Rossini D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.127204; Calabrese P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.227203; Tasaki H, 1998, PHYS REV LETT, V80, P1373, DOI 10.1103/PhysRevLett.80.1373; Kinoshita T, 2006, NATURE, V440, P900, DOI 10.1038/nature04693; Olshanii M, 1998, PHYS REV LETT, V81, P938, DOI 10.1103/PhysRevLett.81.938; Berges J, 2004, Phys Rev Lett, V93, P142002, DOI 10.1103/PhysRevLett.93.142002; van den Worm M, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/8/083007; Short AJ, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/5/053009; KOREPIN VE, 1982, COMMUN MATH PHYS, V86, P391, DOI 10.1007/BF01212176; Kormos M, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.013609; Essler FHL, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.051602; Calabrese Pasquale, 2012, Journal of Statistical Mechanics: Theory and Experiment, V2012, DOI 10.1088/1742-5468/2012/07/P07022; Calabrese Pasquale, 2012, Journal of Statistical Mechanics: Theory and Experiment, V2012, DOI 10.1088/1742-5468/2012/07/P07016; Cassidy AC, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.140405; Caux JS, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/01/P01008; De Nardis J, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.033601; De Nardis J., 2015, PREPRINT; Fagotti M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.245107; Gaudin M, 1983, FONCTION ONDE BETHE; Goldstein G, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.043626; Langen T, 2013, NAT PHYS, V9, P639, DOI 10.1038/NPHYS2739; Mussardo G, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.100401; Neumann J., 1929, Z PHYS, V57, P30, DOI DOI 10.1007/BF01339852; Pozsgay B, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.117203; Rigol M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.050405; Rigol M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.100403; Rossini D, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.144302; Sotiriadis Spyros, 2014, Journal of Statistical Mechanics: Theory and Experiment, V2014, DOI 10.1088/1742-5468/2014/07/P07024; SREDNICKI M, 1994, PHYS REV E, V50, P888, DOI 10.1103/PhysRevE.50.888	50	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-2473	1745-2481		NAT PHYS	Nat. Phys.	DEC	2015	11	12					1050	+		10.1038/NPHYS3478		8	Physics, Multidisciplinary	Physics	CX7QZ	WOS:000365898400023		
J	Kon, T; Miki, Y; Tanji, K; Mori, F; Tomiyama, M; Toyoshima, Y; Kakita, A; Takahashi, H; Utsumi, J; Sasaki, H; Wakabayashi, K				Kon, Tomoya; Miki, Yasuo; Tanji, Kunikazu; Mori, Fumiaki; Tomiyama, Masahiko; Toyoshima, Yasuko; Kakita, Akiyoshi; Takahashi, Hitoshi; Utsumi, Jun; Sasaki, Hidenao; Wakabayashi, Koichi			Localization of nuclear receptor subfamily 4, group A, member 3 (NR4A3) in Lewy body disease and multiple system atrophy	NEUROPATHOLOGY			English	Article						alpha-synuclein; Lewy body; multiple system atrophy; NR4A3; Parkinson's disease	LACKING ALPHA-SYNUCLEIN; NGFI-B; TRANSCRIPTION FACTORS; PARKINSON-DISEASE; MESSENGER-RNAS; NOR-1; NURR1; EXPRESSION; RAT; BRAIN	Nuclear receptor subfamily 4, group A, member 3 (NR4A3), also known as neuron-derived orphan receptor-1, is a nuclear receptor which plays key roles in cell cycle, neuronal differentiation, apoptosis and metabolism. These processes may be involved in the pathogenesis of certain neurodegenerative diseases. Previous studies have shown that there are high levels of NR4A3 mRNA in the CNS. Moreover, NR4A2, a transcription factor with homology to NR4A3, has been reported to contribute to the pathogenesis of Parkinson's disease. However, it is uncertain whether NR4A3 is also involved in diseases such as dementia with Lewy bodies, multiple system atrophy, and other neurodegenerative disorders such as tauopathies, TDP-43 proteinopathies and polyglutamine diseases. In the present study we used immunohistochemistry to examine the brain and spinal cord from patients with various neurodegenerative diseases and normal control subjects using two polyclonal anti-NR4A3 antibodies. In controls, the cytoplasm of neurons and glial cells was faintly immunostained with anti-NR4A3 antibodies. In tissues from patients with neurodegenerative diseases, immunoreactivity for NR4A3 was observed in cortical and brainstem-type Lewy bodies in Parkinson's disease and in dementia with Lewy bodies, as well as in neuronal and glial cytoplasmic inclusions in multiple system atrophy. A double-labeled immunofluorescence study showed co-localization of NR4A3 and phosphorylated -synuclein in these inclusions. Neuronal and glial inclusions in other neurodegenerative disorders were NR4A3 negative. These findings suggest that accumulation of NR4A3 is specific to -synucleinopathy.	[Kon, Tomoya; Miki, Yasuo; Tanji, Kunikazu; Mori, Fumiaki; Wakabayashi, Koichi] Hirosaki Univ, Dept Neuropathol, Grad Sch Med, Hirosaki, Aomori 0368562, Japan; [Kon, Tomoya; Tomiyama, Masahiko] Aomori Prefectural Cent Hosp, Dept Neurol, Aomori, Japan; [Toyoshima, Yasuko; Takahashi, Hitoshi] Niigata Univ, Brain Res Inst, Ctr Bioresource Based Res, Dept Pathol, Niigata, Japan; [Kakita, Akiyoshi] Niigata Univ, Brain Res Inst, Ctr Bioresource Based Res, Dept Pathol Neurosci, Niigata, Japan; [Utsumi, Jun; Sasaki, Hidenao] Hokkaido Univ, Grad Sch Med, Dept Neurol, Sapporo, Hokkaido, Japan	Kon, T (reprint author), Hirosaki Univ, Dept Neuropathol, Inst Brain Sci, Grad Sch Med, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	t-kon@umin.ac.jp			JSPS KAKENHI [26860655, 26430050, 26430049, 24300131]; Grant for Hirosaki University Institutional Research; Collaborative Research Project of the Brain Research Institute, Niigata University [2014-2508]; Ministry of Health, Labor and Welfare, Japan; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [24-5]	This work was supported by JSPS KAKENHI Grant Numbers 26860655 (Y.M.), 26430050 (K.T.), 26430049 (F.M.), 24300131 (K.W.), a Grant for Hirosaki University Institutional Research (K.W.), the Collaborative Research Project (2014-2508) of the Brain Research Institute, Niigata University (F.M.), Grants-in Aid from the Research Committee for Ataxic Disease from the Ministry of Health, Labor and Welfare, Japan (H.S., K.W.) and an Intramural Research Grant (24-5) for Neurological and Psychiatric Disorders of NCNP (K.W.). The authors wish to express their gratitude to M. Nakata and A. Ono for their technical assistance.	OHKURA N, 1994, BIOCHEM BIOPH RES CO, V205, P1959, DOI 10.1006/bbrc.1994.2900; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Hamers AAJ, 2013, CURR OPIN LIPIDOL, V24, P381, DOI 10.1097/MOL.0b013e3283643eac; Gupta A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-68; Sun W, 2007, J NEUROCHEM, V100, P269, DOI 10.1111/j.1471-4159.2006.04214.x; Decressac M, 2013, NAT REV NEUROL, V9, P629, DOI 10.1038/nrneurol.2013.209; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Maheux J, 2005, J PHARMACOL EXP THER, V313, P460, DOI 10.1124/jpet.104.080184; Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Maruyama K, 1997, NEUROENDOCRINOLOGY, V65, P2, DOI 10.1159/000127158; Yavich L, 2004, J NEUROSCI, V24, P11165, DOI 10.1523/JNEUROSCI.2559-04.2004; Schaffer DJ, 2010, BRAIN RES, V1362, P32, DOI 10.1016/j.brainres.2010.09.041; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P111, DOI 10.1007/s00401-011-0845-8; Cabin DE, 2002, J NEUROSCI, V22, P8797; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Vernier P, 2004, ANN NY ACAD SCI, V1035, P231, DOI 10.1196/annals.1332.015; DeYoung RA, 2003, J BIOL CHEM, V278, P47104, DOI 10.1074/jbc.M307496200; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Lee HJ, 2010, OXID MED CELL LONGEV, V3, P283, DOI 10.4161/oxim.3.4.12809; Zheng KN, 2003, ARCH NEUROL-CHICAGO, V60, P722, DOI 10.1001/archneur.60.5.722; Perez RG, 2002, J NEUROSCI, V22, P3090; Ponnio T, 2004, MOL CELL BIOL, V24, P9070, DOI 10.1128/MCB.24.20.9070-9078.2004; McMorrow JP, 2011, BIOCHEM SOC T, V39, P688, DOI 10.1042/BST0390688; St-Hilaire M, 2003, NEUROBIOL DIS, V14, P98, DOI 10.1016/S0969-9961(03)00081-0; Zetterstrom RH, 1996, MOL ENDOCRINOL, V10, P1656, DOI 10.1210/me.10.12.1656; Werme M, 2000, MOL BRAIN RES, V76, P18, DOI 10.1016/S0169-328X(99)00327-7; Novak G, 2010, GENES BRAIN BEHAV, V9, P910, DOI 10.1111/j.1601-183X.2010.00631.x; Achiron A, 2011, J NEUROL SCI, V311, P9, DOI 10.1016/j.jns.2011.06.038; Werme M, 2000, BRAIN RES, V863, P112, DOI 10.1016/S0006-8993(00)02109-0; Dai Zhuo-ya, 2011, Zhonghua Gan Zang Bing Za Zhi, V19, P542, DOI 10.3760/cma.j.issn.1007-3418.2011.07.017; Kurakula K, 2014, BBA-MOL CELL RES, V1843, P2543, DOI 10.1016/j.bbamcr.2014.06.010; Perez-Sieira S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04264; Safe S, 2014, MOL ENDOCRINOL, V28, P157, DOI 10.1210/me.2013-1291; Sekiyama K, 2012, PARKINSONS DIS-US, DOI 10.1155/2012/271732; vansTiel CM, 2012, J STEROID BIOCHEM, V130, P186	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	DEC	2015	35	6					503	509		10.1111/neup.12210		7	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CY1AF	WOS:000366137700001		
J	Sasaki, S				Sasaki, Shoichi			Alterations of the blood-spinal cord barrier in sporadic amyotrophic lateral sclerosis	NEUROPATHOLOGY			English	Article						amyotrophic lateral sclerosis; blood-spinal cord barrier; collagen fiber; endothelial cell; neurovascular unit; pericyte; tight junction	MICE MODELING ALS; BRAIN-BARRIER; CLINICAL-IMPLICATIONS; CEREBRAL CAPILLARIES; CEREBROSPINAL-FLUID; MOTOR CORTEX; PERICYTES; DISEASE; EXPRESSION; REACTIVITY	The blood-spinal cord barrier (BSCB) of the spinal cord capillary consists of non-fenestrated endothelial cells with tight junctions, basal laminae, pericytes and astrocyte feet processes, referred to as a neurovascular unit. The primary function of the BSCB is the maintenance and control of homeostasis of the spinal cord parenchyma by the selective transport of molecules and cells from the systemic compartment. Dysfunction of the BSCB shows important function in the etiology or progression of several pathological conditions of the spinal cord, including amyotrophic lateral sclerosis (ALS). However, the role of BSCB in the pathogenesis of ALS is still unclear. Here the changes of BSCB in sporadic ALS patients were studied by electron microscopy to determine whether the BSCB is disrupted and involved in the pathogenesis of motor neuron degeneration. A total of 358 and 366 cross-sectioned capillaries were quantitatively examined in controls and ALS patients, respectively. The frequency of degenerated endothelia and pericytes, vacuolar changes of the cytoplasm in the endothelia and pericytes, and the replication of basement membranes was significantly higher in ALS patients than in the controls (P=0.0175). The areas of the capillaries with diameters of5 mu m in the ALS patients were significantly smaller than those in the controls (P=0.0124). The frequency of collagen fiber content of more than a moderate degree around the perivascular space was significantly higher in the ALS patients compared to the controls (P=0.048), although there was no significant difference in the mild degree of accumulation of collagen fibers. Thus, the BSCB may be disrupted in sporadic ALS patients due to increased permeability and reduced microcirculation, leading to motor neuron degeneration and to the progression of the disease.	[Sasaki, Shoichi] Tokyo Womens Med Univ, Dept Neurol, Tokyo 1628666, Japan	Sasaki, S (reprint author), Tokyo Womens Med Univ, Dept Neurol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	ssasaki@nij.twmu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [22590965]	This study was supported by a Grant-in-Aid for General Scientific Research (C) from The Ministry of Education, Culture, Sports, Science and Technology (22590965). The author would like to thank Dr. Yoshiharu Horie (Division of Biostatistics, Kitasato University Graduate School) for his assistance with the statistical analysis.	Dalkara T, 2011, ACTA NEUROPATHOL, V122, P1, DOI 10.1007/s00401-011-0847-6; Greif DM, 2014, NATURE, V508, P50, DOI 10.1038/nature13217; Miyazaki K, 2011, J NEUROSCI RES, V89, P718, DOI 10.1002/jnr.22594; DONNENFELD H, 1984, J NEUROIMMUNOL, V6, P51, DOI 10.1016/0165-5728(84)90042-0; LEONARDI A, 1984, J NEUROL, V231, P75, DOI 10.1007/BF00313720; Chan-Ling T, 2004, AM J PATHOL, V165, P1301, DOI 10.1016/S0002-9440(10)63389-5; Rule RR, 2010, NEUROLOGY, V74, P821, DOI 10.1212/WNL.0b013e3181d3e2dd; Garbuzova-Davis S, 2007, BRAIN RES, V1157, P126, DOI 10.1016/j.brainres.2007.04.044; Nicaise C, 2009, BRAIN RES, V1301, P152, DOI 10.1016/j.brainres.2009.09.018; Fisher M, 2009, STROKE, V40, pS13, DOI 10.1161/STROKEAHA.108.533117; Liebner S, 2000, ACTA NEUROPATHOL, V100, P323; Balabanov R, 1998, J NEUROSCI RES, V53, P637, DOI 10.1002/(SICI)1097-4547(19980915)53:6<637::AID-JNR1>3.0.CO;2-6; Henkel JS, 2009, NEUROLOGY, V72, P1614, DOI 10.1212/WNL.0b013e3181a41228; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; ENGELHARDT JI, 1990, ARCH NEUROL-CHICAGO, V47, P1210; ANNUNZIATA P, 1985, ACTA NEUROL SCAND, V72, P61; Winkler EA, 2013, ACTA NEUROPATHOL, V125, P111, DOI 10.1007/s00401-012-1039-8; Fernandez-Klett F, 2010, P NATL ACAD SCI USA, V107, P22290, DOI 10.1073/pnas.1011321108; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; PAWLIK G, 1981, BRAIN RES, V208, P35, DOI 10.1016/0006-8993(81)90619-3; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; HUNZIKER O, 1977, BEITR PATHOL, V161, P244; Lobsiger CS, 2007, P NATL ACAD SCI USA, V104, P7319, DOI 10.1073/pnas.0702230104; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Ono S, 1998, J NEUROL SCI, V160, P140, DOI 10.1016/S0022-510X(98)00223-8; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073; Bartanusz V, 2011, ANN NEUROL, V70, P194, DOI 10.1002/ana.22421; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Garbuzova-Davis S, 2012, BRAIN RES, V1469, P114, DOI 10.1016/j.brainres.2012.05.056; Garbuzova-Davis S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001205; Stefanovic B, 2008, J CEREBR BLOOD F MET, V28, P961, DOI 10.1038/sj.jcbfm.9600590	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	DEC	2015	35	6					518	528		10.1111/neup.12221		11	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CY1AF	WOS:000366137700003		
J	Satoh, J; Kino, Y; Motohashi, N; Ishida, T; Yagishita, S; Jinnai, K; Arai, N; Nakamagoe, K; Tamaoka, A; Saito, Y; Arima, K				Satoh, Jun-ichi; Kino, Yoshihiro; Motohashi, Nobutaka; Ishida, Tsuyoshi; Yagishita, Saburo; Jinnai, Kenji; Arai, Nobutaka; Nakamagoe, Kiyotaka; Tamaoka, Akira; Saito, Yuko; Arima, Kunimasa			Immunohistochemical characterization of CD33 expression on microglia in Nasu-Hakola disease brains	NEUROPATHOLOGY			English	Article						CD33; DAP12; microglia; Nasu-Hakola disease; TREM2	ONSET ALZHEIMERS-DISEASE; MEMBRANOUS LIPODYSTROPHY; COMMON VARIANTS; BONE; LESIONS; RECOGNITION; MUTATIONS; RECEPTORS; RESPONSES; CD2AP	Nasu-Hakola disease (NHD) is a rare autosomal recessive disorder, characterized by formation of multifocal bone cysts and development of leukoencephalopathy, caused by genetic mutations of either DNAX-activation protein 12 (DAP12) or triggering receptor expressed on myeloid cells 2 (TREM2). Although increasing evidence suggests a defect in microglial TREM2/DAP12 function in NHD, the molecular mechanism underlying leukoencephalopathy with relevance to microglial dysfunction remains unknown. TREM2, by transmitting signals via the immunoreceptor tyrosine-based activation motif (ITAM) of DAP12, stimulates phagocytic activity of microglia, and ITAM signaling is counterbalanced by sialic acid-binding immunoglobulin (Ig)-like lectins (Siglecs)-mediated immunoreceptor tyrosine-based inhibitory motif (ITIM) signaling. To investigate a role of CD33, a member of the Siglecs family acting as a negative regulator of microglia activation, in the pathology of NHD, we studied CD33 expression patterns in five NHD brains and 11 controls by immunohistochemistry. In NHD brains, CD33 was identified exclusively on ramified and amoeboid microglia accumulated in demyelinated white matter lesions but not expressed in astrocytes, oligodendrocytes, or neurons. However, the number of CD33-immunoreactive microglia showed great variability from case to case and from lesion to lesion without significant differences between NHD and control brains. These results do not support the view that CD33-expressing microglia play a central role in the development of leukoencephalopathy in NHD brains.	[Satoh, Jun-ichi; Kino, Yoshihiro] Meiji Pharmaceut Univ, Dept Bioinformat & Mol Neuropathol, Tokyo 2048588, Japan; [Motohashi, Nobutaka] Univ Yamanashi, Fac Med, Dept Psychiat, Kofu, Yamanashi, Japan; [Ishida, Tsuyoshi] Natl Ctr Global Hlth & Med, Kohnodai Hosp, Dept Pathol & Lab Med, Chiba, Japan; [Yagishita, Saburo] Kanagawa Rehabil Ctr, Dept Pathol, Atsugi, Kanagawa, Japan; [Jinnai, Kenji] NHO Hyogo Chuo Hosp, Dept Neurol, Aomori, Hyogo, Japan; [Arai, Nobutaka] Tokyo Metropolitan Inst Med Sci, Brain Pathol Res Ctr, Tokyo 113, Japan; [Nakamagoe, Kiyotaka; Tamaoka, Akira] Univ Tsukuba, Dept Neurol, Ibaraki, Japan; [Saito, Yuko] NCNP, Dept Lab Med, Natl Ctr Hosp, Tokyo, Japan; [Arima, Kunimasa] Komoro Kogen Hosp, Dept Psychiat, Nagano, Japan	Satoh, J (reprint author), Meiji Pharmaceut Univ, Dept Bioinformat & Mol Neuropathol, 2-522-1 Noshio, Tokyo 2048588, Japan.	satoj@my-pharm.ac.jp			Research on Intractable Diseases [H21-Nanchi-Ippan-201, H22-Nanchi-Ippan-136]; Ministry of Health, Labour and Welfare of Japan; Science Research Promotion Fund, Promotion and Mutual Aid Corporation for Private Schools of Japan; JSPS KAKENHI [C25430054]; Dementia Drug Development Research Center (DRC) project; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; BioBank of the National Center for Geriatrics and Gerontology [NCGG 26-20]	All autopsied brain samples were obtained from the Research Resource Network (RRN), Japan. This work was supported by grants from the Research on Intractable Diseases, entitled "Clinicopathological and genetic studies of Nasu-Hakola disease" (H21-Nanchi-Ippan-201; H22-Nanchi-Ippan-136), the Ministry of Health, Labour and Welfare of Japan, the Science Research Promotion Fund, Promotion and Mutual Aid Corporation for Private Schools of Japan, and the JSPS KAKENHI (C25430054) and the Dementia Drug Development Research Center (DRC) project, the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and a grant from the BioBank of the National Center for Geriatrics and Gerontology (NCGG 26-20).	Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Roumier A, 2004, J NEUROSCI, V24, P11421, DOI 10.1523/JNEUROSCI.2251-04.2004; Bradshaw EM, 2013, NAT NEUROSCI, V16, P848, DOI 10.1038/nn.3435; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Linnartz B, 2013, GLIA, V61, P37, DOI 10.1002/glia.22359; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Orr SJ, 2007, BLOOD, V109, P1061, DOI 10.1182/blood-2006-05-023556; YAGISHITA S, 1985, VIRCHOWS ARCH A, V408, P211, DOI 10.1007/BF00707983; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Satoh J, 2011, NEUROPATHOLOGY, V31, P363, DOI 10.1111/j.1440-1789.2010.01174.x; Otero K, 2009, NAT IMMUNOL, V10, P734, DOI 10.1038/ni.1744; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Crocker PR, 2012, ANN NY ACAD SCI, V1253, P102, DOI 10.1111/j.1749-6632.2011.06449.x; Nataf S, 2005, AM J PATHOL, V166, P275, DOI 10.1016/S0002-9440(10)62251-1; Kaneko M, 2010, NEUROPATHOLOGY, V30, P463, DOI 10.1111/j.1440-1789.2010.01127.x; Tanaka J, 2000, NEUROPATHOLOGY, V20, pS25; NASU T, 1973, ACTA PATHOL JAPON, V23, P539; Nakamagoe K, 2011, INTERNAL MED, V50, P2839, DOI 10.2169/internalmedicine.50.5891; Aoki N, 2011, NEUROPATHOLOGY, V31, P135, DOI 10.1111/j.1440-1789.2010.01152.x; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Walke DG, 2015, NEUROBIOL AGING, V36, P571, DOI 10.1016/j.neurobiolaging.2014.09.023; MOTOHASHI N, 1995, NEURORADIOLOGY, V37, P549; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Wang Y, 2010, J NEUROSCI, V30, P3482, DOI 10.1523/JNEUROSCI.3940-09.2010; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Lajaunias F, 2005, EUR J IMMUNOL, V35, P243, DOI 10.1002/eji.200425273; Bianchin MM, 2004, CELL MOL NEUROBIOL, V24, P1, DOI 10.1023/B:CEMN.0000012721.08168.ee; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Cao H., 2010, IMMUNOLOGY, V132, P18; Hakola H P, 1972, Acta Psychiatr Scand Suppl, V232, P1; Hernandez-Caselles T, 2006, J LEUKOCYTE BIOL, V79, P46, DOI 10.1189/jlb.0205096; Satoh J, 2013, CLIN EXP NEUROIMM S1, V4, P17; Satoh J, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-68; Wang Y, 2015, CELL, V160, P1	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	DEC	2015	35	6					529	537		10.1111/neup.12222		9	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CY1AF	WOS:000366137700004		
J	Inoue, K; Fujimura, H; Ueda, K; Matsumura, T; Itoh, K; Sakoda, S				Inoue, Kimiko; Fujimura, Harutoshi; Ueda, Kayo; Matsumura, Tsuyoshi; Itoh, Kyoko; Sakoda, Saburo			An autopsy case of neuronal intermediate filament inclusion disease with regard to immunophenotypic and topographical analysis of the neuronal inclusions	NEUROPATHOLOGY			English	Article						frontotemporal lobar degeneration; fused in sarcoma protein; hyaline conglomerate inclusion; motor neuron disease; neuronal intermediate filament inclusion disease	FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; BODY DISEASE; DEMENTIA; DISTINCT; TDP-43; ALS	We report an autopsy case of neuronal intermediate filament inclusion disease (NIFID), in which pyramidal motor dysfunction preceded cognitive disturbance for 3 years from the onset. A 41-year-old Japanese man presented progressive spastic tetraparesis followed by cognitive impairment. His neurological symptoms gradually deteriorated and he died of pneumonia 16 years from the onset. His brain showed severe generalized atrophy with enlargement of ventricles. The microscopic examination revealed severe neuronal loss with gliosis and sponginess predominantly in the fronto-temporal cortices, caudate and putamen. Many hyaline conglomerate inclusions (HC) without immunoreactivity for fused in sarcoma' protein (FUS) and some granular and small round FUS-immunoreactive (FUS-ir) neuronal cytoplasmic inclusions (NCI) were observed in the remaining neurons. Some neurons with HC had small basophilic inclusions which showed positive FUS-ir, attached to HC in the cytoplasm. Otherwise, FUS-ir large compact inclusions (so-called Pick-like) were also observed but were scarce. In the cerebral cortex and the neostriatum, frequency of the inclusions was well correlated with neuronal loss. In the brainstem, neuronal loss was mild and FUS-ir inclusions dominated. In the subthalamic nucleus and red nucleus, there was no HC but there were many FUS-ir inclusions without neuronal loss. The above findings suggest that cytoplasmic mislocalization and aggregation of FUS appear at the early stage of the disease, and the FUS aggregate process may not be a direct precedent structure of HC.	[Inoue, Kimiko; Fujimura, Harutoshi; Matsumura, Tsuyoshi; Sakoda, Saburo] Toneyama Natl Hosp, Dept Neurol, Toyonaka, Osaka 5608552, Japan; [Ueda, Kayo] Toneyama Natl Hosp, Dept Pathol, Toyonaka, Osaka 5608552, Japan; [Itoh, Kyoko] Kyoto Prefectural Univ Med, Div Pathol & Appl Neurobiol, Kyoto, Japan	Inoue, K (reprint author), Toneyama Natl Hosp, Dept Neurol, Toneyama 5-1-1, Toyonaka, Osaka 5608552, Japan.	kinoue@toneyama.go.jp					Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; YOKOO H, 1994, ACTA NEUROPATHOL, V88, P267; Cairns NJ, 2003, NEUROSCI LETT, V341, P177, DOI 10.1016/S0304-3940(03)00100-9; Mackenzie IRA, 2004, CLIN NEUROPATHOL, V23, P183; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V121, P207, DOI 10.1007/s00401-010-0764-0; Cairns NJ, 2004, AM J PATHOL, V164, P2153, DOI 10.1016/S0002-9440(10)63773-X; Yokota O, 2008, ACTA NEUROPATHOL, V115, P561, DOI 10.1007/s00401-007-0329-z; Mosaheb S, 2005, ACTA NEUROPATHOL, V110, P360, DOI 10.1007/s00401-005-1057-x; Molina-Porcel L, 2008, ARCH NEUROL-CHICAGO, V65, P272, DOI 10.1001/archneurol.2007.37; Neumann M, 2009, ACTA NEUROPATHOL, V118, P605, DOI 10.1007/s00401-009-0581-5; Thomas M, 2013, BRAIN, V136, P1345, DOI 10.1093/brain/awt030; Bigio EH, 2003, NEUROPATH APPL NEURO, V29, P239, DOI 10.1046/j.1365-2990.2003.00466.x; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Munoz DG, 2009, ACTA NEUROPATHOL, V118, P617, DOI 10.1007/s00401-009-0598-9; Gearing M, 2003, J NEUROPATH EXP NEUR, V62, P555; Roeber S, 2006, BRAIN PATHOL, V16, P228, DOI 10.1111/j.1750-3639.2006.00013.x; Page T, 2011, J MOL NEUROSCI, V45, P409, DOI 10.1007/s12031-011-9549-8; Brettschneider J, 2014, ACTA NEUROPATHOL, V128, P423, DOI 10.1007/s00401-014-1299-6; Josephs KA, 2003, BRAIN, V126, P2291, DOI 10.1093/brain/awg231	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	DEC	2015	35	6					545	552		10.1111/neup.12213		8	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CY1AF	WOS:000366137700006		
J	Matsumoto, H; Yoshida, Y				Matsumoto, Hiroaki; Yoshida, Yasuhisa			Primary intraventricular oligodendroglioma: A case report of the usefulness of Olig2 immunohistochemistry for diagnosis	NEUROPATHOLOGY			English	Article						central neurocytoma; immunohistchemical staining; intraventricular; oligodendroglioma; Olig 2	ATYPICAL EXTRAVENTRICULAR NEUROCYTOMA; LATERAL VENTRICLE; DIFFERENTIATION; TUMOR; MARKER; CELLS	Primary intraventricular oligodendroglioma (IVO) is a rare form of clear cell neoplasm and diagnosis is challenging because other clear cell neoplasms such as central neurocytoma must be ruled out. We report a case of primary IVO in which Olig2 immunohistochemistry was useful for the diagnosis. A 33-year-old man was admitted to our hospital with severe headaches due to an intraventricular mass lesion and underwent total resection of the mass lesion. The histological diagnosis was oligodendroglioma because the tumor was negative for synaptophysin and positive for Olig2. IVO is rare and differential diagnoses must be considered. The correct pathologic diagnosis is essential for anticipating the prognosis and selecting adjuvant therapy. In this case, Olig2 was useful for the diagnosis of oligodendroglioma.	[Matsumoto, Hiroaki; Yoshida, Yasuhisa] Eisyokai Yoshida Hosp, Dept Neurosurg, Kobe, Hyogo, Japan	Matsumoto, H (reprint author), Daikai Dori9-2-6,Hyogo Ku, Kobe, Hyogo 6520803, Japan.	hiroaki-matsu@umin.ac.jp					PACKER RJ, 1985, CANCER, V56, P195, DOI 10.1002/1097-0142(19850701)56:1<195::AID-CNCR2820560133>3.0.CO;2-3; Pomero E, 2012, CAN J NEUROL SCI, V39, P649; YUEN ST, 1992, CHILD NERV SYST, V8, P383, DOI 10.1007/BF00304785; Natale M, 2005, CLIN NEUROL NEUROSUR, V107, P417, DOI 10.1016/j.clineuro.2004.09.013; Mrak RE, 2004, HUM PATHOL, V35, P1156, DOI 10.1016/j.humpath.2004.05.005; HASUO K, 1987, CT-J COMPUT TOMOGR, V11, P376; Ishizawa K, 2008, CLIN NEUROPATHOL, V27, P118; Makuria AT, 2007, J NEURO-ONCOL, V82, P199, DOI 10.1007/s11060-006-9268-0; Jaiswal S, 2011, J CLIN NEUROSCI, V18, P334, DOI 10.1016/j.jocn.2010.05.031; LEE KS, 1990, SOUTHERN MED J, V83, P254; TEKKOK IH, 1992, NEUROCHIRURGIA, V35, P63; Rychly B, 2010, BRATISL MED J, V111, P41; KUBOTA T, 1991, ACTA NEUROPATHOL, V81, P418; Zada G, 2009, SURG NEUROL, V71, P693, DOI 10.1016/j.surneu.2007.11.013; Okada M, 2011, BRAIN TUMOR PATHOL, V28, P157, DOI 10.1007/s10014-011-0017-5; Yokoo H, 2004, AM J PATHOL, V164, P1717, DOI 10.1016/S0002-9440(10)63730-3; GARZAMERCADO R, 1987, NEUROSURGERY, V21, P78; KAWANO N, 1983, ACTA NEUROPATHOL, V62, P141; Mut M, 2005, CLIN NEUROPATHOL, V24, P225; MARTINEZLAGE JF, 1986, NEUROSURGERY, V19, P125; KIKUCHI K, 1985, SURG NEUROL, V23, P483, DOI 10.1016/0090-3019(85)90243-5; MAIURI F, 1982, SURG NEUROL, V18, P364, DOI 10.1016/0090-3019(82)90153-7; Perry A, 2002, J NEUROPATH EXP NEUR, V61, P947; Marie Y, 2001, LANCET, V358, P298, DOI 10.1016/S0140-6736(01)05499-X; PRAYSON RA, 1992, AM J CLIN PATHOL, V97, P398; Atalay B, 2002, TURK NEUROSURG, V12, P138; Atasoy C, 2002, J ANKARA MED SCH, V55, P39; Geuna E, 1981, J Neurosurg Sci, V25, P49; Kubota T, 1995, Noshuyo Byori, V12, P53; NIOKA H, 1987, Neurological Surgery, V15, P201; SAKAI H, 1980, Neurological Surgery, V8, P827; The committee of Brain Registry of Japan, 2014, NEUROL MED CHIR TOKY, V54, pPS9; YOKOYAMA S, 1983, Neurologia Medico-Chirurgica, V23, P157, DOI 10.2176/nmc.23.157	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	DEC	2015	35	6					553	560		10.1111/neup.12214		8	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CY1AF	WOS:000366137700007		
J	Nagaishi, M; Yokoo, H; Nobusawa, S; Fujii, Y; Sugiura, Y; Suzuki, R; Tanaka, Y; Suzuki, K; Hyodo, A				Nagaishi, Masaya; Yokoo, Hideaki; Nobusawa, Sumihito; Fujii, Yoshiko; Sugiura, Yoshiki; Suzuki, Ryotaro; Tanaka, Yoshihiro; Suzuki, Kensuke; Hyodo, Akio			Localized overexpression of alpha-internexin within nodules in multinodular and vacuolating neuronal tumors	NEUROPATHOLOGY			English	Article						ganglioglioma; HuC; HuD; internexin; multinodular; neuronal tumor	NEUROFILAMENT PROTEIN; RAT-BRAIN; EXPRESSION; MARKER; ADULT; CELLS; OLIG2; DIFFERENTIATION; IDENTIFICATION; NEUROGENESIS	Multinodular and vacuolating neuronal tumors (MVNT) have been recently referred to as a distinctive neuronal tumor entity based on histopathological findings. They are characterized by multiple tumor nodules, vacuolar alteration and widespread immunolabeling for human neuronal protein HuC/HuD. Only 13 cases have been reported in the literature to date and little is known about the histopathology of these tumors. Herein, we report a case of MVNT with additional confirmation of immunohistochemical features. A 22-year-old woman presented with a continuous headache. MRI showed a subcortical white matter lesion with multiple satellite nodules in the frontal lobe appearing as T2/fluid-attenuated inversion recovery (FLAIR) hyperintensities. Histological examination of the resected lesion revealed well-defined multiple nodules composed of predominant vacuolating tumor cells. The tumor cells exhibited consistent immunolabeling for doublecortin, as well as HuC/HuD, both representative neuronal biomarkers associated with earlier stages of neuronal development. Immunopositivity for oligodendrocyte transcription factor 2 (Olig2) and S100 was also detected in tumor cells. Additionally, significant overexpression of alpha-internexin was observed in the background neuropil limited to tumor nodules. Neuronal nuclear antigen (NeuN), synaptophysin and neurofilament, markers for mature neurons, were either negative or weakly positive. The expression profile of neuronal biomarkers can be distinguished from that of classic neuronal tumors and is the immunohistochemical hallmark of MVNT. In summary, we identified the characteristic tumoral expression of HuC/HuD and doublecortin and the presence of abundant neuropil localized in MVNT tumor nodules, which exhibited widespread alpha-internexin expression. These results supported the presumption that MVNT is a distinct histopathological entity.	[Nagaishi, Masaya; Fujii, Yoshiko; Sugiura, Yoshiki; Suzuki, Ryotaro; Tanaka, Yoshihiro; Suzuki, Kensuke; Hyodo, Akio] Dokkyo Med Univ, Dept Neurosurg, Koshigaya Hosp, Koshigaya, Saitama 3438555, Japan; [Yokoo, Hideaki; Nobusawa, Sumihito] Gunma Univ, Grad Sch Med, Dept Human Pathol, Maebashi, Gumma 371, Japan	Nagaishi, M (reprint author), Dokkyo Med Univ, Dept Neurosurg, Koshigaya Hosp, 2-1-50 Minami Koshigaya, Koshigaya, Saitama 3438555, Japan.	nagaishi-nsu@umin.ac.jp					Benson DL, 1996, J NEUROCYTOL, V25, P181, DOI 10.1007/BF02284795; MARUSICH MF, 1994, J NEUROBIOL, V25, P143, DOI 10.1002/neu.480250206; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Huse JT, 2013, BRAIN PATHOL, V23, P515, DOI 10.1111/bpa.12035; Bridge JA, 2013, BRAIN PATHOL, V23, P121, DOI 10.1111/j.1750-3639.2012.00612.x; NAKAZATO Y, 1984, ACTA NEUROPATHOL, V64, P30; Nagaishi M, 2015, J CLIN NEUROSCI, V22, P207, DOI 10.1016/j.jocn.2014.05.037; BARAMI K, 1995, J NEUROBIOL, V28, P82, DOI 10.1002/neu.480280108; Kaya B, 2003, CLIN NEUROPATHOL, V22, P215; Yokoo H, 2004, AM J PATHOL, V164, P1717, DOI 10.1016/S0002-9440(10)63730-3; Deb P, 2006, NEUROPATH APPL NEURO, V32, P461, DOI 10.1111/j.1365-2990.2006.00734.x; Schindler G, 2011, ACTA NEUROPATHOL, V121, P397, DOI 10.1007/s00401-011-0802-6; Chien CL, 1996, J NEUROBIOL, V29, P304, DOI 10.1002/(SICI)1097-4695(199603)29:3<304::AID-NEU3>3.0.CO;2-D; KAPLAN MP, 1990, J NEUROSCI, V10, P2735; Nagaishi M, 2011, NEUROPATHOLOGY, V31, P468, DOI 10.1111/j.1440-1789.2010.01188.x; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Matsumura N, 2013, NEUROPATHOLOGY, V33, P246, DOI 10.1111/j.1440-1789.2012.01355.x; Myung JK, 2013, NEUROPATHOLOGY, V33, P111, DOI 10.1111/j.1440-1789.2012.01330.x; Suzuki T, 1997, BRAIN RES, V765, P74, DOI 10.1016/S0006-8993(97)00492-7; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499; Willoughby V, 2008, APPL IMMUNOHISTO M M, V16, P344, DOI 10.1097/PAI.0b013e318165fe78; Buckley PG, 2011, J NEUROPATH EXP NEUR, V70, P177, DOI 10.1097/NEN.0b013e31820c765b; Bodi Istvan, 2014, Acta Neuropathol Commun, V2, P7, DOI 10.1186/2051-5960-2-7; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Fukushima S, 2014, BRAIN TUMOR PATHOL; Louis DN, 2007, WHO CLASSIFICATION T; Nagaishi M, 2014, BRAIN TUMOR PATHOL, V31, P257, DOI 10.1007/s10014-013-0168-7; von Bohlen Und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI DOI 10.1007/S00441-007-0432-4	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	DEC	2015	35	6					561	568		10.1111/neup.12217		8	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CY1AF	WOS:000366137700008		
J	Miki, Y; Tanji, K; Mori, F; Sakamoto, N; Wakabayashi, K				Miki, Yasuo; Tanji, Kunikazu; Mori, Fumiaki; Sakamoto, Namiko; Wakabayashi, Koichi			An autopsy case of refractory epilepsy due to unilateral polymicrogyria in a 65-year-old man: Histogenesis of four-layered polymicrogyric cortex	NEUROPATHOLOGY			English	Article						aquaporin-1; cortical lamina; four-layered cortex; myelinated layer; polymicrogyria	CORTICAL DEVELOPMENT; MUTATIONS; MICROGYRIA; FEATURES	Polymicrogyria (PMG) is a complex malformation accompanied with abnormal cortical laminations (two-, four- or six-layered cortex), and horizontally oriented myelinated fiber layer is evident in four-layered PMG in older individuals. Here we report a 65-year-old man with refractory epilepsy, in whom postmortem examination revealed four-layered PMG in the left hemisphere. We carried out a histological and immunohistochemical study to clarify the nature of the myelinated band in four-layered PMG cortex. The myelinated band contained no or only few neurons. GFAP- and aquaporin-1-immunoreactive astrocytes were found in the subcortical white matter as well as in the myelinated band. By contrast, GFAP- and aquaporin-1-immunoreactive astrocytes were not found in the band of Baillarger. These findings suggest that the myelinated band in PMG cortex is not the band of Baillarger and that the immunohistochemical characteristics of astrocytes in the myelinated band in PMG cortex are similar to those of the subcortical white matter. Previous studies suggest that PMG is not a cell migration disorder but a post-migration malformation. Taken together, it is likely that the myelinated band in PMG cortex represents abnormality of axonal growth or myelination after migration has terminated.	[Miki, Yasuo; Tanji, Kunikazu; Mori, Fumiaki; Wakabayashi, Koichi] Hirosaki Univ, Grad Sch Med, Dept Neuropathol, Hirosaki, Aomori 0368562, Japan; [Sakamoto, Namiko] Hirosaki Univ, Grad Sch Med, Forens Med, Hirosaki, Aomori 0368562, Japan	Miki, Y (reprint author), Hirosaki Univ, Grad Sch Med, Inst Brain Sci, Dept Neuropathol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	yasuomiki@hotmail.com			JSPS KAKENHI [26860655, 26430050, 26430049, 24300131]; Grant for Hirosaki University Institutional Research	This work was supported by JSPS KAKENHI Grant Numbers 26860655 (YM), 26430050 (KT), 26430049 (FM) and 24300131 (KW), and a Grant for Hirosaki University Institutional Research (KW). The authors wish to express their gratitude to M. Nakata and A. Ono for their technical assistance.	Hayashi N, 2002, NEURORADIOLOGY, V44, P418, DOI 10.1007/s00234-001-0719-1; Santos NF, 2008, AM J MED GENET A, V146A, P1151, DOI 10.1002/ajmg.a.32270; Poirier K, 2010, HUM MOL GENET, V19, P4462, DOI 10.1093/hmg/ddq377; WAKABAYASHI K, 1995, ACTA NEUROPATHOL, V89, P404; DEVILLEMEUR TB, 1992, ACTA NEUROPATHOL, V83, P265; LEVINE DN, 1974, ACTA NEUROPATHOL, V29, P99; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Hadjivassiliou G, 2010, ACTA NEUROPATHOL, V120, P517, DOI 10.1007/s00401-010-0686-x; MCBRIDE MC, 1982, ACTA NEUROPATHOL, V57, P93; RICHMAN DP, 1974, J NEUROPATH EXP NEUR, V33, P374, DOI 10.1097/00005072-197407000-00004; Fallet-Bianco C, 2008, BRAIN, V131, P2304, DOI 10.1093/brain/awn155; KUZNIECKY R, 1993, LANCET, V341, P608, DOI 10.1016/0140-6736(93)90363-L; Leventer RJ, 2010, BRAIN, V133, P1415, DOI 10.1093/brain/awq078; Moftakhar P, 2010, J NEUROPATH EXP NEUR, V69, P1201, DOI 10.1097/NEN.0b013e3181fd252c; Thom M, 2009, J NEUROPATH EXP NEUR, V68, P928, DOI 10.1097/NEN.0b013e3181b05d67; Bielschowsky M., 1915, J PSYCHOL NEUROL, V22, P1; Fried RL., DEV NEUROPATHOLOGY, P330; Jacob H., 1940, Z GES NEUROL PSYCH, V170, P64, DOI 10.1007/BF02869355; Judkins AR, 2011, J NEUROPATH EXP NEUR, V70, P438, DOI 10.1097/NEN.0b013e31821ccf1c; Nieuwenhuijse P., 1913, PSYCHIAT NEUROL BL A, V17, P9; Squier Waney, 2014, Acta Neuropathol Commun, V2, P80, DOI 10.1186/s40478-014-0080-3	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	DEC	2015	35	6					569	574		10.1111/neup.12219		6	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CY1AF	WOS:000366137700009		
J	Hino, S; Sasaki, S				Hino, Shuji; Sasaki, Shoichi			Flail arm syndrome with cytoplasmic vacuoles in remaining anterior horn motor neurons: A peculiar variant of amyotrophic lateral sclerosis	NEUROPATHOLOGY			English	Article						flail arm syndrome; brachial amyotrophic diplegia; cytoplasmic vacuole; amyotrophic lateral sclerosis; motor neuron disease	DISEASE; DEGENERATION; DIPLEGIA; DISORDER; MUTATION; HISTORY; SOD1; FORM	Flail arm (FA) syndrome, a minor subtype of amyotrophic lateral sclerosis (ALS), is characterized by progressive weakness and upper girdle wasting, but the associated pathological changes remain unclear. A 59-year-old man was admitted to our hospital with a 3-year history of upper girdle weakness. Bulbar symptom and gait disturbance gradually developed, and he was clinically diagnosed with FA syndrome. After a 10-year disease course, he died of pulmonary adenocarcinoma. Neuropathological examination revealed severe motor neuronal loss in the brain stem and anterior horn of the cervical spinal cord with bilateral pyramidal tract degeneration. The histological findings were consistent with typical ALS, including Bunina bodies and Lewy body-like and skein-like inclusions. Cytoplasmic vacuoles were found in the remaining anterior horn motor neurons of the lumbar spinal cord. This is a unique autopsy case with a long-standing clinical course that suggests that FA syndrome is an atypical form of ALS.	[Hino, Shuji; Sasaki, Shoichi] Tokyo Womens Med Univ, Dept Neurol, Tokyo 1628666, Japan; [Hino, Shuji] Saitama Red Cross Hosp, Dept Neurol, Saitama, Saitama, Japan	Sasaki, S (reprint author), Tokyo Womens Med Univ, Dept Neurol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	ssasaki@nij.twmu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [22590965]	Part of this study was supported by a Grant-in-Aid for General Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (22590965). We thank Mr. M. Karita and Dr. N. Shibata (Department of Pathology, Tokyo Women's Medical University, Tokyo) for the technical assistance of immunohistochemistry. S. Hino and S. Sasaki report they have no conflict of interest to disclose related to his manuscript.	Andrews JM, 1976, UCLA FORUM MED SCI, V19, P181; Logroscino G, 2008, J NEUROL NEUROSUR PS, V79, P6, DOI 10.1136/jnnp.2006.104828; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; Sasaki S, 1999, J NEUROL NEUROSUR PS, V66, P581, DOI 10.1136/jnnp.66.5.581; Gamez J, 1999, J NEUROL NEUROSUR PS, V67, P258, DOI 10.1136/jnnp.67.2.258; Kong JM, 1998, J NEUROSCI, V18, P3241; KOHN R, 1971, J NEUROL NEUROSUR PS, V34, P427, DOI 10.1136/jnnp.34.4.427; Hu MTM, 1998, J NEUROL NEUROSUR PS, V65, P950, DOI 10.1136/jnnp.65.6.950; Kataoka H, 2010, EUR J NEUROL, V17, pe90, DOI 10.1111/j.1468-1331.2010.03146.x; Katz JS, 1999, NEUROLOGY, V53, P1071; Bruijn LI, 1996, NEUROPATH APPL NEURO, V22, P373, DOI 10.1111/j.1365-2990.1996.tb00907.x; Sasaki S, 1998, NEUROLOGY, V51, P871; MITSUMOTO H, 1990, BRAIN, V113, P497, DOI 10.1093/brain/113.2.497; Wijesekera LC, 2009, NEUROLOGY, V72, P1087, DOI 10.1212/01.wnl.0000345041.83406.a2; Gamez J, 2000, NEUROLOGY, V54, P2355; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Czaplinski A, 2004, EUR J NEUROL, V11, P567, DOI 10.1111/j.1468-1331.2004.00841.x; Visser J, 2008, NEUROLOGY, V70, P723, DOI 10.1212/01.wnl.0000302187.20239.93; Sasaki S, 1999, ACTA NEUROPATHOL, V98, P645; Ince PG, 1996, ACTA NEUROPATHOL, V92, P395; BONDUELLE M, 1982, REV NEUROL, V138, P1027; Chi A, 2011, J NEUROL NEUROSUR PS, V82, P740; delsAguila MA, 2003, NEUROLOGY, V60, P813; Vulpian A, 1886, MALADIES SYSTEME NER, P346	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	DEC	2015	35	6					582	586		10.1111/neup.12223		5	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CY1AF	WOS:000366137700011		
J	Iwase, T; Yoshida, M; Mizuno, T; Sato, S; Nokura, K				Iwase, Tamaki; Yoshida, Mari; Mizuno, Tomoyuki; Sato, Shinya; Nokura, Kazuya			An autopsy case of hemiconvulsion-hemiplegia-epilepsy syndrome manifesting as cerebral hemiatrophy in an elderly man	NEUROPATHOLOGY			English	Article						cerebral amyloid angiopathy; cerebral hemiatrophy; hemiconvulsion-hemiplegia-epilepsy syndrome; senile plaques; temporal lobe epilepsy	CROSSED CEREBELLAR ATROPHY; TEMPORAL-LOBE EPILEPSY; GLIAL FIBRILLARY TANGLES; DAVIDOFF-MASSON SYNDROME; THORN-SHAPED ASTROCYTES; HIPPOCAMPAL SCLEROSIS; FEBRILE SEIZURES; PATHOLOGY; BRAIN; ENCEPHALOPATHY	We report an autopsy case of hemiconvulsion-hemiplegia-epilepsy (HHE) syndrome in a 79-year-old man. HHE syndrome usually occurs in children younger than 4 years of age. Although most HHE syndrome patients live into adult life, only a few cases of the syndrome have been reported in the elderly. In our case, cerebral hemiatrophy, left mesial temporal sclerosis and crossed cerebellar atrophy were observed. Because this is the oldest case ever reported, we further investigated age-related neuropathological changes and found an interhemispheric difference in amyloid--related neuropathologic changes. There were almost no senile plaques or amyloid-laden vessels in the left hemisphere. As far as we know, this is the first report of age-related neuropathology in a brain manifesting HHE syndrome.	[Iwase, Tamaki; Mizuno, Tomoyuki] Nagoya City Koseiin Med Welf Ctr, Dept Neurol, Nagoya, Aichi 4658610, Japan; [Yoshida, Mari] Aichi Med Univ, Inst Med Sci Aging, Dept Neuropathol, Nagakute, Aichi, Japan; [Sato, Shinya] Nagoya City Univ, Grad Sch Med Sci, Dept Expt Pathol & Tumor Biol, Nagoya, Aichi, Japan; [Nokura, Kazuya] Fujita Hlth Univ, Sch Med, Ban Buntane Hotokukai Hosp, Dept Neurol, Toyoake, Aichi, Japan	Iwase, T (reprint author), Nagoya City Koseiin Med Welf Ctr, Dept Neurol, Meito Ku, 1501 2 Chome, Nagoya, Aichi 4658610, Japan.	tamaki@med.nagoya-cu.ac.jp					Aicardi J, 1983, Adv Neurol, V34, P115; Gupta R, 2014, AM J MED GENET A, V164, P186, DOI 10.1002/ajmg.a.36198; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239; Thom M, 2011, BRAIN, V134, P2969, DOI 10.1093/brain/awr209; Blumcke I, 2002, BRAIN PATHOL, V12, P199; Blumcke I, 2013, EPILEPSIA, V54, P1315, DOI 10.1111/epi.12220; Wolf HK, 1997, ACTA NEUROPATHOL, V93, P93; Miyata R, 2012, BRAIN DEV-JPN, V34, P360, DOI 10.1016/j.braindev.2011.06.011; MIRRA SS, 1991, NEUROLOGY, V41, P479; CARRAZANA EJ, 1992, NEURORADIOLOGY, V34, P326; Blumcke I, 2007, ACTA NEUROPATHOL, V113, P235, DOI 10.1007/s00401-006-0187-0; STREFLING AM, 1982, ACTA NEUROPATHOL, V57, P197; Auvin S, 2012, EUR J PAEDIATR NEURO, V16, P413, DOI 10.1016/j.ejpn.2012.01.007; Abou-Khalil B, 2001, NEUROLOGY, V57, P2265; Bahi-Buisson N, 2005, DEV MED CHILD NEUROL, V47, P830, DOI 10.1017/S0012162205001751; Caballero PEJ, 2010, NEUROLOGIA, V25, P461, DOI 10.1016/j.nrl.2010.05.003; AICARDI J, 1970, EPILEPSIA, V11, P187, DOI 10.1111/j.1528-1157.1970.tb03880.x; Serino D, 2014, EUR J PAEDIATR NEURO, V18, P416, DOI 10.1016/j.ejpn.2013.11.001; Yamazaki S, 2011, PEDIATR NEUROL, V45, P193, DOI 10.1016/j.pediatrneurol.2011.04.010; IKEDA K, 1995, ACTA NEUROPATHOL, V90, P620; Hashimoto N, 2003, ACTA NEUROPATHOL, V106, P150, DOI 10.1007/s00401-003-0715-0; TAN N, 1984, ACTA NEUROPATHOL, V62, P332; Thal DR, 2002, NEUROLOGY, V58, P1791; Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Attems J, 2005, ACTA NEUROPATHOL, V110, P345, DOI 10.1007/s00401-005-1074-9; Fiala JC, 2007, ACTA NEUROPATHOL, V114, P551, DOI 10.1007/s00401-007-0284-8; Chand G, 2010, ARCH NEUROL-CHICAGO, V67, P1026, DOI 10.1001/archneurol.2010.185; Tenney JR, 2012, NEUROLOGY, V79, pE1, DOI 10.1212/WNL.0b013e31825dce5f; Mirsattari SM, 2008, EPILEPSY BEHAV, V13, P678, DOI 10.1016/j.yebeh.2008.07.008; Schultz C, 2004, NEUROBIOL AGING, V25, P397, DOI 10.1016/S0197-4580(03)00113-1; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; HUDSON LP, 1993, ANN NEUROL, V33, P622, DOI 10.1002/ana.410330611; Kim DW, 2008, NEUROLOGY, V70, P2116, DOI 10.1212/01.wnl.0000289192.50924.93; Cendes F, 2004, CURR OPIN NEUROL, V17, P161, DOI 10.1097/01.wco.0000124706.48483.da; GASTAUT H, 1960, EPILEPSIA, V1, P418; JOSEPHY H, 1945, J NEUROPATH EXP NEUR, V4, P250, DOI 10.1097/00005072-194504030-00004; MARGERIS.JH, 1966, BRAIN, V89, P499, DOI 10.1093/brain/89.3.499; Miteff CI, 2015, J CHILD NEUROL, V30, P83, DOI 10.1177/0883073813516382; Nokura K, 1989, SHINKEI NAIKA, V30, P378; Wieser Heinz-Gregor, 2004, Epilepsia, V45, P695; Winkler WT, 2001, NEUROPATHOL APPL NEU, V27, P403	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	DEC	2015	35	6					592	598		10.1111/neup.12225		7	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CY1AF	WOS:000366137700013		
J	Momota, H; Shimoyama, Y				Momota, Hiroyuki; Shimoyama, Yoshie			Recurrent papillary glioneuronal tumor presenting as a ganglioglioma with the BRAF V600E mutation	NEUROPATHOLOGY			English	Letter									[Momota, Hiroyuki] Nagoya Univ Hosp, Dept Neurosurg, Nagoya, Aichi, Japan; [Shimoyama, Yoshie] Nagoya Univ Hosp, Dept Pathol & Clin Labs, Nagoya, Aichi, Japan; [Momota, Hiroyuki] Univ Tokyo, Div Innovat Canc Therapy, Tokyo 1138654, Japan; [Momota, Hiroyuki] Univ Tokyo, Dept Surg Neuronncol, Inst Med Sci, Tokyo 1138654, Japan	Momota, H (reprint author), Univ Tokyo, Div Innovat Canc Therapy, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	momota-nsu@umin.ac.jp					Bridge JA, 2013, BRAIN PATHOL, V23, P121, DOI 10.1111/j.1750-3639.2012.00612.x; Myung JK, 2011, AM J SURG PATHOL, V35, P1794, DOI 10.1097/PAS.0b013e31823456e6; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Momota H, 2014, NEUROPATHOLOGY, V34, P484, DOI 10.1111/neup.12123; Robinson GW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-258	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	DEC	2015	35	6					603	605		10.1111/neup.12215		3	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CY1AF	WOS:000366137700015		
J	Kanasaki, H; Oride, A; Mijiddorj, T; Kyo, S				Kanasaki, Haruhiko; Oride, Aki; Mijiddorj, Tselmeg; Kyo, Satoru			Role of thyrotropin-releasing hormone in prolactin-producing cell models	NEUROPEPTIDES			English	Review						TRH; Prolactin; GH3; PACAP	CYCLASE-ACTIVATING POLYPEPTIDE; PITUITARY GH3 CELLS; GROWTH-HORMONE; ADENYLATE-CYCLASE; PROTEIN-KINASE; GENE-EXPRESSION; IN-VITRO; ANTERIOR-PITUITARY; MAP KINASE; RAT	Thyrotropin-releasing hormone (TRH) is a hypothalamic hypophysiotropic neuropeptide that was named for its ability to stimulate the release of thyroid-stimulating hormone in mammals. It later became apparent that it exerts a number of species-dependent hypophysiotropic activities that regulate other pituitary hormones, TRH also regulates the synthesis and release of prolactin, although whether it is a physiological regulator of prolactin that remains unclear. Occupation of the Gq protein-coupled TRH receptor in the prolactin-producing lactotroph increases the turnover of inositol, which in turn activates the protein kinase C pathway and the release of Ca2+ from storage sites. TRH-induced signaling events also include the activation of extracellular signal-regulated kinase (ERK) and induction of MAP kinase phosphatase, an inactivator of activated ERK. TRH stimulates prolactin synthesis through the activation of ERK, whereas prolactin release occurs via elevation of intracellular Ca2+. We have been investigating the role of TRH in a pituitary prolactin- producing cell model. Rat pituitary somatolactotroph GH3 cells, which produce and release both prolactin and growth hormone (GH), are widely used as a model for the study of prolactin- and GH-secreting cells. In this review, we describe the general action of TRH as a hypophysiotropic factor in vertebrates and focus on the role of TRH in prolactin synthesis using GH3 cells. (C) 2015 Elsevier Ltd. All rights reserved.	[Kanasaki, Haruhiko; Oride, Aki; Mijiddorj, Tselmeg; Kyo, Satoru] Shimane Univ, Sch Med, Dept Obstet & Gynecol, Izumo, Shimane 6938501, Japan	Kanasaki, H (reprint author), Shimane Univ, Sch Med, Dept Obstet & Gynecol, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	kanasaki@med.shimane-u.ac.jp					BOOCKFOR FR, 1985, ENDOCRINOLOGY, V117, P418; MERCHENTHALER I, 1988, AM J ANAT, V181, P359, DOI 10.1002/aja.1001810404; Mijiddorj T, 2011, MOL CELL ENDOCRINOL, V339, P172, DOI 10.1016/j.mce.2011.04.010; GORBMAN A, 1973, GEN COMP ENDOCR, V20, P588, DOI 10.1016/0016-6480(73)90092-0; DEGREEF WJ, 1981, NEUROENDOCRINOLOGY, V32, P229, DOI 10.1159/000123164; Kagabu Y, 1998, GEN COMP ENDOCR, V111, P395, DOI 10.1006/gcen.1998.7124; Yamada M, 1997, P NATL ACAD SCI USA, V94, P10862, DOI 10.1073/pnas.94.20.10862; CUI ZJ, 1994, ENDOCRINOLOGY, V134, P2245, DOI 10.1210/en.134.5.2245; HOEFFLER JP, 1985, ENDOCRINOLOGY, V117, P187; BRADFORD AP, 1995, MOL CELL BIOL, V15, P2849; JARRY H, 1992, LIFE SCI, V51, P823, DOI 10.1016/0024-3205(92)90609-S; HORN AM, 1985, J ENDOCRINOL, V104, P205, DOI 10.1677/joe.0.1040205; Oride A, 2008, MOL CELL ENDOCRINOL, V296, P78, DOI 10.1016/j.mce.2008.09.002; POULAT P, 1992, J NEUROCYTOL, V21, P157, DOI 10.1007/BF01194975; IVERSEN E, 1984, SCAND J CLIN LAB INV, V44, P703, DOI 10.3109/00365518409083633; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; ARBOGAST LA, 1994, BRAIN RES, V655, P17, DOI 10.1016/0006-8993(94)91592-X; WILDT L, 1981, ENDOCRINOLOGY, V109, P376; SHAMBAUGH G, 1979, J CLIN ENDOCR METAB, V48, P483; Alexander SL, 2004, J NEUROENDOCRINOL, V16, P906, DOI 10.1111/j.1365-2826.2004.01249.x; FRAWLEY LS, 1985, ENDOCRINOLOGY, V116, P734; Larsen DA, 1998, GEN COMP ENDOCR, V109, P276, DOI 10.1006/gcen.1997.7031; Raptis S, 2004, ENDOCRINOLOGY, V145, P1695, DOI 10.1210/en.2003-1576; NAKAJIMA K, 1993, GEN COMP ENDOCR, V89, P11, DOI 10.1006/gcen.1993.1004; KOCH Y, 1977, ENDOCRINOLOGY, V100, P1476; Mijiddorj T, 2013, MOL CELL ENDOCRINOL, V365, P139, DOI 10.1016/j.mce.2012.10.006; BOOCKFOR FR, 1988, ENDOCRINOLOGY, V122, P762; ADRIAANSE R, 1992, CLIN ENDOCRINOL, V37, P504, DOI 10.1111/j.1365-2265.1992.tb01481.x; SCHONBRUNN A, 1980, J CELL BIOL, V85, P786, DOI 10.1083/jcb.85.3.786; HART GR, 1992, J ENDOCRINOL, V134, P33, DOI 10.1677/joe.0.1340033; Kanasaki H, 2002, BIOL REPROD, V67, P107, DOI 10.1095/biolreprod67.1.107; SNYDER PJ, 1973, J CLIN INVEST, V52, P2324, DOI 10.1172/JCI107421; VERTONGEN P, 1995, MOL CELL ENDOCRINOL, V113, P131, DOI 10.1016/0303-7207(95)03626-I; CASTANO JP, 1993, TISSUE CELL, V25, P165, DOI 10.1016/0040-8166(93)90016-E; BURGUS R, 1970, NATURE, V226, P321, DOI 10.1038/226321a0; MELAMED P, 1995, GEN COMP ENDOCR, V97, P13, DOI 10.1006/gcen.1995.1002; SZABO M, 1984, ENDOCRINOLOGY, V114, P1344; TRAN TN, 1989, PEPTIDES, V10, P835, DOI 10.1016/0196-9781(89)90122-8; WINITZ S, 1993, J BIOL CHEM, V268, P19196; Montagne JJ, 1996, ENDOCRINOLOGY, V137, P185, DOI 10.1210/en.137.1.185; JEFFERSON AB, 1991, J BIOL CHEM, V266, P1484; TASHJIAN AH, 1971, BIOCHEM BIOPH RES CO, V43, P516, DOI 10.1016/0006-291X(71)90644-9; Oride A, 2009, BIOCHEM BIOPH RES CO, V382, P663, DOI 10.1016/j.bbrc.2009.03.061; NOEL GL, 1974, J CLIN ENDOCR METAB, V39, P6; Okada R, 2009, ANN NY ACAD SCI, V1163, P262, DOI 10.1111/j.1749-6632.2008.03662.x; Kanasaki H, 1999, BIOL REPROD, V61, P319, DOI 10.1095/biolreprod61.1.319; LEDAFNIET M, 1990, J CLIN ENDOCR METAB, V71, P480; GERSHENGORN MC, 1986, ANNU REV PHYSIOL, V48, P515; Rawlings SR, 1996, ENDOCR REV, V17, P4, DOI 10.1210/er.17.1.4; LEDUQUE P, 1989, ENDOCRINOLOGY, V125, P1492; Crowley W F Jr, 1985, Recent Prog Horm Res, V41, P473; Knobil E, 1980, Recent Prog Horm Res, V36, P53; NAIR RMG, 1970, BIOCHEMISTRY-US, V9, P1103, DOI 10.1021/bi00807a008; OHMICHI M, 1994, J BIOL CHEM, V269, P3783	54	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4179	1532-2785		NEUROPEPTIDES	Neuropeptides	DEC	2015	54						73	77		10.1016/j.npep.2015.08.001		5	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	CY0CG	WOS:000366073300010		
J	Wang, GQ; Tachibana, T; Gilbert, ER; Cline, MA				Wang, Guoqing; Tachibana, Tetsuya; Gilbert, Elizabeth R.; Cline, Mark A.			Exogenous prolactin-releasing peptide's orexigenic effect is associated with hypothalamic neuropeptide Y in chicks	NEUROPEPTIDES			English	Article						Prolactin-releasing peptide; Chick; Hypothalamus; Food intake	CENTRAL-NERVOUS-SYSTEM; FOOD-INTAKE; FEEDING-BEHAVIOR; INTRACEREBROVENTRICULAR INJECTION; NEONATAL CHICKS; STIMULATING-HORMONE; CARASSIUS RFAMIDE; BODY-WEIGHT; RATS; RECEPTORS	Exogenous administration of prolactin-releasing peptide (PrRP) exerts anorexigenic effects in rats while causing orexigenic effects in chicks. While the central mechanism mediating PrRP's effect on food intake in rodents is somewhat understood, in chicks information is lacking. Therefore, this study was designed to elucidate the hypothalamic mechanism of PrRP induction of hunger perception in chicks. Chicks that received intracerebroventricular (ICV) injections of PrRP dose-dependently increased their food intake with no effect on water intake or whole blood glucose concentration. The threshold of food intake stimulation was as low as 3 pmol, thus as compared to other neuropeptides PrRP is exceptionally potent. The mRNA abundance of several appetite-associated neuropeptide genes was quantified and hypothalamic neuropeptide Y (NPY) mRNA was increased in PrRP-injected chicks. Therefore, the orexigenic effects of PrRP may be associated with increased NPY-ergic tone. These results provide insight into the evolutionary aspects of appetite regulation during the course of divergent evolution of mammals and birds. Published by Elsevier Ltd.	[Wang, Guoqing; Gilbert, Elizabeth R.; Cline, Mark A.] Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA; [Tachibana, Tetsuya] Ehime Univ, Fac Agr, Dept Agrobiol Sci, Matsuyama, Ehime 790, Japan	Cline, MA (reprint author), Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA.	macline2@vt.edu			Virginia Agricultural Experiment Station; Hatch Program of the National Institute of Food and Agriculture, U.S. Department of Agriculture	Funding for this work was provided in part, by the Virginia Agricultural Experiment Station and the Hatch Program of the National Institute of Food and Agriculture, U.S. Department of Agriculture.	MCCORMACK JF, 1988, PEPTIDES, V9, P709, DOI 10.1016/0196-9781(88)90110-6; Tachibana T, 2009, GEN COMP ENDOCR, V161, P407, DOI 10.1016/j.ygcen.2009.02.006; Ellacott KLJ, 2002, ENDOCRINOLOGY, V143, P368, DOI 10.1210/en.143.2.368; Furuse M, 1999, BRIT POULTRY SCI, V40, P698, DOI 10.1080/00071669987115; Jonaidi H, 2003, PHYSIOL BEHAV, V79, P725, DOI 10.1016/S0031-9384(03)00145-8; Wang YJ, 2012, ENDOCRINOLOGY, V153, P1861, DOI 10.1210/en.2011-1719; Richard D, 1996, ENDOCRINOLOGY, V137, P4786, DOI 10.1210/en.137.11.4786; Hinuma S, 1998, NATURE, V393, P272, DOI 10.1038/30515; Saito ES, 2005, REGUL PEPTIDES, V125, P201, DOI 10.1016/j.regpep.2004.09.003; Roland BL, 1999, ENDOCRINOLOGY, V140, P5736, DOI 10.1210/en.140.12.5736; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Cline MA, 2009, COMP BIOCHEM PHYS A, V152, P130, DOI 10.1016/j.cbpa.2008.09.008; Seal LJ, 2000, ENDOCRINOLOGY, V141, P1909, DOI 10.1210/en.141.5.1909; Bechtold DA, 2006, ENDOCRINOLOGY, V147, P4723, DOI 10.1210/en.2006-0753; Tachibana T, 2013, PHYSIOL BEHAV, V120, P40, DOI 10.1016/j.physbeh.2013.06.017; Tachibana T, 2001, NEUROSCI LETT, V305, P131, DOI 10.1016/S0304-3940(01)01827-4; Minami S, 1999, NEUROSCI LETT, V266, P73, DOI 10.1016/S0304-3940(99)00263-3; Delfino KR, 2010, NEUROPEPTIDES, V44, P31, DOI 10.1016/j.npep.2009.11.002; Tachibana T, 2011, J NEUROENDOCRINOL, V23, P74, DOI 10.1111/j.1365-2826.2010.02078.x; Tachibana T, 2004, PHYSIOL BEHAV, V80, P713, DOI 10.1016/j.physbeh.2003.12.005; ARLETTI R, 1990, PHYSIOL BEHAV, V48, P825, DOI 10.1016/0031-9384(90)90234-U; Shiraishi J, 2011, PHYSIOL BEHAV, V103, P233, DOI 10.1016/j.physbeh.2011.02.008; Maruyama M, 2001, ENDOCRINOLOGY, V142, P2032, DOI 10.1210/en.142.5.2032; Matsumoto H, 2000, NEUROSCI LETT, V285, P234, DOI 10.1016/S0304-3940(00)01077-6; Tachibana T, 2008, COMP BIOCHEM PHYS A, V151, P637, DOI 10.1016/j.cbpa.2008.08.001; DAVIS JL, 1979, PHYSIOL BEHAV, V22, P693, DOI 10.1016/0031-9384(79)90233-6; ANDERSON DK, 1972, AM J PHYSIOL, V222, P645; Lawrence CB, 2000, NAT NEUROSCI, V3, P645, DOI 10.1038/76597; Samson WK, 2000, BRAIN RES, V858, P19, DOI 10.1016/S0006-8993(99)02451-8; Kalliomaki ML, 2004, NEUROPHARMACOLOGY, V46, P412, DOI 10.1016/j.neuropharm.2003.09.021; Tachibana T, 2005, GEN COMP ENDOCR, V144, P264, DOI 10.1016/j.ygcen.2005.06.012; CHANGEUX JP, 1992, Q REV BIOPHYS, V25, P395; Kelly SP, 2006, AM J PHYSIOL-REG I, V291, pR1474, DOI 10.1152/ajpregu.00129.2006; Lawrence CB, 2002, ENDOCRINOLOGY, V143, P360, DOI 10.1210/en.143.2.360; lijima N, 1999, NEUROREPORT, V10, P1713; Iijima N, 2001, ENDOCRINOLOGY, V142, P3239, DOI 10.1210/en.142.7.3239; National Research Council, 1994, NUTR REQ POULTR; Puelles L, 2007, CHICK BRAIN STEREOTA	38	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4179	1532-2785		NEUROPEPTIDES	Neuropeptides	DEC	2015	54						79	83		10.1016/j.npep.2015.08.004		5	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	CY0CG	WOS:000366073300011		
J	Mitsui, K; Niwa, T; Kawahara, Y; Morimoto, N; Ohmoto, K; Kato, M; Yamaura, Y; Yoshimoto, N; Suna, H; Katsumata, S				Mitsui, Katsukuni; Niwa, Tomohiro; Kawahara, Yuji; Morimoto, Noriko; Ohmoto, Kazuyuki; Kato, Masashi; Yamaura, Yoshiyuki; Yoshimoto, Naoki; Suna, Hideaki; Katsumata, Seishi			Anti-stress effects of ONO-2952, a novel translocator protein 18 kDa antagonist, in rats	NEUROPHARMACOLOGY			English	Article						ONO-2952; Translocator protein 18 kDa; Stress; Neurosteroid; Noradrenaline	BENZODIAZEPINE BINDING-SITES; IRRITABLE-BOWEL-SYNDROME; CORTICOTROPIN-RELEASING HORMONE; PREGNENOLONE SULFATE; NEUROACTIVE STEROIDS; PSYCHIATRIC-DISORDERS; NORADRENERGIC SYSTEM; MAJOR DEPRESSION; GABA(A) RECEPTOR; COLONIC MOTILITY	Accumulating evidence has shown the pathophysiological significance of the translocator protein 18 kDa (TSPO) in the central nervous system. In this study, we evaluated the beneficial effects of ONO-2952, a novel TSPO antagonist in rat stress models. ONO-2952 potently bound both rat and human TSPO (Ki = 0.330-930 nmol/L) with high selectivity over other receptors, transporters, ion channels and enzymes. ONO-2952 inhibited both neurosteroid accumulation and noradrenaline release in the brain of rats exposed to acute stress. The inhibitory effect of ONO-2952 on stress-induced noradrenaline release was attenuated by co-treatment with the TSPO agonist CB34 in a dose-dependent manner. ONO-2952, at 0.3 mg/kg or higher, dose-dependently suppressed restraint stress-induced defecation in rats with brain TSPO occupancy of more than 50%. In addition, ONO-2952, at 1 mg/kg or higher, suppressed conditioned fear stress-induced freezing behavior in rats with an efficacy equivalent to that of diazepam, given orally at 3 mg/kg. Results of the passive avoidance learning test revealed that ONO-2952, unlike diazepam, did not affect learning and memory even at doses 10 times higher than its effective doses in the stress models. The present findings indicate that ONO-2952 is a promising candidate for the treatment of stress-related disorders. (C) 2015 Elsevier Ltd. All rights reserved.	[Mitsui, Katsukuni; Niwa, Tomohiro; Kawahara, Yuji; Morimoto, Noriko; Katsumata, Seishi] ONO Pharmaceut Co Ltd, Discovery Res Labs 1, Shimamoto, Osaka 6188585, Japan; [Ohmoto, Kazuyuki; Kato, Masashi] ONO Pharmaceut Co Ltd, Med Chem Res Labs, Shimamoto, Osaka 6188585, Japan; [Yamaura, Yoshiyuki] ONO Pharmaceut Co Ltd, Pharmaceut Technol Labs, Shimamoto, Osaka 6188585, Japan; [Yoshimoto, Naoki; Suna, Hideaki] ONO Pharmaceut Co Ltd, Pharmacokinet Res Labs, Shimamoto, Osaka 6188585, Japan	Katsumata, S (reprint author), ONO Pharmaceut Co Ltd, Discovery Res Labs 1, 3-1-1 Sakurai, Shimamoto, Osaka 6188585, Japan.	ka.mitsui@ono.co.jp; niwa@ono.co.jp; kawahara@ono.co.jp; no.morimoto@ono.co.jp; k.ohmoto@ono.co.jp; m.katou@ono.co.jp; yamaura@ono.co.jp; n.yoshimoto@ono.co.jp; suna@ono.co.jp; katsumata@ono.co.jp		Mitsui, Katsukuni/0000-0002-3416-2302	ONO Pharmaceutical Co., Ltd (Osaka, Japan)	This research was funded by ONO Pharmaceutical Co., Ltd (Osaka, Japan).	Guan YF, 2003, BRAIN RES, V984, P33, DOI 10.1016/S0006-8993(03)03016-6; Rao SSC, 1998, AM J GASTROENTEROL, V93, P985, DOI 10.1016/S0002-9270(98)00174-9; MAJEWSKA MD, 1992, PROG NEUROBIOL, V38, P379, DOI 10.1016/0301-0082(92)90025-A; Hirata T, 2007, J PHARMACOL SCI, V104, P263, DOI 10.1254/jphs.FP0070620; Zhang HT, 2005, PSYCHOPHARMACOLOGY, V179, P613, DOI 10.1007/s00213-004-2085-2; LEFUR G, 1983, LIFE SCI, V33, P449, DOI 10.1016/0024-3205(83)90794-4; Strous RD, 2006, EUR NEUROPSYCHOPHARM, V16, P155, DOI 10.1016/j.euroneuro.2005.09.005; Weaver CE, 1998, BRAIN RES, V803, P129, DOI 10.1016/S0006-8993(98)00640-4; Kita A, 2004, BRIT J PHARMACOL, V142, P1059, DOI 10.1038/sj.bjp.0705681; ANSSEAU M, 1991, PHARMACOPSYCHIATRY, V24, P8, DOI 10.1055/s-2007-1014425; Timmermans W, 2013, NEUROSCIENCE, V248, P626, DOI 10.1016/j.neuroscience.2013.05.043; BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; Chauveau F, 2008, EUR J NUCL MED MOL I, V35, P2304, DOI 10.1007/s00259-008-0908-9; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Cascio C, 2000, J NEUROCHEM, V74, P2380, DOI 10.1046/j.1471-4159.2000.0742380.x; Hardwick M, 1999, CANCER RES, V59, P831; Kita A, 2008, PHARMACOL BIOCHEM BE, V89, P171, DOI 10.1016/j.pbb.2007.12.006; Merali Z, 2004, EUR J NEUROSCI, V20, P229, DOI 10.1111/j.1460-9568.2004.03468.x; FERRARESE C, 1991, NEUROPHARMACOLOGY, V30, P1445; IDA Y, 1985, LIFE SCI, V37, P2491, DOI 10.1016/0024-3205(85)90606-X; Suda K, 2013, WORLD J GASTROENTERO, V19, P1200, DOI 10.3748/wjg.v19.i8.1200; Belmar J, 1998, NEUROENDOCRINOLOGY, V68, P264, DOI 10.1159/000054374; Zheng P, 2009, PROG NEUROBIOL, V89, P134, DOI 10.1016/j.pneurobio.2009.07.001; IshidaTokuda K, 1996, JPN J PHARMACOL, V72, P119, DOI 10.1254/jjp.72.119; Blier P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0536; GRANT SJ, 1980, LIFE SCI, V27, P2231, DOI 10.1016/0024-3205(80)90389-6; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Spiller RC, 2011, CURR OPIN PHARMACOL, V11, P68, DOI 10.1016/j.coph.2011.02.005; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; MELCHIOR CL, 1994, PHARMACOL BIOCHEM BE, V48, P893, DOI 10.1016/0091-3057(94)90197-X; Bialer M, 2013, EPILEPSY RES, V103, P2, DOI 10.1016/j.eplepsyres.2012.10.001; Bicikova M, 2000, NEUROCHEM RES, V25, P1623, DOI 10.1023/A:1026622704704; KOSLOW SH, 1983, ARCH GEN PSYCHIAT, V40, P999; Wong ML, 2000, P NATL ACAD SCI USA, V97, P325, DOI 10.1073/pnas.97.1.325; Mensah-Nyagan AG, 1999, PHARMACOL REV, V51, P63; Rasmusson AM, 2006, BIOL PSYCHIAT, V60, P704, DOI 10.1016/j.biopsych.2006.03.026; Strohle A, 2000, J PSYCHIAT RES, V34, P183, DOI 10.1016/S0022-3956(00)00006-6; Sullivan GM, 1999, BIOL PSYCHIAT, V46, P1205, DOI 10.1016/S0006-3223(99)00246-2; Da Pozzo E, 2012, CURR MOL MED, V12, P426; Gavish M, 1999, PHARMACOL REV, V51, P629; STAM R, 1995, PHYSIOL BEHAV, V58, P803, DOI 10.1016/0031-9384(95)00137-8; PAPADOPOULOS V, 1992, P NATL ACAD SCI USA, V89, P5113, DOI 10.1073/pnas.89.11.5113; Belujon P, 2011, ANN NY ACAD SCI, V1216, P114, DOI 10.1111/j.1749-6632.2010.05896.x; Rupprecht R, 2009, SCIENCE, V325, P490, DOI 10.1126/science.1175055; Pardon MC, 2002, NEUROSCIENCE, V115, P229, DOI 10.1016/S0306-4522(02)00364-0; ANHOLT RRH, 1986, J BIOL CHEM, V261, P576; PINTER A, 1993, NEUROREPORT, V4, P1203; Nothdurfter C, 2012, CURR TOP MED CHEM, V12, P360; Mohler H, 2006, CELL TISSUE RES, V326, P505, DOI 10.1007/s00441-006-0284-3; Cosenza-Nashat M, 2009, NEUROPATH APPL NEURO, V35, P306, DOI 10.1111/j.1365-2990.2008.01006.x; Morilak DA, 2005, PROG NEURO-PSYCHOPH, V29, P1214, DOI 10.1016/j.pnpbp.2005.08.007; BONAZ B, 1994, BRAIN RES, V641, P21, DOI 10.1016/0006-8993(94)91810-4; Valentino RJ, 2008, EUR J PHARMACOL, V583, P194, DOI 10.1016/j.ejphar.2007.11.062; MARANGOS PJ, 1982, MOL PHARMACOL, V22, P26; Sarkar J, 2011, J NEUROSCI, V31, P18198, DOI 10.1523/JNEUROSCI.2560-11.2011; COSTA E, 1991, LIFE SCI, V49, P325, DOI 10.1016/0024-3205(91)90440-M; Funatsu T, 2007, EUR J PHARMACOL, V573, P190, DOI 10.1016/j.ejphar.2007.06.041; Torres SR, 2000, EUR J PHARMACOL, V408, P199, DOI 10.1016/S0014-2999(00)00760-3; Barbaccia ML, 1996, PHARMACOL BIOCHEM BE, V54, P205, DOI 10.1016/0091-3057(95)02133-7; Ebner MJ, 2006, ENDOCRINOLOGY, V147, P179, DOI 10.1210/en.2005-1065; Myers B., 2009, FRONT NEUROSCI, V3, P1; Paxinos G., 1998, RAT BRAIN STEREOTAXI; Pinna G, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00166; PURDY RH, 1991, P NATL ACAD SCI USA, V88, P4553, DOI 10.1073/pnas.88.10.4553; Serra M, 1999, BRIT J PHARMACOL, V127, P177, DOI 10.1038/sj.bjp.0702530	67	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	DEC	2015	99						51	66		10.1016/j.neuropharm.2015.07.011		16	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	CY0AA	WOS:000366066800006		
J	Nemoto, W; Ogata, Y; Nakagawasai, O; Yaoita, F; Tadano, T; Tan-No, K				Nemoto, Wataru; Ogata, Yoshiki; Nakagawasai, Osamu; Yaoita, Fukie; Tadano, Takeshi; Tan-No, Koichi			Involvement of p38 MAPK activation mediated through AT1 receptors on spinal astrocytes and neurons in angiotensin II- and III-induced nociceptive behavior in mice	NEUROPHARMACOLOGY			English	Article						Angiotensin II; Angiotensin III; AT1 receptors; Nociceptive behavior; p38 MAPK; Astrocyte; Neuron; Intrathecal administration; Mice	DORSAL-ROOT GANGLIA; CHRONIC-CONSTRICTION-INJURY; PERIPHERAL-NERVE INJURY; SIGNAL-REGULATED KINASE; PROTEIN-KINASE; NEUROPATHIC PAIN; MECHANICAL ALLODYNIA; GLIAL ACTIVATION; DIFFERENTIAL ACTIVATION; CENTRAL SENSITIZATION	We have previously demonstrated the possibility that angiotensin (Ang) II and its N-terminal metabolite Ang (1-7) act as neurotransmitters and/or neuromodulators in the spinal transmission of nociceptive information. Ang III, which is a C-terminal metabolite of Ang II, can also act on AT1 receptors, but its role in spinal nociceptive transmission remains unclear. Therefore, we examined the role of Ang III on the spinal nociceptive system in comparison with that of Ang II. Intrathecal (i.t) administration of Ang III into mice produced a nociceptive behavior, which was dose-dependently inhibited by the co-administration of the AT1 receptor antagonist losartan and the p38 MAPK inhibitor SB203580, but not by the AT2 receptor antagonist PD123319, MEK1/2 inhibitor U0126 and JNK inhibitor SP600125. In addition, Ang III increased the phosphorylation of p38 MAPK in the dorsal lumbar spinal cord, which was inhibited by losartan. These effects were similar to those of observed with Ang II. The nociceptive behavior produced by Ang II or III was also attenuated by the administration of the astrocytic inhibitor L-a-aminoadipic acid, but not by the microglial inhibitor minocycline. Double immunohistochemical staining showed that spinal AT1 receptors were expressed on neurons and astrocytes, and that i.t. administration of either Ang II or III phosphorylated p38 MAPK in both spinal astrocytes and neurons. These results indicate that Ang III produces nociceptive behavior similar to Ang II, and suggest that the phosphorylation of p38 MAPK mediated through AT1 receptors on spinal astrocytes and neurons contributes to Ang II- and III-induced nociceptive behavior. (C) 2015 Elsevier Ltd. All rights reserved.	[Nemoto, Wataru; Ogata, Yoshiki; Nakagawasai, Osamu; Yaoita, Fukie; Tan-No, Koichi] Tohoku Pharmaceut Univ, Dept Pharmacol, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Tadano, Takeshi] Kanazawa Univ, Dept Hlth Care Med Res, Venture Business Lab, Kanazawa, Ishikawa 9201192, Japan	Tan-No, K (reprint author), Tohoku Pharmaceut Univ, Dept Pharmacol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	koichi@tohoku-pharm.ac.jp			JSPS KAKENHI [26460101]; Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank Mr. Daichi Hasegawa, Ms. Satomi Aoki, Mr. Yuki Kawata, Ms. Yoshiko Shimawaki and Ms. Shiori Hino at Tohoku Pharmaceutical University for their technical assistance. This study was supported in part by JSPS KAKENHI Grant Number 26460101 to KT, WN and ON, and Matching Fund Subsidy for Private University from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Patil J, 2010, REGUL PEPTIDES, V162, P90, DOI 10.1016/j.regpep.2010.03.004; Zhuang ZY, 2006, J NEUROSCI, V26, P3551, DOI 10.1523/JNEUROSCI.5290-05.2006; Svensson CI, 2003, J NEUROCHEM, V86, P1534, DOI 10.1046/j.1471-4159.2003.01969.x; Sweitzer SM, 2004, PAIN, V111, P278, DOI 10.1016/j.pain.2004.07.007; Gebke E, 1998, NEUROSCIENCE, V85, P509, DOI 10.1016/S0306-4522(97)00601-5; Moon JY, 2014, BRIT J PHARMACOL, V171, P5881, DOI 10.1111/bph.12893; Gao YJ, 2010, J NEUROCHEM, V115, P505, DOI 10.1111/j.1471-4159.2010.06946.x; Zhang RX, 2005, PAIN, V118, P125, DOI 10.1016/j.pain.2005.08.001; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; Gwak YS, 2008, PAIN, V138, P410, DOI 10.1016/j.pain.2008.01.021; Pavel J, 2008, BRAIN RES, V1246, P111, DOI 10.1016/j.brainres.2008.09.099; Fyhrquist F, 2008, J INTERN MED, V264, P224, DOI 10.1111/j.1365-2796.2008.01981.x; Stegbauer J, 2009, P NATL ACAD SCI USA, V106, P14942, DOI 10.1073/pnas.0903602106; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Bodineau L, 2008, HYPERTENSION, V51, P1318, DOI 10.1161/HYPERTENSIONAHA.107.098772; Hu HJ, 2006, NEURON, V50, P89, DOI 10.1016/j.neuron.2006.03.010; Terayama R, 2008, NEUROSCIENCE, V153, P1245, DOI 10.1016/j.neuroscience.2008.03.041; Gu YW, 2008, NEUROSCI LETT, V431, P129, DOI 10.1016/j.neulet.2007.11.065; DeLeo JA, 2001, PAIN, V90, P1, DOI 10.1016/S0304-3959(00)00490-5; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Tsuda M, 2004, GLIA, V45, P89, DOI 10.1002/glia.10308; Xu L, 2007, ANESTH ANALG, V105, P1838; Santos RAS, 2008, EXP PHYSIOL, V93, P519, DOI 10.1113/expphysiol.2008.042002; Ferrario CM, 2005, AM J PHYSIOL-HEART C, V289, pH2281, DOI 10.1152/ajpheart.00618.2005; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Zhang T, 2009, BRAIN RES BULL, V79, P219, DOI 10.1016/j.brainresbull.2009.01.009; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Pavao-de-Souza GF, 2012, PHARMACOL BIOCHEM BE, V101, P320, DOI 10.1016/j.pbb.2012.01.018; Watkins LR, 2001, PAIN, V93, P201, DOI 10.1016/S0304-3959(01)00359-1; Wu CY, 2013, MOL CELL BIOCHEM, V382, P47, DOI 10.1007/s11010-013-1717-4; Fuchtbauer L, 2011, BRAIN BEHAV IMMUN, V25, P897, DOI 10.1016/j.bbi.2010.09.015; Jin SX, 2003, J NEUROSCI, V23, P4017; Bosnyak S, 2011, CLIN SCI, V121, P297, DOI 10.1042/CS20110036; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Mika J, 2009, EUR J PHARMACOL, V623, P65, DOI 10.1016/j.ejphar.2009.09.030; Ma WY, 2002, PAIN, V99, P175, DOI 10.1016/S0304-3959(02)00097-0; Honore P, 2000, NEUROSCIENCE, V98, P585, DOI 10.1016/S0306-4522(00)00110-X; Yamazato M, 2007, HYPERTENSION, V49, P926, DOI 10.1161/01.HYP.0000259942.38108.20; Sweitzer SM, 1999, BRAIN RES, V829, P209, DOI 10.1016/S0006-8993(99)01326-8; Santos RAS, 2003, HYPERTENSION, V41, P737, DOI 10.1161/01.HYP.0000052947.60363.24; Kim SY, 2002, NEUROREPORT, V13, P2483, DOI 10.1097/01.wnr.0000048540.12213.f2; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Mizoguchi H, 2011, EUR J PHARMACOL, V653, P21, DOI 10.1016/j.ejphar.2010.10.096; Boyle DL, 2006, PLOS MED, V3, P1616, DOI 10.1371/journal.pmed.0030338; Brambilla R, 2014, GLIA, V62, P452, DOI 10.1002/glia.22616; Cui XY, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-17; Ikeda H, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-43; Ji XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060733; Nemoto W, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-38; Nemoto W, 2015, NEUROSCI LETT, V585, P17, DOI 10.1016/j.neulet.2014.11.018; Nemoto W, 2014, EUR J PAIN, V18, P1471, DOI 10.1002/ejp.512; Pelegrini-da-Silva A, 2009, NEUROSCIENCE, V164, P1263, DOI 10.1016/j.neuroscience.2009.09.004; Santos RAS, 2013, J ENDOCRINOL, V216, pR1, DOI 10.1530/JOE-12-0341	54	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	DEC	2015	99						221	231		10.1016/j.neuropharm.2015.07.022		11	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	CY0AA	WOS:000366066800021		
J	Ujihara, I; Hitomi, S; Ono, K; Kakinoki, Y; Hashimoto, H; Ueta, Y; Inenaga, K				Ujihara, Izumi; Hitomi, Suzuro; Ono, Kentaro; Kakinoki, Yasuaki; Hashimoto, Hirofumi; Ueta, Yoichi; Inenaga, Kiyotoshi			The ethanol metabolite acetaldehyde induces water and salt intake via two distinct pathways in the central nervous system of rats	NEUROPHARMACOLOGY			English	Article						Ethanol; Thirst; Acetaldehyde; Angiotensin II	SUBFORNICAL ORGAN; ANGIOTENSIN-II; CIRCUMVENTRICULAR ORGANS; ARGININE VASOPRESSIN; PLASMA VASOPRESSIN; CALCIUM CURRENTS; SODIUM APPETITE; BLOOD-PRESSURE; ALCOHOL; BRAIN	The sensation of thirst experienced after heavy alcohol drinking is widely regarded as a consequence of ethanol (EtOH)-induced diuresis, but EtOH in high doses actually induces anti-diuresis. The present study was designed to investigate the introduction mechanism of water and salt intake after heavy alcohol drinking, focusing on action of acetaldehyde, a metabolite of EtOH and a toxic substance, using rats. The aldehyde dehydrogenase (ALDH) inhibitor cyanamide was used to mimic the effect of prolonged acetaldehyde exposure because acetaldehyde is quickly degraded by ALDH. Systemic administration of a high-dose of EtOH at 2.5 g/kg induced water and salt intake with anti-diuresis. Cyanamide enhanced the fluid intake following EtOH and acetaldehyde administration. Systemic administration of acetaldehyde with cyanamide suppressed blood pressure and increased plasma renin activity. Blockade of central angiotensin receptor AT1R suppressed the acetaldehyde-induced fluid intake and c-Fos expression in the circumventricular organs (CVOs), which form part of dipsogenic mechanism in the brain. In addition, central administration of acetaldehyde together with cyanamide selectively induced water but not salt intake without changes in blood pressure. In electrophysiological recordings from slice preparations, acetaldehyde specifically excited angiotensin-sensitive neurons in the CVO. These results suggest that acetaldehyde evokes the thirst sensation following heavy alcohol drinking, by two distinct and previously unsuspected mechanisms, independent of diuresis. First acetaldehyde indirectly activates AT1R in the dipsogenic centers via the peripheral renin-angiotensin system following the depressor response and induces both water and salt intake. Secondly acetaldehyde directly activates neurons in the dipsogenic centers and induces only water intake. (C) 2015 Elsevier Ltd. All rights reserved.	[Ujihara, Izumi; Hitomi, Suzuro; Ono, Kentaro; Inenaga, Kiyotoshi] Kyushu Dent Univ, Div Physiol, Kitakyushu, Fukuoka 8038580, Japan; [Ujihara, Izumi; Kakinoki, Yasuaki] Kyushu Dent Univ, Div Special Needs & Geriatr Dent, Kitakyushu, Fukuoka 8038580, Japan; [Hashimoto, Hirofumi; Ueta, Yoichi] Univ Occupat & Environm Hlth, Sch Med, Dept Physiol, Kitakyushu, Fukuoka 8078555, Japan	Inenaga, K (reprint author), Kyushu Dent Univ, Div Physiol, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan.	ine@kyu-dent.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23592743, 26462819]	We wish to acknowledge valuable discussion with Dr. T. Isse (University of Occupational & Environmental Health, Kitakyushu, Japan) and technical assistance of Drs. S. Kuramitsu, S. Kanda, T. Kondo, K. Tanaka and T. Yamaguchi and Ms. A. Kuroki (Kyushu Dental University, Kitakyushu, Japan). This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (JSPS KAKENHI 23592743 (K.I.) and 26462819 (K.I.)).	Diana M, 2008, ANN NY ACAD SCI, V1139, P307, DOI 10.1196/annals.1432.009; KAWANO Y, 1992, HYPERTENSION, V20, P219; POSO AR, 1981, TOXICOL LETT, V8, P57, DOI 10.1016/0378-4274(81)90138-7; WEIGHT FF, 1991, ANN NY ACAD SCI, V625, P97, DOI 10.1111/j.1749-6632.1991.tb33833.x; FITTS DA, 1993, BEHAV NEUROSCI, V107, P339, DOI 10.1037/0735-7044.107.2.339; Srivastava S, 1998, J BIOL CHEM, V273, P10893, DOI 10.1074/jbc.273.18.10893; GILL K, 1992, ALCOHOL CLIN EXP RES, V16, P910, DOI 10.1111/j.1530-0277.1992.tb01892.x; TAIVAINEN H, 1995, ALCOHOL CLIN EXP RES, V19, P759, DOI 10.1111/j.1530-0277.1995.tb01579.x; Kodavali L, 2006, CURR HYPERTENS REP, V8, P338, DOI 10.1007/s11906-006-0074-z; Suzuki H, 2009, J NEUROENDOCRINOL, V21, P183, DOI [10.1111/j.1365-2826.2009.01818.x, 10.1111/j.1365-2826.2009.01841.x]; Geerling JC, 2008, EXP PHYSIOL, V93, P177, DOI 10.1113/expphysiol.2007.039891; Melis M, 2009, ALCOHOL, V43, P531, DOI 10.1016/j.alcohol.2009.05.004; OSTROVSKY YM, 1986, ALCOHOL, V3, P239, DOI 10.1016/0741-8329(86)90032-7; Wagner C, 2010, KIDNEY INT, V78, P762, DOI 10.1038/ki.2010.257; WANG XM, 1991, J PHARMACOL EXP THER, V259, P705; JOHNSON AK, 1993, FASEB J, V7, P678; Hirase M, 2008, NEUROREPORT, V19, P323, DOI 10.1097/WNR.0b013e3282f50c51; Fitzsimons JT, 1998, PHYSIOL REV, V78, P583; Penning R, 2012, ALCOHOL ALCOHOLISM, V47, P248, DOI 10.1093/alcalc/ags029; ZIMATKIN SM, 1992, ALCOHOL CLIN EXP RES, V16, P1162, DOI 10.1111/j.1530-0277.1992.tb00713.x; Smith CA, 2007, AM J PHYSIOL-REG I, V292, pR2089, DOI 10.1152/ajpregu.00595.2006; Flynn FW, 2003, PHYSIOL BEHAV, V80, P281, DOI 10.1016/j.physbeh.2003.08.010; Sanchez-Lemus E, 2009, BRAIN BEHAV IMMUN, V23, P945, DOI 10.1016/j.bbi.2009.04.012; Inenaga K, 1995, BRAIN RES, V705, P85, DOI 10.1016/0006-8993(95)01149-8; Hipolito L, 2007, CURR DRUG METAB, V8, P716, DOI 10.2174/138920007782109797; Satoh Yasuo, 2008, Japanese Journal of Alcohol Studies & Drug Dependence, V43, P188; Miyahara N, 2012, BRAIN RES, V1447, P44, DOI 10.1016/j.brainres.2012.01.063; Kinoshita H, 2002, ALCOHOL ALCOHOLISM, V37, P432, DOI 10.1093/alcalc/37.5.432; Bjorkqvist J, 2013, BIOL CHEM, V394, P1195, DOI 10.1515/hsz-2013-0144; Haorah J, 2005, J LEUKOCYTE BIOL, V78, P1223, DOI 10.1189/jlb.0605340; McLaughlin PJ, 2008, PHARMACOL BIOCHEM BE, V89, P304, DOI 10.1016/j.pbb.2008.01.002; Xu SH, 2000, J AUTONOM NERV SYST, V78, P177, DOI 10.1016/S0165-1838(99)00069-7; Closon C, 2009, ALCOHOL CLIN EXP RES, V33, P2005, DOI 10.1111/j.1530-0277.2009.01039.x; HASHIMOTO H, 1985, ENDOCRINOL JAPON, V32, P489; JONES AW, 1988, BRIT J CLIN PHARMACO, V25, P213; POHORECKY LA, 1985, ALCOHOL, V2, P659, DOI 10.1016/0741-8329(85)90143-0; WANG XM, 1991, BRAIN RES, V551, P338, DOI 10.1016/0006-8993(91)90954-T; TSUKAMOTO S, 1989, ALCOHOL ALCOHOLISM, V24, P101; McKinley MJ, 2003, INT J BIOCHEM CELL B, V35, P901, DOI 10.1016/S1357-2725(02)00306-0; GUTMAN MB, 1989, BRAIN RES, V488, P49, DOI 10.1016/0006-8993(89)90692-6; Inenaga K, 2008, BRAIN RES, V1200, P51, DOI 10.1016/j.brainres.2008.01.040; Kinoshita H, 2001, ALCOHOL ALCOHOLISM, V36, P59, DOI 10.1093/alcalc/36.1.59; Orrico A, 2013, PSYCHOPHARMACOLOGY, V228, P563, DOI 10.1007/s00213-013-3065-1; Asami R., 2010, BRAIN RES, V1383, P179; Dopico A.M., 1995, ALCOHOL HORMONES, P209; EISENHOFER G, 1982, AM J PHYSIOL, V242, pR522; Isse Toyohi, 2005, Journal of Toxicological Sciences, V30, P315, DOI 10.2131/jts.30.315; Perez-Idarraga A, 2014, APPL PHYSIOL NUTR ME, V39, P1167, DOI 10.1139/apnm-2013-0434; STUBBS CD, 1993, ALCOHOL, CELL MEMBRANES, AND SIGNAL TRANSDUCTION IN BRAIN, P1; Oka Y, 2015, NATURE, V520, P349, DOI 10.1038/nature14108	50	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	DEC	2015	99						589	599		10.1016/j.neuropharm.2015.08.023		11	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	CY0AA	WOS:000366066800056		
J	Hashimoto, H; Kawamura, K; Takei, M; Igarashi, N; Fujishiro, T; Shiomi, S; Watanabe, R; Muto, M; Furutsuka, K; Ito, T; Yamasaki, T; Yui, J; Nemoto, K; Kimura, Y; Higuchi, M; Zhang, MR				Hashimoto, Hiroki; Kawamura, Kazunori; Takei, Makoto; Igarashi, Nobuyuki; Fujishiro, Tomoya; Shiomi, Satoshi; Watanabe, Ryuji; Muto, Masatoshi; Furutsuka, Kenji; Ito, Takehito; Yamasaki, Tomoteru; Yui, Joji; Nemoto, Kazuyoshi; Kimura, Yasuyuki; Higuchi, Makoto; Zhang, Ming-Rong			Identification of a major radiometabolite of [C-11]PBB3	NUCLEAR MEDICINE AND BIOLOGY			English	Article						[C-11]PBB3; tau probe; PET; radiometabolite; sulfotransferase; cytochrome P450	TAU PATHOLOGY; ALZHEIMERS-DISEASE; PET; RADIOLIGAND; QUANTIFICATION; METABOLISM; C-11-PBB3; F-18	Introduction: [C-11]PBB3 is a clinically used positron emission tomography (PET) probe for in vivo imaging of tau pathology in the brain. Our previous study showed that [C-11]PBB3 was rapidly decomposed to a polar radiometabolite in the plasma of mice. For the pharmacokinetic evaluation of [C-11]PBB3 it is important to elucidate the characteristics of radiometabolites. In this study, we identified the chemical structure of a major radiometabolite of [C-11]PBB3 and proposed the metabolic pathway of [C-11]PBB3. Methods: Carrier-added [C-11]PBB3 was injected into a mouse for in vivo metabolite analysis. The chemical structure of a major radiometabolite was identified using LC-MS. Mouse and human liver microsomes and liver S9 samples were incubated with [C-11]PBB3 in vitro. In silico prediction software was used to assist in the determination of the metabolite and metabolic pathway of [11C]PBB3. Results: In vivo analysis showed that the molecular weight of a major radiometabolite of [C-11]PBB3, which was called as [C-11]M2, was m/z 390 [M+H+]. In vitro analysis assisted by in silica prediction showed that [C-11]M2, which was not generated by cytochrome P450 enzymes (CYPs), was generated by sulfated conjugation mediated by a sulfotransferase. Conclusion: The major radiometabolite, [C-11]M2, was identified as a sulfated conjugate of [C-11]PBB3. [C-11]PBB3 was metabolized mainly by a sulfotransferase and subsidiarily by CYPs. (C) 2015 Elsevier Inc. All rights reserved.	[Hashimoto, Hiroki; Kawamura, Kazunori; Takei, Makoto; Igarashi, Nobuyuki; Fujishiro, Tomoya; Shiomi, Satoshi; Watanabe, Ryuji; Muto, Masatoshi; Furutsuka, Kenji; Ito, Takehito; Yamasaki, Tomoteru; Yui, Joji; Nemoto, Kazuyoshi; Kimura, Yasuyuki; Higuchi, Makoto; Zhang, Ming-Rong] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 2638555, Japan; [Igarashi, Nobuyuki; Fujishiro, Tomoya; Shiomi, Satoshi; Watanabe, Ryuji; Muto, Masatoshi] Tokyo Nucl Serv Co Ltd, Tokyo, Japan; [Furutsuka, Kenji; Ito, Takehito] SHI Accelerator Serv Ltd, Tokyo, Japan	Kawamura, K (reprint author), Natl Inst Radiol Sci, Mol Probe Program, Mol Imaging Ctr, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	kawamur@nirs.go.jp					Peyronneau MA, 2012, NUCL MED BIOL, V39, P347, DOI 10.1016/j.nucmedbio.2011.09.006; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Xu CJ, 2005, ARCH PHARM RES, V28, P249, DOI 10.1007/BF02977789; Okamura N, 2013, J NUCL MED, V54, P1420, DOI 10.2967/jnumed.112.117341; Brandon EFA, 2003, TOXICOL APPL PHARM, V189, P233, DOI 10.1016/S0041-008X(03)00128-5; Xia CF, 2013, ALZHEIMERS DEMENT, V9, P666, DOI 10.1016/j.jalz.2012.11.008; Kimura Y, 2015, J NUCL MED, V56, P1359, DOI 10.2967/jnumed.115.160127; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Peyronneau MA, 2013, DRUG METAB DISPOS, V41, P122, DOI 10.1124/dmd.112.046342; SURH YJ, 1993, CANCER RES, V53, P1017; Furukawa T, 2012, DRUG METAB PHARMACOK, V27, P171, DOI 10.2133/dmpk.DMPK-11-RG-088; Takei M, 2001, APPL RADIAT ISOTOPES, V55, P229, DOI 10.1016/S0969-8043(00)00392-4; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; Pike VW, 2009, TRENDS PHARMACOL SCI, V30, P431, DOI 10.1016/j.tips.2009.05.005; Hashimoto H, 2014, J NUCL MED, V55, P1532, DOI 10.2967/jnumed.114.139550; Harada R, 2015, EUR J NUCL MED MOL I, V42, P1052, DOI 10.1007/s00259-015-3035-4; Wood Heather, 2013, Nat Rev Neurol, V9, P599, DOI 10.1038/nrneurol.2013.216	17	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0969-8051	1872-9614		NUCL MED BIOL	Nucl. Med. Biol.	DEC	2015	42	12					905	910		10.1016/j.nucmedbio.2015.08.006		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CY1EM	WOS:000366149500001		
J	Marchesiello, P; Benshila, R; Almar, R; Uchiyama, Y; McWilliams, JC; Shchepetkin, A				Marchesiello, Patrick; Benshila, Rachid; Almar, Rafael; Uchiyama, Yusuke; McWilliams, James C.; Shchepetkin, Alexander			On tridimensional rip current modeling	OCEAN MODELLING			English	Article						Rip current; Intrinsic variability; Tridimensional modeling; Video imaging; Biscarrosse beach	SHORELINE BOUNDARY-CONDITIONS; WAVE-CURRENT INTERACTION; SURF ZONE; SWASH ZONE; NEARSHORE; ROMS; SYSTEM; DISSIPATION; VARIABILITY; MORPHOLOGY	Do lateral shear instabilities of nearshore circulation account for a substantial part of Very Low-Frequency (VLF) variability? If yes, it would promote stirring and mixing of coastal waters and surf-shelf exchanges. Another question is whether tridimensional transient processes are important for instability generation. An innovative modeling system with tridimensional wave-current interactions was designed to investigate transient nearshore currents and interactions between nearshore and innershelf circulations. We present here some validation of rip current modeling for the Aquitanian coast of France, using in-situ and remote video sensing. We then proceed to show the benefits of 3D versus 2D (depth-mean flow) modeling of rip currents and their low-frequency variability. It appears that a large part of VLF motions is due to intrinsic variability of the tridimensional flow. 3D models may thus provide a valuable, only marginally more expensive alternative to conventional 2D approaches that miss the vertical flow structure and its nonlinear interaction with the depth-averaged flow. (C) 2015 Published by Elsevier Ltd.	[Marchesiello, Patrick; Almar, Rafael] IRD LEGOS, F-31400 Toulouse, France; [Benshila, Rachid] CNRS, LEGOS, F-31400 Toulouse, France; [Uchiyama, Yusuke] Kobe Univ, Civil Eng, Kobe, Hyogo 6578501, Japan; [McWilliams, James C.; Shchepetkin, Alexander] Univ Calif Los Angeles, Atmos Ocean Sci, Los Angeles, CA 90095 USA	Marchesiello, P (reprint author), IRD LEGOS, 14 Ave Edouard Belin, F-31400 Toulouse, France.	Patrick.Marchesiello@ird.fr			ANN in France [COMODO: ANR-11-MONU-005]; LEFE/INSU (COMODO-WAVES) in France; NSF in the USA [OCE-1344970]; ONR in the USA [N000141410626]	This research has received support from grants by ANN (COMODO: ANR-11-MONU-005) and LEFE/INSU (COMODO-WAVES) in France; NSF (OCE-1344970) and ONR (N000141410626) in the USA. It was also granted access to the HPC resources of GENCI-IDRIS under allocation 2014-017298. We thank the EPOC/METHYS coastal dynamics group for providing in-situ data from the June 2007 campaign and Philippe Bonneton for useful discussions. We also thank three anonymous reviewers for their careful reading of our manuscript and their insightful comments and suggestions.	Almar R., 2009, J COASTAL RES SI, P1706; Marchesiello P, 2003, J PHYS OCEANOGR, V33, P753, DOI 10.1175/1520-0485(2003)33<753:ESADOT>2.0.CO;2; LEITH CE, 1968, PHYS FLUIDS, V11, P671, DOI 10.1063/1.1691968; Penven P, 2006, OCEAN MODEL, V12, P157, DOI 10.1016/j.ocemod.2005.05.002; Shepard FP, 1941, J GEOL, V49, P337; Bruneau N, 2009, CONT SHELF RES, V29, P1650, DOI 10.1016/j.csr.2009.05.005; Holland KT, 1997, IEEE J OCEANIC ENG, V22, P81, DOI 10.1109/48.557542; McWilliams JC, 2004, J FLUID MECH, V511, P135, DOI 10.1017/S0022112004009358; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Uchiyama Y, 2010, OCEAN MODEL, V34, P16, DOI 10.1016/j.ocemod.2010.04.002; Debreu L, 2012, OCEAN MODEL, V49-50, P1, DOI 10.1016/j.ocemod.2012.03.003; Warner JC, 2013, COMPUT GEOSCI-UK, V58, P54, DOI 10.1016/j.cageo.2013.05.004; Almar R, 2010, CONT SHELF RES, V30, P781, DOI 10.1016/j.csr.2010.02.001; Yu J, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001105; Brocchini M, 2002, J FLUID MECH, V458, P269, DOI 10.1017/S0022112002007929; CHURCH JC, 1993, COAST ENG, V20, P1, DOI 10.1016/0378-3839(93)90053-B; Hally-Rosendahl K, 2014, J GEOPHYS RES-OCEANS, V119, P4367, DOI 10.1002/2013JC009722; Kennedy AB, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC003814; Bruneau N, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006693; Haller MC, 2001, J FLUID MECH, V433, P161; Shchepetkin AF, 1998, MON WEATHER REV, V126, P1541, DOI 10.1175/1520-0493(1998)126<1541:QMASBO>2.0.CO;2; Haas KA, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001355; DEVRIEND HJ, 1987, COAST ENG, V11, P565, DOI 10.1016/0378-3839(87)90027-5; LIPPMANN TC, 1989, J GEOPHYS RES-OCEANS, V94, P995, DOI 10.1029/JC094iC01p00995; Antuono M, 2007, J FLUID MECH, V573, P399, DOI 10.1017/S0022112006004010; Marchesiello P, 2001, OCEAN MODEL, V3, P1, DOI 10.1016/S1463-5003(00)00013-5; Blaas M, 2007, CONT SHELF RES, V27, P832, DOI 10.1016/j.csr.2006.12.003; MacMahan JH, 2006, COAST ENG, V53, P191, DOI 10.1016/j.coastaleng.2005.10.009; Kennedy AB, 2003, J FLUID MECH, V497, P225, DOI 10.1017/S0022112003006827; MacMahan JH, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002083; Haller MC, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005185; Meyers J, 2006, J FLUID MECH, V569, P287, DOI 10.1017/S0022112006002850; Spydell M, 2009, J PHYS OCEANOGR, V39, P809, DOI 10.1175/2008JPO3892.1; Holman R, 2013, ANNU REV MAR SCI, V5, P95, DOI 10.1146/annurev-marine-121211-172408; Arthur R., 1962, J GEOPHYS RES, V67, P2778; Bickley W., 1939, PHIL MAG SER, V7, P727; Bruneau N., 2009, J COASTAL RES SI, V56, P1731; Butel R, 2002, J COASTAL RES, P96; Castelle B., 2007, MAR GEOL, V245; Haas KA, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000911; Long JW, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004894; Ozkan-Haller H. T., 2003, J GEOPHYS RES-OCEANS, V108, DOI [10.1079/7001JC001787, DOI 10.1029/2001JC001787]; Peregrine DH, 1998, THEOR COMP FLUID DYN, V10, P295, DOI 10.1007/s001620050065; Smagorinsky J, 1963, MON WEATHER REV, V91, P99, DOI [DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.C0;2, 10.1175/1520-0493(1963)091&LT;0099:GCEWTP&GT;2.3.CO;2(1963)]; Soulsby R., 1995, ADV COASTAL MORPHODY, P420; Uchiyama Y, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005135; Weir B, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006232; WRIGHT LD, 1984, MAR GEOL, V56, P93, DOI 10.1016/0025-3227(84)90008-2	48	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1463-5003	1463-5011		OCEAN MODEL	Ocean Model.	DEC	2015	96		1				36	48		10.1016/j.ocemod.2015.07.003		13	Meteorology & Atmospheric Sciences; Oceanography	Meteorology & Atmospheric Sciences; Oceanography	CX9WY	WOS:000366058400004		
J	Webb, A; Fox-Kemper, B				Webb, A.; Fox-Kemper, B.			Impacts of wave spreading and multidirectional waves on estimating Stokes drift	OCEAN MODELLING			English	Article						Stokes drift; Unidirectional waves; Wave spreading	OCEAN MIXED-LAYER; LANGMUIR TURBULENCE; SURFACE-WAVES; DIRECTIONAL DISTRIBUTION; GRAVITY-WAVES; WIND-WAVES; DEEP-WATER; SPECTRA; DRIVEN; MODEL	The Stokes drift, and its leading order approximation, for a random sea depend upon the interaction of different wave groups and the process of wave spreading. Here Stokes drift direction and magnitude from prescribed spectra, local observational buoy data, and global model WAVEWATCH III output are used to analyze approximations of Stokes drift for directional random seas in deep water. To facilitate analysis, a new approximation is defined to incorporate the systematic effects of wave spreading. Stokes drift is typically overestimated by ignoring these effects or by ignoring directional differences in swell and wind seas. These two errors are differentiated and found to be largely uncorrelated. These errors depend strongly on depth, with deeper Stokes drift favoring narrow banded swell and shallower Stokes drift favoring wind seas. Results are consistent among the data examined. Mean Stokes drift magnitude reductions from wave spreading and multidirectional wave effects alone are 14-20% and 7-23% respectively, giving a combined reduction of 20-40% versus unidirectional waves, depending on wave age and depth. Approximations that do not include these reductions however, will on average overestimate Stokes drift by 16-26%, 26-43%, and 45-71% respectively. In addition to magnitude, the direction of Stokes drift is also affected and multidirectional waves generate a directional veer with depth: the 30/60/90% confidence intervals are bounded (approximately) by +/- 0.12/0.28/0.84 radians (+/- 7/16/48 deg) at the surface, with smaller intervals at depth. Complementary depth-integrated approximations are also investigated and directional effects are similar with depth-dependent subsurface results. Furthermore, an optimized directional spread correction for the surface is nearly identical for global simulations and a buoy located at Ocean Weather Station P (50 degrees N 145 degrees W), and does not require directional wave spectrum data. (C) 2015 Elsevier B.V. All rights reserved.	[Webb, A.] Univ Tokyo, Dept Ocean Technol Policy & Environm, Kashiwa, Chiba, Japan; [Fox-Kemper, B.] Brown Univ, Dept Earth Environm & Planetary Sci, Providence, RI 02912 USA	Webb, A (reprint author), Univ Tokyo, Dept Ocean Technol Policy & Environm, Kashiwa, Chiba, Japan.	adrean.webb@gmail.com; baylor@brown.edu			NASA [ROSES-NNX09AF38G]; NSF [OCE-0934737, OCE-1258907, PHY11-25915]	A portion of this work first appeared in the doctoral dissertation of Webb (2013). A. Webb and B. Fox-Kemper were partially supported by NASA ROSES-NNX09AF38G and NSF OCE-0934737. B. Fox-Kemper was also partially supported by NSF OCE-1258907. B. Fox-Kemper would like to thank the Kavli Institute for Theoretical Physics and its Wave-Flow Interaction workshop for additional support during the completion of this manuscript (preprint NSF-KITP-14-084, supported by NSF PHY11-25915).	HASSELMANN K, 1976, J PHYS OCEANOGR, V6, P200, DOI 10.1175/1520-0485(1976)006<0200:APWPM>2.0.CO;2; Rascle N, 2013, OCEAN MODEL, V70, P174, DOI 10.1016/j.ocemod.2012.12.001; WELLER RA, 1985, SCIENCE, V227, P1552, DOI 10.1126/science.227.4694.1552; Feddersen F, 2004, COAST ENG, V51, P473, DOI 10.1016/j.coastaleng.2004.05.008; Ardhuin F, 2009, J PHYS OCEANOGR, V39, P2820, DOI 10.1175/2009JPO4169.1; LYGRE A, 1986, J PHYS OCEANOGR, V16, P2052, DOI 10.1175/1520-0485(1986)016<2052:MEEOTD>2.0.CO;2; MITSUYASU H, 1975, J PHYS OCEANOGR, V5, P750, DOI 10.1175/1520-0485(1975)005<0750:OOTDSO>2.0.CO;2; Belcher SE, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052932; D'Asaro EA, 2014, GEOPHYS RES LETT, V41, P102, DOI 10.1002/2013GL058193; Babanin AV, 2009, J PHYS OCEANOGR, V39, P2675, DOI 10.1175/2009JPO4202.1; McWilliams JC, 2013, J FLUID MECH, V730, P464, DOI 10.1017/jfm.2013.348; Sullivan PP, 2010, ANNU REV FLUID MECH, V42, P19, DOI 10.1146/annurev-fluid-121108-145541; Chapman RD, 1997, J GEOPHYS RES-OCEANS, V102, P18737, DOI 10.1029/97JC00049; Rohrs J, 2014, LIMNOL OCEANOGR, V59, P1213, DOI 10.4319/lo.2014.59.4.1213; OReilly WC, 1996, J ATMOS OCEAN TECH, V13, P231, DOI 10.1175/1520-0426(1996)013<0231:ACODBA>2.0.CO;2; CRAIK ADD, 1976, J FLUID MECH, V73, P401, DOI 10.1017/S0022112076001420; Myrhaug D, 2014, COAST ENG, V88, P27, DOI 10.1016/j.coastaleng.2014.01.014; Forristall GZ, 1998, J ATMOS OCEAN TECH, V15, P440, DOI 10.1175/1520-0426(1998)015<0440:WMODWS>2.0.CO;2; Harcourt RR, 2008, J PHYS OCEANOGR, V38, P1542, DOI 10.1175/2007JPO3842.1; Alves JHGM, 1999, APPL OCEAN RES, V21, P295, DOI 10.1016/S0141-1187(99)00019-X; Liu GQ, 2014, INT J REMOTE SENS, V35, P1966, DOI 10.1080/01431161.2014.880818; Webb A, 2011, OCEAN MODEL, V40, P273, DOI 10.1016/j.ocemod.2011.08.007; Fan YL, 2014, J CLIMATE, V27, P4752, DOI 10.1175/JCLI-D-13-00583.1; Grant ALM, 2009, J PHYS OCEANOGR, V39, P1871, DOI 10.1175/2009JPO4119.1; BANNER ML, 1990, J PHYS OCEANOGR, V20, P966, DOI 10.1175/1520-0485(1990)020<0966:ESOWW>2.0.CO;2; KENYON KE, 1969, J GEOPHYS RES, V74, P6991, DOI 10.1029/JC074i028p06991; THORPE SA, 1985, NATURE, V318, P519, DOI 10.1038/318519a0; Sullivan PP, 2012, J PHYS OCEANOGR, V42, P1959, DOI 10.1175/JPO-D-12-025.1; Breivik O, 2014, J PHYS OCEANOGR, V44, P2433, DOI 10.1175/JPO-D-14-0020.1; Large WG, 2009, CLIM DYNAM, V33, P341, DOI 10.1007/s00382-008-0441-3; McWilliams JC, 1999, J PHYS OCEANOGR, V29, P2523, DOI 10.1175/1520-0485(1999)029<2523:TWDOC>2.0.CO;2; Portilla J, 2009, J ATMOS OCEAN TECH, V26, P107, DOI 10.1175/2008JTECHO609.1; DONELAN MA, 1985, PHILOS T R SOC A, V315, P509, DOI 10.1098/rsta.1985.0054; Thomson J, 2013, J GEOPHYS RES-OCEANS, V118, P5951, DOI 10.1002/2013JC008837; Ewans KC, 1998, J PHYS OCEANOGR, V28, P495, DOI 10.1175/1520-0485(1998)028<0495:OOTDSO>2.0.CO;2; YOUNG IR, 1993, PHILOS T ROY SOC A, V342, P505, DOI 10.1098/rsta.1993.0030; PIERSON WJ, 1964, J GEOPHYS RES, V69, P5181, DOI 10.1029/JZ069i024p05181; YOUNG IR, 1995, J GEOPHYS RES-OCEANS, V100, P773, DOI 10.1029/94JC02218; Cavaleri L, 2012, B AM METEOROL SOC, V93, P1651, DOI 10.1175/BAMS-D-11-00170.1; Van Roekel LP, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007516; McWilliams JC, 2012, J PHYS OCEANOGR, V42, P1793, DOI 10.1175/JPO-D-12-07.1; HASSELMANN DE, 1980, J PHYS OCEANOGR, V10, P1264, DOI 10.1175/1520-0485(1980)010<1264:DWSODJ>2.0.CO;2; Hwang PA, 2000, J PHYS OCEANOGR, V30, P2768, DOI 10.1175/1520-0485(2001)031<2768:AMOTWS>2.0.CO;2; YOUNG IR, 1994, APPL OCEAN RES, V16, P283, DOI 10.1016/0141-1187(94)90017-5; D'Asaro EA, 2014, ANNU REV MAR SCI, V6, P101, DOI 10.1146/annurev-marine-010213-135138; Harcourt RR, 2013, J PHYS OCEANOGR, V43, P673, DOI 10.1175/JPO-D-12-0105.1; Kantha LH, 2004, OCEAN MODEL, V6, P101, DOI 10.1016/S1463-5003(02)00062-8; Belka D., 2014, 1407 APLUW; Bender C. M., 1978, ADV MATH METHODS SCI; Carrasco A, 2014, OCEAN DYNAM, V64, P1815, DOI 10.1007/s10236-014-0783-9; Carrier M. J., 2013, MON WEATHER REV, V142, P1509; Comiso J., 1999, 2 NAT SNOW IC DAT CT; Dalrymple R. A., 1984, WATER WAVE MECH ENG, V2; Gommenginger CP, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017743; Holthuijsen L.H., 2007, WAVES OCEANIC COASTA; Huang CJ, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006320; Luke Y. L., 1969, SPECIAL FUNCTIONS TH; Myrhaug D., 2013, P I MECH ENG M-J ENG; Myrhaug D, 2013, COAST ENG, V78, P53, DOI 10.1016/j.coastaleng.2013.03.008; Qazi W. A., 2013, IEEE T GEOSCI REMOTE, V52, P7559; Rayner NA, 2006, J CLIMATE, V19, P446, DOI 10.1175/JCLI3637.1; Roussos I. M., 2013, IMPROPER RIEMANN INT; Tolman H. L., 2002, 222 NOAANWSNCEPMMAB; Webb A., 2013, THESIS; Young IR, 2010, COAST ENG, V57, P30, DOI 10.1016/j.coastaleng.2009.09.001	65	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1463-5003	1463-5011		OCEAN MODEL	Ocean Model.	DEC	2015	96		1				49	64		10.1016/j.ocemod.2014.12.007		16	Meteorology & Atmospheric Sciences; Oceanography	Meteorology & Atmospheric Sciences; Oceanography	CX9WY	WOS:000366058400005		
J	Kim, S; Mori, N; Mase, H; Yasuda, T				Kim, Sooyoul; Mori, Nobuhito; Mase, Hajime; Yasuda, Tomohiro			The role of sea surface drag in a coupled surge and wave model for Typhoon Haiyan 2013	OCEAN MODELLING			English	Article						Typhoon Haiyan; Wind leveling off; Wind speed-limited drag; Storm surge; Wind wave; Coupled surge and wave model	STORM-SURGE; WIND-STRESS; BOUNDARY-LAYER; HURRICANE; OCEAN; COMPUTATIONS; COEFFICIENTS; VALIDATION; PREDICTION; SPECTRUM	The present study investigates how the wind speed limited wave dependent drag coefficient (C-D) influences the surge and wave generation of Super Typhoon Haiyan, which struck the coasts of the Leyte Gulf, in the Philippines (2013), using a coupled surge and wave model. In addition, we examine the effect of changes of the radius (R-max which the maximum wind speed occurs. Accurate determination of this radius is crucial to the Haiyan wind and pressure field when using a parametric wind and pressure model because of lack of observation data. The calculation results show that the radius ranges from 40 km to 50 km: as the radius becomes narrower, the surge and wave heights are reduced. Our calculation of surge and wave levels uses a modified version of Janssen' method (Janssen, 1989, 1991) with a step function applied to level off C-D in the exponential wave growth term. In the present method, the wind speeds are limited to a certain threshold; below this value the effective roughness is estimated with a logarithmic wind profile. With the newly modified method, we investigate the effect of the wind speed-limited wave dependent drag C-D for high winds (<70 m/s) on the Haiyan surge and wave levels. When leveling off C-D at 25 m/s for R-max = 50 km good agreement with survey data is obtained in terms of surge level (6.5 m) and wave heights (7 m and 17 m inside and outside of the gulf). The numerical experiments suggest that leveling off at wind speeds of 25-30 m/s results in the accurate prediction of Haiyan storm surge and wave levels in the coupled surge and wave model. The study demonstrates the applicability of the present method of leveling off at wind speeds of 25-30 m/s in a coupled surge and wave model for super typhoon conditions. (C) 2015 Elsevier Ltd. All rights reserved.	[Kim, Sooyoul] Tottori Univ, Grad Sch Engn, Minami Ku, Tottori 680850, Japan; [Mori, Nobuhito; Mase, Hajime; Yasuda, Tomohiro] Kyoto Univ, Disaster Prevent Res Inst, Gokasho, Kyoto 6110011, Japan	Kim, S (reprint author), Tottori Univ, Grad Sch Engn, Minami Ku, Koyama Cho, Tottori 680850, Japan.	sooyoul.kim@sse.tottori-u.ac.jp			SOUSEI Program; JSPS KAKENHI [15549699]	This work was partially conducted under the framework of the "Projection of the change in future weather extremes using super-high-resolution atmospheric models" supported by the SOUSEI Program, and supported by JSPS KAKENHI grant no. 15549699. The authors would like to thank Dr. R. McSherry, Cardiff University, UK, for his many valuable suggestions and assistance of writing manuscript.	Brown JM, 2013, COAST ENG, V82, P102, DOI 10.1016/j.coastaleng.2013.08.009; Brown JM, 2009, CONT SHELF RES, V29, P1329, DOI 10.1016/j.csr.2009.03.004; Donelan MA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019460; Kim SY, 2010, COAST ENG, V57, P631, DOI 10.1016/j.coastaleng.2010.02.004; Kennedy AB, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047090; [Anonymous], 1994, APPL METEOROL; HASSELMANN S, 1985, J PHYS OCEANOGR, V15, P1378, DOI 10.1175/1520-0485(1985)015<1378:CAPOTN>2.0.CO;2; MASTENBROEK C, 1993, J PHYS OCEANOGR, V23, P1856, DOI 10.1175/1520-0485(1993)023<1856:TDCOAW>2.0.CO;2; Wright CW, 2001, J PHYS OCEANOGR, V31, P2472, DOI 10.1175/1520-0485(2001)031<2472:HDWSSV>2.0.CO;2; JANSSEN PAEM, 1991, J PHYS OCEANOGR, V21, P1631, DOI 10.1175/1520-0485(1991)021<1631:QLTOWW>2.0.CO;2; Brown JM, 2013, OCEAN SCI, V9, P721, DOI 10.5194/os-9-721-2013; KHANDEKAR ML, 1994, ATMOS OCEAN, V32, P31; GARRATT JR, 1977, MON WEATHER REV, V105, P915, DOI 10.1175/1520-0493(1977)105<0915:RODCOO>2.0.CO;2; Dietrich JC, 2011, COAST ENG, V58, P45, DOI 10.1016/j.coastaleng.2010.08.001; Yasuda T, 2014, COAST ENG, V83, P65, DOI 10.1016/j.coastaleng.2013.10.003; JANSSEN PAEM, 1989, J PHYS OCEANOGR, V19, P745, DOI 10.1175/1520-0485(1989)019<0745:WISATD>2.0.CO;2; Zijlema M, 2012, COAST ENG, V65, P19, DOI 10.1016/j.coastaleng.2012.03.002; Kim SY, 2008, APPL OCEAN RES, V30, P311, DOI 10.1016/j.apor.2009.02.003; CAVALERI L, 1981, J GEOPHYS RES-OC ATM, V86, P961, DOI 10.1029/JC086iC11p10961; FLATHER RA, 1994, J PHYS OCEANOGR, V24, P172, DOI 10.1175/1520-0485(1994)024<0172:ASSPMF>2.0.CO;2; Funakoshi Y, 2008, J WATERW PORT C-ASCE, V134, P321, DOI 10.1061/(ASCE)0733-950X(2008)134:6(321); Xie L, 2008, OCEAN MODEL, V20, P252, DOI 10.1016/j.ocemod.2007.10.001; Black PG, 2007, B AM METEOROL SOC, V88, P357, DOI 10.1175/BAMS-88-3-357; Mori N, 2014, GEOPHYS RES LETT, V41, P5106, DOI 10.1002/2014GL060689; SMITH SD, 1975, Q J ROY METEOR SOC, V101, P665, DOI 10.1256/smsqj.42919; Hersbach H, 1999, J ATMOS OCEAN TECH, V16, P884, DOI 10.1175/1520-0426(1999)016<0884:IOTSFB>2.0.CO;2; Booij N, 1999, J GEOPHYS RES-OCEANS, V104, P7649, DOI 10.1029/98JC02622; Powell MD, 2003, NATURE, V422, P279, DOI 10.1038/nature01481; Battjes J.A., 1978, P 16 INT C COAST ENG, P569; Charnock H., 1955, QUART J ROY METEOROL, V81, P639, DOI DOI 10.1002/QJ.49708135027; Digital Typhoon DB, 2014, TYPH IM INF; Fujii T., 1986, ANN DISASTER PREVE B, VB-1, P229; GEBCO: General Bathymetric Chart of the Ocean, 2003, BRIT OC DAT CTR CENT; Honda T., 1980, ANN J COASTAL ENG JS, V27, P90; Kim S.Y., 2014, J JPN SOC CIVIL E B2, V70, pI_226; Kim S, 2014, OCEAN ENG, V91, P133, DOI 10.1016/j.oceaneng.2014.09.005; Kowalik Z., 1993, NUMERICAL MODELING O, P481; Lalbeharry R., 2004, P 8 INT WORKSH WAV H; Lapidez J.P., 2015, NAT HAZARD EARTH SYS, V3, P919; Madsen O.S., 1988, P 21 INT C COAST ENG, P492; Mase H., 2011, J JPN SOC CIVIL E B2, V67, pI_401; National Disaster Risk Reduction and Management Council, 2013, REEFF TYPH YOL; Schiermeier Q., 2013, NATURE, DOI [10.1038/nature.2013.14139, DOI 10.1038/NATURE.2013.14139]; Schloemer R.W., 1954, HYDROMET REP, P49; Tajima Y, 2014, COAST ENG J, V56, DOI 10.1142/S0578563414500065; Tolman H., 2002, GLOBAL ATMOS OCEAN S, V8, P67, DOI 10.1080/10236730290003392; WU J, 1982, J GEOPHYS RES-OC ATM, V87, P9704, DOI 10.1029/JC087iC12p09704	47	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1463-5003	1463-5011		OCEAN MODEL	Ocean Model.	DEC	2015	96		1				65	84		10.1016/j.ocemod.2015.06.004		20	Meteorology & Atmospheric Sciences; Oceanography	Meteorology & Atmospheric Sciences; Oceanography	CX9WY	WOS:000366058400006		
J	Yu, ZT; Metzger, EJ; Thoppil, P; Hurlburt, HE; Zamudio, L; Smedstad, OM; Na, HN; Nakamura, H; Park, JH				Yu, Zhitao; Metzger, E. Joseph; Thoppil, Prasad; Hurlburt, Harley E.; Zamudio, Luis; Smedstad, Ole Martin; Na, Hanna; Nakamura, Hirohiko; Park, Jae-Hun			Seasonal cycle of volume transport through Kerama Gap revealed by a 20-year global HYbrid Coordinate Ocean Model reanalysis	OCEAN MODELLING			English	Article						Ku rosItio; Mesoscale eddy; HYCOM; Kerama Gap	EAST-CHINA-SEA; MESOSCALE EDDIES; KUROSHIO TRANSPORT; DATA ASSIMILATION; OKINAWA TROUGH; TOKARA STRAIT; VARIABILITY; PACIFIC; TAIWAN; CIRCULATION	The temporal variability of volume transport from the North Pacific Ocean to the East China Sea (ECS) through Kerama Gap (between Okinawa Island and Miyakojima Island a part of Ryukyu Islands Arc) is investigated using a 20-year global HYbrid Coordinate Ocean Model (HYCOM) reanalysis with the Navy Coupled Ocean Data Assimilation from 1993 to 2012. The HYCOM mean transport is 2.1 Sv (positive into the ECS, 1 Sv 106 m(3)/s) from June 2009 to June 2011, in good agreement with the observed 2.0 Sv transport during the same period. This is similar to the 20 year mean Kerama Gap transport of 1.95 zL 4.0 Sv, The 20 year monthly mean volume transport (transport seasonal cycle) is maximum in October (3.0 Sv) and minimum in November (0.5 Sv). The annual variation component (345-400 days), mesoscale eddy component (70-345 days), and Kuroshio meander component (< 10 days) are separated to determine their contributions to the transport seasonal cycle. The annual variation component has a close relation with the local wind field and increases (decreases) transport into the ECS through Keraina Gap in suinmer (winter). Most of the variations in the transport seasonal cycle come from the mesoscale eddy component. The impinging inesoscale eddies increase the transport into the ECS during January, February, May, and October, and decrease it in March, April, November, and December, but have little effect in summer (June-September). The Kuroshio meander components cause smaller transport variations in summer than in winter. (C) 2015 Elsevier Ltd. All rights reserved.	[Yu, Zhitao] Amer Soc Engn Educ, Washington, DC USA; [Yu, Zhitao; Metzger, E. Joseph; Thoppil, Prasad] Naval Res Lab, Stennis Space Ctr, MS 39529 USA; [Hurlburt, Harley E.; Zamudio, Luis] Florida State Univ, Tallahassee, FL 32306 USA; [Smedstad, Ole Martin] Vencore Inc, Stennis Space Ctr, MS USA; [Na, Hanna] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 060, Japan; [Nakamura, Hirohiko] Kagoshima Univ, Fac Fisheries, Kagoshima 890, Japan; [Park, Jae-Hun] Inha Univ, Dept Ocean Sci, Inchon, South Korea	Yu, ZT (reprint author), Naval Res Lab, Div Oceanog, Stennis Space Ctr, MS 39529 USA.	zhitao.yu.ctr@nrlssc.navy.mil			Office of Naval Research [0601135]; American Society for Engineering Education; Naval Research Laboratory, Stennis Space Center	The numerical output used for this paper can be found on the Intp://www.hycom.org data server under the "HYCOM NCODA Global 1/12 degrees Reanalysis" link. This effort was funded by the "6.1 Kuroshio and Ryukyu Current Dynamics" project sponsored by the Office of Naval Research under program element 0601135 N.Z.Y. was supported by a Post-Doctoral Fellowship from the American Society for Engineering Education, with funding provided by the Naval Research Laboratory, Stennis Space Center, MS. Computer time was provided by the Department of Defense (DoD) High Performance Computing Modernization Program and the simulations were performed on the IBM Power 6 (daVinci) and the IBM iDataPlcx (Kilrain) at the Navy DoD Supercomputing Resources Center, Stennis Space Center, MS. This is NRL contribution NRL/JA/7320-15-2704. It has been approved for public release and distribution is unlimited.	Soeyanto E, 2014, J GEOPHYS RES-OCEANS, V119, P3595, DOI 10.1002/2013JC009529; Nakamura H, 2012, J OCEANOGR, V68, P321, DOI 10.1007/s10872-012-0101-4; James C, 1999, J PHYS OCEANOGR, V29, P259, DOI 10.1175/1520-0485(1999)029<0259:KMITEC>2.0.CO;2; Chassignet EP, 2003, J PHYS OCEANOGR, V33, P2504, DOI 10.1175/1520-0485(2003)033<2504:NASWTH>2.0.CO;2; Zhang DX, 2001, J PHYS OCEANOGR, V31, P1054, DOI 10.1175/1520-0485(2001)031<1054:TKEOTM>2.0.CO;2; Lee IH, 2013, OCEAN DYNAM, V63, P1027, DOI 10.1007/s10236-013-0643-z; Guo X, 2006, J PHYS OCEANOGR, V36, P2205, DOI 10.1175/JPO2976.1; Na HN, 2014, J GEOPHYS RES-OCEANS, V119, P689, DOI 10.1002/2013JC008899; DEWAR WK, 1985, J PHYS OCEANOGR, V15, P1771, DOI 10.1175/1520-0485(1985)015<1771:SEOTGS>2.0.CO;2; Andres M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004200; Qu TD, 2003, J PHYS OCEANOGR, V33, P5, DOI 10.1175/1520-0485(2003)033<0005:TBOTNE>2.0.CO;2; Feng M, 2000, J PHYS OCEANOGR, V30, P2257, DOI 10.1175/1520-0485(2000)030<2257:SAVOTK>2.0.CO;2; Nakamura H, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001450; CHARNEY JG, 1947, J METEOROL, V4, P135; Andres M, 2008, J OCEANOGR, V64, P937, DOI 10.1007/s10872-008-0077-2; Nakamura H, 2013, J GEOPHYS RES-OCEANS, V118, P6881, DOI 10.1002/2013JC009326; ROEMMICH D, 1989, PROG OCEANOGR, V22, P171, DOI 10.1016/0079-6611(89)90005-0; Bleck R, 2002, OCEAN MODEL, V4, P55, DOI 10.1016/S1463-5003(01)00012-9; Nakamura H, 2010, J PHYS OCEANOGR, V40, P530, DOI 10.1175/2009JPO4156.1; Andres M, 2013, GEOPHYS RES LETT, V40, P5915, DOI 10.1002/2013GL058013; Ichikawa H, 2004, J OCEANOGR, V60, P351, DOI 10.1023/B:JOCE.0000038341.27622.73; QIU B, 1990, J GEOPHYS RES-OCEANS, V95, P18191; Fox DN, 2002, J ATMOS OCEAN TECH, V19, P240, DOI 10.1175/1520-0426(2002)019<0240:TMODAS>2.0.CO;2; Nakamura H, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004574; Hsin YC, 2010, OCEAN DYNAM, V60, P1293, DOI 10.1007/s10236-010-0294-2; Johns WE, 2001, J PHYS OCEANOGR, V31, P1031, DOI 10.1175/1520-0485(2001)031<1031:TKEOTM>2.0.CO;2; Metzger EJ, 2014, OCEANOGRAPHY, V27, P32; Gordon AL, 2014, J GEOPHYS RES-OCEANS, V119, P4251, DOI 10.1002/2014JC009882; Choi Byungho, 2002, [Journal of Korean Society of Coastal and Ocean Engineers, 한국해안·해양공학회논문집], V14, P41; Cummings JA, 2005, Q J ROY METEOR SOC, V131, P3583, DOI 10.1256/qj.05.105; Cummings J.A., 2013, DATA ASSIMILATION AT, VII; Helber R.W., 2013, NRLMR7320139364; Hsin YC, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004485; Ichikawa K, 2001, J OCEANOGR, V57, P55, DOI 10.1023/A:1011174720390; Jin BG, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006437; Kundu P.K., 2002, FLUID MECH; Morinaga K., 1998, P JAP CHIN JOINT S C, P203; Nagata U., 1985, J OCEANOGR SOC JPN, V41, P244; Nakamura H, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027516; Nitani H., 1972, BEGINNING KUROSHIO, P129; Oka E., 1998, J OCEANOGR, V54, P605, DOI DOI 10.1007/BF02823281; Orlanski I., 1973, Geophysical Fluid Dynamics, V4; Qiu B., 2001, ENCY OCEAN SCI, V3, P1413; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; Stammer D, 1997, J GEOPHYS RES-OCEANS, V102, P20987, DOI 10.1029/97JC01475; SUGIMOTO T, 1988, Journal of the Oceanographical Society of Japan, V44, P125, DOI 10.1007/BF02302619; Thoppil P., 2015, OCEANOGR, P751; You S. - H., 2004, PACIFIC OCEANOGR, V2, P44; Yuan Y., 1994, LA MER, V32, P235; Yuan Y., 1995, LA MER, V33, P1	50	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1463-5003	1463-5011		OCEAN MODEL	Ocean Model.	DEC	2015	96		2				203	213		10.1016/j.ocemod.2015.10.012		11	Meteorology & Atmospheric Sciences; Oceanography	Meteorology & Atmospheric Sciences; Oceanography	CX9XA	WOS:000366058600002		
J	Kamada, K; Hishinuma, K; Kurosawa, S; Shoji, Y; Pejchal, J; Ohashi, Y; Yokota, Y; Yoshikawa, A				Kamada, Kei; Hishinuma, Kousuke; Kurosawa, Shunsuke; Shoji, Yasuhiro; Pejchal, Jan; Ohashi, Yuji; Yokota, Yuui; Yoshikawa, Akira			Directionally solidified Eu doped CaF2/Li3AlF6 eutectic scintillator for neutron detection	OPTICAL MATERIALS			English	Article						Scintillator; Eutectic; Micro-pulling down	OPTICAL-PROPERTIES; CRYSTALS; GROWTH	Eu doped CaF2/Li3AlF6 eutectics were grown by mu-PD method. The directionally solidified eutectic with well-aligned 600 nm diameter Eu:CaF2 scintillator fibers surrounded with Li3AlF6 was prepared. The grown eutectics showed an emission peak at 422 nm ascribed to Eu2+ 4f-5d transition from Eu:CaF2 scintillation fiber. Li concentration in the Eu:CaF2-Li3AlF6 eutectic is around 0.038 mol/cm(3),which is two times higher than that of LiCaAlF6 single crystal (0.016 mol/cm(3)). The light yield of Eu:CaF2-Li3AlF6 eutectic was around 7000 ph/neutron. The decay time was about 550 ns (89%) and 1450 ns (11%). (C) 2015 Elsevier B.V. All rights reserved.	[Kamada, Kei; Shoji, Yasuhiro; Yokota, Yuui; Yoshikawa, Akira] Tohoku Univ, New Ind Creat Hatchery Ctr, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Kamada, Kei; Kurosawa, Shunsuke; Pejchal, Jan; Yoshikawa, Akira] C&A Corp, T Biz, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Kurosawa, Shunsuke; Shoji, Yasuhiro; Ohashi, Yuji; Yoshikawa, Akira] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Pejchal, Jan] Inst Phys AS CR, Prague 16253, Czech Republic; [Hishinuma, Kousuke] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808579, Japan	Kamada, K (reprint author), Tohoku Univ, New Ind Creat Hatchery Ctr, Aoba Ku, 6-6-10 Aoba, Sendai, Miyagi 9808579, Japan.				funding program for next generation world-leading researchers, JSPS; Development of Systems and Technology for Advanced Measurement and Analysis, Japan Science and Technology Agency (JST); Adaptable & Seamless Technology Transfer Program through Target-driven RD (A-STEP), JST; Japan Society for the Promotion of Science (JSPS); JSPS; Health Labour Sciences Research Grant, The Ministry of Health Labour and Welfare; Czech MEYS KONTAKT Cz-jp collaboration project [LH14266]; Crystal Clear Collaboration in CERN; EC Marie Curie Initial Training Network LUMINET [316906]	This work is partially supported by (i) the funding program for next generation world-leading researchers, JSPS, (ii) Development of Systems and Technology for Advanced Measurement and Analysis, Japan Science and Technology Agency (JST), (iii) Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP), JST (iv) Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Exploratory Research, (v) JSPS Research Fellowships for Young Scientists, (vi) the Health Labour Sciences Research Grant, The Ministry of Health Labour and Welfare and (vii) Czech MEYS KONTAKT Cz-jp collaboration LH14266 project, Crystal Clear Collaboration in CERN, and EC Marie Curie Initial Training Network LUMINET, no. 316906. In addition, we would like to thank following persons for their support: Mr. Yoshihiro Nakamura in Institute of Multidisciplinary Research for Advanced Materials (IMRAM), and Mr. Hiroshi Uemura, Ms. Keiko Toguchi, Ms. Megumi Sasaki and Ms. Yuka Takeda in IMR, Tohoku University.	Den T, 2013, IEEE T NUCL SCI, V60, P16, DOI 10.1109/TNS.2012.2233751; Yoshikawa A, 2009, IEEE T NUCL SCI, V56, P3796, DOI 10.1109/TNS.2009.2033115; Yamazaki A, 2011, NUCL INSTRUM METH A, V652, P435, DOI 10.1016/j.nima.2011.02.064; Trojan-Piegza J, 2010, RADIAT MEAS, V45, P163, DOI 10.1016/j.radmeas.2010.01.011; Kamada K, 2011, NUCL INSTRUM METH A, V659, P355, DOI 10.1016/j.nima.2011.06.082; Hamadene M, 2001, PHASE TRANSIT, V73, P423, DOI 10.1080/01411590108224552; Kawaguchi N, 2011, NUCL INSTRUM METH A, V652, P209, DOI 10.1016/j.nima.2011.02.009; Orera VM, 2012, J CRYST GROWTH, V360, P99, DOI 10.1016/j.jcrysgro.2011.11.056; JACKSON KA, 1966, T METALL SOC AIME, V236, P1129; Yanagida T, 2013, J LUMIN, V144, P212, DOI 10.1016/j.jlumin.2013.07.016; Liu S, 2011, ACTA MATER, V59, P3102, DOI 10.1016/j.actamat.2011.01.050; Oliete PB, 2012, J CRYST GROWTH, V360, P123, DOI 10.1016/j.jcrysgro.2011.12.032; Yanagida T, 2012, OPT MATER, V34, P868, DOI 10.1016/j.optmat.2011.11.022; Kouzes RT, 2010, NUCL INSTRUM METH A, V623, P1035, DOI 10.1016/j.nima.2010.08.021; Yoshikawa A, 2007, OPT MATER, V30, P6, DOI 10.1016/j.optmat.2006.10.030; Combes CM, 1999, J LUMIN, V82, P299, DOI 10.1016/S0022-2313(99)00047-2; Ianakiev KD, 2011, NUCL INSTRUM METH A, V652, P417, DOI 10.1016/j.nima.2010.07.081; Kawaguchi N, 2011, NUCL INSTRUM METH A, V652, P351, DOI 10.1016/j.nima.2010.09.155; Llorca J, 2006, PROG MATER SCI, V51, P711, DOI 10.1016/j.pmatsci.2005.10.002; Hishinuma Kosuke K., 2014, KEY ENG MATER, V616, P96; Hishinuma Kosuke K., 2015, JPN J APPL PHYS, V54; Hunt J.D., 1962, J I MET, V11, P338; Kamada K., OPT MAT; Kawaguchi N, 2010, IEEE NUCL SCI CONF R, P1823, DOI 10.1109/NSSMIC.2010.5874090; KOSTENSK.I, 1973, CHEM ZVESTI, V27, P296; Ohashi Y., 2013, APPL PHYS LETT, V102	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467	1873-1252		OPT MATER	Opt. Mater.	DEC	2015	50		A		SI		71	75		10.1016/j.optmat.2015.06.004		5	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	CY2KI	WOS:000366237100014		
J	Kamada, K; Hishinuma, K; Kurosawa, S; Yamaji, A; Shoji, Y; Pejchal, J; Yokota, Y; Ohashi, Y; Yoshikawa, A				Kamada, Kei; Hishinuma, Kosuke; Kurosawa, Shunsuke; Yamaji, Akihiro; Shoji, Yasuhiro; Pejchal, Jan; Yokota, Yuui; Ohashi, Yuji; Yoshikawa, Akira			Growth and scintillation properties of Eu doped BaCl2/LiF eutectic scintillator	OPTICAL MATERIALS			English	Article						Scintillator; Eutectic; Micro-pulling down	LUMINESCENCE PROPERTIES; OPTICAL-PROPERTIES; NEUTRON DETECTION; CRYSTAL-GROWTH; SINGLE-CRYSTAL; LICAALF6; RAY	Eu doped BaCl2/LiF eutectics were grown by the micro-pulling down method and their directionally solidified eutectic (DSE) system has been investigated. The grown eutectic showed main phases of cubic LiF and orthorhombic BaCl2. In these eutectics, the 399 nm emission of Eu2+ 4f5d was obtained. It shows the intrinsic decay time of about 410 ns. The light yield of the 1-mm-thick eutectic showed 7000 ph/5.5 MeV alpha-ray. (C) 2015 Published by Elsevier B.V.	[Kamada, Kei; Shoji, Yasuhiro; Yokota, Yuui; Yoshikawa, Akira] Tohoku Univ, New Ind Creat Hatchery Ctr, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Kamada, Kei; Kurosawa, Shunsuke; Pejchal, Jan; Yoshikawa, Akira] C&A Corp, T Biz, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Hishinuma, Kosuke; Kurosawa, Shunsuke; Yamaji, Akihiro; Shoji, Yasuhiro; Ohashi, Yuji; Yoshikawa, Akira] Tohoku Univ, Inst Mat Reseach, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Pejchal, Jan] Inst Phys AS CR, Prague 16253, Czech Republic	Kamada, K (reprint author), Tohoku Univ, Inst Mat Reseach, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	kamada@imr.tohoku.ac.jp			funding program for next generation world-leading researchers, Japan Society for the Promotion of Science (JSPS); Development of Systems and Technology for Advanced Measurement and Analysis, Japan Science and Technology Agency (JST); Adaptable & Seamless Technology Transfer Program through Target-driven RD (A-STEP), JST; JSPS; Health Labour Sciences Research Grant, The Ministry of Health, Labour and Welfare	This work is partially supported by (i) the funding program for next generation world-leading researchers, Japan Society for the Promotion of Science (JSPS), (ii) Development of Systems and Technology for Advanced Measurement and Analysis, Japan Science and Technology Agency (JST) (iii) Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP), JST (iv) JSPS Grant-in-Aid for Exploratory Research, (v) JSPS Research Fellowships for Young Scientists, (vi) the Health Labour Sciences Research Grant, The Ministry of Health, Labour and Welfare. In addition, we would like to thank following persons for their support: Mr. Yoshihiro Nakamura in Institute of Multidisciplinary Research for Advanced Materials (IMRAM), and Mr. Hiroshi Uemura, Ms. Keiko Toguchi, Ms. Megumi Sasaki and Ms. Yuka Takeda in IMR, Tohoku University.	Den T, 2013, IEEE T NUCL SCI, V60, P16, DOI 10.1109/TNS.2012.2233751; Yoshikawa A, 2009, IEEE T NUCL SCI, V56, P3796, DOI 10.1109/TNS.2009.2033115; Yamazaki A, 2011, NUCL INSTRUM METH A, V652, P435, DOI 10.1016/j.nima.2011.02.064; Trojan-Piegza J, 2010, RADIAT MEAS, V45, P163, DOI 10.1016/j.radmeas.2010.01.011; Kamada K, 2011, NUCL INSTRUM METH A, V659, P355, DOI 10.1016/j.nima.2011.06.082; Kawaguchi N, 2011, NUCL INSTRUM METH A, V652, P209, DOI 10.1016/j.nima.2011.02.009; Orera VM, 2012, J CRYST GROWTH, V360, P99, DOI 10.1016/j.jcrysgro.2011.11.056; Liu S, 2011, ACTA MATER, V59, P3102, DOI 10.1016/j.actamat.2011.01.050; Yoshikawa A, 2010, OPT MATER, V32, P845, DOI 10.1016/j.optmat.2010.04.032; Yan ZW, 2013, NUCL INSTRUM METH A, V698, P7, DOI 10.1016/j.nima.2012.09.026; Oliete PB, 2012, J CRYST GROWTH, V360, P123, DOI 10.1016/j.jcrysgro.2011.12.032; Yanagida T, 2012, OPT MATER, V34, P868, DOI 10.1016/j.optmat.2011.11.022; Kouzes RT, 2010, NUCL INSTRUM METH A, V623, P1035, DOI 10.1016/j.nima.2010.08.021; Yoshikawa A, 2007, OPT MATER, V30, P6, DOI 10.1016/j.optmat.2006.10.030; Kawaguchi N, 2011, NUCL INSTRUM METH A, V652, P351, DOI 10.1016/j.nima.2010.09.155; Hishinuma K, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.04DH04; Hishinuma Kosuke K., 2014, KEY ENG MATER, V616, P96; Hunt J.D., 1962, J I MET, V11, P338; Ianakiev K.D., 2011, METHODS PHYS RES A, V652, P417; Litvin V, 2009, Bulletin of the Russian Academy of Sciences. Physics, V73, DOI 10.3103/S1062873809020191; Ohashi Y., 2013, APPL PHYS LETT, V102; Zakharchenko M.A., 1965, J INORG CHEM, V10, P105	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467	1873-1252		OPT MATER	Opt. Mater.	DEC	2015	50		A		SI		76	80		10.1016/j.optmat.2015.09.028		5	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	CY2KI	WOS:000366237100015		
J	Xue, XJ; Cheng, TL; Suzuki, T; Ohishi, Y				Xue, Xiaojie; Cheng, Tonglei; Suzuki, Takenobu; Ohishi, Yasutake			Upconversion emissions from high energy levels of Tb3+ under near-infrared laser excitation at 976 nm	OPTICAL MATERIALS EXPRESS			English	Article							LUMINESCENCE PROPERTIES; GLASS-CERAMICS; POLYMER-FILM; IONS; NANOCRYSTALS; PHOTOLUMINESCENCE; BEHAVIOR; CE3+; GD3+; YB3+	Ultraviolet upconversion emissions from high energy levels (D-5(1), L-5(8), L-5(9), (5)G(5), and L-5(10)) of Tb3+ were observed in the NaYF4:Tb3+, Yb3+ microcrystals under excitation of a 976 nm laser diode at room temperature. These energy levels were populated by energy transfer and excited state absorption processes. Power dependence measurements confirmed it was caused by a three-photon upconversion process. Concentration quenching did not strongly affect the population of these levels. (C) 2015 Optical Society of America	[Xue, Xiaojie; Cheng, Tonglei; Suzuki, Takenobu; Ohishi, Yasutake] Toyota Technol Inst, Res Ctr Adv Photon Technol, Tempa Ku, Nagoya, Aichi 4688511, Japan	Xue, XJ (reprint author), Toyota Technol Inst, Res Ctr Adv Photon Technol, Tempa Ku, 2-12-1 Hisakata, Nagoya, Aichi 4688511, Japan.	xiaojie.xue1@gmail.com; ohishi@toyota-ti.ac.jp			MEXT, the Support Program for Forming Strategic Research Infrastructure, JSPS KAKENHI [26889058]	This work was supported by MEXT, the Support Program for Forming Strategic Research Infrastructure (2011-2015), JSPS KAKENHI, Grant Number 26889058. We thank Takayuki Iizuka for technical support.	Chen GY, 2010, J OPT SOC AM B, V27, P1158, DOI 10.1364/JOSAB.27.001158; Yamashita T, 2007, JPN J APPL PHYS 2, V46, pL991, DOI [10.1143/JJAP.46.L991, 10.1143/JJAP.46.L.991]; Sun XY, 2009, J LUMIN, V129, P773, DOI 10.1016/j.jlumin.2009.02.017; Jia PY, 2007, J LUMIN, V122, P134, DOI 10.1016/j.jlumin.2006.01.125; Xue XJ, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.092601; Huang LH, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2719028; Wang GF, 2008, OPT EXPRESS, V16, P11907, DOI 10.1364/OE.16.011907; Zhai XS, 2014, J MATER CHEM C, V2, P2037, DOI 10.1039/c3tc31760a; Cao CY, 2013, OPT COMMUN, V301, P106, DOI 10.1016/j.optcom.2013.03.049; Zhang JS, 2009, J APPL PHYS, V106, DOI 10.1063/1.3190511; Sontakke AD, 2009, J LUMIN, V129, P1347, DOI 10.1016/j.jlumin.2009.06.027; Parchur AK, 2012, DALTON T, V41, P11032, DOI 10.1039/c2dt31257c; Chen GY, 2009, OPT EXPRESS, V17, P16366, DOI 10.1364/OE.17.016366; Zhao WY, 2013, OPT MATER, V35, P1748, DOI 10.1016/j.optmat.2013.05.031; Phaomei G, 2011, DALTON T, V40, P11571, DOI 10.1039/c1dt11264c; Terra IAA, 2013, J APPL PHYS, V113, DOI 10.1063/1.4792743; Pollnau M, 2000, PHYS REV B, V61, P3337, DOI 10.1103/PhysRevB.61.3337; Liang HJ, 2009, OPT COMMUN, V282, P3028, DOI 10.1016/j.optcom.2009.04.006; Scarnera V, 2010, OPT MATER, V33, P159, DOI 10.1016/j.optmat.2010.08.006; Lakshminarayana G, 2011, J SOLID STATE CHEM, V184, P1931, DOI 10.1016/j.jssc.2011.05.059; Suyver JF, 2006, J LUMIN, V117, P1, DOI 10.1016/j.jlumin.2005.03.011; Yamashita T, 2008, J NON-CRYST SOLIDS, V354, P1883, DOI 10.1016/j.jnoncrysol.2007.10.026; THOMAS KS, 1963, J CHEM PHYS, V38, P2180, DOI 10.1063/1.1733948; Chen GY, 2007, CHEM PHYS LETT, V448, P127, DOI 10.1016/j.cplett.2007.09.078; Li YC, 2007, J PHYS CHEM C, V111, P10682, DOI 10.1021/jp0719107; Lai H, 2008, J PHYS CHEM C, V112, P282, DOI 10.1021/jp074103g; RISEBERG LA, 1968, PHYS REV, V174, P429, DOI 10.1103/PhysRev.174.429; Lee TJ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2358193; Carnall W., 1978, ENERGY LEVEL STRUCTU; Xue XJ, 2013, OPT MATER EXPRESS, V3, DOI 10.1364/OME.3.000989	30	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2159-3930			OPT MATER EXPRESS	Opt. Mater. Express	DEC 1	2015	5	12					2768	2776		10.1364/OME.5.002768		9	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	CX9SO	WOS:000366045900006		
J	Nobukawa, T; Nomura, T				Nobukawa, Teruyoshi; Nomura, Takanori			Multilayer recording holographic data storage using a varifocal lens generated with a kinoform	OPTICS LETTERS			English	Article							SPATIAL LIGHT-MODULATOR; ZERO-ORDER BEAM; TO-NOISE RATIO; POLARIZATION HOLOGRAPHY; VOLUME HOLOGRAMS; OPTICAL TWEEZERS; DATA PAGES; MEMORY; SELECTIVITY; PROJECTION	A multilayer recording method using a varifocal lens generated with a kinoform is presented. In this recording method, a focus position is axially displaced by adding a defocus phase to a phase modulation pattern, which consists of a random phase mask and a computer-generated reference pattern. Shift selectivity and multiplexed recording are experimentally investigated in coaxial holographic data storage. Experimental results show that the proposed method allows the recording of holograms along an optical axis without any mechanical movement. (C) 2015 Optical Society of America	[Nobukawa, Teruyoshi] Wakayama Univ, Grad Sch Syst Engn, Wakayama 6408510, Japan; [Nobukawa, Teruyoshi] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Nomura, Takanori] Wakayama Univ, Fac Syst Engn, Wakayama 6408510, Japan	Nobukawa, T (reprint author), Wakayama Univ, Grad Sch Syst Engn, 930 Sakaedani, Wakayama 6408510, Japan.	s132072@sys.wakayama-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [15J11996]	Japan Society for the Promotion of Science (JSPS) (15J11996).	Hesselink L, 2004, P IEEE, V92, P1231, DOI 10.1109/JPROC.2004.831212; Yamatsu H, 2004, JPN J APPL PHYS 1, V43, P4949, DOI 10.1143/JJAP.43.4949; King BM, 2000, APPL OPTICS, V39, P6681, DOI 10.1364/AO.39.006681; Anderson K, 2004, OPT LETT, V29, P1402, DOI 10.1364/OL.29.001402; Jenness NJ, 2008, OPT EXPRESS, V16, P15942, DOI 10.1364/OE.16.015942; Berger G, 2008, J OPT A-PURE APPL OP, V10, DOI 10.1088/1464-4258/10/11/115305; PSALTIS D, 1995, OPT LETT, V20, P782; Nishizaki T, 2014, APPL OPTICS, V53, P5733, DOI 10.1364/AO.53.005733; Cao LC, 2014, APPL OPTICS, V53, P1, DOI 10.1364/AO.53.000001; HEANUE JF, 1994, OPT LETT, V19, P1079, DOI 10.1364/OL.19.001079; Tanaka K, 2007, OPT EXPRESS, V15, P16196, DOI 10.1364/OE.15.016196; Sun CC, 2001, APPL OPTICS, V40, P1253, DOI 10.1364/AO.40.001253; Shimura T, 2006, OPT LETT, V31, P1208, DOI 10.1364/OL.31.001208; CURTIS K, 1994, OPT LETT, V19, P993, DOI 10.1364/OL.19.000993; Markov V, 1999, OPT LETT, V24, P265, DOI 10.1364/OL.24.000265; Nobukawa T, 2015, OPT LETT, V40, P2161, DOI 10.1364/OL.40.002161; Kinoshita N, 2011, APPL OPTICS, V50, P2361, DOI 10.1364/AO.50.002361; Horimai H, 2005, APPL OPTICS, V44, P2575, DOI 10.1364/AO.44.002575; Curtis JE, 2002, OPT COMMUN, V207, P169, DOI 10.1016/S0030-4018(02)01524-9; Jesacher A, 2010, OPT EXPRESS, V18, P21090, DOI 10.1364/OE.18.021090; DENZ C, 1991, OPT COMMUN, V85, P171, DOI 10.1016/0030-4018(91)90389-U; Palima D, 2007, APPL OPTICS, V46, P4197, DOI 10.1364/AO.46.004197; RAKULJIC GA, 1992, OPT LETT, V17, P1471, DOI 10.1364/OL.17.001471; Minabe J, 2008, JPN J APPL PHYS, V47, P5968, DOI 10.1143/JJAP.47.5968; Ochiai T, 2013, OPT LETT, V38, P748, DOI 10.1364/OL.38.000748; Nobukawa T, 2014, APPL OPTICS, V53, P3773, DOI 10.1364/AO.53.003773; Zhang H, 2009, APPL OPTICS, V48, P5834, DOI 10.1364/AO.48.005834; Kuroda K, 2011, OPT REV, V18, P374, DOI 10.1007/s10043-011-0072-5; Wu AA, 2015, OPT EXPRESS, V23, P8880, DOI 10.1364/OE.23.008880; Curtis K., 2010, HOLOGRAPHIC DATA STO; Inoue T, 2007, P SOC PHOTO-OPT INS, V6487, pY4870, DOI 10.1117/12.699821; Mermillod-Blondin A, 2008, OPT LETT, V33, P2146, DOI 10.1364/OL.33.002146; Pesce G, 2015, J OPT SOC AM B, V32, pB84, DOI 10.1364/JOSAB.32.000B84; Shibukawa A, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09ME10; Yoshida S, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09LD07	35	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	DEC 1	2015	40	23					5419	5422		10.1364/OL.40.005419		4	Optics	Optics	CY0YY	WOS:000366134100001		
J	Sera, H; Abe, M; Iwakuni, K; Okubo, S; Inaba, H; Hong, FL; Sasada, H				Sera, Hideyuki; Abe, Masashi; Iwakuni, Kana; Okubo, Sho; Inaba, Hajime; Hong, Feng-Lei; Sasada, Hiroyuki			Sub-Doppler resolution mid-infrared spectroscopy using a difference-frequency-generation source spectrally narrowed by laser linewidth transfer	OPTICS LETTERS			English	Article							COMB; LEVEL; LIST; BAND	The spectral linewidth of a 3.28 mu m difference-frequency-generation source has been reduced to 3.5 kHz using a laser linewidth transfer technique [Opt. Express 21, 7891 (2013)]. We use an optical frequency comb with a broad servo bandwidth to transfer a narrow linewidth of a pump laser, a 1.06 mu m Nd:YAG laser, to a signal laser, a 1.57 mu m external-cavity laser diode. This source enables us to record the Lamb dip of the nu(3) band R(2) E transition of methane with a molecular spectral linewidth of 21 kHz while the frequency axis is absolutely calibrated. (C) 2015 Optical Society of America	[Sera, Hideyuki; Abe, Masashi; Iwakuni, Kana; Sasada, Hiroyuki] Keio Univ, Dept Phys, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Sera, Hideyuki; Iwakuni, Kana; Okubo, Sho; Inaba, Hajime; Hong, Feng-Lei] Natl Metrol Inst Japan, Times & Frequency Div, Tsukuba, Ibaraki 3058563, Japan; [Sera, Hideyuki; Abe, Masashi; Iwakuni, Kana; Okubo, Sho; Inaba, Hajime; Hong, Feng-Lei; Sasada, Hiroyuki] JST, ERATO, MINOSHIMA Intelligent Opt Synthesizer Project, Tsukuba, Ibaraki 3058563, Japan	Sera, H (reprint author), Keio Univ, Dept Phys, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	h.setsu@keio.jp			Japan Science and Technology Agency (JST), Exploratory Research for Advanced Technology Intelligent Optical Synthesizer Program; Japan Society for the Promotion of Science, Kakenhi [23244084]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Advanced Photon Science Alliance	Japan Science and Technology Agency (JST), Exploratory Research for Advanced Technology Intelligent Optical Synthesizer Program; Japan Society for the Promotion of Science, Kakenhi (23244084); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Advanced Photon Science Alliance.	Inaba H, 2013, OPT EXPRESS, V21, P7891, DOI 10.1364/OE.21.007891; Nakajima Y, 2010, OPT EXPRESS, V18, P1667, DOI 10.1364/OE.18.001667; Chen HC, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.263002; Abe M, 2015, J MOL SPECTROSC, V312, P90, DOI 10.1016/j.jms.2015.04.003; Rusciano G, 2005, OPT EXPRESS, V13, P8357, DOI 10.1364/OPEX.13.008357; Abe M, 2013, J OPT SOC AM B, V30, P1027, DOI 10.1364/JOSAB.30.001027; Hosaka K, 2010, IEEE T ULTRASON FERR, V57, P606, DOI 10.1109/TUFFC.2010.1454; Wu KY, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.032507; Jones DJ, 2000, SCIENCE, V288, P635, DOI 10.1126/science.288.5466.635; Ricciardi I, 2012, OPT EXPRESS, V20, P9178, DOI 10.1364/OE.20.009178; Argence B, 2015, NAT PHOTONICS, V9, P456, DOI 10.1038/NPHOTON.2015.93; PINE AS, 1992, J CHEM PHYS, V97, P773, DOI 10.1063/1.463943; Porambo MW, 2012, OPT LETT, V37, P4422, DOI 10.1364/OL.37.004422; Iwakuni K, 2013, OPT EXPRESS, V21, P14832, DOI 10.1364/OE.21.014832; Crabtree KN, 2012, CHEM PHYS LETT, V551, P1, DOI 10.1016/j.cplett.2012.09.015; Abe M, 2014, OPT LETT, V39, P5277, DOI 10.1364/OL.39.005277; HALL JL, 1976, PHYS REV LETT, V37, P1339, DOI 10.1103/PhysRevLett.37.1339; Kovalchuk EV, 2001, OPT LETT, V26, P1430, DOI 10.1364/OL.26.001430; Tadanaga O, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2172400; Hodges JN, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4825251; Iwakuni K, 2014, J MOL SPECTROSC, V306, P19, DOI 10.1016/j.jms.2014.09.013	21	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	DEC 1	2015	40	23					5467	5470		10.1364/OL.40.005467		4	Optics	Optics	CY0YY	WOS:000366134100013		
J	Sakuma, J; Kaneda, Y; Oka, N; Ishida, T; Moriizumi, K; Kusunose, H; Furukawa, Y				Sakuma, Jun; Kaneda, Yushi; Oka, Naoya; Ishida, Takayuki; Moriizumi, Koichi; Kusunose, Haruhiko; Furukawa, Yasunori			Continuous-wave 193.4 nm laser with 120 mW output power	OPTICS LETTERS			English	Article							LIGHT GENERATION	This Letter describes an all-solid-state continuous-wave, deep-ultraviolet coherent source that generates more than 100 mW of output power at 193.4 nm. The source is based on nonlinear frequency conversion of three single-frequency infrared fiber laser master-oscillator power-amplifier (MOPA) light sources. (C) 2015 Optical Society of America	[Sakuma, Jun; Ishida, Takayuki; Moriizumi, Koichi; Kusunose, Haruhiko] Lasertec Corp, Kohoku Ku, Yokohama, Kanagawa 2228552, Japan; [Kaneda, Yushi; Oka, Naoya; Furukawa, Yasunori] Oxide Corp, Hokuto, Yamanashi 4080302, Japan	Sakuma, J (reprint author), Lasertec Corp, Kohoku Ku, 2-10-1 Shin Yokohama, Yokohama, Kanagawa 2228552, Japan.	jun.sakuma@Lasertec.co.jp					Sakuma J, 2011, OPT EXPRESS, V19, P15020, DOI 10.1364/OE.19.015020; KATO K, 1994, IEEE J QUANTUM ELECT, V30, P2950, DOI 10.1109/3.362711; Xuan HW, 2015, OPT EXPRESS, V23, P10564, DOI 10.1364/OE.23.010564; BOYD GD, 1968, J APPL PHYS, V39, P3597, DOI 10.1063/1.1656831; Kawai H., 2003, C LAS EL OPT QUANT E; Ohtsuki T., 2000, C LAS EL OPT SOC AM; Scholz M, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4817786; Smith A. V., 2015, SNLO NONLINEAR OPTIC	8	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	DEC 1	2015	40	23					5590	5593		10.1364/OL.40.005590		4	Optics	Optics	CY0YY	WOS:000366134100044		
J	Matsuura, M; Furugori, H; Sato, J				Matsuura, Motoharu; Furugori, Hidehito; Sato, Jun			60 W power-over-fiber feed using double-clad fibers for radio-over-fiber systems with optically powered remote antenna units	OPTICS LETTERS			English	Article							NETWORK; LASERS; ENERGY	We experimentally demonstrated the ability to feed 60 W of optical power into a power-over-fiber link using a double-clad fiber for radio-over-fiber systems with optically powered remote antenna units. In order to improve the available optical feed power and the power transmission efficiency of the power-over-fiber link, we have designed a specially customized tapered fiber bundle divider for the remote antenna unit. We demonstrated, for the first time, bidirectional radio-over-fiber transmission over a 300 m double-clad fiber with an improved power transmission efficiency and optical power feeding up to 60 W input. (C) 2015 Optical Society of America	[Matsuura, Motoharu; Furugori, Hidehito; Sato, Jun] Univ Electrocommun, Grad Sch Informat & Engn, Chofu, Tokyo 1828585, Japan	Matsuura, M (reprint author), Univ Electrocommun, Grad Sch Informat & Engn, 1-5-1 Chofugaoka, Chofu, Tokyo 1828585, Japan.	m.matsuura@uec.ac.jp					Allowood G., 2011, INT S EL DES TEST AP, P78; Kosterin A, 2004, APPL OPTICS, V43, P3893, DOI 10.1364/AO.43.003893; MILLER RC, 1979, AT&T TECH J, V58, P1735; Wake D, 2008, J LIGHTWAVE TECHNOL, V26, P2484, DOI 10.1109/JLT.2008.927171; Nakamura T, 2013, IEEE COMMUN MAG, V51, P98, DOI 10.1109/MCOM.2013.6461192; BANWELL TC, 1993, J LIGHTWAVE TECHNOL, V11, P481, DOI 10.1109/50.219583; Auer G, 2011, IEEE WIREL COMMUN, V18, P40, DOI 10.1109/MWC.2011.6056691; Jauregui C, 2013, NAT PHOTONICS, V7, P861, DOI 10.1038/nphoton.2013.273; Cooper J., 1990, ELECTRON LETT, V26, P2054; Kirham H., 1989, IEEE T POWER DELIVER, V4, P1997; Lethien C, 2012, IEEE PHOTONIC TECH L, V24, P649, DOI 10.1109/LPT.2012.2185224; Matsuura M., 2015, IEEE PHOTONICS J, V7, P1; Miki T., 2003, OPT COMM C; Sato J., 2013, OPT COMM C PHOT SWIT; Sato J., 2015, OPT COMM C EXP; Sauer M, 2007, J LIGHTWAVE TECHNOL, V25, P3301, DOI 10.1109/JLT.2007.906822	16	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	DEC 1	2015	40	23					5598	5601		10.1364/OL.40.005598		4	Optics	Optics	CY0YY	WOS:000366134100046		
J	Kakeya, H; Sawada, S				Kakeya, Hideki; Sawada, Shimpei			Reduction of image discontinuity in coarse integral volumetric imaging	OPTICS LETTERS			English	Article							DISPLAY DEVICES; PLANES; LENSES; SYSTEM; MOIRE	The authors describe two methods to reduce the discontinuity of the image in coarse integral volumetric imaging. The discontinuity of elemental images from neighboring elemental lenses is smoothed by introducing Fresnel elemental lenses with interleaved grooves. The discontinuity of volumetric layers with long intervals is made indistinct by introducing a smoothing filter and an edge filter to connect the layered images smoothly. The effectiveness of the proposed methods is confirmed by the prototype systems. (C) 2015 Optical Society of America	[Kakeya, Hideki; Sawada, Shimpei] Univ Tsukuba, Dept Intelligent Interact Technol, Tsukuba, Ibaraki 3058573, Japan	Kakeya, H (reprint author), Univ Tsukuba, Dept Intelligent Interact Technol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	kake@iit.tsukuba.ac.jp			Japan Society for the Promotion of Science (JSPS) [22680008, 25280070]	Japan Society for the Promotion of Science (JSPS) (22680008, 25280070).	Park JH, 2003, OPT EXPRESS, V11, P1862, DOI 10.1364/OE.11.001862; Kim Y, 2006, APPL OPTICS, V45, P4334, DOI 10.1364/AO.45.004334; Kakeya Hideki, 2008, Proceedings of the SPIE - The International Society for Optical Engineering, V6803, DOI 10.1117/12.766338; Lee B, 2001, OPT LETT, V26, P1481, DOI 10.1364/OL.26.001481; Sawada S, 2014, APPL OPTICS, V53, P6268, DOI 10.1364/AO.53.006268; Min SW, 2003, APPL OPTICS, V42, P4186, DOI 10.1364/AO.42.004186; Kakeya H, 2011, OPT EXPRESS, V19, P20395, DOI 10.1364/OE.19.020395; Kim Y, 2007, APPL OPTICS, V46, P3766, DOI 10.1364/AO.46.003766; Sawada S, 2012, OPT EXPRESS, V20, P25902, DOI 10.1364/OE.20.025902; Gotoda H, 2011, PROC SPIE, V7863, DOI 10.1117/12.872708; Kakeya H, 2012, OPT EXPRESS, V20, P1963, DOI 10.1364/OE.20.001963; Kim Y, 2009, APPL OPTICS, V48, P2178, DOI 10.1364/AO.48.002178; Kakeya H, 2010, P SOC PHOTO-OPT INS, V7524, DOI 10.1117/12.837309; Sawada S, 2012, J ELECTRON IMAGING, V21, DOI 10.1117/1.JEI.21.1.011004; Ebisu H., 2007, P SPIE, V6490; Gotoda H., 2010, P SPIE, V7524; Kakeya H., 2009, P SOC PHOTO-OPT INS, V7237; Lanman D., 2012, P SPIE, V8288; Lippmann G, 1908, CR HEBD ACAD SCI, V146, P446; Marwah K., 2013, ACM T GRAPHIC, V32, P1; Smithwick Q., 2013, SID S DIGEST TECH PA, V44, P310; Sullivan A, 2004, P SOC PHOTO-OPT INS, V5291, P279, DOI 10.1117/12.527543; Ueda Y., 2011, SID INT S, V42, P1116; Wetzstein G., 2012, ACM T GRAPHIC, V31, P1; Yasui R., 2006, P SPIE, V6055	25	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	DEC 1	2015	40	23					5698	5701		10.1364/OL.40.005698		4	Optics	Optics	CY0YY	WOS:000366134100071		
J	Khor, SS; Yang, W; Kawashima, M; Kamitsuji, S; Zheng, X; Nishida, N; Sawai, H; Toyoda, H; Miyagawa, T; Honda, M; Kamatani, N; Tokunaga, K				Khor, S-S; Yang, W.; Kawashima, M.; Kamitsuji, S.; Zheng, X.; Nishida, N.; Sawai, H.; Toyoda, H.; Miyagawa, T.; Honda, M.; Kamatani, N.; Tokunaga, K.			High-accuracy imputation for HLA class I and II genes based on high-resolution SNP data of population-specific references	PHARMACOGENOMICS JOURNAL			English	Article							ALLELES; NARCOLEPSY	Statistical imputation of classical human leukocyte antigen (HLA) alleles is becoming an indispensable tool for fine-mappings of disease association signals from case-control genome-wide association studies. However, most currently available HLA imputation tools are based on European reference populations and are not suitable for direct application to non-European populations. Among the HLA imputation tools, The HIBAG R package is a flexible HLA imputation tool that is equipped with a wide range of population-based classifiers; moreover, HIBAG R enables individual researchers to build custom classifiers. Here, two data sets, each comprising data from healthy Japanese individuals of difference sample sizes, were used to build custom classifiers. HLA imputation accuracy in five HLA classes (HLA-A, HLA-B, HLA-DRB1, HLA-DQB1 and HLA-DPB1) increased from the 82.5-98.8% obtained with the original HIBAG references to 95.2-99.5% with our custom classifiers. A call threshold (CT) of 0.4 is recommended for our Japanese classifiers; in contrast, HIBAG references recommend a CT of 0.5. Finally, our classifiers could be used to identify the risk haplotypes for Japanese narcolepsy with cataplexy, HLA-DRB1*15:01 and HLA-DQB1*06:02, with 100% and 99.7% accuracy, respectively; therefore, these classifiers can be used to supplement the current lack of HLA genotyping data in widely available genome-wide association study data sets.	[Khor, S-S; Kawashima, M.; Nishida, N.; Sawai, H.; Toyoda, H.; Miyagawa, T.; Tokunaga, K.] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo 1130033, Japan; [Yang, W.; Kamitsuji, S.; Kamatani, N.] StaGen Co Ltd, Stat Genet Anal Div, Tokyo, Japan; [Zheng, X.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Nishida, N.] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Japan; [Honda, M.] Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Sleep Disorders Project, Tokyo 113, Japan	Tokunaga, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Human Genet, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	tokunaga@m.u-tokyo.ac.jp	Khor, Seik-Soon/C-4700-2015	Khor, Seik-Soon/0000-0002-6809-4731	Ministry of Education, Culture, Sports, Science and Technology of Japan [22133008]	This study was supported by Grants-in-Aid for Scientific Research on Innovative Areas (22133008, KT) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Andreassen OA, 2014, MOL PSYCHIAT; JUJI T, 1984, TISSUE ANTIGENS, V24, P316, DOI 10.1111/j.1399-0039.1984.tb02144.x; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Lessard CJ, 2013, NAT GENET, V45, P1284, DOI 10.1038/ng.2792; Evseeva I, 2010, EUR J HUM GENET, V18, P924, DOI 10.1038/ejhg.2010.32; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Bryll R, 2003, PATTERN RECOGN, V36, P1291, DOI 10.1016/S0031-3203(02)00121-8; Dilthey A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002877; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Zheng X, 2013, PHARMACOGENOMICS J, V14, P192	15	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1470-269X	1473-1150		PHARMACOGENOMICS J	Pharmacogenomics J.	DEC	2015	15	6					530	537		10.1038/tpj.2015.4		8	Genetics & Heredity; Pharmacology & Pharmacy	Genetics & Heredity; Pharmacology & Pharmacy	CY0WM	WOS:000366127600007		
J	Ahmad, D; Min, BH; Min, GI; Kimura, SI; Seo, J; Kwon, YS				Ahmad, D.; Min, Byeon Hun; Min, Gyeon Im; Kimura, Shin-Ichi; Seo, Jungpil; Kwon, Yong Seung			Evidence of charge-density waves in the optical properties of SmNiC2	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						charge density wave (CDW); optical conductivity; SmNiC2	MAGNETIC-PROPERTIES; RNIC2	In this study, we have measured the optical reflectivity spectra of low-dimensional SmNiC2 (T-C = 18.5 K and T-CDW = 151 K) in the terahertz to ultraviolet frequency range at various temperatures. The optical conductivity spectra were transformed from the reflectivity data using the Kramers-Kronig relation. The optical conductivity of the normal state is well described by the Drude-Lorentz model assuming two bands. In nonmagnetic states below TCDW, two clean gaps opening on top of the Drude response are observed at around 500 and 750 cm(-1). In the ferromagnetic state, the higher-side gap opening remains at the same frequency but the lower-side gap opening disappears, instead an additional absorption due to magnon gap formation is observed at around 70 cm(-1). (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Ahmad, D.; Min, Byeon Hun; Seo, Jungpil; Kwon, Yong Seung] DGIST, Dept Emerging Mat Sci, Taegu 711873, South Korea; [Min, Gyeon Im] Sungkyunkwan Univ, Dept Phys, Suwon 440746, South Korea; [Kimura, Shin-Ichi] Osaka Univ, Grad Sch Frontier Biosci, Osaka 5650871, Japan; [Kimura, Shin-Ichi] Osaka Univ, Dept Phys, Osaka 5650871, Japan	Kwon, YS (reprint author), DGIST, Dept Emerging Mat Sci, Taegu 711873, South Korea.	yskwon@dgist.ac.kr			Leading Foreign Research Institute Recruitment Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST) [2012K1A4A3053565]	We gratefully acknowledge the helpful discussions with Prof. O. Sakai and Dr. J. H. Yun. This work was supported by the Leading Foreign Research Institute Recruitment Program (Grant No. 2012K1A4A3053565) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST).	YAKINTHOS JK, 1994, J MAGN MAGN MATER, V136, P327, DOI 10.1016/0304-8853(94)00306-8; Hanasaki N, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.092402; Laverock J, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.125111; Kim JH, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.235101; Shimomura S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.076404; Dong QY, 2014, SOLID STATE COMMUN, V179, P20, DOI 10.1016/j.ssc.2013.11.012; Onodera H, 1998, J MAGN MAGN MATER, V182, P161, DOI 10.1016/S0304-8853(97)01011-1; Murase M, 2004, J PHYS SOC JPN, V73, P2790, DOI 10.1143/JPSJ.73.2790; Woo B, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.125121; Kwon YS, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/6/063009; Sato T, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.044707; Gruner G., 1994, FRONTIERS PHYS, V89; Kimura S., 2008, JASCO REP, V50, P6; Wolfel A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.054120	14	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	DEC	2015	252	12					2662	2666		10.1002/pssb.201552005		5	Physics, Condensed Matter	Physics	CX9HJ	WOS:000366015300004		
J	Kosogor, A; Lyange, M; Zadorozhnyy, M; Miki, H; Takagi, T; L'vov, VA; Khovaylo, V				Kosogor, Anna; Lyange, Maria; Zadorozhnyy, Mikhail; Miki, Hiroyuki; Takagi, Toshiyuki; L'vov, Victor A.; Khovaylo, Vladimir			Influence of different mechanisms of martensite aging on the features of martensitic transformations	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						differential scanning calorimetry; internal stresses; martensite aging; shape memory alloys	SHAPE-MEMORY ALLOYS; NI; STABILIZATION; CRYSTALS; BEHAVIOR; STRESS	Aging-induced changes in the features of the calorimetric peak accompanying martensitic transformation were considered in the framework of phenomenological theory. Taking into account two different mechanisms of martensite aging, it was demonstrated that the domination of the internal axial stress contribution narrows the calorimetric peak and elevates its magnitude, while the prevalence of the internal pressure contribution broadens the calorimetric peak and diminishes its magnitude. The developed theoretical approach was applied to modeling of experimentally measured calorimetric peaks of Ni-Mn-Ga alloys. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Kosogor, Anna; Lyange, Maria; Zadorozhnyy, Mikhail; Khovaylo, Vladimir] Natl Univ Sci & Technol MISiS, Moscow 119049, Russia; [Kosogor, Anna; L'vov, Victor A.] Inst Magnetism, UA-03142 Kiev, Ukraine; [Miki, Hiroyuki] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 9808578, Japan; [Takagi, Toshiyuki] Tohoku Univ, Inst Fluid Sci, Sendai, Miyagi 9808577, Japan; [Khovaylo, Vladimir] ITMO Univ, St Petersburg 197101, Russia	Kosogor, A (reprint author), Natl Univ Sci & Technol MISiS, Moscow 119049, Russia.	annakosogor@gmail.com			Ministry of Education and Science of the Russian Federation [K4-2014-034, RFMEFI57514X0094]	The authors gratefully acknowledge the financial support of the Ministry of Education and Science of the Russian Federation in the framework of Increase Competitiveness Program of NUST "MISiS" (No. K4-2014-034) and financial support of the Ministry of Education and Science of the Russian Federation (project ID RFMEFI57514X0094).	Khovaylo VV, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.224408; Murakami Y, 1997, MAT SCI ENG A-STRUCT, V237, P87, DOI 10.1016/S0921-5093(97)00120-2; Ren XB, 2000, PHYS REV LETT, V85, P1016, DOI 10.1103/PhysRevLett.85.1016; Otsuka K, 2005, PROG MATER SCI, V50, P511, DOI 10.1016/j.pmatsci.2004.10.001; Kustov S, 2004, ACTA MATER, V52, P3083, DOI 10.1016/j.actamat.2004.03.010; Khovaylo V, 2008, PHILOS MAG, V88, P865, DOI 10.1080/14786430801986670; OTSUKA K, 1974, T JPN I MET, V15, P103; L'vov VA, 2012, ACTA MATER, V60, P1587, DOI 10.1016/j.actamat.2011.11.040; Kosogor A, 2011, ACTA MATER, V59, P3593, DOI 10.1016/j.actamat.2011.02.032; Picornell C, 2009, FUNCT MATER LETT, V2, P83, DOI 10.1142/S1793604709000612; NAKATA Y, 1993, MATER T JIM, V34, P429; Segui C, 2005, SCRIPTA MATER, V53, P315, DOI 10.1016/j.scriptamat.2005.04.009; Ren XB, 1997, NATURE, V389, P579; Khovailo VV, 2004, SCRIPTA MATER, V51, P13, DOI 10.1016/j.scriptamat.2004.03.025; Chernenko VA, 2013, METALS-BASEL, V3, P237, DOI 10.3390/met3030237; GOMONAJ EV, 1994, PHASE TRANSIT, V47, P9, DOI 10.1080/01411599408200334; Hannula S.-P, 2006, Advances in Science and Technology, V49, DOI 10.4028/www.scientific.net/AST.49.109; Kohl M., 2004, SHAPE MEMORY MICROAC; Lagoudas C., 2007, SHAPE MEMORY ALLOYS	19	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	DEC	2015	252	12					2758	2761		10.1002/pssb.201552324		4	Physics, Condensed Matter	Physics	CX9HJ	WOS:000366015300018		
J	Sugishima, M; Wada, H; Mitsuda, A; Kondo, A; Kindo, K				Sugishima, Masaki; Wada, Hirofumi; Mitsuda, Akihiro; Kondo, Akihiro; Kindo, Koichi			Large magnetoresistance of EuPtP1-XAsX	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						EuPtP1-xAsx; magnetoresistance; valence ordering; valence transitions	EU VALENCE STATE; TRANSITION; RESISTIVITY; EUROPIUM; EUPTP	High-field magnetization and magnetoresistance of EuPtP1-xAsx with 0.55 <= x <= 0.70 have been studied. Large negative magnetoresistance associated with the field-induced valence transition was observed. Based on the results, we discuss the nature of the valence transition caused by high magnetic fields. Besides, the compounds exhibit substantial negative magnetoresistance in the low field region below 10 T. It is found that the magnetoresistance is proportional to the square of magnetization. The origin of magnetoresistance in the low field region is also discussed. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Sugishima, Masaki; Wada, Hirofumi; Mitsuda, Akihiro] Kyushu Univ, Dept Phys, Higashi Ku, Fukuoka 8128581, Japan; [Sugishima, Masaki] Iwate Univ, Div Tech Support, Morioka, Iwate 0208550, Japan; [Kondo, Akihiro; Kindo, Koichi] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan	Wada, H (reprint author), Kyushu Univ, Dept Phys, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	wada@phys.kyushu-u.ac.jp					Medvedev SA, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/33/335701; Sugishima M, 2013, J KOREAN PHYS SOC, V62, P2019, DOI 10.3938/jkps.62.2019; Mitsuda A, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.023709; YOSIDA K, 1957, PHYS REV, V107, P396, DOI 10.1103/PhysRev.107.396; Nakama T, 2010, J PHYS CONF SER, V200, DOI 10.1088/1742-6596/200/3/032050; Kumar RS, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4863203; POTT R, 1983, PHYS REV B, V27, P359, DOI 10.1103/PhysRevB.27.359; NOWACK A, 1989, Z PHYS B CON MAT, V77, P381, DOI 10.1007/BF01453786; MICHELS G, 1995, Z PHYS B CON MAT, V98, P75, DOI 10.1007/BF01318282; Inami T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.195133; KASUYA T, 1956, PROG THEOR PHYS, V16, P58, DOI 10.1143/PTP.16.58; FISHER RA, 1995, PHYS REV B, V52, P13519, DOI 10.1103/PhysRevB.52.13519; Seiro S, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/37/375601; Zhai HF, 2014, J AM CHEM SOC, V136, P15386, DOI 10.1021/ja508564s; BAIBICH MN, 1988, PHYS REV LETT, V61, P2472, DOI 10.1103/PhysRevLett.61.2472; Chefki M, 1998, PHYS REV LETT, V80, P802, DOI 10.1103/PhysRevLett.80.802; BAUMINGE.ER, 1973, PHYS REV LETT, V30, P1053, DOI 10.1103/PhysRevLett.30.1053; Hiranaka Y, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.083708; LOSSAU N, 1989, Z PHYS B CON MAT, V74, P227, DOI 10.1007/BF01307389; Mitsuda A, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2011-20807-4	20	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	DEC	2015	252	12					2784	2788		10.1002/pssb.201552370		5	Physics, Condensed Matter	Physics	CX9HJ	WOS:000366015300022		
J	Uedono, A; Takashima, S; Edo, M; Ueno, K; Matsuyama, H; Kudo, H; Naramoto, H; Ishibashi, S				Uedono, Akira; Takashima, Shinya; Edo, Masaharu; Ueno, Katsunori; Matsuyama, Hideaki; Kudo, Hiroshi; Naramoto, Hiroshi; Ishibashi, Shoji			Vacancy-type defects and their annealing behaviors in Mg-implanted GaN studied by a monoenergetic positron beam	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						annealing; defects; GaN; ion implantation; positron annihilation; vacancies	AUGMENTED-WAVE METHOD; ION-IMPLANTATION; IRRADIATED GAN; TEMPERATURE; PHOTOLUMINESCENCE; DEPENDENCE	Vacancy-type defects in Mg-implanted GaN were probed using a monoenergetic positron beam. Mg ions of multiple energies (15-180 keV) were implanted to provide a 200-nm-deep box profile with Mg concentration of 4 x 1019 cm(-3). The major defect species of vacancies introduced by Mg-implantation was a complex between Ga-vacancy (V-Ga) and nitrogen vacancies (V-N(S)). After annealing above 1000 degrees C, these defects started to agglomerate, and the major defect species became (VGa) 2 coupled with V-N(S). The defect reaction occurred between not only the defects introduced by the implantation but also the defects introduced by an excess Mg-doping. The depth distribution of vacancy-type defects agreed well with that of implanted Mg, and no large change in the distribution was observed up to 13008 degrees C annealing. Relationships between photoluminescence bands and vacancy-type defects introduced by Mg-implantation are also discussed. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Uedono, Akira] Univ Tsukuba, Fac Pure & Appl Sci, Div Appl Phys, Tsukuba, Ibaraki 3058573, Japan; [Takashima, Shinya; Edo, Masaharu; Ueno, Katsunori; Matsuyama, Hideaki] Fuji Elect Co Ltd, Adv Technol Lab, Hino, Tokyo 1918502, Japan; [Kudo, Hiroshi; Naramoto, Hiroshi] Univ Tsukuba, Res Facil, Ctr Sci & Technol, Tsukuba, Ibaraki 3058573, Japan; [Ishibashi, Shoji] Natl Inst Adv Ind Sci & Technol, Nanomat Res Inst, Tsukuba, Ibaraki 3058568, Japan	Uedono, A (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, Div Appl Phys, Tsukuba, Ibaraki 3058573, Japan.	uedono.akira.gb@u.tsukuba.ac.jp			Council for Science, Technology and Innovation (CSTI); Cross-ministerial Strategic Innovation Promotion Program (SIP); "Next-generation power electronics" (funding agency: NEDO)	This work was supported by Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP), "Next-generation power electronics" (funding agency: NEDO).	Amano H, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.050001; Reshchikov MA, 2005, J APPL PHYS, V97, DOI 10.1063/1.1868059; Xu JP, 2014, CHEM PHYS LETT, V616, P161, DOI 10.1016/j.cplett.2014.10.045; Whelan S, 2005, J APPL PHYS, V98, DOI 10.1063/1.1940142; Buckeridge J, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.016405; Greenlee JD, 2014, J APPL PHYS, V116, DOI 10.1063/1.4892618; Tuomisto F, 2013, REV MOD PHYS, V85, P1583, DOI 10.1103/RevModPhys.85.1583; Uedono A, 2014, J APPL PHYS, V116, DOI 10.1063/1.4896829; Pearton SJ, 1999, J APPL PHYS, V86, P1, DOI 10.1063/1.371145; PANKOVE JI, 1976, J APPL PHYS, V47, P5387, DOI 10.1063/1.322566; Liu KT, 2005, J APPL PHYS, V98, DOI 10.1063/1.2073969; Uedono A, 2003, J APPL PHYS, V93, P3228, DOI 10.1063/1.1542923; Saarinen K, 2001, PHYSICA B, V308, P77, DOI 10.1016/S0921-4526(01)00659-7; Pong BJ, 1998, J APPL PHYS, V83, P5992, DOI 10.1063/1.367465; Moutanabbir O, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2955832; Hardy MT, 2011, MATER TODAY, V14, P408, DOI 10.1016/S1369-7021(11)70185-7; Hager CE, 2009, J APPL PHYS, V105, DOI 10.1063/1.3068317; Ishibashi S, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.153310; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; VANVEEN A, 1995, APPL SURF SCI, V85, P216, DOI 10.1016/0169-4332(94)00334-3; Sheu JK, 1998, J APPL PHYS, V84, P4590, DOI 10.1063/1.368702; BORONSKI E, 1986, PHYS REV B, V34, P3820, DOI 10.1103/PhysRevB.34.3820; Uedono A, 2007, J APPL PHYS, V102, DOI 10.1063/1.2798586; Van de Walle CG, 2004, J APPL PHYS, V95, P3851, DOI 10.1063/1.1682673; Li XF, 2015, J APPL PHYS, V117, DOI 10.1063/1.4913523; Wang MJ, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3081019; Ishibashi S, 2014, J PHYS CONF SER, V505, DOI 10.1088/1742-6596/505/1/012010; Baliga BJ, 2013, SEMICOND SCI TECH, V28, DOI 10.1088/0268-1242/28/7/074011; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Chu Wei-Kan, 1978, BACKSCATTERING SPECT; Dadgar A, 2000, JPN J APPL PHYS 2, V39, pL1183, DOI 10.1143/JJAP.39.L1183; Irokawa Y, 2005, J APPL PHYS, V97, DOI 10.1063/1.1863458; Krause-Rehberg R., 1999, SEMICONDUCTORS SOLID, V127; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Uedono A., 2013, JPN J APPL PHYS, V52	35	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	DEC	2015	252	12					2794	2801		10.1002/pssb.201552345		8	Physics, Condensed Matter	Physics	CX9HJ	WOS:000366015300024		
J	Kanemura, S; Shindou, T; Sugiyama, H				Kanemura, Shinya; Shindou, Tetsuo; Sugiyama, Hiroaki			R-parity conserving supersymmetric extension of the Zee model	PHYSICAL REVIEW D			English	Article							MAJORANA NEUTRINO MASSES; LEPTON FLAVOR VIOLATION; HIGGS BOSONS; LINEAR COLLIDER; PP COLLISIONS; DARK-MATTER; CP-ODD; SEARCH; DECAYS; MATRIX	We extend the Zee model, where tiny neutrino masses are generated at the one-loop level, to a supersymmetric model with R-parity conservation. It is found that the neutrino mass matrix can be consistent with the neutrino oscillation data thanks to the nonholomorphic Yukawa interaction generated via one-loop diagrams of sleptons. We find a parameter set of the model, where in addition to the neutrino oscillation data, experimental constraints from the lepton flavor violating decays of charged leptons and current LHC data are also satisfied. In the parameter set, an additional CP-even neutral Higgs boson other than the standard-model-like one, a CP-odd neutral Higgs boson, and two charged scalar bosons are light enough to be produced at the LHC and future lepton colliders. If the lightest charged scalar bosons are mainly composed of the SU(2)(L)-singlet scalar boson in the model, they would decay into e nu and mu nu with 50% of a branching ratio for each. In such a case, the relation among the masses of the charged scalar bosons and the CP-odd Higgs in the minimal supersymmetric standard model approximately holds with a radiative correction. Our model can be tested by measuring the specific decay patterns of charged scalar bosons and the discriminative mass spectrum of additional scalar bosons.	[Kanemura, Shinya; Sugiyama, Hiroaki] Toyama Univ, Dept Phys, Toyama 9308555, Japan; [Shindou, Tetsuo] Kogakuin Univ, Div Liberal Arts, Tokyo 1638677, Japan	Kanemura, S (reprint author), Toyama Univ, Dept Phys, 3190 Gofuku, Toyama 9308555, Japan.	kanemu@sci.u-toyama.ac.jp; shindou@cc.kogakuin.ac.jp; sugiyama@sci.u-toyama.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24340046]; Grand H2020-MSCA-RISE [645722]; MEXT, Japan [23104011]	We thank Natsumi Nagata for bringing our attention to the Barr-Zee diagram for mu -> e gamma. This work was supported, in part, by Grant-in-Aid for Scientific Research, the Ministry of Education, Culture, Sports, Science and Technology (MEXT), No. 24340046 (S. K.), and Grand H2020-MSCA-RISE-2014 No. 645722 (Non Minimal Higgs) (S. K.). This work was also supported, in part, by a Grant-in-Aid for Scientific Research from the MEXT, Japan, Grant No. 23104011 (T. S.).	Aad G., ARXIV150803372 ATLAS; Aaij R, 2015, J HIGH ENERGY PHYS, P1, DOI 10.1007/JHEP02(2015)121; Abdurashitov JN, 2009, PHYS REV C, V80, DOI 10.1103/PhysRevC.80.015807; Abe K, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.061802; Abe T., ARXIV10110352 BELL 2; Abe Y, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP10(2014)086; Aharmim B, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.025501; Aad G, 2015, PHYS LETT B, V744, P163, DOI 10.1016/j.physletb.2015.03.054; Ma E, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.077301; Miyazaki Y, 2007, PHYS LETT B, V648, P341, DOI 10.1016/j.physletb.2007.03.027; WOLFENSTEIN L, 1980, NUCL PHYS B, V175, P93, DOI 10.1016/0550-3213(80)90004-8; Hampel W, 1999, PHYS LETT B, V447, P127, DOI 10.1016/S0370-2693(98)01579-2; ZEE A, 1985, PHYS LETT B, V161, P141, DOI 10.1016/0370-2693(85)90625-2; ZEE A, 1980, PHYS LETT B, V95, P461; Kanemura S, 2002, PHYS LETT B, V530, P188, DOI 10.1016/S0370-2693(02)01321-7; Hisano J, 2011, PHYS LETT B, V694, P380, DOI 10.1016/j.physletb.2010.10.026; MINKOWSKI P, 1977, PHYS LETT B, V67, P421, DOI 10.1016/0370-2693(77)90435-X; Abe K, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.052010; Adamson P, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.191801; Kanemura S, 2004, PHYS LETT B, V599, P83, DOI 10.1016/j.physletb.2004.08.024; MAKI Z, 1962, PROG THEOR PHYS, V28, P870, DOI 10.1143/PTP.28.870; Billard J, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.023524; Balaji KRS, 2001, PHYS LETT B, V508, P301, DOI 10.1016/S0370-2693(01)00532-9; [Anonymous], 1980, PROG THEOR PHYS, V64, P1103; Krauss LM, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.085002; Kanemura S, 2014, PHYS LETT B, V738, P178, DOI 10.1016/j.physletb.2014.09.013; Hasegawa K, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.053006; Fukuyama T, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.056016; Kanemura S, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.013005; Brignole A, 2004, NUCL PHYS B, V701, P3, DOI 10.1016/j.nuclphysb.2004.08.037; ZEE A, 1986, NUCL PHYS B, V264, P99, DOI 10.1016/0550-3213(86)90475-X; Borzumati F, 1999, PHYS REV D, V60, DOI 10.1103/PhysRevD.60.115011; Cheung K, 2000, PHYS REV D, V61; CARENA M, 1995, PHYS LETT B, V355, P209, DOI 10.1016/0370-2693(95)00694-G; BABU KS, 1988, PHYS LETT B, V203, P132, DOI 10.1016/0370-2693(88)91584-5; ZEE A, 1980, PHYS LETT B, V93, P389, DOI 10.1016/0370-2693(80)90349-4; He XG, 2004, EUR PHYS J C, V34, P371, DOI 10.1140/epjc/s2004-01669-8; Hisano J, 2007, PHYS LETT B, V646, P34, DOI 10.1016/j.physletb.2007.01.012; Aad G, 2014, J HIGH ENERGY PHYS, P1, DOI 10.1007/JHEP05(2014)071; BILENKY SM, 1980, PHYS LETT B, V94, P495, DOI 10.1016/0370-2693(80)90927-2; Abe K, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.181801; Kanemura S, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.053007; Smirnov AY, 1997, PHYS REV D, V55, P1665, DOI 10.1103/PhysRevD.55.1665; An FP, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.111802; Wendell R, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.092004; Bellini G, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.112007; Adam J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.201801; Babu KS, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.241802; Sher M, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.057301; MOHAPATRA RN, 1980, PHYS REV LETT, V44, P912, DOI 10.1103/PhysRevLett.44.912; Kanemura S, 2014, NUCL PHYS B, V886, P524, DOI 10.1016/j.nuclphysb.2014.07.007; Aoki M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.051805; Gustafsson M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.211802; Aoki M, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP11(2010)049; Aoki M, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2010)084; Gando A, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.052002; Aubert B, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.021802; Baldini A., ARXIV13017225; BARR SM, 1990, PHYS REV LETT, V65, P21, DOI 10.1103/PhysRevLett.65.21; Barroso A, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.075010; BELLGARDT U, 1988, NUCL PHYS B, V299, P1, DOI 10.1016/0550-3213(88)90462-2; Blondel A., ARXIV13016113; Brahmachari B, 2002, PHYS LETT B, V531, P99, DOI 10.1016/S0370-2693(02)01366-7; Camara P. G., 2004, NUCL PHYS B, VB689, P195; Chang WF, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.025017; Cleveland BT, 1998, ASTROPHYS J, V496, P505, DOI 10.1086/305343; CMS Collaboration, CMSPASHIG14011 CMS C; Khachatryan V, 2015, PHYS LETT B, V749, P337, DOI 10.1016/j.physletb.2015.07.053; Djouadi A, 2015, J HIGH ENERGY PHYS, DOI 10.1007/JHEP06(2015)168; Djouadi A, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP10(2013)028; DOI M, 1981, PHYS LETT B, V102, P323, DOI 10.1016/0370-2693(81)90627-4; Abe Y, 2015, J HIGH ENERGY PHYS, P1, DOI 10.1007/JHEP02(2015)074; Eckel J, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP11(2014)117; Endo M, 2015, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2015)176; Figueiredo AJR, 2015, EUR PHYS J C, V75, DOI 10.1140/epjc/s10052-014-3244-1; Frampton PH, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.073014; Frampton PH, 1999, PHYS LETT B, V461, P95, DOI 10.1016/S0370-2693(99)00824-2; Ghosal A, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.053012; Gunion J.F., 2000, FRONT PHYS, V80, P1; Haba N, 2001, PHYS LETT B, V519, P243, DOI 10.1016/S0370-2693(01)01120-0; HALL LJ, 1990, PHYS REV LETT, V65, P2939, DOI 10.1103/PhysRevLett.65.2939; Hayasaka K, 2010, PHYS LETT B, V687, P139, DOI 10.1016/j.physletb.2010.03.037; Hayasaka K, 2008, PHYS LETT B, V666, P16, DOI 10.1016/j.physletb.2008.06.056; He XG, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2012)023; Hisano J, 2015, J HIGH ENERGY PHYS, DOI 10.1007/JHEP06(2015)097; Jarlskog C, 1999, PHYS LETT B, V449, P240, DOI 10.1016/S0370-2693(99)00039-8; Kakizaki M., ARXIV150503761; Kanemura S, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.075001; Khachatryan V, 2014, EUR PHYS J C, V74, DOI 10.1140/epjc/s10052-014-3036-7; Koide Y, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.077301; Koide Y, 2001, PHYS REV D, V63; Lees JP, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.111101; Ma Ernest, 2006, Annales de la Fondation Louis de Broglie, V31; Mann M. Gell-, 1979, C P C, V790927, P315; Mitsuda E, 2001, PHYS LETT B, V516, P47, DOI 10.1016/S0370-2693(01)00842-5; Paradisi P, 2006, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2006/08/047; PETCOV ST, 1982, PHYS LETT B, V115, P401, DOI 10.1016/0370-2693(82)90526-3; Seo SH, 2015, AIP CONF PROC, V1666, DOI 10.1063/1.4915563; SMIRNOV AY, 1994, NUCL PHYS B, V426, P415, DOI 10.1016/0550-3213(94)90318-2; Yanagida T., 1979, C P C, V7902131, P95	100	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1550-7998	1550-2368		PHYS REV D	Phys. Rev. D	DEC 1	2015	92	11							115001	10.1103/PhysRevD.92.115001		10	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	CX7GH	WOS:000365869700013		
J	Mao, Q; Chen, HX; Chen, W; Hosaka, A; Liu, X; Zhu, SL				Mao, Qiang; Chen, Hua-Xing; Chen, Wei; Hosaka, Atsushi; Liu, Xiang; Zhu, Shi-Lin			QCD sum rule calculation for P-wave bottom baryons	PHYSICAL REVIEW D			English	Article							QUARK EFFECTIVE THEORY; OPERATOR PRODUCT EXPANSION; EFFECTIVE FIELD-THEORY; EXCITED HEAVY MESONS; TO-LEADING-ORDER; GLUON CONDENSATE; DIQUARK PICTURE; FORM-FACTORS; MASSES; MODEL	We study the P-wave bottom baryons using the method of QCD sum rule and heavy quark effective theory. Our results suggest that Lambda(b) (5912)(0) and Lambda(b) (5920)(0) can be well described by the baryon doublet [(3) over bar (F), 1, 1, rho], and they belong to the SU(3) IF multiplets of J(P) = 1/2(-) and 3/2(-). Their SU(3) flavor partners, Xi(b)(1/2(-)) and Xi(b) (3/2(-)), have masses 6.06 +/- 0.13 GeV and 6.07 +/- 0.13 GeV, respectively, with mass splitting 9 * 4 McV. The results obtained using baryon doublet [(3) over bar (F), 1, 0, lambda] are similar and also consistent with the experimental data. We also study the SU(3) 6(F) multiplets by using the baryon multiplets [6(F), 0, 1, lambda], [6(F), 1, 0, rho] and [6(F), 2, 1, lambda], and our results suggest that the P-wave bottom baryons Sigma(b), Xi(b)' and Omega(b) have (averaged) masses of about 6.0 GeV, 6.2 GeV and 6.4 GeV, respectively.	[Mao, Qiang] Suzhou Univ, Dept Elect & Elect Engn, Suzhou 234000, Peoples R China; [Mao, Qiang; Chen, Hua-Xing] Beihang Univ, Sch Phys & Nucl Energy Engn, Beijing 100191, Peoples R China; [Mao, Qiang; Chen, Hua-Xing] Beihang Univ, Int Res Ctr Nuclei & Particles Cosmos, Beijing 100191, Peoples R China; [Chen, Hua-Xing] Ist Nazl Fis Nucl, Lab Nazl Frascati, I-00044 Frascati, Italy; [Chen, Wei] Univ Saskatchewan, Dept Phys & Engn Phys, Saskatoon, SK S7N 5E2, Canada; [Hosaka, Atsushi] Osaka Univ, Nucl Phys Res Ctr, Ibaraki 5670047, Japan; [Hosaka, Atsushi] KEK, Inst Particle & Nucl Studies, KEK Theory Ctr, J PARC Branch, Tokai, Ibaraki 3191106, Japan; [Liu, Xiang] Lanzhou Univ, Sch Phys Sci & Technol, Lanzhou 730000, Peoples R China; [Liu, Xiang] Lanzhou Univ, Res Ctr Hadron & CSR Phys, Lanzhou 730000, Peoples R China; [Liu, Xiang] Chinese Acad Sci, Inst Modern Phys, Lanzhou 730000, Peoples R China; [Zhu, Shi-Lin] Peking Univ, Sch Phys, Beijing 100871, Peoples R China; [Zhu, Shi-Lin] Peking Univ, State Key Lab Nucl Phys & Technol, Beijing 100871, Peoples R China; [Zhu, Shi-Lin] Collaborat Innovat Ctr Quantum Matter, Beijing 100871, Peoples R China; [Zhu, Shi-Lin] Peking Univ, Ctr High Energy Phys, Beijing 100871, Peoples R China	Chen, HX (reprint author), Beihang Univ, Sch Phys & Nucl Energy Engn, Beijing 100191, Peoples R China.	hxchen@buaa.edu.cn; wec053@mail.usask.ca; hosaka@rcnp.osaka-u.ac.jp; xiangliu@lzu.edu.cn; zhusl@pku.edu.cn			National Natural Science Foundation of China [11205011, 11475015, 11375024, 11222547, 11175073, 11261130311]; Ministry of Education of China (SREDP) [20120211110002]; Ministry of Education of China (Fundamental Research Funds for the Central Universities); MEXT, Japan [26400273]	We thank Cheng-Ping Shen and Ke-Wei Wei for useful discussions and careful reading of the manuscript. H.-X. C. thanks Profs. Luciano Maiani, Rinaldo Baldini, and Pierluigi Campana for their hospitality during his stay at INEN-LNE. This project is supported by the National Natural Science Foundation of China under Grants No. 11205011, No. 11475015, No. 11375024, No. 11222547, No. 11175073, and No. 11261130311, and the Ministry of Education of China (SREDP under Grant No. 20120211110002 and the Fundamental Research Funds for the Central Universities). A. H. is supported in part by the Grant-in-Aid for Science Research (C) 26400273, from the MEXT, Japan.	Aaltonen T, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.071101; Garcia-Recio C, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.034032; Valcarce A, 2014, PHYS LETT B, V733, P288, DOI 10.1016/j.physletb.2014.04.055; BAGAN E, 1992, PHYS LETT B, V278, P367, DOI 10.1016/0370-2693(92)90208-L; Garcia-Recio C, 2015, PHYS REV D, V92, DOI 10.1103/PhysRevD.92.034011; Ioffe BL, 2003, EUR PHYS J C, V27, P229, DOI 10.1140/epjc/s2002-01099-8; GRINSTEIN B, 1990, NUCL PHYS B, V339, P253, DOI 10.1016/0550-3213(90)90349-I; BALL P, 1994, PHYS REV D, V49, P2472, DOI 10.1103/PhysRevD.49.2472; BROADHURST DJ, 1992, PHYS LETT B, V274, P421, DOI 10.1016/0370-2693(92)92009-6; Liu X, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.014031; BAGAN E, 1993, PHYS LETT B, V301, P243, DOI 10.1016/0370-2693(93)90696-F; NEUBERT M, 1994, PHYS REP, V245, P259, DOI 10.1016/0370-1573(94)90091-4; Aaij R, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.172003; Dai YB, 1997, PHYS REV D, V55, P5719, DOI 10.1103/PhysRevD.55.5719; YANG KC, 1993, PHYS REV D, V47, P3001, DOI 10.1103/PhysRevD.47.3001; Groote S, 1997, PHYS REV D, V55, P3016, DOI 10.1103/PhysRevD.55.3016; Dai YB, 1997, PHYS LETT B, V390, P350, DOI 10.1016/S0370-2693(96)01412-8; Karliner M, 2009, ANN PHYS-NEW YORK, V324, P2, DOI 10.1016/j.aop.2008.05.003; Zhu SL, 2000, PHYS REV D, V61, DOI 10.1103/PhysRevD.61.114019; DAI YB, 1993, Z PHYS C PART FIELDS, V60, P527, DOI 10.1007/BF01560051; Xiao CW, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.056012; Chen C, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.094017; Liang WH, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.054023; Yamaguchi Y, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.034034; NEUBERT M, 1992, PHYS REV D, V45, P2451, DOI 10.1103/PhysRevD.45.2451; SHURYAK EV, 1982, NUCL PHYS B, V198, P83, DOI 10.1016/0550-3213(82)90546-6; Duraes FO, 2007, PHYS LETT B, V658, P40, DOI 10.1016/j.physletb.2007.10.054; Wang ZG, 2008, EUR PHYS J C, V54, P231, DOI 10.1140/epjc/s10052-008-0521-x; HUANG T, 1994, PHYS REV D, V50, P5775, DOI 10.1103/PhysRevD.50.5775; Dai YB, 1996, PHYS LETT B, V387, P379, DOI 10.1016/0370-2693(96)01029-5; OVCHINNIKOV AA, 1988, SOV J NUCL PHYS+, V48, P721; BAGAN E, 1992, PHYS LETT B, V278, P457, DOI 10.1016/0370-2693(92)90585-R; Ebert D, 2008, PHYS LETT B, V659, P612, DOI 10.1016/j.physletb.2007.11.037; BAGAN E, 1992, PHYS LETT B, V287, P176, DOI 10.1016/0370-2693(92)91896-H; CAPSTICK S, 1986, PHYS REV D, V34, P2809, DOI 10.1103/PhysRevD.34.2809; Yasui S, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.015201; Cheng HY, 2015, PHYS REV D, V92, DOI 10.1103/PhysRevD.92.074014; Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001; Huang CS, 2000, PHYS LETT B, V492, P288, DOI 10.1016/S0370-2693(00)01088-1; Gimenez V, 2005, EUR PHYS J C, V41, P535, DOI 10.1140/epjc/s2005-02250-9; Jamin M, 2002, PHYS LETT B, V538, P71, DOI 10.1016/S0370-2693(02)01951-2; Karliner M, 2015, PHYS REV D, V92, DOI 10.1103/PhysRevD.92.074026; GROZIN AG, 1992, PHYS LETT B, V285, P254, DOI 10.1016/0370-2693(92)91462-I; Crede V, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/7/076301; Dai YB, 1996, PHYS LETT B, V371, P99, DOI 10.1016/0370-2693(95)01602-3; Ortega PG, 2013, PHYS LETT B, V718, P1381, DOI 10.1016/j.physletb.2012.12.025; Lee JP, 2000, PHYS LETT B, V476, P303, DOI 10.1016/S0370-2693(00)00144-1; Roberts W, 2008, INT J MOD PHYS A, V23, P2817, DOI 10.1142/S0217751X08041219; COPLEY LA, 1981, PHYS REV D, V23, P817, DOI 10.1103/PhysRevD.23.817.3; Lu JX, 2015, PHYS REV D, V92, DOI 10.1103/PhysRevD.92.014036; Torres-Rincon JM, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.074042; Wang DW, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.034019; REINDERS LJ, 1985, PHYS REP, V127, P1, DOI 10.1016/0370-1573(85)90065-1; Garcilazo H, 2007, J PHYS G NUCL PARTIC, V34, P961, DOI 10.1088/0954-3899/34/5/014; Burch T., ARXIV150200675; Chen B, 2015, EUR PHYS J A, V51, DOI 10.1140/epja/i2015-15082-3; Chen HX, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.054034; Colangelo P., 2001, FRONTIER PARTICLE PH, V3, P1495; Colangelo P., 1998, Physical Review D, V58, DOI 10.1103/PhysRevD.58.116005; Dai YB, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.114011; EICHTEN E, 1990, PHYS LETT B, V234, P511, DOI 10.1016/0370-2693(90)92049-O; FALK AF, 1990, NUCL PHYS B, V343, P1, DOI 10.1016/0550-3213(90)90591-Z; Mu C, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/11/113101; Narison S., 2002, CAMBRIDGE MONOGRAPHS, V17; SHIFMAN MA, 1979, NUCL PHYS B, V147, P385, DOI 10.1016/0550-3213(79)90022-1; Yoshida T., ARXIV151001067; Zhou D, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.114035	67	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1550-7998	1550-2368		PHYS REV D	Phys. Rev. D	DEC 1	2015	92	11							114007	10.1103/PhysRevD.92.114007		9	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	CX7GH	WOS:000365869700009		
J	Huttmann, F; Martinez-Galera, AJ; Caciuc, V; Atodiresei, N; Schumacher, S; Standop, S; Hamada, I; Wehling, TO; Blugel, S; Michely, T				Huttmann, Felix; Martinez-Galera, Antonio J.; Caciuc, Vasile; Atodiresei, Nicolae; Schumacher, Stefan; Standop, Sebastian; Hamada, Ikutaro; Wehling, Tim O.; Bluegel, Stefan; Michely, Thomas			Tuning the van der Waals Interaction of Graphene with Molecules via Doping	PHYSICAL REVIEW LETTERS			English	Article							DOPED GRAPHENE; ENERGY; INTERCALATION	We use scanning tunneling microscopy to visualize and thermal desorption spectroscopy to quantitatively measure that the binding of naphthalene molecules to graphene, a case of pure van der Waals interaction, strengthens with n and weakens with p doping of graphene. Density-functional theory calculations that include the van der Waals interaction in a seamless, ab initio way accurately reproduce the observed trend in binding energies. Based on a model calculation, we propose that the van der Waals interaction is modified by changing the spatial extent of graphene's pi orbitals via doping.	[Huttmann, Felix; Martinez-Galera, Antonio J.; Schumacher, Stefan; Standop, Sebastian; Michely, Thomas] Univ Cologne, Phys Inst 2, D-50937 Cologne, Germany; [Caciuc, Vasile; Atodiresei, Nicolae; Bluegel, Stefan] Forschungszentrum Julich, Peter Grunberg Inst, D-52428 Julich, Germany; [Caciuc, Vasile; Atodiresei, Nicolae; Bluegel, Stefan] Forschungszentrum Julich, Inst Adv Simulat, D-52428 Julich, Germany; [Hamada, Ikutaro] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050044, Japan; [Hamada, Ikutaro] Natl Inst Mat Sci, Global Res Ctr Environm & Energy Based Nanomat Sc, Tsukuba, Ibaraki 3050044, Japan; [Wehling, Tim O.] Univ Bremen, BCCMS, D-28359 Bremen, Germany	Huttmann, F (reprint author), Univ Cologne, Phys Inst 2, Zulpicher Str 77, D-50937 Cologne, Germany.	huttmann@ph2.uni-koeln.de; n.atodiresei@fz-juelich.de	Hamada, Ikutaro/E-8040-2010	Hamada, Ikutaro/0000-0001-5112-2452	VSR at the computer JUROPA; GCS at the high-performance computer JUQUEEN; Volkswagen-Stiftung through the "Optically Controlled Spin Logic" project; European Commission through a Marie Curie Fellowship; Institutional Strategy of the University of Cologne within the German Excellence Initiative; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) through the "World Premier International Research Center Initiative"; "Development of Environmental Technology using Nanotechnology" program; DFG Priority Program "Graphene" [MI581/20-1, 1459]	The computations were performed under the auspices of the VSR at the computer JUROPA and the GCS at the high-performance computer JUQUEEN operated by the JSC at the Forschungszentrum Julich. We gratefully acknowledge financial support from the Volkswagen-Stiftung through the "Optically Controlled Spin Logic" project (N. A. and V. C.), from the European Commission through a Marie Curie Fellowship (A. J. M.-G.), from the Institutional Strategy of the University of Cologne within the German Excellence Initiative (F. H.), from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) through the "World Premier International Research Center Initiative" and the "Development of Environmental Technology using Nanotechnology" program (I. H.), and from the DFG Priority Program 1459 "Graphene" within Project No. MI581/20-1.	Zacharia R, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.155406; Schumacher S, 2013, NANO LETT, V13, P5013, DOI 10.1021/nl402797j; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Brar VW, 2011, NAT PHYS, V7, P43, DOI [10.1038/nphys1807, 10.1038/NPHYS1807]; Ulstrup S, 2014, 2D MATER, V1, DOI 10.1088/2053-1583/1/2/025002; Larciprete R, 2012, ACS NANO, V6, P9551, DOI 10.1021/nn302729j; Berland K, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.205421; Bostwick A, 2010, SCIENCE, V328, P999, DOI 10.1126/science.1186489; Wang HB, 2012, ACS CATAL, V2, P781, DOI 10.1021/cs200652y; BECKE AD, 1986, J CHEM PHYS, V85, P7184, DOI 10.1063/1.451353; Lee K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.081101; Pletikosic I, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.056808; Efetov DK, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.256805; Hamada I, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.121103; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; BADER RFW, 1990, ATOMS MOL QUANTUM TH; Berland K, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/6/066501; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Busse C, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.036101; Chakarova-Kack SD, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.146107; Coletti C, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.235401; Dion M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.246401; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; Horcas I., 2007, REV SCI INSTRUM, V78; Huang LF, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3624657; Jolie W, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.155435; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Londero E, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/42/424212; Martinez-Galera A. J., 2015, NANOSCALE, DOI [10.1039/C5NR04976H, DOI 10.1039/C5NR04976H]; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Petrovic M., 2014, THESIS; Petrovic M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3772; Riedl C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.246804; Roy D, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4755990; Schumacher S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.086111; Schumacher S, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.235437; Tait SL, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2400235; van Gastel R, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3225554; Wehling TO, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.085422	40	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007	1079-7114		PHYS REV LETT	Phys. Rev. Lett.	DEC 1	2015	115	23							236101	10.1103/PhysRevLett.115.236101		6	Physics, Multidisciplinary	Physics	CX7JJ	WOS:000365877700009		
J	Wang, Z; Andrews, MA; Wu, ZX; Wang, L; Bauch, CT				Wang, Zhen; Andrews, Michael A.; Wu, Zhi-Xi; Wang, Lin; Bauch, Chris T.			Coupled disease-behavior dynamics on complex networks: A review	PHYSICS OF LIFE REVIEWS			English	Review						Disease-behavior dynamics; Decision-making; Vaccination; Networks; Social distancing	ACUTE RESPIRATORY SYNDROME; SCALE-FREE NETWORKS; INFECTIOUS-DISEASES; GAME-THEORY; VACCINATION POLICY; EPIDEMIOLOGIC MODELS; EVOLUTIONARY GAMES; PUBLIC AVOIDANCE; SOCIAL NETWORKS; MOMENT CLOSURE	It is increasingly recognized that a key component of successful infection control efforts is understanding the complex, two-way interaction between disease dynamics and human behavioral and social dynamics. Human behavior such as contact precautions and social distancing clearly influence disease prevalence, but disease prevalence can in turn alter human behavior, forming a coupled, nonlinear system. Moreover, in many cases, the spatial structure of the population cannot be ignored, such that social and behavioral processes and/or transmission of infection must be represented with complex networks. Research on studying coupled disease behavior dynamics in complex networks in particular is growing rapidly, and frequently makes use of analysis methods and concepts from statistical physics. Here, we review some of the growing literature in this area. We contrast network-based approaches to homogeneous-mixing approaches, point out how their predictions differ, and describe the rich and often surprising behavior of disease behavior dynamics on complex networks, and compare them to processes in statistical physics. We discuss how these models can capture the dynamics that characterize many real-world scenarios, thereby suggesting ways that policy makers can better design effective prevention strategies. We also describe the growing sources of digital data that are facilitating research in this area. Finally, we suggest pitfalls which might be faced by researchers in the field, and we suggest several ways in which the field could move forward in the coming years. (C) 2015 Elsevier B.V. All rights reserved.	[Wang, Zhen] Northwestern Polytech Univ, Sch Automat, Xian 710072, Peoples R China; [Wang, Zhen] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Fukuoka 8168580, Japan; [Andrews, Michael A.] Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada; [Wu, Zhi-Xi] Lanzhou Univ, Inst Computat Phys & Complex Syst, Lanzhou 730000, Gansu, Peoples R China; [Wang, Lin] Tianjin Univ Technol, Sch Comp & Commun Engn, Tianjin 300384, Peoples R China; [Bauch, Chris T.] Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada	Wang, Z (reprint author), Northwestern Polytech Univ, Sch Automat, Xian 710072, Peoples R China.	zhenwang0@gmail.com; mandre04@uoguelph.ca; wuzhx@lzu.edu.cn; wanglinieee@outlook.com; cbauch@uwaterloo.ca			National Natural Science Foundation of China [61374169, 11135001, 11475074]; Natural Sciences and Engineering Council of Canada (NSERC)	We would like to acknowledge gratefully Yao Yao, Yang Liu, Ke-ke Huang, Yan Zhang, Eriko Fukuda, Dr. Wen-bo Du, Dr. Ming Tang, Dr. Hai-feng Zhang and Prof. Zhen Jin for their constructive helps and discussions, also appreciate all the other friends with whom we maintained (and are currently maintaining) interactions and discussions on the topic covered in our report. This work was partly supported by the National Natural Science Foundation of China (Grant No. 61374169, 11135001, 11475074) and the Natural Sciences and Engineering Council of Canada (NSERC; MA and CTB).	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Galvani AP, 2007, P NATL ACAD SCI USA, V104, P5692, DOI 10.1073/pnas.0606774104; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Zanette D, 2008, J BIOL PHYS, V34, P135, DOI 10.1007/s10867-008-9060-9; CAPASSO V, 1978, MATH BIOSCI, V42, P43, DOI 10.1016/0025-5564(78)90006-8; Aguirre J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.248701; Bauch CT, 2013, SCIENCE, V342, P47, DOI 10.1126/science.1244492; Wang L, 2014, CHINESE SCI BULL, V59, P3511, DOI 10.1007/s11434-014-0499-8; Sigmund K, 1999, CURR BIOL, V9, pR503, DOI 10.1016/S0960-9822(99)80321-2; Wu QC, 2012, CHAOS, V22, DOI 10.1063/1.3673573; JACQUEZ JA, 1988, MATH BIOSCI, V92, P119, DOI 10.1016/0025-5564(88)90031-4; Takaguchi T, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011008; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Vespignani A, 2012, NAT PHYS, V8, P32; Risau-Gusman S, 2009, J THEOR BIOL, V257, P52, DOI 10.1016/j.jtbi.2008.10.027; [Anonymous], 1989, LECTURE NOTES BIOMAT; Kiss IZ, 2010, MATH BIOSCI, V225, P1, DOI 10.1016/j.mbs.2009.11.009; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Gross T, 2008, J R SOC INTERFACE, V5, P259, DOI 10.1098/rsif.2007.1229; Shim E, 2012, J R SOC INTERFACE, V9, P2234, DOI 10.1098/rsif.2012.0115; Youn H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.128701; Chapman GB, 2012, PSYCHOL SCI, V23, P1008, DOI 10.1177/0956797612437606; Mao L, 2014, APPL GEOGR, V50, P31, DOI 10.1016/j.apgeog.2014.02.005; Tanaka MM, 2002, THEOR POPUL BIOL, V62, P111, DOI 10.1006/tpbi.2002.1585; Liu ZH, 2005, EUROPHYS LETT, V72, P315, DOI 10.1209/epl/i2004-10550-5; Zhang HF, 2014, CHAOS, V24, DOI 10.1063/1.4896333; Evans TS, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056101; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Salathe M, 2008, J R SOC INTERFACE, V5, P1505, DOI 10.1098/rsif.2008.0271; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Morsky B, 2012, COMPUT MATH METHOD M, DOI 10.1155/2012/652562; Marceau V, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036116; Mao L, 2012, SOC SCI MED, V74, P167, DOI 10.1016/j.socscimed.2011.10.012; Xia CY, 2013, PHYSICA A, V392, P1577, DOI 10.1016/j.physa.2012.11.043; Helbing D, 2013, NATURE, V497, P51, DOI 10.1038/nature12047; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Araz OM, 2013, TECHNOL FORECAST SOC, V80, P1775, DOI 10.1016/j.techfore.2012.09.018; Reluga TC, 2013, B MATH BIOL, V75, P1961, DOI 10.1007/s11538-013-9879-5; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Masuda N, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.188701; Auld MC, 2003, J HEALTH ECON, V22, P361, DOI 10.1016/S0167-6296(02)00103-0; Lloyd-Smith JO, 2003, P ROY SOC B-BIOL SCI, V270, P1979, DOI 10.1098/rspb.2003.2481; Zhang YQ, 2013, CHAOS, V23, DOI 10.1063/1.4793540; BRITO DL, 1991, J PUBLIC ECON, V45, P69, DOI 10.1016/0047-2727(91)90048-7; Meloni S, 2009, P NATL ACAD SCI USA, V106, P16897, DOI 10.1073/pnas.0907121106; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Chen F, 2012, J THEOR BIOL, V302, P18, DOI 10.1016/j.jtbi.2012.03.002; Ruan ZY, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036117; Valdez LD, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036108; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106; Liu XT, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.051132; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Geoffard PY, 1996, INT ECON REV, V37, P603, DOI 10.2307/2527443; Volz E, 2007, P R SOC B, V274, P2925, DOI 10.1098/rspb.2007.1159; Wang Y, 2011, INT CONF ACOUST SPEE, P1, DOI 10.1109/PLASMA.2011.5993071; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Moreno Y, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.035103; Eagle N, 2006, PERS UBIQUIT COMPUT, V10, P255, DOI 10.1007/s00779-005-0046-3; Lee S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028702; Granell C, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.012808; Wang Z, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042145; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Meszaros JR, 1996, J CLIN EPIDEMIOL, V49, P697, DOI 10.1016/0895-4356(96)00007-8; Pocock MJO, 2012, SCIENCE, V335, P973, DOI 10.1126/science.1214915; Sun GQ, 2014, COMMUN NONLINEAR SCI, V19, P1507, DOI 10.1016/j.cnsns.2013.09.016; Heffernan JM, 2005, J ROY SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Newman MEJ, 1999, PHYS REV E, V60, P7332, DOI 10.1103/PhysRevE.60.7332; Fu F, 2011, P ROY SOC B-BIOL SCI, V278, P42, DOI 10.1098/rspb.2010.1107; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Misra AK, 2011, MATH COMPUT MODEL, V53, P1221, DOI 10.1016/j.mcm.2010.12.005; Poletti P, 2009, J THEOR BIOL, V260, P31, DOI 10.1016/j.jtbi.2009.04.029; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; Atkins KE, 2012, VACCINE, V30, P552, DOI 10.1016/j.vaccine.2011.11.064; Wang ZG, 2014, CHAOS SOLITON FRACT, V61, P1, DOI 10.1016/j.chaos.2014.01.004; Kwok KO, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0709; Cohen R, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.036113; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Cardillo A, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032803; Bauch CT, 2003, P NATL ACAD SCI USA, V100, P10564, DOI 10.1073/pnas.1731324100; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Gross T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.208701; Saumell-Mendiola A, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026106; Yang H, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/12/123017; Shaw LB, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066101; Shoham Y, 2008, COMMUN ACM, V51, P74, DOI 10.1145/1378704.1378721; Zhou J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036107; Wang Z, 2015, PHYS LIFE REV, V14, P1, DOI 10.1016/j.plrev.2015.04.033; Schwarzkopf Y, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036112; Sun GQ, 2010, J THEOR BIOL, V264, P95, DOI 10.1016/j.jtbi.2010.01.006; Hyman James M., 2007, Journal of Biological Dynamics, V1, P109, DOI 10.1080/17513750601040383; Poletti P, 2012, MATH BIOSCI, V238, P80, DOI 10.1016/j.mbs.2012.04.003; He DH, 2007, THEOR POPUL BIOL, V72, P274, DOI 10.1016/j.tpb.2007.04.004; Shaw LB, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046120; Granell C, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.128701; Chen F, 2011, J THEOR BIOL, V278, P107, DOI 10.1016/j.jtbi.2011.03.007; Isella L, 2011, J THEOR BIOL, V271, P166, DOI 10.1016/j.jtbi.2010.11.033; Hyman JM, 1997, SIAM J APPL MATH, V57, P1082, DOI 10.1137/S0036139995294123; Fenichel EP, 2011, P NATL ACAD SCI USA, V108, P6306, DOI 10.1073/pnas.1011250108; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Fukuda E, 2015, CHAOS SOLITON FRACT, V80, P47, DOI 10.1016/j.chaos.2015.04.018; Bagnoli F, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061904; Barabasi A-L, 2010, BURSTS HIDDEN PATTER; Barclay VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087042; Barrat A, 2013, TEMPORAL NETWORKS, P191; Bauch C, 2000, P ROY SOC B-BIOL SCI, V267, P2019; Boguna M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.028701; Campbell E, 1905, SCI REP, V3; Cardillo A, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.052825; Castellano C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00371; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Chakrabarti Deepayan, 2008, ACM Transactions on Information and Systems Security, V10, DOI 10.1145/1284680.1284681; Cialdini RB, SOCIAL INFLUENCE SOC; Coelho FC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000425; Comforth DM, 2011, PLOS COMPUT BIOL, V7; Demirel G, ARXIV12092541; Dunbar R. I., 1998, BRAIN, V9, P178, DOI [10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.3.CO;2-P, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.3.C0;2-P]; Epstein JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003955; Friedman JW, 1990, GAME THEORY APPL EC; Fukuda E, 2014, CHAOS SOLITON FRACT, V68, P1, DOI 10.1016/j.chaos.2014.07.004; Gomez S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028701; Gomez-Gardenes J, 2008, P NATL ACAD SCI USA, V105, P1399, DOI 10.1073/pnas.0707332105; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; Gross T, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/38004; Guo QT, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.012822; Hammerstein P., 1994, HDB GAME THEORY EC A, V2, P929, DOI 10.1016/S1574-0005(05)80060-8; HERSHEY JC, 1994, ORGAN BEHAV HUM DEC, V59, P177, DOI 10.1006/obhd.1994.1055; Ibuka Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-296; Ibuka Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087164; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Kan J-Q, ARXIV15020392; Kivela M., 2014, J COMPLEX NETWORK, V2, P203, DOI DOI 10.1093/COMNET/CNU016; Kremer M, 1996, Q J ECON, V111, P549, DOI 10.2307/2946687; Lee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036439; Lessler J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1432; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; Manfredi P, 2013, MODELING INTERPLAY H; Marro J, 2005, NONEQUILIBRIUM PHASE; Mbah MLN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002469; Medus AD, ARXIV14120583; Monsalve MN, 2014, INFECT CONT HOSP EP, V35, P1277, DOI 10.1086/678068; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Sheehan JJ, 2007, MIL MED, V172, P1170; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Naylor D, 2011, INT M EM DIS SURV IM; Pastor-Satorras R, 2005, HDB GRAPHS NETWORKS, P111; Perisic A, 2007, PLOS COMPUT BIOL, V5; Perra N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00469; Perra N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023084; Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016460; Rand DA, 1999, CORRELATION EQUATION; Reluga TC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000793; Renyi A, 1960, PUBL MATH I HUNG, V5, P17; Richard J, 2008, MEASLES OUTBREAK SWI; Sahneh FD, 2012, SCI REP-UK, V2, DOI 10.1038/srep00632; Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199; Schmid D, 2008, COMMUNICABLE DIS B, V13; Sola Conde L, 2013, CHAOS, V23, DOI 10.1063/1.4818544; Stamini M, 2012, PHYS REV E, V85; Stamini M, 2013, J THEOR BIOL, V337, P89; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00576; Tanimoto J, 2014, J STAT MECH-THEORY E, V2014; Twigg G, 1984, BLACK DEATH BIOL REA; von Neumann J., 1944, THEORY GAMES EC BEHA; Wang W, 2014, SCI REP-UK, V4, DOI 10.1038/srep05097; Wang Z., 2015, EUR PHYS J B, V88, P1, DOI DOI 10.1140/EPJB/E2015-60270-7; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep02470; World Health Organization, 1996, WORLD HLTH REP 1996; Wu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020577; Wu ZX, 2013, EPL-EUROPHYS LETT, V104, DOI 10.1209/0295-5075/104/10002; Xia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060373; Zhang HF, 2014, SCI REP-UK, V4, DOI 10.1038/srep05666; Zhang HF, 2013, SCI REP-UK, V3, DOI 10.1038/srep03292; Zhang Y, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/68002; Zhang Y-Q, 2012, P ACM SIGKDD INT WOR, P25	185	13	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1571-0645	1873-1457		PHYS LIFE REV	Phys. Life Rev.	DEC	2015	15						1	29		10.1016/j.plrev.2015.07.006		29	Biology; Biophysics	Life Sciences & Biomedicine - Other Topics; Biophysics	CY5IC	WOS:000366440300001		
J	Jusup, M; Iwami, S; Podobnik, B; Stanley, HE				Jusup, Marko; Iwami, Shingo; Podobnik, Boris; Stanley, H. Eugene			Dynamically rich, yet parameter-sparse models for spatial epidemiology Comment on "Coupled disease-behavior dynamics on complex networks: A review" by Z. Wang et al	PHYSICS OF LIFE REVIEWS			English	Editorial Material						Disease-behavior dynamics; Risk management; Parameter estimation; Heterogeneous topology; Phase transitions			[Jusup, Marko; Iwami, Shingo] Kyushu Univ, Fac Sci, Fukuoka 8128581, Japan; [Iwami, Shingo] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Podobnik, Boris; Stanley, H. Eugene] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; [Podobnik, Boris] Univ Rijeka, Fac Civil Engn, Rijeka 51000, Croatia; [Podobnik, Boris] Zagreb Sch Econ & Management, Zagreb 10000, Croatia	Jusup, M (reprint author), Kyushu Univ, Fac Sci, Fukuoka 8128581, Japan.	mjusup@gmail.com					ABBEY HELEN, 1952, HUMAN BIOL, V24, P201; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Ruddle NH, 2014, J CLIN INVEST, V124, P953, DOI 10.1172/JCI71611; Qatarneh Sharif M., 2006, Anatomical Record Part B:The New Anatomist, V289, P98, DOI 10.1002/ar.b.20102; Majdandzic A, 2014, NAT PHYS, V10, P34, DOI [10.1038/nphys2819, 10.1038/NPHYS2819]; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Qu J, 2015, SCI REP-UK, V5, DOI 10.1038/srep15450; Podobnik B, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.042807; Briand S, 2014, NEW ENGL J MED, V371, P1180, DOI 10.1056/NEJMp1409858; Horiike M, 2012, VIROLOGY, V423, P107, DOI 10.1016/j.virol.2011.11.024; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Aiello W, 2001, EXP MATH, V10, P53; Bah EI, 2015, NEW ENGL J MED, V372, P40, DOI 10.1056/NEJMoa1411249; Bogoch II, 2015, LANCET, V384, P29, DOI 10.1016/S0140-6736(14)61828-6; De Masi G, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.066112; Lee JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126447; Podobnik B, 2014, EPL-EUROPHYS LETT, V106, DOI 10.1209/0295-5075/106/68003; Poletto C., 2014, Eurosurveillance, V19, P20936, DOI 10.2807/1560-7917.ES2014.19.42.20936; Sato K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003812; Sato K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004453; Wang Z, 2015, PHYS LIFE REV, V15, P1, DOI 10.1016/j.plrev.2015.07.006; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499	26	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1571-0645	1873-1457		PHYS LIFE REV	Phys. Life Rev.	DEC	2015	15						43	46		10.1016/j.plrev.2015.09.006		4	Biology; Biophysics	Life Sciences & Biomedicine - Other Topics; Biophysics	CY5IC	WOS:000366440300008		
J	Wang, Z; Andrews, MA; Wu, ZX; Wang, L; Bauch, CT				Wang, Zhen; Andrews, Michael A.; Wu, Zhi-Xi; Wang, Lin; Bauch, Chris T.			Spatial coupled disease-behavior framework as a dynamic and adaptive system Reply to comments on "Coupled disease-behavior dynamics on complex networks: A review"	PHYSICS OF LIFE REVIEWS			English	Editorial Material						Disease; Behavior; Empirical data; Networks	VACCINATION; PARADOX; GAME		[Wang, Zhen] Northwestern Polytech Univ, Sch Automat, Xian 710072, Peoples R China; [Wang, Zhen] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Fukuoka 8168580, Japan; [Andrews, Michael A.] Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada; [Wu, Zhi-Xi] Lanzhou Univ, Inst Computat Phys & Complex Syst, Lanzhou 730000, Gansu, Peoples R China; [Wang, Lin] Tianjin Univ Technol, Key Lab Comp Vis & Syst, Minist Educ, Tianjin 300384, Peoples R China; [Wang, Lin] Tianjin Univ Technol, Tianjin Key Lab Intelligence Comp & Novel Softwar, Tianjin 300384, Peoples R China; [Bauch, Chris T.] Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada	Wang, Z (reprint author), Northwestern Polytech Univ, Sch Automat, Xian 710072, Peoples R China.	zhenwang0@gmail.com; mandre04@uoguelph.ca; wuzhx@lzu.edu.cn; wanglinieee@outlook.com; cbauch@uwaterloo.ca					Aguiar M, 2015, PHYS LIFE REV, V15, P41, DOI 10.1016/j.plrev.2015.09.007; Amaku M, 2015, PHYS LIFE REV, V15, P39, DOI 10.1016/j.plrev.2015.09.004; Wang L, 2014, CHINESE SCI BULL, V59, P3511, DOI 10.1007/s11434-014-0499-8; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Amaku M, 2015, PREV VET MED, V121, P306, DOI 10.1016/j.prevetmed.2015.08.002; Vietri JT, 2011, PREV MED, V52, P405, DOI 10.1016/j.ypmed.2011.03.002; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Wang ZG, 2014, CHAOS SOLITON FRACT, V61, P1, DOI 10.1016/j.chaos.2014.01.004; Bauch CT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002452; Fukuda E, 2014, CHAOS SOLITON FRACT, V68, P1, DOI 10.1016/j.chaos.2014.07.004; Holme P, 2015, PHYS LIFE REV, V15, P47, DOI 10.1016/j.plrev.2015.10.014; Jusup M, 2015, PHYS LIFE REV, V15, P43, DOI 10.1016/j.plrev.2015.09.006; Lee J-H, 2015, PLOS ONE, V10; Oraby T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3172; Perisic A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000280; Rodrigues FA, 2015, PHYS LIFE REV, V15, P37, DOI 10.1016/j.plrev.2015.10.010; Rosati DP, 2015, PHYS LIFE REV, V15, P51, DOI 10.1016/j.plrev.2015.10.005; Shen Z, 2014, NAT COMMUN, V5; Small M, 2015, PHYS LIFE REV, V15, P49, DOI 10.1016/j.plrev.2015.10.012; Sun GQ, 2015, PHYS LIFE REV, V15, P30, DOI 10.1016/j.plrev.2015.08.002; Wang Z, 2015, PHYS LIFE REV, V15, P1, DOI 10.1016/j.plrev.2015.07.006; Wells CR, 2015, PHYS LIFE REV, V15, P55, DOI 10.1016/j.plrev.2015.10.013; Xia CY, 2015, PHYS LIFE REV, V15, P32, DOI 10.1016/j.plrev.2015.10.003; Yang HM, 2015, PHYS LIFE REV, V15, P35, DOI 10.1016/j.plrev.2015.08.001; Zhang HF, 2014, SCI REP-UK, V4, DOI 10.1038/srep05666; Zhang HF, 2013, SCI REP-UK, V3, DOI 10.1038/srep03292; Zhao DW, 2015, PHYS LIFE REV, V15, P53, DOI 10.1016/j.plrev.2015.10.001	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1571-0645	1873-1457		PHYS LIFE REV	Phys. Life Rev.	DEC	2015	15						57	60		10.1016/j.plrev.2015.11.002		4	Biology; Biophysics	Life Sciences & Biomedicine - Other Topics; Biophysics	CY5IC	WOS:000366440300014		
J	Shukla, G; Topsakal, M; Wentzcovitch, RM				Shukla, Gaurav; Topsakal, Mehmet; Wentzcovitch, Renata M.			Spin crossovers in iron-bearing MgSiO3 and MgGeO3: Their influence on the post-perovskite transition	PHYSICS OF THE EARTH AND PLANETARY INTERIORS			English	Article						Iron-spin crossover; Ferrous and ferric iron; Pv to PPv transition	X-RAY-DIFFRACTION; EQUATION-OF-STATE; LOWER-MANTLE PEROVSKITE; FERROUS IRON; PHASE-TRANSITION; MOSSBAUER-SPECTROSCOPY; (MG,FE)SIO3 PEROVSKITE; SYNCHROTRON MOSSBAUER; MOLECULAR-DYNAMICS; CRYSTAL-CHEMISTRY	MgGeO3-perovskite is known to be a low-pressure analog of MgSiO3-perovskite in many respects, but especially in regard to the post-perovskite transition. As such, investigation of spin state changes in Fe-bearing MgGeO3 might help to clarify some aspects of this type of state change in Fe-bearing MgSiO3. Using DFT + U calculations, we have investigated pressure induced spin state changes in Fe2+ and Fe3+ in MgGeO3 perovskite and post-perovskite. Owing to the larger ionic radius of germanium compared to silicon, germanate phases have larger unit cell volume and inter-atomic distances than equivalent silicate phases at same pressures. As a result, all pressure induced state changes in iron occur at higher pressures in germanate phases than in the silicate ones, be it a spin state change or position change of (ferrous) iron in the perovskite A site. We showed that iron state transitions occur at particular average Fe-O bond-length (i.e., similar to 2.22(1) angstrom and similar to 1.86(1) angstrom for Fe2+ and Fe3+ substitutions, respectively) irrespective of mineral composition (silicate or germanate) or exchange-correlation functionals used in the calculation (LDA + U-sc or GGA + U-sc). Ferrous iron substitution decreases the perovskite to postperovskite (PPv) transition pressure while coupled ferric iron substitution increases it noticeably. (C) 2015 Elsevier B.V. All rights reserved.	[Shukla, Gaurav; Wentzcovitch, Renata M.] Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA; [Topsakal, Mehmet; Wentzcovitch, Renata M.] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; [Wentzcovitch, Renata M.] Univ Minnesota, Minnesota Supercomp Inst, Minneapolis, MN 55455 USA; [Wentzcovitch, Renata M.] Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, Tokyo 1528550, Japan	Shukla, G (reprint author), Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA.	shukla@physics.umn.edu; mtopsaka@umn.edu; wentz002@umn.edu			 [NSF/EAR 1319368];  [NSF/CAREER 1151738]	This work was supported primarily by grants NSF/EAR 1319368 and NSF/CAREER 1151738. Computations were performed at the Minnesota Supercomputing Institute (MSI) and at the Blue Waters System at NCSA. We thank Han Hsu for helpful discussions.	Hsu H, 2010, EARTH PLANET SC LETT, V294, P19, DOI 10.1016/j.epsl.2010.02.031; Lin JF, 2008, NAT GEOSCI, V1, P688, DOI 10.1038/ngeo310; Dubrovinsky L, 2010, HIGH PRESSURE RES, V30, P620, DOI 10.1080/08957959.2010.534092; Hsu H, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.195205; Tsuchiya T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.198501; Merkel S, 2006, SCIENCE, V311, P644, DOI 10.1126/science.1121808; Karki BB, 2000, PHYS REV B, V62, P14750, DOI 10.1103/PhysRevB.62.14750; Catalli K, 2009, NATURE, V462, P782, DOI 10.1038/nature08598; Hsu H, 2012, EARTH PLANET SC LETT, V359, P34, DOI 10.1016/j.epsl.2012.09.029; Mao WL, 2004, P NATL ACAD SCI USA, V101, P15867, DOI 10.1073/pnas.0407135101; Yu YGG, 2012, EARTH PLANET SC LETT, V331, P1, DOI 10.1016/j.epsl.2012.03.002; Caracas R, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023164; Antonangeli D, 2011, SCIENCE, V331, P64, DOI 10.1126/science.1198429; Shieh SR, 2006, P NATL ACAD SCI USA, V103, P3039, DOI 10.1073/pnas.0506811103; Catalli K, 2010, EARTH PLANET SC LETT, V289, P68, DOI 10.1016/j.epsl.2009.10.029; Stackhouse S, 2007, EARTH PLANET SC LETT, V253, P282, DOI 10.1016/j.epsl.2006.10.035; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Oganov AR, 2004, NATURE, V430, P445, DOI 10.1038/nature02701; Tsuchiya T, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.092105; Hsu H, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.125124; WENTZCOVITCH RM, 1993, PHYS REV LETT, V70, P3947, DOI 10.1103/PhysRevLett.70.3947; Wentzcovitch RM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.018501; Badro J, 2004, SCIENCE, V305, P383, DOI 10.1126/science.1098840; Himmetoglu B, 2014, INT J QUANTUM CHEM, V114, P14, DOI 10.1002/qua.24521; Runge CE, 2006, PHYS CHEM MINER, V33, P699, DOI 10.1007/s00269-006-0116-8; Shim SH, 2007, EARTH PLANET SC LETT, V260, P166, DOI 10.1016/j.epsl.2007.05.027; Sinmyo R, 2014, PHYS CHEM MINER, V41, P409, DOI 10.1007/s00269-013-0639-8; Badro J, 2003, SCIENCE, V300, P789, DOI 10.1126/science.1081311; Ito E, 2010, EARTH PLANET SC LETT, V293, P84, DOI 10.1016/j.epsl.2010.02.023; Lin JF, 2013, REV GEOPHYS, V51, P244, DOI 10.1002/rog.20010; Kulik HJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.103001; Cococcioni M, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.035105; ROSS NL, 1988, AM MINERAL, V73, P1355; Jackson JM, 2005, AM MINERAL, V90, P199, DOI 10.2138/am.2005.1633; Wu ZQ, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.228501; Hsu H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.118501; Li J, 2004, P NATL ACAD SCI USA, V101, P14027, DOI 10.1073/pnas.0405804101; Shukla G, 2015, GEOPHYS RES LETT, V42, P1741, DOI 10.1002/2014GL062888; Tsuchiya T, 2004, EARTH PLANET SC LETT, V224, P241, DOI 10.1016/j.epsl.2004.05.017; Hirose K, 2008, AM MINERAL, V93, P1678, DOI 10.2138/am.2008.3001; Wu Z, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.014409; Zhang FW, 2006, EARTH PLANET SC LETT, V249, P436, DOI 10.1016/j.epsl.2006.07.023; Hummer DR, 2012, AM MINERAL, V97, P1915, DOI 10.2138/am.2012.4144; Karki BB, 1999, SCIENCE, V286, P1705, DOI 10.1126/science.286.5445.1705; McCammon C, 2008, NAT GEOSCI, V1, P684, DOI 10.1038/ngeo309; Tateno S, 2007, PHYS EARTH PLANET IN, V160, P319, DOI 10.1016/j.pepi.2006.11.010; Caracas R, 2008, PHYS EARTH PLANET IN, V168, P147, DOI 10.1016/j.pepi.2008.06.002; Lin JF, 2012, AM MINERAL, V97, P592, DOI 10.2138/am.2012.4000; Nunez-Valdez M, 2013, GEOPHYS RES LETT, V40, P290, DOI 10.1002/grl.50131; Hirose K, 2005, AM MINERAL, V90, P262, DOI 10.2138/am.2005.1702; Crowhurst JC, 2008, SCIENCE, V319, P451, DOI 10.1126/science.1149606; WENTZCOVITCH RM, 1991, PHYS REV B, V44, P2358, DOI 10.1103/PhysRevB.44.2358; Catalli K, 2010, AM MINERAL, V95, P418, DOI 10.2138/am.2010.3352; Duffy TS, 2008, PHILOS T R SOC A, V366, P4273, DOI 10.1098/rsta.2008.0172; Li J, 2006, PHYS CHEM MINER, V33, P575, DOI 10.1007/s00269-006-0105-y; Bengtson A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038340; CEPERLEY DM, 1980, PHYS REV LETT, V45, P566, DOI 10.1103/PhysRevLett.45.566; Hirose K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024468; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kubo A., 2006, GEOPHYS RES LETT, V33; LEINENWEBER K, 1994, AM MINERAL, V79, P197; Mao Z., 2010, GEOPHYS RES LETT, V37; Marquardt M., 2009, SCIENCE, V324, P224, DOI [10.1126/science.1169365, DOI 10.1126/SCIENCE.1169365]; McCammon C., 2008, PHYS EARTH PLANET IN, V180, P215; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; Nunez Valdez Maribel, 2012, Applied Physics Letters, V101, DOI 10.1063/1.4754548; Nunez Valdez Maribel, 2012, Earth and Planetary Science Letters, V351-352, DOI 10.1016/j.epsl.2012.07.024; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Stackhouse S., 2006, GEOPHYS RES LETT, V33, DOI DOI 10.1029/2005GL023887; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Wentzcovitch R. M., 2009, P NATL ACAD SCI USA, V106, P21; Wu Z., 2014, P NATL ACAD SCI USA, V111, P29	73	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0031-9201	1872-7395		PHYS EARTH PLANET IN	Phys. Earth Planet. Inter.	DEC	2015	249						11	17		10.1016/j.pepi.2015.10.002		7	Geochemistry & Geophysics	Geochemistry & Geophysics	CY2JR	WOS:000366235300002		
J	Uno, K; Yamashita, D; Onoue, T; Uehara, D				Uno, Koji; Yamashita, Daisuke; Onoue, Tetsuji; Uehara, Daiki			Paleomagnetism of Triassic bedded chert from Japan for determining the age of an impact ejecta layer deposited on pen-equatorial latitudes of the paleo-Pacific Ocean: A preliminary analysis	PHYSICS OF THE EARTH AND PLANETARY INTERIORS			English	Article						Impact ejecta layer; Magnetic stratigraphy; Paleolatitude; Triassic; Japan	POLARITY TIME-SCALE; MASS EXTINCTION; INUYAMA AREA; ORIGIN; MAGNETOSTRATIGRAPHY; MANICOUAGAN; EVENT; BASIN	Bedded chert samples from the Norian (Upper Triassic) Sakahogi section of the Mino Terrane in the Inuyama area, southwest Japan, have been collected for paleomagnetic study in order to determine the age of an impact ejecta layer interbedded within it and the paleolatitude of its deposition. Thermal demagnetization of the bedded chert samples revealed four distinct remanent magnetization components. The last demagnetized component with both polarities is interpreted to be the primary magnetization, which produced the first magnetostratigraphic data of the middle to upper Norian from Panthalassa, consistent with Tethyan magnetostratigraphic sections. Tie points were derived from paleomagnetic and paleontological data, from which the stratigraphic position of the ejecta layer was compared with the astronomically tuned geomagnetic polarity time scale (APTS). The age of ejecta layer is estimated to be about 212 Ma. This magnetostratigraphic age is consistent with the radiometric age of the Manicouagan impact that formed the second largest known crater in the Phanerozoic at Quebec, Canada. The results of this study, as well as previous studies, suggest that the chert section, which includes the ejecta layer, was deposited within a paleolatitude range of 0.3-14.4 degrees N. This indicates that the material ejected by the Manicouagan impact event reached near the equatorial region of the paleo-Pacific Ocean. (C) 2015 Elsevier B.V. All rights reserved.	[Uno, Koji; Uehara, Daiki] Okayama Univ, Dept Earth Sci, Kita Ku, Okayama 7008530, Japan; [Yamashita, Daisuke; Onoue, Tetsuji] Kumamoto Univ, Dept Earth & Environm, Chuo Ku, Kumamoto 8608555, Japan	Uno, K (reprint author), Okayama Univ, Fac Educ, Dept Earth Sci, Kita Ku, 3-1-1 Tsushimanaka, Okayama 7008530, Japan.	unokoji@okayama-u.ac.jp			Center for Advanced Marine Core Research, Kochi University [13A001, 13B001]	We thank Dr. Kazuto Kodama, Dr. Yuhji Yamamoto, Dr. Tadahiro Hatakeyama, and Dr. Yo-ichiro Otofuji for allowing us to use the paleomagnetic and rock magnetic laboratory. We thank Dr. Honami Sato, Ms. Yoko Kaneshige, and Mr. Yuji Moriyama for their help in the field. Reviews by Dr. John Spray are greatly appreciated. This study was performed under the cooperative research program of the Center for Advanced Marine Core Research, Kochi University (Nos. 13A001 and 13B001).	Channell JET, 2003, PALAEOGEOGR PALAEOCL, V191, P65, DOI 10.1016/S0031-0182(02)006545; GERHARD LC, 1982, AAPG BULL, V66, P989; Liu SB, 2009, GEOL SOC AM SPEC PAP, V452, P37, DOI 10.1130/2009.2452(04); MCFADDEN PL, 1990, GEOPHYS J INT, V103, P163, DOI 10.1111/j.1365-246X.1990.tb01761.x; Onoue T, 2012, P NATL ACAD SCI USA, V109, P19134, DOI 10.1073/pnas.1209486109; MCFADDEN PL, 1982, GEOPHYS J ROY ASTR S, V69, P307, DOI 10.1111/j.1365-246X.1982.tb04950.x; Oda H, 2000, J GEOPHYS RES-SOL EA, V105, P25743, DOI 10.1029/2000JB900267; SHIBUYA H, 1986, J GEOPHYS RES-SOLID, V91, P14105, DOI 10.1029/JB091iB14p14105; Spray JG, 2010, PLANET SPACE SCI, V58, P538, DOI 10.1016/j.pss.2009.09.010; Spray JG, 1998, NATURE, V392, P171, DOI 10.1038/32397; Ando A, 2001, J GEOPHYS RES-SOL EA, V106, P1973, DOI 10.1029/2000JB900305; Olsen PE, 2010, EARTH ENV SCI T R SO, V101, P201, DOI 10.1017/S1755691011020032; Heslop D, 2002, GEOPHYS J INT, V148, P58, DOI 10.1046/j.0956-540x.2001.01558.x; Gallet Y, 1996, EARTH PLANET SC LETT, V140, P113, DOI 10.1016/0012-821X(96)00044-1; HODYCH JP, 1994, GEOPHYS J INT, V117, P640, DOI 10.1111/j.1365-246X.1994.tb02459.x; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; HODYCH JP, 1992, GEOLOGY, V20, P51, DOI 10.1130/0091-7613(1992)020<0051:DTMITE>2.3.CO;2; van Soest MC, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003465; LOWRIE W, 1990, GEOPHYS RES LETT, V17, P159, DOI 10.1029/GL017i002p00159; MCFADDEN PL, 1990, GEOPHYS J INT, V103, P725, DOI 10.1111/j.1365-246X.1990.tb05683.x; Muttoni G, 2004, GEOL SOC AM BULL, V116, P1043, DOI 10.1130/B25326.1; KIRSCHVINK JL, 1980, GEOPHYS J ROY ASTR S, V62, P699, DOI 10.1111/j.1365-246X.1980.tb02601.x; Walkden G, 2002, SCIENCE, V298, P2185, DOI 10.1126/science.1076249; Biren MB, 2014, CHEM GEOL, V377, P56, DOI 10.1016/j.chemgeo.2014.03.013; Cogne JP, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000227; Ogg James G., 2014, Albertiana, V41, P3; Ramezani J., 2005, GOLDSCHM C, pA321; Robertson W.A., 1967, CAN J EARTH SCI, V4, P641; Sato H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3455; Wrobel K.E., 2003, LUNAR PLANET SCI C, V34, P1190; YAO A, 1980, Journal of Geosciences Osaka City University, V23, P135; Zijderveld J., 1967, METHODS PALEOMAGNETI, P254	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0031-9201	1872-7395		PHYS EARTH PLANET IN	Phys. Earth Planet. Inter.	DEC	2015	249						59	67		10.1016/j.pepi.2015.10.004		9	Geochemistry & Geophysics	Geochemistry & Geophysics	CY2JR	WOS:000366235300007		
J	Isami, S; Sakamoto, N; Nishimori, H; Awazu, A				Isami, Shuhei; Sakamoto, Naoaki; Nishimori, Hiraku; Awazu, Akinori			Simple Elastic Network Models for Exhaustive Analysis of Long Double-Stranded DNA Dynamics with Sequence Geometry Dependence	PLOS ONE			English	Article							NUCLEIC-ACID FLEXIBILITY; COARSE-GRAINED MODEL; B-DNA; MOLECULAR-DYNAMICS; DODECAMER D(CGCGAATTCGCG); CHROMATIN INSULATORS; SOFTWARE PACKAGE; WEB SERVER; BASE-PAIR; SIMULATIONS	Simple elastic network models of DNA were developed to reveal the structure-dynamics relationships for several nucleotide sequences. First, we propose a simple all-atom elastic network model of DNA that can explain the profiles of temperature factors for several crystal structures of DNA. Second, we propose a coarse-grained elastic network model of DNA, where each nucleotide is described only by one node. This model could effectively reproduce the detailed dynamics obtained with the all-atom elastic network model according to the sequence-dependent geometry. Through normal-mode analysis for the coarse-grained elastic network model, we exhaustively analyzed the dynamic features of a large number of long DNA sequences, approximately similar to 150 bp in length. These analyses revealed positive correlations between the nucleosome-forming abilities and the inter-strand fluctuation strength of double-stranded DNA for several DNA sequences.	[Isami, Shuhei; Sakamoto, Naoaki; Nishimori, Hiraku; Awazu, Akinori] Hiroshima Univ, Dept Math & Life Sci, Higashihiroshima 7398526, Japan; [Sakamoto, Naoaki; Nishimori, Hiraku; Awazu, Akinori] Hiroshima Univ, Res Ctr Math Chromatin Live Dynam, Higashihiroshima 7398526, Japan	Awazu, A (reprint author), Hiroshima Univ, Dept Math & Life Sci, Kagami Yama 1-3-1, Higashihiroshima 7398526, Japan.	awa@hiroshima-u.ac.jp			Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and Development (AMED); MEXT of Japan [3306, 24115515, 4503, 26120525, 25430169]	This work was supported by Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Japan Agency for Medical Research and Development (AMED). Grant-in-Aid for Scientific Research on Innovative Areas "Spying minority in biological phenomena" (No. 3306) (24115515) and "Initiative for High-Dimensional Data-Driven Science through Deepening of Sparse Modeling" (No. 4503) (26120525) of MEXT of Japan (A. A) Grants-in-Aid for Scientific Research (C) (No. 25430169) of MEXT of Japan (N. S).	Albert B, 2008, MOL BIOL CELL; Allis C.D., 2007, EPIGENETICS; Hinsen K, 2000, CHEM PHYS, V261, P25, DOI 10.1016/S0301-0104(00)00222-6; SADASIVAN C, 1995, J MOL BIOL, V248, P918, DOI 10.1006/jmbi.1995.9894; Fujii S, 2007, NUCLEIC ACIDS RES, V35, P6063, DOI 10.1093/nar/gkm627; Fukue Y, 2004, NUCLEIC ACIDS RES, V32, P5834, DOI 10.1093/nar/gkh905; Setny P, 2013, J CHEM THEORY COMPUT, V9, P5460, DOI 10.1021/ct400814n; Yang L, 2009, P NATL ACAD SCI USA, V106, P12347, DOI 10.1073/pnas.0902159106; Tama F, 2006, ANNU REV BIOPH BIOM, V35, P115, DOI 10.1146/annurev.biophys.35.040405.102010; Atilgan C, 2012, ANNU REV BIOPHYS, V41, P205, DOI [10.1146/annurev-biophys-050511-102305, 10.1146/annurev-biophys-050511-102385]; Cheatham TE, 2013, BIOPOLYMERS, V99, P969, DOI 10.1002/bip.22331; Ng HL, 2000, P NATL ACAD SCI USA, V97, P2035, DOI 10.1073/pnas.040571197; Naome A, 2014, J CHEM THEORY COMPUT, V10, P3541, DOI 10.1021/ct500222s; Korolev N, 2014, POLYMERS-BASEL, V6, P1655, DOI 10.3390/polym6061655; Perez A, 2008, NUCLEIC ACIDS RES, V36, P2379, DOI 10.1093/nar/gkn082; TIMSIT Y, 1991, NATURE, V354, P167, DOI 10.1038/354167a0; HOLBROOK SR, 1985, ACTA CRYSTALLOGR B, V41, P255, DOI 10.1107/S0108768185002087; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Lavery R, 2010, NUCLEIC ACIDS RES, V38, P299, DOI 10.1093/nar/gkp834; HAHN M, 1993, ACTA CRYSTALLOGR D, V49, P468, DOI 10.1107/S0907444993004858; Geyer PK, 2002, CELL MOL LIFE SCI, V59, P2112, DOI 10.1007/s000180200011; Raab JR, 2010, NAT REV GENET, V11, P439, DOI 10.1038/nrg2765; Stolz RC, 2010, NUCLEIC ACIDS RES, V38, pW254, DOI 10.1093/nar/gkq496; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Bahar I, 2010, CHEM REV, V110, P1463, DOI 10.1021/cr900095e; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Van Wynsberghe AW, 2006, STRUCTURE, V14, P1647, DOI 10.1016/j.str.2006.09.003; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Savelyev A, 2010, P NATL ACAD SCI USA, V107, P20340, DOI 10.1073/pnas.1001163107; Takagi H, 2012, J BIOCHEM, V151, P75, DOI 10.1093/jb/mvr118; Matsumoto A, 2002, BIOPHYS J, V83, P22; Moritsugu K, 2007, BIOPHYS J, V93, P3460, DOI 10.1529/biophysj.107.111898; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Goni JR, 2008, BIOINFORMATICS, V24, P1731, DOI 10.1093/bioinformatics/btn259; Atilgan AR, 2001, BIOPHYS J, V80, P505; Guo SH, 2014, BIOINFORMATICS, V30, P1522, DOI 10.1093/bioinformatics/btu083; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Beveridge DL, 2012, J BIOSCIENCES, V37, P379, DOI 10.1007/s12038-012-9222-6; Morozov AV, 2009, NUCLEIC ACIDS RES, V37, P4707, DOI 10.1093/nar/gkp475; WESTHOF E, 1987, J BIOMOL STRUCT DYN, V5, P581; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Dans PD, 2012, NUCLEIC ACIDS RES, V40, P10668, DOI 10.1093/nar/gks884; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Orozco M, 2008, CURR OPIN STRUC BIOL, V18, P185, DOI 10.1016/j.sbi.2008.01.005; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Hospital A, 2013, NUCLEIC ACIDS RES, V41, pW47, DOI 10.1093/nar/gkt378; Bomble YJ, 2008, BIOPOLYMERS, V89, P722, DOI 10.1002/bip.21000; Dans PD, 2010, J CHEM THEORY COMPUT, V6, P1711, DOI 10.1021/ct900653p; KNEALE G, 1985, J MOL BIOL, V186, P805, DOI 10.1016/0022-2836(85)90398-5; Valenzuela L, 2006, ANNU REV GENET, V40, P107, DOI 10.1146/annurev.genet.39.073003.113546; Gibcus JH, 2013, MOL CELL, V49, P773, DOI [10.1016/j.molcel.2013.02.011, 10.1016/j.molce1.2013.02.011]; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Flechsig H, 2010, P NATL ACAD SCI USA, V107, P20875, DOI 10.1073/pnas.1014631107; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Lankas F, 2003, BIOPHYS J, V85, P2872; Lin DH, 1997, J CHEM PHYS, V107, P3684, DOI 10.1063/1.474724; Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Apostolou E, 2013, CELL STEM CELL, V13, P1; Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047843; Dehouck Y, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003209; DREW HR, 1981, P NATL ACAD SCI-BIOL, V78, P2179, DOI 10.1073/pnas.78.4.2179; Dykeman EC, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/42/423202; Freeman GS, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.168101; Freeman GS, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3652956; Freeman GS, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4897649; Gonzalez O, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4789411; Knotts TA, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2431804; Latchman DS, 2010, GENE CONTROL; Morriss-Andrews A, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3269994; Ohyama T, 2005, DNA CONFORMATION TRA; Olson WK, 2006, COMPUTATIONAL STUDIE, P235, DOI 10.1007/978-1-4020-4851-3_9; Pasi M, 2014, NUCLEIC ACIDS RES, V42, P12272, DOI 10.1093/nar/gku855; Petkeviciute D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku825; Pinamonti G, 2015, NUCLEIC ACIDS RES; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Turner BM, 2001, CHROMATIN GENE REGUL	81	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143760	10.1371/journal.pone.0143760		22	Multidisciplinary Sciences	Science & Technology - Other Topics	CX7OL	WOS:000365891600048		
J	Kinjo, T; Tanaka, M; Osanai, T; Shibutani, S; Narita, I; Tanno, T; Nishizaki, K; Ichikawa, H; Kimura, Y; Ishida, Y; Yokota, T; Shimada, M; Homma, Y; Tomita, H; Okumura, K				Kinjo, Takahiko; Tanaka, Makoto; Osanai, Tomohiro; Shibutani, Shuji; Narita, Ikuyo; Tanno, Tomohiro; Nishizaki, Kimitaka; Ichikawa, Hiroaki; Kimura, Yoshihiro; Ishida, Yuji; Yokota, Takashi; Shimada, Michiko; Homma, Yoshimi; Tomita, Hirofumi; Okumura, Ken			Enhanced p122RhoGAP/DLC-1 Expression Can Be a Cause of Coronary Spasm	PLOS ONE			English	Article							PHOSPHOLIPASE-C ACTIVITY; VARIANT ANGINA-PECTORIS; ARTERY SPASM; MYOCARDIAL-INFARCTION; PRINZMETAL ANGINA; NERVOUS-SYSTEM; SMOOTH MUSCLE; PROTEIN; PATHOGENESIS; VASOSPASM	Background We previously showed that phospholipase C (PLC)-delta 1 activity was enhanced by 3-fold in patients with coronary spastic angina (CSA). We also reported that p122Rho GTPase-activating protein/deleted in liver cancer-1 (p122RhoGAP/DLC-1) protein, which was discovered as a PLC-delta 1 stimulator, was upregulated in CSA patients. We tested the hypothesis that p122RhoGAP/DLC-1 overexpression causes coronary spasm. Methods and Results We generated transgenic (TG) mice with vascular smooth muscle (VSM)-specific overexpression of p122RhoGAP/DLC-1. The gene and protein expressions of p122RhoGAP/DLC-1 were markedly increased in the aorta of homozygous TG mice. Stronger staining with anti-p122RhoGAP/DLC-1 in the coronary artery was found in TG than in WT mice. PLC activities in the plasma membrane fraction and the whole cell were enhanced by 1.43 and 2.38 times, respectively, in cultured aortic vascular smooth muscle cells from homozygous TG compared with those from WT mice. Immediately after ergometrine injection, ST-segment elevation was observed in 1 of 7 WT (14%), 6 of 7 heterozygous TG (84%), and 7 of 7 homozygous TG mice (100%) (p<0.05, WT versus TGs). In the isolated Langendorff hearts, coronary perfusion pressure was increased after ergometrine in TG, but not in WT mice, despite of the similar response to prostaglandin F-2 alpha between TG and WT mice (n = 5). Focal narrowing of the coronary artery after ergometrine was documented only in TG mice. Conclusions VSM-specific overexpression of p122RhoGAP/DLC-1 enhanced coronary vasomotility after ergometrine injection in mice, which is relevant to human CSA.	[Kinjo, Takahiko; Shibutani, Shuji; Narita, Ikuyo; Tanno, Tomohiro; Nishizaki, Kimitaka; Ichikawa, Hiroaki; Kimura, Yoshihiro; Ishida, Yuji; Yokota, Takashi; Shimada, Michiko; Tomita, Hirofumi; Okumura, Ken] Hirosaki Univ, Grad Sch Med, Dept Cardiol & Nephrol, Hirosaki, Aomori, Japan; [Tanaka, Makoto; Okumura, Ken] Hirosaki Univ, Grad Sch Med, Dept Hypertens & Stroke Med, Hirosaki, Aomori, Japan; [Osanai, Tomohiro] Hirosaki Univ, Grad Sch Hlth Sci, Dept Hlth Promot, Hirosaki, Aomori, Japan; [Homma, Yoshimi] Fukushima Med Univ, Sch Med, Dept Biomol Sci, Fukushima, Japan	Okumura, K (reprint author), Hirosaki Univ, Grad Sch Med, Dept Cardiol & Nephrol, Hirosaki, Aomori, Japan.	okumura@hirosaki-u.ac.jp			Japan Society for the Promotion of Science of Japan [26461120, 25860577]; Takeda Science Foundation; Japan Heart Foundation; Astellas/Pfizer Grant for Research on Atherosclerosis Update	This study was supported in part by grant-in-aid for scientific research 26461120 from Japan Society for the Promotion of Science of Japan (http://www.jsps.go.jp/english/) to Dr. Okumura, and 25860577 to Dr. Yokota, the Takeda Science Foundation (http://www.takeda-sci.or.jp/) to Dr. Tomita, Japan Heart Foundation and Astellas/Pfizer Grant for Research on Atherosclerosis Update (http://www.jhf.or.jp/josei/12_update/) to Dr. Shibutani. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Kakkar R, 2006, CIRC RES, V98, P682, DOI 10.1161/01.RES.0000207498.40005.e7; Malester B, 2007, FASEB J, V21, P2162, DOI 10.1096/fj.06-7821com; OLIVA PB, 1973, NEW ENGL J MED, V288, P745, DOI 10.1056/NEJM197304122881501; KUGA T, 1993, J AM COLL CARDIOL, V22, P144; MCFADDEN EP, 1991, NEW ENGL J MED, V324, P648, DOI 10.1056/NEJM199103073241002; KASKI JC, 1986, CIRCULATION, V74, P1255; Tsutsumi Y, 1999, J CLIN INVEST, V104, P925, DOI 10.1172/JCI7886; Sekimata M, 1999, J BIOL CHEM, V274, P17757, DOI 10.1074/jbc.274.25.17757; Murakami R, 2010, ARTERIOSCL THROM VAS, V30, P1968, DOI 10.1161/ATVBAHA.110.203083; Yamaga M, 2008, ADV ENZYME REGUL, V48, P41, DOI 10.1016/j.advenzreg.2007.11.006; MASERI A, 1978, NEW ENGL J MED, V299, P1271, DOI 10.1056/NEJM197812072992303; Masaki H, 1998, J CLIN INVEST, V101, P527, DOI 10.1172/JCI1885; Lanza GA, 2011, CIRCULATION, V124, P1774, DOI 10.1161/CIRCULATIONAHA.111.037283; Okumura K, 1996, J AM COLL CARDIOL, V27, P45, DOI 10.1016/0735-1097(95)00432-7; Sanna T, 2009, RESUSCITATION, V80, P393, DOI 10.1016/j.resuscitation.2008.12.013; Miki T, 2002, NAT MED, V8, P466, DOI 10.1038/nm0502-466; Yamaga M, 2004, GENES CELLS, V9, P25, DOI 10.1111/j.1365-2443.2004.00698.x; ITO A, 1994, CIRCULATION, V90, P2425; Shibutani S, 2012, CIRCULATION, V125, P1027, DOI 10.1161/CIRCULATIONAHA.111.064303; CREA F, 1986, CIRCULATION, V74, P262; YASUE H, 1986, CIRCULATION, V74, P955; EGASHIRA K, 1992, CIRC RES, V71, P435; Kosugi T, 2003, J HYPERTENS, V21, P583, DOI 10.1097/01.hjh.0000052475.40108.80; KORN ED, 1988, ANNU REV BIOPHYS BIO, V17, P23; Matsumoto H, 2000, EUR J BIOCHEM, V267, P46, DOI 10.1046/j.1432-1327.2000.00949.x; HOSHIO A, 1989, J AM COLL CARDIOL, V14, P604; Eddahibi S, 2000, J CLIN INVEST, V105, P1555, DOI 10.1172/JCI8678; HEUPLER FA, 1978, AM J CARDIOL, V41, P631, DOI 10.1016/0002-9149(78)90810-X; Ito K, 2003, J PHYSIOL-LONDON, V546, P823, DOI 10.1113/jphysiol.2002.030775; Chutkow WA, 2002, J CLIN INVEST, V110, P203, DOI 10.1172/JCI200215672; Nakano T, 2002, CIRCULATION, V105, P2024, DOI 10.1161/01.CIR.0000014613.36469.3F; Tomita H, 2006, INT J MOL MED, V18, P589; Emanuele E, 2003, INT J MOL MED, V12, P509; Liao YC, 2008, INT J BIOCHEM CELL B, V40, P843, DOI 10.1016/j.biocel.2007.04.008; OLIVA PB, 1977, CIRCULATION, V56, P366; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; GINSBURG R, 1981, AM HEART J, V102, P819, DOI 10.1016/0002-8703(81)90030-2; YASUE H, 1974, CIRCULATION, V50, P534; HOMMA Y, 1995, EMBO J, V14, P286; Okumura K, 2000, J AM COLL CARDIOL, V36, P1847, DOI 10.1016/S0735-1097(00)00966-9; Kaku B, 2015, BIOMED CENTRAL, V9, P26, DOI [10.1186/1752-1947-9-26, DOI 10.1186/1752-1947-9-26]; Pasupathy S, 2015, CIRCULATION, V131, P861, DOI 10.1161/CIRCULATIONAHA.114.011201; Shibutani S, 2011, HIROSAKI MED J, V62, P27; Wang ZC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075044	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143884	10.1371/journal.pone.0143884		17	Multidisciplinary Sciences	Science & Technology - Other Topics	CX7OL	WOS:000365891600065		
J	Kojima, M; Takehara, H; Akagi, T; Shiono, H; Ichiki, T				Kojima, Mari; Takehara, Hiroaki; Akagi, Takanori; Shiono, Hirofumi; Ichiki, Takanori			Flexible Sheet-Type Sensor for Noninvasive Measurement of Cellular Oxygen Metabolism on a Culture Dish	PLOS ONE			English	Article							SINGLE CELLS; TECHNOLOGIES	A novel flexible sensor was developed for the noninvasive oxygen metabolism measurement of cultivated cells and tissues. This device is composed of a transparent double-layered polymer sheet of ethylene-vinyl alcohol (EVOH) and poly(dimethylsiloxane) (PDMS) having an array of microhole structures of 90 mu m diameter and 50 mu m depth on its surface. All the microhole structures were equipped with a 1-mu m-thick optical chemical sensing layer of platinum porphyrin-fluoropolymer on their bottom. The three-dimensional microstructures of the sensor were fabricated by a newly developed simple and low-cost production method named self-aligned hot embossing. The device was designed to be attached slightly above the cells cultivated on a dish to form a temporarily closed microspace over the target cells during measurement. Since the change in oxygen concentration is relatively fast in the microcompartmentalized culture medium, a rapid evaluation of the oxygen consumption rate is possible by measuring the phosphorescence lifetime of the platinum porphyrin-fluoropolymer. The combined use of the device and an automated optical measurement system enabled the high-throughput sensing of cellular oxygen consumption (100 points/min). We monitored the oxygen metabolism of the human breast cancer cell line MCF7 on a Petri dish and evaluated the oxygen consumption rate to be 0.72 +/- 0.12 fmol/min/cell. Furthermore, to demonstrate the utility of the developed sensing system, we demonstrated the mapping of the oxygen consumption rate of rat brain slices and succeeded in visualizing a clear difference among the layer structures of the hippocampus, i.e., the cornu ammonis (CA1 and CA3) and dentate gyrus (DG).	[Kojima, Mari; Takehara, Hiroaki; Akagi, Takanori; Ichiki, Takanori] Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo, Japan; [Shiono, Hirofumi] Nikon Inc, Minato Ku, Tokyo, Japan	Ichiki, T (reprint author), Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, 2-11-16 Yayoi, Tokyo, Japan.	ichiki@bioeng.t.u-tokyo.ac.jp			Nikon Corporation	This study was funded in part by Nikon Corporation. Hirofumi Shiono is employed by Nikon Corporation, but the funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abe H, 2007, J MAMM OVA RES, V24, P70, DOI 10.1274/jmor.24.70; Sinkala E, 2010, LAB CHIP, V10, P3291, DOI 10.1039/c0lc00244e; Mason C, 2007, TISSUE ENG, V13, P301, DOI 10.1089/ten.2006.0177; Yotter RA, 2004, IEEE SENS J, V4, P412, DOI 10.1109/JSEN.2004.830954; Bambrick LL, 2011, BIOTECHNOL PROGR, V27, P1185, DOI 10.1002/btpr.622; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Reinecke H, 2008, CIRC RES, V103, P1058, DOI 10.1161/CIRCRESAHA.108.180588; Yotter RA, 2004, IEEE SENS J, V4, P395, DOI 10.1109/JSEN.2004.830952; Ramamoorthy R, 2003, J MATER SCI, V38, P4271, DOI 10.1023/A:1026370729205; Lossi L, 2009, PROG NEUROBIOL, V88, P221, DOI 10.1016/j.pneurobio.2009.01.002; Gillanders RN, 2004, ANAL CHIM ACTA, V502, P1, DOI 10.1016/j.aca.2003.09.053; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Notingher L, 2005, J MOL STRUCT, V744, P179, DOI 10.1016/j.molstruc.2004.12.046; [Anonymous], DAT SHEET SOARN; Fang Y, 2006, ASSAY DRUG DEV TECHN, V4, P583, DOI 10.1089/adt.2006.4.583; Akagi T, 2008, ANAL BIOANAL CHEM, V391, P2433, DOI 10.1007/s00216-008-2203-9; Laermer F, 2003, MICROELECTRON ENG, V67-8, P349, DOI 10.1016/S0167-9317(03)00089-3; Molter TW, 2009, SENSOR ACTUAT B-CHEM, V135, P678, DOI 10.1016/j.snb.2008.10.036; Fuller L, 2007, CSH PROTOC, V2007; Jacobson MK, 2007, METHODS MODULATING P; Kalyanasundaram K, 1991, PHOTOCHEMISTRY POLYP; Lakowicz JR, 2013, PRINCIPLES FLUORESCE, P239; Takehara H, 2015, BIOFABRICATION, V7, DOI [10.1088/1758-5090/7/4/045006, DOI 10.1088/1758-5090/7/4/045006]; Utsunomiya T, 2008, J MAMM OVA RES, V25, P2, DOI 10.1274/jmor.25.2	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143774	10.1371/journal.pone.0143774		12	Multidisciplinary Sciences	Science & Technology - Other Topics	CX7OL	WOS:000365891600049		
J	Kuroda, K; Kiyono, T; Isogai, E; Masuda, M; Narita, M; Okuno, K; Koyanagi, Y; Fukuda, T				Kuroda, Kengo; Kiyono, Tohru; Isogai, Emiko; Masuda, Mizuki; Narita, Moe; Okuno, Katsuya; Koyanagi, Yukako; Fukuda, Tomokazu			Immortalization of Fetal Bovine Colon Epithelial Cells by Expression of Human Cyclin D1, Mutant Cyclin Dependent Kinase 4, and Telomerase Reverse Transcriptase: An In Vitro Model for Bacterial Infection	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNE-SYSTEM; HUMAN FIBROBLASTS; WALL COMPONENTS; CUTTING EDGE; SV40-MEDIATED IMMORTALIZATION; SALMONELLA-TYPHIMURIUM; PATHOGEN RECOGNITION; PATTERN-RECOGNITION; DIFFERENTIAL ROLES	Cattle are the economically important animals in human society. They are essential for the production of livestock products such as milk and meats. The production efficiency of livestock products is negatively impacted by infection with zoonotic pathogens. To prevent and control infectious diseases, it is important to understand the interaction between cattle tissue and pathogenic bacteria. In this study, we established an in vitro infection model of an immortalized bovine colon-derived epithelial cell line by transducing the cells with lentiviral vectors containing genes encoding cell cycle regulators cyclin D1, mutant cyclin dependent kinase 4 (CDK4), and human telomerase reverse transcriptase (TERT). The established cell line showed continuous cell proliferation, expression of epithelial markers, and an intact karyotype, indicating that the cells maintained their original nature as colon-derived epithelium. Furthermore, we exposed the established cell line to two strains of Salmonella enterica and EHEC. Interestingly, S. Typhimurium showed higher affinity for the established cell line and invaded the cytoplasm than S. Enteritidis. Quantitative RT-PCR revealed that gene expression of Toll-like receptor 1 (TLR1), TLR 2 and TLR 3, whereas TLR 4, 5 and 6 were not detectable in established cells. Our established immortalized colon-derived epithelial cell should be a useful tool for studies evaluating the molecular mechanisms underlying bacterial infection.	[Kuroda, Kengo; Isogai, Emiko; Masuda, Mizuki; Narita, Moe; Okuno, Katsuya; Koyanagi, Yukako; Fukuda, Tomokazu] Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 980, Japan; [Kiyono, Tohru] Natl Canc Ctr, Res Inst, Div Carcinogenesis & Canc Prevent, Chuo Ku, Tokyo 104, Japan	Kiyono, T (reprint author), Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, 1-1 Tsutsumidori Amamiyamachi, Sendai, Miyagi 980, Japan.	tkiyono@ncc.go.jp; tomofukuda@bios.tohoku.ac.jp					Jha KK, 1998, EXP CELL RES, V245, P1, DOI 10.1006/excr.1998.4272; Means TK, 1999, J IMMUNOL, V163, P3920; Roy P, 2002, AVIAN DIS, V46, P17, DOI 10.1637/0005-2086(2002)046[0017:ROSIFP]2.0.CO;2; Isogai E, 2005, COMP IMMUNOL MICROB, V28, P363, DOI 10.1016/j.cimid.2005.10.001; Sasaki R, 2009, CARCINOGENESIS, V30, P423, DOI 10.1093/carcin/bgp007; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Donai K, 2014, J BIOTECHNOL, V176, P50, DOI 10.1016/j.jbiotec.2014.02.017; Pagan R, 1996, EXP CELL RES, V222, P333, DOI 10.1006/excr.1996.0043; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Qin XY, 2012, CANCER BIOL THER, V13, P296, DOI [10.4161/cbt.18942, 10.4161/cbt.13.5.18942]; Pan D, 2015, VET IMMUNOL IMMUNOP, V165, P14, DOI 10.1016/j.vetimm.2015.03.006; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Yoshimura A, 1999, J IMMUNOL, V163, P1; Whitehead RH, 2009, AM J PHYSIOL-GASTR L, V296, pG455, DOI 10.1152/ajpgi.90381.2008; Fukuda T, 2012, BIOSCI BIOTECH BIOCH, V76, P1372, DOI 10.1271/bbb.120155; RAY FA, 1990, J CELL BIOCHEM, V42, P13, DOI 10.1002/jcb.240420103; Ozer HL, 1996, EXP GERONTOL, V31, P303, DOI 10.1016/0531-5565(95)00024-0; Takaya A, 2005, CELL MICROBIOL, V7, P79, DOI 10.1111/j.1462-5822.2004.00435.x; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Zeiler M, 2007, CELLS TISSUES ORGANS, V186, P229, DOI 10.1159/000107947; Bai H, 2014, ANIM SCI J, V85, P799, DOI 10.1111/asj.12202; Costa LF, 2012, RES VET SCI, V93, P1, DOI 10.1016/j.rvsc.2012.03.002; Rosselin M, 2011, MICROBIOL-SGM, V157, P839, DOI 10.1099/mic.0.044941-0; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; Gantois I, 2009, FEMS MICROBIOL REV, V33, P718, DOI 10.1111/j.1574-6976.2008.00161.x; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Duensing S, 2000, P NATL ACAD SCI USA, V97, P10002, DOI 10.1073/pnas.170093297; Younis EE, 2009, RES VET SCI, V87, P373, DOI 10.1016/j.rvsc.2009.04.006; Takeuchi O, 2000, INT IMMUNOL, V12, P113, DOI 10.1093/intimm/12.1.113; Hoshino K, 1999, J IMMUNOL, V162, P3749; SMITH BP, 1984, AM J VET RES, V45, P59; Loret S, 2009, RES VET SCI, V87, P123, DOI 10.1016/j.rvsc.2008.12.002; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; RANKIN JD, 1966, VET REC, V78, P706; Matsumoto M, 2003, J IMMUNOL, V171, P3154; Miyazawa K, 2010, HISTOCHEM CELL BIOL, V133, P125, DOI 10.1007/s00418-009-0648-3; Shiomi K, 2011, GENE THER, V18, P857, DOI 10.1038/gt.2011.44; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Bridger PS, 2010, VET IMMUNOL IMMUNOP, V137, P54, DOI 10.1016/j.vetimm.2010.04.010; Takeuchi O, 2002, J IMMUNOL, V169, P10; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Flo TH, 2000, J IMMUNOL, V164, P2064; Desmarets LMB, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-71; Fukuda T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001776; Fukuda T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054312; Kuroda K, 2015, J CELL BIOCHEM, V116, P205, DOI 10.1002/jcb.24963; LAX AJ, 1995, BRIT VET J, V151, P351, DOI 10.1016/S0007-1935(95)80126-X; Piatyszek Mieczyslaw A., 1995, Methods in Cell Science, V17, P1, DOI 10.1007/BF00981880; Rolli J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012687	54	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143473	10.1371/journal.pone.0143473		18	Multidisciplinary Sciences	Science & Technology - Other Topics	CX7OL	WOS:000365891600031		
J	Mitsuishi, S; Nishimura, R; Ando, K; Tsujino, D; Utsunomiya, K				Mitsuishi, Sumie; Nishimura, Rimei; Ando, Kiyotaka; Tsujino, Daisuke; Utsunomiya, Kazunori			Can Fasting Glucose Levels or Post-Breakfast Glucose Fluctuations Predict the Occurrence of Nocturnal Asymptomatic Hypoglycemia in Type 1 Diabetic Patients Receiving Basal-Bolus Insulin Therapy with Long-Acting Insulin?	PLOS ONE			English	Article							MONITORING-SYSTEM; MELLITUS; FREQUENCY; SLEEP; DEATH	Objective To investigate whether the occurrence of nocturnal asymptomatic hypoglycemia may be predicted based on fasting glucose levels and post-breakfast glucose fluctuations. Patients and Methods The study subjects comprised type 1 diabetic patients who underwent CGM assessments and received basal-bolus insulin therapy with long-acting insulin. The subjects were evaluated for I) fasting glucose levels and II) the range of post-breakfast glucose elevation (from fasting glucose levels to postprandial 1- and 2-hour glucose levels). The patients were divided into those with asymptomatic hypoglycemia during nighttime and those without for comparison. Optimal cut-off values were also determined for relevant parameters that could predict nighttime hypoglycemia by using ROC analysis. Results 64 patients (mean HbA1c 8.7 +/- 1.8%) were available for analysis. Nocturnal asymptomatic hypoglycemia occurred in 23 patients (35.9%). Fasting glucose levels (I) were significantly lower in those with hypoglycemia than those without (118 +/- 35 mg/dL vs. 179 +/- 65 mg/dL; P < 0.001). The range of post-breakfast glucose elevation (II) was significantly greater in those with hypoglycemia than in those without (postprandial 1-h, P = 0.003; postprandial 2-h, P = 0.005). The cut-off values determined for relevant factors were as follows: (I) fasting glucose level < 135 mg/dL (sensitivity 0.73/specificity 0.83/AUC 0.79, P < 0.001); and (II) 1-h postprandial elevation > 54 mg/dL (0.65/0.61/0.71, P = 0.006), 2-h postprandial elevation > 78 mg/dL (0.65/0.73/0.71, P = 0.005). Conclusions Nocturnal asymptomatic hypoglycemia was associated with increases in post- breakfast glucose levels in type 1 diabetes. Study findings also suggest that fasting glucose levels and the range of post-breakfast glucose elevation could help predict the occurrence of nocturnal asymptomatic hypoglycemia.	[Mitsuishi, Sumie; Nishimura, Rimei; Ando, Kiyotaka; Tsujino, Daisuke; Utsunomiya, Kazunori] Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Tokyo, Japan; [Nishimura, Rimei] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA	Nishimura, R (reprint author), Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Tokyo, Japan.	rimei@jikei.ac.jp			Japan Diabetes Foundation; Kowa; Ono; Taishyo	The authors have read the journal's policy and the authors of this manuscript have the following competing interests: R.N. has received research support from Japan Diabetes Foundation, has participated in speaker's bureau/advisory panels for Astellas, Astra Zeneca, Boehringer Ingelheim, Daiichi-Sankyo, Eli Lilly, Johnson & Johnson, Kissei, Kowa, Medtronic, Novo Nordisk, Ono, Sanofi, Taishyo, Takeda and Tanabe-Mitsubishi, and served as a consultant for Abbott, Boehringer Ingelheim, Eli Lilly, and Taisho. K.U. has received research support from Kowa, Ono and Taishyo, and has participated in speaker's bureau/advisory panels for Astellas, Astra Zeneca and Sanofi. All the other authors have no conflict of interest to declare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	ADVANCE Collaborative Group, 2008, NEW ENGL J MED, V358, P2560, DOI [10.1056/NEJMoa0802987, DOI 10.1056/NEJM0A0802987]; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Wiltshire EJ, 2006, J PAEDIATR CHILD H, V42, P758, DOI 10.1111/j.1440-1754.2006.00973.x; Weston PJ, 1999, DIABETIC MED, V16, P626, DOI 10.1046/j.1464-5491.1999.00121.x; Hoi-Hansen T, 2005, DIABETOLOGIA, V48, P2437, DOI 10.1007/s00125-005-1946-5; Miller CD, 2001, ARCH INTERN MED, V161, P1653, DOI 10.1001/archinte.161.13.1653; Suys B, 2006, DIABETES CARE, V29, P427, DOI 10.2337/diacare.29.02.06.dc05-1450; Chow E, 2014, DIABETES, V63, P1738, DOI 10.2337/db13-0468; PERRIELLO G, 1988, NEW ENGL J MED, V319, P1233, DOI 10.1056/NEJM198811103191901; Banarer S, 2003, DIABETES, V52, P1195, DOI 10.2337/diabetes.52.5.1195; Robinson RTCE, 2004, DIABETOLOGIA, V47, P312, DOI 10.1007/s00125-003-1292-4; Wentholt IME, 2007, DIABETIC MED, V24, P527, DOI 10.1111/j.1464-5491.2007.02107.x; SOMOGYI M, 1959, AM J MED, V26, P169, DOI 10.1016/0002-9343(59)90307-9; Kaufman FR, 2002, J PEDIATR-US, V141, P625, DOI 10.1067/mpd.2002.129175; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; TATTERSALL RB, 1991, DIABETIC MED, V8, P49; Jones TW, 1998, NEW ENGL J MED, V338, P1657, DOI 10.1056/NEJM199806043382303; Heise T, 2012, DIABETES OBES METAB, V14, P859, DOI 10.1111/j.1463-1326.2012.01627.x; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795; Woodward A, 2009, QJM-INT J MED, V102, P603, DOI 10.1093/qjmed/hcp082; Tsujimoto T, 2014, DIABETES CARE, V37, P217, DOI 10.2337/dc13-0701; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545; Choudhary P, 2013, DIABETIC MED, V30, P914, DOI 10.1111/dme.12175; Diabetes Research in Children Network (DirecNet) Study Group, 2007, PEDIAT DIABETES, V8, P199; The Diabetes Control and Complications Trial Research Group, 1993, NEW ENGL J MED, V329, P977, DOI [10.1056/NEJM199309303291401, DOI 10.1056/NEJM199309303291401]; Diabet Control Complications Trial Res Grp, 1995, DIABETES CARE, V18, P1415; DCCT Res Grp, 1991, AM J MED, V90, P450	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0144041	10.1371/journal.pone.0144041		9	Multidisciplinary Sciences	Science & Technology - Other Topics	CX7OL	WOS:000365891600086		
J	Ohashi, K; Komada, H; Uda, S; Kubota, H; Iwaki, T; Fukuzawa, H; Komori, Y; Fujii, M; Toyoshima, Y; Sakaguchi, K; Ogawa, W; Kuroda, S				Ohashi, Kaoru; Komada, Hisako; Uda, Shinsuke; Kubota, Hiroyuki; Iwaki, Toshinao; Fukuzawa, Hiroki; Komori, Yasunori; Fujii, Masashi; Toyoshima, Yu; Sakaguchi, Kazuhiko; Ogawa, Wataru; Kuroda, Shinya			Glucose Homeostatic Law: Insulin Clearance Predicts the Progression of Glucose Intolerance in Humans	PLOS ONE			English	Article							BETA-CELL FUNCTION; TYPE-2 DIABETIC-PATIENTS; TOLERANCE TEST DATA; MINIMAL MODEL; C-PEPTIDE; INTRAVENOUS GLUCOSE; HEALTHY-VOLUNTEERS; OBESE SUBJECTS; AKT PATHWAY; ORAL-TEST	Homeostatic control of blood glucose is regulated by a complex feedback loop between glucose and insulin, of which failure leads to diabetes mellitus. However, physiological and pathological nature of the feedback loop is not fully understood. We made a mathematical model of the feedback loop between glucose and insulin using time course of blood glucose and insulin during consecutive hyperglycemic and hyperinsulinemic-euglycemic clamps in 113 subjects with variety of glucose tolerance including normal glucose tolerance (NGT), impaired glucose tolerance (IGT) and type 2 diabetes mellitus (T2DM). We analyzed the correlation of the parameters in the model with the progression of glucose intolerance and the conserved relationship between parameters. The model parameters of insulin sensitivity and insulin secretion significantly declined from NGT to IGT, and from IGT to T2DM, respectively, consistent with previous clinical observations. Importantly, insulin clearance, an insulin degradation rate, significantly declined from NGT, IGT to T2DM along the progression of glucose intolerance in the mathematical model. Insulin clearance was positively correlated with a product of insulin sensitivity and secretion assessed by the clamp analysis or determined with the mathematical model. Insulin clearance was correlated negatively with postprandial glucose at 2h after oral glucose tolerance test. We also inferred a square-law between the rate constant of insulin clearance and a product of rate constants of insulin sensitivity and secretion in the model, which is also conserved among NGT, IGT and T2DM subjects. Insulin clearance shows a conserved relationship with the capacity of glucose disposal among the NGT, IGT and T2DM subjects. The decrease of insulin clearance predicts the progression of glucose intolerance.	[Ohashi, Kaoru; Uda, Shinsuke; Kubota, Hiroyuki; Komori, Yasunori; Fujii, Masashi; Toyoshima, Yu; Kuroda, Shinya] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan; [Komada, Hisako; Sakaguchi, Kazuhiko; Ogawa, Wataru] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet & Endocrinol,Chuo Ku, Kobe, Hyogo 657, Japan; [Iwaki, Toshinao; Kuroda, Shinya] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Bunkyo Ku, Tokyo, Japan; [Fukuzawa, Hiroki] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 113, Japan	Ogawa, W (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan.	ogawa@med.kobe-u.ac.jp; skuroda@bs.s.u-tokyo.ac.jp			Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics, CREST, of the Japan Science and Technology Agency (JST); Kakenhi Scientific Research grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [21240025]; Human Frontier Science Project (HFSP) grant [RGP0061/2011]	This work was supported by Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics, CREST, of the Japan Science and Technology Agency (JST), http://www.jst.go.jp/kisoken/crest/en/; Kakenhi Scientific Research grant (A) (#21240025) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, https://www.jsps.go.jp/english/e-grants/; and Human Frontier Science Project (HFSP) grant (RGP0061/2011), http://www.hfsp.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader M, 2013, OBESITY SILVER SPRIN, DOI [10.1002/oby.20625, DOI 10.1002/OBY.20625]; Ajmera I, 2013, CPT Pharmacometrics Syst Pharmacol, V2, pe54, DOI 10.1038/psp.2013.30; BOLIE VW, 1961, J APPL PHYSIOL, V16, P783; Antuna-Puente B, 2011, DIABETES METAB, V37, P179, DOI 10.1016/j.diabet.2011.01.002; Jauslin PM, 2007, J CLIN PHARMACOL, V47, P1244, DOI 10.1177/0091270007302168; Brys G, 2004, J COMPUT GRAPH STAT, V13, P996, DOI 10.1198/106186004X12632; Toffolo G, 2006, AM J PHYSIOL-ENDOC M, V290, pE169, DOI 10.1152/ajpendo.00473.2004; Jones CNO, 1997, J CLIN ENDOCR METAB, V82, P1834, DOI 10.1210/jc.82.6.1834; Watanabe RM, 1998, AM J PHYSIOL-ENDOC M, V274, pE172; POLONSKY KS, 1988, J CLIN INVEST, V81, P435, DOI 10.1172/JCI113338; Kubota H, 2012, MOL CELL, V46, P820, DOI 10.1016/j.molcel.2012.04.018; Silber HE, 2007, J CLIN PHARMACOL, V47, P1159, DOI 10.1177/0091270007304457; Tamaki M, 2013, J CLIN INVEST, V123, P4513, DOI 10.1172/JCI68807; Lee CC, 2013, DIABETES CARE, V36, P901, DOI 10.2337/dc12-1316; VOLUND A, 1987, DIABETES, V36, P1195, DOI 10.2337/diabetes.36.10.1195; CASTILLO MJ, 1994, DIABETES METAB REV, V10, P119; Campioni M, 2009, AM J PHYSIOL-ENDOC M, V297, pE941, DOI 10.1152/ajpendo.90842.2008; Marini MA, 2014, ACTA DIABETOL, V51, P257, DOI 10.1007/s00592-013-0511-9; TOFFOLO G, 1995, DIABETES, V44, P845, DOI 10.2337/diabetes.44.7.845; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; EATON RP, 1980, J CLIN ENDOCR METAB, V51, P520; BONORA E, 1983, METABOLISM, V32, P438, DOI 10.1016/0026-0495(83)90004-5; COBELLI C, 1988, DIABETES, V37, P223, DOI 10.2337/diabetes.37.2.223; De Gaetano A, 2000, J MATH BIOL, V40, P136, DOI 10.1007/s002850050007; Komada H, 2011, J DIABETES INVEST, V2, P293, DOI 10.1111/j.2040-1124.2010.00099.x; Hubert M, 2008, J CHEMOMETR, V22, P235, DOI 10.1002/cem.1123; Thomaseth K, 1996, AM J PHYSIOL-ENDOC M, V270, pE522; Schofield CJ, 2012, DIABETIC MED, V29, P972, DOI 10.1111/j.1464-5491.2012.03655.x; Toffolo G, 2001, AM J PHYSIOL-ENDOC M, V280, pE2; Okuno Y, 2013, METABOLISM, V62, P1470, DOI 10.1016/j.metabol.2013.05.022; Pedersen MG, 2010, AM J PHYSIOL-ENDOC M, V298, pE597, DOI 10.1152/ajpendo.00670.2009; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Kashyap S, 2003, DIABETES, V52, P2461, DOI 10.2337/diabetes.52.10.2461; Matveyenko AV, 2006, DIABETES, V55, P2347, DOI 10.2337/db06-0345; Denti P, 2010, AM J PHYSIOL-ENDOC M, V298, pE950, DOI 10.1152/ajpendo.00656.2009; Rudovich NN, 2004, DIABETES, V53, P2359, DOI 10.2337/diabetes.53.9.2359; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Hovorka R, 1998, J CLIN ENDOCR METAB, V83, P744, DOI 10.1210/jc.83.3.744; Neuhauser M, 2001, BIOMETRICAL J, V43, P571, DOI 10.1002/1521-4036(200109)43:5<571::AID-BIMJ571>3.0.CO;2-N; Mari A, 2002, AM J PHYSIOL-ENDOC M, V283, pE1159, DOI 10.1152/ajpendo.00093.2002; Breda E, 2001, DIABETES, V50, P150, DOI 10.2337/diabetes.50.1.150; POLONSKY KS, 1986, J CLIN INVEST, V77, P98, DOI 10.1172/JCI112308; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667; Silber HE, 2010, J CLIN PHARMACOL, V50, P246, DOI 10.1177/0091270009341185; Retnakaran R, 2008, OBESITY, V16, P1901, DOI 10.1038/oby.2008.307; Hovorka R, 1996, COMPUT METH PROG BIO, V50, P253, DOI 10.1016/0169-2607(96)01755-5; BENZI L, 1994, DIABETES, V43, P297, DOI 10.2337/diabetes.43.2.297; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; Choi Eunsu, 2011, Korean J Anesthesiol, V60, P226, DOI 10.4097/kjae.2011.60.3.226; Dalla Man C, 2002, IEEE T BIO-MED ENG, V49, P419; Dalla Man C, 2004, AM J PHYSIOL-ENDOC M, V287, pE637, DOI 10.1152/ajpendo.00319.2003; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Fujita KA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000810; Noguchi R, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.19; Mari A, 2001, DIABETES CARE, V24, P539, DOI 10.2337/diacare.24.3.539; Toyoshima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1745	56	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143880	10.1371/journal.pone.0143880		19	Multidisciplinary Sciences	Science & Technology - Other Topics	CX7OL	WOS:000365891600063		
J	Sato, M; Takahashi, G; Shibata, S; Onodera, M; Suzuki, Y; Inoue, Y; Endo, S				Sato, Masayuki; Takahashi, Gaku; Shibata, Shigehiro; Onodera, Makoto; Suzuki, Yasushi; Inoue, Yoshihiro; Endo, Shigeatsu			Clinical Performance of a New Soluble CD14-Subtype Immunochromatographic Test for Whole Blood Compared with Chemiluminescent Enzyme Immunoassay: Use of Quantitative Soluble CD14-Subtype Immunochromatographic Tests for the Diagnosis of Sepsis	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT; SERUM PROCALCITONIN; ORGAN FAILURE; PRESEPSIN; PREDICTION; SEVERITY; SCORE	We previously reported that a soluble CD14-subtype (sCD14-ST) immunochromatographic test (ICT) for plasma is more convenient than chemiluminescent enzyme immunoassay (CLEIA), but plasma separation makes bedside measurements difficult. We developed a new sCD14-ST ICT for whole blood and investigated whether quantitative determinations of sCD14-ST by ICT were useful for diagnosing sepsis and severe sepsis/septic shock. We studied 20 patients who fulfilled two or more systemic inflammatory response syndrome (SIRS) criteria and 32 patients who had been diagnosed with sepsis or severe sepsis/septic shock. Whole blood was collected on day 0 (on admission) and day 7, and the sCD14-ST concentration was quantitatively measured by CLEIA and ICT for whole blood. The patients' Acute Physiology and Chronic Health Evaluation (APACHE) II, Sequential Organ Failure Assessment (SOFA), and Mortality in Emergency Department Sepsis (MEDS) scores were also calculated. The cut-off values obtained by the quantitative measurements made by ICT were 464.5 pg/mL for sepsis and 762.7 pg/mL for severe sepsis/septic shock (P < 0.0001). A Bland-Altman plot showed that no fixed bias or proportional bias was detected between CLEIA and quantitative ICT for whole blood. sCD14-ST concentrations were significantly correlated with APACHE II, SOFA, and MEDS scores (P < 0.0001). These results suggest that the new sCD14-ST ICT for whole blood may be a useful tool for the convenient, rapid bedside diagnosis and treatment of sepsis.	[Sato, Masayuki; Takahashi, Gaku; Shibata, Shigehiro; Onodera, Makoto; Suzuki, Yasushi; Inoue, Yoshihiro; Endo, Shigeatsu] Iwate Med Univ, Dept Crit Care Med, Morioka, Iwate 020, Japan	Sato, M (reprint author), Iwate Med Univ, Dept Crit Care Med, Morioka, Iwate 020, Japan.	masato@iwate-med.ac.jp					Aikawa Naoki, 2005, Journal of Infection and Chemotherapy, V11, P152, DOI 10.1007/s10156-005-0388-9; NYLEN ES, 1992, HORM METAB RES, V24, P439, DOI 10.1055/s-2007-1003354; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Shozushima T, 2011, J INFECT CHEMOTHER, V17, P764, DOI 10.1007/s10156-011-0254-x; Endo S, 2012, J INFECT CHEMOTHER, V18, P891, DOI 10.1007/s10156-012-0435-2; Madenci OC, 2014, BURNS, V40, P664, DOI 10.1016/j.burns.2013.08.024; Nylen ES, 1997, CRIT CARE MED, V25, P1362, DOI 10.1097/00003246-199708000-00024; Shapiro NI, 2003, CRIT CARE MED, V31, P670, DOI 10.1097/01.CCM.0000054867.01688.D1; Rudiger A, 2008, SWISS MED WKLY, V138, P629, DOI 2008/43/smw-12319; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Vodnik T, 2013, CLIN CHEM LAB MED, V51, P2053, DOI 10.1515/cclm-2013-0061; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Ammori BJ, 2003, BRIT J SURG, V90, P197, DOI 10.1002/bjs.4036; Kweon OJ, 2014, J CRIT CARE, V29, P965, DOI 10.1016/j.jcrc.2014.06.014; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Dellinger RP, 2012, INTENS CARE MED, V39, P165, DOI DOI 10.1007/S00134-012-2769-8; Ishikura H, 2014, CRIT CARE, V18, DOI 10.1186/cc13700; Kanda Y, 2012, BONE MARROW TRANSPL, V48, P452; Liu B, 2013, CRIT CARE, V17, DOI 10.1186/cc13070; BLAND JM, 1986, LANCET, V1, P307; Meisner M, 2006, CRIT CARE, V10, DOI 10.1186/cc3910; Miyata M, 2007, J IWATE MED ASS, V59, P325; Shozushima T, 2010, J IWATE MED ASS, V62, P411; Takahashi G, 2010, MED POSTGRAD, V48, P15; Takahashi G, 2010, MED POSTGRAD, V48, P25; Ulla M, 2013, CRIT CARE, V17, DOI 10.1186/cc12847; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Yaegashi Yasunori, 2005, Journal of Infection and Chemotherapy, V11, P234, DOI 10.1007/s10156-005-0400-4	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143971	10.1371/journal.pone.0143971		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CX7OL	WOS:000365891600081		
J	Tachibana, Y; Koizumi, T; Takehara, K; Kakee, N; Tsujii, H; Mori, R; Inoue, E; Ota, E; Yoshida, K; Kasai, K; Okuyama, M; Kubo, T				Tachibana, Yoshiyuki; Koizumi, Tomoe; Takehara, Kenji; Kakee, Naoko; Tsujii, Hiromi; Mori, Rintaro; Inoue, Eisuke; Ota, Erika; Yoshida, Keiko; Kasai, Keiko; Okuyama, Makiko; Kubo, Takahiko			Antenatal Risk Factors of Postpartum Depression at 20 Weeks Gestation in a Japanese Sample: Psychosocial Perspectives from a Cohort Study in Tokyo	PLOS ONE			English	Article							POSTNATAL DEPRESSION; SOCIAL SUPPORT; MENTAL-HEALTH; PERINATAL DEPRESSION; MATERNAL DEPRESSION; PREGNANT-WOMEN; LOW-INCOME; SCALE; METAANALYSIS; SYMPTOMS	Background Prevalence of postnatal depression (PND) is high (Western countries, 10-15%; Japan, 17%). PND can cause parenting impairment and affect family health (e.g. child behaviors, cognitive development and physical health). This study aimed to reveal the risk factors of PND during the pregnancy period in a Japanese sample, and to identify the psychosocial risk factors of PND that should be appended to existing obstetric interview sheets. A cohort study with a Japanese sample was conducted. Methods All 14 obstetrics hospitals in the Setagaya ward, Tokyo, Japan, participated in this study. Pregnant women who booked their delivery between December 2012 and May 2013 were enrolled. Data used for this study were collected at 20 weeks gestation, a few days and one month postnatal. The questionnaires consisted of psychosocial factors and the Edinburgh Postnatal Depression Scale (EPDS). To identify PND risk factors, multivariate analyses were performed. Results A total of 1,775 women participated in this study. Eventually, the data of 1,133 women were used for the multivariate analyses. The demonstrated significant risk factors include EPDS score, primipara, "a perceived lack of family cohesion", "current physical illness treatment" and "current psychiatric illness treatment". Conclusion This study highlights the importance of mental health screening using psychological measures during the pregnancy period. In addition, family environment, parity, physical and psychiatric illness should be paid attention by professionals in maternal and child health. The results also suggest that mothers' feelings of developing their families should be supported.	[Tachibana, Yoshiyuki] Natl Ctr Child Hlth & Dev, Dept Psychosocial Med, Div Infant & Toddler Mental Hlth, Tokyo, Japan; [Koizumi, Tomoe] Natl Res Inst Child Hlth & Dev, Tokyo, Japan; [Takehara, Kenji; Mori, Rintaro; Ota, Erika] Natl Res Inst Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Kakee, Naoko] Natl Ctr Child Hlth & Dev, Div Bioeth, Tokyo, Japan; [Tsujii, Hiromi; Okuyama, Makiko] Natl Ctr Child Hlth & Dev, Dept Psychosocial Med, Tokyo, Japan; [Inoue, Eisuke] Natl Ctr Child Hlth & Dev, Clin Res Ctr, Dept Biostat, Tokyo, Japan; [Kasai, Keiko] Japanese Midw Assoc, Tokyo, Japan; [Yoshida, Keiko] Kyushu Univ Hosp, Dept Child Psychiat, Fukuoka 812, Japan; [Kubo, Takahiko] Shirota Obstetr & Gynecol Hosp, Tokyo, Japan	Tachibana, Y (reprint author), Natl Ctr Child Hlth & Dev, Dept Psychosocial Med, Div Infant & Toddler Mental Hlth, Tokyo, Japan.	tachibana-y@ncchd.go.jp			Ministry of Health, Labor and Welfare of Japan [H24-Jisedai-Shitei-006, H25-Seisin-Wakate-013]; National Center for Child Health and Development [H26-48]	This study was conducted under the title, "Research on the assessment of the mental health condition of women during the prenatal and postnatal periods, and appropriate interventions", supported by the Health and Labor Sciences Research Grant on Children, Youth and Families (H24-Jisedai-Shitei-006), and the title "Research on the promotion for networks cooperating with hospitals, public health, and welfare to support women with depression in the perinatal periods" (H25-Seisin-Wakate-013) by the Health and Labor Science Research Grant on Psychiatry and Neurological Disease and Mental Health, provided by the Ministry of Health, Labor and Welfare of Japan, and the title "Research on child abuse prevention and follow-up for families at high risk of child abuse" by Research Development Grant for Child Health and Development from National Center for Child Health and Development (H26-48).	Allison P, 1999, LOGISTIC REGRESSION, P167; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Chee CYI, 2005, J AFFECT DISORDERS, V89, P157, DOI 10.1016/j.jad.2005.09.004; Munk-Olsen T, 2014, BIPOLAR DISORD, V16, P300, DOI 10.1111/bdi.12145; Gress-Smith JL, 2012, MATERN CHILD HLTH J, V16, P887, DOI 10.1007/s10995-011-0812-y; Adouard F, 2005, ARCH WOMEN MENT HLTH, V8, P89, DOI 10.1007/s00737-005-0077-9; Furukawa TA, 1999, SOC PSYCH PSYCH EPID, V34, P216, DOI 10.1007/s001270050136; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; Kokubu M, 2012, ARCH WOMEN MENT HLTH, V15, P211, DOI 10.1007/s00737-012-0279-x; Patel V, 2004, BRIT MED J, V328, P820, DOI 10.1136/bmj.328.7443.820; Rubertsson C, 2005, ARCH WOMEN MENT HLTH, V8, P97, DOI 10.1007/s00737-005-0078-8; Condon JT, 2004, AUST NZ J PSYCHIAT, V38, P56, DOI 10.1111/j.1440-1614.2004.01298.x; Kitamura T, 2006, ARCH WOMEN MENT HLTH, V9, P121, DOI 10.1007/s00737-006-0122-3; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Matthey S, 2006, ARCH WOMEN MENT HLTH, V9, P309, DOI 10.1007/s00737-006-0152-x; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; O'Hara MW, 2013, ANNU REV CLIN PSYCHO, V9, P379, DOI 10.1146/annurev-clinpsy-050212-185612; Lydsdottir LB, 2014, J CLIN PSYCHIAT, V75, P393, DOI 10.4088/JCP.13m08646; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Flykt M, 2010, INFANT CHILD DEV, V19, P530, DOI 10.1002/icd.679; Lancaster CA, 2010, AM J OBSTET GYNECOL, V202, P5, DOI 10.1016/j.ajog.2009.09.007; Wisner KL, 2013, JAMA PSYCHIAT, V70, P490, DOI 10.1001/jamapsychiatry.2013.87; Leung SSK, 2005, RES NURS HEALTH, V28, P27, DOI 10.1002/nur.20053; Iwasaki K, 2006, IND HEALTH, V44, P537, DOI 10.2486/indhealth.44.537; Dennis CL, 2009, PEDIATRICS, V123, pE736, DOI 10.1542/peds.2008-1629; Kitamura T, 1996, PSYCHOTHER PSYCHOSOM, V65, P117; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; Yoshida K, 2001, PEDIATR INT, V43, P189, DOI 10.1046/j.1442-200x.2001.01370.x; de Tychey C, 2005, J AFFECT DISORDERS, V85, P323, DOI 10.1016/J.JAD.2004.11.004; Brand SR, 2009, CLIN OBSTET GYNECOL, V52, P441, DOI 10.1097/GRF.0b013e3181b52930; Cadzow SP, 1999, CHILD ABUSE NEGLECT, V23, P845, DOI 10.1016/S0145-2134(99)00063-0; Miyake Y, 2011, J AFFECT DISORDERS, V130, P133, DOI 10.1016/j.jad.2010.10.024; Morse CA, 2000, J PSYCHOSOM OBST GYN, V21, P109, DOI 10.3109/01674820009075616; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Barbarin O, 1984, MEASURING BASI UNPUB; Barber BK, 1996, J MARRIAGE FAM, V58, P433, DOI 10.2307/353507; Barnett B, 2005, SCREENING PERINATAL, P68; Beck CT, 1996, NURS RES, V45, P297, DOI 10.1097/00006199-199609000-00008; Boyce P. M., 2003, ARCH WOMEN MENT HLTH, V6, P43, DOI 10.1080/0004867070151795910.1007/s00737-003-0005-9; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dorheim SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094674; Force UPST, 2009, ANN INTERN MED, V151, P784, DOI [10.7326/0003-4819-151-11-200912010-00006, DOI 10.7326/0003-4819-151-11-200912010-00006]; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Lebra TS, 1985, JAPANESE WOMEN CONST; Lee D. T. S., 2000, Hong Kong Medical Journal, V6, P349; Ministry of Health LaW, 2013, YB JAPANESE MINISTRY; Moos RH, 1980, SOCIAL CLIMATE SCALE; Morikawa M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10520; Murakami M, 2010, STATISTICS, P13; Murray D, 1990, J REPRODUCTIVE INFAN, V8, P99, DOI DOI 10.1080/02646839008403615; Okano T MM, 1996, ARCH PSYCHIAT DIAGN, V7, P525; RICKHAM PP, 1964, BRIT MED J, V5402, P177; Tachibana Y, 2013, RES REPORT PROMOTION, P1	53	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0142410	10.1371/journal.pone.0142410		19	Multidisciplinary Sciences	Science & Technology - Other Topics	CX7OL	WOS:000365891600007		
J	Tanaka, Y; Aoyagi, K; Minashi, K; Komatsuzaki, R; Komatsu, M; Chiwaki, F; Tamaoki, M; Nishimura, T; Takahashi, N; Oda, I; Tachimori, Y; Arao, T; Nishio, K; Kitano, S; Narumi, K; Aoki, K; Fujii, S; Ochiai, A; Yoshida, T; Muto, M; Yamada, Y; Sasaki, H				Tanaka, Yosuke; Aoyagi, Kazuhiko; Minashi, Keiko; Komatsuzaki, Rie; Komatsu, Masayuki; Chiwaki, Fumiko; Tamaoki, Masashi; Nishimura, Takao; Takahashi, Naoki; Oda, Ichiro; Tachimori, Yuji; Arao, Tokuzo; Nishio, Kazuto; Kitano, Shigehisa; Narumi, Kenta; Aoki, Kazunori; Fujii, Satoshi; Ochiai, Atsushi; Yoshida, Teruhiko; Muto, Manabu; Yamada, Yasuhide; Sasaki, Hiroki			Discovery of a Good Responder Subtype of Esophageal Squamous Cell Carcinoma with Cytotoxic T-Lymphocyte Signatures Activated by Chemoradiotherapy	PLOS ONE			English	Article							DEFINITIVE CHEMORADIOTHERAPY; TUMOR MICROENVIRONMENT; THORACIC ESOPHAGUS; PHASE-II; CANCER; IRRADIATION; IMMUNOTHERAPY; CHEMOTHERAPY; METAANALYSIS; PHENOTYPE	Definitive chemoradiotherapy (CRT) is a less invasive therapy for esophageal squamous cell carcinoma (ESCC). Five-year survival rate of locally advanced ESCC patients by definitive CRT were 37%. We previously reported that tumor-specific cytotoxic T-lymphocyte (CTL) activation signatures were preferentially found in long-term survivors. However, it is unknown whether the CTL activation is actually driven by CRT. We compared gene expression profiles among pre- and post-treatment biopsy specimens of 30 ESCC patients and 121 pre-treatment ESCC biopsy specimens. In the complete response (CR) cases, 999 overexpressed genes including at least 234 tumor-specific CTL-activation associated genes such as IFNG, PRF1, and GZMB, were found in post-treatment biopsy specimens. Clustering analysis using expression profiles of these 234 genes allowed us to distinguish the immune-activated cases, designating them as I-type, from other cases. However, despite the better CR rate in the I-type, overall survival was not significantly better in both these 30 cases and another 121 cases. Further comparative study identified a series of epithelial to mesenchymal transition-related genes overexpressed in the early relapse cases. Importantly, the clinical outcome of CDH2-negative cases in the I-type was significantly better than that of the CDH2-positive cases in the I-type. Furthermore, NK cells, which were activated by neutrophils-producing S100A8/S100A9, and CTLs were suggested to cooperatively enhance the effect of CRT in the CDH2-negative I-type. These results suggested that CTL gene activation may provide a prognostic advantage in ESCCs with epithelial characteristics.	[Tanaka, Yosuke; Takahashi, Naoki; Yamada, Yasuhide] Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan; [Oda, Ichiro] Natl Canc Ctr, Dept Gastrointestinal Oncol & Endoscopy, Tokyo, Japan; [Tachimori, Yuji] Natl Canc Ctr, Dept Esophageal Surg, Tokyo, Japan; [Kitano, Shigehisa] Natl Canc Ctr, Dept Expt Therapeut, Tokyo, Japan; [Aoyagi, Kazuhiko; Komatsuzaki, Rie; Komatsu, Masayuki; Chiwaki, Fumiko; Tamaoki, Masashi; Nishimura, Takao; Sasaki, Hiroki] Natl Canc Ctr, Dept Translat Oncol, Tokyo, Japan; [Narumi, Kenta; Aoki, Kazunori] Natl Canc Ctr, Div Mol & Cellular Med, Tokyo, Japan; [Yoshida, Teruhiko] Natl Canc Ctr, Div Genet, Tokyo, Japan; [Fujii, Satoshi; Ochiai, Atsushi] Fundamental Innovat Oncol Core Ctr, Natl Canc Ctr Res Inst, Tokyo, Japan; [Arao, Tokuzo; Nishio, Kazuto] Kinki Univ, Fac Med, Dept Genome Biol, Osaka, Japan; [Minashi, Keiko] Chiba Canc Ctr, Dept Clin Trial Promot, Chiba 2608717, Japan; [Muto, Manabu] Kyoto Univ, Dept Therapeut Oncol, Kyoto, Japan	Muto, M (reprint author), Kyoto Univ, Dept Therapeut Oncol, Kyoto, Japan.	mmuto@kuhp.kyoto-u.ac.jp; yamada0304@aol.com; hksasaki@ncc.go.jp			National Institute of Biomedical Innovation (the Advanced Research for Medical Products Mining Programme); Japan Agency for Medical Research and Development (Practical Research for Innovative Cancer Control); National Cancer Center Research and Development Fund; Ministry of Education, Culture, Sports, Science and Technology of Japan; Princess Takamatsu Cancer Research Fund; Foundation of Promotion of Cancer Research in Japan	This work was supported by The National Institute of Biomedical Innovation (the Advanced Research for Medical Products Mining Programme), Japan Agency for Medical Research and Development (Practical Research for Innovative Cancer Control), National Cancer Center Research and Development Fund, The Ministry of Education, Culture, Sports, Science and Technology of Japan, and The Princess Takamatsu Cancer Research Fund. Dr M Komatsu was the recipient of a Research Resident Fellowship from the Foundation of Promotion of Cancer Research in Japan.	Ohtsu A, 1999, J CLIN ONCOL, V17, P2915; Cho Y, 2003, CANCER RES, V63, P1555; Barrett DM, 2014, ANNU REV MED, V65, P333, DOI 10.1146/annurev-med-060512-150254; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Menetrier-Caux C, 2012, TARGET ONCOL, V7, P15, DOI 10.1007/s11523-012-0208-y; Ishikura S, 2003, J CLIN ONCOL, V21, P2697, DOI 10.1200/JCO.2003.03.055; Chakraborty M, 2003, J IMMUNOL, V170, P6338; Ashida A, 2006, INT J ONCOL, V28, P1345; Kato K, 2013, JPN J CLIN ONCOL, V43, P608, DOI 10.1093/jjco/hyt048; Kato K, 2011, INT J RADIAT ONCOL, V81, P684, DOI 10.1016/j.ijrobp.2010.06.033; AKIYAMA H, 1994, ANN SURG, V220, P364, DOI 10.1097/00000658-199409000-00012; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ROTH JA, 1994, SEMIN ONCOL, V21, P453; Garnett CT, 2004, CANCER RES, V64, P7985, DOI 10.1158/0008-5472.CAN-04-1525; Costantini C, 2011, J LEUKOCYTE BIOL, V89, P221, DOI 10.1189/jlb.0510250; Schumacher K, 2001, CANCER RES, V61, P3932; Gebski V, 2007, LANCET ONCOL, V8, P226, DOI 10.1016/S1470-2045(07)70039-6; Lesokhin AM, 2012, CANCER RES, V72, P876, DOI 10.1158/0008-5472.CAN-11-1792; Tanabe S, 2014, INT J ONCOL, V44, P1955, DOI 10.3892/ijo.2014.2387; Tsuchikawa T, 2012, ANN SURG ONCOL, V19, P1713, DOI 10.1245/s10434-011-1906-x; Mei Z, 2014, BRIT J CANCER, V110, P1595, DOI 10.1038/bjc.2014.46; Komatsu M, 2014, EPIGENOMICS-UK, V6, P567, DOI [10.2217/epi.14.56, 10.2217/EPI.14.56]; Narumi K, 2015, J IMMUNOL, V195, P5539; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Tang C, 2014, CANCER IMMUNOL RES, V2, P831, DOI 10.1158/2326-6066.CIR-14-0069	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143804	10.1371/journal.pone.0143804		13	Multidisciplinary Sciences	Science & Technology - Other Topics	CX7OL	WOS:000365891600053		
J	Tanigaki, Y; Higashi, T; Takayama, K; Nagano, AJ; Honjo, MN; Fukuda, H				Tanigaki, Yusuke; Higashi, Takanobu; Takayama, Kotaro; Nagano, Atsushi J.; Honjo, Mie N.; Fukuda, Hirokazu			Transcriptome Analysis of Plant Hormone-Related Tomato (Solanum lycopersicum) Genes in a Sunlight-Type Plant Factory	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; ARABIDOPSIS CIRCADIAN CLOCK; SALICYLIC-ACID; STRESS RESPONSES; PROTEIN-KINASE; CELL-DEATH; RNA-SEQ; ETHYLENE; GROWTH; PATHOGEN	In plant factories, measurements of plant conditions are necessary at an early stage of growth to predict harvest times of high value-added crops. Moreover, harvest qualities depend largely on environmental stresses that elicit plant hormone responses. However, the complexities of plant hormone networks have not been characterized under nonstress conditions. In the present study, we determined temporal expression profiles of all genes and then focused on plant hormone pathways using RNA-Seq analyses of gene expression in tomato leaves every 2 h for 48 h. In these experiments, temporally expressed genes were found in the hormone synthesis pathways for salicylic acid, abscisic acid, ethylene, and jasmonic acid. The timing of CAB expression 1 (TOC1) and abscisic acid insensitive 1 (ABA1) and open stomata 1 (OST1) control gating stomata. In this study, compare with tomato and Arabidopsis thaliana, expression patterns of TOC1 have similarity. In contrast, expression patterns of tomato ABI1 and OST1 had expression peak at different time. These findings suggest that the regulation of gating stomata does not depend predominantly on TOC1 and significantly reflects the extracellular environment. The present data provide new insights into relationships between temporally expressed plant hormone-related genes and clock genes under normal sunlight conditions.	[Tanigaki, Yusuke; Fukuda, Hirokazu] Osaka Prefecture Univ, Grad Sch Engn, Dept Mech Engn, Sakai, Osaka 591, Japan; [Higashi, Takanobu] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Appl Life Sci, Sakai, Osaka 591, Japan; [Takayama, Kotaro] Ehime Univ, Fac Agr, Natl Univ Corp, Matsuyama, Ehime 790, Japan; [Nagano, Atsushi J.] Ryukoku Univ, Fac Agr, Otsu, Shiga, Japan; [Nagano, Atsushi J.] JST PRESTO, Kawaguchi, Saitama, Japan; [Nagano, Atsushi J.; Honjo, Mie N.] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan	Fukuda, H (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Dept Mech Engn, Sakai, Osaka 591, Japan.	fukuda@bioinfo.osakafu-u.ac.jp			Canon Foundation; Joint Usage /Research program of Center for Ecological Research, Kyoto University;  [25712029];  [25119721]	Funding was provided by Grants-in-Aid for Scientific Research, https://www.jsps.go.jp/english/e-grants/, No. 25712029 and 25119721 to HF (the funders had role in data analysis); the Canon Foundation, http://www.canon-foundation.jp/index.html, to HF (the funders had role in data collection); and the Joint Usage /Research program of Center for Ecological Research, Kyoto University (the funders had roles in data analysis).	Legnaioli T, 2009, EMBO J, V28, P3745, DOI 10.1038/emboj.2009.297; Haydon MJ, 2013, NATURE, V502, P689, DOI 10.1038/nature12603; Dempsey DA, 2012, TRENDS PLANT SCI, V17, P538, DOI 10.1016/j.tplants.2012.05.011; BURG SP, 1973, P NATL ACAD SCI USA, V70, P591, DOI 10.1073/pnas.70.2.591; Takayama Kotaro, 2007, Environment Control in Biology, V45, P241; Nemchenko A, 2006, J EXP BOT, V57, P3767, DOI 10.1093/jxb/erl137; Seo M, 2002, TRENDS PLANT SCI, V7, P41, DOI 10.1016/S1360-1385(01)02187-2; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; HIGHKIN HR, 1954, PLANT PHYSIOL, V29, P301, DOI 10.1104/pp.29.3.301; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Lai AG, 2012, P NATL ACAD SCI USA, V109, P17129, DOI 10.1073/pnas.1209148109; O'Donnell PJ, 2001, PLANT J, V25, P315, DOI 10.1046/j.1365-313x.2001.00968.x; Yanagisawa S, 2003, NATURE, V425, P521, DOI 10.1038/nature01984; Tang DZ, 2005, PLANT PHYSIOL, V138, P1018, DOI 10.1104/pp.105.060400; Ferrari S, 2003, PLANT J, V35, P193, DOI 10.1046/j.1365-313X.2003.01794.x; Gagne JM, 2004, P NATL ACAD SCI USA, V101, P6803, DOI 10.1073/pnas.0401698101; Jia CG, 2013, J EXP BOT, V64, P637, DOI 10.1093/jxb/ers360; Yasuda M, 2008, PLANT CELL, V20, P1678, DOI 10.1105/tpc.107.054296; Barak S, 2000, TRENDS PLANT SCI, V5, P517, DOI 10.1016/S1360-1385(00)01785-4; De Vleesschauwer D, 2010, PLANT PHYSIOL, V152, P2036, DOI 10.1104/pp.109.152702; Rodrigues A, 2013, PLANT CELL, V25, P3871, DOI 10.1105/tpc.113.114066; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; CREELMAN RA, 1992, P NATL ACAD SCI USA, V89, P4938, DOI 10.1073/pnas.89.11.4938; Murakami M, 2007, PLANT CELL PHYSIOL, V48, P110, DOI 10.1093/pcp/pcl043; Nakamichi N, 2010, PLANT CELL, V22, P594, DOI 10.1105/tpc.109.072892; Coquoz JL, 1998, PLANT PHYSIOL, V117, P1095, DOI 10.1104/pp.117.3.1095; Higashi Takanobu, 2015, Environment Control in Biology, V53, P7, DOI 10.2525/ecb.53.7; Kozai T, 2013, P JPN ACAD B-PHYS, V89, P447, DOI 10.2183/pjab.89.447; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Moldau Heino, 2011, Plant Signal Behav, V6, P311; Nagano AJ, 2015, METHODS MOL BIOL, V1236, P89, DOI 10.1007/978-1-4939-1743-3_8; Rico A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008977; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026426	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143412	10.1371/journal.pone.0143412		18	Multidisciplinary Sciences	Science & Technology - Other Topics	CX7OL	WOS:000365891600028		
J	Tong, XL; Aoyama, H; Sudhakar, S; Chen, HH; Shilton, BH; Bai, DL				Tong, Xiaoling; Aoyama, Hiroshi; Sudhakar, Swathy; Chen, Honghong; Shilton, Brian H.; Bai, Donglin			The First Extracellular Domain Plays an Important Role in Unitary Channel Conductance of Cx50 Gap Junction Channels	PLOS ONE			English	Article							ICHTHYOSIS-DEAFNESS SYNDROME; INCREASED HEMICHANNEL ACTIVITY; 3.5 ANGSTROM RESOLUTION; PORE-LINING RESIDUES; VOLTAGE-DEPENDENCE; CONFORMATIONAL-CHANGES; CONNEXIN HEMICHANNELS; FUNCTIONAL-PROPERTIES; CA2+ REGULATION; AMINO-TERMINUS	Gap junction (GJ) channels provide direct passage for ions and small molecules to be exchanged between neighbouring cells and are crucial for many physiological processes. GJ channels can be gated by transjunctional voltage (known as V-j-gating) and display a wide range of unitary channel conductance (gamma(j)), yet the domains responsible for Vj-gating and gamma(j) are not fully clear. The first extracellular domain (E1) of several connexins has been shown to line part of their GJ channel pore and play important roles in Vj-gating properties and/or ion permeation selectivity. To test roles of the E1 of Cx50 GJ channels, we generated a chimera, Cx50Cx36E1, where the E1 domain of Cx50 was replaced with that of Cx36, a connexin showing quite distinct Vj-gating and gamma(j) from those of Cx50. Detailed characterizations of the chimera and three point mutants in E1 revealed that, although the E1 domain is important in determining gamma(j), the E1 domain of Cx36 is able to effectively function within the context of the Cx50 channel with minor changes in Vj-gating properties, indicating that sequence differences between the E1 domains in Cx36 and Cx50 cannot account for their drastic differences in Vj-gating and gamma(j). Our homology models of the chimera and the E1 mutants revealed that electrostatic properties of the pore-lining residues and their contribution to the electric field in the pore are important factors for the rate of ion permeation of Cx50 and possibly other GJ channels.	[Tong, Xiaoling; Sudhakar, Swathy; Chen, Honghong; Bai, Donglin] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Aoyama, Hiroshi] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan; [Shilton, Brian H.] Univ Western Ontario, Dept Biochem, London, ON, Canada	Bai, DL (reprint author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.	donglin.bai@schulich.uwo.ca			Natural Sciences and Engineering Research Council of Canada [288241, 217494]; Ministry of Education, Culture, Sports, Science and Technology of Japan [26440029]	This work was supported by grants from Natural Sciences and Engineering Research Council of Canada to D.B. (288241) and B.H.S. (217494). This work was also supported by Grants-in-Aid for Scientific Research (26440029 to H.A.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; Moreno AP, 2005, AM J PHYSIOL-ENDOC M, V288, pE948, DOI 10.1152/ajpendo.00216.2004; Brelidze TI, 2003, P NATL ACAD SCI USA, V100, P9017, DOI 10.1073/pnas.1532257100; Minogue PJ, 2009, INVEST OPHTH VIS SCI, V50, P5837, DOI 10.1167/iovs.09-3759; Srinivas M, 2006, J GEN PHYSIOL, V127, P67, DOI 10.1085/jgp.200509397; Srinivas M, 1999, J NEUROSCI, V19, P9848; Geng YY, 2011, J GEN PHYSIOL, V137, P533, DOI 10.1085/jgp.201110616; Trexler EB, 2000, BIOPHYS J, V79, P3036; Sanchez HA, 2013, J GEN PHYSIOL, V142, P3, DOI 10.1085/jgp.201310962; Tong JJ, 2011, AM J PHYSIOL-CELL PH, V300, pC1055, DOI 10.1152/ajpcell.00384.2010; Haubrich S, 1996, MOL BIOL CELL, V7, P1995; Bai DL, 2014, BIOCHEM J, V458, P1, DOI 10.1042/BJ20131162; Kwon T, 2013, J GEN PHYSIOL, V141, P243, DOI 10.1085/jgp.201210839; Sanchez HA, 2010, J GEN PHYSIOL, V136, P47, DOI 10.1085/jgp.201010433; Rubinos C, 2014, AM J PHYSIOL-CELL PH, V306, pC212, DOI 10.1152/ajpcell.00098.2013; WILDERS R, 1992, BIOPHYS J, V63, P942; RUBIN JB, 1992, BIOPHYS J, V62, P183, DOI 10.1016/S0006-3495(92)81804-0; Beyer EC, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00043; Sun WM, 2011, MOL VIS, V17, P1508; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Bargiello TA, 2012, BBA-BIOMEMBRANES, V1818, P1807, DOI 10.1016/j.bbamem.2011.09.019; Al-Ubaidi MR, 2000, J NEUROSCI RES, V59, P813, DOI 10.1002/(SICI)1097-4547(20000315)59:6<813::AID-JNR14>3.0.CO;2-#; Teubner B, 2000, J MEMBRANE BIOL, V176, P249, DOI 10.1007/s002320001094; Xin L, 2010, BIOPHYS J, V99, P2077, DOI 10.1016/j.bpj.2010.07.032; Suga M, 2009, ACTA CRYSTALLOGR D, V65, P758, DOI 10.1107/S0907444909014711; Lee JR, 2009, J INVEST DERMATOL, V129, P870, DOI 10.1038/jid.2008.335; Mhaske PV, 2013, AM J PHYSIOL-CELL PH, V304, pC1150, DOI 10.1152/ajpcell.00374.2012; Srinivas M, 2005, BIOPHYS J, V88, P1725, DOI 10.1529/biophysj.104.054023; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Pfahnl A, 1997, PFLUG ARCH EUR J PHY, V433, P773, DOI 10.1007/s004240050344; Zhou XW, 1997, BIOPHYS J, V72, P1946; Gerido DA, 2007, AM J PHYSIOL-CELL PH, V293, pC337, DOI 10.1152/ajpcell.00626.2006; Bargiello Thaddeus, 2009, P103, DOI 10.1007/978-1-59745-489-6_4; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Gonzalez D, 2007, PROG BIOPHYS MOL BIO, V94, P66, DOI 10.1016/j.pbiomolbio.2007.03.007; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Kronengold J, 2003, J GEN PHYSIOL, V122, P389, DOI 10.1085/jgp.200308861; Srinivas M, 1999, J PHYSIOL-LONDON, V517, P673, DOI 10.1111/j.1469-7793.1999.0673s.x; Lopez W, 2013, J GEN PHYSIOL, V142, P23, DOI 10.1085/jgp.201210893; Bukauskas FF, 2004, BBA-BIOMEMBRANES, V1662, P42, DOI 10.1016/j.bbamem.2004.01.008; Gong XQ, 2013, J CELL SCI, V126, P3113, DOI 10.1242/jcs.123430; Verselis VK, 2009, J BIOL CHEM, V284, P4484, DOI 10.1074/jbc.M807430200; Bai DL, 2006, J PHARMACOL EXP THER, V319, P1452, DOI 10.1124/jpet.106.112045; Nakagawa S, 2011, J BIOL CHEM, V286, P19672, DOI 10.1074/jbc.M110.204958; Mese G, 2011, MOL BIOL CELL, V22, P4776, DOI 10.1091/mbc.E11-09-0778; Oh S, 2000, J GEN PHYSIOL, V116, P13, DOI 10.1085/jgp.116.1.13; DeLano WL, 2006, PYMOL MOL GRAPHICS S; Palacios-Prado N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5667; Pellegrini-Calace M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000440; Tong XL, 2014, J PHYSIOL-LONDON, V592, P5187, DOI 10.1113/jphysiol.2014.280636	50	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143876	10.1371/journal.pone.0143876		20	Multidisciplinary Sciences	Science & Technology - Other Topics	CX7OL	WOS:000365891600062		
J	Yanagida, N; Imai, T; Sato, S; Ebisawa, M				Yanagida, Noriyuki; Imai, Takanori; Sato, Sakura; Ebisawa, Motohiro			Do Longer Intervals between Challenges Reduce the Risk of Adverse Reactions in Oral Wheat Challenges?	PLOS ONE			English	Article							FOOD ALLERGY; CLINICAL IMMUNOLOGY; EUROPEAN ACADEMY; GUIDELINES; ANAPHYLAXIS; MANAGEMENT; DIAGNOSIS	Background The use of oral food challenges (OFCs) in clinics is limited because they are complicated and associated with anaphylactic symptoms. To increase their use, it is necessary to develop novel, effective, and safe methods. However, the effectiveness of different OFCs has not been compared. Objective To investigate the effect of ingestion methods on wheat allergy symptoms and treatment during OFCs. Method Without changing the total challenge dose, we changed the administration method from a 5-installment dose titration every 15 min (15-min interval method) to 3 installments every 30 min (30-min interval method). We retrospectively reviewed and compared the results of 65 positive 15-min interval wheat challenge tests conducted between July 2005 and February 2008 and 87 positive 30-min interval tests conducted between March 2008 and December 2009. Results A history of immediate symptoms was more common for the 30-min interval method; however, no difference between methods was observed in other background parameters. Switching from the 15-min to the 30-min interval method did not increase symptoms or require treatment. The rate of cardiovascular symptoms (p = 0.032), and adrenaline use (p = 0.017) was significantly lower with the 30-min interval method. The results did not change after adjusting for the effects of immediate symptom history in multivariate analysis. Conclusion This study suggests that the 30-min interval method reduces the risk of adverse events, compared to the 15-min interval method.	[Yanagida, Noriyuki; Imai, Takanori] Sagamihara Natl Hosp, Dept Pediat, Kanagawa, Japan; [Sato, Sakura; Ebisawa, Motohiro] Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Kanagawa, Japan	Yanagida, N (reprint author), Sagamihara Natl Hosp, Dept Pediat, Kanagawa, Japan.	n-yanagida@sagamihara-hosp.gr.jp			Ministry of Health, Labour and Welfare;  [201414009A]	This study was supported by the Scientific Research Fund of the Ministry of Health, Labour and Welfare in 2014. Motohiro Ebisawa received the funding. Grant number is 201414009A. https://mhlw-grants.niph.go.jp/niph/search/NIDD00.do?resrchNum=201414009A.	Pettersson ME, 2014, PEDIAT ALLERG IMM-UK, V25, P615, DOI 10.1111/pai.12256; Sampson HA, 2003, PEDIATRICS, V111, P1601; Imai T, 2014, ALLERGOL INT, V63, P205, DOI 10.2332/allergolint.12-OA-0513; Muraro A, 2014, ALLERGY, V69, P1008, DOI 10.1111/all.12429; Burks AW, 2011, PEDIATRICS, V128, P955, DOI 10.1542/peds.2011-0539; Sampson HA, 2012, J ALLERGY CLIN IMMUN, V130, P1260, DOI 10.1016/j.jaci.2012.10.017; Bindslev-Jensen C, 2004, ALLERGY, V59, P690, DOI 10.1111/j.1398-9995.2004.00466.x; Simons FER, 2012, CURR OPIN ALLERGY CL, V12, P389, DOI 10.1097/ACI.0b013e328355b7e4; Ebisawa Motohiro, 2009, Allergology International, V58, P475, DOI 10.2332/allergolint.09-RAI-0143; Keet CA, 2009, ANN ALLERG ASTHMA IM, V102, P410, DOI 10.1016/S1081-1206(10)60513-3; Nowak-Wegrzyn A, 2009, J ALLERGY CLIN IMMUN, V123, pS365, DOI 10.1016/j.jaci.2009.03.042; Urisu A, 2014, ALLERGOL INT, V63, P399, DOI 10.2332/allergolint.14-RAI-0770; Boyce JA, 2010, J ALLERGY CLIN IMMUN, V126, P1105, DOI 10.1016/j.jaci.2010.10.008; Rancé F, 2009, Eur Ann Allergy Clin Immunol, V41, P35; Rolinck-Werninghaus C, 2012, ALLERGY, V67, P951, DOI 10.1111/j.1398-9995.2012.02838.x; Simons FER, 2011, J ALLERGY CLIN IMMUN, V127, P587, DOI 10.1016/j.jaci.2011.01.038; Zhu YD, 2014, J NUTR, V144, P114, DOI 10.3945/jn.113.184663	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143717	10.1371/journal.pone.0143717		9	Multidisciplinary Sciences	Science & Technology - Other Topics	CX7OL	WOS:000365891600046		
J	Inoue, J; Sato, Y; Sinclair, R; Tsukamoto, K; Nishida, M				Inoue, Jun; Sato, Yukuto; Sinclair, Robert; Tsukamoto, Katsumi; Nishida, Mutsumi			Rapid genome reshaping by multiple-gene loss after whole-genome duplication in teleost fish suggested by mathematical modeling	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						orthologous gene; bony vertebrates; post-WGD genome evolution	PHYLOGENETIC ANALYSES; EVOLUTION; SEQUENCE; VERTEBRATES; CLUSTERS; INSIGHTS; DNA; MAINTENANCE; ADAPTATION; GENERATION	Whole-genome duplication (WGD) is believed to be a significant source of major evolutionary innovation. Redundant genes resulting from WGD are thought to be lost or acquire new functions. However, the rates of gene loss and thus temporal process of genome reshaping after WGD remain unclear. The WGD shared by all teleost fish, one-half of all jawed vertebrates, was more recent than the two ancient WGDs that occurred before the origin of jawed vertebrates, and thus lends itself to analysis of gene loss and genome reshaping. Using a newly developed orthology identification pipeline, we inferred the post-teleost-specific WGD evolutionary histories of 6,892 protein-coding genes from nine phylogenetically representative teleost genomes on a time-calibrated tree. We found that rapid gene loss did occur in the first 60 My, with a loss of more than 70-80% of duplicated genes, and produced similar genomic gene arrangements within teleosts in that relatively short time. Mathematical modeling suggests that rapid gene loss occurred mainly by events involving simultaneous loss of multiple genes. We found that the subsequent 250 My were characterized by slow and steady loss of individual genes. Our pipeline also identified about 1,100 shared single-copy genes that are inferred to have become singletons before the divergence of clupeocephalan teleosts. Therefore, our comparative genome analysis suggests that rapid gene loss just after the WGD reshaped teleost genomes before the major divergence, and provides a useful set of marker genes for future phylogenetic analysis.	[Inoue, Jun; Sinclair, Robert] Okinawa Inst Sci & Technol Grad Univ, Math Biol Unit, Okinawa 9040495, Japan; [Inoue, Jun; Tsukamoto, Katsumi; Nishida, Mutsumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Sato, Yukuto] Tohoku Univ, Tohoku Med Megabank Org, Dept Integrat Genom, Sendai, Miyagi 9808573, Japan; [Sato, Yukuto] Natl Inst Genet, DNA Data Anal Lab, Mishima, Shizuoka 4118540, Japan; [Tsukamoto, Katsumi] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan; [Nishida, Mutsumi] Univ Ryukyus, Nishihara, Okinawa 9030213, Japan	Nishida, M (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan.	nishida@jim.u-ryukyu.ac.jp			Mathematical Biology Unit of OIST; Japan Society for Promotion of Science [24770070, 21228005]	We thank S. Kinjo and the Information Service Section of the Okinawa Institute of Science and Technology Graduate University (OIST) for putting our database online. The manuscript has benefited from the comments of two anonymous reviewers. Cluster computing resources were provided by OIST and Human Genome Center of The University of Tokyo. This work was supported in part by funding from the Mathematical Biology Unit of OIST, and Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research 24770070 (to J.I.) and 21228005 (to K.T.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Trachana K, 2011, BIOESSAYS, V33, P769, DOI 10.1002/bies.201100062; Buggs RJA, 2012, CURR BIOL, V22, P248, DOI 10.1016/j.cub.2011.12.027; Edgecombe GD, 2011, ORG DIVERS EVOL, V11, P151, DOI 10.1007/s13127-011-0044-4; Kassahn KS, 2009, GENOME RES, V19, P1404, DOI 10.1101/gr.086827.108; Stankiewicz P, 2003, COLD SPRING HARB SYM, V68, P445, DOI 10.1101/sqb.2003.68.445; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Martin KJ, 2014, MOL BIOL EVOL, V31, P2592, DOI 10.1093/molbev/msu202; Gout JF, 2015, MOL BIOL EVOL, V32, P2141, DOI 10.1093/molbev/msv095; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Hufton AL, 2009, CURR OPIN GENET DEV, V19, P600, DOI 10.1016/j.gde.2009.10.005; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Xu P, 2014, NAT GENET, V46, P1212, DOI 10.1038/ng.3098; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; YANG ZB, 1994, J MOL EVOL, V39, P105; Schartl M, 2013, NAT GENET, V45, P567, DOI 10.1038/ng.2604; Makino T, 2010, P NATL ACAD SCI USA, V107, P9270, DOI 10.1073/pnas.0914697107; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Sato Y, 2010, ENVIRON BIOL FISH, V88, P169, DOI 10.1007/s10641-010-9628-7; NEI M, 1973, AM NAT, V107, P362, DOI 10.1086/282840; Lemmon EM, 2013, ANNU REV ECOL EVOL S, V44, P99, DOI 10.1146/annurev-ecolsys-110512-135822; Kuraku S, 2009, INT J DEV BIOL, V53, P765, DOI 10.1387/ijdb.072533km; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Force A, 1999, GENETICS, V151, P1531; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Yu WP, 2008, P NATL ACAD SCI USA, V105, P3819, DOI 10.1073/pnas.0800398105; Hillis DM, 1998, SYST BIOL, V47, P3, DOI 10.1080/106351598260987; Azuma Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-215; Berthelot Camille, 2014, Nature Communications, V5, P3657, DOI 10.1038/ncomms4657; Braasch I, 2012, POLYPLOIDY GENOME EV, P341; Braasch I, 2014, J EXPT ZOOLOGY B, V324, P316; Broughton RE, 2013, PLOS CURR, V5, P5; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Faircloth BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065923; Henkel CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032231; Jiao YNA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0355; Lovell PV, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0565-1; Lynch M, 2007, ORIGINS GENOME ARCHI; Nelson J. S., 2006, FISHES WORLD; Miya M, 2015, ICHTHYOL RES, V62, P29, DOI 10.1007/s10228-014-0440-9; Sato Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-127; Selmecki AM, 2015, NATURE, V519, P349, DOI 10.1038/nature14187; SMITH J M, 1974, Genetical Research, V23, P23; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; TAMURA K, 1993, MOL BIOL EVOL, V10, P512; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	49	0	0	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	DEC 1	2015	112	48					14918	14923		10.1073/pnas.1507669112		6	Multidisciplinary Sciences	Science & Technology - Other Topics	CX8XR	WOS:000365988900056		
J	Tomoike, F; Nakagawa, N; Kuramitsu, S; Masui, R				Tomoike, Fumiaki; Nakagawa, Noriko; Kuramitsu, Seiki; Masui, Ryoji			Structural and Biochemical Studies on the Reaction Mechanism of Uridine-Cytidine Kinase	PROTEIN JOURNAL			English	Article						Uridine-cytidine kinase; Phosphate transfer; Crystal structure; Mutational study; Pyrimidine nucleoside; pH dependence	THERMUS-THERMOPHILUS HB8; PYRIMIDINE METABOLISM; SUBSTRATE-SPECIFICITY; CONFORMATION; TUMOR; ADP	Uridine-cytidine kinase catalyzes phosphorylation of the pyrimidine nucleosides uridine and cytidine and plays an important role in nucleotide metabolism. However, the detailed molecular mechanism of these reactions remains to be elucidated. Here, we determined the structure of the ternary complex of Uridine-cytidine kinase from Thermus thermophilus HB8 with both cytidine and beta,gamma-methyleneadenosine 5'-triphosphate, a non-hydrolysable ATP analogue. Substrate binding is accompanied by substantial domain movement that allows the substrate-binding cleft to close. The terminal phosphodiester bond of the ATP analogue is in an ideal location for an inline attack of the 5'-hydroxyl group of cytidine. Asp40 is located near the 5'-hydroxyl group of cytidine. Mutation of this conserved residue to Asn or Ala resulted in a complete loss of enzyme activity, which is consistent with the notion that Asp40 acts as a general base that activates the 5'-hydroxyl group of cytidine. The pH profile of the activity showed an apparent pK (a) value of 7.4. Based on this structure, a likely mechanism of the catalytic step is discussed.	[Tomoike, Fumiaki; Kuramitsu, Seiki] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Nakagawa, Noriko; Kuramitsu, Seiki; Masui, Ryoji] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan; [Masui, Ryoji] Osaka City Univ, Grad Sch Sci, Div Biol & Geosci, Sumiyoshi Ku, Osaka 5588585, Japan	Masui, R (reprint author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, 1-1 Machikaneyama Cho, Toyonaka, Osaka 5600043, Japan.	rmasui@sci.osaka-cu.ac.jp			Ministry of Education, Science, Sports and Culture [25650008]; Japan Society for the Promotion of Science [10J0180400-00]	This work was partially supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Challenging Exploratory Research 25650008 (to RM) and the Japan Society for the Promotion of Science for Young Scientists (10J0180400-00, FT).	ANDERSON EP, 1973, ENZYMES, V8, P49; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI 10.1107/S0907444906022657; ANDERSON EP, 1964, BIOCHIM BIOPHYS ACTA, V91, P380, DOI 10.1016/0926-6550(64)90067-2; CANELLAKIS ES, 1957, J BIOL CHEM, V227, P329; Antosiewicz J, 1996, BIOCHEMISTRY-US, V35, P7819, DOI 10.1021/bi9601565; Picard M, 2005, J BIOL CHEM, V280, P18745, DOI 10.1074/jbc.M501596200; Sekulic N, 2002, J BIOL CHEM, V277, P30236, DOI 10.1074/jbc.M204668200; [Anonymous], 1998, ACTA CRYSTALLOGR D; Smith AJT, 2009, ORG BIOMOL CHEM, V7, P2716, DOI 10.1039/b901429b; Suzuki NN, 2004, STRUCTURE, V12, P751, DOI 10.1016/j.str.2004.02.038; ORENGO A, 1969, J BIOL CHEM, V244, P2204; Iino H, 2008, ACTA CRYSTALLOGR F, V64, P487, DOI 10.1107/S1744309108013572; Ueno Go, 2006, Journal of Structural and Functional Genomics, V7, P15, DOI 10.1007/s10969-005-9005-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SKOLD O, 1960, J BIOL CHEM, V235, P3273; Bellinzoni M, 2006, PROTEIN SCI, V15, P1489, DOI 10.1110/ps.062163406; Shimamoto Y, 2002, JPN J CANCER RES, V93, P825; PORTNER HO, 1984, J COMP PHYSIOL B, V155, P1, DOI 10.1007/BF00688785; Iwai T, 2004, J BIOL CHEM, V279, P21732, DOI 10.1074/jbc.M312018200; Tomoike F, 2011, BIOCHEMISTRY-US, V50, P4597, DOI 10.1021/bi102054n; Yan HG, 1999, ADV ENZYMOL RAMB, V73, P103, DOI 10.1002/9780470123195.ch4; ODONOVAN GA, 1970, BACTERIOL REV, V34, P278; Murata D, 2004, DRUG METAB DISPOS, V32, P1178, DOI 10.1124/dmd.104.000737; Karp DA, 2010, BIOCHEMISTRY-US, V49, P4138, DOI 10.1021/bi902114m; LIACOURAS AS, 1975, ARCH BIOCHEM BIOPHYS, V168, P74, DOI 10.1016/0003-9861(75)90229-5; TAIRA K, 1990, PROTEIN ENG, V3, P691, DOI 10.1093/protein/3.8.691; Cowan JA, 1995, BIOL CHEM MAGNESIUM; Duncan EM, 1992, J MOL GRAPHICS, V10, P44; Fersht A., 1999, STRUCTURE MECH PROTE; Kim YG, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-59; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Otwinowski z, 1997, ENZYMOLOGY, V276, P307	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1572-3887	1573-4943		PROTEIN J	Protein J.	DEC	2015	34	6					411	420		10.1007/s10930-015-9636-8		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CY1AJ	WOS:000366138200004		
J	Moossen, H; Bendle, J; Seki, O; Quillmann, U; Kawamura, K				Moossen, Heiko; Bendle, James; Seki, Osamu; Quillmann, Ursula; Kawamura, Kimitaka			North Atlantic Holocene climate evolution recorded by high-resolution terrestrial and marine biomarker records	QUATERNARY SCIENCE REVIEWS			English	Article						Iceland; GDGT; Alkenone; n-alkane; Holocene; Climate reconstruction	SURFACE TEMPERATURE VARIABILITY; HYDROGEN-ISOTOPIC COMPOSITION; LAKE-SEDIMENT PROXIES; LAST 2000 YEARS; SOUTHERN-OCEAN; SEA-LEVEL; ENVIRONMENTAL-CHANGE; LIPID BIOMARKERS; WEST ICELAND; MULTI-PROXY	Holocene climatic change is driven by a plethora of forcing mechanisms acting on different time scales, including: insolation, internal ocean (e.g. Atlantic Meridional Overturning Circulation; AMOC) and atmospheric (e.g. North Atlantic Oscillation; NAO) variability. However, it is unclear how these driving mechanisms interact with each other. Here we present five, biomarker based, paleoclimate records (air-, sea surface temperature and precipitation), from a fjordic sediment core, revealing North Atlantic terrestrial and marine climate in unprecedented detail. The Early Holocene (10.7-7.8 kyrs BP) is characterised by relatively high air temperatures while SSTs are dampened by melt water events, and relatively low precipitation. The Middle Holocene (7.8-3.2 kyrs BP) is characterised by peak SSTs, declining air temperatures and high precipitation. A pronounced marine thermal maximum occurs between similar to 7 -5.5 kyrs BP, 3000 years after the terrestrial thermal maximum, driven by melt water cessation and an accelerating AMOC. The neoglacial cooling, between 5.8 and 3.2 kyrs BP leads into the late Holocene. We demonstrate that an observed modern link between Icelandic precipitation variability during different NAO phases, may have existed from similar to 7.5 kyrs BP. A simultaneous decoupling of both air, and sea surface temperature records from declining insolation at similar to 3.2 kyrs BP may indicate a threshold, after which internal feedback mechanisms, namely the NAO evolved to be the primary drivers of Icelandic climate on centennial time-scales. (C) 2015 Elsevier Ltd. All rights reserved.	[Moossen, Heiko; Bendle, James] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England; [Seki, Osamu; Kawamura, Kimitaka] Hokkaido Univ, Inst Low Temp Sci, Kita Ku, Sapporo, Hokkaido 0600819, Japan; [Quillmann, Ursula] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA	Moossen, H (reprint author), Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England.	h.moossen@bham.ac.uk			Scottish Alliance for Geoscience, Environment and Society (SAGES); Japanese society for the promotion of science (JSPS)	We thank an anonymous reviewer for the helpful and insightful comments. We thank the crew and staff of the Marion Dufresne II, and the CALYPSO coring team on the 1999 IMAGES cruise. We also thank Professor John Andrews for providing the core material for this research, and the technical staff at the Institute of Arctic and Alpine Research. We thank Dr. Richard Pancost and technical staff at the Organic Geochemistry Unit, Bristol. We thank Dr. Ellen Roosen from the Woods Hole Oceanographic Institution who sent additional u-channels of the top most 3.5 m of the sediment core archive half. We thank Dr. Fiona Meade for her help on Fig. 1 (https://sites.google.com/site/meadescientificservices). We thank the Scottish Alliance for Geoscience, Environment and Society (SAGES) who funded the PhD to Dr. Heiko Moossen. We thank the Japanese society for the promotion of science (JSPS) for funding a two months bursary to Dr. Heiko Moossen to Hokkaido University.	Andersen C., 2004, PALEOCEANOGRAPHY, V19; Smittenberg RH, 2006, SCIENCE, V314, P1283, DOI 10.1126/science.1129376; Jackson MG, 2005, GEOLOGY, V33, P509, DOI 10.1130/G21489.1; Schefuss E, 2003, GEOCHIM COSMOCHIM AC, V67, P1757, DOI 10.1016/S0016-7037(02)01414-X; EGLINTON G, 1962, PHYTOCHEMISTRY, V1, P89, DOI 10.1016/S0031-9422(00)88006-1; D'Andrea WJ, 2011, P NATL ACAD SCI USA, V108, P9765, DOI 10.1073/pnas.1101708108; Vogts A, 2012, ORG GEOCHEM, V47, P109, DOI 10.1016/j.orggeochem.2012.03.011; Johnson DW, 1998, WATER AIR SOIL POLL, V105, P251, DOI 10.1023/A:1005039711434; Peterse F, 2009, ORG GEOCHEM, V40, P692, DOI 10.1016/j.orggeochem.2009.03.004; Trouet V, 2009, SCIENCE, V324, P78, DOI 10.1126/science.1166349; Vogts A, 2009, ORG GEOCHEM, V40, P1037, DOI 10.1016/j.orggeochem.2009.07.011; Howe JA, 2010, GEOL SOC SPEC PUBL, V344, P5, DOI 10.1144/SP344.2; Fietz S, 2012, GLOBAL PLANET CHANGE, V92-93, P275, DOI 10.1016/j.gloplacha.2012.05.020; Axford Y, 2009, J PALEOLIMNOL, V41, P7, DOI 10.1007/s10933-008-9251-1; Wang G, 2011, HYDROL EARTH SYST SC, V15, P57, DOI 10.5194/hess-15-57-2011; Arnalds O, 2008, JOKULL, V58, P409; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Hanna E, 2004, INT J CLIMATOL, V24, P1193, DOI 10.1002/joc.1051; Sachse D, 2012, ANNU REV EARTH PL SC, V40, P221, DOI 10.1146/annurev-earth-042711-105535; Giraudeau J, 2010, QUATERNARY SCI REV, V29, P1276, DOI 10.1016/j.quascirev.2010.02.014; Niedermeyer EM, 2010, QUATERNARY SCI REV, V29, P2996, DOI 10.1016/j.quascirev.2010.06.039; Wastl M, 2001, ARCT ANTARCT ALP RES, V33, P191, DOI 10.2307/1552220; Sicre MA, 2008, QUATERNARY SCI REV, V27, P2041, DOI 10.1016/j.quascirev.2008.08.009; OBRIEN SR, 1995, SCIENCE, V270, P1962, DOI 10.1126/science.270.5244.1962; Alley RB, 2005, QUATERNARY SCI REV, V24, P1123, DOI 10.1016/j.quascirev.2004.12.004; Rueda G, 2013, HOLOCENE, V23, P692, DOI 10.1177/0959683612470177; Hurrell JW, 2009, J MARINE SYST, V78, P28, DOI 10.1016/j.jmarsys.2008.11.026; Prahl FG, 2010, GEOCHIM COSMOCHIM AC, V74, P131, DOI 10.1016/j.gca.2009.09.027; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Caseldine C, 2003, J PALEOLIMNOL, V30, P55, DOI 10.1023/A:1024781918181; Schulz M, 2002, COMPUT GEOSCI-UK, V28, P421, DOI 10.1016/S0098-3004(01)00044-9; Olsen J, 2012, NAT GEOSCI, V5, P808, DOI [10.1038/ngeo1589, 10.1038/NGEO1589]; Grootes PM, 1997, J GEOPHYS RES-OCEANS, V102, P26455, DOI 10.1029/97JC00880; SCHLESINGER ME, 1994, NATURE, V367, P723, DOI 10.1038/367723a0; Axford Y, 2011, J QUATERNARY SCI, V26, P645, DOI 10.1002/jqs.1487; Bendle J, 2007, GEOCHIM COSMOCHIM AC, V71, P5934, DOI 10.1016/j.gca.2007.09.029; Badewien T, 2015, QUATERNARY SCI REV, V125, P160, DOI 10.1016/j.quascirev.2015.08.004; Sikes EL, 1997, GEOCHIM COSMOCHIM AC, V61, P1495, DOI 10.1016/S0016-7037(97)00017-3; Rohling EJ, 2005, NATURE, V434, P975, DOI 10.1038/nature03421; Andrews JT, 2014, CLIM PAST, V10, P325, DOI 10.5194/cp-10-325-2014; Damste JSS, 2011, APPL ENVIRON MICROB, V77, P4147, DOI 10.1128/AEM.00466-11; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Graham NE, 2011, CLIM DYNAM, V37, P1217, DOI 10.1007/s00382-010-0914-z; Weijers JWH, 2007, SCIENCE, V315, P1701, DOI 10.1126/science.1138131; Schefuss E, 2005, NATURE, V437, P1003, DOI 10.1038/nature03945; Broecker WS, 1997, SCIENCE, V278, P1582, DOI 10.1126/science.278.5343.1582; Kerr RA, 2000, SCIENCE, V288, P1984, DOI 10.1126/science.288.5473.1984; Quillmann U, 2010, J QUATERNARY SCI, V25, P1144, DOI 10.1002/jqs.1395; Fawcett PJ, 2011, NATURE, V470, P518, DOI 10.1038/nature09839; Hanna E, 2006, J CLIMATE, V19, P5652, DOI 10.1175/JCLI3933.1; Sicre MA, 2008, EARTH PLANET SC LETT, V268, P137, DOI 10.1016/j.eps1.2008.01.011; Vage K, 2011, NAT GEOSCI, V4, P723, DOI [10.1038/NGEO1234, 10.1038/ngeo1234]; Larsen DJ, 2012, QUATERNARY SCI REV, V39, P14, DOI 10.1016/j.quascirev.2012.02.006; Weijers JWH, 2007, GEOCHIM COSMOCHIM AC, V71, P703, DOI 10.1016/j.gca.2006.10.003; Hopmans EC, 2004, EARTH PLANET SC LETT, V224, P107, DOI 10.1016/j.epsl.2004.05.012; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Bendle JAP, 2007, HOLOCENE, V17, P9, DOI 10.1177/0959683607073269; Quillmann U, 2012, QUATERNARY RES, V78, P528, DOI 10.1016/j.yqres.2012.08.003; Rueda G, 2009, ORG GEOCHEM, V40, P287, DOI 10.1016/j.orggeochem.2008.10.012; Bjune AE, 2005, HOLOCENE, V15, P177, DOI 10.1191/0959683605hl798rp; Renssen H, 2005, CLIM DYNAM, V24, P23, DOI 10.1007/s00382-004-0485-y; Ineson S, 2011, NAT GEOSCI, V4, P753, DOI [10.1038/ngeo1282, 10.1038/NGEO1282]; Siddall M, 2010, J QUATERNARY SCI, V25, P19, DOI 10.1002/jqs.1270; HARRISON SP, 1992, QUATERNARY SCI REV, V11, P283, DOI 10.1016/0277-3791(92)90002-P; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; deMenocal PB, 2001, SCIENCE, V292, P667, DOI 10.1126/science.1059827; Geirsdottir A, 2009, QUATERNARY SCI REV, V28, P2107, DOI 10.1016/j.quascirev.2009.03.013; Shanahan TM, 2013, ORG GEOCHEM, V64, P119, DOI 10.1016/j.orggeochem.2013.09.010; Rommerskirchen F, 2006, ORG GEOCHEM, V37, P1303, DOI 10.1016/j.orggeochem.2005.12.013; Geirsdottir A, 2002, POLAR RES, V21, P291, DOI 10.1111/j.1751-8369.2002.tb00083.x; Langdon PG, 2010, HOLOCENE, V20, P205, DOI 10.1177/0959683609354301; Al-Kayssi AW, 1990, J AGR ENG RES, V45, P241, DOI 10.1016/S0021-8634(05)80152-0; Geirsdottir A, 2009, J PALEOLIMNOL, V41, P95, DOI 10.1007/s10933-008-9253-z; Olafsdottir KB, 2013, QUATERNARY SCI REV, V69, P142, DOI 10.1016/j.quascirev.2013.03.009; Peterse F, 2010, ORG GEOCHEM, V41, P1171, DOI 10.1016/j.orggeochem.2010.07.004; Weijers JWH, 2011, GEOCHIM COSMOCHIM AC, V75, P3179, DOI 10.1016/j.gca.2011.03.015; Andrews JT, 2008, ARCT ANTARCT ALP RES, V40, P1, DOI 10.1657/1523-0430(05-072)[ANDREWS)2.0.CO;2; BRASSELL SC, 1986, NATURE, V320, P129, DOI 10.1038/320129a0; Hansen B, 2000, PROG OCEANOGR, V45, P109, DOI 10.1016/S0079-6611(99)00052-X; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; Buntgen U, 2011, SCIENCE, V331, P578, DOI 10.1126/science.1197175; Wanner H, 2011, QUATERNARY SCI REV, V30, P3109, DOI 10.1016/j.quascirev.2011.07.010; Gao L, 2012, PALAEOGEOGR PALAEOCL, V317, P128, DOI 10.1016/j.palaeo.2011.12.021; Ternois Y, 1998, ORG GEOCHEM, V28, P489, DOI 10.1016/S0146-6380(98)00008-4; Eglinton TI, 2008, EARTH PLANET SC LETT, V275, P1, DOI 10.1016/j.epsl.2008.07.012; Collins JA, 2013, QUATERNARY SCI REV, V65, P88, DOI 10.1016/j.quascirev.2013.01.007; Peterse F, 2012, GEOCHIM COSMOCHIM AC, V96, P215, DOI 10.1016/j.gca.2012.08.011; Solanki SK, 2004, NATURE, V431, P1084, DOI 10.1038/nature02995; Jennings A, 2011, QUATERNARY SCI REV, V30, P980, DOI 10.1016/j.quascirev.2011.01.016; Shindell DT, 2001, SCIENCE, V294, P2149, DOI 10.1126/science.1064363; [Anonymous], 2006, PALEOCEANOGRAPHY, DOI DOI 10.1029/2005PA001214; Justwan A, 2008, QUATERNARY SCI REV, V27, P1571, DOI 10.1016/j.quascirev.2008.05.006; Zhu C, 2011, ORG GEOCHEM, V42, P376, DOI 10.1016/j.orggeochem.2011.02.002; Jennings AE, 2002, HOLOCENE, V12, P49, DOI 10.1191/0959683602hl519rp; Bendle J., 2004, GEOCHEM GEOPHYS GEOS, V5; Blindheim J., 2005, NORDIC SEAS INTEGRAT, P65; Calvo E., 2004, PALEOCEANOGRAPHY, V19, P10; Conte M.H., 2006, GEOCHEM GEOPHYS GEOS, V7; Geirsdottir A, 2013, QUATERNARY SCI REV, V70, P48, DOI 10.1016/j.quascirev.2013.03.010; Gray LJ, 2010, REV GEOPHYS, V48, P53; Hall IR, 2004, QUATERNARY SCI REV, V23, P1529, DOI 10.1016/j.quascirev.2004.04.004; Hallsdottir Margret, 1995, Buvisindi, V9, P17; HAMMER O., 2001, PALAEONTOL ELECTRON, V4, DOI DOI 10.1111/J.1398-9995.2007.01603.X; Hurrell J.W., 2003, OVERVIEW N ATLANTIC; Kaufman D. S., 2004, QUATERNARY SCI REV, V23, P23, DOI DOI 10.1016/J.QUASCIREV.2003.09.007; Kawamura K, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001810; Knudsen M.F., 2011, NAT COMMUN, V2; LeGrande A.N., 2008, PALEOCEANOGRAPHY, V23; Mayewski PA, 2004, QUATERNARY RES, V62, P243, DOI 10.1016/j.yqres.2004.07.001; Moossen H., 2013, HOLOCENE, V23, P11; Ogilvie AEJ, 2001, CLIMATIC CHANGE, V48, P9, DOI 10.1023/A:1005625729889; Olafsdottir S, 2010, MAR MICROPALEONTOL, V77, P101, DOI 10.1016/j.marmicro.2010.08.002; Prahl E. G., 1987, NATURE, V330, P367; Rommerskirchen F, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001223; Rossi A, 2011, GLOBAL PLANET CHANGE, V78, P1, DOI 10.1016/j.gloplacha.2011.04.008; Schlitzer R., 2010, OCEAN DATA VIEW; Schouten S., 2011, QUATERNARY SCI REV, V30, P2851; Sicre MA, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002169	119	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-3791			QUATERNARY SCI REV	Quat. Sci. Rev.	DEC 1	2015	129						111	127		10.1016/j.quascirev.2015.10.013		17	Geography, Physical; Geosciences, Multidisciplinary	Physical Geography; Geology	CY2IO	WOS:000366232300007		
J	Shibata, M; Shimasaki, T; Satoh, H; Iwai, M; Neda, M				Shibata, Mitsuhiro; Shimasaki, Toshiaki; Satoh, Hiroyuki; Iwai, Misaki; Neda, Makiyo			Bio-based thermosetting resins composed of aliphatic polyol-derived polymaleimides and allyleugenol	REACTIVE & FUNCTIONAL POLYMERS			English	Article						Glycerol; Diglycerol; 1,3-propanediol; Polymaleimide; Thermosetting resins	EPOXY-RESIN; WOOD FLOUR; MECHANICAL-PROPERTIES; PHENOLIC RESINS; CURE KINETICS; OIL; BISMALEIMIDE; BIOCOMPOSITES; PLASTICS; ACID	Bio-based bismaleimide (2MPD), trismaleimide (3MGC) and tetramaleimide (4MDG) were synthesized by reactions of 4-isocyanatophenylmalehnide with 1,3-propanediol, glycerol and alpha,alpha'-diglycerol, respectively. Although 2MPD did not melt until the temperature where thermal decomposition starts, 3MGC and 4MDG exhibited broad melting temperatures with onset points at 165 degrees C and 124 degrees C, respectively. 3MGC and 4MDG were homogeneously prepolymerized at 170 degrees C with 2,4-diallyI-6-methoxyphenol (rAEG) which was prepared by the Claisen rearrangement of allyl-etherifled eugenol (AEG). The prepolymers were compression-molded at 250 degrees C to produce cured rAEG/3MGC (A3Mxy) and rAEG/4MDG (A4Mxy) with the allyl/maleimide ratio of x/y = 1/1, 1/2 or 1/3. The FT-IR analysis revealed that the ene reaction of allyl and maleimide groups and subsequent addition copolymerization occurred for the cured resins. The thermal and mechanical properties of the cured resins were compared with those of the cured rAEG/4,4'-bismaleimidodiphenylmethane (BMI) (ABMxy) with the same allyl/maleimide ratio. A3M13 and A4M13 showed no inflection point of thermal expansion due to glass transition until 300 degrees C, which is a little lower than the thermo-degradation temperature. Flexural strengths and flexural strains at break for A3Ms and A4Ms increased with the polymaleimide contents, and those of A3M13 and A4M13 were much higher than those of ABM13. (C) 2015 Elsevier B.V. All rights reserved.	[Shibata, Mitsuhiro; Shimasaki, Toshiaki; Satoh, Hiroyuki; Iwai, Misaki; Neda, Makiyo] Chiba Inst Technol, Dept Life & Environm Sci, Fac Engn, Narashino, Chiba 2750016, Japan	Shibata, M (reprint author), Chiba Inst Technol, Dept Life & Environm Sci, Fac Engn, 2-17-1 Tsudanuma, Narashino, Chiba 2750016, Japan.	mitsuhiro.shibata@p.chibakoudai.jp			Chiba Institute of Technology	We gratefully acknowledge financial support from the Chiba Institute of Technology. We thank Dr. Naozumi Teramoto of our department for his helpful suggestions.	Takada Y, 2009, J APPL POLYM SCI, V113, P479, DOI 10.1002/app.30015; Lukaszczyk J, 2011, EUR POLYM J, V47, P1601, DOI 10.1016/j.eurpolymj.2011.05.009; Ikeda T, 2013, POLYMER, V54, P3206, DOI 10.1016/j.polymer.2013.04.052; Effendi A, 2008, RENEW SUST ENERG REV, V12, P2092, DOI 10.1016/j.rser.2007.04.008; Rozenberg BA, 2002, POLYM ADVAN TECHNOL, V13, P837, DOI 10.1002/pat.230; Shibahara S, 1996, POLYM J, V28, P752, DOI 10.1295/polymj.28.752; Shibata M, 2013, J APPL POLYM SCI, V128, P2753, DOI 10.1002/app.38438; Kim JR, 2012, IND CROP PROD, V36, P485, DOI 10.1016/j.indcrop.2011.10.036; Raquez JM, 2010, PROG POLYM SCI, V35, P487, DOI 10.1016/j.progpolymsci.2010.01.001; Chrysanthos M, 2011, POLYMER, V52, P3611, DOI 10.1016/j.polymer.2011.06.001; Yang XJ, 2015, IND CROP PROD, V63, P17, DOI 10.1016/j.indcrop.2014.10.024; Gupta AP, 2010, POLYM-PLAST TECHNOL, V49, P657, DOI 10.1080/03602551003681796; Takahashi T, 2008, J APPL POLYM SCI, V108, P1596, DOI 10.1002/app.27866; Apprich S, 2014, LWT-FOOD SCI TECHNOL, V56, P222, DOI 10.1016/j.lwt.2013.12.003; Gaina C, 2009, EXPRESS POLYM LETT, V3, P352, DOI 10.3144/expresspolymlett.2009.44; Shibata M, 2013, J APPL POLYM SCI, V129, P282, DOI 10.1002/app.38739; Reddy MM, 2013, PROG POLYM SCI, V38, P1653, DOI 10.1016/j.progpolymsci.2013.05.006; Morgan RJ, 1997, POLYMER, V38, P639, DOI 10.1016/S0032-3861(96)00542-3; Mulhaupt R, 2013, MACROMOL CHEM PHYS, V214, P159, DOI 10.1002/macp.201200439; Guo WX, 2007, POLYM DEGRAD STABIL, V92, P407, DOI 10.1016/j.polymdegradstab.2006.11.018; Nair CPR, 2004, PROG POLYM SCI, V29, P401, DOI 10.1016/j.progpolymsci.2004.01.004; Ronda JC, 2013, REACT FUNCT POLYM, V73, P381, DOI 10.1016/j.reactfunctpolym.2012.03.015; Ghaznavi T, 2014, BIOMASS BIOENERG, V71, P285, DOI 10.1016/j.biombioe.2014.09.029; Devi A, 2007, MAT SCI ENG A-STRUCT, V458, P336, DOI 10.1016/j.msea.2006.12.081; Shibata M, 2013, REACT FUNCT POLYM, V73, P1086, DOI 10.1016/j.reactfunctpolym.2013.05.002; Huo SP, 2014, THERMOCHIM ACTA, V587, P18, DOI 10.1016/j.tca.2014.03.015; Neda M, 2014, MATER CHEM PHYS, V148, P319, DOI 10.1016/j.matchemphys.2014.07.050; Miao SD, 2014, ACTA BIOMATER, V10, P1692, DOI 10.1016/j.actbio.2013.08.040; Shibata M, 2010, J APPL POLYM SCI, V118, P2998, DOI 10.1002/app.32695; Tan SG, 2013, IND CROP PROD, V43, P378, DOI 10.1016/j.indcrop.2012.07.049; Liu CG, 2014, IND CROP PROD, V52, P329, DOI 10.1016/j.indcrop.2013.11.010; Assanvo EF, 2015, IND CROP PROD, V65, P293, DOI 10.1016/j.indcrop.2014.11.049; Harmsen PFH, 2014, BIOFUEL BIOPROD BIOR, V8, P306, DOI 10.1002/bbb.1468; Becker J, 2015, CURR OPIN BIOTECH, V36, P168, DOI 10.1016/j.copbio.2015.08.022; Enoki T., 1995, HIGH PERFORM POLYM, V7, P399, DOI 10.1088/0954-0083/7/4/002; Gandini A., PROG POLYM IN PRESS; Guner FS, 2006, PROG POLYM SCI, V31, P633, DOI 10.1016/j.progpolymsci.2006.07.001; King J.J., 29 SAMPE S, P392; Mamat MRZ, 2014, J CLEAN PROD, V83, P463, DOI 10.1016/j.jclepro.2014.07.064; Niedermann P, 2015, EXPRESS POLYM LETT, V9, P85, DOI 10.3144/expresspolymlett.2015.10	40	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-5148	1873-166X		REACT FUNCT POLYM	React. Funct. Polym.	DEC	2015	97						69	76		10.1016/j.reactfunctpolym.2015.10.009		8	Chemistry, Applied; Engineering, Chemical; Polymer Science	Chemistry; Engineering; Polymer Science	CY0EO	WOS:000366079400009		
J	Hannoda, Y; Akasaka, Y; Shibata, M				Hannoda, Yoshiki; Akasaka, Yuld; Shibata, Mitsuhiro			Bio-based thermosetting bismaleimide resins using cardany linolenate and allyl cardanyl ether	REACTIVE & FUNCTIONAL POLYMERS			English	Article						Renewable resources; Thermosets; Bismaleimide; Cardanyl linolenate; Allyl cardanyl ether	RENEWABLE RESOURCE; PHENOLIC RESIN; NOVOLAC RESINS; CURING AGENTS; EPOXY; POLYMERIZATION; OIL; BENZOXAZINE; COMPOSITES; NETWORKS	Cardanyl linolenate (CDLN) and ally! cardanyl ether (ACDE) were synthesized from cardanol (CD) which is one of the inexpensive natural resources. Prepolymerized compounds of CDLN/4,4'-bismaleimidodiphenylmethane (BMI) and ACDE/BMI with the molar ratios of 1/2, 1/2.5 and 1/3 at 200 degrees C were compression-molded at 250 degrees C to produce cured CDLN/BMI and ACDE/BMI resins (cCDLN/BMI and cACDE/BMI), respectively. The.thermal and mechanical properties of cCDLN/BMI and cACDE/BMI were investigated in relation to the difference of reactivity between the linolenate group of CDLN and the allyl group of ACDE. The H-1 NMR and mass spectral analyses of the reaction product of methyl linolenate and N-phenylmaleimide (PMI) revealed that PMI-rich oligomer was produced by the addition copolymerization. FT-IR analyses of cCDIN/BMI and cACDE/BMI revealed that the terminal olefins have a higher reactivity toward the addition copolymerization or ene reaction with maleimide groups than the internal olefins. Although some components which were not incorporated into the polymer networks for cCDLN/BMIs caused a little reduction of storage modulus (E') before the glass transition starts, E's of cACDE/BMIs did not decrease until the glass transition starts at similar to 300 degrees C. The 5% weight loss temperatures (444-453 degrees C) of cACDE/BMIs were higher than those (327-426 degrees C) of cCDLN/BMIs. Also, cACDE/BMIs displayed much better flexural properties than cCDLN/BMIs. The fact that cACDE/BMIs showed better thermal and mechanical properties was attributed to a higher functionality (1.41) of terminal olefins for ACDE than that (0.41) for CDLN. (C) 2015 Elsevier B.V. All rights reserved.	[Hannoda, Yoshiki; Akasaka, Yuld; Shibata, Mitsuhiro] Chiba Inst Technol, Dept Life & Environm Sci, Fac Engn, Narashino, Chiba 2750016, Japan	Shibata, M (reprint author), Chiba Inst Technol, Dept Life & Environm Sci, Fac Engn, 2-17-1 Tsudanuma, Narashino, Chiba 2750016, Japan.	mitsuhiro.shibata@p.chibakoudai.jp			Chiba Institute of Technology	We gratefully acknowledge the financial support from the Chiba Institute of Technology. We thank Dr. Naozumi Teramoto and Dr. Toshiaki Shimasaki of our department for their helpful suggestions. We are also grateful to Mr. Ryusuke Osada of Material Analysis Center at the Chiba Institute of Technology for assisting in the FE-SEM analysis reported here.	Rao BS, 2013, EUR POLYM J, V49, P2365, DOI 10.1016/j.eurpolymj.2013.05.029; Chen ZG, 2009, PROG ORG COAT, V65, P246, DOI 10.1016/j.porgcoat.2008.11.008; Patel CJ, 2014, PROG ORG COAT, V77, P997, DOI 10.1016/j.porgcoat.2014.02.006; Raquez JM, 2010, PROG POLYM SCI, V35, P487, DOI 10.1016/j.progpolymsci.2010.01.001; Maffezzoli A, 2004, COMPOS SCI TECHNOL, V64, P839, DOI 10.1016/j.compscitech.2003.09.010; Rao BS, 2011, REACT FUNCT POLYM, V71, P148, DOI 10.1016/j.reactfunctpolym.2010.11.025; Bai WB, 2012, PROG ORG COAT, V75, P184, DOI 10.1016/j.porgcoat.2012.04.016; Kim YH, 2007, J MOL CATAL B-ENZYM, V45, P39, DOI 10.1016/j.molcatb.2006.11.004; Aggarwal LK, 2007, PROG ORG COAT, V59, P76, DOI 10.1016/j.porgcoat.2007.01.010; Kang H, 2014, EUR POLYM J, V61, P13, DOI 10.1016/j.eurpolymj.2014.09.019; Yadav R, 2007, MATER CHEM PHYS, V106, P74, DOI 10.1016/j.matchemphys.2007.05.020; Nair CPR, 2004, PROG POLYM SCI, V29, P401, DOI 10.1016/j.progpolymsci.2004.01.004; Hirayama KI, 2009, J APPL POLYM SCI, V114, P1033, DOI 10.1002/app.30562; Ronda JC, 2013, REACT FUNCT POLYM, V73, P381, DOI 10.1016/j.reactfunctpolym.2012.03.015; Campaner P, 2009, J APPL POLYM SCI, V114, P3585, DOI 10.1002/app.30979; Pullen J, 2012, RENEW SUST ENERG REV, V16, P5924, DOI 10.1016/j.rser.2012.06.024; Yadav R, 2007, EUR POLYM J, V43, P3531, DOI 10.1016/j.eurpolymj.2007.05.033; Rao BS, 2006, J APPL POLYM SCI, V100, P3956, DOI 10.1002/app.23008; Yadav R, 2009, J APPL POLYM SCI, V114, P1670, DOI 10.1002/app.29376; Devi A, 2007, MAT SCI ENG A-STRUCT, V458, P336, DOI 10.1016/j.msea.2006.12.081; Shibata M, 2013, REACT FUNCT POLYM, V73, P1086, DOI 10.1016/j.reactfunctpolym.2013.05.002; Santos RD, 2010, COMPOS PART A-APPL S, V41, P1123, DOI 10.1016/j.compositesa.2010.04.010; PILLAI CKS, 1990, J APPL POLYM SCI, V41, P2487, DOI 10.1002/app.1990.070410947; Chrysanthos M, 2013, MACROMOL MATER ENG, V298, P1209, DOI 10.1002/mame.201200405; Rekha N, 2008, J APPL POLYM SCI, V109, P2781, DOI 10.1002/app.28342; Neda M, 2014, MATER CHEM PHYS, V148, P319, DOI 10.1016/j.matchemphys.2014.07.050; Miao SD, 2014, ACTA BIOMATER, V10, P1692, DOI 10.1016/j.actbio.2013.08.040; Shibata M, 2013, POLYM J, V45, P758, DOI 10.1038/pj.2012.195; Dumas L, 2015, EUR POLYM J, V67, P494, DOI 10.1016/j.eurpolymj.2014.11.030; Suresh KI, 2005, J POLYM SCI POL CHEM, V43, P5953, DOI 10.1002/pola.21088; Pathak SK, 2006, J APPL POLYM SCI, V102, P4741, DOI 10.1002/app.25005; Agag T, 2013, J APPL POLYM SCI, V127, P2710, DOI 10.1002/app.37584; Shibata M, 2011, J APPL POLYM SCI, V119, P896, DOI 10.1002/app.32770; Shibata M, 2013, J APPL POLYM SCI, V129, P301, DOI 10.1002/app.38477; Li SH, 2014, PROG ORG COAT, V77, P388, DOI 10.1016/j.porgcoat.2013.11.011; Enoki T., 1991, J THERMOSETTING PLAS, V12, P9; Huang K, 2012, PROG ORG COAT, V74, P240, DOI 10.1016/j.porgcoat.2011.12.015; Islam MR, 2014, J APPL POLYM SCI, V131, DOI [10.1002/app.40787, 10.1002/APP.40787]; JOHN G, 1992, MAKROMOL CHEM-RAPID, V13, P255; King J.J., 1984, 29TH NAT SAMPE S, V29, P392	40	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-5148	1873-166X		REACT FUNCT POLYM	React. Funct. Polym.	DEC	2015	97						96	104		10.1016/j.reactfunctpolym.2015.10.014		9	Chemistry, Applied; Engineering, Chemical; Polymer Science	Chemistry; Engineering; Polymer Science	CY0EO	WOS:000366079400012		
J	Mori, A; Kouyama, S; Yamaguchi, M; Iijima, Y; Abe-Ohtomo, A				Mori, Akio; Kouyama, Satoshi; Yamaguchi, Miyako; Iijima, Yo; Abe-Ohtomo, Akemi			PHARMACOLOGICAL CHARACTERIZATION OF T CELL-INDUCED BRONCHOCONSTRICTION RESPONSE	RESPIROLOGY			English	Meeting Abstract									[Mori, Akio; Kouyama, Satoshi; Yamaguchi, Miyako; Iijima, Yo; Abe-Ohtomo, Akemi] Sagamihara Natl Hosp, Natl Hosp Org, Sagamihara, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	119	2	2				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400008		
J	Hojo, M; Hirashima, J; Iikura, M; Sugiyama, H				Hojo, Masayuki; Hirashima, Junko; Iikura, Motoyasu; Sugiyama, Haruhito			A COMPARISON OF ANTI-INFLAMMATORY EFFECT OF ONCE-DAILY FLUTICASONE FUROATE/VILANTEROL 200/25 WITH TWICE-DAILY FLUTICASONE PROPIONATE/SALMETEROL 500/50 IN MODERATE TO SEVERE ASTHMATICS	RESPIROLOGY			English	Meeting Abstract									[Hojo, Masayuki] Natl Ctr Global Hlth & Med, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	215	4	4				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400016		
J	Hinds, D; Chapman, KR; Disantostefano, R; Gaalswyk, K; Greulich, T; Gibbs, M; Piazza, P; Lin, JT; Adachi, M; Raherison, C; Davis, KJ				Hinds, David; Chapman, Kenneth R.; Disantostefano, Rachael; Gaalswyk, Kenneth; Greulich, Timm; Gibbs, Michael; Piazza, Peter; Lin, Jiangtao; Adachi, Mitsuru; Raherison, Chantal; Davis, Kourtney J.			PHYSICIAN PERCEPTIONS AND TREATMENT OF ASTHMA IN FIVE COUNTRIES: THE GLOBAL ASTHMA PHYSICIAN SURVEY	RESPIROLOGY			English	Meeting Abstract									[Hinds, David; Davis, Kourtney J.] GlaxoSmithKline, Worldwide Epidemiol, Stockley Pk, England; [Chapman, Kenneth R.] Univ Toronto, Toronto, ON, Canada; [Disantostefano, Rachael] PAREXEL Int, Durham, NC USA; [Gaalswyk, Kenneth] Abt SRBI, Silver Spring, MD USA; [Greulich, Timm] Univ Marburg, D-35032 Marburg, Germany; [Gibbs, Michael] GlaxoSmithKline, Global Resp Franchise, Stockley Pk, England; [Piazza, Peter] Five Dock Family Med Practice, Five Dock, Australia; [Lin, Jiangtao] China Japan Friendship Hosp, Beijing, Peoples R China; [Adachi, Mitsuru] Int Univ Hlth & Welf, Tokyo, Japan; [Raherison, Chantal] Univ Bordeaux, Segalen, France								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	397	11	11				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400041		
J	Asano, F; Shinagawa, N; Ishida, T; Tsuzuku, A; Tachihara, M				Asano, Fumihiro; Shinagawa, Naofumi; Ishida, Takashi; Tsuzuku, Akifumi; Tachihara, Motoko			SUBGROUP FOR WHICH VIRTUAL BRONCHOSCOPIC NAVIGATION IS USEFUL FOR ENDOBRONCHIAL ULTRASONOGRAPHY OF PERIPHERAL PULMONARY LESIONS	RESPIROLOGY			English	Meeting Abstract									[Asano, Fumihiro] Gifu Prefectural Gen Med Ctr, Dept Pulm Med, Gifu, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	20	21	21				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400074		
J	Kato, A; Yasuo, M; Hama, M; Ichiyama, T; Hanaoka, M				Kato, Akane; Yasuo, Masanori; Hama, Mineyuki; Ichiyama, Takashi; Hanaoka, Masayuki			CONTRIBUTION OF VIRTUAL BRONCHOSCOPIC NAVIGATION TO REDUCTION OF RADIATION EXPOSURE IN COMPUTED TOMOGRAPHY GUIDED BRONCHOSCOPY	RESPIROLOGY			English	Meeting Abstract									[Kato, Akane] Shinshu Univ, Sch Med, Dept Internal Med 1, Matsumoto, Nagano, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	139	22	22				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400076		
J	Mizumori, Y; Nakahara, Y; Kawamura, T; Sasaki, S; Mochiduki, Y				Mizumori, Yasuyuki; Nakahara, Yasuharu; Kawamura, Tetsuji; Sasaki, Shin; Mochiduki, Yoshiro			NEW METHOD FOR INTRACTABLE PNEUMOTHORAX IN PATIENTS WITH EMPHYSEMA: COMBINATION THERAPY FOR BRONCHIAL OCCLUSION AND TRANSBRONCHIAL INFUSION OF AUTOLOGOUS BLOOD AND THROMBIN	RESPIROLOGY			English	Meeting Abstract									[Mizumori, Yasuyuki] Himeji Med Ctr, Natl Hosp Org, Himeji, Hyogo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	185	23	23				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400079		
J	Sakugawa, M; Hosokawa, S; Fukamatsu, N; Ogata, Y; Bessho, A				Sakugawa, Makoto; Hosokawa, Shinobu; Fukamatsu, Nobuaki; Ogata, Yoshiko; Bessho, Akihiro			BRONCHOSCOPIC TREATMENT USING SILICONE SPIGOTS FOR SECONDARY SPONTANEOUS PNEUMOTHORAX DUE TO PULMONARY EMPHYSEMA	RESPIROLOGY			English	Meeting Abstract									[Sakugawa, Makoto] Japanese Red Cross Okayama Hosp, Dept Resp Med, Okayama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	356	23	23				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400082		
J	Haruna, K; Mato, N; Yamauchi, H; Sawata, T; Sata, M; Nakayama, M; Nakaya, T; Fujiwara, S; Yamasawa, H; Bando, M; Fukushima, N; Sugiyama, Y				Haruna, Kogawara; Mato, Naoko; Yamauchi, Hiroyoshi; Sawata, Testuro; Sata, Masashi; Nakayama, Masayuki; Nakaya, Takakiyo; Fujiwara, Shinichiro; Yamasawa, Hideaki; Bando, Masashi; Fukushima, Noriyoshi; Sugiyama, Yukihiko			BRONCHOSCOPIC APPROACHES FOR MALIGNANT LYMPHOMA WITH PULMONARY LESIONS	RESPIROLOGY			English	Meeting Abstract									[Haruna, Kogawara] Jichi Med Univ, Shimotsuke, Tochigi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	420	24	24				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400084		
J	Kato, Y; Kato, Y; Tanaka, Y; Hino, M				Kato, Yasuhiro; Kato, Yasuhiro; Tanaka, Yosuke; Hino, Mitsunori			INVESTIGATION OF UTILITY OF EBUS-TBNA IN THE DIAGNOSIS OF SARCOIDOSIS	RESPIROLOGY			English	Meeting Abstract									[Kato, Yasuhiro] Chiba Hokusoh Hosp, Resp Dis Ctr, Nippon Med Sch, Chiba, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	386	24	24				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400083		
J	Hiraishi, Y; Matsumoto, Y; Tsuchida, T; Izumo, T				Hiraishi, Yoshihisa; Matsumoto, Yuji; Tsuchida, Takaaki; Izumo, Takehiro			EVALUATION OF BRONCHOALVEOLAR LAVAGE FLUID FINDINGS FOR THE DIFFERENTIAL DIAGNOSIS OF BILATERAL DIFFUSE INFILTRATION AFTER CHEMOTHERAPY	RESPIROLOGY			English	Meeting Abstract									[Hiraishi, Yoshihisa] Natl Canc Ctr Hosp, Dept Endoscopy, Resp Endoscopy Div, Kashiwa, Chiba, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	638	25	25				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400089		
J	Kurihara, M; Mizobuchi, T; Yamanaka, S				Kurihara, Masatoshi; Mizobuchi, Teruaki; Yamanaka, Sumitaka			THORACOGRAPHIC FIBRIN GLUE SEALING METHOD (TGF) FOR INOPERABLE INTRACTABLE PNEUMOTHORAX	RESPIROLOGY			English	Meeting Abstract									[Kurihara, Masatoshi] Nissan Tamagawa Hosp, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	587	25	25				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400087		
J	Ise, Y; Oki, M; Saka, H; Kitagawa, C; Kogure, Y; Oka, S; Nakahata, M; Hori, K; Murakaki, Y; Ishida, A				Ise, Yuko; Oki, Masahide; Saka, Hideo; Kitagawa, Chiyoe; Kogure, Yoshihito; Oka, Saori; Nakahata, Masashi; Hori, Kazumi; Murakaki, Yasushi; Ishida, Akane			BRONCHIAL EMBOLIZATION USING AN ENDOBRONCHIAL WATANABE SPIGOT FOR INTRACTABLE PULMONARY FISTULA	RESPIROLOGY			English	Meeting Abstract									[Ise, Yuko; Oki, Masahide; Saka, Hideo; Kitagawa, Chiyoe; Kogure, Yoshihito; Oka, Saori; Nakahata, Masashi; Hori, Kazumi; Murakaki, Yasushi; Ishida, Akane] Nagoya Med Ctr, Dept Resp Med, Nagoya, Aichi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	726	26	26				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400093		
J	Matsumoto, Y; Hiraishi, Y; Tsuchida, T; Izumo, T				Matsumoto, Yuji; Hiraishi, Yoshihisa; Tsuchida, Takaaki; Izumo, Takehiro			IN VIVO FINDINGS OF PROBE BASED CONFOCAL LASER ENDOMICROSCOPY FOR PERIPHERAL PULMONARY LESIONS	RESPIROLOGY			English	Meeting Abstract									[Matsumoto, Yuji; Hiraishi, Yoshihisa; Tsuchida, Takaaki; Izumo, Takehiro] Natl Canc Ctr, Dept Endoscopy, Resp Endoscopy Div, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	687	26	26				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400092		
J	Okamoto, H; Higashi, TO; Higashi, TS; Nakano, Y; Horie, M				Okamoto, Hiroki; Higashi, Tetsuya Oguma; Higashi, Takuya Sakashita; Nakano, Yasutaka; Horie, Minoru			REMOVAL OF A BRONCHIAL FOREIGN BODY AFTER NINE-YEARS INTERVAL	RESPIROLOGY			English	Meeting Abstract									[Okamoto, Hiroki] Shiga Univ Med Sci, Clin Educ Ctr Phys, Shiga, Japan; [Higashi, Tetsuya Oguma; Higashi, Takuya Sakashita] Ohmi Gen Med Ctr, Nagoya, Aichi, Japan; [Nakano, Yasutaka] Shiga Univ Med Sci, Shiga, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	742	26	26				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400094		
J	Oki, M; Saka, H; Kogure, Y; Tsuboi, R; Oka, S; Nakahata, M; Hori, K; Murakami, Y; Ise, Y				Oki, Masahide; Saka, Hideo; Kogure, Yoshihito; Tsuboi, Rie; Oka, Saori; Nakahata, Masashi; Hori, Kazumi; Murakami, Yasushi; Ise, Yuko			RIGID BRONCHOSCOPIC INTERVENTION FOR ENDOBRONCHIAL HAMARTOMA	RESPIROLOGY			English	Meeting Abstract									[Oki, Masahide; Saka, Hideo; Kogure, Yoshihito; Tsuboi, Rie; Oka, Saori; Nakahata, Masashi; Hori, Kazumi; Murakami, Yasushi] Nagoya Med Ctr, Dept Resp Med, Nagoya, Aichi, Japan; [Ise, Yuko] Chiyoe Kitagawa, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	680	26	26				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400091		
J	Mori, T; Niwa, T; Katano, T; Komaki, C				Mori, Tamami; Niwa, Takashi; Katano, Takuma; Komaki, Chihito			THE SHORT TERM EFFICACY OF BRONCHIAL ARTERY EMBOLIZATION FOR HEMOPTYSIS: A RETROSPECTIVE COHORT STUDY	RESPIROLOGY			English	Meeting Abstract									[Mori, Tamami; Niwa, Takashi; Katano, Takuma; Komaki, Chihito] Matsunami Gen Hosp, Dept Respirol, Hashima, Gifu, Japan							[Anonymous], 2012, SEMIN INTERVENT RADI, V29; [Anonymous], 2009, TECH VASC INTERVENTI, V12, P130	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	755	27	27				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400097		
J	Muhammad, NA; Aflah, SSS; Nordin, KM; Abu Bakar, Z; Marzuki, N; Muttalif, ARA				Muhammad, Noorul Afidza; Aflah, Syazatul Syakirin Sirol; Nordin, Kasuma Mohd; Abu Bakar, Zamzurina; Marzuki, Nurhayati; Muttalif, Abdul Razak Abdul			SEMI-RIGID THORACOSCOPY: EXPERIENCE FROM A TERTIARY CARE CENTRE	RESPIROLOGY			English	Meeting Abstract									[Muhammad, Noorul Afidza] Inst Resp Med, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	746	27	27				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400095		
J	Tanaka, KI				Tanaka, Ken-Ichiro			DRUG DEVELOPMENT FOR COPD BY DRUG RE-POSITIONING STRATEGY	RESPIROLOGY			English	Meeting Abstract									[Tanaka, Ken-Ichiro] Keio Univ, Tokyo 108, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	36	31	31				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400110		
J	Furukawa, H; Kishino, Y; Tanaka, A; Yokoe, T; Sagara, H				Furukawa, Hitomi; Kishino, Yasunari; Tanaka, Akihiko; Yokoe, Takuya; Sagara, Hironori			CONCURRENT ASTHMA STRONGLY PARTICIPATES IN ACUTE EXACERBATIONS IN JAPANESE PATIENTS WITH COPD	RESPIROLOGY			English	Meeting Abstract									[Furukawa, Hitomi] Showa Univ, Sch Med, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	192	36	36				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400125		
J	Tanaka, Y; Hino, M; Gemma, A; Kobayashi, Y; Katoh, Y				Tanaka, Yosuke; Hino, Mitsunori; Gemma, Akihiko; Kobayashi, Yumiko; Katoh, Yasuhiro			2ND INTERIM REPORT: EFFECT OF TIOTROPIUM MONOTHERAPY VERSUS TIOTROPIUM PLUS INDACATEROL IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE-SINGLE-CENTRE, RANDOMIZED, PROSPECTIVE, REAL-WORLD STUDY	RESPIROLOGY			English	Meeting Abstract									[Tanaka, Yosuke] Chiba Hokusoh Hosp, Nippon Med Sch, Resp Dis Ctr, Chiba, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	231	37	37				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400130		
J	Fuseya, Y; Muro, S; Mishima, M; Nakayama, T				Fuseya, Yoshinori; Muro, Shigeo; Mishima, Michiaki; Nakayama, Takeo			COPD PATIENTS' VIEW OF END OF LIFE IN JAPAN	RESPIROLOGY			English	Meeting Abstract									[Fuseya, Yoshinori] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto 6068501, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	339	40	40				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400143		
J	Kume, H; Higashimoto, Y; Thoda, Y				Kume, Hiroaki; Higashimoto, Yuji; Thoda, Yuji			EFFECTS OF COMBINATION OF LABA WITH ICS ON COPD WITH AIRWAY EOSINOPHILIA	RESPIROLOGY			English	Meeting Abstract									[Kume, Hiroaki] Kinki Univ, Fac Med, Dept Resp Med & Allergol, Higashiosaka, Osaka 577, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	330	40	40				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400142		
J	Kikuchi, T; Sugiura, H; Kanai, K; Ichikawa, T; Koarai, A; Ichinose, M				Kikuchi, Takashi; Sugiura, Hisatoshi; Kanai, Kuninobu; Ichikawa, Tomohiro; Koarai, Akira; Ichinose, Masakazu			NITROSATIVE-STRESS-MEDIATED PROMOTIONAL EFFECT OF 27-HYDROXYCHOLESTEROL IN THE RELEASE OF MATRIX METALLOPROTEINASES BY LUNG FIBROBLASTS	RESPIROLOGY			English	Meeting Abstract									[Kikuchi, Takashi] Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	468	45	45				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400160		
J	Buhl, R; Jons, O; Bothner, U; Tetzlaff, K; Zhao, YH; Ichinose, M				Buhl, Roland; Joens, Olaf; Bothner, Ulrich; Tetzlaff, Kay; Zhao, Yihua; Ichinose, Masakazu			SAFETY OF ONCE-DAILY TIOTROPIUM PLUS OLODATEROL VIA THE RESPIMAT (R) IN EAST ASIAN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)	RESPIROLOGY			English	Meeting Abstract									[Buhl, Roland] Mainz Univ Hosp, Dept Pulm, Mainz, Germany; [Joens, Olaf; Bothner, Ulrich; Tetzlaff, Kay] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; [Zhao, Yihua] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Ichinose, Masakazu] Tohoku Univ, Dept Resp Med, Grad Sch Med, Sendai, Miyagi 980, Japan							Buhl R, 2015, EUR RESPIR J, V45, P969, DOI 10.1183/09031936.00136014	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	489	47	47				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400165		
J	Kasagi, S; Narui, K; Kawagoe, J; Fujiwara, A; Sugiyama, S; Yamakoshi, S; Togashi, Y; Nakayama, H; Setoguchi, Y				Kasagi, Satoshi; Narui, Koji; Kawagoe, Junichiro; Fujiwara, Akahito; Sugiyama, Shinya; Yamakoshi, Shiho; Togashi, Yuki; Nakayama, Hideaki; Setoguchi, Yasuhiro			RELATIONSHIP BETWEEN SLEEP APNOEA SYNDROME AND IMPAIRMENT OF PULMONARY FUNCTION IN CHRONIC RESPIRATORY DISEASES	RESPIROLOGY			English	Meeting Abstract									[Kasagi, Satoshi] Tokyo Med Univ, Dept Resp, Sch Med, Tokyo 1608402, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	586	49	49				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400174		
J	Buhl, R; Jons, O; Zhao, Y; Ichinose, M				Buhl, Roland; Joens, Olaf; Zhao, Yihua; Ichinose, Masakazu			LUNG FUNCTION WITH TIOTROPIUM PLUS OLODATEROL IN EAST ASIAN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)	RESPIROLOGY			English	Meeting Abstract									[Buhl, Roland] Mainz Univ Hosp, Dept Pulm, Mainz, Germany; [Joens, Olaf] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; [Zhao, Yihua] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA; [Ichinose, Masakazu] Tohoku Univ, Grad Sch Med, Dept Resp Med, Sendai, Miyagi 980, Japan							Buhl R, 2015, EUR RESPIR J, V46, P969	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	629	51	51				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400179		
J	Bai, CX; Buhl, R; Lee, SH; Lee, KH; Jons, O; Zhao, YH; Ichinose, M				Bai, Chunxue; Buhl, Roland; Lee, Sang Haak; Lee, Kwan Ho; Joens, Olaf; Zhao, Yihua; Ichinose, Masakazu			LUNG FUNCTION WITH TIOTROPIUM PLUS OLODATEROL IN EAST ASIAN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)	RESPIROLOGY			English	Meeting Abstract									[Bai, Chunxue] Shanghai Resp Res Inst, Shanghai, Peoples R China; [Bai, Chunxue] Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Buhl, Roland] Mainz Univ Hosp, Dept Pulm, Mainz, Germany; [Lee, Sang Haak] Catholic Univ Korea, Coll Med, St Pauls Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Kwan Ho] Yeungnam Univ, Med Ctr, Dept Resp Med, Taegu, South Korea; [Joens, Olaf] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; [Zhao, Yihua] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA; [Ichinose, Masakazu] Tohoku Univ, Grad Sch Med, Dept Resp Med, Sendai, Miyagi 980, Japan							Buhl R, 2015, EUR RESPIR J, V46, P969	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	701	53	53				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400186		
J	Ogawa, E; Ryujin, Y; Seto, R; Tho, NV; Higami, Y; Nakagawa, H; Fukunaga, K; Yamaguchi, M; Nagao, T; Kurosawa, H; Nakano, Y				Ogawa, Emiko; Ryujin, Yasushi; Seto, Ruriko; Nguyen Van Tho; Higami, Yuichi; Nakagawa, Hiroaki; Fukunaga, Kentaro; Yamaguchi, Masafumi; Nagao, Taishi; Kurosawa, Hajime; Nakano, Yasutaka			THE NEW PHENOTYPE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE BASED ON RESPIRATORY IMPEDANCE AND THE PROGRESSION OF AIRFLOW LIMITATION	RESPIROLOGY			English	Meeting Abstract									[Ogawa, Emiko; Ryujin, Yasushi; Seto, Ruriko; Nguyen Van Tho; Higami, Yuichi; Nakagawa, Hiroaki; Fukunaga, Kentaro; Yamaguchi, Masafumi; Nagao, Taishi; Kurosawa, Hajime; Nakano, Yasutaka] Shiga Univ Med Sci, Dept Internal Med, Div Resp Med, Shiga, Shiga, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	738	54	54				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400190		
J	Bai, CX; Buhl, R; Lee, SH; Lee, KH; Jons, O; Bothner, U; Tetzlaff, K; Zhao, YH; Ichinose, M				Bai, Chunxue; Buhl, Roland; Lee, Sang Haak; Lee, Kwan Ho; Joens, Olaf; Bothner, Ulrich; Tetzlaff, Kay; Zhao, Yihua; Ichinose, Masakazu			SAFETY OF ONCE-DAILY TIOTROPIUM PLUS OLODATEROL VIA THE RESPIMAT (R) IN EAST ASIAN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)	RESPIROLOGY			English	Meeting Abstract									[Bai, Chunxue] Shanghai Resp Res Inst, Shanghai, Peoples R China; [Bai, Chunxue] Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Buhl, Roland] Mainz Univ Hosp, Dept Pulm, Mainz, Germany; [Lee, Sang Haak] Catholic Univ Korea, Coll Med, St Pauls Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Kwan Ho] Yeungnam Univ, Med Ctr, Dept Resp Med, Taegu, South Korea; [Joens, Olaf; Bothner, Ulrich; Tetzlaff, Kay] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; [Zhao, Yihua] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Ichinose, Masakazu] Tohoku Univ, Grad Sch Med, Dept Resp Med, Sendai, Miyagi 980, Japan							Buhl R, 2015, EUR RESPIR J, V45, P969, DOI 10.1183/09031936.00136014	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	748	55	55				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400191		
J	Sano, A				Sano, Atsushi			IS OUTPATIENT DRAINAGE THERAPY SUITABLE FOR PATIENTS WITH SPONTANEOUS PNEUMOTHORAX OVER 50 YEARS OF AGE?	RESPIROLOGY			English	Meeting Abstract									[Sano, Atsushi] Chigasaki Municipal Hosp, Chigasaki, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	16	63	63				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400222		
J	Ichinose, M; Takizawa, A; Hamilton, A; Zhao, YH; Fukuchi, Y				Ichinose, Masakazu; Takizawa, Ayako; Hamilton, Alan; Zhao, Yihua; Fukuchi, Yoshinosuke			EFFICACY AND SAFETY OF TIOTROPIUM AND OLODATEROL FIXED-DOSE COMBINATION VIA THE RESPIMAT (R) IN COPD PATIENTS: JAPANESE SUBGROUP ANALYSIS OF TONADO 1 AND 2	RESPIROLOGY			English	Meeting Abstract									[Ichinose, Masakazu] Tohoku Univ, Dept Resp Med, Grad Sch Med, Sendai, Miyagi 980, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	94	64	64				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400224		
J	Nakao, J; Harada, H; Handa, Y; Tsubokawa, N; Yamashita, Y				Nakao, Junichi; Harada, Hiroaki; Handa, Yoshinori; Tsubokawa, Norifumi; Yamashita, Yoshinori			CLINICAL BENEFIT OF COMPREHENSIVE PREOPERATIVE PULMONARY REHABILITATION INCLUDING INTENSIVE NUTRITIONAL SUPPORT FOR THE ELDERLY, LOW BODY WEIGHT, LUNG CANCER PATIENTS	RESPIROLOGY			English	Meeting Abstract									[Nakao, Junichi] NHO Yamaguchi Ube Med Ctr, Yamaguchi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	116	64	64				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400225		
J	Sano, A				Sano, Atsushi			COUGH-INDUCED RIB FRACTURES	RESPIROLOGY			English	Meeting Abstract									[Sano, Atsushi] Chigasaki Municipal Hosp, Chigasaki, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	41	64	64				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400223		
J	Ichinose, M; Engel, M; Luhmann, R; Moroni-Zentgraf, P				Ichinose, Masakazu; Engel, Michael; Luehmann, Reinhold; Moroni-Zentgraf, Petra			ONCE-DAILY TIOTROPIUM RESPIMAT (R) ADDED-ON TO ICS FOR PATIENTS WITH MODERATE SYMPTOMATIC ASTHMA: JAPANESE PATIENTS AND OVERALL PATIENTS.	RESPIROLOGY			English	Meeting Abstract									[Ichinose, Masakazu] Tohoku Univ, Grad Sch Med, Dept Resp Med, Sendai, Miyagi 980, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	120	65	65				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400226		
J	Kitamura, T; Nitta, Y; Taketa, T; Fukumori, T; Nakamura, T				Kitamura, Tomotaka; Nitta, Yuko; Taketa, Tomoyo; Fukumori, Tatsuya; Nakamura, Takahito			CATAMENIAL HAEMOPTYSIS SECONDARY TO PULMONARY ENDOMETRIOSIS PRESENTING THE REVERSED HALO SIGN ON CHEST CT	RESPIROLOGY			English	Meeting Abstract									[Kitamura, Tomotaka] Japan Community Healthcare Org, Hoshigaoka Med Ctr, Dept Resp Med, Yamaguchi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	138	65	65				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400227		
J	Ogura, T; Azuma, A; Kim, DS				Ogura, Takashi; Azuma, Arata; Kim, Dong-Soon			DOUBLE-BLIND, CONTROLLED TRIAL OF PC-SOD IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS EVALUATION OF SAFETY AND TOLERABILITY FOLLOWING INHALED ADMINISTRATION	RESPIROLOGY			English	Meeting Abstract									[Ogura, Takashi] Kanagawa Cardiovasc & Resp Ctr, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	141	65	65				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400228		
J	Ichinose, M; Takizawa, A; Gronke, L; Voss, F; Fukuchi, Y				Ichinose, Masakazu; Takizawa, Ayako; Groenke, Lars; Voss, Florian; Fukuchi, Yoshinosuke			ANALYSIS OF THE EFFICACY AND SAFETY OF TIOTROPIUM AND OLODATEROL FIXED-DOSE COMBINATION VIA THE RESPIMAT (R) IN PATIENTS WITH COPD BY DISEASE SEVERITY: TONADO TRIALS	RESPIROLOGY			English	Meeting Abstract									[Ichinose, Masakazu] Tohoku Univ, Grad Sch Med, Dept Resp Med, Sendai, Miyagi 980, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	456	66	66				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400233		
J	Yoshimatsu, Y; Miyamoto, N; Suginaka, M; Furukawa, K; Nakamura, N; Yamairi, K; Kagawa, N; Yoshida, Y; Takata, M; Otani, K; Kamimori, T; Fujiwara, H				Yoshimatsu, Yuki; Miyamoto, Natsuko; Suginaka, Miho; Furukawa, Koichi; Nakamura, Naoki; Yamairi, Kazushi; Kagawa, Naomi; Yoshida, Yae; Takata, Munetake; Otani, Kenichiro; Kamimori, Takao; Fujiwara, Hiroshi			CLINICAL FEATURES OF IDIOPATHIC HAEMOPTYSIS AND THE EFFECTIVENESS OF BRONCHIAL ARTERY EMBOLIZATION	RESPIROLOGY			English	Meeting Abstract									[Yoshimatsu, Yuki] Yodogawa Christians Hosp, Osaka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	436	66	66				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400232		
J	Koichi, F; Yamairi, K; Nakamura, N; Yoshimatsu, Y; Yoshida, Y; Takata, M; Miyamoto, N; Otani, K; Kamimori, T; Fujiwara, H				Koichi, Furukawa; Yamairi, Kazushi; Nakamura, Naoki; Yoshimatsu, Yuki; Yoshida, Yae; Takata, Munetake; Miyamoto, Natsuko; Otani, Kenichiro; Kamimori, Takao; Fujiwara, Hiroshi			CLINICAL STUDY OF 40 CASES WITH SPONTANEOUS PNEUMOMEDIASTINUM	RESPIROLOGY			English	Meeting Abstract									[Koichi, Furukawa] Yodogawa Christians Hosp, Dept Resp Med, Osaka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	523	67	67				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400234		
J	Takata, T; Hara, S; Ukai, I; Ninomiya, N; Kohno, M; Hagiwara, A; Iwama, Y; Kinoshita, Y; Hosoi, K; Min, K				Takata, Tetsuo; Hara, Satoshi; Ukai, Isao; Ninomiya, Norihisa; Kohno, Masanobu; Hagiwara, Akira; Iwama, Yuki; Kinoshita, Yoshinori; Hosoi, Keita; Min, Kyongyob			CHOICE OF CT LUNG IMAGES AS INDICATORS FOR PREDICTING RESPIRATORY IMPAIRMENT IN DROWNING SURVIVORS	RESPIROLOGY			English	Meeting Abstract									[Takata, Tetsuo] Itami City Hosp, Internal Med, Resp Div, Itami, Hyogo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	160	76	76				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400267		
J	Inui, T; Nakamoto, K; Sada, M; Ishii, H; Kogane, T; Koyama, H; Matsuzaki, H; Noguchi, S; Mikami, Y; Horie, M; Yamauchi, Y; Kohyama, T; Takizawa, H				Inui, Toshiya; Nakamoto, Keitaro; Sada, Mitsuru; Ishii, Haruyuki; Kogane, Toshiyuki; Koyama, Hikari; Matsuzaki, Hirotaka; Noguchi, Satoshi; Mikami, Yu; Horie, Masafumi; Yamauchi, Yasuhiro; Kohyama, Tadashi; Takizawa, Hajime			INFLUENCE OF GENE POLYMORPHISM ON BIOLOGICAL MARKERS IN PATIENTS WITH ASTHMA AND COPD ASSOCIATED WITH AIR POLLUTANTS	RESPIROLOGY			English	Meeting Abstract									[Inui, Toshiya] Kyorin Univ, Sch Med, Dept Resp Med, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	373	78	78				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400272		
J	Hiroki, E; Mizobuchi, T; Kurihara, M; Ando, K; Takahashi, K; Seyama, K				Hiroki, Ebana; Mizobuchi, Teruaki; Kurihara, Masatoshi; Ando, Katsutoshi; Takahashi, Kazuhisa; Seyama, Kuniaki			CLINICAL FEATURES PREDICTIVE FOR PNEUMOTHORAX SECONDARY TO BIRT-HOGG-DUBE SYNDROME: A COMPARISON WITH PRIMARY SPONTANEOUS PNEUMOTHORAX	RESPIROLOGY			English	Meeting Abstract									[Hiroki, Ebana; Ando, Katsutoshi; Takahashi, Kazuhisa; Seyama, Kuniaki] Juntendo Univ, Grad Sch Med, Div Resp Med, Tokyo, Japan; [Mizobuchi, Teruaki; Kurihara, Masatoshi] Nissan Tamagawa Hosp, Pneumothorax Res Ctr, Tokyo, Japan; [Mizobuchi, Teruaki; Kurihara, Masatoshi] Nissan Tamagawa Hosp, Div Thorac Surg, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	719	79	79				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400276		
J	Yasuda, Y; Taguchi, Y; Tanaka, E; Hajiro, T; Hashimoto, S; Yasuda, T; Kaji, Y; Okamori, S; Yasuda, I; Morimoto, C; Inao, T; Hamao, N; Noma, S				Yasuda, Yuto; Taguchi, Yoshio; Tanaka, Eisaku; Hajiro, Takashi; Hashimoto, Seishu; Yasuda, Takehiro; Kaji, Yusuke; Okamori, Satoshi; Yasuda, Ikko; Morimoto, Chie; Inao, Takashi; Hamao, Nobuyoshi; Noma, Satoshi			COMPARISON OF RESPONSE TO METHYLPREDNISOLONE PULSE THERAPY ON DRUG-INDUCED LUNG INJURY IN PATIENTS OF NON-SMALL CELL LUNG CANCER WITH OR WITHOUT INTERSTITIAL LUNG DISEASES	RESPIROLOGY			English	Meeting Abstract									[Yasuda, Yuto] Tenri Hosp, Dept Resp Med, Tenri, Nara, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	418	83	83				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400292		
J	Takeyasu, M; Takahashi, Y; Ogawa, K; Murase, K; Mochizuki, S; Hanata, S; Uruga, K; Takaya, H; Miyamoto, A; Morokawa, N; Kishi, K				Takeyasu, Makiko; Takahashi, Yui; Ogawa, Kazumasa; Murase, Kyoko; Mochizuki, Sayaka; Hanata, Shigeo; Uruga, Kiminori; Takaya, Hisashi; Miyamoto, Atsushi; Morokawa, Nasa; Kishi, Kazuma			NONINVASIVE VENTILATION IN PATIENTS WITH ACUTE EXACERBATION OF INTERSTITIAL PNEUMONIA	RESPIROLOGY			English	Meeting Abstract									[Takeyasu, Makiko] Toranomon Gen Hosp, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	545	84	84				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400297		
J	Okuda, R; Matsushima, H; Aoshiba, K; Oba, T; Kawabe, R; Honda, K; Amano, M; Sato, S; Fujiwara, N; Nunokawa, H				Okuda, Ryo; Matsushima, Hidekazu; Aoshiba, Kazutetsu; Oba, Tomohiro; Kawabe, Rie; Honda, Koujiro; Amano, Masako; Sato, Shintaro; Fujiwara, Naoko; Nunokawa, Hiroki			SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 FOR STABLE AND ACUTE PHASES OF IDIOPATHIC PULMONARY FIBROSIS	RESPIROLOGY			English	Meeting Abstract									[Okuda, Ryo] Saitama Red Cross Hosp, Saitama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	670	85	85				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400302		
J	Nakaya, T; Nakayama, M; Mato, N; Yamasawa, H; Bando, M; Sugiyama, Y				Nakaya, Takakiyo; Nakayama, Masayuki; Mato, Naoko; Yamasawa, Hideaki; Bando, Masashi; Sugiyama, Yukihiko			CLINICAL CHARACTERISTICS OF MPO-ANCA POSITIVE PATIENTS WITH PULMONARY INVOLVEMENT	RESPIROLOGY			English	Meeting Abstract									[Nakaya, Takakiyo] Jichi Med Univ, Dept Med, Div Pulm Med, Shimotsuke, Tochigi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	673	86	86				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400303		
J	Ramadhaniah, F				Ramadhaniah, Fariha			NEUROLOGY CLINICAL FEATURES OF LUNG CANCER PATIENTS WITH BRAIN METASTASES IN DHARMAIS NATIONAL CANCER HOSPITAL (NCH), JAKARTA	RESPIROLOGY			English	Meeting Abstract						clinical features; lung cancer; brain metastases			[Ramadhaniah, Fariha] Dharmais Natl Canc Ctr, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	18	87	87				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400309		
J	Harada, H; Miyamoto, K; Yamashita, Y; Tsubokawa, N; Okada, M				Harada, Hiroaki; Miyamoto, Kazuaki; Yamashita, Yoshinori; Tsubokawa, Norifumi; Okada, Morihito			EPIGENETIC INACTIVATION OF MDFI PREDICTS POOR RECURRENCE-FREE SURVIVAL AFTER COMPLETE RESECTION OF PATHOLOGIC STAGE I NON-SMALL CELL LUNG CANCER	RESPIROLOGY			English	Meeting Abstract									[Harada, Hiroaki; Yamashita, Yoshinori; Tsubokawa, Norifumi] NHO Kure Med Ctr, Chugoku Canc Ctr, Dept Resp Surg, Kure, Japan; [Miyamoto, Kazuaki] NHO Higashihiroshima Med Ctr, Dept Surg, Higashihiroshima, Japan; [Okada, Morihito] Hiroshima Univ Hosp, Dept Surg Oncol, Hiroshima, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	103	88	88				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400311		
J	Kazuyori, T; Fujimoto, S; Yamanaka, Y; Shinohara, W; Komatsu, A; Ichikawa, A; Kojima, A; Kuwano, K				Kazuyori, Taisuke; Fujimoto, Shota; Yamanaka, Yumie; Shinohara, Wakako; Komatsu, Akina; Ichikawa, Akihiro; Kojima, Akira; Kuwano, Kazuyoshi			PROGNOSIS OF PATIENTS WITH NON-SMALL CELL LUNG CANCER RECEIVED CARBOPLATIN, PACLITAXEL AND BEVACIZUMAB (CPB).	RESPIROLOGY			English	Meeting Abstract									[Kazuyori, Taisuke; Fujimoto, Shota; Yamanaka, Yumie; Shinohara, Wakako; Komatsu, Akina; Ichikawa, Akihiro; Kojima, Akira] Jikei Univ, Sch Med, Katsushika Med Ctr, Div Resp Med, Tokyo, Japan; [Kuwano, Kazuyoshi] Jikei Univ, Sch Med, Div Resp Med, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	137	88	88				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400313		
J	Morikawa, N; Sugawara, S; Miyauchi, E; Inoue, A; Ichinose, M				Morikawa, Naoto; Sugawara, Shunichi; Miyauchi, Eisaku; Inoue, Akira; Ichinose, Masakazu			PHASE II STUDY OF CARBOPLATIN (CBDCA) PLUS WEEKLY NAB-PACLITAXEL (NAB-PTX) IN ELDERLY PATIENTS (PTS) WITH NON-SMALL CELL LUNG CANCER (NSCLC): NORTH JAPAN LUNG CANCER STUDY GROUP TRIAL 1301	RESPIROLOGY			English	Meeting Abstract									[Morikawa, Naoto] Iwate Med Univ, Div Pulm Med Allergy & Rheumatol, Dept Internal Med, Sch Med, Morioka, Iwate, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	183	89	89				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400317		
J	Sakamoto, Y; Mitani, A; Papadaki, V; Sasai, N; Isago, H; Saito, A; Horie, M; Davaapil, H; Ohnuma, S; Nagase, T				Sakamoto, Yukiyo; Mitani, Akihisa; Papadaki, Vasiliki; Sasai, Noriaki; Isago, Hideaki; Saito, Akira; Horie, Masafumi; Davaapil, Hongorzul; Ohnuma, Shinichi; Nagase, Takahide			ROLE OF PRELP AND OMD IN NON-SMALL CELL LUNG CANCER	RESPIROLOGY			English	Meeting Abstract									[Sakamoto, Yukiyo] Univ Tokyo, Grad Sch Med, Dept Resp Med, Tokyo 1138654, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	392	93	93				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400333		
J	Chiba, R; Morikawa, N; Saito, H; Moriguchi, S; Moriguchi, N; Nagashima, H; Sekimura, K; Nakamura, Y; Shigeeda, W; Deguchi, H; Tomoyasu, M; Tanita, T; Yamauchi, K				Chiba, Ryosuke; Morikawa, Naoto; Saito, Heisuke; Moriguchi, Satoshi; Moriguchi, Naomi; Nagashima, Hiromi; Sekimura, Kenshi; Nakamura, Yutaka; Shigeeda, Wataru; Deguchi, Hiroyuki; Tomoyasu, Makoto; Tanita, Tatsuo; Yamauchi, Kohei			EVALUATION OF EGFR-TKIS EFFICACY ACCORDING TO MUTATION TYPE AND BODY SIZE IN PATIENTS WITH NON-SMALL CELL LUNG CANCER HARBOURING EGFR MUTATIONS	RESPIROLOGY			English	Meeting Abstract									[Chiba, Ryosuke; Morikawa, Naoto; Saito, Heisuke; Moriguchi, Satoshi; Moriguchi, Naomi; Nagashima, Hiromi; Sekimura, Kenshi; Nakamura, Yutaka; Yamauchi, Kohei] Iwate Med Univ, Sch Med, Dept Internal Med, Div Pulm Med Allergy & Rheumatol, Morioka, Iwate, Japan; [Shigeeda, Wataru; Deguchi, Hiroyuki; Tomoyasu, Makoto; Tanita, Tatsuo] Iwate Med Univ, Sch Med, Dept Resp Surg, Morioka, Iwate, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	411	94	94				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400335		
J	Matsuo, A; Sonehara, K; Makino, M; Kawaguchi, K; Kanemoto, R; Shionoya, R; Nakamura, E				Matsuo, Akemi; Sonehara, Kei; Makino, Mutsuki; Kawaguchi, Kenji; Kanemoto, Ryoko; Shionoya, Rie; Nakamura, Emiko			CELL BLOCK PREPARATION OF MALIGNANT PLEURAL EFFUSION IN 30 CASES. - A SIMPLE AND USEFUL DIAGNOSTIC PROCEDURE	RESPIROLOGY			English	Meeting Abstract									[Matsuo, Akemi; Sonehara, Kei] Shinonoi Gen Hosp, Dept Diagnost Pathol, Nagano, Japan; [Makino, Mutsuki; Kawaguchi, Kenji] Shinonoi Gen Hosp, Dept Clin Lab, Nagano, Japan; [Kanemoto, Ryoko; Shionoya, Rie; Nakamura, Emiko] Shinonoi Gen Hosp, Nagano, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	453	95	95				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400339		
J	Kato, R; Fujimoto, D; Morimoto, T; Nagata, K; Nakagawa, A; Otsuka, K; Hatachi, Y; Katakami, N; Imai, Y; Tomii, K				Kato, Ryoji; Fujimoto, Daichi; Morimoto, Takeshi; Nagata, Kazuma; Nakagawa, Atsushi; Otsuka, Kojiro; Hatachi, Yukimasa; Katakami, Nobuyuki; Imai, Yukihiro; Tomii, Keisuke			PROGNOSTIC IMPACT OF DECREASING DIETARY INTAKE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER WHO RECEIVED CHEMOTHERAPY	RESPIROLOGY			English	Meeting Abstract									[Kato, Ryoji] Kobe City Med Ctr Gen Hosp, Kobe, Hyogo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	463	96	96				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400340		
J	Niwa, T; Yoshioka, H; Ikeo, S; Morit, M; Ito, Y; Sone, N; Takaiwa, T; Ito, A; Yokoyama, T; Tachibana, H; Arita, M; Hashimoto, T; Ishida, T				Niwa, Takashi; Yoshioka, Hiroshige; Ikeo, Satoshi; Morit, Mitsunori; Ito, Yuhei; Sone, Naoyuki; Takaiwa, Takuya; Ito, Akihiro; Yokoyama, Toshihide; Tachibana, Hiromasa; Arita, Machiko; Hashimoto, Toru; Ishida, Tadashi			SHORT HYDRATION USING FUROSEMIDE IN CISPLATINE-BASED CHEMOTHERAPY IN PATIENTS WITH LUNG CANCER: A PROSPECTIVE COHORT STUDY	RESPIROLOGY			English	Meeting Abstract									[Niwa, Takashi; Yoshioka, Hiroshige; Ikeo, Satoshi; Morit, Mitsunori; Ito, Yuhei; Sone, Naoyuki; Takaiwa, Takuya; Ito, Akihiro] Kurashiki Cent Hosp, Dept Respirol, Kurashiki, Okayama, Japan; [Niwa, Takashi] Matsunami Gen Hosp, Dept Respirol, Hashima, Gifu, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	508	96	96				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400342		
J	Sato, Y; Fujimoto, D; Imai, Y; Tomii, K				Sato, Yuki; Fujimoto, Daichi; Imai, Yukihiro; Tomii, Keisuke			ANALYSIS OF CLINICAL CHARACTERISTICS OF YOUNG ADVANCED NON-SMALL-CELL LUNG CARCINOMA	RESPIROLOGY			English	Meeting Abstract									[Sato, Yuki] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo, Japan							Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	478	96	96				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400341		
J	Kuribayashi, K; Ieki, R; Terada, T; Otsuki, TI; Mikami, K; Kamiya, H; Masachika, E; Tanaka, A; Nishizaki, T; Nakano, T				Kuribayashi, Kozo; Ieki, Ryuji; Terada, Takayuki; Otsuki, Tai-Ichiro; Mikami, Koji; Kamiya, Hitomi; Masachika, Eriko; Tanaka, Akito; Nishizaki, Tomoyuki; Nakano, Takashi			POTENT ANTI-MESOTHELIOMA ACTIVITY OF NOVEL NAFTOPIDIL ANALOGUE HUHS1015	RESPIROLOGY			English	Meeting Abstract									[Kuribayashi, Kozo] Hyogo Coll Med, Dept Internal Med, Div Resp Med, Nishinomiya, Hyogo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	581	97	97				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400348		
J	Takagi, I; Yoshimatsu, Y; Suginaka, M; Furukawa, K; Nakamura, N; Yamairi, K; Kagawa, N; Yoshida, Y; Takata, M; Miyamoto, N; Otani, K; Kamimori, T				Takagi, Ikumi; Yoshimatsu, Yuki; Suginaka, Miho; Furukawa, Koichi; Nakamura, Naoki; Yamairi, Kazushi; Kagawa, Naomi; Yoshida, Yae; Takata, Munetake; Miyamoto, Natsuko; Otani, Kenichiro; Kamimori, Takao			POLYARTHRITIS AS THE FIRST SIGN OF LUNG CANCER	RESPIROLOGY			English	Meeting Abstract									[Takagi, Ikumi] Yodogawa Christians Hosp, Osaka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	590	98	98				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400349		
J	Takata, M; Suginaka, M; Furukawa, K; Nakamura, N; Yoshimatsu, Y; Yamairi, K; Yoshida, Y; Miyamoto, N; Otani, K; Kamimori, T; Fujiwara, H				Takata, Munetake; Suginaka, Miho; Furukawa, Koichi; Nakamura, Naoki; Yoshimatsu, Yuki; Yamairi, Kazushi; Yoshida, Yae; Miyamoto, Natsuko; Otani, Kenichiro; Kamimori, Takao; Fujiwara, Hiroshi			A CASE OF SMALL CELL CARCINOMA IN THE TRACHEA	RESPIROLOGY			English	Meeting Abstract									[Takata, Munetake] Yodogawa Christians Hosp, Osaka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	599	98	98				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400350		
J	Ando, K; Fukui, M; Suzuki, K; Oh, S; Suzuki, K; Takahashi, K; Takamochi, K				Ando, Katsutoshi; Fukui, Mariko; Suzuki, Kazuhiro; Oh, Shiaki; Suzuki, Kenji; Takahashi, Kazuhisa; Takamochi, Kazuya			CLINICAL FEATURES OF LUNG CANCER AND EFFECT OF ITS RESECTION ON PULMONARY FUNCTION IN PATIENTS WITH COMBINED PULMONARY FIBROSIS AND EMPHYSEMA	RESPIROLOGY			English	Meeting Abstract									[Ando, Katsutoshi; Takahashi, Kazuhisa] Juntendo Univ, Dept Resp Med, Tokyo, Japan; [Fukui, Mariko; Oh, Shiaki; Suzuki, Kenji; Takamochi, Kazuya] Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Tokyo, Japan; [Suzuki, Kazuhiro] Juntendo Univ, Sch Med, Dept Radiol, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	698	99	99				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400353		
J	Kato, M; Shukuya, T; Kanemaru, R; Honma, Y; Muraki, K; Shibayama, R; Koyama, R; Shimada, N; Takahashi, F; Sasaki, S; Takahashi, K				Kato, Motoyasu; Shukuya, Takehito; Kanemaru, Ryota; Honma, Yuichiro; Muraki, Keiko; Shibayama, Rina; Koyama, Ryo; Shimada, Naoko; Takahashi, Fumiyuki; Sasaki, Shinichi; Takahashi, Kazuhisa			CEREBRAL INFARCTION IN ADVANCED NON-SMALL CELL LUNG CANCER	RESPIROLOGY			English	Meeting Abstract									[Kato, Motoyasu; Shukuya, Takehito; Kanemaru, Ryota; Honma, Yuichiro; Muraki, Keiko; Shibayama, Rina; Koyama, Ryo; Shimada, Naoko; Takahashi, Fumiyuki; Sasaki, Shinichi; Takahashi, Kazuhisa] Juntendo Univ, Grad Sch Med, Dept Resp Med, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	737	99	99				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400355		
J	Harada, H; Miyamoto, K; Yamashita, Y; Tsubokawa, N; Okada, M				Harada, Hiroaki; Miyamoto, Kazuaki; Yamashita, Yoshinori; Tsubokawa, Norifumi; Okada, Morihito			HOXD METHYLATION STATUS IN THE ORAL EPITHELIUM IS A PROMISING BIOMARKER FOR LUNG CANCER RISK STRATIFICATION	RESPIROLOGY			English	Meeting Abstract									[Harada, Hiroaki; Yamashita, Yoshinori; Tsubokawa, Norifumi] Chugoku Canc Ctr, NHO Kure Med Ctr, Dept Resp Surg, Kure, Japan; [Miyamoto, Kazuaki] NHO Higashihiroshima Med Ctr, Dept Surg, Higashihiroshima, Japan; [Okada, Morihito] Hiroshima Univ Hosp, Dept Surg Oncol, Hiroshima, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	758	100	100				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400358		
J	Yamakawa, D; Nakayama, M; Bando, M; Araki, K; Sekine, T; Nakaya, T; Mato, N; Yamasawa, H; Sugiyama, Y				Yamakawa, Daisuke; Nakayama, Masayuki; Bando, Masashi; Araki, Kouji; Sekine, Toshie; Nakaya, Takakiyo; Mato, Naoko; Yamasawa, Hideaki; Sugiyama, Yukihiko			OUTDOOR PHYSICAL ACTIVITY IN CHRONIC RESPIRATORY DISEASE PATIENTS WHO USE HOME OXYGEN THERAPY	RESPIROLOGY			English	Meeting Abstract									[Yamakawa, Daisuke; Nakayama, Masayuki; Bando, Masashi; Mato, Naoko; Yamasawa, Hideaki; Sugiyama, Yukihiko] Jichi Med Univ, Dept Med, Div Pulm Med, Shimotsuke, Tochigi, Japan; [Araki, Kouji; Sekine, Toshie] Jichi Med Univ Hosp, Rehabil Ctr, Shimotsuke, Tochigi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	118	105	105				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400376		
J	Kamada, N; Yazaki, K; Sato, Y; Sasaki, S; Shibuya, Y				Kamada, Naoko; Yazaki, Kenji; Sato, Yukimi; Sasaki, Shigeki; Shibuya, Yoshimi			DIFFERENCE OF VENTILATOR CONDITIONS IN INTELLIGENT VOLUME ASSURED PRESSURE SUPPORT MODE IN COPD AND RTD	RESPIROLOGY			English	Meeting Abstract									[Kamada, Naoko] AIBA Shoten Inc, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	236	107	107				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400381		
J	Kato, T; Kawai, Y; Kurihara, T; Miyashita, N; Okimoto, N				Kato, Tadashi; Kawai, Yasuhiro; Kurihara, Takeyuki; Miyashita, Naoyuki; Okimoto, Niro			TWO CASE OF PULMONARY CRYPTOCOCCOSIS WITH CAVITY LESIONS THAT REQUIRED FOR DISCRIMINATION OF PULMONARY TUBERCULOSIS	RESPIROLOGY			English	Meeting Abstract									[Kato, Tadashi] Kawasaki Med Univ, Dept Internal Med 1, Kurashiki, Okayama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	246	107	107				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400382		
J	Matsunuma, R; Takato, H; Kase, K; Murakami, S; Kawaura, Y				Matsunuma, Ryo; Takato, Hazuki; Kase, Kazumasa; Murakami, Shinya; Kawaura, Yukimitsu			PATIENTS WITH TERMINAL INTERSTITIAL LUNG DISEASE SHOULD MORE FREQUENTLY RECEIVE PALLIATIVE CARE COMPARED WITH LUNG CANCER	RESPIROLOGY			English	Meeting Abstract									[Matsunuma, Ryo] Komatsu Municipal Hosp, Komatsu, Ishikawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	235	107	107				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400380		
J	Ando, K; Fujino, N; Mitani, K; Ota, C; Okada, Y; Kondo, T; Mizobuchi, T; Kurihara, M; Suzuki, K; Hoshika, Y; Ebana, H; Kobayashi, E; Kubo, H; Seyama, K; Takahashi, K				Ando, Katsutoshi; Fujino, Naoya; Mitani, Keiko; Ota, Chiharu; Okada, Yoshinori; Kondo, Takashi; Mizobuchi, Teruaki; Kurihara, Masatoshi; Suzuki, Kenji; Hoshika, Yoshito; Ebana, Hiroki; Kobayashi, Etsuko; Kubo, Hiroshi; Seyama, Kuniaki; Takahashi, Kazuhisa			A NOVEL METHOD OF ISOLATING INDIVIDUAL CELLS FROM LUNG LESIONS OF LYMPHANGIOLEIOMYOMATOSIS	RESPIROLOGY			English	Meeting Abstract									[Ando, Katsutoshi; Fujino, Naoya; Mitani, Keiko; Ota, Chiharu; Okada, Yoshinori; Kondo, Takashi; Mizobuchi, Teruaki; Kurihara, Masatoshi; Suzuki, Kenji; Hoshika, Yoshito; Ebana, Hiroki; Kobayashi, Etsuko; Kubo, Hiroshi; Seyama, Kuniaki; Takahashi, Kazuhisa] Juntendo Univ, Grad Sch Med, Div Resp Med, Dept Internal Med, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	328	108	108				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400385		
J	Ishii, H; Nakata, K; Tazawa, R; Inoue, Y				Ishii, Haruyuki; Nakata, Koh; Tazawa, Ryushi; Inoue, Yoshikazu			SIGNIFICANCE OF QUANTITATIVE CT FINDINGS BY USING DENSITOMETRY IN PATIENT WITH PULMONARY ALVEOLAR PROTEINOSIS - WHAT RANGE OF DENSITY IS APPLIED IN GROUND GLASS OPACITY IN PATIENTS WITH PAP?	RESPIROLOGY			English	Meeting Abstract									[Ishii, Haruyuki; Nakata, Koh; Tazawa, Ryushi; Inoue, Yoshikazu] Kyorin Univ, Sch Med, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	334	108	108				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400386		
J	Otsuki, Y; Kuwahara, H; Iwasaki, S; Suzuki, A; Furuya, M				Otsuki, Yuji; Kuwahara, Hiroaki; Iwasaki, Sari; Suzuki, Akira; Furuya, Michiko			CASE REPORT: BIRT-HOGG-DUBE SYNDROME WITH RARE MUTATION IN INTRON 10	RESPIROLOGY			English	Meeting Abstract									[Otsuki, Yuji; Kuwahara, Hiroaki; Iwasaki, Sari; Suzuki, Akira; Furuya, Michiko] KKR Sapporo Med Ctr, Sapporo, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	311	108	108				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400384		
J	Kuwahara, H; Ohtsuki, Y; Kondo, K; Adachi, H; Yamashiro, K; Suzuki, H				Kuwahara, Hiroaki; Ohtsuki, Yuji; Kondo, Keishi; Adachi, Hirohumi; Yamashiro, Katsushige; Suzuki, Hiroaki			CASE REPORT: RARE PERIPHERAL LUNG TUMOUR, MUCOUS GLAND ADENOMA, WITH THE AIR CRESCENT SIGN ON CHEST CT	RESPIROLOGY			English	Meeting Abstract									[Kuwahara, Hiroaki; Ohtsuki, Yuji; Kondo, Keishi; Adachi, Hirohumi; Yamashiro, Katsushige; Suzuki, Hiroaki] KKR Sapporo Med Ctr, Sapporo, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	514	111	111				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400398		
J	Mizobuchi, T; Kurihara, M; Yamanaka, S; Ebana, H				Mizobuchi, Teruaki; Kurihara, Masatoshi; Yamanaka, Sumitaka; Ebana, Hiroki			SENSITIVITY OF NARROW BAND IMAGING IN CONJUNCTION WITH WHITE LIGHT FOR DETECTION OF DISSEMINATED THORACIC ENDOMETRIOSIS	RESPIROLOGY			English	Meeting Abstract									[Mizobuchi, Teruaki; Kurihara, Masatoshi; Yamanaka, Sumitaka; Ebana, Hiroki] Nissan Tamagawa Hosp, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	588	112	112				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400399		
J	Ura, M; Tanaka, H; Takahashi, K; Yamazaki, H; Fujimoto, K				Ura, Midori; Tanaka, Hitomi; Takahashi, Kaori; Yamazaki, Haruna; Fujimoto, Keisaku			VALUE OF FRACTIONAL EXHALED NITRIC OXIDE AFTER USING A BETA-2 BRONCHODILATOR IN THE DIFFERENTIAL DIAGNOSIS OF BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE	RESPIROLOGY			English	Meeting Abstract									[Ura, Midori; Tanaka, Hitomi; Takahashi, Kaori; Yamazaki, Haruna; Fujimoto, Keisaku] Shinshu Univ, Dept Clin Lab Sci, Sch Hlth Sci, Matsumoto, Nagano, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	618	112	112				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400401		
J	Murata, Y; Kuwahara, N; Furukawa, H; Yasunari, K; Sougiro, K; Shirai, T; Ohnishi, T; Sagara, H				Murata, Yasunori; Kuwahara, Naota; Furukawa, Hitomi; Yasunari, Kishino; Sougiro, Kusumoto; Shirai, Takao; Ohnishi, Tukasa; Sagara, Hironori			A CASE OF TRACHEAL-MEDIASTINAL FISTULA DUE TO TRACHEAL INVASION BY MALIGNANT LYMPHOMA	RESPIROLOGY			English	Meeting Abstract									[Murata, Yasunori] Showa Univ, Div Allergol & Resp Med, Sch Med, Tokyo, Japan; [Kuwahara, Naota; Furukawa, Hitomi; Yasunari, Kishino; Sougiro, Kusumoto; Shirai, Takao; Ohnishi, Tukasa; Sagara, Hironori] Showa Univ, Sch Med, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	703	114	114				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400407		
J	Marukawa, M; Hirabae, A; Suzaki, N; Nagata, T				Marukawa, Masaomi; Hirabae, Atsko; Suzaki, Noriyuki; Nagata, Takuya			EVALUATION OF AN ENZYME IMMUNOASSAY KIT FOR THE SERODIAGNOSIS OF MYCOBACTERIUM AVIUM COMPLEX PULMONARY DISEASE	RESPIROLOGY			English	Meeting Abstract									[Marukawa, Masaomi; Hirabae, Atsko; Suzaki, Noriyuki; Nagata, Takuya] Kagawa Rosai Hosp, Japan Labour Hlth & Welf Org, Dept Resp Med, Marugame City, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	168	129	129				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400467		
J	Okimoto, N; Kawai, Y; Kato, T; Hayashi, T; Kurihara, T; Miyashita, N				Okimoto, Niro; Kawai, Yasuhiro; Kato, Tadashi; Hayashi, Toshikiyo; Kurihara, Takeyuki; Miyashita, Naoyuki			CLINICAL EFFECT OF BIAPENEM ON NURSING AND HEALTHCARE-ASSOCIATED PNEUMONIA (NHCAP)	RESPIROLOGY			English	Meeting Abstract									[Okimoto, Niro; Kawai, Yasuhiro; Kato, Tadashi; Hayashi, Toshikiyo; Kurihara, Takeyuki; Miyashita, Naoyuki] Kawasaki Hosp, Kawasaki Med Sch, Dept Genera Internal Med 1, Okayama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	227	130	130				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400469		
J	Kinoshita, R; Takeda, K; Takazono, T; Tashiro, M; Saijo, T; Kosai, K; Morinaga, Y; Imamura, Y; Kurihara, S; Tsukamoto, M; Miyazaki, T; Izumikawa, K; Yanagihara, K; Kohno, S				Kinoshita, Rie; Takeda, Kazuaki; Takazono, Takahiro; Tashiro, Masato; Saijo, Tomomi; Kosai, Kosuke; Morinaga, Yoshitomo; Imamura, Yoshifumi; Kurihara, Shintaro; Tsukamoto, Misuzu; Miyazaki, Taiga; Izumikawa, Koichi; Yanagihara, Katsunori; Kohno, Shigeru			CLINICAL CHARACTERISTICS AND MORTALITY PREDICTIVE FACTORS OF CHRONIC NECROTIZING PULMONARY ASPERGILLOSIS AND CHRONIC CAVITARY PULMONARY ASPERGILLOSIS	RESPIROLOGY			English	Meeting Abstract									[Kinoshita, Rie; Takeda, Kazuaki; Takazono, Takahiro; Tashiro, Masato; Saijo, Tomomi; Imamura, Yoshifumi; Kurihara, Shintaro; Tsukamoto, Misuzu; Miyazaki, Taiga; Kohno, Shigeru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Resp Dis, Nagasaki 852, Japan; [Takeda, Kazuaki; Kosai, Kosuke; Morinaga, Yoshitomo; Yanagihara, Katsunori] Nagasaki Univ Hosp, Dept Lab Med, Nagasaki, Japan; [Takazono, Takahiro; Tashiro, Masato; Saijo, Tomomi; Imamura, Yoshifumi; Kurihara, Shintaro; Tsukamoto, Misuzu; Izumikawa, Koichi] Nagasaki Univ, Dept Infect Dis, Grad Sch Biomed Sci, Nagasaki 852, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	296	131	131				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400472		
J	Kuroki, T; Yamasawa, H; Nakayama, M; Mato, N; Nakaya, T; Bando, M; Sugiyama, Y				Kuroki, Tomonori; Yamasawa, Hdeaki; Nakayama, Masayuki; Mato, Naoko; Nakaya, Takakiyo; Bando, Masashi; Sugiyama, Yukihiko			CLINICAL FEATURES OF FOUR CASES WITH ISOLATION OF ASPERGILLUS FROM PLEURAL EFFUSION	RESPIROLOGY			English	Meeting Abstract									[Kuroki, Tomonori; Yamasawa, Hdeaki; Nakayama, Masayuki; Mato, Naoko; Nakaya, Takakiyo; Bando, Masashi; Sugiyama, Yukihiko] Jichi Med Univ, Dept Med, Div Pulm Med, Shimotsuke, Tochigi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	348	132	132				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400475		
J	Oka, K; Takeda, N; Kuramae, H; Shibata, H; Kitagawa, H; Katoh, T				Oka, Keisuke; Takeda, Naoya; Kuramae, Hitoshi; Shibata, Hirofumi; Kitagawa, Hiroyoshi; Katoh, Toshiyuki			USEFULNESS OF BLOOD CULTURE BOTTLE CULTURE OF PLEURAL EFFUSION IN A BACTERIAL PLEURISY AND EMPYEMA	RESPIROLOGY			English	Meeting Abstract									[Oka, Keisuke; Takeda, Naoya; Kuramae, Hitoshi; Shibata, Hirofumi; Kitagawa, Hiroyoshi; Katoh, Toshiyuki] Kariya Toyota Gen Hosp, Kariya, Aichi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	333	132	132				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400474		
J	Nakamoto, K; Saraya, T; Sada, M; Inui, T; Ogawa, Y; Koide, T; Takata, S; Watanabe, M; Yokoyama, T; Kurai, D; Ishii, H; Takizawa, H				Nakamoto, Keitaro; Saraya, Takeshi; Sada, Mitsuru; Inui, Toshiya; Ogawa, Yukari; Koide, Takashi; Takata, Saori; Watanabe, Masato; Yokoyama, Takuma; Kurai, Daisuke; Ishii, Haruyuki; Takizawa, Hajime			RESPIRATORY INFECTIONS IN PATIENTS UNDERGOING FIRST-LINE BIOLOGIC THERAPY FOR RHEUMATOID ARTHRITIS	RESPIROLOGY			English	Meeting Abstract									[Nakamoto, Keitaro; Saraya, Takeshi; Sada, Mitsuru; Inui, Toshiya; Ogawa, Yukari; Koide, Takashi; Takata, Saori; Watanabe, Masato; Yokoyama, Takuma; Kurai, Daisuke; Ishii, Haruyuki; Takizawa, Hajime] Kyorin Univ, Sch Med, Dept Resp Med, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	395	133	133				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400478		
J	Kawai, Y; Miyashita, N; Kato, T; Kurihara, T; Okimoto, N				Kawai, Yasuhiro; Miyashita, Naoyuki; Kato, Tadashi; Kurihara, Takeyuki; Okimoto, Niro			PREVALENCE OF EXTRA-PULMONARY COMPLICATIONS AND SEVERE PNEUMONIA ASSOCIATED WITH MYCOPLASMA PNEUMONIAE PNEUONIA IN ADOLESCENTS AND ADULTS	RESPIROLOGY			English	Meeting Abstract									[Kawai, Yasuhiro; Miyashita, Naoyuki; Kato, Tadashi; Kurihara, Takeyuki; Okimoto, Niro] Kawasaki Med Univ, Dept Internal Med 1, Kawasaki, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	532	134	134				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400482		
J	Yamawaki, S; Aoshima, M; Nakashima, K; Suzuki, F; Otsuki, A; Watanabe, J; Takai, M; Katsurada, M; Katsurada, N; Misawa, M; Otuska, Y				Yamawaki, Satoshi; Aoshima, Masahiro; Nakashima, Kei; Suzuki, Fumi; Otsuki, Ayumu; Watanabe, Junko; Takai, Motohisa; Katsurada, Masahiro; Katsurada, Naoko; Misawa, Masafumi; Otuska, Yoshihito			NASOPHARYNGEAL CARRIAGE OF STREPTOCOCCUS PNEUMONIAE IN ASPIRATION PNEUMONIA PATIENTS: A SINGLE CENTRE PROSPECTIVE COHORT STUDY	RESPIROLOGY			English	Meeting Abstract									[Yamawaki, Satoshi; Aoshima, Masahiro; Nakashima, Kei; Suzuki, Fumi; Otsuki, Ayumu; Watanabe, Junko; Takai, Motohisa; Katsurada, Masahiro; Katsurada, Naoko; Misawa, Masafumi] Kameda Med Ctr, Dept Pulm Med, Tokyo, Japan; [Otuska, Yoshihito] Kameda Med Ctr, Dept Lab Med, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	747	137	137				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400494		
J	Hino, M; Tanaka, Y; Onda, N; Katoh, Y; Kobayashi, Y; Kosaihira, S; Motohashi, N; Ookubo, T				Hino, Mitsunori; Tanaka, Yosuke; Onda, Naomi; Katoh, Yasuhiro; Kobayashi, Yumiko; Kosaihira, Seiji; Motohashi, Norihisa; Ookubo, Teruyoshi			INFLUENCE OF INFLUENZA VIRUS INFECTION ON HOSPITALIZATION DUE TO PNEUMONIA OF VERY ELDERLY JAPANESE PATIENTS	RESPIROLOGY			English	Meeting Abstract									[Hino, Mitsunori; Tanaka, Yosuke; Onda, Naomi; Katoh, Yasuhiro; Kobayashi, Yumiko; Kosaihira, Seiji; Motohashi, Norihisa] Nippon Med Sch, Dept Resp Med, INBAHITEC Med Ctr, Sendai, Miyagi, Japan; [Ookubo, Teruyoshi] Ookubo Mem Hosp, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	762	138	138				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400495		
J	Mio, T; Miura, Y; Uchida, T; Shinomiya, S; Miyauchi, S; Noguchi, T; Yamazaki, S; Uchida, Y; Komiyama, K; Nagai, Y; Miyashita, T; Ohta, H; Nakagome, K; Soma, T; Nakamura, H; Kanazawa, M; Nagata, M				Mio, Tomohiko; Miura, Yu; Uchida, Takahiro; Shinomiya, Shun; Miyauchi, Sachiko; Noguchi, Toru; Yamazaki, Susumu; Uchida, Yoshitaka; Komiyama, Kenichiro; Nagai, Yoshiaki; Miyashita, Tatsuyuki; Ohta, Hiromitsu; Nakagome, Kazuyuki; Soma, Tomoyuki; Nakamura, Hidetoshi; Kanazawa, Minoru; Nagata, Makoto			INVESTIGATION OF NOCTURNAL SLEEP DISORDER IN PATIENTS WITH ASTHMA	RESPIROLOGY			English	Meeting Abstract									[Mio, Tomohiko; Miura, Yu; Uchida, Takahiro; Shinomiya, Shun; Miyauchi, Sachiko; Noguchi, Toru; Yamazaki, Susumu; Uchida, Yoshitaka; Komiyama, Kenichiro; Nagai, Yoshiaki; Miyashita, Tatsuyuki; Ohta, Hiromitsu; Nakagome, Kazuyuki; Soma, Tomoyuki; Nakamura, Hidetoshi; Kanazawa, Minoru; Nagata, Makoto] Saitama Med Univ, Dept Resp Med, Saitama, Japan; [Miyashita, Tatsuyuki] Matsuda Hosp, Sendai, Miyagi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	263	140	140				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400503		
J	Yamazaki, H; Fujimoto, K; Ura, M; Osaki, R				Yamazaki, Haruna; Fujimoto, Keisaku; Ura, Midori; Osaki, Rie			MEASUREMENT OF DYNAMIC LUNG COMPLIANCE USING THE METHOD OF PHOTOPLETHYSMOGRAPHY IN PATIENTS WITH COPD, ASTHMA AND PULMONARY FIBROSIS	RESPIROLOGY			English	Meeting Abstract									[Yamazaki, Haruna; Ura, Midori] Shinshu Univ, Grad Sch Med, Dept Biomed Lab Sci, Matsumoto, Nagano, Japan; [Fujimoto, Keisaku] Shinshu Univ, Sch Hlth Sci, Dept Clin Lab Sci, Matsumoto, Nagano, Japan; [Osaki, Rie] DENSO CORP, Healthcare Business Dept, Matsumoto, Nagano, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	DEC	2015	20			3	SI	391	142	142				1	Respiratory System	Respiratory System	CX8KN	WOS:000365952400510		
J	Pastene, LA; Acevedo, J; Siciliano, S; Sholl, TGC; de Moura, JF; Ott, PH; Aguayo-Lobo, A				Pastene, Luis A.; Acevedo, Jorge; Siciliano, Salvatore; Sholl, Thais G. C.; de Moura, Jailson F.; Ott, Paulo Henrique; Aguayo-Lobo, Anelio			Population genetic structure of the South American Bryde's whale	REVISTA DE BIOLOGIA MARINA Y OCEANOGRAFIA			English	Article						Balaenoptera brydei; mitochondrial DNA; eastern South Pacific; western South Atlantic	MITOCHONDRIAL-DNA; BALAENOPTERA-ACUTOROSTRATA; MEGAPTERA-NOVAEANGLIAE; CONTROL REGION; BRAZIL; SUBSTITUTIONS; SEQUENCES; PACIFIC; EDENI	A genetic analysis based on mitochondrial DNA control region sequences was conducted to investigate both species identity and populations genetic structure of South American Bryde's whales. The genetic analysis was based on historical, biopsy and stranding samples from Chile (n=10) and Brazil (n=8). For comparative purposes published sequences of the Bryde's whales from different localities of the Indian and Pacific Oceans (including Peru, n=24) were incorporated into the analysis. Results of the phylogenetic analysis identified the Bryde's whales of South America as Balaenoptera brydei. No statistically significant genetic differentiation was found between Chilean and Peruvian Bryde's whales. However, striking differences were found between western South Atlantic (Brazil) and eastern South Pacific (Peru and Chile) animals. In addition, striking genetic differences were found between all South American localities and those from the western North Pacific, Fiji and Java. These results suggest movement of B. brydei in the eastern South Pacific in the latitudinal range corresponding to Chile and Peru. These results also suggest no or very limited movement of whales between the South Pacific and the South Atlantic Oceans. This is consistent with the notion that B. brydei is not distributed further south of approximately 40 degrees S on both sides of South America.	[Pastene, Luis A.] Inst Cetacean Res, Chuo Ku, Tokyo 1040055, Japan; [Acevedo, Jorge] Fdn CEQUA, Ctr Estudios Cuaternario Fuego Patagonia & Antart, Punta Arenas 1690, Chile; [Siciliano, Salvatore; Sholl, Thais G. C.; de Moura, Jailson F.] Escola Nacl Saude Publ FIOCRUZ, BR-21041210 Rio De Janeiro, RJ, Brazil; [Siciliano, Salvatore; Sholl, Thais G. C.] Grp Estudos Mamiferos Marinhos Regiao Lagos GEMM, BR-21041210 Rio De Janeiro, RJ, Brazil; [de Moura, Jailson F.] Leibniz Ctr Trop Marine Ecol ZMT, Syst Ecol, D-28359 Bremen, Germany; [Ott, Paulo Henrique] UERGS, BR-95625000 Rio Grande Do Sul, RS, Brazil; [Ott, Paulo Henrique] Grp Estudos Mamiferos Aquat Rio Grande Sul GEMARS, BR-95625000 Rio Grande Do Sul, RS, Brazil; [Aguayo-Lobo, Anelio] Inst Antartico, Punta Arenas, Chile	Pastene, LA (reprint author), Inst Cetacean Res, Chuo Ku, Toyomi 4-5, Tokyo 1040055, Japan.	jorge.acevedo@cequa.cl			CONICYT [R13A1002]; CAPES [BEX 0128/14-7]; Alexander von Humboldt Foundation [BEX 0128/14-7]	We thank M. Goto, Institute of Cetacean Research, for his assistance in the analysis of data. We also thank the researchers from GEMARS for collaborating in the collection and necropsies of the specimens along the Brazilian coast. We are also grateful to the respective Directorships of Fundacion CEQUA and Instituto Antartico Chileno for providing time for preparation of the manuscript (CONICYT Regional Grant number R13A1002), and Inti Gonzalez of CEQUA for the preparation of map in SIG. J. F. Moura gratefully acknowledge CAPES and the Alexander von Humboldt Foundation for financial support (Proc. BEX 0128/14-7).	Aguayo Anelio, 1998, Revista de Biologia Marina y Oceanografia, V33, P101; Yoshida H, 1999, MAR MAMMAL SCI, V15, P1269, DOI 10.1111/j.1748-7692.1999.tb00890.x; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Engel MH, 2008, CONSERV GENET, V9, P1253, DOI 10.1007/s10592-007-9453-5; BAKER CS, 1994, MOL ECOL, V3, P313, DOI 10.1111/j.1365-294X.1994.tb00071.x; Kanda N, 2007, CONSERV GENET, V8, P853, DOI 10.1007/s10592-006-9232-8; Pastene LA, 2007, MOL ECOL, V16, P1481, DOI 10.1111/j.1365-294X.2007.03244.x; Andriolo A, 2010, ZOOLOGIA-CURITIBA, V27, P741, DOI 10.1590/S1984-46702010000500011; Pastene LA, 2010, CONSERV GENET, V11, P1553, DOI 10.1007/s10592-009-9944-7; Kershaw F, 2013, J HERED, V104, P755, DOI 10.1093/jhered/est057; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Siciliano S, 2004, J MAR BIOL ASSOC UK, V84, P857, DOI 10.1017/S0025315404010082h; Cassens I, 2003, MOL ECOL, V12, P1781, DOI 10.1046/j.1365-294X.2003.01876.x; Artico LO, 2010, BRAZ J MED BIOL RES, V43, P816, DOI 10.1590/S0100-879X2010007500074; Krutzen M, 2002, MAR MAMMAL SCI, V18, P863, DOI 10.1111/j.1748-7692.2002.tb01078.x; Wada S, 2003, NATURE, V426, P278, DOI 10.1038/nature02103; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Nielsen R, 2001, GENETICS, V158, P885; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Arnason U, 1993, J MOL BIOL EVOLUTION, V70, P960; Bastida R, 2009, MARINE MAMMALS PATAG; Clarke R., 1965, Norsk Hvalfangsttidende Sandefjord, V54, P141; Donovan G.P., 1991, Reports of the International Whaling Commission Special Issue, P39; Felsenstein J, 1993, PHYLIP PHYLOGENNY IN; Figueiredo L.D., 2014, Brazilian Journal of Aquatic Science and Technology, V18, P59; Gallardo VA, 1983, REPORT INT WHALING C, V33, P481; Maddison DR, 2000, ANAL PHYLOGENY CHARA; NEI M, 1987, MOL EVOLUTIONARY GEN; Pastene LA., 1982, THESIS; Rice DW, 1998, SPECIAL PUBLICATION, V4; Sambrook J., 2001, MOL CLONING LAB MANU; TAMURA K, 1993, MOL BIOL EVOL, V10, P512; Valdivia J, 1981, REPORT INT WHALING C, V31, P441; Zerbini Alexandre N., 1997, Report of the International Whaling Commission, V47, P407	35	0	0	UNIV VALPARAISO	VINA DEL MAR	FACULTAD CIENCIAS MAR RECURSOS NATURALES, CASILLA 5080 - RENACA, VINA DEL MAR, 00000, CHILE	0717-3326	0718-1957		REV BIOL MAR OCEANOG	Rev. Biol. Mar. Oceanogr.	DEC	2015	50	3					453	464				12	Marine & Freshwater Biology; Oceanography	Marine & Freshwater Biology; Oceanography	CY3DH	WOS:000366288000005		
J	Pyo, Y; Nakashima, K; Kuwahata, S; Kurazume, R; Tsuji, T; Morooka, K; Hasegawa, T				Pyo, Yoonseok; Nakashima, Kouhei; Kuwahata, Shunya; Kurazume, Ryo; Tsuji, Tokuo; Morooka, Ken'ichi; Hasegawa, Tsutomu			Service robot system with an informationally structured environment	ROBOTICS AND AUTONOMOUS SYSTEMS			English	Article						Informationally structured environment; Intelligent space; Distributed sensor; Service robot; Robot operating system; Motion planning	HOME AUTOMATION SYSTEM	Daily life assistance is one of the most important applications for service robots. For comfortable assistance, service robots must recognize the surrounding conditions correctly, including human motion, the position of objects, and obstacles. However, since the everyday environment is complex and unpredictable, it is almost impossible to sense all of the necessary information using only a robot and sensors attached to it. In order to realize a service robot for daily life assistance, we have been developing an informationally structured environment using distributed sensors embedded in the environment. The present paper introduces a service robot system with an informationally structured environment referred to the ROS-TMS. This system enables the integration of various data from distributed sensors, as well as storage of these data in an on-line database and the planning of the service motion of a robot using real-time information about the surroundings. In addition, we discuss experiments such as detection and fetch-and-give tasks using the developed real environment and robot. (C) 2015 The Authors. Published by Elsevier B.V.	[Pyo, Yoonseok; Nakashima, Kouhei; Kuwahata, Shunya] Kyushu Univ, Grad Sch Informat Sci & Elect Engn, Nishi Ku, Fukuoka, Fukuoka 8190395, Japan; [Kurazume, Ryo; Tsuji, Tokuo; Morooka, Ken'ichi] Kyushu Univ, Fac Informat Sci & Elect Engn, Nishi Ku, Fukuoka, Fukuoka 8190395, Japan; [Hasegawa, Tsutomu] Kumamoto Natl Coll Technol, Koshi, Kumamoto 8611102, Japan	Pyo, Y (reprint author), Kyushu Univ, Grad Sch Informat Sci & Elect Engn, Nishi Ku, 744 Motooka, Fukuoka, Fukuoka 8190395, Japan.	pyo@irvs.ait.kyushu-u.ac.jp			JSPS KAKENHI [263244, 26249029]; Japan Science and Technology Agency (JST) through its "Center of Innovation Science and Technology based Radical Innovation and Entrepreneurship Program (COI Program)"	This research is supported in part by a JSPS KAKENHI Grant Number 263244, a Grant-in-Aid for Scientific Research (A) (26249029) and the Japan Science and Technology Agency (JST) through its "Center of Innovation Science and Technology based Radical Innovation and Entrepreneurship Program (COI Program)."	Alimi P., SEMANTIC PERCEPTION, V7; Tan JD, 2003, INT J ROBOT RES, V22, P337; Kim M, 2009, IEEE ROBOT AUTOM MAG, V16, P34, DOI 10.1109/MRA.2008.931636; Kogure K, 2003, IROS 2003: PROCEEDINGS OF THE 2003 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P1826; Kato Y, 2011, IEEE IND ELEC, P2158, DOI 10.1109/IECON.2011.6119642; [Anonymous], 2015, IEEE S ROB INT INF S; Dehais F, 2011, APPL ERGON, V42, P785, DOI 10.1016/j.apergo.2010.12.005; Alheraish A, 2004, IEEE T CONSUM ELECTR, V50, P1087, DOI 10.1109/TCE.2004.1362503; Pyo Y, 2014, SENSORS-BASEL, V14, P7524, DOI 10.3390/s140407524; INOUE M, 1985, IEEE T CONSUM ELECTR, V31, P516, DOI 10.1109/TCE.1985.289966; Murakami K, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION (ICRA), P2210, DOI 10.1109/ICRA.2012.6225329; Lee JH, 2002, ADV ROBOTICS, V16, P265, DOI 10.1163/156855302760121936; KAWAMURA K, 1994, IROS '94 - INTELLIGENT ROBOTS AND SYSTEMS: ADVANCED ROBOTIC SYSTEMS AND THE REAL WORLD, VOLS 1-3, P1647, DOI 10.1109/IROS.1994.407636; Nozawa S, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P1558, DOI 10.1109/IROS.2008.4650903; Tenorth M, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION (ICRA), P1284, DOI 10.1109/ICRA.2012.6224812; Gross HM, 2011, IEEE SYS MAN CYBERN, P2481, DOI 10.1109/ICSMC.2011.6084050; Nozawa S, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION (ICRA), P1428, DOI 10.1109/ICRA.2012.6224884; Kim JH, 2007, IEEE INT CONF ROBOT, P2853, DOI 10.1109/ROBOT.2007.363904; Lee JH, 2004, IEEE-ASME T MECH, V9, P535, DOI 10.1109/TMECH.2004.834655; Arndt M, 2013, ROBOT AUTON SYST, V61, P1173, DOI 10.1016/j.robot.2013.04.007; Nugent CD, 2008, IEEE T AUTOM SCI ENG, V5, P1, DOI 10.1109/TASE.2007.912247; Lamiraux F, 2004, IEEE T ROBOTIC AUTOM, V20, P967, DOI 10.1109/TRO.2004.829459; Broxvall M., 2007, P IROS WORKSH UB ROB, P212; Brscic D., IEEE RSJ INT C ROB S; Edsinger Aaron, 2007, 16th IEEE International Conference on Robot and Human Interactive Communication; Hasegawa T., 2006, P 3 INT C UB ROB AMB, P119; Hasegawa T., 2007, P INT C UB ROB AMB I, P22; Hubei N., 2015, ROBOEARTH PROJECT; Kayama K., 2003, P 2003 IEEE RSJ INT, V3, P2606, DOI 10.1109/IROS.2003.1249263; Kim B. K., 2006, INT ROB SYST 2006 IE, P4809; Kim JH, 2005, ADV SOFT COMP, P451; Kim J.-H., P 2 INT C AUT ROB AG; Koay K. L., 2007, AAAI SPRING S MULT C, P18; Kurazume R., 2011, 15 INT S ROB RES ISR; Mori T., 2005, 2005 IEEE/RSJ International Conference on Intelligent Robots and Systems; Morioka Kazuyuki, 2008, Advances in Service Robotics; Murakami K., 2010, INT ROB SYST IROS 20, P3712; Murakami K., 2008, SENSORS, P705; Nakaoka S., IEEE SICE INT S SYST; Nakauchi Y., 2003, INT ROB SYST 2003 IR, V1, P773; Nishida Y., 2003, IEEE RSJ INT C INT R, V1, P785; Nishio S., 2010, Cutting Edge Robotics 2010; Noguchi H., 2006, INT ROB SYST 2006 IE, P2008; Nohara Y., 2010, IEEE RSJ INT C INT R, P1030; Nor N. S. M., INT J ADV ROBOT SYST, V11; Quigley M., 2009, ICRA WORKSH OP SOURC, V3, P5; Roy N., 2000, WORKSH INT ROB ENT W, V25, P184; Saffiotti A., 2005, P JOINT C SMART OBJ, P277, DOI 10.1145/1107548.1107615; Scholz J., 2011, ROB AUT ICAR 2011 IE, P6115; Shinzaki M., 2015, IEEE WINT C APPL COM, P670; Stilman M., 2005, INT J HUM ROBOT, V2, P479, DOI 10.1142/S0219843605000545; Strabala K. W., 2013, J HUMAN ROBOT INTERA, V2, P112, DOI DOI 10.5898/JHRI.2.1.STRABALA; Tan J., 2001, P IEEE RSJ INT C INT, V2, P865; Ukai K, 2009, J ROBOTICS MECHATRON, V21, P489; Waibel M., IEEE ROBOT AUTOM MAG; Gill K, 2009, IEEE T CONSUM ELECTR, V55, P422, DOI 10.1109/TCE.2009.5174403	56	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8890	1872-793X		ROBOT AUTON SYST	Robot. Auton. Syst.	DEC	2015	74		A				148	165		10.1016/j.robot.2015.07.010		18	Automation & Control Systems; Computer Science, Artificial Intelligence; Robotics	Automation & Control Systems; Computer Science; Robotics	CY0BI	WOS:000366070700013		
J	Kawabata, K; Ma, L; Xue, JR; Zhu, CW; Zheng, NN				Kawabata, Kuniaki; Ma, Liang; Xue, Jianru; Zhu, Chengwei; Zheng, Nanning			A path generation for automated vehicle based on Bezier curve and via-points	ROBOTICS AND AUTONOMOUS SYSTEMS			English	Article						Path generation; Automated vehicle; Bezier curve; Designated via-points; Constrained optimization	SYSTEM	This paper presents a path generation method for automated vehicle based on Bezier curve. Derivation of smooth path is one of important subjects for vehicle navigation system. Bezier curve is a smooth parametric curve, but adequate assignment of its control points that determine the shape of Bezier curve is not a simple problem. In the proposed method, first nth-order base Bezier curve in N-dimension is derived with the end point constraints (location and velocity). As a next step, path modification is done by using constrained optimization with designated via-points. The presented method is tested by several calculation experiments in case of 2-dimensional and 3-dimensional path. The results are shown and discussed in this paper. (C) 2015 Elsevier B.V. All rights reserved.	[Kawabata, Kuniaki] RIKEN, RIKEN XJTU Joint Res Unit, Wako, Saitama, Japan; [Kawabata, Kuniaki; Ma, Liang; Xue, Jianru; Zhu, Chengwei; Zheng, Nanning] Xi An Jiao Tong Univ, Inst Artificial Intelligence & Robot, Xian, Peoples R China	Kawabata, K (reprint author), RIKEN, RIKEN XJTU Joint Res Unit, Wako, Saitama, Japan.	kuniakik@riken.jp			NSFC of China [91320301, 61273252]; MEXT of Japan [23300074, 15H03953]	This research was partially supported by the NSFC of China under Grant Nos. 91320301, 61273252 and by Grant-in-Aid for Scientific Research (B), MEXT of Japan (Nos. 23300074, 15H03953).	Jolly KG, 2009, ROBOT AUTON SYST, V57, P23, DOI 10.1016/j.robot.2008.03.009; Maekawa T, 2010, COMPUT AIDED DESIGN, V42, P350, DOI 10.1016/j.cad.2009.12.007; Ferguson D, 2008, J FIELD ROBOT, V25, P939, DOI 10.1002/rob.20265; Paromtchik IE, 2001, IEEE INT CONF ROBOT, P2935; Kuwata Y, 2009, IEEE T CONTR SYST T, V17, P1105, DOI 10.1109/TCST.2008.2012116; Hilario L, 2011, IEEE INT C INT ROBOT, P1567, DOI 10.1109/IROS.2011.6048168; Mukai T, 2010, IEEE INT C INT ROBOT, P5996; Han L, 2010, IEEE INT VEH SYM, P1036, DOI 10.1109/IVS.2010.5548085; Kawabata K, 2013, IEEE ASME INT C ADV, P991, DOI 10.1109/AIM.2013.6584223; Bernstein N.A., 1967, COORDINATION REGULAT; Bezier P., 1986, COURBES SURFACES MAT, P69; Hanson S., 2004, GEOGRAPHY URBAN TRAN; Hwang HS, 2002, COMPUT IND ENG, V43, P283, DOI 10.1016/S0360-8352(02)00075-X; Ma L., 2012, P INT C INT SYST DES, P661; Moore E. H., 1920, B AM MATH SOC, V26, P394; Nagy B., 2001, P INT C FIELD SERV R; Pandunata Priza, 2010, Proceedings of the 2010 Seventh International Conference on Computer Graphics, Imaging and Visualization (CGIV 2010), DOI 10.1109/CGIV.2010.18; Paromtchik I. E., 2000, Proceedings 2000 ICRA. Millennium Conference. IEEE International Conference on Robotics and Automation. Symposia Proceedings (Cat. No.00CH37065), DOI 10.1109/ROBOT.2000.844764; Penrose R., 1955, P CAMBRIDGE PHILOS S, V51, P406, DOI DOI 10.1017/S0305004100030401; Plass M., 1983, Computer Graphics, V17; Schrank D.L., 2007, 2007 URBAN MOBILITY; Wu Q.-B., 2005, J ZHEJIANG U SC A S1, V6A, P124, DOI 10.1631/jzus.2005.AS0124; [Xu Li 徐立], 2002, [软件学报, Journal of Software], V13, P1069	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8890	1872-793X		ROBOT AUTON SYST	Robot. Auton. Syst.	DEC	2015	74		A				243	252		10.1016/j.robot.2015.08.001		10	Automation & Control Systems; Computer Science, Artificial Intelligence; Robotics	Automation & Control Systems; Computer Science; Robotics	CY0BI	WOS:000366070700020		
J	Menegatti, E; Berns, K; Michael, N; Yamaguchi, H				Menegatti, Emanuele; Berns, Karsten; Michael, Nathan; Yamaguchi, Hiroaki			Special Issue on Intelligent Autonomous Systems	ROBOTICS AND AUTONOMOUS SYSTEMS			English	Editorial Material									[Menegatti, Emanuele] Univ Padua, Sch Engn, Intelligent Autonomous Syst Lab, DEI, Padua, Italy; [Berns, Karsten] Univ Kaiserslautern, Dept Comp Sci, Robot Res Lab, D-67663 Kaiserslautern, Germany; [Michael, Nathan] Carnegie Mellon Univ, Inst Robot, Pittsburgh, PA 15213 USA; [Yamaguchi, Hiroaki] Aoyama Gakuin Univ, Dept Integrated Informat Technol, Tokyo, Japan	Menegatti, E (reprint author), Univ Padua, Sch Engn, Intelligent Autonomous Syst Lab, DEI, Padua, Italy.	emg@dei.unipd.it; berns@informatik.uni-kl.de; nmichael@cmu.edu; yamaguchi@it.aoyama.ac.jp						0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8890	1872-793X		ROBOT AUTON SYST	Robot. Auton. Syst.	DEC	2015	74		B		SI		297	298		10.1016/j.robot.2015.10.005		2	Automation & Control Systems; Computer Science, Artificial Intelligence; Robotics	Automation & Control Systems; Computer Science; Robotics	CY0BK	WOS:000366071000001		
J	Artho, C; Ouml;lveczky, PC				Artho, Cyrille; Olveczky, Peter Csaba			Formal Techniques for Safety-Critical Systems Preface	SCIENCE OF COMPUTER PROGRAMMING			English	Editorial Material									[Artho, Cyrille] AIST, Ikeda, Osaka, Japan; [Olveczky, Peter Csaba] Univ Oslo, N-0316 Oslo, Norway	Artho, C (reprint author), AIST, Ikeda, Osaka, Japan.	c.artho@aist.go.jp; peterol@ifi.uio.no						0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6423	1872-7964		SCI COMPUT PROGRAM	Sci. Comput. Program.	DEC 1	2015	113		2				83	84		10.1016/j.scico.2015.10.001		2	Computer Science, Software Engineering	Computer Science	CY2HV	WOS:000366230300001		
J	Fujita, M; Yamada, S; Imai, T				Fujita, Mayumi; Yamada, Shigeru; Imai, Takashi			Irradiation induces diverse changes in invasive potential in cancer cell lines	SEMINARS IN CANCER BIOLOGY			English	Review						Invasion; Radiation; Heterogeneity; Carbon ion radiotherapy; Cell lines	CARBON-ION IRRADIATION; EPITHELIAL-MESENCHYMAL TRANSITION; RADIATION-INDUCED MIGRATION; PANCREATIC-CARCINOMA CELLS; RHO SIGNALING PATHWAY; BREAST-CANCER; IONIZING-RADIATION; PROSTATE-CANCER; IN-VITRO; K-RAS	Cancer patients without metastasis are generally considered as candidates for curative localized radiation therapy. However, while the benefits of localized radiation have been demonstrated by many clinical studies, recurrences or distant metastases that develop after local treatment remain a major therapeutic challenge. Several in vitro and in vivo studies have reported that irradiation may subsequently alter tumor aggression by reducing or promoting the invasiveness of the remaining cancer cells after radiation, which appears to differ depending on the form of radiation, as well as the investigated cell lines. Cell lines recapitulate cancer heterogeneity based on the characteristics reflected in their genetic abnormalities, and thus can be used as a tool to investigate the genetic basis of cancer aggression. Importantly, molecular insights into this process would allow us to tailor drug treatments for use in combination with local radiation treatment. This review summarizes the diverse responses of cancer cell invasiveness induced by radiation, and discusses the possible molecular pathways and the genetic variations that may affect radiation-altered invasion. (C) 2015 The Authors. Published by Elsevier Ltd.	[Fujita, Mayumi; Imai, Takashi] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Adv Radiat Biol Res Program, Chiba 2638555, Japan; [Yamada, Shigeru] Natl Inst Radiol Sci, Res Ctr Hosp, Res Ctr Charged Particle Therapy, Chiba 2638555, Japan	Imai, T (reprint author), Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Adv Radiat Biol Res Program, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	imait@nirs.go.jp			Japan Society for the Promotion of Science [22591394, 25461934, 23791467]	This work was supported in part by a Grant-in-Aid for Scientific Research (C) (grant no. 22591394, and 25461934 to TI) and for Young Scientists (B) (grant no. 23791467 to MF) from the Japan Society for the Promotion of Science. This work was performed as a Research Project with Heavy Ions at the NIRS-HIMAC. We thank to Screening Committee of Anticancer Drugs supported by Grant-in-Aid for Scientific Research on Innovative Areas, Scientific Support Programs for Cancer Research, from The Ministry of Education, Culture, Sports, Science and Technology, Japan for providing us the Screening Committee of Anticancer Drugs (SCADS) Inhibitor Kit. KYSE cell lines were kindly provided from Dr. Yutaka Shimada (Graduate School of Medicine, Kyoto University) through Dr. Johji Inazawa (Medical Research Institute, Tokyo Medical and Dental University). We thank Dr. Fumiaki Nakayama for helpful discussions and advice, Tomo Suga, Atsuko Ishikawa, Kaori Imadome, and Yoshimi Shoji for technical help, and Editage for providing English editorial assistance.	Yoshimasu T, 2004, CANCER SCI, V95, P142, DOI 10.1111/j.1349-7006.2004.tb03195.x; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Kamada T, 2015, LANCET ONCOL, V16, pE93, DOI 10.1016/S1470-2045(14)70412-7; Wild-Bode C, 2001, CANCER RES, V61, P2744; Suetens A, 2014, INT J ONCOL, V44, P1056, DOI 10.3892/ijo.2014.2287; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; Oberoi TK, 2012, EMBO J, V31, P14, DOI 10.1038/emboj.2011.423; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Ghosh S, 2014, CARCINOGENESIS, V35, P383, DOI 10.1093/carcin/bgt303; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Goetze K, 2010, RADIAT ENVIRON BIOPH, V49, P427, DOI 10.1007/s00411-010-0297-x; Akino Y, 2009, INT J RADIAT ONCOL, V75, P475, DOI 10.1016/j.ijrobp.2008.12.090; Quesada V, 2009, NUCLEIC ACIDS RES, V37, pD239, DOI 10.1093/nar/gkn570; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Nethe M, 2010, J CELL SCI, V123, P4011, DOI 10.1242/jcs.078360; Fokas E, 2009, BBA-REV CANCER, V1796, P216, DOI 10.1016/j.bbcan.2009.07.005; Miwa W, 1996, BIOCHEM BIOPH RES CO, V225, P968, DOI 10.1006/bbrc.1996.1280; De Franceschi N, 2015, J CELL SCI, V128, P839, DOI 10.1242/jcs.161653; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Cheng JCH, 2006, ONCOGENE, V25, P7009, DOI 10.1038/sj.onc.1209706; Noh H, 2013, THERANOSTICS, V3, P487, DOI 10.7150/thno.4218; Burrows N, 2013, RADIOTHER ONCOL, V108, P548, DOI 10.1016/j.radonc.2013.06.027; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Yan S, 2013, INT J ONCOL, V42, P1801, DOI 10.3892/ijo.2013.1852; Burrows N, 2011, J CLIN ENDOCR METAB, V96, pE1934, DOI 10.1210/jc.2011-1426; Koul D, 2001, ONCOGENE, V20, P6669, DOI 10.1038/sj.onc.1204799; Nguyen DHD, 1999, J CELL BIOL, V146, P149; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Arboleda MJ, 2003, CANCER RES, V63, P196; Yadav L, 2014, ASIAN PAC J CANCER P, V15, P1085, DOI 10.7314/APJCP.2014.15.3.1085; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Jung JW, 2007, EUR J CANCER, V43, P1214, DOI 10.1016/j.ejca.2007.01.034; Gogineni VR, 2011, INT J ONCOL, V38, P1615, DOI 10.3892/ijo.2011.987; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Cantero D, 1997, BRIT J CANCER, V75, P388, DOI 10.1038/bjc.1997.63; Yamazaki D, 2009, ONCOGENE, V28, P1570, DOI 10.1038/onc.2009.2; Radisky ES, 2010, J MAMMARY GLAND BIOL, V15, P201, DOI 10.1007/s10911-010-9177-x; Dreissigacker U, 2006, CELL SIGNAL, V18, P1156, DOI 10.1016/j.cellsig.2005.09.004; Delaney G, 2005, CANCER, V104, P1129, DOI 10.1002/cncr.21324; Ogata T, 2011, J RADIAT RES, V52, P374, DOI 10.1269/jrr.10102; Chargari C, 2013, ANN ONCOL, V24, P38, DOI 10.1093/annonc/mds217; Stahler C, 2013, INT J RADIAT BIOL, V89, P454, DOI 10.3109/09553002.2013.766769; Fujita M, 2011, CANCER SCI, V102, P792, DOI 10.1111/j.1349-7006.2011.01852.x; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Zhai GG, 2006, J NEURO-ONCOL, V76, P227, DOI 10.1007/s11060-005-6499-4; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Park CM, 2006, CANCER RES, V66, P8511, DOI 10.1158/0008-5472.CAN-05-4340; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Kuo YC, 2015, INT J BIOCHEM CELL B, V64, P229, DOI 10.1016/j.biocel.2015.04.015; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Su WH, 2012, AM J PATHOL, V180, P862, DOI 10.1016/j.ajpath.2011.10.018; Schramm K, 2000, INT J CANCER, V87, P155, DOI 10.1002/1097-0215(20000715)87:2<155::AID-IJC1>3.0.CO;2-J; Fehlauer F, 2007, ONCOL REP, V17, P941; Goetze K, 2007, INT J RADIAT BIOL, V83, P889, DOI 10.1080/09553000701753826; Dillon LM, 2014, CURR DRUG TARGETS, V15, P65, DOI 10.2174/1389450114666140106100909; Gonzalez E, 2009, P NATL ACAD SCI USA, V106, P7004, DOI 10.1073/pnas.0901933106; Murata K, 2014, J RADIAT RES, V55, P658, DOI 10.1093/jrr/rru002; Qian LW, 2002, CLIN CANCER RES, V8, P1223; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Wistuba II, 1998, CLIN CANCER RES, V4, P2931; Fujita M, 2015, INT J RADIAT ONCOL, V93, P173, DOI 10.1016/j.ijrobp.2015.05.009; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Ogata T, 2005, CANCER RES, V65, P113; Kawamoto A, 2012, ONCOL REP, V27, P51, DOI 10.3892/or.2011.1485; Fujita M, 2012, CANCER SCI, V103, P677, DOI 10.1111/j.1349-7006.2011.02190.x; Virtakoivu R, 2012, MOL BIOL CELL, V23, P3357, DOI 10.1091/mbc.E12-03-0213; Davies G, 2001, CLIN CANCER RES, V7, P3289; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Fujita M, 2014, FEBS LETT, V588, P3240, DOI 10.1016/j.febslet.2014.07.006; Blasi F, 2010, FEBS LETT, V584, P1923, DOI 10.1016/j.febslet.2009.12.039; Park MJ, 2002, CANCER RES, V62, P6318; Ban S, 2005, INT J EXP PATHOL, V86, P231, DOI 10.1111/j.0959-9673.2005.00431.x; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Gu Q, 2015, ONCOTARGET, V6, P10893; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Suzuki M, 2000, INT J RADIAT ONCOL, V48, P241, DOI 10.1016/S0360-3016(00)00568-X; Rieken S, 2012, INT J RADIAT ONCOL, V83, P394, DOI 10.1016/j.ijrobp.2011.06.2004; ATCC, GLOB BIOR CTR ATCC D; Bacco Fd, 2011, JNCI-J NATL CANCER I, V103, P645; Badiga AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020614; Chang L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.407; Furmanova-Hollenstein P, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-105; Greshock J, CANC RES; Huang H, 2014, ONCOGENE, V33, P532, DOI 10.1038/onc.2012.619; Jacob Abitha, 2015, Front Cell Dev Biol, V3, P4, DOI 10.3389/fcell.2015.00004; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Iida K, 2011, BRIT J CANCER, V105, P420, DOI 10.1038/bjc.2011.222; Lund IK, CURR DRUG TARGETS; McCubrey JA, J CELL PHYSL; Memmel S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087052; Moncharmont C, 2014, CRIT REV ONCOL HEMAT, V92, P133, DOI 10.1016/j.critrevonc.2014.05.006; Nalla AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013006; Pickhard AC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-388; Ria Roberto, 2002, Haematologica, V87, P836; Sadok A, 2014, SMALL GTPASES, V5, DOI DOI 10.4161/SGTP.29710); Saiselet Manuel, 2012, Front Endocrinol (Lausanne), V3, P133, DOI 10.3389/fendo.2012.00133	102	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1044-579X			SEMIN CANCER BIOL	Semin. Cancer Biol.	DEC	2015	35						45	52		10.1016/j.semcancer.2015.09.003		8	Oncology	Oncology	CY0BQ	WOS:000366071600006		
J	Kusakabe, R; Inoue, K				Kusakabe, Rie; Inoue, Kunio			Developmental regulation and evolution of muscle-specific microRNAs	SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY			English	Review						MicroRNA; Target mRNAs; Myogenesis; Vertebrates; Evolution	SERUM RESPONSE FACTOR; CARDIOMYOCYTE CELL-CYCLE; HEART REGENERATION; EXPRESSION; PAX3; DIFFERENTIATION; VERTEBRATE; MIR-206; ORIGIN; MOUSE	MicroRNAs (miRs) are a group of small RNAs that play a major role in post-transcriptional regulation of gene expression. In animals, many of the miRs are expressed in a conserved spatiotemporal manner. Muscle tissues, the major cellular systems involved in the locomotion and physiological functions of animals, have been one of the main sites for verification of miR targets and analysis of their developmental functions. During the determination and differentiation of muscle cells, numerous miRs bind to and repress target mRNAs in a highly specific but redundant manner. Interspecific comparisons of the sequences and expression of miRs have suggested that miR regulation became increasingly important during the course of vertebrate evolution. However, the detailed molecular interactions that have led to the highly complex morphological structures still await investigation. In this review, we will summarize the recent findings on the functional and developmental characteristics of miRs that have played major roles in vertebrate myogenesis, and discuss how the evolution of miRs is related to the morphological complexity of the vertebrates. (C) 2015 Elsevier Ltd. All rights reserved.	[Kusakabe, Rie] RIKEN, Evolutionary Morphol Lab, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Inoue, Kunio] Kobe Univ, Grad Sch Sci, Dept Biol, Nada Ku, Kobe, Hyogo 6578501, Japan	Kusakabe, R (reprint author), RIKEN, Evolutionary Morphol Lab, Chuo Ku, 2-2-3 Minatojima Minami, Kobe, Hyogo 6500047, Japan.	rie.kusakabe@riken.jp			JSPS [21770257, 25440108, 20310115]; Shiseido Female Researcher Science Grant; Astellas Foundation for Research on Metabolic Disorders; Asahi Glass Foundation	We express our gratitude to the members of Inoue Laboratory and Sakamoto Laboratory at Kobe University for the valuable discussions, and to Drs. Shigehiro Kuraku and Shigeru Kuratani at RIKEN for their constant encouragement and discussions. This work was supported by Grants-in-Aid for Scientific Research from JSPS to R.K. (21770257 and 25440108) and K.I. (20310115), and in part by a Shiseido Female Researcher Science Grant (R.K.), the research grant of Astellas Foundation for Research on Metabolic Disorders (R.K.) and the Asahi Glass Foundation (K.I.).	Sweetman D, 2006, DEV DYNAM, V235, P2185, DOI 10.1002/dvdy.20881; Luo Y, 2009, GENE, V428, P41, DOI 10.1016/j.gene.2008.09.022; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; CHRIST B, 1977, ANAT EMBRYOL, V150, P171, DOI 10.1007/BF00316649; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Bicknell KA, 2007, J MOL CELL CARDIOL, V42, P706, DOI 10.1016/j.yjmcc.2007.01.006; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Tani S, 2013, EVOL DEV, V15, P293, DOI 10.1111/ede.12039; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Bland CS, 2007, DEV CELL, V12, P171, DOI 10.1016/j.devcel.2007.01.014; Neyt C, 2000, NATURE, V408, P82; Mehta TK, 2013, P NATL ACAD SCI USA, V110, P16044, DOI 10.1073/pnas.1315760110; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Kusakabe R, 2013, GENE EXPR PATTERNS, V13, P43, DOI 10.1016/j.gep.2012.11.001; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Pasut A, 2012, CELL STEM CELL, V10, P237, DOI 10.1016/j.stem.2012.02.009; Tremblay P, 1998, DEV BIOL, V203, P49, DOI 10.1006/dbio.1998.9041; Mishima Y, 2009, GENE DEV, V23, P619, DOI 10.1101/gad.1760209; Callis TE, 2008, EXP BIOL MED, V233, P131, DOI 10.3181/0709-MR-237; Kelly RG, 2002, TRENDS GENET, V18, P210, DOI 10.1016/S0168-9525(02)02642-2; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Nguyen HT, 2006, CURR OPIN GENET DEV, V16, P533, DOI 10.1016/j.gde.2006.08.010; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Boutet SC, 2012, CELL STEM CELL, V10, P327, DOI 10.1016/j.stem.2012.01.017; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Hirai H, 2010, J CELL BIOL, V191, P347, DOI 10.1083/jcb.201006025; Bergmann O, 2011, EXP CELL RES, V317, P188, DOI 10.1016/j.yexcr.2010.08.017; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Campo-Paysaa F, 2011, EVOL DEV, V13, P15, DOI 10.1111/j.1525-142X.2010.00452.x; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Heimberg AM, 2010, P NATL ACAD SCI USA, V107, P19379, DOI 10.1073/pnas.1010350107; Peterson KJ, 2008, PHILOS T R SOC B, V363, P1435, DOI 10.1098/rstb.2007.2233; Shi WY, 2009, NAT STRUCT MOL BIOL, V16, P183, DOI 10.1038/nsmb.1536; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Goljanek-Whysall K, 2011, P NATL ACAD SCI USA, V108, P11936, DOI 10.1073/pnas.1105362108; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Janvier P., 1996, EARLY VERTEBRATES; Ketting RF, 2001, GENE DEV, V15, P2654; Kosik KS, 2009, NAT REV NEUROSCI, V10, P754, DOI 10.1038/nrn2713; McCarthy JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC451, DOI 10.1152/ajpcell.00077.2007; Nachtigall PG, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0196-x	67	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1084-9521			SEMIN CELL DEV BIOL	Semin. Cell Dev. Biol.	DEC	2015	47-48						9	16		10.1016/j.semcdb.2015.10.020		8	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CY1AO	WOS:000366138700003		
J	Lim, RSM; Kai, T				Lim, Robyn S. M.; Kai, Toshie			A piece of the pi(e): The diverse roles of animal piRNAs and their PIWI partners	SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY			English	Review						PIWI-interacting RNA (piRNA); PIWI protein; piRNA biogenesis; Transposable elements; Gene regulation; Evolutionary conservation	CELL SELF-RENEWAL; PLANARIAN STEM-CELLS; HUMAN GASTRIC-CANCER; ANNELID PLATYNEREIS-DUMERILII; PROGRAMMED DNA ELIMINATION; SMALL INTERFERING RNAS; PRIMORDIAL GERM-CELLS; SOFT-TISSUE SARCOMA; TUMOR-RELATED DEATH; DROSOPHILA-MELANOGASTER	Small non-coding RNAs are indispensable to many biological processes. A class of endogenous small RNAs, termed PIWI-interacting RNAs (piRNAs) because of their association with PIWI proteins, has known roles in safeguarding the genome against inordinate transposon mobilization, embryonic development, and stem cell regulation, among others. This review discusses the biogenesis of animal piRNAs and their diverse functions together with their PIWI protein partners, both in the germline and in somatic cells, and highlights the evolutionarily conserved aspects of these molecular players in animal biology. (C) 2015 Elsevier Ltd. All rights reserved.	[Lim, Robyn S. M.; Kai, Toshie] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; [Lim, Robyn S. M.; Kai, Toshie] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Kai, T (reprint author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	robyn.lim.s.m@sgh.com.sg; toshie_kai@fbs.osaka-u.ac.jp			Temasek Life Sciences Laboratory; Singapore Millennium Foundation	We thank Amit Anand for critical reading of the manuscript and for suggestions. This work was supported by the Temasek Life Sciences Laboratory and the Singapore Millennium Foundation.	Handler D, 2011, EMBO J, V30, P3977, DOI 10.1038/emboj.2011.308; Armisen J, 2009, GENOME RES, V19, P1766, DOI 10.1101/gr.093054.109; Taubert H, 2007, ONCOGENE, V26, P1098, DOI 10.1038/sj.onc.1209880; Ross RJ, 2014, NATURE, V505, P353, DOI 10.1038/nature12987; van Wolfswinkel JC, 2009, CELL, V139, P135, DOI 10.1016/j.cell.2009.09.012; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Mochizuki K, 2004, GENE DEV, V18, P2068, DOI 10.1101/gad.1219904; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; Chambeyron S, 2005, CYTOGENET GENOME RES, V110, P215, DOI 10.1159/000084955; Zeng A, 2013, J CELL BIOL, V201, P409, DOI 10.1083/jcb.201207172; Millane RC, 2011, DEVELOPMENT, V138, P2429, DOI 10.1242/dev.064931; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Xiol J, 2014, CELL, V157, P1698, DOI 10.1016/j.cell.2014.05.018; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Wang SH, 2011, P NATL ACAD SCI USA, V108, P21164, DOI 10.1073/pnas.1107892109; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Beyret E, 2012, CELL RES, V22, P1429, DOI 10.1038/cr.2012.120; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; COWARD SJ, 1974, ANAT REC, V180, P533, DOI 10.1002/ar.1091800312; Turner MJ, 2014, CELL CYCLE, V13, P772, DOI 10.4161/cc.27679; Vagin Vasily V, 2004, RNA Biol, V1, P54; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Guo TX, 2006, DEV CELL, V11, P159, DOI 10.1016/j.devcel.2006.06.004; Luteijn MJ, 2012, EMBO J, V31, P3422, DOI 10.1038/emboj.2012.213; Kawaoka S, 2011, MOL CELL, V43, P1015, DOI 10.1016/j.molcel.2011.07.029; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Kiuchi T, 2014, NATURE, V509, P633, DOI 10.1038/nature13315; Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040; de Vanssay A, 2012, NATURE, V490, P112, DOI 10.1038/nature11416; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Mochizuki K, 2000, DEV GENES EVOL, V210, P591, DOI 10.1007/s004270000105; Handler D, 2013, MOL CELL, V50, P762, DOI 10.1016/j.molcel.2013.04.031; COE EH, 1959, P NATL ACAD SCI USA, V45, P828, DOI 10.1073/pnas.45.6.828; Houwing S, 2008, EMBO J, V27, P2702, DOI 10.1038/emboj.2008.204; Anand A, 2012, EMBO J, V31, P870, DOI 10.1038/emboj.2011.449; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grentzinger T, 2012, GENOME RES, V22, P1877, DOI 10.1101/gr.136614.111; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Huang XA, 2013, DEV CELL, V24, P502, DOI 10.1016/j.devcel.2013.01.023; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; DESUTTER D, 1979, DEV COMP IMMUNOL, V3, P389, DOI 10.1016/S0145-305X(79)80036-1; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Nishida KM, 2007, RNA, V13, P1911, DOI 10.1261/rna.744307; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Vagin VV, 2009, GENE DEV, V23, P1749, DOI 10.1101/gad.1814809; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Josse T, 2007, PLOS GENET, V3, P1633, DOI 10.1371/journal.pgen.0030158; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Zhao S, 2013, DEV CELL, V24, P13, DOI 10.1016/j.devcel.2012.12.006; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; EDDY EM, 1974, ANAT REC, V178, P731, DOI 10.1002/ar.1091780406; [Anonymous], 2012, NUC RNA, DOI DOI 10.1261/RNA.034967.112; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Nagao A, 2010, RNA, V16, P2503, DOI 10.1261/rna.2270710; Kawaoka S, 2011, RNA, V17, P1401, DOI 10.1261/rna.2709411; Rebscher N, 2007, DEV BIOL, V306, P599, DOI 10.1016/j.ydbio.2007.03.521; Grochola LF, 2008, BRIT J CANCER, V99, P1083, DOI 10.1038/sj.bjc.6604653; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Zhang F, 2012, CELL, V151, P871, DOI 10.1016/j.cell.2012.09.040; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Zhao YM, 2012, CANCER-AM CANCER SOC, V118, P2708, DOI 10.1002/cncr.26524; Schoeberl UE, 2011, J BIOL CHEM, V286, P37045, DOI 10.1074/jbc.R111.276964; Cox DN, 2000, DEVELOPMENT, V127, P503; Tatsuke T, 2010, CELL MOL BIOL LETT, V15, P118, DOI 10.2478/s11658-009-0038-9; Tian YA, 2011, P NATL ACAD SCI USA, V108, P903, DOI 10.1073/pnas.1017762108; Cheng J, 2012, CANCER LETT, V315, P12, DOI 10.1016/j.canlet.2011.10.004; RUBIN GM, 1982, CELL, V29, P987, DOI 10.1016/0092-8674(82)90462-7; Mochizuki K, 2001, DEV GENES EVOL, V211, P299, DOI 10.1007/s004270100156; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Ohara T, 2007, NAT STRUCT MOL BIOL, V14, P349, DOI 10.1038/nsmb1220; BUCHETON A, 1984, CELL, V38, P153, DOI 10.1016/0092-8674(84)90536-1; Unhavaithaya Y, 2009, J BIOL CHEM, V284, P6507, DOI 10.1074/jbc.M809104200; Krishna S, 2013, NUCLEIC ACIDS RES, V41, P599, DOI 10.1093/nar/gks1020; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Yan Z, 2011, NUCLEIC ACIDS RES, V39, P6596, DOI 10.1093/nar/gkr298; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; Seth M, 2013, DEV CELL, V27, P656, DOI 10.1016/j.devcel.2013.11.014; PELISSON A, 1981, MOL GEN GENET, V183, P123, DOI 10.1007/BF00270149; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Gangaraju VK, 2011, NAT GENET, V43, P153, DOI 10.1038/ng.743; Rinkevich Y, 2013, DEV CELL, V24, P76, DOI 10.1016/j.devcel.2012.11.010; Wagner DE, 2012, CELL STEM CELL, V10, P299, DOI 10.1016/j.stem.2012.01.016; Cichocki F, 2010, J IMMUNOL, V185, P2009, DOI 10.4049/jimmunol.1000855; Zhang Z, 2014, CELL, V157, P1353, DOI 10.1016/j.cell.2014.04.030; Kawaoka S, 2011, RNA, V17, P2144, DOI 10.1261/rna.027565.111; Le Thomas A, 2013, GENE DEV, V27, P390, DOI 10.1101/gad.209841.112; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Donertas D, 2013, GENE DEV, V27, P1693, DOI 10.1101/gad.221150.113; Okamura K, 2008, NAT REV MOL CELL BIO, V9, P673, DOI 10.1038/nrm2479; de Rosa R, 2005, EVOL DEV, V7, P574; Jin ZG, 2013, CURR BIOL, V23, P1442, DOI 10.1016/j.cub.2013.06.021; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Nishimasu H, 2012, NATURE, V491, P284, DOI 10.1038/nature11509; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Ibrahim F, 2010, P NATL ACAD SCI USA, V107, P3906, DOI 10.1073/pnas.0912632107; Mohn F, 2014, CELL, V157, P1364, DOI 10.1016/j.cell.2014.04.031; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Xiol J, 2012, MOL CELL, V47, P970, DOI 10.1016/j.molcel.2012.07.019; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Wang JQ, 2009, CURR BIOL, V19, P640, DOI 10.1016/j.cub.2009.02.061; Perrat PN, 2013, SCIENCE, V340, P91, DOI 10.1126/science.1231965; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Muotri AR, 2009, HIPPOCAMPUS, V19, P1002, DOI 10.1002/hipo.20564; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Lee EJ, 2011, RNA, V17, P1090, DOI 10.1261/rna.2565011; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Rehwinkel J, 2006, MOL CELL BIOL, V26, P2965, DOI 10.1128/MCB.26.8.2965-2975.2006; De Fazio S, 2011, NATURE, V480, P259, DOI 10.1038/nature10547; Chen C, 2009, P NATL ACAD SCI USA, V106, P20336, DOI 10.1073/pnas.0911640106; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Aravin AA, 2011, DEV CELL, V20, P287, DOI 10.1016/j.devcel.2011.03.003; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Gazave E, 2013, DEV BIOL, V382, P246, DOI 10.1016/j.ydbio.2013.07.013; Rodriguez AJ, 2005, RNA, V11, P646, DOI 10.1261/rna.7198205; Marchetto MCN, 2013, NATURE, V503, P525, DOI 10.1038/nature12686; Mani SR, 2013, MOL REPROD DEV, V80, P632, DOI 10.1002/mrd.22195; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Denker E, 2008, DEV BIOL, V315, P99, DOI 10.1016/j.ydbio.2007.12.023; Khurana JS, 2011, CELL, V147, P1551, DOI 10.1016/j.cell.2011.11.042; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; MAHOWALD AP, 1968, J EXP ZOOL, V167, P237, DOI 10.1002/jez.1401670211; Chen Y, 2014, CELL PROLIFERAT, V47, P448, DOI 10.1111/cpr.12120; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Srivastava M, 2014, CURR BIOL, V24, P1107, DOI 10.1016/j.cub.2014.03.042; Wei ZL, 2012, MAR BIOTECHNOL, V14, P459, DOI 10.1007/s10126-011-9426-z; Klenov MS, 2011, P NATL ACAD SCI USA, V108, P18760, DOI 10.1073/pnas.1106676108; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Seipel K, 2004, INT J DEV BIOL, V48, P1, DOI 10.1387/ijdb.15005568; Pfister D, 2008, DEV BIOL, V319, P146, DOI 10.1016/j.ydbio.2008.02.045; Sun GA, 2011, BRAIN RES, V1373, P183, DOI 10.1016/j.brainres.2010.11.097; Klenov MS, 2014, NUCLEIC ACIDS RES, V42, P6208, DOI 10.1093/nar/gku268; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kirino Y, 2007, RNA, V13, P1397, DOI 10.1261/rna.659307; Wang Y, 2012, INT J CLIN EXP PATHO, V5, P315; Reuter M, 2009, NAT STRUCT MOL BIOL, V16, P639, DOI 10.1038/nsmb.1615; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Juliano C, 2010, SCIENCE, V329, P640, DOI 10.1126/science.1194037; Plickert G, 2012, INT J DEV BIOL, V56, P519, DOI 10.1387/ijdb.123502gp; Holstein TW, 2010, METHOD CELL BIOL, V96, P285, DOI 10.1016/S0091-679X(10)96013-5; Tanaka EM, 2011, DEV CELL, V21, P172, DOI 10.1016/j.devcel.2011.06.016; Kirino Y, 2009, NAT CELL BIOL, V11, P652, DOI 10.1038/ncb1872; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Darricarrere N, 2013, P NATL ACAD SCI USA, V110, P1297, DOI 10.1073/pnas.1213283110; Friedlander MR, 2009, P NATL ACAD SCI USA, V106, P11546, DOI 10.1073/pnas.0905222106; Szakmary A, 2005, CURR BIOL, V15, P171, DOI 10.1016/j.cub.2005.01.005; Muerdter F, 2013, MOL CELL, V50, P736, DOI 10.1016/j.molcel.2013.04.006; Mochizuki K, 2012, DEV GROWTH DIFFER, V54, P108, DOI 10.1111/j.1440-169X.2011.01305.x; Fang WW, 2012, CELL, V151, P1243, DOI 10.1016/j.cell.2012.10.045; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; BRINK RA, 1956, GENETICS, V41, P872; Gou LT, 2014, CELL RES, V24, P680, DOI 10.1038/cr.2014.41; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Kawaoka S, 2009, RNA, V15, P1258, DOI 10.1261/rna.1452209; Zhu W, 2012, DEV BIOL, V370, P42, DOI 10.1016/j.ydbio.2012.07.021; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Zhang Z, 2011, MOL CELL, V44, P572, DOI 10.1016/j.molcel.2011.10.011; Chen Y, 2007, CURR BIOL, V17, P637, DOI 10.1016/j.cub.2007.02.027; Rinkevich Y, 2010, DEV BIOL, V345, P94, DOI 10.1016/j.ydbio.2010.05.500; Funayama N, 2010, EVOL DEV, V12, P275, DOI 10.1111/j.1525-142X.2010.00413.x; Hobmayer B, 2012, INT J DEV BIOL, V56, P509, DOI 10.1387/ijdb.113426bh; KIDWELL MG, 1983, P NATL ACAD SCI-BIOL, V80, P1655, DOI 10.1073/pnas.80.6.1655; McDonald J F, 1993, Curr Opin Genet Dev, V3, P855, DOI 10.1016/0959-437X(93)90005-A; Rossi L, 2006, DEV GENES EVOL, V216, P335, DOI 10.1007/s00427-006-0060-0; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Chambeyron S, 2008, P NATL ACAD SCI USA, V105, P14964, DOI 10.1073/pnas.0805943105; EDDY EM, 1975, INT REV CYTOL, V43, P229; Murchison EP, 2008, GENOME RES, V18, P995, DOI 10.1101/gr.073056.107; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Pane A, 2011, EMBO J, V30, P4601, DOI 10.1038/emboj.2011.334; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Wu QL, 2010, BIOCHEM BIOPH RES CO, V396, P915, DOI 10.1016/j.bbrc.2010.05.022; Akkouche A, 2013, EMBO REP, V14, P458, DOI 10.1038/embor.2013.38; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Liu XY, 2006, INT J CANCER, V118, P1922, DOI 10.1002/ijc.21575; Patil VS, 2010, CURR BIOL, V20, P724, DOI 10.1016/j.cub.2010.02.046; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Mochizuki K, 2005, GENE DEV, V19, P77, DOI 10.1101/gad.1265105; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Juliano CE, 2010, DEVELOPMENT, V137, P4113, DOI 10.1242/dev.047969; HAY ED, 1975, J ULTRA MOL STRUCT R, V50, P1, DOI 10.1016/S0022-5320(75)90003-9; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005; Pek JW, 2011, CURR BIOL, V21, P39, DOI 10.1016/j.cub.2010.11.051; MORITA M, 1969, J ULTRA MOL STRUCT R, V27, P7, DOI 10.1016/S0022-5320(69)90017-3; Castro JP, 2004, GENETICA, V121, P107, DOI 10.1023/B:GENE.0000040382.48039.a2; Palakodeti D, 2008, RNA, V14, P1174, DOI 10.1261/rna.1085008; Ewen-Campen B, 2013, CURR BIOL, V23, P835, DOI 10.1016/j.cub.2013.03.063; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; Rozhkov NV, 2013, GENE DEV, V27, P400, DOI 10.1101/gad.209767.112; Rosner A, 2009, DEV BIOL, V331, P113, DOI 10.1016/j.ydbio.2009.04.025; Kamminga LM, 2010, EMBO J, V29, P3688, DOI 10.1038/emboj.2010.233; Nishida KM, 2009, EMBO J, V28, P3820, DOI 10.1038/emboj.2009.365; Alie A, 2011, DEV BIOL, V350, P183, DOI 10.1016/j.ydbio.2010.10.019; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Li XZG, 2013, MOL CELL, V50, P67, DOI 10.1016/j.molcel.2013.02.016; Deragon JM, 2000, ANN MED, V32, P264, DOI 10.3109/07853890009011768; Cecere G, 2012, MOL CELL, V47, P734, DOI 10.1016/j.molcel.2012.06.021; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Juliano CE, 2014, P NATL ACAD SCI USA, V111, P337, DOI 10.1073/pnas.1320965111; Saxe JP, 2013, EMBO J, V32, P1869, DOI 10.1038/emboj.2013.121; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P581, DOI 10.1038/nsmb.1438; Lee JH, 2010, CANCER RES, V70, P4569, DOI 10.1158/0008-5472.CAN-09-2670; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Extavour CGM, 2007, INTEGR COMP BIOL, V47, P770, DOI 10.1093/icb/icm027; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Qiao D, 2002, ONCOGENE, V21, P3988, DOI 10.1038/sj.onc.1205505; Ipsaro JJ, 2012, NATURE, V491, P279, DOI 10.1038/nature11502; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Chen C, 2011, NAT REV MOL CELL BIO, V12, P629, DOI 10.1038/nrm3185; Rouhana L, 2012, DEVELOPMENT, V139, P1083, DOI 10.1242/dev.076182; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Gustafson EA, 2010, BIOESSAYS, V32, P626, DOI 10.1002/bies.201000001; Huang HY, 2011, EMBO J, V30, P3298, DOI 10.1038/emboj.2011.228; Yao MC, 2003, SCIENCE, V300, P1581, DOI 10.1126/science.1084737; Sharma AK, 2001, BLOOD, V97, P426, DOI 10.1182/blood.V97.2.426; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Wilson JE, 1996, DEVELOPMENT, V122, P1631; Billi AC, 2012, PLOS GENET, V8, P84, DOI 10.1371/journal.pgen.1002617; BUSCEMA M, 1980, Wilhelm Roux's Archives of Developmental Biology, V188, P45, DOI 10.1007/BF00848609; Chak Li-Ling, 2014, Frontiers in Genetics, V5, DOI 10.3389/fgene.2014.00172; Chen L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000293; Cheng EC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097821; Chu HY, 2015, CANCER LETT, V356, P561, DOI 10.1016/j.canlet.2014.10.004; Claycomb JM, 2014, CURR BIOL, V24, pR703, DOI 10.1016/j.cub.2014.06.009; De Mulder K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-69; Feltzin VL, 2015, AGING CELL; Giani VC, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-10; Greither T, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-272; Gu TT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003780; Ha H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-545; Hashim A, 2014, ONCOTARGET, V5, P9901; Hori I, 1982, MICROSCOPE, V31, P63; Huang V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008848; Janssen R, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-374; Kamminga LM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002702; Kataoka K, 2011, ADV EXP MED BIOL, V722, P156, DOI 10.1007/978-1-4614-0332-6_10; Khurana JS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001246; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lau NC, 2009, EMBO J, V28, P2945; Liang D, 2013, NEOPLASMA; Lim RSM, 2014, DEV BIOL, V386, P237, DOI 10.1016/j.ydbio.2013.12.007; Lim SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099687; Lin HF, 1997, DEVELOPMENT, V124, P2463; Ma X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090267; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-29; Mani SR, 2014, DEV BIOL, V385, P340, DOI 10.1016/j.ydbio.2013.10.017; Montgomery TA, 2012, PLOS GENET, V8, P72, DOI 10.1371/journal.pgen.1002616; Nishida KM, 2015, CELL REP, V10, P193, DOI 10.1016/j.celrep.2014.12.013; NODA K, 1977, J ULTRA MOL STRUCT R, V61, P284, DOI 10.1016/S0022-5320(77)80053-1; Nolde MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071950; Okamura K, 2012, WIRES RNA, V3, P351, DOI 10.1002/wrna.113; Schwager EE, 2014, DEV BIOL; Shao Peng, 2012, RNA Biol, V9, P212, DOI 10.4161/rna.18489; Todeschini AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011032; Voronina E, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002774; Vourekas A, 2015, GENES DEV; Wang W, 2014, MOL CELL, V56, P708, DOI 10.1016/j.molcel.2014.10.016; Wang XY, 2014, INT J ONCOL, V45, P2385, DOI 10.3892/ijo.2014.2673; Watanabe T, 2015, GENOME RES, V25, P368, DOI 10.1101/gr.180802.114; ALMUKHTA.KA, 1971, J EMBRYOL EXP MORPH, V26, P195; Xie Y, 2014, MOL MED REP; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yan H, 2015, LEUKEMIA, V29, P196, DOI 10.1038/leu.2014.135; Yao Y, 2014, ONCOTARGET; Zhang QJ, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-17	306	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1084-9521			SEMIN CELL DEV BIOL	Semin. Cell Dev. Biol.	DEC	2015	47-48						17	31		10.1016/j.semcdb.2015.10.025		15	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CY1AO	WOS:000366138700004		
J	Sasaki, H				Sasaki, Hiroshi			Position- and polarity-dependent Hippo signaling regulates cell fates in preimplantation mouse embryos	SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY			English	Review						Preimplantation mouse embryo; Hippo signaling pathway; Cell fate specification; Trophectoderm	TRANSCRIPTION FACTOR; CONTACT INHIBITION; STEM-CELLS; E-CADHERIN; LINEAGE DIFFERENTIATION; TROPHECTODERM LINEAGE; PATHWAY COMPONENTS; SPEMANNS ORGANIZER; MAMMALIAN EMBRYO; TUMOR-SUPPRESSOR	During the preimplantation stage, mouse embryos establish two cell lineages by the time of early blastocyst formation: the trophectoderm (TE) and the inner cell mass (ICM). Historical models have proposed that the establishment of these two lineages depends on the cell position within the embryo (e.g., the positional model) or cell polarization along the apicobasal axis (e.g., the polarity model). Recent findings have revealed that the Hippo signaling pathway plays a central role in the cell fate-specification process: active and inactive Hippo signaling in the inner and outer cells promote ICM and TE fates, respectively. Intercellular adhesion activates, while apicobasal polarization suppresses Hippo signaling, and a combination of these processes determines the spatially regulated activation of the Hippo pathway in 32-cell-stage embryos. Therefore, there is experimental evidence in favor of both positional and polarity models. At the molecular level, phosphorylation of the Hippo-pathway component angiomotin at adherens junctions (AJs) in the inner (apolar) cells activates the Lats protein kinase and triggers Hippo signaling. In the outer cells, however, cell polarization sequesters Amot from basolateral AJs and suppresses activation of the Hippo pathway. Other mechanisms, including asymmetric cell division and Notch signaling, also play important roles in the regulation of embryonic development. In this review, I discuss how these mechanisms cooperate with the Hippo signaling pathway during cell fate-specification processes. (C) 2015 Elsevier Ltd. All rights reserved.	[Sasaki, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Lab Embryogenesis, Suita, Osaka 5650871, Japan	Sasaki, H (reprint author), Osaka Univ, Grad Sch Frontier Biosci, Lab Embryogenesis, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	sasaki@fbs.osaka-u.ac.jp			MEXT [21116003, 26112715, 15H01495]; JSPS [23247036]	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) from MEXT (21116003, 26112715, 15H01495) and JSPS (23247036) to H.S.	Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Barry ER, 2013, CURR OPIN CELL BIOL, V25, P247, DOI 10.1016/j.ceb.2012.12.006; Suwinska A, 2008, DEV BIOL, V322, P133, DOI 10.1016/j.ydbio.2008.07.019; Morris SA, 2010, P NATL ACAD SCI USA, V107, P6364, DOI 10.1073/pnas.0915063107; HYAFIL F, 1980, CELL, V21, P927, DOI 10.1016/0092-8674(80)90456-0; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Havrda MC, 2008, J NEUROSCI, V28, P14074, DOI 10.1523/JNEUROSCI.3188-08.2008; Kaneko KJ, 2013, DEVELOPMENT, V140, P3680, DOI 10.1242/dev.093799; Hirate Y, 2013, CURR BIOL, V23, P1181, DOI 10.1016/j.cub.2013.05.014; TARKOWSKI AK, 1959, NATURE, V184, P1286, DOI 10.1038/1841286a0; Ernkvist M, 2008, BBA-MOL CELL RES, V1783, P429, DOI 10.1016/j.bbamcr.2007.11.018; JOHNSON MH, 1988, DEVELOPMENT, V102, P143; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; KELLY SJ, 1977, J EXP ZOOL, V200, P365, DOI 10.1002/jez.1402000307; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Ralston A, 2010, DEVELOPMENT, V137, P395, DOI 10.1242/dev.038828; Ernkvist M, 2006, FEBS J, V273, P2000, DOI 10.1111/j.1742-4658.2006.05216.x; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; Alarcon VB, 2010, BIOL REPROD, V83, P347, DOI 10.1095/biolreprod.110.084400; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Anani S, 2014, DEVELOPMENT, V141, P2813, DOI 10.1242/dev.107276; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; ZIOMEK CA, 1982, DEV BIOL, V91, P440, DOI 10.1016/0012-1606(82)90050-1; Plachta N, 2011, NAT CELL BIOL, V13, P117, DOI 10.1038/ncb2154; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Yamanaka Y, 2010, DEVELOPMENT, V137, P715, DOI 10.1242/dev.043471; Hibi M, 2002, RES PRO CEL, V40, P48; ZIOMEK CA, 1982, J EXP ZOOL, V221, P345, DOI 10.1002/jez.1402210310; Eckert JJ, 2005, DEV BIOL, V288, P234, DOI 10.1016/j.ydbio.2005.09.037; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Home P, 2012, P NATL ACAD SCI USA, V109, P7362, DOI 10.1073/pnas.1201595109; PEDERSEN RA, 1986, DEV BIOL, V117, P581, DOI 10.1016/0012-1606(86)90327-1; Gladden AB, 2010, DEV CELL, V19, P727, DOI 10.1016/j.devcel.2010.10.008; GERHART J, 1989, DEVELOPMENT, V107, P37; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Cockburn K, 2013, CURR BIOL, V23, P1195, DOI 10.1016/j.cub.2013.05.044; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Mana-Capelli S, 2014, MOL BIOL CELL, V25, P1676, DOI 10.1091/mbc.E13-11-0701; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Hirate Y, 2012, P NATL ACAD SCI USA, V109, pE3389, DOI 10.1073/pnas.1211810109; MARO B, 1985, J EMBRYOL EXP MORPH, V90, P287; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Zernicka-Goetz M, 1998, DEVELOPMENT, V125, P4803; SHIRAYOSHI Y, 1983, CELL, V35, P631, DOI 10.1016/0092-8674(83)90095-8; Lorthongpanich C, 2013, GENE DEV, V27, P1441, DOI 10.1101/gad.219618.113; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Plusa B, 2005, J CELL SCI, V118, P505, DOI 10.1242/jcs.01666; McDole K, 2012, GENESIS, V50, P775, DOI 10.1002/dvg.22049; Wang CJ, 2012, BIOCHEM J, V444, P279, DOI 10.1042/BJ20111983; McDole K, 2011, DEV BIOL, V355, P239, DOI 10.1016/j.ydbio.2011.04.024; Stephenson RO, 2010, DEVELOPMENT, V137, P3383, DOI 10.1242/dev.050195; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; GOODALL H, 1986, J CELL BIOL, V102, P568, DOI 10.1083/jcb.102.2.568; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Duffield GE, 2009, CURR BIOL, V19, P297, DOI 10.1016/j.cub.2008.12.052; HILLMAN N, 1972, J EMBRYOL EXP MORPH, V28, P263; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; ROSSANT J, 1979, DEV BIOL, V70, P255, DOI 10.1016/0012-1606(79)90022-8; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Chan SW, 2013, J BIOL CHEM, V288, P37296, DOI 10.1074/jbc.M113.527598; FLEMING TP, 1987, DEV BIOL, V119, P520, DOI 10.1016/0012-1606(87)90055-8; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Rayon T, 2014, DEV CELL, V30, P410, DOI 10.1016/j.devcel.2014.06.019; Dai XM, 2013, J BIOL CHEM, V288, P34041, DOI 10.1074/jbc.M113.518019; Tabansky I, 2013, CURR BIOL, V23, P21, DOI 10.1016/j.cub.2012.10.054; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Hirate Y, 2014, TISSUE BARRIERS, V2; Johnson MH, 1981, CELLULAR MOL ASPECTS, P55; Leung CY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3251; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Parsons LM, 2014, CURR BIOL, V24, P2073, DOI 10.1016/j.cub.2014.07.075; Piotrowska-Nitsche K, 2005, DEVELOPMENT, V132, P479, DOI 10.1242/dev.01602; ROSSANT J, 1976, J EMBRYOL EXP MORPH, V36, P283; TARKOWSKI ANDRZEJ K., 1959, ACTA THERIOL, V3, P191; TARKOWSK.AK, 1967, J EMBRYOL EXP MORPH, V18, P155; Wicklow E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004618; Yi CL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004060	90	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1084-9521			SEMIN CELL DEV BIOL	Semin. Cell Dev. Biol.	DEC	2015	47-48						80	87		10.1016/j.semcdb.2015.05.003		8	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CY1AO	WOS:000366138700011		
J	Hamada, H				Hamada, Hiroshi			Role of physical forces in embryonic development	SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY			English	Review						Body axis; Convergent extension; Fluid flow; Symmetry breaking	ANTERIOR-POSTERIOR AXIS; LEFT-RIGHT ASYMMETRY; MOUSE EMBRYO; FLUID-FLOW; PRIMARY CILIUM; NODE; CALCIUM; XENOPUS; MECHANOTRANSDUCTION; TISSUES	Physical forces play essential roles in animal development. Given that embryonic development takes place under spatial constraints, cells experience forces from neighboring cells and/or remote tissues and can transduce such forces into biochemical signals. Cells can also generate forces through active migration, movement, or deformation and thereby influence the behavior of their neighbors. Although the contribution of mechanical forces to development has been well established in general, here I will focus on recent findings that address the involvement of physical forces in body axis determination, gastrulation and cardiovascular development. (C) 2015 Elsevier Ltd. All rights reserved.	[Hamada, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Dev Genet Grp, Suita, Osaka 5650871, Japan; [Hamada, Hiroshi] Japan Sci & Technol Corp JST, CREST, Suita, Osaka 5650871, Japan	Hamada, H (reprint author), Osaka Univ, Grad Sch Frontier Biosci, Dev Genet Grp, 1-3 Yamada Oka, Suita, Osaka 5650871, Japan.	hamada@fbs.osaka-u.ac.jp					Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; BELOUSSOV LV, 1988, CELL DIFFER DEV, V25, P165, DOI 10.1016/0922-3371(88)90113-X; Eaton S, 2011, CURR OPIN GENET DEV, V21, P747, DOI 10.1016/j.gde.2011.08.010; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Shawky JH, 2015, DEV BIOL, V401, P152, DOI 10.1016/j.ydbio.2014.12.005; Desprat N, 2008, DEV CELL, V15, P470, DOI 10.1016/j.devcel.2008.07.009; Hiramatsu R, 2013, DEV CELL, V27, P131, DOI 10.1016/j.devcel.2013.09.026; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Hara Y, 2013, DEV BIOL, V382, P482, DOI 10.1016/j.ydbio.2013.07.023; Takaoka K, 2006, DEV CELL, V10, P451, DOI 10.1016/j.devcel.2006.02.017; WILSON P, 1991, DEVELOPMENT, V112, P289; Takao D, 2013, DEV BIOL, V376, P23, DOI 10.1016/j.ydbio.2013.01.018; Kawasumi A, 2011, DEV BIOL, V353, P321, DOI 10.1016/j.ydbio.2011.03.009; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Kamura K, 2011, DEVELOPMENT, V138, P1121, DOI 10.1242/dev.058271; Imuta Y, 2014, MECH DEVELOP, V132, P44, DOI 10.1016/j.mod.2014.01.004; Schweickert A, 2010, CURR BIOL, V20, P738, DOI 10.1016/j.cub.2010.02.061; Yashiro K, 2007, NATURE, V450, P285, DOI 10.1038/nature06254; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Yoshiba S, 2012, SCIENCE, V338, P226, DOI 10.1126/science.1222538; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Marques S, 2004, GENE DEV, V18, P2342, DOI 10.1101/gad.306504; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Somogyi K, 2004, DEV CELL, V7, P85, DOI 10.1016/j.devcel.2004.05.020; Field S, 2011, DEVELOPMENT, V138, P1131, DOI 10.1242/dev.058149; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Jones EAV, 2006, PHYSIOLOGY, V21, P388, DOI 10.1152/physiol.00020.2006; Tan H, 2013, DEV BIOL, V374, P345, DOI 10.1016/j.ydbio.2012.11.023; Nauli SM, 2008, CIRCULATION, V117, P1161, DOI 10.1161/CIRCULATIONAHA.107.710111; Takaoka K, 2012, DEVELOPMENT, V139, P3, DOI 10.1242/dev.060095; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Banjo T, 2013, NAT COMMUN, P4; Bedzhov I, 2014, NAT PROTOC, V9, P2732, DOI 10.1038/nprot.2014.186; BELOUSSOV L V, 1990, International Journal of Developmental Biology, V34, P409; Iskratsch T, 2014, NAT REV MOL CELL BIO, V15, P825, DOI 10.1038/nrm3903; MOORE SW, 1994, IEEE T BIO-MED ENG, V41, P45, DOI 10.1109/10.277270; Morris SA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1671; Nakamura T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2319; Shinohara K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1624; Yuan SL, 2015, CURR BIOL, V25, P556, DOI 10.1016/j.cub.2014.12.051	41	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1084-9521			SEMIN CELL DEV BIOL	Semin. Cell Dev. Biol.	DEC	2015	47-48						88	91		10.1016/j.semcdb.2015.10.011		4	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CY1AO	WOS:000366138700012		
J	Mizuno, M				Mizuno, Maki			Clinical experience and perception of abortion: A cross-sectional survey of gynecologists in Japan	SEXUAL & REPRODUCTIVE HEALTHCARE			English	Article						Abortion; Mifepristone; Gynecologist; Dilation and evacuation; Dilation and curettage; Pain management		This study describes aspects of early induced abortion from the experience and perspectives of a sample of gynecologists in Japan. The survey questionnaire data were collected from 343 gynecologists from September to October 2010. Approximately 83% of participants preferred using only dilation and curettage (D&C), and 10.4% used electric vacuum aspiration (EVA). The cost of surgical abortion was not covered by insurance. Most gynecologists used intravenous pain management during abortion. Approximately 50% of the gynecologists were opposed to introducing medical abortion in Japan. (C) 2015 Elsevier B.V. All rights reserved.	[Mizuno, Maki] Kanazawa Univ, Div Hlth Sci, Kanazawa, Ishikawa 9200942, Japan	Mizuno, M (reprint author), Kanazawa Univ, Div Hlth Sci, 5-11-80 Kodatuno, Kanazawa, Ishikawa 9200942, Japan.	maki@mhs.mp.kanazawa-u.ac.jp					Abortion Legislation in Europe, 2012, AB LEG EUR; Kimura K, 2008, IRYO TO SHAKAI, V18, P459; Ministry of Health Labour and Welfare, 2012, REP PUBL HLTH ADM 20, P9; National Institution of Population and Social Security Research, 2011, 14 JAP NAT FERT SURV; Official Statistics Japan, 2000, REP MAT PROT LAW; Sato R., 2006, JAPANESE J POPULATIO, V4, P33; World Health Organization, 2012, SAF AB TECHN POL GUI, P2	7	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1877-5756	1877-5764		SEX REPROD HEALTHC	Sex. Reprod. Healthc.	DEC	2015	6	4					255	256		10.1016/j.srhc.2015.04.005		2	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CY5KD	WOS:000366445600011		
J	Mori, K; Horibe, T; Ishikawa, S; Shindo, Y; Narita, F				Mori, Kotaro; Horibe, Tadashi; Ishikawa, Shigekazu; Shindo, Yasuhide; Narita, Fumio			Characteristics of vibration energy harvesting using giant magnetostrictive cantilevers with resonant tuning	SMART MATERIALS AND STRUCTURES			English	Article						energy harvesting; self-tuning; giant magnetostrictive material; cantilever	POWER	This work deals with the dynamic bending and energy harvesting characteristics of giant magnetostrictive cantilevers with resonant tuning both numerically and experimentally. The giant magnetostrictive cantilever is fabricated using a thin Terfenol-D layer, SUS layer, movable proof mass, etc, and, is designed to automatically adjust its own resonant frequency to match the external vibration frequency in real time. Three-dimensional finite element analysis was conducted, and the resonant frequency, induced voltage and stress in the magnetostrictive cantilevers were predicted. The resonant frequency and induced voltage were also measured, and comparison was made between simulation and experiment. The time-varying behavior and self-tuning ability are discussed in detail.	[Mori, Kotaro; Horibe, Tadashi; Ishikawa, Shigekazu] Ibaraki Univ, Dept Mech Engn, Coll Engn, Hitachi, Ibaraki 3168511, Japan; [Shindo, Yasuhide; Narita, Fumio] Tohoku Univ, Grad Sch Engn, Dept Mat Proc, Sendai, Miyagi 9808579, Japan	Mori, K (reprint author), Ibaraki Univ, Dept Mech Engn, Coll Engn, Nakanarusawa Cho 4-12-1, Hitachi, Ibaraki 3168511, Japan.	mori-k@mx.ibaraki.ac.jp					Peigney M, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/9/095019; Lallart M, 2010, J INTEL MAT SYST STR, V21, P897, DOI 10.1177/1045389X10369716; Wang L, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/4/045009; Miller LM, 2013, J SOUND VIB, V332, P7142, DOI 10.1016/j.jsv.2013.08.023; Bayrashev A, 2004, SENSOR ACTUAT A-PHYS, V114, P244, DOI 10.1016/j.sna.2004.01.007; ALSHITS VI, 1992, WAVE MOTION, V16, P265, DOI 10.1016/0165-2125(92)90033-X; Hu J, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/1/015021; Valadkhan S, 2009, J INTEL MAT SYST STR, V20, P131, DOI 10.1177/1045389X08093563; Shindo Y, 2014, INT J MECH MATER DES, V10, P305, DOI 10.1007/s10999-014-9247-0; Aboulfotoh NA, 2013, SENSOR ACTUAT A-PHYS, V201, P328, DOI 10.1016/j.sna.2013.07.030; Bozorth R M, 1993, FERROMAGNETISM; Butler J L, 1988, APPL MANUAL DESIGN E; Engdahl G., 2000, HDB GIANT MAGNETOSTR; Jia D.W., 2009, FRONT ENERGY POWER E, V3, P27; Mori K, 2012, SMART MATER STRUCT, V21, DOI 10.1088/0964-1726/21/11/115003; University of Bristol/University of Southampton, NEXT GEN EN HARV EL; Zhao X, 2006, J APPL PHYS, V99, DOI 10.1063/1.2165133	17	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0964-1726	1361-665X		SMART MATER STRUCT	Smart Mater. Struct.	DEC	2015	24	12							125032	10.1088/0964-1726/24/12/125032		7	Instruments & Instrumentation; Materials Science, Multidisciplinary	Instruments & Instrumentation; Materials Science	CY0QV	WOS:000366111500033		
J	Nambu, Y; Takashima, T; Inagaki, A				Nambu, Yohsuke; Takashima, Toshihide; Inagaki, Akiya			Robust design method and thermostatic experiment for multiple piezoelectric vibration absorber system	SMART MATERIALS AND STRUCTURES			English	Article						dynamic vibration absorber; piezoelectric material; real-coded genetic algorithm; robust design; thermal dependency	TUNED-MASS DAMPERS; SUPPRESSION; OPTIMIZATION; TRANSDUCERS; ACTUATOR; DEVICE	This paper examines the effects of connecting multiplexing shunt circuits composed of inductors and resistors to piezoelectric transducers so as to improve the robustness of a piezoelectric vibration absorber (PVA). PVAs are well known to be effective at suppressing the vibration of an adaptive structure; their weakness is low robustness to changes in the dynamic parameters of the system, including the main structure and the absorber. In the application to space structures, the temperature-dependency of capacitance of piezoelectric ceramics is the factor that causes performance reduction. To improve robustness to the temperature-dependency of the capacitance, this paper proposes a multiple-PVA system that is composed of distributed piezoelectric transducers and several shunt circuits. The optimization problems that determine both the frequencies and the damping ratios of the PVAs are multi-objective problems, which are solved using a real-coded genetic algorithm in this paper. A clamped aluminum beam with four groups of piezoelectric ceramics attached was considered in simulations and experiments. Numerical simulations revealed that the PVA systems designed using the proposed method had tolerance to changes in the capacitances. Furthermore, experiments using a thermostatic bath were conducted to reveal the effectiveness and robustness of the PVA systems. The maximum peaks of the transfer functions of the beam with the open circuit, the single-PVA system, the double-PVA system, and the quadruple-PVA system at 20 degrees C were 14.3 dB, -6.91 dB, -7.47 dB, and -8.51 dB, respectively. The experimental results also showed that the multiple-PVA system is more robust than a single PVA in a variable temperature environment from -10 degrees C to 50 degrees C. In conclusion, the use of multiple PVAs results in an effective, robust vibration control method for adaptive structures.	[Nambu, Yohsuke] Osaka Prefecture Univ, Grad Sch Engn, Naka Ku, Sakai, Osaka 5998531, Japan; [Takashima, Toshihide] Osaka Prefecture Univ, Dept Aerosp Engn, Naka Ku, Sakai, Osaka 5998531, Japan; [Inagaki, Akiya] Tokyo Inst Technol, Dept Mech & Aerosp Engn, Meguro Ku, Tokyo 1528552, Japan	Nambu, Y (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Naka Ku, Gakuen Cho 1, Sakai, Osaka 5998531, Japan.	nambu@aero.osakafu-u.ac.jp			MEXT/JSPS KAKENHI [25820412]	This work was supported by MEXT/JSPS KAKENHI grant number 25820412.	Alujevic N, 2012, J SOUND VIB, V331, P2731; Nishimura I, 1998, SMART MATER STRUCT, V7, P637, DOI 10.1088/0964-1726/7/5/008; HAGOOD NW, 1991, J SOUND VIB, V146, P243, DOI 10.1016/0022-460X(91)90762-9; Pinkaew T, 2001, ENG STRUCT, V23, P850, DOI 10.1016/S0141-0296(00)00091-2; Corr LR, 2001, P SOC PHOTO-OPT INS, V4331, P262, DOI 10.1117/12.432709; Williams KA, 2005, J SOUND VIB, V280, P211, DOI 10.1016/j.jsv.2003.12.040; Takeuchi S, 2012, J VIB ACOUST, V134, DOI 10.1115/1.4005027; Makihara K, 2004, T JPN SOC AERONAUT S, V47, P167, DOI 10.2322/tjsass.47.167; Kodejska M, 2012, IEEE T ULTRASON FERR, V59, P2785, DOI 10.1109/TUFFC.2012.2520; Asami T, 2002, J VIB ACOUST, V124, P284, DOI 10.1115/1.1456458; Yamada K, 2010, J SOUND VIB, V329, P5036, DOI 10.1016/j.jsv.2010.06.021; [Anonymous], 2003, ADV EVOLUTIONARY COM; Moheimani SOR, 2003, IEEE T CONTR SYST T, V11, P482, DOI 10.1109/TCST.2003.813371; Clark WW, 2000, J INTEL MAT SYST STR, V11, P263, DOI 10.1106/18CE-77K4-DYMG-RKBB; Zuo L, 2005, J VIB ACOUST, V127, P77, DOI 10.1115/1.1855929; Zuo L, 2004, J SOUND VIB, V272, P893, DOI 10.1016/S0022-460X(03)00500-5; Behrens S, 2003, SMART MATER STRUCT, V12, P18, DOI 10.1088/0964-1726/12/1/303; ANTONIOU A, 1969, P I ELECTR ENG, V116, P1838; Richard C, 2000, P SOC PHOTO-OPT INS, V3989, P288, DOI 10.1117/12.384569; [Anonymous], 2001, P C EV COMP CEC2001; Makihara K, 2007, SMART MATER STRUCT, V16, P455, DOI 10.1088/0964-1726/16/2/025; Den Hartog J P, 1956, MECH VIBRATIONS; Goldberg D E, 1989, GENETIC ALGORITHMS; Kita H, 1999, P 1999 C EV COMP, V2, P1588; Makihara K, 2011, AIAA J, V50, P2004; Nambu Y, 2014, SMART MATER STRUCT, V23, P25; Ohnuki O, 1996, T JAPAN SOC MECH E C, V63, P328; Onoda J, 2003, AIAA J, V41, P711, DOI 10.2514/2.2002; Petit L, 2004, P SOC PHOTO-OPT INS, V5386, P414, DOI 10.1117/12.532716; Richard C, 1999, P SOC PHOTO-OPT INS, V3672, P104, DOI 10.1117/12.349773	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0964-1726	1361-665X		SMART MATER STRUCT	Smart Mater. Struct.	DEC	2015	24	12							125016	10.1088/0964-1726/24/12/125016		15	Instruments & Instrumentation; Materials Science, Multidisciplinary	Instruments & Instrumentation; Materials Science	CY0QV	WOS:000366111500017		
J	Bockelee-Morvan, D; Calmonte, U; Charnley, S; Duprat, J; Engrand, C; Gicquel, A; Hassig, M; Jehin, E; Kawakita, H; Marty, B; Milam, S; Morse, A; Rousselot, P; Sheridan, S; Wirstrom, E				Bockelee-Morvan, Dominique; Calmonte, Ursina; Charnley, Steven; Duprat, Jean; Engrand, Cecile; Gicquel, Adeline; Haessig, Myrtha; Jehin, Emmanuel; Kawakita, Hideyo; Marty, Bernard; Milam, Stefanie; Morse, Andrew; Rousselot, Philippe; Sheridan, Simon; Wirstrom, Eva			Cometary Isotopic Measurements	SPACE SCIENCE REVIEWS			English	Review						Comets; Isotopes	INTERPLANETARY DUST PARTICLES; O1 HALE-BOPP; ULTRACARBONACEOUS ANTARCTIC MICROMETEORITES; DENSE INTERSTELLAR CLOUDS; GRAIN SURFACE-CHEMISTRY; SOLAR-SYSTEM; ABUNDANCE RATIO; DARK CLOUDS; C/1995 O1; LOW-MASS	Isotopic ratios in comets provide keys for the understanding of the origin of cometary material, and the physical and chemical conditions in the early Solar Nebula. We review here measurements acquired on the D/H, N-14/N-15, O-16/O-18, C-12/C-13, and S-32/S-34 ratios in cometary grains and gases, and discuss their cosmogonic implications. The review includes analyses of potential cometary material available in collections on Earth, recent measurements achieved with the Herschel Space Observatory, large optical telescopes, and Rosetta, as well as recent results obtained from models of chemical-dynamical deuterium fractionation in the early solar nebula. Prospects for future measurements are presented.	[Bockelee-Morvan, Dominique] Univ Paris Diderot, UPMC, CNRS, Observ Paris, F-92195 Meudon, France; [Calmonte, Ursina] Univ Bern, Inst Phys, Space Res & Planetary Sci, CH-3012 Bern, Switzerland; [Charnley, Steven; Milam, Stefanie] NASA, Goddard Space Flight Ctr Greenbelt, Astrochem Lab, Greenbelt, MD 20771 USA; [Duprat, Jean; Engrand, Cecile] Univ Paris 11, CNRS, IN2P3, CSNSM,UMR 8609, F-91405 Orsay, France; [Gicquel, Adeline] Max Planck Inst Solar Syst Res, D-37077 Gottingen, Germany; [Haessig, Myrtha] SW Res Inst, San Antonio, TX USA; [Jehin, Emmanuel] Univ Liege, Dept Astrophys Geophys & Oceanog, B-4000 Liege, Belgium; [Kawakita, Hideyo] Kyoto Sangyo Univ, Koyama Astron Observ, Kita Ku, Kyoto 6038555, Japan; [Marty, Bernard] Univ Lorraine, CNRS, CRPG, F-54500 Vandoeuvre Les Nancy, France; [Morse, Andrew; Sheridan, Simon] Open Univ, Space Sci, Milton Keynes MK7 6AA, Bucks, England; [Rousselot, Philippe] Univ Franche Comte, Inst UTINAM, Observ Sci Univers THETA, UMR CNRS 6213, F-25010 Besancon, France; [Wirstrom, Eva] Chalmers, Onsala Space Observ, S-43992 Onsala, Sweden	Bockelee-Morvan, D (reprint author), Univ Paris Diderot, UPMC, CNRS, Observ Paris, 5 Pl Jules Janssen, F-92195 Meudon, France.	dominique.bockelee@obspm.fr			NASA; Swedish Space Board	This work was supported by NASA's Planetary Astronomy and Planetary Atmospheres Programs (SNM and SBC), and by the Swedish Space Board (ESW).	Aleon J., 2010, AP J, V72, P1342; Altwegg K., 2014, SCIENCE, V347; Altwegg K., 1996, HABILITATIONSSCHRIFT; Ikeda M, 2002, ASTROPHYS J, V575, P250, DOI 10.1086/341287; Hartogh P, 2011, NATURE, V478, P218, DOI 10.1038/nature10519; Wooden DH, 2008, SPACE SCI REV, V138, P75, DOI 10.1007/s11214-008-9424-2; Rubin M, 2015, SCIENCE, V348, P232, DOI 10.1126/science.aaa6100; Blake GA, 1999, NATURE, V398, P213, DOI 10.1038/18372; Kakazu Y, 2014, METEORIT PLANET SCI, V49, pA195; Brasser R, 2013, ICARUS, V225, P40, DOI 10.1016/j.icarus.2013.03.012; Parise B, 2006, ASTRON ASTROPHYS, V453, P949, DOI 10.1051/0004-6361:20054476; Goesmann F, 2007, SPACE SCI REV, V128, P257, DOI 10.1007/s11214-006-9000-6; Bockelee-Morvan D, 2008, ASTROPHYS J LETT, V679, pL49, DOI 10.1086/588781; Remusat L, 2006, EARTH PLANET SC LETT, V243, P15, DOI 10.1016/j.epsl.2005.12.010; Jewitt DC, 1997, SCIENCE, V278, P90, DOI 10.1126/science.278.5335.90; ASPREY LB, 1976, J FLUORINE CHEM, V7, P359, DOI 10.1016/S0022-1139(00)84009-9; KLEINE M, 1995, ASTROPHYS J, V439, P1021, DOI 10.1086/175239; Messenger S, 2005, SCIENCE, V309, P737, DOI 10.1126/science.1109602; Jorgensen JK, 2004, ASTRON ASTROPHYS, V416, P603, DOI 10.1051/0004-6361:20034440; Marty B, 2012, EARTH PLANET SC LETT, V313, P56, DOI 10.1016/j.epsl.2011.10.040; UREY HC, 1957, NATURE, V179, P556, DOI 10.1038/179556a0; Dobrica E, 2012, GEOCHIM COSMOCHIM AC, V76, P68, DOI 10.1016/j.gca.2011.10.025; Simon SB, 2008, METEORIT PLANET SCI, V43, P1861; Charnley SB, 1997, ASTROPHYS J, V482, pL203, DOI 10.1086/310697; Biver N, 2007, PLANET SPACE SCI, V55, P1058, DOI 10.1016/j.pss.2006.11.010; Owen T, 2001, ASTROPHYS J, V553, pL77, DOI 10.1086/320501; HUEBNER WF, 1992, ASTROPHYS SPACE SCI, V195, P1, DOI 10.1007/BF00644558; Harker DE, 2002, ASTROPHYS J, V565, pL109, DOI 10.1086/339363; Herbst E, 2009, ANNU REV ASTRON ASTR, V47, P427, DOI 10.1146/annurev-astro-082708-101654; Mousis O, 2000, ICARUS, V148, P513, DOI 10.1006/icar.2000.6499; Hanner MS, 2010, LECT NOTES PHYS, V815, P203, DOI 10.1007/978-3-642-13259-9_4; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; Roberts H, 2003, ASTROPHYS J, V591, pL41, DOI 10.1086/376962; Brownlee D, 2014, ANNU REV EARTH PL SC, V42, P179, DOI 10.1146/annurev-earth-050212-124203; Gulkis S, 2007, PLANET SPACE SCI, V55, P1050, DOI 10.1016/j.pss.2006.11.011; Bockelee-Morvan D, 2011, IAU SYMP P SERIES, P261, DOI 10.1017/S1743921311025038; Alexander CMO, 2012, SCIENCE, V337, P721, DOI 10.1126/science.1223474; Marty B, 2011, SCIENCE, V332, P1533, DOI 10.1126/science.1204656; Rodgers SD, 2008, ASTROPHYS J, V689, P1448, DOI 10.1086/592195; Manfroid J, 2009, ASTRON ASTROPHYS, V503, P613, DOI 10.1051/0004-6361/200911859; Lee JE, 2008, METEORIT PLANET SCI, V43, P1351; Kramers JD, 2013, EARTH PLANET SC LETT, V382, P21, DOI 10.1016/j.epsl.2013.09.003; Messenger S, 2003, SCIENCE, V300, P105, DOI 10.1126/science.1080576; Shah RY, 2001, ASTROPHYS J, V554, P933, DOI 10.1086/321396; BRADLEY JP, 1986, SCIENCE, V231, P1542, DOI 10.1126/science.231.4745.1542; Mandt KE, 2009, PLANET SPACE SCI, V57, P1917, DOI 10.1016/j.pss.2009.06.005; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; ANDERS E, 1975, ICARUS, V24, P363, DOI 10.1016/0019-1035(75)90132-3; Kawakita H, 2003, ASTROPHYS J, V590, P573, DOI 10.1086/374969; McKeegan KD, 2006, SCIENCE, V314, P1724, DOI 10.1126/science.1135992; Hutsemekers D, 2008, ASTRON ASTROPHYS, V490, pL31, DOI 10.1051/0004-6361:200810833; Fontani F, 2014, MON NOT R ASTRON SOC, V440, P448, DOI 10.1093/mnras/stu298; MCSWEEN HY, 1989, GEOCHIM COSMOCHIM AC, V53, P3263, DOI 10.1016/0016-7037(89)90106-3; Stadermann FJ, 2008, METEORIT PLANET SCI, V43, P299; Lis DC, 2008, ASTROPHYS J, V675, P931, DOI 10.1086/527345; Hassig M, 2013, PLANET SPACE SCI, V84, P148, DOI 10.1016/j.pss.2013.05.014; Walsh KJ, 2011, NATURE, V475, P206, DOI 10.1038/nature10201; Turner BE, 2001, ASTROPHYS J SUPPL S, V136, P579, DOI 10.1086/322536; Dones L, 2004, SPACE SCI S, P153; Piani L, 2015, EARTH PLANET SC LETT, V415, P154, DOI 10.1016/j.epsl.2015.01.039; BALLY J, 1982, ASTROPHYS J, V255, P143, DOI 10.1086/159812; Yurimoto H, 2004, SCIENCE, V305, P1763, DOI 10.1126/science.1100989; Kawakita H, 2003, ASTROPHYS J, V582, P534, DOI 10.1086/344520; Finzi AE, 2007, SPACE SCI REV, V128, P281, DOI 10.1007/s11214-006-9134-6; Hersant F, 2001, ASTROPHYS J, V554, P391, DOI 10.1086/321355; TURNER BE, 1990, ASTROPHYS J, V362, pL29, DOI 10.1086/185840; Starkey NA, 2013, GEOCHIM COSMOCHIM AC, V105, P73, DOI 10.1016/j.gca.2012.11.040; SANTROCK J, 1985, ANAL CHEM, V57, P1444, DOI 10.1021/ac00284a060; Balsiger H, 2007, SPACE SCI REV, V128, P745, DOI 10.1007/s11214-006-8335-3; Charnley SB, 2008, SPACE SCI REV, V138, P59, DOI 10.1007/s11214-008-9331-6; ADAMS NG, 1981, ASTROPHYS J, V247, pL123, DOI 10.1086/183604; BLAKE GA, 1987, ASTROPHYS J, V315, P621, DOI 10.1086/165165; Meier R, 1998, SCIENCE, V279, P842, DOI 10.1126/science.279.5352.842; Matzel JEP, 2010, SCIENCE, V328, P483, DOI 10.1126/science.1184741; DRESSLER K, 1959, PHILOS TR R SOC S-A, V251, P553, DOI 10.1098/rsta.1959.0011; Gounelle M, 2006, METEORIT PLANET SCI, V41, P135; Marty B, 2008, SCIENCE, V319, P75, DOI 10.1126/science.1148001; Wright IP, 2007, SPACE SCI REV, V128, P363, DOI 10.1007/s11214-006-9001-5; Noguchi T, 2015, EARTH PLANET SC LETT, V410, P1, DOI 10.1016/j.epsl.2014.11.012; WATSON WD, 1976, ASTROPHYS J, V205, pL165, DOI 10.1086/182115; Nakashima D, 2015, EARTH PLANET SC LETT, V410, P54, DOI 10.1016/j.epsl.2014.11.020; Remusat L, 2010, ASTROPHYS J, V713, P1048, DOI 10.1088/0004-637X/713/2/1048; MINH YC, 1990, ASTROPHYS J, V360, P136, DOI 10.1086/169103; Villanueva GL, 2009, ASTROPHYS J LETT, V690, pL5, DOI 10.1088/0004-637X/690/1/L5; Bourke TL, 2006, ASTROPHYS J, V649, pL37, DOI 10.1086/508161; Bonev BP, 2009, ASTROPHYS J, V699, P1563, DOI 10.1088/0004-637X/699/2/1563; Brownlee DE, 2004, SCIENCE, V304, P1764, DOI 10.1126/science.1097899; Davidson J, 2012, METEORIT PLANET SCI, V47, P1748, DOI 10.1111/maps.12010; EBERHARDT P, 1995, ASTRON ASTROPHYS, V302, P301; Ziurys LM, 1999, ASTROPHYS J, V527, pL67, DOI 10.1086/312388; Waite JH, 2009, NATURE, V460, P487, DOI 10.1038/nature08153; Duprat J, 2014, METEORIT PLANET SCI, V49, pA103; EBERHARDT P, 1994, ASTRON ASTROPHYS, V288, P315; Kawakita H, 2005, ASTROPHYS J, V623, pL49, DOI 10.1086/429872; Keller LP, 2013, GEOCHIM COSMOCHIM AC, V107, P341, DOI 10.1016/j.gca.2012.11.012; Woods PM, 2009, ASTROPHYS J, V693, P1360, DOI 10.1088/0004-637X/693/2/1360; Brown RH, 2012, PLANET SPACE SCI, V60, P166, DOI 10.1016/j.pss.2011.07.023; MILLAR TJ, 1989, ASTROPHYS J, V340, P906, DOI 10.1086/167444; Roberts H, 2002, PLANET SPACE SCI, V50, P1173, DOI 10.1016/S0032-0633(02)00079-X; Jehin E, 2009, EARTH MOON PLANETS, V105, P167, DOI 10.1007/s11038-009-9322-y; Crovisier J, 2004, ASTRON ASTROPHYS, V418, P1141, DOI 10.1051/0004-6361:20035688; Jacquet E, 2013, ICARUS, V223, P722, DOI 10.1016/j.icarus.2013.01.022; Fouchet T, 2004, ICARUS, V172, P50, DOI 10.1016/j.icarus.2003.11.011; Milam SN, 2005, ASTROPHYS J, V634, P1126, DOI 10.1086/497123; Arpigny C, 2003, SCIENCE, V301, P1522, DOI 10.1126/science.1086711; Lis DC, 2010, ASTROPHYS J LETT, V710, pL49, DOI 10.1088/2041-8205/710/1/L49; Nakashima D, 2012, EARTH PLANET SC LETT, V357, P355, DOI 10.1016/j.epsl.2012.09.041; Hily-Blant P, 2013, ICARUS, V223, P582, DOI 10.1016/j.icarus.2012.12.015; HOWE DA, 1994, MON NOT R ASTRON SOC, V267, P59; Biver N, 2005, ESA SP PUBL, V577, P151; Bridges JC, 2012, EARTH PLANET SC LETT, V341, P186, DOI 10.1016/j.epsl.2012.06.011; LAWLER ME, 1992, NATURE, V359, P810, DOI 10.1038/359810a0; WYCKOFF S, 1989, ASTROPHYS J, V339, P488, DOI 10.1086/167312; Bockelee-Morvan D, 1998, ICARUS, V133, P147, DOI 10.1006/icar.1998.5916; STAWIKOWSKI A, 1964, ASTROPHYS J, V140, P1280, DOI 10.1086/148023; Bockelee-Morvan D, 2000, ASTRON ASTROPHYS, V353, P1101; Charnley SB, 2002, ASTROPHYS J, V569, pL133, DOI 10.1086/340484; Bockelee-Morvan D, 2008, ASTROPHYS SPACE SCI, V313, P183, DOI 10.1007/s10509-007-9641-2; Geiss J, 1998, SPACE SCI REV, V84, P239, DOI 10.1023/A:1005039822524; Elsila JE, 2009, METEORIT PLANET SCI, V44, P1323, DOI 10.1111/j.1945-5100.2009.tb01224.x; Biver N, 2006, ASTRON ASTROPHYS, V449, P1255, DOI 10.1051/0004-6361:20053849; Campins H, 1998, METEORIT PLANET SCI, V33, P1201; Bockelee-Morvan D, 2002, ASTRON ASTROPHYS, V384, P1107, DOI 10.1051/0004-6361:20020086; Yang L, 2013, ICARUS, V226, P256, DOI 10.1016/j.icarus.2013.05.027; Busemann H, 2006, SCIENCE, V312, P727, DOI 10.1126/science.1123878; Bradley JP, 2013, GEOCHIM COSMOCHIM AC, V107, P336, DOI 10.1016/j.gca.2012.04.061; Keller LP, 2004, GEOCHIM COSMOCHIM AC, V68, P2577, DOI 10.1016/j.gca.2003.10.044; Ishii HA, 2008, SCIENCE, V319, P447, DOI 10.1126/science.1150683; MANGUM JG, 1991, ASTROPHYS J, V369, P169, DOI 10.1086/169747; DANKS AC, 1974, ASTROPHYS J, V194, P745, DOI 10.1086/153297; OWEN T, 1973, ASTROPHYS J, V184, P33, DOI 10.1086/152300; Dartois E, 2013, ICARUS, V224, P243, DOI 10.1016/j.icarus.2013.03.002; Aikawa Y, 1999, ASTROPHYS J, V526, P314, DOI 10.1086/307973; Terzieva R, 2000, MON NOT R ASTRON SOC, V317, P563, DOI 10.1046/j.1365-8711.2000.03618.x; Charnley SB, 2004, MON NOT R ASTRON SOC, V347, P157, DOI 10.1111/j.1365-2966.2004.07188.x; Nakamura T, 2008, SCIENCE, V321, P1664, DOI 10.1126/science.1160995; Wyckoff S, 2000, ASTROPHYS J, V535, P991, DOI 10.1086/308863; Duprat J, 2010, SCIENCE, V328, P742, DOI 10.1126/science.1184832; Meier R, 1998, SCIENCE, V279, P1707, DOI 10.1126/science.279.5357.1707; Busemann H, 2009, EARTH PLANET SC LETT, V288, P44, DOI 10.1016/j.epsl.2009.09.007; Meier R, 1998, ICARUS, V136, P268, DOI 10.1006/icar.1998.6022; NIER AO, 1993, METEORITICS, V28, P675; Tennekes PP, 2006, ASTRON ASTROPHYS, V456, P1037, DOI 10.1051/0004-6361:20040294; Briani G, 2009, P NATL ACAD SCI USA, V106, P10522, DOI 10.1073/pnas.0901546106; THOMAS KL, 1993, GEOCHIM COSMOCHIM AC, V57, P1551, DOI 10.1016/0016-7037(93)90012-L; Brunetto R, 2011, ICARUS, V212, P896, DOI 10.1016/j.icarus.2011.01.038; Floss C, 2006, GEOCHIM COSMOCHIM AC, V70, P2371, DOI 10.1016/j.gca.2006.01.023; KISSEL J, 1987, NATURE, V326, P755, DOI 10.1038/326755a0; Dobrica E, 2011, METEORIT PLANET SCI, V46, P1363, DOI 10.1111/j.1945-5100.2011.01235.x; LAMBERT DL, 1983, ASTROPHYS J, V268, P428, DOI 10.1086/160969; Bibring JP, 2007, SPACE SCI REV, V128, P205, DOI 10.1007/s11214-006-9138-2; BROWNLEE DE, 1985, ANNU REV EARTH PL SC, V13, P147, DOI 10.1146/annurev.ea.13.050185.001051; Abraham P, 2009, NATURE, V459, P224, DOI 10.1038/nature08004; Kawakita H, 2009, ASTROPHYS J, V693, P388, DOI 10.1088/0004-637X/693/1/388; Gerin M, 2009, ASTRON ASTROPHYS, V498, pL9, DOI 10.1051/0004-6361/200911759; BALSIGER H, 1995, J GEOPHYS RES, V100, P5827, DOI 10.1029/94JA02936; Bardin N., 2014, LUNAR PLANET SCI C A, V45, P2647; Bergin EA, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/201015071; Bibring J.-P., 2007, SPACE SCI REV, V128, P363; Biver N., 2008, LPI CONTRIB, V1405, P8146; Biver N., 2012, ASTRON ASTROPHYS, V539, P68; Bizzocchi L, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201321276; Bizzocchi L., 2014, ASTRON ASTROPHYS, V569, pA27; Bockelee-Morvan D, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219744; Bradley J.P., 2005, METEORITES COMETS PL, P689; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Brownlee DE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002087; Brownlee D.E., 1995, LUNAR PLANET SCI, VXXVI, P183; Ceccarelli C., 2014, PROTOSTARS PLANETS 4, VVI, P859; Cleeves LI, 2014, SCIENCE, V345, P1590, DOI [10.1126/science.1258055, 10.1126/science.1258066]; Connolly H.C., 2008, LUNAR PLANET SCI, VXXXIX; Daniel F., 2013, ASTRON ASTROPHYS, V560, pAA3; Decock A., 2014, INTERNATIONAL COMET; Delsemme A.H., 1977, IAU C, V39, P499; Esplugues GB, 2013, ASTRON ASTROPHYS, V559, DOI 10.1051/0004-6361/201322073; Fecacheux A., 2003, ASTRON ASTROPHYS, V402, P55; Floss C., 2012, LUNAR PLANET SCI, V43, P1217; Floss C, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/2/140; Gibb EL, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/102; Gicquel A, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/1/1; GILES K, 1992, J PHYS CHEM-US, V96, P7645, DOI 10.1021/j100198a030; Greenberg J. M., 1982, IAU C, V61, P131; Haack H., 2011, LPI CONTRIBUTIONS, V1639, P9100; Haenecour P., 2014, LPI CONTRIBUTIONS, V1783, P5017; Heays AN, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201322832; Hily-Blant P, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321364; Hutsemekers D., 2005, ASTRON ASTROPHYS, V440, P21; Jehin E., 2008, LPI CONTRIB, V1405, P8319; Jehin E., 2006, APJ, V641, P145; Jehin E., 2011, EPSC DPS JOINT M 201, P1463; Jehin E., 2004, ASTROPHYS J, V613, P161; Jessberger E.K., 1991, IAU C, V116, P1075; Kavelaars J.J., 2011, ASTROPHYS J, V734, pLL30; KELLER LP, 1994, AIP CONF PROC, P159; LANGER WD, 1984, ASTROPHYS J, V277, P581, DOI 10.1086/161730; Lis DC, 2013, ASTROPHYS J LETT, V774, DOI 10.1088/2041-8205/774/1/L3; Manfroid J., 2005, ASTRON ASTROPHYS, V432, P5; Milam S.N., 2012, LUN PLAN I SCI C LUN, V43, P2618; Nakamura T., 2005, METEORIT PLANET SC S, V40, P5046; Neill JL, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/2/85; Niemann HB, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2010JE003659; Ogliore RC, 2012, ASTROPHYS J LETT, V745, DOI 10.1088/2041-8205/745/2/L19; Pagani L, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/2/L35; Roueff E, 2015, ASTRON ASTROPHYS, V576, DOI 10.1051/0004-6361/201425113; Rousselot P, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219265; Rousselot P, 2014, ASTROPHYS J LETT, V780, DOI 10.1088/2041-8205/780/2/L17; SchlaPpi B., 2010, J GEOPHYS RES SPACE, V115, P12313; Shinnaka Y, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/81; Shinnaka Y., 2014, AAS DIV PLAN SCI M, V46; Shinnaka Y, 2014, ASTROPHYS J LETT, V782, DOI 10.1088/2041-8205/782/2/L16; Slodzian G., 2013, MICROSC MICROANAL, V20, P577; Starkey NA, 2014, GEOCHIM COSMOCHIM AC, V142, P115, DOI 10.1016/j.gca.2014.07.011; Taquet V, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/1/1; March RE, 2005, CHEM ANAL SERIES MON, V165, P1, DOI 10.1002/0471717983; Wampfler S.F., 2014, ASTRON ASTROPHYS, V20, P577; Weaver H.A., 2008, LPI CONTRIBUTION, V1405, P8216; Wirstrom ES, 2012, ASTROPHYS J LETT, V757, DOI 10.1088/2041-8205/757/1/L11; Wirstrom E.S., 2011, ASTRON ASTROPHYS, V533, P24; Wootten Alwyn, 2008, Astrophysics and Space Science, V313, DOI 10.1007/s10509-007-9520-x	219	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0038-6308	1572-9672		SPACE SCI REV	Space Sci. Rev.	DEC	2015	197	1-4					47	83		10.1007/s11214-015-0156-9		37	Astronomy & Astrophysics	Astronomy & Astrophysics	CY4KN	WOS:000366377100003		
J	Dones, L; Brasser, R; Kaib, N; Rickman, H				Dones, Luke; Brasser, Ramon; Kaib, Nathan; Rickman, Hans			Origin and Evolution of the Cometary Reservoirs	SPACE SCIENCE REVIEWS			English	Review						Comets; Long-period comets; Jupiter-family comets; Main-belt comets; Oort Cloud; Kuiper Belt; Comets: individual: 67P/Churyumov-Gerasimenko	LATE-HEAVY BOMBARDMENT; JUPITER-FAMILY COMETS; KUIPER-BELT OBJECTS; INNER SOLAR-SYSTEM; LONG-PERIOD COMETS; TRANS-NEPTUNIAN OBJECTS; TERRESTRIAL PLANET FORMATION; EMBEDDED STAR-CLUSTERS; HALLEY-TYPE COMETS; OORT CLOUD COMETS	Comets have three known reservoirs: the roughly spherical Oort Cloud (for long-period comets), the flattened Kuiper Belt (for ecliptic comets), and, surprisingly, the asteroid belt (for main-belt comets). Comets in the Oort Cloud were thought to have formed in the region of the giant planets and then placed in quasi-stable orbits at distances of thousands or tens of thousands of AU through the gravitational effects of the planets and the Galaxy. The planets were long assumed to have formed in place. However, the giant planets may have undergone two episodes of migration. The first would have taken place in the first few million years of the Solar System, during or shortly after the formation of the giant planets, when gas was still present in the protoplanetary disk around the Sun. The Grand Tack (Walsh et al. in Nature 475:206-209, 2011) models how this stage of migration could explain the low mass of Mars and deplete, then repopulate the asteroid belt, with outer-belt asteroids originating between, and outside of, the orbits of the giant planets. The second stage of migration would have occurred later (possibly hundreds of millions of years later) due to interactions with a remnant disk of planetesimals, i.e., a massive ancestor of the Kuiper Belt. Safronov (Evolution of the Protoplanetary Cloud and Formation of the Earth and the Planets, 1969) and Fernandez and Ip (Icarus 58:109-120, 1984) proposed that the giant planets would have migrated as they interacted with leftover planetesimals; Jupiter would have moved slightly inward, while Saturn and (especially) Uranus and Neptune would have moved outward from the Sun. Malhotra (Nature 365:819-821, 1993) showed that Pluto's orbit in the 3:2 resonance with Neptune was a natural outcome if Neptune captured Pluto into resonance while it migrated outward. Building on this work, Tsiganis et al. (Nature 435:459-461, 2005) proposed the Nice model, in which the giant planets formed closer together than they are now, and underwent a dynamical instability that led to a flood of comets and asteroids throughout the Solar System (Gomes et al. in Nature 435:466-469, 2005b). In this scenario, it is somewhat a matter of luck whether an icy planetesimal ends up in the Kuiper Belt or Oort Cloud (Brasser and Morbidelli in Icarus 225:40-49, 2013), as a Trojan asteroid (Morbidelli et al. in Nature 435:462-465, 2005; NesvornA1/2 and VokrouhlickA1/2 in Astron. J. 137:5003-5011, 2009; NesvornA1/2 et al. in Astrophys. J. 768:45, 2013), or as a distant "irregular" satellite of a giant planet (NesvornA1/2 et al. in Astron. J. 133:1962-1976, 2007). Comets could even have been captured into the asteroid belt (Levison et al. in Nature 460:364-366, 2009). The remarkable finding of two "inner Oort Cloud" bodies, Sedna and 2012 , with perihelion distances of 76 and 81 AU, respectively (Brown et al. in Astrophys. J. 617:645-649, 2004; Trujillo and Sheppard in Nature 507:471-474, 2014), along with the discovery of other likely inner Oort Cloud bodies (Chen et al. in Astrophys. J. Lett. 775:8, 2013; Brasser and Schwamb in Mon. Not. R. Astron. Soc. 446:3788-3796, 2015), suggests that the Sun formed in a denser environment, i.e., in a star cluster (Brasser et al. in Icarus 184:59-82, 2006, 191:413-433, 2007, 217:1-19, 2012b; Kaib and Quinn in Icarus 197:221-238, 2008). The Sun may have orbited closer or further from the center of the Galaxy than it does now, with implications for the structure of the Oort Cloud (Kaib et al. in Icarus 215:491-507, 2011). We focus on the formation of cometary nuclei; the orbital properties of the cometary reservoirs; physical properties of comets; planetary migration; the formation of the Oort Cloud in various environments; the formation and evolution of the Kuiper Belt and Scattered Disk; and the populations and size distributions of the cometary reservoirs. We close with a brief discussion of cometary analogs around other stars and a summary.	[Dones, Luke] SW Res Inst, Boulder, CO 80302 USA; [Brasser, Ramon] Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, Tokyo 1528550, Japan; [Kaib, Nathan] Univ Oklahoma, HL Dodge Dept Phys & Astron, Norman, OK 73019 USA; [Rickman, Hans] Uppsala Univ, Dept Phys & Astron, S-75120 Uppsala, Sweden; [Rickman, Hans] PAS Space Res Ctr, PL-00716 Warsaw, Poland	Dones, L (reprint author), SW Res Inst, 1050 Walnut St,Suite 300, Boulder, CO 80302 USA.	luke@boulder.swri.edu			NASA Cassini Data Analysis Program	We thank the NASA Cassini Data Analysis Program for support of some of the work described here.	Agnor CB, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/143; Alexander R., 2014, DISPERSAL PROTOPLANE, P475; Alexander R., 2014, IAU S, V299, P179; Alexandersen M., 2014, 14117953ASTROPH ARXI; Allen L., 2007, PROTOSTARS PLANETS, VV, P361; Allen R.L., 2001, ASTROPHYS J, V549, P241; Altwegg K, 2015, SCIENCE, V347, DOI 10.1126/science.1261952; Andrews S.M., 2015, 150704758ASTROPH ARX; Andrews SM, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/162; Morbidelli A, 2015, ICARUS, V258, P418, DOI 10.1016/j.icarus.2015.06.003; Haskin LA, 1998, J GEOPHYS RES-PLANET, V103, P1679, DOI 10.1029/97JE03035; MARSDEN BG, 1978, ASTRON J, V83, P64, DOI 10.1086/112177; Gilbert AM, 2009, ICARUS, V201, P714, DOI 10.1016/j.icarus.2009.01.011; Cuk M, 2012, ICARUS, V218, P69, DOI 10.1016/j.icarus.2011.11.031; Montgomery SL, 2012, PUBL ASTRON SOC PAC, V124, P1042, DOI 10.1086/668293; Parker AH, 2015, ICARUS, V247, P112, DOI 10.1016/j.icarus.2014.09.043; Kokubo E, 1998, ICARUS, V131, P171, DOI 10.1006/icar.1997.5840; Hartogh P, 2011, NATURE, V478, P218, DOI 10.1038/nature10519; Marchi S, 2013, NAT GEOSCI, V6, P303, DOI [10.1038/ngeo1769, 10.1038/NGEO1769]; DELSEMME AH, 1971, PLANET SPACE SCI, V19, P1229, DOI 10.1016/0032-0633(71)90180-2; BRIN GD, 1979, ASTROPHYS J, V229, P402, DOI 10.1086/156966; Cuzzi JN, 2008, ASTROPHYS J, V687, P1432, DOI 10.1086/591239; HARTMANN WK, 1987, ICARUS, V69, P33, DOI 10.1016/0019-1035(87)90005-4; Lawler SM, 2009, ASTROPHYS J, V705, P89, DOI 10.1088/0004-637X/705/1/89; Krolikowska M, 2001, ASTRON ASTROPHYS, V376, P316, DOI 10.1051/0004-6361:20010945; Fernandez JA, 1997, ICARUS, V129, P106, DOI 10.1006/icar.1997.5754; Brasser R, 2013, ICARUS, V225, P40, DOI 10.1016/j.icarus.2013.03.012; Hsieh HH, 2010, MON NOT R ASTRON SOC, V403, P363, DOI 10.1111/j.1365-2966.2009.16120.x; HEISLER J, 1990, ICARUS, V88, P104, DOI 10.1016/0019-1035(90)90180-H; Bierhaus EB, 2012, ICARUS, V218, P602, DOI 10.1016/j.icarus.2011.12.011; [Anonymous], 1989, ADV SPACE RES, DOI 10.1016/0273-1177(89)90241-X; MARSDEN BG, 1973, ASTRON J, V78, P211, DOI 10.1086/111402; Brasser R, 2008, CELEST MECH DYN ASTR, V100, P1, DOI 10.1007/s10569-007-9100-y; Chambers JE, 2014, ICARUS, V233, P83, DOI 10.1016/j.icarus.2014.01.036; Hsieh HH, 2015, ICARUS, V248, P289, DOI 10.1016/j.icarus.2014.10.031; Barucci MA, 2005, ASTRON J, V130, P1291, DOI 10.1086/431957; HUBNER WF, 1965, Z ASTROPHYS, V63, P22; Campins H, 2010, NATURE, V464, P1320, DOI 10.1038/nature09029; Barr AC, 2010, NAT GEOSCI, V3, P164, DOI 10.1038/NGEO746; MALHOTRA R, 1993, NATURE, V365, P819, DOI 10.1038/365819a0; HILLS JG, 1981, ASTRON J, V86, P1730, DOI 10.1086/113058; Opik E, 1932, P AM ACAD ARTS SCI, V67, P169, DOI 10.2307/20022899; Hahn JM, 2005, ASTRON J, V130, P2392, DOI 10.1086/452638; Blum J, 2014, ICARUS, V235, P156, DOI 10.1016/j.icarus.2014.03.016; Hurwitz DM, 2014, J GEOPHYS RES-PLANET, V119, P1110, DOI 10.1002/2013JE004530; Bonsor A, 2011, MON NOT R ASTRON SOC, V414, P930, DOI 10.1111/j.1365-2966.2011.18524.x; Levison HF, 2006, ICARUS, V182, P161, DOI 10.1016/j.icarus.2005.12.016; Davidsson BJR, 2004, ICARUS, V168, P392, DOI 10.1016/j.icarus.2003.11.009; KRESAK L, 1980, MOON PLANETS, V22, P83, DOI 10.1007/BF00896869; Fuentes CI, 2008, ASTRON J, V136, P83, DOI 10.1088/0004-6265/136/1/83; Fraser WC, 2010, ICARUS, V210, P944, DOI 10.1016/j.icarus.2010.08.001; KRESAK L, 1989, B ASTRON I CZECH, V40, P269; Elliot JL, 2005, ASTRON J, V129, P1117, DOI 10.1086/427395; Fouchard M, 2014, ICARUS, V231, P110, DOI 10.1016/j.icarus.2013.11.032; Laskar J, 2009, NATURE, V459, P817, DOI 10.1038/nature08096; Brasser R, 2008, ICARUS, V196, P274, DOI 10.1016/j.icarus.2008.02.016; Hsieh HH, 2004, ASTRON J, V127, P2997, DOI 10.1086/383208; Kaib NA, 2008, ICARUS, V197, P221, DOI 10.1016/j.icarus.2008.03.020; Li GJ, 2015, MON NOT R ASTRON SOC, V448, P344, DOI 10.1093/mnras/stv012; Jutzi M, 2015, SCIENCE, V348, P1355, DOI 10.1126/science.aaa4747; GREENBERG JM, 1990, ASTROPHYS J, V361, P260, DOI 10.1086/169191; Morbidelli A, 2009, ICARUS, V204, P558, DOI 10.1016/j.icarus.2009.07.011; KRESAK L, 1987, ASTRON ASTROPHYS, V187, P906; EVERHART E, 1967, ASTRON J, V72, P716, DOI 10.1086/110299; Adams FC, 2001, ICARUS, V150, P151, DOI 10.1006/icar.2000.6567; Brownlee D, 2014, ANNU REV EARTH PL SC, V42, P179, DOI 10.1146/annurev-earth-050212-124203; Qi CH, 2013, SCIENCE, V341, P630, DOI 10.1126/science.1239560; Barranco JA, 2005, ASTROPHYS J, V623, P1157, DOI 10.1086/428639; Bernstein GM, 2004, ASTRON J, V128, P1364, DOI 10.1086/422919; SAGDEEV RZ, 1987, SOV ASTRON LETT+, V13, P259; BALDWIN RB, 1974, ICARUS, V23, P157, DOI 10.1016/0019-1035(74)90003-7; Di Sisto RP, 2009, ICARUS, V203, P140, DOI 10.1016/j.icarus.2009.05.002; Alexander CMO, 2012, SCIENCE, V337, P721, DOI 10.1126/science.1223474; Johansen A, 2007, NATURE, V448, P1022, DOI 10.1038/nature06086; Duffard R, 2002, ICARUS, V160, P44, DOI 10.1006/icar.2002.6938; Lissauer JJ, 2009, ICARUS, V199, P338, DOI 10.1016/j.icarus.2008.10.004; GOLDREICH P, 1980, ASTROPHYS J, V241, P425, DOI 10.1086/158356; Raymond SN, 2009, ICARUS, V203, P644, DOI 10.1016/j.icarus.2009.05.016; Kenyon SJ, 1998, ASTRON J, V115, P2136, DOI 10.1086/300331; Rivkin AS, 2010, NATURE, V464, P1322, DOI 10.1038/nature09028; Schlichting HE, 2009, NATURE, V462, P895, DOI 10.1038/nature08608; Bonsor A, 2014, MON NOT R ASTRON SOC, V441, P2380, DOI 10.1093/mnras/stu721; Gilbert AM, 2010, ICARUS, V210, P998, DOI 10.1016/j.icarus.2010.07.016; DeMeo FE, 2014, NATURE, V505, P629, DOI 10.1038/nature12908; Gronkowski P, 2015, MON NOT R ASTRON SOC, V451, P3068, DOI 10.1093/mnras/stv1122; Cuk M, 2011, ICARUS, V216, P363, DOI 10.1016/j.icarus.2011.08.011; Kenyon SJ, 1999, ASTROPHYS J, V526, P465, DOI 10.1086/308000; RICKMAN H, 1990, ASTRON ASTROPHYS, V237, P524; Dones L, 2009, SATURN FROM CASSINI-HUYGENS, P613, DOI 10.1007/978-1-4020-9217-6_19; Benavidez PG, 2009, PLANET SPACE SCI, V57, P201, DOI 10.1016/j.pss.2008.09.007; Levison HF, 2015, NATURE, V524, P322, DOI 10.1038/nature14675; Horner J, 2002, MON NOT R ASTRON SOC, V335, P641, DOI 10.1046/j.1365-8711.2002.05649.x; Kenyon SJ, 2005, ASTRON J, V130, P269, DOI 10.1086/430461; Brown ME, 2004, ASTROPHYS J, V617, P645, DOI 10.1086/422095; Lada CJ, 2010, PHILOS T R SOC A, V368, P713, DOI 10.1098/rsta.2009.0264; Ruffner JA, 2010, J HIST ASTRON, V41, P425; Brasser R, 2013, MON NOT R ASTRON SOC, V433, P3417, DOI 10.1093/mnras/stt986; Luu J, 1997, NATURE, V387, P573, DOI 10.1038/42413; McKeegan KD, 2006, SCIENCE, V314, P1724, DOI 10.1126/science.1135992; Asphaug E, 1996, ICARUS, V121, P225, DOI 10.1006/icar.1996.0083; Levison HF, 2010, SCIENCE, V329, P187, DOI 10.1126/science.1187535; NAKAGAWA Y, 1986, ICARUS, V67, P375, DOI 10.1016/0019-1035(86)90121-1; Minton DA, 2014, ICARUS, V232, P118, DOI 10.1016/j.icarus.2014.01.001; Delsanti A, 2006, S-P B ASTRON PLANET, P267, DOI 10.1007/3-540-37683-6_11; Brasser R, 2006, ICARUS, V184, P59, DOI 10.1016/j.icarus.2006.04.010; Jewitt D, 2010, NATURE, V467, P817, DOI 10.1038/nature09456; HEISLER J, 1987, ICARUS, V70, P269, DOI 10.1016/0019-1035(87)90135-7; Fernandez JA, 2012, MON NOT R ASTRON SOC, V423, P1674, DOI 10.1111/j.1365-2966.2012.20989.x; Levison HF, 2009, NATURE, V460, P364, DOI 10.1038/nature08094; Hughes DW, 2001, MON NOT R ASTRON SOC, V326, P515, DOI 10.1046/j.1365-8711.2001.04544.x; Jewitt D, 1996, EARTH MOON PLANETS, V72, P185, DOI 10.1007/BF00117517; Gomes RS, 2005, CELEST MECH DYN ASTR, V91, P109, DOI 10.1007/s10569-004-4623-y; Cuk M, 2010, ICARUS, V207, P590, DOI 10.1016/j.icarus.2009.12.013; HEISLER J, 1986, ICARUS, V65, P13, DOI 10.1016/0019-1035(86)90060-6; Cohen BA, 2000, SCIENCE, V290, P1754, DOI 10.1126/science.290.5497.1754; Dones L, 2004, SPACE SCI S, P153; Hsieh HH, 2009, ASTRON ASTROPHYS, V505, P1297, DOI 10.1051/0004-6361/200912342; Dybczynski PA, 2002, ASTRON ASTROPHYS, V396, P283, DOI 10.1051/0004-6361:20021400; Morbidelli A, 2004, ASTRON J, V128, P2564, DOI 10.1086/424617; PAPALOIZOU J, 1984, ASTROPHYS J, V285, P818, DOI 10.1086/162561; FERNANDEZ JA, 1980, MON NOT R ASTRON SOC, V192, P481; Hartmann WK, 2003, METEORIT PLANET SCI, V38, P579; Fernandez YR, 2005, ASTRON J, V130, P308, DOI 10.1086/430802; Bottke WF, 2012, NATURE, V485, P78, DOI 10.1038/nature10967; Morbidelli A, 2012, EARTH PLANET SC LETT, V355, P144, DOI 10.1016/j.epsl.2012.07.037; Canup RM, 2005, SCIENCE, V307, P546, DOI 10.1126/science.1106818; Malhotra R, 2011, ICARUS, V216, P359, DOI 10.1016/j.icarus.2010.11.037; Nesvorny D, 2007, ASTRON J, V133, P1962, DOI 10.1086/512850; Fouchard M, 2011, ICARUS, V214, P334, DOI 10.1016/j.icarus.2011.04.012; Rickman H, 1998, ADV SPACE RES, V21, P1491, DOI 10.1016/S0273-1177(97)00942-3; Fouchard M, 2013, ICARUS, V222, P20, DOI 10.1016/j.icarus.2012.10.027; Gladman B, 1998, ASTRON J, V116, P2042, DOI 10.1086/300573; Di Sisto RP, 2007, ICARUS, V190, P224, DOI 10.1016/j.icarus.2007.02.012; Izidoro A, 2015, MON NOT R ASTRON SOC, V453, P3619, DOI 10.1093/mnras/stv1835; Morbidelli A, 2010, ASTRON J, V140, P1391, DOI 10.1088/0004-6256/140/5/1391; Davidsson BJR, 2006, ICARUS, V180, P224, DOI 10.1016/j.icarus.2005.07.023; Bottke WF, 2015, SCIENCE, V348, P321, DOI 10.1126/science.aaa0602; Krolikowska M, 2006, ASTRON ASTROPHYS, V448, P401, DOI 10.1051/0004-6361:20053756; JEWITT D, 1993, NATURE, V362, P730, DOI 10.1038/362730a0; Bernstein GM, 2006, ASTRON J, V131, P2364, DOI 10.1086/503194; Dybczynski PA, 2011, MON NOT R ASTRON SOC, V416, P51, DOI 10.1111/j.1365-2966.2011.19005.x; HAHN G, 1985, ICARUS, V61, P417, DOI 10.1016/0019-1035(85)90134-4; Brasser R, 2015, MON NOT R ASTRON SOC, V446, P3788, DOI 10.1093/mnras/stu2374; Brown ME, 2001, ASTRON J, V121, P2804, DOI 10.1086/320391; Fernandez JA, 2000, ICARUS, V145, P580, DOI 10.1006/icar.2000.6348; FERNANDEZ JA, 1984, ICARUS, V58, P109, DOI 10.1016/0019-1035(84)90101-5; Duncan MJ, 1997, SCIENCE, V276, P1670, DOI 10.1126/science.276.5319.1670; Knight MM, 2010, ASTRON J, V139, P926, DOI 10.1088/0004-6256/139/3/926; Howard AW, 2013, SCIENCE, V340, P572, DOI 10.1126/science.1233545; Garcia-Sanchez J, 2001, ASTRON ASTROPHYS, V379, P634, DOI 10.1051/0004-6361:20011330; HARTMANN WK, 1975, ICARUS, V24, P181, DOI 10.1016/0019-1035(75)90095-0; Bertini I, 2011, PLANET SPACE SCI, V59, P365, DOI 10.1016/j.pss.2011.01.014; Nimmo F, 2012, ICARUS, V219, P508, DOI 10.1016/j.icarus.2012.01.016; Minton DA, 2009, NATURE, V457, P1109, DOI 10.1038/nature07778; Krolikowska M, 2010, MON NOT R ASTRON SOC, V404, P1886, DOI 10.1111/j.1365-2966.2010.16403.x; Gomes RS, 2004, ICARUS, V170, P492, DOI 10.1016/j.icarus.2004.03.011; Cuzzi JN, 2010, ICARUS, V208, P518, DOI 10.1016/j.icarus.2010.03.005; Kaib NA, 2011, ICARUS, V215, P491, DOI 10.1016/j.icarus.2011.07.037; Rickman H, 2014, METEORIT PLANET SCI, V49, P8, DOI 10.1111/maps.12080; Eggers S, 1997, PLANET SPACE SCI, V45, P1099, DOI 10.1016/S0032-0633(97)00065-2; Kelley MSP, 2015, ICARUS, V262, P187, DOI 10.1016/j.icarus.2015.09.004; Kaib NA, 2009, SCIENCE, V325, P1234, DOI 10.1126/science.1172676; Levison HF, 2006, ICARUS, V184, P619, DOI 10.1016/j.icarus.2006.05.008; Davidsson BJR, 2007, ICARUS, V187, P306, DOI 10.1016/j.icarus.2006.07.022; Bibring JP, 2015, SCIENCE, V349, P493, DOI 10.1126/science.aac5116; EVERHART E, 1968, ASTRON J, V73, P1039, DOI 10.1086/110766; Petit JM, 2004, ICARUS, V168, P409, DOI 10.1016/j.icarus.2003.12.013; KISSEL J, 1986, NATURE, V321, P336, DOI 10.1038/321336a0; Chiang E, 2010, ANNU REV EARTH PL SC, V38, P493, DOI 10.1146/annurev-earth-040809-152513; Levison HF, 2001, ASTRON J, V121, P1730, DOI 10.1086/319420; Gomes RS, 2003, ICARUS, V161, P404, DOI 10.1016/S0019-1035(02)00056-8; COHEN CJ, 1965, ASTRON J, V70, P10, DOI 10.1086/109674; Blum J, 2015, ICARUS, V248, P135, DOI 10.1016/j.icarus.2014.10.025; Krolikowska M, 2006, ACTA ASTRONOM, V56, P385; Levison HF, 2001, ICARUS, V151, P286, DOI 10.1006/icar.2001.6608; Marchi S, 2012, EARTH PLANET SC LETT, V325, P27, DOI 10.1016/j.epsl.2012.01.021; Adams FC, 2010, ANNU REV ASTRON ASTR, V48, P47, DOI 10.1146/annurev-astro-081309-130830; Krolikowska M, 2003, ACTA ASTRONOM, V53, P195; Fouchard M, 2006, CELEST MECH DYN ASTR, V95, P299, DOI 10.1007/s10569-006-9027-8; Malmberg D, 2007, MON NOT R ASTRON SOC, V378, P1207, DOI 10.1111/j.1365-2966.2007.11885.x; Kelley MS, 2013, ICARUS, V222, P634, DOI 10.1016/j.icarus.2012.09.037; EBERHARDT P, 1995, ASTRON ASTROPHYS, V302, P301; Levison HF, 2003, NATURE, V426, P419, DOI 10.1038/nature02120; Dybczynski PA, 2015, MON NOT R ASTRON SOC, V448, P588, DOI 10.1093/mnras/stv013; Schwamb ME, 2014, NATURE, V507, P435, DOI 10.1038/507435a; Gladman B, 2002, ICARUS, V157, P269, DOI 10.1006/icar.2002.6860; Pierens A, 2008, ASTRON ASTROPHYS, V482, P333, DOI 10.1051/0004-6361:20079062; Fernandez YR, 2013, ICARUS, V226, P1138, DOI 10.1016/j.icarus.2013.07.021; Schwamb ME, 2010, ASTROPHYS J, V720, P1691, DOI 10.1088/0004-637X/720/2/1691; Hillenbrand LA, 2008, ASTROPHYS J, V677, P630, DOI 10.1086/529027; Johansen A, 2011, EARTH MOON PLANETS, V108, P39, DOI 10.1007/s11038-010-9370-3; Pfalzner S, 2015, PHYS SCRIPTA, V90, DOI 10.1088/0031-8949/90/6/068001; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; Gladman B, 2001, ASTRON J, V122, P1051, DOI 10.1086/322080; Hasegawa I, 2003, MON NOT R ASTRON SOC, V345, P883, DOI 10.1046/j.1365-8711.2003.07009.x; GAIDOS EJ, 1995, ICARUS, V114, P258, DOI 10.1006/icar.1995.1060; Hahn JM, 1999, ASTRON J, V117, P3041, DOI 10.1086/300891; Haskin LA, 1998, METEORIT PLANET SCI, V33, P959; Fernandez JA, 1999, ASTRON ASTROPHYS, V352, P327; Emel'yanenko VV, 2003, MON NOT R ASTRON SOC, V338, P443, DOI 10.1046/j.1365-8711.2003.06066.x; Kring DA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001529; Chapman CR, 2007, ICARUS, V189, P233, DOI 10.1016/j.icarus.2006.12.020; Nesvorny D, 2009, ASTRON J, V137, P5003, DOI 10.1088/0004-6256/137/6/5003; Meech KJ, 2004, ICARUS, V170, P463, DOI [10.1016/j.icarus.2004.03.014, 10.1016/uj.icarus.2004.03.014]; Brasser R, 2009, ASTRON ASTROPHYS, V507, P1053, DOI 10.1051/0004-6361/200912878; Marchi S, 2014, NATURE, V511, P578, DOI 10.1038/nature13539; Levison HF, 2001, ICARUS, V153, P224, DOI 10.1006/icar.2001.6672; Duncan MJ, 1995, ASTRON J, V110, P3073, DOI 10.1086/117748; Kouwenhoven MBN, 2010, MON NOT R ASTRON SOC, V404, P1835, DOI 10.1111/j.1365-2966.2010.16399.x; Hamilton DP, 2004, ASTRON J, V128, P2510, DOI 10.1086/424534; Jewitt D, 2010, ASTRON J, V140, P1519, DOI 10.1088/0004-6256/140/5/1519; Cuzzi JN, 2001, ASTROPHYS J, V546, P496, DOI 10.1086/318233; Hansen BMS, 2009, ASTROPHYS J, V703, P1131, DOI 10.1088/0004-637X/703/1/1131; Fraser WC, 2009, ASTROPHYS J, V706, P119, DOI 10.1088/0004-637X/706/1/119; CHEN J, 1994, ICARUS, V108, P265, DOI 10.1006/icar.1994.1061; Brasser R, 2012, MON NOT R ASTRON SOC, V420, P3396, DOI 10.1111/j.1365-2966.2011.20264.x; Morbidelli A, 2007, ICARUS, V191, P158, DOI 10.1016/j.icarus.2007.04.001; Kuppers M, 2014, NATURE, V505, P525, DOI 10.1038/nature12918; Chambers JE, 2001, ICARUS, V152, P205, DOI 10.1006/icar.2001.6639; JOSS PC, 1973, ASTRON ASTROPHYS, V25, P271; Rickman H, 2008, CELEST MECH DYN ASTR, V102, P111, DOI 10.1007/s10569-008-9140-y; Chambers JE, 2010, ICARUS, V208, P505, DOI 10.1016/j.icarus.2010.03.004; Leinhardt ZM, 2009, ICARUS, V199, P542, DOI 10.1016/j.icarus.2008.09.013; Neukum G, 2001, SPACE SCI REV, V96, P55, DOI 10.1023/A:1011989004263; Rubie DC, 2015, ICARUS, V248, P89, DOI 10.1016/j.icarus.2014.10.015; Bockelee-Morvan D, 2004, SPACE SCI S, P391; EVERHART E, 1967, ASTRON J, V72, P1002, DOI 10.1086/110376; Levison HF, 2010, ASTRON J, V139, P1297, DOI 10.1088/0004-6256/139/4/1297; Lamy PL, 2004, SPACE SCI S, P223; Harmon JK, 2004, SPACE SCI S, P265; QUINN T, 1990, ASTROPHYS J, V355, P667, DOI 10.1086/168800; Levison HF, 1998, ASTRON J, V116, P1998, DOI 10.1086/300557; Morbidelli A, 2007, ASTRON J, V134, P1790, DOI 10.1086/521705; Morbidelli A, 2009, ICARUS, V202, P310, DOI 10.1016/j.icarus.2009.02.033; Groussin O, 2007, MON NOT R ASTRON SOC, V376, P1399, DOI 10.1111/j.1365-2966.2007.11553.x; Kennedy GM, 2014, MON NOT R ASTRON SOC, V444, P3164, DOI 10.1093/mnras/stu1665; Kretke KA, 2015, ICARUS, V262, P9, DOI 10.1016/j.icarus.2015.08.017; Fouchard M, 2005, CELEST MECH DYN ASTR, V93, P229, DOI 10.1007/s10569-005-1149-x; Morbidelli A, 2005, NATURE, V435, P462, DOI 10.1038/nature03540; Bus SJ, 2001, ICARUS, V150, P94, DOI 10.1006/icar.2000.6555; Hogan RC, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056305; Petit JM, 2008, SCIENCE, V322, P432, DOI 10.1126/science.1163148; Murray N, 1998, SCIENCE, V279, P69, DOI 10.1126/science.279.5347.69; Lin DNC, 1996, NATURE, V380, P606, DOI 10.1038/380606a0; Nakamura T, 2008, SCIENCE, V321, P1664, DOI 10.1126/science.1160995; Farinella P, 1996, SCIENCE, V273, P938, DOI 10.1126/science.273.5277.938; Levison HF, 2008, ICARUS, V196, P258, DOI 10.1016/j.icarus.2007.11.035; CARUSI A, 1987, ASTRON ASTROPHYS, V187, P899; Pan M, 2005, ICARUS, V173, P342, DOI 10.1016/j.icarus.2004.09.004; RICKMAN H, 1991, ASTRON J, V102, P1446, DOI 10.1086/115972; Brasser R, 2012, ICARUS, V217, P1, DOI 10.1016/j.icarus.2011.10.012; DUNCAN M, 1987, ASTRON J, V94, P1330, DOI 10.1086/114571; A'Hearn MF, 2011, SCIENCE, V332, P1396, DOI 10.1126/science.1204054; Mumma MJ, 2011, ANNU REV ASTRON ASTR, V49, P471, DOI 10.1146/annurev-astro-081309-130811; Koeberl C, 2003, EARTH MOON PLANETS, V92, P79, DOI 10.1023/B:MOON.0000031927.85937.9e; Carusi A, 1995, EARTH MOON PLANETS, V68, P71, DOI 10.1007/BF00671499; Piskunov N, 2008, PHYS SCRIPTA, VT130, DOI 10.1088/1402-4896/2008/T130/011001; Emel'yanenko VV, 2005, MON NOT R ASTRON SOC, V361, P1345, DOI 10.1111/j.1365-2966.2005.09267.x; Norman MD, 2014, EARTH PLANET SC LETT, V388, P387, DOI 10.1016/j.epsl.2013.11.040; Francis PJ, 2005, ASTROPHYS J, V635, P1348, DOI 10.1086/497684; Jewitt D, 1998, ASTRON J, V115, P2125, DOI 10.1086/300335; Joshi YC, 2007, MON NOT R ASTRON SOC, V378, P768, DOI 10.1111/j.1365-2966.2007.11831.x; Martinez-Barbosa CA, 2015, MON NOT R ASTRON SOC, V446, P823, DOI 10.1093/mnras/stu2094; Breiter S, 2005, MON NOT R ASTRON SOC, V364, P1222, DOI 10.1111/j.1365-2966.2005.09658.x; Papaloizou JCB, 2006, REP PROG PHYS, V69, P119, DOI 10.1088/0034-4885/69/1/R03; Lamers HJGLM, 2005, ASTRON ASTROPHYS, V441, P117, DOI 10.1051/0004-6361:20042241; Kirsh DR, 2009, ICARUS, V199, P197, DOI 10.1016/j.icarus.2008.05.028; Levison HF, 2001, ASTRON J, V121, P2253, DOI 10.1086/319943; Brasser R, 2007, ICARUS, V191, P413, DOI 10.1016/j.icarus.2007.05.003; Fraser WC, 2009, ASTRON J, V137, P72, DOI 10.1088/0004-6256/137/1/72; Applebaum W, 1996, HIST SCI, V34, P451; DeMeo FE, 2014, ICARUS, V229, P392, DOI 10.1016/j.icarus.2013.11.026; Bottke WF, 2007, ICARUS, V190, P203, DOI 10.1016/j.icarus.2007.02.010; Levison HF, 2015, P NATL ACAD SCI USA, V112, P14180, DOI 10.1073/pnas.1513364112; Hurley JR, 2005, MON NOT R ASTRON SOC, V363, P293, DOI 10.1111/j.1365-2966.2005.09448.x; Davidsson BJR, 2005, ICARUS, V176, P453, DOI 10.1016/j.icarus.2005.02.006; Higuchi A, 2007, ASTRON J, V134, P1693, DOI 10.1086/521815; Lissauer JJ, 2014, NATURE, V513, P336, DOI 10.1038/nature13781; Morbidelli A, 2009, ASTRON ASTROPHYS, V507, P1041, DOI 10.1051/0004-6361/200912876; PEALE SJ, 1989, ICARUS, V82, P36, DOI 10.1016/0019-1035(89)90021-3; HUGHES DW, 1988, ICARUS, V73, P149, DOI 10.1016/0019-1035(88)90089-9; Prialnik D, 2004, SPACE SCI S, P359; Armitage P.J., 2014, ASTROPH0701485 ARXIV; Armitage P.J., 2015, 150906382ASTROPH ARX; Armitage P.J., 2010, ASTROPHYSICS PLANET; Bailer-Jones C.A.L., 2015, MON NOT R ASTRON SOC, V454, P3267; Bailer-Jones C.A.L., 2015, ASTRON ASTROPHYS, V575, P35; Bailey M E, 1990, THE ORIGIN OF COMETS; Baruteau C., 2014, PROTOSTARS PLANETS 6, VVI, P667; Bash F., 1986, GALAXY SOLAR SYSTEM, P35; Batygin K, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/13; Batygin K., 2012, APJ, V744, P3; Batygin K, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/2/120; Becker H., 2011, LUNAR PLANET SCI, V42, P1414; Belton MJS, 2015, ICARUS, V245, P87, DOI 10.1016/j.icarus.2014.09.022; Beuther H., 2014, PROTOSTARS PLANETS, VVI; Bierhaus EB, 2015, ICARUS, V246, P165, DOI 10.1016/j.icarus.2014.05.044; Bitsch B., 2015, ASTRON ASTROPHYS, V582, P112; Bitsch B., 2014, ASTRON ASTROPHYS, V564, P135; Bockelee-Morvan D, 2015, SPACE SCI REV, V197, P47, DOI 10.1007/s11214-015-0156-9; Bockelee-Morvan D., 2012, ASTRON ASTROPHYS, V544, P15; Boley A.C., 2009, APJ, V695, P53; Boyajian T.S., 2015, 150903622ASTROPH ARX; Brasser R., 2010, ASTRON ASTROPHYS, V516, P72; Brown M., 2015, AAS DIVISION PLANETA, V47; Brown M.E., 2008, SOLAR SYSTEM NEPTUNE, P335; Brown M.E., 2005, APJ, V635, P97; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Carlson RW, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0246; Carrera D., 2015, ASTRON ASTROPHYS, V579, P43; Carusi A., 1984, B AM ASTRON SOC, V16, P704; Carusi A., 1985, LONG TERM EVOLUTION; Chambers J.E., 2015, 151008448ASTROPH ARX; Chapin S.L., 1952, LEAFL ASTRON SOC PAC, V6, P221; Chapman R.D., 1989, ASTROPHYS J LETT, V346, P105; Chen Y.-T., 2013, ASTROPHYS J LETT, V775; Cloutier R, 2015, ASTROPHYS J, V813, DOI 10.1088/0004-637X/813/1/8; Cloutier R, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/2/127; Cochran AL, 2015, SPACE SCI REV, V197, P9, DOI 10.1007/s11214-015-0183-6; Cohen B.A., 2015, EARLY SOLAR SYSTEM I, VIII, P3019; Davidsson B., 2015, ASTRON ASTROPH UNPUB; Davies M.B., 2014, LONG TERM DYNAMICAL, P787; Davis A.M., 2014, PROTOSTARS PLANETS, VVI, P809; Davis A.M., 2014, TREATISE GEOCHEMISTR, P361; Dawson RI, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/43; Deienno R, 2014, ASTRON J, V148, DOI 10.1088/0004-6256/148/2/25; Deienno R., 2011, ASTRON ASTROPHYS, V536, P57; Donn B., 1982, IAU C, V61, P203; Doyle PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8444; Eicher DJ, 2013, COMETS!: VISITORS FROM DEEP SPACE, P1, DOI 10.1017/CBO9781107045255; EVERHART E, 1972, ASTROPHYS LETT COMM, V10, P131; Fernandez J.A., 2005, ASTROPHYSICS SPACE S; Festou M.C., 2004, COMETS 2, VII; Fouchard M., 2006, CELEST MECH DYN ASTR, V96, P341, DOI 10.1007/s10569-006-9055-4; Fouchard M., 2011, ASTRON ASTROPHYS, V535, P86; Fraser WC, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/2/100; Genzel R, 2010, REV MOD PHYS, V82, DOI 10.1103/RevModPhys.82.3121; Gladman B, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/1/23; Gladman B., 2008, SOLAR SYSTEM NEPTUNE, P43; Gladman B., 2009, APJ, V697, P91; Gomes R.S., 2012, AAS DIVISION PLANETA, V44; Greaves J.S., 2004, MNRAS, V351, P54; Greaves J.S., 2005, APJ, V619, P187; Greenberg J.M., 1987, ADV SPACE RES, V7, P33, DOI 10.1016/0273-1177(87)90353-X; Groussin O., 2015, 150902707ASTROPH ARX; Gudipati MS, 2015, SPACE SCI REV, V197, P101, DOI 10.1007/s11214-015-0192-5; Guilbert-Lepoutre A, 2015, SPACE SCI REV, V197, P271, DOI 10.1007/s11214-015-0148-9; Guttler C., 2010, ASTRON ASTROPHYS, V513, P56; Habashi F., 2014, BIOGRAPHICAL ENCY AS, P967; Halle A., 2015, ASTRON ASTROPHYS, V578, P58; Hanner M.S., 1985, ADV SPACE RES, V4, P189; Hartmann W.K., 2014, AAS DIVISION PLANETA, V46; Hartmann W.K., 2000, ORIGIN EARTH MOON, P493; Hayashi C., 1981, PROG THEOR PHYS SUPP, V70, P35, DOI 10.1143/PTPS.70.35; Hayden Michael R., 2015, Astrophysical Journal, V808, DOI 10.1088/0004-637X/808/2/132; Heidarzadeh T., 2008, HIST PHYS THEORIES C; Hind J.R., 1852, COMETS DECRIPTIVE TR; Hirabayashi M., 2014, ASTROPHYS J LETT, V789, P12; Ho P.-Y., 1962, VISTAS ASTRON, V5, P127; Hopkins P.F., 2014, 14012458ASTROPH ARXI; Hsieh H.H., 2011, ASTROPHYS J LETT, V736, P18; Hynek J.A., 1951, ASTROPHYSICS, P357; Ivanov B.A., 2002, ASTEROIDS 3, P89; Izidoro A, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/1/31; Jeans J.H., 1919, MNRAS, V79, P408; Jewitt D, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/5/133; Jewitt D., 2015, 151007069ASTROPH ARX; Jewitt D., 2014, ASTROPHYS J LETT, V784, P8; Jewitt D., 2015, 150202361ASTROPH ARX, VIV; Jewitt D, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/3/66; Jewitt D., 2011, APJ, V733, P4; Jewitt D, 2015, ASTRON J, V150, DOI 10.1088/0004-6256/150/3/76; Jewitt DC, 2002, ASTRON J, V123, P1039, DOI 10.1086/338692; Johansen A., 2015, ASTEROIDS, VIV; Johansen A., 2012, ASTRON ASTROPHYS, V537, P125; Johansen A., 2015, SCI ADV, V1, P15109; Johansen A., 2014, ASTRON ASTROPHYS, V572, P107; Johansen A., 2012, ASTRON ASTROPHYS, V544, P32, DOI DOI 10.1051/0004-6361/201219127; Johansen A., 2013, ASTRON ASTROPHYS, V552, P137; Johansen A., 2014, PROTOSTARS PLANETS, VVI, P547; Jorda L., 2015, ICARUS UNPUB; Jura M, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/5/155; Kaib NA, 2015, ICARUS, V252, P161, DOI 10.1016/j.icarus.2015.01.013; Kalas P, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/56; Kavelaars J., 2008, SOLAR SYSTEM NEPTUNE, P59; Kavelaars J.J., 2010, ASTROPHYS J LETT, V722, P204; Keller H.U., 1994, ICARUS, V109, P121; KELLER HU, 1986, NATURE, V321, P320, DOI 10.1038/321320a0; Keller H.U., 1989, ESA SP, V302, P39; Kelley M.S.P., 2015, 151005878ASTROPH ARX; Kiefer F, 2014, NATURE, V514, P462, DOI 10.1038/nature13849; Kim Y, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/2/151; Kofman W., 2015, SCIENCE, V349; Higuchi A, 2015, ASTRON J, V150, DOI 10.1088/0004-6256/150/1/26; Kretke KA, 2014, ASTRON J, V148, DOI 10.1088/0004-6256/148/6/109; Krolikowska M., 2014, ASTRON ASTROPHYS, V567, P126; Krolikowska M., 2014, ASTRON ASTROPHYS, V571, P63; Kronk G.W., 2007, COMETOGRAPHY CATALOG, V3; Kronk G.W., 2003, COMETOGRAPHY CATALOG, V2; Kronk G.W., 2009, COMETOGRAPHY CATALOG, V4; Kronk G.W., 1999, COMETOGRAPHY CATALOG, V1; Krumholz M.R., 2014, PROTOSTARS PLANETS, VVI, P243; Dukes D, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/56; Lada CJ, 2003, ANNU REV ASTRON ASTR, V41, P57, DOI 10.1146/annurev.astro.41.011802.094844; Laibe G., 2012, ASTRON ASTROPHYS, V537, P61; Lamy PL, 2015, SPACE SCI REV, V197, P85, DOI 10.1007/s11214-015-0160-0; Lardner D., 1853, MNRAS, V13, P188; Laskar J., 1997, ASTRON ASTROPHYS, V317, P75; Brasser R, 2015, ASTRON J, V150, DOI 10.1088/0004-6256/150/5/157; Lega E., 2015, ASTRON ASTROPHYS, V579, P79; Levison HF, 1997, ICARUS, V127, P13, DOI 10.1006/icar.1996.5637; Levison H.F., 2007, PROTOSTARS PLANETS, VV, P669; Levison HF, 1996, ASTR SOC P, V107, P173; Levison HF, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/5/152; Lewis AR, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/1/16; Li Z.-Y., 2014, PROTOSTARS PLANETS, VVI, P173; LIN DNC, 1986, ASTROPHYS J, V309, P846, DOI 10.1086/164653; Lis D.C., 2013, ASTROPHYS J LETT, V774, P3; Lissauer J.J., 2015, 150105685ASTROPH ARX; Lisse CM, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/2/93; Lubow S.H., 2011, EXOPLANETS, P347; Lykawka P. S., 2012, MONOGRAPHS ENV EARTH, V1, P121; MALHOTRA R, 1995, ASTRON J, V110, P420, DOI 10.1086/117532; Malhotra R., 2000, Protostars and planets 4; Mandt KE, 2015, SPACE SCI REV, V197, P297, DOI 10.1007/s11214-015-0161-z; Maquet L., 2015, ASTRON ASTROPHYS, V579, P78; Matthews B.C., 2014, PROTOSTARS PLANETS, VVI, P521; MAYOR M, 1995, NATURE, V378, P355, DOI 10.1038/378355a0; McDonnell J.A.M., 1986, ESA SP 2, V250, P25; Meech K.J., 2011, ASTROPHYS J, V734, P1; Melita O., 1986, ESA SP, V249, P195; Meyer M., 2010, COMETOGRAPHY CATALOG, V5; Meynet G., 2012, ASTRON ASTROPHYS, V545, P4; Milam S.N., 2015, 151004567ASTROPH ARX; Hopkins MD, 2015, CONTRIB MINERAL PETR, V169, DOI 10.1007/s00410-015-1123-x; Molinari S., 2014, MILKY WAY STAR FORMA, P125; Morbidelli A., 2014, IAU S, V310, P194; Morbidelli A., 2005, ASTROPH0512256 ARXIV; Moro-Martin A, 2007, ASTROPHYS J, V658, P1312, DOI 10.1086/511746; Moro-Martin A., 2009, ASTROPHYS J, V704, P733; Moro-Martin A, 2015, ASTROPHYS J, V801, DOI 10.1088/0004-637X/801/2/143; Movshovitz N, 2015, GEOPHYS RES LETT, V42, P256, DOI 10.1002/2014GL062133; Movshovitz N, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/2/93; Murray C. D., 1999, SOLAR SYSTEM DYNAMIC; Myers PC, 2009, ASTROPHYS J, V700, P1609, DOI 10.1088/0004-637X/700/2/1609; Nesvorny D, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/45; Nesvorny D, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/22; Nesvorny D, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/4/117; Nesvorny D, 2014, ASTRON J, V148, DOI 10.1088/0004-6256/148/3/52; Nesvorny D., 2011, APJ, V742, P22; Nesvorny D, 2015, ASTRON J, V150, DOI 10.1088/0004-6256/150/3/73; Nesvorny D., 2015, ASTEROIDS, VIV; Nesvorny D, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/5/159; Nesvorny D, 2015, ASTRON J, V150, DOI 10.1088/0004-6256/150/3/68; Noll K.S., 2014, AAS DIVISION PLANETA, V46; Noll K.S., 2008, SOLAR SYSTEM NEPTUNE, P345; Noll Keith S, 2008, Icarus, V194, DOI 10.1016/j.icarus.2007.10.022; Norwood J., 2014, 14036845ASTROPH ARXI; Ogihara M., 2015, ASTRON ASTROPHYS, V579, P65; Onehag A., 2011, ASTRON ASTROPHYS, V528, P85; Oort J.H., 1950, B ASTRON I NETH, V11, P91; Ormel CW, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/80; Ouzman S., 2010, SEEING KNOWING UNDER, P10; Pankenier D., 2008, ARCHAEOASTRONOMY E A; Parker AH, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/1; Peixinho N., 2015, ASTRON ASTROPHYS, V577, P35; Petit JM, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/131; Pichardo B, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/3/73; Pike RE, 2015, ASTRON J, V149, DOI 10.1088/0004-6256/149/6/202; Raettig N, 2015, ASTROPHYS J, V804, DOI 10.1088/0004-637X/804/1/35; Reyes-Ruiz M, 2015, ASTROPHYS J, V804, DOI 10.1088/0004-637X/804/2/91; Richardson James E, 2007, Icarus, V191, DOI 10.1016/j.icarus.2007.08.033; Rickman H., 2015, 150507021ASTROPH ARX; Rickman H., 1983, COMETARY EXPLORATION, P75; Rickman H., 1987, ESA SP, V278, P471; Rickman H., 2015, 150404512ASTROPH ARX; Rivkin A.S., 2015, 151008414ASTROPH ARX; Roberge A, 2014, NATURE, V514, P440, DOI 10.1038/514440a; Rosenberg E.D., 2009, MNRAS, V399, P79; Roskar R., 2008, APJ, V684, P79; Ruggles C.F.N., 2015, HDB ARCHAEOASTRONOMY; Ruggles C.L.N., 2015, HDB ARCHAEOASTRONOMY, P1031; Ryder G., 1990, EOS T AGU, V71, P313, DOI 10.1029/ 90EO00086; Safronov V.S., 1972, EVOLUTION PROTOPLANE; Murray-Clay RA, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/132; Schlichting HE, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/150; Schmidt M., 1951, B ASTRON I NETH, V11, P259; Schwamb M.E., 2014, ASTRON J, V147, P2; Schwamb M.E., 2009, MINOR PLANET ELECT C, V42; Snellgrove M., 2001, MNRAS, V320, P55; Sommeria J., 1995, ASTRON ASTROPHYS, V295, P1; Space Studies Board, 2012, VIS VOYAG PLAN SCI D; Walsh K.J., 2015, 150203852ASTROPH ARX; Wang J.-H., 2015, ASTRON ASTROPHYS, V573, P102; GOLDREIC.P, 1973, ASTROPHYS J, V183, P1051, DOI 10.1086/152291; Whitmire D., 1996, APJ, V472, P41; Wilkening L.L., 1982, COMETS, P56; Williams G., 2003, CATALOGUE COMETARY O; Williams G.V., 1993, CATALOGUE COMETARY O; Williams G.V., 2008, CATALOGUE COMETARY O; Tegler SC, 2000, NATURE, V407, P979, DOI 10.1038/35039572; Sheppard SS, 2006, SCIENCE, V313, P511, DOI 10.1126/science.1127173; Thommes EW, 1999, NATURE, V402, P635; YEOMANS DK, 1986, J ROY ASTRON SOC CAN, V80, P62; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539; Solontoi M, 2012, ICARUS, V218, P571, DOI 10.1016/j.icarus.2011.10.008; Steel DI, 1996, MON NOT R ASTRON SOC, V281, P937; Weidenschilling SJ, 1997, ICARUS, V127, P290, DOI 10.1006/icar.1997.5712; Stephens DC, 2006, ASTRON J, V131, P1142, DOI 10.1086/498715; Weidenschilling SJ, 2011, ICARUS, V214, P671, DOI 10.1016/j.icarus.2011.05.024; Stern SA, 1996, ASTRON J, V112, P1203, DOI 10.1086/118091; SMITH BA, 1984, SCIENCE, V226, P1421, DOI 10.1126/science.226.4681.1421; Strom RG, 2005, SCIENCE, V309, P1847, DOI 10.1126/science.1113544; Wiegert P, 1999, ICARUS, V137, P84, DOI 10.1006/icar.1998.6040; [Anonymous], 2015, SCIENCE; Walsh KJ, 2012, METEORIT PLANET SCI, V47, P1941, DOI 10.1111/j.1945-5100.2012.01418.x; WHIPPLE FL, 1978, MOON PLANETS, V18, P343, DOI 10.1007/BF00896489; Weidenschilling SJ, 2004, SPACE SCI S, P97; Zahnle K, 2003, ICARUS, V163, P263, DOI 10.1016/S0019-1035(03)00048-4; WEISSMAN PR, 1980, NATURE, V288, P242, DOI 10.1038/288242a0; Walsh KJ, 2011, NATURE, V475, P206, DOI 10.1038/nature10201; Tancredi G, 2006, ICARUS, V182, P527, DOI 10.1016/j.icarus.2006.01.007; Young ED, 2014, EARTH PLANET SC LETT, V392, P16, DOI 10.1016/j.epsl.2014.02.014; Shannon A, 2015, MON NOT R ASTRON SOC, V446, P2059, DOI 10.1093/mnras/stu2267; Toth I, 2000, ASTRON ASTROPHYS, V360, P375; Sekanina Z, 2005, ASTROPHYS J SUPPL S, V161, P551, DOI 10.1086/497374; Trujillo CA, 2014, NATURE, V507, P471, DOI 10.1038/nature13156; Tiscareno MS, 2003, ASTRON J, V126, P3122, DOI 10.1086/379554; STERN SA, 1995, ASTRON J, V110, P856, DOI 10.1086/117568; WARD WR, 1986, ICARUS, V67, P164, DOI 10.1016/0019-1035(86)90182-X; TANCREDI G, 1995, ASTRON ASTROPHYS, V299, P288; Weidenschilling SJ, 2008, PHYS SCRIPTA, VT130, DOI 10.1088/0031-8949/2008/T130/014021; Sunshine JM, 2006, SCIENCE, V311, P1453, DOI 10.1126/science.1123632; Stoffler D, 2001, SPACE SCI REV, V96, P9, DOI 10.1023/A:1011937020193; Yeomans DK, 2005, SPACE SCI REV, V117, P123, DOI 10.1007/s11214-005-3392-6; Visser R, 2009, ASTRON ASTROPHYS, V495, P881, DOI 10.1051/0004-6361/200810846; Ward WR, 2004, ASTRON J, V128, P2501, DOI 10.1086/424533; Sellwood JA, 2002, MON NOT R ASTRON SOC, V336, P785, DOI 10.1046/j.1365-8711.2002.05806.x; WEISSMAN PR, 1983, ASTRON ASTROPHYS, V118, P90; WEISSMAN PR, 1986, NATURE, V320, P242, DOI 10.1038/320242a0; Winn JN, 2015, ANNU REV ASTRON ASTR, V53, P409, DOI 10.1146/annurev-astro-082214-122246; WILLIAMS JG, 1971, ASTRON J, V76, P167, DOI 10.1086/111100; Tang HL, 2012, EARTH PLANET SC LETT, V359, P248, DOI 10.1016/j.epsl.2012.10.011; Youdin AN, 2005, ASTROPHYS J, V620, P459, DOI 10.1086/426895; TORBETT MV, 1986, MON NOT R ASTRON SOC, V223, P885; Ward WR, 1997, ICARUS, V126, P261, DOI 10.1006/icar.1996.5647; SIMPSON JA, 1987, ASTRON ASTROPHYS, V187, P742; Waszczak A, 2013, MON NOT R ASTRON SOC, V433, P3115, DOI 10.1093/mnras/stt951; Zheng JQ, 1990, CELEST MECH DYN ASTR, V49, P265, DOI 10.1007/BF00049417; Volk K, 2008, ASTROPHYS J, V687, P714, DOI 10.1086/591839; Wyckoff S, 2000, ASTROPHYS J, V535, P991, DOI 10.1086/308863; Vincent JB, 2015, NATURE, V523, P63, DOI 10.1038/nature14564; Tancredi G, 2014, ICARUS, V234, P66, DOI 10.1016/j.icarus.2014.02.013; TERA F, 1974, EARTH PLANET SC LETT, V22, P1, DOI 10.1016/0012-821X(74)90059-4; Tancredi G, 1998, CELEST MECH DYN ASTR, V70, P181, DOI 10.1023/A:1008331422678; Snodgrass C, 2011, MON NOT R ASTRON SOC, V414, P458, DOI 10.1111/j.1365-2966.2011.18406.x; Sosa A, 2011, MON NOT R ASTRON SOC, V416, P767, DOI 10.1111/j.1365-2966.2011.19111.x; Johansen A., 2014, ASTRON ASTROPHYS, V570, P47; Leinhardt Z.M., 2009, ASTROPHYS J, V691, P133; Morbidelli A., 2011, ASTRON ASTROPHYS, V526, P126; Palla F., 2004, FORMATION STARS; Ruggles C.L.N., 2015, HDB ARCHAEOASTRONOMY, P913; Seager S., 2010, SPACE SCI SERIES; Shankman C., 2013, ASTROPHYS J LETT, V764, P2; Shannon A., 2015, 151001323ASTROPH ARX; Spudis PD, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2011JE003903; Spudis P.D., 1996, ONCE FUTURE MOON; Sterken C., 2011, ICARUS, V212, P351; STERN SA, 1991, ICARUS, V90, P271, DOI 10.1016/0019-1035(91)90106-4; Strom RG, 2015, RES ASTRON ASTROPHYS, V15, P407, DOI 10.1088/1674-4527/15/3/009; Su K.Y.E., 2007, APJ, V657, P41; Taylor MGGT, 2015, SCIENCE, V347, P387, DOI 10.1126/science.aaa4542; Testi L., 2014, PROTOSTARS PLANETS, VVI, P339; Todorovic-Juchniewicz B., 1981, Acta Astronomica, V31; Tomida K, 2015, ASTROPHYS J, V801, DOI 10.1088/0004-637X/801/2/117; TREMAINE S, 1993, ASTR SOC P, V36, P335; Trujillo C.A., 2010, APJ, V723, P233; van Dishoeck E.F., 2014, PROTOSTARS PLANETS, VVI, P835; Visser R., 2011, ASTRON ASTROPHYS, V534, P132; Vokrouhlicky D., 2015, ASTEROIDS, VIV; Vokrouhlicky D, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/1/143; Vsekhsvyatskij S.K., 1964, F80 NASA TT; Weaver H.A., 2011, APJ, V734, P5; WEIDENSCHILLING SJ, 1977, MON NOT R ASTRON SOC, V180, P57; Weidenschilling S.J., 1993, PROTOSTARS PLANETS, VIII, P1031; Weissman P., 1986, LUN PLAN SCI C, V17, P935; Weissman PR, 1996, ASTR SOC P, V107, P265; Weissman P.R., 2002, ASTEROIDS 3, VIII, P669; Weissman P.R., 2015, AM ASTR SOC DPS M, V47; Westfall R.S., 1983, NEVER REST BIOGRAPHY; Wetherill G.W., 1975, LUNAR SCI C, V6, P1539; WHIPPLE FL, 1950, ASTROPHYS J, V111, P375, DOI 10.1086/145272; Wilhelms D.E., 1987, GEOLOGIC HIST MOON; Willacy K, 2015, SPACE SCI REV, V197, P151, DOI 10.1007/s11214-015-0167-6; Wolff S, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/171; Wright J.T., 2015, 151004606ASTROPH ARX; Wyatt MC, 2008, ANNU REV ASTRON ASTR, V46, P339, DOI 10.1146/annurev.astro.45.051806.110525; Xu Z., 2000, E ASIAN ARCHAEOASTRO; Stephenson F. R., 1985, Journal of the British Interplanetary Society, V38; Yeomans D.K., 1991, COMETS CHRONOLOGICAL; Zsom A., 2010, ASTRON ASTROPHYS, V513, P57; Zuckerman B, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/77	602	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0038-6308	1572-9672		SPACE SCI REV	Space Sci. Rev.	DEC	2015	197	1-4					191	269		10.1007/s11214-015-0223-2		79	Astronomy & Astrophysics	Astronomy & Astrophysics	CY4KN	WOS:000366377100007		
J	Abdulmadjid, SN; Idris, N; Pardede, M; Jobiliong, E; Hedwig, R; Lie, ZS; Suyanto, H; Tjia, MO; Kurniawan, KH; Kagawa, K				Abdulmadjid, Syahrun Nur; Idris, Nasrullah; Pardede, Marincan; Jobiliong, Eric; Hedwig, Rinda; Lie, Zener Sukra; Suyanto, Hery; Tjia, May On; Kurniawan, Koo Hendrik; Kagawa, Kiichiro			Sensitive analysis of carbon, chromium and silicon in steel using picosecond laser induced low pressure helium plasma	SPECTROCHIMICA ACTA PART B-ATOMIC SPECTROSCOPY			English	Article						C analysis; Cr analysis; Si analysis; ps laser plasma; He metastable excited state; Low pressure He plasma	INDUCED BREAKDOWN SPECTROSCOPY; VACUUM-ULTRAVIOLET; DETECTION LIMITS; LIBS; PULSES; SPECTROMETRY; SAMPLES	An experimental study has been performed on the gas pressure and laser energy dependent variations of plasma emission intensities in Ar, He and N-2 ambient gases induced by picosecond (ps) Nd-YAG laser irradiation on low alloy steel (JSS) samples. The study is aimed to demonstrate distinct advantage of using low pressure He ambient gas in combination with ps laser for the sensitive ppm level detection of C, Si and Cr emission lines in the UV-VIS spectral region. The much shorter pulses of ps laser are chosen for the effective ablation at much lower energy and for the benefit of reducing the undesirable long heating of the sample surface. It is found that the C I 247.8 nm, Fe I 253.5 nm, and Si I 251.4 nm emission lines induced by the ps laser at 15 mJ are readily detected with He ambient gas of 2.6 kPA, featuring generally sharp spectral signals with very low background. The following experimental results using samples with various concentrations of C, Si and Cr impurities are shown to produce for each of those elements a linear calibration line with extrapolated zero intercept, demonstrating the applicability for their quantitative analyses, with a preliminary estimated detection limits of 20 mu g/g, 15 mu g/g, and 5 mu g/g, for C, Si, and Cr, respectively. The possibility of applying the same setup for concentration depth profiling is also demonstrated. (C) 2015 Elsevier B.V. All rights reserved.	[Abdulmadjid, Syahrun Nur; Idris, Nasrullah] Syiah Kuala Univ, Fac Math & Nat Sci, Dept Phys, Banda Aceh 23111, NAD, Indonesia; [Pardede, Marincan] Univ Pelita Harapan, Dept Elect Engn, Lippo Village 15811, Tangerang, Indonesia; [Jobiliong, Eric] Univ Pelita Harapan, Dept Ind Engn, Lippo Village 15811, Tangerang, Indonesia; [Hedwig, Rinda] Bina Nusantara Univ, Dept Comp Engn, Jakarta 14810, Indonesia; [Lie, Zener Sukra; Tjia, May On; Kurniawan, Koo Hendrik; Kagawa, Kiichiro] Maju Makmur Mandiri Fdn, Res Ctr, Jakarta 11630, Indonesia; [Suyanto, Hery] Udayana Univ, Fac Math & Nat Sci, Dept Phys, Denpasar 80361, Bali, Indonesia; [Tjia, May On] Bandung Inst Technol, Fac Math & Nat Sci, Phys Magnetism & Photon Grp, Bandung 40132, Indonesia; [Kagawa, Kiichiro] Fukui Sci Educ Acad, Fukui 9100804, Japan	Kurniawan, KH (reprint author), Maju Makmur Mandiri Fdn, Res Ctr, 40-80 Srengseng Raya, Jakarta 11630, Indonesia.	kurniawan@mmmfoundation.org					Peter L, 2003, APPL OPTICS, V42, P6199, DOI 10.1364/AO.42.006199; Sturm V, 2004, J ANAL ATOM SPECTROM, V19, P451, DOI 10.1039/b31563k; Sobral H, 2014, SPECTROCHIM ACTA B, V94-95, P1, DOI 10.1016/j.sab.2014.02.002; Wang ZZ, 2013, APPL SPECTROSC, V67, P1242, DOI 10.1366/13-07131; Hubmer G, 2006, ANAL BIOANAL CHEM, V385, P219, DOI 10.1007/s00216-006-0321-9; Ismail MA, 2006, ANAL BIOANAL CHEM, V385, P316, DOI 10.1007/s00216-006-0363-z; Wormhoudt J, 2005, APPL SPECTROSC, V59, P1098, DOI 10.1366/0003702055012528; Noll R, 2004, J ANAL ATOM SPECTROM, V19, P419, DOI 10.1039/b315718k; Rohwetter P, 2004, J ANAL ATOM SPECTROM, V19, P437, DOI 10.1039/b316343a; Sturm V, 2000, APPL SPECTROSC, V54, P1275, DOI 10.1366/0003702001951183; ARAGON C, 1993, APPL SPECTROSC, V47, P606, DOI 10.1366/0003702934067324; Khater MA, 2002, APPL SPECTROSC, V56, P970, DOI 10.1366/000370202760249693; Eland KL, 2001, APPL SPECTROSC, V55, P279, DOI 10.1366/0003702011951894; De Lucia Jr. Frank C., 2009, ARLTR5000; Effenberger AJ, 2010, SENSORS-BASEL, V10, P4907, DOI 10.3390/s100504907; Kurniawan K.H., 2014, APPL SPECTROSC REV, V5, P323; Radziemski L.J., HDB LASER INDUCED BR; Sattmann R, 1998, APPL SPECTROSC, V52, P456, DOI 10.1366/0003702981943680	18	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0584-8547			SPECTROCHIM ACTA B	Spectroc. Acta Pt. B-Atom. Spectr.	DEC 1	2015	114						1	6		10.1016/j.sab.2015.09.019		6	Spectroscopy	Spectroscopy	CY0CC	WOS:000366072900001		
J	Alshehabi, A; Sasaki, N; Kawai, J				Alshehabi, Abbas; Sasaki, Nobuharu; Kawai, Jun			Total reflection X-ray photoelectron spectroscopy as a semiconductor lubricant elemental analysis method	SPECTROCHIMICA ACTA PART B-ATOMIC SPECTROSCOPY			English	Article						XPS; TRXPS; Fluorocarbon; Hard disk; Storage media	PHOTOEMISSION-SPECTROSCOPY; OXIDIZED GAAS(100); INCIDENCE ANGLES; CARBON-FILMS; SPECTRA; MULTILAYER; MEDIA; LAYER; SI	Photoelectron spectra from a typical hard disk storage media device (HDD) were measured at total reflection and non-total reflection at unbumished, acetone-cleaned, and argon-sputtered conditions. F, O, N, and C usually making the upper layer of a typical hard disk medium were detected. Enhancement of the photoelectron emission of the fluorocarbon lubricant was observed at total reflection. Pt and Co were only found by non-total X-ray photoelectron spectroscopy (XPS) because they are constituents of a deeper region than the top and interface regions. Argon-sputtered, ultrasonic acetone-cleaned, and unbumished top layers were compared at total and non-total reflection conditions. Total reflection X-ray photoelectron spectroscopy (TRXPS) is demonstrated to be a powerful tool for storage media lubrication layer chemical state analysis, reliable for industrial quality control application, and reproducible. (C) 2015 Elsevier B.V. All rights reserved.	[Alshehabi, Abbas; Sasaki, Nobuharu; Kawai, Jun] Kyoto Univ, Dept Mat Sci & Engn, Sakyo Ku, Kyoto 6068501, Japan	Alshehabi, A (reprint author), Kyoto Univ, Dept Mat Sci & Engn, Sakyo Ku, Kyoto 6068501, Japan.	abbas.jaafar@gmail.com					Alshehabi A., 2012, ADV XRAY CHEM ANAL J, V43, P235; Khurshudov A, 2001, WEAR, V251, P1124, DOI 10.1016/S0043-1648(01)00723-2; Hayashi K, 1996, APPL PHYS LETT, V68, P1921, DOI 10.1063/1.115626; MEHTA M, 1975, PHYS LETT A, V55, P59, DOI 10.1016/0375-9601(75)90394-1; Kawai J, 2010, J ELECTRON SPECTROSC, V178, P268, DOI 10.1016/j.elspec.2009.12.001; Karis TE, 1997, J VAC SCI TECHNOL A, V15, P2382, DOI 10.1116/1.580751; Kawai J, 1995, APPL PHYS LETT, V67, P3889, DOI 10.1063/1.115307; MEHTA M, 1977, CHEM PHYS LETT, V46, P225, DOI 10.1016/0009-2614(77)85248-2; CHESTER MJ, 1993, PHYS REV B, V48, P17262, DOI 10.1103/PhysRevB.48.17262; Donnet C, 1997, SURF COAT TECH, V94-5, P531, DOI 10.1016/S0257-8972(97)00462-3; Alshehabi A, 2010, ANAL METHODS-UK, V2, P1555, DOI 10.1039/c0ay00216j; CHESTER MJ, 1993, J VAC SCI TECHNOL B, V11, P1609, DOI 10.1116/1.586978; Kawai J, 1995, J ELECTRON SPECTROSC, V76, P313, DOI 10.1016/0368-2048(95)02518-9; Jacobsohn LG, 2000, J VAC SCI TECHNOL A, V18, P2230, DOI 10.1116/1.1289540; JACH T, 1994, NUCL INSTRUM METH A, V347, P507, DOI 10.1016/0168-9002(94)91938-0; JACH T, 1994, REV SCI INSTRUM, V65, P339, DOI 10.1063/1.1145193; Clark D.T., 1990, J POLYM SCI POL CHEM, V18, P1651; Daniel E.D., 1990, MAGNETIC RECORDING H; HENKE BL, 1972, PHYS REV A, V6, P94, DOI 10.1103/PhysRevA.6.94; Jach T, 1999, SPECTROCHIM ACTA B, V54, P1539, DOI 10.1016/S0584-8547(99)00103-2; Kawai J., 1997, SPECTROCHIM ACTA B, V47, P983; Kawai J, 1997, SPECTROCHIM ACTA B, V52, P873, DOI 10.1016/S0584-8547(96)01646-1; Mickevicius S., 2006, OPT APPL, V45, P235; Tsutsumi K., 2007, JEOL NEWS E, V42E, P40	24	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0584-8547			SPECTROCHIM ACTA B	Spectroc. Acta Pt. B-Atom. Spectr.	DEC 1	2015	114						34	37		10.1016/j.sab.2015.09.016		4	Spectroscopy	Spectroscopy	CY0CC	WOS:000366072900006		
J	Wang, ZZ; Yan, JJ; Liu, JP; Deguchi, Y; Katsumori, S; Ikutomo, A				Wang, Zhen Zhen; Yan, Jun Jie; Liu, Ji Ping; Deguchi, Yoshihiro; Katsumori, Shunpei; Ikutomo, Akihiro			Sensitive cesium measurement in liquid sample using low-pressure laser-induced breakdown spectroscopy	SPECTROCHIMICA ACTA PART B-ATOMIC SPECTROSCOPY			English	Article						Laser-induced breakdown spectroscopy; Liquid jet; Low pressure; Focal position; Measurement area	FUKUSHIMA NUCLEAR ACCIDENT; POWER-PLANT; QUANTITATIVE-DETERMINATION; HIGH-TEMPERATURE; WEAR METALS; LIBS; PULSE	The environmental pollution by trace heavy metals is a severe problem for the environment and human health. In this paper, the liquid jet of CsNO3 solution employed was introduced to the measurement chamber and detected using laser-induced breakdown spectroscopy (LIBS) directly at low pressure to determine the detection features of trace Cs element in liquid. The distinct and round plasma can be acquired when reducing the pressure. The interaction between the plasma core of the liquid jet and the surrounding gas can be controlled to enhance Cs detection ability. Cs emission was mainly in the surrounding area in the plasma. The influences of laser focal point and plasma measurement area on the measured signals were studied under low-pressure condition. When employing the defocus mode and varying the measurement area within a certain range, Cs signal and the signal-to-background ratio were improved. Cs detection limit can reach to 22.8 ppb (3 sigma/m(s)) at pressure of 26 kPa in this paper. According to the discussion, the detection limit will be enhanced when improving the experimental conditions using this method, which shows the great application potential of liquid sample measurement. (C) 2015 Elsevier B.V. All rights reserved.	[Wang, Zhen Zhen; Yan, Jun Jie] Xi An Jiao Tong Univ, State Key Lab Multiphase Flow Power Engn, Xian 710049, Peoples R China; [Wang, Zhen Zhen; Deguchi, Yoshihiro; Katsumori, Shunpei; Ikutomo, Akihiro] Univ Tokushima, Grad Sch Adv Technol & Sci, Tokushima 7708501, Japan; [Liu, Ji Ping] Xi An Jiao Tong Univ, Moe Key Lab Thermofluid Sci & Engn, Xian 710049, Peoples R China	Deguchi, Y (reprint author), Univ Tokushima, Grad Sch Adv Technol & Sci, 2-1 Minamijyosanjima, Tokushima 7708506, Japan.	ydeguchi@tokushima-u.ac.jp			National Natural Science Foundation of China [51125027, U1261210]; National Key Basic Research Development Plan [2015CB251504]	This work was supported by National Natural Science Foundation of China (No.51125027, No.U1261210) and the National Key Basic Research Development Plan (No. 2015CB251504).	Buesseler K, 2011, ENVIRON SCI TECHNOL, V45, P9931, DOI 10.1021/es202816c; Yaroshchyk P, 2005, SPECTROCHIM ACTA B, V60, P986, DOI 10.1016/j.sab.2005.03.011; Ohno T, 2014, J ANAL ATOM SPECTROM, V29, P347, DOI 10.1039/c3ja50291k; Sakka T, 2009, SPECTROCHIM ACTA B, V64, P981, DOI 10.1016/j.sab.2009.07.018; Chen ZJ, 2008, SPECTROCHIM ACTA B, V63, P64, DOI 10.1016/j.sab.2007.11.010; Hahn DW, 2012, APPL SPECTROSC, V66, P347, DOI 10.1366/11-06574; Manolopoulou M, 2011, J ENVIRON RADIOACTIV, V102, P796, DOI 10.1016/j.jenvrad.2011.04.010; Noda M, 2002, SPECTROCHIM ACTA B, V57, P701, DOI 10.1016/S0584-8547(01)00403-7; Papp Z, 2002, J ENVIRON RADIOACTIV, V59, P191, DOI 10.1016/S0265-931X(01)00071-6; Kumar A, 2003, APPL OPTICS, V42, P6040, DOI 10.1364/AO.42.006040; Kim CK, 2012, J ENVIRON RADIOACTIV, V111, P70, DOI 10.1016/j.jenvrad.2011.10.018; Kanai Y, 2012, J ENVIRON RADIOACTIV, V111, P33, DOI 10.1016/j.jenvrad.2011.10.011; Tanaka K, 2012, GEOCHEM J, V46, P73; Kaper H, 2014, MATER CHEM PHYS, V147, P147, DOI 10.1016/j.matchemphys.2014.04.021; Sakka T, 2009, APPL SURF SCI, V255, P9576, DOI 10.1016/j.apsusc.2009.04.086; Gerginov V, 2005, OPT LETT, V30, P1734, DOI 10.1364/OL.30.001734; Zhang XB, 2014, J ANAL ATOM SPECTROM, V29, P1082, DOI 10.1039/c4ja00044g; Rai NK, 2008, J HAZARD MATER, V150, P835, DOI 10.1016/j.jhazmat.2007.10.044; Wang ZB, 2013, FREQUENZ, V67, P67, DOI 10.1515/freq-2012-0700; Giordani A, 2014, SURF INTERFACE ANAL, V46, P31, DOI 10.1002/sia.5652; Yueh FY, 2002, J AIR WASTE MANAGE, V52, P1307; Wang Z, 2012, SPECTROCHIM ACTA B, V68, P58, DOI 10.1016/j.sab.2012.01.005; Brim H, 2003, APPL ENVIRON MICROB, V69, P4575, DOI 10.1128/AEM.69.8.4575-4582.2003; Yaroshchyk P, 2005, SPECTROCHIM ACTA B, V60, P1482, DOI 10.1016/j.sab.2005.09.002; St-Onge L, 2004, J PHARMACEUT BIOMED, V36, P277, DOI 10.1016/j.jpba.2004.06.004; Lee DH, 2011, ANAL CHEM, V83, P9456, DOI 10.1021/ac2021689; Glumac N, 2007, OPT LASER ENG, V45, P27, DOI 10.1016/j.optlaseng.2006.04.002; Caffrey JA, 2012, J ENVIRON RADIOACTIV, V111, P120, DOI 10.1016/j.jenvrad.2011.12.015; Eland KL, 2001, APPL SPECTROSC, V55, P279, DOI 10.1366/0003702011951894; DeGiacomo A, 2009, SPECTROCHIM ACTA B, V64, P981; Deguchi Y., 2011, IND APPL LASER DIAGN; Li XW, 2013, SPECTROCHIM ACTA B, V88, P180, DOI 10.1016/j.sab.2013.07.005; Megan R.L.H., 2013, SENSORS, V10, P4342; Russo RE, 2006, LASER-INDUCED BREAKDOWN SPECTROSCOPY (LIBS): FUNDAMENTALS AND APPLICATIONS, pXV; Moore C.E., 1975, NAT STAND REF DATA S, V3; Noll R., 2012, LASER INDUCED BREAKD; Omenetto N., 2010, APPL SPECTROSC, V67, p335A; Sato I., 2011, J TOXICOL SCI, V36, P859; Wang ZZ, 2015, SPECTROSC LETT, V48, P128, DOI 10.1080/00387010.2013.859158; Wang ZZ, 2013, SPECTROCHIM ACTA B, V87, P130, DOI 10.1016/j.sab.2013.05.034; Zhang X.B., 2012, JPN J APPL PHYS, V51	41	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0584-8547			SPECTROCHIM ACTA B	Spectroc. Acta Pt. B-Atom. Spectr.	DEC 1	2015	114						74	80		10.1016/j.sab.2015.10.006		7	Spectroscopy	Spectroscopy	CY0CC	WOS:000366072900012		
J	Kato, T				Kato, Tsukasa			Coping with Workplace Interpersonal Stress among Japanese Employees	STRESS AND HEALTH			English	Article						interpersonal stress; coping behaviour; job stress; burnout; depressive symptoms; sleep problems	EPWORTH SLEEPINESS SCALE; PSYCHOLOGICAL HEALTH; WORK STRESS; DEPRESSION; CONFLICT; CULTURE; MANAGEMENT; RESPONSES; BURNOUT; IMPACT	The current study examined the relationship between coping with workplace interpersonal stress (WIS) and psychological dysfunction (i.e. depressive symptoms, burnout, general distress and daytime sleepiness). Three hundred twenty-four Japanese full-time workers completed measures assessing coping strategies with WIS and psychological dysfunction. Three strategies of coping with WIS were measured: distancing coping, reassessing coping and constructive coping. Multiple regression analyses revealed that distancing coping, which reflects strategies to actively damage, disrupt and dissolve a stressful relationship, was related to high levels of depressive symptoms, burnout, general distress and daytime sleepiness. Reassessing coping, which incorporates efforts to patiently wait for an appropriate opportunity to act, such as a change or improvement in the situation, was related to low levels of depressive symptoms, burnout, general distress and daytime sleepiness. Constructive coping was not significantly associated with psychological dysfunction. Implications for workplace stress are discussed. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Kato, Tsukasa] Toyo Univ, Dept Social Psychol, Tokyo 1128606, Japan	Kato, T (reprint author), Toyo Univ, Dept Social Psychol, Bunkyo Ku, 5-28-20 Hakusan, Tokyo 1128606, Japan.	mtsukasa@hotmail.com			Amour-Science Research	This research was supported by a grant from the Amour-Science Research to Tsukasa Kato.	Rudolph KD, 2009, HANDBOOK OF DEPRESSION IN ADOLESCENTS, P377; Ptacek JT, 2008, ANXIETY STRESS COPIN, V21, P155, DOI 10.1080/10615800701466467; Yeh CJ, 2006, INT CUL PSY, P55; Lam AG, 2004, J CROSS CULT PSYCHOL, V35, P446, DOI 10.1177/0022022104266108; Teasdale JD, 2002, J CONSULT CLIN PSYCH, V70, P275, DOI 10.1037//0022-006X.70.2.275; Briner RB, 2004, BRIT J GUID COUNS, V32, P223, DOI 10.1080/03069880410001692256; Keng SL, 2011, CLIN PSYCHOL REV, V31, P1041, DOI 10.1016/j.cpr.2011.04.006; Chung-Yan GA, 2010, INT J CONFL MANAGE, V21, P382, DOI 10.1108/10444061011079930; Hammen C, 2009, CURR DIR PSYCHOL SCI, V18, P200; Viswesvaran C, 1999, J VOCAT BEHAV, V54, P314, DOI 10.1006/jvbe.1998.1661; Monnier J, 2000, J FAM PSYCHOL, V14, P570, DOI 10.1037//0893-3200.14.4.570; Takegami M, 2009, SLEEP MED, V10, P556, DOI 10.1016/j.sleep.2008.04.015; Kato T, 2012, J COUNS PSYCHOL, V59, P262, DOI 10.1037/a0027770; Hashimoto T, 2012, J CROSS CULT PSYCHOL, V43, P527, DOI 10.1177/0022022112438396; Otsuka Y, 2009, IND HEALTH, V47, P22; Londahl EA, 2005, COGNITIVE THER RES, V29, P445, DOI 10.1007/s10608-005-4442-9; Utsugi M, 2005, SLEEP, V28, P728; Doi Y, 2003, SLEEP, V26, P467; [Anonymous], 1997, PL S STRESS; Chun CA, 2006, INT CUL PSY, P29; Van Reeth O, 2000, SLEEP MED REV, V4, P201, DOI 10.1053/smrv.1999.0097; Dijkstra MTM, 2009, EUR J WORK ORGAN PSY, V18, P405, DOI 10.1080/13594320802510880; Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452; IWATA N, 1995, PSYCHIAT RES, V58, P237, DOI 10.1016/0165-1781(95)02734-E; LONG BC, 1992, J COUNS PSYCHOL, V39, P227, DOI 10.1037//0022-0167.39.2.227; Doi Y, 2003, PSYCHIAT CLIN NEUROS, V57, P379, DOI 10.1046/j.1440-1819.2003.01135.x; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Seiffge-Krenke I, 2006, J YOUTH ADOLESCENCE, V35, P25, DOI 10.1007/s10964-005-9015-4; Cohen J., 1988, STAT POWER ANAL BEHA; DEWE P, 1993, J SOC BEHAV PERS, V8, P673; Frone M R, 2000, J Occup Health Psychol, V5, P246, DOI 10.1037//1076-8998.5.2.246; Goldberg D., 1988, USERS GUIDE GEN HLTH; JOHNS MW, 1991, SLEEP, V14, P540; Jeffrey VJ, 2006, AM J IND MED, V49, P921, DOI 10.1002/ajim.20383; Kabat-Zinn J, 1990, FULL CATASTROPHE LIV; Kato T, 2013, INT PERSPECT PSYCHOL, V2, P100, DOI DOI 10.1037/IPP0000002; Kato T, 2014, J HEALTH PSYCHOL, V19, P977, DOI 10.1177/1359105313482168; Kato T., 2008, TAIJIN SUTORESU KOUP; Kitaoka-Higashiguchi K, 2004, STRESS HEALTH, V20, P255, DOI 10.1002/smi.1030; KRAMER BJ, 1993, FAM RELAT, V42, P383, DOI 10.2307/585338; Lazarus R. S., 1999, STRESS EMOTION NEW S; Lazarus R. S., 1984, STRESS APPRAISAL COP; Linehan M., 1993, SKILLS TRAINING MANU; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Nakata A., 2004, SOC SCI MED, V64, P2520; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Schaufeli W. B., 1996, MASLACH BURNOUT INVE, P19; Segal Z. V., 2002, MINDFULNESS BASED CO; Smith C. S., 1995, JOB STRESS INTERVENT, P109, DOI DOI 10.1037/10183-008; Wells A., 2006, J RATION-EMOT COGN-B, V23, P337, DOI DOI 10.1007/S10942-005-0018-6	50	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1532-3005	1532-2998		STRESS HEALTH	Stress Health	DEC	2015	31	5					411	418		10.1002/smi.2566		8	Psychology, Applied; Psychiatry; Psychology	Psychology; Psychiatry	CX9WR	WOS:000366057100007		
J	Gai, ZQ; Matsuno, A; Kato, K; Kato, S; Khan, MRI; Shimizu, T; Yoshioka, T; Kato, Y; Kishimura, H; Kanno, G; Miyabe, Y; Terada, T; Tanaka, Y; Yao, M				Gai, Zuoqi; Matsuno, Asuka; Kato, Koji; Kato, Sanae; Khan, Md Rafiqul Islam; Shimizu, Takeshi; Yoshioka, Takeya; Kato, Yuki; Kishimura, Hideki; Kanno, Gaku; Miyabe, Yoshikatsu; Terada, Tohru; Tanaka, Yoshikazu; Yao, Min			Crystal Structure of the 3.8-MDa Respiratory Supermolecule Hemocyanin at 3.0 angstrom Resolution	STRUCTURE			English	Article							SEPIA-OFFICINALIS HEMOCYANIN; CRYO-EM STRUCTURE; FUNCTIONAL UNIT; GASTROPOD HEMOCYANIN; CRYOELECTRON MICROSCOPY; HALIOTIS-TUBERCULATA; NAUTILUS-POMPILIUS; PROTEIN-STRUCTURE; MOLECULAR-MODEL; SEQUENCE	Molluscan hemocyanin, a copper-containing oxygen transporter, is one of the largest known proteins. Although molluscan hemocyanins are currently applied as immunotherapeutic agents, their precise structure has not been determined because of their enormous size. Here, we have determined the first X-ray crystal structure of intact molluscan hemocyanin. The structure unveiled the architecture of the 3.8-MDa supermolecule composed of homologous functional units (FUs), wherein the dimers of FUs hierarchically associated to form the entire cylindrical decamer. Most of the specific inter-FU interactions were localized at narrow regions in the FU dimers, suggesting that rigid FU dimers formed by specific interactions assemble with flexibility. Furthermore, the roles of carbohydrates in assembly and allosteric effect, and conserved sulfur-containing residues in copper incorporation, were revealed. The precise structural information obtained in this study will accelerate our understanding of the molecular basis of hemocyanin and its future applications.	[Gai, Zuoqi; Kato, Koji; Tanaka, Yoshikazu; Yao, Min] Hokkaido Univ, Fac Adv Life Sci, Lab Xray Struct Biol, Sapporo, Hokkaido 0600810, Japan; [Matsuno, Asuka; Kato, Koji; Tanaka, Yoshikazu; Yao, Min] Hokkaido Univ, Grad Sch Life Sci, Lab Xray Struct Biol, Sapporo, Hokkaido 0600810, Japan; [Kato, Sanae; Khan, Md Rafiqul Islam] Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan; [Shimizu, Takeshi; Yoshioka, Takeya; Kato, Yuki] Hokkaido Ind Technol Ctr, Food Sci Div, Hakodate, Hokkaido 0410801, Japan; [Kishimura, Hideki; Kanno, Gaku; Miyabe, Yoshikatsu] Hokkaido Univ, Grad Sch Fisheries Sci, Div Marine Life Sci, Hakodate, Hokkaido 0418611, Japan; [Terada, Tohru] Univ Tokyo, Grad Sch Agr & Life Sci, Agr Bioinformat Res Unit, Tokyo 1138657, Japan	Tanaka, Y (reprint author), Hokkaido Univ, Fac Adv Life Sci, Lab Xray Struct Biol, Sapporo, Hokkaido 0600810, Japan.	tanaka@sci.hokudai.ac.jp			JSPS [26291008, 24000011, 26102501, 25450298]; Ministry of Education, Culture, Sports, Science and Technology (Japan); Platform for Drug Discovery, Informatics, and Structural Life Science	We thank Prof. Isao Tanaka of Hokkaido University (Japan) for his helpful discussions. This work was supported by JSPS KAKENHI, grant numbers 26291008, 24000011, 26102501 (to Y.T.) and 25450298 (to S.K.), Platform for Drug Discovery, Informatics, and Structural Life Science (to S.K. and Y.T.), and Regional Innovation Strategy Support Program (to S.K., T.S., T.Y., and Y.K.) from the Ministry of Education, Culture, Sports, Science and Technology (Japan). The X-ray diffraction experiments were performed under the proposal numbers 2013G165, 2015G067 (Photon Factory), 2013A6829, 2013A1096, 2013B6829, 2013B1031, 2014A1193, 2014B6930, 2014B1295, 2014B1292, 2015A6524, 2015A1114 (SPring-8), and 20121296 (Swiss Light Source).	Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Matoba Y, 2011, J BIOL CHEM, V286, P30219, DOI 10.1074/jbc.M111.256818; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Decker H, 2000, J EXP BIOL, V203, P1777; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Lieb B, 2000, J BIOL CHEM, V275, P5675, DOI 10.1074/jbc.275.8.5675; Stoeva S, 2002, ARCH BIOCHEM BIOPHYS, V399, P149, DOI 10.1006/abbi.2001.2741; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Geyer H, 2005, J BIOL CHEM, V280, P40731, DOI 10.1074/jbc.M505985200; Siddiqui NI, 2007, BIOCHEM BIOPH RES CO, V361, P705, DOI 10.1016/j.bbrc.2007.07.098; Jaenicke E, 2010, BIOCHEM J, V426, P373, DOI 10.1042/BJ20091501; Gatsogiannis C, 2009, J MOL BIOL, V385, P963, DOI 10.1016/j.jmb.2008.10.080; Stoeva S, 1999, BBA-PROTEIN STRUCT M, V1435, P94, DOI 10.1016/S0167-4838(99)00198-3; Perbandt M, 2003, BIOCHEMISTRY-US, V42, P6341, DOI 10.1021/bi020672x; MILLER KI, 1990, P NATL ACAD SCI USA, V87, P1496, DOI 10.1073/pnas.87.4.1496; Lamy J, 1998, J MOL BIOL, V284, P1051, DOI 10.1006/jmbi.1998.2235; Cuff ME, 1998, J MOL BIOL, V278, P855, DOI 10.1006/jmbi.1998.1647; Harris JR, 1999, MICRON, V30, P597, DOI 10.1016/S0968-4328(99)00036-0; Jaenicke E, 2011, IUBMB LIFE, V63, P183, DOI 10.1002/iub.435; Miller KI, 1998, J MOL BIOL, V278, P827, DOI 10.1006/jmbi.1998.1648; Zhang QF, 2013, STRUCTURE, V21, P604, DOI 10.1016/j.str.2013.02.018; Gatsogiannis C, 2007, J MOL BIOL, V374, P465, DOI 10.1016/j.jmb.2007.09.036; Markl J, 2013, BBA-PROTEINS PROTEOM, V1834, P1840, DOI 10.1016/j.bbapap.2013.02.020; Harris JR, 2004, MICRON, V35, P23, DOI 10.1016/j.micron.2003.10.008; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Meissner U, 2000, J MOL BIOL, V298, P21, DOI 10.1006/jmbi.2000.3631; Boisset N, 2000, J MOL BIOL, V296, P459, DOI 10.1006/jmbi.1999.3460; Bergmann S, 2006, J MOL EVOL, V62, P362, DOI 10.1007/s00239-005-0160-x; Matsuno A, 2015, J STRUCT BIOL, V190, P379, DOI 10.1016/j.jsb.2015.04.015; Fujieda N, 2013, J BIOL CHEM, V288, P22128, DOI 10.1074/jbc.M113.477612; Nishimura SI, 2005, ANGEW CHEM INT EDIT, V44, P91, DOI 10.1002/anie.200461685; Becker M.I., 2014, IMMUNE RESPONSE ACTI, P45; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Gatsogiannis C, 2015, STRUCTURE, V23, P93, DOI 10.1016/j.str.2014.10.013; Thonig A, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-6; Zhu HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098766	38	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0969-2126	1878-4186		STRUCTURE	Structure	DEC 1	2015	23	12					2204	2212		10.1016/j.str.2015.09.008		9	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CY1MQ	WOS:000366171500003		
J	Ainslie, MD; Zou, J; Mochizuki, H; Fujishiro, H; Shi, YH; Dennis, AR; Cardwell, DA				Ainslie, M. D.; Zou, J.; Mochizuki, H.; Fujishiro, H.; Shi, Y-H; Dennis, A. R.; Cardwell, D. A.			Pulsed field magnetization of 0 degrees-0 degrees and 45 degrees-45 degrees bridge-seeded Y-Ba-Cu-O bulk superconductors	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Article						bulk superconductors; multi-seeding; bridge-shaped seeds; trapped field magnets; pulsed field magnetization; numerical modelling; finite element method (FEM) modelling	PROCESSED YBCO SUPERCONDUCTORS; COATED CONDUCTORS; GRAIN-BOUNDARIES; AC-LOSSES; GROWTH; JUNCTIONS	Large, single-grain (RE) BCO (where RE = rare earth or Y) bulk superconductors with complicated geometries are required for a variety of potential applications, such as rotating machines, magnetic bearings and magnetic separation. As a consequence, the top multi-seeded melt growth process has been studied over many years in an attempt to deliver large, single grains for practical applications. Among these techniques, the so-called bridge-seeding produces the best alignment of two seeds during melt processing of multi-seed samples. In this paper, the trapped field performance and magnetic flux dynamics of two bridge-seeded, multi-seed samples magnetized by pulsed field magnetization are analyzed: one with a 45 degrees-45 degrees and another with a 0 degrees-0 degrees bridge seed. Based on an analysis of the flux penetration across the seeds and in-between the seeds of the 45 degrees-45 degrees multi-seed sample, an estimated J(c) distribution over the ab-plane is determined, which provides the basis for further analysis via numerical simulation. A three-dimensional finite-element model, developed to qualitatively reproduce and interpret the experimental results, was employed to investigate the influence of the length of the bridge seed for such multi-seed samples. The simulation results agree well with the observed experimental results, in that the multi-seed sample's particular inhomogeneous J(c) distribution acts to distort the trapped field profile from a traditional conical Bean's profile, which is determined by the length and direction of the bridge seed on the bulk surface.	[Ainslie, M. D.; Zou, J.; Shi, Y-H; Dennis, A. R.; Cardwell, D. A.] Univ Cambridge, Dept Engn, Bulk Superconduct Grp, Cambridge CB2 1PZ, England; [Mochizuki, H.; Fujishiro, H.] Iwate Univ, Dept Mat Sci & Engn, Fac Engn, Morioka, Iwate 0208551, Japan	Ainslie, MD (reprint author), Univ Cambridge, Dept Engn, Bulk Superconduct Grp, Trumpington St, Cambridge CB2 1PZ, England.	mda36@cam.ac.uk			Royal Academy of Engineering Research Fellowship; Churchill College, Cambridge; China Scholarship Council; Cambridge Commonwealth, European and International Trust; Ministry of Education, Culture, Sports, Science and Technology, Japan; Royal Society International Exchanges Scheme [IE131084]	Mark Ainslie would like to acknowledge the support of a Royal Academy of Engineering Research Fellowship. Jin Zou would like to acknowledge the support of Churchill College, Cambridge, the China Scholarship Council and the Cambridge Commonwealth, European and International Trust. Hiroyuki Fujishiro would like to acknowledge support in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This research was also supported in part by a Royal Society International Exchanges Scheme grant, IE131084.	Shi YH, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/1/015012; Kim CJ, 2001, PHYSICA C, V357, P635, DOI 10.1016/S0921-4534(01)00353-7; Hong Z, 2006, SUPERCOND SCI TECH, V19, P1246, DOI 10.1088/0953-2048/19/12/004; Ainslie MD, 2011, COMPEL, V30, P762, DOI 10.1108/03321641111101195; Todt VR, 1996, APPL PHYS LETT, V69, P3746, DOI 10.1063/1.117209; Shi Y, 2005, SUPERCOND SCI TECH, V18, pL13, DOI 10.1088/0953-2048/18/4/L01; Ainslie MD, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2227639; Shi YH, 2013, J AM CERAM SOC, V96, P1757, DOI 10.1111/jace.12350; Zou J, 2015, SUPERCOND SCI TECH, V28, DOI 10.1088/0953-2048/28/7/075009; BEAN CP, 1962, PHYS REV LETT, V8, P250, DOI 10.1103/PhysRevLett.8.250; Durrell JH, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/8/082001; Shi YH, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/4/045006; PLUMMER CJG, 1987, IEEE T MAGN, V23, P1179, DOI 10.1109/TMAG.1987.1064997; Kim CJ, 2000, PHYSICA C, V338, P205, DOI 10.1016/S0921-4534(00)00310-5; Zou J, 2015, SUPERCOND SCI TECH, V28, DOI 10.1088/0953-2048/28/3/035016; Zhang M, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/1/015009; RHYNER J, 1993, PHYSICA C, V212, P292, DOI 10.1016/0921-4534(93)90592-E; Haindl S, 2005, IEEE T APPL SUPERCON, V15, P3129, DOI 10.1109/TASC.2005.848978; Tomita M, 2003, NATURE, V421, P517, DOI 10.1038/nature01350; Ainslie MD, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/6/065008; Ainslie MD, 2012, PHYSICA C, V472, P50, DOI 10.1016/j.physc.2011.10.008; Koshizuka N, 2006, PHYSICA C, V445, P1103, DOI 10.1016/j.physc.2006.05.045; BEAN CP, 1964, REV MOD PHYS, V36, P31, DOI 10.1103/RevModPhys.36.31; Ainslie MD, 2011, SUPERCOND SCI TECH, V24, DOI 10.1088/0953-2048/24/4/045005; Zhou DF, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/10/103001; Li TY, 2010, J APPL PHYS, V108, DOI 10.1063/1.3465301; Kim CJ, 2000, PHYSICA C, V336, P233, DOI 10.1016/S0921-4534(00)00292-6; Ainslie MD, 2015, SUPERCOND SCI TECH, V28, DOI 10.1088/0953-2048/28/5/053002; Nariki S, 2005, SUPERCOND SCI TECH, V18, pS126, DOI 10.1088/0953-2048/18/2/026; Wongsatanawarid A, 2010, J PHYS CONF SER, V234, DOI 10.1088/1742-6596/234/1/012047; Zou J, 2015, IEEE T APPL SUPERCON, V25, DOI 10.1109/TASC.2014.2379692; Zermeno VMR, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/5/052001; Oka T, 2007, PHYSICA C, V463, P7, DOI 10.1016/j.physc.2007.03.432; Babu Hari N, 2005, NAT MATER, V4, P476; Hull JR, 2000, SUPERCOND SCI TECH, V13, pR1, DOI 10.1088/0953-2048/13/2/201; Sino H, 2008, J PHYS C SER, V97	36	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	DEC	2015	28	12							125002	10.1088/0953-2048/28/12/125002		14	Physics, Applied; Physics, Condensed Matter	Physics	CY3DI	WOS:000366288100011		
J	Cristiano, R; Ejrnaes, M; Casaburi, A; Zen, N; Ohkubo, M				Cristiano, R.; Ejrnaes, M.; Casaburi, A.; Zen, N.; Ohkubo, M.			Superconducting nano-strip particle detectors	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Article						superconducting detectors; superconducting nano-strip; SSPD; ion detectors; particle detectors; TOF-MS	FLIGHT MASS-SPECTROMETRY; SINGLE-PHOTON DETECTORS; ION DETECTION; TIME; FILM; STATE; MACROMOLECULES; EFFICIENCY; NANOWIRES; MOLECULES	We review progress in the development and applications of superconducting nano-strip particle detectors. Particle detectors based on superconducting nano-strips stem from the parent devices developed for single photon detection (SSPD) and share with them ultra-fast response times (sub-nanosecond) and the ability to operate at a relatively high temperature (2-5 K) compared with other cryogenic detectors. SSPDs have been used in the detection of electrons, neutral and charged ions, and biological macromolecules; nevertheless, the development of superconducting nano-strip particle detectors has mainly been driven by their use in time-of-flight mass spectrometers (TOF-MSs) where the goal of 100% efficiency at large mass values can be achieved. Special emphasis will be given to this case, reporting on the great progress which has been achieved and which permits us to overcome the limitations of existing mass spectrometers represented by low detection efficiency at large masses and charge/mass ambiguity. Furthermore, such progress could represent a breakthrough in the field. In this review article we will introduce the device concept and detection principle, stressing the peculiarities of the nano-strip particle detector as well as its similarities with photon detectors. The development of parallel strip configuration is introduced and extensively discussed, since it has contributed to the significant progress of TOF-MS applications.	[Cristiano, R.; Ejrnaes, M.] UOS Napoli, CNR SPIN Inst Superconductors Innovat Mat & Devic, I-80125 Naples, Italy; [Casaburi, A.] Univ Glasgow, Sch Engn, Glasgow G12 8LT, Lanark, Scotland; [Zen, N.] Natl Inst Adv Ind Sci & Technol, Nanoelect Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Ohkubo, M.] Natl Inst Adv Ind Sci & Technol, Dept Elect & Mfg, Tsukuba, Ibaraki 3058568, Japan	Cristiano, R (reprint author), UOS Napoli, CNR SPIN Inst Superconductors Innovat Mat & Devic, I-80125 Naples, Italy.	roberto.cristiano@cnr.it			UK Engineering & Physical Sciences Research Council; Japan Society for the Promotion of Science [24619013]	The authors would like to express thanks to S Shiki, G Fujii, K Suzuki, K Sano, N Yoshikawa and M Ukibe for their assistance and fruitful discussions. A Casaburi thanks Marie Curie Actions, the staff of the James Watt Nanofabrication Centre at the University of Glasgow and support from the UK Engineering & Physical Sciences Research Council. N Zen acknowledges a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (Grant No. 24619013). The authors thank Barbara Pizzicato for figure 4(a).	Casaburi A, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3142419; Bulaevskii LN, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.144526; Ejrnaes M, 2009, J MOD OPTIC, V56, P390, DOI 10.1080/09500340802673182; Marsili F, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3691944; Zen N, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4913844; Casaburi A, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4813087; Marsili F, 2011, NANO LETT, V11, P2048, DOI 10.1021/nl2005143; Ovchinnikov YN, 1998, PHYS REV B, V58, P12416, DOI 10.1103/PhysRevB.58.12416; Marsili F, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3560458; Marksteiner M, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/45/455501; Hilton GC, 1998, NATURE, V391, P672, DOI 10.1038/35582; Ohkubo M, 2012, J LOW TEMP PHYS, V167, P943, DOI 10.1007/s10909-012-0542-6; ANDREWS DH, 1949, PHYS REV, V76, P154, DOI 10.1103/PhysRev.76.154.2; Zotova AN, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.024509; Suzuki K, 2008, J LOW TEMP PHYS, V151, P766, DOI 10.1007/s10909-008-9748-z; Suzuki K, 2009, PHYSICA C, V469, P1677, DOI 10.1016/j.physc.2009.05.042; Kerman AJ, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2183810; Rosticher M, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3506692; KAPLAN SB, 1979, J LOW TEMP PHYS, V37, P343, DOI 10.1007/BF00119193; Marsili F, 2013, NAT PHOTONICS, V7, P210, DOI [10.1038/nphoton.2013.13, 10.1038/NPHOTON.2013.13]; Suzuki K, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.083101; Semenov AD, 2001, PHYSICA C, V351, P349, DOI 10.1016/S0921-4534(00)01637-3; Gol'tsman GN, 2001, APPL PHYS LETT, V79, P705, DOI 10.1063/1.1388868; Frank M, 1999, MASS SPECTROM REV, V18, P155, DOI 10.1002/(SICI)1098-2787(1999)18:3/4<155::AID-MAS1>3.0.CO;2-W; Sclafani M, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/6/065501; Renema JJ, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.174526; Zen N, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3256220; Casaburi A, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/4/044029; Ejrnaes M, 2009, SUPERCOND SCI TECH, V22, DOI 10.1088/0953-2048/22/5/055006; Casaburi A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3537808; Zen N, 2009, IEEE T APPL SUPERCON, V19, P354, DOI 10.1109/TASC.2009.2018845; Semenov A, 2005, EUR PHYS J B, V47, P495, DOI 10.1140/epjb/e2005-00351-8; Zen N, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4861225; Natarajan CM, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/6/063001; Twerenbold D, 1996, APPL PHYS LETT, V68, P3503, DOI 10.1063/1.115772; Suzuki K, 2010, RAPID COMMUN MASS SP, V24, P3290, DOI 10.1002/rcm.4780; Hofherr M, 2010, J APPL PHYS, V108, DOI 10.1063/1.3437043; Ejrnaes M, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2828138; Men'shchikov EM, 1997, TECH PHYS LETT+, V23, P486, DOI 10.1134/1.1261724; KADIN AM, 1990, PHYS REV LETT, V65, P3193, DOI 10.1103/PhysRevLett.65.3193; Sano K, 2014, PHYSICA C, V504, P97, DOI 10.1016/j.physc.2014.02.016; Annunziata AJ, 2010, J APPL PHYS, V108, DOI 10.1063/1.3498809; Kerman AJ, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.100509; Kozorezov AG, 2000, PHYS REV B, V61, P11807, DOI 10.1103/PhysRevB.61.11807; Suzuki K, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.031702; Casaburi A, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/11/115004; Suzuki K, 2008, PHYSICA C, V468, P2001, DOI 10.1016/j.physc.2008.05.115; Ohkubo M, 2011, INT J MASS SPECTROM, V299, P94, DOI 10.1016/j.ijms.2010.09.027; de Lara DP, 2008, J LOW TEMP PHYS, V151, P771, DOI 10.1007/s10909-008-9745-2; Gerlich S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1263; Koppenaal D W, 2005, J ANAL CHEM+, V77, P418; Ohkubo M, 2015, IEEE CSC ESAS EUROPE, V32, pST434; Renema JJ, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.117604; Seidel P, 2015, HDB DEVICES APPL; Zen N, 2015, CHINESE PHYS B, V24, DOI 10.1088/1674-1056/24/9/098501	55	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	DEC	2015	28	12							124004	10.1088/0953-2048/28/12/124004		15	Physics, Applied; Physics, Condensed Matter	Physics	CY3DI	WOS:000366288100006		
J	Iida, K				Iida, Kazumasa			A new member has joined: pnictide bulk superconducting magnets	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Editorial Material									[Iida, Kazumasa] Nagoya Univ, Grad Sch Engn, Dept Crystalline Mat Sci, Nagoya, Aichi 4648603, Japan	Iida, K (reprint author), Nagoya Univ, Grad Sch Engn, Dept Crystalline Mat Sci, Nagoya, Aichi 4648603, Japan.	iida@nuap.nagoya-u.ac.jp					Weiss JD, 2012, NAT MATER, V11, P682, DOI [10.1038/nmat3333, 10.1038/NMAT3333]; Pogrebnyakov AV, 2004, APPL PHYS LETT, V85, P2017, DOI 10.1063/1.1782258; Yamamoto A, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4890724; Durrell JH, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/8/082001; Viznichenko RV, 2003, APPL PHYS LETT, V83, P4360, DOI 10.1063/1.1629148; SAWANO K, 1991, JPN J APPL PHYS 2, V30, pL1157; Ogawa K, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3598440; Sakai N, 2000, PHYSICA C, V335, P107, DOI 10.1016/S0921-4534(00)00153-2; Gao ZS, 2015, SUPERCOND SCI TECH, V28, DOI 10.1088/0953-2048/28/1/012001; Murakami A., 2015, Physics Procedia, V67, DOI 10.1016/j.phpro.2015.06.166; Weiss JD, 2015, SUPERCOND SCI TECH, V28, DOI 10.1088/0953-2048/28/11/112001	11	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	DEC	2015	28	12							120501	10.1088/0953-2048/28/12/120501		2	Physics, Applied; Physics, Condensed Matter	Physics	CY3DI	WOS:000366288100001		
J	Pyon, S; Yamasaki, Y; Kajitani, H; Koizumi, N; Tsuchiya, Y; Awaji, S; Watanabe, K; Tamegai, T				Pyon, Sunseng; Yamasaki, Yuji; Kajitani, Hideki; Koizumi, Norikiyo; Tsuchiya, Yuji; Awaji, Satoshi; Watanabe, Kazuo; Tamegai, Tsuyoshi			Effects of drawing and high-pressure sintering on the superconducting properties of (Ba,K)Fe2As2 powder-in-tube wires	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Article						superconducting wires; hot isostatic pressing (HIP); (Ba,K)Fe2As2; powder-in-tube (PIT); critical current density; effects of drawing and sintering	CRITICAL-CURRENT DENSITY; TRANSPORT J(C); SR0.6K0.4FE2AS2; TAPES	The evolution of the superconducting properties of round wires of (Ba,K)Fe2As2 fabricated by the powder-in-tube (PIT) method is systematically studied. After establishing the method to obtain the largest transport critical current density (J(c)) in round wires using the hot isostatic press technique, we investigated how the transition temperature (T-c), J(c), and microstructures change at each step of the wire fabrication. Unexpectedly, we find that superconducting properties of the wire core are significantly damaged by the drawing process. Systematic measurements of J(c) and T-c of the core superconductor after each drawing and sintering process clarified the evolution of degradation by the drawing process and recovery by heat treatment.	[Pyon, Sunseng; Yamasaki, Yuji; Tamegai, Tsuyoshi] Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; [Kajitani, Hideki; Koizumi, Norikiyo] JAEA, Fus Res & Dev Directorate, Naka, Ibaraki 3110193, Japan; [Tsuchiya, Yuji; Awaji, Satoshi; Watanabe, Kazuo] Tohoku Univ, Inst Mat Res, High Field Lab Superconducting Mat, Sendai, Miyagi 9808577, Japan	Pyon, S (reprint author), Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan.	pyon@ap.t.u-tokyo.ac.jp			Japan-China Bilateral Joint Research Project by the Japan Society for the Promotion of Science (JSPS); Sumitomo foundation; TEPCO memorial foundation	This work was partially supported by the Japan-China Bilateral Joint Research Project by the Japan Society for the Promotion of Science (JSPS), by research grant of the Sumitomo foundation, and by research grant (general research) of TEPCO memorial foundation.	Weiss JD, 2012, NAT MATER, V11, P682, DOI [10.1038/nmat3333, 10.1038/NMAT3333]; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Gurevich A, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/12/124501; Pyon S, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.123101; Tapp JH, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.060505; Zhang XP, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4879557; Pyon S, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/9/095002; Qi YP, 2010, SUPERCOND SCI TECH, V23, DOI 10.1088/0953-2048/23/5/055009; Fang L, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4731204; [Anonymous], 2005, PHYS REV B, DOI DOI 10.1103/PHYSREVB.71.012504; Tamegai T, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2235133; Wang XL, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.024525; Kobayashi S, 2005, IEEE T APPL SUPERCON, V15, P2534, DOI 10.1109/TASC.2005.847520; Rotter M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.107006; Chen XH, 2008, NATURE, V453, P761, DOI 10.1038/nature07045; Moll PJW, 2010, NAT MATER, V9, P628, DOI [10.1038/nmat2795, 10.1038/NMAT2795]; Togano K, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/6/065003; Hayashi K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.080001; Yuan HQ, 2009, NATURE, V457, P565, DOI 10.1038/nature07676; Senatore C, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.054514; Nakajima Y, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.012510; Hsu FC, 2008, P NATL ACAD SCI USA, V105, P14262, DOI 10.1073/pnas.0807325105; Prozorov R, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/12/124505; Gao ZS, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3671109; Taen T, 2015, SUPERCOND SCI TECH, V28, DOI 10.1088/0953-2048/28/8/085003; Pyon S, 2014, PHYSICA C, V504, P69, DOI 10.1016/j.physc.2014.03.008; Nakajima Y, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.023702; GALLEGO LJ, 1988, PHYSICA B, V154, P82, DOI 10.1016/0921-4526(88)90020-8; Sasmal K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.107007; Togano K, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.043101; Kim JS, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.144512; Ma YW, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/11/113001; Ding QP, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/3/035019; Evtushinsky DV, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055069; Gao ZS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04065; Gao ZS, 2015, SUPERCOND SCI TECH, V28, DOI 10.1088/0953-2048/28/1/012001; Gao ZS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00998; Jaroszynski J, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.064511; Lin H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11506; Lin H, 2014, SCI REP-UK, V4, DOI 10.1038/srep04465; Lin H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06944; Stewart GR, 1984, LOS ALAMOS SCI, V10, P59; Tamegai T, 2015, IEEE T APPL SUPERCON, V25, DOI 10.1109/TASC.2014.2381554	43	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	DEC	2015	28	12							125014	10.1088/0953-2048/28/12/125014		9	Physics, Applied; Physics, Condensed Matter	Physics	CY3DI	WOS:000366288100023		
J	Yanagisawa, Y; Xu, Y; Iguchi, S; Hamada, M; Matsumoto, S; Nishijima, G; Nakagome, H; Takao, T; Suematsu, H; Oshima, Y; Jin, X; Takahashi, M; Maeda, H				Yanagisawa, Y.; Xu, Y.; Iguchi, S.; Hamada, M.; Matsumoto, S.; Nishijima, G.; Nakagome, H.; Takao, T.; Suematsu, H.; Oshima, Y.; Jin, X.; Takahashi, M.; Maeda, H.			Combination of high hoop stress tolerance and a small screening current-induced field for an advanced Bi-2223 conductor coil at 4.2K in an external field	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Article						hoop stress tolerance; screening current-induced field; Bi-2223; NMR; high field	MHZ NMR; 1 GHZ; T-C; OPERATION; SOLENOIDS; PROGRESS; MAGNETS; TAPES; WIRES	An advanced Bi-2223 conductor with Ni-Cr reinforcement is a likely candidate to achieve a compact super-high field nuclear magnetic resonance (NMR) magnet capable of operation beyond 1 GHz (23.5 T). However, the conductors must show both high hoop stress tolerance, typically >300 MPa, and a small screening current-induced magnetic field, both of which are essential for a compact magnet generating a highly accurate field. These two conditions have not yet been demonstrated in a working coil. This is the first paper to systematically investigate both characteristics for a layer-wound coil made with the advanced Bi-2223 conductor operated mainly at 4.2 K in an external field of <= 17 T. The coil tolerated a hoop stress of 370 MPa, even though the conductor had a bending strain corresponding to a diameter of 120 mm. On the other hand, the coil showed a notable screening current-induced field in a low external field, which may be explained by weak-link and direct contacts between highly packed Bi-2223 filaments in the silver matrix. The field sharply decreased with increasing external field between 0-1 T. Thus, the conductor should be useful for inner coils in compact super-high field NMR magnets.	[Yanagisawa, Y.; Xu, Y.; Iguchi, S.; Jin, X.; Takahashi, M.; Maeda, H.] RIKEN Ctr Life Sci Technol, Yokohama, Kanagawa 2300045, Japan; [Yanagisawa, Y.; Xu, Y.; Nakagome, H.] Chiba Univ, Grad Sch Engn, Chiba 2638522, Japan; [Iguchi, S.; Takao, T.] Sophia Univ, Fac Sci & Technol, Yotsuya 1028554, Japan; [Hamada, M.] Japan Superconductor Technol Inc, Kobe, Hyogo 6512271, Japan; [Matsumoto, S.; Nishijima, G.] Natl Inst Mat Sci, Sperconducting Wire Unit, Tsukuba, Ibaraki 3050003, Japan; [Suematsu, H.] JEOL RESONANCE Inc, Akishima, Tokyo 1968558, Japan; [Oshima, Y.] RIKEN, Condensed Mol Mat Lab, Wako, Saitama 3510198, Japan	Yanagisawa, Y (reprint author), RIKEN Ctr Life Sci Technol, Yokohama, Kanagawa 2300045, Japan.	yoshinori.yanagisawa@riken.jp			Japan Science and Technology Agency (JST) under the Strategic Promotion of Innovative Research and Development Program	This work was partially supported by the Japan Science and Technology Agency (JST) under the Strategic Promotion of Innovative Research and Development Program. A part of the work was carried out in the Special Postdoctoral Researcher Program of RIKEN. The authors appreciate Dr S Kobayashi of SEI, Dr T Nakashima of SEI, and Dr H Kitaguchi of NIMS for discussions on the screening current-induced field.	Ayai N, 2008, PHYSICA C, V468, P1747, DOI 10.1016/j.physc.2008.05.197; Hashi K, 2015, J MAGN RESON, V256, P30, DOI 10.1016/j.jmr.2015.04.009; Iwasa Y, 2006, PHYSICA C, V445, P1088, DOI 10.1016/j.physc.2006.05.040; Schmidt C, 2004, CRYOGENICS, V44, P187, DOI 10.1016/j.cryogenics.2003.11.003; ARP V, 1977, J APPL PHYS, V48, P2026, DOI 10.1063/1.323913; Otsuka A, 2011, IEEE T APPL SUPERCON, V21, P2076, DOI 10.1109/TASC.2010.2080254; Zhang M, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/9/095010; Hahn S, 2009, J APPL PHYS, V105, DOI 10.1063/1.3065538; Amemiya N, 2003, PHYSICA C, V392, P1083, DOI 10.1016/S0921-4534(03)00838-4; Souc J, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/7/075020; Chen P, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/7/075009; Nishijima G, 2011, PHYSICA C, V471, P1062, DOI 10.1016/j.physc.2011.05.124; Nakashima T, 2011, PHYSICA C, V471, P1086, DOI 10.1016/j.physc.2011.05.130; Hahn SY, 2008, IEEE T APPL SUPERCON, V18, P856, DOI 10.1109/TASC.2008.921225; Uglietti D, 2010, SUPERCOND SCI TECH, V23, DOI 10.1088/0953-2048/23/11/115002; Takeuchi T, 2009, IEEE T APPL SUPERCON, V19, P2661, DOI 10.1109/TASC.2009.2018467; Yanagisawa Y, 2010, IEEE T APPL SUPERCON, V20, P744, DOI 10.1109/TASC.2010.2043240; Nishijima G, 2008, IEEE T APPL SUPERCON, V18, P1131, DOI 10.1109/TASC.2008.921240; Hazelton DW, 2009, IEEE T APPL SUPERCON, V19, P2218, DOI 10.1109/TASC.2009.2018791; Weijers HW, 2014, IEEE T APPL SUPERCON, V24, DOI 10.1109/TASC.2013.2288919; Yanagisawa Y, 2010, J MAGN RESON, V203, P274, DOI 10.1016/j.jmr.2010.01.007; DYACHENKO AI, 1993, PHYSICA C, V213, P167, DOI 10.1016/0921-4534(93)90773-J; URATA M, 1987, IEEE T MAGN, V23, P1596, DOI 10.1109/TMAG.1987.1065028; Yanagisawa Y, 2011, IEEE T APPL SUPERCON, V21, P1640, DOI 10.1109/TASC.2010.2087311; Maeda H, 2014, IEEE T APPL SUPERCON, V24, DOI 10.1109/TASC.2013.2287707; Machi T, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/10/105016; Miyoshi Y, 2015, SUPERCOND SCI TECH, V28, DOI 10.1088/0953-2048/28/7/075013; Ekin J W, 2006, EXPT TECHNIQUES LOW; Fujita S, 2015, IEEE T APPL SUPERCON, V25; Henmi T, 2005, IEEE T APPL SUPERCON, V15, P1711; Iwasa Y, 2015, IEEE T APPL SUPERCON, V25; Iwasa Y, 2009, CASE STUDIES SUPERCO; Kajita K, 2015, 24 INT C MAGN TECHN; Kametani F, 2015, SCI REP-UK, V5, DOI 10.1038/srep08285; Kiyoshi T, 2009, IEEE T APPL SUPERCON, V18, P1529; Koyama K, 2009, PHYSICA C, V469, P694; Larbalestier D., 2014, NAT MATER, V13, P1; Matsumoto S, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/2/025017; Miyoshi Y, 2014, SCI TECHNOL, V27; Nakashima T, 2014, COMMUNICATION; Nakashima T, 2015, IEEE T APPL SUPERCON, V25; Nawa M, 2015, CRYOG ENG C INT CRYO; Otsuka A, 2010, IEEE T APPL SUPERCON, V18, P596; Otsuka 'A., 2007, J CRUOGENIC SOC JPN, V42, P196; Senatore C, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/10/103001; Ueda H, 2015, IEEE T APPL SUPERCON, V25, DOI 10.1109/TASC.2014.2375953; Yanagisawa Y, 2014, J MAGN RESON, V249, P38, DOI 10.1016/j.jmr.2014.10.006; Yanagisawa Y, 2015, RES FABRICA IN PRESS, VIII; Yanagisawa Y, 2015, IEEE T APPL SUPERCON, V25, DOI 10.1109/TASC.2014.2377492	49	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	DEC	2015	28	12							125005	10.1088/0953-2048/28/12/125005		10	Physics, Applied; Physics, Condensed Matter	Physics	CY3DI	WOS:000366288100014		
J	Koga, R; Oishi, T; Torikai, K				Koga, Rintaro; Oishi, Tohru; Torikai, Kohei			Tuned Classical Thermal Aromatization Furnishing an Estrogenic Benzoacridine	SYNLETT			English	Article						arenes; cyclization; heterocycles; medicinal chemistry; aminotriarylmethanol; 12-arylbenzoacridine; diversity-oriented doubling strategy; estrogenic activity	POSTMENOPAUSAL WOMEN; ARYL; HETEROCYCLES; CHEMISTRY; SERMS	The diversity-oriented doubling strategy, which generates two 12-arylbenzoacridines from a single triarylmethanol precursor was developed to construct a library of drug candidates for the identification of biologically active compounds. Exploration of this 12-arylbenzoacridine library furnished a 4-OH derivative as an estrogenic compound.	[Koga, Rintaro; Oishi, Tohru; Torikai, Kohei] Kyushu Univ, Fac & Grad Sch Sci, Dept Chem, Higashi Ku, Fukuoka 8128581, Japan	Torikai, K (reprint author), Kyushu Univ, Fac & Grad Sch Sci, Dept Chem, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	torikai@chem.kyushu-univ.jp			Fukuoka Foundation for Sound Health; MEXT	We thank Profs. Hiroshi Noguchi and Kaoru Umehara from the University of Shizuoka for invaluable discussions. This work was financially supported by a grant from the Fukuoka Foundation for Sound Health and the MEXT project of Integrated Research on Chemical Synthesis.	Ajani O. O., 2015, EUR J MED CHEM, V85, P688; Yi CY, 2008, J ORG CHEM, V73, P3596, DOI 10.1021/jo800260b; Humphrey GR, 2006, CHEM REV, V106, P2875, DOI 10.1021/cr0505270; Martins MAP, 2009, CHEM REV, V109, P4140, DOI 10.1021/cr9001098; [Anonymous], 1997, ENGL J MED; Kshirsagar UA, 2015, ORG BIOMOL CHEM, V13, P9336, DOI 10.1039/c5ob01379h; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; [Anonymous], 1992, ENGL J MED; Brase S, 2002, BIOORGAN MED CHEM, V10, P2415, DOI 10.1016/S0968-0896(02)00025-1; Komm BS, 2014, J STEROID BIOCHEM, V143, P207, DOI 10.1016/j.jsbmb.2014.03.003; Anderson KW, 2006, J AM CHEM SOC, V128, P10694, DOI 10.1021/ja0639719; Vorogushin AV, 2005, J AM CHEM SOC, V127, P8146, DOI 10.1021/ja050471r; Jiang B, 2011, ORG BIOMOL CHEM, V9, P3834, DOI 10.1039/c1ob05034f; VICTORY P, 1993, HETEROCYCLES, V36, P2273; Zeni G, 2006, CHEM REV, V106, P4644, DOI 10.1021/cr0683966; Alonso C, 2015, CHEM REV, V115, P1847, DOI 10.1021/cr500368h; Hu Y, 2014, CHEM REV, V114, P5572, DOI 10.1021/cr400131u; Kimura H, 2009, CHEM PHARM BULL, V57, P393; PETYUNIN PA, 1956, ZH OBSHCH KHIM+, V26, P159; Kaur K, 2014, EUR J MED CHEM, V77, P121, DOI 10.1016/j.ejmech.2014.02.063; Zhang J, 2014, TETRAHEDRON, V70, P5820, DOI 10.1016/j.tet.2014.06.031; Yuan KD, 2015, ACS CATAL, V5, P978, DOI 10.1021/cs501686d; Fujiwara Y., 2012, NATURE, V495, P95; Jiang B., 2011, EUR J ORG CHEM, V16, P3026; Johansen LM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005471; KONSHIN ME, 1973, KHIM GETEROTSIKL+, P1391; Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88; Petyunin P. A., 1956, ZH OBSHCH KHIM, V26, P163; Pinkerton JV, 2014, J STEROID BIOCHEM, V142, P142, DOI 10.1016/j.jsbmb.2013.12.011; Shiro Tomoya, 2015, Eur J Med Chem, V97, P397, DOI 10.1016/j.ejmech.2014.12.004; Victory P., 1993, HETEROCYCLES, V36, P796	31	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	DEC	2015	26	20					2801	2805		10.1055/s-0035-1560521		5	Chemistry, Organic	Chemistry	CY2BZ	WOS:000366215100010		
J	Kuninobu, Y; Sueki, S				Kuninobu, Yoichiro; Sueki, Shunsuke			C-H Bond Transformations Leading to the Synthesis of Organic Functional Materials	SYNTHESIS-STUTTGART			English	Review						catalyst; C-H activation; C-H functionalization; pi-conjugated molecule; pi-conjugation; functional material; oligomer; polymer	POLYCYCLIC AROMATIC-HYDROCARBONS; STEP-GROWTH COPOLYMERIZATION; CATALYZED DEHYDROGENATIVE CYCLIZATION; HEXA-PERI-HEXABENZOCORONENES; PI-CONJUGATED MATERIALS; DIRECT ARYLATION; PERYLENE BISIMIDES; INTERNAL ALKYNES; FACILE SYNTHESIS; STRAIGHTFORWARD ACCESS	In this review, transition-metal-catalyzed or -mediated C-H transformations leading to the synthesis of organic functional materials, such as oligomers, polymers, and -conjugated molecules, are summarized. 1 Introduction 2 Oligomers and Polymers 2.1 Synthesis of Oligomers and Polymers 2.2 Chemical Modification of Polymers 3 -Conjugated Molecules 3.1 Indenes and Fluorenes 3.2 Acenes 3.3 Triphenylenes 3.4 Chemical Modification of Perylene Diimides 3.5 Nanographenes 3.6 Condensed Polycyclic -Conjugated Molecules with Five-Membered Heteroaromatic Rings 3.7 -Conjugated Molecules with Nitrogen-Containing Six-Membered Heteroaromatics 3.8 Porphyrins 3.9 Miscellaneous (-Conjugated Molecules) 4 Miscellaneous (Excluding Polymers and -Conjugated Molecules) 5 Outlook and Conclusions	[Kuninobu, Yoichiro; Sueki, Shunsuke] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kuninobu, Yoichiro; Sueki, Shunsuke] Japan Sci & Technol Agcy JST, CREST, Bunkyo Ku, Tokyo 1130033, Japan	Kuninobu, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kuninobu@mol.f.u-tokyo.ac.jp			CREST from JST; Ministry of Education, Culture, Sports, Science, and Technology of Japan	We are grateful for financial support by CREST from JST and Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Anderson HL, 1999, CHEM COMMUN, P2323, DOI 10.1039/a904209a; Qin RP, 2009, J AM CHEM SOC, V131, P14612, DOI 10.1021/ja9057986; Ito S, 2014, CHEM LETT, V43, P1309, DOI 10.1246/c1.140330; Kawamata Y, 2011, ANGEW CHEM INT EDIT, V50, P8867, DOI 10.1002/anie.201102318; Jayakumar J, 2014, ANGEW CHEM INT EDIT, V53, P9889, DOI 10.1002/anie.201405183; Patureau FW, 2011, J AM CHEM SOC, V133, P2154, DOI 10.1021/ja110650m; Nakazono S, 2009, ORG LETT, V11, P5426, DOI 10.1021/ol902271b; Jo TS, 2009, J AM CHEM SOC, V131, P1656, DOI 10.1021/ja808374e; Zhang JX, 2013, J MATER CHEM C, V1, P5093, DOI 10.1039/c3tc30918e; Wencel-Delord J, 2013, NAT CHEM, V5, P369, DOI 10.1038/nchem.1607; Togashi K, 2012, J MATER CHEM, V22, P20689, DOI 10.1039/c2jm33669c; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Kawasumi K, 2013, NAT CHEM, V5, P739, DOI [10.1038/nchem.1704, 10.1038/NCHEM.1704]; Sueki S, 2013, ANGEW CHEM INT EDIT, V52, P11879, DOI 10.1002/anie.201306360; Zhang X, 2014, ORG LETT, V16, P4830, DOI 10.1021/ol502317c; Masuda N, 2009, ORG LETT, V11, P2297, DOI 10.1021/ol900622h; Kuninobu Y, 2013, ANGEW CHEM INT EDIT, V52, P1520, DOI 10.1002/anie.201207723; Ye Q, 2014, CHEM MATER, V26, P4046, DOI 10.1021/cm501536p; Lyall CL, 2014, CHEM COMMUN, V50, P13837, DOI 10.1039/c4cc06522k; Wakioka M, 2013, MACROMOLECULES, V46, P370, DOI 10.1021/ma302558z; Iitsuka T, 2014, CHEM-EUR J, V20, P385, DOI 10.1002/chem.201303847; Tolosa J, 2009, ANGEW CHEM INT EDIT, V48, P4610, DOI 10.1002/anie.200900980; Hiroto S, 2005, ANGEW CHEM INT EDIT, V44, P6763, DOI 10.1002/anie.200502335; Mochida K, 2011, J AM CHEM SOC, V133, P10716, DOI 10.1021/ja202975w; Saito K, 2015, CHEM-EUR J, V21, P8365, DOI 10.1002/chem.201501116; He CY, 2010, J AM CHEM SOC, V132, P12850, DOI 10.1021/ja106046p; Sevignon M, 1999, TETRAHEDRON LETT, V40, P5873, DOI 10.1016/S0040-4039(99)01164-8; Oechsle P, 2014, ORG LETT, V16, P4086, DOI 10.1021/ol501752f; Yamaguchi S, 2003, J AM CHEM SOC, V125, P13662, DOI 10.1021/ja038487+; Mori A, 2003, J AM CHEM SOC, V125, P1700, DOI 10.1021/ja0269189; Luo L, 2014, ORG LETT, V16, P6080, DOI 10.1021/ol502883x; Iwasaki M, 2013, ORG LETT, V15, P5326, DOI [10.1021/ol4025869, 10.1021/oI4025869]; Wencel-Delord J, 2011, CHEM SOC REV, V40, P4740, DOI 10.1039/c1cs15083a; Vasquez-Cespedes S, 2015, ANGEW CHEM INT EDIT, V54, P5772, DOI 10.1002/anie.201411997; Wu JS, 2015, CHEM SOC REV, V44, P1113, DOI 10.1039/c4cs00250d; Nakazono S, 2009, CHEM-EUR J, V15, P7530, DOI 10.1002/chem.200901318; Kawazoe K, 1999, PHYTOCHEMISTRY, V50, P493, DOI 10.1016/S0031-9422(98)00471-3; Kitazawa K, 2011, CHEM LETT, V40, P300, DOI 10.1246/cl.2011.300; Qi ZS, 2015, J ORG CHEM, V80, P3471, DOI 10.1021/acs.joc.5b00059; Mitschke U, 2000, J MATER CHEM, V10, P1471, DOI 10.1039/a908713c; Boaen NK, 2005, CHEM SOC REV, V34, P267, DOI 10.1039/b311405h; Shin J, 2007, MACROMOLECULES, V40, P8600, DOI 10.1021/ma701984q; Wakioka M, 2014, MACROMOLECULES, V47, P626, DOI 10.1021/ma4023668; Shintani R, 2012, J AM CHEM SOC, V134, P7305, DOI 10.1021/ja302278s; Beydoun K, 2012, CATAL SCI TECHNOL, V2, P1242, DOI 10.1039/c2cy00491g; Segawa Y, 2015, ANGEW CHEM INT EDIT, V54, P66, DOI 10.1002/anie.201403729; Teraoka T, 2011, ORG LETT, V13, P2532, DOI 10.1021/ol2004534; Okamoto K, 2013, MACROMOLECULES, V46, P8059, DOI 10.1021/ma401190r; Lu W, 2012, MACROMOLECULES, V45, P4128, DOI 10.1021/ma3004899; Thomas SW, 2007, CHEM REV, V107, P1339, DOI 10.1021/cr0501339; Weil T, 2010, ANGEW CHEM INT EDIT, V49, P9068, DOI 10.1002/anie.200902532; Ackermann L, 2011, CHEM REV, V111, P1315, DOI 10.1021/cr100412j; Kuninobu Y, 2013, ANGEW CHEM INT EDIT, V52, P4431, DOI 10.1002/anie.201210328; Cho SH, 2011, CHEM SOC REV, V40, P5068, DOI 10.1039/c1cs15082k; Kamiya H, 2011, ORG LETT, V13, P6394, DOI 10.1021/ol2026069; Morimoto K, 2012, ANGEW CHEM INT EDIT, V51, P5359, DOI 10.1002/anie.201201526; Kaneko H, 2011, J AM CHEM SOC, V133, P19626, DOI 10.1021/ja208293h; Scherf U, 1999, J MATER CHEM, V9, P1853, DOI 10.1039/a900447e; Watson MD, 2001, CHEM REV, V101, P1267, DOI 10.1021/cr990322p; Itoh M, 2013, J ORG CHEM, V78, P1365, DOI 10.1021/jo4000465; Kawano T, 2009, ORG LETT, V11, P3072, DOI 10.1021/ol9011212; Matsumura D, 2012, ORG LETT, V14, P3882, DOI 10.1021/ol301608m; Kitazawa K, 2009, ORG LETT, V11, P1951, DOI 10.1021/ol900393x; Holten D, 2002, ACCOUNTS CHEM RES, V35, P57, DOI 10.1021/ar970264z; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Scherf U, 2009, MACROMOL RAPID COMM, V30, P1059, DOI 10.1002/marc.200900088; Jones BA, 2004, ANGEW CHEM INT EDIT, V43, P6363, DOI 10.1002/anie.200461324; Chen RF, 2006, ORG LETT, V8, P203, DOI 10.1021/ol0524499; Ureshino T, 2010, J AM CHEM SOC, V132, P14324, DOI 10.1021/ja107698p; Unoh Y, 2013, ANGEW CHEM INT EDIT, V52, P12975, DOI 10.1002/anie.201307211; Grimsdale AC, 2009, CHEM REV, V109, P897, DOI 10.1021/cr000013v; Cho JY, 2002, SCIENCE, V295, P305, DOI 10.1126/science.1067074; Beydoun K, 2012, CHEM COMMUN, V48, P11951, DOI 10.1039/c2cc37046h; Ozawa R, 2011, CHEM LETT, V40, P941, DOI 10.1246/cl.2011.941; Hata H, 2005, J AM CHEM SOC, V127, P8264, DOI 10.1021/ja051073r; Pu KY, 2010, CHEM COMMUN, V46, P1470, DOI 10.1039/b915984c; Maekawa T, 2013, CHEM SCI, V4, P2369, DOI 10.1039/c3sc50585e; Umeda N, 2008, ANGEW CHEM INT EDIT, V47, P4019, DOI 10.1002/anie.200800924; Zhang QY, 2012, J AM CHEM SOC, V134, P15664, DOI 10.1021/ja306992k; Osaka I, 2008, ACCOUNTS CHEM RES, V41, P1202, DOI 10.1021/ar800130s; Martinez R, 2009, J AM CHEM SOC, V131, P7887, DOI 10.1021/ja9017489; LIN VSY, 1994, SCIENCE, V264, P1105, DOI 10.1126/science.8178169; Zhu C, 2012, CHEM-ASIAN J, V7, P1502, DOI 10.1002/asia.201200035; Wu B, 2014, ANGEW CHEM INT EDIT, V53, P7543, DOI 10.1002/anie.201404019; Usta H, 2011, ACCOUNTS CHEM RES, V44, P501, DOI 10.1021/ar200006r; GUO HJ, 1995, MACROMOLECULES, V28, P4714, DOI 10.1021/ma00117a051; Shi ZZ, 2009, ANGEW CHEM INT EDIT, V48, P7895, DOI 10.1002/anie.200903975; Yamaguchi R, 2013, CHEM-ASIAN J, V8, P178, DOI 10.1002/asia.201200723; Umeda N, 2011, J ORG CHEM, V76, P13, DOI 10.1021/jo1021184; Bon JL, 2014, J ORG CHEM, V79, P7766, DOI 10.1021/jo501416j; Okamoto K, 2013, POLYM CHEM-UK, V4, P3499, DOI 10.1039/c3py00412k; Wakaki T, 2015, ORG LETT, V17, P1758, DOI 10.1021/acs.orglett.5b00529; Verbelen B, 2012, CHEM COMMUN, V48, P9129, DOI 10.1039/c2cc34549h; Eliseeva MN, 2012, J AM CHEM SOC, V134, P15169, DOI 10.1021/ja307547j; Debreczeny MP, 1996, SCIENCE, V274, P584, DOI 10.1126/science.274.5287.584; Kimura M, 2008, ANGEW CHEM INT EDIT, V47, P9768, DOI 10.1002/anie.200804404; Wang QF, 2012, MACROMOL RAPID COMM, V33, P1203, DOI 10.1002/marc.201200076; Zhao DB, 2015, ANGEW CHEM INT EDIT, V54, P4508, DOI 10.1002/anie.201411994; Mochida K, 2009, J AM CHEM SOC, V131, P8350, DOI 10.1021/ja901622b; Wei Y, 2011, ORG LETT, V13, P5504, DOI 10.1021/ol202229w; Lee JJ, 2012, ANGEW CHEM INT EDIT, V51, P8490, DOI 10.1002/anie.201203284; Tamba S, 2011, CHEM LETT, V40, P398, DOI 10.1246/cl.2011.398; Bae C, 2005, J AM CHEM SOC, V127, P767, DOI 10.1021/ja044440s; Shimizu M, 2008, ANGEW CHEM INT EDIT, V47, P9760, DOI 10.1002/anie.200804146; Kuninobu Y, 2011, J ORG CHEM, V76, P7005, DOI 10.1021/jo200861s; Masui K, 2004, ORG LETT, V6, P2011, DOI 10.1021/ol049386z; Narita A, 2015, CHEM SOC REV, V44, P6616, DOI 10.1039/c5cs00183h; Lu P, 1996, MACROMOLECULES, V29, P8583, DOI 10.1021/ma9609691; Kawasumi K, 2013, TETRAHEDRON, V69, P4371, DOI 10.1016/j.tet.2013.01.037; Kuninobu Y, 2011, CHEM REV, V111, P1938, DOI 10.1021/cr100241u; Collins KD, 2015, CHEM SCI, V6, P1816, DOI 10.1039/c4sc03051f; Yue W, 2009, ORG LETT, V11, P5430, DOI 10.1021/ol9023198; Finke AD, 2008, ORG LETT, V10, P4851, DOI 10.1021/ol8019605; Kimoto T, 2009, ORG LETT, V11, P3658, DOI 10.1021/ol901420p; Gao M, 2013, POLYM CHEM-UK, V4, P2841, DOI 10.1039/c3py00045a; Engle KM, 2012, ACCOUNTS CHEM RES, V45, P788, DOI 10.1021/ar200185g; Kuninobu Y, 2006, J AM CHEM SOC, V128, P12376, DOI 10.1021/ja065643e; Sueki S, 2015, CHEM COMMUN, V51, P7685, DOI 10.1039/c5cc01569c; Yeh HC, 2008, MACROMOLECULES, V41, P3801, DOI 10.1021/ma800391e; Arockiam PB, 2012, CHEM REV, V112, P5879, DOI [10.1021/cr300153j, 10.1021/cr300153J]; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; Kondo Y, 2002, J AM CHEM SOC, V124, P1164, DOI 10.1021/ja016763j; Hata H, 2007, CHEM-ASIAN J, V2, P849, DOI 10.1002/asia.200700086; Kawasumi K, 2012, ORG LETT, V14, P418, DOI 10.1021/ol203235w; Funaki K, 2011, CHEM LETT, V40, P1050, DOI 10.1246/cl.2011.1050; Bae CS, 2005, ANGEW CHEM INT EDIT, V44, P6410, DOI 10.1002/anie.200501837; Battagliarin G, 2012, CHEMPHYSCHEM, V13, P923, DOI 10.1002/cphc.201100833; Huang YM, 2014, ANGEW CHEM INT EDIT, V53, P12158, DOI 10.1002/anie.201406445; Beydoun K, 2012, CHEM COMMUN, V48, P1260, DOI 10.1039/c2cc16327f; Zhao J, 2013, J AM CHEM SOC, V135, P10222, DOI 10.1021/ja403382d; Lee SK, 2009, J POLYM SCI POL CHEM, V47, P6873, DOI 10.1002/pola.23726; Takimiya K, 2011, ADV MATER, V23, P4347, DOI 10.1002/adma.201102007; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Lee PS, 2013, ANGEW CHEM INT EDIT, V52, P1240, DOI 10.1002/anie.201207958; Chang NH, 2013, CHEM LETT, V42, P1257, DOI 10.1246/cl.130584; Wu YT, 2008, CHEM-EUR J, V14, P6697, DOI 10.1002/chem.200800538; Mitamura Y, 2011, CHEM SCI, V2, P2017, DOI 10.1039/c1sc00372k; Chong H, 2015, ORG LETT, V17, P3198, DOI 10.1021/acs.orglett.5b00875; Lu W, 2011, MACROMOLECULES, V44, P1252, DOI 10.1021/ma1028517; Xiao Q, 2014, ANGEW CHEM INT EDIT, V53, P3168, DOI 10.1002/anie.201310293; Kim JH, 2015, ANGEW CHEM INT EDIT, V54, P10975, DOI 10.1002/anie.201504757; Gust D, 2001, ACCOUNTS CHEM RES, V34, P40, DOI 10.1021/ar9801301; Fukazawa A, 2009, CHEM-ASIAN J, V4, P1386, DOI 10.1002/asia.200900179; Kuninobu Y, 2010, ORG LETT, V12, P5287, DOI 10.1021/ol102349r; Baggett AW, 2015, J AM CHEM SOC, V137, P5536, DOI 10.1021/jacs.5b01916; Zhang JX, 2012, J MATER CHEM, V22, P21392, DOI 10.1039/c2jm35398a; Li BJ, 2012, CHEM SOC REV, V41, P5588, DOI 10.1039/c2cs35096c; Kuhl N, 2012, ANGEW CHEM INT EDIT, V51, P10236, DOI 10.1002/anie.201203269; DUBAC J, 1990, CHEM REV, V90, P215, DOI 10.1021/cr00099a008; Kuninobu Y, 2011, J ORG CHEM, V76, P7370, DOI 10.1021/jo201030j; WASIELEWSKI MR, 1992, CHEM REV, V92, P435, DOI 10.1021/cr00011a005; Vasu D, 2015, ANGEW CHEM INT EDIT, V54, P7162, DOI 10.1002/anie.201501992; Kang XW, 2014, CHEM MATER, V26, P4486, DOI 10.1021/cm5016355; Huang Q, 2014, CHEM COMMUN, V50, P13739, DOI 10.1039/c4cc06291d; Wang GH, 1996, J ORGANOMET CHEM, V521, P351, DOI 10.1016/0022-328X(96)06236-5; Zhang J, 2014, TETRAHEDRON, V70, P5820, DOI 10.1016/j.tet.2014.06.031; SHUMAN RF, 1977, J ORG CHEM, V42, P1914, DOI 10.1021/jo00431a019; Yamaguchi J, 2012, ANGEW CHEM INT EDIT, V51, P8960, DOI 10.1002/anie.201201666; Zhu MR, 2011, J PHYS CHEM C, V115, P17965, DOI 10.1021/jp203892q; Wu JS, 2007, CHEM REV, V107, P718, DOI 10.1021/cr068010r; Chen YR, 2013, J AM CHEM SOC, V135, P16754, DOI 10.1021/ja407373g; Ito S, 2015, ANGEW CHEM INT EDIT, V54, P7256, DOI 10.1002/anie.201502599; Yamaguchi R, 2012, ORG LETT, V14, P2472, DOI 10.1021/ol300743f; Droge T, 2011, CHEM-EUR J, V17, P11974, DOI 10.1002/chem.201101850; GUO HJ, 1995, MACROMOLECULES, V28, P5686, DOI 10.1021/ma00120a042; Anthony JE, 2008, ANGEW CHEM INT EDIT, V47, P452, DOI 10.1002/anie.200604045; Bao Z., 1990, MACROMOLECULES, V26, P5281; Blouin I., 2008, ACCOUNTS CHEM RES, V41, P1110; Chen C.-C., 2010, J POLYM SCI A, V48, P74; Coventry DN, 2005, CHEM COMMUN, P2172, DOI 10.1039/b501778e; Hunger K., 2012, ULLMANNS ENCY IND CH; Imuta J., 1994, EP, Patent No. 0653433; Kawai H, 2008, CHEM COMMUN, P1464, DOI 10.1039/b717251f; Liao YF, 2015, CHEM COMMUN, V51, P1031, DOI 10.1039/c4cc08370a; Liu T, 2014, CHEM COMMUN, V50, P13261, DOI 10.1039/c4cc05222f; Meng J., 2014, PHYS LETT B, V28; Morioka R, 2014, CHEM-EUR J, V20, P12720, DOI 10.1002/chem.201404656; Nagata T, 2014, J ORG CHEM, V79, P8960, DOI 10.1021/jo501835u; Ozaki K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7251; Pham MV, 2014, ANGEW CHEM INT EDIT, V53, P3484, DOI 10.1002/anie.201310723; Rouquet G, 2013, ANGEW CHEM INT EDIT, V52, P11726, DOI 10.1002/anie.201301451; Samarat A, 2011, SYNLETT, P2177, DOI 10.1055/s-0030-1261199; Shinokubo H, 2009, CHEM COMMUN, P1011, DOI 10.1039/b817941g; Shinokubo H, 2014, P JPN ACAD B-PHYS, V90, P1, DOI 10.2183/pjab.90.1; Song YT, 2014, ADV SYNTH CATAL, V356, P3761, DOI 10.1002/adsc.201400524; Tsarev A. A., 2014, Z RUSS CHEM B, V63, P684; Wang QF, 2010, J AM CHEM SOC, V132, P11420, DOI 10.1021/ja105767z; Yu JQ, 2010, TOP CURR CHEM, V292, P1, DOI 10.1007/978-3-642-12356-6	188	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	DEC	2015	47	24					3823	3845		10.1055/s-0035-1560346		23	Chemistry, Organic	Chemistry	CY2AB	WOS:000366209800002		
J	Kanase, Y; Kuniyoshi, M; Tabata, H; Takahashi, Y; Kayama, S; Wakamatsu, S; Oshitari, T; Natsugari, H; Takahashi, H				Kanase, Yuki; Kuniyoshi, Mai; Tabata, Hidetsugu; Takahashi, Yuka; Kayama, Susumu; Wakamatsu, Shintaro; Oshitari, Tetsuta; Natsugari, Hideaki; Takahashi, Hideyo			Freezing the Butterfly Motion of Carbamazepine Derivatives	SYNTHESIS-STUTTGART			English	Article						amides; atropisomerism; chirality; heterocycles; acylation	VASOPRESSIN RECEPTOR; CRYSTAL-STRUCTURE; ATROPISOMERISM; CONFORMATION; POLYMORPHS; NEVIRAPINE; LIGANDS	Atropisomeric properties were found in carbamazepine derivatives. The atropisomers of N-acyl and N-thiocarbamoyl derivatives of carbamazepine were isolated, with high stereochemical stability. It has been elucidated that the rotation about the N-C1 axis around the outer amide N-(C=O) does not coordinate with the rotation of the butterfly-like motion.	[Kanase, Yuki; Kuniyoshi, Mai; Tabata, Hidetsugu; Takahashi, Yuka; Kayama, Susumu; Wakamatsu, Shintaro; Oshitari, Tetsuta; Natsugari, Hideaki; Takahashi, Hideyo] Teikyo Univ, Fac Pharma Sci, Itabashi Ku, Tokyo 1738605, Japan	Takahashi, H (reprint author), Teikyo Univ, Fac Pharma Sci, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	hide-tak@pharm.teikyo-u.ac.jp			Japan Society for the Promotion of Science [24590020]; Astellas Foundation for Research on Metabolic Disorders; MEXT	This work was supported in part by a Grant-in-Aid for Scientific Research (C) (24590020) from the Japan Society for the Promotion of Science. H. Takahashi is grateful for financial support from the Astellas Foundation for Research on Metabolic Disorders (2013) and MEXT-Supported 53.6 Program for the Strategic Research Foundation at Private Universities (2013-2017).	Yoneda T, 2015, J MED CHEM, V58, P3268, DOI 10.1021/acs.jmedchem.5b00289; Boiadjiev SE, 2002, TETRAHEDRON, V58, P7411, DOI 10.1016/S0040-4020(02)00827-X; Wakamatsu S, 2013, CHEM-EUR J, V19, P7056, DOI 10.1002/chem.201300064; Grzesiak AL, 2003, J PHARM SCI-US, V92, P2260, DOI 10.1002/jps.10455; Petit M, 2005, J AM CHEM SOC, V127, P14994, DOI 10.1021/ja055666d; TRUMMLITZ G, 1984, ARZNEIMITTEL-FORSCH, V34-2, P849; Benes J, 1999, J MED CHEM, V42, P2582, DOI 10.1021/jm980627g; Takahashi H, 2011, ORG LETT, V13, P760, DOI 10.1021/ol103008d; Ravinder B, 2013, TETRAHEDRON LETT, V54, P2841, DOI 10.1016/j.tetlet.2013.03.089; Burke EWD, 2012, ORG BIOMOL CHEM, V10, P716, DOI 10.1039/c1ob06490h; Harris RK, 2005, ORG PROCESS RES DEV, V9, P902, DOI 10.1021/op0500990; EVELEIGH P, 1989, MOL PHARMACOL, V35, P477; Martinez R, 1996, J HETEROCYCLIC CHEM, V33, P715; Takahashi Y, 2015, SYNTHESIS-STUTTGART, V47, P2125, DOI 10.1055/s-0034-1380537; Tabata H, 2011, ANGEW CHEM INT EDIT, V50, P3075, DOI 10.1002/anie.201007772; Lang MD, 2002, J PHARM SCI, V91, P1186, DOI 10.1002/jps.10093; Tabata H, 2014, ORG LETT, V16, P1514, DOI 10.1021/ol500417t; MUI PW, 1992, J MED CHEM, V35, P201, DOI 10.1021/jm00079a029; Carril M., 2007, TETRAHEDRON, V63, P690, DOI DOI 10.1016/J.TET.2006.11.003; Loiseau Pierre, 1995, P555; LOWES MMJ, 1987, J PHARM SCI, V76, P744, DOI 10.1002/jps.2600760914; Tian MQ, 2014, BIOORGAN MED CHEM, V22, P1077, DOI 10.1016/j.bmc.2013.12.035	22	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	DEC	2015	47	24					3907	3913		10.1055/s-0035-1560201		7	Chemistry, Organic	Chemistry	CY2AB	WOS:000366209800010		
J	Nemoto, T; Tsuruda, K; Yoshida, M; Kono, M; Hamada, Y				Nemoto, Tetsuhiro; Tsuruda, Kazuki; Yoshida, Mariko; Kono, Masato; Hamada, Yasumasa			Diastereoselective Synthesis of Trisubstituted Cyclopropanes by Palladium-Catalyzed Intramolecular Allylic Alkylation of -Aryl Esters	SYNTHESIS-STUTTGART			English	Article						allylations; lactonizations; palladium; cyclopropanes; asymmetric catalysis	NMDA RECEPTOR ANTAGONISTS; ALPHA-AMINO-ACIDS; ENANTIOSELECTIVE SYNTHESIS; ASYMMETRIC CYCLOPROPANATION; 1,1-CYCLOPROPANE DIESTERS; ENOLATE EQUIVALENTS; ACYCLIC AMIDES; ALLYLATION; DERIVATIVES; CARBONATES	We have developed a novel method for synthesizing trisubstituted cyclopropane derivatives by a palladium-catalyzed intramolecular allylic alkylation of -aryl esters. By using -aryl -(methoxycarbonyl) -vinyl -lactones as substrates, decarboxylative formation of -allylpalladium(II) intermediates followed by an intramolecular allylic alkylation of the ester enolates proceeded in the presence of 5 mol% of a palladium catalyst, producing 1-aryl-1-(methoxycarbonyl)-2-vinylcyclopropanes in good to excellent yields and high diastereoselectivities. The relative configuration of the major isomer was determined by transforming the product into a known intermediate of milnacipran synthesis. When we extended our method to asymmetric catalysis, we obtained methyl (1S,2S)-1-phenyl-2-vinylcyclopropanecarboxylate in up to 55% ee by using (S)-[2-(diphenylmethoxy)-1,1-binaphthalen-2-yl](diphenyl)phosphine as a chiral monodentate phosphorus ligand.	[Nemoto, Tetsuhiro; Tsuruda, Kazuki; Yoshida, Mariko; Kono, Masato; Hamada, Yasumasa] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan	Nemoto, T (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.	tnemoto@faculty.chiba-u.jp			JSPS KAKENHI [15K07850]; Chiba University	This work was supported by JSPS KAKENHI (Grant Number 15K07850) and by Chiba University.	Kinouchi W, 2015, TETRAHEDRON LETT, V56, P2265, DOI 10.1016/j.tetlet.2015.03.063; Moreau B, 2005, J AM CHEM SOC, V127, P18014, DOI 10.1021/ja056192l; Chen WY, 2012, J AM CHEM SOC, V134, P15249, DOI 10.1021/ja306850b; Xie XG, 2005, ORG LETT, V7, P4057, DOI 10.1021/ol051653t; Meletis P, 2011, CHEM-EUR J, V17, P11243, DOI 10.1002/chem.201101406; Lu Z, 2008, ANGEW CHEM INT EDIT, V47, P258, DOI 10.1002/anie.200605113; Yan XX, 2005, ANGEW CHEM INT EDIT, V44, P6544, DOI 10.1002/anie.200502020; Trost BM, 2010, J AM CHEM SOC, V132, P8915, DOI 10.1021/ja103771w; Trost BM, 2005, CHEM-EUR J, V11, P174, DOI 10.1002/chem.200400666; Zhang K, 2008, ANGEW CHEM INT EDIT, V47, P1741, DOI 10.1002/anie.200704629; Behenna DC, 2011, CHEM-EUR J, V17, P14199, DOI 10.1002/chem.201003383; Yoshida M, 2009, ORG LETT, V11, P4752, DOI 10.1021/ol901964z; Zhao LG, 2005, J ORG CHEM, V70, P4059, DOI 10.1021/jo050121n; [Anonymous], 2011, J ORG CHEM; Trost BM, 2005, J AM CHEM SOC, V127, P2846, DOI 10.1021/ja043472c; Doyle MP, 2001, ADV SYNTH CATAL, V343, P299, DOI 10.1002/1615-4169(20010330)343:3<299::AID-ADSC299>3.3.CO;2-P; SHIMIZU I, 1980, TETRAHEDRON LETT, V21, P3199, DOI 10.1016/S0040-4039(00)77444-2; Trost BM, 1999, J AM CHEM SOC, V121, P6759, DOI 10.1021/ja991135b; BURGESS K, 1985, TETRAHEDRON LETT, V26, P3049, DOI 10.1016/S0040-4039(00)98615-5; Goudreau SR, 2010, ANGEW CHEM INT EDIT, V49, P486, DOI 10.1002/anie.200905109; Yoshida M, 2013, TETRAHEDRON, V69, P9609, DOI 10.1016/j.tet.2013.09.042; Pellissier H, 2008, TETRAHEDRON, V64, P7041, DOI 10.1016/j.tet.2008.04.079; Shuto S, 1996, TETRAHEDRON LETT, V37, P641, DOI 10.1016/0040-4039(95)02221-X; UOZUMI Y, 1993, J ORG CHEM, V58, P1945, DOI 10.1021/jo00059a059; Trost BM, 2009, J AM CHEM SOC, V131, P18343, DOI 10.1021/ja9053948; Shuto S, 1996, J ORG CHEM, V61, P915, DOI 10.1021/jo9518056; Deng C, 2012, ANGEW CHEM INT EDIT, V51, P11620, DOI 10.1002/anie.201206376; Yamanoi T, 1998, J CARBOHYD CHEM, V17, P819, DOI 10.1080/07328309808002354; TSUDA T, 1980, J AM CHEM SOC, V102, P6381, DOI 10.1021/ja00540a053; Behenna DC, 2004, J AM CHEM SOC, V126, P15044, DOI 10.1021/ja044812x; Braun M, 2000, ANGEW CHEM INT EDIT, V39, P3494, DOI 10.1002/1521-3773(20001002)39:19<3494::AID-ANIE3494>3.0.CO;2-4; Yip SF, 2007, ORG LETT, V9, P3469, DOI 10.1021/ol701473p; Kazuta Y, 2002, BIOORGAN MED CHEM, V10, P1777, DOI 10.1016/S0968-0896(02)00030-5; Hoshiya N, 2013, ORG LETT, V15, P6202, DOI 10.1021/ol4030452; Wang YH, 2010, CHEM COMMUN, V46, P577, DOI 10.1039/b913348h; Trost BM, 2012, ANGEW CHEM INT EDIT, V51, P204, DOI 10.1002/anie.201105801; Makosza M, 2015, J ORG CHEM, V80, P5436, DOI 10.1021/acs.joc.5b00204; Goudreau SR, 2009, J ORG CHEM, V74, P470, DOI 10.1021/jo802208q; Lindsay VNG, 2009, J AM CHEM SOC, V131, P16383, DOI 10.1021/ja9044955; Lebel H, 2003, CHEM REV, V103, P977, DOI 10.1021/cr010007e; Shintani R, 2007, J AM CHEM SOC, V129, P14866, DOI 10.1021/ja077236o; Trost BM, 1997, ANGEW CHEM INT EDIT, V36, P2635, DOI 10.1002/anie.199726351; TSUJI J, 1983, TETRAHEDRON LETT, V24, P1793, DOI 10.1016/S0040-4039(00)81772-4; Doyle MP, 2000, ORG LETT, V2, P1145, DOI 10.1021/ol005730q; Alliot J, 2012, CHEM COMMUN, V48, P8111, DOI 10.1039/c2cc33743f; HAYASHI T, 1988, TETRAHEDRON LETT, V29, P669, DOI 10.1016/S0040-4039(00)80179-3; Chen LR, 2015, ANGEW CHEM INT EDIT, V54, P11084, DOI 10.1002/anie.201504236; Okamoto N, 2006, ORG LETT, V8, P1889, DOI 10.1021/ol060469k; Graening T, 2005, J AM CHEM SOC, V127, P17192, DOI 10.1021/ja0566275; Trost BM, 2003, CHEM REV, V103, P2921, DOI 10.1021/cr020027w; Xu X, 2013, ANGEW CHEM INT EDIT, V52, P11857, DOI 10.1002/anie.201305883; You SL, 2001, ORG LETT, V3, P149, DOI 10.1021/ol0067033; Liu W, 2009, J AM CHEM SOC, V131, P8734, DOI 10.1021/ja902410w; Alford JS, 2012, ORG LETT, V14, P6020, DOI 10.1021/ol3029127; Kazmaier U, 1999, ANGEW CHEM INT EDIT, V38, P1468, DOI 10.1002/(SICI)1521-3773(19990517)38:10<1468::AID-ANIE1468>3.0.CO;2-O; Braun M, 2005, SYNLETT, P2968, DOI 10.1055/s-2005-921908; Franzone G, 1996, SYNLETT, P1067; Gnamm C, 2007, SYNLETT, P790, DOI 10.1055/s-2007-970754; Hayashi T, 2000, ACCOUNTS CHEM RES, V33, P354, DOI 10.1021/ar990080f; Kaneyama T., 2003, ANGEW CHEM INT EDIT, V42, P2054	60	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	DEC	2015	47	24					3914	3924		10.1055/s-0035-1560658		11	Chemistry, Organic	Chemistry	CY2AB	WOS:000366209800011		
J	Garud, DR; Rode, ND; Bathe, SR; Ranpise, VS; Joshi, RA; Joshi, RR; Koketsu, M				Garud, Dinesh R.; Rode, Navnath D.; Bathe, Sagar R.; Ranpise, Vinod S.; Joshi, Ramesh A.; Joshi, Rohini R.; Koketsu, Mamoru			Synthesis of 3-Thia-1-dethiacephems via Regioselective Iodocyclization Reaction	SYNTHESIS-STUTTGART			English	Article						-lactams; iodocyclization; thiourea; 3-thia-1-dethiacephems; regioselective	BICYCLIC BETA-LACTAMS; ESCHENMOSER SULFIDE CONTRACTION; SUBSTITUTED ACETYL CHLORIDES; CYCLOADDITION REACTIONS; MEDIATED CYCLIZATION; HETEROCYCLES; DERIVATIVES; HETEROATOM; 1,3-BENZOTHIAZINES; ANTIBIOTICS	The key N-homopropargylthiourea intermediates, N-substituted 2-oxo-4-propargylazetidine-1-carbothioamides, were prepared by the reaction of a 4-propargylazetidin-2-one with isothiocyanates. Bicyclic -lactams, i.e. 3-thia-1-dethiacephems, were prepared via highly regioselective iodocyclization reaction of N-substituted 2-oxo-4-propargylazetidine-1-carbothioamides with molecular iodine at room temperature in moderate to excellent yields. A variety of functional groups were well tolerated under the reaction conditions.	[Garud, Dinesh R.; Bathe, Sagar R.; Ranpise, Vinod S.] Sir Parashurambhau Coll, Dept Chem, Pune 411030, Maharashtra, India; [Rode, Navnath D.; Joshi, Ramesh A.; Joshi, Rohini R.] Natl Chem Lab, Div Organ Chem, Pune 411008, Maharashtra, India; [Koketsu, Mamoru] Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, Gifu 5011193, Japan	Garud, DR (reprint author), Sir Parashurambhau Coll, Dept Chem, Tilak Rd, Pune 411030, Maharashtra, India.	ddgarud@gmail.com			University Grant Commission, India [47-1964/11(WRO)]	The author D.R.G. is grateful to the University Grant Commission, India (File No. 47-1964/11(WRO)) for financial support of this work.	Anada M, 1998, CHEM COMMUN, P1517, DOI 10.1039/a803176b; Shen ZL, 2013, CHEM REV, V113, P271, DOI 10.1021/cr300051y; SAKURAI O, 1994, TETRAHEDRON LETT, V35, P2187, DOI 10.1016/S0040-4039(00)76792-X; Fodor L, 2010, J MOL STRUCT, V983, P54, DOI 10.1016/j.molstruc.2010.08.030; HAKIMELAHI GH, 1982, TETRAHEDRON LETT, V23, P913, DOI 10.1016/S0040-4039(00)86981-6; Palisse A, 2012, ORG BIOMOL CHEM, V10, P8041, DOI 10.1039/c2ob26508g; SOHAR P, 1984, TETRAHEDRON, V40, P4387, DOI 10.1016/S0040-4020(01)98814-3; Fodor L, 2010, TETRAHEDRON LETT, V51, P3205, DOI 10.1016/j.tetlet.2010.04.051; Lee PH, 2005, ANGEW CHEM INT EDIT, V44, P1840, DOI 10.1002/anie.200462512; Mphahlele MJ, 2009, MOLECULES, V14, P4814, DOI 10.3390/molecules14124814; von Nussbaum F, 2006, ANGEW CHEM INT EDIT, V45, P5072, DOI 10.1002/anie.200600350; REN XF, 1995, J ORG CHEM, V60, P6468, DOI 10.1021/jo00125a038; Sakurai O, 1996, J ORG CHEM, V61, P7889, DOI 10.1021/jo960764q; Garud DR, 2014, TETRAHEDRON LETT, V55, P5998, DOI 10.1016/j.tetlet.2014.09.004; Hwu JR, 1998, J MED CHEM, V41, P4681, DOI 10.1021/jm980476h; Garud DR, 2008, ORG LETT, V10, P3319, DOI 10.1021/ol801010y; Ren XF, 1998, J ORG CHEM, V63, P8898, DOI 10.1021/jo9811219; FODOR L, 1981, TETRAHEDRON, V37, P963, DOI 10.1016/S0040-4020(01)97668-9; Zambron B, 2010, TETRAHEDRON, V66, P8974, DOI 10.1016/j.tet.2010.09.024; da Silva FM, 2005, CURR ORG SYNTH, V2, P393, DOI 10.2174/1570179054368491; BOSE AK, 1969, TETRAHEDRON, V25, P1191, DOI 10.1016/S0040-4020(01)82692-2; Godoi B, 2011, CHEM REV, V111, P2937, DOI 10.1021/cr100214d; GLEASON JG, 1980, TETRAHEDRON LETT, V21, P3947, DOI 10.1016/S0040-4039(00)92840-5; MUKERJEE AK, 1991, CHEM REV, V91, P1, DOI 10.1021/cr00001a001; Garud DR, 2010, HETEROCYCLES, V81, P2439, DOI 10.3987/REV-10-678; Alcaide B, 2004, CURR MED CHEM, V11, P1921; Brabandt W. V., 2006, J ORG CHEM, V71, P7083; Frederickson M, 1997, ORG PREP PROCED INT, V29, P33; Kang H. C., 1984, J AM CHEM SOC, V106, P2680; Mori M., 1986, J CHEM SOC CHEM COMM, P1376; Morin R. B., 1982, CHEM BIOL BETA LACTA; Southgate R., 1993, RECENT PROGR CHEM SY, V2, P621; Southgate R., 1994, CONTEMP ORG SYNTH, V1, P417, DOI 10.1039/co9940100417	33	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	DEC	2015	47	24					3956	3962		10.1055/s-0035-1560350		7	Chemistry, Organic	Chemistry	CY2AB	WOS:000366209800015		
J	Iwanaga, T; Yamamoto, Y; Nishioka, K; Toyota, S				Iwanaga, Tetsuo; Yamamoto, Yuta; Nishioka, Keita; Toyota, Shinji			Efficient Synthesis and Electronic Spectra of Unsymmetrical 5,12-Diethynyltetracene Derivatives	SYNTHESIS-STUTTGART			English	Article						tetracene; ethynyllithium; one-pot process; Sonogashira coupling; electronic spectrum	FLUORESCENT MATERIALS; COLOR CONTROL; PEROXYOXALATE CHEMILUMINESCENCE; PHOTOPHYSICAL PROPERTIES; ORGANIC ELECTRONICS; 9,10-BIS(PHENYLETHYNYL)ANTHRACENE; ANTHRACENE; PENTACENE; ACENES; INTEGRATION	Unsymmetrical 5,12-diethynyltetracene derivatives were synthesized from tetracenequinone by the addition of two types of ethynyllithium reagents, followed by reductive aromatization with SnCl2. These three-step reactions could be integrated into a one-pot process to give unsymmetrically substituted 5,12-diethynyltetracene derivatives in moderate yields. Some unsymmetrical 5,12-bis(phenylethynyl)tetracene derivatives were synthesized from 5-ethynyl-12-phenylethynyltetracene and iodobenzenes by Sonogashira coupling. This integrated process was applied to the synthesis of a -extended tetracene dimer. The photophysical properties of these compounds were examined by UV/Vis and fluorescence spectroscopy.	[Iwanaga, Tetsuo; Yamamoto, Yuta; Nishioka, Keita; Toyota, Shinji] Okayama Univ Sci, Fac Sci, Dept Chem, Kita Ku, Okayama 7000005, Japan	Iwanaga, T (reprint author), Okayama Univ Sci, Fac Sci, Dept Chem, Kita Ku, 1-1 Ridaicho, Okayama 7000005, Japan.	iwanaga@chem.ous.ac.jp; stoyota@cms.titech.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [22106543, 24106743]; MEXT	This work was partly supported by Grants-in-Aid for Scientific Research on Innovative Areas (Integrated Organic Synthesis) Nos. 22106543 and 24106743 from The Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) and by MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2009-2013.	AKIYAMA S, 1991, J CHEM SOC CHEM COMM, P948, DOI 10.1039/c39910000948; Landis CA, 2005, JPN J APPL PHYS 1, V44, P3921, DOI 10.1143/JJAP.44.3921; Toyota S, 2015, B CHEM SOC JPN, V88, P192, DOI 10.1246/bcsj.20140279; Taylor MS, 2007, ORG LETT, V9, P3695, DOI 10.1021/ol701642j; Toyota S, 2014, SYNTHESIS-STUTTGART, V46, P1667, DOI 10.1055/s-0033-1338608; Marrocchi A, 2010, J PHOTOCH PHOTOBIO A, V211, P162, DOI 10.1016/j.jphotochem.2010.03.002; Fudickar W, 2012, J AM CHEM SOC, V134, P15071, DOI 10.1021/ja306056x; Gimenez R, 2004, CHEM MATER, V16, P1377, DOI 10.1021/cm030582u; SWAGER TM, 1995, J PHYS CHEM-US, V99, P4886, DOI 10.1021/j100014a003; Lehnherr D, 2011, AUST J CHEM, V64, P919, DOI 10.1071/CH11169; Griffith OL, 2008, J PHYS CHEM C, V112, P20518, DOI 10.1021/jp8070629; Bendikov M, 2004, CHEM REV, V104, P4891, DOI 10.1021/cr030666m; HANHELA PJ, 1984, AUST J CHEM, V37, P553; LUKACS J, 1992, J PHOTOCH PHOTOBIO A, V63, P59, DOI 10.1016/1010-6030(92)85152-K; Toyota S, 2013, SYNTHESIS-STUTTGART, V45, P1060, DOI 10.1055/s-0032-1316867; Seri M, 2011, ADV MATER, V23, P3827, DOI 10.1002/adma.201101700; Lehnherr D, 2008, ORG LETT, V10, P4779, DOI 10.1021/ol801886h; Lehnherr D, 2010, ANGEW CHEM INT EDIT, V49, P6190, DOI 10.1002/anie.201000555; HANHELA PJ, 1981, AUST J CHEM, V34, P1669; Suga S, 2010, CHEM LETT, V39, P404, DOI 10.1246/cl.2010.404; Lydon DP, 2005, NEW J CHEM, V29, P972, DOI 10.1039/b502950c; Lehnherr D, 2009, CHEM-EUR J, V15, P12580, DOI 10.1002/chem.200902179; Xu ZG, 2011, CHEM PHYS LETT, V518, P65, DOI 10.1016/j.cplett.2011.11.007; HANHELA PJ, 1981, AUST J CHEM, V34, P1701; Odom SA, 2003, ORG LETT, V5, P4245, DOI 10.1021/OL035415E; MAULDING DR, 1969, J ORG CHEM, V34, P1734, DOI 10.1021/jo01258a045; Lehnherr D, 2008, ORG LETT, V10, P4163, DOI [10.1021/ol801464k, 10.1021/o1801464k]; Anthony JE, 2006, CHEM REV, V106, P5028, DOI 10.1021/cr050966z; Zhang JJ, 2012, J MATER CHEM, V22, P6182, DOI 10.1039/c2jm16173g; Anthony JE, 2008, ANGEW CHEM INT EDIT, V47, P452, DOI 10.1002/anie.200604045; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE; Levitus M, 2000, J PHYS CHEM A, V104, P8632, DOI 10.1021/jp001483w; Malakhov AD, 2004, EUR J ORG CHEM, P1298, DOI 10.1002/ejoc.200300677; Marrocchi A, 2009, CHEM COMMUN, P1380, DOI 10.1039/b820829h; Nakatsuiji S., 1992, J CHEM SOC P1, P755; Toyota S, 2015, J SYN ORG CHEM JPN, V73, P328; Yoshida J, 2011, SYNLETT, P1189, DOI 10.1055/s-0030-1259946	37	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	DEC	2015	47	24					3997	4007		10.1055/s-0035-1560474		11	Chemistry, Organic	Chemistry	CY2AB	WOS:000366209800020		
J	Kawano, Y; Ohtsuka, T				Kawano, Yu; Ohtsuka, Toshiyuki			Stability criteria with nonlinear eigenvalues for diagonalizable nonlinear systems	SYSTEMS & CONTROL LETTERS			English	Article						Nonlinear systems; Nonlinear eigenvalues; Diagonal form; Stability	GLOBAL STABILITY	Stability of the linear system, especially the diagonalizable system, can be verified by computing the signs of the real parts of its eigenvalues. In this paper, we generalize this result to the diagonalizable nonlinear system in terms of nonlinear eigenvalues. According to the main results, the unique equilibrium point of the diagonalizable system is globally asymptotically stable if a specific set of nonlinear eigenvalues is not positive at each point in the state space. (C) 2015 Elsevier B.V. All rights reserved.	[Kawano, Yu; Ohtsuka, Toshiyuki] Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Kyoto 6068501, Japan	Kawano, Y (reprint author), Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Kyoto 6068501, Japan.	ykawano@i.kyoto-u.ac.jp; ohtsuka@i.kyoto-u.ac.jp			JSPS KAKENHI [15K18087, 15H02257]; JST CREST	This work was partly supported by JSPS KAKENHI Grant Numbers 15K18087 and 15H02257 and JST CREST. We thank Prof. Miroslav Halas from Slovak University of Technology for fruitful discussions about nonlinear eigenvalues. We thank the reviewers for their valuable comments and suggestions that helped us to improve the paper.	Fernandes A, 2004, J DIFFER EQUATIONS, V206, P470, DOI 10.1016/j.jde.2004.04.015; Mukherji A, 2007, J ECON THEORY, V134, P583, DOI 10.1016/j.jet.2006.03.013; Monzon P, 2003, IEEE T AUTOMAT CONTR, V48, P631, DOI 10.1109/TAC.2003.809786; Aranda-Bricaire E, 2004, SYST CONTROL LETT, V52, P113, DOI 10.1016/j.sysconle.2003.11.005; Rantzer A, 2001, SYST CONTROL LETT, V42, P161, DOI 10.1016/S0167-6911(00)00087-6; Conway J., 1973, FUNCTIONS ONE COMPLE, VI; Flanders H., 1963, DIFFERENTIAL FORMS A; Haddad WM, 2008, NONLINEAR DYNAMICAL; Halas M., 2013, P 9 IFAC S NONL CONT, P600; Hartman P., 1962, T AM MATH SOC, V104, P154, DOI 10.2307/1993939; Kawano Y., 2013, P 9 IFAC S NONL CONT, P606; Khalil HK., 1996, NONLINEAR SYSTEMS; Lam T., 2008, P CONT MATH, P73; Leroy A, 1995, B BELG MATH SOC, V2, P321; Markus L., 1960, OSAKA MATH J, V12, P305; Menini L, 2011, SYMMETRIES AND SEMI-INVARIANTS IN THE ANALYSIS OF NONLINEAR SYSTEMS, P1, DOI 10.1007/978-0-85729-612-2_1; Rudin W., 1987, REAL COMPLEX ANAL; Sabatini M., 1990, REND SEM MAT U POL T, V48, P97	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6911	1872-7956		SYST CONTROL LETT	Syst. Control Lett.	DEC	2015	86						41	47		10.1016/j.sysconle.2015.10.001		7	Automation & Control Systems; Operations Research & Management Science	Automation & Control Systems; Operations Research & Management Science	CY3XB	WOS:000366342100006		
J	Abe, K				Abe, Kiyoshi			Ulrich Beck and Japan	THEORY CULTURE & SOCIETY			English	Article						atomic energy plants; disasters in Fukushima; Japan		Looking back, the process in which Ulrich Beck's epoch-making work of Risikogesellschaft was introduced and translated into Japanese attracted great public interest there. This paper revisits the significance of the concept risk society' in the context of postwar Japan. Facing both the natural and artificial disasters caused by the huge earthquake in Fukushima in 2011, Japanese society was compelled to reconsider its atomic energy policy implemented after the end of the Second World War. While the general public has strongly embraced an anti-nuclear sentiment after witnessing the 3/11 disasters, the government and leading LDP are still eager to restart the atomic plants that have been suspended since the tragedy in Fukushima. Considering those complicated sociopolitical conditions concerning the legitimacy of the atomic energy policy in Japan, Risikogesellschaft redux might be a useful way through which we can envisage a future direction to take.	[Abe, Kiyoshi] Kwansei Gakuin Univ, Grad Sch Sociol, Nishinomiya, Hyogo, Japan	Abe, K (reprint author), Kwansei Gakuin Univ, Grad Sch Sociol, Nishinomiya, Hyogo, Japan.	k-abe@kwansei.ac.jp						0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0263-2764	1460-3616		THEOR CULT SOC	Theory Cult. Soc.	DEC	2015	32	7-8					339	342		10.1177/0263276415615945		4	Cultural Studies	Cultural Studies	CX9AZ	WOS:000365998400025		
J	Terasako, T; Nomoto, J; Makino, H; Yamamoto, N; Shitakata, S; Yamamoto, T				Terasako, Tomoaki; Nomoto, Junichi; Makino, Hisao; Yamamoto, Naoki; Shitakata, Sho; Yamamoto, Tetsuya			Effects of oxygen gas flow rates and Ga contents on structural properties of Ga-doped ZnO films prepared by ion-plating with a DC arc discharge	THIN SOLID FILMS			English	Article						Ga doped ZnO; Ion-plating; X-ray diffraction; Stress	OXIDE THIN-FILMS; PULSED-LASER DEPOSITION; ZINC-OXIDE; ELECTRICAL-PROPERTIES; OPTICAL-PROPERTIES; INTERNAL-STRESS; PRESSURE; PHOTOLUMINESCENCE; PLASMA; GROWTH	Structural properties of highly c-axis oriented polycrystalline Ga-doped ZnO (GZO) films prepared by ion plating with a DC arc discharge were studied in terms of the oxygen gas flow rate (F-O2) introduced into the chamber during the deposition process and the Ga2O3 content in the GZO sintered pellet The X-ray diffraction (XRD) measurements revealed that the GZO films have the residual compressive stress along the a-axis direction (in plane) and he tensile stress along the c-axis direction (out-of-plane). The increase in F-O2, or the increase in Ga2O3 content was effective for relaxing the in plane compressive stress induced by the so-called atomic peening effect. The positive correlation between the carrier concentration (n) and the primitive cell volume (V) would be clue to the incorporation of Ga atoms substituting Zn sites (Ga(Zn)s) together with the generation of n-type intrinsic defects or complex defects. (C) 2015 Elsevier B.V. All rights reserved	[Terasako, Tomoaki; Shitakata, Sho] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Nomoto, Junichi; Makino, Hisao; Yamamoto, Naoki; Yamamoto, Tetsuya] Kochi Univ Technol, Res Inst, Kami, Kochi 7828502, Japan	Terasako, T (reprint author), Ehime Univ, Grad Sch Sci & Engn, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	terasako.tomoaki.mz@ehime-u.ac.jp					JOU JH, 1992, J APPL PHYS, V71, P4333, DOI 10.1063/1.350815; Lee HW, 2004, THIN SOLID FILMS, V458, P15, DOI 10.1016/j.tsf.2003.11.167; Shirakata S, 2003, THIN SOLID FILMS, V445, P278, DOI 10.1016/S0040-6090(03)01161-1; Cheong KY, 2002, THIN SOLID FILMS, V410, P142, DOI 10.1016/S0040-6090(02)00286-9; MANIV S, 1982, J VAC SCI TECHNOL, V20, P162, DOI 10.1116/1.571350; Ri KH, 2011, APPL SURF SCI, V258, P1283, DOI 10.1016/j.apsusc.2011.07.022; Iwata K, 2005, APPL SURF SCI, V244, P504, DOI 10.1016/j.apsusc.2004.10.109; Lai KC, 2011, SOL ENERG MAT SOL C, V95, P415, DOI 10.1016/j.solmat.2010.10.010; Minami T, 2000, MRS BULL, V25, P38, DOI 10.1557/mrs2000.149; Yamamoto N, 2012, THIN SOLID FILMS, V520, P4131, DOI 10.1016/j.tsf.2011.04.067; Hong RJ, 2005, THIN SOLID FILMS, V473, P58, DOI 10.1016/j.tsf.2004.06.159; Terasako T, 2013, THIN SOLID FILMS, V549, P12, DOI 10.1016/j.tsf.2013.06.039; Gomez H, 2005, SOL ENERG MAT SOL C, V87, P107, DOI 10.1016/j.solmat.2004.07.016; Ma QB, 2007, J CRYST GROWTH, V304, P64, DOI 10.1016/j.jcrysgro.2007.01.037; Kato H, 2002, J CRYST GROWTH, V237, P538, DOI 10.1016/S0022-0248(01)01972-8; Yamamoto T, 2008, J SOC INF DISPLAY, V16, P713, DOI 10.1889/1.2953477; Yu XH, 2005, J CRYST GROWTH, V274, P474, DOI 10.1016/j.jcrysgro.2004.10.037; Terasako T, 2013, THIN SOLID FILMS, V528, P19, DOI 10.1016/j.tsf.2012.07.140; Liu ZF, 2004, J ELECTROCERAM, V13, P183, DOI 10.1007/s10832-004-5096-9; Reddy KTR, 2000, J CRYST GROWTH, V210, P516; Sasabayashi T, 2003, THIN SOLID FILMS, V445, P219, DOI 10.1016/j.tsf.2003.08.047; THORNTON JA, 1989, THIN SOLID FILMS, V171, P5, DOI 10.1016/0040-6090(89)90030-8; Cebulla R, 1998, J APPL PHYS, V83, P1087, DOI 10.1063/1.366798; Hinze J, 2000, J APPL PHYS, V88, P2443, DOI 10.1063/1.1288162; Tao YM, 2011, VACUUM, V85, P744, DOI 10.1016/j.vacuum.2010.11.009; Lorenz M, 2003, SOLID STATE ELECTRON, V47, P2205, DOI 10.1016/S0038-1101(03)00198-9; Kashiwaba Y, 2002, THIN SOLID FILMS, V411, P87, DOI 10.1016/S0040-6090(02)00193-1; Kladko V, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-289; Liang C.-H., 2013, APPL SURF SCI, V265, P621; Lu JG, 2006, J APPL PHYS, V100, DOI 10.1063/1.2357638; Mattox D. M., 1982, DEPOSITION TECHNOLOG, P69; Minami T., 1985, JPN J APPL PHYS, V24, P781; Nomoto J, 2015, J APPL PHYS, V117, DOI 10.1063/1.4906353; VANDERDR.A, 1967, PHILIPS RES REP, V22, P267; Yamada T, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2767213; Shirakata S, 2006, SUPERLATTICE MICROST, V39, P218, DOI 10.1016/j.spmi.2005.08.045; Yamamoto T., 2004, Thin Solid Films, V451-452, DOI 10.1016/j.tsf.2003.10.138	37	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	DEC 1	2015	596						24	28		10.1016/j.tsf.2015.08.056		5	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CY1YQ	WOS:000366204900005		
J	Show, Y; Hirai, A; Almowarai, A; Ueno, Y				Show, Yoshiyuki; Hirai, Akira; Almowarai, Anas; Ueno, Yoram			Platinum catalyst formed on carbon nanotube by the in-liquid plasma method for fuel cell	THIN SOLID FILMS			English	Article						Carbon nanotube; In-liquid plasma; Platinum catalyst; Fuel cell		In-liquid plasma was generated in the carbon nanotube (CNT) dispersion fluid using platinum electrodes. The generated plasma spattered the surface of the platinum electrodes and dispersed platinum particles into the CNT dispersion. Therefore, the platinum nanoparticles were successfully formed on the CNT surface in the dispersion. The platinum nanoparticles were applied to the proton exchange membrane fuel cell (PEMFC) as a catalyst. The electrical power of 108 mW/cm(2) was observed from the fuel cell which was assembled with the platinum catalyst formed on the CNT by the in-liquid plasma method. (C) 2015 Elsevier B.V. All rights reserved.	[Show, Yoshiyuki; Hirai, Akira; Almowarai, Anas; Ueno, Yoram] Tokai Univ, Sch Engn, Dept Elect & Elect Engn, Hiratsuka, Kanagawa 2591292, Japan	Show, Y (reprint author), Tokai Univ, Sch Engn, Dept Elect & Elect Engn, 4-1-1 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan.				JSPN KAKENHI [26420683]	This work was supported by JSPN KAKENHI Grant Number 26420683. The author would like to thank Mr. Y. Miyamoto of the Technical Service Coordination Office, Tokai University, for the SEM investigation.	[Anonymous], FUEL CELL HDB; Long NV, 2013, J NANOSCI NANOTECHNO, V13, P4799, DOI 10.1166/jnn.2013.7570; [Anonymous], 2011, CARB NAN GROWTH APPL, P568; Holton OT, 2013, PLATIN MET REV, V57, P259, DOI 10.1595/147106713X671222; Naoki M., 2014, ELECTROCHIM ACTA, V146, P73; Wan Z., 2011, ENERGY, V2, P68	6	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	DEC 1	2015	596						198	200		10.1016/j.tsf.2015.08.053		3	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CY1YQ	WOS:000366204900033		
J	Terasako, T; Hambali, NA; Jayah, NA; Wakisaka, T; Hashim, AM; Yagi, M				Terasako, Tomoaki; Hambali, Nur Ashikyn; Jayah, Nurul Azzyaty; Wakisaka, Toshiya; Hashim, Abdul Manaf; Yagi, Masakazu			Shape controlled growth of ZnO nanorods and fabrication of ZnO/CuO heterojunctions by chemical bath deposition using zinc nitrate hexahydrate and copper (III) nitrate trihydrate	THIN SOLID FILMS			English	Article						ZnO; CuO; Chemical bath deposition; Scanning electron microscope; X-ray diffraction	VAPOR-DEPOSITION; OPTICAL-PROPERTIES; OXIDE NANOWIRES; SOLAR-CELLS; FILMS; ARRAYS; SUBSTRATE; PHOTOLUMINESCENCE; NANOBELTS; DENSITY	Vertically aligned zinc oxide (ZnO) nanorods (NRs) were successfully grown on Au/alkali-free glass substrates by chemical bath deposition (CBD) using themixed aqueous solution of zinc nitrate hexahydrate [Zn(NO3)(2)center dot 6H(2)O] and hexamethylenetetramine (HMT) (denoted by "ZnNit solution"). Even if both the growth time and growth temperature were constant, both the diameter and length of the NRs increased with increasing the concentration of the ZnNit solution. The ZnO NRs grown from the ZnNit solutions with the high concentrations exhibited a strong near-band-edge emission on their PL spectra, indicating their high crystalline quality. Using two different types of substrate holders realizing the different substrate configurations in the ZnNit solution, ZnO NRs standing perpendicular to the CuO surface or inclined with respect to the normal of the CuO surface were obtained on the CuO films prepared by CBD using the aqueous solution of copper (II) nitrate trihydrate [Zn(NO3)(2)center dot 3H(2)O]. The CBD experiments of ZnO NRs/CuO heterostructures were performed by using the ZnNit solutions with different concentrations in the range of 0.01-0.1M. Remarkable differences between the NRs grown using the two different substrate holders can be observed on the densities and the average diameters of the NRs, but not on the average lengths of the NRs. This finding suggests that the configuration of the substrate in the ZnNit solution during the deposition process is one of the important factors for controlling the shapes of the NRs as well as the concentration of the solution. (C) 2015 Elsevier B.V. All rights reserved.	[Terasako, Tomoaki] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Hambali, Nur Ashikyn; Jayah, Nurul Azzyaty; Hashim, Abdul Manaf] Univ Teknol Malaysia, Malaysia Japan Int Inst Technol, Kuala Lumpur 54100, Malaysia; [Wakisaka, Toshiya] Ehime Univ, Fac Engn, Matsuyama, Ehime 7908577, Japan; [Yagi, Masakazu] Kagawa Coll, Natl Inst Technol, Kagawa 7691192, Japan	Terasako, T (reprint author), Ehime Univ, Grad Sch Sci & Engn, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	terasako.tomoaki.mz@ehime-u.ac.jp					Yang PD, 2002, ADV FUNCT MATER, V12, P323, DOI 10.1002/1616-3028(20020517)12:5<323::AID-ADFM323>3.0.CO;2-G; Yang LL, 2009, J ALLOY COMPD, V469, P623, DOI 10.1016/j.jallcom.2008.08.002; Fan HB, 2007, CHINESE PHYS LETT, V24, P2108, DOI 10.1088/0256-307X/24/7/089; Geng CY, 2004, ADV FUNCT MATER, V14, P589, DOI 10.1002/adfm.200305074; SERNELIUS BE, 1988, PHYS REV B, V37, P10244, DOI 10.1103/PhysRevB.37.10244; Wang Z, 2004, LANGMUIR, V20, P3441, DOI 10.1021/la036098n; Terasako T, 2015, SOL ENERG MAT SOL C, V132, P74, DOI 10.1016/j.solmat.2014.08.023; Xu S, 2008, J MATER RES, V23, P2072, DOI 10.1557/JMR.2008.0274; Sounart TL, 2006, ADV FUNCT MATER, V16, P335, DOI 10.1002/adfm.200500468; Kong YC, 2001, APPL PHYS LETT, V78, P407, DOI 10.1063/1.1342050; MINAMI T, 1992, JPN J APPL PHYS 2, V31, pL1106; Minami T, 2012, THIN SOLID FILMS, V520, P3803, DOI 10.1016/j.tsf.2011.10.067; Terasako T, 2005, JPN J APPL PHYS 2, V44, pL1410, DOI 10.1143/JJAP.44.L1410; Huang MH, 2001, ADV MATER, V13, P113, DOI 10.1002/1521-4095(200101)13:2<113::AID-ADMA113>3.0.CO;2-H; Zainelabdin A, 2010, CRYST GROWTH DES, V10, P3250, DOI 10.1021/cg100390x; Saji KJ, 2013, PHYS STATUS SOLIDI A, V210, P1386, DOI 10.1002/pssa.201228293; Kidowaki H, 2012, J PHYS CONF SER, V352, DOI 10.1088/1742-6596/352/1/012022; WENAS WW, 1991, J APPL PHYS, V70, P7119, DOI 10.1063/1.349794; Meyer BK, 2012, PHYS STATUS SOLIDI B, V249, P1487, DOI 10.1002/pssb.201248128; Terasako T, 2013, THIN SOLID FILMS, V549, P292, DOI 10.1016/j.tsf.2013.05.174; Studenikin SA, 1998, J APPL PHYS, V84, P2287, DOI 10.1063/1.368295; Greene LE, 2006, INORG CHEM, V45, P7535, DOI 10.1021/ic0601900; Abe H, 2012, PHYS STATUS SOLIDI C, V9, P1396, DOI 10.1002/pssc.201100666; Terasako T, 2007, SURF COAT TECH, V201, P8924, DOI 10.1016/j.surfcoat.2007.04.017; Soomro MY, 2012, PHYS STATUS SOLIDI-R, V6, P80, DOI 10.1002/pssr.201105519; Amin G, 2011, PHYS STATUS SOLIDI-R, V5, P71, DOI 10.1002/pssr.201004446; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Li YB, 2002, APPL PHYS LETT, V81, P144, DOI 10.1063/1.1492008; Li QW, 2010, APPL SURF SCI, V256, P1698, DOI 10.1016/j.apsusc.2009.09.097; Aziz Nur Suhaili Abd, 2014, Nanoscale Res Lett, V9, P95, DOI 10.1186/1556-276X-9-95; Halls DC, 1998, ACTA MATER, V46, P6237, DOI 10.1016/S1359-6454(98)00245-6; Hambali NA, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-609; Hupkes J., 2007, TRANSPARENT CONDUCTI, P359; Hussain MS, 2014, J EXP NANOSCI, V9, P1, DOI 10.1080/17458080.2014.869005; Khan A, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4766921; Lang J., 2008, CRYST RES TECHNOL, V12, P1314; Nakada T., 1991, P 22 IEEE PVSC LAS V, P1389; Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120; Shi SB, 2011, J APPL PHYS, V109, DOI 10.1063/1.3586243; Triboulet R, 2003, PROG CRYST GROWTH CH, V47, P65, DOI 10.1016/j.pcrysgrow.2005.01.003	40	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	DEC 1	2015	596						201	208		10.1016/j.tsf.2015.07.082		8	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CY1YQ	WOS:000366204900034		
J	Nishida, N; Ohashi, J; Sugiyama, M; Tsuchiura, T; Yamamoto, K; Hino, K; Honda, M; Kaneko, S; Yatsuhashi, H; Koike, K; Yokosuka, O; Tanaka, E; Taketomi, A; Kurosaki, M; Izumi, N; Sakamoto, N; Eguchi, Y; Sasazuki, T; Tokunaga, K; Mizokami, M				Nishida, N.; Ohashi, J.; Sugiyama, M.; Tsuchiura, T.; Yamamoto, K.; Hino, K.; Honda, M.; Kaneko, S.; Yatsuhashi, H.; Koike, K.; Yokosuka, O.; Tanaka, E.; Taketomi, A.; Kurosaki, M.; Izumi, N.; Sakamoto, N.; Eguchi, Y.; Sasazuki, T.; Tokunaga, K.; Mizokami, M.			Effects of HLA-DPB1 genotypes on chronic hepatitis B infection in Japanese individuals	TISSUE ANTIGENS			English	Article						chronic hepatitis B infection; hepatitis B virus; hepatocellular carcinoma; HLA-DPB1	GENOME-WIDE ASSOCIATION; VARIANTS; LOCUS; RISK	Significant associations of HLA-DP alleles with chronic hepatitis B (CHB) infection are evident in Asian and Arabian populations, including Japanese, Han Chinese, Korean, and Saudi Arabian populations. Here, significant associations between CHB infection and five DPB1 alleles (two susceptibility alleles, DPB1*05: 01 and *09:01, and three protective alleles, DPB1*02:01, *04:01, and *04: 02) were confirmed in a population comprising of 2582 Japanese individuals. Furthermore, odds ratios for CHB were higher for those with both DPB1 susceptibility alleles than for those with only one susceptibility allele; therefore, effects of susceptibility alleles were additive for risk of CHB infection. Similarly, protective alleles showed an additive effect on protection from CHB infection. Moreover, heterozygotes of any protective allele showed stronger association with CHB than did homozygotes, suggesting that heterozygotes may bind a greater variety of hepatitis B-derived peptides, and thus present these peptides more efficiently to T-cell receptors than homozygotes. Notably, compound heterozygote of the protective allele (any one of DPB1*02: 01, *04: 01, and *04: 02) and the susceptible allele DPB1*05: 01 was significantly associated with protection against CHB infection, which indicates that one protective HLA-DPB1 molecule can provide dominant protection. Identification of the HLA-DPB1 genotypes associated with susceptibility to and protection from CHB infection is essential for future analysis of the mechanisms responsible for immune recognition of hepatitis B virus antigens by HLA-DPB1 molecules.	[Nishida, N.; Sugiyama, M.; Tsuchiura, T.; Mizokami, M.] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Dept Hepat Dis, Chiba, Japan; [Nishida, N.; Tokunaga, K.] Univ Tokyo, Dept Human Genet, Grad Sch Med, Tokyo, Japan; [Ohashi, J.] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo, Japan; [Yamamoto, K.] Kurume Univ, Sch Med, Dept Med Chem, Kurume, Fukuoka 830, Japan; [Hino, K.] Kawasaki Med Univ, Dept Hepatol & Pancreatol, Kurashiki, Okayama, Japan; [Honda, M.; Kaneko, S.] Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Yatsuhashi, H.] Natl Nagasaki Med Ctr, Clin Res Ctr, Nagasaki, Japan; [Koike, K.] Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Tokyo, Japan; [Yokosuka, O.] Chiba Univ, Dept Gastroenterol & Nephrol, Grad Sch Med, Chiba, Japan; [Tanaka, E.] Shinshu Univ, Sch Med, Dept Med, Matsumoto, Nagano 390, Japan; [Taketomi, A.] Hokkaido Univ, Dept Gastroenterol Surg 1, Grad Sch Med, Sapporo, Hokkaido, Japan; [Kurosaki, M.; Izumi, N.] Musashino Red Cross Hosp, Div Gastroenterol & Hepatol, Tokyo, Japan; [Sakamoto, N.] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan; [Eguchi, Y.] Saga Med Sch, Div Hepatol, Saga, Japan; [Sasazuki, T.] Kyushu Univ, Inst Adv Study, Fukuoka 812, Japan	Nishida, N (reprint author), Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, 1-7-1 Kohnodai Ichikawa, Ichikawa, Chiba 2728516, Japan.	nishida-75@umin.ac.jp			Ministry of Health, Labor, and Welfare of Japan [H24-Bsou-kanen-ippan-011, H24-kanen-ippan-004, H26-kanenjitsu-kanen-ippan-004, H25-kanen-wakate-013]; National Center for Global Health and Medicine [24-shi-107]; Ministry of Education, Culture, Sports, Science of Japan [22133008, 22133009]	We thank contributors for sample collection in the previous study, including Prof. Yasuhito Tanaka (Nagoya City University Hospital), Prof. Satoshi Mochida (Saitama Medical University), Prof. Yasuhito Asahina (Tokyo Medical and Dental University), Dr. Shuhei Hige (Sapporo-Kosei General Hospital), Dr. Tatsuya Ide (Kurume University School of Medicine), Prof. Kazuhide Yamamoto (Okayama University Graduate School of Medicine), Prof. Isao Sakaida (Yamaguchi University Graduate School of Medicine), Prof. Yoshikazu Murawaki (Tottori University), Pm of. Yoshi to Itoh (Kyoto Prefectural University of Medicine), Dr. Akihiro Tamori (Osaka City University Graduate School of Medicine), Dr. Etsuro Onto (Nagoya Daini Red Cross Hospital), Prof. Yoichi Hiasa (Ehime University Graduate School of Medicine), Eiji Mita (National Hospital Organization Osaka National Hospital), Prof. Kazuyuki Suzuki (Iwate Medical University), and Dr. Masaaki Watanabe (Kitasato University School of Medicine). We also thank Dr. Hiromi Sawai, Ms. Yuko Ogasawara-Hirano, Natsumi Baba, Rieko Shirahashi, Ayumi Nakayama and Megumi Yamaoka-Sageshima (University of Tokyo), and Ms. Yoriko Mawatari and Mayumi Ishii (National Center for Global Health and Medicine) for technical assistance. This work- was supported by four Grants-in-Aid from the Ministry of Health, Labor, and Welfare of Japan (H24-Bsou-kanen-ippan-011 and H24-kanen-ippan-004 to Masashi Mizokami, H26-kanenjitsu-kanen-ippan-004 to Katsushi Tokunaga, H25-kanen-wakate-013 to Nao Nishida) and by a Grant from the National Center for Global Health and Medicine (24-shi-107 to Nao Nishida). Partial support by Grant in Aid from the Ministry of Education, Culture, Sports, Science of Japan for Scientific Research on Innovative Areas to Katsushi Tokunaga [Grant number: 22133008] and to Takehiko Sasazuki [Grant number: 22133009] is also acknowledged. NN contributed to study design, generated data, performed genotyping and statistical analyses, and drafted the manuscript. KT and MM contributed to study design, collected samples, and helped draft the manuscript. JO performed statistical analyses and helped draft the manuscript. KY and TS collected the healthy control samples and performed genotyping. TT performed genotyping and assisted with statistical analysis. MS, KH, MH, SK, HY, KK, OY, ET, AT, MK, NI, NS, YE. contributed to study design and sample collection.	Al-Qahtani AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080445; Hu ZB, 2013, NAT GENET, V45, P1499, DOI 10.1038/ng.2809; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Kim YJ, 2013, HUM MOL GENET, V22, P4233, DOI 10.1093/hmg/ddt266; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Ueda S, 2014, J CLIN ENDOCR METAB, V99, pE379, DOI 10.1210/jc.2013-2841; Guo XC, 2011, HEPATOLOGY, V53, P422, DOI 10.1002/hep.24048; Nishida N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086449; Nishida Nao, 2013, J Clin Transl Hepatol, V1, P45, DOI 10.14218/JCTH.2013.010XX; Nishida N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039175	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-2815	1399-0039		TISSUE ANTIGENS	Tissue Antigens	DEC	2015	86	6					406	412		10.1111/tan.12684		7	Cell Biology; Immunology; Pathology	Cell Biology; Immunology; Pathology	CX1GR	WOS:000365445000003		
J	Miyadera, H; Bungener, LB; Kusano, S; Yokoyama, S; Tokunaga, K; Hepkema, BG				Miyadera, H.; Bungener, L. B.; Kusano, S.; Yokoyama, S.; Tokunaga, K.; Hepkema, B. G.			Questionable expression of unstable DQ heterodimer containing HLA-DQA1*01:07	TISSUE ANTIGENS			English	Article						HLA-DQ; human leukocyte antigens; low expression allele; questionable expression allele	SEQUENCE; ALLELES; HLA; SUSCEPTIBILITY; POPULATION; HLA-DQ0602	Human leukocyte antigens (HLA)-DQA1*01:07 was identified as an HLA-DQ blank specificity that segregated with the serological HLA-A2, -B7, -DR14, -DR52 haplotype, which carried DQB1*05:03. The blank specificity of DQA1*01:07-DQB1*05:03 may be because of lack of reactivity of available typing sera, or disruption of proper assembly of DQ heterodimer. The cDNA sequence of DQA1*01: 07 is nearly identical to DQA1*01: 04 except for a variant at position 304, which results in the replacement of an arginine with a cysteine at 79 alpha. To determine whether the DQA1*01: 07 product can be expressed on cell-surface, we co-expressed DQA1*01: 07 with various DQB1*05 or *06 alleles in fibroblast cells. Cell-surface expression of DQ was detectable when DQA1*01: 07 was co-expressed with DQB1*06:04 but undetectable with other DQB1*05 and DQB1*06 alleles, including DQB1*05: 03, to which DQA1*01: 07 was encoded in cis. These data suggest that DQA1*01: 07 may act as a phenotypically null allele in the DQA1*01: 07-DQB1*05: 03 haplotype, while it can be expressed at a low level in the presences of certain DQB1*06 alleles, such as DQB1*06: 04, in trans. Based on the null or low expression of DQA1*01: 07 as shown in the previous and present studies, DQA1*01: 07 has recently been renamed to DQA1*01:07Q, indicating its questionable expression.	[Miyadera, H.; Tokunaga, K.] Univ Tokyo, Dept Human Genet, Grad Sch Med, Tokyo, Japan; [Miyadera, H.] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Chiba 2728516, Japan; [Bungener, L. B.; Hepkema, B. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Kusano, S.; Yokoyama, S.] RIKEN Struct Biol Lab, Yokohama, Kanagawa, Japan	Miyadera, H (reprint author), Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, 1-7-1 Kohnodai Ichikawa, Chiba 2728516, Japan.	miyadera-h@umin.net			Japan Society for the Promotion of Science (JSPS) KAKENHI [22133008, 22133006]	We thank T. Kitamura for PLAT-E cells, pMXs-puro, and pMXs-IG vectors. We thank the RIKEN Cell Bank for the NIH3T3 cell line. This work was funded by grants from the Japan Society for the Promotion of Science (JSPS) KAKENHI (22133008 to KT and 22133006 to HM).	Henderson KN, 2007, IMMUNITY, V27, P23, DOI 10.1016/j.immuni.2007.05.015; Siebold C, 2004, P NATL ACAD SCI USA, V101, P1999, DOI 10.1073/pnas.0308458100; Bondinas GP, 2007, IMMUNOGENETICS, V59, P539, DOI 10.1007/s00251-007-0224-8; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Reichstetter S, 2002, HUM IMMUNOL, V63, P185, DOI 10.1016/S0198-8859(01)00377-9; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Foll D, 2012, TISSUE ANTIGENS, V79, P340, DOI 10.1111/j.1399-0039.2012.01864.x; Hancock LN, 2005, HUM IMMUNOL, V66, P1248, DOI 10.1016/j.humimm.2005.08.239; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Sethi DK, 2011, J EXP MED, V208, P91, DOI 10.1084/jem.20100725; Voorter CEM, 2006, HUM IMMUNOL, V67, P756, DOI 10.1016/j.humimm.2006.01.002; Lardy NM, 1997, TISSUE ANTIGENS, V50, P334, DOI 10.1111/j.1399-0039.1997.tb02883.x; Witter K, 2014, TISSUE ANTIGENS, V83, P49, DOI 10.1111/tan.12270; Lee KH, 2001, NAT IMMUNOL, V2, P501, DOI 10.1038/88694; Miyadera H, 2015, J CLIN INVEST, V125, P275, DOI 10.1172/JCI74961; MONOS DS, 1995, IMMUNOGENETICS, V42, P172	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-2815	1399-0039		TISSUE ANTIGENS	Tissue Antigens	DEC	2015	86	6					413	418		10.1111/tan.12686		6	Cell Biology; Immunology; Pathology	Cell Biology; Immunology; Pathology	CX1GR	WOS:000365445000004		
J	Takeshima, SN; Giovambattista, G; Okimoto, N; Matsumoto, Y; Rogberg-Munoz, A; Acosta, TJ; Onuma, M; Aida, Y				Takeshima, S-N.; Giovambattista, G.; Okimoto, N.; Matsumoto, Y.; Rogberg-Munoz, A.; Acosta, T. J.; Onuma, M.; Aida, Y.			Characterization of bovine MHC class II DRB3 diversity in South American Holstein cattle populations	TISSUE ANTIGENS			English	Article						BoLA-DRB3; genetic diversity; Holstein; principal components analysis; tropical disease resistance	MAJOR HISTOCOMPATIBILITY COMPLEX; HETEROZYGOTE ADVANTAGE; LYMPHOCYTE ANTIGEN; JAPANESE SHORTHORN; BOLA-DRB3 ALLELES; LEUKOCYTE ANTIGEN; VIRUS-INFECTION; CREOLE CATTLE; DAIRY-CATTLE; HEAT-STRESS	Holstein cattle dominate the global milk production industry because of their outstanding milk production, however, this breed is susceptible to tropical endemic pathogens and suffers from heat stress and thus fewer Holstein populations are raised in tropical areas. The bovine major histocompatibility complex (BoLA)-DRB3 class II gene is used as a marker for disease and immunological traits, and its polymorphism has been studied extensively in Holstein cattle from temperate and cold regions. We studied the genetic diversity of the BoLA-DRB3 gene in South American Holstein populations to determine whether tropical populations have diverged from those bred in temperate and cold regions by selection and/or crossbreeding with local native breeds. We specifically studied Exon 2 of this gene from 855 South American Holstein individuals by a polymerase chain reaction (PCR) sequence-based typing method. We found a high degree of gene diversity at the allelic (N-a > 20 and H-e > 0.87) and molecular (pi > 0.080) levels, but a low degree of population structure (F-ST = 0.009215). A principal components analysis and tree showed that the Bolivian subtropical population had the largest genetic divergence compared with Holsteins bred in temperate or cold regions, and that this population was closely related to Bolivian Creole cattle. Our results suggest that Holstein genetic divergence can be explained by selection and/or gene introgression from local germplasms. This is the first examination of BoLA-DRB3 in Holsteins adapted to tropical environments, and contributes to an ongoing effort to catalog bovine MHC allele frequencies by breed and location.	[Takeshima, S-N.; Matsumoto, Y.; Onuma, M.; Aida, Y.] RIKEN, Viral Infect Dis Unit, Wako, Saitama 3510198, Japan; [Giovambattista, G.; Rogberg-Munoz, A.] UNLP, FCV, CCT LA PLATA CONICET, IGEVET, La Plata, Buenos Aires, Argentina; [Okimoto, N.] RIKEN, Quantitat Biol Ctr QBiC, Computat Biol Res Core, Lab Computat Mol Design, Kobe, Hyogo, Japan; [Acosta, T. J.] Obihiro Univ Agr & Vet Med, Field Ctr Anim Sci & Agr, Obihiro, Hokkaido 080, Japan	Aida, Y (reprint author), RIKEN, Viral Infect Dis Unit, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	aida@riken.jp			Japan Society for the Promotion of Science (JSPS) [18255013, 25450405]; Integration research for Agriculture and Interdisciplinary Fields in Japan [14538311]	We are grateful to Drs. Jiyun Kim, Tomoyuki Murakami, Kazunori Yamada, Mariluz Arainga, Mayuko Jimba, and Taku Miyasaka for helpful experimental assistance. We thank Drs. Guangai Xue, Veronica de la Barra Diaz, Manuel Ortiz, Jorge Misao Kanemaki, Luz Angela Alvarez Franco, and Hideki Saito, the veterinarians in Chile, Argentina, Paraguay, Bolivia, and Peril, and members of the National University of LA PLATA and Universidad Austral de Chile for samples from many farms. We are thankful for the computational resources of the RIKEN Integrated Cluster of Clusters (RICC) and for the Support Unit at the Bio-material Analysis, RIKEN BSI Research Resources Center, for help with sequence analysis. This work was supported by Grants-in-Aid for Scientific Research [A(18255013) and C(25450405)] from the Japan Society for the Promotion of Science (JSPS), a grant from Integration research for Agriculture and Interdisciplinary Fields in Japan [14538311].	Aggarwal A, 2012, HEAT STRESS ANIMAL P, P113; Aida Y, 1995, B SOC FRANCO JAPONAI, V6, P17; SULIMOVA GE, 1995, GENETIKA+, V31, P1294; Takeshima SN, 2006, ANIM SCI J, V77, P138, DOI 10.1111/j.1740-0929.2006.00332.x; Georges M, 1996, GENOME RES, V6, P907, DOI 10.1101/gr.6.10.907; [Anonymous], 2001, PALAEONTOL ELECTRON, DOI DOI 10.1016/J.BCP.2008.05.025; Baxter R, 2008, ANIM GENET, V39, P561, DOI 10.1111/j.1365-2052.2008.01757.x; Baxter R, 2009, VACCINE, V28, P28, DOI 10.1016/j.vaccine.2009.09.131; HEDRICK PW, 1991, P NATL ACAD SCI USA, V88, P5897, DOI 10.1073/pnas.88.13.5897; West JW, 2003, J DAIRY SCI, V86, P2131, DOI 10.3168/jds.S0022-0302(03)73803-X; NEI M, 1978, GENETICS, V89, P583; Boyce WM, 1997, GENETICS, V145, P421; Ballingall KT, 2004, INFECT IMMUN, V72, P2738, DOI 10.1128/IAI.72.5.2738-2741.2004; Miyasaka T, 2012, J DAIRY SCI, V95, P420, DOI 10.3168/jds.2011-4621; Dietz AB, 1997, J DAIRY SCI, V80, P406; Takeshima SN, 2011, TISSUE ANTIGENS, V78, P208, DOI 10.1111/j.1399-0039.2011.01708.x; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Mikko S, 1999, IMMUNOL REV, V167, P169, DOI 10.1111/j.1600-065X.1999.tb01390.x; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ellis SA, 1999, IMMUNOL REV, V167, P159, DOI 10.1111/j.1600-065X.1999.tb01389.x; Takeshima S, 2002, J DAIRY SCI, V85, P1630; Giovambattista G, 2013, GENE, V519, P150, DOI 10.1016/j.gene.2013.01.002; Thursz MR, 1997, NAT GENET, V17, P11, DOI 10.1038/ng0997-11; Qanbari S, 2010, ANIM GENET, V41, P346, DOI 10.1111/j.1365-2052.2009.02011.x; Dietz AB, 1997, J DAIRY SCI, V80, P400; Miyasaka T, 2011, GENE, V472, P42, DOI 10.1016/j.gene.2010.10.007; Giovambattista G, 2001, ANIM GENET, V32, P240, DOI 10.1046/j.1365-2052.2001.00774.x; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; MARKOW T, 1993, AM J HUM GENET, V53, P943; Germain RN, 2004, CURR OPIN IMMUNOL, V16, P120, DOI 10.1016/j.coi.2003.11.001; BLACK FL, 1981, AM J HUM GENET, V33, P894; De Rensis F, 2003, THERIOGENOLOGY, V60, P1139, DOI 10.1016/S0093-691X(03)00126-2; Lee BY, 2012, ANIM GENET, V43, P438, DOI 10.1111/j.1365-2052.2011.02264.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Starkenburg RJ, 1997, J DAIRY SCI, V80, P3411; BLACK FL, 1983, AM J PHYS ANTHROPOL, V60, P327, DOI 10.1002/ajpa.1330600305; Takeshima S, 2003, GENE, V316, P111, DOI 10.1016/S0378-1119(03)00744-3; Sharif S, 1998, ANIM GENET, V29, P185, DOI 10.1046/j.1365-2052.1998.00318.x; Maillard JC, 2002, ANN NY ACAD SCI, V969, P92; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Baltian LR, 2012, MOL BIOL REP, V39, P7215, DOI 10.1007/s11033-012-1526-y; Takeshima S, 2008, TISSUE ANTIGENS, V72, P525, DOI 10.1111/j.1399-0039.2008.01140.x; Hraber P, 2007, HEPATOLOGY, V46, P1713, DOI 10.1002/hep.21889; Glass EJ, 2000, J IMMUNOL, V165, P134; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Cavalli-Sforza LL, 1994, HIST GEOGRAPHY HUMAN; Langella O, 1999, POPULATIONS POPULATI; Muehlhoff E, 2013, MILK DAIRY PRODUCTS; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Notter DR, 1999, J ANIM SCI, V77, P61; Obata T, 1996, ANIM GENET RESOUR, V18, P65; Schneider S, 2000, ARLEQUIN VERSION 2 0; Slatkin M, 1996, GENET RES, V68, P259; Sncath PHA, 1973, NUMERICAL TAXONOMY P; Takeshima SN, 2015, TISSUE ANTIGENS, V85, P35, DOI 10.1111/tan.12481; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.2307/2408641	57	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-2815	1399-0039		TISSUE ANTIGENS	Tissue Antigens	DEC	2015	86	6					419	430		10.1111/tan.12692		12	Cell Biology; Immunology; Pathology	Cell Biology; Immunology; Pathology	CX1GR	WOS:000365445000005		
J	Nishita, Y; Abramov, AV; Kosintsev, PA; Lin, LK; Watanabe, S; Yamazaki, K; Kaneko, Y; Masuda, R				Nishita, Y.; Abramov, A. V.; Kosintsev, P. A.; Lin, L. -K.; Watanabe, S.; Yamazaki, K.; Kaneko, Y.; Masuda, R.			Genetic variation of the MHC class II DRB genes in the Japanese weasel, Mustela itatsi, endemic to Japan, compared with the Siberian weasel, Mustela sibirica	TISSUE ANTIGENS			English	Article						balancing selection; conservation; DRB gene; major histocompatibility complex; molecular evolution; mustelidae; trans-species polymorphism	MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR PHYLOGENY; CARNIVORA MUSTELIDAE; MULTIGENE FAMILIES; MELES-MELES; DIVERSITY; EVOLUTION; SEQUENCE; POLYMORPHISM; MODELS	Major histocompatibility complex (MHC) genes encode proteins that play a critical role in vertebrate immune system and are highly polymorphic. To further understand the molecular evolution of the MHC genes, we compared MHC class II DRB genes between the Japanese weasel (Mustela itatsi), a species endemic to Japan, and the Siberian weasel (Mustela sibirica), a closely related species on the continent. We sequenced a 242-bp region of DRB exon 2, which encodes antigen-binding sites (ABS), and found 24 alleles from 31 M. itatsi individuals and 17 alleles from 21 M. sibirica individuals, including broadly distributed, species-specific and/or geographically restricted alleles. Our results suggest that pathogen-driven balancing selection have acted to maintain the diversity in the DRB genes. For predicted ABS, nonsynonymous substitutions exceeded synonymous substitutions, also indicating positive selection, which was not seen at non-ABS. In a Bayesian phylogenetic tree, two M. sibirica DRB alleles were basal to the rest of the sequences from mustelid species and may represent ancestral alleles. Trans-species polymorphism was evident between many mustelid DRB alleles, especially between M. itatsi and M. sibirica. These two Mustela species divided about 1.7 million years ago, but still share many MHC alleles, indicative of their close phylogenetic relationship.	[Nishita, Y.; Masuda, R.] Hokkaido Univ, Fac Sci, Dept Biol Sci, Sapporo, Hokkaido 0600810, Japan; [Abramov, A. V.] Russian Acad Sci, Inst Zool, Moscow, Russia; [Kosintsev, P. A.] Russian Acad Sci, Inst Plant & Anim Ecol, Moscow, Russia; [Lin, L. -K.] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Watanabe, S.] Seian Univ Art & Design, Otsu, Shiga, Japan; [Yamazaki, K.] Tokyo Univ Agr, Fac Reg Environm Sci, Dept Forest Sci, Forest Ecol Lab, Fuchu, Tokyo, Japan; [Kaneko, Y.] Tokyo Univ Agr & Technol, Dept Ecoreg Sci, Fac Agr, Fuchu, Tokyo, Japan	Masuda, R (reprint author), Hokkaido Univ, Fac Sci, Dept Biol Sci, Kita Ku, North 10,West 8, Sapporo, Hokkaido 0600810, Japan.	masudary@mail.sci.hokudai.ac.jp			Japan Society for the Promotion of Science (JSPS); Russian Foundation for the Basic Research [RFBR 15-04-03882]; JSPS [26257404]	We thank Prof. Matthew Dick (Hokkaido University) for valuable comments on the manuscript. This study was partly supported by the Joint Research Project (between Japan and Russia) Grant from the Japan Society for the Promotion of Science (JSPS), a grant from the Russian Foundation for the Basic Research (RFBR 15-04-03882), and a Grant-in-Aid for Scientific Research (26257404) from JSPS.	Abbas AK, 2009, BASIC IMMUNOLOGY FUN; Kurose Naoko, 2008, Mammal Study, V33, P25, DOI 10.3106/1348-6160(2008)33[25:MPATOT]2.0.CO;2; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Goda N, 2010, TISSUE ANTIGENS, V76, P404, DOI 10.1111/j.1399-0039.2010.01528.x; Boehm T, 2006, TRENDS NEUROSCI, V29, P100, DOI 10.1016/j.tins.2005.11.006; Abramov AV, 2013, BIOL BULL+, V40, P52, DOI 10.1134/S1062359013010020; Abramov AV, 2000, ZOOL ZH, V79, P80; Reche PA, 2003, J MOL BIOL, V331, P623, DOI 10.1016/S0022-2836(03)00750-2; Talavera G, 2007, SYSTEMATIC BIOL, V56, P564, DOI 10.1080/10635150701472164; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Yonezawa T, 2007, GENE, V396, P1, DOI 10.1016/j.gene.2006.12.040; Sin YW, 2012, IMMUNOGENETICS, V64, P313, DOI 10.1007/s00251-011-0578-9; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Babik W, 2010, MOL ECOL RESOUR, V10, P237, DOI 10.1111/j.1755-0998.2009.02788.x; Spurgin LG, 2010, P R SOC B, V277, P979, DOI 10.1098/rspb.2009.2084; Aguilar A, 2008, ANIM CONSERV, V11, P35, DOI 10.1111/j.1469-1795.2007.00144.x; Kumanovics A, 2003, ANNU REV IMMUNOL, V21, P629, DOI 10.1146/annurev.immunol.21.090501.080116; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; Babik W, 2005, MOL ECOL, V14, P4249, DOI 10.1111/j.1365-294X.2005.02751.x; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; Castro-Prieto A, 2011, MOL BIOL EVOL, V28, P1455, DOI 10.1093/molbev/msq330; MASUDA R, 1994, ZOOL SCI, V11, P605; Toh H, 2000, BIOPOLYMERS, V54, P318, DOI 10.1002/1097-0282(20001015)54:5<318::AID-BIP30>3.0.CO;2-T; Siddle HV, 2007, IMMUNOGENETICS, V59, P753, DOI 10.1007/s00251-007-0238-2; Flynn JJ, 2005, SYST BIOL, V54, P317, DOI 10.1080/10635150590923326; Masuda R, 2012, BIOL J LINN SOC, V107, P307, DOI 10.1111/j.1095-8312.2012.01948.x; KLEIN J, 1994, PHILOS T ROY SOC B, V346, P351, DOI 10.1098/rstb.1994.0152; Siddle HV, 2007, P NATL ACAD SCI USA, V104, P16221, DOI 10.1073/pnas.0704580104; Oomen RA, 2013, MOL ECOL RESOUR, V13, P103, DOI 10.1111/1755-0998.12027; SWAIN SL, 1983, IMMUNOL REV, V74, P129, DOI 10.1111/j.1600-065X.1983.tb01087.x; [Anonymous], 1994, PHILOS T R SOC LOND; Becker L, 2009, IMMUNOGENETICS, V61, P281, DOI 10.1007/s00251-009-0362-2; Kurose N, 2000, ZOOL SCI, V17, P673, DOI 10.2108/zsj.15.673; YAMAZAKI K, 1976, J EXP MED, V144, P1324, DOI 10.1084/jem.144.5.1324; Yang ZH, 2002, MOL BIOL EVOL, V19, P908; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; KLEIN J, 1990, IMMUNOGENETICS, V31, P217; Kennedy LJ, 1999, TISSUE ANTIGENS, V54, P312, DOI 10.1034/j.1399-0039.1999.540319.x; Dionne M, 2009, MOL ECOL, V18, P4523, DOI 10.1111/j.1365-294X.2009.04375.x; Westerdahl H, 2007, J ORNITHOL, V148, pS469, DOI 10.1007/s10336-007-0230-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Sin YW, 2015, MOL ECOL, V24, P3138, DOI 10.1111/mec.13217; Avise J.C., 2000, PHYLOGEOGRAPHY; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; KLEIN J, 1987, HUM IMMUNOL, V19, P155, DOI 10.1016/0198-8859(87)90066-8; KLEIN J, 1986, CRIT REV IMMUNOL, V6, P295; Lowe A, 2004, ECOLOGICAL GENETICS; Masuda Ryuichi, 1994, Journal of the Mammalogical Society of Japan, V19, P33; Murrell B, 2012, PLOS GENET, V8; Nei M, 2000, MOL EVOLUTION PHYLOG; Rambaut A., 2014, TRACER V1 6; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; Beck S, 1999, NATURE, V401, P921; Wozencraft WC, 2005, MAMMAL SPECIES WORLD, V1, P532; Zhu L, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-29	60	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-2815	1399-0039		TISSUE ANTIGENS	Tissue Antigens	DEC	2015	86	6					431	442		10.1111/tan.12700		12	Cell Biology; Immunology; Pathology	Cell Biology; Immunology; Pathology	CX1GR	WOS:000365445000006		
J	Kashiwabara, Y; Ambe, K; Nakagawa, T; Watanabe, H				Kashiwabara, Yoshiaki; Ambe, Kimiharu; Nakagawa, Toshihiro; Watanabe, Hiroki			Immunohistochemical localization of Nox in mouse circumvallate papillae	TISSUE & CELL			English	Article						NADPH oxidase; Nox; Reactive oxygen species; Circumvallate papillae; Taste bud; Immunohistochemistry	ENDOTHELIAL GROWTH-FACTOR; NADPH OXIDASE; HUMAN KERATINOCYTES; TASTE-BUDS; CELLS; DIFFERENTIATION; EXPRESSION; GENERATION; RECEPTOR; HOMOLOG	Recently it has been reported that reactive oxygen species plays an important role in several physiological processes. Reactive oxygen species are generated by reactive oxygen-synthesizing enzymes (Nox). We immunohistochemically investigated expression and localization of the Nox family in a mouse circumvallate papillae. In the epithelium of the circumvallate papilla, Nox 1, 2, 3, and 4, Noxo1, and Noxa1 were expressed. In the circumvallate papilla, Nox2 was more weakly expressed in the lateral than in the upper part, and Nox3 was not expressed. In the taste buds, Nox 1, 2, 3, and 4, Noxo1, and Noxa1 were expressed; the Nox expression pattern varied with the cell type. In type II cells, Nox 1, 3, and 4, Noxo1, and Noxa1 were expressed. In type III cells, Nox2, besides Nox 1, 3, and 4, Noxo1, and Noxa1, were specifically expressed, unlike in other taste bud cells. In the mouse circumvallate papilla, Nox is always expressed, suggesting the generation of reactive oxygen species. Of note, all cells comprising taste buds expressed Nox, with each showing a specific Nox expression pattern. (C) 2015 Elsevier Ltd. All rights reserved.	[Kashiwabara, Yoshiaki] Ohu Univ, Grad Sch Dent, Dept Cell Biol & Oral Histol, Koriyama, Fukushima 9638611, Japan; [Ambe, Kimiharu; Nakagawa, Toshihiro; Watanabe, Hiroki] Ohu Univ, Sch Dent, Dept Morphol Biol, Div Oral Histol, Koriyama, Fukushima 9638611, Japan	Watanabe, H (reprint author), Ohu Univ, Sch Dent, Dept Morphol Biol, Div Oral Histol, 31-1 Misumido,Tomita Machi, Koriyama, Fukushima 9638611, Japan.	hi-watanabe@den.ohu-u.ac.jp					LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Kawahara T, 2001, INFECT IMMUN, V69, P4382, DOI 10.1128/IAI.69.7.4382-4389.2001; Chamulitrat W, 2004, J INVEST DERMATOL, V122, P1000, DOI 10.1111/j.0022-202X.2004.22410.x; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; Cheng GJ, 2004, J BIOL CHEM, V279, P34250, DOI 10.1074/jbc.M400660200; Nakanishi M, 2012, AM J RESP CELL MOL, V46, P217, DOI 10.1165/rcmb.2010-0115OC; Harfouche R, 2005, FASEB J, V19, P1728, DOI 10.1096/fj.04-3621fje; Kim JY, 2005, CELL TISSUE RES, V320, P409, DOI 10.1007/s00441-005-1091-y; Chou HC, 2001, ANAT EMBRYOL, V204, P161, DOI 10.1007/s004290100190; Ago T, 2004, CIRCULATION, V109, P227, DOI 10.1161/01.CIR.0000105680.92873.70; Kennedy LH, 2013, TOXICOL SCI, V132, P235, DOI 10.1093/toxsci/kfs325; Uchida N, 2003, ARCH HISTOL CYTOL, V66, P17, DOI 10.1679/aohc.66.17; Chamulitrat W, 2003, ONCOGENE, V22, P6045, DOI 10.1038/sj.onc.1206654; Katsuyama M, 2012, J CLIN BIOCHEM NUTR, V50, P9, DOI 10.3164/jcbn.11-06SR; Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200; Tateishi Y, 2008, BIOCHEM BIOPH RES CO, V366, P301, DOI 10.1016/j.bbre.2007.11.039; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Niki M, 2010, BIOL PHARM BULL, V33, P1772, DOI 10.1248/bpb.33.1772; Zhou LJ, 2000, J PHARMACOL EXP THER, V293, P982; Yamagishi S, 2006, J BIOL CHEM, V281, P20213, DOI 10.1074/jbc.M602110200; Mandal CC, 2011, BIOCHEM J, V433, P393, DOI 10.1042/BJ20100357; Mander PK, 2006, J IMMUNOL, V176, P1046; Kikuchi H, 2000, GENE, V254, P237, DOI 10.1016/S0378-1119(00)00258-4; Ibi M, 2008, J NEUROSCI, V28, P9486, DOI 10.1523/JNEUROSCI.1857-08.2008; DELORENZO AJ, 1958, J BIOPHYS BIOCHEM CY, V4, P143, DOI 10.1083/jcb.4.2.143; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638; Patil S, 2004, AM J PHYSIOL-LUNG C, V287, pL1314, DOI 10.1152/ajplung.00383.2003; Schroeder K, 2009, ARTERIOSCL THROM VAS, V29, P239, DOI 10.1161/ATVBAHA.108.174219; Wójcicka Grazyna, 2004, Postepy Hig Med Dosw (Online), V58, P183	32	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0040-8166			TISSUE CELL	Tissue Cell	DEC	2015	47	6					550	558		10.1016/j.tice.2015.10.001		9	Anatomy & Morphology; Cell Biology	Anatomy & Morphology; Cell Biology	CY1AR	WOS:000366139000002		
J	Pandey, BD; Pandey, K; Neupane, B; Shah, Y; Adhikary, KP; Gautam, I; Hagge, DA; Morita, K				Pandey, Basu Dev; Pandey, Kishor; Neupane, Biswas; Shah, Yogendra; Adhikary, Krishna P.; Gautam, Ishan; Hagge, Deanna A.; Morita, Kouichi			Persistent dengue emergence: the 7 years surrounding the 2010 epidemic in Nepal	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Dengue fever; Epidemiology; Nepal	VIRUS; DISEASE	Background: Dengue fever (DF) is an emerging public health problem in Nepal, and yet neither the magnitude of the DF burden or its epidemiological trends are well understood. Methods: We conducted a sero-epidemiological, seasonal trend and demographic analysis of the trends in DF in the Terai region of Nepal, from 2007 to 2013. In that period, 2002 serum samples were collected from febrile patients suspected of dengue virus infection. Samples were screened by IgM antibody ELISA analysis for the presence of anti-dengue IgM antibodies. Results: The overall prevalence of DF cases was found to range from 26.1 to 55.4%. Infection was found to be more common among adults and males. Seasonal trends revealed that cases peaked in October and November. Conclusions: The study offers perspective on the dengue fever burden before, during and after a major epidemic and can now be used as a basis for formulating strategies by policy makers that will enhance and develop relevant control and preventive measures against dengue fever. The findings of this study reinforce the perceived need for urgent dengue virus surveillance to enhance dengue control strategies that need to be developed for future preparedness. In the light of the recent earthquakes, future major outbreaks of vector borne disease are likely to recur.	[Pandey, Basu Dev; Pandey, Kishor; Neupane, Biswas; Shah, Yogendra] Everest Int Clin & Res Ctr, Kathmandu, Nepal; [Adhikary, Krishna P.] Nepal Hlth Res Council, Kathmandu, Nepal; [Gautam, Ishan] Tribhuvan Univ, Nat Hist Museum, Kathmandu, Nepal; [Hagge, Deanna A.] Anandaban Hosp, Mycobacterial Res Labs, Kathmandu, Nepal; [Morita, Kouichi] Nagasaki Univ, Inst Trop Med, Dept Virol, Nagasaki 852, Japan	Pandey, BD (reprint author), Minist Hlth & Populat, Dept Hlth Serv, Leprosy Control Div, Kathmandu, Nepal.	drbasupandey@gmail.com			Global COE program, MEXT, Japan; KAKENHI [21256004]; Program of Founding Research Centers for Emerging and Re-emerging Infectious Diseases, JST, Japan; Health Labor Sciences Research Grant	This work was partially supported by a Grant-in-Aid for Scientific Research (KAKENHI) No. 21256004, and Global COE program, MEXT, Japan; and the Health Labor Sciences Research Grant and the Program of Founding Research Centers for Emerging and Re-emerging Infectious Diseases, JST, Japan.	Gupta E, 2005, INDIAN J MED RES, V121, P36; Pandey BD, 2008, EMERG INFECT DIS, V14, P514, DOI 10.3201/eid1403.070473; Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x; Pun SB, 2011, J NEPAL MED ASSOC, V51, P203; Endy TP, 2010, FRONTIERS IN DENGUE VIRUS RESEARCH, P3; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Malla S, 2008, EMERG INFECT DIS, V14, P1669, DOI 10.3201/eid1410.080432; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Rothman AL, 2003, ADV VIRUS RES, V60, P397, DOI 10.1016/S0065-3527(03)60010-2; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Ooi EE, 2006, EMERG INFECT DIS, V12, P887; Teixeira MG, 2008, EMERG INFECT DIS, V14, P1663, DOI 10.3201/eid1410.071164; Chakravorti A, 2005, J VIROL, V2, P1; DARSIE R F JR, 1990, Mosquito Systematics, V22, P69; Dhimal M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003035; EDCD, ANN REP 2013 2014 ED; Halstead SB, 1970, J BIOL MED, V42, P311; Kurane I, 2000, EMERG INFECT DIS, V6, P1; Neupane B, 2013, DENGUE B, V37, P1; Pandey BD, 2010, TROP MED HLTH, V41, P103; Pandey Basu Dev, 2004, Nepal Med Coll J, V6, P157; Rutvisuttinunt W, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0606-0; SAARC, 2010, S AS DIS REP 2010; Teixeira MDG, 2002, DENGUE B, V26, P70; Teng Ang Kim, 2001, Dengue Bulletin, V25, P7; WHO, 2015, DENG SEV DENG; WHO, 2006, SCI WORK GROUP REP D; WHO, 2012, DENG HDB CLIN MAN DE; WHO, 1997, DENG HEM FEV DIAGN T; WHO Regional Office for South East Asia, 2012, SEARO DENG SIT UPD	30	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	DEC	2015	109	12					775	782		10.1093/trstmh/trv087		8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CY4SJ	WOS:000366398300006		
J	Takeshita, T; Yamamoto, Y; Yamamoto-Ibusuki, M; Inao, T; Sueta, A; Fujiwara, S; Omoto, Y; Iwase, H				Takeshita, Takashi; Yamamoto, Yutaka; Yamamoto-Ibusuki, Mutsuko; Inao, Toko; Sueta, Aiko; Fujiwara, Saori; Omoto, Yoko; Iwase, Hirotaka			Droplet digital polymerase chain reaction assay for screening of ESR1 mutations in 325 breast cancer specimens	TRANSLATIONAL RESEARCH			English	Article							INTERNATIONAL EXPERT CONSENSUS; CIRCULATING TUMOR DNA; PRIMARY THERAPY; COPY NUMBER; RECEPTOR; PCR; HIGHLIGHTS; ETHINYLESTRADIOL; QUANTIFICATION; INHIBITION	Droplet digital polymerase chain reaction (ddPCR), which could perform thousands of PCRs on a nanoliter scale simultaneously, would be an attractive method to massive parallel sequencing for identifying and studying the significance of low-frequency rare mutations. Recent evidence has shown that the key potential mechanisms of the failure of aromatase inhibitors-based therapy involve identifying activating mutations affecting the ligand-binding domain of the ESR1 gene. Therefore, the detection of ESR1 mutations may be useful as a biomarker predicting an effect of the treatment. We aimed to develop a ddPCR-based method for the sensitive detection of ESR1 mutations in 325 breast cancer specimens, in which 270 primary and 55 estrogen receptor-positive (ER+) metastatic breast cancer (MBC) specimens. Our ddPCR assay could detect the ESR1 mutant molecules with low concentration of 0.25 copies/mu L. According to the selected cutoff, ESR1 mutations occurred in 7 (2.5%) of 270 primary breast cancer specimens and in 11(20%) of 55 ER+ MBC specimens. Among the 11 MBC specimens, 5 specimens (45.5%) had the most common ESR1 mutation, Y537S, 4 specimens (36.3%) each had D538G, Y537N, and Y537C. Interestingly, 2 patients had 2 ESR1 mutations, Y537N/D538G and Y537S/Y537C, and 2 patients had 3 ESR1 mutations, Y537S/Y537N/D538G. Biopsy was performed in heterochrony in 8 women twice. In 8 women, 4 women had primary breast cancer and MBC specimens and 4 women had 2 specimens when treatment was failure. Four of these 8 women acquired ESR1 mutation, whereas no ESR1 mutation could be identified at first biopsy. ddPCR technique could be a promising tool for the next-generation sequencing-free precise detection of ESR1 mutations in endocrine therapy resistant cases and may assist in determining the treatment strategy. (Translational Research 2015;166:540-553)	[Takeshita, Takashi] Kumamoto Univ, Grad Sch Med Sci, Dept Breast & Endocrine Surg, Kumamoto 8608556, Japan; Kumamoto Univ Hosp, Dept Mol Targeting Therapy Breast Canc, Kumamoto, Japan; Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Breast Surg, Kyoto, Japan	Iwase, H (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Breast & Endocrine Surg, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hiwase@kumamoto-u.ac.jp			Ministry of Education, Science and Culture of Japan [26461952]	This work was supported in part by a grant-in-aid (project numbers 26461952) for scientific research from the Ministry of Education, Science and Culture of Japan	Ellis MJ, 2009, JAMA-J AM MED ASSOC, V302, P774, DOI 10.1001/jama.2009.1204; Weis KE, 1996, MOL ENDOCRINOL, V10, P1388, DOI 10.1210/me.10.11.1388; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Baum M, 2002, LANCET, V359, P2131; Sefrioui D, 2015, INT J CANCER, V137, P2513, DOI 10.1002/ijc.29612; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Jordan VC, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv075; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Fan X, 2001, INT J ONCOL, V18, P1023; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Iwase H, 2013, BRIT J CANCER, V109, P1537, DOI 10.1038/bjc.2013.520; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; FUQUA SAW, 1992, CANCER RES, V52, P483; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Jeselsohn R, 2014, CLIN CANCER RES, V20, P1757, DOI 10.1158/1078-0432.CCR-13-2332; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Goldhirsch A, 2003, J CLIN ONCOL, V21, P3357, DOI 10.1200/JCO.2003.04.576; Iwase H, 2008, BREAST CANCER-TOKYO, V15, P278, DOI 10.1007/s12282-008-0071-y; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Gradishar WJ, 2014, J NATL COMPR CANC NE, V12, P542; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Goldhirsch A, 2005, ANN ONCOL, V16, P1569, DOI 10.1093/annonc/mdi326; Bell DW, 2005, J CLIN ONCOL, V23, P8081, DOI 10.1200/JCO.2005.02.7078; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Takeshita T, 2013, ENDOCR-RELAT CANCER, V20, pL15, DOI 10.1530/ERC-13-0317; Omoto Y, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0851-8	30	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1931-5244	1878-1810		TRANSL RES	Transl. Res.	DEC	2015	166	6					540	553		10.1016/j.trsl.2015.09.003		14	Medical Laboratory Technology; Medicine, General & Internal; Medicine, Research & Experimental	Medical Laboratory Technology; General & Internal Medicine; Research & Experimental Medicine	CY5JR	WOS:000366444400003		
J	Aoki, I; Yoneyama, M; Hirose, J; Minemoto, Y; Koyama, T; Kokuryo, D; Bakalova, R; Murayama, S; Saga, T; Aoshima, S; Ishizaka, Y; Kono, K				Aoki, Ichio; Yoneyama, Misao; Hirose, Jun; Minemoto, Yuzuru; Koyama, Takayoshi; Kokuryo, Daisuke; Bakalova, Rumiana; Murayama, Shuhei; Saga, Tsuneo; Aoshima, Sadahito; Ishizaka, Yukihito; Kono, Kenji			Thermoactivatable polymer-grafted liposomes for low-invasive image-guided chemotherapy	TRANSLATIONAL RESEARCH			English	Article							TEMPERATURE-SENSITIVE LIPOSOMES; LIVING CATIONIC-POLYMERIZATION; POSITRON-EMISSION-TOMOGRAPHY; TUMOR-SPECIFIC CHEMOTHERAPY; TRIGGERED DRUG-RELEASE; MAGNETIC-RESONANCE; THERMOSENSITIVE LIPOSOMES; MANGANESE NEUROTOXICITY; LOCAL HYPERTHERMIA; XENOGRAFT MODEL	The objective of this study was to develop a thermotriggered, polymer-based liposomal drug carrier with an activatable magnetic resonance imaging (MRI) contrast property for monitoring the release of substances and for localized tumor therapy. The multimodal thermoactivatable polymer-grafted liposomes (MTPLs) were tested to investigate whether the accumulation of MTPLs in colon-26 grafted tumors could be visualized in vivo using MRI and optical imaging, whether MTPLs induce signal enhancement, reflecting the release of their contents, after triggering by short-term heating (42.5 degrees C for 10 minutes) 9 hours after MTPL administration (late-phase triggering), and whether MTPLs can provide a sufficient antitumor effect. The imaging and therapeutic properties of MTPLs were tested both in vitro and in vivo (BALB/c nude mice: heated group with MTPLs (n = 5), nonheated group with MTPLs (n = 5), heated group with doxorubicin-free MTPLs (n = 5), nonheated group with manganese-free MTPLs (n = 5), and kinetics observation group (n = 3); N = 23). Through in vivo MRI and fluorescent imaging, the MTPLs were shown to have significantly accumulated in the grafted colon-26 tumors 8 hours after administration. Delayed thermotriggering (9 hours after administration) caused MR signal enhancement, reflecting the release of their contents, after a short exposure to tolerable heat. In addition, significant antitumor effects were observed after treatment. The proposed polymer-based activatable MTPLs with a "delayed thermotrigger" provide a promising technology for cancer theranostics that allows minimal adverse effects and rapid interactive therapy.	Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 2638555, Japan; Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Sakai, Osaka 591, Japan; Natl Ctr Global Hlth & Med, Dept Intractable Dis, Tokyo, Japan; Osaka Univ, Grad Sch Sci, Dept Macromol Sci, Toyonaka, Osaka 560, Japan	Aoki, I (reprint author), Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, Anagawa 4-9-1, Chiba 2638555, Japan.	aoki@nirs.go.jp			Kakenhi [24300167]; Center of Innovation (COI) Stream from Ministry of Education, Culture, Sports, Science, and Technology	This research was partly supported by grants from the Kakenhi (#24300167) and the Center of Innovation (COI) Stream from Ministry of Education, Culture, Sports, Science, and Technology.	de Smet M, 2010, J CONTROL RELEASE, V143, P120, DOI 10.1016/j.jconrel.2009.12.002; SCHEUHAMMER AM, 1985, BIOCHIM BIOPHYS ACTA, V840, P163, DOI 10.1016/0304-4165(85)90115-1; Kono K, 2005, BIOCONJUGATE CHEM, V16, P1367, DOI 10.1021/bc050004z; Kong G, 2001, CANCER RES, V61, P3027; Bikram M, 2008, EXPERT OPIN DRUG DEL, V5, P1077, DOI 10.1517/17425247.5.10.1077 ; Urakami T, 2007, J MED CHEM, V50, P6454, DOI 10.1021/jm7010518; Aoki I, 2004, NEUROIMAGE, V22, P1046, DOI 10.1016/j.neuroimage.2004.03.031; Aoki I, 2006, NMR BIOMED, V19, P50, DOI 10.1002/nbm.1000; Viglianti BL, 2006, MAGN RESON MED, V56, P1011, DOI 10.1002/mrm.21032; Itoh K, 2008, NEUROSCIENCE, V154, P732, DOI 10.1016/j.neuroscience.2008.03.080; UNGER EC, 1989, RADIOLOGY, V171, P81; Northfelt DW, 1996, J CLIN PHARMACOL, V36, P55; Ponce AM, 2007, J NATL CANCER I, V99, P53, DOI 10.1093/jnci/djk005; CHAN TW, 1992, INVEST RADIOL, V27, P443, DOI 10.1097/00004424-199206000-00009; Kono K, 2010, BIOMATERIALS, V31, P7096, DOI 10.1016/j.biomaterials.2010.05.045; Wells J, 2003, INT J PHARM, V261, P105, DOI 10.1016/S0378-5173(03)00290-4; Kono K, 2002, J CONTROL RELEASE, V80, P321, DOI 10.1016/S0168-3659(02)00018-4; YATVIN MB, 1978, SCIENCE, V202, P1290, DOI 10.1126/science.364652; Cheung BCL, 1998, BBA-BIOMEMBRANES, V1414, P205, DOI 10.1016/S0005-2736(98)00168-0; ARCHIBALD FS, 1987, ARCH BIOCHEM BIOPHYS, V256, P638, DOI 10.1016/0003-9861(87)90621-7; MILDVAN AS, 1963, BIOCHEMISTRY-US, V2, P910, DOI 10.1021/bi00905a003; Kong G, 2000, CANCER RES, V60, P4440; Davidsen J, 2003, BBA-BIOMEMBRANES, V1609, P95, DOI 10.1016/S0005-2736(02)00659-4; CHAPMAN BE, 1973, BIOINORG CHEM, V3, P27, DOI 10.1016/S0006-3061(00)81011-X; Needham D, 2000, CANCER RES, V60, P1197; Kono K, 2011, BIOMATERIALS, V32, P1387, DOI 10.1016/j.biomaterials.2010.10.050; Kong G, 2000, CANCER RES, V60, P6950; MARUYAMA K, 1993, BIOCHIM BIOPHYS ACTA, V1149, P209, DOI 10.1016/0005-2736(93)90203-C; Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5; BULTE JWM, 1993, MAGNET RESON MED, V29, P32, DOI 10.1002/mrm.1910290108; Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]; Kano MR, 2007, P NATL ACAD SCI USA, V104, P3460, DOI 10.1073/pnas.0611660104; Herth MM, 2009, BIOMACROMOLECULES, V10, P1697, DOI 10.1021/bm8014736; GRAHAM DG, 1984, NEUROTOXICOLOGY, V5, P83; Ni Y, 1997, ACTA RADIOL, V38, P700; WEINSTEIN JN, 1979, SCIENCE, V204, P188, DOI 10.1126/science.432641; BARBEAU A, 1984, NEUROTOXICOLOGY, V5, P13; AOSHIMA S, 1992, J POLYM SCI POL CHEM, V30, P2407, DOI 10.1002/pola.1992.080301115; FORNASIERO D, 1987, INVEST RADIOL, V22, P322, DOI 10.1097/00004424-198704000-00008; Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V58, P409, DOI 10.1016/j.ejpb.2004.03.019; Viglianti BL, 2004, MAGNET RESON MED, V51, P1153, DOI 10.1002/mrm.20074; Ponce AM, 2006, INT J HYPERTHER, V22, P205, DOI 10.1080/02656730600582956; Mills JK, 2005, BBA-BIOMEMBRANES, V1716, P77, DOI 10.1016/j.bbamem.2005.08.007; Tsukioka Y, 2002, JPN J CANCER RES, V93, P1145; Ruel-Gariepy E, 2002, J CONTROL RELEASE, V82, P373, DOI 10.1016/S0168-3659(02)00146-3; MATSUMURA Y, 1986, CANCER RES, V46, P6387; YATVIN MB, 1984, STRAHLENTHER ONKOL, V160, P732; GUSS R, 1984, INVEST OPHTH VIS SCI, V25, P758; GERDIN B, 1985, INT J TISSUE REACT, V7, P373; Koylu MZ, 2009, MOLECULES, V14, P1537, DOI 10.3390/molecules14041537; HUNTER DR, 1980, CIRC RES, V47, P721; Aoki I, 2008, 16 SCI M EXH INT SOC, P796; ASCHNER M, 1991, NEUROSCI BIOBEHAV R, V15, P333, DOI 10.1016/S0149-7634(05)80026-0; CARIDE V J, 1984, Magnetic Resonance Imaging, V2, P107, DOI 10.1016/0730-725X(84)90064-X; Han HD, 2006, J PHARM SCI-US, V95, P1909, DOI 10.1002/jps.20646; Kokuryo D, 2015, NANOMED-NANOTECHNOL, V11, P229, DOI 10.1016/j.nano.2014.09.001; MAEDA H, 1989, CRIT REV THER DRUG, V6, P193; NANDEDKA.AK, 1973, INT J PEPT PROT RES, V5, P279; World-Health-Organization, 1996, GUID DRINK WAT QUAL, P276	59	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1931-5244	1878-1810		TRANSL RES	Transl. Res.	DEC	2015	166	6					660	673		10.1016/j.trsl.2015.07.009		14	Medical Laboratory Technology; Medicine, General & Internal; Medicine, Research & Experimental	Medical Laboratory Technology; General & Internal Medicine; Research & Experimental Medicine	CY5JR	WOS:000366444400012		
J	Tyutyunnikov, D; Mitsuhara, M; Koch, CT				Tyutyunnikov, Dmitry; Mitsuhara, Masatoshi; Koch, Christoph T.			Two-dimensional misorientation mapping by rocking dark-field transmission electron microscopy	ULTRAMICROSCOPY			English	Article						Crystal lattice misorientation mapping; Transmission electron microscopy; Dark-field imaging; Ni-based superalloy; Numerical optimization	STRAIN-MEASUREMENTS; DIFFRACTION DATA; TEM; HOLOGRAPHY	In this paper we introduce an approach for precise orientation mapping of crystalline specimens by means of transmission electron microscopy. We show that local orientation values can be reconstructed from experimental dark-field image data acquired at different specimen tilts and multiple Bragg reflections. By using the suggested method it is also possible to determine the orientation of the tilt axis with respect to the image or diffraction pattern. The method has been implemented to automatically acquire the necessary data and then map crystal orientation for a given region of interest. We have applied this technique to a specimen prepared from a Ni-based super-alloy CMSX-4. The functionality and limitations of our method are discussed and compared to those of other techniques available. (C) 2015 Elsevier B.V. All rights reserved.	[Tyutyunnikov, Dmitry; Koch, Christoph T.] Univ Ulm, Inst Expt Phys, D-89081 Ulm, Germany; [Mitsuhara, Masatoshi] Kyushu Univ, Fac Engn Sci, Dept Engn Sci Elect & Mat, Fukuoka 8168580, Japan	Tyutyunnikov, D (reprint author), Univ Ulm, Inst Expt Phys, Albert Einstein Allee 11, D-89081 Ulm, Germany.	dmitry.tyutyunnikov@uni-ulm.de			Carl Zeiss Foundation; German Research Foundation (DFG) [KO 2911/7-1]	The authors acknowledge financial support by the Carl Zeiss Foundation as well as the German Research Foundation (DFG, Grant no. KO 2911/7-1). The authors also acknowledge the Stuttgart Center for Electron Microscopy (StEM) headed by Prof. Peter van Aken for the opportunity to carry out the experiment. The authors also acknowledge Kersten Hahn for assistance during the microscope sessions and for measuring the rotation of diffraction plane with respect to the specimen.	Koch CT, 2006, MICROSC MICROANAL, V12, P506, DOI 10.1017/S1431927606060624; Kumar V, 2013, IEEE T IMAGE PROCESS, V22, P2637, DOI 10.1109/TIP.2013.2255299; Wright SI, 1998, MATER SCI FORUM, V273-2, P209; Pennington RS, 2015, ULTRAMICROSCOPY, V155, P42, DOI 10.1016/j.ultramic.2015.04.002; Liu HH, 2011, SCIENCE, V332, P833, DOI 10.1126/science.1202202; Beche A, 2013, ULTRAMICROSCOPY, V131, P10, DOI 10.1016/j.ultramic.2013.03.014; Schaffer B, 2004, ULTRAMICROSCOPY, V102, P27, DOI 10.1016/j.ultramic.2004.08.003; Hytch MJ, 1998, ULTRAMICROSCOPY, V74, P131, DOI 10.1016/S0304-3991(98)00035-7; Ozdol VB, 2010, J APPL PHYS, V108, DOI 10.1063/1.3476285; Morawiec A, 2014, ULTRAMICROSCOPY, V136, P107, DOI [10.1016/j.ultramic.2013.08.008, 10.1010/j.ultramic.2013.08.008]; Rauch EF, 2014, MATER CHARACT, V98, P1, DOI 10.1016/j.matchar.2014.08.010; Javon E, 2014, ULTRAMICROSCOPY, V147, P70, DOI 10.1016/j.ultramic.2014.06.005; Fundenberger JJ, 2003, ULTRAMICROSCOPY, V96, P127, DOI 10.1016/S0304-3991(02)00435-7; Wilkinson AJ, 2010, PHILOS MAG, V90, P1159, DOI 10.1080/14786430903304145; Hytch M, 2008, NATURE, V453, P1086, DOI 10.1038/nature07049; Volkl R, 1998, ACTA MATER, V46, P4395, DOI 10.1016/S1359-6454(98)00085-8; Fundenberger JJ, 2005, SOL ST PHEN, V105, P37; Dingley DJ, 2006, MICROCHIM ACTA, V155, P19, DOI 10.1007/s00604-006-0502-4; Pennington RS, 2015, ULTRAMICROSCOPY, V148, P105, DOI 10.1016/j.ultramic.2014.10.006; Carter C. B., 2009, TRANSMISSION ELECT M; De Graef M., 2003, INTRO CONVENTIONAL T; Dingley DJ, 2005, MATER SCI FORUM, V495-497, P225; Feller William, 1950, INTRO PROBABILITY TH, V1; Igel C, 2000, P 2 INT ICSC S NEUR, P115; Koch C. T., 2010, APPL PHYS LETT, V96; Lattman Eaton E., 1972, ACTA CRYSTALLOGR B, P1065; LIU Q, 1995, ULTRAMICROSCOPY, V60, P81, DOI 10.1016/0304-3991(95)00049-7; Martin Y., ULTRAMICROS IN PRESS; MOCK P, 1991, CRYST RES TECHNOL, V26, P653, DOI 10.1002/crat.2170260519; Moeck Peter, 2011, 2011 11 IEEE INT C N; Pennington R. S., 2014, PHYS REV B, V89; Rauch E. F., 2008, MICROSC ANAL, V22, pS5; Song K., 2014, ADV MATER INTERFACES, V2014; Spence J.C.H., 1992, ELECT MICRODIFFRACTI; Taylor Camillo J., 1994, 9405 YAL U; Tyutyunnikov Dmitry, 2014, ULTRAMICROSCOPY, V150, P37; Vineet Kumar, 2012, Patent No. [US 20120025073, 20120025073]; Wu Guilin, 2009, ULTRAMICROSCOPY	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3991	1879-2723		ULTRAMICROSCOPY	Ultramicroscopy	DEC	2015	159		1				26	33		10.1016/j.ultramic.2015.07.003		8	Microscopy	Microscopy	CY2DW	WOS:000366220000004		
J	Yoshida, K; Biskupek, J; Kurata, H; Kaiser, U				Yoshida, Kaname; Biskupek, Johannes; Kurata, Hiroki; Kaiser, Ute			Critical conditions for atomic resolution imaging of molecular crystals by aberration-corrected HRTEM	ULTRAMICROSCOPY			English	Article						Molecular crystal; Aberration-corrected HRTEM; Light element imaging	TRANSMISSION ELECTRON-MICROSCOPY; CHLORINATED COPPER PHTHALOCYANINE; EPITAXIAL-GROWTH; RADIATION-DAMAGE; PHASE PLATES; CRYO-EM; GRAPHENE; VOLTAGE; BEAM; MICROGRAPHS	Atomically resolved imaging of organic molecules consisting of thin crystals by aberration-corrected (AC) HRTEM was studied by experimental observations and image simulations. An atomically resolved image of the hexadecachlorophthalocyanatocopper (CuPcCl16) molecule was obtained under low-dose conditions. The conditions for imaging organic frameworks were found to be more restricted than those for heavier elements such as copper and chlorine. For the characterization of the benzene rings within CuPcCl16 molecules, the specimen thickness had to be less than similar to 5 nm. The effects of the defocus conditions were examined by changing the image according to the location of the inclined specimen. The optimal defocus range for atomic resolution imaging of organic molecules was limited to a narrow region around the Scherzer defocus. Compared with scanning transmission microscopy, AC-HRTEM is more suitable for low-dose imaging, but the optimum conditions were severely restricted. (C) 2015 Elsevier B.V. All rights reserved.	[Yoshida, Kaname] Japan Fine Ceram Ctr, Atsuta Ku, Nagoya, Aichi 4568587, Japan; [Biskupek, Johannes; Kaiser, Ute] Univ Ulm, Electron Microscopy Grp Mat Sci, D-89081 Ulm, Germany; [Kurata, Hiroki] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan	Yoshida, K (reprint author), Japan Fine Ceram Ctr, Atsuta Ku, 2-4-1 Mutsuno, Nagoya, Aichi 4568587, Japan.	kaname_yoshida@jfcc.or.jp					Allegretti M, 2014, ELIFE, V3, DOI 10.7554/eLife.01963; SYMONS MCR, 1982, ULTRAMICROSCOPY, V10, P15, DOI 10.1016/0304-3991(82)90183-8; SAITO Y, 1984, J CRYST GROWTH, V67, P91, DOI 10.1016/0022-0248(84)90135-0; Kuznetsov YG, 1997, BIOPHYS J, V72, P2357; Zhang ZL, 2003, SCIENCE, V302, P846, DOI 10.1126/science.1089785; Findlay SD, 2010, ULTRAMICROSCOPY, V110, P903, DOI 10.1016/j.ultramic.2010.04.004; Guillermet O, 2011, CHEM PHYS LETT, V511, P482, DOI 10.1016/j.cplett.2011.06.079; KIRKLAND EJ, 1985, ULTRAMICROSCOPY, V17, P87, DOI 10.1016/0304-3991(85)90002-6; Kurasch S, 2012, NANO LETT, V12, P3168, DOI 10.1021/nl301141g; STENN K, 1970, J ULTRA MOL STRUCT R, V31, P526, DOI 10.1016/S0022-5320(70)90167-X; CLARK WRK, 1979, NATURE, V277, P368, DOI 10.1038/277368a0; UYEDA N, 1979, CHEM SCRIPTA, V14, P47; Ishikawa R, 2011, NAT MATER, V10, P278, DOI [10.1038/nmat2957, 10.1038/NMAT2957]; KIRKLAND EJ, 1984, ULTRAMICROSCOPY, V15, P151, DOI 10.1016/0304-3991(84)90037-8; Jia CL, 2008, NAT MATER, V7, P57, DOI 10.1038/nmat2080; Jia CL, 2003, SCIENCE, V299, P870, DOI 10.1126/science.1079121; Girlando A, 2010, CRYST GROWTH DES, V10, P2752, DOI 10.1021/cg100253k; FUJIYOSHI Y, 1980, ULTRAMICROSCOPY, V5, P459, DOI 10.1016/0304-3991(80)90046-7; CLARK WRK, 1980, ULTRAMICROSCOPY, V5, P195, DOI 10.1016/0304-3991(80)90024-8; Lentzen M, 2006, MICROSC MICROANAL, V12, P191, DOI 10.1017/S1431927606060326; Ruskin RS, 2013, J STRUCT BIOL, V184, P385, DOI 10.1016/j.jsb.2013.10.016; Malac M, 2008, ULTRAMICROSCOPY, V108, P126, DOI 10.1016/j.ultramic.2007.03.008; UYEDA N, 1972, J APPL PHYS, V43, P5181, DOI 10.1063/1.1661094; COWLEY JM, 1957, ACTA CRYSTALLOGR, V10, P609, DOI 10.1107/S0365110X57002194; Bammes BE, 2012, J STRUCT BIOL, V177, P589, DOI 10.1016/j.jsb.2012.01.008; Swart I, 2011, CHEM COMMUN, V47, P9011, DOI 10.1039/c1cc11404b; Krivanek OL, 2010, ULTRAMICROSCOPY, V110, P935, DOI 10.1016/j.ultramic.2010.02.007; SCHERZER O, 1949, J APPL PHYS, V20, P20, DOI 10.1063/1.1698233; Westenfelder B, 2011, NANO LETT, V11, P5123, DOI 10.1021/nl203224z; Girit CO, 2009, SCIENCE, V323, P1705, DOI 10.1126/science.1166999; WANG ZL, 1993, ULTRAMICROSCOPY, V52, P504, DOI 10.1016/0304-3991(93)90067-8; Puzzo DP, 2011, NANO LETT, V11, P1457, DOI 10.1021/nl104036c; Yoshida K, 2013, MICROSCOPY-JPN, V62, P369, DOI 10.1093/jmicro/dfs087; Egerton RF, 2014, ULTRAMICROSCOPY, V145, P85, DOI 10.1016/j.ultramic.2013.10.019; Rajeswaran M, 2009, POLYHEDRON, V28, P835, DOI 10.1016/j.poly.2008.12.022; Lee Z, 2012, ULTRAMICROSCOPY, V112, P39, DOI 10.1016/j.ultramic.2011.10.009; SAITO Y, 1985, APPL SURF SC, V22-3, P574, DOI 10.1016/0378-5963(85)90188-6; Lentzen M, 2002, ULTRAMICROSCOPY, V92, P233, DOI 10.1016/S0304-3991(02)00139-0; Danev R, 2011, ULTRAMICROSCOPY, V111, P1305, DOI 10.1016/j.ultramic.2011.04.004; LICHTE H, 1991, ULTRAMICROSCOPY, V38, P13, DOI 10.1016/0304-3991(91)90105-F; Goswami M, 2009, CHEM CENT J, V3, DOI 10.1186/1752-153X-3-15; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Jia CL, 2004, SCIENCE, V303, P2001, DOI 10.1126/science.1093617; Findlay SD, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.116603; Haruta M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00252; Huang R, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3551538; Ichii T, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3114380; Kilaas R, 1998, J MICROSC-OXFORD, V190, P45, DOI 10.1046/j.1365-2818.1998.3070861.x; Komeda T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1210; Kotakoski J, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.105505; Kotakoski J, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.245420; Lunt RR, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.064114; Okunishi E, 2009, MICROSC MICROANAL, V15, P164, DOI 10.1017/S1431927609093891; Reimer L., 1997, TRANSMISSION ELECT M	54	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3991	1879-2723		ULTRAMICROSCOPY	Ultramicroscopy	DEC	2015	159		1				73	80		10.1016/j.ultramic.2015.08.006		8	Microscopy	Microscopy	CY2DW	WOS:000366220000009		
J	Close, R; Chen, Z; Shibata, N; Findlay, SD				Close, R.; Chen, Z.; Shibata, N.; Findlay, S. D.			Towards quantitative, atomic-resolution reconstruction of the electrostatic potential via differential phase contrast using electrons	ULTRAMICROSCOPY			English	Article						Scanning transmission electron microscopy (STEM); Differential phasecontrast (DPC) imaging	BLOCH WAVE ANALYSIS; WEAK-PHASE; OBJECT APPROXIMATION; IMAGE-RECONSTRUCTION; FOCUS-VARIATION; MICROSCOPY; STEM; FIELD; RETRIEVAL; DETECTOR	Differential phase contrast images in scanning transmission electron microscopy can be directly and quantitatively related to the gradient or the projected specimen potential provided that (a) the specimen can be treated as a phase object and (b) loll 20 diffraction patterns as a function of probe position can be obtained. Both are challenging to achieve in atomic resolution imaging. The former is fundamentally limited by probe spreading and dynamical electron scattering, and we explore its validity domain in the context of atomic resolution differential phase contrast imaging. The latter, for which proof-of-principle experimental data sets exist, is not yet routine. We explore the extent to which more established segmented detector geometries can instead be used to reconstruct a quantitatively good approximation to the projected specimen potential. (C) 2015 Elsevier B.V. All rights reserved	[Close, R.; Chen, Z.; Findlay, S. D.] Monash Univ, Sch Phys & Astron, Clayton, Vic 3800, Australia; [Shibata, N.] Univ Tokyo, Sch Engn, Inst Engn Innovat, Tokyo 1138656, Japan	Findlay, SD (reprint author), Monash Univ, Sch Phys & Astron, Clayton, Vic 3800, Australia.	scott.findlay@monash.edu			Australian Research Councils [DP110101570, DP140102538]; SENTAN; JST; JSPS KAKENHI [26289234]	S.D.F. thanks M.D. de Jonge and L.J. Allen for helpful discussions. This research was supported under the Australian Research Councils Discovery Projects funding scheme (Projects DP110101570 and DP140102538). N.S. acknowledges support from SENTAN, JST and JSPS KAKENHI Grant number 26289234.	CHAPMAN JN, 1992, ULTRAMICROSCOPY, V47, P331, DOI 10.1016/0304-3991(92)90162-D; Maiden AM, 2012, J OPT SOC AM A, V29, P1606, DOI 10.1364/JOSAA.29.001606; Zuo JM, 2003, SCIENCE, V300, P1419, DOI 10.1126/science.1083887; Cosgriff EC, 2007, ULTRAMICROSCOPY, V107, P626, DOI 10.1016/j.ultramic.2006.12.004; Coene WMJ, 1996, ULTRAMICROSCOPY, V64, P109, DOI 10.1016/0304-3991(96)00010-1; LI FH, 1985, ACTA CRYSTALLOGR A, V41, P376, DOI 10.1107/S0108767385000800; Shibata N, 2010, J ELECTRON MICROSC, V59, P473, DOI 10.1093/jmicro/dfq014; COENE W, 1992, PHYS REV LETT, V69, P3743, DOI 10.1103/PhysRevLett.69.3743; ROSE H, 1977, ULTRAMICROSCOPY, V2, P251; DEKKERS NH, 1974, OPTIK, V41, P452; Pennycook TJ, 2015, ULTRAMICROSCOPY, V151, P160, DOI 10.1016/j.ultramic.2014.09.013; CHAPMAN JN, 1990, IEEE T MAGN, V26, P1506, DOI 10.1109/20.104427; D'Alfonso AJ, 2007, ULTRAMICROSCOPY, V108, P17, DOI 10.1016/j.ultramic.2007.02.026; Kimoto K, 2011, ULTRAMICROSCOPY, V111, P1111, DOI 10.1016/j.ultramic.2011.01.029; Yang H, 2015, ULTRAMICROSCOPY, V151, P232, DOI 10.1016/j.ultramic.2014.10.013; Bauer B, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4880209; CHAPMAN JN, 1978, ULTRAMICROSCOPY, V3, P203, DOI 10.1016/S0304-3991(78)80027-8; HAMMEL M, 1995, ULTRAMICROSCOPY, V58, P403, DOI 10.1016/0304-3991(95)00007-N; Meyer RR, 2002, ULTRAMICROSCOPY, V92, P89, DOI 10.1016/S0304-3991(02)00071-2; de Jonge MD, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.163902; MORRISON GR, 1983, OPTIK, V64, P1; COWLEY JM, 1993, ULTRAMICROSCOPY, V49, P4, DOI 10.1016/0304-3991(93)90208-F; Faulkner HML, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.023903; Shibata N, 2012, NAT PHYS, V8, P611, DOI [10.1038/nphys2337, 10.1038/NPHYS2337]; Haigh SJ, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.126101; NELLIST PD, 1995, NATURE, V374, P630, DOI 10.1038/374630a0; Uhlig T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.237205; Morishita S, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3003582; ROSE H, 1974, OPTIK, V39, P416; Ishida T, 2015, MICROSCOPY-JPN, V64, P121, DOI 10.1093/jmicro/dfu113; McCallum BC, 1995, OPTIK, V101, P53; Rodenburg JM, 2004, APPL PHYS LETT, V85, P4795, DOI 10.1063/1.1823034; Peng YP, 2004, J ELECTRON MICROSC, V53, P257, DOI 10.1093/jmicro/53.3.257; Xin HL, 2010, MICROSC MICROANAL, V16, P445, DOI 10.1017/S1431927610093360; LOANE RF, 1991, ACTA CRYSTALLOGR A, V47, P267, DOI 10.1107/S0108767391000375; Piana M, 1996, J OPT SOC AM A, V13, P1516, DOI 10.1364/JOSAA.13.001516; Morgan AJ, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.094115; Allen LJ, 2004, ULTRAMICROSCOPY, V100, P91, DOI 10.1016/j.ultramic.2004.01.012; Jia CL, 1999, PHYS REV LETT, V82, P5052, DOI 10.1103/PhysRevLett.82.5052; Uhlig T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.047203; Wu JS, 2005, NAT MATER, V4, P912, DOI 10.1038/nmat1531; LeBeau JM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.206101; RODENBURG JM, 1992, PHILOS T ROY SOC A, V339, P521, DOI 10.1098/rsta.1992.0050; Putkunz CT, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.073901; Allen LJ, 2001, OPT COMMUN, V199, P65, DOI 10.1016/S0030-4018(01)01556-5; Ishida T, 2015, MICROSCOPY-JPN, V64, P69, DOI 10.1093/jmicro/dfu098; Lohr M, 2012, ULTRAMICROSCOPY, V117, P7, DOI 10.1016/j.ultramic.2012.03.020; WADDELL EM, 1979, OPTIK, V54, P83; LANDAUER MN, 1995, OPTIK, V100, P37; HAIDER M, 1994, ULTRAMICROSCOPY, V54, P41, DOI 10.1016/0304-3991(94)90091-4; PENNYCOOK SJ, 1991, ULTRAMICROSCOPY, V37, P14, DOI 10.1016/0304-3991(91)90004-P; Vulovic M, 2014, ULTRAMICROSCOPY, V136, P61, DOI [10.1016/j.ultramic.2013.08.002, 10.1010/j.ultramic.2013.08.002]; Burge R. E., 1980, I PHYSICS C SERIES, V52, P249; D'Alfonso AJ, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.064101; VANDYCK D, 1985, ADV IMAG ELECTR PHYS, V65, P295; Huang W., 2005, NAT MATER, V4, P912; Humphry MJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1733; Kikland A., 1995, ULTRAMICRSOCOPY, V57, P355; Kirkland E. J., 1998, ADV COMPUTING ELECT; Lichte H, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/1/016102; Lick M., 2012, ULTRAMICROSCOPY, V116, P13; Lubk A, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.023805; LYNCH DF, 1975, ACTA CRYSTALLOGR A, VA 31, P300, DOI 10.1107/S0567739475000642; Majert S., 2014, ULTRAMICROSCOPY, V148, P81; MISELL DL, 1976, J PHYS D APPL PHYS, V9, P1849, DOI 10.1088/0022-3727/9/13/006; Muller K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6653; Plamann T, 1998, ACTA CRYSTALLOGR A, V54, P61, DOI 10.1107/S0108767397010507; Shibata N, 2015, SCI REP-UK, V5, DOI 10.1038/srep10040	68	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3991	1879-2723		ULTRAMICROSCOPY	Ultramicroscopy	DEC	2015	159		1				124	137		10.1016/j.ultramic.2015.09.002		14	Microscopy	Microscopy	CY2DW	WOS:000366220000014		
J	Takahashi, J; Haga, J; Kawakami, K; Ushioda, K				Takahashi, J.; Haga, J.; Kawakami, K.; Ushioda, K.			Observation of co-segregation of titanium and boron at the interface between recrystallized and unrecrystallized grains in cold-rolled interstitial-free steel sheets	ULTRAMICROSCOPY			English	Article						Atom probe; Interface; Grain boundary; Segregation; Boron; Titanium; Solute drag	ATOM-PROBE TOMOGRAPHY; BOUNDARY MOTION; CARBON; APFIM; IRON; DRAG	It has been reported that the addition of ppm levels of B strongly retarded the growth of recrystallized grain into unrecrystallized grains in the process of cold-rolling and annealing of Ti-added interstitial-free (IF) ferritic steels. This phenomenon was explained by solute drag effect based on the assumption that, during annealing, B atoms segregate at the interface between recrystallized and unrecrystallized grains where they interact with Ti atoms. To verify this, atom probe tomography analysis of the interface was performed in Ti-added IF steels with and without B addition. Needle tips containing the interface identified from electron backscattering diffraction analysis, were produced by focused ion beam milling with the lift-out method. To increase the experiment reliability, the misorientation angle of the aimed interface was compared with that estimated by field ion microscopy analysis. Considerable amount of Ti segregation was observed at the interface in the steel without B addition, which increased with increasing amount of B segregation in the steel with B addition. The results suggest that the retardation of the interface migration was caused by solute drag effect based on the simultaneous co-segregation of Ti and B due to their attractive interaction. (C) 2015 Elsevier B.V. All rights reserved.	[Takahashi, J.; Haga, J.; Kawakami, K.; Ushioda, K.] Nippon Steel & Sumitomo Met Corp, Adv Technol Res Labs, Futtsu, Chiba 2938511, Japan	Takahashi, J (reprint author), Nippon Steel & Sumitomo Met Corp, Adv Technol Res Labs, 20-1 Shintomi, Futtsu, Chiba 2938511, Japan.	takahashi.3ct.jun@jp.nssmc.com					Boll T, 2007, ULTRAMICROSCOPY, V107, P796, DOI 10.1016/j.ultramic.2007.02.011; Miller MK, 2005, ULTRAMICROSCOPY, V102, P287, DOI [10.1016/j.ultramic.2004.10.011, 10.1016/J.ULTRAMIC.2004.10.011]; Rademacher T, 2011, ULTRAMICROSCOPY, V111, P719, DOI 10.1016/j.ultramic.2010.12.009; Takahashi J, 2014, ULTRAMICROSCOPY, V140, P20, DOI 10.1016/j.ultramic.2014.01.011; Thuvander M, 2000, MATER CHARACT, V44, P87, DOI 10.1016/S1044-5803(99)00052-2; Yao L, 2013, SCRIPTA MATER, V69, P622, DOI 10.1016/j.scriptamat.2013.07.013; Brechet YJM, 2003, ACTA MATER, V51, P5587, DOI 10.1016/S1359-6454(03)00422-1; Blavette D, 1996, ACTA MATER, V44, P4995, DOI 10.1016/S1359-6454(96)00087-0; SUZUKI S, 1981, SCRIPTA METALL MATER, V15, P1139, DOI 10.1016/0036-9748(81)90175-7; LUCKE K, 1971, ACTA METALL MATER, V19, P1087, DOI 10.1016/0001-6160(71)90041-1; Haga J, 1998, ISIJ INT, V38, P580, DOI 10.2355/isijinternational.38.580; Maruyama N, 2003, MAT SCI ENG A-STRUCT, V353, P126, DOI 10.1016/S0921-5093(02)00678-0; Gault B, 2012, ULTRAMICROSCOPY, V113, P182, DOI 10.1016/j.ultramic.2011.06.005; Takahashi J, 2007, ULTRAMICROSCOPY, V107, P744, DOI 10.1016/j.ultramic.2007.02.008; CAHN JW, 1962, ACTA METALL MATER, V10, P789, DOI 10.1016/0001-6160(62)90092-5; Haga J., 1999, CAMP ISIJ, V12, P1279; Haga J., 2015, CAMP ISIJ, V28, P317; KIMURA H, 1993, TETSU TO HAGANE, V79, pN754; Lejcek P, 2010, SPRINGER SER MATER S, V136, P1, DOI 10.1007/978-3-642-12505-8; MAITREPIERRE P, 1975, METALL TRANS A, V6, P287, DOI 10.1007/BF02667283; Miller M. K., 2000, ATOM PROBE TOMOGRAPH; Seidman D.N., 1992, MAT INTERFACES; Takahashi J, 2012, SCRIPTA MATER, V66, P207, DOI 10.1016/j.scriptamat.2011.10.026; Wachowicz E, 2011, MODEL SIMUL MATER SC, V19, DOI 10.1088/0965-0393/19/2/025001	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3991	1879-2723		ULTRAMICROSCOPY	Ultramicroscopy	DEC	2015	159		2				299	307		10.1016/j.ultramic.2015.03.019		9	Microscopy	Microscopy	CY2DX	WOS:000366220100024		
J	Tachibana, D; Kurihara, Y; Wada, N; Kitada, K; Nakagawa, K; Koyama, M				Tachibana, D.; Kurihara, Y.; Wada, N.; Kitada, K.; Nakagawa, K.; Koyama, M.			Flow velocity waveforms of the ductus venosus and atrioventricular valves in a case of fetal hemangiolymphangioma	ULTRASOUND IN OBSTETRICS & GYNECOLOGY			English	Letter							REFERENCE RANGES		[Tachibana, D.; Kurihara, Y.; Wada, N.; Kitada, K.; Nakagawa, K.; Koyama, M.] Osaka City Univ, Grad Sch Med, Dept Obstet & Gynecol, Abeno Ku, Osaka 558, Japan	Tachibana, D (reprint author), Osaka City Univ, Grad Sch Med, Dept Obstet & Gynecol, Abeno Ku, 1-4-3 Asahimachi, Osaka 558, Japan.	dtachibana@med.osaka-cu.ac.jp					Tachibana D, 2015, ULTRASOUND OBST GYN, V45, P544, DOI 10.1002/uog.13449; Nakagawa K, 2012, PRENATAL DIAG, V32, P803, DOI 10.1002/pd.3908; Wada N, 2015, ULTRASOUND OBST GYN, V46, P221, DOI 10.1002/uog.14717; Kurihara Y, 2015, PRENATAL DIAG, V35, P236, DOI 10.1002/pd.4527; MULLIKEN JB, 1982, PLAST RECONSTR SURG, V69, P412, DOI 10.1097/00006534-198203000-00002	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7692	1469-0705		ULTRASOUND OBST GYN	Ultrasound Obstet. Gynecol.	DEC	2015	46	6					744	745		10.1002/uog.14848		2	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	CX7BM	WOS:000365855700020		
J	Ishido, H; Masutani, S; Hishitani, T; Taketadu, M; Senzaki, H				Ishido, H.; Masutani, S.; Hishitani, T.; Taketadu, M.; Senzaki, H.			Re: 'Post-LA space index' as a potential novel marker for the prenatal diagnosis of isolated total anomalous pulmonary venous connection	ULTRASOUND IN OBSTETRICS & GYNECOLOGY			English	Letter									[Ishido, H.; Masutani, S.; Taketadu, M.; Senzaki, H.] Saitama Med Univ, Saitama Med Ctr, Dept Pediat, Kawagoe, Saitama 3508550, Japan; [Ishido, H.; Masutani, S.; Taketadu, M.; Senzaki, H.] Saitama Med Univ, Saitama Med Ctr, Dept Pediat Cardiol, Kawagoe, Saitama 3508550, Japan; [Hishitani, T.] Saitama Childrens Med Ctr, Pediat Cardiol, Saitama, Japan	Masutani, S (reprint author), Saitama Med Univ, Saitama Med Ctr, Dept Pediat, Staff Off Bldg 110,1981 Kamoda, Kawagoe, Saitama 3508550, Japan.	masutani@saitama-med.ac.jp					Seale AN, 2012, ULTRASOUND OBST GYN, V40, P310, DOI 10.1002/uog.11093; Kawazu Y, 2014, ULTRASOUND OBST GYN, V44, P682, DOI 10.1002/uog.13357	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7692	1469-0705		ULTRASOUND OBST GYN	Ultrasound Obstet. Gynecol.	DEC	2015	46	6					747	+		10.1002/uog.15756		2	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	CX7BM	WOS:000365855700023		
J	Kawazu, Y				Kawazu, Y.			Re: 'Post-LA space index' as a potential novel marker for the prenatal diagnosis of isolated total anomalous pulmonary venous connection Reply	ULTRASOUND IN OBSTETRICS & GYNECOLOGY			English	Letter									[Kawazu, Y.] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Dept Pediat Cardiol, Izumi Ku, Osaka, Japan	Kawazu, Y (reprint author), Osaka Med Ctr & Res Inst Maternal & Child Hlth, Dept Pediat Cardiol, Izumi Ku, Osaka, Japan.	kadoy@mch.pref.osaka.jp					Akkurt MO, 2015, J PERINAT MED, DOI [10.1515/jpm-2015-0147, DOI 10.1515/JPM-2015-0147]; Carvalho JS, 2013, ULTRASOUND OBST GYN, V41, P348, DOI 10.1002/uog.12403	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7692	1469-0705		ULTRASOUND OBST GYN	Ultrasound Obstet. Gynecol.	DEC	2015	46	6					748	748		10.1002/uog.15757		1	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	CX7BM	WOS:000365855700024		
J	Hamanaka, T; Nishizawa, K; Sakasegawa, Y; Teruya, K; Doh-ura, K				Hamanaka, Taichi; Nishizawa, Keiko; Sakasegawa, Yuji; Teruya, Kenta; Doh-ura, Katsumi			Structure-activity analysis and antiprion mechanism of isoprenoid compounds	VIROLOGY			English	Article						Isoprenoid; Prion; Juvenile hormone; Farnesol; Geranylgeraniol; Cholesterol; Prenylation; N2a cell; Antiprion; Strain	TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; PRION PROTEIN ACCUMULATION; CREUTZFELDT-JAKOB-DISEASE; CELL-SURFACE; NATURAL-PRODUCTS; CULTURED-CELLS; INFECTED CELLS; DOUBLE-BLIND; IN-VITRO; CHOLESTEROL	The prion strain-specific mechanism by which normal prion protein is converted to abnormal prion protein remains largely unknown. This study found that insect juvenile hormone III reduced abnormal prion protein levels only in cells infected with the RML prion. We conducted a structure-activity analysis using juvenile hormone III biosynthetic intermediates in the isoprenoid pathway. Both farnesol and geranylgeraniol, the most potent inhibitors of abnormal prion protein formation, behaved in an RML prion-dependent fashion. Neither of them modified cellular and cell surface prion protein levels. Events downstream of this pathway include cholesterol biosynthesis and protein prenylation. However, neither of these isoprenoid compounds modified lipid raft microdomains and cellular cholesterol levels and neither affected the representative prenylated protein expression levels of prenylation pathways. Therefore, these isoprenoid compounds are a new class of prion strain-dependent antiprion compounds. They are useful for exploring strain-specific prion biology. (C) 2015 Elsevier Inc. All rights reserved.	[Hamanaka, Taichi; Nishizawa, Keiko; Sakasegawa, Yuji; Teruya, Kenta; Doh-ura, Katsumi] Tohoku Univ, Grad Sch Med, Dept Neurochem, Sendai, Miyagi 9808575, Japan	Doh-ura, K (reprint author), Tohoku Univ, Grad Sch Med, Dept Neurochem, Aoba Ku, 2-1 Seiryocho, Sendai, Miyagi 9808575, Japan.	doh-ura@med.tohoku.ac.jp			JSPS [22390172]; MHLW, Japan [H22-ippan-009]; NIBIO, Japan [06-43]	We thank Yuka Fujiwara and Ayumi Oguma for technical assistance. This research was supported by a Grant (22390172) from JSPS, a Grant (H22-ippan-009) from MHLW, Japan, and a Grant (06-43) from NIBIO, Japan.	Doh-ura K, 2007, ANTIMICROB AGENTS CH, V51, P2274, DOI 10.1128/AAC.00917-06; Prior M, 2007, J VIROL, V81, P11195, DOI 10.1128/JVI.02559-06; Klingenstein R, 2006, J NEUROCHEM, V98, P748, DOI 10.1111/j.1471-4159.2006.03889.x; Ishikawa K, 2006, J NEUROCHEM, V99, P198, DOI 10.1111/j.1471-4159.2006.04035.x; Hirakawa T, 1996, GASTROENTEROLOGY, V111, P345, DOI 10.1053/gast.1996.v111.pm8690199; Endo S, 2007, MOL PHARMACOL, V72, P1337, DOI 10.1124/mol.107.039164; Kocisko DA, 2003, J VIROL, V77, P10288, DOI 10.1128/JVI.77.19.10288-10294.2003; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Pani A, 2007, ANTIMICROB AGENTS CH, V51, P4141, DOI 10.1128/AAC.00524-07; Kawasaki Y, 2007, J VIROL, V81, P12889, DOI 10.1128/JVI.01563-07; Ezzati-Tabrizi R, 2013, CURR PROTEIN PEPT SC, V14, P698; Bate C, 2004, J BIOL CHEM, V279, P14983, DOI 10.1074/jbc.M313061200; Supattapone S, 2009, CNS NEUROL DISORD-DR, V8, P323; Bate C, 2010, J BIOL CHEM, V285, P22017, DOI 10.1074/jbc.M110.108548; Gilch S, 2009, CELL MOL LIFE SCI, V66, P3979, DOI 10.1007/s00018-009-0158-4; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/aw1150; Lewis V, 2011, FRONT BIOSCI-LANDMRK, V16, P151, DOI 10.2741/3681; Teruya K, 2013, CURR TOP MED CHEM, V13, P2522; Ishikawa K, 2004, J GEN VIROL, V85, P1785, DOI 10.1099/vir.0.19754-0; Tagliavini F, 2000, J MOL BIOL, V300, P1309, DOI 10.1006/jmbi.2000.3840; Gilch S, 2006, MOL CELL NEUROSCI, V31, P346, DOI 10.1016/j.mcn.2005.10.008; Coxon FP, 2005, BONE, V37, P349, DOI 10.1016/j.bone.2005.04.021; Silber BM, 2013, PHARM RES-DORDR, V30, P932, DOI 10.1007/s11095-012-0912-4; Cui HHL, 2014, J BIOL CHEM, V289, P789, DOI 10.1074/jbc.M113.535807; Sim Valerie L., 2012, Infectious Disorders - Drug Targets, V12, P144; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Marella M, 2002, J BIOL CHEM, V277, P25457, DOI 10.1074/jbc.M203248200; Ratcliffe NA, 2011, INSECT BIOCHEM MOLEC, V41, P747, DOI 10.1016/j.ibmb.2011.05.007; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Heiseke A, 2010, CURR ISSUES MOL BIOL, V12, P87; Haik S, 2014, LANCET NEUROL, V13, P150, DOI 10.1016/S1474-4422(13)70307-7; Hamanaka T, 2011, BIOCHEM BIOPH RES CO, V405, P285, DOI 10.1016/j.bbrc.2011.01.030; Kumar R, 2008, J GEN VIROL, V89, P1525, DOI 10.1099/vir.0.83358-0; Otto M, 2004, NEUROLOGY, V62, P714; Slocinska M, 2008, PROTEIN PEPTIDE LETT, V15, P578, DOI 10.2174/092986608784966912; Tsuboi Y, 2009, NEUROPATHOLOGY, V29, P632, DOI 10.1111/j.1440-1789.2009.01058.x; Beranger F, 2002, J BIOL CHEM, V277, P38972, DOI 10.1074/jbc.M205110200; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Berry DB, 2013, P NATL ACAD SCI USA, V110, pE4160, DOI 10.1073/pnas.1317164110; Yamasaki T, 2014, VIROLOGY, V450, P324, DOI 10.1016/j.virol.2013.11.007; Nishizawa K, 2014, J VIROL, V88, P4083, DOI 10.1128/JVI.03775-13; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Collinge J, 2009, LANCET NEUROL, V2009, P334; Geschwind MD, 2013, NEUROLOGY, V81, P2015, DOI 10.1212/WNL.0b013e3182a9f3b4; Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426; Natori S., 1994, CIBA F SYMP, V186, P132; NATORI S, 1994, CIBA F SYMP, V186, P123; Rouvinski A, 2014, J CELL BIOL, V204, P423, DOI 10.1083/jcb.201308028	50	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	DEC	2015	486						63	70		10.1016/j.virol.2015.09.002		8	Virology	Virology	CY2HQ	WOS:000366229800010		
J	Kusano, S; Yoshimitsu, M; Hachiman, M; Ikeda, M				Kusano, Shuichi; Yoshimitsu, Makoto; Hachiman, Miho; Ikeda, Masanori			I-mfa domain proteins specifically interact with HTLV-1 Tax and repress its transactivating functions	VIROLOGY			English	Article						HTLV-1; Tax; I-mfa-domain protein; Protein-protein interaction; Transcription; LTR; NF-kappa B	T-CELL LEUKEMIA; VIRUS-TYPE-I; NF-KAPPA-B; PHOSPHOLIPID SCRAMBLASE 1; DEPENDENT TRANSCRIPTION; PROTEASOMAL DEGRADATION; HSP90 CHAPERONE; NUCLEAR IMPORT; HIC GENE; ACTIVATION	The I-mfa domain proteins HIC (also known as MDFIC) and I-mfa (also known as MDFI) are candidate tumor suppressor genes that are involved in cellular and viral transcriptional regulation. Here, we show that HIC and I-mfa directly interact with human T-cell leukemia virus type-1 (HTLV-1) Tax protein in vitro. In addition, HIC and I-mfa repress Tax-dependent transactivation of an HTLV-1 long terminal repeat (LTR) reporter construct in COS-1, Jurkat and high-Tax-producing HTLV-1-infected T cells. HIC also interacts with Tax through its I-mfa domain in vivo and represses Tax-dependent transactivation of HTLV-1 LTR and NF-kappa B reporter constructs in an interaction-dependent manner. Furthermore, we show that HIC decreases the nuclear distribution and stimulates the proteasomal degradation of Tax. These data reveal that HIC specifically interacts with HTLV-1 Tax and negatively regulates Tax transactivational activity by altering its subcellular distribution and stability. (C) 2015 Elsevier Inc. All rights reserved.	[Kusano, Shuichi; Ikeda, Masanori] Kagoshima Univ, Grad Sch Med & Dent Sci, Ctr Chron Viral Dis, Div Persistent & Oncogen Viruses, Kagoshima 8908544, Japan; [Yoshimitsu, Makoto; Hachiman, Miho] Kagoshima Univ, Grad Sch Med & Dent Sci, Ctr Chron Viral Dis, Div Hematol & Immunol, Kagoshima 8908544, Japan	Kusano, S (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Ctr Chron Viral Dis, Div Persistent & Oncogen Viruses, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	skusano@m2.kufm.kagoshima-u.ac.jp					Kusano S, 2002, MOL CELL BIOL, V22, P6393, DOI 10.1128/MCB.22.18.6393-6405.2002; Gao LL, 2013, J VIROL, V87, P13640, DOI 10.1128/JVI.02006-13; Young TM, 2003, MOL CELL BIOL, V23, P6373, DOI 10.1128/MCB.23.18.6373-6384.2003; Chen CMA, 1996, CELL, V86, P731, DOI 10.1016/S0092-8674(00)80148-8; Omura N, 2008, CANCER BIOL THER, V7, P1146, DOI 10.4161/cbt.7.7.6208; Cigognini D, 2007, LEUKEMIA RES, V31, P477, DOI 10.1016/j.leukres.2006.09.007; OSAME M, 1986, LANCET, V1, P1031; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Nicot C, 1998, J VIROL, V72, P6777; Tsuji T, 2007, J BIOL CHEM, V282, P13875, DOI 10.1074/jbc.M611629200; Huang JN, 2009, J BIOL CHEM, V284, P6208, DOI 10.1074/jbc.M806390200; Wang Q, 2007, J MOL BIOL, V367, P630, DOI 10.1016/j.jmb.2007.01.020; Nyborg JK, 2010, BBA-GENE REGUL MECH, V1799, P266, DOI 10.1016/j.bbagrm.2009.09.002; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; Kusano S, 2010, BIOCHEM BIOPH RES CO, V396, P608, DOI 10.1016/j.bbrc.2010.04.111; Cho WK, 2007, J VIROL, V81, P11179, DOI 10.1128/JVI.00408-07; Ohtsubo H, 1997, EXP HEMATOL, V25, P1246; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Yan PR, 2009, BLOOD, V113, P4370, DOI 10.1182/blood-2008-10-185660; Gu L, 2009, IMMUNOL LETT, V123, P179, DOI 10.1016/j.imlet.2009.03.010; Benovic S, 1998, VIROLOGY, V244, P294, DOI 10.1006/viro.1998.9111; Jin DY, 1997, NUCLEIC ACIDS RES, V25, P379, DOI 10.1093/nar/25.2.379; Kusano S, 2013, BIOCHEM BIOPH RES CO, V433, P438, DOI 10.1016/j.bbrc.2013.02.098; Kusano S, 2011, BIOCHIMIE, V93, P1555, DOI 10.1016/j.biochi.2011.05.016; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; Kusano S, 2012, VIROLOGY, V432, P343, DOI 10.1016/j.virol.2012.06.019; Thebault S, 2000, J BIOL CHEM, V275, P4848, DOI 10.1074/jbc.275.7.4848; Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-76; Gu LL, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-17; Ikebe E, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.30; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Simonis N, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-26; Zhou Qiang, 2006, Microbiol Mol Biol Rev, V70, P646, DOI 10.1128/MMBR.00011-06	33	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	DEC	2015	486						219	227		10.1016/j.virol.2015.09.020		9	Virology	Virology	CY2HQ	WOS:000366229800026		
J	Kuriya, K; Higashiyama, E; Avsar-Ban, E; Tamaru, Y; Ogata, S; Takebayashi, S; Ogata, M; Okumura, K				Kuriya, Kenji; Higashiyama, Eriko; Avsar-Ban, Eriko; Tamaru, Yutaka; Ogata, Shin; Takebayashi, Shin-ichiro; Ogata, Masato; Okumura, Katsuzumi			Direct Visualization of DNA Replication Dynamics in Zebrafish Cells	ZEBRAFISH			English	Article							MAMMALIAN-CELLS; S-PHASE; SPATIOTEMPORAL ORGANIZATION; DEVELOPMENTAL CONTROL; REPLICON CLUSTERS; LIVING CELLS; HUMAN GENOME; IN-VIVO; SITES; HETEROCHROMATIN	Spatiotemporal regulation of DNA replication in the S-phase nucleus has been extensively studied in mammalian cells because it is tightly coupled with the regulation of other nuclear processes such as transcription. However, little is known about the replication dynamics in nonmammalian cells. Here, we analyzed the DNA replication processes of zebrafish (Danio rerio) cells through the direct visualization of replicating DNA in the nucleus and on DNA fiber molecules isolated from the nucleus. We found that zebrafish chromosomal DNA at the nuclear interior was replicated first, followed by replication of DNA at the nuclear periphery, which is reminiscent of the spatiotemporal regulation of mammalian DNA replication. However, the relative duration of interior DNA replication in zebrafish cells was longer compared to mammalian cells, possibly reflecting zebrafish-specific genomic organization. The rate of replication fork progression and ori-to-ori distance measured by the DNA combing technique were approximate to 1.4kb/min and 100kb, respectively, which are comparable to those in mammalian cells. To our knowledge, this is a first report that measures replication dynamics in zebrafish cells.	[Kuriya, Kenji; Higashiyama, Eriko; Ogata, Shin; Okumura, Katsuzumi] Mie Univ, Grad Sch Bioresources, Dept Life Sci, Lab Mol & Cellular Biol, Tsu, Mie 5145807, Japan; [Avsar-Ban, Eriko; Tamaru, Yutaka] Mie Univ, Grad Sch Bioresources, Dept Life Sci, Lab Utilizat Aquat Bioresources, Tsu, Mie 5145807, Japan; [Takebayashi, Shin-ichiro; Ogata, Masato] Mie Univ, Grad Sch Med, Dept Biochem & Prote, Tsu, Mie 5145807, Japan	Okumura, K (reprint author), Mie Univ, Grad Sch Bioresources, Dept Life Sci, Lab Mol & Cellular Biol, Tsu, Mie 5145807, Japan.	katsu@bio.mie-u.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan; Kieikai Research Foundation; Public Foundation of Elizabeth Arnold-Fuji; Yamazaki Spice Promotion Foundation	This work was supported partly by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan; Kieikai Research Foundation; the Public Foundation of Elizabeth Arnold-Fuji; and Yamazaki Spice Promotion Foundation (to K.O.).	Sugimura K, 2008, J CELL BIOL, V183, P1203, DOI 10.1083/jcb.200806068; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Mikhailov A, 2002, CURR BIOL, V12, P1797, DOI 10.1016/S0960-9822(02)01226-5; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Katsuno Y, 2009, P NATL ACAD SCI USA, V106, P3184, DOI 10.1073/pnas.0809350106; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Panning MM, 2005, J CELL BIOCHEM, V95, P74, DOI 10.1002/jcb.20395; Techer H, 2013, J MOL BIOL, V425, P4845, DOI 10.1016/j.jmb.2013.03.040; Leuner B, 2009, J COMP NEUROL, V517, P123, DOI 10.1002/cne.22107; Rimmele P, 2010, CANCER RES, V70, P6757, DOI 10.1158/0008-5472.CAN-09-4691; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; NAKAMURA H, 1986, EXP CELL RES, V165, P291, DOI 10.1016/0014-4827(86)90583-5; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Shimura T, 2007, J MOL BIOL, V367, P665, DOI 10.1016/j.jmb.2007.01.018; Ryba T, 2012, GENOME RES, V22, P1833, DOI 10.1101/gr.138511.112; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Mathias JR, 2012, FUTURE MED CHEM, V4, P1811, DOI [10.4155/fmc.12.115, 10.4155/FMC.12.115]; Murphey RD, 2006, CHEM BIOL DRUG DES, V68, P213, DOI 10.1111/j.1747-0285.2006.00439.x; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Schwaiger M, 2010, GENOME RES, V20, P771, DOI 10.1101/gr.101790.109; Ma H, 1998, J CELL BIOL, V143, P1415, DOI 10.1083/jcb.143.6.1415; Takebayashi SI, 2001, EXP CELL RES, V271, P263, DOI 10.1006/excr.2001.5389; Koseki N, 2014, J TOXICOL SCI, V39, P579; Takebayashi S, 2005, EXP CELL RES, V304, P162, DOI 10.1016/j.yexcr.2004.10.024; Meister P, 2007, EMBO J, V26, P1315, DOI 10.1038/sj.emboj.7601538; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Berezney R, 2000, CHROMOSOMA, V108, P471, DOI 10.1007/s004120050399; Takebayashi S, 2012, NUCLEUS-AUSTIN, V3, P500, DOI [10.4161/nucl.22318, 10.4161/nucleus.22318]; Ahmad K, 2001, J CELL BIOL, V153, P101, DOI 10.1083/jcb.153.1.101; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Moss SP, 2011, GENOME BIOL EVOL, V3, P1187, DOI 10.1093/gbe/evr090; NAKAYASU H, 1989, J CELL BIOL, V108, P1, DOI 10.1083/jcb.108.1.1; Dimitrova DS, 2002, J CELL SCI, V115, P4037, DOI 10.1242/jcs.00087; MANDERS EMM, 1992, J CELL SCI, V103, P857; Koberna K, 1999, CHROMOSOMA, V108, P325, DOI 10.1007/s004120050384; Tanaka T, 2003, CHROMOSOME RES, V11, P153, DOI 10.1023/A:1022820032433; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099; Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Bialic Marta, 2015, Methods Mol Biol, V1300, P67, DOI 10.1007/978-1-4939-2596-4_4; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Hiratani Ichiro, 2009, Curr Opin Genet Dev, V19, P142, DOI 10.1016/j.gde.2009.02.002; Lee MS, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-12; Maya-Mendoza A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000900	45	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1545-8547	1557-8542		ZEBRAFISH	Zebrafish	DEC 1	2015	12	6					432	439		10.1089/zeb.2015.1151		8	Developmental Biology; Zoology	Developmental Biology; Zoology	CY3NV	WOS:000366317400007		
J	Mori, M; Masuno, T; Kozaki, D; Nakatani, N; Tanaka, K; Itabashi, H				Mori, M.; Masuno, T.; Kozaki, D.; Nakatani, N.; Tanaka, K.; Itabashi, H.			Cations on Ion Chromatography by Phosphate-Coated Zirconia Stationary Phase Column	ACTA CHROMATOGRAPHICA			English	Article						ion chromatography; zirconia; phosphate; cations; temperature	INORGANIC ANIONS; CARBON COLUMN; SEPARATION; EXCHANGE; CHEMISTRY; TITANIA; SUPPORT	Ion chromatography of inorganic cations using a phosphate-coated zirconia stationary phase (PZ) was first attempted. The retentions of cations to PZ increased by elevating the column temperature and the reproducibility of the separation could improve at the higher temperature. The PZ functioned as a cation-exchanger from changes in the retention factor of cations as a function of eluent pH. Furthermore, the Gibbs free energies of cations were estimated from enthalpy and entropy using the retention factors of cations as a function of the column temperature. The reaction was based on the endothermic reaction.	[Mori, M.; Masuno, T.; Itabashi, H.] Gunma Univ, Grad Sch Sci & Technol, Kiryu, Gumma 3768515, Japan; [Kozaki, D.] Univ Malaysia Pahang, Fac Ind Sci & Technol, Gambang Kuantan 26300, Pahang Darul Ma, Malaysia; [Nakatani, N.] Rakuno Gakuen Univ, Coll Agr Food & Environm Sci, Dept Environm & Symbiot Sci, Ebetsu, Hokkaido 0698501, Japan; [Tanaka, K.] Chubu Univ, Coll Engn, Kasugai, Aichi 4878501, Japan	Mori, M (reprint author), Gunma Univ, Grad Sch Sci & Technol, 1-5-1 Tenjin Cho, Kiryu, Gumma 3768515, Japan.	mori@gunma-u.ac.jp			Japan Society for the Promotion of Science [23615003]	This work was supported by a Grant-in-Aid for Scientific Research (23615003) from the Japan Society for the Promotion of Science.	ALBERTI G, 1968, J INORG NUCL CHEM, V30, P317, DOI 10.1016/0022-1902(68)80096-X; Nagashima H, 1999, J CHROMATOGR A, V855, P261, DOI 10.1016/S0021-9673(99)00654-8; BLACKWELL JA, 1991, J LIQ CHROMATOGR, V14, P2875, DOI 10.1080/01483919108049363; Clausen AM, 1998, ANAL CHEM, V70, P378, DOI 10.1021/ac970480l; Tani K, 1997, CHROMATOGRAPHIA, V46, P623, DOI 10.1007/BF02490522; Yao LF, 2004, TALANTA, V64, P244, DOI 10.1016/j.talanta.2004.02.019; Subramanian A, 2002, J CHROMATOGR A, V944, P179, DOI 10.1016/S0021-9673(01)01369-3; Mullick A, 1999, BIOTECHNOL BIOENG, V65, P282, DOI 10.1002/(SICI)1097-0290(19991105)65:3<282::AID-BIT5>3.0.CO;2-G; Schubert S, 2009, J CHROMATOGR A, V1216, P3831, DOI 10.1016/j.chroma.2009.02.074; Yoshikawa K, 2007, TALANTA, V72, P305, DOI 10.1016/j.talanta.2006.10.020; Sarkar S, 2003, J CHROMATOGR B, V790, P143, DOI 10.1016/S1570-0232(03)00126-0; Tani K, 1998, CHROMATOGRAPHIA, V47, P655, DOI 10.1007/BF02467449; Hanai T, 2003, J CHROMATOGR A, V989, P183, DOI 10.1016/S0021-9673(02)02017-4; BLACKWELL JA, 1992, J CHROMATOGR, V596, P27, DOI 10.1016/0021-9673(92)80199-5; [Anonymous], 1979, IUPAC CHEM DATA SERI, V22, P45; NAWROCKI J, 1993, J CHROMATOGR A, V657, P229, DOI 10.1016/0021-9673(93)80284-F; Ueki Y, 2004, ANAL CHEM, V76, P7007, DOI 10.1021/ac040079g	17	0	0	AKADEMIAI KIADO RT	BUDAPEST	PRIELLE K U 19, PO BOX 245,, H-1117 BUDAPEST, HUNGARY	1233-2356	2083-5736		ACTA CHROMATOGR	Acta Chromatogr.	DEC	2015	27	4					767	773		10.1556/AChrom.27.2015.4.13		7	Chemistry, Analytical	Chemistry	CX2SR	WOS:000365547600013		
J	Nakane, T; Song, CY; Suzuki, M; Nango, E; Kobayashi, J; Masuda, T; Inoue, S; Mizohata, E; Nakatsu, T; Tanaka, T; Tanaka, R; Shimamura, T; Tono, K; Joti, Y; Kameshima, T; Hatsui, T; Yabashi, M; Nureki, O; Iwata, S; Sugahara, M				Nakane, Takanori; Song, Changyong; Suzuki, Mamoru; Nango, Eriko; Kobayashi, Jun; Masuda, Tetsuya; Inoue, Shigeyuki; Mizohata, Eiichi; Nakatsu, Toru; Tanaka, Tomoyuki; Tanaka, Rie; Shimamura, Tatsuro; Tono, Kensuke; Joti, Yasumasa; Kameshima, Takashi; Hatsui, Takaki; Yabashi, Makina; Nureki, Osamu; Iwata, So; Sugahara, Michihiro			Native sulfur/chlorine SAD phasing for serial femtosecond crystallography	ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY			English	Article						serial femtosecond crystallography; X-ray free-electron laser; sulfur/chlorine SAD	FREE-ELECTRON LASER; X-RAY-DIFFRACTION; BIOLOGICAL MACROMOLECULES; ANOMALOUS DIFFRACTION; CRYSTAL-STRUCTURE; PROTEIN; SYSTEM; SOFTWARE; SULFUR; SIGNAL	Serial femtosecond crystallography (SFX) allows structures to be determined with minimal radiation damage. However, phasing native crystals in SFX is not very common. Here, the structure determination of native lysozyme from single-wavelength anomalous diffraction (SAD) by utilizing the anomalous signal of sulfur and chlorine at a wavelength of 1.77 angstrom is successfully demonstrated. This sulfur SAD method can be applied to a wide range of proteins, which will improve the determination of native crystal structures.	[Nakane, Takanori; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Song, Changyong; Suzuki, Mamoru; Nango, Eriko; Kobayashi, Jun; Masuda, Tetsuya; Inoue, Shigeyuki; Nakatsu, Toru; Tanaka, Tomoyuki; Tanaka, Rie; Hatsui, Takaki; Yabashi, Makina; Iwata, So; Sugahara, Michihiro] RIKEN, SPring Ctr 8, Sayo, Hyogo 6795148, Japan; [Song, Changyong] POSTECH, Dept Phys, Pohang 790784, South Korea; [Suzuki, Mamoru] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Masuda, Tetsuya] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Uji, Kyoto 6110011, Japan; [Inoue, Shigeyuki] Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan; [Mizohata, Eiichi] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Nakatsu, Toru] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Sakyo Ku, Kyoto 6068501, Japan; [Shimamura, Tatsuro; Iwata, So] Kyoto Univ, Grad Sch Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Tono, Kensuke; Joti, Yasumasa; Kameshima, Takashi] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan	Sugahara, M (reprint author), RIKEN, SPring Ctr 8, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	msuga@spring8.or.jp			RIKEN; X-ray Free-Electron Laser Priority Strategy Program (MEXT); Japan Society for the Promotion of Science (KAKENHI) [25650026]; Japan Science and Technology Agency; Platform for Drug Discovery, Informatics and Structural Life Science (MEXT)	The XFEL experiments were carried out on BL3 of SACLA with the approval of the Japan Synchrotron Radiation Research Institute (JASRI; proposal Nos. 2013B8045, 2014A8032, 2014B8050 and 2014B8051). This work was supported by RIKEN, by the X-ray Free-Electron Laser Priority Strategy Program (MEXT), partly by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (KAKENHI No. 25650026), partly by the Research Acceleration Program of the Japan Science and Technology Agency and partly by the Platform for Drug Discovery, Informatics and Structural Life Science (MEXT). The authors thank the SACLA beamline staff for technical assistance and A. Nisbet for editing assistance. We are grateful for the computational support from the SACLA HPC system and Mini-K supercomputer system. M. Sugahara conceived the study; M. Suzuki, J. Kobayashi, T. Masuda, S. Inoue, E. Mizohata, T. Nakatsu, E. Nango, T. Tanaka, R. Tanaka, C. Song and M. Sugahara performed data collection; T. Nakane, M. Sugahara and O. Nureki performed data processing and solved the structure; E. Nango, J. Kobayashi and T. Shimamura prepared microcrystals; K. Tono, Y. Joti, T. Kameshima, T. Hatsui and M. Yabashi developed DAPHNIS and detectors; M. Sugahara, C. Song, T. Nakane and S. Iwata wrote the manuscript with input from all of the coauthors; and S. Iwata coordinated the project. The authors declare no competing financial interests.	Kupitz C, 2014, NATURE, V513, P261, DOI 10.1038/nature13453; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Kameshima T, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4867668; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Liu W, 2013, SCIENCE, V342, P1521, DOI 10.1126/science.1244142; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Rose JP, 2015, IUCRJ, V2, P431, DOI 10.1107/S2052252515008337; Tenboer J, 2014, SCIENCE, V346, P1242, DOI 10.1126/science.1259357; Johansson LC, 2012, NAT METHODS, V9, P263, DOI [10.1038/nmeth.1867, 10.1038/NMETH.1867]; Barends TRM, 2013, ACTA CRYSTALLOGR D, V69, P838, DOI 10.1107/S0907444913002448; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Liu Q, 2013, ACTA CRYSTALLOGR D, V69, P1314, DOI 10.1107/S0907444913001479; Liu Q, 2012, SCIENCE, V336, P1033, DOI 10.1126/science.1218753; Yumoto H, 2013, NAT PHOTONICS, V7, P43, DOI [10.1038/nphoton.2012.306, 10.1038/NPHOTON.2012.306]; Sugahara M, 2015, NAT METHODS, V12, P61, DOI [10.1038/nmeth.3172, 10.1038/NMETH.3172]; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Barty A, 2014, J APPL CRYSTALLOGR, V47, P1118, DOI 10.1107/S1600576714007626; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749; Dauter Z, 1999, J MOL BIOL, V289, P83, DOI 10.1006/jmbi.1999.2743; Schlichting I, 2012, CURR OPIN STRUC BIOL, V22, P613, DOI 10.1016/j.sbi.2012.07.015; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; Ishikawa T, 2012, NAT PHOTONICS, V6, P540, DOI 10.1038/nphoton.2012.141; Schlichting I, 2015, IUCRJ, V2, P246, DOI 10.1107/S205225251402702X; Tono K, 2015, J SYNCHROTRON RADIAT, V22, P532, DOI 10.1107/S1600577515004464; Barends TRM, 2014, NATURE, V505, P244, DOI 10.1038/nature12773; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/nphoton.2010.176, 10.1038/NPHOTON.2010.176]; Tono K, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/8/083035; White TA, 2012, J APPL CRYSTALLOGR, V45, P335, DOI 10.1107/S0021889812002312; Barty A, 2012, NAT PHOTONICS, V6, P35, DOI [10.1038/nphoton.2011.297, 10.1038/NPHOTON.2011.297]; HENDRICKSON WA, 1981, NATURE, V290, P107, DOI 10.1038/290107a0; Joti Y, 2015, J SYNCHROTRON RADIAT, V22, P571, DOI 10.1107/S1600577515004506; Thorn A, 2011, J APPL CRYSTALLOGR, V44, P1285, DOI [10.1107/S00218898110417681285, 10.1107/S0021889811041768]; Botha S, 2015, ACTA CRYSTALLOGR D, V71, P387, DOI 10.1107/S1399004714026327; Duisenberg A. J. M., 1992, J APPL CRYSTALLOGR, V25, P92; Kern J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5371; Mykhaylyk Vitaliy, 2013, Journal of Physics: Conference Series, V425, DOI 10.1088/1742-6596/425/1/012010; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Weierstall U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4309	43	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	1399-0047			ACTA CRYSTALLOGR D	Acta Crystallogr. Sect. D-Biol. Crystallogr.	DEC	2015	71		12				2519	2525		10.1107/S139900471501857X		7	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CX5WT	WOS:000365773900015		
J	Kang, ZY; Bui, TQ; Nguyen, DD; Saitoh, T; Hirose, S				Kang, Zuoyi; Tinh Quoc Bui; Du Dinh Nguyen; Saitoh, Takahiro; Hirose, Sohichi			An extended consecutive-interpolation quadrilateral element (XCQ4) applied to linear elastic fracture mechanics	ACTA MECHANICA			English	Article							FATIGUE-CRACK GROWTH; GRADED PIEZOELECTRIC MATERIALS; INTENSITY FACTORS; XFEM SIMULATION; X-FEM; FINITE; STRESS; PLATES; LOADS; XIGA	A novel extended 4-node quadrilateral finite element (XCQ4) based on a consecutive-interpolation procedure (CIP) with continuous nodal stress for accurately modeling singular stress fields near crack tips of two-dimensional (2D) cracks in solids is presented. In contrast to the traditional approaches, the approximation functions constructed based on the CIP involve both nodal values and averaged nodal gradients as interpolation conditions. Our objective is to exhibit a pioneering extension of the recently developed CQ4 element enhanced by enrichment to precisely model 2D elastic crack problems, taking advantages of the strengths and making use all the desirable features of both techniques, the CIP and the local enriched partition of unity method. The stress intensity factors (SIFs) are estimated using the interaction integral. The accuracy and performance of the proposed XCQ4 and its numerical properties are illustrated by numerical examples, considering both single and mixed-mode problems with complicated configurations. Compared with reference solutions available in the literature and the conventional XQ4 results, it is found that the accuracy of the XCQ4 is high. Studies on the convergence rate of the SIFs in relative errors also reveal a better performance of the XCQ4 over the classical XQ4. The fracture parameters are found to be stable for different areas of integration paths around the crack tip. Further applications of the developed XCQ4 to other complex problems are potential.	[Kang, Zuoyi; Tinh Quoc Bui; Hirose, Sohichi] Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Dept Mech & Environm Informat, Meguro Ku, Tokyo 1528552, Japan; [Du Dinh Nguyen] Lac Hong Univ, Dept Civil Engn, Bien Hoa City, Dong Nai Provin, Vietnam; [Saitoh, Takahiro] Gunma Univ, Fac Sci & Technol, Div Environm Engn Sci, Maebashi, Gumma 371, Japan	Bui, TQ (reprint author), Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Dept Mech & Environm Informat, Meguro Ku, 2-12-1-W8-22 Ookayama, Tokyo 1528552, Japan.	tinh.buiquoc@gmail.com			Japan Society for the Promotion of Sciences (JSPS) [26-04055, P14055]; Tokyo Institute of Technology; MEXT Japanese Government Scholarship	The financial support of the Grant-in-Aid for Scientific Research (No. 26-04055)-Japan Society for the Promotion of Sciences (JSPS, ID No. P14055)-is gratefully acknowledged. The first author expresses sincere thanks to all the supports of Tokyo Institute of Technology and MEXT Japanese Government Scholarship. The authors would like to thank the anonymous reviewers for their valuable suggestions and useful comments to improve the quality of the manuscript.	Yang YT, 2014, COMPUT STRUCT, V141, P46, DOI 10.1016/j.compstruc.2014.05.001; Yu TT, 2015, INT J SOLIDS STRUCT, V67-68, P205, DOI 10.1016/j.ijsolstr.2015.03.037; Hematiyan MR, 2013, ENG ANAL BOUND ELEM, V37, P691, DOI 10.1016/j.enganabound.2013.02.004; Zheng C, 2010, ACTA MECH SINICA-PRC, V26, P265, DOI 10.1007/s10409-009-0265-3; Fries TP, 2010, INT J NUMER METH ENG, V84, P253, DOI 10.1002/nme.2914; Wu SC, 2012, INT J COMP METH-SING, V9, DOI 10.1142/S0219876212500557; Moes N, 1999, INT J NUMER METH ENG, V46, P131, DOI 10.1002/(SICI)1097-0207(19990910)46:1<131::AID-NME726>3.0.CO;2-J; Shi LY, 2015, SOIL MECH FOUND ENG+, V52, P74, DOI 10.1007/s11204-015-9309-9; Stazi FL, 2003, COMPUT MECH, V31, P38, DOI 10.1007/s00466-002-0391-2; Tanaka S, 2015, ACTA MECH, V226, P2159, DOI 10.1007/s00707-015-1306-6; Pathak H, 2012, INT J MECH MATER DES, V8, P9, DOI 10.1007/s10999-011-9173-3; Lei J, 2014, INT J FRACTURE, V189, P111, DOI 10.1007/s10704-014-9964-2; GIFFORD LN, 1978, ENG FRACT MECH, V10, P485; Bhardwaj G, 2015, COMPUT METHOD APPL M, V284, P186, DOI 10.1016/j.cma.2014.08.015; Yuan H, 1997, ACTA MECH, V121, P51, DOI 10.1007/BF01262523; SRAWLEY JE, 1976, INT J FRACTURE, V12, P475; Fries TP, 2008, INT J NUMER METH ENG, V75, P503, DOI 10.1002/nme.2259; Singh IV, 2011, INT J MECH MATER DES, V7, P199, DOI 10.1007/s10999-011-9159-1; Bhardwaj G, 2015, COMPOS STRUCT, V126, P347, DOI 10.1016/j.compstruct.2015.02.066; Liu P, 2013, COMP MATER SCI, V69, P542, DOI 10.1016/j.commatsci.2012.11.009; Belytschko T, 2003, INT J NUMER METH ENG, V58, P1873, DOI 10.1002/nme.941; Bhattacharya S, 2013, COMPUT MECH, V52, P799, DOI 10.1007/s00466-013-0845-8; KITAGAWA H, 1979, FATIGUE ENG MATER, V2, P195, DOI 10.1111/j.1460-2695.1979.tb01355.x; Racz D, 2012, INT J NUMER METH ENG, V90, P1414, DOI 10.1002/nme.4268; Wu J, 2014, THEOR APPL FRACT MEC, V72, P28, DOI 10.1016/j.tafmec.2014.07.001; Babuska I, 1997, INT J NUMER METH ENG, V40, P727, DOI 10.1002/(SICI)1097-0207(19970228)40:4<727::AID-NME86>3.0.CO;2-N; KWON YW, 1989, COMPUT STRUCT, V31, P467, DOI 10.1016/0045-7949(89)90394-5; Liu P, 2012, COMPUT METHOD APPL M, V233, P68, DOI 10.1016/j.cma.2012.04.008; Kumar S, 2014, INT J MECH MATER DES, V10, P165, DOI 10.1007/s10999-014-9238-1; Liu P, 2014, INT J SOLIDS STRUCT, V51, P2167, DOI 10.1016/j.ijsolstr.2014.02.024; Sharma K, 2013, ENG FRACT MECH, V104, P114, DOI 10.1016/j.engfracmech.2013.03.012; Bechet E, 2005, INT J NUMER METH ENG, V64, P1033, DOI 10.1002/nme.1386; Kumar S, 2014, THEOR APPL FRACT MEC, V72, P121, DOI 10.1016/j.tafmec.2014.03.005; Ventura G, 2002, INT J NUMER METH ENG, V54, P923, DOI 10.1002/nme.471; Kumar S, 2015, COMPUT METHOD APPL M, V283, P1425, DOI 10.1016/j.cma.2014.10.019; Liu P, 2015, COMPOS PART B-ENG, V77, P179, DOI 10.1016/j.compositesb.2015.03.036; Bui Q.T., 2015, COMPUT METHODS APPL, V295, P470; Bui Q.T., 2013, FINITE ELEM ANAL DES, V69, P19; Bui Q.T., 2009, INT J NUMER METH ENG, V77, P1371; Bui Q.T., 2011, COMPUT METHODS APPL, V200, P1354; Bui Q.T., 2014, FINITE ELEM ANAL DES, V84, P14; Bui QT, 2013, ENG STRUCT, V47, P90; Bui QT., 2012, COMP MATER SCI, V62, P243; Ewalds H., 1989, FRACTURE MECH; Khoei R.A., 2015, EXTENDED FINITE ELEM; Kumar S, 2015, COMPUT STRUCT, V150, P1, DOI 10.1016/j.compstruc.2014.12.008; Kumar S., 2015, INT J IMPACT ENG, DOI [10.1016/j.ijimpeng.2015.03.005, DOI 10.1016/J.IJIMPENG.2015.03.005]; Mohit P., 2011, APPL MATH MODEL, V35, P3443; Nguyen T.N., 2014, ENG ANAL BOUND ELEM, V44, P87; Yu T.T., 2014, INT J MECH MATER DES, DOI [10.1007/s10999-014-9282-x, DOI 10.1007/S10999-014-9282-X]; Zhang X.D., 2015, ENG COMPUT, V2, P473	51	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-5970	1619-6937		ACTA MECH	Acta Mech.	DEC	2015	226	12					3991	4015		10.1007/s00707-015-1451-y		25	Mechanics	Mechanics	CX2GB	WOS:000365513500005		
J	Xiong, XG; Kikuuwe, R; Yamamoto, M				Xiong, Xiaogang; Kikuuwe, Ryo; Yamamoto, Motoji			Implicit Euler simulation of one-dimensional Burridge-Knopoff model of earthquakes with set-valued friction laws	ADVANCES IN COMPUTATIONAL MATHEMATICS			English	Article						Computational seismology; Set-valued friction; Sliding mode system	DIFFERENTIAL-INCLUSIONS; DYNAMICAL-SYSTEMS; FAULT	In the simulations of Burridge-Knopoff (BK) model of earthquakes, the friction force laws are important to produce earthquake-like stick-slip behaviors. Some friction force laws are set-valued and the BK model with them can produce consistent results with observed data of earthquakes in some aspects. However, it is cumbersome to simulate the BK model with set-valued laws by conventional explicit integration methods. In the presence of set-valued laws, the explicit integration methods can easily lead to the numerical chattering, violated constraints on the velocity of force laws, and the difficulty of identifying the states of blocks of the BK model. This paper employs an implicit Euler integration method to simulate the BK model with symmetric and asymmetric set-valued laws. This method removes the numerical chattering in the BK model, even in the cases of large time step sizes. It can easily detect the stuck or slipping state of a block element. Comparing to previous results integrated by explicit integration methods in the literature, the results integrated by this implicit method show smoother curves and lower irregularities in the magnitude distribution of events.	[Xiong, Xiaogang; Kikuuwe, Ryo; Yamamoto, Motoji] Kyushu Univ, Nishi Ku, Fukuoka 8190395, Japan	Xiong, XG (reprint author), Kyushu Univ, Nishi Ku, Motooka 744, Fukuoka 8190395, Japan.	xiong@ctrl.mech.kyushu-u.ac.jp					Acary V., 2009, RR6886 INRIA; Acary V, 2008, LECT NOTES APPL COMP, V35, P1, DOI 10.1007/978-3-540-75392-6; Bastien J, 2002, ESAIM-MATH MODEL NUM, V36, P427, DOI 10.1051/m2an:2002020; CARLSON JM, 1991, PHYS REV A, V44, P884, DOI 10.1103/PhysRevA.44.884; Erickson BA, 2011, GEOPHYS J INT, V187, P178, DOI 10.1111/j.1365-246X.2011.05123.x; Acary V, 2010, IEEE T COMPUT AID D, V29, P1042, DOI 10.1109/TCAD.2010.2049134; Moreau JJ, 1999, COMPUT METHOD APPL M, V177, P329, DOI 10.1016/S0045-7825(98)00387-9; Brogliato B, 2006, SYST CONTROL LETT, V55, P45, DOI 10.1016/j.sysconle.2005.04.015; BURRIDGE R, 1967, B SEISMOL SOC AM, V57, P341; Dupont P, 2002, IEEE T AUTOMAT CONTR, V47, P787, DOI 10.1109/TAC.2002.1000274; Marone C, 1998, ANNU REV EARTH PL SC, V26, P643, DOI 10.1146/annurev.earth.26.1.643; Xiong XG, 2013, J APPL MATH, DOI 10.1155/2013/320276; Acary V, 2010, SYST CONTROL LETT, V59, P284, DOI 10.1016/j.sysconle.2010.03.002; Kikuuwe R, 2006, IEEE T ROBOT, V22, P1176, DOI 10.1109/TRO.2006.886262; CARLSON JM, 1989, PHYS REV A, V40, P6470, DOI 10.1103/PhysRevA.40.6470; Scholz CH, 1998, NATURE, V391, P37, DOI 10.1038/34097; Greenhalgh S, 2013, NUMER MATH, V125, P601, DOI 10.1007/s00211-013-0553-5; CARLSON JM, 1989, PHYS REV LETT, V62, P2632, DOI 10.1103/PhysRevLett.62.2632; Dicterich J., 1994, J GEOPHYS RES, V99, P2601; Dirkse S. P., 1995, OPTIMIZATION METHODS, V5, P123, DOI DOI 10.1080/10556789508805606; Helmstetter A., 2004, PHYS REV E, V70; Helmstetter A., 2002, PHYS REV LETT, V88; Leine R. I., 2004, LECT NOTES APPL COMP, V18; Marques M.M., 1993, DIFFERENTIAL INCLUSI, V9; MOREAU JJ, 1977, J DIFFER EQUATIONS, V26, P347, DOI 10.1016/0022-0396(77)90085-7; Mori T., 2008, J GEOPHYS RES SOLID, V113; Mori T., 2005, PHYS REV LETT, V94; Mori T., 2006, J GEOPHYS RES SOLID, V111; Scholz C. H., 1990, MECH EARTHQUAKES FAU; Xia J., 2005, PHYS REV LETT, V95; Xia J., 2008, PHYS REV E, V77	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1019-7168	1572-9044		ADV COMPUT MATH	Adv. Comput. Math.	DEC	2015	41	6					1039	1057		10.1007/s10444-014-9398-4		19	Mathematics, Applied	Mathematics	CX5KP	WOS:000365740800004		
J	Inamori, T; Sugawara, Y; Satou, Y				Inamori, Takaya; Sugawara, Yoshiki; Satou, Yasutaka			Electromagnetic panel deployment and retraction using the geomagnetic field in LEO satellite missions	ADVANCES IN SPACE RESEARCH			English	Article						Extensible structure; Deployment; Retraction; Electromagnetic force	ESTCUBE-1 NANOSATELLITE; FUROSHIKI SATELLITE; SYSTEM	Increasingly, spacecraft are installed with large-area structures that are extended and deployed post-launch. These extensible structures have been applied in several missions for power generation, thermal radiation, and solar propulsion. Here, we propose a deployment and retraction method using the electromagnetic force generated when the geomagnetic field interacts with electric current flowing on extensible panels. The panels are installed on a satellite in low Earth orbit. Specifically, electrical wires placed on the extensible panels generate magnetic moments, which interfere with the geomagnetic field. The resulting repulsive and retraction forces enable panel deployment and retraction. In the proposed method, a satellite realizes structural deployment using simple electrical wires. Furthermore, the satellite can achieve not only deployment but also retraction for avoiding damage from space debris and for agile attitude maneuvers. Moreover, because the proposed method realizes quasi-static deployment and the retraction of panels by electromagnetic forces, low impulsive force is exerted on fragile panels. The electrical wires can also be used to detect the panel deployment and retraction and generate a large magnetic moment for attitude control. The proposed method was assessed in numerical simulations based on multibody dynamics. Simulation results shows that a small cubic satellite with a wire current of 25 AT deployed 4 panels (20 cm x 20 cm) in 500 s and retracted 4 panels in 100 s. (C) 2015 COSPAR. Published by Elsevier Ltd. All rights reserved.	[Inamori, Takaya] Univ Tokyo, Dept Aeronaut & Astronaut, Fac Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Sugawara, Yoshiki] Akita Univ, Engn & Resource Studies, Akita 010, Japan; [Satou, Yasutaka] Tokyo Inst Technol, Midori Ku, Yokohama, Kanagawa 2268502, Japan	Inamori, T (reprint author), Univ Tokyo, Dept Aeronaut & Astronaut, Fac Engn, Bunkyo Ku, 110,Bldg 7,7-3-1 Hongo, Tokyo 1138656, Japan.	takayainamori@gmail.com					Santoni F, 2014, ACTA ASTRONAUT, V95, P210, DOI 10.1016/j.actaastro.2013.11.011; Nakasuka S, 2001, ACTA ASTRONAUT, V48, P461, DOI 10.1016/S0094-5765(01)00056-X; Latt S, 2014, P EST ACAD SCI, V63, P200, DOI 10.3176/proc.2014.2S.01; Nakasuka S, 2006, ACTA ASTRONAUT, V58, P395, DOI 10.1016/j.actaastro.2005.12.010; Nagatomo M, 1996, SOL ENERGY, V56, P111, DOI 10.1016/0038-092X(95)00098-C; Slavinskis A, 2014, P EST ACAD SCI, V63, P242, DOI 10.3176/proc.2014.2S.05; [Anonymous], 2005, P 11 ESMATS S; Calassa M. C., 1995, P 29 AER MECH S, V1, P79; Cosmo M., 1997, TETHERS SPACE HDB; Inamori T., 2011, J AEROSPACE ENG, V26, P594; Inamori Takaya, 2012, UN JAP NAN S NAG, V2008; Inamori T, 2015, ACTA ASTRONAUT, V109, P14, DOI 10.1016/j.actaastro.2014.11.035; Inamori Takaya, 2012, P SPAC SCI TECHN C; Komatsu M., 2009, T JPN SOC, V7, P19; Mori B. O., 2009, T SPACE TECHNOL JAPA, V7, P87; Santoni F., 2014, J AEROSPACE ENG, V28; Sawada H., 2011, 52 AIAA ASME ASCE AH; Sugawara Y., 2013, 22 SPAC ENG C TOK; Wittenburg J., 2008, DYNAMICS MULTIBODY S; Wittenburg J., 1977, DYNAMICS SYSTEMS RIG	20	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0273-1177	1879-1948		ADV SPACE RES	Adv. Space Res.	DEC 1	2015	56	11					2455	2472		10.1016/j.asr.2015.08.025		18	Astronomy & Astrophysics; Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences	Astronomy & Astrophysics; Geology; Meteorology & Atmospheric Sciences	CX0DU	WOS:000365367900014		
J	Miyake, W; Miyoshi, Y; Matsuoka, A				Miyake, W.; Miyoshi, Y.; Matsuoka, A.			An empirical modeling of spatial distribution of trapped protons from solar cell degradation of the Akebono satellite	ADVANCES IN SPACE RESEARCH			English	Article						Proton radiation belt; Akebono satellite; Solar cell degradation	RADIATION BELT; CRAND	Output current of silicon solar cells of Akebono satellite orbiting in the inner magnetosphere decreased from 13 A in 1989 to about 7 A in 2009, due to accumulated damage by energetic particles. Annual decrease from the same month in the previous year shows a clear oscillation due to orbit precession correlated with trapped energetic proton flux up to 1996. Although phase of the oscillation in annual variation shows a clear correlation, the amplitude tends to be larger than that expected from a degradation model based on energetic proton distribution of the NASA's AP8 model. We have worked on modeling of the L-shell distribution of trapped energetic protons which provides best-fit for the degradation of solar cells. The results by assuming Gaussian distribution of proton flux for L value are as follows. (1) If we assume a steady state before 1996, the best-fitted distribution has a peak around L = 1.6 and a width of dL = 0.1 (i.e., half width of 1/e decrease from the peak). (2) If we employ a dynamic model with temporal variation and introduce a different distribution between April 1991 and June 1992, RMSE is further improved from the static model. Modeled distributions have its center around L = 1.9, suggesting outward shift or expansion of the proton radiation belt during the interval. Our modeling gives more confined distribution than given by the AP8 and AP9 models, but is more consistent with the CRRESPRO model based on the observation before November 1991. (C) 2015 COSPAR. Published by Elsevier Ltd. All rights reserved.	[Miyake, W.] Tokai Univ, Dept Aeronaut & Astronaut, Hiratsuka, Kanagawa 2591292, Japan; [Miyoshi, Y.] Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan; [Matsuoka, A.] Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan	Miyake, W (reprint author), Tokai Univ, Dept Aeronaut & Astronaut, 4-1-1 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan.	wmiyake@keyaki.cc.u-tokai.ac.jp					Selesnick RS, 2010, J GEOPHYS RES-SPACE, V115, DOI [10.1029/2010JA01S247, 10.1029/2010JA015247]; Hudson MK, 1997, J GEOPHYS RES-SPACE, V102, P14087, DOI 10.1029/97JA03995; Looper MD, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021502; OYA H, 1990, J GEOMAGN GEOELECTR, V42, P367; TSURUDA K, 1991, GEOPHYS RES LETT, V18, P293, DOI 10.1029/91GL00039; Obara T, 2003, ADV SPACE RES, V31, P1027, DOI 10.1016/S0273-1177(02)00811-6; Gussenhoven MS, 1996, IEEE T NUCL SCI, V43, P353, DOI 10.1109/23.490755; Ishikawa H, 2013, EARTH PLANETS SPACE, V65, P121, DOI 10.5047/eps.2012.06.004; Selesnick RS, 2013, J GEOPHYS RES-SPACE, V118, P7532, DOI 10.1002/2013JA019338; Miyake W, 2014, ADV SPACE RES, V53, P1603, DOI 10.1016/j.asr.2014.03.002; BLAKE JB, 1992, GEOPHYS RES LETT, V19, P821, DOI 10.1029/92GL00624; Ginet GP, 2013, SPACE SCI REV, V179, P579, DOI 10.1007/s11214-013-9964-y; Mauk BH, 2013, SPACE SCI REV, V179, P3, DOI 10.1007/s11214-012-9908-y; Knoll G. F., 1989, RAD DETECTION MEASUR, P754; Lauenstein J.-M., 2005, IEEE RAD EFFECTS DAT, P102, DOI DOI 10.1109/REDW.2005.1532674; Lorentzen KR, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000276; Patel M. R., 2005, SPACECRAFT POWER SYS; Selesnick RS, 2014, J GEOPHYS RES-SPACE, V119, DOI 10.1002/2014JA020188; Takagi S., 1995, B ISAS, V80	19	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0273-1177	1879-1948		ADV SPACE RES	Adv. Space Res.	DEC 1	2015	56	11					2575	2581		10.1016/j.asr.2015.10.021		7	Astronomy & Astrophysics; Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences	Astronomy & Astrophysics; Geology; Meteorology & Atmospheric Sciences	CX0DU	WOS:000365367900024		
J	Avanzi, F; Yamaguchi, S; Hirashima, H; De Michele, C				Avanzi, Francesco; Yamaguchi, Satoru; Hirashima, Hiroyuki; De Michele, Carlo			Bulk volumetric liquid water content in a seasonal snowpack: modeling its dynamics in different climatic conditions	ADVANCES IN WATER RESOURCES			English	Article						Liquid water content; Degree-hour; Temperature-index; Refreezing; Snow; Numerical model	WETTING FRONT ADVANCE; WET-SNOW; SURFACE-AREA; PREFERENTIAL FLOW; NUMERICAL-MODEL; ENERGY-BALANCE; ALPINE SITE; TEMPERATURE; MELTWATER; COVER	d We focus on the dynamics of volumetric liquid water content in seasonal snow covers. This is a key variable describing the fate of snowpacks during the melting season. However, its measurement and/or prediction by means of models at high spatial and temporal resolutions is still difficult due to both practical and theoretical reasons. To overcome these limitations in operational applications, we test the capability of a one-dimensional model to predict the dynamics of bulk volumetric liquid water content during a snow season. Multi-year data collected in three experimental sites in japan are used as an evaluation. These sites are subjected to different climatic conditions. The model requires the calibration of one or two parameters, according to the degree of detail used. Either a simple temperature-index or a coupled melt-freeze temperature-index approach are considered to predict melting and/or melt-freeze dynamics of liquid water. Results show that, if melt-freeze dynamics are modeled, median absolute differences between data and predictions are consistently lower than 1 vol% at the sites where data of liquid water content are available. In addition, we find also that the model predicts correctly a dry condition in 80% of the observed cases at a site where calibration data are scarce. At the same site, observed isothermal conditions of the snow cover at 0 degrees C correspond to predictions of bulk volumetric liquid water content that are greater than 0. (C) 2015 Elsevier Ltd. All rights reserved.	[Avanzi, Francesco; De Michele, Carlo] Politecn Milan, Dept Civil & Environm Engn, I-20133 Milan, Italy; [Yamaguchi, Satoru; Hirashima, Hiroyuki] Natl Res Inst Earth Sci & Disaster Prevent, Snow & Ice Res Ctr, Nagaoka, Niigata 9400821, Japan	Avanzi, F (reprint author), Politecn Milan, Dept Civil & Environm Engn, Piazza Leonardo da Vinci, I-20133 Milan, Italy.	francesco.avanzi@polimi.it			Grant for Joint Research Program, Institute of Low Temperature Science, Hokkaido University; Japan Society for the Promotion of Science (JSPS) [23221004]	We would like to thank the staff of the Snow and Ice Research Center, National Research Institute for Earth Science and Disaster Prevention, for helpful discussions. FA is grateful for the support received during his research period at the Snow and Ice Research Center. Gratitude is due to Masaki Nemoto and Kenji Kosugi (Shinjo Cryospheric Environment Laboratory, Snow and Ice Research Center, NIED) for Shinjo observations, and to Teruo Aoki (Meteorological Research Institute, Tsukuba-shi, Ibaraki-ken) and Sumito Matoba (Institute of Low Temperature Science, Hokkaido University) for Sapporo observations. Data in Sapporo were obtained with the support by the Grant for Joint Research Program, Institute of Low Temperature Science, Hokkaido University, and the Japan Society for the Promotion of Science (JSPS), Grant-in-Aid for Scientific Research (S), no. 23221004. We would like to thank the Editor, Prof. Paolo D'Odorico, and two anonymous reviewers, for valuable comments on the manuscript.	Schneebeli M, 2004, HYDROL PROCESS, V18, P3655, DOI 10.1002/hyp.5800; Techel F, 2011, CRYOSPHERE, V5, P405, DOI 10.5194/tc-5-405-2011; Tedesco M, 2006, IEEE T GEOSCI REMOTE, V44, P3563, DOI 10.1109/TGRS.2006.881759; Zermatten E, 2014, COLD REG SCI TECHNOL, V97, P33, DOI 10.1016/j.coldregions.2013.09.013; Carmagnola CM, 2014, CRYOSPHERE, V8, P417, DOI 10.5194/tc-8-417-2014; Calonne N, 2012, CRYOSPHERE, V6, P939, DOI 10.5194/tc-6-939-2012; Avanzi F, 2014, ADV WATER RESOUR, V68, P32, DOI 10.1016/j.advwatres.2014.02.012; MARSH P, 1984, WATER RESOUR RES, V20, P1853, DOI 10.1029/WR020i012p01853; Kerbrat M, 2008, ATMOS CHEM PHYS, V8, P1261; Techel F, 2011, COLD REG SCI TECHNOL, V65, P382, DOI 10.1016/j.coldregions.2010.12.006; Hock R, 2003, J HYDROL, V282, P104, DOI 10.1016/S0022-1694(03)00257-9; Katsushima T, 2009, COLD REG SCI TECHNOL, V59, P143, DOI 10.1016/j.coldregions.2009.09.002; Eiriksson D, 2013, HYDROL PROCESS, V27, P640, DOI 10.1002/hyp.9666; Yamaguchi S, 2004, ANN GLACIOL, V38, P266, DOI 10.3189/172756404781815239; Mitterer C, 2011, ANN GLACIOL, V52, P201, DOI 10.3189/172756411797252077; TSENG PH, 1994, WATER RESOUR RES, V30, P2363, DOI 10.1029/94WR00764; Heilig A, 2010, HYDROL PROCESS, V24, P3133, DOI 10.1002/hyp.7749; Matzl M, 2006, J GLACIOL, V52, P558, DOI 10.3189/172756506781828412; Hirashima H, 2004, ANN GLACIOL, V38, P123, DOI 10.3189/172756404781815121; De Michele C, 2013, CRYOSPHERE, V7, P433, DOI 10.5194/tc-7-433-2013; Pfeffer WT, 1996, J GLACIOL, V42, P292; Yamaguchi S, 2009, J APPL METEOROL CLIM, V48, P2403, DOI 10.1175/2009JAMC2008.1; Marshall HP, 1999, COLD REG SCI TECHNOL, V30, P35, DOI 10.1016/S0165-232X(99)00011-7; BRUN E, 1992, J GLACIOL, V38, P13; [Anonymous], 1989, ANN GLACIOL; Koch F, 2014, SENSORS-BASEL, V14, P20975, DOI 10.3390/s141120975; Wever N, 2014, CRYOSPHERE, V8, P257, DOI 10.5194/tc-8-257-2014; Hirashima H, 2010, COLD REG SCI TECHNOL, V64, P94, DOI 10.1016/j.coldregions.2010.09.003; Yamaguchi S, 2010, COLD REG SCI TECHNOL, V64, P87, DOI 10.1016/j.coldregions.2010.05.008; ILLANGASEKARE TH, 1990, WATER RESOUR RES, V26, P1001, DOI 10.1029/WR026i005p01001; KONDO J, 1990, J APPL METEOROL, V29, P375, DOI 10.1175/1520-0450(1990)029<0375:APMFSS>2.0.CO;2; Formetta G, 2014, GEOSCI MODEL DEV, V7, P725, DOI 10.5194/gmd-7-725-2014; Gallet JC, 2014, CRYOSPHERE, V8, P1139, DOI 10.5194/tc-8-1139-2014; Mitterer C, 2011, COLD REG SCI TECHNOL, V69, P129, DOI 10.1016/j.coldregions.2011.06.003; Gabbi J, 2015, CRYOSPHERE, V9, P1385, DOI 10.5194/tc-9-1385-2015; MARSH P, 1984, WATER RESOUR RES, V20, P1865, DOI 10.1029/WR020i012p01865; Erbe EF, 2003, MICROSC RES TECHNIQ, V62, P19, DOI 10.1002/jemt.10383; Saito K, 2012, POLAR SCI, V6, P79, DOI 10.1016/j.polar.2012.02.003; Yamaguchi S, 2012, ANN GLACIOL, V53, P6, DOI 10.3189/2012AoG61A001; Schaefli B, 2014, GEOSCI MODEL DEV, V7, P2733, DOI 10.5194/gmd-7-2733-2014; Waldner PA, 2004, HYDROL PROCESS, V18, P1271, DOI 10.1002/hyp.1401; Bartelt P, 2002, COLD REG SCI TECHNOL, V35, P123, DOI 10.1016/S0165-232X(02)00074-5; Katsushima T, 2013, COLD REG SCI TECHNOL, V85, P206, DOI 10.1016/j.coldregions.2012.09.012; Mitterer C, 2013, CRYOSPHERE, V7, P205, DOI 10.5194/tc-7-205-2013; MARSH P, 1985, WATER RESOUR RES, V21, P1710, DOI 10.1029/WR021i011p01710; Essery R, 1999, CLIM DYNAM, V15, P583, DOI 10.1007/s003820050302; PFEFFER WT, 1990, J GLACIOL, V36, P238; STURM M, 1995, J CLIMATE, V8, P1261, DOI 10.1175/1520-0442(1995)008<1261:ASSCCS>2.0.CO;2; Vionnet V, 2012, GEOSCI MODEL DEV, V5, P773, DOI 10.5194/gmd-5-773-2012; Kirchner HOK, 2001, PHILOS MAG A, V81, P2161, DOI 10.1080/01418610010029043; Aoki T, 2007, ANN GLACIOL, V46, P375; Avanzi F, 2014, ADV WATER RESOUR, V73, P16, DOI 10.1016/j.advwatres.2014.06.011; Baggi S, 2008, NAT HAZARDS, V50, P97; Coleou C, 1998, ANN GLACIOL, V26, P64; Colbeck SC, 1972, J GLACIOL, V11, P369; Colbeck SC, 1973, TECHNICAL REPORT; Denoth A., 1980, J GLACIOL, V78, P357; DENOTH A, 1994, ANN GLACIOL-SER, V19, P104; DeWalle DR, 2011, PRINCIPLES SNOW HYDR; Domine F, 2013, CRYOSPHERE, V7, P1915; Domine F, 2007, J GEOPHYS RES EARTH, V112; Essery R, 2013, ADV WATER RESOUR, V55, P131, DOI 10.1016/j.advwatres.2012.07.013; Fierz C, 1994, P INT SNOW SCI WORKS; Heilig A, 2015, J GEOPHYS RES EARTH; Herz C, 2009, IHP VILL TECHNICAL D; Hirashima H, 2015, SEPPYO, V77, P5; Hirashima H, 2014, COLD REG SCI TECHNOL, V108, P80, DOI 10.1016/j.coldregions.2014.09.004; Ishizaka M, 1998, ANN GLACIOL, V26, P131; Kaempfer TU, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD009047; Kajikawa M., 1989, SEPPYO, V51, P178; Kelleners TJ, 2009, VADOSE ZONE J, V8, P1013, DOI 10.2136/vzj2008.0183; Kienzle SW, 2008, HYDROL PROCESS, V22, P5067, DOI 10.1002/hyp.7131; Legagneux L, 2002, J GEOPHYS RES-ATMOS, V107; Mitterer C, 2013, INT SNOW SCI WORKSH; Morland LW, 1990, COLD REGIONS SCI TEC, V17, P217; Nakamura K, 2015, TECHNICAL REPORT, V390, P47; Nash J, 1970, J HYDROL, V10, P282, DOI DOI 10.1016/0022-1694(70)90255-6; Pinzer BR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039618; Rosso R., 2008, APPL STAT CIVIL ENV; Schleef S, 2011, ACTA MAT, V71, P185; Schmid L, 2015, GEOPHYS RES LETT, V42, P1; Schneebeli M, 1995, IAHS PUBL, V228; Shimizu H, 1970, CONTRIB I LOW TEMP A, VA22, P1; Tarboton DG, 1996, TECHNICAL REPORT; Wergin WP, 1995, SCANNING, V17, P41; Yamaguchi S, 2013, INT SNOW SCI WORKSH	86	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0309-1708	1872-9657		ADV WATER RESOUR	Adv. Water Resour.	DEC	2015	86		A				1	13		10.1016/j.advwatres.2015.09.021		13	Water Resources	Water Resources	CX3TT	WOS:000365623000001		
J	Loehr, JA; Guilliams, ME; Petersen, N; Hirsch, N; Kawashima, S; Ohshima, H				Loehr, James A.; Guilliams, Mark E.; Petersen, Nora; Hirsch, Natalie; Kawashima, Shino; Ohshima, Hiroshi			Physical Training for Long-Duration Spaceflight	AEROSPACE MEDICINE AND HUMAN PERFORMANCE			English	Article						physiologic deconditioning; exercise training		Physical training has been conducted on the International Space Station (ISS) for the past 10 yr as a countermeasure to physiological deconditioning during spaceflight. Each member space agency has developed its own approach to creating and implementing physical training protocols for their astronauts. We have divided physical training into three distinct phases (preflight, in-flight, and postflight) and provided a description of each phase with its constraints and limitations. We also discuss how each member agency (NASA, ESA, CSA, and JAXA) prescribed physical training for their crewmembers during the first 10 yr of ISS operations. It is important to understand the operational environment, the agency responsible for the physical training program, and the constraints and limitations associated with spaceflight to accurately design and implement exercise training or interpret the exercise data collected on ISS. As exploration missions move forward, resolving agency differences in physical training programs will become important to maximizing the effectiveness of exercise as a countermeasure and minimizing any mission impacts.	[Loehr, James A.; Guilliams, Mark E.] Wyle Sci Technol & Engn Grp, Houston, TX USA; [Petersen, Nora] Wyle Labs GmbH, European Space Agcy Space Med Off, Cologne, Germany; [Hirsch, Natalie] Canadian Space Agcy, St Hubert, PQ, Canada; [Kawashima, Shino] Adv Engn Serv Co Ltd, Tsukuba, Ibaraki, Japan; [Ohshima, Hiroshi] Japan Aerosp Explorat Agcy, Tsukuba, Ibaraki, Japan	Loehr, JA (reprint author), Care Of Reeves JM, NASA Johnson Space Ctr, Div Resource Support, Biomed Res & Environm Sci Div, 2101 NASA Pkwy,MC Wyle SK-37, Houston, TX 77058 USA.	Jacqueline.m.reeves@nasa.gov			NASA ISS Program Office [SSP 50260, SSP 50667]	This report was sponsored by the NASA ISS Program Office with reference to SSP 50260 - ISS Medical Operations Requirements Document (MORD) and SSP 50667 - Medical Evaluations Documentation (MED) Volume B.	Loehr JA, 2011, MED SCI SPORT EXER, V43, P146, DOI 10.1249/MSS.0b013e3181e4f161; Lee SMC, 2004, AVIAT SPACE ENVIR MD, V75, P405; Wood SJ, 2011, NEUROREHABILITATION, V29, P185, DOI 10.3233/NRE-2011-0694; Borg G., 1998, BORGS PERCEIVED EXER	4	3	3	AEROSPACE MEDICAL ASSOC	ALEXANDRIA	320 S HENRY ST, ALEXANDRIA, VA 22314-3579 USA	2375-6314	2375-6322		AEROSP MED HUM PERF	Aerosp. Med.Hum. Perform.	DEC	2015	86	12		S			A14	A23		10.3357/AMHP.EC03.2015		10	Public, Environmental & Occupational Health; Medicine, General & Internal; Sport Sciences	Public, Environmental & Occupational Health; General & Internal Medicine; Sport Sciences	CX6VB	WOS:000365838700003		
J	Ejima, K; Kato, K; Iwanami, Y; Henmi, R; Yagishita, D; Manaka, T; Fukushima, K; Arai, K; Ashihara, K; Shoda, M; Hagiwara, N				Ejima, Koichiro; Kato, Ken; Iwanami, Yuji; Henmi, Ryuta; Yagishita, Daigo; Manaka, Tetsuyuki; Fukushima, Keiko; Arai, Kotaro; Ashihara, Kyomi; Shoda, Mono; Hagiwara, Nobuhisa			Impact of an Empiric Isolation of the Superior Vena Cava in Addition to Circumferential Pulmonary Vein Isolation on the Outcome of Paroxysmal Atrial Fibrillation Ablation	AMERICAN JOURNAL OF CARDIOLOGY			English	Article							CATHETER ABLATION; ELECTROPHYSIOLOGICAL CHARACTERISTICS; RADIOFREQUENCY ABLATION; ELECTRICAL ISOLATION; RECOMMENDATIONS; CONDUCTION; FOCI; TIME	The safety and efficacy of an empiric superior vena cava isolation (SVCI) in addition to circumferential pulmonary vein isolation (CPVI) in patients with paroxysmal atrial fibrillation (PAF) have not been clarified. A total of 186 consecutive patients who underwent catheter ablation of PAF were included. All patients underwent a CPVI. Patients in the first half underwent an additional SVCI only if SVC-triggered AF or rapid SVC activity was observed during the procedure (n = 93, as-needed SVCI, group I), and those in the second half underwent an empirical SVCI after the CPVI (n = 93, empiric SVCI, group II). The CPVI was successfully performed in all patients. An SVCI was performed in 8 of 93 patients (9%) in group I and 81 of the 93 patients (87%) in group II. In the remaining 12 patients in group II, an SVCI was not performed because of the lack of SVC potentials. During a mean follow-up of 27 12 months, the atrial tachyarrhythmia recurrence rate after a single ablation procedure in the patients in group II was lower than that in group I (44% vs 23%, p = 0.035). A Cox regression multivariate analysis demonstrated that an empiric SVCI was an independent predictor of an atrial tachyarrhythmia recurrence after a single ablation procedure (odds ratio: 0.57, 95% confidence interval 0.31 to 0.999; p = 0.049). Neither sinus node injury nor any injury to the phrenic nerve was observed. In conclusion, an empiric SVCI in addition to the CPVI improved the outcome of AF ablation in patients with PAF without any additional adverse effects. (C) 2015 Elsevier Inc. All rights reserved.	[Ejima, Koichiro; Kato, Ken; Iwanami, Yuji; Henmi, Ryuta; Yagishita, Daigo; Manaka, Tetsuyuki; Fukushima, Keiko; Arai, Kotaro; Ashihara, Kyomi; Shoda, Mono; Hagiwara, Nobuhisa] Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan	Ejima, K (reprint author), Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan.	koichiro@qf6.so-net.ne.jp					Tsai CF, 2000, CIRCULATION, V102, P67; Shah D, 2003, PACE, V26, P1631, DOI 10.1046/j.1460-9592.2003.t01-1-00243.x; Miyazaki S, 2014, J CARDIOVASC ELECTR, V25, P380, DOI 10.1111/jce.12342; Corrado A, 2010, J CARDIOVASC ELECTR, V21, P1, DOI 10.1111/j.1540-8167.2009.01577.x; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Wang XH, 2007, EUROPACE, V9, P481, DOI 10.1093/europace/eum101; Arruda M, 2007, J CARDIOVASC ELECTR, V18, P1261, DOI 10.1111/j.1540-8167.2007.00953.x; Yamane T, 2011, CIRC-ARRHYTHMIA ELEC, V4, P601, DOI 10.1161/CIRCEP.110.960138; Calkins H, 2012, EUROPACE, V14, P528, DOI 10.1093/europace/eus027; Miyazaki S, 2013, CIRC J, V77, P352, DOI 10.1253/circj.CJ-12-0951; Wang XH, 2008, EUROPACE, V10, P600, DOI 10.1093/europace/eun077; Miyazaki S, 2013, CIRC-ARRHYTHMIA ELEC, V6, P497, DOI 10.1161/CIRCEP.113.000281; Lin WS, 2003, CIRCULATION, V107, P3176, DOI 10.1161/01.CIR.0000074206.52056.2D; HASHIZUME H, 1995, ARCH HISTOL CYTOL, V58, P457, DOI 10.1679/aohc.58.457; Takigawa M, 2015, J CARDIOVASC ELECTR, V26, P739, DOI 10.1111/jce.12681; Ejima K, 2014, CIRC J, V78, P872, DOI 10.1253/circj.CJ-13-1391; CHEN SA, 1994, CIRCULATION, V90, P1262; Zhang JL, 2014, J CARDIOVASC ELECTR, V25, P364, DOI 10.1111/jce.12362; Matsuo S, 2007, J CARDIOVASC ELECTR, V18, P704, DOI 10.1111/j.1540-8167.2007.00842.x; Goya M, 2002, CIRCULATION, V106, P1317	20	0	0	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9149	1879-1913		AM J CARDIOL	Am. J. Cardiol.	DEC 1	2015	116	11					1711	1716		10.1016/j.amjcard.2015.09.005		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CX6SH	WOS:000365831200011		
J	Hidaka, A; Shimazu, T; Sawada, N; Yamaji, T; Iwasaki, M; Sasazuki, S; Inoue, M; Tsugane, S				Hidaka, Akihisa; Shimazu, Taichi; Sawada, Norie; Yamaji, Taiki; Iwasaki, Motoki; Sasazuki, Shizuka; Inoue, Manami; Tsugane, Shoichiro		Japan Publ Hlth Ctr Based	Fish, n-3 PUFA consumption, and pancreatic cancer risk in Japanese: a large, population-based, prospective cohort study	AMERICAN JOURNAL OF CLINICAL NUTRITION			English	Article						pancreatic cancer; fish consumption; n-3 PUFAs; prospective study; Japanese	CASE-CONTROL CONSORTIUM; FOLLOW-UP SURVEY; LONG-CHAIN OMEGA-3-FATTY-ACIDS; FATTY-ACIDS; DIETARY RECORDS; NUTRIENT INTAKE; FREQUENCY; JPHC; MEAT; FOOD	Background: Most previous prospective studies in Western countries found no association between consumption of fish and n-3 (v-3) polyunsaturated fatty acids (PUFAs), such as eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA), for which the main source is fish, and pancreatic cancer risk. However, prospective evidence is still lacking among populations who have a relatively higher fish consumption. Objective: We investigated the association between fish and n-3 PUFA consumption and pancreatic cancer risk in a population-based, prospective study in Japanese men and women. Design: The Japan Public Health Center-based Prospective Study (JPHC study) has enrolled 140,420 subjects. We analyzed data on 82,024 eligible participants aged 45-74 y without a history of cancer who responded to a validated food-frequency questionnaire that included 138 items in 1995 for cohort I and in 1998 for cohort II. Participants were followed through 2010. HRs and corresponding 95% CIs for the highest compared with lowest quartile were calculated by using multivariable-adjusted Cox proportional hazards regression models. Results: During 1,068,774 person-years of follow-up, 449 newly diagnosed pancreatic cancers were identified. After the exclusion of pancreatic cancer cases in the first 3 y of follow-up, we found an inverse association of marine n-3 PUFA (EPA+DPA+DHA) and DHA consumption with pancreatic cancer risk: compared with the lowest quartile, multivariate-adjusted HRs in the highest quartile were 0.70 (95% CI: 0.51, 0.95; P-trend = 0.07) and 0.69 (0.51, 0.94; P-trend = 0.03), respectively. Associations for total fish, n-3 PUFA, EPA, and DPA consumption were similar but were not significant. Conclusion: High n-3 PUFA, especially marine n-3 PUFAs, and DHA consumption was associated with a lower risk of pancreatic cancer in a population with a large variation in fish consumption, although the data apply to only a portion of the JPHC study subjects.	[Hidaka, Akihisa; Shimazu, Taichi; Sawada, Norie; Yamaji, Taiki; Iwasaki, Motoki; Sasazuki, Shizuka; Inoue, Manami; Tsugane, Shoichiro] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Grp, Tokyo 104, Japan; [Inoue, Manami] Univ Tokyo, Grad Sch Med, Tokyo, Japan	Shimazu, T (reprint author), Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Grp, Tokyo 104, Japan.	tshimazu@ncc.go.jp			National Cancer Center Research and Development Fund [23-A-31, 26-A-2]; Ministry of Health, Labor, and Welfare of Japan	Supported by the National Cancer Center Research and Development Fund [23-A-31 (toku) and 26-A-2] (since 2011) and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor, and Welfare of Japan (from 1989 to 2010).	Cui XJ, 2014, PANCREAS, V43, P135, DOI 10.1097/MPA.0b013e3182a8d41f; Qin B, 2012, J NUTR, V142, P1067, DOI 10.3945/jn.111.156711; Gukovsky I, 2013, GASTROENTEROLOGY, V144, P1199, DOI 10.1053/j.gastro.2013.02.007; Shen X, 2013, CURR MED CHEM, V20, P4153; Neff MR, 2014, FOOD CHEM, V164, P544, DOI 10.1016/j.foodchem.2014.04.104; Ferrucci L, 2006, J CLIN ENDOCR METAB, V91, P439, DOI 10.1210/jc.2005-1303; Thiebaut ACM, 2009, J NATL CANCER I, V101, P1001, DOI 10.1093/jnci/djp168; Roshani R, 2014, CANCER LETT, V345, P157, DOI 10.1016/j.canlet.2013.07.014; Iso H, 2005, J EPIDEMIOL, V15, pS24, DOI 10.2188/jea.15.S24; Heinen MM, 2009, INT J CANCER, V125, P1118, DOI 10.1002/ijc.24387; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17; Nothlings U, 2005, J NATL CANCER I, V97, P1458, DOI 10.1093/jnci/dji292; Boutros C, 2010, ARCH SURG-CHICAGO, V145, P515, DOI 10.1001/archsurg.2010.91; Rohrmann S, 2013, INT J CANCER, V132, P617, DOI 10.1002/ijc.27637; Bosetti C, 2012, ANN ONCOL, V23, P1880, DOI 10.1093/annonc/mdr541; ISO H, 1989, INT J EPIDEMIOL, V18, P374, DOI 10.1093/ije/18.2.374; Michaud DS, 2003, AM J EPIDEMIOL, V157, P1115, DOI 10.1093/aje/kwg098; Duell EJ, 2012, ANN ONCOL, V23, P2964, DOI 10.1093/annonc/mds140; Lin YS, 2006, NUTR CANCER, V56, P40, DOI 10.1207/s15327914nc5601_6; Aune D, 2012, ANN ONCOL, V23, P843, DOI 10.1093/annonc/mdr398; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Larsson SC, 2006, INT J CANCER, V118, P2866, DOI 10.1002/ijc.21732; He K, 2013, AM J EPIDEMIOL, V177, P152, DOI 10.1093/aje/kws232; Bell GA, 2014, AM J EPIDEMIOL, V179, P710, DOI 10.1093/aje/kwt326; Bosetti C, 2014, ANN ONCOL, V25, P2065, DOI 10.1093/annonc/mdu276; Kobayashi M, 2003, J EPIDEMIOL, V13, pS64; Kolodecik Thomas, 2013, Front Physiol, V4, P415, DOI 10.3389/fphys.2013.00415; Mozaffarian D, 2005, ALTERN THER HEALTH M, V11, P79; Mozaffarian D, 2005, ALTERN THER HEALTH M, V11, P24; Mozaffarian D, 2012, J NUTR, V142, P614; Mozaffarian D, 2005, ALTERN THER HEALTH M, V11, P1; Sasaki S, 1999, J Epidemiol, V9, P190; Sasaki S, 2003, J EPIDEMIOL, V13, pS115; Sasaki S, 2003, J EPIDEMIOL, V13, pS57; Science and Technology Agency, 1990, FATT AC CHOL VIT E C; Stolzenberg-Solomon RZ, 2002, AM J EPIDEMIOL, V155, P783, DOI 10.1093/aje/155.9.783; Tsubono Y, 2003, J EPIDEMIOL, V13, pS125; Tsugane S, 2014, JPN J CLIN ONCOL, V44, P777, DOI 10.1093/jjco/hyu096; WHO, 2000, INT CLASSIFICATION D; World Cancer Research Fund/American Institute for Cancer Research, 2012, CONT UPD PROJ FIND R; Zhang YF, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-204; Zheng W, 1993, Cancer Causes Control, V4, P477, DOI 10.1007/BF00050867	42	0	0	AMER SOC NUTRITION-ASN	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0002-9165	1938-3207		AM J CLIN NUTR	Am. J. Clin. Nutr.	DEC	2015	102	6					1490	1497		10.3945/ajcn.115.113597		8	Nutrition & Dietetics	Nutrition & Dietetics	CX5BY	WOS:000365717300024		
J	Fujino, K; Motooka, Y; Hassan, WA; Abdalla, MOA; Sato, Y; Kudoh, S; Hasegawa, K; Niimori-Kita, K; Kobayashi, H; Kubota, I; Wakimoto, J; Suzuki, M; Ito, T				Fujino, Kosuke; Motooka, Yamato; Hassan, Wael A.; Abdalla, Mohamed O. Ali; Sato, Yonosuke; Kudoh, Shinji; Hasegawa, Koki; Niimori-Kita, Kanako; Kobayashi, Hironori; Kubota, Ichiro; Wakimoto, Joeji; Suzuki, Makoto; Ito, Takaaki			Insulinoma-Associated Protein 1 Is a Crucial Regulator of Neuroendocrine Differentiation in Lung Cancer	AMERICAN JOURNAL OF PATHOLOGY			English	Article							FINGER TRANSCRIPTION FACTOR; THERAPEUTIC TARGETS; TRANSGENIC MICE; FACTOR INSM1; CELL-LINES; EXPRESSION; IA-1; GENE; PROMOTES; TUMORS	Insulinoma-associated protein 1 (INSM1) is expressed exclusively in embryonic developing neuroendocrine (NE) tissues. INSM1 gene expression is specific for small-cell lung cancer (SCLC), along with achaetescute homolog-like 1 (ASCL1) and several NE molecules, such as chromogranin A, synaptophysin, and neural cell adhesion molecule 1. However, the underlying biological role of INSM1 in lung cancer remains largely unknown. We first showed that surgically resected SCLC samples specifically expressed INSM1. Forced expression of the INSM1 gene in adenocarcinoma cell lines (H358 and H1975) induced the expression of ASCL1, brain-2 (BRN2), chromogranin A, synaptophysin, and neural cell adhesion molecule 1; in contrast, knockdown of the INSM1 gene by siRNA in SCLC (H69 and H889) decreased their expression. However, forced/knockdown expression of ASCL1 and BRN2 did not affect INSM1 expression. A chromatin immunoprecipitation study revealed that INSM1 bound to the promoter region of the ASCL1 gene. A xenotransplantation assay using tet-on INSM1 gene-transfected adenocarcinoma cell Lines demonstrated that INSM1 induced NE differentiation and growth inhibition. Furthermore, we found that INSM1 was not expressed in non small-cell lung cancer and some SCLC cell lines expressing Notch1-Hes1. By forced/knockdown expression of Notch1 or Hes1 genes, we revealed that Notch1-Hes1 signaling suppressed INSM1, as well as ASCL1 and BRN2. INSM1, expressed exclusively in SCLC, is a crucial regulator of NE differentiation in SCLCs, and is regulated by the Notch1-Hes1 signaling pathway.	[Fujino, Kosuke; Motooka, Yamato; Hassan, Wael A.; Sato, Yonosuke; Kudoh, Shinji; Hasegawa, Koki; Niimori-Kita, Kanako; Ito, Takaaki] Kumamoto Univ, Grad Sch Med Sci, Dept Pathol & Expt Med, Kumamoto 8608556, Japan; [Fujino, Kosuke; Motooka, Yamato; Suzuki, Makoto] Kumamoto Univ, Grad Sch Med Sci, Dept Thorac Surg, Kumamoto 8608556, Japan; [Abdalla, Mohamed O. Ali] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto 8608556, Japan; [Hassan, Wael A.] Suez Canal Univ, Fac Med, Dept Pathol, Ismaileya, Egypt; [Abdalla, Mohamed O. Ali] Suez Canal Univ, Fac Med, Dept Clin Pathol, Ismaileya, Egypt; [Kobayashi, Hironori] Kumamoto Saishunso Hosp, Natl Hosp Org, Dept Thorac Surg, Kumamoto, Japan; [Kubota, Ichiro; Wakimoto, Joeji] Minami Kyushu Hosp, Natl Hosp Org, Dept Thorac Surg & Pathol, Kagoshima, Japan	Ito, T (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Pathol & Expt Med, Chuo Ku, Honjo 1-1-1, Kumamoto 8608556, Japan.	takaito@kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23220010]	Supported in part by a Ministry of Education, Culture, Sports, Science and Technology of Japan Grant-in-Aid for Scientific Research No. 23220010 (TI.).	Linnoila RI, 2000, CANCER RES, V60, P4005; Ishii J, 2013, PATHOL INT, V63, P158, DOI 10.1111/pin.12042; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Wildner H, 2008, DEVELOPMENT, V135, P473, DOI 10.1242/dev.011783; Shan L, 2007, AM J PHYSIOL-LUNG C, V292, pL500, DOI 10.1152/ajplung.00052.2006; Wael H, 2014, LUNG CANCER, V85, P131, DOI 10.1016/j.lungcan.2014.05.001; Christensen CL, 2010, CLIN CANCER RES, V16, P2308, DOI 10.1158/1078-0432.CCR-09-3057; May M, 2007, SCAND J UROL NEPHROL, V41, P375, DOI 10.1080/00365590701224445; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Rodriguez E, 2010, CURR ONCOL REP, V12, P327, DOI 10.1007/s11912-010-0120-5; Xie JP, 2002, GENOMICS, V80, P54, DOI 10.1006/geno.2002.6800; Lan MS, 2009, FASEB J, V23, P2024, DOI 10.1096/fj.08-125971; Zhu M, 2002, PANCREAS, V24, P139, DOI 10.1097/00006676-200203000-00004; Kris MG, 2010, J CLIN ONCOL, V28, P5327, DOI 10.1200/JCO.2010.33.2742; Pedersen N, 2003, CANCER RES, V63, P1943; BALL DW, 1993, P NATL ACAD SCI USA, V90, P5648, DOI 10.1073/pnas.90.12.5648; Michaelsen SR, 2012, J GENE MED, V14, P445, DOI 10.1002/jgm.2630; GOTO Y, 1992, J BIOL CHEM, V267, P15252; Farkas LM, 2008, NEURON, V60, P40, DOI 10.1016/j.neuron.2008.09.020; Hamanaka W, 2014, HUM PATHOL, V45, P1045, DOI 10.1016/j.humpath.2014.01.001; Taniwaki M, 2006, INT J ONCOL, V29, P567; Sriuranpong V, 2002, MOL CELL BIOL, V22, P3129, DOI 10.1128/MCB.22.9.3129-3139.2002; LAN MS, 1993, CANCER RES, V53, P4169; Osada H, 2005, CANCER RES, V65, P10680, DOI 10.1158/0008-5472.CAN-05-1404; Augustyn A, 2014, P NATL ACAD SCI USA, V111, P14788, DOI 10.1073/pnas.1410419111; Yoshida R, 2013, LAB INVEST, V93, P1068, DOI 10.1038/labinvest.2013.95; Byers LA, 2012, CANCER DISCOV, V2, P798, DOI 10.1158/2159-8290.CD-12-0112; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Breslin MB, 2003, J BIOL CHEM, V278, P38991, DOI 10.1074/jbc.M306795200; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Travis WD, 2014, THORAC SURG CLIN, V24, P257, DOI 10.1016/j.thorsurg.2014.04.001; Osada H, 2008, CANCER RES, V68, P1647, DOI 10.1158/0008-5472.CAN-07-5039; Ito T, 2000, DEVELOPMENT, V127, P3913; Gierl MS, 2006, GENE DEV, V20, P2465, DOI 10.1101/gad.381806; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Niederst MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7377; Oser MG, 2015, LANCET ONCOL, V16, pE165, DOI 10.1016/S1470-2045(14)71180-5; Rosenbaum JN, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-6; Travis WD, 2015, WHO CLASSIFICATION T, P63; Wikenheiser-Brokamp KA, 2004, DEVELOPMENT, V131, P4299, DOI 10.1242/dev.01232	40	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	DEC	2015	185	12					3164	3177		10.1016/j.ajpath.2015.08.018		14	Pathology	Pathology	CX8CB	WOS:000365929000004		
J	Harada, C; Azuchi, Y; Noro, T; Guo, XL; Kimura, A; Namekata, K; Harada, T				Harada, Chikako; Azuchi, Yuriko; Noro, Takahiko; Guo, Xiaoli; Kimura, Atsuko; Namekata, Kazuhiko; Harada, Takayuki			TrkB Signaling in Retinal Glia Stimulates Neuroprotection after Optic Nerve Injury	AMERICAN JOURNAL OF PATHOLOGY			English	Article							NORMAL-TENSION GLAUCOMA; NEURAL CELL-DEATH; GANGLION-CELLS; NEUROTROPHIC FACTOR; MOUSE MODEL; GLUTAMATE TRANSPORTERS; AXONAL OUTGROWTH; MULLER CELLS; ADULT RATS; IN-VIVO	Brain-derived neurotrophic factor (BDNF) regulates neural cell survival mainly by activating TrkB receptors. Several tines of evidence support a key role for BDNF-TrkB signaling in survival of adult retinal ganglion cells in animal models of optic nerve injury (ONI), but the neuroprotective effect of exogenous BDNF is transient. Glial cells have recently attracted considerable attention as mediators of neural cell survival, and TrkB expression in retinal glia suggests its role in neuroprotection. To elucidate this point directly, we examined the effect of ONI on TrkB(flox/flox):glial fibrillary acidic protein (GFAP)-Cre+ (TrkB(GFAP)) knockout (KO) mice, in which TrkB is deleted in retinal glial cells. ONI markedly increased mRNA expression Levels of basic fibroblast growth factor (bFGF) in wild-type (WT) mice but not in TrkB(GFAP) KO mice. Immunohistochemical analysis at 7 days after ONI (d7) revealed bFGF up-regulation mainly occurred in Muller glia. ONI-induced retinal ganglion cell Loss in WT mice was consistently mild compared with TrkB(GFAP) KO mice at d7. On the other hand, ONI severely decreased TrkB expression in both WT and TrkB(GFAP) KO mice after d7, and the severity of retinal degeneration was comparable with TrkB(GFAP) KO mice at d14. Our data provide direct evidence that glial TrkB signaling plays an important role in the early stage of neural protection after traumatic injury.	[Harada, Chikako; Azuchi, Yuriko; Noro, Takahiko; Guo, Xiaoli; Kimura, Atsuko; Namekata, Kazuhiko; Harada, Takayuki] Tokyo Metropolitan Inst Med Sci, Visual Res Project, Tokyo 1568506, Japan; [Noro, Takahiko] Jikei Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan	Namekata, K (reprint author), Tokyo Metropolitan Inst Med Sci, Visual Res Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	namekata-kz@igakuken.or.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25462766, 25430082, 26861479, 256400043, 26640048, 15H04999]; Funding Program for Next Generation World-Leading Researchers (NEXT Program) [LS133]; Uehara Memorial Foundation	Supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (25462766 to C.H., 25430082 to X.G., 26861479 to A.K., 256400043 to K.N., 26640048 and 15H04999 to T.H.), the Funding Program for Next Generation World-Leading Researchers (NEXT Program; LS133 to T.H.), and the Uehara Memorial Foundation (T.H.).	Wahlin KJ, 2000, INVEST OPHTH VIS SCI, V41, P927; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Namekata K, 2013, CELL DEATH DIFFER, V20, P1250, DOI 10.1038/cdd.2013.91; Namekata K, 2012, J NEUROSCI, V32, P264, DOI 10.1523/JNEUROSCI.4884-11.2012; Miller G, 2005, SCIENCE, V308, P778, DOI 10.1126/science.308.5723.778; Harada C, 2010, CELL DEATH DIFFER, V17, P1751, DOI 10.1038/cdd.2010.62; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Koeberle PD, 1998, VISION RES, V38, P1505, DOI 10.1016/S0042-6989(97)00364-7; Soto I, 2003, J NEUROSCI RES, V73, P507, DOI 10.1002/jnr.10673; Noro T, 2015, INVEST OPHTH VIS SCI, V56, P5012, DOI 10.1167/iovs.15-17142; Chen H, 2004, BRAIN RES, V1011, P99, DOI 10.1016/j.brainres.2004.03.024; Harada T, 2007, J CLIN INVEST, V117, P1763, DOI 10.1172/JCI30178; Harada T, 1998, P NATL ACAD SCI USA, V95, P4663, DOI 10.1073/pnas.95.8.4663; Berk BA, 2015, NEUROSCIENCE, V295, P175, DOI 10.1016/j.neuroscience.2015.03.037; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Blanco RE, 2000, J COMP NEUROL, V423, P646; Harada C, 2006, AM J PATHOL, V168, P261, DOI 10.2353/ajpath.2006.050765; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; Namekata K, 2010, P NATL ACAD SCI USA, V107, P7586, DOI 10.1073/pnas.0914514107; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; Clarke DB, 1998, VISION RES, V38, P1517, DOI 10.1016/S0042-6989(97)00341-6; Tonari M, 2012, INVEST OPHTH VIS SCI, V53, P3490, DOI 10.1167/iovs.11-9415; Katome T, 2013, CELL DEATH DIFFER, V20, P270, DOI 10.1038/cdd.2012.122; Schuettauf F, 2004, CURR EYE RES, V29, P379, DOI 10.1080/02713680490517872; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008; Harada T, 2002, J NEUROSCI, V22, P9228; Di Polo A, 1998, P NATL ACAD SCI USA, V95, P3978, DOI 10.1073/pnas.95.7.3978; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Lindqvist N, 2004, EXP NEUROL, V187, P487, DOI 10.1016/j.expneurol.2004.02.002; Harada T, 2000, NEURON, V26, P533, DOI 10.1016/S0896-6273(00)81185-X; KOSTYK SK, 1994, J NEUROSCI, V14, P1441; Cheng L, 2002, J NEUROSCI, V22, P3977; Fujita Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.298; Harada C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1190; Kimura A, 2015, AM J PATHOL, V185, P756, DOI 10.1016/j.ajpath.2014.11.005; Luikart BW, 2005, J NEUROSCI, P25; Namekata K, 2014, PROG RETIN EYE RES, V43, P1, DOI 10.1016/j.preteyeres.2014.06.005; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; Noro T, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.93; Parrilla-Reverter G, 2009, EXP EYE RES, V89, P32, DOI 10.1016/j.exer.2009.02.015; Semba K, 2014, NEUROSCI LETT, V581, P89, DOI 10.1016/j.neulet.2014.08.034; Semba K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.296; Semba K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.306; Xie JX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119119	45	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	DEC	2015	185	12					3238	3247		10.1016/j.ajpath.2015.08.005		10	Pathology	Pathology	CX8CB	WOS:000365929000010		
J	Tanno, H; Kawakami, K; Ritsu, M; Kanno, E; Suzuki, A; Kamimatsuno, R; Takagi, N; Miyasaka, T; Ishii, K; Imai, Y; Maruyama, R; Tachi, M				Tanno, Hiromasa; Kawakami, Kazuyoshi; Ritsu, Masae; Kanno, Emi; Suzuki, Aiko; Kamimatsuno, Rina; Takagi, Naoyuki; Miyasaka, Tomomitsu; Ishii, Keiko; Imai, Yoshimichi; Maruyama, Ryoko; Tachi, Masahiro			Contribution of Invariant Natural Killer T Cells to Skin Wound Healing	AMERICAN JOURNAL OF PATHOLOGY			English	Article							STREPTOCOCCUS-PNEUMONIAE INFECTION; V-ALPHA-14 NKT CELLS; IFN-GAMMA; GROWTH-FACTORS; HOST-DEFENSE; MYOFIBROBLAST; CYTOKINES; INNATE; LUNGS; MICE	In the present study, we determined the contribution of invariant natural killer T (iNKT) cells to the skin wound healing process. In iNKT cell-deficient (J alpha 18K0) mice lacking iNKT cells, wound closure was significantly delayed compared with wild-type mice. Collagen deposition, expression of alpha-smooth muscle actin and CD31, and wound breaking strength were significantly attenuated in J alpha 18K0 mice. The adoptive transfer of Liver mononuclear cells from wild-type but not from J alpha 18K0 or interferon (IFN)-gamma gene-disrupted (IFN-gamma K0) mice resulted in the reversal of this impaired wound healing in J alpha 18K0 mice. IFN-gamma expression was induced in the wounded tissues, which was significantly decreased at 6, 12, and 24 hours, but increased on day 3 after wounding in J alpha 18K0 mice. The main source of the Late-phase IFN-gamma production in J alpha 18K0 mice were neutrophils rather than NK cells and T cells. Administration of alpha-galactosylceramide, an activator of iNKT cells, resulted in the acceleration of wound healing on day 3 in wild-type mice. This effect was not observed in IFN-gamma K0 mice. These results indicate that iNKT cells play important roles in wound healing. The iNKT cell-induced IFN-gamma production may regulate the wound healing process in the early phase.	[Tanno, Hiromasa; Ritsu, Masae; Suzuki, Aiko; Kamimatsuno, Rina; Takagi, Naoyuki; Imai, Yoshimichi; Tachi, Masahiro] Tohoku Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kawakami, Kazuyoshi; Miyasaka, Tomomitsu; Ishii, Keiko] Tohoku Univ, Grad Sch Med, Dept Med Microbiol Mycol & Immunol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kanno, Emi; Maruyama, Ryoko] Tohoku Univ, Grad Sch Med, Dept Sci Nursing Practice, Aoba Ku, Sendai, Miyagi 9808575, Japan	Tachi, M (reprint author), Tohoku Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	tachi@med.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [21390476, 24592705]	Supported in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan grants-in-aid for scientific research (B) 21390476 and (C) 24592705 (M.T.).	Toulon A, 2009, J EXP MED, V206, P743, DOI 10.1084/jem.20081787; Schneider DF, 2011, J SURG RES, V168, P325, DOI 10.1016/j.jss.2009.09.030; Ishikawa S, 2011, J HEPATOL, V54, P1195, DOI 10.1016/j.jhep.2010.08.022; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Nakamatsu M, 2007, MICROBES INFECT, V9, P364, DOI 10.1016/j.micinf.2006.12.003; Kawakami K, 2003, EUR J IMMUNOL, V33, P3322, DOI 10.1002/eji.200324254; Cornelissen AMH, 2000, J DENT RES, V79, P1782; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; EFRON JE, 1990, J SURG RES, V48, P460, DOI 10.1016/0022-4804(90)90013-R; Schneider DF, 2011, J SURG RES, V171, P361, DOI 10.1016/j.jss.2010.03.030; Kawakami K, 2001, J IMMUNOL, V167, P6525; Kuroda E, 2007, EUR J IMMUNOL, V37, P2185, DOI 10.1002/eji.200737041; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Hijioka K, 2008, BIOCHEM BIOPH RES CO, V374, P38, DOI 10.1016/j.bbrc.2008.06.080; Jameson JM, 2005, J EXP MED, V201, P1269, DOI 10.1084/jem.20042057; Goldberg MT, 2007, J INVEST DERMATOL, V127, P2645, DOI 10.1038/sj.jid.5700890; Ishida Y, 2004, J IMMUNOL, V172, P1848; Rumalla VK, 2001, PLAST RECONSTR SURG, V108, P719, DOI 10.1097/00006534-200109010-00019; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.ummunol.21.120601.141057; Chen Lin, 2014, Exp Dermatol, V23, P189, DOI 10.1111/exd.12346; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Gu XY, 2013, DIABETES RES CLIN PR, V102, P53, DOI 10.1016/j.diabres.2013.08.004; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Tagawa Y, 1997, J IMMUNOL, V159, P1418; Ulloa L, 1999, NATURE, V397, P710; Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x; Nakamura Y, 2015, INFECT IMMUN, V83, P671, DOI 10.1128/IAI.02835-14; Robson M C, 2001, Curr Probl Surg, V38, P72, DOI 10.1067/msg.2001.111167	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	DEC	2015	185	12					3248	3257		10.1016/j.ajpath.2015.08.012		10	Pathology	Pathology	CX8CB	WOS:000365929000011		
J	Devarajan, S; Yahiro, E; Uehara, Y; Habe, S; Nishiyama, A; Miura, S; Saku, K; Urata, H				Devarajan, Sankar; Yahiro, Eiji; Uehara, Yoshinari; Habe, Shigehisa; Nishiyama, Akira; Miura, Shin-ichiro; Saku, Keijiro; Urata, Hidenori			Depressor effect of chymase inhibitor in mice with high salt-induced moderate hypertension	AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY			English	Article						mouse; high salt; hypertension; renin-angiotensin system; chymase inhibitor	DEOXYCORTICOSTERONE-ACETATE-SALT; CONVERTING ENZYME-INHIBITION; RENIN-ANGIOTENSIN SYSTEM; II-FORMING ACTIVITY; BLOOD-PRESSURE; SENSITIVE HYPERTENSION; OXIDATIVE STRESS; DIETARY-SODIUM; HEART-FAILURE; RATS	The aim of the present study was to determine whether long-term high salt intake in the drinking water induces hypertension in wild-type (WT) mice and whether a chymase inhibitor or other antihypertensive drugs could reverse the increase of blood pressure. Eight-week-old male WT mice were supplied with drinking water containing 2% salt for 12 wk (high-salt group) or high-salt drinking water plus an oral chymase inhibitor (TPC-806) at four different doses (25, 50, 75, or 100 mg/kg), captopril (75 mg/kg), losartan (100 mg/kg), hydrochlorothiazide (3 mg/kg), eplerenone (200 mg/kg), or amlodipine (6 mg/kg). Control groups were given normal water with or without the chymase inhibitor. Blood pressure and heart rate gradually showed a significant increase in the high-salt group, whereas a dose-dependent depressor effect of the chymase inhibitor was observed. There was also partial improvement of hypertension in the losartan- and eplerenone-treated groups but not in the captopril-, hydrochlorothiazide-, and amlodipine-treated groups. A high salt load significantly increased chymasedependent ANG II-forming activity in the alimentary tract. In addition, the relative contribution of chymase to ANG II formation, but not actual average activity, showed a significant increase in skin and skeletal muscle, whereas angiotensin-converting enzyme-dependent ANG II-forming activity and its relative contribution were reduced by high salt intake. Plasma and urinary renin-angiotensin system components were significantly increased in the high-salt group but were significantly suppressed in the chymase inhibitor-treated group. In conclusion, 2% salt water drinking for 12 wk caused moderate hypertension and activated the renin-angiotensin system in WT mice. A chymase inhibitor suppressed both the elevation of blood pressure and heart rate, indicating a definite involvement of chymase in salt-sensitive hypertension.	[Devarajan, Sankar; Urata, Hidenori] Fukuoka Univ, Chikushi Hosp, Dept Cardiovasc Dis, Fukuoka 8188502, Japan; [Yahiro, Eiji; Uehara, Yoshinari; Miura, Shin-ichiro; Saku, Keijiro] Fukuoka Univ, Sch Med, Dept Cardiol, Fukuoka 81401, Japan; [Habe, Shigehisa] Fukuoka Univ, Sch Med, Dept Parasitol, Fukuoka 81401, Japan; [Nishiyama, Akira] Kagawa Univ, Fac Med, Dept Pharmacol, Kagawa, Japan	Urata, H (reprint author), Fukuoka Univ, Chikushi Hosp, Dept Cardiovasc Dis, 1-1-1 Zokumyoin, Fukuoka 8188502, Japan.	uratah@fukuoka-u.ac.jp			Japan Society for the Promotion of Science [21590916, 26461118]	This work was supported by Japan Society for the Promotion of Science Scientific Research C Grants 21590916 and 26461118.	Ikeda T, 1999, HYPERTENSION, V34, P514; Vanhooren V, 2013, AGEING RES REV, V12, P8, DOI 10.1016/j.arr.2012.03.010; DENTON D, 1995, NAT MED, V1, P1009, DOI 10.1038/nm1095-1009; Chandrasekharan UM, 1996, SCIENCE, V271, P502, DOI 10.1126/science.271.5248.502; Cholewa BC, 2001, AM J PHYSIOL-REG I, V281, pR987; Midgley JP, 1996, JAMA-J AM MED ASSOC, V275, P1590, DOI 10.1001/jama.275.20.1590; Bahk TJ, 2008, INT J CARDIOL, V125, P85, DOI 10.1016/j.ijcard.2007.04.062; CORBETT WT, 1979, AM J CLIN NUTR, V32, P2068; Bayorh MA, 2005, CLIN EXP HYPERTENS, V27, P355, DOI 10.1081/CEH-200057423; Gu JW, 2006, AM J PHYSIOL-REG I, V291, pR1817, DOI 10.1152/ajpregu.00153.2006; Lenda DM, 2002, AM J PHYSIOL-HEART C, V282, pH395; Lantelme P, 2002, HYPERTENSION, V39, P1007, DOI 10.1161/01.HYP.0000016177.20565.A0; Kobori H, 2003, HYPERTENSION, V41, P592, DOI 10.1161/01.HYP.0000056768.03657.B4; Ozaykan B, 2011, BOSNIAN J BASIC MED, V11, P228; Ito K, 2009, CIRC RES, V104, P1004, DOI 10.1161/CIRCRESAHA.108.188995; AZIZI M, 1995, CIRCULATION, V92, P825; Laursen JB, 1997, CIRCULATION, V95, P588; Akasu M, 1998, HYPERTENSION, V32, P514; Makhanova N, 2008, HYPERTENSION, V51, P134, DOI 10.1161/HYPERTENSIONAHA.107.098897; Nishiyama A, 2002, HYPERTENSION, V39, P129, DOI 10.1161/hy0102.100536; Ihara M, 2000, CARDIOLOGY, V94, P247, DOI 10.1159/000047325; Takai S, 1998, EUR J PHARMACOL, V358, P229, DOI 10.1016/S0014-2999(98)00622-0; Keidar S, 2001, ARTERIOSCL THROM VAS, V21, P1464, DOI 10.1161/hq0901.095547; Inagaki K, 2002, J MOL CELL CARDIOL, V34, P1377, DOI 10.1006/jmcc.2002.2089; Obih P, 2008, BLOOD PRESSURE, V17, P55, DOI 10.1080/08037050701789278; WEINBERGER MH, 1986, HYPERTENSION, V8, P127; Li M, 2004, J CLIN INVEST, V114, P112, DOI 10.1172/JC1200420805; Wei CC, 2010, J CLIN INVEST, V120, P1229, DOI 10.1172/JCI39345; SMITHIES O, 1994, P NATL ACAD SCI USA, V91, P3612, DOI 10.1073/pnas.91.9.3612; Merrill DC, 1996, J CLIN INVEST, V97, P1047, DOI 10.1172/JCI118497; Helle F, 2013, ACTA PHYSIOL, V207, P577, DOI 10.1111/apha.12049; Takeda Y, 2001, J HYPERTENS, V19, P635, DOI 10.1097/00004872-200103001-00017; Ihara M, 1999, HYPERTENSION, V33, P1399; Simard E, 2009, J PHARMACOL EXP THER, V328, P540, DOI 10.1124/jpet.108.142992; Tsai YS, 2004, J CLIN INVEST, V114, P240, DOI 10.1172/JCI200420964; Wang DH, 2004, J CARD FAIL, V10, P67, DOI 10.1016/S1071-9164(03)00578-5; Nussberger J, 2008, HYPERTENSION, V51, P1306, DOI 10.1161/HYPERTENSIONAHA.108.110932; Tamura K, 1999, J ENDOCRINOL, V160, P401, DOI 10.1677/joe.0.1600401; Tojo A, 2002, HYPERTENSION, V40, P834, DOI 10.1161/01.HYP.0000039506.43589.D5; Somers MJ, 2000, CIRCULATION, V101, P1722; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Zhu JX, 2007, J VASC RES, V44, P382, DOI 10.1159/000102955; CHERCHOVICH GM, 1976, J APPL PHYSIOL, V40, P601; Rodriguez-Iturbe B, 2004, AM J PHYSIOL-RENAL, V286, pF606, DOI 10.1152/ajprenal.00269.2003; Osborn JW, 2010, EXP PHYSIOL, V95, P61, DOI 10.1113/expphysiol.2008.046326; Titze J, 2006, HYPERTENSION, V47, P1101, DOI 10.1161/01.HYP.0000221039.17735.1a; Fujita M, 2007, HYPERTENSION, V50, P360, DOI 10.1161/HYPERTENSIONAHA.107.091009; SRINIVASAN SR, 1984, AM J CLIN NUTR, V39, P792; Gallwitz M, 2006, IMMUNOGENETICS, V58, P641, DOI 10.1007/s00251-006-0123-4; Ganong WF, 2005, REV MED PHYSL, P600; Ingert C, 2002, AM J PHYSIOL-RENAL, V283, pF995, DOI 10.1152/ajprenal.00321.2001; Intersalt Cooperative Research Group, 1988, BMJ-BRIT MED J, V297, P319, DOI DOI 10.1136/BMJ.297.66; Macknik A, 2009, NAT MED, V15, P545; Treuting PM, 2012, COMP ANATOMY HISTOLO	54	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6135	1522-1539		AM J PHYSIOL-HEART C	Am. J. Physiol.-Heart Circul. Physiol.	DEC 1	2015	309	11					H1987	H1996		10.1152/ajpheart.00721.2014		10	Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular Disease	Cardiovascular System & Cardiology; Physiology	CX7MR	WOS:000365886500018		
J	Higashi, K; Yamada, Y; Minatoguchi, S; Baba, S; Iwasa, M; Kanamori, H; Kawasaki, M; Nishigaki, K; Takemura, G; Kumazaki, M; Akao, Y; Minatoguchi, S				Higashi, Kenshi; Yamada, Yoshihisa; Minatoguchi, Shingo; Baba, Shinya; Iwasa, Masamitsu; Kanamori, Hiromitsu; Kawasaki, Masanori; Nishigaki, Kazuhiko; Takemura, Genzou; Kumazaki, Minami; Akao, Yukihiro; Minatoguchi, Shinya			MicroRNA-145 repairs infarcted myocardium by accelerating cardiomyocyte autophagy	AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY			English	Article						myocardial infarction; miR-145; autophagy; cardiomyocyte	NEOINTIMAL LESION FORMATION; REGULATING AUTOPHAGY; PATHWAY; REPERFUSION; HEART; SIZE; DIFFERENTIATION; INHIBITION; ACTIVATION; PROTECTS	We investigated whether microRNA-145 (miR-145) has a cardioprotective effect in a rabbit model of myocardial infarction (MI) and in H9c2 rat cardiomyoblasts. Rabbits underwent 30 min of coronary occlusion, followed by 2 days or 2 wk of reperfusion. Control microRNA (control group; 2.5 nmol/kg, n = 10) or miR-145 (miR-145 group, 2.5 nmol/kg, n = 10) encapsulated in liposomes was intravenously administered immediately after the start of reperfusion. H9c2 rat cardiomyoblasts were transfected with miR-145. The MI size was significantly smaller in the miR-145 group than in the control group at 2 days and 2 wk post-MI. miR-145 had improved the cardiac function and remodeling at 2 wk post-MI. These effects were reversed by chloroquine. Western blot analysis showed that miR-145 accelerated the transition of LC3B I to II and downregulated p62/SQSTM1 at 2 days or 2 wk after MI, but not at 4 wk, and activated Akt in the ischemic area at 2 days after MI. miR-145 inhibited the growth of H9c2 cells, accelerated the transition of LC3B I to II, and increased phosphorylated Akt in the H9c2 cells at 2 days after miR-145 transfection. Antagomir-145 significantly abolished the morphological change, the transition of LC3B I to II, and the increased phosphorylated Akt induced by miR-145 in H9c2 cells. We determined fibroblast growth factor receptor substrate 2 mRNA to be a target of miR-145, both in an in vivo model and in H9c2 cells. In conclusion, post-MI treatment with miR-145 protected the heart through the induction of cardiomyocyte autophagy by targeting fibroblast growth factor receptor substrate 2.	[Higashi, Kenshi; Yamada, Yoshihisa; Minatoguchi, Shingo; Baba, Shinya; Iwasa, Masamitsu; Kanamori, Hiromitsu; Kawasaki, Masanori; Nishigaki, Kazuhiko; Takemura, Genzou; Minatoguchi, Shinya] Gifu Univ, Grad Sch Med, Dept Cardiol, Gifu 50111946, Japan; [Kumazaki, Minami; Akao, Yukihiro] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu 50111946, Japan	Minatoguchi, S (reprint author), Gifu Univ, Grad Sch Med, Dept Cardiol, Yanagido 1-1, Gifu 50111946, Japan.	minatos@gifu-u.ac.jp			Gifu University Graduate School of Medicine	This work was supported by a grant from Gifu University Graduate School of Medicine (to Shinya Minatoguchi).	Minatoguchi S, 1999, BRIT J PHARMACOL, V128, P1667, DOI 10.1038/sj.bjp.0702970; Zhang KQ, 2013, CANCER RES, V73, P1298, DOI 10.1158/0008-5472.CAN-12-2086; Penna C, 2008, J CELL MOL MED, V12, P435, DOI 10.1111/j.1582-4934.2007.00210.x; Kanamori H, 2011, AM J PHYSIOL-HEART C, V300, pH2261, DOI 10.1152/ajpheart.01056.2010; Huang CQ, 2010, J CARDIOVASC TRANSL, V3, P365, DOI 10.1007/s12265-010-9189-3; Hausenloy DJ, 2005, AM J PHYSIOL-HEART C, V288, pH971, DOI 10.1152/ajpheart.00374.2004; Yamada Y, 2013, AM J PHYSIOL-HEART C, V304, pH1124, DOI 10.1152/ajpheart.00707.2012; Xie M, 2011, CURR OPIN CARDIOL, V26, P216, DOI 10.1097/HCO.0b013e328345980a; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Dubbelhuis PF, 2002, BIOCHEM J, V368, P827, DOI 10.1042/BJ20021340; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; HORWITZ LD, 1994, CIRCULATION, V89, P1792; Luo TF, 2014, INT J MOL SCI, V15, P15426, DOI 10.3390/ijms150915426; Zhang J, 2012, AUTOPHAGY, V8, P690, DOI 10.4161/auto.19290; Tsang A, 2004, CIRC RES, V95, P230, DOI 10.1161/01.RES.0000138303.76488.fe; REIMER KA, 1979, LAB INVEST, V40, P633; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Zhang J, 2012, CIRC RES, V110, pE29, DOI 10.1161/CIRCRESAHA.111.255950; Zhou WC, 2009, CELL RES, V19, P1165, DOI 10.1038/cr.2009.95; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Wei YY, 2013, AM J PHYSIOL-HEART C, V304, pH1050, DOI 10.1152/ajpheart.00267.2012; Iwai-Kanai Eri, 2008, Autophagy, V4, P322; Li RT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044907; Luo LY, 2015, MOL CANCER RES, V13, P502, DOI 10.1158/1541-7786.MCR-14-0407; Moyzis AG, 2015, AM J PHYSIOL-HEART C, V308, pH183, DOI 10.1152/ajpheart.00708.2014; Orogo AM, 2015, CIRC RES, V116, P489, DOI 10.1161/CIRCRESAHA.116.303791; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH578	28	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6135	1522-1539		AM J PHYSIOL-HEART C	Am. J. Physiol.-Heart Circul. Physiol.	DEC 1	2015	309	11					H1813	H1826		10.1152/ajpheart.00709.2014		14	Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular Disease	Cardiovascular System & Cardiology; Physiology	CX7MR	WOS:000365886500002		
J	Tatsumoto, N; Yamada, S; Tokumoto, M; Eriguchi, M; Noguchi, H; Torisu, K; Tsuruya, K; Kitazono, T				Tatsumoto, Narihito; Yamada, Shunsuke; Tokumoto, Masanori; Eriguchi, Masahiro; Noguchi, Hideko; Torisu, Kumiko; Tsuruya, Kazuhiko; Kitazono, Takanari			Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification	AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY			English	Article						chronic kidney disease; hyperphosphatemia; mineralocorticoid receptor; spironolactone; vascular calcification	CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; REGULATED KINASE 1; OXIDATIVE STRESS; HEART-FAILURE; ALDOSTERONE BLOCKADE; CELL-PROLIFERATION; INFLAMMATION; PHOSPHATE; SERUM	Vascular calcification (VC) is a critical complication in patients with chronic kidney disease (CKD). The effects of spironolactone (SPL), a mineralocorticoid receptor (MR) antagonist, on VC have not been fully investigated in CKD. The present in vivo study determined the protective effects of SPL on VC in CKD rats. Rats were divided into a control group and four groups of rats with adenine-induced CKD. Three groups were treated with 0, 50, and 100 mg.kg(-1).day(-1) SPL for 8 wk, and one group was treated with 100 mg.kg(-1).day(-1) SPL for the last 2 wk of the 8-wk treatment period. After 8 wk, CKD rats developed azotemia and hyperphosphatemia, with increases in the expression of serum and glucocorticoid-regulated kinase-1 and sodium-phosphate cotransporter, in inflammation and oxidative stress level, in osteogenic signaling and apoptosis, and in aortic calcification, compared with control rats. SPL dose dependently decreased these changes in the aortas, concomitant with improvements in renal inflammation, tubulointerstitial nephritis, and kidney function. SPL neither lowered blood pressure level nor induced hyperkalemia. Treatment of CKD rats for the last 2 wk with 100 mg.kg(-1).day(-1) SPL attenuated VC compared with CKD rats with the same degree of kidney function and hyperphosphatemia. In conclusion, SPL dose dependently inhibits the progression of VC by suppressing MR signaling, local inflammation, osteogenic transition, and apoptosis in the aortas of CKD rats.	[Tatsumoto, Narihito; Yamada, Shunsuke; Eriguchi, Masahiro; Noguchi, Hideko; Torisu, Kumiko; Tsuruya, Kazuhiko; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 8128582, Japan; [Tsuruya, Kazuhiko] Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Fukuoka 8128582, Japan; [Yamada, Shunsuke; Tokumoto, Masanori] Fukuoka Dent Coll Med & Dent Hosp, Div Internal Med, Fukuoka, Japan	Tsuruya, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	tsuruya@intmed2.med.kyushu-u.ac.jp			Japanese Association of Dialysis Physicians; Ministry of Education, Culture, Sports, Science, and Technology; Clinical Research Promotion Foundation	This study was supported in part by the Japanese Association of Dialysis Physicians, the Ministry of Education, Culture, Sports, Science, and Technology-Supported Program for the Strategic Research Foundation at Private Universities, and a grant from The Clinical Research Promotion Foundation 2014.	Perez-Rojas J, 2007, AM J PHYSIOL-RENAL, V292, pF131, DOI 10.1152/ajprenal.00147.2006; Bhan I, 2009, CLIN J AM SOC NEPHRO, V4, pS102, DOI 10.2215/CJN.04800709; Wu SY, 2012, EXP BIOL MED, V237, P31, DOI 10.1258/ebm.2011.011175; Voelkl J, 2013, J CLIN INVEST, V123, P812, DOI 10.1172/JCI64093; Jaffe IZ, 2007, ARTERIOSCL THROM VAS, V27, P799, DOI 10.1161/01.ATV.0000258414.59393.89; Zhong W, 2014, CELL SIGNAL, V26, P2765, DOI 10.1016/j.cellsig.2014.08.002; Vizzardi E, 2010, AM J CARDIOL, V106, P1292, DOI 10.1016/j.amjcard.2010.06.052; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Wei YZ, 2009, HYPERTENSION, V53, P158, DOI 10.1161/HYPERTENSIONAHA.108.121954; Cheng JZ, 2010, KIDNEY INT, V78, P668, DOI 10.1038/ki.2010.214; Zhao GX, 2012, KIDNEY INT, V82, P34, DOI 10.1038/ki.2012.40; Chen H, 2013, KIDNEY BLOOD PRESS R, V37, P557, DOI 10.1159/000355736; McCurley A, 2012, MOL CELL ENDOCRINOL, V350, P256, DOI 10.1016/j.mce.2011.06.014; Nitta K, 2003, AM J MED, V115, P250; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Kawata T, 2008, KIDNEY INT, V74, P1270, DOI 10.1038/ki.2008.407; Chan AKY, 2007, J AM COLL CARDIOL, V50, P591, DOI 10.1016/j.jacc.2007.03.062; Newfell BG, 2011, ARTERIOSCL THROM VAS, V31, P1871, DOI 10.1161/ATVBAHA.111.229070; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Terada Y, 2008, J AM SOC NEPHROL, V19, P298, DOI 10.1681/ASN.2007050531; Mathew S, 2008, J AM SOC NEPHROL, V19, P1509, DOI 10.1681/ASN.2007080902; Ohnishi M, 2009, CIRC-CARDIOVASC GENE, V2, P583, DOI 10.1161/CIRCGENETICS.108.847814; Vallon V, 2005, AM J PHYSIOL-REG I, V288, pR4, DOI 10.1152/ajpregu.00369.2004; Gonzalez M, 2009, CURR VASC PHARMACOL, V7, P506; BENNETT WM, 1982, LAB INVEST, V47, P330; YOKOZAWA T, 1986, NEPHRON, V44, P230, DOI 10.1159/000183992; Rautureau Y, 2011, STEROIDS, V76, P834, DOI 10.1016/j.steroids.2011.02.015; Yamada S, 2012, J BONE MINER RES, V27, P474, DOI 10.1002/jbmr.539; Yamada S, 2014, AM J PHYSIOL-RENAL, V306, pF1418, DOI 10.1152/ajprenal.00633.2013; Giachelli CM, 2004, J AM SOC NEPHROL, V15, P2959, DOI 10.1097/01.ASN.00001.45894.57533.C4; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; Aoshima Y, 2012, NEPHROL DIAL TRANSPL, V27, P1800, DOI 10.1093/ndt/gfr758; Briet M, 2013, J VASC RES, V50, P89, DOI 10.1159/000345243; Iijima K, 2014, J ATHEROSCLER THROMB, V21, P917; Vallon V, 2006, J MOL MED-JMM, V84, P396, DOI 10.1007/s00109-005-0027-z; Ikeda H, 2009, KIDNEY INT, V75, P147, DOI 10.1038/ki.2008.507; Wu MT, 2013, CALCIFIED TISSUE INT, V93, P365, DOI 10.1007/s00223-013-9712-z; Feria I, 2003, KIDNEY INT, V63, P43, DOI 10.1046/j.1523-1755.2003.00707.x; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Adijiang A, 2010, BIOCHEM BIOPH RES CO, V399, P637, DOI 10.1016/j.bbrc.2010.07.130; Namsolleck P, 2014, NEPHROL DIAL TRANSPL, V29, pI62, DOI 10.1093/ndt/gft402; Brown NJ, 2013, NAT REV NEPHROL, V9, P459, DOI 10.1038/nrneph.2013.110; Sarafidis PA, 2014, KIDNEY INT, V85, P536, DOI 10.1038/ki.2013.355; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Katsumata K, 2003, KIDNEY INT, V64, P441, DOI 10.1046/j.1523-1755.2003.00126.x; Zhang LP, 2005, CANCER RES, V65, P457; Borst O, 2015, ARTERIOSCL THROM VAS, V35, P547, DOI 10.1161/ATVBAHA.114.304454	49	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	1931-857X	1522-1466		AM J PHYSIOL-RENAL	Am. J. Physiol.-Renal Physiol.	DEC 1	2015	309	11					F967	F979		10.1152/ajprenal.00669.2014		13	Physiology; Urology & Nephrology	Physiology; Urology & Nephrology	CX7QS	WOS:000365897700009		
J	Takenaga, T; Sugimoto, K; Goto, H; Nozaki, M; Fukuyoshi, M; Tsuchiya, A; Murase, A; Ono, T; Otsuka, T				Takenaga, Tetsuya; Sugimoto, Katsumasa; Goto, Hideyuki; Nozaki, Masahiro; Fukuyoshi, Masaki; Tsuchiya, Atsushi; Murase, Atsunori; Ono, Tetsuya; Otsuka, Takanobu			Posterior Shoulder Capsules Are Thicker and Stiffer in the Throwing Shoulders of Healthy College Baseball Players: A Quantitative Assessment Using Shear-Wave Ultrasound Elastography	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						shoulder; baseball; glenohumeral internal rotation deficit (GIRD); posterior capsule of the shoulder; ultrasound elastography	INTERNAL-ROTATION DEFICIT; HUMERAL RETROVERSION; GLENOHUMERAL RANGE; MOTION; PITCHERS; IMPINGEMENT; BIOMECHANICS; TIGHTNESS; THICKNESS; THROWERS	Background: Posterior and posteroinferior capsules in the shoulder joints of throwing athletes have been reported to be thicker in throwing than nonthrowing shoulders, and this has a relationship to glenohumeral internal rotation deficit (GIRD). However, the stiffness of these thickened capsules has not been reported. Shear-wave ultrasound elastography is a new technology that can measure tissue elasticity quantitatively. Hypothesis: The posterior and posteroinferior capsules are stiffer as well as thicker in the throwing shoulders of baseball players than in their nonthrowing shoulders. The thickness and elasticity of these capsules are inversely correlated with glenohumeral internal rotation. Study Design: Cross-sectional study; Level of evidence, 3. Methods: Forty-five male college baseball players were examined. The thickness and elasticity of the posterior capsule beneath the infraspinatus and the posteroinferior capsule beneath the teres minor were measured using an ultrasonic device equipped with shear-wave elastographic technology. Glenohumeral internal rotation at 90 degrees of shoulder abduction and humeral retrotorsion were also measured. Results: The mean thickness and elasticity of the posterior capsule were significantly greater for the throwing compared with the nonthrowing shoulder (thickness: 1.34 vs 1.04 mm, respectively; elasticity: 40.0 vs 32.2 kPa, respectively; P < .001 for both). The mean thickness and elasticity of the posteroinferior capsule were also significantly greater in the throwing compared with the nonthrowing shoulder (thickness: 1.40 vs 1.04 mm, respectively; elasticity: 39.4 vs 31.6 kPa, respectively; P < .001 for both). After correcting the range of motion for bilateral differences in retrotorsion, correlation coefficients showed that posterior capsule thickness and elasticity (Pearson r = -0.43 and -0.56, respectively; P < .001 for both) and posteroinferior capsule thickness and elasticity (Pearson r = -0.51 and -0.52, respectively; P < .001 for both) were negatively correlated with the corrected glenohumeral internal rotation. Bilateral differences in posterior and posteroinferior capsule elasticity correlated with bilateral differences in the corrected glenohumeral internal rotation (Pearson r = 0.46 [P = .0015] and 0.48 [P < .001], respectively), whereas bilateral differences in posterior and posteroinferior capsule thickness did not (Pearson r = -0.13 [P = .38] and 0.17 [P = .28], respectively). Conclusion: The posterior and posteroinferior capsules were stiffer as well as thicker in the throwing shoulder of college baseball players compared with the nonthrowing shoulder. Posterior capsule elasticity appeared to have a greater effect on GIRD than did posterior capsule thickness. This technology could be used as a noninvasive screening method for throwing athletes to identify players at potential risk of shoulder injuries.	[Takenaga, Tetsuya; Goto, Hideyuki; Nozaki, Masahiro; Murase, Atsunori; Otsuka, Takanobu] Nagoya City Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Takenaga, Tetsuya; Sugimoto, Katsumasa; Fukuyoshi, Masaki; Tsuchiya, Atsushi; Ono, Tetsuya] Nagoya City Univ, Nagoya, Aichi 4678601, Japan	Takenaga, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	take10280425@yahoo.co.jp					Shanley E, 2012, J SHOULDER ELB SURG, V21, P1605, DOI 10.1016/j.jse.2011.11.035; Tokish JM, 2014, SPORTS MED ARTHROSC, V22, P88, DOI 10.1097/JSA.0000000000000015; Osbahr DC, 2002, AM J SPORT MED, V30, P347; Crockett HC, 2002, AM J SPORT MED, V30, P20; Sebag F, 2010, J CLIN ENDOCR METAB, V95, P5281, DOI 10.1210/jc.2010-0766; Madsen EL, 2006, ULTRASOUND MED BIOL, V32, P857, DOI 10.1016/j.ultrasmedbio.2006.02.1428; Reagan KM, 2002, AM J SPORT MED, V30, P354; Chen XM, 2013, J ULTRAS MED, V32, P449; Bigliani LU, 1997, AM J SPORT MED, V25, P609, DOI 10.1177/036354659702500504; Tuite MJ, 2007, SKELETAL RADIOL, V36, P495, DOI 10.1007/s00256-007-0278-6; Nakamura M, 2014, ULTRASOUND MED BIOL, V40, P1991, DOI 10.1016/j.ultrasmedbio.2014.03.024; Myers JB, 2006, AM J SPORT MED, V34, P385, DOI 10.1177/0363546505281804; Werner SL, 2001, AM J SPORT MED, V29, P354; Thomas SJ, 2012, J SHOULDER ELB SURG, V21, P910, DOI 10.1016/j.jse.2011.05.028; Tyler TF, 2000, AM J SPORT MED, V28, P668; Burkhart SS, 2003, ARTHROSCOPY, V19, P404, DOI 10.1053/jars.2003.50128; Noonan TJ, 2015, AM J SPORT MED, V43, P1448, DOI 10.1177/0363546515575020; Athanasiou A, 2010, RADIOLOGY, V256, P297, DOI 10.1148/radiol.10090385; Sporea I, 2013, ULTRASOUND MED BIOL, V39, P1933, DOI 10.1016/j.ultrasmedbio.2013.05.003; DILLMAN CJ, 1993, J ORTHOP SPORT PHYS, V18, P402; Yoshitake Y, 2014, MUSCLE NERVE, V50, P103, DOI 10.1002/mus.24104; Ooi CC, 2014, SKELETAL RADIOL, V43, P1, DOI 10.1007/s00256-013-1695-3; Thomas SJ, 2011, J SHOULDER ELB SURG, V20, P708, DOI 10.1016/j.jse.2010.08.031; Arai R, 2013, SHOULDER JOINT, V37, P915; Arda K, 2011, AM J ROENTGENOL, V23, P532; Digiovine N M, 1992, J Shoulder Elbow Surg, V1, P15, DOI 10.1016/S1058-2746(09)80011-6; Hayashi N, 1996, RIGAKURYOUHOUGAKU, V23, P522; Kot BCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044348; Myers JB, 2012, AM J SPORTS MED, V40, P1154; Romanes GJ, 1981, CUNNINGHAMS TXB ANAT, P318; Vergari C, 2014, EUR RADIOL, V24, P3210, DOI 10.1007/s00330-014-3382-8; Wilk EK, 1993, AM J SPORTS MED, V21, P61; Williams PL, 1980, GRAY ANATOMY, P570	33	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	DEC	2015	43	12					2935	2942		10.1177/0363546515608476		8	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	CX5RU	WOS:000365761000010		
J	Kita, K; Tanaka, Y; Toritsuka, Y; Amano, H; Uchida, R; Takao, R; Horibe, S				Kita, Keisuke; Tanaka, Yoshinari; Toritsuka, Yukiyoshi; Amano, Hiroshi; Uchida, Ryohei; Takao, Rikio; Horibe, Shuji			Factors Affecting the Outcomes of Double-Bundle Medial Patellofemoral Ligament Reconstruction for Recurrent Patellar Dislocations Evaluated by Multivariate Analysis	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						recurrent patellar dislocation; MPFL reconstruction; surgical outcome; risk factor	TROCHLEAR GROOVE DISTANCE; SOFT-TISSUE RESTRAINTS; TIBIAL TUBEROSITY; CLINICAL-OUTCOMES; YOUNG-PATIENTS; RISK-FACTORS; INSTABILITY; DYSPLASIA; TROCHLEOPLASTY; STABILITY	Background: Many factors are involved in causing patellar instability or recurrent patellar dislocations. However, factors affecting the outcomes of anatomic medial patellofemoral ligament (MPFL) reconstruction have not been fully documented. Purpose: To evaluate the rate of recurrent patellar instability after isolated MPFL reconstruction and to elucidate factors affecting the outcomes of isolated MPFL reconstruction using multivariable statistics. Study Design: Case-control study; Level of evidence, 3. Methods: A total of 42 patients (44 knees) who underwent isolated, anatomic MPFL reconstruction using a semitendinosus autograft without any additional patellar stabilization procedures for treating recurrent patellar dislocations were included in this study. All patients were followed for more than 2 years; the mean follow-up period was 3.2 years (range, 2-9 years). Postoperative patellofemoral instability was diagnosed when the patient complained of recurrent patellar subluxations or dislocations or had a positive apprehension sign during follow-up. Preoperative radiographic findings were obtained using plain radiography and computed tomography. Femoral tunnel positions were assessed on postoperative radiographs. The strength of the relationship between postoperative patellofemoral instability and potential risk factors such as preoperative age, sex, body mass index, patellar type, sulcus angle, congruence angle, lateral tilt angle, patellar height, tibial tubercle-trochlear groove (TT-TG) distance, degree of trochlear dysplasia, and femoral bone tunnel position were evaluated by univariate and multivariate logistic regression analyses. Results: At follow-up, 2 knees had experienced a redislocation (4.5%). A positive apprehension sign was still evident in 8 knees (18.2%). Three factors, including the sulcus angle, the congruence angle, and trochlear dysplasia, were extracted by single linear regression analysis. Univariate logistic regression analysis showed that the sulcus angle (odds ratio [OR], 1.11; 95% CI, 1.01-1.22; P = .04) and trochlear dysplasia (OR, 3.04; 95% CI, 1.39-6.63; P = .01) were associated with postoperative patellofemoral instability. Trochlear dysplasia was independently associated with postoperative patellofemoral instability by multivariable logistic regression analysis (P < .05). An increased TT-TG distance exerted a significant effect on the outcomes of MPFL reconstruction, particularly in patients with type D trochlea. Conclusion: Severe trochlear dysplasia is the most important predictor of residual patellofemoral instability after isolated MPFL reconstruction. In addition, an increased TT-TG distance affected the outcomes in patients with type D trochlea. Additional patellar stabilization procedures should be considered for patients with severe trochlear dysplasia and an increased TT-TG distance.	[Kita, Keisuke; Tanaka, Yoshinari; Amano, Hiroshi] Osaka Rosai Hosp, Dept Sports Orthopaed, Sakai, Osaka 5918025, Japan; [Kita, Keisuke; Toritsuka, Yukiyoshi; Uchida, Ryohei; Takao, Rikio; Horibe, Shuji] Osaka Rosai Hosp, Sakai, Osaka 5918025, Japan	Kita, K (reprint author), Osaka Rosai Hosp, Dept Sports Orthopaed, Kita Ku, 1179-3 Nagasone Cho, Sakai, Osaka 5918025, Japan.	keikita@hera.eonet.ne.jp					Smith TO, 2007, KNEE SURG SPORT TR A, V15, P1301, DOI 10.1007/s00167-007-0390-0; Banke IJ, 2014, KNEE SURG SPORT TR A, V22, P2591, DOI 10.1007/s00167-013-2603-z; Mountney J, 2005, J BONE JOINT SURG BR, V87B, P36; Wagner D, 2013, KNEE SURG SPORT TR A, V21, P318, DOI 10.1007/s00167-012-2015-5; NOYES FR, 1976, J BONE JOINT SURG AM, V58, P1074; Ahmad CS, 2009, AM J SPORT MED, V37, P791, DOI 10.1177/0363546508328113; Fithian DC, 2004, AM J SPORT MED, V32, P1114, DOI 10.1177/0363546503260788; Servien E, 2011, AM J SPORT MED, V39, P134, DOI 10.1177/0363546510381362; Toritsuka Y, 2011, KNEE, V18, P214, DOI 10.1016/j.knee.2010.05.007; Bollier M, 2011, ARTHROSCOPY, V27, P1153, DOI 10.1016/j.arthro.2011.02.014; Pennock AT, 2014, AM J SPORT MED, V42, P389, DOI 10.1177/0363546513509058; Parikh SN, 2013, AM J SPORT MED, V41, P1030, DOI 10.1177/0363546513482085; Elias JJ, 2006, AM J SPORT MED, V34, P1478, DOI 10.1177/0363546506287486; Shah JN, 2012, AM J SPORT MED, V40, P1916, DOI 10.1177/0363546512442330; Kita K, 2012, KNEE SURG SPORT TR A, V20, P829, DOI 10.1007/s00167-011-1609-7; Nelitz M, 2013, AM J SPORT MED, V41, P58, DOI 10.1177/0363546512463683; Amis AA, 2008, J BONE JOINT SURG BR, V90B, P864, DOI 10.1302/0301-620X.90B7.20447; GOUTALLIER D, 1978, REV CHIR ORTHOP, V64, P423; Song GY, 2014, ARTHROSCOPY, V30, P523, DOI 10.1016/j.arthro.2014.01.011; MERCHANT AC, 1974, J BONE JOINT SURG AM, VA 56, P1391; Howells NR, 2012, J BONE JOINT SURG BR, V94B, P1202, DOI 10.1302/0301-620X.94B9.28738; Nomura E, 1999, INT ORTHOP, V23, P260, DOI 10.1007/s002640050366; Quirbach S, 2012, OPER ORTHOP TRAUMATO, V24, P131, DOI 10.1007/s00064-011-0123-x; Berard JB, 2014, AM J SPORT MED, V42, P297, DOI 10.1177/0363546513512771; Steiner TM, 2006, AM J SPORT MED, V34, P1254, DOI 10.1177/0363546505285584; Amis AA, 2007, SPORTS MED ARTHROSC, V15, P48, DOI 10.1097/JSA.0b013e318053eb74; Hautamaa PV, 1998, CLIN ORTHOP RELAT R, P174; INSALL J, 1971, RADIOLOGY, V101, P101; Schottle PB, 2007, AM J SPORT MED, V35, P801, DOI 10.1177/0363546506296415; Hopper GP, 2014, AM J SPORT MED, V42, P716, DOI 10.1177/0363546513518413; Thaunat M, 2008, KNEE SURG SPORT TR A, V16, P40, DOI 10.1007/s00167-007-0418-5; Kuroda R, 2001, AM J SPORT MED, V29, P403; Schottle PB, 2005, KNEE SURG SPORT TR A, V13, P516, DOI 10.1007/s00167-005-0659-0; Nomura E, 2007, AM J SPORT MED, V35, P1851, DOI 10.1177/0363546507306161; GRELSAMER RP, 1994, AM J SPORT MED, V22, P61, DOI 10.1177/036354659402200111; Burks R T, 1998, Am J Knee Surg, V11, P24; Camathias C, 2015, KNEE SURG SPORT TR A, DOI [10.1007/s00167-015-3508-9, DOI 10.1007/S00167-015-3508-9]; CONLAN T, 1993, J BONE JOINT SURG AM, V75A, P682; Dejour H, 1994, Knee Surg Sports Traumatol Arthrosc, V2, P19, DOI 10.1007/BF01552649; Dornacher D, 2014, KNEE SURG SPORT TR A, V22, P2382, DOI 10.1007/s00167-014-3083-5; Enderlein D, 2014, KNEE SURG SPORT TR A, V22, P2458, DOI 10.1007/s00167-014-3164-5; Feller JA, 2014, KNEE SURG SPORT TR A, V22, P2470, DOI 10.1007/s00167-014-3132-0; LAURIN CA, 1979, CLIN ORTHOP RELAT R, P16; Magnussen RA, 2014, KNEE SURG SPORT TR A, V22, P2545, DOI 10.1007/s00167-013-2445-8; Matsushita T, 2014, KNEE SURG SPORT TR A, V22, P2438, DOI 10.1007/s00167-014-2919-3; Nelitz M, 2014, INT ORTHOP, V38, P2265, DOI 10.1007/s00264-014-2437-4; Ntagiopoulos PG, 2014, KNEE SURG SPORT TR A, V22, P2531, DOI 10.1007/s00167-014-3013-6; Stephen JM, 2015, AM J SPORT MED, V43, P186, DOI 10.1177/0363546514554553; Wiberg G, 1941, ACTA ORTHOP SCAND, V12, P319	49	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	DEC	2015	43	12					2988	2996		10.1177/0363546515606102		9	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	CX5RU	WOS:000365761000017		
J	Basturk, O; Hong, SM; Wood, LD; Adsay, NV; Albores-Saavedra, J; Biankin, AV; Brosens, LAA; Fukushima, N; Goggins, M; Hruban, RH; Kato, Y; Klimstra, DS; Kloppel, G; Krasinskas, A; Longnecker, DS; Matthaei, H; Offerhaus, GJA; Shimizu, M; Takaori, K; Terris, B; Yachida, S; Esposito, I; Furukawa, T				Basturk, Olca; Hong, Seung-Mo; Wood, Laura D.; Adsay, N. Volkan; Albores-Saavedra, Jorge; Biankin, Andrew V.; Brosens, Lodewijk A. A.; Fukushima, Noriyoshi; Goggins, Michael; Hruban, Ralph H.; Kato, Yo; Klimstra, David S.; Kloeppel, Guenter; Krasinskas, Alyssa; Longnecker, Daniel S.; Matthaei, Hanno; Offerhaus, G. Johan A.; Shimizu, Michio; Takaori, Kyoichi; Terris, Benoit; Yachida, Shinichi; Esposito, Irene; Furukawa, Toru			A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						pancreatic intraepithelial neoplasia (PanIN); intraductal papillary mucinous neoplasm (IPMN); mucinous cystic neoplasm (MCN); precursor; adenocarcinoma; atypical flat lesions (AFL)	PAPILLARY-MUCINOUS NEOPLASMS; BRANCH-DUCT-TYPE; INTRAEPITHELIAL NEOPLASIA; INFILTRATING ADENOCARCINOMA; MALIGNANT-TRANSFORMATION; CARCINOEMBRYONIC ANTIGEN; INTRADUCTAL NEOPLASIAS; COLORECTAL ADENOMAS; SIGNALING PATHWAYS; TUBULAR COMPLEXES	International experts met to discuss recent advances and to revise the 2004 recommendations for assessing and reporting precursor lesions to invasive carcinomas of the pancreas, including pancreatic intraepithelial neoplasia (PanIN), intraductal papillary mucinous neoplasm (IPMN), mucinous cystic neoplasm, and other lesions. Consensus recommendations include the following: (1) To improve concordance and to align with practical consequences, a 2-tiered system (low vs. high grade) is proposed for all precursor lesions, with the provision that the current PanIN-2 and neoplasms with intermediate-grade dysplasia now be categorized as low grade. Thus, high-grade dysplasia is to be reserved for only the uppermost end of the spectrum (carcinoma in situ-type lesions). (2) Current data indicate that PanIN of any grade at a margin of a resected pancreas with invasive carcinoma does not have prognostic implications; the clinical significance of dysplasia at a margin in a resected pancreas with IPMN lacking invasive carcinoma remains to be determined. (3) Intraductal lesions 0.5 to 1 cm can be either large PanINs or small IPMNs. The term incipient IPMN should be reserved for lesions in this size with intestinal or oncocytic papillae or GNAS mutations. (4) Measurement of the distance between an IPMN and invasive carcinoma and sampling of intervening tissue are recommended to assess concomitant versus associated status. Conceptually, concomitant invasive carcinoma (in contrast with the associated group) ought to be genetically distinct from an IPMN elsewhere in the gland. (5) Intraductal spread of invasive carcinoma (aka, colonization) is recommended to describe lesions of invasive carcinoma invading back into and extending along the ductal system, which may morphologically mimic high-grade PanIN or even IPMN. (6) Simple mucinous cyst is recommended to describe cysts >1 cm having gastric-type flat mucinous lining at most minimal atypia without ovarian-type stroma to distinguish them from IPMN. (7) Human lesions resembling the acinar to ductal metaplasia and atypical flat lesions of genetically engineered mouse models exist and may reflect an alternate pathway of carcinogenesis; however, their biological significance requires further study. These revised recommendations are expected to improve our management and understanding of precursor lesions in the pancreas.	[Basturk, Olca; Klimstra, David S.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Wood, Laura D.; Goggins, Michael; Hruban, Ralph H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA; [Adsay, N. Volkan; Krasinskas, Alyssa] Emory Univ Hosp, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Longnecker, Daniel S.] Dartmouth Hitchcock Med Ctr, Dept Pathol, Lebanon, NH 03766 USA; [Hong, Seung-Mo] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Ulsan 680749, South Korea; [Albores-Saavedra, Jorge] Med Sur Clin & Fdn, Dept Pathol, Mexico City, DF, Mexico; [Biankin, Andrew V.] Univ Glasgow, Wolfson Wohl Canc Res Ctr, Glasgow, Lanark, Scotland; [Brosens, Lodewijk A. A.; Offerhaus, G. Johan A.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Fukushima, Noriyoshi] Jichi Med Univ, Dept Pathol, Shimotsuke, Japan; [Kato, Yo] Japanese Fdn Canc Res, Inst Canc, Dept Pathol, Tokyo 170, Japan; [Shimizu, Michio] Hakujikai Mem Hosp, Dept Pathol, Tokyo, Japan; [Yachida, Shinichi] Natl Canc Ctr, Div Canc Genom, Tokyo, Japan; [Furukawa, Toru] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo, Japan; [Takaori, Kyoichi] Kyoto Univ, Dept Surg, Kyoto, Japan; [Kloeppel, Guenter] Tech Univ Munich, Dept Pathol, D-80290 Munich, Germany; [Matthaei, Hanno] Univ Bonn, Dept Gen Visceral Thorac & Vasc Surg, Bonn, Germany; [Esposito, Irene] Univ Dusseldorf, Inst Pathol, D-40225 Dusseldorf, Germany; [Esposito, Irene] Univ Hosp Dusseldorf, Dusseldorf, Germany; [Terris, Benoit] Hop Cochin, Serv Anat Pathol, F-75674 Paris, France	Esposito, I (reprint author), Univ Dusseldorf, Inst Pathol, Moorenstr 5, D-40225 Dusseldorf, Germany.	irene_esposito@gmx.de; furukawa.toru@twmu.ac.jp			Sol Goldman Pancreatic Cancer Research Center - National Institutes of Health [P50 CA62924]	The meeting at which this classification was established was funded by the Sol Goldman Pancreatic Cancer Research Center supported by National Institutes of Health grant (P50 CA62924). The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.	Adsay NV, 2010, PATHOLOGY GENETICS T, P304; Adsay V, 2015, ANN SURG; Matthaei H, 2014, AM J SURG PATHOL, V38, P360, DOI 10.1097/PAS.0000000000000117; Leng KM, 2012, DIGEST SURG, V29, P213, DOI 10.1159/000339334; Sugiyama M, 2003, BRIT J SURG, V90, P1244, DOI 10.1002/bjs.4265; Seki M, 2010, LANGENBECK ARCH SURG, V395, P589, DOI 10.1007/s00423-009-0579-4; Kosmahl M, 2002, MODERN PATHOL, V15, P154, DOI 10.1038/modpathol.3880507; Konstantinidis IT, 2013, ANN SURG ONCOL, V20, P3643, DOI 10.1245/s10434-013-3042-2; McCarthy DM, 2001, HUM PATHOL, V32, P638, DOI 10.1053/hupa.2001.24991; Bausch D, 2009, J GASTROINTEST SURG, V13, P1948, DOI 10.1007/s11605-009-1001-9; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Yamaguchi K, 2011, PANCREAS, V40, P571, DOI 10.1097/MPA.0b013e318215010c; Simons JP, 2011, J SURG RES, V167, P251, DOI 10.1016/j.jss.2009.05.035; Esposito I, 2007, PANCREAS, V35, P212; Tanno S, 2010, PANCREATOLOGY, V10, P173, DOI 10.1159/000231982; LeBlanc JK, 2014, PANCREAS, V43, P849, DOI 10.1097/MPA.0000000000000142; Tomimaru Y, 2010, ONCOL REP, V24, P613, DOI 10.3892/or_00000899; Waxman AG, 2012, OBSTET GYNECOL, V120, P1465, DOI [http://10.1097/AOG.0b013e31827001d5, 10.1097/AOG.0b013e31827001d5]; POUR PM, 1982, AM J CLIN PATHOL, V77, P137; Manfredi R, 2009, RADIOLOGY, V253, P106, DOI 10.1148/radiol.2531080604; Kang MJ, 2014, ANN SURG, V260, P356, DOI 10.1097/SLA.0000000000000470; Bockman DE, 2003, LAB INVEST, V83, P853, DOI 10.1097/01.LAB.0000074918.31303.5A; Salvia R, 2007, GUT, V56, P1086, DOI 10.1136/gut.2006.100628; WILLEMER S, 1989, DIGEST DIS SCI, V34, P46, DOI 10.1007/BF01536153; Darragh TM, 2013, INT J GYNECOL PATHOL, V32, P76, DOI 10.1097/PGP.0b013e31826916c7; EPSTEIN JI, 1995, AM J SURG PATHOL, V19, P873, DOI 10.1097/00000478-199508000-00002; Brune K, 2006, AM J SURG PATHOL, V30, P1067; Akita H, 2011, AM J SURG, V202, P214, DOI 10.1016/j.amjsurg.2010.06.020; Fritz S, 2009, ANN SURG, V249, P440, DOI 10.1097/SLA.0b013e31819a6e16; Abraham SC, 2003, AM J SURG PATHOL, V27, P110, DOI 10.1097/00000478-200301000-00012; Eguchi H, 2006, CANCER, V107, P2567, DOI 10.1002/cncr.22301; Tanno S, 2008, GUT, V57, DOI 10.1136/gut.2007.129684; Le H, 2008, CANCER EPIDEM BIOMAR, V17, P2737, DOI 10.1158/1055-9965.EPI-08-0417; Terris B, 2000, AM J SURG PATHOL, V24, P1372, DOI 10.1097/00000478-200010000-00006; FURUKAWA T, 1994, ARCH PATHOL LAB MED, V118, P227; REID BJ, 1988, HUM PATHOL, V19, P166, DOI 10.1016/S0046-8177(88)80344-7; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Murtaugh LC, 2007, CANCER CELL, V11, P211, DOI 10.1016/j.ccr.2007.02.020; Gigot JF, 2001, ARCH SURG-CHICAGO, V136, P1256, DOI 10.1001/archsurg.136.11.1256; Shi G, 2013, ONCOGENE, V32, P1950, DOI 10.1038/onc.2012.210; Andea A, 2003, MODERN PATHOL, V16, P996, DOI 10.1097/01.MP.0000087422.24733.62; Wada Keita, 2002, J Hepatobiliary Pancreat Surg, V9, P76, DOI 10.1007/s005340200007; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; JENSEN P, 1995, DIS COLON RECTUM, V38, P195, DOI 10.1007/BF02052450; Lohr M, 2005, NEOPLASIA, V7, P17, DOI 10.1593/neo.04445; Bartsch DK, 2013, FAM CANCER, V12, P89, DOI 10.1007/s10689-012-9582-y; Mueller J, 2003, HEPATO-GASTROENTEROL, V50, P541; Garcia-Carracedo D, 2014, PANCREAS, V43, P245, DOI 10.1097/MPA.0000000000000034; Cioc AM, 2002, ARCH PATHOL LAB MED, V126, P1169; Maguchi H, 2011, PANCREAS, V40, P364, DOI 10.1097/MPA.0b013e31820a5975; Yamasaki S, 2002, PANCREATOLOGY, V2, P407, DOI 10.1159/000065089; Shi CJ, 2009, MOL CANCER RES, V7, P230, DOI 10.1158/1541-7786.MCR-08-0206; Salvia R, 2004, ANN SURG, V239, P678, DOI 10.1097/01.sla.0000124386.54496.15; Kawamoto S, 2005, RADIOGRAPHICS, V25, P1451, DOI 10.1148/rg.256055036; Laffan TA, 2008, AM J ROENTGENOL, V191, P802, DOI 10.2214/AJR.07.3340; Frankel TL, 2013, HPB, V15, P814, DOI 10.1111/hpb.12137; Mimura T, 2010, J CLIN GASTROENTEROL, V44, pE224, DOI 10.1097/MCG.0b013e3181d8fb91; Raut CP, 2006, ANN SURG ONCOL, V13, P582, DOI 10.1245/ASO.2006.05.002; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Ammori JB, 2014, J GASTROINTEST SURG, V18, P911, DOI 10.1007/s11605-014-2449-9; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Fukushima N, 2002, AM J PATHOL, V160, P1573, DOI 10.1016/S0002-9440(10)61104-2; Park M, 2014, MODERN PATHOL, V27, P580, DOI 10.1038/modpathol.2013.154; Lee CJ, 2008, J GASTROINTEST SURG, V12, P234, DOI 10.1007/s11605-007-0381-y; PARSA I, 1985, CANCER RES, V45, P1285; Sadakari Y, 2010, PANCREAS, V39, P232, DOI 10.1097/MPA.0b013e3181bab60e; Shimizu Y, 2013, PANCREAS, V42, P883, DOI 10.1097/MPA.0b013e31827a7b84; Ito Hiroyuki, 2015, Case Rep Oncol, V8, P30, DOI 10.1159/000371842; Fritz S, 2011, BRIT J SURG, V98, P104, DOI 10.1002/bjs.7280; Jiao YC, 2014, J PATHOL, V232, P428, DOI 10.1002/path.4310; KLOPPEL G, 1980, VIRCHOWS ARCH A, V387, P221, DOI 10.1007/BF00430702; Ohno E, 2012, PANCREAS, V41, P855, DOI 10.1097/MPA.0b013e3182480c44; Hwang DW, 2011, J KOREAN MED SCI, V26, P740, DOI 10.3346/jkms.2011.26.6.740; Fujii H, 1997, AM J PATHOL, V151, P1447; Irie H, 2004, J COMPUT ASSIST TOMO, V28, P117, DOI 10.1097/00004728-200401000-00020; Allen PJ, 2006, ANN SURG, V244, P572, DOI 10.1097/01.sla.0000237652.84466.54; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Shimamoto T, 2010, PANCREAS, V39, P879, DOI 10.1097/MPA.0b013e3181d6ba04; Fujii T, 2010, SURGERY, V148, P285, DOI 10.1016/j.surg.2010.03.013; Detlefsen S, 2005, VIRCHOWS ARCH, V447, P800, DOI 10.1007/s00428-005-0032-1; Furukawa T, 2005, VIRCHOWS ARCH, V447, P794, DOI 10.1007/s00428-005-0039-7; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; Brat DJ, 1998, AM J SURG PATHOL, V22, P163, DOI 10.1097/00000478-199802000-00003; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Aichler M, 2012, J PATHOL, V226, P723, DOI 10.1002/path.3017; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Matthaei H, 2011, ANN SURG ONCOL, V18, P3493, DOI 10.1245/s10434-011-1745-9; Yamaguchi K, 2002, PANCREATOLOGY, V2, P484, DOI 10.1159/000064716; BOCKMAN DE, 1982, AM J SURG, V144, P243, DOI 10.1016/0002-9610(82)90518-9; Winter JM, 2006, ANN SURG, V243, P673, DOI 10.1097/01.sla.0000216763.27673.97; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; FENGER C, 1990, J CLIN PATHOL, V43, P320, DOI 10.1136/jcp.43.4.320; Yachida S, 2012, AM J SURG PATHOL, V36, P173, DOI 10.1097/PAS.0b013e3182417d36; Nakagohri T, 2007, ANN SURG ONCOL, V14, P3174, DOI 10.1245/s10434-007-9546-x; Cone MM, 2011, AM J SURG, V201, P574, DOI 10.1016/j.amjsurg.2011.01.003; de la OJ, 2008, P NATL ACAD SCI USA, V105, P18907, DOI DOI 10.1073/PNAS.0810111105.PUBMED:19028876.AVAILABLE; Dejean Nayima M Clermont, 2013, Int J Surg Case Rep, V4, P789, DOI 10.1016/j.ijscr.2013.05.009; Furlan D, 2014, VIRCHOWS ARCH, V464, P553, DOI 10.1007/s00428-014-1562-1; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; Hruban RH, 2007, TUMORS PANCREAS; Ideno N, 2013, ANN SURG, V258, P141, DOI 10.1097/SLA.0b013e31828cd008; Ito R, 2008, HEPATO-GASTROENTEROL, V55, P1103; Kawada Natsuko, 2013, Case Rep Gastroenterol, V7, P30, DOI 10.1159/000346693; Kent Tara S, 2010, World J Gastrointest Surg, V2, P319, DOI 10.4240/wjgs.v2.i10.319; Hruban RH, 2014, SEMIN DIAGN PATHOL, V31, P443, DOI 10.1053/j.semdp.2014.08.004; Konukiewitz B, 2013, PANCREATOLOGY, V13, pS14; Krasinskas A, 2012, MOD PATHOL, V25, p445A; Lami Gabriele, 2014, World J Gastrointest Endosc, V6, P272, DOI 10.4253/wjge.v6.i7.272; Matsuda Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117575; Nakanuma Y, 2010, WHO CLASSIFICATION T, V3, P217; Ray KC, 2011, PLOS ONE, V6; Rebours V, 2015, CLIN CANCER RES, V21, P3522, DOI 10.1158/1078-0432.CCR-14-2385; White R, 2007, J AM COLL SURGEONS, V204, P987, DOI 10.1016/j.jamcollsurg.2006.12.040; White R, 2007, J AM COLL SURGEONS, V204, P993; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543	115	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	DEC	2015	39	12					1730	1741		10.1097/PAS.0000000000000533		12	Pathology; Surgery	Pathology; Surgery	CX3VI	WOS:000365627200015		
J	Aoyama, A; Chen, F; Minakata, K; Yamazaki, K; Yamada, T; Sato, M; Date, H				Aoyama, A.; Chen, F.; Minakata, K.; Yamazaki, K.; Yamada, T.; Sato, M.; Date, H.			Sparing Native Upper Lobes in Living-Donor Lobar Lung Transplantation: Five Cases From a Single Center	AMERICAN JOURNAL OF TRANSPLANTATION			English	Article						donors and donation: living; lung transplantation: living donor; primary nonfunction	COMPUTED TOMOGRAPHIC VOLUMETRY	Living-donor lobar lung transplantation (LDLLT) is indicated for rapidly deteriorating patients, and the total volume of two lower lobe grafts must be sufficient for the recipient. To rescue patients with small lobar grafts, we performed five LDLLTs sparing native upper lobes. This strategy was used when upper lobes or segments were preoperatively less impaired. There were no hospital deaths. Extracorporeal circulation time and operative time were similar to those of conventional LDLLTs. The length of intensive care unit stay was also similar. Late complications attributed to the spared lungs were airway infection in one recipient and pneumothorax in two but they were successfully managed. All recipients were discharged without supplemental oxygen. The spared lung volumes measured by volumetry did not change after LDLLT. Lung perfusion scintigraphy performed at 1 year showed remaining perfusion in the spared lungs, although much less than in the grafts. These results suggested that the spared lobes kept adequate space in the thoracic cavity and kept functioning to a limited extent. The new lobar-sparing strategy appears feasible and effective in LDLLT using small grafts for selected patients when the upper lobes or segments are less impaired.	[Aoyama, A.; Chen, F.; Yamada, T.; Sato, M.; Date, H.] Kyoto Univ, Dept Thorac Surg, Grad Sch Med, Kyoto, Japan; [Minakata, K.; Yamazaki, K.] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Surg, Kyoto, Japan	Date, H (reprint author), Kyoto Univ, Dept Thorac Surg, Grad Sch Med, Kyoto, Japan.	hdate@kuhp.kyoto-u.ac.jp					Suga K, 2010, NUCL MED COMMUN, V31, P673, DOI 10.1097/MNM.0b013e328339ea9b; Fujinaga T, 2011, J HEART LUNG TRANSPL, V30, P351, DOI 10.1016/j.healun.2010.10.006; Date H, 2003, J THORAC CARDIOV SUR, V126, P476, DOI 10.1016/S0022-5223(03)00235-6; Starnes VA, 2004, J THORAC CARDIOV SUR, V127, P114, DOI 10.1016/j.jtcvs.2003.07.042; Sugimoto S, 2006, J THORAC CARDIOV SUR, V132, P1213, DOI 10.1016/j.jtcvs.2006.07.012; Chen FS, 2012, INTERACT CARDIOV TH, V15, P1077, DOI 10.1093/icvts/ivs386; Haddy SM, 2002, ANESTHESIOLOGY, V97, P1315, DOI 10.1097/00000542-200211000-00042; Chen FS, 2010, TRANSPL INT, V23, pe41, DOI 10.1111/j.1432-2277.2010.01123.x; Yamane M, 2008, J HEART LUNG TRANSPL, V27, P1046, DOI 10.1016/j.healun.2008.05.025; Eberlein M, 2012, J HEART LUNG TRANSPL, V31, P492, DOI 10.1016/j.healun.2011.12.009; Zuercher AJ, 2013, PEDIATR TRANSPLANT, V17, P800, DOI 10.1111/petr.12155; Chen F, 2013, AM J TRANSPLANT, V13, P1336, DOI 10.1111/ajt.12188; Date H, 2014, EUR J CARDIO THORAC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Sato Masaaki, 2014, Gen Thorac Cardiovasc Surg, V62, P594, DOI 10.1007/s11748-014-0418-6; Starnes VA, 1994, J THORAC CARDIOVASC, V108, P10; STARNES VA, 1994, J THORAC CARDIOV SUR, V108, P403	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-6135	1600-6143		AM J TRANSPLANT	Am. J. Transplant.	DEC	2015	15	12					3202	3207		10.1111/ajt.13357		6	Surgery; Transplantation	Surgery; Transplantation	CX2NP	WOS:000365534100020		
J	Saito, T; Hasegawa-Moriyama, M; Kurimoto, T; Yamada, T; Inada, E; Kanmura, Y				Saito, Takayuki; Hasegawa-Moriyama, Maiko; Kurimoto, Tae; Yamada, Tomotsugu; Inada, Eichi; Kanmura, Yuichi			Resolution of Inflammation by Resolvin D1 Is Essential for Peroxisome Proliferator-activated Receptor-gamma-mediated Analgesia during Postincisional Pain Development in Type 2 Diabetes	ANESTHESIOLOGY			English	Article							NECROSIS-FACTOR-ALPHA; NERVE GROWTH-FACTOR; LIPID MEDIATORS; PPAR-GAMMA; MACROPHAGE POLARIZATION; DIMETHYL-SULFOXIDE; MOUSE MODEL; CELLS; HYPERALGESIA; NOCICEPTION	Background: The wound healing process following acute inflammation after surgery is impaired in diabetes. Altered macrophage functions are linked to delayed tissue repair and pain development in diabetes. Although peroxisome proliferator-activated receptor (PPAR)- agonists are used to treat diabetes, their postoperative analgesic effects in diabetes have not been evaluated. Methods: The PPAR agonist rosiglitazone (rosi) was injected at the incision site of diabetic (db/db) mice with resolvin (Rv) D1, a lipid mediator involved in resolution of inflammation. Pain-related behavior, neutrophil infiltration, phagocytosis, and macrophage polarity were assessed for 7 days postoperatively. Results: Rosiglitazone and RvD1 alleviated mechanical hyperalgesia in db/db (db) mice, whereas rosiglitazone alone did not alter mechanical thresholds on days 4 (db rosi + RvD1 vs. db rosi: 0.506 0.106 vs. 0.068 +/- 0.12) and 7 (0.529 +/- 0.184 vs. 0.153 +/- 0.183) after incision (n = 10 per group). In control m/m mice, the rosiglitazone-induced analgesic effects were reversed by knockdown with arachidonate 5-lipoxygenase small interfering RNA, but these were restored by addition of RvD1. In db/db mice treated with rosiglitazone and RvD1, local infiltration of neutrophils was markedly reduced, with an associated decrease in total TdT-mediated dUTP nick-end labeling cells. Acceleration of rosiglitazone-induced phenotype conversion of infiltrated macrophages from M1 to M2 was impaired in db/db mice, but it was effectively restored by RvD1 in db/db wounds. Conclusions: In diabetes, exogenous administration of RvD1 is essential for PPAR-mediated analgesia during development of postincisional pain. Resolution of inflammation accelerated by RvD1 might promote PPAR-mediated macrophage polarization to the M2 phenotype.	[Saito, Takayuki; Hasegawa-Moriyama, Maiko; Kurimoto, Tae; Yamada, Tomotsugu; Kanmura, Yuichi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Anesthesiol & Crit Care Med, Kagoshima 8908520, Japan; [Saito, Takayuki; Inada, Eichi] Juntendo Univ, Sch Med, Dept Anesthesiol & Pain Med, Tokyo 113, Japan	Hasegawa-Moriyama, M (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Anesthesiol & Crit Care Med, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	hase-mai@m3.kufm.kagoshima-u.ac.jp			Japan Society for the Promotion of Science, Tokyo, Japan	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, Tokyo, Japan (to Dr. Hasegawa-Moriyama).	Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Schafers M, 2003, PAIN, V104, P579, DOI 10.1016/S0304-3959(03)00115-5; Bannon P, 2013, DIS MODEL MECH, V6, P1434, DOI 10.1242/dmm.012237; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Majai G, 2007, EUR J IMMUNOL, V37, P1343, DOI 10.1002/eji.200636398; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; ASHLEY FL, 1967, ANN NY ACAD SCI, V141, P463, DOI 10.1111/j.1749-6632.1967.tb34911.x; Colucci M, 2008, PHARMACOL RES, V57, P419, DOI 10.1016/j.phrs.2008.04.004; Cheng HT, 2009, J NEUROPATH EXP NEUR, V68, P1229, DOI 10.1097/NEN.0b013e3181bef710; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Naguib G, 2004, J INVEST DERMATOL, V123, P87, DOI 10.1111/j.0022-202X.2004.22711.x; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512; Kettritz R, 1997, J AM SOC NEPHROL, V8, P1091; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; FAHEY TJ, 1991, J SURG RES, V50, P308, DOI 10.1016/0022-4804(91)90196-S; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Pogatzki EM, 2003, ANESTHESIOLOGY, V99, P1023, DOI 10.1097/00000542-200310000-00041; Piercy V, 1999, J DIABETES COMPLICAT, V13, P163, DOI 10.1016/S1056-8727(99)00034-3; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Buck M, 1996, AM J PATHOL, V149, P195; PREZIOSI P, 1966, CURR THER RES CLIN E, V8, P261; Bang S, 2010, BRIT J PHARMACOL, V161, P707, DOI 10.1111/j.1476-5381.2010.00909.x; Claria J, 2013, AM J PHYSIOL-CELL PH, V304, pC1141, DOI 10.1152/ajpcell.00351.2012; Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264; Bourlier V, 2008, CIRCULATION, V117, P806, DOI 10.1161/CIRCULATIONAHA.107.724096; Tang YN, 2013, DIABETES, V62, P618, DOI 10.2337/db12-0684; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; Sahbaie P, 2012, ANESTHESIOLOGY, V117, P602, DOI 10.1097/ALN.0b013e3182655f9f; Schaper NC, 2008, DIABETES-METAB RES, V24, pS40, DOI 10.1002/dmrr.862; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Woolf CJ, 1997, BRIT J PHARMACOL, V121, P417, DOI 10.1038/sj.bjp.0701148; Ariel A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00004; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CUNHA FQ, 1992, BRIT J PHARMACOL, V107, P660; Hasegawa-Moriyama M, 2013, PAIN, V154, P1402, DOI 10.1016/j.pain.2013.04.039; Hasegawa-Moriyama M, 2012, BIOCHEM BIOPH RES CO, V426, P76, DOI 10.1016/j.bbrc.2012.08.039; Lee HN, 2013, J CELL SCI, V126, P4037, DOI 10.1242/jcs.131003; Li LY, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-72; Liao ZL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-110; Recchiuti A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00298; Rocha ACC, 2006, BRIT J PHARMACOL, V148, P688, DOI 10.1038/sj.bjp.0706775; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	49	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	DEC	2015	123	6					1420	1434		10.1097/ALN.0000000000000892		15	Anesthesiology	Anesthesiology	CX1VL	WOS:000365483600025		
J	Takanishi, N; Oishi, K; Kumagai, H; Uemura, M; Hirooka, H				Takanishi, N.; Oishi, K.; Kumagai, H.; Uemura, M.; Hirooka, H.			Factors influencing the priority of access to food and their effects on the carcass traits for Japanese Black (Wagyu) cattle	ANIMAL			English	Article						access to food; carcass weight; Japanese Black cattle; marbling score; social dominance	SOCIAL-DOMINANCE; BEEF-CATTLE; DAIRY GOATS; BEHAVIOR; TEMPERAMENT; COWS; ORGANIZATION; BREED; RANK	The factors influencing the priority of access to food and the effects of the priority of access to food on their carcass traits were analyzed for Japanese Black (Wagyu) cattle in a semi-intensive fattening production system. The records of 96 clinically healthy steers and heifers were analyzed. The calves at similar to 3 to 4 months of age were allocated to pens with four animals per pen; all four animals in the same pen were of the same sex and of similar body size. The ranking of the animals' priority of access to food (15t, 2nd, 3rd and 4th) which was determined by the farm manager, was used as an indicator of social dominance in the present study. Four models including sire line, maternal grandsire line and the difference in the animals' birth dates as fixed effects were used to analyze factors influencing the priority of access to food. Ranking was represented by ordinal scores (highest = 4, lowest = 1) in Model 1, and the binary scores were assigned in Model 2 (highest = 1; 2nd, 3rd and 4th = 0), Model 3 (15t and 2nd = 1; 3rd and 4th = 0) and Model 4 (1st, 2nd and 3rd = 1; lowest = 0). The results showed that the difference in the animals' birth dates had a significant effect on the establishment of the priority of access to food in Model 3 (P <0.05), suggesting that animals born earlier may become more dominant in the pen. The maternal grandsire line tended to affect the social rank score in Models 2 and 3 (P < 0.10). Our results indicated that the maternal grandsire line may affect the temperament of calves through their mothers' genetic performance and thereby more aggressive calves may be more dominant and have higher priority of access to food. On the other hand, there was a significant effect of the priority of access to food on beef marbling score (BMS; P < 0.05), and the priority of access to food also tended to influence the carcass weight (P = 0.09). The highest BMS was observed for animals with the first rank of the priority of access to food (P < 0.05), and the higher-ranking animals had the tendency to be heavier carcass than the lower-ranking animals. Our findings emphasized the importance of information about the priority of access to food determined by farmers' own observation on implementing best management practices in small-scaled semi-intensive beef cattle production systems.	[Takanishi, N.; Oishi, K.; Kumagai, H.; Hirooka, H.] Kyoto Univ, Grad Sch Agr, Lab Anim Husb Resources,Div Appl Biosci, Sakyo Ku, Kyoto 6068502, Japan; [Uemura, M.] Uemura Farm Ltd, Ishiyama, Hokkaido 0590921, Japan	Takanishi, N (reprint author), Kyoto Univ, Grad Sch Agr, Lab Anim Husb Resources,Div Appl Biosci, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	hirooka@kais.kyoto-u.ac.jp					Nkrumah JD, 2007, J ANIM SCI, V85, P2382, DOI 10.2527/jas.2006-657; Hirooka H, 1996, J ANIM SCI, V74, P2112; Partida JA, 2007, MEAT SCI, V76, P266, DOI 10.1016/j.meatsci.2006.11.008; Miranda-de la Lama GC, 2011, APPL ANIM BEHAV SCI, V134, P48, DOI 10.1016/j.applanim.2011.06.004; Fordyce G, 2002, ANIM REPROD SCI, V71, P81, DOI 10.1016/S0378-4320(02)00027-1; Miranda-de la Lama GC, 2013, J VET BEHAV, V8, P342, DOI 10.1016/j.jveb.2013.03.001; Solano J, 2004, PHYSIOL BEHAV, V82, P679, DOI 10.1016/j.physbeh.2004.06.005; FRANCIS RC, 1988, ETHOLOGY, V78, P223; Huzzey JM, 2014, J DAIRY SCI, V97, P2953, DOI 10.3168/jds.2013-7434; DICKSON DP, 1967, BEHAVIOUR, V29, P195, DOI 10.1163/156853967X00118; MacKay JRD, 2013, J ANIM SCI, V91, P4917, DOI 10.2527/jas.2012-5473; Maeno H, 2014, MEAT SCI, V96, P1365, DOI 10.1016/j.meatsci.2013.11.017; DICKSON DP, 1970, J DAIRY SCI, V53, P904; Langbein J, 2004, APPL ANIM BEHAV SCI, V87, P293, DOI 10.1016/j.applanim.2004.01.007; LENEINDRE P, 1989, APPL ANIM BEHAV SCI, V23, P129, DOI 10.1016/0168-1591(89)90013-0; STRICKLIN WR, 1980, APPL ANIM ETHOL, V6, P211, DOI 10.1016/0304-3762(80)90022-X; Asada M., 2004, Reproduction Fertility and Development, V16, P287, DOI 10.1071/RDv16n1Ab335; Bolker BM, 2008, TRENDS ECOL EVOL, V24, P127, DOI DOI 10.1016/J.TREE.2008.10.008; Bouissou Marie-France, 2001, P113, DOI 10.1079/9780851993973.0113; DREWS C, 1993, BEHAVIOUR, V125, P283, DOI 10.1163/156853993X00290; Freeman Jr DH, 1987, APPL CATEGORICAL DAT; Hafez ESE, 1975, BEHAV DOMESTIC ANIMA, P247; Hart BL, 1985, BEHAV DOMESTIC ANIMA; Houpt KA, 2011, DOMESTIC ANIMAL BEHA, P416; Ikeda K., 2006, Journal of the Japan Veterinary Medical Association, V59, P623; Japan Meat Grading Association, 1989, TRAD STAND CARC RET; Landaeta-Hernandez AJ, 2005, REV CIENT-FAC CIEN V, V15, P148; Landaeta-Hernandez AJ, 2013, LIVEST SCI, V152, P47, DOI 10.1016/j.livsci.2012.11.019; MCPHEE C. P., 1964, ANIM PROD, V6, P9; Miranda-de la Lama G C, 2013, Meat Sci, V94, P432, DOI 10.1016/j.meatsci.2013.03.026; SAS, 2008, US GUID STAT VERS 9	31	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1751-7311	1751-732X		ANIMAL	Animal	DEC	2015	9	12					2017	2023		10.1017/S1751731115001214		7	Agriculture, Dairy & Animal Science; Veterinary Sciences	Agriculture; Veterinary Sciences	CX2GG	WOS:000365514200012		
J	Nishiura, A; Sasaki, O; Aihara, M; Takeda, H; Satoh, M				Nishiura, Akiko; Sasaki, Osamu; Aihara, Mitsuo; Takeda, Hisato; Satoh, Masahiro			Genetic analysis of fat-to-protein ratio, milk yield and somatic cell score of Holstein cows in Japan in the first three lactations by using a random regression model	ANIMAL SCIENCE JOURNAL			English	Article						dairy cow; fat-to-protein ratio (FPR); genetic parameter; random regression model	BODY CONDITION SCORE; DAILY ENERGY-BALANCE; DAIRY-CATTLE; CLINICAL MASTITIS; PRODUCTION TRAITS; HEALTH TRAITS; FEED-INTAKE; PARAMETERS; CURVE; PERSISTENCY	We estimated the genetic parameters of fat-to-protein ratio (FPR) and the genetic correlations between FPR and milk yield or somatic cell score in the first three lactations in dairy cows. Data included 3079517 test-day records of 201138 Holstein cows in Japan from 2006 to 2011. Genetic parameters were estimated with a multiple-trait random regression model in which the records within and between parities were treated as separate traits. The phenotypic values of FPR increased soon after parturition and peaked at 10 to 20 days in milk, then decreased slowly in mid- and late lactation. Heritability estimates for FPR yielded moderate values. Genetic correlations of FPR among parities were low in early lactation. Genetic correlations between FPR and milk yield were positive and low in early lactation, but only in the first lactation. Genetic correlations between FPR and somatic cell score were positive in early lactation and decreased to become negative in mid- to late lactation. By using these results for genetic evaluation it should be possible to improve energy balance in dairy cows.	[Nishiura, Akiko; Sasaki, Osamu; Takeda, Hisato; Satoh, Masahiro] NARO Inst Livestock & Grassland Sci, Anim Breeding & Reprod Res Div, Tsukuba, Ibaraki 3050901, Japan; [Aihara, Mitsuo] Livestock Improvement Assoc Japan, Tokyo, Japan	Nishiura, A (reprint author), NARO Inst Livestock & Grassland Sci, Ikenodai 2, Tsukuba, Ibaraki 3050901, Japan.	akinishi@affrc.go.jp					ALI AKA, 1980, J DAIRY SCI, V63, P487; Togashi K, 2008, LIVEST SCI, V114, P194, DOI 10.1016/j.livsci.2007.04.023; GRIEVE DG, 1986, LIVEST PROD SCI, V14, P239, DOI 10.1016/0301-6226(86)90083-7; Samore AB, 2008, J DAIRY SCI, V91, P4013, DOI 10.3168/jds.2007-0718; Suriyasathaporn W, 2000, J DAIRY SCI, V83, P1248; Coffey MP, 2001, ANIM SCI, V73, P29; Collard BL, 2000, J DAIRY SCI, V83, P2683; Huttmann H, 2009, ANIMAL, V3, P181, DOI 10.1017/S175173110800325X; Jakobsen JH, 2003, J DAIRY SCI, V86, P3000, DOI 10.3168/jds.S0022-0302(03)73898-3; Heringstad B, 2000, LIVEST PROD SCI, V64, P95, DOI 10.1016/S0301-6226(99)00128-1; Hagiya K, 2013, ANIMAL, V7, P1423, DOI 10.1017/S1751731113000633; Togashi K, 2007, J DAIRY SCI, V90, P5753, DOI 10.3168/jds.2007-0363; Carlen E, 2004, J DAIRY SCI, V87, P3062; Hammami H, 2008, J DAIRY SCI, V91, P2118, DOI 10.3168/jds.2007-0382; Buttchereit N, 2010, J DAIRY SCI, V93, P1702, DOI 10.3168/jds.2009-2198; Togashi K, 2004, J DAIRY SCI, V87, P3047; Togashi K, 2003, J DAIRY SCI, V86, P1487; Ingvartsen KL, 2003, LIVEST PROD SCI, V83, P277, DOI 10.1016/S0301-6226(03)00110-6; Spurlock DM, 2012, J DAIRY SCI, V95, P5393, DOI 10.3168/jds.2012-5407; Miglior F, 2009, J DAIRY SCI, V92, P4697, DOI 10.3168/jds.2009-2212; Strabel T, 1999, J DAIRY SCI, V82, P2805; Friggens NC, 2007, J DAIRY SCI, V90, P5453, DOI 10.3168/jds.2006-821; Rupp R, 1999, J DAIRY SCI, V82, P2198; Heuer C, 1999, J DAIRY SCI, V82, P295; Negussie E, 2013, J DAIRY SCI, V96, P1237, DOI 10.3168/jds.2012-5720; Reist M, 2002, J DAIRY SCI, V85, P3314, DOI 10.3168/jds.S0022-0302(02)74420-2; Koeck A, 2013, J DAIRY SCI, V96, P4688, DOI 10.3168/jds.2012-6408; Zavadilova L, 2005, CZECH J ANIM SCI, V50, P142; Buttchereit N, 2011, J DAIRY SCI, V94, P1586, DOI 10.3168/jds.2010-3396; Jamrozik J, 2012, J ANIM BREED GENET, V129, P11, DOI 10.1111/j.1439-0388.2011.00929.x; Dekkers JCM, 1998, LIVEST PROD SCI, V53, P237, DOI 10.1016/S0301-6226(97)00124-3; Coffey MP, 2002, J DAIRY SCI, V85, P2669, DOI 10.3168/jds.S0022-0302(02)74352-X; Buttchereit N, 2010, P 9 WORLD C GEN APPL; desVries MJ, 1999, J DAIRY SCI, V82, P1927; desVries MJ, 2000, J DAIRY SCI, V83, P62; Goff JP, 1997, J DAIRY SCI, V80, P1260; Gredler B, 2006, P 8 WORLD C GEN APPL; Hagiya K, 2010, J ANIM GEN, V38, P29; INTERBULL, 2009, INT ROUT GEN EV UDD; Jamrozik J, 1998, P 6 WORLD C GEN APPL, V23, P303; Liu Z., 2001, INTERBULL B, V26, P61; Liu Z, 2000, INTERBULL B, V25, P74; Misztal I., 2002, P 7 WORLD C GEN APPL; Mrode R. A., 1996, Animal Breeding Abstracts, V64, P847; Pena J, 2006, INTERBULL B, V34, P31; van Straten M, 2009, J DAIRY SCI, V92, P4386, DOI 10.3168/jds.2009-2204; Yamaguchi S, 2007, NIHON CHIKUSAN GAKKA, V78, P415, DOI 10.2508/chikusan.78.415; Yamazaki T, 2013, NIHON CHIKUSAN GAKKA, V84, P11	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	DEC	2015	86	12					961	969		10.1111/asj.12388		9	Agriculture, Dairy & Animal Science	Agriculture	CX5VC	WOS:000365769600001		
J	Somfai, T; Matoba, S; Inaba, Y; Nakai, M; Imai, K; Nagai, T; Geshi, M				Somfai, Tamas; Matoba, Satoko; Inaba, Yasushi; Nakai, Michiko; Imai, Kei; Nagai, Takashi; Geshi, Masaya			Cytoskeletal and mitochondrial properties of bovine oocytes obtained by Ovum Pick-Up: the effects of follicle stimulation and in vitro maturation	ANIMAL SCIENCE JOURNAL			English	Article						bovine oocyte; cytoskeleton; in vitro maturation; in vivo maturation; mitochondria	ADENOSINE-TRIPHOSPHATE CONTENT; INTRACYTOPLASMIC SPERM INJECTION; MATURED PORCINE OOCYTES; X-SORTED SPERM; DEVELOPMENTAL COMPETENCE; EMBRYO PRODUCTION; OXIDATIVE STRESS; ACTIVE MITOCHONDRIA; GENE-EXPRESSION; MEIOTIC SPINDLE	Follicle stimulation by follicular stimulating hormone (FSH) is known to improve developmental competence of bovine oocytes obtained by Ovum Pick-Up (OPU); however, the exact factors in oocytes affected by this treatment have remained unclear. We compared in vitro matured (IVM) oocytes obtained at the immature stage from cows by OPU either without or with stimulation with FSH (non-stimulated and stimulated OPU, respectively) to those obtained by superstimulation and in vivo maturation in terms of cytoskeleton morphology, mitochondrial distribution, intracellular adenosine triphosphate (ATP) content and H2O2 levels at the metaphase-II stage and intracellular Ca2+ levels after in vitro fertilization (IVF). Confocal microscopy after immunostaining revealed reduced size of the meiotic spindle, associated with increased tendencies of microfilament degradation and insufficient mitochondrial re-distribution in non-stimulated OPU-derived IVM oocytes compared with those collected by stimulated OPU, which in turn resembled in vivo matured oocytes. However, there was no difference in mitochondrial functions between oocytes obtained by stimulated or non-stimulated OPU in terms of ATP content, cytoplasmic H2O2 levels, base Ca2+ levels and the frequencies and amplitudes of Ca2+ oscillations after IVF. Larger size of metaphase spindles in oocytes obtained by stimulated OPU may reflect and potentially contribute to their high developmental competence.	[Somfai, Tamas; Matoba, Satoko; Inaba, Yasushi; Geshi, Masaya] NARO Inst Livestock & Grassland Sci, Anim Breeding & Reprod Div, Tsukuba, Ibaraki 9050901, Japan; [Nakai, Michiko] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Imai, Kei] Natl Livestock Breeding Ctr, Nishigo, Japan; [Nagai, Takashi] Food & Fertilizer Technol Ctr, Taipei, Taiwan	Geshi, M (reprint author), NARO Inst Livestock & Grassland Sci, Anim Breeding & Reprod Div, 2 Ikenodai, Tsukuba, Ibaraki 9050901, Japan.	geshi@affrc.go.jp			Research and development projects for application in promoting new policy of agriculture, forestry and fisheries [22016]	This study was supported by the 'Research and development projects for application in promoting new policy of agriculture, forestry and fisheries' grant number 22016 to T. Somfai, S. Matoba, Y. Inaba, K. Imai and M. Geshi. The authors are grateful to Y. Hasegawa and K. Kajitani at the Livestock Research Support Center in NILGS and the staff of the Reproductive biology and Technology Division in the National Livestock Breeding Center (NLBC) for help in oocyte collection and animal management.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Brevini TAL, 2005, BIOL REPROD, V72, P1218, DOI 10.1095/biolreprod.104.038141; Iwata H, 2011, REPROD FERT DEVELOP, V23, P424, DOI 10.1071/RD10133; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; NASRESFAHANI MH, 1990, DEVELOPMENT, V109, P501; KUHNE W, 1993, AM J PHYSIOL, V264, pH1599; Raju GAR, 2007, REPROD BIOMED ONLINE, V14, P166; Brad AM, 2003, MOL REPROD DEV, V64, P492, DOI 10.1002/mrd.10254; Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8; Hyttel P, 2001, REPRODUCTION, V122, P21, DOI 10.1530/rep.0.1220021; Matoba S, 2012, REPROD DOMEST ANIM, V47, P515; Koyama K, 2014, J REPROD DEVELOP, V60, P136, DOI 10.1262/jrd.2013-115; Mourot M, 2006, MOL REPROD DEV, V73, P1367, DOI 10.1002/mrd.20585; Machaty Z, 2012, THERIOGENOLOGY, V78, P937, DOI 10.1016/j.theriogenology.2012.04.003; HINSHAW DB, 1988, AM J PATHOL, V132, P479; FISSORE RA, 1995, BIOL REPROD, V53, P766, DOI 10.1095/biolreprod53.4.766; Sugimura S, 2012, CELL REPROGRAM, V14, P29, DOI 10.1089/cell.2011.0060; Ueno S, 2005, J REPROD DEVELOP, V51, P405, DOI 10.1262/jrd.16091; Yu YS, 2010, J CELL PHYSIOL, V224, P672, DOI 10.1002/jcp.22171; Matoba S, 2014, J DAIRY SCI, V97, P743, DOI 10.3168/jds.2013-6838; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; Sun QY, 2001, REPRODUCTION, V122, P155, DOI 10.1530/rep.0.1220155; Somfai T, 2012, REPROD FERT DEVELOP, V24, P743, DOI 10.1071/RD11251; Imai K, 2008, REPROD FERT DEVELOP, V20, P182, DOI 10.1071/RDv20n1Ab206; Tamassia M, 2004, BIOL REPROD, V71, P697, DOI 10.1095/biolreprod.103.026104; Wang WH, 2001, FERTIL STERIL, V75, P348, DOI 10.1016/S0015-0282(00)01692-7; Somfai T, 2011, ANAT HISTOL EMBRYOL, V40, P335, DOI 10.1111/j.1439-0264.2011.01079.x; Ferreira EM, 2009, THERIOGENOLOGY, V71, P836, DOI 10.1016/j.theriogenology.2008.10.023; Lequarre AS, 2005, THERIOGENOLOGY, V63, P841, DOI 10.1016/j.theriogenology.2004.05.015; Stojkovic M, 2001, BIOL REPROD, V64, P904, DOI 10.1095/biolreprod64.3.904; Nagashima H, 1996, MOL REPROD DEV, V45, P359, DOI 10.1002/(SICI)1098-2795(199611)45:3<359::AID-MRD13>3.0.CO;2-U; FAIR T, 1995, MOL REPROD DEV, V42, P437, DOI 10.1002/mrd.1080420410; Malcuit C, 2006, REPROD FERT DEVELOP, V18, P39, DOI 10.1071/RD05131; Rosenbusch BE, 2008, FERTIL STERIL, V90, P49, DOI 10.1016/j.fertnstert.2007.06.031; Machaty Z, 1997, BIOL REPROD, V56, P921, DOI 10.1095/biolreprod56.4.921; Zhang X, 2006, CELL RES, V16, P841, DOI 10.1038/sj.cr.7310095; Wang WH, 2006, FRONT BIOSCI, V11, P620, DOI 10.2741/1822; Labrecque R, 2013, MOL REPROD DEV, V80, P428, DOI 10.1002/mrd.22177; Dumollard R, 2004, DEVELOPMENT, V131, P3057, DOI 10.1242/dev.01181; Ju JC, 2003, MOL REPROD DEV, V64, P482, DOI 10.1002/mrd.10234; NARO (National Agriculture and Food Research Organization), 2006, JAP FEED STAND DAIR; National Research Council, 2001, NUTR REQ DAIR CATTL	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	DEC	2015	86	12					970	980		10.1111/asj.12387		11	Agriculture, Dairy & Animal Science	Agriculture	CX5VC	WOS:000365769600002		
J	Dang, VS; Tagane, S; Toyama, H; Tran, H				Van-Son Dang; Tagane, Shuichiro; Toyama, Hironori; Hop Tran			Lasianthus yaharae (Rubiaceae), a new species from Hon Ba Nature Reserve, southern Vietnam	ANNALES BOTANICI FENNICI			English	Article								Lasianthus yaharae V.S. Dang, Tagane & H. Tran (Rubiaceae) is described and illustrated here based on material discovered in the Hon Ba Nature Reserve, southern Vietnam. It is most similar to L. dalatensis but differs in having fewer secondary veins in the leaves, a larger calyx and larger flowers (corolla tube and corolla lobes), and a different flower color at anthesis.	[Van-Son Dang] VNM Herbarium, Inst Trop Biol, Vast, Ho Chi Minh City, Vietnam; [Tagane, Shuichiro; Toyama, Hironori] Kyushu Univ, Higashi Ku, Fukuoka 8128581, Japan; [Hop Tran] Univ Sci, Ho Chi Minh City, Vietnam	Dang, VS (reprint author), VNM Herbarium, Inst Trop Biol, Vast, 85 Tran Quoc Toan St,Dist 3, Ho Chi Minh City, Vietnam.	dvsonitb@yahoo.com.vn			Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [S9]	We are grateful to the staff of Hon Ba Nature Reserve for their kind assistance in the field. We are also grateful to the curators of HN and BKF for their kind help and permission to access specimens for our studies. This work was partly supported by the Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan.	Zhu H, 2012, BLUMEA, V57, P1, DOI 10.3767/000651912X652012; Pham H. H., 2000, CAY CO VIET NAM ILLU, V3, P432; Zhu H, 2001, ACTA PHYTOTAX SINICA, V39, P116; Zhu Hua, 2002, Systematics and Geography of Plants, V72, P63	4	0	0	FINNISH ZOOLOGICAL BOTANICAL PUBLISHING BOARD	UNIV HELSINKI	P O BOX 26, FI-00014 UNIV HELSINKI, FINLAND	0003-3847	1797-2442		ANN BOT FENN	Ann. Bot. Fenn.	DEC	2015	52	5-6					352	354				3	Plant Sciences	Plant Sciences	CX4CB	WOS:000365644700012		
J	Gazda, MA; Kuehn, R; Sato, NJ; Tanaka, KD; Okahisa, Y; Ueda, K; Gula, R; Theuerkauf, J				Gazda, Malgorzata A.; Kuehn, Ralph; Sato, Nozomu J.; Tanaka, Keita D.; Okahisa, Yuji; Ueda, Keisuke; Gula, Roman; Theuerkauf, Joern			Establishment of microsatellite markers to assess the mating system of the fan-tailed gerygone (Gerygone flavolateralis) for studying cuckoo-host arms race	ANNALES ZOOLOGICI FENNICI			English	Article							NESTLINGS; SOFTWARE	We developed a set of microsatellite markers for the fan-tailed gerygone (Gerygone flavolateralis), host of a brood parasite, the shining bronze-cuckoo (Chalcites lucidus). We used 454 pyro-sequencing to establish 17 polymorphic microsatellite markers. The number of alleles per locus ranged from 6 to 18, the expected heterozygosity from 0.328 to 0.931 and the polymorphism information content from 0.306 to 0.916. The developed set of microsatellites will allow us to determine the gerygone's mating system, which is crucial to understand inheritance of dichromatism in skin colour of their chicks.	[Gazda, Malgorzata A.; Gula, Roman; Theuerkauf, Joern] Polish Acad Sci, Museum & Inst Zool, PL-00679 Warsaw, Poland; [Kuehn, Ralph] Tech Univ Munich, Dept Anim Sci, Chair Zool, Unit Mol Zool, D-85354 Freising Weihenstephan, Germany; [Kuehn, Ralph] New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA; [Kuehn, Ralph] New Mexico State Univ, Program Mol Biol, Las Cruces, NM 88003 USA; [Sato, Nozomu J.; Tanaka, Keita D.; Okahisa, Yuji; Ueda, Keisuke] Rikkyo Univ, Dept Life Sci, Tokyo 1718501, Japan	Theuerkauf, J (reprint author), Polish Acad Sci, Museum & Inst Zool, Wilcza 64, PL-00679 Warsaw, Poland.	jtheuer@miiz.eu	Theuerkauf, Jorn/B-6823-2009	Theuerkauf, Jorn/0000-0002-7273-3073	Polish National Science Centre [NCN 2012/05/E/NZ8/02694]; Japan Society for the Promotion of Science [24-4578, 24770028, 23255004]; Rikkyo University [SFR 11-54]	This study was financed by the Polish National Science Centre (grant NCN 2012/05/E/NZ8/02694), the Japan Society for the Promotion of Science (grant 24-4578 to N.J.S., grant 24770028 to K.D.T., grant 23255004 to K.U.), and Rikkyo University (grant SFR 11-54 to N.J.S.). The Province Sud and Province Nord (New Caledonia) issued permits. We thank H. Bloc, P. Guichard, Y. Kawa, S. Keletaona and B. Rinck for their support, H. Abe, K. Eguchi, A. Ishii, M. Kamioki, M. Kojima, T. Nakahara and F. Thiel for help during field work, and anonymous reviewers for useful comments.	Feeney WE, 2014, ANNU REV ECOL EVOL S, V45, P227, DOI 10.1146/annurev-ecolsys-120213-091603; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Opgenoorth L, 2009, CONSERV GENET RESOUR, V1, P253, DOI 10.1007/s12686-009-9062-3; Tokue K, 2010, IBIS, V152, P835; Langmore NE, 2011, P ROY SOC B-BIOL SCI, V278, P2455, DOI 10.1098/rspb.2010.2391; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; LOTEM A, 1993, NATURE, V362, P743, DOI 10.1038/362743a0; Langmore NE, 2003, NATURE, V422, P157, DOI 10.1038/nature01460; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sato NJ, 2010, BIOL LETTERS, V6, P67, DOI 10.1098/rsbl.2009.0540; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Hogan B., 1994, MANIPULATING MOUSE E; Park S. D. E., 2001, THESIS; Rozen S, 2000, Methods Mol Biol, V132, P365	15	0	0	FINNISH ZOOLOGICAL BOTANICAL PUBLISHING BOARD	UNIV HELSINKI	P O BOX 26, FI-00014 UNIV HELSINKI, FINLAND	0003-455X	1797-2450		ANN ZOOL FENN	Ann. Zool. Fenn.	DEC	2015	52	5-6					280	284		10.5735/086.052.0503		5	Ecology; Zoology	Environmental Sciences & Ecology; Zoology	CX4CK	WOS:000365645600002		
J	Yamawaki, K; Inuo, C; Nomura, T; Tanaka, K; Nakajima, Y; Kondo, Y; Yoshikawa, T; Urisu, A; Tsuge, I				Yamawaki, Kazuo; Inuo, Chisato; Nomura, Takayasu; Tanaka, Kenichi; Nakajima, Yoichi; Kondo, Yasuto; Yoshikawa, Tetsushi; Urisu, Atsuo; Tsuge, Ikuya			Multicolor flow-cytometric analysis of milk allergen-specific T-helper type 2 cells revealed coexpression of interleukin-4 with Foxp3	ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY			English	Article							CYTOKINE PRODUCTION; PERIPHERAL-BLOOD; EXPRESSION; RESPONSES; ACTIVATION; SUBSETS; PROLIFERATION; IMMUNOTHERAPY; STIMULATION; INDUCTION	Background: Allergen-specific T-helper type 2 (TH2) cells play an important role in the development of allergic inflammation; however, investigations of the properties of allergen-specific T cells have been challenging in humans. Despite clear evidence that forkhead box p3 (Foxp3) is expressed in conventional effector T cells, its function has remained unknown. Objective: To characterize allergen-specific TH2 cells in milk allergy, with particular focus on the expression of Foxp3. Methods: Twenty-one children with milk allergy and 11 children without milk allergy were studied. Peripheral blood mononuclear cells from subjects were stimulated with milk allergen for 6 hours and analyzed using multicolor flow cytometry to identify CD154(+) allergen-specific T-helper cells. Simultaneously, the expression of intracellular cytokines and Foxp3 was analyzed. Results: The milk allergy group had significantly larger numbers of milk allergen-specific interleukin (IL)-4 and IL-5-producing CD4(+) T cells than the control group. Subjects in the milk allergy group had significantly more CD154(+)CD4(+)IL-10-producing cells and CD154(+)Foxp3(+)CD4(+) cells than those in the control group. In addition, the number of milk allergen-specific CD154(+)Foxp3(+)CD4(+) cells strongly correlated with that of CD154(+)IL4(+)CD4(+) cells. Bcl-2 expression in CD154(+)IL-4(+)Foxp3(+) T-helper cells was significantly lower compared with that in total CD4 cells. Conclusion: Increased numbers of IL-4-producing allergen-specific T-helper cells were found in patients with milk allergy. In addition, Foxp3 was coexpressed with IL-4 in allergen-specific TH2 cells from patients. This coexpression was associated with lower Bcl-2 levels and could contribute to the phenotype and function of TH2 cells. (C) 2015 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.	[Yamawaki, Kazuo; Inuo, Chisato; Yoshikawa, Tetsushi; Tsuge, Ikuya] Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi 4701192, Japan; [Nomura, Takayasu] Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Nagoya, Aichi, Japan; [Tanaka, Kenichi; Nakajima, Yoichi; Kondo, Yasuto; Urisu, Atsuo] Fujita Hlth Univ, Teaching Hosp 2, Dept Pediat, Nagoya, Aichi, Japan	Tsuge, I (reprint author), Fujita Hlth Univ, Sch Med, Dept Pediat, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	itsuge@fujita-hu.ac.jp			Health and Labor Sciences Research Grants of the Research on Allergic Disease and Immunology from the Ministry of Health, Labour and Welfare of Japan	This study was supported in part by the Health and Labor Sciences Research Grants of the Research on Allergic Disease and Immunology from the Ministry of Health, Labour and Welfare of Japan (to U.A. and I.T.).	Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Tai X, 2013, IMMUNITY, V38, P1116, DOI 10.1016/j.immuni.2013.02.022; Noyan F, 2014, EUR J IMMUNOL, V44, P2592, DOI 10.1002/eji.201344381; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Schade RP, 2000, J ALLERGY CLIN IMMUN, V106, P1155, DOI 10.1067/mai.2000.110802; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Hayashi N, 2002, P NATL ACAD SCI USA, V99, P6187, DOI 10.1073/pnas.092129899; Woodfolk JA, 2007, J ALLERGY CLIN IMMUN, V119, P280, DOI 10.1016/j.jaci.2006.11.008; Campbell JD, 2010, CLIN EXP ALLERGY, V40, P1025, DOI 10.1111/j.1365-2222.2010.03505.x; Wambre E, 2012, CURR OPIN IMMUNOL, V24, P700, DOI 10.1016/j.coi.2012.07.009; Tsuge I, 2006, CLIN EXP ALLERGY, V36, P1538, DOI 10.1111/j.1365-2222.2006.02600.x; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1077, DOI 10.1016/j.jaci.2010.02.038; Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Tiemessen MM, 2004, J ALLERGY CLIN IMMUN, V113, P932, DOI 10.1016/j.jaci.2003.12.016; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Magg T, 2012, EUR J IMMUNOL, V42, P1627, DOI 10.1002/eji.201141838; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; McMurchy AN, 2013, BLOOD, V121, P1265, DOI 10.1182/blood-2012-05-431023; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Nomura T, 2013, ANN ALLERG ASTHMA IM, V110, P380, DOI 10.1016/j.anai.2013.02.015; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Michaud B, 2014, ALLERGY, V69, P1473, DOI 10.1111/all.12484; Smith KA, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-14; Stelmaszczyk-Emmel A, 2013, INT ARCH ALLERGY IMM, V162, P16, DOI 10.1159/000350769; Zhang HY, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-125	30	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1081-1206	1534-4436		ANN ALLERG ASTHMA IM	Ann. Allergy Asthma Immunol.	DEC	2015	115	6					503	508		10.1016/j.anai.2015.09.020		6	Allergy; Immunology	Allergy; Immunology	CX3PY	WOS:000365612700010		
J	Kobayashi, R; Tsunoda, K; Ueha, R; Fujimaki, Y; Saijo, H; Itoh, K; Yamasoba, T				Kobayashi, Rika; Tsunoda, Koichi; Ueha, Rumi; Fujimaki, Yoko; Saijo, Hideto; Itoh, Kenji; Yamasoba, Tatsuya			Effect of a nasal clip on inhaling a sufficient cortico steroid powder dose	ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY			English	Letter							PALATE		[Kobayashi, Rika; Tsunoda, Koichi; Fujimaki, Yoko; Itoh, Kenji] Univ Tokyo, Dept Artificial Organs, Natl Hosp Org, Tokyo Med Ctr, Tokyo, Japan; [Kobayashi, Rika; Tsunoda, Koichi; Fujimaki, Yoko; Itoh, Kenji] Univ Tokyo, Dept Med Creat, Natl Hosp Org, Tokyo Med Ctr, Tokyo, Japan; [Kobayashi, Rika; Tsunoda, Koichi; Fujimaki, Yoko; Itoh, Kenji] Univ Tokyo, Dept Otolaryngol, Natl Hosp Org, Tokyo Med Ctr, Tokyo 113, Japan; [Ueha, Rumi; Fujimaki, Yoko; Yamasoba, Tatsuya] Univ Tokyo, Dept Otolaryngol, Tokyo 113, Japan; [Saijo, Hideto] Univ Tokyo, Dept Oral Maxillofacial Surg, Tokyo, Japan	Kobayashi, R (reprint author), Univ Tokyo, Dept Artificial Organs, Natl Hosp Org, Tokyo Med Ctr, Tokyo, Japan.	tsunodakoichi@kankakuki.go.jp					Tsunoda K, 2013, J ALLERGY CLIN IMMUN, V131, P619, DOI 10.1016/j.jaci.2012.07.040; MCWILLIAMS BJ, 1991, CLEFT PALATE-CRAN J, V28, P247, DOI 10.1597/1545-1569(1991)028<0247:SCOTPH>2.3.CO;2; Vaswani R, 2005, J ASTHMA, V42, P793, DOI 10.1080/02770900500308528; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; DeWeese DD, 1988, OTOLARYNGOLOGY HEAD; Lass NJ, 1988, HDB SPEECH LANGUAGE; Newall C, 2007, Chron Respir Dis, V4, P53, DOI 10.1177/1479972306072889	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1081-1206	1534-4436		ANN ALLERG ASTHMA IM	Ann. Allergy Asthma Immunol.	DEC	2015	115	6					525	526				4	Allergy; Immunology	Allergy; Immunology	CX3PY	WOS:000365612700014		
J	Heianna, J; Toita, T; Endo, W; Kasuya, G; Ariga, T; Hashimoto, S; Maemoto, H; Terui, K; Miura, N; Togashi, A; Miyauchi, T; Murayama, S				Heianna, Joichi; Toita, Takafumi; Endo, Wataru; Kasuya, Goro; Ariga, Takuro; Hashimoto, Seiji; Maemoto, Hitoshi; Terui, Kazuyuki; Miura, Naoki; Togashi, Aki; Miyauchi, Takaharu; Murayama, Sadayuki			Concurrent use of strontium-89 with external beam radiotherapy for multiple bone metastases: early experience	ANNALS OF NUCLEAR MEDICINE			English	Article						Strontium-89; External beam radiotherapy; Concurrent; Multiple bone metastases	SPINAL-CORD COMPRESSION; BREAST-CANCER; PROSTATE; THERAPY; PALLIATION; PAIN	The aim of the present study was to consider the safety and efficacy of concurrent use of strontium-89 (Sr-89) with external beam radiotherapy (EBRT) for multiple bone metastases, including lesions that require urgent therapy. A retrospective review was performed of a consecutive series of patients who received Sr-89 for multiple bone metastases. Forty-five patients with multiple bone metastases received Sr-89 injection. Since 17 of the 45 patients had osteolytic bone lesions requiring emergent EBRT, they underwent concurrent use of Sr-89 with EBRT (concurrent group). The remaining 28 patients, none of whom had osteolytic lesions requiring urgent EBRT, were given Sr-89 injection only (singularity group). The injection of Sr-89 was to be given during EBRT, or on the day before the first day of EBRT. The dose of EBRT was 30 Gy in 10 fractions or 40 Gy in 20 fractions. Adverse events were evaluated according to hematological toxicity as measured by the Common Terminology Criteria for Adverse Events (V4.0). To assess efficacy, we checked changes in the pain scale and analgesic drug dosages, and the presence or absence of serious complications from bone metastases. Fifteen of 17 patients (88.2 %) in the concurrent group and 17 of 28 patients (60.7 %) in the singularity group reported bone pain relief. A statistically significant difference was found between the two groups, and severe complications (spinal cord compression and pathological fracture) from bone metastases could be prevented in all patients in the concurrent group. Severe hematological toxicity (grade 3 or higher) was not observed in the two groups. There was no statistical difference between the two groups. No one required additional intervention. The adverse events were tolerable. The results of our study suggest that concurrent use of Sr-89 with EBRT for multiple bone metastases can be performed safely if it is carried out with care, and that it may be an effective therapy in cases requiring emergency treatment.	[Heianna, Joichi; Toita, Takafumi; Kasuya, Goro; Ariga, Takuro; Hashimoto, Seiji; Maemoto, Hitoshi; Murayama, Sadayuki] Ryukyus Univ Med, Dept Radiol, Nishihara, Okinawa 9030215, Japan; [Endo, Wataru; Terui, Kazuyuki; Miura, Naoki; Togashi, Aki; Miyauchi, Takaharu] Akita Red Cross Hosp, Dept Radiat Oncol, Akita 0101406, Japan	Heianna, J (reprint author), Ryukyus Univ Med, Dept Radiol, 207 Uehara, Nishihara, Okinawa 9030215, Japan.	jana@mx51.et.tiki.ne.jp					McEwan AJB, 1997, SEMIN NUCL MED, V27, P165, DOI 10.1016/S0001-2998(97)80046-3; Tu SM, 2005, J CLIN ONCOL, V23, P7904, DOI 10.1200/JCO.2005.01.2310; Kohno N, 2008, INT J CLIN ONCOL, V13, P18, DOI 10.1007/s10147-007-0726-2; Serafini AN, 2002, NUCL MED A, P253; GILBERT RW, 1978, ANN NEUROL, V3, P40, DOI 10.1002/ana.410030107; Lipton A, 2001, CANCER TREAT REV, V27, P181, DOI 10.1053/ctrv.2001.0212; Baczyk M, 2007, NUCL MED COMMUN, V28, P245; TONG D, 1982, CANCER, V50, P893, DOI 10.1002/1097-0142(19820901)50:5<893::AID-CNCR2820500515>3.0.CO;2-Y; Yamada K, 2012, EXP THER MED, V3, P226, DOI 10.3892/etm.2011.405; RUFF RL, 1989, CANCER, V63, P2234, DOI 10.1002/1097-0142(19890601)63:11<2234::AID-CNCR2820631130>3.0.CO;2-T; Bruckman JE, 1978, SEMIN ONCOL, V5, P134; COLEMAN RE, 1987, BRIT J CANCER, V55, P61, DOI 10.1038/bjc.1987.13; Finlay Ilora G, 2005, Lancet Oncol, V6, P392, DOI 10.1016/S1470-2045(05)70206-0; Silberstein Edward B, 2003, Eur J Nucl Med Mol Imaging, V30, pBP7; Soerdjbalie-Maikoe V, 2002, EUR J NUCL MED MOL I, V29, P494, DOI 10.1007/s00259-001-0728-7	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	DEC	2015	29	10					848	853		10.1007/s12149-015-1010-6		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CX5ED	WOS:000365723900002		
J	Shimizu, K; Okita, R; Saisho, S; Yukawa, T; Maeda, A; Nojima, Y; Nakata, M				Shimizu, Katsuhiko; Okita, Riki; Saisho, Shinsuke; Yukawa, Takuro; Maeda, Ai; Nojima, Yuji; Nakata, Masao			Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer	ANNALS OF NUCLEAR MEDICINE			English	Article						Non-small cell lung cancer; Lymph node metastasis; Dual-time-point imaging 18F-FDG PET; Retention index	POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUES; F-18 FDG-PET/CT; LYMPH-NODE METASTASIS; COMPUTED-TOMOGRAPHY; MULTICENTER TRIALS; PULMONARY NODULES; ROI DEFINITION; QUANTIFICATION; ADENOCARCINOMA	The maximal standardized uptake value (SUVmax) of pulmonary lesions on dual-time-point (DTP) fluorodeoxyglucose positron emission tomography (FDG-PET) has been shown to be useful for differentiation between malignant and non-malignant pulmonary lesions, and also to be of value for intrathoracic nodal staging of non-small cell lung cancer (NSCLC). However, a few NSCLC lesions have been found to show decreased FDG uptake on delayed images, and the significance of this finding remains unknown. We conducted a retrospective review of the data of 284 patients with NSCLC who underwent DTP FDG-PET before surgery. Cases of adenocarcinoma in situ and minimally invasive adenocarcinoma were excluded, because these lesions show little FDG uptake. Each patient was scanned at 60 min (early acquisition; SUV-E) and 115 min (delayed acquisition; SUV-D) after the radiopharmaceutical injection. The intratumoral retention index (RI) of 18F-FDG was measured for each examination by the DTP method. Recurrence-free survival (RFS) was determined by the Kaplan-Meier method and compared in relation to the SUV-E, SUV-D, and RI by univariate and multivariate analysis using models including the clinico-pathological prognostic factors. Of the 284 cases, the RI a parts per thousand currency sign 0 was in 49 cases (17.3 %). This group of patients showed lower values of SUV-E and SUV-D, a smaller tumor size, and a lower rate of lymphatic invasion or vascular invasion. It was particularly noteworthy that lymph node metastasis was not histopathologically confirmed in any of these patients. Univariate analysis identified the RI, SUV-E and SUV-D, besides age, tumor size, lymph node metastasis, and tumor differentiation grade as predictors of the RFS. On the other hand, multivariate analysis identified the RI and lymph node metastasis, but not the SUV-E and SUV-D, as independent predictors of the RFS. This study demonstrated that DTP FDG-PET of the primary tumor in NSCLC can be useful to predict the RFS of the patients. In addition, this method may also be useful to predict the presence/absence of intrathoracic lymph node metastasis in these patients.	[Shimizu, Katsuhiko; Okita, Riki; Saisho, Shinsuke; Yukawa, Takuro; Maeda, Ai; Nojima, Yuji; Nakata, Masao] Kawasaki Med Univ, Dept Gen Thorac Surg, Kurashiki, Okayama 7010192, Japan	Shimizu, K (reprint author), Kawasaki Med Univ, Dept Gen Thorac Surg, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	kshimizu@med.kawasaki-m.ac.jp					Matthies A, 2002, J NUCL MED, V43, P871; Kubota K, 2001, EUR J NUCL MED, V28, P696, DOI 10.1007/s002590100537; Ung YC, 2007, J NATL CANCER I, V99, P1753, DOI 10.1093/jnci/djm232; Satoh Y, 2012, EUR J RADIOL, V81, P3530, DOI 10.1016/j.ejrad.2011.11.047; Vesselle H, 2007, CLIN CANCER RES, V13, P3255, DOI 10.1158/1078-0432.CCR-06-1128; Vansteenkiste JF, 1999, J CLIN ONCOL, V17, P3201; Mamede M, 2005, NEOPLASIA, V7, P369, DOI 10.1593/neo.04577; Paesmans M, 2010, J THORAC ONCOL, V5, P612, DOI 10.1097/JTO.0b013e3181d0a4f5; Westerterp M, 2007, EUR J NUCL MED MOL I, V34, P392, DOI 10.1007/s00259-006-0224-1; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Nomori H, 2004, J THORAC CARDIOV SUR, V128, P396, DOI 10.1016/j.jtcvs.2004.03.020; MacDonald K, 2011, CLIN RADIOL, V66, P244, DOI 10.1016/j.crad.2010.10.008; Bryant AS, 2006, ANN THORAC SURG, V82, P1016, DOI 10.1016/j.athoracsur.2006.03.095; Boellaard R, 2008, EUR J NUCL MED MOL I, V35, P2320, DOI 10.1007/s00259-008-0874-2; Gould MK, 2003, ANN INTERN MED, V139, P879; Scott WJ, 1996, J THORAC CARDIOV SUR, V111, P642, DOI 10.1016/S0022-5223(96)70317-3; Uesaka D, 2008, J NUCL MED, V49, P1606, DOI 10.2967/jnumed.108.051250; Cheng G, 2014, CLIN NUCL MED, V39, P147, DOI 10.1097/RLU.0000000000000313; Cerfolio RJ, 2005, J THORAC CARDIOV SUR, V130, P151, DOI 10.1016/j.jtcvs.2004.11.007; WOODARD HQ, 1975, J NUCL MED, V16, P958; Sun JS, 2009, LUNG CANCER, V66, P205, DOI 10.1016/j.lungcan.2009.01.009; Demura Y, 2003, J NUCL MED, V44, P540; Boellaard R, 2004, J NUCL MED, V45, P1519; Nishiyama Y, 2008, ANN NUCL MED, V22, P245, DOI 10.1007/s12149-007-0103-2; Shinya T, 2009, CLIN NUCL MED, V34, P216, DOI 10.1097/RLU.0b013e31819a1f3d; Kim SJ, 2011, CLIN NUCL MED, V36, P434, DOI 10.1097/RLU.0b013e31820adef8	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	DEC	2015	29	10					854	860		10.1007/s12149-015-1013-3		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CX5ED	WOS:000365723900003		
J	Takamura, T; Horiguchi, Y; Kanna, M; Matsushita, H; Sudo, Y; Kikuchi, S; Ueda, T; Sasaki, R; Morita, Y				Takamura, Tomoko; Horiguchi, Yoriko; Kanna, Masahiko; Matsushita, Hirooki; Sudo, Yuta; Kikuchi, Shinnosuke; Ueda, Tomohiro; Sasaki, Ryo; Morita, Yukiko			Validation of prone myocardial perfusion SPECT with a variable-focus collimator versus supine myocardial perfusion SPECT with or without computed tomography-derived attenuation correction	ANNALS OF NUCLEAR MEDICINE			English	Article						IQ-SPECT; Multifocal collimator; Prone imaging; CT-derived attenuation correction; Myocardial perfusion imaging	CORONARY-ARTERY-DISEASE; MULTIFOCAL COLLIMATOR; IQ-SPECT; TL-201; TIME; REDISTRIBUTION; PROTOCOL; IMAGES	The purpose of this study is to evaluate whether prone myocardial perfusion single-photon emission computed tomography (MPS) with thallium-201 acquired through a variable-focus collimator (IQ-SPECT) can correct for soft-tissue attenuation. Thirty-nine patients underwent thallium-201 stress MPS with IQ-SPECT. Delayed images acquired with the patients in the prone position were compared with delayed images obtained with the patients in the supine position with computed tomography-derived attenuation correction (CTAC) (S-CTAC images) or without CTAC (S-NCTAC images). Quantitative tracer uptake (QTU) and semi-quantitative defect scores were determined for the 17 standard myocardial segments. Segments were categorized into anterior-anteroseptal, lateral, inferior, and apex, and areas with defect decision were determined by using the defect scores. Image quality in the prone images was similar to that of S-NCTAC and S-CTAC images. In male patients, QTU in prone images was equivalent to that in S-CTAC images in the anterior-anteroseptal area, but was significantly lower than that in S-CTAC images in the inferior area. In female patients, QTU in prone images was similar to that in S-CTAC images in the anterior-anteroseptal, lateral, and inferior areas. In male and in female patients, QTU in the apex was significantly greater in the prone images than that in the S-CTAC images. In the combined male and female patient group, the defect decision for prone images was similar to that for S-CTAC images in the anterior-anteroseptal, lateral, and inferior areas. Apical defects were observed more frequently in S-CTAC images than in prone or S-NCTAC images. Fewer artificial defects were observed in the apex of images acquired by prone imaging than by S-CTAC imaging. Prone images improved attenuation and had similar defect decision as S-CTAC images in the anterior-anteroseptal, lateral, and inferior areas.	[Takamura, Tomoko; Horiguchi, Yoriko; Kanna, Masahiko; Matsushita, Hirooki; Sudo, Yuta; Kikuchi, Shinnosuke; Morita, Yukiko] Sagamihara Natl Hosp, Natl Hosp Org, Dept Cardiol, Minami Ku, Sagamihara, Kanagawa 2520392, Japan; [Ueda, Tomohiro; Sasaki, Ryo] Sagamihara Natl Hosp, Natl Hosp Org, Dept Radiol, Sagamihara, Kanagawa 2520392, Japan	Horiguchi, Y (reprint author), Sagamihara Natl Hosp, Natl Hosp Org, Dept Cardiol, Minami Ku, 18-1 Sakuradai, Sagamihara, Kanagawa 2520392, Japan.	dzq04361@nifty.com					ESQUERRE JP, 1989, J NUCL MED, V30, P398; SEGALL GM, 1989, J NUCL MED, V30, P548; Purser NJ, 2008, NUCL MED COMMUN, V29, P382, DOI 10.1097/MNM.0b013e3282f4a22e; GORDON DG, 1979, CLIN NUCL MED, V4, P150, DOI 10.1097/00003072-197904000-00003; JOHNSTONE DE, 1979, J NUCL MED, V20, P183; Ogino Y, 2015, ANN NUCL MED, V29, P366, DOI 10.1007/s12149-015-0955-9; Nishina H, 2006, J NUCL MED, V47, P51; BELLER GA, 1980, CIRCULATION, V61, P791; OCONNOR MK, 1995, J NUCL MED, V36, P1102; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Rajaram R, 2011, IEEE NUCL SCI CONF R, P2451, DOI 10.1109/NSSMIC.2011.6152666; Matsuo S, 2015, ANN NUCL MED, V29, P452, DOI 10.1007/s12149-015-0965-7; Vija AH, 2010, IEEE NUCL SCI CONF R, P3433, DOI 10.1109/NSSMIC.2010.5874444; Caobelli F, 2013, NUKLEARMED-NUCL MED, V52, P178, DOI 10.3413/Nukmed-0570-13-03; KIAT H, 1992, J NUCL MED, V33, P1509; Buck AK, 2008, J NUCL MED, V49, P1305, DOI 10.2967/jnumed.107.050195; Caobelli F, 2014, J NUCL MED, V55, P2064, DOI 10.2967/jnumed.114.143560; Hedén Bo, 2009, BMC Med Imaging, V9, P16, DOI 10.1186/1471-2342-9-16; Horiguchi Y, 2014, ANN NUCL MED, V28, P707, DOI 10.1007/s12149-014-0880-3; Nakata T, 2008, SHINZOUKAKUIGAKU, V9, P6; Wakabayashi Yasuharu, 2010, Nihon Hoshasen Gijutsu Gakkai Zasshi, V66, P371	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	DEC	2015	29	10					890	896		10.1007/s12149-015-1019-x		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CX5ED	WOS:000365723900008		
J	Ito, R; Iwano, S; Kishimoto, M; Ito, S; Kato, K; Naganawa, S				Ito, Rintaro; Iwano, Shingo; Kishimoto, Mariko; Ito, Shinji; Kato, Katsuhiko; Naganawa, Shinji			Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma?	ANNALS OF NUCLEAR MEDICINE			English	Article						Non-small-cell lung cancer; Adenocarcinoma; Squamous cell carcinoma; Adenosquamous carcinoma; Positron emission tomography	POSITRON-EMISSION-TOMOGRAPHY; RECURRENCE FOLLOWING SEGMENTECTOMY; RESOLUTION COMPUTED-TOMOGRAPHY; STANDARDIZED-UPTAKE VALUE; IA LUNG ADENOCARCINOMA; CLINICAL STAGE; PATIENT SELECTION; RESECTION MARGINS; VESSEL INVASION; PREDICTOR	The maximum standardized uptake value (SUVmax) of FDG-PET/CT is commonly used as an indicator to evaluate the invasiveness and prognosis of non-small-cell lung cancers (NSCLC). We investigated the correlation between SUVmax and tumor invasiveness or postoperative recurrence of solid type NSCLC and compared squamous cell carcinoma (SCC)/adenosquamous carcinoma (ASC) to adenocarcinoma (AC). A retrospective review of preoperative PET/CT, thin-section CT, and postoperative pathological records obtained over a 5-year period was conducted. Solid type NSCLC tumors on thin-section CT with confirmed diagnosis from surgical resection (diameter a parts per thousand currency sign3 cm) were included. Multivariate logistic regression was used to evaluate the correlation between tumor characteristics and pathological prognostic factors or postoperative recurrence. 150 patients (111 males, 39 females; mean age 67 years; 106 cases of AC, 36 cases of SCC, and 8 cases of ASC) were included. SUVmax was significantly correlated with pleural involvement (p = 0.047), lymphatic permeation (p = 0.003), lymph node metastasis (p = 0.027), and tumor invasiveness (p < 0.001). Receiver operating characteristic analysis indicated an optimal SUVmax threshold of 5.0 for tumor invasiveness. Histopathological type was significantly correlated with pleural involvement (p = 0.042), but not with other types of invasiveness. Twenty-nine patients experienced postoperative recurrence. SUVmax was significantly correlated with tumor recurrence (p = 0.004), but size and histopathological type were not (p = 0.502 and p = 0.351, respectively). SUVmax of the primary lesion in solid type NSCLC was significantly correlated with tumor invasiveness and postoperative recurrence. No differences in tumor invasiveness were observed between solid type AC and SCC/ASC. However, in solid type AC, SUVmax of the primary lesion was more significantly correlated with recurrence.	[Ito, Rintaro; Iwano, Shingo; Kishimoto, Mariko; Ito, Shinji; Naganawa, Shinji] Nagoya Univ, Grad Sch Med, Dept Radiol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Kato, Katsuhiko] Nagoya Univ, Grad Sch Med, Dept Radiol, Higashi Ku, Nagoya, Aichi 4618673, Japan; [Kato, Katsuhiko] Nagoya Univ, Grad Sch Med, Med Lab Sci, Higashi Ku, Nagoya, Aichi 4618673, Japan	Iwano, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Radiol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	iwano45@med.nagoya-u.ac.jp	Naganawa, Shinji/I-1572-2012; IWANO, Shingo/I-7355-2014	Naganawa, Shinji/0000-0002-0214-613X; 			Okada M, 2011, J THORAC CARDIOV SUR, V141, P1384, DOI 10.1016/j.jtcvs.2011.02.007; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Ohde Y, 2003, LUNG CANCER-J IASLC, V42, P303, DOI 10.1016/j.tungcan.2003.07.001; Suzuki K, 2006, ANN THORAC SURG, V81, P413, DOI 10.1016/j.athoracsur.2005.07.058; Alberg AJ, 2013, CHEST, V143, pE1, DOI 10.1378/chest.12-2345; Ozeki N, 2014, INTERACT CARDIOV TH, V19, P830, DOI 10.1093/icvts/ivu233; Shiono S, 2013, EUR J CARDIO-THORAC, V43, pE7, DOI 10.1093/ejcts/ezs573; Tsutani Y, 2011, JPN J CLIN ONCOL, V41, P890, DOI 10.1093/jjco/hyr062; TAKAMORI S, 1991, CANCER, V67, P649, DOI 10.1002/1097-0142(19910201)67:3<649::AID-CNCR2820670321>3.0.CO;2-B; Uehara H, 2013, ANN THORAC SURG, V96, P1958, DOI 10.1016/j.athoracsur.2013.06.086; Higashi K, 2005, J NUCL MED, V46, P267; Sawabata N, 2010, J THORAC ONCOL, V5, P1369, DOI 10.1097/JTO.0b013e3181e452b9; Cooke DT, 2010, ANN THORAC SURG, V90, P943, DOI 10.1016/j.athoracsur.2010.05.025; Watanabe Y, 2014, ANN THORAC SURG, V97, P245, DOI 10.1016/j.athoracsur.2013.09.018; Chen X, 2008, MOL MED REP, V1, P889, DOI 10.3892/mmr_00000046; Aoki T, 2001, RADIOLOGY, V220, P803, DOI 10.1148/radiol.2203001701; Jeong HJ, 2002, NUCL MED COMMUN, V23, P865, DOI 10.1097/00006231-200209000-00010; Ohtsuka T, 2006, CANCER, V107, P2468, DOI 10.1002/cncr.22268; Pechet TTV, 2004, ANN THORAC SURG, V78, P1748, DOI 10.1016/j.athoracsur.2004.04.061; Li MH, 2010, LUNG CANCER, V68, P394, DOI 10.1016/j.lungcan.2009.07.009; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Nomori H, 2012, J THORAC CARDIOV SUR, V144, P87, DOI 10.1016/j.jtcvs.2012.03.034; Ishibashi T, 2011, ANN NUCL MED, V25, P547, DOI 10.1007/s12149-011-0502-2; Usui S, 2013, LUNG CANCER, V82, P407, DOI 10.1016/j.lungcan.2013.09.001; Lu PO, 2010, NUCL MED COMMUN, V31, P646, DOI 10.1097/MNM.0b013e328339bddb; Iwano S, 2013, LUNG CANCER, V79, P132, DOI 10.1016/j.lungcan.2012.10.018; Iwano S, 2014, CANC IMAGING, V14; Koike T, 2012, ANN THORAC SURG, V93, P1788, DOI 10.1016/j.athoracsur.2012.02.093; Sienel W, 2007, EUR J CARDIO-THORAC, V31, P522, DOI 10.1016/j.ejcts.2006.12.018; Jeyasingham K, 2007, EUR J CARDIO-THORAC, V31, P527	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	DEC	2015	29	10					897	905		10.1007/s12149-015-1025-z		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CX5ED	WOS:000365723900009		
J	Shintawati, R; Achmad, A; Higuchi, T; Shimada, H; Hirasawa, H; Arisaka, Y; Takahashi, A; Nakajima, T; Tsushima, Y				Shintawati, Rini; Achmad, Arifudin; Higuchi, Tetsuya; Shimada, Hirotaka; Hirasawa, Hiromi; Arisaka, Yukiko; Takahashi, Ayako; Nakajima, Takahito; Tsushima, Yoshito			Evaluation of bone scan index change over time on automated calculation in bone scintigraphy	ANNALS OF NUCLEAR MEDICINE			English	Article						Bone scintigraphy; Bone scan index; BONENAVI; Computer-assisted diagnostic software	PROSTATE-CANCER; DIAGNOSIS SYSTEM; METASTASES; SEGMENTATION; HMDP; MDP	Bone scintigraphy (bone scan) is useful in detecting metastatic bone lesions through visual assessment of hot spots. A semi-quantitative analysis method that evaluates bone scan images has been eagerly anticipated. BONENAVI is software that enables automatic assessment of bone scan index (BSI). BSI is useful for stratifying cancer patients and monitoring their therapeutic response. The purpose of this study was to evaluate the BONENAVI reading in determining BSI and hot spots at different time intervals after radioisotope injection. We evaluated 32 patients, including 22 males and 10 females. Ten patients had breast cancer, 20 patients had prostate cancer, and 2 had malignant pheochromocytoma. Patients were injected with 740 MBq of Tc-99m-methylene diphosphonate and bone scintigraphy was performed at 2, 4, and 6 h after injection on each patient. The BSI and the number of hot spots were obtained from BONENAVI software. Bone scan images were also visually assessed to exclude false positives due to artifacts. Analyses were performed in all lesions, selected true lesions, segment based and cancer type based. Non-parametric statistical analyses for pairwise multiple group comparison were performed using Friedman test followed with post hoc analysis. The BSIs and the number of hot spots were significantly increased with time, with significant differences between each of time points (P < 0.001). Analysis of regional BSI (rBSI) and hot spot number changes of selected 15 true lesions also showed similar increase (P < 0.001). In general, the pelvic segment was the most prone to rBSI changes and the chest segment was the most prone to hot spot number changes. Visual assessment showed that BONENAVI diagnosed some typical artifacts as metastases (hot spots). BONENAVI reading of BSIs and hot spot numbers was highly affected by acquisition time. In serial or follow-up examinations (in particular, for monitoring therapeutic efficacy), acquisition time should be fixed for each patient. Cautious interpretation should be made on segments with high physiological uptake. BONENAVI reading was prone to misinterpretation of artifacts. Visual assessment is necessary to rule out this possibility.	[Shintawati, Rini; Achmad, Arifudin; Higuchi, Tetsuya; Hirasawa, Hiromi; Arisaka, Yukiko; Takahashi, Ayako; Tsushima, Yoshito] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Maebashi, Gunma 3718511, Japan; [Shintawati, Rini] Dr Hasan Sadikin Cent Gen Hosp, Bandung 40161, Indonesia; [Shimada, Hirotaka] Gunma Univ Hosp, Dept Radiol, Maebashi, Gunma 3718511, Japan; [Nakajima, Takahito] Gunma Univ, Grad Sch Med, Dept Mol Imaging, Maebashi, Gunma 3718511, Japan	Higuchi, T (reprint author), Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Showa Machi 3-39-22, Maebashi, Gunma 3718511, Japan.	tetsuyah92md@gmail.com					Agatonovic-Kustrin S, 2000, J PHARMACEUT BIOMED, V22, P717, DOI 10.1016/S0731-7085(99)00272-1; Lecouvet FE, 2014, EUR J CANCER, V50, P2519, DOI 10.1016/j.ejca.2014.07.002; Imbriaco M, 1998, CLIN CANCER RES, V4, P1765; Wakabayashi H, 2013, ANN NUCL MED, V27, P802, DOI 10.1007/s12149-013-0749-x; TOFE AJ, 1975, J NUCL MED, V16, P986; Sadik M, 2008, EUR J NUCL MED MOL I, V35, P1464, DOI 10.1007/s00259-008-0721-5; Erdi YE, 1997, J NUCL MED, V38, P1401; Kikuchi A, 2012, NUCL MED COMMUN, V33, P947, DOI 10.1097/MNM.0b013e3283567407; VANDUZEE BF, 1984, J NUCL MED, V25, P166; Donohoe KJ, 1996, J NUCL MED, V37, P1903; Sadik M, 2008, J NUCL MED, V49, P1958, DOI 10.2967/jnumed.108.055061; ROSENTHALL L, 1981, CLIN NUCL MED, V6, P353, DOI 10.1097/00003072-198108000-00003; COAKLEY FV, 1995, CLIN RADIOL, V50, P327, DOI 10.1016/S0009-9260(05)83426-9; Tokuda O, 2014, ANN NUCL MED, V28, P329, DOI 10.1007/s12149-014-0819-8; Ulmert D, 2012, EUR UROL, V62, P78, DOI 10.1016/j.eururo.2012.01.037; SOLOWAY MS, 1988, CANCER, V61, P195, DOI 10.1002/1097-0142(19880101)61:1<195::AID-CNCR2820610133>3.0.CO;2-Y; Bombardieri E., 2003, EUR J NUCL MED MOL I, V30, P99; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Gnanasegaran G, 2007, CLIN NUCL MED, P241, DOI 10.1007/978-3-540-28026-2_10; Iwase T, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000269; Karesh SM, 2006, NUCL MED, P334; Koizumi M, 2015, ANN NUCL MED, V29, P138, DOI 10.1007/s12149-014-0921-y; Nakajima K, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-83; Saha GB, 2010, FUNDAMENTALS NUCL PH, P297; Weiner RE, 2006, NUCL MED, P1117; Yoneyama S, 2014, ANN ONCOL, V25, P276	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	DEC	2015	29	10					911	920		10.1007/s12149-015-1021-3		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CX5ED	WOS:000365723900011		
J	Palge, V; Dunningham, J				Palge, Veiko; Dunningham, Jacob			Behavior of Werner states under relativistic boosts	ANNALS OF PHYSICS			English	Article						Quantum mechanics; Relativity; Quantum information; Entanglement	ENTANGLEMENT	We study the structure of maps that Lorentz boosts induce on the spin degree of freedom of a system consisting of two massive spin-1/2 particles. We consider the case where the spin state is described by the Werner state and the momenta are discrete. Transformations on the spins are systematically investigated in various boost scenarios by calculating the orbit and concurrence of the bipartite spin state with different kinds of product and entangled momenta. We confirm the general conclusion that Lorentz boosts cause non-trivial behavior of bipartite spin entanglement. Visualization of the evolution of the spin state is shown to be valuable in explaining the pattern of concurrence. The idealized model provides a basis of explanation in terms of which phenomena in systems involving continuous momenta can be understood. (C) 2015 Elsevier Inc. All rights reserved.	[Palge, Veiko] Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan; [Dunningham, Jacob] Univ Sussex, Dept Phys & Astron, Brighton BN1 9QH, E Sussex, England	Palge, V (reprint author), Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan.	veiko.palge@gmail.com; J.Dunningham@sussex.ac.uk			Japan Society for the Promotion of Science (JSPS) [25-03757]	We thank Xavier Calmet for useful discussions. This work was financially supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for JSPS Fellows No. 25-03757.	Ahn D., 2002, ARXIVQUANTPH0207018; Friis N, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.042114; Ahn D., 2003, Physical Review A (Atomic, Molecular, and Optical Physics), V67, DOI 10.1103/PhysRevA.67.032309; WERNER RF, 1989, PHYS REV A, V40, P4277, DOI 10.1103/PhysRevA.40.4277; Gingrich RM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.270402; Rhodes JA, 2004, AM J PHYS, V72, P943, DOI 10.1119/1.1652040; Alsing PM, 2002, QUANTUM INFORM COMPU, V2, P487; Caban P, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.012103; Chakrabarti A, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/24/245205; Wootters WK, 1998, PHYS REV LETT, V80, P2245, DOI 10.1103/PhysRevLett.80.2245; Jordan TF, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.022101; Alsing PM, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.032326; Ahn D, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.012103; Caban P, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.042103; Terashima H, 2003, INT J QUANTUM INF, V1, P93, DOI 10.1142/S0219749903000061; Palge V, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.042322; Horodecki M, 1996, PHYS LETT A, V223, P1, DOI 10.1016/S0375-9601(96)00706-2; Friis N, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.081701; Lamata L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.250502; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Fuentes I, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.045030; Bertlmann RA, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.032319; Czachor M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.078901; Thomas LH, 1926, NATURE, V117, P514, DOI 10.1038/117514a0; Martin-Martinez E, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.160501; Czachor M, 1997, PHYS REV A, V55, P72, DOI 10.1103/PhysRevA.55.72; Wigner E, 1939, ANN MATH, V40, P149, DOI 10.2307/1968551; Dunningham J, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.044302; Lee D, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/067; Bengtsson I., 2006, GEOMETRY QUANTUM STA; Bohm D., 1951, PRENTICE HALL PHYS S; Halpern F. R., 1968, SPECIAL RELATIVITY Q; Paige V., 2011, PHYS REV A, V84; Palge V., 2014, ARXIV14091316QUANTPH; Sexl R. U., 2001, RELATIVITY GROUPS PA; Thomas L.H., 1927, PHILOS MAG, V7; Tung W.-K., 1985, GROUP THEORY PHYS; Weinberg S., 1995, QUANTUM THEORY FIELD, V1	38	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-4916	1096-035X		ANN PHYS-NEW YORK	Ann. Phys.	DEC	2015	363						275	304		10.1016/j.aop.2015.09.028		30	Physics, Multidisciplinary	Physics	CX6TP	WOS:000365834900017		
J	Rad, MS; Hendi, SH; Matsuno, K; Sheykhi, A				Rad, Masoud Sepehri; Hendi, Seyed Hossein; Matsuno, Ken; Sheykhi, Ahrnad			Extremal Einstein-Born-Infeld black holes in dilaton gravity	ANNALS OF PHYSICS			English	Article							NONLINEAR-ELECTRODYNAMICS; COSMOLOGICAL CONSTANT; DIMENSIONS; BRANES; THERMODYNAMICS; STRINGS	Motivated by considerable interests of Myers-Perry black holes, we employ the perturbative method to obtain a family of extremal charged rotating black hole solutions in odd dimensional Einstein-Born-Infeld-dilaton gravity. We start with an extremal Myers-Perry black hole with equal angular momenta, and then by adding the dilaton field and the nonlinear Born-Infeld electrodynamics, we find an extremal nonlinearly charged rotating black holes. The perturbative parameter is assumed to be the electric charge q and the perturbations are performed up to the third order. We then study the physical properties of these Born-Infeld-dilaton black holes. In particular, we show that the perturbative parameter, q, the dilaton coupling constant, alpha, and the Born-Infeld parameter, beta, modify the Smarr formula and the values of the gyromagnetic ratio of the extremal charged rotating black holes. (C) 2015 Elsevier Inc. All rights reserved.	[Rad, Masoud Sepehri] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul 136791, South Korea; [Hendi, Seyed Hossein; Sheykhi, Ahrnad] Shiraz Univ, Coll Sci, Dept Phys, Shiraz 71454, Iran; [Hendi, Seyed Hossein; Sheykhi, Ahrnad] Shiraz Univ, Coll Sci, Biruni Observ, Shiraz 71454, Iran; [Hendi, Seyed Hossein; Sheykhi, Ahrnad] RIAAM, Maragha, Iran; [Matsuno, Ken] Osaka City Univ, Dept Math & Phys, Sumiyoshi Ku, Osaka 5588585, Japan	Rad, MS (reprint author), Korea Inst Sci & Technol, Ctr Funct Connect, Seoul 136791, South Korea.	masoud.alahverdi@gmail.com; hendi@shirazu.ac.ir; matuno@sci.osaka-cu.ac.jp; asheykhi@shirazu.ac.ir			CFC grant; Research Institute for Astronomy and Astrophysics of Maragha, Iran	M. Sepehri Rad is supported by a CFC grant. S.H.H. and A.S. thank Shiraz University Research Council. The works of S.H.H. and A.S. have been supported financially by the Research Institute for Astronomy and Astrophysics of Maragha, Iran.	Aliev AN, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.084041; Allaverdizadeh M, 2014, INT J MOD PHYS D, V23, DOI 10.1142/S0218271814500321; FRADKIN ES, 1985, PHYS LETT B, V163, P123, DOI 10.1016/0370-2693(85)90205-9; Sheykhi A, 2009, INT J MOD PHYS D, V18, P25, DOI 10.1142/S021827180901425X; BERGSHOEFF E, 1987, PHYS LETT B, V188, P70, DOI 10.1016/0370-2693(87)90707-6; HORNE JH, 1992, PHYS REV D, V46, P1340, DOI 10.1103/PhysRevD.46.1340; Gauntlett JP, 1999, CLASSICAL QUANT GRAV, V16, P1, DOI 10.1088/0264-9381/16/1/001; Hendi SH, 2008, J MATH PHYS, V49, DOI 10.1063/1.2968342; Gubser SS, 1999, NUCL PHYS B, V551, P667, DOI 10.1016/S0550-3213(99)00194-7; Allahverdizadeh M, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.064034; Aiello M, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.104014; SHIRAISHI K, 1992, PHYS LETT A, V166, P298, DOI 10.1016/0375-9601(92)90712-U; Allahverdizadeh M, 2011, J PHYS CONF SER, V314, DOI 10.1088/1742-6596/314/1/012109; Strominger A, 1996, PHYS LETT B, V379, P99, DOI 10.1016/0370-2693(96)00345-0; Dey TK, 2004, PHYS LETT B, V595, P484, DOI [10.1016/j.physletb.2004.06.047, 10.1016/j.physleetb.2004.06.047]; Allahverdizadeh M, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.084049; Brihaye Y, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.105013; Kim HC, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.024045; Aliev AN, 2007, CLASSICAL QUANT GRAV, V24, P4669, DOI 10.1088/0264-9381/24/18/008; WILTSHIRE DL, 1988, PHYS REV D, V38, P2445, DOI 10.1103/PhysRevD.38.2445; Clement G, 2000, PHYS REV D, V62, DOI 10.1103/PhysRevD.62.124013; Tamaki T, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.024027; Navarro-Lerida F, 2010, GEN RELAT GRAVIT, V42, P2891, DOI 10.1007/s10714-010-1033-1; Aliev AN, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.024011; Hawking SW, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.064005; Sheykhi A, 2008, PHYS LETT B, V662, P7, DOI 10.1016/j.physletb.2008.02.017; Sheykhi A, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.104022; Sheykhi A, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.044025; Kunz J, 2007, PHYS LETT B, V649, P463, DOI 10.1016/j.physletb.2007.04.030; Aharony O, 2000, PHYS REP, V323, P183, DOI 10.1016/S0370-1573(99)00083-6; GREGORY R, 1993, PHYS REV LETT, V70, P2837, DOI 10.1103/PhysRevLett.70.2837; METSAEV RR, 1987, PHYS LETT B, V193, P207, DOI 10.1016/0370-2693(87)91223-8; Tamaki T, 2000, PHYS REV D, V62, DOI 10.1103/PhysRevD.62.061501; Aliev AN, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.044004; Dehghani MH, 2007, INT J MOD PHYS D, V16, P1829, DOI 10.1142/S0218271807011127; Kunz J, 2006, PHYS LETT B, V639, P362, DOI 10.1016/j.physletb.2006.06.066; Cai RG, 1999, MOD PHYS LETT A, V14, P1895, DOI 10.1142/S0217732399001966; Dehghani M, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.064028; Emparan R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.101101; Hendi SH, 2010, PROG THEOR PHYS, V124, P493; BANADOS M, 1994, PHYS REV D, V49, P975, DOI 10.1103/PhysRevD.49.975; Kunz J, 2005, PHYS LETT B, V614, P104, DOI 10.1016/j.physletb.2005.03.056; Aliev AN, 2006, MOD PHYS LETT A, V21, P751, DOI 10.1142/S0217732306019281; Breton N, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.124004; DEOLIVEIRA HP, 1994, CLASSICAL QUANT GRAV, V11, P1469, DOI 10.1088/0264-9381/11/6/012; CHAN KCK, 1995, NUCL PHYS B, V447, P441, DOI 10.1016/0550-3213(95)00205-7; Allahverdizadeh M, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.024030; Sheykhi A, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.064073; Yamazaki R, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.024009; GARCIA A, 1984, NUOVO CIMENTO B, V84, P65, DOI 10.1007/BF02721649; Allahverdizadeh M, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.084002; Yazadjiev SS, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.044006; Chamblin A, 1999, PHYS REV D, V60, DOI 10.1103/PhysRevD.60.064018; Cvetic M, 1999, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/1999/04/024; Dehghani M.H., 2007, JCAP, V0702; Dias GAS, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.024030; Emparan R, 2008, LIVING REV RELATIV, V11; Fujii Y, 2003, SCALAR TENSOR THEORY; Green M.B., 1987, SUPERSTRING THEORY; Gunasekaran S., 2012, J HIGH ENERGY PHYS, V1211, P110; MYERS RC, 1986, ANN PHYS-NEW YORK, V172, P304, DOI 10.1016/0003-4916(86)90186-7; NORTON JD, 1992, ARCH HIST EXACT SCI, V45, P17, DOI 10.1007/BF00375886; Sheykhi A, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.024021; Tamaki T., 2004, J COSMOL ASTROPART P, V0405	64	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-4916	1096-035X		ANN PHYS-NEW YORK	Ann. Phys.	DEC	2015	363						485	495		10.1016/j.aop.2015.10.002		11	Physics, Multidisciplinary	Physics	CX6TP	WOS:000365834900028		
J	Suzuki, S; Shintani, M; Sanchez, ZK; Kimura, K; Numata, M; Yamazoe, A; Kimbara, K				Suzuki, Sho; Shintani, Masaki; Sanchez, Zoe Kuizon; Kimura, Kohei; Numata, Mitsuru; Yamazoe, Atsushi; Kimbara, Kazuhide			Effects of phosphate addition on methane fermentation in the batch and upflow anaerobic sludge blanket (UASB) reactors	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Ammonia inhibition; Anaerobic digestion; Methanogen; Microbial community; Phosphate; Methane fermentation; UASB	PIGGERY WASTE-WATER; GRANULAR SLUDGE; METHANOGENIC ARCHAEA; AMMONIA; DIGESTION; REMOVAL; COMMUNITY; STRUVITE; MANURE; DEGRADATION	Ammonia inhibition of methane fermentation is one of the leading causes of failure of anaerobic digestion reactors. In a batch anaerobic digestion reactor with 429 mM NH3-N/L of ammonia, the addition of 25 mM phosphate resulted in an increase in methane production rate. Similar results were obtained with the addition of disodium phosphate in continuous anaerobic digestion using an upflow anaerobic sludge blanket (UASB) reactor. While methane content and production rate decreased in the presence of more than 143 mM NH3-N/L of ammonium chloride in UASB, the addition of 5 mM disodium phosphate suppressed ammonia inhibition at 214 mM NH3-N/L of ammonium chloride. The addition prevented acetate/propionate accumulation, which might be one of the effects of the phosphate on the ammonia inhibition. The effects on the microbial community in the UASB reactor was also assessed, which was composed of Bacteria involved in hydrolysis, acidogenesis, acetogenesis, and dehydrogenation, as well as Archaea carrying out methanogenesis. The change in the microbial community was observed by ammonia inhibition and the addition of phosphate. The change indicates that the suppression of ammonia inhibition by disodium phosphate addition could stimulate the activity of methanogens, reduce shift in bacterial community, and enhance hydrogen-producing bacteria. The addition of phosphate will be an important treatment for future studies of methane fermentation.	[Suzuki, Sho; Shintani, Masaki; Sanchez, Zoe Kuizon; Kimura, Kohei; Kimbara, Kazuhide] Shizuoka Univ, Appl Chem & Biochem Engn Course, Grad Sch Integrated Sci & Technol, Dept Engn,Naka Ku, Hamamatsu, Shizuoka 4328561, Japan; [Numata, Mitsuru; Yamazoe, Atsushi] Natl Inst Technol & Evaluat, NITE Biol Resource Ctr, Shibuya Ku, Tokyo 1510066, Japan	Kimbara, K (reprint author), Shizuoka Univ, Appl Chem & Biochem Engn Course, Grad Sch Integrated Sci & Technol, Dept Engn,Naka Ku, 3-5-1 Johoku, Hamamatsu, Shizuoka 4328561, Japan.	tkkimba@ipc.shizuoka.ac.jp			Shizuoka Industrial Foundation; Japan Science and Technology Agency on Initiatives for Atomic Energy Basic and Generic Strategic Research [240408]	This study was funded by grant from Shizuoka Industrial Foundation and Japan Science and Technology Agency on Initiatives for Atomic Energy Basic and Generic Strategic Research (240408).	Oh YK, 2003, BIOTECHNOL BIOPROC E, V8, P54, DOI 10.1007/BF02932899; Tiwari MK, 2006, APPL MICROBIOL BIOT, V71, P145, DOI 10.1007/s00253-006-0397-3; Turker M, 2007, BIORESOURCE TECHNOL, V98, P1529, DOI 10.1016/j.biortech.2006.06.026; Garcia SL, 2011, BIORESOURCE TECHNOL, V102, P7249, DOI 10.1016/j.biortech.2011.04.098; Zhou HB, 2006, J CENT SOUTH UNIV T, V13, P63, DOI 10.1007/s11771-006-0108-3; Tabatabaei M, 2010, PROCESS BIOCHEM, V45, P1214, DOI 10.1016/j.procbio.2010.05.017; Arogo J, 1999, J AGR ENG RES, V73, P77, DOI 10.1006/jaer.1998.0390; [Anonymous], 1998, K0101 JIS JAP STAND; Gallert C, 1997, APPL MICROBIOL BIOT, V48, P405; Ueno Y, 2001, ENVIRON TECHNOL, V22, P1373, DOI 10.1080/09593332208618196; Pastor L, 2010, BIORESOURCE TECHNOL, V101, P118, DOI 10.1016/j.biortech.2009.08.002; Sawayama S, 2004, J BIOSCI BIOENG, V97, P65, DOI 10.1016/S1389-1723(04)70167-X; Jabari L, 2012, INT J SYST EVOL MICR, V62, P2522, DOI 10.1099/ijs.0.032508-0; Battistoni P, 2001, WATER RES, V35, P2167, DOI 10.1016/S0043-1354(00)00498-X; Zhang L, 2010, J HAZARD MATER, V182, P536, DOI 10.1016/j.jhazmat.2010.06.065; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Sung SW, 2003, CHEMOSPHERE, V53, P43, DOI 10.1016/S0045-6535(03)00434-X; Ito T, 2011, ISME J, V5, P1844, DOI 10.1038/ismej.2011.59; Zhang C, 2011, BIORESOURCE TECHNOL, V102, P8344, DOI 10.1016/j.biortech.2011.06.018; Yabu H, 2011, J BIOSCI BIOENG, V111, P312, DOI 10.1016/j.jbiosc.2010.10.011; Abreu AA, 2011, BIOTECHNOL BIOENG, V108, P1766, DOI 10.1002/bit.23145; Qiao S, 2010, BIORESOURCE TECHNOL, V101, P111, DOI 10.1016/j.biortech.2009.08.003; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; Rao AG, 2008, BIORESOURCE TECHNOL, V99, P8679, DOI 10.1016/j.biortech.2008.04.016; Godon JJ, 2005, ENVIRON MICROBIOL, V7, P213, DOI 10.1111/j.1462-2920.2004.00693.x; Calli B, 2006, BIORESOURCE TECHNOL, V97, P641, DOI 10.1016/j.biortech.2005.03.021; Uludag-Demirer S, 2008, J ENVIRON MANAGE, V86, P193, DOI 10.1016/j.jenvman.2006.12.002; Uysal A, 2010, J HAZARD MATER, V181, P248, DOI 10.1016/j.jhazmat.2010.05.004; Lei ZF, 2010, BIORESOURCE TECHNOL, V101, P4343, DOI 10.1016/j.biortech.2010.01.083; Krylova NI, 1997, J CHEM TECHNOL BIOT, V70, P99, DOI 10.1002/(SICI)1097-4660(199709)70:1<99::AID-JCTB684>3.0.CO;2-C; Quan XJ, 2010, J HAZARD MATER, V178, P326, DOI 10.1016/j.jhazmat.2010.01.083; Ban QY, 2013, J MICROBIOL BIOTECHN, V23, P382, DOI 10.4014/jmb.1210.10008; Li TL, 2009, ENVIRON MICROBIOL, V11, P889, DOI 10.1111/j.1462-2920.2008.01810.x; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; APHA, 1989, STANDARD METHODS EXA; Kugelman IJ, 1965, J WATER POLLUT CONTR, V37, P97	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	DEC	2015	99	24					10457	10466		10.1007/s00253-015-6942-1		10	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CX5AJ	WOS:000365712300008		
J	Maeda, H; Nakagawa, K; Murayama, K; Goto, M; Watanabe, K; Takeuchi, M; Yamagata, Y				Maeda, Hiroshi; Nakagawa, Kanako; Murayama, Kazutaka; Goto, Masafumi; Watanabe, Kimiko; Takeuchi, Michio; Yamagata, Youhei			Cloning a neutral protease of Clostridium histolyticum, determining its substrate specificity, and designing a specific substrate	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Clostridium histolyticum; Neutral protease; Purification; Substrate specificity; Islet separation	HUMAN ISLET ISOLATION; COLLAGENASE; TRANSPLANTATION; PANCREAS; ENZYME; DISSOCIATION; OPTIMIZATION; LANGERHANS; PROTEINASE; VARIABLES	Islet transplantation is a prospective treatment for restoring normoglycemia in patients with type 1 diabetes. Islet isolation from pancreases by decomposition with proteolytic enzymes is necessary for transplantation. Two collagenases, collagenase class I (ColG) and collagenase class II (ColH), from Clostridium histolyticum have been used for islet isolation. Neutral proteases have been added to the collagenases for human islet isolation. A neutral protease from C. histolyticum (NP) and thermolysin from Bacillus thermoproteolyicus has been used for the purpose. Thermolysin is an extensively studied enzyme, but NP is not well known. We therefore cloned the gene encoding NP and constructed a Bacillus subtilis overexpression strain. The expressed enzyme was purified, and its substrate specificity was examined. We observed that the substrate specificity of NP was higher than that of thermolysin, and that the protein digestion activities of NP, as determined by colorimetric methods, were lower than those of thermolysin. It seems that decomposition using NP does not negatively affect islets during islet preparation from pancreases. Furthermore, we designed a novel substrate that allows the measurement of NP activity specifically in the enzyme mixture for islet preparation and the culture broth of C. histolyticum. The activity of NP can also be monitored during islet isolation. We hope the purified enzyme and this specific substrate contribute to the optimization of islet isolation from pancreases and that it leads to the success of islet transplantation and the improvement of the quality of life (QOL) for diabetic patients.	[Maeda, Hiroshi; Nakagawa, Kanako; Goto, Masafumi; Watanabe, Kimiko; Yamagata, Youhei] Tohoku Univ, New Ind Creat Hatchery Ctr, Aoba Ku, Sendai, Miyagi 9800872, Japan; [Murayama, Kazutaka] Tohoku Univ, Grad Sch Biomed Engn, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Goto, Masafumi] Tohoku Univ, Sch Med, Div Adv Surg Sci & Technol, Sendai, Miyagi 9800872, Japan; [Takeuchi, Michio; Yamagata, Youhei] Tokyo Univ Agr & Technol, Grad Sch Agr Sci, Fuchu, Tokyo 1838509, Japan; [Nakagawa, Kanako] Tokyo Univ Technol, Sch Biosci & Biotechnol, Hachioji, Tokyo 1920982, Japan	Yamagata, Y (reprint author), Tohoku Univ, New Ind Creat Hatchery Ctr, Aoba Ku, 6-6-10 Aramaki Aza Aoba, Sendai, Miyagi 9800872, Japan.	y-yama@cc.tuat.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Meiji Seika Pharma Co., Ltd.	This study was partly supported by the grant of "Coordination, Support and Training Program for Translational Research" from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors of this publication received a partial financial support by Meiji Seika Pharma Co., Ltd. according to a collaborative research contract.	Ambrosius D, 1996, Patent No. [WO1996019583 A1, 1996019583]; Ponte GM, 2007, CELL TRANSPLANT, V16, P595; WUNSCH E, 1963, H-S Z PHYSIOL CHEM, V333, P149, DOI 10.1515/bchm2.1963.333.1.149; Kin T, 2007, AM J TRANSPLANT, V7, P1233, DOI 10.1111/j.1600-6143.2007.01760.x; YOSHIHARA K, 1994, J BACTERIOL, V176, P6489; MCQUADE AB, 1968, BIOCHIM BIOPHYS ACTA, V167, P619, DOI 10.1016/0005-2744(68)90055-7; JONGENEEL CV, 1989, FEBS LETT, V242, P211, DOI 10.1016/0014-5793(89)80471-5; Lakey JRT, 1996, TRANSPLANTATION, V61, P1047, DOI 10.1097/00007890-199604150-00010; WOLTERS GHJ, 1992, DIABETOLOGIA, V35, P735; NAKAMURA A, 1990, AGR BIOL CHEM TOKYO, V54, P1307; Goto M, 2004, TRANSPLANTATION, V78, P1367, DOI 10.1097/01.TP.0000140882.53773.DC; VANWART HE, 1981, ANAL BIOCHEM, V113, P356, DOI 10.1016/0003-2697(81)90089-0; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; Brandhorst H, 2009, TRANSPLANTATION, V87, P370, DOI 10.1097/TP.0b013e31819499f0; Nano R, 2005, DIABETOLOGIA, V48, P906, DOI 10.1007/s00125-005-1725-3; SPARROW LG, 1973, BIOCHIM BIOPHYS ACTA, V302, P90, DOI 10.1016/0005-2744(73)90011-9; Bucher P, 2004, TRANSPLANT P, V36, P1145, DOI 10.1016/j.transproceed.2004.04.024; Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710; Saito Y, 2009, TRANSPL P, V41, P307, DOI 10.1016/j.transproceed.2008.10.080; Balamurugan AN, 2012, TRANSPLANTATION, V93, P693, DOI 10.1097/TP.0b013e318247281b; Matsushita O, 1999, J BACTERIOL, V181, P923; Saito T, 2010, TRANSPL P, V42, P4213, DOI 10.1016/j.transproceed.2010.09.142; Dendo M, 2015, TRANSPLANTATION, V99, P1345, DOI [10.1097/TP.0000000000000662, DOI 10.1097/TP.0000000000000662]; Heinrikson R L, 1977, Methods Enzymol, V47, P175; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Seifter S, 1971, THE ENZYME 3, P649; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Ullmann D, 2004, HDB PROTEOLITIC ENZY, V2, P1317	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	DEC	2015	99	24					10489	10499		10.1007/s00253-015-6923-4		11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CX5AJ	WOS:000365712300011		
J	Yabe, K; Hatabayashi, H; Ikehata, A; Zheng, YZ; Kushiro, M				Yabe, Kimiko; Hatabayashi, Hidemi; Ikehata, Akifumi; Zheng, Yazhi; Kushiro, Masayo			Development of the dichlorvos-ammonia (DV-AM) method for the visual detection of aflatoxigenic fungi	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Visible detection; Dichlorvos; Ammonia vapor; Fungi; Aflatoxin	VERSICONAL HEMIACETAL ACETATE; ASPERGILLUS-PARASITICUS; GENE-CLUSTER; BIOSYNTHESIS; STERIGMATOCYSTIN; ENZYME; FLAVUS; CONTAMINATION; RESISTANCE; POTASSIUM	Aflatoxins (AFs) are carcinogenic and toxic secondary metabolites produced mainly by Aspergillus flavus and Aspergillus parasiticus. To monitor and regulate the AF contamination of crops, a sensitive and precise detection method for these toxigenic fungi in environments is necessary. We herein developed a novel visual detection method, the dichlorvos-ammonia (DV-AM) method, for identifying AF-producing fungi using DV and AM vapor on agar culture plates, in which DV inhibits the esterase in AF biosynthesis, causing the accumulation of anthraquinone precursors (versiconal hemiacetal acetate and versiconol acetate) of AFs in mycelia on the agar plate, followed by a change in the color of the colonies from light yellow to brilliant purple-red by the AM vapor treatment. We also investigated the appropriate culture conditions to increase the color intensity. It should be noted that other species producing the same precursors of AFs such as Aspergillus nidulans and Aspergillus versicolor could be discriminated from the Aspergillus section Flavi based on the differences of their phenotypes. The DV-AM method was also useful for the isolation of nonaflatoxigenic fungi showing no color change, for screening microorganisms that inhibit the AF production by fungi, and for the characterization of the fungi infecting corn kernels. Thus, the DV-AM method can provide a highly sensitive and visible indicator for the detection of aflatoxigenic fungi.	[Yabe, Kimiko; Hatabayashi, Hidemi; Ikehata, Akifumi; Zheng, Yazhi; Kushiro, Masayo] Natl Agr & Food Res Org NARO, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	Yabe, K (reprint author), Fukui Univ Technol, Dept Environm & Food Sci, 3-6-1 Gakuen, Fukui, Fukui 9108505, Japan.	yabek@fukui-ut.ac.jp			Ministry of Agriculture, Forestry and Fisheries, Japan; Gender Equality Program, NARO	This study was funded by the Grant-in-aid, Ministry of Agriculture, Forestry and Fisheries, Japan, and partially supported by the Gender Equality Program, NARO.	BAGGERMAN WI, 1981, EUR J APPL MICROBIOL, V12, P242, DOI 10.1007/BF00499496; Yoshinari T, 2007, MICROBIOL-SGM, V153, P2774, DOI 10.1099/mic.0.2006/005629-0; YABE K, 1991, J GEN MICROBIOL, V137, P2469; YABE K, 1987, APPL ENVIRON MICROB, V53, P230; Luo J, 2014, FOOD MICROBIOL, V44, P142, DOI 10.1016/j.fm.2014.06.004; Yabe K, 2003, APPL ENVIRON MICROB, V69, P66, DOI 10.1128/AEM.69.1.66-73.2003; Song FH, 2014, APPL MICROBIOL BIOT, V98, P3753, DOI 10.1007/s00253-013-5409-5; RABIE CJ, 1976, APPL ENVIRON MICROB, V32, P206; Payne GA, 1998, ANNU REV PHYTOPATHOL, V36, P329, DOI 10.1146/annurev.phyto.36.1.329; Yabe K, 2011, FOOD HYG SAFE SCI, V52, P135; YABE K, 1988, APPL ENVIRON MICROB, V54, P2096; DAVIS ND, 1987, APPL ENVIRON MICROB, V53, P1593; Levin RE, 2012, INT J FOOD MICROBIOL, V156, P1, DOI 10.1016/j.ijfoodmicro.2012.03.001; Abalunan A. J. F., 2013, International Research Journal of Biological Sciences, V2, P51; CAO YW, 1993, PLANT PHYSIOL, V102, P983, DOI 10.1104/pp.102.3.983; Anukul N, 2013, J FOOD DRUG ANAL, V21, P227, DOI 10.1016/j.jfda.2013.07.009; Brown DW, 1996, P NATL ACAD SCI USA, V93, P1418, DOI 10.1073/pnas.93.4.1418; Yabe K, 2012, FUNGAL GENET BIOL, V49, P744, DOI 10.1016/j.fgb.2012.06.011; HSIEH DPH, 1978, APPL ENVIRON MICROB, V35, P980; Yan PS, 2004, APPL ENVIRON MICROB, V70, P7466, DOI 10.1128/AEM.7012.7466-7473.2004; Abbas HK, 2011, TOXIN REV, V30, P59, DOI 10.3109/15569543.2011.591539; Williams JH, 2004, AM J CLIN NUTR, V80, P1106; Yabe K, 2004, APPL MICROBIOL BIOT, V64, P745, DOI 10.1007/s00253-004-1566-x; Yabe K, 2008, FOOD ADDIT CONTAM A, V25, P1111, DOI 10.1080/02652030802403760; Yu JJ, 2012, TOXINS, V4, P1024, DOI 10.3390/toxins4111024; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; PITT JI, 1983, J APPL BACTERIOL, V54, P109, DOI 10.1111/j.1365-2672.1983.tb01307.x; Chang PK, 2004, APPL ENVIRON MICROB, V70, P3593, DOI 10.1128/AEM.70.6.3593-3599.2004; Shima Y, 2009, FUNGAL GENET BIOL, V46, P221, DOI 10.1016/j.fgb.2008.12.005; Reisser C, 2013, G3-GENES GENOM GENET, V3, P733, DOI 10.1534/g3.113.005884; El Khoury A, 2011, J FOOD SCI, V76, pM247, DOI 10.1111/j.1750-3841.2011.02153.x; Abbas HK, 2004, J TOXICOL-TOXIN REV, V23, P295, DOI 10.1081/TXR-200027854; Kelkar HS, 1996, APPL ENVIRON MICROB, V62, P4296; Abbas HK, 2004, CAN J MICROBIOL, V50, P193, DOI 10.1139/W04-006; Carmody WR, 1961, J CHEM EDUC, V38, P559, DOI [10.1021/ed038p559, DOI 10.1021/ED038P559]; Cole RJ, 1990, PERSPECTIVE AFLATOXI, P62; Cotty P J, 2006, Mycotoxin Res, V22, P110, DOI 10.1007/BF02956774; Do Jin Hwan, 2007, Biotechnology and Bioprocess Engineering, V12, P585; Fente CA, 2001, APPL ENVIRON MICROB, DOI [10.1128/AEM.67.10.4858, DOI 10.1128/AEM.67.10.4858]; Gowda NKS, 2004, EFFECT SOME CHEM NAD, P281; Grace D, 2013, ROLE RISK ASSESSMENT; Hess DC, 2006, PLOS BIOL, V4, P2012, DOI 10.1371/journal.pbio.0040351; Lizarraga-Paulin EG, 2010, AFLATOXINS THEIR IMP, P1; Mostafa A, 2012, RES J RECENT SCI, V1, P90; Rajani P., 2012, International Journal of Chemical, Environmental and Pharmaceutical Research, V3, P83; Saito Michihiko, 1999, Mycoscience, V40, P205, DOI 10.1007/BF02464300; SPROTT GD, 1984, J BIOL CHEM, V259, P2602; Wacoo AP, 2014, J APPL CHEM-USSR, V2014, P1	48	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	DEC	2015	99	24					10681	10694		10.1007/s00253-015-6924-3		14	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CX5AJ	WOS:000365712300026		
J	Kanazawa, S; Kuwamura, K; Kihara, Y; Hirukawa, Y; Saiki, T				Kanazawa, Shohei; Kuwamura, Kenta; Kihara, Yuya; Hirukawa, Yusuke; Saiki, Toshiharu			Computations with near-field coupled plasmon particles interacting with phase-change materials	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							CHANGE MEMORY; DEVICES	The computing functionality emerging from spatial correlations due to near-field interactions between local processing and memory elements is discussed. In particular, we investigate the possibility of solving a problem analogous to the spin-glass problem by using a coupled dipole system, in which the individual coupling strengths can be modified to optimize the system so that the exact solution can be easily reached. For this algorithm, we propose an implementation based on a coupled plasmon-particle system interacting with a phase-change material; this system exhibits threshold behavior and plasticity to provide processing and memory functions, respectively.	[Kanazawa, Shohei; Kuwamura, Kenta; Kihara, Yuya; Hirukawa, Yusuke; Saiki, Toshiharu] Keio Univ, Grad Sch Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Saiki, T (reprint author), Keio Univ, Grad Sch Sci & Technol, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	saiki@elec.keio.ac.jp			JSPS KAKENHI [24226006]; Core-to-Core Program, Advanced Research Networks; Advanced Photon Science Alliance Project of Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This research was supported by JSPS KAKENHI Grant Number 24226006 and the Core-to-Core Program, Advanced Research Networks, and partially by the Advanced Photon Science Alliance Project of the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Kuzum D, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/38/382001; Di Ventra M, 2013, NAT PHYS, V9, P200, DOI 10.1038/nphys2566; Wright CD, 2013, ADV FUNCT MATER, V23, P2248, DOI 10.1002/adfm.201202383; Hira T, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4906037; Linn E, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/30/305205; Hasegawa T, 2012, ADV MATER, V24, P252, DOI 10.1002/adma.201102597; Cassinerio M, 2013, ADV MATER, V25, P5975, DOI 10.1002/adma.201301940; Hira T, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4841975; Wuttig M, 2007, NAT MATER, V6, P824, DOI 10.1038/nmat2009; Wright CD, 2011, ADV MATER, V23, P3408, DOI 10.1002/adma.201101060; Brongersma M.L., 2000, PHYS REV B, V62, P356; Hira T., 2015, ADV OPT TECHNOL, V2015; Kim SJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02370; Lee TH, 2014, ADV MATER, V26, P7493, DOI 10.1002/adma.201402696; Li Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01619; Negro Luca Dal, 2007, Optics Express, V15, DOI 10.1364/OE.15.014396; Nishimori H, 2001, STAT PHYS SPIN GLASS	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	DEC	2015	121	4					1323	1327		10.1007/s00339-015-9338-2		5	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CX5DT	WOS:000365722800001		
J	Sato, Y; Kanazawa, S; Yamamura, A; Kuwahara, M; Regreny, P; Gendry, M; Saiki, T				Sato, Yu; Kanazawa, Shohei; Yamamura, Ariyoshi; Kuwahara, Masashi; Regreny, Philippe; Gendry, Michel; Saiki, Toshiharu			Tuning of emission energy of single quantum dots using phase-change mask for resonant control of their interactions	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							FIELD	We demonstrated tuning of the emission energy of semiconductor quantum dots (QDs) in order to control the resonant interaction between the QDs. In this approach, a thin layer of phase-change material in a crystalline phase is deposited on QDs and a local strain is applied through amorphization, resulting in a volume expansion, forming an indenter, which induces an energy shift of the QDs. We successfully tuned the emission energies of two closely located QDs to the same energy by controlling the direction and magnitude of the peak shift through the precise adjustment of the position and size of an indenter.	[Sato, Yu; Kanazawa, Shohei; Yamamura, Ariyoshi; Saiki, Toshiharu] Keio Univ, Grad Sch Sci & Technol, Yokohama, Kanagawa 2238522, Japan; [Kuwahara, Masashi] Natl Inst Adv Ind Sci & Technol, Elect & Photon Res Inst, Tsukuba, Ibaraki 3058562, Japan; [Regreny, Philippe; Gendry, Michel] Ecole Cent Lyon, Inst Nanotechnol Lyon, F-69134 Ecully, France	Saiki, T (reprint author), Keio Univ, Grad Sch Sci & Technol, Yokohama, Kanagawa 2238522, Japan.	saiki@elec.keio.ac.jp			JSPS KAKENHI [24226006]; Core-to-Core Program, Advanced Research Networks; Advanced Photon Science Alliance Project of Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This research was supported by JSPS KAKENHI Grant Number 24226006 and the Core-to-Core Program, Advanced Research Networks, and partially by the Advanced Photon Science Alliance Project of the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Robinson HD, 1998, APPL PHYS LETT, V72, P2081, DOI 10.1063/1.121282; Kubota R, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.041201; Trotta R, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.150502; Seidl S, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2204843; Liu C, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021048; Bose R, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3571446; Finley JJ, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.161305; Scheibner M, 2007, NAT PHYS, V3, P106, DOI 10.1038/nphys494; Sun S, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824712; PRIESTER C, 1988, PHYS REV B, V37, P8519, DOI 10.1103/PhysRevB.37.8519; Humam NSB, 2014, OPT EXPRESS, V22, P14830, DOI 10.1364/OE.22.014830; Mintairov AM, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.155306; Abdussalam W, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.125307; Zallo E, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.241303; Kuklewicz CE, 2012, NANO LETT, V12, P3761, DOI 10.1021/nl301621u; Reitzenstein S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.127401; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Sangouard N, 2011, REV MOD PHYS, V83, P33, DOI 10.1103/RevModPhys.83.33; Takahashi M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4795291; Pustovit VN, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.077401; Tsumori N, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3683537; Skold N, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.016804; Kim H, 2011, OPT EXPRESS, V19, P2589, DOI 10.1364/OE.19.002589; Englund D, 2007, NATURE, V450, P857, DOI 10.1038/nature06234; Kim SJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02370; Kremer PE, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.201408	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	DEC	2015	121	4					1329	1333		10.1007/s00339-015-9339-1		5	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CX5DT	WOS:000365722800002		
J	Nagumo, R; Brandenburg, F; Ermakova, A; Jelezko, F; Yatsui, T				Nagumo, R.; Brandenburg, F.; Ermakova, A.; Jelezko, F.; Yatsui, T.			Spectral control of nanodiamond using dressed photon-phonon etching	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							FLUORESCENT NANODIAMONDS; ROOM-TEMPERATURE; DIAMOND; SURFACE; LUMINESCENCE; SPECTROSCOPY; CENTERS; STATE	The luminescence of a nitrogen-vacancy (NV) center in a nanodiamond (ND) is of great interest because of its features, especially in the field of nanophotonics. When an NV center in an ND is located in the vicinity of the surface, the emission is often disturbed by any surface defects, resulting in non-radiative recombination. In this work, we performed dressed photon-phonon (DPP) etching of the NDs, and found that the size of the NDs decreased, while the cathodoluminescence (CL) intensity increased. We assume that this increase in the CL intensity originates from the removal of the surface protrusions and/or defects by DPP etching.	[Nagumo, R.; Brandenburg, F.; Yatsui, T.] Univ Tokyo, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Ermakova, A.; Jelezko, F.] Univ Ulm, Inst Quantum Opt, D-89081 Ulm, Germany; [Ermakova, A.; Jelezko, F.] Univ Ulm, Ctr IQST, D-89081 Ulm, Germany	Yatsui, T (reprint author), Univ Tokyo, Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	yatsui@ee.t.u-tokyo.ac.jp	Yatsui, Takashi/C-5956-2008		Asahi Glass Foundation [26286022, 26630122]; Nanotechnology Platform of MEXT [12024046]; CNR/JSPS; Core-to-Core Program of JSPS (A. Advanced Research Networks)	This work was partially supported by a research grant (Basic Research) from The Asahi Glass Foundation, a Grant-in-Aid for Scientific Research (B) (No. 26286022), the Exploratory Research Program (No. 26630122), Nanotechnology Platform (No. 12024046) of MEXT, bilateral joint research projects of CNR/JSPS, and Core-to-Core Program of JSPS (A. Advanced Research Networks).	BURCHARD B, 1994, DIAM RELAT MATER, V3, P947, DOI 10.1016/0925-9635(94)90306-9; KOCH F, 1993, J LUMIN, V57, P271, DOI 10.1016/0022-2313(93)90145-D; Gruber A, 1997, SCIENCE, V276, P2012, DOI 10.1126/science.276.5321.2012; KEILIN D, 1950, NATURE, V165, P543, DOI 10.1038/165543a0; Nomura W, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1920419; Mizuochi N, 2012, NAT PHOTONICS, V6, P299, DOI [10.1038/nphoton.2012.75, 10.1038/NPHOTON.2012.75]; Fu CC, 2007, P NATL ACAD SCI USA, V104, P727, DOI 10.1073/pnas.0605409104; Yatsui T, 2008, APPL PHYS B-LASERS O, V93, P55, DOI 10.1007/s00340-008-3142-z; VAVILOV VS, 1980, SOV PHYS SEMICOND+, V14, P1078; COLLINS AT, 1990, J MATER RES, V5, P2507, DOI 10.1557/JMR.1990.2507; COLLINS AT, 1992, DIAM RELAT MATER, V1, P457, DOI 10.1016/0925-9635(92)90146-F; Norberg NS, 2005, J PHYS CHEM B, V109, P20810, DOI 10.1021/jp0535285; Yatsui T, 2014, PHYS STATUS SOLIDI A, V211, P2339, DOI 10.1002/pssa.201431161; Cai JM, 2013, NAT PHYS, V9, P168; Bradac C, 2013, SMALL, V9, P132, DOI 10.1002/smll.201200574; Hui YY, 2010, OPT EXPRESS, V18, P5896, DOI 10.1364/OE.18.005896; Sailor MJ, 1997, ADV MATER, V9, P783, DOI 10.1002/adma.19970091004; Muller C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5703; Ohtsu M, 2012, NANOPHOTONICS-BERLIN, V1, P83, DOI 10.1515/nanoph-2011-0001	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	DEC	2015	121	4					1335	1339		10.1007/s00339-015-9400-0		5	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CX5DT	WOS:000365722800003		
J	Nomura, S; Mamyouda, S; Ito, H; Shibata, Y; Ohira, T; Yoshikawa, L; Ootuka, Y; Kashiwaya, S; Yamaguchi, M; Tamura, H; Akazaki, T				Nomura, Shintaro; Mamyouda, Syuhei; Ito, Hironori; Shibata, Yusuke; Ohira, Tomoya; Yoshikawa, Luno; Ootuka, Youiti; Kashiwaya, Satoshi; Yamaguchi, Masumi; Tamura, Hiroyuki; Akazaki, Tatsushi			Circularly polarized near-field scanning optical microscope for investigations of edge states of a two-dimensional electron system	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							SPECTROSCOPY; CHANNELS; DOTS	We report on investigations of the quantum Hall chiral edge states using a near-field scanning optical microscope that enables us to irradiate circularly polarized light from the probe tip with spatial resolution below the diffraction limit. We have found a clear evidence for the formation of spin-split incompressible strips near the edge of a two-dimensional electron system in high magnetic fields.	[Nomura, Shintaro; Mamyouda, Syuhei; Ito, Hironori; Shibata, Yusuke; Ohira, Tomoya; Yoshikawa, Luno; Ootuka, Youiti] Univ Tsukuba, Div Phys, Tsukuba, Ibaraki 3058571, Japan; [Kashiwaya, Satoshi] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Yamaguchi, Masumi; Tamura, Hiroyuki; Akazaki, Tatsushi] NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan	Nomura, S (reprint author), Univ Tsukuba, Div Phys, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058571, Japan.	nomura.shintaro.ge@u.tsukuba.ac.jp			Kakenhi [22103002, 26610079, 25103704, 15H03673, 15H05853]	This work was partly supported by Kakenhi Nos. 22103002, 25103704, 26610079, 15H03673, 15H05853.	Cruz JL, 1996, APPL OPTICS, V35, P922, DOI 10.1364/AO.35.000922; Ihnatsenka S, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.155314; HAROOTUNIAN A, 1986, APPL PHYS LETT, V49, P674, DOI 10.1063/1.97565; STOOF TH, 1995, PHYS REV B, V52, P12143, DOI 10.1103/PhysRevB.52.12143; Saiki T, 1998, JPN J APPL PHYS 1, V37, P1638, DOI 10.1143/JJAP.37.1638; Shashkin AA, 1997, PHYS REV LETT, V79, P5114, DOI 10.1103/PhysRevLett.79.5114; POHL DW, 1984, APPL PHYS LETT, V44, P651, DOI 10.1063/1.94865; MANOLESCU A, 1995, PHYS REV B, V51, P1703, DOI 10.1103/PhysRevB.51.1703; Mamyouda S, 2015, NANO LETT, V15, P2417, DOI 10.1021/nl504767w; Nomura S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.096803; Eytan G, 1998, PHYS REV LETT, V81, P1666, DOI 10.1103/PhysRevLett.81.1666; Matsuda K, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.177401; CHKLOVSKII DB, 1992, PHYS REV B, V46, P4026, DOI 10.1103/PhysRevB.46.4026; Vurgaftman I, 2001, J APPL PHYS, V89, P5815, DOI 10.1063/1.1368156; Nomura S, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.085318; Ito H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.256803; Saiki T, 1996, APPL PHYS LETT, V68, P2612, DOI 10.1063/1.116198; LIER K, 1994, PHYS REV B, V50, P7757, DOI 10.1103/PhysRevB.50.7757; Fornberg B., 1994, ACTA NUMERICA, P203; Giuliani G., 2005, QUANTUM THEORY ELECT	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	DEC	2015	121	4					1341	1345		10.1007/s00339-015-9420-9		5	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CX5DT	WOS:000365722800004		
J	Yamaguchi, K; Fujii, M				Yamaguchi, Kenzo; Fujii, Masamitsu			Electrically controlled infrared optical transmission and reflection through metallic grating using NEMS technology	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							METAMATERIAL; ARRAYS	The enhanced optical properties of metallic subwavelength gratings with very narrow slits have recently been extensively studied in the field of plasmonics. The optical transmission and reflection of such nanostructures, which act as nano-electro-mechanical systems (NEMS) actuators, can be electrically controlled by varying their geometrical parameters, giving them great flexibility for numerous applications in photonics, opto-electronics, and sensing. The previous challenges in controlling the optical properties were overcome by forming a metallic subwavelength grating with an NEMS actuator in mid-air, allowing the grating to be physically moved with the bias voltage. The device can shift the plasmon resonance wavelength with an electrical signal. The resonance wavelength for Wood's anomaly at the infrared region is predicted through simulations to shift by approximately 150 nm. We discuss the effect of polarization on the optical properties and grating mechanism. The reported effect may be used to achieve active spectral tuning and switching in a wide range of applications.	[Yamaguchi, Kenzo] Kagawa Univ, Fac Engn, Dept Adv Mat Sci, Takamatsu, Kagawa 7610396, Japan; [Fujii, Masamitsu] Toba Natl Coll Maritime Technol, Dept Elect & Mech, Toba, Mie 5178501, Japan	Yamaguchi, K (reprint author), Kagawa Univ, Fac Engn, Dept Adv Mat Sci, 2217-20 Hayashi Cho, Takamatsu, Kagawa 7610396, Japan.	kenzo@eng.kagawa-u.ac.jp			JSPS KAKENHI [15H03546, 15K13977]	This work was supported by JSPS KAKENHI Grant Numbers 15H03546 and 15K13977.	Dennis BS, 2015, NAT PHOTONICS, V9, P267, DOI [10.1038/nphoton.2015.40, 10.1038/NPHOTON.2015.40]; Dickson W, 2008, NANO LETT, V8, P281, DOI 10.1021/nl072613g; Wood RW, 1935, PHYS REV, V48, P928, DOI 10.1103/PhysRev.48.928; STEWART JE, 1962, APPL OPTICS, V1, P421, DOI 10.1364/AO.1.000421; Honma H, 2014, MICRO NANO LETT, V9, P891, DOI 10.1049/mnl.2014.0423; Rakic AD, 1998, APPL OPTICS, V37, P5271, DOI 10.1364/AO.37.005271; Yamaguchi K, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.012201; Itoh T, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3146788; Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Yamamoto YS, 2014, J PHOTOCH PHOTOBIO C, V21, P81, DOI 10.1016/j.jphotochemrev.2014.10.001; Liu HT, 2008, NATURE, V452, P728, DOI 10.1038/nature06762; Ou JY, 2013, NAT NANOTECHNOL, V8, P252, DOI 10.1038/nnano.2013.25; Palik E.D., 1985, HDB OPTICAL CONSTANT, V1, P771; Taflove A., 1995, COMPUTATIONAL ELECTR; Valente J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8021; Zhu WM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2285	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	DEC	2015	121	4					1353	1357		10.1007/s00339-015-9422-7		5	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CX5DT	WOS:000365722800006		
J	Mori, T; Tanaka, Y; Suzaki, Y; Yamaguchi, K				Mori, T.; Tanaka, Y.; Suzaki, Y.; Yamaguchi, K.			Fabrication of silver thin film for single-crystalline nanopillar: effects of thickness and grain size	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							WAVE-GUIDE; PLASMONICS; OPTICS	A single-crystalline metallic nanostructure with a controlled crystallographic texture is expected to reduce optical losses. We have attempted to fabricate a single-crystalline metallic nanostructure using a physical technique only. The grain growth mechanism in silver films deposited on a highly transparent SiO2 substrate was elucidated by electron backscatter diffraction (EBSD) methods with nanoscale resolution. EBSD analysis suggested that the silver films deposited on SiO2 at lower thicknesses have a strong (111) texture. Additionally, we performed a grain size analysis using the EBSD crystal orientation map. When the film thickness increased from 154 to 1017 nm, most of the grains grew to a size of approximately 800 nm. Moreover, we successfully fabricated a conical nanopillar (undersurface diameter 450 nm) in a (111)-oriented large growing grain at the film thickness of 1017 nm by focused ion beam milling. A single-crystalline silver nanopillar was directly fabricated in controlled silver films using only physical processing.	[Mori, T.; Tanaka, Y.; Suzaki, Y.; Yamaguchi, K.] Kagawa Univ, Fac Engn, Dept Adv Mat Sci, Takamatsu, Kagawa 7610396, Japan; [Mori, T.] Ind Technol Ctr Wakayama Prefecture, Wakayama, Wakayama 6496261, Japan	Mori, T (reprint author), Kagawa Univ, Fac Engn, Dept Adv Mat Sci, Hayashicho 2217-20, Takamatsu, Kagawa 7610396, Japan.	tomohiro_mori@wakayama-kg.jp			JSPS KAKENHI [15H03546, 15K13977]	This work was supported by JSPS KAKENHI Grant Numbers 15H03546 and 15K13977.	Yu NF, 2007, OPT EXPRESS, V15, P13272, DOI 10.1364/OE.15.013272; West PR, 2010, LASER PHOTONICS REV, V4, P795, DOI 10.1002/lpor.200900055; BIALAS H, 1994, VACUUM, V45, P79, DOI 10.1016/0042-207X(94)90346-8; Park JH, 2012, ADV MATER, V24, P3988, DOI 10.1002/adma.201200812; BASKI AA, 1994, SURF SCI, V313, P275, DOI 10.1016/0039-6028(94)90048-5; Kern AM, 2011, NANO LETT, V11, P482, DOI 10.1021/nl1032588; Barna PB, 1998, THIN SOLID FILMS, V317, P27, DOI 10.1016/S0040-6090(97)00503-8; Liu N, 2011, NAT MATER, V10, P631, DOI [10.1038/nmat3029, 10.1038/NMAT3029]; VAIDYA S, 1981, THIN SOLID FILMS, V75, P253, DOI 10.1016/0040-6090(81)90404-1; THORNTON JA, 1974, J VAC SCI TECHNOL, V11, P666, DOI 10.1116/1.1312732; Hostetler JL, 1999, APPL OPTICS, V38, P3614, DOI 10.1364/AO.38.003614; Kollmann H, 2014, NANO LETT, V14, P4778, DOI 10.1021/nl5019589; Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Oulton RF, 2008, NAT PHOTONICS, V2, P496, DOI 10.1038/nphoton.2008.131; Choo H, 2012, NAT PHOTONICS, V6, P837, DOI 10.1038/NPHOTON.2012.277; Huang JS, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1143; Petrov I., 2003, J VAC SCI TECHNOL A, V21, P117, DOI DOI 10.1116/1.1601610; Yamaguchi K., 2007, J MICROSC-OXFORD, V229, P545; Zhao H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01511	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	DEC	2015	121	4					1359	1363		10.1007/s00339-015-9497-1		5	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CX5DT	WOS:000365722800007		
J	Mononobe, S				Mononobe, Shuji			Fabrication of a double-tapered probe with enhanced aspect ratio for near-field scanning optical microscopy	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							FIBER PROBE	A double-tapered probe has widely been used for high-throughput NSOM, which has an infrared cutoff wavelength of around 0.8 mu m. Some researchers often need a single-mode fiber probe with a visible wavelength cutoff for polarization-modulation NSOM and related techniques. Improvement in the aspect ratio of the probe is the most important issue to be addressed for apertured NSOM applications. This paper proposes a new NSOM fiber and a double-tapered probe with the protruding clad and single-mode waveguide. The fiber consists of Ge-SiO2 core, SiO2 clad, and F-SiO2 support and has a cutoff wavelength of 0.47 mu m. The doping ratio profiles of Cl and F must be carefully controlled while fabricating the fiber preform rod. Furthermore, the double-tapered probe is optimized for the aspect ratio on the basis of geometric consideration. To fabricate the proposed probe, the new single-mode fiber was tapered by immersing it in buffered HF solutions. Owing to the protruding clad, the fabricated probe has an aspect ratio of 0.24. The aspect ratio is 1.8 times as high as the fabricated previous probe.	[Mononobe, Shuji] Toyo Univ, Kawagoe, Saitama 3508585, Japan	Mononobe, S (reprint author), Toyo Univ, 2100 Kujirai, Kawagoe, Saitama 3508585, Japan.	mononobe@toyo.jp					Maruyama K, 2006, ANAL CHEM, V78, P1904, DOI 10.1021/ac0502549; Nakamura H, 2001, J MICROSC-OXFORD, V202, P50, DOI 10.1046/j.1365-2818.2001.00804.x; Burgos P, 2003, J MICROSC-OXFORD, V211, P37, DOI 10.1046/j.1365-2818.2003.01197.x; Yatsui T, 1997, APPL PHYS LETT, V71, P1756, DOI 10.1063/1.119390; Qin J, 2007, CHINESE PHYS LETT, V24, P2906, DOI 10.1088/0256-307X/24/10/054; Izawa T., 1986, OPTICAL FIBERS MAT F; Mononobe S., 2013, HDB NANOOPTICS NANOP, P281; Ohtsu M., 2003, NEAR FIELD NANOATOM; Sakai M., 2014, JPN J APPL PHYS, V53	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	DEC	2015	121	4					1365	1368		10.1007/s00339-015-9499-z		4	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CX5DT	WOS:000365722800008		
J	Tamura, M; Iida, T				Tamura, Mamoru; Iida, Takuya			Three-dimensional nano-optical assembly of antenna structures with collective near-field coupling	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							NANOPARTICLES; ARRAYS; LITHOGRAPHY	Metallic nanostructures are used for various applications because of their characteristic optical responses that generate strong near-fields. We have theoretically clarified that the configuration of nanoparticles (NPs) and their optical properties can be controlled by optical manipulation. In this study, we greatly improved our previously reported simulation method, and this improvement enables investigation of the stable states of optically trapped NPs in a three-dimensional system. On the basis of this method, the assembly process of rod-shaped silver NPs is concisely clarified, where NPs of a specific shape are selectively assembled even in a mixture of NPs of different shapes. In particular, our simulation method clarifies how a light-induced force drives assembly processes, which is an important subject to consider for extending the degree of freedom of an optical manipulation. Furthermore, as reported in our previous studies, an assembled structure inherits the properties of light used for the optical trapping; e.g., rod-shaped silver NPs are radially connected to each other and assembled into a ring-shaped structure under the irradiation of a radially polarized vector beam with a ring-shaped intensity distribution. The assembled structure is an artificial light-harvesting antenna because it theoretically exhibits an enhancement of near-field and extinction in a broader wavelength range than that of the original NPs composing the antenna and also a response to the non-polarized light such as the sunlight. On the basis of an optically manipulated configuration of NPs and their optical properties, we discuss the selective optical assembly in a three-dimensional simulation.	[Tamura, Mamoru; Iida, Takuya] Osaka Prefecture Univ, Grad Sch Sci, Dept Phys Sci, Osaka 5998531, Japan; [Tamura, Mamoru] Osaka Prefecture Univ, Grad Sch Engn, Dept Phys & Elect, Osaka 5998531, Japan	Tamura, M (reprint author), Osaka Prefecture Univ, Grad Sch Sci, Dept Phys Sci, Osaka 5998531, Japan.	m-tamura@pe.osakafu-u.ac.jp; t-iida@p.s.osakafu-u.ac.jp			JSPS [14J08760, 26286029, 26610089]; JST-SENTAN; Nakatani Foundation; Canon Foundation	The authors thank Prof. S. Ito and Prof. S. Tokonami for their helpful discussions from the experimental viewpoints. We also thank Prof. H. Ishihara for his encouragement and support. This work was supported in part by a Grant-in-Aid for JSPS Fellows (No. 14J08760), a Grant-in-Aid for Scientific Research (B) No. 26286029 from the JSPS, and Grants-in-Aid for Exploratory Research No. 26610089 from JSPS, JST-SENTAN, the Nakatani Foundation, and the Canon Foundation.	Iida T, 2012, J PHYS CHEM LETT, V3, P332, DOI 10.1021/jz2014924; Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Kim T, 2005, LANGMUIR, V21, P9524, DOI 10.1021/la0504560; Tokonami S, 2012, ANAL CHIM ACTA, V716, P76, DOI 10.1016/j.aca.2011.12.025; Iida T, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.245319; Engheta N, 2007, SCIENCE, V317, P1698, DOI 10.1126/science.1133268; Zhong Y, 2014, ACS NANO, V8, P827, DOI 10.1021/nn405492d; Belousov S, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.174201; Edel JB, 2013, ACS NANO, V7, P9526, DOI 10.1021/nn405712r; Stamplecoskie KG, 2011, J PHYS CHEM C, V115, P1403, DOI 10.1021/jp106666t; Wang JJ, 2014, ACS APPL MATER INTER, V6, P9207, DOI 10.1021/am501326w; Tamura M, 2012, NANO LETT, V12, P5337, DOI 10.1021/nl302716c; Rajendran A, 2011, ACS NANO, V5, P665, DOI 10.1021/nn1031627; Tamura M, 2014, RES CHEM INTERMEDIAT, V40, P2303, DOI 10.1007/s11164-014-1607-8; Vazquez-Mena O, 2011, ACS NANO, V5, P844, DOI 10.1021/nn1019253; Chen S, 2013, ACS NANO, V7, P8824, DOI 10.1021/nn403287a; Mahmoud MA, 2013, J PHYS CHEM LETT, V4, P1541, DOI 10.1021/jz4005015; Nehl CL, 2006, NANO LETT, V6, P683, DOI 10.1021/nl052409y; Boltasseva A., 2008, METAMATERIALS, V2, P1, DOI DOI 10.1016/J.METAMAT.2008.03.004; Ito S, 2013, SCI REP-UK, V3, DOI 10.1038/srep03047	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	DEC	2015	121	4					1369	1375		10.1007/s00339-015-9511-7		7	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CX5DT	WOS:000365722800009		
J	Tanaka, H; Kawazoe, T; Ohtsu, M; Akahane, K; Yamamoto, N				Tanaka, H.; Kawazoe, T.; Ohtsu, M.; Akahane, K.; Yamamoto, N.			Evaluation of optical amplification properties using dressed photons in a silicon waveguide	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							STIMULATED-EMISSION; LASER; GAIN; INJECTION	We fabricated an optical waveguide having a high optical confinement effect using a silicon-on-insulator substrate, and we eliminated the difficulty involved with optical alignment for making laser light pass through a p-n homojunction that is transparent to infrared light. Laser light was introduced via one of the cleaved edges of the optical waveguide and was guided to the transparent p-n homojunction, and the power of the light emitted from the other edge was measured. As a result, we successfully evaluated the optical amplification properties with high precision. For light with a wavelength of 1.31 A mu m, we obtained a differential gain coefficient of g = 2.6 x 10(-2) cm/A, a transparency current density of J (tr) = 1 mA/cm(2), and a saturation optical power density of P (sat) = 30 kW/cm(2). The observation of gain saturation due to the incident optical power shows that this measurement method was suitable for evaluating the optical amplification properties.	[Tanaka, H.; Kawazoe, T.; Ohtsu, M.] Univ Tokyo, Grad Sch Engn, Dept Elect Engn & Informat Syst, Bunkyo Ku, Tokyo 1138656, Japan; [Kawazoe, T.; Ohtsu, M.] Specified Nonprofit Corp Nanophoton Engn Org, Bunkyo Ku, Tokyo 1120014, Japan; [Ohtsu, M.] Univ Tokyo, Grad Sch Engn, Int Ctr Nano Elect & Photon Technol, Bunkyo Ku, Tokyo 1138656, Japan; [Akahane, K.; Yamamoto, N.] Natl Inst Informat & Commun Technol, Koganei, Tokyo 1848795, Japan	Tanaka, H (reprint author), Univ Tokyo, Grad Sch Engn, Dept Elect Engn & Informat Syst, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1138656, Japan.	tanaka@nanophotonics.t.u-tokyo.ac.jp			JSPS [25 905]; JSPS Core-to-Core Program, A. Advanced Research Networks	This research was supported in part by Grant-in-Aid for JSPS Fellows Number 25 905 and the JSPS Core-to-Core Program, A. Advanced Research Networks. This research was performed in part by the Advanced ICT Research Institute of NICT.	Altukhov IV, 2001, APPL PHYS LETT, V79, P3909, DOI 10.1063/1.1423771; Rong HS, 2005, NATURE, V433, P725, DOI 10.1038/nature03346; Kawazoe T, 2012, APPL PHYS B-LASERS O, V107, P659, DOI 10.1007/s00340-012-5053-2; Claps R, 2002, ELECTRON LETT, V38, P1352, DOI 10.1049/el:20020931; Pleumeekers JL, 2002, IEEE PHOTONIC TECH L, V14, P12, DOI 10.1109/68.974145; Espinola RL, 2004, OPT EXPRESS, V12, P3713, DOI 10.1364/OPEX.12.003713; Takahashi Y, 2013, NATURE, V498, P470, DOI 10.1038/nature12237; Cloutier SG, 2005, NAT MATER, V4, P887, DOI 10.1038/nmat1530; Tanaka H, 2012, APPL PHYS B-LASERS O, V108, P51, DOI 10.1007/s00340-012-5077-7; Kazi ZI, 1999, IEEE PHOTONIC TECH L, V11, P1563, DOI 10.1109/68.806847; Chen MJ, 2004, APPL PHYS LETT, V84, P2163, DOI 10.1063/1.1687458; Di Liang, 2010, Nature Photonics, V4, DOI 10.1038/NPHOTON.2010.167; GREEN MA, 1995, PROG PHOTOVOLTAICS, V3, P189, DOI 10.1002/pip.4670030303; Kawazoe T, 2011, APPL PHYS B-LASERS O, V104, P747, DOI 10.1007/s00340-011-4596-y; Ohtsu M., 2013, DRESSED PHOTONS CONC; Tanaka H., 2015, FLUORESC MAT, DOI [10.1515/fma-2015-0001, DOI 10.1515/FMA-2015-0001]	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	DEC	2015	121	4					1377	1381		10.1007/s00339-015-9419-2		5	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CX5DT	WOS:000365722800010		
J	Tate, N; Naruse, M; Matsumoto, T; Hoga, M; Ohyagi, Y; Nishio, S; Nomura, W; Ohtsu, M				Tate, Naoya; Naruse, Makoto; Matsumoto, Tsutomu; Hoga, Morihisa; Ohyagi, Yasuyuki; Nishio, Shumpei; Nomura, Wataru; Ohtsu, Motoichi			Non-scanning optical near-field microscopy for nanophotonic security	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							SIGNAL RECONSTRUCTION; INFORMATION	We propose a novel method for observing and utilizing nanometrically fluctuating signals due to optical near-field interactions between a probe and target in near-field optical microscopy. Based on a hierarchical structure of the interactions, it is possible to obtain signals that represent two-dimensional spatial patterns without requiring any scanning process. Such signals reveal individual features of each target, and these features, when appropriately extracted and defined, can be used in security applications-an approach that we call nanophotonic security. As an experimental demonstration, output signals due to interactions between a SiO2 probe and Al nanorods were observed by using near-field optical microscopy at a single readout point, and these signals were quantitatively evaluated using an algorithm that we developed for extracting and defining features that can be used for security applications.	[Tate, Naoya; Nomura, Wataru] Kyushu Univ, Fac Informat Sci & Elect Engn, Nishi Ku, Fukuoka 8190395, Japan; [Naruse, Makoto] Natl Inst Informat & Commun Technol, Photon Network Res Inst, Koganei, Tokyo 1848795, Japan; [Matsumoto, Tsutomu] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan; [Hoga, Morihisa; Ohyagi, Yasuyuki; Nishio, Shumpei] Dai Nippon Printing Co Ltd, Kashiwa, Chiba 2770871, Japan; [Ohtsu, Motoichi] Univ Tokyo, Dept Elect Engn & Informat Syst, Bunkyo Ku, Tokyo 1138656, Japan	Tate, N (reprint author), Kyushu Univ, Fac Informat Sci & Elect Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	tate@ed.kyushu-u.ac.jp			JSPS Core-to-Core Program (A. Advanced Research Networks)	The authors wish to thank Y. Pihosh, K. Mawatari, and T. Kitamori in the Department of Applied Chemistry at The University of Tokyo for their technical assistance in preparing the Al nanorods used for our experimental demonstrations. This work was partially supported by the JSPS Core-to-Core Program (A. Advanced Research Networks).	Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Buchanan JDR, 2005, NATURE, V436, P475, DOI 10.1038/436475a; Lim D, 2005, IEEE T VLSI SYST, V13, P1200, DOI 10.1109/TVLSI.2005.859470; Tanaka Y, 2007, PHYSICA E, V40, P297, DOI 10.1016/j.physe.2007.06.045; Pappu R, 2002, SCIENCE, V297, P2026, DOI 10.1126/science.1074376; Naruse M, 2009, J OPT SOC AM B, V26, P1772, DOI 10.1364/JOSAB.26.001772; Haupt J, 2006, IEEE T INFORM THEORY, V52, P4036, DOI 10.1109/TIT.2006.880031; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Smith SM, 1997, INT J COMPUT VISION, V23, P45, DOI 10.1023/A:1007963824710; DeJean G, 2007, LECT NOTES COMPUT SC, V4727, P346; Harris C., 1988, ALV VIS C, P147, DOI DOI 10.5244/C.2.23; Ikeda T., 2009, 3 INT C ANT SEC ID C, P382; Kobayashi K, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.013806; Matsumoto H., 2003, IPSJ J, V44, P1991; Matsumoto T., 1997, P IEICE S CRYPT INF; Ohtsu M., 2004, OPTICAL NEAR FIELDS; Ohtsu M., 2013, DRESSED PHOTONS CONC; Pihosh Y., 2009, ECS T, V16, P49; Rosten E., 2006, EUR C COMP VIS, V1, P430, DOI DOI 10.1007/11744023_; van Renesse R. L., 1994, OPTICAL DOCUMENT SEC; Yamakoshi M., 2008, P SPIE, V6819	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	DEC	2015	121	4					1383	1387		10.1007/s00339-015-9387-6		5	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CX5DT	WOS:000365722800011		
J	Yamaguchi, M; Kawazoe, T; Yatsui, T; Ohtsu, M				Yamaguchi, M.; Kawazoe, T.; Yatsui, T.; Ohtsu, M.			Spectral properties of a lateral p-n homojunction-structured visible silicon light-emitting diode fabricated by dressed-photon-phonon-assisted annealing	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							OPTICAL NEAR-FIELD; CRYSTALLINE SILICON; EMISSION	We developed a visible silicon light-emitting diode (Si-LED) with a lateral p-n homojunction using dressed-photon-phonon (DPP)-assisted annealing. The lateral p-n homojunction was fabricated in order to decrease the absorption loss inherent in light emission with a photon energy higher than the band-gap energy of the material. The fabricated Si-LED emitted light in the entire visible range, including the three primary colors. The light extraction efficiency of the Si-LED was estimated to be 7.8 times higher than that of a conventional LED structure with a vertical p-n homojunction. Owing to the efficient light extraction, we clearly observed two novel features in the electroluminescence (EL) spectrum: a nonlinear increase in the EL intensity with the injected forward current, and an emission peak at 2.7 eV, at which there is no singular point in the electronic structure. From these features, we concluded that the EL from the Si-LED originated from the phonon-assisted radiative recombination of carriers with much higher energy than that of the bottom of the conduction band, via DPPs.	[Yamaguchi, M.; Kawazoe, T.; Yatsui, T.; Ohtsu, M.] Univ Tokyo, Grad Sch Engn, Dept Elect Engn & Informat Syst, Bunkyo Ku, Tokyo 1138656, Japan; [Yatsui, T.; Ohtsu, M.] Univ Tokyo, Grad Sch Engn, Int Ctr Nano Elect & Photon Technol, Bunkyo Ku, Tokyo 1138656, Japan; [Kawazoe, T.; Ohtsu, M.] Specified Nonprofit Corp Nanophoton Engn Org, Bunkyo Ku, Tokyo 1120014, Japan	Yatsui, T (reprint author), Univ Tokyo, Grad Sch Engn, Dept Elect Engn & Informat Syst, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1138656, Japan.	yatsui@ee.t.u-tokyo.ac.jp	Yatsui, Takashi/C-5956-2008		MEXT [26286022, 26630122]; JSPS Core-to-Core Program (A. Advanced Research Networks)	The authors thank Teijin Co. Ltd. for providing the NanoGram (R) Si ink. This work was partially supported by a MEXT Grant-in-Aid for Scientific Research (B) (No. 26286022), a MEXT Grant-in-Aid for Exploratory Research Program (No. 26630122), and the JSPS Core-to-Core Program (A. Advanced Research Networks).	Kawazoe T, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1828034; Wada N, 2012, APPL PHYS B-LASERS O, V108, P25, DOI 10.1007/s00340-012-5100-z; NEWMAN R, 1955, PHYS REV, V100, P700, DOI 10.1103/PhysRev.100.700; Schmidt P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.246103; Cho CH, 2013, NAT PHOTONICS, V7, P285, DOI 10.1038/NPHOTON.2013.25; Tanaka Y, 2007, PHYSICA E, V40, P297, DOI 10.1016/j.physe.2007.06.045; SIEH KS, 1985, PHYS STATUS SOLIDI B, V129, P259, DOI 10.1002/pssb.2221290125; Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/nmat2398, 10.1038/NMAT2398]; Tanaka Y, 2008, J MICROSC-OXFORD, V229, P228, DOI 10.1111/j.1365-2818.2008.01891.x; GIANNOZZI P, 1991, PHYS REV B, V43, P7231, DOI 10.1103/PhysRevB.43.7231; WILSON WL, 1993, SCIENCE, V262, P1242, DOI 10.1126/science.262.5137.1242; Yamaguchi M, 2014, APPL PHYS A-MATER, V115, P119, DOI 10.1007/s00339-013-7904-z; Maier-Flaig F, 2013, NANO LETT, V13, P475, DOI 10.1021/nl3038689; Cloutier SG, 2005, NAT MATER, V4, P887, DOI 10.1038/nmat1530; CULLIS AG, 1991, NATURE, V353, P335, DOI 10.1038/353335a0; CANHAM LT, 1990, APPL PHYS LETT, V57, P1046, DOI 10.1063/1.103561; GREEN MA, 1995, PROG PHOTOVOLTAICS, V3, P189, DOI 10.1002/pip.4670030303; Kawazoe T, 2011, APPL PHYS B-LASERS O, V104, P747, DOI 10.1007/s00340-011-4596-y; Ohtsu M., 2013, DRESSED PHOTONS CONC; Tran M., 2013, APPL PHYS A, V115, P105	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	DEC	2015	121	4					1389	1394		10.1007/s00339-015-9432-5		6	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CX5DT	WOS:000365722800012		
J	Kim, JH; Kawazoe, T; Ohtsu, M				Kim, Jun Hyoung; Kawazoe, Tadashi; Ohtsu, Motoichi			Optimization of dressed-photon-phonon-assisted annealing for fabricating GaP light-emitting diodes	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							OPTICAL-PROPERTIES; EFFICIENT; GLASSES	Using the two-level two-state model, we analyzed the characteristics of enhanced electroluminescence intensity from a GaP LED fabricated by dressed-photon-phonon-assisted annealing. In this model, we utilized the fact that the adiabatic potential barrier of the electronic excited level in configuration space is lower than that of the ground level. It was confirmed by experiments that, in an actual excited level, the barrier was reduced to 0.48 eV. From this finding, it was shown that the spatial distribution of Zn atoms can be changed by means of current injection and light irradiation even at room temperature. In addition, we showed that a structure that is suitable for light emission via DPPs is formed by means of a transition between a low-barrier excited level and a high-barrier ground level, due to stimulated emission. Also, regarding the optimized conditions for maximizing the effect of DPP-assisted annealing, it was found that the optimum ratio of the number of injected electrons to the number of irradiated photons is close to 1, and this was confirmed experimentally.	[Kim, Jun Hyoung; Kawazoe, Tadashi; Ohtsu, Motoichi] Univ Tokyo, Grad Sch Engn, Dept Elect Engn & Informat Syst, Bunkyo Ku, Tokyo 1138656, Japan; [Kawazoe, Tadashi; Ohtsu, Motoichi] Specified Nonprofit Corp Nanophoton Engn Org, Bunkyo Ku, Tokyo 1120014, Japan; [Ohtsu, Motoichi] Univ Tokyo, Grad Sch Engn, Int Ctr Nano Elect & Photon Technol, Bunkyo Ku, Tokyo 1138656, Japan	Kim, JH (reprint author), Univ Tokyo, Grad Sch Engn, Dept Elect Engn & Informat Syst, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1138656, Japan.	kimjh@nanophotonics.t.u-tokyo.ac.jp			Core-to-Core Program of JSPS (A. Advanced Research Network); MEXT [24360023]	This work was partially supported by the Core-to-Core Program of JSPS (A. Advanced Research Network) and a Grant-in-Aid for Scientific Research (B) (No. 24360023) of MEXT.	BOUR DP, 1987, APPL PHYS LETT, V50, P615, DOI 10.1063/1.98098; Hoglund A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.113201; Sugahara T, 1998, JPN J APPL PHYS 2, V37, pL1195, DOI 10.1143/JJAP.37.L1195; KOLODZIEJSKI LA, 1995, ANNU REV MATER SCI, V25, P711; Einstein A, 1923, Z PHYS, V19, P301, DOI 10.1007/BF01327565; Kawazoe T, 2014, APPL PHYS A-MATER, V115, P127, DOI 10.1007/s00339-013-7930-x; LOGAN RA, 1971, SOLID STATE ELECTRON, V14, P55, DOI 10.1016/0038-1101(71)90048-7; Tanaka Y, 2008, J MICROSC-OXFORD, V229, P228, DOI 10.1111/j.1365-2818.2008.01891.x; KOHLER W, 1987, PHYS REV B, V35, P4031, DOI 10.1103/PhysRevB.35.4031; HAKKI BW, 1970, J APPL PHYS, V41, P5291, DOI 10.1063/1.1658665; Takeuchi T, 1997, JPN J APPL PHYS 2, V36, pL177, DOI 10.1143/JJAP.36.L177; JANKOWIAK R, 1985, J PHYS CHEM-US, V89, P4569, DOI 10.1021/j100267a031; Kawazoe T, 2015, APPL PHYS A-MATER, V121, P1409, DOI 10.1007/s00339-015-9288-8; Kawazoe T, 2011, APPL PHYS B-LASERS O, V104, P747, DOI 10.1007/s00340-011-4596-y; Kim J. H., 2015, ADV OPT TECHNOL, V2015, DOI [10.1155/2015/236014, DOI 10.1155/2015/236014]; Ohtsu M, 2012, NANOPHOTONICS-BERLIN, V1, P83, DOI 10.1515/nanoph-2011-0001	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	DEC	2015	121	4					1395	1401		10.1007/s00339-015-9465-9		7	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CX5DT	WOS:000365722800013		
J	Nomura, W; Yatsui, T; Kawazoe, T; Tate, N; Ohtsu, M				Nomura, W.; Yatsui, T.; Kawazoe, T.; Tate, N.; Ohtsu, M.			High-speed flattening of crystallized glass substrates by dressed-photon-phonon etching	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							SURFACES	Dressed-photon-phonon (DPP) etching is a non-contact flattening technology that realizes ultra-flat surfaces and has been reported to achieve an arithmetic mean surface roughness, R (a), on the order of 0.1 nm in various materials, such as fused silica, plastic films, and GaN crystal. In this study, we successfully flattened the surface of a crystallized glass substrate in several seconds using laser light with a higher power density than that used in previous studies. The target substrate had an initial appearance similar to frosted glass, with an R (a) of 92.5 nm. We performed DPP etching under a Cl-2 atmosphere using a CW laser with a wavelength of 532 nm, a power of 8 W, and a spot diameter of 0.2 mm. After 1 s of processing, we obtained a flat surface with an R (a) of 5.00 nm. This surface roughness equaled or surpassed that of a substrate flattened by conventional chemical mechanical polishing, with an R (a) of 5.77 nm. Through the detailed analysis of atomic force microscopic images, we found the DPP etching resulted in the smaller standard deviation of the height difference than CMP in the smaller lateral size than 50 nm.	[Nomura, W.; Yatsui, T.; Kawazoe, T.; Tate, N.; Ohtsu, M.] Univ Tokyo, Grad Sch Engn, Dept Elect Engn & Informat Syst, Bunkyo Ku, Tokyo 1138656, Japan; [Kawazoe, T.; Ohtsu, M.] Univ Tokyo, Int Ctr Nano Elect & Photon Technol, Bunkyo Ku, Tokyo 1138656, Japan; [Kawazoe, T.; Ohtsu, M.] Specified Nonprofit Corp Nanophoton Engn Org, Bunkyo Ku, Tokyo 1120014, Japan	Nomura, W (reprint author), Kyushu Univ, Educ Ctr Global Leaders Mol Syst Devices, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	nomura@molecular-device.kyushu-u.ac.jp	Yatsui, Takashi/C-5956-2008		Ministry of Economy, Trade and Industry (METI)	This research was supported in part by the Ministry of Economy, Trade and Industry (METI). The crystallized glass substrates used in this study were provided by Showa Denko K.K.	COOK LM, 1990, J NON-CRYST SOLIDS, V120, P152, DOI 10.1016/0022-3093(90)90200-6; Lee SJ, 2012, INT J ELECTROCHEM SC, V7, P12495; Bradley JDB, 2007, APPL PHYS B-LASERS O, V89, P311, DOI 10.1007/s00340-007-2815-3; Gao FM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.015502; Hsu YP, 2005, OPT MATER, V27, P1171, DOI 10.1016/j.optmat.2004.08.076; Elmore WC, 1939, J APPL PHYS, V10, P724, DOI 10.1063/1.1707257; Jeong CH, 2002, MAT SCI ENG B-SOLID, V93, P60, DOI 10.1016/S0921-5107(02)00019-3; Yatsui T, 2011, APPL PHYS B-LASERS O, V103, P527, DOI 10.1007/s00340-011-4569-1; Yatsui T, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/47/475302; Yatsui T, 2008, APPL PHYS B-LASERS O, V93, P55, DOI 10.1007/s00340-008-3142-z; Frost F, 2004, THIN SOLID FILMS, V459, P100, DOI 10.1016/j.tsf.2003.12.107; Yatsui T, 2013, BEILSTEIN J NANOTECH, V4, P875, DOI 10.3762/bjnano.4.99; Ilias S, 1996, DIAM RELAT MATER, V5, P835, DOI 10.1016/0925-9635(95)00412-2; Ohtsu M., 2013, DRESSED PHOTONS	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	DEC	2015	121	4					1403	1407		10.1007/s00339-015-9466-8		5	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CX5DT	WOS:000365722800014		
J	Kawazoe, T; Nishioka, K; Ohtsu, M				Kawazoe, Tadashi; Nishioka, Katsuhiro; Ohtsu, Motoichi			Polarization control of an infrared silicon light-emitting diode by dressed photons and analyses of the spatial distribution of doped boron atoms	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							OPTICAL NEAR-FIELD; ROOM-TEMPERATURE; HOMOJUNCTION; EFFICIENT	This paper reports the fabrication of a polarization-controlled infrared LED fabricated by dressed-photon-phonon (DPP)-assisted annealing of a bulk Si crystal. For the DPP-assisted annealing, linearly polarized infrared light with a wavelength of 1.342 mu m was made normally incident on the top surface of the crystal. The photon energy at the peak of the emitted light spectrum of the fabricated LED was close to that of the light irradiated during the DPP-assisted annealing. A degree of polarization of as large as 0.07 was obtained. The spatial distribution of the doped B atoms in the fabricated LED was measured, and the following findings were obtained: (1) B atoms formed pairs in which the separation between the two B atoms was three times the lattice constant of the Si crystal; and (2) the B atom pairs were apt to orient along the direction perpendicular to the propagation direction and to the polarization direction of the light irradiated during the DPP-assisted annealing. Based on these findings (1) and (2), photon breeding was confirmed with respect to photon energy and spin, respectively.	[Kawazoe, Tadashi; Nishioka, Katsuhiro; Ohtsu, Motoichi] Univ Tokyo, Grad Sch Engn, Dept Elect Engn & Informat Syst, Bunkyo Ku, Tokyo 1138656, Japan; [Kawazoe, Tadashi; Ohtsu, Motoichi] Specified Nonprofit Corp Nanophoton Engn Org, Bunkyo Ku, Tokyo 1120014, Japan; [Ohtsu, Motoichi] Univ Tokyo, Grad Sch Engn, Int Ctr Nano Elect & Photon Technol, Bunkyo Ku, Tokyo 1138656, Japan	Ohtsu, M (reprint author), Univ Tokyo, Grad Sch Engn, Dept Elect Engn & Informat Syst, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1138656, Japan.	ohtsu@ee.t.u-tokyo.ac.jp			MEXT [24360023, 15K13374]; Core-to-Core Program of JSPS (A. Advanced Research Network)	This work was partially supported by the Core-to-Core Program of JSPS (A. Advanced Research Network), a Grant-in-Aid for Scientific Research (B) (No. 24360023) of MEXT, and the Exploratory Research program (No. 15K13374) of MEXT.	ANASTASS.E, 1970, SOLID STATE COMMUN, V8, P133, DOI 10.1016/0038-1098(70)90588-0; Dal Negro L, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2920435; Wada N, 2012, APPL PHYS B-LASERS O, V108, P25, DOI 10.1007/s00340-012-5100-z; LU ZH, 1995, NATURE, V378, P258, DOI 10.1038/378258a0; Kawazoe T, 2012, APPL PHYS B-LASERS O, V107, P659, DOI 10.1007/s00340-012-5053-2; Schubert MF, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2757594; Tanaka Y, 2007, PHYSICA E, V40, P297, DOI 10.1016/j.physe.2007.06.045; Hono K, 2002, PROG MATER SCI, V47, P621, DOI 10.1016/S0079-6425(01)00007-X; Wada N, 2014, APPL PHYS A-MATER, V115, P113, DOI 10.1007/s00339-013-7906-x; Stern BE, 2008, MON NOT R ASTRON SOC, V383, P1695, DOI 10.1111/j.1365-2966.2007.12706.x; Zhang L, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3276074; Kawazoe T, 2014, APPL PHYS A-MATER, V115, P127, DOI 10.1007/s00339-013-7930-x; Hirschman KD, 1996, NATURE, V384, P338, DOI 10.1038/384338a0; Yamaguchi M, 2014, APPL PHYS A-MATER, V115, P119, DOI 10.1007/s00339-013-7904-z; Tran MA, 2014, APPL PHYS A-MATER, V115, P105, DOI 10.1007/s00339-013-7907-9; Tanaka H, 2012, APPL PHYS B-LASERS O, V108, P51, DOI 10.1007/s00340-012-5077-7; JANKOWIAK R, 1985, J PHYS CHEM-US, V89, P4569, DOI 10.1021/j100267a031; GODWOD K, 1974, PHYS STATUS SOLIDI A, V21, P227, DOI 10.1002/pssa.2210210124; Kawazoe T, 2011, APPL PHYS B-LASERS O, V104, P747, DOI 10.1007/s00340-011-4596-y; Kawazoe Tadashi, 2014, Advances in Optical Technologies, DOI 10.1155/2014/958327; Kawazoe T., 2014, 21 INT DISPL WORKSH; KOMODA T, 1995, NUCL INSTRUM METH B, V96, P387, DOI 10.1016/0168-583X(94)00525-7; Ohtsu M., 2013, DRESSED PHOTONS, P11; Ohtsu M., 2011, PROGR NANOPHOTONICS, V1, P8; Ray SK, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-224; Shinohara Y., 2012, J PHYS SOC JPN, V67, P685; Tanaka H., 2015, FLUORESC MAT, V1, P1; Yerci S, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3483771; Yu PY, 2010, GRAD TEXTS PHYS, P345, DOI 10.1007/978-3-642-00710-1_7	29	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	DEC	2015	121	4					1409	1415		10.1007/s00339-015-9288-8		7	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CX5DT	WOS:000365722800015		
J	Ganeev, RA; Suzuki, M; Yoneya, S; Kuroda, H				Ganeev, R. A.; Suzuki, M.; Yoneya, S.; Kuroda, H.			Electron density measurements using high-order harmonic generation in laser-produced plasmas	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							TEMPERATURE; ABLATION	We demonstrate the method of the measurements of electron density in the low-dense, low-ionized laser-produced plasma using the nonlinear optical process of high-order harmonic generation of ultrashort pulses at the conditions of the quasi-phase-matching of driving and harmonic waves. Electron density was defined using the relations of quasi-phase-matching. We show the results of our measurements of electron density in the range of 10(16)-10(17) cm(-3) using the multi-jet silver plasma produced for the harmonic generation.	[Ganeev, R. A.; Suzuki, M.; Yoneya, S.; Kuroda, H.] Saitama Med Univ, Ophthalmol & Adv Laser Med Ctr, Saitama 3500495, Japan	Ganeev, RA (reprint author), Saitama Med Univ, Ophthalmol & Adv Laser Med Ctr, Saitama 3500495, Japan.	rashid_ganeev@mail.ru					SHKOLNIKOV PL, 1994, PHYS REV A, V50, pR4461; Smijesh N, 2013, J APPL PHYS, V114, DOI 10.1063/1.4820575; Willner A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.175002; Sangines R, 2007, PHYS LETT A, V367, P351, DOI [10.1016/j.physleta.2007.03.016, 10.1016/j.physieta.2007.03.016]; Harilal SS, 2005, J APPL PHYS, V98, DOI 10.1063/1.1977200; MOCHIZUKI T, 1989, OPT COMMUN, V72, P302, DOI 10.1016/0030-4018(89)90189-2; Lindner F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.113001; Tamaki Y, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.063802; Singhal H, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.023807; Zheng L, 2007, OPT EXPRESS, V15, P17985, DOI 10.1364/OE.15.017985; Gordillo-Vazquez FJ, 2001, APPL PHYS LETT, V78, P7, DOI 10.1063/1.1335853; Singhal H, 2008, J APPL PHYS, V103, DOI 10.1063/1.2825570; Cameron SM, 1996, IEEE T PLASMA SCI, V24, P45, DOI 10.1109/27.491683; Seres J, 2007, NAT PHYS, V3, P878, DOI 10.1038/nphys775; Ruiz M, 2014, J PHYS CONF SER, V511, DOI 10.1088/1742-6596/511/1/012064; Bahabad A, 2010, NAT PHOTONICS, V4, P570, DOI 10.1038/NPHOTON.2010.122; Paul A, 2003, NATURE, V421, P51, DOI 10.1038/nature01222; Verhoff B, 2012, J APPL PHYS, V112, DOI 10.1063/1.4764060; Ganeev RA, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.033821; Harilal SS, 1997, J APPL PHYS, V82, P2140, DOI 10.1063/1.366276; Ganeev RA, 2014, J PHYS B-AT MOL OPT, V47, DOI 10.1088/0953-4075/47/10/105401; Lowndes DH, 1996, SCIENCE, V273, P898, DOI 10.1126/science.273.5277.898; Tosa V, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/2/025016; de Posada E, 2011, Journal of Physics: Conference Series, V274, DOI 10.1088/1742-6596/274/1/012079; Ganeev RA, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.043823; Griem H. R., 1974, SPECTRAL LINE BROADE; Griem H.R., 1964, PLASMA SPECTROSCOPY; Pirri A, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.011801; Salieres P., 1999, ADV ATOM MOL OPT PHY, V41, P83	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	DEC	2015	121	3					307	313		10.1007/s00340-015-6230-x		7	Optics; Physics, Applied	Optics; Physics	CX6BB	WOS:000365785100010		
J	Eltarabily, MGA; Negm, AM; Valeriano, OCS; Gafar, KE				Eltarabily, Mohamed Galal A.; Negm, Abdelazim M.; Valeriano, Oliver C. Saavedra; Gafar, Khalid E.			Effects of di-ammonium phosphate on hydraulic, compaction, and shear strength characteristic of sand and clay soils	ARABIAN JOURNAL OF GEOSCIENCES			English	Article						Di-ammonium phosphates; Atterberg limits; Compaction characteristics; Hydraulic conductivity; Shear strength parameters	GEOTECHNICAL PROPERTIES; CONDUCTIVITY	The large amounts of phosphate fertilizers which are used in agriculture activities in Egypt lead to the contamination of large quantities of soil surrounding the agricultural fields. Also, the use of traditional flood irrigation method makes the problem more worse. An extensive laboratory testing program is carried out to determine the Atterberg limits, compaction characteristics, hydraulic conductivity, and shear strength parameters of clean and contaminated soils. Three types of soils are used including coarse sand, fine to medium sand, and silty clay. Batch tests are used to study the short-term effect of di-ammonium phosphate (DAP) contamination on the soil properties. Contaminated specimens are prepared by mixing the dried soil samples with different di-ammonium phosphate concentrations of 5, 10, and 20 %. The results indicate a significant reduction in Atterberg limits and increase in hydraulic conductivity for silty clay soil with the increase of phosphate concentration. The change that is induced by chemical reaction in the micro-structure of the soil is studied by laser scanning microscope before and after soil contamination. For sand soil, gamma (dmax) is significantly increased with the increase of DAP concentrations up to 5 % and slightly increased with concentrations from 5 to 20 % which indicates excess phosphate in the soil. However, the general trend of hydraulic conductivity is towards reduction. In addition, the friction angle of two sand samples decreases about 10 % due to the increase of DAP concentration up to 20 %. For silty clay, the reduction in cohesion is about 20 % and the increase of friction angle is about 10 % with the increase of DAP up to 20 %.	[Eltarabily, Mohamed Galal A.; Negm, Abdelazim M.] E JUST, Sch Energy & Environm Engn, Dept Environm Engn, New Borg Al Arab City 21934, Alexandria, Egypt; [Valeriano, Oliver C. Saavedra] Tokyo Inst Technol, Dept Civil Engn, Meguro Ku, Tokyo 1520033, Japan; [Gafar, Khalid E.] Univ Alexandria, Fac Engn, Dept Civil Engn, Alexandria, Egypt	Eltarabily, MGA (reprint author), E JUST, Sch Energy & Environm Engn, Dept Environm Engn, New Borg Al Arab City 21934, Alexandria, Egypt.	eng_mohamad1987@hotmail.com; negm@ejust.edu.eg; saavedra.o.aa@m.titech.ac.jp; khaledgaaver@yahoo.com	Negm, Abdelazim/M-2808-2015	Negm, Abdelazim/0000-0002-4838-5558	Egyptian Ministry of Higher Education (MoHE)	The first author would like to thank the Egyptian Ministry of Higher Education (MoHE) for providing him the financial support (PhD scholarship) for this research as well as the Egypt-Japan University of Science and Technology (E-JUST) and JICA for offering the facilities and tools needed to conduct this work and also the faculty of Engineering, Alexandria University.	Spagnoli G, 2012, B ENG GEOL ENVIRON, V71, P135, DOI 10.1007/s10064-011-0372-9; [Anonymous], 2009, J ENG GEOL, DOI DOI 10.1016/J.ENGGEO.2008.12.011; Nayak S, 2007, ENG GEOL, V94, P137, DOI 10.1016/j.enggeo.2007.05.002; Soule NM, 2001, J GEOTECH GEOENVIRON, V127, P363, DOI 10.1061/(ASCE)1090-0241(2001)127:4(363); Roque AJ, 2006, ENG GEOL, V85, P147, DOI 10.1016/j.enggeo.2005.09.034; SRIDHARAN A, 1988, GEOTECHNIQUE, V38, P191; Di Matteo L, 2011, J GEOTECH GEOENVIRON, V137, P846, DOI 10.1061/(ASCE)GT.1943-5606.0000494; Saussaye L, 2014, CONSTR BUILD MATER, V65, P303, DOI 10.1016/j.conbuildmat.2014.04.109; UPPOT JO, 1989, J GEOTECH ENG-ASCE, V115, P115; LUTZ JF, 1975, SOIL SCI SOC AM J, V39, P33; FERNANDEZ F, 1985, CAN GEOTECH J, V22, P205; FERNANDEZ F, 1988, CAN GEOTECH J, V25, P582, DOI 10.1139/t88-063; Sunil BM, 2006, ENG GEOL, V85, P197, DOI 10.1016/j.enggeo.2005.09.039; Brandenburg U., 1988, Applied Clay Science, V3, P263, DOI 10.1016/0169-1317(88)90033-6; FAO, 2005, FERT US CROP EG; Hamissa MR, 2000, GOLD JUB C 1950 2000; Khoraminezhad B, 2009, 8 INT C CIV ENG SHIR; MALR, 2003, B AGR EC; Rajeev Kumar P, 2011, 14 AS REG C SOIL MEC; Sridharan A, 1986, GEOTECH TEST J, V9, P156, DOI DOI 10.1520/GTJ10623J; Sridharan A, 1987, 3 INT S ENV GEOT PRO; Taha MH, 2000, REG WORKSH SOIL FERT	22	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1866-7511	1866-7538		ARAB J GEOSCI	Arab. J. Geosci.	DEC	2015	8	12					10419	10432		10.1007/s12517-015-1959-4		14	Geosciences, Multidisciplinary	Geology	CX1IV	WOS:000365450800020		
J	Azizi, M; Saibi, H; Cooper, GRJ				Azizi, Masood; Saibi, Hakim; Cooper, G. R. J.			Mineral and structural mapping of the Aynak-Logar Valley (eastern Afghanistan) from hyperspectral remote sensing data and aeromagnetic data	ARABIAN JOURNAL OF GEOSCIENCES			English	Article						Aeromagnetic data; Anomaly; Aynak-Logar Valley; Afghanistan	TILT	The Aynak-Logar Valley is located about 30 km south of Kabul in Afghanistan and contains the Aynak copper-cobalt deposit. Satellite remote sensing data obtained from Landsat Enhanced Thematic Mapper (ETM+) and DEM extracted from the Shuttle Radar Topography Mission (SRTM) were used to study the surface geology, while regional aeromagnetic data were used to identify the main magnetic sources in the region. The main magnetic anomaly appeared to originate at a depth of less than 1 km, although the coarse 1-km spacing of the gridded aeromagnetic data makes it difficult to be more precise. Other magnetic anomalies in the data were identified using a variety of edge-enhancement filters, 2.5D forward modeling, and 3D inversion model.	[Azizi, Masood; Saibi, Hakim] Kyushu Univ, Fac Engn, Dept Earth Resources Engn, Lab Explorat Geophys,Nishi Ku, Fukuoka 8190395, Japan; [Cooper, G. R. J.] Univ Witwatersrand, Sch Geosci, Johannesburg, South Africa	Saibi, H (reprint author), Kyushu Univ, Fac Engn, Dept Earth Resources Engn, Lab Explorat Geophys,Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	saibi-hakim@mine.kyushu-u.ac.jp					MILLER HG, 1994, J APPL GEOPHYS, V32, P213, DOI 10.1016/0926-9851(94)90022-1; Ferreira FJF, 2013, GEOPHYSICS, V78, pJ33, DOI 10.1190/GEO2011-0441.1; Ashan Said, 2007, AEROMAGNETIC SURVEY; Benham AJ, 2009, T I MIN METALL B, V118, P45; Bosum W, 1968, AIRBORNE MAGNETOMETE, P46; Doebrich JL, 2006, 20061038 US GEOL SUR; Jahne B, 2005, DIGITAL IMAGE PROCES; Kleimenev MA, 1974, REPORT RESULTS GEO 1, P74; Kokaly R. F., 2008, 20081235 US GEOL SUR; Kokaly RF, 2011, PRISM PROCESSING ROU; Li X, 2006, GEOPHYSICS, V71, P13, DOI DOI 10.1190/1.2184367; Nabighian MN, 1984, GEOPHYSICS, V49, P957, DOI DOI 10.1190/1.1441706; Peters SG, 2007, 20071214 US GEOL SUR, P822; Phillips JD, 1998, 0298 US GEOL SURV; Salem Ahmed, 2007, Leading Edge, V26, DOI 10.1190/1.2821934; Shenwary GS, 2011, 20111055 US GEOL SUR, P8; USGS, 2004, PROJ AFGH	17	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1866-7511	1866-7538		ARAB J GEOSCI	Arab. J. Geosci.	DEC	2015	8	12					10911	10918		10.1007/s12517-015-1993-2		8	Geosciences, Multidisciplinary	Geology	CX1IV	WOS:000365450800052		
J	Kato, Y; Yokoyama, U; Yanai, C; Ishige, R; Kurotaki, D; Umemura, M; Fujita, T; Kubota, T; Okumura, S; Sata, M; Tamura, T; Ishikawa, Y				Kato, Yuko; Yokoyama, Utako; Yanai, Chiharu; Ishige, Rina; Kurotaki, Daisuke; Umemura, Masanari; Fujita, Takayuki; Kubota, Tetsuo; Okumura, Satoshi; Sata, Masataka; Tamura, Tomohiko; Ishikawa, Yoshihiro			Epac1 Deficiency Attenuated Vascular Smooth Muscle Cell Migration and Neointimal Formation	ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY			English	Article						arterial injury; intima-media thickness; migration; signal transduction; vascular smooth muscle	PHOSPHOLIPASE-C-EPSILON; PROTEIN-KINASE-A; GROWTH-FACTOR; INTIMAL HYPERPLASIA; DIFFERENTIAL ROLES; FOCAL ADHESION; ACTIVATION; COFILIN; PROLIFERATION; PDGF	Objective Vascular smooth muscle cell (SMC) migration causes neointima, which is related to vascular remodeling after mechanical injury and atherosclerosis development. We previously reported that an exchange protein activated by cAMP (Epac) 1 was upregulated in mouse arterial neointima and promoted SMC migration. In this study, we examined the molecular mechanisms of Epac1-induced SMC migration and the effect of Epac1 deficiency on vascular remodeling in vivo. Approach and Results Platelet-derived growth factor-BB promoted a 2-fold increase in SMC migration in a primary culture of aortic SMCs obtained from Epac1(+/+) mice (Epac1(+/+)-ASMCs), whereas there was only a 1.2-fold increase in Epac1(-/-)-ASMCs. The degree of platelet-derived growth factor-BB-induced increase in intracellular Ca2+ was smaller in Fura2-labeled Epac1(-/-)-ASMCs than in Epac1(+/+)-ASMCs. In Epac1(+/+)-ASMCs, an Epac-selective cAMP analog or platelet-derived growth factor-BB increased lamellipodia accompanied by cofilin dephosphorylation, which is induced by Ca2+ signaling, whereas these effects were rarely observed in Epac1(-/-)-ASMCs. Furthermore, 4 weeks after femoral artery injury, prominent neointima were formed in Epac1(+/+) mice, whereas neointima formation was significantly attenuated in Epac1(-/-) mice in which dephosphorylation of cofilin was inhibited. The chimeric mice generated by bone marrow cell transplantation from Epac1(+/+) into Epac1(-/-) mice and vice versa demonstrated that the genetic background of vascular tissues, including SMCs rather than of bone marrow-derived cells affected Epac1-mediated neointima formation. Conclusions These data suggest that Epac1 deficiency attenuates neointima formation through, at least in part, inhibition of SMC migration, in which a decrease in Ca2+ influx and a suppression of cofilin-mediated lamellipodia formation occur.	[Kato, Yuko; Yokoyama, Utako; Yanai, Chiharu; Umemura, Masanari; Fujita, Takayuki; Ishikawa, Yoshihiro] Yokohama City Univ, Cardiovasc Res Inst, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan; [Kurotaki, Daisuke; Tamura, Tomohiko] Yokohama City Univ, Dept Immunol, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan; [Kato, Yuko; Ishige, Rina; Kubota, Tetsuo] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Dept Microbiol & Immunol, Tokyo, Japan; [Okumura, Satoshi] Tsurumi Univ, Sch Dent Med, Dept Physiol, Yokohama, Kanagawa, Japan; [Sata, Masataka] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Cardiovasc Med, Tokushima 770, Japan	Yokoyama, U (reprint author), Yokohama City Univ, Cardiovasc Res Inst, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	utako@yokohama-cu.ac.jp			Japan Society for Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology [24790558, 25293236, 24659100, 26670506, 25670131, 22136009]; Ministry of Health, Labor and Welfare; Yokohama Foundation for Advanced Medical Science; Vehicle Racing Commemorative Foundation; Research and Development Project of Yokohama City University	This work was supported by grants from The Japan Society for Promotion of Science and The Ministry of Education, Culture, Sports, Science and Technology (grant numbers: 24790558 to Y.K.; 25293236, 24659100, and 26670506 to U.Y.; and 25670131 and 22136009 to Y.I.), and grants from the Ministry of Health, Labor and Welfare (Y.I.), the Yokohama Foundation for Advanced Medical Science (U.Y.), the Vehicle Racing Commemorative Foundation (U.Y.), and a grant for Research and Development Project of Yokohama City University (Y.I.).	Bornfeldt KE, 1997, J CLIN INVEST, V100, P875, DOI 10.1172/JCI119603; Smrcka AV, 2012, CELL SIGNAL, V24, P1333, DOI 10.1016/j.cellsig.2012.01.009; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; San Martin A, 2008, CIRC RES, V102, P432, DOI 10.1161/CIRCRESAHA.107.158923; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; JAWIEN A, 1992, J CLIN INVEST, V89, P507, DOI 10.1172/JCI115613; Infante E, 2011, J LEUKOCYTE BIOL, V89, P577, DOI 10.1189/jlb.0810441; Suzuki S, 2010, J BIOL CHEM, V285, P24248, DOI 10.1074/jbc.M109.094581; Tanaka K, 2003, CIRC RES, V93, P783, DOI 10.1161/01.RES.0000096651.13001.B4; Lee MR, 2012, J MICROBIOL, V50, P555, DOI 10.1007/s12275-012-2246-7; Schmidt M, 2007, CURR OPIN PHARMACOL, V7, P193, DOI 10.1016/j.coph.2006.10.004; Basoni C, 2005, FASEB J, V19, P822, DOI 10.1096/fj.04-3085fje; Lyle KS, 2008, CELL SIGNAL, V20, P1104, DOI 10.1016/j.cellsig.2008.01.018; Kimura TE, 2014, J MOL CELL CARDIOL, V72, P9, DOI 10.1016/j.yjmcc.2014.02.001; Heldin CH, 1999, PHYSIOL REV, V79, P1283; Baljinnyam E, 2010, CANCER RES, V70, P5607, DOI 10.1158/0008-5472.CAN-10-0056; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sano H, 2001, CIRCULATION, V103, P2955; Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Lorenowicz MJ, 2006, J LEUKOCYTE BIOL, V80, P1542, DOI 10.1189/jlb.0506357; Yokoyama U, 2008, P NATL ACAD SCI USA, V105, P6386, DOI 10.1073/pnas.0801490105; Okumura S, 2014, J CLIN INVEST, V124, P2785, DOI 10.1172/JCI64784; BAI HZ, 1994, ARTERIOSCLER THROMB, V14, P1846; Severson EA, 2009, MOL BIOL CELL, V20, P1916, DOI 10.1091/mbc.E08-10-1014; Howe AK, 2011, CURR OPIN CELL BIOL, V23, P554, DOI 10.1016/j.ceb.2011.05.006; Graves LM, 1996, J BIOL CHEM, V271, P505; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Yokoyama U, 2008, J BIOL CHEM, V283, P28702, DOI 10.1074/jbc.M804223200; Song CH, 2002, ONCOGENE, V21, P8105, DOI 10.1038/sj.onc.1206003; Cospedal R, 1999, CARDIOVASC RES, V41, P708, DOI 10.1016/S0008-6363(98)00232-6; Torres RA, 2011, ARTERIOSCL THROM VAS, V31, P2424, DOI 10.1161/ATVBAHA.111.232769; Martins M, 2012, J CELL SCI, V125, P5758, DOI 10.1242/jcs.110007; Li MZ, 2009, CARCINOGENESIS, V30, P1424, DOI 10.1093/carcin/bgp125; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Takuma T, 1996, J BIOCHEM-TOKYO, V120, P35; Indolfi C, 1997, NAT MED, V3, P775, DOI 10.1038/nm0797-775; Hewer RC, 2011, J MOL CELL CARDIOL, V50, P87, DOI 10.1016/j.yjmcc.2010.10.010; Worth DC, 2010, J CELL BIOL, V189, P369, DOI 10.1083/jcb.200912014; Yokoyama U, 2008, AM J PHYSIOL-HEART C, V295, pH1547, DOI 10.1152/ajpheart.01317.2007; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Raines EW, 2004, CYTOKINE GROWTH F R, V15, P237, DOI 10.1016/j.cytogfr.2004.03.004; Tambur AR, 2006, J HEART LUNG TRANSPL, V25, P690, DOI 10.1016/j.healun.2006.02.006; Grandoch M, 2009, BRIT J CANCER, V101, P2038, DOI 10.1038/sj.bjc.6605439; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Scherberich A, 2000, J CELL SCI, V113, P653; DAVIDSON MML, 1994, BIOCHEM J, V301, P41; Lee CK, 2007, CARDIOVASC RES, V74, P159, DOI 10.1016/j.cardiores.2007.01.012; Gao L, 2006, CANCER RES, V66, P7880, DOI 10.1158/0008-5472.CAN-06-0254; Hu LZ, 2010, J IMMUNOL, V184, P993, DOI 10.4049/jimmunol.0901816; Baljinnyam E, 2009, AM J PHYSIOL-CELL PH, V297, pC802, DOI 10.1152/ajpcell.00129.2009; Sartore S, 2001, CIRC RES, V89, P1111, DOI 10.1161/hh2401.100844; Sur S, 2014, CURR VASC PHARMACOL, V12, P190	55	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1079-5642	1524-4636		ARTERIOSCL THROM VAS	Arterioscler. Thromb. Vasc. Biol.	DEC	2015	35	12					2617	2625		10.1161/ATVBAHA.115.306534		9	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CX3JE	WOS:000365594100016		
J	Terao, C; Yamakawa, N; Yano, K; Markusse, IM; Ikari, K; Yoshida, S; Furu, M; Hashimoto, M; Ito, H; Fujii, T; Ohmura, K; Murakami, K; Takahashi, M; Hamaguchi, M; Tabara, Y; Taniguchi, A; Momohara, S; Raychaudhuri, S; Allaart, CF; Yamanaka, H; Mimori, T; Matsuda, F				Terao, Chikashi; Yamakawa, Noriyuki; Yano, Koichiro; Markusse, Iris M.; Ikari, Katsunori; Yoshida, Shinji; Furu, Moritoshi; Hashimoto, Motomu; Ito, Hiromu; Fujii, Takao; Ohmura, Koichiro; Murakami, Kosaku; Takahashi, Meiko; Hamaguchi, Masahide; Tabara, Yasuharu; Taniguchi, Atsuo; Momohara, Shigeki; Raychaudhuri, Soumya; Allaart, Cornelia F.; Yamanaka, Hisashi; Mimori, Tsuneyo; Matsuda, Fumihiko			Rheumatoid Factor Is Associated With the Distribution of Hand Joint Destruction in Rheumatoid Arthritis	ARTHRITIS & RHEUMATOLOGY			English	Article							CITRULLINATED PEPTIDE ANTIBODY; SHARED EPITOPE ALLELES; RADIOLOGIC DAMAGE; HLA-DRB1 ALLELES; SUSCEPTIBILITY; ABNORMALITIES; METHOTREXATE; POPULATION; TRIAL; RA	Objective. Rheumatoid arthritis (RA) is a chronic disease leading to joint destruction. Although many studies have addressed factors potentially correlated with the speed of joint destruction, less attention has been paid to the distribution of joint destruction in patients with RA. In this study, destruction of the hand bones in patients with RA was classified into 2 anatomic subgroups, the fingers and the non-fingers, with the aim of analyzing which factors are associated with destruction of the finger joints. Methods. A total of 1,215 Japanese patients with RA were recruited from 2 different populations. The degree of joint destruction was assessed using the total modified Sharp/van der Heijde score (SHS) of radiographic joint damage. The SHS score of joint damage in the finger joints was used as the dependent variable, and the SHS score in the non-finger joints was used as a covariate. Age, sex, disease duration, smoking, C-reactive protein level, treatment for RA, and positivity for and levels of anti-citrullinated protein antibodies and rheumatoid factor (RF) were evaluated as candidate correlates. Overall effect sizes were assessed in a meta-analysis. In addition, associations observed in the Japanese patients were compared to those in a cohort of 157 Dutch RA patients in the BeSt study (a randomized, controlled trial involving 4 different strictly specified treatment strategies for early RA). Results. Not surprisingly, disease duration in Japanese patients with RA was associated with the finger SHS score (P <= 0.00037). Both positivity for and levels of RF showed significant associations with the finger SHS score after adjustment for covariates (P=0.0022 and P=8.1 x 10(-7), respectively). These associations were also true in relation to the time-averaged finger SHS score. An association between RF positivity and the finger SHS score was also observed in Dutch patients with RA in the BeSt study (P=0.049). Conclusion. Positivity for and levels of RF are associated with finger joint destruction independent of non-finger joint destruction and other covariates. Our findings suggest that there are different mechanisms of joint destruction operating in the finger joints of patients with RA.	[Terao, Chikashi; Yamakawa, Noriyuki; Furu, Moritoshi; Hashimoto, Motomu; Ito, Hiromu; Fujii, Takao; Ohmura, Koichiro; Murakami, Kosaku; Takahashi, Meiko; Tabara, Yasuharu; Mimori, Tsuneyo; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Terao, Chikashi; Raychaudhuri, Soumya] Brigham & Womens Hosp, Boston, MA 02115 USA; [Terao, Chikashi; Raychaudhuri, Soumya] Harvard Univ, Sch Med, Boston, MA USA; [Terao, Chikashi; Raychaudhuri, Soumya] Broad Inst, Cambridge, MA USA; [Yano, Koichiro; Ikari, Katsunori; Yoshida, Shinji; Taniguchi, Atsuo; Momohara, Shigeki; Yamanaka, Hisashi] Tokyo Womens Med Univ, Tokyo, Japan; [Markusse, Iris M.; Allaart, Cornelia F.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Ikari, Katsunori] Japan Sci & Technol Agcy, CREST Program, Tokyo, Japan; [Hamaguchi, Masahide] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kyoto, Japan; [Raychaudhuri, Soumya] Univ Manchester, Manchester, Lancs, England; [Raychaudhuri, Soumya] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	Terao, C (reprint author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	a0001101@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	Supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Ohmura K, 2010, RHEUMATOLOGY, V49, P2298, DOI 10.1093/rheumatology/keq273; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Terao C, 2015, ARTHRITIS RHEUMATOL, V67, P2038, DOI 10.1002/art.39133; Han B, 2014, AM J HUM GENET, V94, P522, DOI 10.1016/j.ajhg.2014.02.013; van der Heijde D, 1999, J RHEUMATOL, V26, P743; Bukhari M, 2007, ARTHRITIS RHEUM, V56, P2929, DOI 10.1002/art.22868; Scherer HU, 2011, ANN RHEUM DIS, V70, P1461, DOI 10.1136/ard.2010.146506; Vander Cruyssen B, 2007, ANN RHEUM DIS, V66, P364, DOI 10.1136/ard.2006.053470; Hashimoto J, 2011, MOD RHEUMATOL, V21, P10, DOI 10.1007/s10165-010-0325-3; PANAYI GS, 1987, BRIT J RHEUMATOL, V26, P172; Drossaers-Bakker KW, 1999, ARTHRITIS RHEUM, V42, P1854, DOI 10.1002/1529-0131(199909)42:9<1854::AID-ANR9>3.0.CO;2-F; Terao C, 2011, ANN RHEUM DIS, V70, P2134, DOI 10.1136/annrheumdis-2011-200353; Schellekens GA, 2000, ARTHRITIS RHEUM, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Smolen JS, 2006, ARTHRITIS RHEUM, V54, P702, DOI 10.1002/art.21678; Terao C, 2012, ANN RHEUM DIS, V71, P1095, DOI 10.1136/annrheumdis-2011-200907; Navarro-Compan V, 2015, RHEUMATOLOGY, V54, P83, DOI 10.1093/rheumatology/keu284; Terao C, 2015, ARTHRITIS RHEUMATOL, V67, P1744, DOI 10.1002/art.39105; Hashiramoto A, 2009, MOD RHEUMATOL, V19, P637, DOI 10.1007/s10165-009-0205-x; SHARP JT, 1971, ARTHRITIS RHEUM, V14, P706, DOI 10.1002/art.1780140605; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM, V52, P3381, DOI 10.1002/art.21405; Okada Y, 2014, HUM MOL GENET, V23, P6916, DOI 10.1093/hmg/ddu387; SHARP JT, 1985, ARTHRITIS RHEUM, V28, P16, DOI 10.1002/art.1780280104; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061045; Terao C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059341; Terao C, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0623-4; Terao C., 2014, INFLAMM REGEN, V34, P71; Terao C, 2014, ARTHRIT CARE RES, V66, P1818, DOI 10.1002/acr.22385; Terao C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020457; Terao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040067; VAINIO K, 1956, Ann Chir Gynaecol Fenn Suppl, V45, P1	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	DEC	2015	67	12					3113	3123		10.1002/art.39306		11	Rheumatology	Rheumatology	CX4SV	WOS:000365691500004		
J	Ichimura, Y; Asano, Y; Akamata, K; Noda, S; Taniguchi, T; Takahashi, T; Toyama, T; Tada, Y; Sugaya, M; Sato, S; Kadono, T				Ichimura, Yohei; Asano, Yoshihide; Akamata, Kaname; Noda, Shinji; Taniguchi, Takashi; Takahashi, Takehiro; Toyama, Tetsuo; Tada, Yayoi; Sugaya, Makoto; Sato, Shinichi; Kadono, Takafumi			Progranulin Overproduction Due to Fli-1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic Sclerosis	ARTHRITIS & RHEUMATOLOGY			English	Article							GROWTH-FACTOR-BETA; GRANULIN-EPITHELIN PRECURSOR; TRANSCRIPTION FACTOR FLI1; PROTEIN-ASSOCIATED FACTOR; FACTOR-ALPHA; SCLERODERMA FIBROBLASTS; DOWN-REGULATION; COLLAGEN PRODUCTION; TGF-BETA; INCREASED EXPRESSION	Objective. Progranulin is a growth factor that is active in wound repair and is an antagonist of tumor necrosis factor (TNF) receptors, regulating fibroblast activation, angiogenesis, and inflammation. Because long-standing activation of gene programs related to wound healing is a hallmark of systemic sclerosis (SSc), we sought to investigate the role of progranulin in SSc. Methods. Progranulin expression levels in human and murine skin samples were determined by immunohistochemical analysis and quantitative reverse transcription-polymerase chain reaction. The role of progranulin in fibroblast activation was examined using a gene-silencing technique. Progranulin levels in serum obtained from 60 patients with SSc and 16 healthy control subjects were determined by enzyme-linked immunosorbent assay. Results. Progranulin expression was increased in SSc dermal fibroblasts compared with normal dermal fibroblasts, both in vivo and in vitro. Transcription factor Fli-1, a deficiency of which is involved in the activation of SSc dermal fibroblasts, served as a potent repressor of the progranulin gene, and Fli-1(+/-) mice and bleomycintreated wild-type mice exhibited up-regulated expression of progranulin in dermal fibroblasts. SSc dermal fibroblasts were resistant to the antifibrotic effect of TNF, but this resistance was reversed by gene silencing of progranulin. Serum progranulin levels were elevated in patients with early diffuse cutaneous SSc (dcSSc), especially in those with inflammatory skin symptoms, and were positively correlated with the C-reactive protein level. Conclusion. Progranulin overproduction due to Fli-1 deficiency may contribute to the constitutive activation of SSc dermal fibroblasts by antagonizing the antifibrotic effect of TNF. Progranulin may also be involved in the inflammatory process associated with progressive skin sclerosis in early dcSSc.	[Ichimura, Yohei; Asano, Yoshihide; Akamata, Kaname; Noda, Shinji; Taniguchi, Takashi; Takahashi, Takehiro; Toyama, Tetsuo; Tada, Yayoi; Sugaya, Makoto; Sato, Shinichi; Kadono, Takafumi] Univ Tokyo, Grad Sch Med, Tokyo 1138655, Japan	Asano, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yasano-tky@umin.ac.jp; kadono-der@h.u-tokyo.ac.jp			Ministry of Health, Labor, and Welfare of Japan	Supported in part by grants from the Ministry of Health, Labor, and Welfare of Japan.	Chizzolini C, 1998, ARTHRITIS RHEUM, V41, P2039; LEROY EC, 1988, J RHEUMATOL, V15, P202; Noda S, 2013, RHEUMATOLOGY, V52, P790, DOI 10.1093/rheumatology/kes379; Ichimura Y, 2014, ARCH DERMATOL RES, V306, P331, DOI 10.1007/s00403-013-1431-9; Abraham DJ, 2009, RHEUMATOLOGY, V48, P3, DOI 10.1093/rheumatology/ken481; Kim JY, 2008, CLIN EXP IMMUNOL, V152, P328, DOI 10.1111/j.1365-2249.2008.03637.x; Guerra RR, 2007, GROWTH FACTORS, V25, P280, DOI 10.1080/08977190701781222; Jian JL, 2013, J LEUKOCYTE BIOL, V93, P199, DOI 10.1189/jlb.0812429; Yamane K, 2003, J IMMUNOL, V171, P3855; Asano Y, 2009, MOL CELL BIOL, V29, P425, DOI 10.1128/MCB.01278-08; Gruschwitz MS, 1997, ARTHRITIS RHEUM, V40, P540, DOI 10.1002/art.1780400321; Asano Y, 2010, J DERMATOL, V37, P54, DOI 10.1111/j.1346-8138.2009.00758.x; SOLISHERRUZO JA, 1988, J BIOL CHEM, V263, P5841; Spyropoulos DD, 2000, MOL CELL BIOL, V20, P5643, DOI 10.1128/MCB.20.15.5643-5652.2000; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098; KOCH AE, 1993, PATHOBIOLOGY, V61, P239, DOI 10.1159/000163802; Jelaska A, 2000, ARTHRITIS RHEUM, V43, P2230, DOI 10.1002/1529-0131(200010)43:10<2230::AID-ANR10>3.0.CO;2-8; Ong CHP, 2003, HISTOL HISTOPATHOL, V18, P1275; Yoshizaki A, 2008, AM J PATHOL, V172, P1650, DOI 10.2353/ajpath.2008.071049; MAUVIEL A, 1991, J INVEST DERMATOL, V96, P243, DOI 10.1111/1523-1747.ep12462185; Verrecchia F, 2000, J BIOL CHEM, V275, P30226, DOI 10.1074/jbc.M005310200; Distler JHW, 2007, ARTHRITIS RHEUM, V56, P311, DOI 10.1002/art.22314; Cenik B, 2012, J BIOL CHEM, V287, P32298, DOI 10.1074/jbc.R112.399170; Shirasaki F, 1999, ONCOGENE, V18, P7755; KAHARI VM, 1990, J CLIN INVEST, V86, P1489, DOI 10.1172/JCI114866; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Nakerakanti SS, 2006, J BIOL CHEM, V281, P25259, DOI 10.1074/jbc.M600466200; Park B, 2011, IMMUNITY, V34, P505, DOI 10.1016/j.immuni.2011.01.018; Liu CJ, 2011, FEBS LETT, V585, P3675, DOI 10.1016/j.febslet.2011.04.065; Asano Y, 2004, J CLIN INVEST, V113, P253, DOI 10.1172/JCI200416269; Asano Y, 2007, J BIOL CHEM, V282, P34672, DOI 10.1074/jbc.M703907200; Asano Y, 2004, AM J PATHOL, V164, P1275, DOI 10.1016/S0002-9440(10)63215-4; Chizzolini C, 2003, ARTHRITIS RHEUM, V48, P2593, DOI 10.1002/art.11129; Akamata K, 2015, RHEUMATOLOGY, V54, P1308, DOI 10.1093/rheumatology/keu479; Kubo M, 2003, AM J PATHOL, V163, P571, DOI 10.1016/S0002-9440(10)63685-1; Santiago B, 2001, ARTHRITIS RHEUM, V44, P1667, DOI 10.1002/1529-0131(200107)44:7<1667::AID-ART291>3.0.CO;2-Y; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Duan H, 2008, ARTHRITIS RHEUM, V58, P1465, DOI 10.1002/art.23451; Asano Y, 2009, MOL CELL BIOL, V29, P1882, DOI 10.1128/MCB.01320-08; Wang YQ, 2006, ARTHRITIS RHEUM, V54, P2271, DOI 10.1002/art.21948; Asano Y, 2010, AM J PATHOL, V176, P1983, DOI 10.2353/ajpath.2010.090593; Czuwara-Ladykowska J, 2002, J BIOL CHEM, V277, P20399, DOI 10.1074/jbc.M200206200; Noda S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6797; Noda S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032272; Saigusa R, 2015, EXP DERMATOL, V24, P127, DOI 10.1111/exd.12602; Takahashi T, 2015, BR J DERMATOL; Taniguchi T, 2015, ARTHRITIS RHEUMATOL, V67, P517, DOI 10.1002/art.38948; Varga John, 2009, Front Biosci (Schol Ed), V1, P226, DOI 10.2741/s22	49	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	DEC	2015	67	12					3245	3255		10.1002/art.39312		11	Rheumatology	Rheumatology	CX4SV	WOS:000365691500019		
J	Kim, RC; Moon, J				Kim, Rebecca Chunghee; Moon, Jeremy			Dynamics of corporate social responsibility in Asia: Knowledge and norms	ASIAN BUSINESS & MANAGEMENT			English	Editorial Material						corporate social responsibility; Asia; CSR dynamics; CSR research; community; institutions	CREATING SHARED VALUE; STAKEHOLDER ENGAGEMENT; SOUTH-KOREA; CSR; PERSPECTIVE; BUSINESS; CHINA; MANAGEMENT; FIRM; GOVERNMENT	This article investigates Corporate Social Responsibility (CSR) in Asia through two related themes: research knowledge and ethical norms. 'CSR in Asia' research is shown to be growing, particularly in East Asia. Compared with Western CSR literature, it is shown to be dominated by empirical, particularly quantitative, research. More substantively, this research is dominated by an issue focus on ethical norms, though this is in real decline. In this light, this article offers a closer investigation of the nature of ethical systems underpinning Asian business, and a comparison of Asian and Western conceptions of the community as a stakeholder.	[Kim, Rebecca Chunghee] Ritsumeikan Asia Pacific Univ, Coll Int Management, Beppu, Oita 8748577, Japan; [Moon, Jeremy] Copenhagen Business Sch, Corp Sustainabil, DK-2000 Frederiksberg, Denmark	Kim, RC (reprint author), Ritsumeikan Asia Pacific Univ, Coll Int Management, Beppu, Oita 8748577, Japan.	chunghee@apu.ac.jp; chkim1472@gmail.com					Aguilera RV, 2007, ACAD MANAGE REV, V32, P836; Allinson A., 2011, PALGRAVE HDB SPIRITU, P95; Pearce R, 2010, ASIAN BUS MANAG, V9, P481, DOI 10.1057/abm.2010.29; Wong L, 2009, ASIAN BUS MANAG, V8, P129, DOI 10.1057/abm.2009.1; Williams G, 2010, J BUS ETHICS, V91, P519, DOI 10.1007/s10551-009-0097-x; Orlitzky M, 2003, ORGAN STUD, V24, P403, DOI 10.1177/0170840603024003910; Kannabiran G, 2009, ASIAN BUS MANAG, V8, P205, DOI 10.1057/abm.2009.6; Witt MA, 2013, SOCIO-ECON REV, V11, P265, DOI 10.1093/ser/mwt002; Gond JP, 2011, ECON SOC, V40, P640, DOI 10.1080/03085147.2011.607364; Yin JL, 2012, J BUS ETHICS, V111, P301, DOI 10.1007/s10551-012-1243-4; BOSWELL J, 1983, BUS HIST REV, V57, P237, DOI 10.2307/3114356; Gilbert DU, 2011, BUS ETHICS Q, V21, P23; OTOOLE J, 1991, CALIF MANAGE REV, V33, P9; Porter ME, 2006, HARVARD BUS REV, V84, P78; Tokoro N, 2007, ASIAN BUS MANAG, V6, P143, DOI 10.1057/palgrave.abm.9200218; Scherer AG, 2011, J MANAGE STUD, V48, P899, DOI 10.1111/j.1467-6486.2010.00950.x; Doh JP, 2006, J MANAGE STUD, V43, P47, DOI 10.1111/j.1467-6486.2006.00582.x; Branco MC, 2006, J BUS ETHICS, V69, P111, DOI 10.1007/s10551-006-9071-z; Clulow V, 2005, EUR J MARKETING, V39, P978, DOI 10.1108/03090560510610671; Cho S, 2009, PUBLIC RELAT REV, V35, P147, DOI 10.1016/j.pubrev.2008.09.012; Beekun RI, 2005, J BUS ETHICS, V60, P131, DOI 10.1007/s10551-004-8204-5; Campbell JL, 2006, AM BEHAV SCI, V49, P925, DOI 10.1177/0002764205285172; Matten D, 2008, ACAD MANAGE REV, V33, P404; Moon J, 2010, J BUS ETHICS, V94, P613, DOI 10.1007/s10551-009-0341-4; Dzever S, 2012, ASIAN BUS MANAG, V11, P273, DOI 10.1057/abm.2012.11; McWilliams A, 2001, ACAD MANAGE REV, V26, P117, DOI 10.5465/AMR.2001.4011987; Garriga E, 2004, J BUS ETHICS, V53, P51, DOI 10.1023/B:BUSI.0000039399.90587.34; Lund-Thomsen P, 2014, J BUS ETHICS, V123, P11, DOI 10.1007/s10551-013-1796-x; Valax M, 2012, ASIAN BUS MANAG, V11, P347, DOI 10.1057/abm.2012.9; Lockett A, 2006, J MANAGE STUD, V43, P115, DOI 10.1111/j.1467-6486.2006.00585.x; Wang L, 2009, J BUS ETHICS, V88, P433, DOI 10.1007/s10551-009-0306-7; Yang XH, 2009, J BUS ETHICS, V86, P155, DOI 10.1007/s10551-009-0191-0; Kim CH, 2013, J BUS RES, V66, P2581, DOI 10.1016/j.jbusres.2012.05.015; Akiyama T, 2010, ASIAN BUS MANAG, V9, P223, DOI 10.1057/abm.2010.4; Walsh JP, 2003, J MANAGE, V29, P859, DOI 10.1016/S0149-2063(03)00082-5; Witt MA, 2012, SOCIO-ECON REV, V10, P109, DOI 10.1093/ser/mwr026; Knudsen JS, 2015, POLICY POLIT, V43, P81, DOI 10.1332/030557312X656016; Bae J, 2011, J PUBLIC RELAT RES, V23, P141, DOI 10.1080/1062726X.2010.504794; Baughn C Christopher, 2007, Corporate Social Responsibility and Environmental Management, V14, DOI 10.1002/csr.160; Birch D., 2004, J CORPORATE CITIZENS, V13, P18, DOI 10.9774/GLEAF.4700.2004.sp.00004; Bouckaert L., 2011, PALGRAVE HDB SPIRITU; Carroll A. B., 1979, ACAD MANAGE REV, V4, P497, DOI DOI 10.5465/AMR.1979.4498296; Carroll Archie B., 2012, CORPORATE RESPONSIBI; Chapple W., 2005, BUS SOC, V44, P415, DOI 10.1177/0007650305281658; Chapple W., 2014, AC MAN ANN C 2014 PH; Chapple Wendy, 2007, Corporate Social Responsibility and Environmental Management, V14, DOI 10.1002/csr.159; Chia H. -B., 2007, ASIA PACIFIC J MANAG, V24, P305, DOI DOI 10.1007/S10490-006-9033-0; CIA, 2015, WORLD FACT BOOK; Crane A, 2014, CALIF MANAGE REV, V56, P130, DOI 10.1525/cmr.2014.56.2.130; De Bakker F. G. A., 2005, BUS SOC, V44, P283, DOI DOI 10.1177/0007650305278086; de Bettignies H.-C., 2007, INT MANAGEMENT REV, V3, P17; Drucker P.F., 1981, HARVARD BUSINESS JAN, P83; Dusuki A., 2008, REV ISLAMIC EC, V12, P5; Freeman R., 1984, STRATEGIC MANAGEMENT; Freeman R. E., 2000, BUSINESS ETHICS Q, V10, P169, DOI 10.2307/3857703; Freeman R. E., 1994, BUSINESS ETHICS Q, V4, P409, DOI DOI 10.2307/3857340; Freeman R.E., 2007, MANAGING STAKEHOLDER; Fukukawa K., 2004, J CORPORATE CITIZENS, V16, P45; Gond J.-P., 2011, INTRO CORPORATE SOCI, V4; Grayson D., 2013, CORPORATE RESPONSIBI; Hague R., 2013, COMP POLITICS INTRO; Hall P., 2001, VARIETIES CAPITALISM; Hamdan M.H., 2014, CORPORATE SOCIAL RES, P85; Hanlon R.J., 2014, CORPORATE SOCIAL RES; Ip PK, 2009, J BUS ETHICS, V88, P463, DOI 10.1007/s10551-009-0120-2; Jamali D., 2012, CSR MIDDLE E FRESH P; Kamla R, 2006, ACCOUNTING FORUM, V30, P245, DOI 10.1016/j.accfor.2006.05.003; Kang N., 2011, SOCIO-ECON REV, V10, P85; Knott K., 2000, HINDUISM VERY SHORT; Koehn D., 2004, HDB ASIAN MANAGEMENT, P265, DOI 10.1007/1-4020-7932-X_9; KPMG, 2013, KPMG SURV CORP RESP; Kraisornsuthasinee S., 2012, SOCIAL RESPONSIBILIT, V8, P186; Lee H.J., 2005, KOREAN NPO REV, V4, P101; Lorenzo-Molo M.C.F., 2009, ASIA BUSINESS MANAGE, V8, P149; Macfarlane A., 1987, CULTURE CAPITALISM; Molteni M., 2006, CORPORATE GOVERNANCE, V6, P516, DOI [10.1108/14720700610689612, DOI 10.1108/14720700610689612]; Moon H.K., 2005, KOREAN NPO REV, V4, P183; Moon J., 2009, GETTING ENGAGED ROLE; Moon J., 2007, ROLE STAKEHOLDER ENG; Moon J., 2014, CORPORATE SOCIAL RES; Muniapan B., 2004, CORPORATE SOCIAL RES, P19; Muniapan Balakrishnan, 2013, J HUMAN VALUES, V19.2, P173, DOI DOI 10.1177/0971685813492265; PAINE LS, 1994, HARVARD BUS REV, V72, P106; Pew Research Center, 2012, GLOB REL LANDSC; PFEFFER J, 1994, CALIF MANAGE REV, V36, P9; Phillips R, 2003, BUS ETHICS Q, V13, P479; Porter M., 2002, HARVARD BUS REV, V80, P57; Porter ME, 2011, HARVARD BUS REV, V89, P62; Porter M.E., 2004, GLOBAL COMPETITIVENE; Rafik I., 2005, J BUS ETHICS, V60, P131; Redington I., 2005, MAKING CSR HAPPEN CO; Saito A., 2008, ENCY BUSINESS ETHICS, P208; Saito A., 2008, J JAPAN SOC BUSINESS, V15, P283; Stark A, 1993, HARVARD BUSINESS MAY, P38; Strand R, 2015, J BUS ETHICS, V127, P65, DOI 10.1007/s10551-013-1792-1; Tajima K, 2008, ENCY BUSINESS ETHICS, P1245; Tamney J.B., 1998, ENCY RELIG SOC, P31; Ullah S., 2010, INT REV BUSINESS RES, V6, P619; van Zyl, 2013, INT J INNOVATION SUS, V7, P46; Welford R., 2005, J CORPORATE CITIZENS, V17, P33; Welford R., 2004, J CORPORATE CITIZENS, V2004, P31; Wokutch RE, 1999, BUSINESS ETHICS Q, V9, P527, DOI DOI 10.2307/3857515; Wright P, 1981, HARVARD BUS REV, P34; Wu B., BUSINESS SO IN PRESS; Wu J., 2015, BUSINESS SOC REV, V120, P1; Zhu YX, 2015, J BUS ETHICS, V126, P613, DOI 10.1007/s10551-013-1970-1; Zsolnai L, 2011, PALGRAVE HDB SPIRITU, P88; Zsolnai L, 2006, SOC BUSINESS REV, V1, P37, DOI 10.1108/17465680610643337	108	0	0	PALGRAVE MACMILLAN LTD	BASINGSTOKE	BRUNEL RD BLDG, HOUNDMILLS, BASINGSTOKE RG21 6XS, HANTS, ENGLAND	1472-4782	1476-9328		ASIAN BUS MANAG	Asian. Bus. Manag.	DEC	2015	14	5					349	382		10.1057/abm.2015.15		34	Business; Management	Business & Economics	CX6VO	WOS:000365840000001		
J	Karato, K; Movshuk, O; Shimizu, C				Karato, Koji; Movshuk, Oleksandr; Shimizu, Chihiro			Semiparametric Model of Hedonic Housing Prices in Japan	ASIAN ECONOMIC JOURNAL			English	Article						age effect; cohort effect; generalized additive model; hedonic price index	DEPRECIATION; MAINTENANCE; COHORT; RATES; AGE	We propose a semiparametric hedonic model of housing prices with nonlinearity in age and cohort effects. The model avoids the simultaneity problem among age, cohort and year effects, which is a common problem in linear hedonic models. Applying the model to housing prices in Tokyo between 1990 and 2008 revealed significant nonlinearities in both the age and cohort effects, and significant interactions between these effects, with the shape of the age effect differing across housing cohorts. Estimates of the year effect indicated a declining trend in prices that was more pronounced compared with those of conventional linear hedonic models.	[Karato, Koji; Movshuk, Oleksandr] Toyama Univ, Fac Econ, Toyama 9308555, Japan; [Shimizu, Chihiro] Natl Univ Singapore, Inst Real Estate Studies, Singapore 119613, Singapore	Movshuk, O (reprint author), Toyama Univ, Fac Econ, 3190 Gofuku, Toyama 9308555, Japan.	movshuk@eco.u-toyama.ac.jp					McKenzie DJ, 2006, OXFORD B ECON STAT, V68, P473, DOI 10.1111/j.1468-0084.2006.00173.x; Wilhelmsson M, 2008, J HOUS ECON, V17, P88, DOI 10.1016/j.jhe.2007.09.001; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Fu WJ, 2008, SOCIOL METHOD RES, V36, P327, DOI 10.1177/0049124107310637; Sirmans GS, 2006, J REAL ESTATE FINANC, V33, P215, DOI 10.1007/s11146-006-9983-5; Harding JP, 2007, J URBAN ECON, V61, P193, DOI 10.1016/j.jue.2006.07.007; BAILEY MJ, 1963, J AM STAT ASSOC, V58, P933; Coulson E. N., 2008, J HOUS ECON, V17, P138; Japan Housing Finance Agency, 2015, INF INT RAT FLAT 35; Karato K., 2010, 256 U TOYAM; Ministry of Land Infrastructure Transport and Tourism, 2015, JAP RES PROP PRIC IN; Wood S. N., 2006, GEN ADDITIVE MODELS; Yang Y., 2013, AGE PERIOD COHORT AN	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-3958	1467-8381		ASIAN ECON J	Asian Econ. J.	DEC	2015	29	4					325	345		10.1111/asej.12077		21	Economics	Business & Economics	CX9GB	WOS:000366011900002		
J	Hakim, H; Thammakarn, C; Suguro, A; Ishida, Y; Nakajima, K; Kitazawa, M; Takehara, K				Hakim, Hakimullah; Thammakarn, Chanathip; Suguro, Atsushi; Ishida, Yuki; Nakajima, Katsuhiro; Kitazawa, Minori; Takehara, Kazuaki			Aerosol Disinfection Capacity of Slightly Acidic Hypochlorous Acid Water Towards Newcastle Disease Virus in the Air: An In Vivo Experiment	AVIAN DISEASES			English	Article						aerosol disinfectant; biosecurity; Newcastle disease virus; spray; virus inactivation	AVIAN INFLUENZA-VIRUS; ELECTROLYZED WATER; INFECTED CHICKENS; AIRBORNE SPREAD; TRANSMISSION; POULTRY; VACCINATION; ENVIRONMENT; MICROBES; BACTERIA	Existence of bioaerosol contaminants in farms and outbreaks of some infectious organisms with the ability of transmission by air increase the need for enhancement of biosecurity, especially for the application of aerosol disinfectants. Here we selected slightly acidic hypochlorous acid water (SAHW) as a candidate and evaluated its virucidal efficacy toward a virus in the air. Three-day-old conventional chicks were challenged with 25 doses of Newcastle disease live vaccine (B1 strain) by spray with nebulizer (particle size <3 mu m in diameter), while at the same time reverse osmosis water as the control and SAHW containing 50 or 100 parts per million (ppm) free available chlorine in pH 6 were sprayed on the treated chicks with other nebulizers. Exposed chicks were kept in separated cages in an isolator and observed for clinical signs. Oropharyngeal swab samples were collected from 2 to 5 days postexposure from each chick, and then the samples were titrated with primary chicken kidney cells to detect the virus. Cytopathic effects were observed, and a hemagglutination test was performed to confirm the result at 5 days postinoculation. Clinical signs (sneezing) were recorded, and the virus was isolated from the control and 50 ppm treatment groups, while no clinical signs were observed in and no virus was isolated from the 100 ppm treatment group. The virulent Newcastle disease virus (NDV) strain Sato, too, was immediately inactivated by SAHW containing 50 ppm chlorine in the aqueous phase. These data suggest that SAHW containing 100 ppm chlorine can be used for aerosol disinfection of NDV in farms.	[Hakim, Hakimullah; Thammakarn, Chanathip; Suguro, Atsushi; Ishida, Yuki; Nakajima, Katsuhiro; Kitazawa, Minori; Takehara, Kazuaki] Tokyo Univ Agr & Technol, Fac Agr, Dept Vet Med, Hlth Anim Lab, Fuchu, Tokyo 1838509, Japan; [Hakim, Hakimullah; Thammakarn, Chanathip; Takehara, Kazuaki] Gifu Univ, United Grad Sch Vet Sci, Gifu 5011193, Japan	Takehara, K (reprint author), Tokyo Univ Agr & Technol, Fuchu, Tokyo 183, Japan.	takehara@cc.tuat.ac.jp					Alexander D. J., 1997, DIS POULTRY, P541; Alexander DJ, 2008, DIS POULTRY, V12, P75; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Zhao Y, 2011, AEROSOL SCI TECH, V45, P432, DOI 10.1080/02786826.2010.543197; Seo IH, 2013, ACTA HORTIC, V1008, P57; TAKEHARA K, 1987, AVIAN DIS, V31, P125, DOI 10.2307/1590784; Kinde H, 2004, AVIAN DIS, V48, P669, DOI 10.1637/7161-020104R; Guan JW, 2013, AVIAN DIS, V57, P645, DOI 10.1637/10486-010913-Reg.1; Zhao Y, 2014, ANN AGR ENV MED, V21, P249, DOI 10.5604/1232-1966.1108585; van Boven M, 2008, AVIAN PATHOL, V37, P1, DOI 10.1080/03079450701772391; Zheng WC, 2013, J AIR WASTE MANAGE, V63, P1205, DOI 10.1080/10962247.2013.812815; Spekreijse D, 2013, INFLUENZA OTHER RESP, V7, P132, DOI 10.1111/j.1750-2659.2012.00362.x; Seal BS, 2000, DEV COMP IMMUNOL, V24, P257, DOI 10.1016/S0145-305X(99)00077-4; MAY KR, 1968, J GEN MICROBIOL, V51, P353; HOFSTAD MS, 1966, AVIAN DIS, V10, P230, DOI 10.2307/1588355; Yen HL, 2012, NATURE, V486, P332, DOI 10.1038/nature11192; Alexander DJ, 2000, REV SCI TECH OIE, V19, P443; Dortmans JCFM, 2012, VET MICROBIOL, V160, P17, DOI 10.1016/j.vetmic.2012.05.003; Gast RK, 2004, AVIAN DIS, V48, P148, DOI 10.1637/7086; COUCH RB, 1966, BACTERIOL REV, V30, P517; Ruenphet S, 2012, J VET MED SCI, V74, P905, DOI 10.1292/jvms.11-0502; Brodka K, 2012, INT J OCCUP MED ENV, V25, P281, DOI 10.2478/S13382-012-0032-8; Li XX, 2009, VET MICROBIOL, V136, P226, DOI 10.1016/j.vetmic.2008.11.002; Thomas C, 2008, J FOOD PROTECT, V71, P1214; Yao ML, 2011, BERL MUNCH TIERARZTL, V124, P136, DOI 10.2376/0005-9366-124-136; ALEXANDER DJ, 1995, J COMP PATHOL, V112, P105, DOI 10.1016/S0021-9975(05)80054-4; Alphin RL, 2010, AVIAN DIS, V54, P757, DOI 10.1637/8764-033109-Reg.1; Couch R B, 1969, Trans Am Clin Climatol Assoc, V80, P205; CUMMING R B, 1970, Avian Diseases, V14, P191, DOI 10.2307/1588572; Hakim H, 2015, J VET MED SCI, V77, P211, DOI 10.1292/jvms.14-0413; Hao XX, 2013, POULTRY SCI, V92, P2560, DOI 10.3382/ps.2013-03117; HUGHJONE.M, 1973, J HYG-CAMBRIDGE, V71, P325; Kaleta E. F., 1988, Newcastle disease., P197; Kawamura H., 1965, National Institute of Animal Health Quarterly, V5, P115; Knight V, 1980, Ann N Y Acad Sci, V353, P147, DOI 10.1111/j.1749-6632.1980.tb18917.x; Marinova-Petkova A., 2015, EMERG MICROBES INFEC, V3, pe11; MATUMOTO M., 1949, JAP JOUR EXPTL MED, V20, P175; Pedersen K., 2013, AVIAN DIS, V58, P129; Ssematimba A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031114; Umino Y., 1991, BEHRING I MITT, V89, P59	40	0	0	AMER ASSOC AVIAN PATHOLOGISTS	ATHENS	953 COLLEGE STATION RD, ATHENS, GA 30602-4875 USA	0005-2086	1938-4351		AVIAN DIS	Avian Dis.	DEC	2015	59	4					486	491				6	Veterinary Sciences	Veterinary Sciences	CX5VO	WOS:000365770800003		
J	Deiana, S; Watanabe, A; Yamasaki, Y; Amada, N; Kikuchi, T; Stott, C; Riedel, G				Deiana, Serena; Watanabe, Akihito; Yamasaki, Yuki; Amada, Naoki; Kikuchi, Tetsuro; Stott, Colin; Riedel, Gernot			MK-801-induced deficits in social recognition in rats: reversal by aripiprazole, but not olanzapine, risperidone, or cannabidiol	BEHAVIOURAL PHARMACOLOGY			English	Article						aripiprazole; cannabidiol; dizocilpine (MK-801); rat; recognition; risperidone; short-term memory; social interaction; three-chamber apparatus	SPATIAL WORKING-MEMORY; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; ATYPICAL ANTIPSYCHOTIC-DRUG; NMDA RECEPTOR ANTAGONISTS; MORRIS WATER MAZE; COGNITIVE IMPAIRMENT; SCHIZOPHRENIC-PATIENTS; DOPAMINE-D-2 RECEPTOR; NEGATIVE SYMPTOMS; 5-HT1A RECEPTORS	Deficiencies in social activities are hallmarks of numerous brain disorders. With respect to schizophrenia, social withdrawal belongs to the category of negative symptoms and is associated with deficits in the cognitive domain. Here, we used the N-methyl-d-aspartate receptor antagonist dizocilpine (MK-801) for induction of social withdrawal in rats and assessed the efficacy of several atypical antipsychotics with different pharmacological profiles as putative treatment. In addition, we reasoned that the marijuana constituent cannabidiol (CBD) may provide benefit or could be proposed as an adjunct treatment in combination with antipsychotics. Hooded Lister rats were tested in the three-chamber version for social interaction, with an initial novelty phase, followed after 3min by a short-term recognition memory phase. No drug treatment affected sociability. However, distinct effects on social recognition were revealed. MK-801 reduced social recognition memory at all doses (>0.03mg/kg). Predosing with aripiprazole dose-dependently (2 or 10mg/kg) prevented the memory decline, but doses of 0.1mg/kg risperidone or 1mg/kg olanzapine did not. Intriguingly, CBD impaired social recognition memory (12 and 30mg/kg) but did not rescue the MK-801-induced deficits. When CBD was combined with protective doses of aripiprazole (CBD-aripiprazole at 12:1 or 5:2mg/kg) the benefit of the antipsychotic was lost. At the same time, activity-related changes in behaviour were excluded as underlying reasons for these pharmacological effects. Collectively, the combined activity of aripiprazole on dopamine D2 and serotonin 5HT1A receptors appears to provide a significant advantage over risperidone and olanzapine with respect to the rescue of cognitive deficits reminiscent of schizophrenia. The differential pharmacological properties of CBD, which are seemingly beneficial in human patients, did not back-translate and rescue the MK-801-induced social memory deficit. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Deiana, Serena; Watanabe, Akihito; Yamasaki, Yuki; Amada, Naoki; Riedel, Gernot] Sch Med Sci, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Stott, Colin] GW Res Ltd, Histon, Cambs, England; [Watanabe, Akihito; Yamasaki, Yuki; Amada, Naoki; Kikuchi, Tetsuro] Otsuka Pharmaceut Co Ltd, Qs Res Inst, Tokushima 77101, Japan	Riedel, G (reprint author), Sch Med Sci, Inst Med Sci, Aberdeen AB25 2ZD, Scotland.	g.riedel@abdn.ac.uk			GW Pharma Ltd (UK); Otsuka Pharmaceuticals Co. Ltd (Japan)	This study was supported by GW Pharma Ltd (UK) and Otsuka Pharmaceuticals Co. Ltd (Japan).	ANDREASSON S, 1987, LANCET, V2, P1483; Bruins Slot Liesbeth A, 2005, Neuropharmacology, V49, P996, DOI 10.1016/j.neuropharm.2005.05.013; Gao XM, 2009, PHARMACOL BIOCHEM BE, V92, P236, DOI 10.1016/j.pbb.2008.11.016; Lawler CP, 1999, NEUROPSYCHOPHARMACOL, V20, P612, DOI 10.1016/S0893-133X(98)00099-2; SamsDodd F, 1997, BEHAV PHARMACOL, V8, P196; Grunder G, 2003, ARCH GEN PSYCHIAT, V60, P974, DOI 10.1001/archpsyc.60.10.974; Pertwee RG, 2005, LIFE SCI, V76, P1307, DOI 10.1016/j.lfs.2004.10.025; Long LE, 2010, INT J NEUROPSYCHOPH, V13, P861, DOI 10.1017/S1461145709990605; Zuardi AW, 2006, BRAZ J MED BIOL RES, V39, P421, DOI 10.1590/S0100-879X2006000400001; Nowakowska E, 1999, POL J PHARMACOL, V51, P295; Fagherazzi EV, 2012, PSYCHOPHARMACOLOGY, V219, P1133, DOI 10.1007/s00213-011-2449-3; Almeida V, 2014, SCHIZOPHR RES, V153, P150, DOI 10.1016/j.schres.2014.01.039; Millan MJ, 2013, NEUROSCI BIOBEHAV R, V37, P2166, DOI 10.1016/j.neubiorev.2013.09.012; Petitet F, 1998, LIFE SCI, V63, pPL1, DOI 10.1016/S0024-3205(98)00238-0; van der Staay FJ, 2011, BEHAV BRAIN RES, V220, P215, DOI 10.1016/j.bbr.2011.01.052; Winsauer PJ, 1999, J PHARMACOL EXP THER, V288, P335; Kimberg DY, 2001, HUM BRAIN MAPP, V12, P246, DOI 10.1002/1097-0193(200104)12:4<246::AID-HBM1019>3.0.CO;2-9; Roesch-Ely D, 2005, PSYCHOPHARMACOLOGY, V178, P420, DOI 10.1007/s00213-004-2027-z; Bisogno T, 2001, BRIT J PHARMACOL, V134, P845, DOI 10.1038/sj.bjp.0704327; Malone DT, 2009, PHARMACOL BIOCHEM BE, V93, P91, DOI 10.1016/j.pbb.2009.04.010; Deiana S, 2013, DRUG TEST ANAL, V5, P46, DOI 10.1002/dta.1425; Mehta MA, 2004, PSYCHOPHARMACOLOGY, V176, P331, DOI 10.1007/s00213-004-1899-2; Malhotra AK, 1997, NEUROPSYCHOPHARMACOL, V17, P141; Suzuki H, 2011, PROG NEURO-PSYCHOPH, V35, P161, DOI 10.1016/j.pnpbp.2010.10.021; Davidson M, 1999, AM J PSYCHIAT, V156, P1328; CARLI M, 1995, BEHAV BRAIN RES, V67, P67, DOI 10.1016/0166-4328(94)00105-O; Robinson L, 2010, BEHAV BRAIN RES, V208, P584, DOI 10.1016/j.bbr.2010.01.004; Inoue A, 1997, EUR J PHARMACOL, V321, P105, DOI 10.1016/S0014-2999(96)00920-X; Ishiyama T, 2007, EUR J PHARMACOL, V572, P160, DOI 10.1016/j.ejphar.2007.06.058; DEUTCH AY, 1987, EUR J PHARMACOL, V134, P257, DOI 10.1016/0014-2999(87)90356-6; Zhang W, 1999, PSYCHOPHARMACOLOGY, V141, P267, DOI 10.1007/s002130050834; Keefe RSE, 2007, ARCH GEN PSYCHIAT, V64, P633, DOI 10.1001/archpsyc.64.6.633; Long LE, 2006, NEUROPSYCHOPHARMACOL, V31, P795, DOI 10.1038/sj.npp.1300838; STECKLER T, 1995, BEHAV BRAIN RES, V67, P165, DOI 10.1016/0166-4328(94)00157-B; Goonawardena AV, 2010, LEARN MEMORY, V17, P502, DOI 10.1101/lm.1893710; Hallak JEC, 2010, REV BRAS PSIQUIATR, V32, P56, DOI 10.1590/S1516-44462010000100011; Parker LA, 2011, BRIT J PHARMACOL, V163, P1411, DOI 10.1111/j.1476-5381.2010.01176.x; Furuie H, 2013, BEHAV PHARMACOL, V24, P678, DOI 10.1097/FBP.0000000000000003; Jentsch JD, 1997, J NEUROSCI, V17, P1769; Mutlu O, 2011, PHARMACOL BIOCHEM BE, V98, P398, DOI 10.1016/j.pbb.2011.02.009; Leite JV, 2008, EUR J PHARMACOL, V578, P222, DOI 10.1016/j.ejphar.2007.09.016; JANSSEN PAJ, 1988, J PHARMACOL EXP THER, V244, P685; Burris KD, 2002, J PHARMACOL EXP THER, V302, P381, DOI 10.1124/jpet.102.033175; Houthoofd SAMK, 2008, CLIN THER, V30, P1565, DOI 10.1016/j.clinthera.2008.09.014; Reilly JL, 2006, ARCH GEN PSYCHIAT, V63, P1189, DOI 10.1001/archpsyc.63.11.1189; Cheng D, 2014, PSYCHOPHARMACOLOGY, V231, P3009, DOI 10.1007/s00213-014-3478-5; Strange PG, 2001, PHARMACOL REV, V53, P119; Maat A, 2014, EUR NEUROPSYCHOPHARM, V24, P575, DOI 10.1016/j.euroneuro.2013.12.009; Carrier EJ, 2006, P NATL ACAD SCI USA, V103, P7895, DOI 10.1073/pnas.0511232103; CORBETT R, 1995, PSYCHOPHARMACOLOGY, V120, P67, DOI 10.1007/BF02246146; Cassol OJ, 2010, BRAIN RES, V1348, P128, DOI 10.1016/j.brainres.2010.06.023; Kapur S, 2003, PROG NEURO-PSYCHOPH, V27, P1081, DOI 10.1016/j.pnpbp.2003.09.004; Newman-Tancredi A, 2010, CURR OPIN INVEST DR, V11, P802; Morales M, 2013, BEHAV BRAIN RES, V250, P18, DOI 10.1016/j.bbr.2013.04.050; Rock EM, 2011, PSYCHOPHARMACOLOGY, V215, P505, DOI 10.1007/s00213-010-2157-4; Russo EB, 2005, NEUROCHEM RES, V30, P1037, DOI 10.1007/s11064-005-6978-1; Gururajan A, 2011, BEHAV BRAIN RES, V222, P299, DOI 10.1016/j.bbr.2011.03.053; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Palmer BW, 1997, NEUROPSYCHOLOGY, V11, P437, DOI 10.1037//0894-4105.11.3.437; Miller DW, 1996, BRAIN RES BULL, V40, P57, DOI 10.1016/0361-9230(95)02144-2; Roberts DL, 2010, PSYCHIAT RES, V178, P46, DOI 10.1016/j.psychres.2010.04.006; Thomas A, 2007, BRIT J PHARMACOL, V150, P613, DOI 10.1038/sj.bjp.0707133; Fadda P, 2004, NEUROPHARMACOLOGY, V47, P1170, DOI 10.1016/j.neuropharm.2004.08.009; Inoue T, 1996, J PHARMACOL EXP THER, V277, P137; Leweke FM, 1999, NEUROREPORT, V10, P1665, DOI 10.1097/00001756-199906030-00008; Riedel G, 2009, BEHAV BRAIN RES, V204, P217, DOI 10.1016/j.bbr.2009.06.012; McGurk SR, 2005, AM J PSYCHIAT, V162, P1013, DOI 10.1176/appi.ajp.162.5.1013; Purdon SE, 2001, J PSYCHIATR NEUROSCI, V26, P137; KIKUCHI T, 1995, J PHARMACOL EXP THER, V274, P329; Hlinak Z, 2003, PHYSIOL RES, V52, P805; Martin P, 1998, NEUROREPORT, V9, P2985, DOI 10.1097/00001756-199809140-00012; Bertrand MC, 2007, SCHIZOPHR RES, V95, P124, DOI 10.1016/j.schres.2007.05.033; Jolas T, 1997, BRAIN RES, V755, P229, DOI 10.1016/S0006-8993(97)00103-0; LAHTI AC, 1995, NEUROPSYCHOPHARMACOL, V13, P9, DOI 10.1016/0893-133X(94)00131-I; Shapiro DA, 2003, NEUROPSYCHOPHARMACOL, V28, P1400, DOI 10.1038/sj.npp.1300203; Morales M, 2014, PSYCHOPHARMACOLOGY, V231, P1797, DOI 10.1007/s00213-013-3278-3; Leweke FM, 2007, SCHIZOPHR RES, V94, P29, DOI 10.1016/j.schres.2007.04.025; Zuardi AW, 2012, CURR PHARM DESIGN, V18, P5131, DOI 10.2174/138161212802884681; [Anonymous], 1996, BEHAV BRAIN RES; Nuechterlein KH, 2004, SCHIZOPHR RES, V72, P29, DOI 10.1016/j.schres.2004.09.007; Dyck B, 2011, SCHIZOPHR RES, V125, P88, DOI 10.1016/j.schres.2010.09.025; Mishara AL, 2004, BIOL PSYCHIAT, V55, P1013, DOI 10.1016/j.biopsych.2004.01.027; Parolaro D, 2010, EXP NEUROL, V224, P3, DOI [10.1016/j.expneurol.2010.03.018, 10.1016/j.expneuro1.2010.03.018]; Green MF, 2004, SCHIZOPHR RES, V72, P41, DOI 10.1016/j.schres.2004.09.009; Green MF, 1997, AM J PSYCHIAT, V154, P799; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199; Chadman KK, 2011, PHARMACOL BIOCHEM BE, V97, P586, DOI 10.1016/j.pbb.2010.09.012; Littrell KH, 2004, SCHIZOPHR RES, V66, P201, DOI 10.1016/S0920-9964(03)00185-3; Almeida V, 2013, PROG NEURO-PSYCHOPH, V41, P30, DOI 10.1016/j.pnpbp.2012.10.024; CASSENS G, 1990, SCHIZOPHRENIA BULL, V16, P477; Oshiro Y, 1998, J MED CHEM, V41, P658, DOI 10.1021/jm940608g; Mamo D, 2007, AM J PSYCHIAT, V164, P1411, DOI 10.1176/appi.apj.2007.0601479; Gururajan A, 2012, J PSYCHOPHARMACOL, V26, P1317, DOI 10.1177/0269881112441865; Didriksen M, 2006, EUR J PHARMACOL, V542, P108, DOI 10.1016/j.ejphar.2006.05.021; Kovasznay B, 1997, SCHIZOPHRENIA BULL, V23, P195; Black MD, 2002, NEUROPHARMACOLOGY, V42, P414, DOI 10.1016/S0028-3908(01)00180-0; Stefanik P, 2015, PHARMACOL BIOCHEM BE, V131, P42, DOI 10.1016/j.pbb.2015.01.021; Beasley CM, 1996, NEUROPSYCHOPHARMACOL, V14, P111, DOI 10.1016/0893-133X(95)00069-P; Kapur S, 2004, TRENDS PHARMACOL SCI, V25, P402, DOI 10.1016/j.tips.2004.06.005; Skarsfeldt T, 1996, PSYCHOPHARMACOLOGY, V124, P126, DOI 10.1007/BF02245612; Pinkham AE, 2014, J CLIN PSYCHIAT, V75, P14, DOI 10.4088/JCP.13065su1.04; Harvey PD, 2005, AM J PSYCHIAT, V162, P1888, DOI 10.1176/appi.ajp.162.10.1888; Verma V, 2005, J PHARMACOL EXP THER, V315, P1228, DOI 10.1124/jpet.105.091256; Campos AC, 2012, PHILOS T R SOC B, V367, P3364, DOI 10.1098/rstb.2011.0389; Keefe RSE, 1999, SCHIZOPHRENIA BULL, V25, P201; Liou GI, 2008, INVEST OPHTH VIS SCI, V49, P5526, DOI 10.1167/iovs.08-2196; Madhusoodanan S, 1999, CNS DRUGS, V12, P135, DOI 10.2165/00023210-199912020-00006; COLE BJ, 1994, PSYCHOPHARMACOLOGY, V116, P135, DOI 10.1007/BF02245055; Mehta MA, 2001, PSYCHOPHARMACOLOGY, V159, P10, DOI 10.1007/s002130100851; Zuardi AW, 2008, REV BRAS PSIQUIATR, V30, P271, DOI 10.1590/S1516-44462008000300015; ZUARDI AW, 1995, J CLIN PSYCHIAT, V56, P485; ZUARDI AW, 1991, PSYCHOPHARMACOLOGY, V104, P260, DOI 10.1007/BF02244189; Yoshimi N, 2015, EUR NEUROPSYCHOPHARM, V25, P356, DOI 10.1016/j.euroneuro.2014.12.014; Pertwee RG, 2010, CURR MED CHEM, V17, P1360; Enomoto T, 2008, BEHAV BRAIN RES, V186, P197, DOI 10.1016/j.bbr.2007.08.012; Bubenikova-Valesova V, 2008, P NATL ACAD SCI USA, V105, P1061, DOI 10.1073/pnas.0711273105; Campos AC, 2014, NEUROSCIENCE, V289, P166; Cheng D, 2014, J ALZHEIMERS DIS, V42, P1383, DOI 10.3233/JAD-140921; Chua L., 2001, SMJ Singapore Medical Journal, V42, P243; De Marchi Nicola, 2003, Lipids Health Dis, V2, P5, DOI 10.1186/1476-511X-2-5; Depoortere R, 2007, BRIT J PHARMACOL, V151, P253, DOI 10.1038/sj.bjp.0707159; Iseger TA, 2015, SCHIZOPHR RES, V162, P153, DOI 10.1016/j.schres.2015.01.033; Levin R, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00010; Leweke FM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.15; Leweke FM, 2007, EUR PSYCHIAT S, VS22, P21; Leweke FM, 2009, EUR PSYCHIAT, V24, pS207; Ma GF, 2014, INT J NEUROPSYCHOPHA, V18; Madhusoodanan S, 2001, Ann Clin Psychiatry, V13, P201, DOI 10.3109/10401230109147384; Matsukawa Noriko, 2013, Nihon Rinsho, V71, P615; McPartland JM, 2015, BRIT J PHARMACOL, V172, P737, DOI 10.1111/bph.12944; Medalia A, 1988, Arch Clin Neuropsychol, V3, P249, DOI 10.1016/0887-6177(88)90018-2; Mueser KT, 1998, HDB SOCIAL FUNCTIONI, P79; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Richelson E, 2000, LIFE SCI, V68, P29, DOI 10.1016/S0024-3205(00)00911-5; Rung JP, 2005, PROG NEURO-PSYCHOPH, V29, P827, DOI 10.1016/j.pnpbp.2005.03.004; Zanelati TV, 2010, BRIT J PHARMACOL, V159, P122, DOI 10.1111/j.1476-5381.2009.00521.x	136	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0955-8810	1473-5849		BEHAV PHARMACOL	Behav. Pharmacol.	DEC	2015	26	8			SI		748	765		10.1097/FBP.0000000000000178		18	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	CX2UK	WOS:000365552100005		
J	Yang, CJ; Takeda, M; Terauchi, T; Jee, J; Kainosho, M				Yang, Chun-Jiun; Takeda, Mitsuhiro; Terauchi, Tsutomu; Jee, JunGoo; Kainosho, Masatsune			Differential Large-Amplitude Breathing Motions in the Interface of FKBP12-Drug Complexes	BIOCHEMISTRY			English	Article							PANCREATIC TRYPSIN-INHIBITOR; AROMATIC SIDE-CHAINS; NUCLEAR-MAGNETIC-RESONANCE; HYDROGEN-EXCHANGE RATES; TYROSINE RING FLIPS; NMR-SPECTROSCOPY; IMMUNOSUPPRESSANT FK506; C-13 RELAXATION; PROTEIN RECOGNITION; BINDING-PROTEIN	The tight complexes FKBP12 forms with immunosuppressive drugs, such as FK506 and rapamycin, are frequently used as models for developing approaches to structure-based drug design. Although the interfaces between FKBP12 and these ligands are well-defined structurally and are almost identical in the X-ray crystallographic structures of various complexes, our nuclear magnetic resonance studies have revealed the existence of substantial large-amplitude motions in the FKBP12-ligand interfaces that depend on the nature of the ligand. We have monitored these motions by measuring the rates of Tyr and Phe aromatic ring flips, and hydroxyl proton exchange for residues clustered within the FKBP12-ligand interface. The results show that the rates of hydroxyl proton exchange and ring flipping for Tyr26 are much slower in the FK506 complex than in the rapamycin complex, whereas the rates of ring flipping for Phe48 and Phe99 are significantly faster in the FK506 complex than in the rapamycin complex. The apparent rate differences observed for the interfacial aromatic residues in the two complexes confirm that these dynamic processes occur without ligand dissociation. We tentatively attribute the differential interface dynamics for these complexes to a single hydrogen bond between the zeta-hydrogen of Phe46 and the C32 carbonyl oxygen of rapamycin, which is not present in the KF506 complex. This newly identified Phe46 zeta-hydrogen bond in the rapamycin complex imposes motional restriction on the surrounding hydrophobic cluster and subsequently regulates the dynamics within the protein-ligand interface. Such information concerning large-amplitude dynamics at drug-target interfaces has the potential to provide novel clues for drug design.	[Yang, Chun-Jiun; Terauchi, Tsutomu; Jee, JunGoo; Kainosho, Masatsune] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Chem, Hachioji, Tokyo 1920397, Japan; [Takeda, Mitsuhiro; Kainosho, Masatsune] Nagoya Univ, Grad Sch Sci, Struct Biol Res Ctr, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Kainosho, M (reprint author), Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Chem, 1-1 Minami Ohsawa, Hachioji, Tokyo 1920397, Japan.	kainosho@tmu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [21121002, 26119005, 25440018]; Platform Project for Supporting in Drug Discovery and Life Science Research from MEXT; Japan Agency for Medical Research and Development (AMED); Advanced Research Program, under the Asian Human Resources Fund Program - Tokyo Metropolitan Government	Financial support from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) by a Grant-in-Aid in Innovative Areas (21121002) to M.K. and J.J., a Grant-in-Aid in Innovative Areas (26119005) to M.K., and a Grant-in-Aid for Scientific Research (C) (25440018) to M.T. is acknowledged. This research was supported in part by the Platform Project for Supporting in Drug Discovery and Life Science Research from MEXT, and Japan Agency for Medical Research and Development (AMED). C.-J.Y. and M.K. were also supported by the Advanced Research Program, under the Asian Human Resources Fund Program sponsored by the Tokyo Metropolitan Government.	GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; FEJZO J, 1990, J AM CHEM SOC, V112, P2574, DOI 10.1021/ja00163a014; LIEPINSH E, 1992, J BIOMOL NMR, V2, P447, DOI 10.1007/BF02192808; Sapienza PJ, 2011, J MOL BIOL, V405, P378, DOI 10.1016/j.jmb.2010.10.037; Carroll MJ, 2012, NAT CHEM BIOL, V8, P246, DOI [10.1038/nchembio.769, 10.1038/NCHEMBIO.769]; Weininger U, 2012, J BIOMOL NMR, V53, P181, DOI 10.1007/s10858-012-9650-5; Takeda M, 2009, J AM CHEM SOC, V131, P18556, DOI 10.1021/ja907911y; WUTHRICH K, 1975, FEBS LETT, V50, P265, DOI 10.1016/0014-5793(75)80504-7; Rao DK, 2007, J BIOMOL NMR, V39, P187, DOI 10.1007/s10858-007-9186-2; Weininger U, 2014, J BIOMOL NMR, V59, P23, DOI 10.1007/s10858-014-9826-2; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Klaholz BP, 2002, STRUCTURE, V10, P1197, DOI 10.1016/S0969-2126(02)00828-6; Brath U, 2009, J MOL BIOL, V387, P233, DOI 10.1016/j.jmb.2009.01.047; Teilum K, 2006, J AM CHEM SOC, V128, P2506, DOI 10.1021/ja055660o; Liepinsh E, 1996, MAGNET RESON MED, V35, P30, DOI 10.1002/mrm.1910350106; Horowitz S, 2012, J BIOL CHEM, V287, P41576, DOI 10.1074/jbc.R112.418574; Miyanoiri Y, 2011, J BIOMOL NMR, V51, P425, DOI 10.1007/s10858-011-9568-3; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Kasinath V, 2013, J AM CHEM SOC, V135, P9560, DOI 10.1021/ja4001129; Tomita A, 2009, P NATL ACAD SCI USA, V106, P2612, DOI 10.1073/pnas.0807774106; Smrcka AV, 2010, P NATL ACAD SCI USA, V107, P639, DOI 10.1073/pnas.0909503107; Palmer AG, 2001, METHOD ENZYMOL, V339, P204; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; Kainosho M, 2006, NATURE, V440, P52, DOI 10.1038/nature04525; Lichtenecker RJ, 2013, J BIOMOL NMR, V57, P327, DOI 10.1007/s10858-013-9796-9; Torizawa T, 2005, J AM CHEM SOC, V127, P12620, DOI 10.1021/ja051388m; WAGNER G, 1983, Q REV BIOPHYS, V16, P1; Krishna MMG, 2004, METHODS, V34, P51, DOI 10.1016/j.ymeth.2004.03.005; PITTARD J, 1966, J BACTERIOL, V91, P1494; WAGNER G, 1978, NATURE, V275, P247, DOI 10.1038/275247a0; Brath U, 2006, J AM CHEM SOC, V128, P5718, DOI 10.1021/ja0570279; Takeda M, 2011, J AM CHEM SOC, V133, P17420, DOI 10.1021/ja206799v; BERGLUND B, 1980, J CHEM PHYS, V73, P2037, DOI 10.1063/1.440423; Xu XF, 2008, J AM CHEM SOC, V130, P6395, DOI 10.1021/ja7101357; Fulton KF, 2003, BIOCHEMISTRY-US, V42, P2364, DOI 10.1021/bi020564a; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050; Takeda M, 2014, J MAGN RESON, V241, P148, DOI 10.1016/j.jmr.2013.10.001; Takeda M, 2010, J BIOMOL NMR, V46, P45, DOI 10.1007/s10858-009-9360-9; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Wang H, 1999, J AM CHEM SOC, V121, P1611, DOI 10.1021/ja983897x; Maity H, 2003, PROTEIN SCI, V12, P153, DOI 10.1110/ps.0225803; Hattori M, 2004, PROTEIN SCI, V13, P3104, DOI 10.1110/ps.04877104; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; WILSON KP, 1995, ACTA CRYSTALLOGR D, V51, P511, DOI 10.1107/S0907444994014514; Craescu CT, 1996, BIOCHEMISTRY-US, V35, P11045, DOI 10.1021/bi960975p; Kasinath V, 2015, ANGEW CHEM INT EDIT, V54, P102, DOI 10.1002/anie.201408220; CAMPBELL ID, 1976, FEBS LETT, V70, P96, DOI 10.1016/0014-5793(76)80734-X; Weininger U, 2013, J PHYS CHEM B, V117, P9241, DOI 10.1021/jp4058065; BIERER BE, 1990, P NATL ACAD SCI USA, V87, P9231, DOI 10.1073/pnas.87.23.9231; Skalicky JJ, 2001, J AM CHEM SOC, V123, P388, DOI 10.1021/ja0032201; Baturin SJ, 2011, J BIOMOL NMR, V51, P379, DOI 10.1007/s10858-011-9564-7; Takeda M, 2010, J AM CHEM SOC, V132, P6254, DOI 10.1021/ja101205j; Boyer JA, 2008, BIOCHEMISTRY-US, V47, P4876, DOI 10.1021/bi702330t; CHENG JW, 1994, BIOCHEMISTRY-US, V33, P4093, DOI 10.1021/bi00180a001; CLORE GM, 1991, BIOCHEMISTRY-US, V30, P12, DOI 10.1021/bi00215a002; Goddard T. D., 2007, SPARKY, V3; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; Liang J, 1999, ACTA CRYSTALLOGR D, V55, P736, DOI 10.1107/S0907444998014747; NALL BT, 1990, BIOCHEMISTRY-US, V29, P7576, DOI 10.1021/bi00485a006; ROSEN MK, 1990, SCIENCE, V248, P863, DOI 10.1126/science.1693013; Scheiner S, 2000, J MOL STRUC-THEOCHEM, V500, P441, DOI 10.1016/S0166-1280(00)00375-4; SHAKA AJ, 1983, J MAGN RESON, V52, P335, DOI 10.1016/0022-2364(83)90207-X; VANDUYNE GD, 1991, SCIENCE, V252, P839, DOI 10.1126/science.1709302; Wahl MC, 1997, TRENDS BIOCHEM SCI, V22, P97, DOI 10.1016/S0968-0004(97)01004-9; Weininger U, 2014, BIOCHEMISTRY-US, V53, P4519, DOI 10.1021/bi500462k	67	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0006-2960			BIOCHEMISTRY-US	Biochemistry	DEC 1	2015	54	47					6983	6995		10.1021/acs.biochem.5b00820		13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CX8CR	WOS:000365930700003		
J	Matsubara, T; Uchikata, A; Morimoto, J				Matsubara, Takamitsu; Uchikata, Akimasa; Morimoto, Jun			Spatiotemporal synchronization of biped walking patterns with multiple external inputs by style-phase adaptation	BIOLOGICAL CYBERNETICS			English	Article						Style-phase adaptation; Spatiotemporal synchronization; Biped walking; Teleoperation	POLICY GRADIENT-METHOD; LOCOMOTION CONTROL; HUMANOID ROBOTS; CPG; OSCILLATORS; PRIMITIVES	In this paper, we propose a framework for generating coordinated periodic movements of robotic systems with multiple external inputs. We developed an adaptive pattern generator model that is composed of a two-factor observation model with a style parameter and phase dynamics with a phase variable. The style parameter controls the spatial patterns of the generated trajectories, and the phase variable manages its temporal profiles. By exploiting the style-phase separation in the pattern generation, we can independently design adaptation schemes for the spatial and temporal profiles of the pattern generator to multiple external inputs. To validate the effectiveness of our proposed method, we applied it to a user-exoskeleton model to achieve user-adaptive walking assistance for which the exoskeleton robot's movements need to be coordinated with the user walking patterns and environment. As a result, the exoskeleton robot successfully performed stable biped walking behaviors for walking assistance even when the style of the observed walking pattern and the period were suddenly changed.	[Matsubara, Takamitsu; Uchikata, Akimasa; Morimoto, Jun] ATR Computat Neurosci Labs, Dept Brain Robot Interface, Kyoto, Japan; [Matsubara, Takamitsu; Uchikata, Akimasa] Nara Inst Sci & Technol NAIST, Nara, Japan	Matsubara, T (reprint author), ATR Computat Neurosci Labs, Dept Brain Robot Interface, Kyoto, Japan.	takam-m@is.naist.jp; xmorimo@atr.jp			JSPS KAKENHI [25540085]	This study is the result of Development of BMI Technologies for Clinical Application carried out under SRPBS, MEXT; by MIC-SCOPE; International Cooperative Program, JST and by JSPS and MIZS: Japan-Slovenia research Cooperative Program; by MEXT KAKENHI 23120004; and by JSPS KAKENHI Grant Number 25540085; by ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan); by the project commissioned by the New Energy and Industrial Technology Development Organization (NEDO).	Andre J, 2015, J INTELL ROBOT SYST, V80, P625, DOI 10.1007/s10846-015-0196-0; Nakamura Y, 2007, NEURAL NETWORKS, V20, P723, DOI 10.1016/j.neunet.2007.01.002; Suzuki K, 2007, ADV ROBOTICS, V21, P1441, DOI 10.1163/156855307781746061; Gams A, 2009, AUTON ROBOT, V27, P3, DOI 10.1007/s10514-009-9118-y; Matsubara T, 2013, IEEE T BIO-MED ENG, V60, P2205, DOI 10.1109/TBME.2013.2250502; Morimoto J, 2008, IEEE T ROBOT, V24, P185, DOI 10.1109/TRO.2008.915457; Righetti L, 2006, IEEE INT CONF ROBOT, P1585; Fukuoka Y, 2003, INT J ROBOT RES, V22, P187, DOI 10.1177/0278364903022003004; Endo G, 2008, INT J ROBOT RES, V27, P213, DOI 10.1177/0278364907084980; Nassour J, 2014, BIOL CYBERN, V108, P291, DOI 10.1007/s00422-014-0592-8; Hase K, 1998, ANTHROPOL SCI, V106, P327; Tenenbaum JB, 2000, NEURAL COMPUT, V12, P1247, DOI 10.1162/089976600300015349; Matsubara T, 2012, NEURAL NETWORKS, V25, P191, DOI 10.1016/j.neunet.2011.08.008; Nakanishi J, 2004, ROBOT AUTON SYST, V47, P79, DOI 10.1016/j.robot.2004.03.003; Matsubara T, 2006, ROBOT AUTON SYST, V54, P911, DOI 10.1016/j.robot.2006.05.012; Matsubara T, 2011, NEURAL NETWORKS, V24, P493, DOI 10.1016/j.neunet.2011.02.004; TAGA G, 1991, BIOL CYBERN, V65, P147, DOI 10.1007/BF00198086; Endo G, 2004, IEEE INT CONF ROBOT, P3036, DOI 10.1109/ROBOT.2004.1307523; Ronsse R, 2010, P IEEE RAS-EMBS INT, P668; Silva P, 2014, ROBOT AUTON SYST, V62, P1531, DOI 10.1016/j.robot.2014.05.008; Degallier S, 2011, AUTON ROBOT, V31, P155, DOI 10.1007/s10514-011-9235-2; Morimoto J, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION (ICRA), P3909, DOI 10.1109/ICRA.2012.6225236; Righetti L, 2006, PHYSICA D, V216, P269, DOI [10.1016/j.physd.2006.02.009, 10.1016/j.phvsd.2006.02.009]; Brand M, 2000, P SIGGRAPH 2000, P183, DOI 10.1145/344779.344865; Hyon S, 2011, P IEEE RSJ INT C INT, P2715; Kanda T, 2003, P INT JOINT C ART IN, P177; Kotosaka S, 2000, P INT S AD MOT AN MA, P1; Li C, 2014, FRONT NEUROROBOTICS, V8, P1, DOI 10.3389/fnbot.2014.00023; Matos V, 2014, ROBOT AUTON SYST, V62, P1669, DOI 10.1016/j.robot.2014.08.010; MATSUOKA K, 1985, BIOL CYBERN, V52, P367, DOI 10.1007/BF00449593; Michalowski MP, 2007, P 12 INT S DYN PROBL, P1, DOI 10.1145/1341012.1341021; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Ronsse R, 2011, P IEEE INT REH ROB I, P1; Strogtz SH, 1994, NONLINEAR DYNAMICS C; Taylor GW, 2009, P 26 ANN INT C MACH, P1025; Tsuchiya K., 2003, Proceedings 2003 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2003) (Cat. No.03CH37453); Wang JM, 2007, P 24 INT C MACH LEAR, P975, DOI DOI 10.1145/1273496.1273619; Zhang X, 2009, P IEEE ICRA, P659	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-1200	1432-0770		BIOL CYBERN	Biol. Cybern.	DEC	2015	109	6					597	610		10.1007/s00422-015-0663-5		14	Computer Science, Cybernetics; Neurosciences	Computer Science; Neurosciences & Neurology	CX2GH	WOS:000365514300003		
J	Inami, M; Fukushima, A; Ueno, T; Yamada, T; Tsunemi, A; Matsumoto, Y; Fukuda, N; Soma, M; Moriyama, M				Inami, Makiko; Fukushima, Akiko; Ueno, Takahiro; Yamada, Tsutomu; Tsunemi, Akiko; Matsumoto, Yoshiaki; Fukuda, Noboru; Soma, Masayoshi; Moriyama, Mitsuhiko			Reduction of Dimethylnitrosamine-Induced Liver Fibrosis by the Novel Gene Regulator PI Polyamide Targeting Transforming Growth Factor beta 1 Gene	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						pyrrole-imidazole (PI) polyamide; liver fibrosis; transforming growth factor (TGF)beta 1	PYRROLE-IMIDAZOLE POLYAMIDES; STELLATE CELL ACTIVATION; TGF-BETA; HEPATIC-FIBROSIS; RENAL-DISEASE; MINOR-GROOVE; RAT-LIVER; RECOGNITION; EXPRESSION; DNA	Pyrrole-imidazole (PI) polyamide is a novel gene regulating agent that competitively inhibits transcription factor binding to the promoter of the specific target gene. Liver fibrosis is an integral stage in the development of chronic liver disease, and transforming growth factor beta (TGF beta) is known to play a central role in the progression of this entity. The aim of this study was to evaluate the effect of PI polyamide targeting TGF beta 1 on rat liver fibrosis. PI polyamide was designed to inhibit activator protein 1 (AP-1) transcription factor binding to the TGF beta 1 gene promoter. The effect of PI polyamide on hepatic stellate cells was evaluated by real time polymerase chain reaction (PCR) in RI-T cells. To determine the effect of PI polyamide in vivo, PI polyamide was intravenously administered at a dose of 3 mg/kg/week in dimethylnitrosamine (DMN)-induced rat model of liver fibrosis. Treatment of RI-T cells with 1.0 mu M PI polyamide targeting TGF beta 1 significantly inhibited TGF beta 1 mRNA expression. Azan staining showed that DMN treatment significantly increased areas of fibrous materials compared with controls. PI polyamide targeting TGF beta 1 significantly decreased the fibrous area compared with DMN group. mRNA expression levels of alpha-smooth muscle actin and matrix metalloproteinase-2 were significantly increased in DMN-treated group compared with control. Treatment with TGF beta 1 PI polyamide significantly decreased mRNA expression of these genes compared with DMN group. The novel gene regulator PI polyamide targeting TGF beta 1 may be a feasible therapeutic agent for the treatment of chronic liver disease.	[Inami, Makiko; Fukushima, Akiko; Moriyama, Mitsuhiko] Nihon Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol,Itabashi Ku, Tokyo 1738610, Japan; [Ueno, Takahiro; Tsunemi, Akiko; Fukuda, Noboru; Soma, Masayoshi] Nihon Univ, Sch Med, Dept Med, Div Nephrol Hypertens & Endocrinol,Itabashi Ku, Tokyo 1738610, Japan; [Yamada, Tsutomu] Nihon Univ, Sch Med, Dept Pathol, Itabashi Ku, Tokyo 1738610, Japan; [Matsumoto, Yoshiaki] Nihon Univ, Coll Pharm, Dept Clin Pharmacokinet, Funabashi, Chiba 2748555, Japan	Ueno, T (reprint author), Nihon Univ, Sch Med, Dept Med, Div Nephrol Hypertens & Endocrinol,Itabashi Ku, 30-1 Ohyaguchi Kami, Tokyo 1738610, Japan.	ueno.takahiro@nihon-u.ac.jp			"Strategic Research Base Development" Program for Private Universities - MEXT	This work was partially supported by a Grant from the "Strategic Research Base Development" Program for Private Universities subsidized by MEXT (2014).	Murty MSRC, 2004, BIOL PHARM BULL, V27, P468, DOI 10.1248/bpb.27.468; Dervan PB, 2001, BIOORGAN MED CHEM, V9, P2215, DOI 10.1016/S0968-0896(01)00262-0; Yao EH, 2008, HYPERTENSION, V52, P86, DOI 10.1161/HYPERTENSIONAHA.108.112797; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Gabriel A, 2008, HEPATOL RES, V38, P141, DOI 10.1111/j.1872-034X.2007.00258.x; Mauviel A, 2005, METH MOLEC MED, V117, P69; Lai YM, 2005, J PHARMACOL EXP THER, V315, P571, DOI 10.1124/jpet.105.089086; Meindl-Beinker NM, 2008, J GASTROEN HEPATOL, V23, pS122, DOI 10.1111/j.1440-1746.2007.05297.x; Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6; Matsuda H, 2011, KIDNEY INT, V79, P46, DOI 10.1038/ki.2010.330; Bando T, 2006, ACCOUNTS CHEM RES, V39, P935, DOI 10.1021/ar030287f; Tsunemi A, 2014, J MOL MED, V92, P509, DOI 10.1007/s00109-013-1118-x; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Wang Y, 2010, J HEPATOL, V53, P132, DOI 10.1016/j.jhep.2010.02.027; Kajiwara M, 2012, BIOL PHARM BULL, V35, P2028; White S, 1997, CHEM BIOL, V4, P569, DOI 10.1016/S1074-5521(97)90243-X; Ueno T, 2009, J HYPERTENS, V27, P508, DOI 10.1097/HJH.0b013e3283207fe1; Wan JX, 2011, BIOL PHARM BULL, V34, P1572; Trauger JW, 1996, NATURE, V382, P559, DOI 10.1038/382559a0; Dervan PB, 2003, CURR OPIN STRUC BIOL, V13, P284, DOI 10.1016/S0959-440X(03)00081-2; Wurtz NR, 2001, ORG LETT, V3, P1201, DOI 10.1021/ol0156796; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Friedman SL, 1999, ALCOHOL CLIN EXP RES, V23, P904, DOI 10.1097/00000374-199905000-00020; Hautekeete ML, 1997, VIRCHOWS ARCH, V430, P195, DOI 10.1007/BF01324802; Baroni GS, 1996, HEPATOLOGY, V23, P1189; Tahira Y, 2002, HYPERTENS RES, V25, P911; Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; DeBleser PJ, 1997, J HEPATOL, V26, P886, DOI 10.1016/S0168-8278(97)80257-7; Chen WX, 2002, WORLD J GASTROENTERO, V8, P379; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Atzori L, 2009, INT J BIOCHEM CELL B, V41, P1639, DOI 10.1016/j.biocel.2009.03.001; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Friedman SL, 2008, CLIN LIVER DIS, V12, pXIII, DOI 10.1016/j.cld.2008.07.009; Fukuda N, 2006, J AM SOC NEPHROL, V17, P422, DOI 10.1681/ASN.2005060650	36	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2015	38	12					1836	1842				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UC	WOS:000365694800002		
J	Kajizono, M; Sada, H; Sugiura, Y; Soga, Y; Kitamura, Y; Matsuoka, J; Sendo, T				Kajizono, Makoto; Sada, Hikaru; Sugiura, Yuhko; Soga, Yoshihiko; Kitamura, Yoshihisa; Matsuoka, Junji; Sendo, Toshiaki			Incidence and Risk Factors of Osteonecrosis of the Jaw in Advanced Cancer Patients after Treatment with Zoledronic Acid or Denosumab: A Retrospective Cohort Study	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						medication-related osteonecrosis of the jaw (MRONJ); zoledronic acid; denosumab; periodical dentistry maintenance	SKELETAL-RELATED EVENTS; ANGIOGENESIS IN-VITRO; MULTIPLE-MYELOMA; BONE METASTASES; BREAST-CANCER; POSTMENOPAUSAL OSTEOPOROSIS; PREVENTIVE MEASURES; AMERICAN-SOCIETY; SOLID TUMORS; DOUBLE-BLIND	Zoledronic acid and denosumab are two antiresorptive drugs currently in use for treating osteoporosis. They have different mechanisms of action, but both have been shown to delay the onset of skeletal-related events in patients with advanced cancer. However, medication-related osteonecrosis of the jaw (MRONJ) has been reported in cancer patients treated with zoledronic acid or denosumab. We studied 155 patients with several types of advanced cancer who were treated with zoledronic acid or denosumab in our hospital during the period from April 2010 through March 2013. Thirteen of these 155 patients (8.4%) developed MRONJ. MRONJ development was significantly associated with the number of zoledronic acid or denosumab infusions (p<0.001) and the duration of zoledronic acid or denosumab therapy (p<0.001). Logistic regression analysis showed that diabetes [odds ratio (OR)=6.699, 95% confidence interval (CI), 1.435-31.277, p=0.016], anemia [OR=14.559, 95% CI, 2.161-98.069, p=0.006], and pus discharge [OR=6.491, 95% CI, 1.514-27.835, p=0.012] significantly increased the risk of developing MRONJ. However, the risk of MRONJ was significantly lower [OR=0.137, 95% CI, 0.020-0.944, p=0.043] when patients received periodical dentistry maintenance. Diabetes, anemia, and pus discharge may also play roles in its development. These findings suggest that the active inclusion of dentistry maintenance in bisphosphonate or denosumab treatment of cancer patients can reduce MRONJ development.	[Kajizono, Makoto; Sada, Hikaru; Kitamura, Yoshihisa; Sendo, Toshiaki] Okayama Univ Hosp, Dept Pharm, Kita Ku, Okayama 7008558, Japan; [Sugiura, Yuhko] Okayama Univ Hosp, Div Dent Hygienist, Kita Ku, Okayama 7008558, Japan; [Soga, Yoshihiko] Okayama Univ Hosp, Cent Clin Dept, Div Hosp Dent, Kita Ku, Okayama 7008558, Japan; [Matsuoka, Junji] Okayama Univ Hosp, Dept Palliat & Support Care, Kita Ku, Okayama 7008558, Japan	Kitamura, Y (reprint author), Okayama Univ Hosp, Dept Pharm, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	kitamu-y@cc.okayama-u.ac.jp					Berenson JR, 1996, NEW ENGL J MED, V334, P488, DOI 10.1056/NEJM199602223340802; Dimopoulos MA, 2006, HAEMATOL-HEMATOL J, V91, P968; Marx RE, 2005, J ORAL MAXIL SURG, V63, P1567, DOI 10.1016/j.joms.2005.07.010; Dimopoulos MA, 2009, ANN ONCOL, V20, P117, DOI 10.1093/annonc/mdn554; Greenberg MS, 2004, ORAL SURG ORAL MED O, V98, P259, DOI 10.1016/j.tripleo.2004.08.001; Badros A, 2006, J CLIN ONCOL, V24, P945, DOI 10.1200/JCO.2005.04.2465; Tarassoff P, 2003, J ORAL MAXIL SURG, V61, P1238, DOI 10.1053/S0278-2391(03)00883-8; Vincenzi B, 2003, ANN ONCOL, V14, P806, DOI 10.1093/annonc/mdg194; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Hillner BE, 2003, J CLIN ONCOL, V21, P4042, DOI 10.1200/JCO.2003.08.017; Nancollas GH, 2006, BONE, V38, P617, DOI 10.1016/j.bone.2005.05.003; Ripamonti CI, 2009, ANN ONCOL, V20, P137, DOI 10.1093/annonc/mdn526; Van den Wyngaert T, 2006, ANN ONCOL, V17, P1197, DOI 10.1093/annonc/mdl294; Robinson NA, 2004, ANN ACAD MED SINGAP, V33, P48; Migliorati CA, 2010, SUPPORT CARE CANCER, V18, P1099, DOI 10.1007/s00520-010-0882-1; Henry DH, 2011, J CLIN ONCOL, V29, P1125, DOI 10.1200/JCO.2010.31.3304; Zervas K, 2006, BRIT J HAEMATOL, V134, P620, DOI 10.1111/j.1365-2141.2006.06230.x; Dunstan CR, 2007, NAT CLIN PRACT ONCOL, V4, P42, DOI 10.1038/ncponc0688; Fisher JE, 2000, ENDOCRINOLOGY, V141, P4793, DOI 10.1210/en.141.12.4793; Scott LJ, 2011, BIODRUGS, V25, P397, DOI 10.2165/11207650-000000000-00000; Ruggiero SL, 2004, J ORAL MAXIL SURG, V62, P527, DOI 10.1016/j.joms.2004.02.004; Fournier P, 2002, CANCER RES, V62, P6538; Guarneri V, 2010, BREAST CANCER RES TR, V122, P181, DOI 10.1007/s10549-010-0866-3; Berenson JR, 2002, J CLIN ONCOL, V20, P3719, DOI 10.1200/JCO.2002.06.037; Hoff AO, 2008, J BONE MINER RES, V23, P826, DOI [10.1359/jbmr.080205, 10.1359/JBMR.080205]; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Stopeck AT, 2010, J CLIN ONCOL, V28, P5132, DOI 10.1200/JCO.2010.29.7101; Rosen LS, 2004, CANCER, V100, P2613, DOI 10.1002/cncr.20308; Aragon-Ching JB, 2009, CANCER INVEST, V27, P221, DOI 10.1080/07357900802208608; Assael LA, 2004, J ORAL MAXIL SURG, V62, P125, DOI 10.1016/j.joms.2003.11.009; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Bamias A, 2005, J CLIN ONCOL, V23, P8580, DOI 10.1200/JCO.2005.02.8670; Lipton A, 2012, EUR J CANCER, V48, P3082, DOI 10.1016/j.ejca.2012.08.002; Hortobagyi GN, 1998, J CLIN ONCOL, V16, P2038; Vahtsevanos K, 2009, J CLIN ONCOL, V27, P5356, DOI 10.1200/JCO.2009.21.9584; Fizazi K, 2011, LANCET, V377, P813, DOI 10.1016/S0140-6736(10)62344-6; Wood J, 2002, J PHARMACOL EXP THER, V302, P1055, DOI 10.1124/jpet.102.035295; Otto S, 2013, J CRANIO MAXILL SURG, V41, P694, DOI 10.1016/j.jcms.2013.05.038; Ribatti D, 2007, CLIN RHEUMATOL, V26, P1094, DOI 10.1007/s10067-006-0455-3; Russell RGG, 1999, BONE, V25, P97, DOI 10.1016/S8756-3282(99)00116-7; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Dune BG, 2005, NEW ENGL J MED, V353, P99; Hortobagyi GN, 2014, J CLIN ONCOL, V32; Reszka Alfred A, 2003, Curr Osteoporos Rep, V1, P45, DOI 10.1007/s11914-003-0008-5; Roodman G David, 2004, Discov Med, V4, P144; Ruggiero SL, 2014, J ORAL MAXIL SURG, V72, P1938, DOI 10.1016/j.joms.2014.04.031	46	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2015	38	12					1850	1855				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UC	WOS:000365694800004		
J	Taguchi, K; Hida, M; Matsumoto, T; Kobayashi, T				Taguchi, Kumiko; Hida, Mari; Matsumoto, Takayuki; Kobayashi, Tsuneo			Resveratrol Ameliorates Clonidine-Induced Endothelium-Dependent Relaxation Involving Akt and Endothelial Nitric Oxide Synthase Regulation in Type 2 Diabetic Mice	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						resveratrol (RV); endothelial dysfunction; nitric oxide (NO); Akt	RECEPTOR KINASE 2; BETA-ARRESTIN 2; RED WINE; RAT AORTA; MESENTERIC-ARTERY; PROGENITOR CELLS; MOUSE AORTA; GRAPE JUICE; TNF-ALPHA; GREEN TEA	Diabetic vascular complication is one of the manifestations of endothelial dysfunction. Resveratrol (RV) is considered to be beneficial in protecting endothelial function. However, the exact protective effect and mechanisms involved have not been fully clarified. In this study, we investigated the relationship between Akt/endothelial nitric oxide synthase (eNOS) activation and RV in diabetes-induced endothelial dysfunction. Aortas were dissected and placed in organ chambers, and nitric oxide (NO) production in response to acetylcholine (ACh) and RV was measured. ACh-induced endothelium-dependent relaxation was markedly increased in controls by RV pretreatment. Furthermore, RV caused NO-dependent relaxation via the Akt signaling pathway, which was weaker in the aortas of diabetic mice than age-matched controls. To further examine the underlying mechanisms, we measured the phosphorylation of Akt and eNOS by Western blotting. RV caused the phosphorylation of Akt and eNOS in aortas, which was decreased in diabetic mice. However, RV augmented the impaired clonidine-induced relaxation in diabetic mice. Interestingly, the phosphorylation of Akt and eNOS was increased under stimulation with RV and clonidine only in diabetic mice. Thus, either RV or clonidine causes Akt-dependent NO-mediated relaxation, which is weaker in diabetic mice than controls. However, additional exposure to RV and clonidine has an augmenting effect on the Akt/eNOS signaling pathway under diabetic conditions. RV-induced Akt/eNOS activity may be a common link involved in the clonidine-induced Akt/eNOS activity, so RV and clonidine may have a synergistic effect.	[Taguchi, Kumiko; Hida, Mari; Matsumoto, Takayuki; Kobayashi, Tsuneo] Hoshi Univ, Inst Med Chem, Dept Physiol & Morphol, Shinagawa Ku, Tokyo 1428501, Japan	Kobayashi, T (reprint author), Hoshi Univ, Inst Med Chem, Dept Physiol & Morphol, Shinagawa Ku, Tokyo 1428501, Japan.	tkoba@hoshi.ac.jp			JSPS KAKENHI [15K07975, 15K21419, 26460107]	This work was supported in part by JSPS KAKENHI Grant Numbers 15K07975, 15K21419 and 26460107.	Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Miyagi Y, 1997, AM J CARDIOL, V80, P1627, DOI 10.1016/S0002-9149(97)00755-8; Wallerath T, 2002, CIRCULATION, V106, P1652, DOI 10.1161/01.CIR.0000029925.18593.5C; Kamata K, 2005, BIOL PHARM BULL, V28, P267, DOI 10.1248/bpb.28.267; Taguchi K, 2013, ACTA PHYSIOL, V207, P142, DOI 10.1111/j.1748-1716.2012.02473.x; Taguchi K, 2012, DIABETES, V61, P1978, DOI 10.2337/db11-1729; Lal BK, 2001, MICROVASC RES, V62, P252, DOI 10.1006/mvre.2001.2338; Taguchi K, 2012, PFLUG ARCH EUR J PHY, V464, P205, DOI 10.1007/s00424-012-1131-x; Takenouchi Y, 2010, BIOL PHARM BULL, V33, P1692; Wang NS, 2011, AM J PHYSIOL-ENDOC M, V300, pE195, DOI 10.1152/ajpendo.00414.2010; Brandes RP, 2005, CARDIOVASC RES, V66, P286, DOI 10.1016/j.cardiores.2004.12.027; Sasaki Y, 2010, BIOL PHARM BULL, V33, P1555, DOI 10.1248/bpb.33.1555; Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Anselm E, 2007, CARDIOVASC RES, V73, P404, DOI 10.1016/j.cardiores.2006.08.004; Taguchi K, 2014, BIOL PHARM BULL, V37, P1056, DOI 10.1248/bpb.b14-00157; Naderali EK, 2000, CLIN SCI, V98, P537, DOI 10.1042/CS19990303; Chen CK, 1996, GEN PHARMACOL, V27, P363; Taguchi K, 2012, PHARMACOL RES, V65, P56, DOI 10.1016/j.phrs.2011.08.009; Taguchi K, 2012, ENDOCRINOLOGY, V153, P2985, DOI 10.1210/en.2012-1101; Matsumoto T, 2010, BIOL PHARM BULL, V33, P844, DOI 10.1248/bpb.33.844; Truelsen T, 1998, STROKE, V29, P2467; Sasazuki S, 2000, ANN EPIDEMIOL, V10, P401, DOI 10.1016/S1047-2797(00)00066-1; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Zhang HR, 2009, ARTERIOSCL THROM VAS, V29, P1164, DOI 10.1161/ATVBAHA.109.187146; Xia L, 2008, BRIT J PHARMACOL, V155, P387, DOI 10.1038/bjp.2008.272; Napoli R, 2005, METABOLISM, V54, P306, DOI 10.1016/j.metabol.2004.09.010; Taguchi K, 2011, PHARMACOL RES, V64, P535, DOI 10.1016/j.phrs.2011.05.001; Kane MO, 2009, VASC PHARMACOL, V51, P140, DOI 10.1016/j.vph.2009.05.002; Nakachi K, 2000, BIOFACTORS, V13, P49; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Goff Jr DC, 2007, AM J CARDIOL, V99, p4i, DOI DOI 10.1016/J.AMJCARD.2007.03.002; Lamming D. W., 2012, J CLIN EXP PATHOL, V4, P7327; Ndiaye Mamadou, 2005, FASEB J, V19, P455; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Saxena B, 2010, Drug Discov Ther, V4, P334	35	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2015	38	12					1864	1872				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UC	WOS:000365694800006		
J	Michihara, A; Mido, M; Matsuoka, H; Mizutani, Y				Michihara, Akihiro; Mido, Mayuko; Matsuoka, Hiroshi; Mizutani, Yurika			Lower Squalene Epoxidase and Higher Scavenger Receptor Class B Type 1 Protein Levels Are Involved in Reduced Serum Cholesterol Levels in Stroke-Prone Spontaneously Hypertensive Rats	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						squalene epoxidase; scavenger receptor class B type 1; stroke; cholesterol; liver	MEVALONATE PYROPHOSPHATE DECARBOXYLASE; FACTOR INTERVENTION TRIAL; GENE-EXPRESSION LEVELS; HMG-COA REDUCTASE; LIPID-METABOLISM; WISTAR-KYOTO; LDL RECEPTOR; 7-ALPHA-HYDROXYLASE; MORTALITY; MECHANISM	A lower serum cholesterol level was recently shown to be one of the causes of stroke in an epidemiological study. Spontaneously hypertensive rats stroke-prone (SHRSP) have lower serum cholesterol levels than normotensive Wistar-Kyoto rats (WKY). To elucidate the mechanisms responsible for the lower serum cholesterol levels in SHRSP, we determined whether the amounts of cholesterol biosynthetic enzymes or the receptor and transporter involved in cholesterol uptake and efflux in the liver were altered in SHRSP. When the mRNA levels of seven cholesterol biosynthetic enzymes were measured using real-time polymerase chain reaction (PCR), farnesyl pyrophosphate synthase and squalene epoxidase (SQE) levels in the liver of SHRSP were significantly lower than those in WKY. SQE protein levels were significantly reduced in tissues other than the brain of SHRSP. No significant differences were observed in low-density lipoprotein (LDL) receptor (uptake of serum LDL-cholesterol) or ATP-binding cassette transporter A1 (efflux of cholesterol from the liver/formation of high-density lipoprotein (HDL)) protein levels in the liver and testis between SHRSP and WKY, whereas scavenger receptor class B type 1 (SRB1: uptake of serum HDL-cholesterol) protein levels were higher in the livers of SHRSP. These results indicated that the lower protein levels of SQE and higher protein levels of SRB1 in the liver were involved in the reduced serum cholesterol levels in SHRSP.	[Michihara, Akihiro; Mido, Mayuko; Matsuoka, Hiroshi; Mizutani, Yurika] Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Fukuyama, Hiroshima 7290292, Japan	Michihara, A (reprint author), Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Fukuyama, Hiroshima 7290292, Japan.	mitihara@fupharm.fukuyama-u.ac.jp			Fukuyama University Grant for Academic Research Projects (GARP)	This work was supported by Fukuyama University Grant for Academic Research Projects (GARP).	YAMORI Y, 1978, JPN HEART J, V19, P665; YAMAMOTO S, 1970, J BIOL CHEM, V245, P1670; Lastres-Becker I, 2008, HUM MOL GENET, V17, P1465, DOI 10.1093/hmg/ddn035; YAMORI Y, 1981, JPN CIRC J, V45, P1068; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Nemoto K, 2013, BIOL PHARM BULL, V36, P1216; Duong PT, 2006, J LIPID RES, V47, P832, DOI 10.1194/jlr.M500531-JLR200; Michihara A, 2001, BIOL PHARM BULL, V24, P1417, DOI 10.1248/bpb.24.1417; Ueno M, 2010, HISTOCHEM CELL BIOL, V133, P669, DOI 10.1007/s00418-010-0705-y; Wang L, 2013, MOL CELL BIOL, V33, P1956, DOI 10.1128/MCB.01580-12; SAWAMURA M, 1992, J BIOL CHEM, V267, P6051; SHEFER S, 1994, HEPATOLOGY, V20, P213; Ikeda I, 2001, METABOLISM, V50, P1361, DOI 10.1053/meta.2001.26739; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Michihara A, 1998, J BIOCHEM-TOKYO, V124, P40; IRITANI N, 1977, ATHEROSCLEROSIS, V28, P217, DOI 10.1016/0021-9150(77)90171-X; SIRTORI CR, 1990, PHARMACOL RES, V22, P555, DOI 10.1016/S1043-6618(05)80047-7; Ueno M, 2004, HISTOCHEM CELL BIOL, V122, P131, DOI 10.1007/s00418-004-0684-y; Michihara A, 2010, J HEALTH SCI, V56, P733, DOI 10.1248/jhs.56.733; Morita I, 1997, ENDOTHELIUM-NEW YORK, V5, P107, DOI 10.3109/10623329709079868; Hu ZG, 2012, MOL CELL BIOL, V32, P5035, DOI 10.1128/MCB.01002-12; Roberts CK, 2004, KIDNEY INT, V66, P1503, DOI 10.1111/j.1523-1755.2004.00914.x; IRITANI N, 1982, JPN CIRC J, V46, P151; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; NEATON JD, 1992, ARCH INTERN MED, V152, P1490, DOI 10.1001/archinte.152.7.1490; BRUCKDOR.KR, 1969, BIOCHIM BIOPHYS ACTA, V183, P334, DOI 10.1016/0005-2736(69)90089-3; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Isomura M, 2015, J Hypertens, V33 Suppl 1, pe2, DOI 10.1097/01.hjh.0000467355.97086.6a; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Michihara Akihiro, 2015, Biosci Biotechnol Biochem, V79, P1759, DOI 10.1080/09168451.2015.1061417; Okamoto K, 1974, CIRCUL RES        S1, V34, P143; Sato I, 1998, J Atheroscler Thromb, V4, P102; Shiota C, 1981, MED J KINKI U, V6, P125; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Yamori Y., 1977, GENE ENV INTERACTION, P141	36	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2015	38	12					1879	1890				12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UC	WOS:000365694800008		
J	Noda, M; Miyauchi, R; Danshiitsoodol, N; Higashikawa, F; Kumagai, T; Matoba, Y; Sugiyama, M				Noda, Masafumi; Miyauchi, Rumi; Danshiitsoodol, Narandalai; Higashikawa, Fumiko; Kumagai, Takanori; Matoba, Yasuyuki; Sugiyama, Masanori			Characterization and Mutational Analysis of a Two-Polypeptide Bacteriocin Produced by Citrus Iyo-Derived Lactobacillus brevis 174A	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						bacteriocin; Lactobacillus brevis; lactic acid bacteria	LACTIC-ACID BACTERIA; GRAM-POSITIVE BACTERIA; CLASS-II BACTERIOCINS; IMMUNITY; PURIFICATION; SALIVARIUS; PLANTARUM	In the present study, we isolated a lactic acid bacterium (LAB) from a citrus iyo fruit and identified it as Lactobacillus brevis. This plant-derived LAB strain, designated 174A, produces bacteriocin consisting of two polypeptides designated brevicin 174A-beta and 174A-gamma. Although each polypeptide itself displays antibacterial activity, the ability is enhanced 100 fold by mixing both polypeptides at a 1:1 ratio. Significantly, brevicin 174A inhibits even the growth of several pathogenic bacteria that are more resistant to a lantibiotic bacteriocin, nisin A, which is commonly utilized as a preservative added to foodstuffs. Structural analysis of the 174A bacteriocin using a program that predicts secondary structure suggests that both component polypeptides have a positively charged N-terminal region, as well as two cysteine residues in both the N- and C-terminals. Judging from a mutational analysis of the antibacterial polypeptides, these unique amino acid sequences of 174A-beta might be important for the expression of the synergistic activity that occurs in the presence of the two polypeptides combined.	[Noda, Masafumi; Miyauchi, Rumi; Danshiitsoodol, Narandalai; Higashikawa, Fumiko; Kumagai, Takanori; Matoba, Yasuyuki; Sugiyama, Masanori] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Biotechnol, Minami Ku, Hiroshima 7348551, Japan	Sugiyama, M (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Biotechnol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	sugi@hiroshima-u.ac.jp			JSPS [22790069]	This work was supported by JSPS Grants-in-Aid for Scientific Research, Grant Number 22790069. We wish to thank the Research Center for Molecular Medicine, the Faculty of Medicine, and the Analysis Center of Life Science, Hiroshima University, for the use of their facilities. We thank the staffs of the Research Center for Bioscience and Technology at Tottori University for MALDI-TOF/MS analysis.	Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; KLAENHAMMER TR, 1988, BIOCHIMIE, V70, P337, DOI 10.1016/0300-9084(88)90206-4; Ehrmann MA, 2000, BBA-GENE STRUCT EXPR, V1490, P355, DOI 10.1016/S0167-4781(00)00003-8; Barrett E, 2007, APPL ENVIRON MICROB, V73, P3719, DOI 10.1128/AEM.00666-06; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Wada T, 2009, MICROBIOL-SGM, V155, P1726, DOI 10.1099/mic.0.022871-0; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Kawamoto S, 2002, APPL ENVIRON MICROB, V68, P3830, DOI 10.1128/AEM.68.8.3830-3840.2002; Jeon HJ, 2009, BIOCHEM BIOPH RES CO, V378, P574, DOI 10.1016/j.bbrc.2008.11.093; WEISBURG WG, 1991, J BACTERIOL, V173, P697; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1240; Jin HK, 2010, BIOL PHARM BULL, V33, P289, DOI 10.1248/bpb.33.289; Nissen-Meyer J, 2009, CURR PHARM BIOTECHNO, V10, P19; Kleerebezem M, 2001, PEPTIDES, V22, P1579, DOI 10.1016/S0196-9781(01)00493-4; HIRAISHI A, 1992, LETT APPL MICROBIOL, V15, P210, DOI 10.1111/j.1472-765X.1992.tb00765.x; Flynn S, 2002, MICROBIOL-SGM, V148, P973; van Reenen CA, 1998, J APPL MICROBIOL, V84, P1131; Nissen-Meyer J, 2010, PROBIOTICS ANTIMICRO, V2, P52, DOI 10.1007/s12602-009-9021-z; Oppegard C, 2007, J MOL MICROB BIOTECH, V13, P210, DOI 10.1159/000104750; Higashikawa F, 2010, NUTRITION, V26, P367, DOI 10.1016/j.nut.2009.05.008; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Lane DJ, 1991, NUCL ACID TECHNIQUES, P115; Margaret AR, 1998, ANNU REV GENET, V32, P255; SAMBROOK J, 1989, MOL CLONING LAB MANU	24	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2015	38	12					1902	1909				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UC	WOS:000365694800010		
J	Nagai, N; Iwamae, A; Tanimoto, S; Yoshioka, C; Ito, Y				Nagai, Noriaki; Iwamae, Aya; Tanimoto, Shion; Yoshioka, Chiaki; Ito, Yoshimasa			Pharmacokinetics and Antiinflammatory Effect of a Novel Gel System Containing Ketoprofen Solid Nanoparticles	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						nanoparticle; ketoprofen; gel ointment; drug delivery; adjuvant-induced arthritis	ADJUVANT-INDUCED ARTHRITIS; ENHANCED TRANSDERMAL DELIVERY; IN-VIVO; PLGA NANOPARTICLES; PHYSICOCHEMICAL CHARACTERISTICS; RHEUMATOID-ARTHRITIS; DRUG-DELIVERY; RATS; IONTOPHORESIS; INDOMETHACIN	We previously reported that dermal application using nanoparticles improves skin penetration. In this study, we prepared novel topical formulations containing ketoprofen (KET) solid nanoparticles (KETnano gel ointment) and investigated the antiinflammatory effect of the KET nanoparticle formulations on rheumatoid arthritis using adjuvant-induced arthritis (AA) rats. The KETnano gel ointment was prepared using a bead mill method and additives including methylcellulose and Carbopol 934; the mean particle size of the KET nanoparticles was 83nm. In the in vitro skin penetration experiment, the penetration rate (J(c)) and penetration coefficient through the skin (K-p) values of the KETnano gel ointment were significantly higher than those of gel ointment containing KET microparticles (KETmicro gel ointment; mean particle size 7.7 mu m). On the other hand, in the in vivo percutaneous absorption experiment, the apparent absorption rate constant (k(a)) and the areas under the KET concentration-time curve values in the skin of rats receiving the KETnano gel ointment were significantly higher than those of rats receiving the KETmicro gel ointment, and the amounts of KET in the skin tissues of rats receiving the KETnano gel ointment were also significantly higher than those of rats receiving the KETmicro gel ointment. In addition, the application of the KETnano gel ointment attenuated the enhancement of paw edema of the hind feet of AA rats more than the application of the KETmicro gel ointment. Our findings suggest that a topical drug delivery system using nanoparticles could lead to expansion in the therapeutic use of KET.	[Nagai, Noriaki; Iwamae, Aya; Tanimoto, Shion; Yoshioka, Chiaki; Ito, Yoshimasa] Kinki Univ, Sch Pharm, Osaka 5778502, Japan	Nagai, N (reprint author), Kinki Univ, Sch Pharm, 3-4-1 Higashi Osaka, Osaka 5778502, Japan.	nagai_n@phar.kindai.ac.jp					Al-Jamal Wafa T, 2009, Mol Pharm, V6, P520, DOI 10.1021/mp800187d; Huang HC, 2011, J CONTROL RELEASE, V155, P344, DOI 10.1016/j.jconrel.2011.06.004; Bareford LA, 2007, ADV DRUG DELIVER REV, V59, P748, DOI 10.1016/j.addr.2007.06.008; Paolino D, 2002, INT J PHARM, V244, P21, DOI 10.1016/S0378-5173(02)00295-8; Heyneman CA, 2000, DRUGS, V60, P555, DOI 10.2165/00003495-200060030-00004; Kato S, 2001, YAKUGAKU ZASSHI, V121, P743, DOI 10.1248/yakushi.121.743; Ilbasmis-Tamer S, 2010, J BIOMED NANOTECHNOL, V6, P20, DOI 10.1166/jbn.2010.1099; Huang XH, 2010, ACS NANO, V4, P5887, DOI 10.1021/nn102055s; Debbage P, 2009, CURR PHARM DESIGN, V15, P153; Nagai N, 2014, J OLEO SCI, V63, P177, DOI 10.5650/jos.ess13082; Cagnie B, 2003, PHYS THER, V83, P707; Tomoda K, 2011, COLLOID SURFACE B, V88, P706, DOI 10.1016/j.colsurfb.2011.08.004; Sakuma S, 2001, INFLAMM RES, V50, P509, DOI 10.1007/PL00000227; VALENTA C, 1995, DRUG DEV IND PHARM, V21, P1799, DOI 10.3109/03639049509069267; Nagai N, 2014, BIOL PHARM BULL, V37, P1109; ITO Y, 1993, BIOL PHARM BULL, V16, P583; Shinkai N, 2008, J CONTROL RELEASE, V131, P107, DOI 10.1016/j.jconrel.2008.07.012; Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev; Nagai N, 2015, J OLEO SCI, V64, P337, DOI 10.5650/jos.ess14170; Tomoda K, 2012, COLLOID SURFACE B, V92, P50, DOI 10.1016/j.colsurfb.2011.11.016; Shah PP, 2012, J CONTROL RELEASE, V158, P336, DOI 10.1016/j.jconrel.2011.11.016; DeLouise LA, 2012, J INVEST DERMATOL, V132, P964, DOI 10.1038/jid.2011.425; Shinkai N, 2011, EUR J PHARM BIOPHARM, V78, P415, DOI 10.1016/j.ejpb.2011.03.005; Boisselier E, 2009, CHEM SOC REV, V38, P1759, DOI 10.1039/b806051g; So JW, 2009, DRUG DELIV, V16, P52, DOI 10.1080/10717540802518082; Tomoda K, 2012, COLLOID SURFACE B, V97, P84, DOI 10.1016/j.colsurfb.2012.04.002; Kato S, 2002, JPN J PHARMACOL, V89, P1, DOI 10.1254/jjp.89.1; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Tashiro Y, 2000, BIOL PHARM BULL, V23, P1486; Beetge E, 2000, INT J PHARMACEUT, V193, P261, DOI 10.1016/S0378-5173(99)00340-3; Kim BS, 2008, DRUG DELIV, V15, P465, DOI 10.1080/10717540802328599 ; Dobrovolskaia MA, 2008, MOL PHARMACEUT, V5, P487, DOI 10.1021/mp800032f; Panus PC, 1997, J CONTROL RELEASE, V44, P113, DOI 10.1016/S0168-3659(96)01509-X; Toy R, 2014, NANOMEDICINE-UK, V9, P121, DOI 10.2217/nnm.13.191; Nagai N, 2014, BIOL PHARM BULL, V37, P96; Goosen C, 1998, INT J PHARMACEUT, V163, P203, DOI 10.1016/S0378-5173(97)00359-1; Banga AK, 2011, TRANSDERMAL INTRADER, P309; Begley DJ, 2004, PHARMACOL THERAPEUT, V104, P29, DOI 10.1016/j.pharmthera.2004.08.001; BILLINGHAM MEJ, 1983, PHARMACOL THERAPEUT, V21, P389, DOI 10.1016/0163-7258(83)90062-1; Chouly C, 1996, J MICROENCAPSUL, V13, P245, DOI 10.3109/02652049609026013; Gürol Z, 1996, Pharm Acta Helv, V71, P205, DOI 10.1016/0031-6865(96)00011-8; Maestrelli F, 2005, INT J PHARM, V298, P55, DOI 10.1016/j.ijpharm.2005.03.033; Moribe K, 2015, DRUG DELIV SYST, V30, P92; Nagai N, 2015, EXP EYE RES, V132, P115, DOI 10.1016/j.exer.2015.01.022; Sharma DN, 1999, MIDDLE E J INT MED, V2, P9; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879	46	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2015	38	12					1918	1924				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UC	WOS:000365694800012		
J	Ide, N; Arisawa, K; Ogura, K; Kagawa, Y; Maeda, T				Ide, Naohito; Arisawa, Kasumi; Ogura, Kanami; Kagawa, Yoshiyuki; Maeda, Toshio			Age-Dependent Onset of Insulin Resistance in Insulin-Resistant Mice	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						insulin resistance; age-related onset; insulin secretion; insulin receptor	GLUCOSE-TRANSPORT; KINASE-ACTIVITY; GROWTH-HORMONE; ADIPOSE-TISSUE; IRS-1; CELL; RAT; MECHANISM; LIVER; MODEL	We have previously isolated spontaneous insulin-resistant mice (ddY-H) and non-insulin-resistant mice (ddY-L) from ddY mice. In the present study, age-dependent onset of insulin resistance in obese ddY-H mice was investigated by comparing with lean ddY-L mice. In ddY-H mice fed a standard diet, an increase in elevation of glucose-stimulated plasma insulin level, glucose intolerance in an intraperitoneal glucose tolerance test, and a reduction of hypoglycemic action of insulin were found at 9 weeks of age, but not at 6 weeks of age. When ddY-H mice were administered nateglinide, a greater elevation of plasma insulin level and a less decrease of serum glucose level were observed at 9 weeks of age. These changes developed progressively with age. These findings suggest that insulin resistance is induced at 9 weeks of age. The age-related change in insulin resistance was correlated with reductions in mRNA expression and protein content of the insulin receptor (InsR), and insulin receptor substrate (IRS)-1 and IRS-2 in the epididymal adipose tissue. On the other hand, in the liver, mRNA expression of InsR and IRS-1 did not change at any age, although that of the IRS-2 was reduced. Thus, in ddY-H mice, insulin resistance and glucose-stimulated hyper-secretion of insulin are induced at 9 weeks of age and are reciprocally affected, resulting in progression to a more severe state at an older age. Insulin resistance may be attributed, at least in part, to the decreases in the mRNA expressions and proteins of InsR, IRS-1 and IRS-2 in adipose tissue.	[Ide, Naohito; Arisawa, Kasumi; Ogura, Kanami; Kagawa, Yoshiyuki; Maeda, Toshio] Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Clin Pharmaceut & Pharm Practice, Suruga Ku, Shizuoka 4228526, Japan	Maeda, T (reprint author), Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Clin Pharmaceut & Pharm Practice, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	maeda@u-shizuoka-ken.ac.jp					MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Lafontan M, 2014, DIABETES METAB, V40, P16, DOI 10.1016/j.diabet.2013.08.002; Satoh H, 2013, BIOL PHARM BULL, V36, P616; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; CARO JF, 1986, J CLIN INVEST, V78, P249, DOI 10.1172/JCI112558; Maeda T, 2001, BIOL PHARM BULL, V24, P950, DOI 10.1248/bpb.24.950; Karlsson HKR, 2007, CELL BIOCHEM BIOPHYS, V48, P103, DOI 10.1007/s12013-07-0030-9; Maeda T, 2013, BIOL PHARM BULL, V36, P825; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Chachin M, 2003, J PHARMACOL EXP THER, V304, P1025, DOI 10.1124/jpet.102.044917; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Dominici FP, 1999, J ENDOCRINOL, V161, P383, DOI 10.1677/joe.0.1610383; Hara K, 2014, HUM MOL GENET, V23, P239, DOI 10.1093/hmg/ddt399; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Sasaki T, 2015, ENDOCR J, V62, P787, DOI 10.1507/endocrj.EJ15-0255; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Watada S, 2014, J BURN CARE RES, V35, pE66, DOI 10.1097/BCR.0b013e31828a8ede; Matsumoto F, 2002, BIOCHEM BIOPH RES CO, V295, P630, DOI 10.1016/S0006-291X(02)00711-8; Uchida T, 2005, NAT MED, V11, P175, DOI 10.1038/nm1187; Withers DJ, 1998, NATURE, V391, P900; DAVIDSON MB, 1987, ENDOCR REV, V8, P115; BACKER JM, 1992, EMBO J, V11, P3469; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Alessi DR, 1996, EMBO J, V15, P6541; GOTO Y, 1976, TOHOKU J EXP MED, V119, P85; Noge I, 2010, BIOL PHARM BULL, V33, P988; BISBIS S, 1993, AM J PHYSIOL, V265, pE807; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Ashcroft F.M., 2012, CELL, V148, P148, DOI DOI 10.1016/J.CELL.2012.02.010; Hanif W, 2001, Expert Opin Pharmacother, V2, P1027; Langenberg C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001647; Nakamura M, 1967, Diabetologia, V3, P212, DOI 10.1007/BF01222198; Xia JN, 2013, J ETHNOPHARMACOL, V150, P692, DOI 10.1016/j.jep.2013.09.038; Rozman Jan, 2015, Curr Protoc Mouse Biol, V5, P65, DOI 10.1002/9780470942390.mo140111; ZUCKER LM, 1965, ANN NY ACAD SCI, V131, P447, DOI 10.1111/j.1749-6632.1965.tb34810.x	40	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2015	38	12					1925	1934				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UC	WOS:000365694800013		
J	Shimizu, C; Oki, Y; Mitani, Y; Nakamura, T; Nabeshima, T				Shimizu, Chikako; Oki, Yasuhiro; Mitani, Yutaka; Nakamura, Takeshi; Nabeshima, Toshitaka			Factors Affecting Ethanol-Induced Conditioned Place Preference and Locomotor Sensitization in Mice	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						moderate alcohol (ethanol: EtOH); conditioned place preference (CPP); reward; sensitization; paired associative learning	BEHAVIORAL SENSITIZATION; ALCOHOL-CONSUMPTION; DBA/2J MICE; METHAMPHETAMINE; ACAMPROSATE; DRINKING; MORPHINE; EXPRESSION; DEPENDENCE; DURATION	The rewarding effects of alcohol can lead to progressively heavier and more frequent drinking. Since studies of reward have mainly focused on responses to higher alcohol doses, the relations between reward and moderate/sustained alcohol exposure remain unknown. Our objective was to evaluate factors affecting the reward value of low alcohol doses and risk factors for increasing alcohol doses due to reward progression caused by alcohol exposure patterns. We thus performed conditioned place preference (CPP) and ethanol (EtOH)-induced locomotor sensitization tests in mice. Low-dose EtOH (0.5 or 1g/kg twice/week)-induced CPP was stronger than that produced by saline control treatment, but the effect decreased with increasing numbers of conditioning trials. Moderate-dose/long-term EtOH exposure induced a weaker CPP than high-dose/short-term EtOH (2 g/kg twice/week) exposure with the same total EtOH dose (8 g/kg/experiment). Acamprosate calcium, an anti-relapse drug, preclusively reduced EtOH-induced CPP. EtOH induced CPP and locomotor sensitization in black but not white chamber, although the initial preference and the basal locomotion in each chamber were equal. Therefore the brightness of the chamber had an effect on EtOH-induced sensitization. Moreover, additional studies indicated that EtOH-induced locomotor sensitization also depends on the dose but not the administration interval. Paired associative learning with EtOH exposure is a potent factor influencing the level of reward produced by EtOH. Moreover, exposure to high doses of alcohol, even on an intermittent schedule, carries a higher risk of addiction than exposure to moderate doses over longer periods.	[Shimizu, Chikako; Oki, Yasuhiro; Mitani, Yutaka; Nakamura, Takeshi] SAPPORO BREWERIES LTD, Frontier Labs Value Creat, Yaizu, Shizuoka 4250013, Japan; [Nabeshima, Toshitaka] Meijo Univ, Nabeshima Lab, Nagoya, Aichi 4688503, Japan; [Nabeshima, Toshitaka] NPO Japanese Drug Org Appropriate Use & Res, Nagoya, Aichi 4688503, Japan	Shimizu, C (reprint author), SAPPORO BREWERIES LTD, Frontier Labs Value Creat, Yaizu, Shizuoka 4250013, Japan.	Chikako.Shimizu@sapporobeer.co.jp					Chester JA, 2001, BEHAV PHARMACOL, V12, P535; Gamsby JJ, 2013, BEHAV BRAIN RES, V249, P15, DOI 10.1016/j.bbr.2013.04.016; Abrahao KP, 2013, J NEUROSCI, V33, P4834, DOI 10.1523/JNEUROSCI.5839-11.2013; SCHMIDT W, 1975, DRUG ALCOHOL DEPEN, V1, P27, DOI 10.1016/0376-8716(75)90005-8; Niwa M, 2007, J NEUROSCI, V27, P7604, DOI 10.1523/JNEUROSCI.1575-07.2007; Carvajal F, 2015, BEHAV BRAIN RES, V287, P230, DOI 10.1016/j.bbr.2015.03.046; Cunningham CL, 2006, NAT PROTOC, V1, P1662, DOI 10.1038/nprot.2006.279; Kurokawa K, 2013, J PHARMACOL SCI, V122, P289, DOI 10.1254/jphs.13056FP; Littleton J, 1998, ALCOHOL HEALTH RES W, V22, P13; Funada M, 2002, BRAIN RES PROTOC, V10, P47; Bagnardi V, 2001, ALCOHOL RES HEALTH, V25, P263; CUNNINGHAM CL, 1992, ANIM LEARN BEHAV, V20, P187, DOI 10.3758/BF03200416; Clapp P, 2008, ALCOHOL RES HEALTH, V31, P310; Suzuki T, 1999, LIFE SCI, V64, pPL151, DOI 10.1016/S0024-3205(99)00036-3; Groblewski PA, 2008, PSYCHOPHARMACOLOGY, V201, P97, DOI 10.1007/s00213-008-1251-3; Mcgeehan AJ, 2003, BRIT J PHARMACOL, V138, P9, DOI 10.1038/sj.bjp.0705059; Boehm SL, 2008, PSYCHOPHARMACOLOGY, V197, P191, DOI 10.1007/s00213-007-1022-6; Font L, 2012, PHARMACOL BIOCHEM BE, V101, P222, DOI 10.1016/j.pbb.2012.01.009; Sprow GM, 2012, PHYSIOL BEHAV, V106, P325, DOI 10.1016/j.physbeh.2011.12.026; Ide S, 2004, NEUROPSYCHOPHARMACOL, V29, P1656, DOI 10.1038/sj.npp.1300463; Cunningham CL, 2003, PSYCHOPHARMACOLOGY, V170, P409, DOI 10.1007/s00213-003-1559-y; Crabbe JC, 2012, ALCOHOL ALCOHOLISM, V47, P509, DOI 10.1093/alcalc/ags067; Steketee JD, 2011, PHARMACOL REV, V63, P348, DOI 10.1124/pr.109.001933; Niwa M, 2007, BIOL PSYCHIAT, V61, P890, DOI 10.1016/j.biopsych.2006.06.016; Broadbent J, 2005, ALCOHOL, V35, P137, DOI 10.1016/j.alcohol.2005.03.006; Corbit LH, 2012, BIOL PSYCHIAT, V72, P389, DOI 10.1016/j.biopsych.2012.02.024; Ishikawa K, 2006, INT J NEUROPSYCHOPH, V9, P407, DOI 10.1017/S1461145705005870; Voorhees CM, 2011, PSYCHOPHARMACOLOGY, V214, P805, DOI 10.1007/s00213-010-2082-6; Cunningham CL, 2014, PHARMACOL BIOCHEM BE, V124, P443, DOI 10.1016/j.pbb.2014.07.012; Didone V, 2014, ADDICT BIOL, V24, DOI [10.1111/adb.12216, DOI 10.1111/ADB.12216]; HIRABAYASI M, 1991, JPN J PHARMACOL, V57, P91, DOI 10.1254/jjp.57.91; Hirabayashi M, 1992, Arukoru Kenkyuto Yakubutsu Ison, V27, P91; Horio M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035494; Nuutinen Saara, 2012, Front Syst Neurosci, V6, P36, DOI 10.3389/fnsys.2012.00036; Osaki Yoneatsu, 2005, Nihon Arukoru Yakubutsu Igakkai Zasshi, V40, P455; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Varela P, 2014, INT J NEUROPSYCHOPH, V17, P1815, DOI 10.1017/S1461145714000480; World Health Organization, 2010, GLOB STRAT RED HARMF	38	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2015	38	12					1935	1945				11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UC	WOS:000365694800014		
J	Sasamori, J; Abe, Y; Marunouchi, T; Manome, Y; Uchibori, T; Tanonaka, K				Sasamori, Jun; Abe, Yohei; Marunouchi, Tetsuro; Manome, Yoichi; Uchibori, Takehiro; Tanonaka, Kouichi			Effects of 2-Octynyladenosine (YT-146) on Mitochondrial Function in Ischemic/Reperfused Rat Hearts	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						YT-146; adenosine receptor agonist; cardioprotection; mitochondrial function	MYOCARDIAL-INFARCTION; ISCHEMIA; ADENOSINE; PRESERVATION; REPERFUSION; INJURY; DAMAGE; MECHANISM; RECEPTOR; NA+	This study investigated the effects of an adenosine receptor agonist, 2-octynyladenosine (YT-146), on mitochondrial function in ischemic and ischemic/reperfused hearts. Isolated rat hearts were perfused in the Langendorff manner with a constant flow rate, and exposed to 30 min of ischemia followed by 60 mm of reperfusion. Preischemic treatment with YT-146 significantly improved postischemic recovery of left ventricular developed pressure. The high-energy phosphate content in reperfused hearts treated with YT-146 was also more greatly restored than in untreated hearts. YT-146 treatment attenuated the Na+ content of a mitochondria-enriched fraction, but not the myocardial Na+ content, at the end of ischemia. These results suggest that preischemic YT-146 treatment preserves the energy-producing ability of mitochondria during ischemia in the Na+-accumulated myocardium. YT-146 also attenuated both the sodium lactate-induced decrease in mitochondrial energy-producing ability and the increase in mitochondrial Na+ concentration in the myocardial skinned fibers. YT-146 may attenuate Na+ influx to myocardial mitochondria in ischemic cardiac cells, resulting in both preservation of the ability of mitochondria to produce energy and enhancement of the contractile recovery in reperfused hearts. Our findings suggest that the cardioprotective effects of YT-146 against ischemia/reperfusion injury are at least partially due to the preservation of mitochondrial function in the ischemic myocardium.	[Sasamori, Jun; Manome, Yoichi; Uchibori, Takehiro] Toa Eiyo Ltd, Fukushima Res Labs, Drug Res Dept, Fukushima 9600280, Japan; [Abe, Yohei; Marunouchi, Tetsuro; Tanonaka, Kouichi] Tokyo Univ Pharm & Life Sci, Dept Mol & Cellular Pharmacol, Hachioji, Tokyo 1920355, Japan	Sasamori, J (reprint author), Toa Eiyo Ltd, Fukushima Res Labs, Drug Res Dept, Fukushima 9600280, Japan.	sasamori.jun@toaeiyo.co.jp					Andres J, 1994, J Physiol Pharmacol, V45, P91; ABIRU T, 1991, EUR J PHARMACOL, V196, P69, DOI 10.1016/0014-2999(91)90410-R; Tanonaka K, 2012, BIOL PHARM BULL, V35, P1661; Tanonaka K, 1999, EUR J PHARMACOL, V372, P37, DOI 10.1016/S0014-2999(99)00172-7; Yoneyama F, 1999, TOHOKU J EXP MED, V188, P31, DOI 10.1620/tjem.188.31; LIU GS, 1991, CIRCULATION, V84, P350; OLAFSSON B, 1987, CIRCULATION, V76, P1135; NOHL H, 1993, FREE RADICAL RES COM, V18, P127, DOI 10.3109/10715769309147486; SANBE A, 1993, J MOL CELL CARDIOL, V25, P995, DOI 10.1006/jmcc.1993.1113; Sasamori J, 2006, J CARDIOVASC PHARM, V47, P614, DOI 10.1097/01.fjc.0000211739.40336.c5; Iwai T, 2002, CARDIOVASC RES, V55, P141, DOI 10.1016/S0008-6363(02)00282-1; Sasamori J, 2011, J CARDIOVASC PHARM, V57, P166, DOI 10.1097/FJC.0b013e318201c264; ELY SW, 1985, J THORAC CARDIOV SUR, V90, P549; Tanonaka K, 2003, CARDIOVASC RES, V57, P416, DOI 10.1016/S0008-6363(02)00698-3; Konno T, 2005, J PHARMACOL SCI, V97, P501, DOI 10.1254/jphs.FP0040730; KOGI K, 1991, JPN J PHARMACOL, V57, P153, DOI 10.1254/jjp.57.153; REGITZ V, 1984, BASIC RES CARDIOL, V79, P207, DOI 10.1007/BF01908307; Takeo S, 2004, BIOCHEM PHARMACOL, V67, P565, DOI 10.1016/j.bcp.2003.09.016; Motegi K, 2007, BRIT J PHARMACOL, V151, P963, DOI 10.1038/sj.bjp.0707321; Iwai T, 2000, BRIT J PHARMACOL, V129, P1219, DOI 10.1038/sj.bjp.0703148; Iwai T, 2002, J MOL CELL CARDIOL, V34, P725, DOI 10.1006/jmcc.2002.2002; DONOSO P, 1992, J PHYSIOL-LONDON, V448, P493; Ferrari R, 1996, J CARDIOVASC PHARM, V28, P1; JUNG DW, 1992, AM J PHYSIOL, V262, pC1047	24	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2015	38	12					1946	1953				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UC	WOS:000365694800015		
J	Matsui, N; Ito, D; Takabatake, Y; Nashioka, E; Tada, S; Kanagawa, M; Fukuishi, N; Akagi, M				Matsui, Nobuaki; Ito, Daisuke; Takabatake, Yukari; Nashioka, Eri; Tada, Shingo; Kanagawa, Masato; Fukuishi, Nobuyuki; Akagi, Masaaki			Compound 48/80, a Mast Cell Stimulator, Enhances Synthesis of IgE and IgG Induced by Intranasal Application of Ovalbumin in Mice	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						compound 48/80; allergic rhinitis; local immunoglobulin E (IgE) synthesis	ALLERGIC RHINITIS; NASAL-MUCOSA; GUINEA-PIGS; HISTAMINE; INDUCTION; ADJUVANT	Mast cells are well established effector cells of type I hypersensitivity reactions such as allergic rhinitis. However, recent studies have suggested that activated mast cells enhance local immunoglobulin E (IgE) synthesis in the nasal mucosa of allergic rhinitis patients. Therefore, we hypothesized that non-immunological mast cell activators may have the potential to enhance local IgE synthesis. Here, we examined the effect of compound 48/80 (C48/80), a mast cell activator, on IgE and immunoglobulin G (IgG) synthesis. Female Balb/c mice were intranasally administered a mixture of ovalbumin (OVA) (1-10 mu g/nose) and C48/80 (1-100 mu g/nose) on days 0, 7, 14 and 21 and on consecutive days from day 28 to day 42. Intranasal administration of C48/80 with OVA increased serum OVA-specific IgE and IgG. Double staining with fluorescent-labeled OVA and fluorescent-labeled IgE- or IgG-specific antibody demonstrated the presence of OVA-specific IgE- or IgG-producing cells in the nasal mucosa of sensitized mice. Moreover, intranasal administration of C48/80 with OVA increased the nasal mucosal interleukin (IL)-4 level and enhanced the OVA-induced symptom of sneezing. These results suggested that simultaneous activation of mast cells with antigen exposure enhances local IgE and IgG synthesis.	[Matsui, Nobuaki; Ito, Daisuke; Takabatake, Yukari; Nashioka, Eri; Tada, Shingo; Kanagawa, Masato; Akagi, Masaaki] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Pharmacol, Yamashiro, Tokushima 7708514, Japan; [Fukuishi, Nobuyuki] Kinjo Gakuin Univ, Coll Pharm, Moriyama Ku, Nagoya, Aichi 4638521, Japan	Matsui, N (reprint author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Pharmacol, 180 Nishihama Bouji, Yamashiro, Tokushima 7708514, Japan.	matsui@ph.bunri-u.ac.jp					GAUCHAT JF, 1993, NATURE, V365, P340, DOI 10.1038/365340a0; KleinJan A, 1997, J ALLERGY CLIN IMMUN, V99, P515, DOI 10.1016/S0091-6749(97)70079-4; Fukuishi N, 2001, PHYTOMEDICINE, V8, P460, DOI 10.1078/S0944-7113(04)70065-3; Pawankar R, 2000, AM J RHINOL, V14, P309, DOI 10.2500/105065800781329582; Okano M, 1999, ALLERGY, V54, P593, DOI 10.1034/j.1398-9995.1999.00063.x; Nabe T, 1997, JPN J PHARMACOL, V75, P243, DOI 10.1254/jjp.75.243; Kulka M, 2008, IMMUNOLOGY, V123, P398, DOI 10.1111/j.1365-2567.2007.02705.x; Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047; Smurthwaite L, 2001, EUR J IMMUNOL, V31, P3422, DOI 10.1002/1521-4141(200112)31:12<3422::AID-IMMU3422>3.0.CO;2-T; McLachlan JB, 2008, NAT MED, V14, P536, DOI 10.1038/nm1757; Zeng LB, 2015, VACCINE, V33, P1008, DOI 10.1016/j.vaccine.2015.01.013; ENNIS M, 1984, AGENTS ACTIONS, V14, P397, DOI 10.1007/BF01973836; Chang HC, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-174; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Hofmaier S, 2014, Eur Ann Allergy Clin Immunol, V46, P6; Kato Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103540; Klein Jan A, 2000, EUR RESPIR J, V15, P491	17	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2015	38	12					1954	1959				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UC	WOS:000365694800016		
J	Tomono, T; Otsuka, K; Yano, K; Kanagawa, M; Arakawa, H; Ogihara, T				Tomono, Takumi; Otsuka, Kyoma; Yano, Kentaro; Kanagawa, Masahiko; Arakawa, Hiroshi; Ogihara, Takuo			Recommended Daily Dose of Sesame Lignans Has No Influence on Oral Absorption of P-Glycoprotein Substrates in Rats	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						sesamin (SM); episesamin (ESM); P-glycoprotein (P-gp); drug-food interaction; oral absorption	BACTERIAL TRANSPORT PROTEINS; MULTIDRUG-RESISTANCE GENE; CANCER; CELLS; CHOLESTEROL; INHIBITION; EXPRESSION; HOMOLOGY	Sesamin (SM) and episesamin (ESM) are constituents of sesame seeds, which are used in health foods and considered to have various beneficial effects in the prevention of lifestyle-related diseases. P-Glycoprotein (P-gp) is an ATP-binding cassette transporter involved in drug absorption in the human gastrointestinal tract. A recent report indicated that SM influences P-gp-mediated drug transport. In the present study, we investigated whether SM and ESM inhibit P-gp in vitro, using Caco-2 cells and the typical P-gp substrates rhodamine123 (Rho123) and fexofenadine. SM and ESM showed no effect on accumulation of these compounds, indicating that SM and ESM do not influence P-gp function. In addition, an in vivo study using Rho123 indicated that SM and ESM do not affect absorption of P-gp substrates. Overall, these results suggest that health foods containing SM and ESM are unlikely to interact with P-gp substrates.	[Tomono, Takumi; Ogihara, Takuo] Takasaki Univ Hlth & Welfare, Grad Sch Pharmaceut Sci, Clin Pharmacokinet Lab, Takasaki, Gunma 3700033, Japan; [Otsuka, Kyoma; Yano, Kentaro; Kanagawa, Masahiko; Arakawa, Hiroshi] Takasaki Univ Hlth & Welfare, Fac Pharm, Takasaki, Gunma 3700033, Japan	Ogihara, T (reprint author), Takasaki Univ Hlth & Welfare, Grad Sch Pharmaceut Sci, Clin Pharmacokinet Lab, 60 Nakaorui Machi, Takasaki, Gunma 3700033, Japan.	togihara@takasaki-u.ac.jp			Minisry of Education, Culture, Sports, Science and Technology of Japan [24590667]	This work was partially supported by Grant-in-Aid for Scientific Research from the Minisry of Education, Culture, Sports, Science and Technology of Japan (No. 24590667).	Adachi Y, 2011, Oral absorption improving agent and pharmaceutical compositions utilizing these agents, Patent No. [P2011-231127 A, 2011231127]; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Akl MR, 2013, FITOTERAPIA, V84, P347, DOI 10.1016/j.fitote.2012.12.013; Muppavarapu R, 2014, BIOMED CHROMATOGR, V28, P1048, DOI 10.1002/bmc.3114; Saeed M, 2014, PHYTOMEDICINE, V21, P689, DOI 10.1016/j.phymed.2014.01.006; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; Penalvo JL, 2006, EUR J NUTR, V45, P439, DOI 10.1007/s00394-006-0617-8; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/bse0500161, 10.1042/BSE0500161]; KITA S, 1995, BIOL PHARM BULL, V18, P1283; Zhu WY, 2012, ANAT REC, V295, P208, DOI 10.1002/ar.21523; Hirata F, 1996, ATHEROSCLEROSIS, V122, P135, DOI 10.1016/0021-9150(95)05769-2; Ide T, 2014, J CLIN BIOCHEM NUTR, V54, P210, DOI 10.3164/jcbn.13-83; Kast C, 1996, J BIOL CHEM, V271, P9240; HIROSE N, 1991, J LIPID RES, V32, P629; Okura T, 2010, BIOL PHARM BULL, V33, P255, DOI 10.1248/bpb.33.255; Deng PY, 2013, BIOL PHARM BULL, V36, P1540, DOI 10.1248/bpb.b13-00235; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; JURANKA PF, 1989, FASEB J, V3, P2583; Li CY, 2005, J NAT PROD, V68, P1622, DOI 10.1021/np050106d; Wessler JD, 2013, J AM COLL CARDIOL, V61, P2495, DOI 10.1016/j.jacc.2013.02.058; FDA, 2000, GUID IND WAIV IN VIV; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; Nakai M, 2003, J AGR FOOD CHEM, V51, P1666, DOI 10.1021/jf0258961; Nakano D, 2004, VASC DIS PREV, V1, P233, DOI 10.2174/1567270043404836	25	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2015	38	12					1960	1963				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UC	WOS:000365694800017		
J	Kosuge, Y; Miyagishi, H; Shinomiya, T; Nishiyama, K; Suzuki, S; Osada, N; Ishige, K; Okubo, M; Kawaguchi, M; Ito, Y				Kosuge, Yasuhiro; Miyagishi, Hiroko; Shinomiya, Takashi; Nishiyama, Kenta; Suzuki, Satomi; Osada, Nobuhiro; Ishige, Kumiko; Okubo, Migiwa; Kawaguchi, Mitsuru; Ito, Yoshihisa			Characterization of Motor Neuron Prostaglandin E2 EP3 Receptor Isoform in a Mouse Model of Amyotrophic Lateral Sclerosis	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						motor neuron; prostaglandin E2 (PGE2); E-prostanoid 3 (EP3) receptor isoform; amyotrophic lateral sclerosis; laser microdissection	SPINAL-CORD; CELL-DEATH; CYCLOOXYGENASE-2; ACTIVATION; EXPRESSION; SURVIVAL; ALS; SUBTYPE; STRESS; PGE2	Amyotrophic lateral sclerosis (ALS) is a motor neuron disease with adult onset, characterized by progressive loss of motor neurons. Prostaglandin E2 (PGE2), a lipid mediator, exerts its biological functions by binding to four subtypes of E-prostanoid (EP1-4). Among them, EP3 has been shown to have multiple isoforms, EP3 alpha, EP3 beta, and EP3 gamma, produced by alternative splicing. Since PGE2 has been shown to have important pathophysiological roles in ALS, experiments were performed to identify EP3 receptor isoform(s) in spinal motor neurons of wild-type (WT) and ALS model (G93A) mice. Reverse transcription-polymerase chain reaction (RT-PCR) analysis of adult mice demonstrated expression of EP3 alpha and EP3 gamma mRNAs in the lumbar spinal cord, whereas EP3 beta mRNA was barely detectable. Laser capture microdissection was used to dissect out motor neurons from frozen samples of lumbar spinal cord in these mice for analysis by real-time PCR. We found that expression of EP3 gamma mRNA was predominant in these neurons, whereas EP3 alpha and EP3 beta mRNAs were undetectable. At the early symptomatic stage, the mRNA expression profiles of these splice isoforms in G93A motor neurons were comparable to those in neurons from WT mice. These results suggest that the PGE2-to-EP3 signaling pathway is mediated mainly by the EP3 gamma isoform in the motor neurons of mice, and that modulation of the EP3 gamma isoform in motor neurons may be a promising new therapeutic approach for ALS.	[Kosuge, Yasuhiro; Miyagishi, Hiroko; Nishiyama, Kenta; Suzuki, Satomi; Osada, Nobuhiro; Ishige, Kumiko; Ito, Yoshihisa] Nihon Univ, Pharmacol Lab, Sch Pharm, Funabashi, Chiba 2748555, Japan; [Kosuge, Yasuhiro; Shinomiya, Takashi; Okubo, Migiwa; Kawaguchi, Mitsuru] Tokyo Dent Coll, Dept Pharmacol, Chiyoda Ku, Tokyo 1010061, Japan; [Miyagishi, Hiroko] Int Univ Hlth & Welfare, Sch Pharm, Dept Pharmacol, Ohtawara, Tochigi 3248501, Japan	Kosuge, Y (reprint author), Nihon Univ, Pharmacol Lab, Sch Pharm, 7-7-1 Narashinodai, Funabashi, Chiba 2748555, Japan.	kosuge.yasuhiro@nihon-u.ac.jp			Takeda Science Foundation; School of Pharmacy Nihon University; Japan Society for the Promotion of Science (JSPS) [15K14966]	We thank K. Tadokoro (T.D.C.) for technical assistance. This work was supported by a Grant from the Takeda Science Foundation (Y.K.), a Grant for novel research project in the School of Pharmacy Nihon University (Y.K.), and a Grant-in-Aid for Challenging Exploratory Research (15K14966 to Y.I.) from Japan Society for the Promotion of Science (JSPS).	Almer G, 2002, NEUROLOGY, V58, P1277; Kosuge Y, 2008, NEUROCHEM INT, V52, P1204, DOI 10.1016/j.neuint.2007.12.010; Sobhan U, 2013, CELL TISSUE RES, V354, P507, DOI 10.1007/s00441-013-1691-x; Tonges L, 2014, GLIA, V62, P217, DOI 10.1002/glia.22601; Popp L, 2009, EUR J PAIN, V13, P691, DOI 10.1016/j.ejpain.2008.09.001; Oda T, 2008, NEUROSCI RES, V60, P29, DOI 10.1016/j.neures.2007.09.005; Shin JH, 2012, J NEUROCHEM, V122, P952, DOI 10.1111/j.1471-4159.2012.07771.x; IRIE A, 1994, EUR J BIOCHEM, V224, P161, DOI 10.1111/j.1432-1033.1994.tb20007.x; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tamiji J, 2010, BIOCHEM BIOPH RES CO, V398, P450, DOI 10.1016/j.bbrc.2010.06.098; Klivenyi P, 2004, J NEUROCHEM, V88, P576, DOI 10.1046/j.1471-4159.2003.02160.x; Negishi M, 1996, FEBS LETT, V386, P165, DOI 10.1016/0014-5793(96)00354-7; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; Miyagishi H, 2012, J PHARMACOL SCI, V118, P225, DOI 10.1254/jphs.11221FP; Vasilache AM, 2007, NEUROSCI LETT, V423, P179, DOI 10.1016/j.neulet.2007.06.048; Miyagishi H, 2013, J PHARMACOL SCI, V121, P347, DOI 10.1254/jphs.12274SC; Almer G, 2001, ANN NEUROL, V49, P176, DOI 10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.0.CO;2-X; Ilzecka J, 2003, ACTA NEUROL SCAND, V108, P125, DOI 10.1034/j.1600-0404.2003.00102.x; Hasegawa H, 1996, J BIOL CHEM, V271, P1857; Bilak M, 2004, ANN NEUROL, V56, P240, DOI 10.1002/ana.20179; Drachman DB, 2002, ANN NEUROL, V52, P771, DOI 10.1002/ana.10374; Abood ME, 2001, NEUROSCI LETT, V309, P197, DOI 10.1016/S0304-3940(01)02065-1; Yasojima K, 2001, NEUROLOGY, V57, P952; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Huang G, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.378; Sher RB, 2014, AMYOTROPH LAT SCL FR, V15, P588, DOI 10.3109/21678421.2014.932381; Zhao W, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-51	27	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2015	38	12					1964	1968				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UC	WOS:000365694800018		
J	Ishimoto, T; Azechi, K; Mori, H				Ishimoto, Tetsuya; Azechi, Kenji; Mori, Hisashi			Identification of a Novel Protein Kinase A Inhibitor by Bioluminescence-Based Screening	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						protein kinase A; high-throughput screening; inhibitor; split luciferase	CREB; ACTIVATION; CELLS; FACES; CAMP	We screened inhibitors in the adenylyl cyclase/protein kinase A/cAMP response element binding protein pathway (AC/PKA/CREB pathway) from a 2400 chemical library by a cell-based assay method using bioluminescence probes. We found a compound that inhibited forskolin-induced cAMP response element (CRE)-dependent transcription, the interaction between the kinase-inducible domain (KID) and the interacting domain (KIX), and endogenous CREB phosphorylation. Furthermore, this compound suppressed the activity of the PKA catalytic subunit dose-dependently. On the other hand, this compound did not inhibit forskolin-induced cAMP up-regulation. Taken together, we conclude that we have identified a new PKA inhibitor that binds to the catalytic subunit directly. We also succeeded in shortening the screening protocol by excluding a screening step which was used in a previous method.	[Ishimoto, Tetsuya; Azechi, Kenji; Mori, Hisashi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol Neurosci, Toyama 9300194, Japan	Ishimoto, T (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol Neurosci, 2630 Sugitani, Toyama 9300194, Japan.	ishimoto@med.u-toyama.ac.jp			PRESTO of the Japan Science and Technology Corporation (JST) [2602]; Japan Society for the Promotion of Science (JSPS) [25350998, 23650231]; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank Drs. Tetsuo Nagano and Takayoshi Okabe for helpful advice. We also thank Ms. Ayumi Yoto for technical assistance. This work was supported by PRESTO of the Japan Science and Technology Corporation (JST, No. 2602), Japan Society for the Promotion of Science (JSPS, Nos. 25350998 and 23650231), and Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Sato Y, 2014, SCIENCE, V344, P917, DOI 10.1126/science.1252328; Briand LA, 2010, BRAIN RES, V1314, P219, DOI 10.1016/j.brainres.2009.11.002; Ozawa T, 2001, ANAL CHEM, V73, P2516, DOI 10.1021/ac0013296; Best JL, 2004, P NATL ACAD SCI USA, V101, P17622, DOI 10.1073/pnas.0406374101; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Dalton GD, 2006, NEUROPEPTIDES, V40, P23, DOI 10.1016/j.npep.2005.10.002; James MA, 2009, CANCER RES, V69, P2108, DOI 10.1158/0008-5472.CAN-08-3495; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1; Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Coxon A, 2005, CANCER RES, V65, P7137, DOI 10.1158/0008-5472.CAN-05-1125; Ishimoto T, 2012, BIOCONJUGATE CHEM, V23, P923, DOI 10.1021/bc200491j; Siu YT, 2007, FEBS J, V274, P3224, DOI 10.1111/j.1742-4658.2007.05884.x; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Muschamp JW, 2011, J NEUROSCI, V31, P3095, DOI 10.1523/JNEUROSCI.5973-10.2011; DEWIT RJW, 1984, EUR J BIOCHEM, V142, P255; Mano H, 2014, BIOL PHARM BULL, V37, P1689	18	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2015	38	12					1969	1974				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UC	WOS:000365694800019		
J	Senda, A; Mukai, Y; Toda, T; Hayakawa, T; Yamashita, M; Eliasson, E; Rane, A; Inotsume, N				Senda, Asuna; Mukai, Yuji; Toda, Takaki; Hayakawa, Toru; Yamashita, Miki; Eliasson, Erik; Rane, Anders; Inotsume, Nobuo			Effects of Angiotensin II Receptor Blockers on Metabolism of Arachidonic Acid via CYP2C8	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						epoxyeicosatrienoic acid; arachidonic acid; drug-endogenous interaction; angiotensin II receptor blocker; dihydroxyeicosatrienoic acid	CYTOCHROME P450-DERIVED EICOSANOIDS; EPOXYGENASE-DERIVED EICOSANOIDS; CORONARY ARTERIOLAR DILATION; CA2+-ACTIVATED K+ CHANNELS; EPOXYEICOSATRIENOIC ACIDS; DIHYDROXYEICOSATRIENOIC ACIDS; CARDIOVASCULAR-DISEASE; LIVER-MICROSOMES; HYPERTENSION; INHIBITION	Arachidonic acid (AA) is metabolized to epoxyeicosatrienoic acids (EETs) via cytochrome enzymes such as CYP 2C9, 2C8 and 2J2. EETs play a role in cardioprotection and regulation of blood pressure. Recently, adverse reactions such as sudden heart attack and fatal myocardial infarction were reported among patients taking angiotensin II receptor blockers (ARBs). As some ARBs have affinity for these CYP enzymes, metabolic inhibition of AA by ARBs is a possible cause for the increase in cardiovascular events. In this study, we quantitatively investigated the inhibitory effects of ARBs on the formation of EETs and further metabolites, dihydroxyeicosatrienoic acids (DHETs), from AA via CYP2C8. In incubations with recombinant CYP2C8 in vitro, the inhibitory effects were compared by measuring EETs and DHETs by HPLC-MS/MS. Inhibition of AA metabolism by ARBs was detected in a concentration-dependent manner with IC50 values of losartan (42.7 mu M), telmisartan (49.5 mu M), irbesartan (55.6 mu M), olmesartan (66.2 mu M), candesartan (108 mu M), and valsartan (279 mu M). Losartan, telmisartan and irbesartan, which reportedly accumulate in the liver and kidneys, have stronger inhibitory effects than other ARBs. The lower concentration of EETs leads to less protective action on the cardiovascular system and a higher incidence of adverse effects such as sudden heart attack and myocardial infarction in patients taking ARBs.	[Senda, Asuna; Mukai, Yuji; Toda, Takaki; Inotsume, Nobuo] Hokkaido Pharmaceut Univ, Sch Pharm, Div Clin Pharmacol, Sapporo, Hokkaido 0068590, Japan; [Hayakawa, Toru] Hokkaido Pharmaceut Univ, Sch Pharm, Div Pharmacotherapy, Sapporo, Hokkaido 0068590, Japan; [Yamashita, Miki] Hokkaido Pharmaceut Univ, Sch Pharm, Div Clin Pharmaceut, Sapporo, Hokkaido 0068590, Japan; [Eliasson, Erik; Rane, Anders] Kalorinska Univ Hosp, Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, SE-14186 Stockholm, Sweden	Inotsume, N (reprint author), Hokkaido Pharmaceut Univ, Sch Pharm, Div Clin Pharmacol, 7-Jo 15-4-1 Maeda, Sapporo, Hokkaido 0068590, Japan.	nobuo_inotsume@hokuyakudai.ac.jp			JSPS KAKENHI [22590141]	This work was supported by JSPS KAKENHI Grant Number 22590141. The authors would like to thank Ms. Mizuki Edasawa, Mr. Masatoshi Kando, and Mr. Shota Saiki for their technical assistance.	Israili ZH, 2000, J HUM HYPERTENS, V14, pS73, DOI 10.1038/sj.jhh.1000991; CAPDEVILA J, 1981, P NATL ACAD SCI-BIOL, V78, P5362, DOI 10.1073/pnas.78.9.5362; Wienen W, 2000, CARDIOVASC DRUG REV, V18, P127; Kamiyama E, 2007, DRUG METAB PHARMACOK, V22, P267, DOI 10.2133/dmpk.22.267; Campbell WB, 1999, CIRC RES, V84, P484; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Miura H, 1998, CIRC RES, V83, P501; Gauthier KM, 2007, J CARDIOVASC PHARM, V50, P601; Bylund J, 1998, J PHARMACOL EXP THER, V284, P51; Zou AP, 1996, AM J PHYSIOL-RENAL, V270, pF822; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Roman RJ, 2002, PHYSIOL REV, V82, P131; Schuck RN, 2013, ATHEROSCLEROSIS, V227, P442, DOI 10.1016/j.atherosclerosis.2013.01.034; Theken KN, 2012, ATHEROSCLEROSIS, V222, P530, DOI 10.1016/j.atherosclerosis.2012.03.022; Luksha L, 2009, ATHEROSCLEROSIS, V202, P330, DOI 10.1016/j.atherosclerosis.2008.06.008; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Mukai Y, 2015, BIOL PHARM BULL, V38, P1673, DOI 10.1248/bpb.b15-00480; Miura H, 1999, CIRCULATION, V99, P3132; Spiecker M, 2005, ARCH BIOCHEM BIOPHYS, V433, P413, DOI 10.1016/j.abb.2004.10.009; Gottlieb RA, 2003, ARCH BIOCHEM BIOPHYS, V420, P262, DOI 10.1016/j.abb.2003.07.004; Totah RA, 2005, CLIN PHARMACOL THER, V77, P341, DOI 10.1016/j.clpt.2004.12.267; Spector AA, 2004, PROG LIPID RES, V43, P55, DOI 10.1016/S0163-7827(03)00049-3; Walsky RL, 2005, J CLIN PHARMACOL, V45, P68, DOI 10.1177/0091270004270642; OLIW EH, 1981, J BIOL CHEM, V256, P9924; Taavitsainen P, 2000, EUR J CLIN PHARMACOL, V56, P135, DOI 10.1007/s002280050731; DAIKH BE, 1994, J PHARMACOL EXP THER, V271, P1427; Capdevila J, 2013, CURR OPIN NEPHROL HY, V22, P163, DOI 10.1097/MNH.0b013e32835d911e; Bangalore S, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2234; R Core Team, R LANG ENV STAT COMP; Takayama F, 1995, XENOBIO METAB DISPOS, V10, P223; Agodoa L, 2007, J HYPERTENS, V25, P951	31	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2015	38	12					1975	1979				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UC	WOS:000365694800020		
J	Kimura, K; Inoue, K; Okubo, J; Ueda, Y; Kawaguchi, K; Sakurai, H; Wada, I; Morita, M; Imanaka, T				Kimura, Koji; Inoue, Kengo; Okubo, Jun; Ueda, Yumiko; Kawaguchi, Kosuke; Sakurai, Hiroaki; Wada, Ikuo; Morita, Masashi; Imanaka, Tsuneo			Endoplasmic Reticulum Stress Response and Mutant Protein Degradation in CHO Cells Accumulating Antithrombin (C95R) in Russell Bodies	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						endoplasmic reticulum (ER); ER stress; mutant antithrombin; unfolded protein response; ER-overload response; Russell body	NF-KAPPA-B; INTRACELLULAR ACCUMULATION; MESSENGER-RNA; MUTATION; DEFICIENCY; PATHWAY; IRE1	Newly synthesized secretory proteins are folded and assembled in the endoplasmic reticulum (ER), where an efficient protein quality control system performs a critically important function. When unfolded or aggregated proteins accumulate in the ER, certain signaling pathways such as the unfolded protein response (UPR) and ER-overload response (EOR) are functionally active in maintaining cell homeostasis. Recently we prepared Chinese hamster ovary (CHO) cells expressing mutant antithrombin (AT)(C95R) under control of the Tet-On system and showed that AT(C95R) accumulated in Russell bodies (RB), large distinctive structures derived from the ER. To characterize whether ER stress takes place in CHO cells, we examined characteristic UPR and EOR in ER stress responses. We found that the induction of ER chaperones such as Grp97, Grp78 and protein disulfide isomerase (PDI) was limited to a maximum of approximately two-fold. The processing of X-box-binding protein-1 (XBP1) mRNA and the phosphorylation of eukaryotic translation initiation factor 2 alpha (eIF2 alpha) subunit were not induced. Furthermore, the activation of nuclear factor-kappa B (NF-kappa B) was not observed. In contrast, CHO cells displayed UPR and EOR when the cells were treated with thapsigargin and tumor necrosis factor (TNF)-alpha, respectively. In addition, a portion of the mutant AT(C95R) was degraded through proteasomes and autophagy. CHO cells do respond to ER stress but the folding state of mutant AT(C95R) does not appear to activate the ER stress signal pathway.	[Kimura, Koji; Inoue, Kengo; Okubo, Jun; Ueda, Yumiko; Kawaguchi, Kosuke; Morita, Masashi; Imanaka, Tsuneo] Toyama Univ, Dept Biol Chem, Toyama 9300194, Japan; [Sakurai, Hiroaki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Canc Cell Biol, Toyama 9300194, Japan; [Wada, Ikuo] Fukushima Med Univ, Sch Med, Inst Biomed Sci, Dept Cell Sci, Fukushima 9601295, Japan	Imanaka, T (reprint author), Toyama Univ, Dept Biol Chem, 2630 Sugitani, Toyama 9300194, Japan.	imanaka@pha.u-toyama.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [20590054, 40182969]	This research was supported in part by the Ministry of Education, Culture, Sports, Science and Technology of Japan (20590054 (TI) and 40182969 (IW)). Pacific Edit reviewed the manuscript prior to submission.	Tanaka Y, 2005, J BIOCHEM, V137, P273, DOI 10.1093/jb/mvi/040; Tanaka Y, 2002, J BIOL CHEM, V277, P51058, DOI 10.1074/jbc.M210231200; Davies MJ, 2009, J BIOL CHEM, V284, P18202, DOI 10.1074/jbc.M109.010744; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Suzuki S, 2006, FEBS LETT, V580, P3257, DOI 10.1016/j.febslet.2006.04.086; Kimura K, 2015, BIOL PHARM BULL, V38, P852, DOI 10.1248/bpb.b14-00773; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Ordonez A, 2013, HEPATOLOGY, V57, P2049, DOI 10.1002/hep.26173; Hidvegi T, 2005, J BIOL CHEM, V280, P39002, DOI 10.1074/jbc.M508652200; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038	13	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2015	38	12					1980	1984				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UC	WOS:000365694800021		
J	Zhang, XK; Aoyama, T; Yasuda, T; Oike, M; Ito, A; Tajino, J; Nagai, M; Fujioka, R; Iijima, H; Yamaguchi, S; Kakinuma, N; Kuroki, H				Zhang, Xiangkai; Aoyama, Tomoki; Yasuda, Takashi; Oike, Makoto; Ito, Akira; Tajino, Junichi; Nagai, Momoko; Fujioka, Rune; Iijima, Hirotaka; Yamaguchi, Shoki; Kakinuma, Norihiro; Kuroki, Hiroshi			Effect of microfabricated microgroove-surface devices on the morphology of mesenchymal stem cells	BIOMEDICAL MICRODEVICES			English	Article						Mesenchymal stem cell; Microgroove; Cell shape; Zigzag	MARROW STROMAL CELLS; EXTRACELLULAR-MATRIX; CONTACT GUIDANCE; DIFFERENTIATION; ORGANIZATION; CYTOSKELETON; INTERFACE; ADHESION; SCAFFOLD; FATE	The surface of a material that is in contact with cells is known to affect cell morphology and function. To develop an appropriate surface for tendon engineering, we used zigzag microgroove surfaces, which are similar to the tenocyte microenvironment. The purpose of this study was to investigate the effect of microgroove surfaces with different ridge angles (RAs), ridge lengths (RLs), ridge widths (RWs), and groove widths (GWs) on human bone marrow-derived mesenchymal stem cell (MSC) shape. Dishes with microgroove surfaces were fabricated using cyclic olefin polymer by injection-compression molding. The other parameters were fixed, and effects of different RAs (180 - 30 degrees), RLs (5 - 500 mu m), RWs (5 - 500 mu m), and GWs (5 - 500 mu m) were examined. Changes in the zigzag shape of the cell due to different RAs, RLs, RWs, and GWs were observed by optical microscopy and scanning electron microscopy. Cytoskeletal changes were investigated using Phalloidin immunofluorescence staining. As observed by optical microscopy, MSCs changed to a zigzag shape in response to microgroove surfaces with different ridge and groove properties.. As observed by scanning electron microscopy, the cell shape changed at turns in the microgroove surface. Phalloidin immunofluorescence staining indicated that F-actin, not only in cell filopodia but also inside the cell body, changed orientation to conform to the microgrooves. In conclusion, the use of zigzag microgroove surfaces microfabricated by injection-compression molding demonstrated the property of MSCs to alter their shapes to fit the surface.	[Zhang, Xiangkai; Aoyama, Tomoki; Ito, Akira; Tajino, Junichi; Nagai, Momoko; Fujioka, Rune; Iijima, Hirotaka; Yamaguchi, Shoki; Kuroki, Hiroshi] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Sakyo Ku, Kyoto 6068507, Japan; [Yasuda, Takashi; Oike, Makoto; Kakinuma, Norihiro] SEIKOH GIKEN Co Ltd, Precis Machinery Dept, Chiba, Japan	Aoyama, T (reprint author), Kyoto Univ, Grad Sch Med, Human Hlth Sci, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	blue@hs.med.kyoto-u.ac.jp			SEIKOH GIKEN Co., Ltd.	This study was funded by collaborative research funding from SEIKOH GIKEN Co., Ltd.	Nandakumar A, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015006; Jarvinen TAH, 2004, J ORTHOP RES, V22, P1303, DOI 10.1016/j.orthres.2004.04.003; Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Liu Y, 2008, TRENDS BIOTECHNOL, V26, P201, DOI 10.1016/j.tibtech.2008.01.003; Kolind K, 2010, BIOMATERIALS, V31, P9182, DOI 10.1016/j.biomaterials.2010.08.048; Karuri NW, 2008, SCANNING, V30, P405, DOI 10.1002/sca.20123; Mountain KM, 2011, MAGN RESON MED, V66, P520, DOI 10.1002/mrm.23036; Zhu J, 2010, BIOMATERIALS, V31, P6952, DOI 10.1016/j.biomaterials.2010.05.058; Schu S, 2012, J CELL MOL MED, V16, P2094, DOI 10.1111/j.1582-4934.2011.01509.x; Rajnicek AM, 1997, J CELL SCI, V110, P2905; De Luca AC, 2015, J BIOMED MATER RES A, V103, P2689, DOI 10.1002/jbm.a.35407; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004; Ventre M, 2012, J R SOC INTERFACE, V9, P2017, DOI 10.1098/rsif.2012.0308; Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245; Alaerts JA, 2001, BIOMATERIALS, V22, P1635, DOI 10.1016/S0142-9612(00)00321-5; Xu Y, 2013, TISSUE ENG PART C-ME, V19, P925, DOI [10.1089/ten.TEC.2012.0328, 10.1089/ten.tec.2012.0328]; Iannone M, 2015, NANO LETT, V15, P1517, DOI 10.1021/nl503737k; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Pham QP, 2008, BIOMATERIALS, V29, P2729, DOI 10.1016/j.biomaterials.2008.02.025; Higuchi A, 2013, CHEM REV, V113, P3297, DOI 10.1021/cr300426x; Mai JY, 2007, BIOMED MICRODEVICES, V9, P523, DOI 10.1007/s10544-007-9060-8; Boggiano J.C., 2012, DEV CELL, V22, P1534; Gong T, 2014, ADV HEALTHC MATER, V3, P1608, DOI 10.1002/adhm.201300692; Kean T.J., 2013, STEL CELLS INT, V2013, P13; Nagato K, 2011, J VAC SCI TECHNOL B, V29, DOI 10.1116/1.3662405	29	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1387-2176	1572-8781		BIOMED MICRODEVICES	Biomed. Microdevices	DEC	2015	17	6								10.1007/s10544-015-0016-0		8	Engineering, Biomedical; Nanoscience & Nanotechnology	Engineering; Science & Technology - Other Topics	CX4XT	WOS:000365704800015		
J	Tanimoto, Y; Okada, K; Hayashi, F; Morigaki, K				Tanimoto, Yasushi; Okada, Keisuke; Hayashi, Fumio; Morigaki, Kenichi			Evaluating the Raftophilicity of Rhodopsin Photoreceptor in a Patterned Model Membrane	BIOPHYSICAL JOURNAL			English	Article							PROTEIN-COUPLED RECEPTOR; MIMICKING LIPID MIXTURES; GTP-BINDING PROTEIN; LATERAL DIFFUSION; SUPPORTED MEMBRANES; PHASE-SEPARATION; SOLID SUBSTRATE; DISC MEMBRANES; OUTER SEGMENTS; RAFTS	Lipid rafts in the cell membrane are believed to affect various membrane functions, including the signaling by G-protein coupled receptors (GPCRs). However, the regulatory roles of lipid rafts on GPCRs' functions are still poorly understood, partially owing to the lack of the methods to quantitatively evaluate the affinity of membrane proteins to lipid raft (raftophilicity). Here, we describe a methodology to gauge the raftophilicity of a representative GPCR in vertebrate photoreceptor, i.e., rhodopsin (Rh), and its cognate G protein transducin (G(t)) by using a patterned model membrane. We generated a substrate-supported planar lipid bilayer that has patterned regions of liquid-ordered (L-0) and liquid-disordered (L-d) membrane domains. We reconstituted Rh and Gt into the patterned membrane and observed their lateral distribution and diffusion. Mobile and functional Rh molecules could be reconstituted through the rapid dilution of solubilized Rh, by optimizing the reconstitution conditions including the chamber design, protein/detergent concentrations, and solution mixing. We determined the partition and diffusion coefficients of Rh and Gt in the L-0-rich and L-d-rich regions. Both Rh and G(t) were predominantly localized in the L-d phase, suggesting their low affinity to lipid rafts. Patterned model membrane offers a robust and scalable platform for systematically and quantitatively studying the functional roles of lipid rafts in biological membranes including retinal disk membranes.	[Tanimoto, Yasushi; Okada, Keisuke; Morigaki, Kenichi] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 657, Japan; [Hayashi, Fumio] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 657, Japan; [Morigaki, Kenichi] Kobe Univ, Res Ctr Environm Genom, Kobe, Hyogo 657, Japan	Hayashi, F (reprint author), Kobe Univ, Grad Sch Sci, Kobe, Hyogo 657, Japan.	fhayashi@port.kobe-u.ac.jp; fhayashi@port.kobe-u.ac.jp			Japan Society for the Promotion of Science [26291031]; Hyogo Science and Technology Association	This work was supported by a Grant-in-Aid for Scientific research from Japan Society for the Promotion of Science (No. 26291031) and Hyogo Science and Technology Association.	Ichinose J, 2004, BIOCHEM BIOPH RES CO, V324, P1143, DOI 10.1016/j.bbrc.2004.09.173; HAYASHI F, 1991, P NATL ACAD SCI USA, V88, P4746, DOI 10.1073/pnas.88.11.4746; Okazaki T, 2009, LANGMUIR, V25, P345, DOI 10.1021/la802670t; Yoon TY, 2006, NAT MATER, V5, P281, DOI 10.1038/nmat1618; Siegel AP, 2011, BIOPHYS J, V101, P1642, DOI 10.1016/j.bpj.2011.08.040; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Comar WD, 2014, J AM CHEM SOC, V136, P8342, DOI 10.1021/ja501948w; Quemeneur F, 2014, P NATL ACAD SCI USA, V111, P5083, DOI 10.1073/pnas.1321054111; Alves ID, 2005, BIOPHYS J, V88, P198, DOI 10.1529/biophj.104.046722; Oates J, 2011, CURR OPIN STRUC BIOL, V21, P802, DOI 10.1016/j.sbi.2011.09.007; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Heyse S, 1998, BIOCHEMISTRY-US, V37, P507, DOI 10.1021/bi971564r; LITMAN BJ, 1982, METHOD ENZYMOL, V81, P150; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Seno K, 2001, J BIOL CHEM, V276, P20813, DOI 10.1074/jbc.C100032200; Morigaki K, 2007, LANGMUIR, V23, P12254, DOI 10.1021/la701346x; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Sumino A, 2011, BIOMACROMOLECULES, V12, P2850, DOI 10.1021/bm200585y; Okada F, 2015, RSC ADV, V5, P1507, DOI 10.1039/c4ra09981h; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; OBRIEN PJ, 1984, J BIOL CHEM, V259, P5054; POO MM, 1974, NATURE, V247, P438, DOI 10.1038/247438a0; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Chiantia S, 2006, CHEMPHYSCHEM, V7, P2409, DOI 10.1002/cphc.200600464; LIEBMAN PA, 1974, SCIENCE, V185, P457, DOI 10.1126/science.185.4149.457; Wang Q, 2008, J BIOL CHEM, V283, P30015, DOI 10.1074/jbc.M803953200; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; KAMEYAMA K, 1990, J COLLOID INTERF SCI, V137, P1, DOI 10.1016/0021-9797(90)90037-O; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; Gutierrez MG, 2014, J AM CHEM SOC, V136, P13530, DOI 10.1021/ja507221m; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Okazaki T, 2010, LANGMUIR, V26, P4126, DOI 10.1021/la9032892; Subramaniam V, 2005, J AM CHEM SOC, V127, P5320, DOI 10.1021/ja0423973; Roder F, 2013, J AM CHEM SOC, V135, P1189, DOI 10.1021/ja310186g; Shogomori H, 2005, J BIOL CHEM, V280, P18931, DOI 10.1074/jbc.M500247200; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; FUKADA Y, 1990, NATURE, V346, P658, DOI 10.1038/346658a0; Ge Y, 2014, BIOPHYS J, V107, P2101, DOI 10.1016/j.bpj.2014.09.021; KOKAME K, 1992, NATURE, V359, P749, DOI 10.1038/359749a0; KUHN H, 1980, NATURE, V283, P587, DOI 10.1038/283587a0; Soubias O, 2012, BBA-BIOMEMBRANES, V1818, P234, DOI 10.1016/j.bbamem.2011.08.034; Tarantino N, 2014, J CELL BIOL, V204, P231, DOI 10.1083/jcb.201307172; Vaz L. C. W., 1984, FEBS LETT, V174, P199; Whited AM, 2015, BBA-BIOMEMBRANES, V1848, P26, DOI 10.1016/j.bbamem.2014.10.007; YAMAZAKI A, 1988, METHOD ENZYMOL, V159, P702; YAMAZAKI A, 1987, J BIOL CHEM, V262, P9316; Yang JP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-57; Zheng H, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-6	50	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0006-3495	1542-0086		BIOPHYS J	Biophys. J.	DEC 1	2015	109	11					2307	2316		10.1016/j.bpj.2015.10.015		10	Biophysics	Biophysics	CX8CG	WOS:000365929500011		
J	Nishijima, K; Orisaka, M; Takahashi, J; Yamamoto, M; Nakago, S; Yoshida, A; Masuzaki, H; Kotsuji, F; Yoshida, Y				Nishijima, Koji; Orisaka, Makoto; Takahashi, Jin; Yamamoto, Makoto; Nakago, Satoshi; Yoshida, Atsushi; Masuzaki, Hideaki; Kotsuji, Fumikazu; Yoshida, Yoshio			Re: Transverse uterine fundal incision for placenta praevia with accreta, involving the entire anterior uterine wall: a case series How to reduce overuse of the new method for dealing with placenta praevia suggested by Kotsuji et al. Reply	BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY			English	Letter									[Nishijima, Koji; Orisaka, Makoto; Takahashi, Jin; Yamamoto, Makoto; Yoshida, Yoshio] Univ Fukui, Fac Med Sci, Dept Obstet & Gynaecol, Fukui 910, Japan; [Nakago, Satoshi; Kotsuji, Fumikazu] Takatsuki Gen Hosp, Dept Obstet & Gynaecol, Osaka, Japan; [Yoshida, Atsushi; Masuzaki, Hideaki] Nagasaki Univ, Sch Med, Dept Obstet & Gynaecol, Nagasaki 852, Japan	Nishijima, K (reprint author), Univ Fukui, Fac Med Sci, Dept Obstet & Gynaecol, Fukui 910, Japan.						Kotsuji F, 2013, BJOG-INT J OBSTET GY, V120, P1144, DOI 10.1111/1471-0528.12252; Esakoff TF, 2011, ULTRASOUND OBST GYN, V37, P324, DOI 10.1002/uog.8827; Kim TH, 2015, BJOG-INT J OBSTET GY, V122, P1843, DOI 10.1111/1471-0528.13609	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1470-0328	1471-0528		BJOG-INT J OBSTET GY	BJOG	DEC	2015	122	13					1844	1845		10.1111/1471-0528.13610		2	Obstetrics & Gynecology	Obstetrics & Gynecology	CX1JJ	WOS:000365452200024		
J	Matsubara, S				Matsubara, Shigeki			Re: The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next?: The treatment of postpartum haemorrhage: holding the intrauterine balloon "there'	BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY			English	Letter							MANAGEMENT		[Matsubara, Shigeki] Jichi Med Univ, Dept Obstet & Gynaecol, Shimotsuke, Tochigi, Japan	Matsubara, S (reprint author), Jichi Med Univ, Dept Obstet & Gynaecol, Shimotsuke, Tochigi, Japan.						Jain V, 2011, AM J OBSTET GYNECOL, V205, pE15, DOI 10.1016/j.ajog.2011.01.051; Kawamura A, 2013, J OBSTET GYNAECOL RE, V39, P733, DOI 10.1111/j.1447-0756.2012.02017.x; Khalil MI, 2011, INT J GYNECOL OBSTET, V115, P198, DOI 10.1016/j.ijgo.2011.04.018; Weeks A, 2015, BJOG-INT J OBSTET GY, V122, P202, DOI 10.1111/1471-0528.13098	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1470-0328	1471-0528		BJOG-INT J OBSTET GY	BJOG	DEC	2015	122	13					1846	1846		10.1111/1471-0528.13686		1	Obstetrics & Gynecology	Obstetrics & Gynecology	CX1JJ	WOS:000365452200027		
J	Motzer, RJ; Escudier, B; Mcdermott, DF; George, S; Hammers, HJ; Srinivas, S; Tykodi, SS; Sosman, JA; Procopio, G; Plimack, ER; Castellano, D; Gurney, H; Donskov, F; Bono, P; Wagstaff, J; Gauler, TC; Ueda, T; Xu, LA; Waxman, IM; Sharma, P				Motzer, Robert J.; Escudier, Bernard; Mcdermott, David F.; George, Saby; Hammers, Hans J.; Srinivas, Sandhya; Tykodi, Scott S.; Sosman, Jeffrey A.; Procopio, Giuseppe; Plimack, Elizabeth R.; Castellano, Daniel; Gurney, Howard; Donskov, Frede; Bono, Petri; Wagstaff, John; Gauler, Thomas C.; Ueda, Takeshi; Xu, Li-An; Waxman, Ian M.; Sharma, Padmanee		Checkmate 025 Invest	CheckMate 025: a randomized, open-label, phase Ill study of nivolumab versus everolimus in advanced renal cell carcinoma (RCC)	BJU INTERNATIONAL			English	Meeting Abstract	14th International Kidney Cancer Symposium	NOV 06-07, 2015	Miami, FL						[Motzer, Robert J.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Escudier, Bernard] Inst Gustave Roussy, Villejuif, France; [Mcdermott, David F.] Dana Farber Harvard Canc Inst, Beth Israel Deaconess Med Ctr, Boston, MA USA; [George, Saby] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Hammers, Hans J.] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Srinivas, Sandhya] Stanford Canc Inst, Stanford, CA USA; [Tykodi, Scott S.] Univ Washington, Seattle, WA 98195 USA; [Tykodi, Scott S.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Sosman, Jeffrey A.] Vanderbilt Univ, Med Ctr, Nashville, TN 37235 USA; [Procopio, Giuseppe] Fdn Ist Nazl Tumori, Milan, Italy; [Plimack, Elizabeth R.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Castellano, Daniel] Hosp Univ 12 De Octubre, Madrid, Spain; [Gurney, Howard] Westmead Hosp, Westmead, NSW, Australia; [Donskov, Frede] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; [Bono, Petri] Helsinki Univ Hosp, Ctr Comprehens Canc, Helsinki, Finland; [Bono, Petri] Univ Helsinki, Helsinki, Finland; [Wagstaff, John] South West Wales Canc Inst, Swansea, W Glam, Wales; [Wagstaff, John] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Gauler, Thomas C.] Univ Duisburg Essen, Univ Hosp Essen, Essen, Germany; [Ueda, Takeshi] Chiba Canc Ctr, Chiba 2608717, Japan; [Xu, Li-An] Bristol Myers Squibb Co, Hopewell, NJ USA; [Waxman, Ian M.] Bristol Myers Squibb Co, Lawrenceville, NJ USA; [Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1464-4096	1464-410X		BJU INT	BJU Int.	DEC	2015	116			5	SI		17	17				1	Urology & Nephrology	Urology & Nephrology	CY3CD	WOS:000366284900033		
J	Morales, JMR; Wells, JC; Donskov, F; Bjarnason, GA; Lee, JL; Knox, JJ; Beuselinck, B; Vasihampayan, U; Brugarolas, J; Broom, R; Koutsoukos, K; Yuasa, T; Srinivas, S; Ernst, DS; Pezaro, C; Wood, LA; Kollmannsberger, C; Rini, BI; Choueiri, TK; Heng, DYC				Morales, Jose Manuel Ruiz; Wells, J. Connor; Donskov, Frede; Bjarnason, Georg A.; Lee, Jae Lyun; Knox, Jennifer J.; Beuselinck, Benoit; Vasihampayan, Ulka; Brugarolas, James; Broom, Reuben; Koutsoukos, Konstantinos; Yuasa, Takeshi; Srinivas, Sandy; Ernst, D. Scott; Pezaro, Carmel; Wood, Lori A.; Kollmannsberger, Christian; Rini, Brian I.; Choueiri, Toni K.; Heng, Daniel Y. C.			First line sunitinib versus pazopanib in metastatic renal cell carcinoma: results from the international metastatic renal cell carcinoma database consortium	BJU INTERNATIONAL			English	Meeting Abstract	14th International Kidney Cancer Symposium	NOV 06-07, 2015	Miami, FL						[Morales, Jose Manuel Ruiz] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada; [Wells, J. Connor] Tom Baker Canc Clin, Calgary, AB, Canada; [Donskov, Frede] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark; [Bjarnason, Georg A.] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada; [Lee, Jae Lyun] Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, Seoul, South Korea; [Knox, Jennifer J.] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada; [Beuselinck, Benoit] Univ Hosp Leuven, Dept Gen Med Oncol, Leuven, Belgium; [Vasihampayan, Ulka] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; [Brugarolas, James] Univ Texas SW Med Ctr Dallas, Med Ctr, Dallas, TX 75390 USA; [Broom, Reuben] Auckland City Hosp, Auckland, New Zealand; [Koutsoukos, Konstantinos] Univ Athens, Dept Clin Therapeut, Athens, Greece; [Yuasa, Takeshi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Urol, Tokyo, Japan; [Srinivas, Sandy] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Ernst, D. Scott] London Reg Canc Ctr, London, ON N6A 4L6, Canada; [Pezaro, Carmel] Royal Marsden NHS Fdn Trust, Inst Canc Res, Sutton, Surrey, England; [Wood, Lori A.] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada; [Kollmannsberger, Christian] BC Canc Agcy, Vancouver Canc Ctr, Vancouver, BC, Canada; [Rini, Brian I.] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA; [Choueiri, Toni K.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Heng, Daniel Y. C.] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1464-4096	1464-410X		BJU INT	BJU Int.	DEC	2015	116			5	SI		20	20				1	Urology & Nephrology	Urology & Nephrology	CY3CD	WOS:000366284900040		
J	Stukalina, I; Wellsa, JC; Donskovb, F; Rinic, BI; Leed, JL; Bjarnasone, GA; Beuselinckf, B; Smoragiewicz, M; Alvah, AS; Srinivasi, S; Woodi, L; Saleemk, S; Pal, SK; Yuasam, T; Broomn, RJ; Kanesvaran, R; Bamiasp, A; Knoxq, JJ; Henga, DYC; Choueirir, TK				Stukalina, Igor; Wellsa, J. Connor; Donskovb, Frede; Rinic, Brian I.; Leed, Jae-Lyun; Bjarnasone, Georg A.; Beuselinckf, Benoit; Smoragiewicz, Martin; Alvah, Ajjai Shivaram; Srinivasi, Sandy; Woodi, Lori; Saleemk, Sadia; Pal, Sumanta Kumar; Yuasam, Takeshi; Broomn, Reuben James; Kanesvaran, Ravindran; Bamiasp, Aristotelis; Knoxq, Jennifer J.; Henga, Daniel Y. C.; Choueirir, Toni K.			Third line therapy in metastatic renal cell carcinoma (mRCC): results from the international mRCC database consortium (IMDC)	BJU INTERNATIONAL			English	Meeting Abstract	14th International Kidney Cancer Symposium	NOV 06-07, 2015	Miami, FL						[Stukalina, Igor; Pal, Sumanta Kumar] Tom Baker Canc Clin, Calgary, AB, Canada; [Wellsa, J. Connor] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; [Donskovb, Frede] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA; [Rinic, Brian I.] Asan Med Ctr, Seoul, South Korea; [Leed, Jae-Lyun] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada; [Bjarnasone, Georg A.] Univ Hosp Leuven, Leuven, Belgium; [Beuselinckf, Benoit] BC Canc Agcy, Vancouver, BC, Canada; [Smoragiewicz, Martin] Univ Michigan, Ann Arbor, MI 48109 USA; [Alvah, Ajjai Shivaram] Stanford Med Ctr, Stanford, CA USA; [Srinivasi, Sandy] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada; [Woodi, Lori] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Saleemk, Sadia] City Hope Natl Med Ctr, Duarte, CA 91010 USA; [Yuasam, Takeshi] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan; [Broomn, Reuben James] Auckland City Hosp, Auckland, New Zealand; [Kanesvaran, Ravindran] Natl Canc Ctr Singapore, Singapore, Singapore; [Bamiasp, Aristotelis] Univ Athens, Athens 11528, Greece; [Knoxq, Jennifer J.] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Henga, Daniel Y. C.; Choueirir, Toni K.] Dana Farber Canc Inst, Boston, MA 02115 USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1464-4096	1464-410X		BJU INT	BJU Int.	DEC	2015	116			5	SI		21	21				1	Urology & Nephrology	Urology & Nephrology	CY3CD	WOS:000366284900042		
J	Mitsui, Y; Chang, I; Fukuhara, S; Hiraki, M; Arichi, N; Yasumoto, H; Hirata, H; Yamamura, S; Shahryari, V; Deng, G; Wong, DK; Majid, S; Shiina, H; Dahiya, R; Tanaka, Y				Mitsui, Yozo; Chang, Inik; Fukuhara, Shinichiro; Hiraki, Miho; Arichi, Naoko; Yasumoto, Hiroaki; Hirata, Hiroshi; Yamamura, Soichiro; Shahryari, Varahram; Deng, Guoren; Wong, Darryn K.; Majid, Shahana; Shiina, Hiroaki; Dahiya, Rajvir; Tanaka, Yuichiro			CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma	BMC CANCER			English	Article						Cytochrome 450 1B1; Renal cell carcinoma; Apoptosis; CDC20; DAPK1	SPINDLE ASSEMBLY CHECKPOINT; POOR-PROGNOSIS; PROTEIN-KINASE; CYTOCHROME-P450 1B1; KIDNEY CANCER; IN-VITRO; OVEREXPRESSION; METHYLATION; DEATH; CARCINOGENESIS	Background: Cytochrome P450 1B1 (CYP1B1) has been shown to be up-regulated in many types of cancer including renal cell carcinoma (RCC). Several reports have shown that CYP1B1 can influence the regulation of tumor development; however, its role in RCC has not been well investigated. The aim of the present study was to determine the functional effects of CYP1B1 gene on tumorigenesis in RCC. Methods: Expression of CYP1B1 was determined in RCC cell lines, and tissue microarrays of 96 RCC and 25 normal tissues. To determine the biological significance of CYP1B1 in RCC progression, we silenced the gene in Caki-1 and 769-P cells by RNA interference and performed various functional analyses. Results: First, we confirmed that CYP1B1 protein expression was significantly higher in RCC cell lines compared to normal kidney tissue. This trend was also observed in RCC samples (p < 0.01). Interestingly, CYP1B1 expression was associated with tumor grade and stage. Next, we silenced the gene in Caki-1 and 769-P cells by RNA interference and performed various functional analyses to determine the biological significance of CYP1B1 in RCC progression. Inhibition of CYP1B1 expression resulted in decreased cell proliferation, migration and invasion of RCC cells. In addition, reduction of CYP1B1 induced cellular apoptosis in Caki-1. We also found that these anti-tumor effects on RCC cells caused by CYP1B1 depletion may be due to alteration of CDC20 and DAPK1 expression based on gene microarray and confirmed by real-time PCR. Interestingly, CYP1B1 expression was associated with CDC20 and DAPK1 expression in clinical samples. Conclusions: CYP1B1 may promote RCC development by inducing CDC20 expression and inhibiting apoptosis through the down-regulation of DAPK1. Our results demonstrate that CYP1B1 can be a potential tumor biomarker and a target for anticancer therapy in RCC.	[Mitsui, Yozo; Hiraki, Miho; Arichi, Naoko; Yasumoto, Hiroaki; Shiina, Hiroaki] Shimane Univ, Fac Med, Dept Urol, Izumo, Shimane 6938501, Japan; [Mitsui, Yozo; Hirata, Hiroshi; Yamamura, Soichiro; Shahryari, Varahram; Deng, Guoren; Wong, Darryn K.; Majid, Shahana; Dahiya, Rajvir; Tanaka, Yuichiro] San Francisco VA Med Ctr, Dept Urol, San Francisco, CA 94121 USA; [Mitsui, Yozo; Yamamura, Soichiro; Shahryari, Varahram; Deng, Guoren; Wong, Darryn K.; Majid, Shahana; Dahiya, Rajvir; Tanaka, Yuichiro] Univ Calif San Francisco, San Francisco, CA 94121 USA; [Chang, Inik] Yonsei Univ, Coll Dens, Dept Oral Biol, Seoul 120749, South Korea; [Chang, Inik; Fukuhara, Shinichiro] Osaka Univ, Grad Sch Med, Dept Urol, Suita, Osaka 5650871, Japan	Mitsui, Y (reprint author), Shimane Univ, Fac Med, Dept Urol, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	mitsui@med.shimane-u.ac.jp; Yuichiro.tanaka@ucsf.edu					Saini S, 2009, CANCER RES, V69, P7038, DOI 10.1158/0008-5472.CAN-09-1691; Hayes CL, 1996, P NATL ACAD SCI USA, V93, P9776, DOI 10.1073/pnas.93.18.9776; Rudin CM, 1997, ANNU REV MED, V48, P267; Gayed BA, 2013, J UROLOGY, V190, P1662, DOI 10.1016/j.juro.2013.06.037; De Mulder PHM, 2004, ANN ONCOL, V15, P319, DOI 10.1093/annonc/mdh946; Martinez VG, 2008, BRIT J CANCER, V98, P564, DOI 10.1038/sj.bjc.6604195; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P391, DOI 10.1021/tx00022a001; Christoph F, 2006, BRIT J CANCER, V95, P1701, DOI 10.1038/sj.bjc.6603482; Hu CY, 2014, CLIN CANCER RES, V20, P4349, DOI 10.1158/1078-0432.CCR-14-0494; McFadyen MCE, 2004, BRIT J CANCER, V91, P966, DOI 10.1038/sj.bjc.6602053; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; Murray GI, 1997, CANCER RES, V57, P3026; Chang I, 2015, ONCOTARGET, V6, P7774; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Shatalova EG, 2011, CANCER PREV RES, V4, P107, DOI 10.1158/1940-6207.CAPR-10-0133; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Karra H, 2014, BRIT J CANCER, V110, P2905, DOI 10.1038/bjc.2014.252; Kato T, 2012, J SURG ONCOL, V106, P423, DOI 10.1002/jso.23109; WEINSTEIN J, 1994, MOL CELL BIOL, V14, P3350; Wethkamp N, 2006, EUR J CANCER, V42, P264, DOI 10.1016/j.ejca.2005.10.019; Taniguchi K, 2008, ANTICANCER RES, V28, P1559; Craig AL, 2007, MOL CELL BIOL, V27, P3542, DOI 10.1128/MCB.01595-06; Choi JW, 2013, VIRCHOWS ARCH, V463, P681, DOI 10.1007/s00428-013-1473-6; Gajjar K, 2012, CANCER LETT, V324, P13, DOI 10.1016/j.canlet.2012.04.021; GONZALEZ FJ, 1994, DRUG METAB REV, V26, P165, DOI 10.3109/03602539409029789; Ye M, 2012, EUR J CANCER PREV, V21, P241, DOI 10.1097/CEJ.0b013e32834c9caa; Ahmad ST, 2012, TUMOR BIOL, V33, P395, DOI 10.1007/s13277-011-0235-9; Kawaguchi K, 2004, HUM PATHOL, V35, P1266, DOI 10.1016/j.humpath.2004.07.007; Arai Eri, 2010, Int J Clin Exp Pathol, V4, P58; Zhang Y, 2007, METABOLISM, V56, P887, DOI 10.1016/j.metabol.2007.03.001; LIEHR JG, 1986, J STEROID BIOCHEM, V24, P353, DOI 10.1016/0022-4731(86)90080-4; Gade P, 2009, INT J CANCER, V125, P1566, DOI 10.1002/ijc.24493; Ding ZY, 2014, INT J CLIN EXP PATHO, V7, P722; Raveh T, 2001, NAT CELL BIOL, V3, P1; Gayed BA, 2014, BJU INT, V113, P668, DOI 10.1111/bju.12263; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Kristensen LS, 2014, ONCOTARGET, V5, P9798; LI JJ, 1987, FASEB J, V46, P1858; Mondal G, 2007, CARCINOGENESIS, V28, P81, DOI 10.1093/carcin/bg1100; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Wu WJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-142; Zhu ZY, 2015, INT J MOL MED, V35, P340, DOI 10.3892/ijmm.2014.2041	44	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2407			BMC CANCER	BMC Cancer	DEC 1	2015	15								942	10.1186/s12885-015-1951-0		12	Oncology	Oncology	CX1YB	WOS:000365490600002		
J	Nakagawa, M; Choi, YY; An, JY; Chung, H; Seo, SH; Shin, HB; Bang, HJ; Li, S; Kim, HI; Cheong, JH; Hyung, WJ; Noh, SH				Nakagawa, Masatoshi; Choi, Yoon Young; An, Ji Yeong; Chung, Hyunsoo; Seo, Sang Hyuk; Shin, Hyun Beak; Bang, Hui-Jae; Li, Shuangxi; Kim, Hyung-Il; Cheong, Jae-Ho; Hyung, Woo Jin; Noh, Sung Hoon			Difficulty of predicting the presence of lymph node metastases in patients with clinical early stage gastric cancer: a case control study	BMC CANCER			English	Article						Early gastric cancer; Lymph node metastasis; Preoperative prediction	ENDOSCOPIC RESECTION; FORCEPS BIOPSY; DISSECTION; DIAGNOSIS; RISK; SIZE; DYSPLASIA; EUS	Background: The relationship between pathological factors and lymph node metastasis of pathological stage early gastric cancer has been extensively investigated. By contrast, the relationship between preoperative factors and lymph node metastasis of clinical stage early gastric cancer has not been investigated. The present study was to investigate discrepancies between preoperative and postoperative values. Methods: From January 2011 to December 2013, 1042 patients with clinical stage early gastric cancer who underwent gastrectomy with lymphadenectomy were enrolled. Preoperative and postoperative values were collected for subsequent analysis. Receiver operating characteristics curves were computed using independent predictive factors. Results: Several discrepancies were observed between preoperative and postoperative values, including existence of ulcer, gross type, and histology (all McNemar p-values were < 0.001). Multivariate analyses identified the following independent predictive factors for lymph node metastasis: postoperative values including age (p = 0.002), tumor size (p < 0.001), and tumor depth (p < 0.001); preoperative values including age (p = 0.017), existence of ulcer (p = 0.037), tumor size (p = 0.009), and prediction of the presence of lymph node metastasis in computed tomography scans (p = 0.002). These postoperative and preoperative independent predictive factors produced areas under the receiver operating characteristics curves of 0.824 and 0.660, respectively. Conclusions: Surgeons need to be aware of limitations in preoperative predictions of the presence of lymph node metastasis for clinical stage early gastric cancer.	[Nakagawa, Masatoshi; Choi, Yoon Young; An, Ji Yeong; Seo, Sang Hyuk; Shin, Hyun Beak; Bang, Hui-Jae; Li, Shuangxi; Kim, Hyung-Il; Cheong, Jae-Ho; Hyung, Woo Jin; Noh, Sung Hoon] Yonsei Univ, Coll Med, Hlth Syst, Dept Surg, Seoul 120752, South Korea; [Noh, Sung Hoon] Yonsei Univ, Coll Med, Hlth Syst, Brain Korea 21 Plus Project Med Sci, Seoul 120752, South Korea; [Chung, Hyunsoo] Yonsei Univ, Coll Med, Hlth Syst, Dept Internal Med,Inst Gastroenterol, Seoul 120752, South Korea; [Nakagawa, Masatoshi] Tokyo Med & Dent Univ, Dept Gastr Surg, Tokyo, Japan; [Li, Shuangxi] Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Dept Gastrointestinal Surg, Beijing 100871, Peoples R China; [An, Ji Yeong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul 06351, South Korea; [Seo, Sang Hyuk] Inje Univ, Coll Med, Busan Paik Hosp, Dept Surg, Busan, South Korea	Noh, SH (reprint author), Yonsei Univ, Coll Med, Hlth Syst, Dept Surg, 50 Yonsei Ro, Seoul 120752, South Korea.	sunghoonn@yuhs.ac			National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea [1020390, 1320360]	This research was supported by a grant of the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (1020390, 1320360).	Nashimoto A, 2013, GASTRIC CANCER, V16, P1, DOI 10.1007/s10120-012-0163-4; Park JS, 2013, DIGEST LIVER DIS, V45, P170, DOI 10.1016/j.dld.2012.09.008; Choi J, 2013, DIGEST DIS SCI, V58, P2329, DOI 10.1007/s10620-013-2644-7; Lee JH, 2008, J SURG ONCOL, V98, P331, DOI 10.1002/jso.21115; Lee CK, 2010, J GASTROEN HEPATOL, V25, P1507, DOI 10.1111/j.1440-1746.2010.006367.x; Schaafsma BE, 2013, BJOG-INT J OBSTET GY, V120, P758, DOI 10.1111/1471-0528.12173; Choi KS, 2011, CANCER SCI, V102, P1559, DOI 10.1111/j.1349-7006.2011.01982.x; Mochiki E, 2004, WORLD J SURG, V28, P247, DOI 10.1007/s00268-003-7191-5; Hamashima C, 2008, JPN J CLIN ONCOL, V38, P259, DOI 10.1093/jjco/hyn017; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; An JY, 2007, ANN SURG, V246, P749, DOI 10.1097/SLA.0b013e31811f3fb7; Takao M, 2012, GASTRIC CANCER, V15, P91, DOI 10.1007/s10120-011-0075-8; Roviello F, 2006, J SURG ONCOL, V94, P275, DOI 10.1002/jso.20566; Ishikawa K, 2007, SURG ENDOSC, V21, P1131, DOI 10.1007/s00464-006-9062-2; [Anonymous], 2011, GASTRIC CANC, V14, P101; Shim CN, 2014, SURG ENDOSC, V28, P2199, DOI 10.1007/s00464-014-3453-6; Lee JH, 2015, ANN SURG ONCOL, V22, P1813, DOI 10.1245/s10434-014-4167-7; Park CH, 2015, GASTROINTEST ENDOSC, V81, P898, DOI 10.1016/j.gie.2014.08.024; Mitsumori N, 2014, WORLD J GASTROENTERO, V20, P5685, DOI 10.3748/wjg.v20.i19.5685; Dassen AE, 2009, EJSO-EUR J SURG ONC, V35, P449, DOI 10.1016/j.ejso.2008.11.010; Kim BS, 2014, SURGERY, V155, P1030, DOI 10.1016/j.surg.2013.08.016; Takizawa K, 2013, GASTRIC CANCER, V16, P531, DOI 10.1007/s10120-012-0220-z; Son SY, 2013, SURG ENDOSC, V27, P3247, DOI 10.1007/s00464-013-2901-z; Lee SE, 2009, ANN SURG ONCOL, V16, P603, DOI 10.1245/s10434-008-0283-6; Pelz J, 2004, EJSO, V30, P935, DOI 10.1016/j.ejso.2004.07.016; Cardoso R, 2012, GASTRIC CANCER, V15, pS19, DOI 10.1007/s10120-011-0115-4; Nimura H, 2004, BRIT J SURG, V91, P575, DOI 10.1002/bjs.4470; Monig SP, 1999, AM J ROENTGENOL, V173, P365; Won CS, 2011, GUT LIVER, V5, P187, DOI 10.5009/gnl.2011.5.2.187; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gotoda T, 2000, GASTRIC CANCER, V3, P219, DOI 10.1007/PL00011720; Japanese Gastric Cancer Association, 2011, GASTRIC CANCER, V14, P113, DOI [10.1007/s10120-011-0042-4, DOI 10.1007/S10120-011-0042-4]]; Khullar Onkar, 2009, Semin Thorac Cardiovasc Surg, V21, P309, DOI 10.1053/j.semtcvs.2009.11.009; Min BH, 2014, DIGEST DIS SCI, V59, P2536, DOI 10.1007/s10620-014-3196-1; Mouri Ritsuo, 2009, J Clin Gastroenterol, V43, P318, DOI 10.1097/MCG.0b013e3181775966; Mukai Kota, 2006, Gastric Cancer, V9, P192, DOI 10.1007/s10120-006-0374-7; Pasechnikov V, 2014, WORLD J GASTROENTERO, V20, P13842, DOI 10.3748/wjg.v20.i38.13842; R Core Team, 2014, LANG ENV STAT COMP; Schaafsma BE, 2014, J SURG ONCOL, V110, P845, DOI 10.1002/jso.23740	39	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2407			BMC CANCER	BMC Cancer	DEC 1	2015	15								943	10.1186/s12885-015-1940-3		9	Oncology	Oncology	CX1YB	WOS:000365490600003		
J	Chen, CC; Fu, SF; Norikazu, M; Yang, YW; Liu, YJ; Ikeo, K; Gojobori, T; Huang, HJ				Chen, Chi-Chien; Fu, Shih-Feng; Norikazu, Monma; Yang, Yau-Wen; Liu, Yu-Ju; Ikeo, Kazuho; Gojobori, Takashi; Huang, Hao-Jen			Comparative miRNAs analysis of Two contrasting broccoli inbred lines with divergent head-forming capacity under temperature stress	BMC GENOMICS			English	Article						Broccoli; Deep sequencing; Genotype; Head-forming capacity; High temperature; MicroRNA	ARABIDOPSIS-THALIANA; BRASSICA-OLERACEA; GENE-EXPRESSION; FLOWERING-TIME; OXIDATIVE STRESS; PLANT MICRORNAS; RNA; IDENTIFICATION; PROTEIN; L.	Background: MicroRNAs (miRNAs) play a vital role in growth, development, and stress response at the post-transcriptional level. Broccoli (Brassica oleracea L. var italic) is an important vegetable crop, and the yield and quality of broccoli are decreased by heat stress. The broccoli inbred lines that are capable of producing head at high temperature in summer are unique varieties in Taiwan. However, knowledge of miRNAomes during the broccoli head formation under heat stress is limited. Methods: In this study, molecular characterization of two nearly isogenic lines with contrasting head-forming capacity was investigated. Head-forming capacity was better for heat-tolerant (HT) than heat-sensitive (HS) broccoli under heat stress. Results: By deep sequencing and computational analysis, 20 known miRNAs showed significant differential expression between HT and HS genotypes. According to the criteria for annotation of new miRNAs, 24 novel miRNA sequences with differential expression between the two genotypes were identified. To gain insight into functional significance, 213 unique potential targets of these 44 differentially expressed miRNAs were predicted. These targets were implicated in shoot apical development, phase change, response to temperature stimulus, hormone and energy metabolism. The head-forming capacity of the unique HT line was related to autonomous regulation of Bo-FT genes and less expression level of heat shock protein genes as compared to HS. For the genotypic comparison, a set of miRNAs and their targets had consistent expression patterns in various HT genotypes. Conclusions: This large-scale characterization of broccoli miRNAs and their potential targets is to unravel the regulatory roles of miRNAs underlying heat-tolerant head-forming capacity.	[Chen, Chi-Chien; Liu, Yu-Ju; Huang, Hao-Jen] Natl Cheng Kung Univ, Dept Life Sci, Tainan 701, Taiwan; [Fu, Shih-Feng] Natl Chunghua Univ Educ, Dept Biol, Changhua 500, Taiwan; [Norikazu, Monma; Ikeo, Kazuho; Gojobori, Takashi] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 4118540, Japan; [Norikazu, Monma; Ikeo, Kazuho; Gojobori, Takashi] Natl Inst Genet, DNA Data Bank Japan, Mishima, Shizuoka 4118540, Japan; [Yang, Yau-Wen] Kale Biotech Co, Tainan 701, Taiwan	Huang, HJ (reprint author), Natl Cheng Kung Univ, Dept Life Sci, 1 Univ Rd, Tainan 701, Taiwan.	haojen@mail.ncku.edu.tw			Ministry of Science and Technology of Taiwan [NSC-98-B-2321-B006-005-MY3, MOST 104-2321-B-018-001]	This work was supported by the Ministry of Science and Technology of Taiwan [no. NSC-98-B-2321-B006-005-MY3] and [no. MOST 104-2321-B-018-001]. The authors thank Professor Lien-Chung Chang at Asian Vegetable Research and Development Center, AVRDC-The World Vegetable Center, Taiwan, for genotyping/technical support.	Wellmer F, 2010, TRENDS GENET, V26, P519, DOI 10.1016/j.tig.2010.09.001; Vi SL, 2013, P NATL ACAD SCI USA, V110, P13994, DOI 10.1073/pnas.1303967110; Xu MY, 2014, J EXP BOT, V65, P89, DOI 10.1093/jxb/ert353; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Vanderauwera S, 2011, P NATL ACAD SCI USA, V108, P1711, DOI 10.1073/pnas.1018359108; Bjorkman T, 1998, J EXP BOT, V49, P101, DOI 10.1093/jexbot/49.318.101; Takahashi H, 2010, INT REV CEL MOL BIO, V281, P129, DOI 10.1016/S1937-6448(10)81004-4; Lee H, 2010, NUCLEIC ACIDS RES, V38, P3081, DOI 10.1093/nar/gkp1240; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Fahey JW, 2002, P NATL ACAD SCI USA, V99, P7610, DOI 10.1073/pnas.112203099; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Karve A, 2012, PLANT PHYSIOL, V158, P1965, DOI 10.1104/pp.112.195636; Cheng MC, 2013, PLANT PHYSIOL, V162, P1566, DOI [10.1104/pp.113.221911, 10.1104]; Larkindale J, 2005, PLANT PHYSIOL, V138, P882, DOI 10.1104/pp.105.062257; Wang JY, 2011, GENOME, V54, P1029, DOI [10.1139/g11-069, 10.1139/G11-069]; Xiong LM, 2001, DEV CELL, V1, P771, DOI 10.1016/S1534-5807(01)00087-9; Teotia S, 2015, MOL PLANT, V8, P359, DOI 10.1016/j.molp.2014.12.018; OSTERYOUNG KW, 1993, MOL GEN GENET, V239, P323, DOI 10.1007/BF00276930; GALLIE DR, 1995, PLANT PHYSIOL, V108, P1703; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; McConnell JR, 1998, DEVELOPMENT, V125, P2935; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Li T, 2011, NUCLEIC ACIDS RES, V39, P2821, DOI 10.1093/nar/gkq1047; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Jia LX, 2007, MOL BIOL CELL, V18, P1897, DOI 10.1091/mbc.E06-10-0925; Queval G, 2007, PLANT J, V52, P640, DOI 10.1111/j.1365-313X.2007.03263.x; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Yamamoto M, 2008, PLANT CELL PHYSIOL, V49, P1547, DOI 10.1093/pcp/pcn119; Kutter C, 2007, PLANT CELL, V19, P2417, DOI 10.1105/tpc.107.050377; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; He XF, 2008, FEBS LETT, V582, P2445, DOI 10.1016/j.febslet.2008.06.011; Ausin I, 2005, INT J DEV BIOL, V49, P689, DOI 10.1387/ijdb.052022ia; Ihnatowicz A, 2004, PLANT J, V37, P839, DOI 10.1111/j.1365-313X.2003.02011.x; Li YY, 2010, CLIN CANCER RES, V16, P2580, DOI 10.1158/1078-0432.CCR-09-2937; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Hasanuzzaman M, 2013, INT J MOL SCI, V14, P9643, DOI 10.3390/ijms14059643; Jung JH, 2011, PLANT MOL BIOL, V76, P35, DOI 10.1007/s11103-011-9759-z; Yu X, 2012, J EXP BOT, V63, P1025, DOI 10.1093/jxb/err337; Lundmark M, 2010, PHYSIOL PLANTARUM, V140, P57, DOI 10.1111/j.1399-3054.2010.01384.x; Spanudakis E, 2014, J EXP BOT, V65, P365, DOI 10.1093/jxb/ert453; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Caplan JL, 2009, CELL HOST MICROBE, V6, P457, DOI 10.1016/j.chom.2009.10.005; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Yamaguchi A, 2012, J PLANT RES, V125, P693, DOI 10.1007/s10265-012-0513-7; Li SJ, 2009, PLANT CELL REP, V28, P683, DOI 10.1007/s00299-008-0666-y; Bokszczanin KL, 2012, FRONT PLANT SCI, V4, P315; Gangappa SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062194; Leyva-Gonzalez MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048138; Liu SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4930; Parkin IAP, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r77; Prasad BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012761; Scarpeci Telma E, 2008, Plant Signal Behav, V3, P856; Solomon S, 2007, PHYS SCI BASIS CONTR; Umate Pavan, 2010, Plant Signal Behav, V5, P1537, DOI 10.4161/psb.5.12.13410; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wang Y. J., 2006, Journal of Applied Horticulture (Lucknow), V8, P87; Wu HJ, 2012, NUCLEIC ACIDS RES, V40, pW22, DOI 10.1093/nar/gks554; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Xue TT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-550; Yang HC, 2012, PLOS GENET, V8, P496, DOI 10.1371/journal.pgen.1002664; Yang YW, 1998, HEAT TOLERANT BROCCO, P33; Yu JY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-664	67	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	DEC 1	2015	16								1026	10.1186/s12864-015-2201-1		19	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	CX1UL	WOS:000365481000007		
J	Endo, S; Mishima, E; Takeuchi, Y; Ohi, T; Ishida, M; Yanai, M; Kiyomoto, H; Nagasawa, T; Ito, S				Endo, Shun; Mishima, Eikan; Takeuchi, Yoichi; Ohi, Takashi; Ishida, Masatsugu; Yanai, Masaru; Kiyomoto, Hideyasu; Nagasawa, Tasuku; Ito, Sadayoshi			Periodontitis-associated septic pulmonary embolism caused by Actinomyces species identified by anaerobic culture of bronchoalveolar lavage fluid: a case report	BMC INFECTIOUS DISEASES			English	Article						Septic pulmonary embolism; Periodontitis; Actinomyces species; Dental infection; Bronchoalveolar lavage; Anaerobic culture; Chest pain	PENETRATION; DISEASE	Background: Periodontal disease is a less common but important cause of septic pulmonary embolism (SPE). However, the pathogens causing periodontal disease-associated SPE (PD-SPE) have been poorly understood. Actinomyces species are resident microbiota in the oral cavity. Here we report a case of PD-SPE caused by Actinomyces species, which was identified by anaerobic culture of bronchoalveolar lavage fluid (BAL). Case presentation: A 64-year-old Asian man, complicated with severe chronic periodontitis, was admitted with chest pain and fever. Chest CT revealed multiple bilateral pulmonary nodules located subpleurally. We diagnosed the case as SPE associated with periodontitis. Although blood cultures were negative for the usual 5-day incubation, anaerobic culture of the BAL fluid sample yielded Actinomyces species. Antibacterial therapy alone did not ameliorate the symptoms; however, additional dental treatment, including tooth extraction, promptly did. The patient was discharged 23 days after admission. The 3-month follow-up revealed no recurrence of the symptoms and complete resolution of the lung lesions. Conclusion: This case demonstrated that Actinomyces species can cause PD-SPE. Additionally, clinicians should consider performing appropriate anaerobic culture of BAL fluid to identify the pathogen of SPE, and to ordering dental treatment, if necessary, in addition to antibiotics for the initial management of PD-SPE.	[Endo, Shun; Takeuchi, Yoichi; Nagasawa, Tasuku] Japanese Ishinomaki Red Cross Hosp, Dept Internal Med, Ishinomaki, Japan; [Ohi, Takashi] Japanese Ishinomaki Red Cross Hosp, Dept Dent, Ishinomaki, Japan; [Ishida, Masatsugu; Yanai, Masaru] Japanese Ishinomaki Red Cross Hosp, Dept Resp Med, Ishinomaki, Japan; [Mishima, Eikan; Kiyomoto, Hideyasu] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan; [Mishima, Eikan; Ito, Sadayoshi] Tohoku Univ, Div Nephrol Endocrinol & Vasc Med, Grad Sch Med, Sendai, Miyagi 980, Japan; [Ohi, Takashi] Tohoku Univ, Grad Sch Dent, Dept Oral Funct & Morphol, Div Aging & Geriatr Dent, Sendai, Miyagi 980, Japan	Mishima, E (reprint author), Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan.	eikan@med.tohoku.ac.jp					Gupta R, 2013, MAYO CLIN PROC, V88, pE137, DOI 10.1016/j.mayocp.2013.04.032; Ye R, 2014, RESP MED, V108, P1, DOI 10.1016/j.rmed.2013.10.012; Mattar CS, 2006, RESP MED, V100, P1470, DOI 10.1016/j.rmed.2005.11.010; Peretz A, 2015, EUR J CLIN MICROBIOL, V34, P1539, DOI 10.1007/s10096-015-2383-0; HENRIQUEZ AH, 1991, J INFECT DIS, V164, P414; Niwa T, 2006, RESP MED, V100, P324, DOI 10.1016/j.rmed.2005.05.009; Shiota Y, 2002, CHEST, V121, P652, DOI 10.1378/chest.121.2.652; Mabeza GF, 2003, EUR RESPIR J, V21, P545, DOI 10.1183/09031936.03.00089103; Amaral CDF, 2009, J DENT, V37, P643, DOI 10.1016/j.jdent.2009.04.011; Mealey BL, 2006, J PERIODONTOL, V77, P1289, DOI 10.1902/jop.2006.050459; Bouza E, 2004, CLIN INFECT DIS, V39, P1161, DOI 10.1086/424520; Byl B, 2003, ANTIMICROB AGENTS CH, V47, P2015, DOI 10.1128/AAC.47.6.2015-2017.2003; Cook RJ, 2005, CHEST, V128, P162, DOI 10.1378/chest.128.1.162; Liebler JM, 2000, CRIT CARE CLIN, V16, P83, DOI 10.1016/S0749-0704(05)70098-1; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Chung G, 2000, CURR INFECT DIS REP, V2, P238, DOI 10.1007/s11908-000-0041-9; Kouidhi B, 2015, MICROB PATHOGENESIS, V80, P39, DOI 10.1016/j.micpath.2015.02.007	17	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2334			BMC INFECT DIS	BMC Infect. Dis.	DEC 1	2015	15								552	10.1186/s12879-015-1286-0		5	Infectious Diseases	Infectious Diseases	CX2DA	WOS:000365504100003		
J	Takashina, H; Watanabe, A; Tsuneoka, H				Takashina, Hirotsugu; Watanabe, Akira; Tsuneoka, Hiroshi			Influence of silicone oil tamponade on self-sealing sclerotomy using 25-gauge transconjunctival sutureless vitrectomy: a retrospective comparative study	BMC OPHTHALMOLOGY			English	Article						Self-sealing; Silicone oil injection; Silicone oil removal; Sclerotomy leakage; Hypotony	POSTOPERATIVE INTRAOCULAR-PRESSURE; RHEGMATOGENOUS RETINAL-DETACHMENT; 23-GAUGE VITRECTOMY; SURGERY; HYPOTONY; COMPLICATIONS; INCISION; LEAKAGE; SYSTEM	Background: Characteristic complications have been reported for transconjunctival sutureless vitrectomy, such as postoperative sclerotomy leakage and postoperative hypotony. Particular attention to sclerotomy closure is required in cases of silicone oil tamponade, because postoperative supplementation of silicone oil implies reoperation, whereas postoperative supplement of gas is comparatively easy. This study investigated sclerotomy closure in cases of silicone oil tamponade using 25-gauge transconjunctival sutureless vitrectomy. Methods: We enrolled 19 consecutive eyes with silicone oil injection (Group A, self-sealing sclerotomies, n = 10) (Group B, sutured sclerotomies, n = 9) and 10 eyes with silicone oil removal (Group C, self-sealing sclerotomies) using 25-gauge TSV. Postoperative intraocular pressure was compared between Groups A and B, and between Groups A and C using repeated-measures analysis of variance (ANOVA), one-way factorial ANOVA, and the Tukey-Kramer test. Results: No significant differences in age or axial length were seen among groups, but surgical time differed significantly between Group C and the other groups. Mean duration of silicone oil tamponade was 3.2 +/- 1.4 months in Group C, and no sclerotomies in Group A or C required suture placement. Postoperative silicone oil leakage to the subconjunctival space was not encountered in Group A. No cases showed postoperative hypotony (defined as intraocular pressure <5 mmHg). Significant differences in intraocular pressure within the same postoperative period were not identified between Groups A and B. Conversely, significant differences in intraocular pressure within the same postoperative period were identified at postoperative days 1 and 2, although not at postoperative week 1 or postoperative month 1 between Groups A and C. Conclusions: The procedure for sclerotomy closure seems to have little influence on postoperative intraocular pressure in eyes with silicone oil tamponade using 25-gauge transconjunctival sutureless vitrectomy, because silicone oil tamponade may avoid postoperative hypotony by decreasing sclerotomy leakage in the early postoperative period.	[Takashina, Hirotsugu] Sagamihara Hosp, Natl Hosp Org, Dept Ophthalmol, Minami Ku, Sagaminara, Kanagawa 2520392, Japan; [Takashina, Hirotsugu; Watanabe, Akira; Tsuneoka, Hiroshi] Jikei Univ, Sch Med, Dept Ophthalmol, Minato Ku, Tokyo 1058471, Japan	Takashina, H (reprint author), Sagamihara Hosp, Natl Hosp Org, Dept Ophthalmol, Minami Ku, 18-1 Sakuradai, Sagaminara, Kanagawa 2520392, Japan.	two-shina@s7.dion.ne.jp					Byeon SH, 2008, OPHTHAL SURG LAS IM, V39, P94; FEDERMAN JL, 1988, OPHTHALMOLOGY, V95, P870; Colyer MH, 2010, RETINA-J RET VIT DIS, V30, P1678, DOI 10.1097/IAE.0b013e3181dd6da1; Song Y, 2011, RETINA-J RET VIT DIS, V31, P243, DOI 10.1097/IAE.0b013e3181e586ce; Yamane S, 2011, RETINA-J RET VIT DIS, V31, P702, DOI 10.1097/IAE.0b013e3181f0d2e6; Rizzo S, 2007, GRAEF ARCH CLIN EXP, V245, P1281, DOI 10.1007/s00417-006-0533-x; CIBIS PA, 1962, ARCH OPHTHALMOL-CHIC, V68, P590; Yamane S, 2012, AM J OPHTHALMOL, V153, P1099, DOI 10.1016/j.ajo.2011.11.001; Fine HF, 2007, OPHTHALMOLOGY, V114, P1197, DOI 10.1016/j.ophtha.2007.02.020; Fujii GY, 2002, OPHTHALMOLOGY, V109, P1814, DOI 10.1016/S0161-6420(02)01119-3; Tsang CW, 2008, RETINA-J RET VIT DIS, V28, P1075, DOI 10.1097/IAE.0b013e31817b98ba; Hassani RTJ, 2013, GRAEF ARCH CLIN EXP, V251, P1285, DOI 10.1007/s00417-012-2183-5; Shimada H, 2005, JPN J OPHTHALMOL, V49, P397, DOI 10.1007/s10384-004-0214-4; Amato JE, 2007, OPHTHAL SURG LAS IM, V38, P100; Eckardt C, 2005, RETINA-J RET VIT DIS, V25, P208, DOI 10.1097/00006982-200502000-00015; Lin AL, 2011, RETINA-J RET VIT DIS, V31, P1101, DOI 10.1097/IAE.0b013e3181ff0d77; Parolini B, 2010, RETINA-J RET VIT DIS, V30, P107, DOI 10.1097/IAE.0b013e3181b21082; Kapran Z, 2007, RETINA-J RET VIT DIS, V27, P1059; Shimozono M, 2011, OPHTHAL SURG LAS IM, V42, DOI 10.3928/15428877-20101025-02; Takashina H, 2014, SEMIN OPHTHALMOL, V24, P1; Woo SJ, 2009, RETINA-J RET VIT DIS, V29, P456, DOI 10.1097/IAE.0b013e318195cb28	21	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2415			BMC OPHTHALMOL	BMC Ophthalmol.	DEC 1	2015	15								171	10.1186/s12886-015-0159-z		5	Ophthalmology	Ophthalmology	CX8MD	WOS:000365956900001		
J	Imamura, M; Nishimukai, A; Higuchi, T; Ozawa, H; Yanai, A; Miyagawa, Y; Murase, K; Sakita, I; Hatada, T; Takatsuka, Y; Katagiri, T; Miyoshi, Y				Imamura, Michiko; Nishimukai, Arisa; Higuchi, Tomoko; Ozawa, Hiromi; Yanai, Ayako; Miyagawa, Yoshimasa; Murase, Keiko; Sakita, Isao; Hatada, Takuya; Takatsuka, Yuichi; Katagiri, Toyomasa; Miyoshi, Yasuo			High levels at baseline of serum pyridinoline crosslinked carboxyterminal telopeptide of type I collagen are associated with worse prognosis for breast cancer patients	BREAST CANCER RESEARCH AND TREATMENT			English	Article						Breast cancer; Bone turnover marker; Metastasis; 1CTP; Bisphosphonate	INTERNATIONAL EXPERT CONSENSUS; BONE-MINERAL DENSITY; ADJUVANT ENDOCRINE THERAPY; ZOLEDRONIC ACID; HIGHLIGHTS; TRIAL; METASTASIS; TURNOVER; WOMEN; SECRETION	It is speculated that adjuvant use of bisphosphonate reduces recurrence in breast cancer patients through suppression of bone resorption. To determine the prognostic impact of bone resorption markers, we investigated serum levels of the pyridinoline crosslinked carboxyterminal telopeptide of type I collagen (1CTP) and N-terminal crosslinking telopeptides of type I collagen (NTX). 1CTP and NTX were measured at baseline (before operation or neoadjuvant therapies) and afterward in 469 patients operated on breast cancer. The optimal cutoff value of 1CTP for relapse-free survival (RFS) was set at 3.6 ng/ml with an area under the receiver operating characteristics curve of 0.641 [95 % confidence interval (CI) = 0.560-0.721; p = 0.0011]. However, we were unable to determine a significant cutoff value for NTX. RFS was significantly worse for 1CTP-high patients with than for those with low levels of 1CTP (p = 0.0002). Multivariate analysis with tumor size, lymph node metastasis, and nuclear grade showed that 1CTP was a significant independent prognostic factor (hazard ratio = 2.04, 95 % CI = 1.13-3.68; p = 0.018). Worse prognosis for the subset with high 1CTP levels applied only to postmenopausal patients (p = 0.0002). RFS of 130 patients whose 1CTP changed from low at baseline to high at 6 months postoperatively showed RFS almost as poor as that for patients with high 1CTP throughout. These findings suggest that 1CTP may be useful not only for identifying patients with unfavorable prognosis, but also for selecting patients who may benefit from administration of bone-modifying agents in an adjuvant setting.	[Imamura, Michiko; Nishimukai, Arisa; Higuchi, Tomoko; Ozawa, Hiromi; Yanai, Ayako; Miyagawa, Yoshimasa; Murase, Keiko; Takatsuka, Yuichi; Miyoshi, Yasuo] Hyogo Coll Med, Dept Surg, Div Breast & Endocrine Surg, Nishinomiya, Hyogo 6638501, Japan; [Sakita, Isao] Sakita Clin, Nishinomiya, Hyogo, Japan; [Hatada, Takuya] Uminosato Clin, Minamiawaji, Hyogo, Japan; [Katagiri, Toyomasa] Univ Tokushima, Inst Genome Res, Div Genome Med, Tokushima, Tokushima 770, Japan	Miyoshi, Y (reprint author), Hyogo Coll Med, Dept Surg, Div Breast & Endocrine Surg, Mukogawa Cho 1-1, Nishinomiya, Hyogo 6638501, Japan.	ymiyoshi@hyo-med.ac.jp			Hyogo College of Medicine	The present study was supported by the grant of Hyogo College of Medicine.	Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Pectasides D, 2005, J PHARMACEUT BIOMED, V37, P171, DOI 10.1016/j.jpba.2004.10.007; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Greenspan SL, 1997, CALCIFIED TISSUE INT, V60, P419; Coleman R, 2013, ANN ONCOL, V24, P398, DOI 10.1093/annonc/mds277; Lipton A, 2011, J CLIN ONCOL, V29, P3605, DOI 10.1200/JCO.2010.31.5069; Kiuchi K, 2002, ONCOL REP, V9, P595; Eastell R, 2011, ANN ONCOL, V22, P857, DOI 10.1093/annonc/mdq541; BISMAR H, 1995, J CLIN ENDOCR METAB, V80, P3351, DOI 10.1210/jc.80.11.3351; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Coleman R, 2014, LANCET ONCOL, V15, P997, DOI 10.1016/S1470-2045(14)70302-X; Neudert M, 2003, INT J CANCER, V107, P468, DOI 10.1002/ijc.11397; Cheleuitte D, 1998, J CLIN ENDOCR METAB, V83, P2043, DOI 10.1210/jc.83.6.2043; Mundy GR, 1997, CANCER, V80, P1546, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I; Keskikuru R, 2002, ONCOL REP, V9, P1323; Brufsky AM, 2012, CANCER-AM CANCER SOC, V118, P1192, DOI 10.1002/cncr.26313; Gnant M, 2008, LANCET ONCOL, V9, P840, DOI 10.1016/S1470-2045(08)70204-3; Ju HSJ, 1997, CLIN CHEM, V43, P1570; Goldhirsch A, 2005, ANN ONCOL, V16, P1569, DOI 10.1093/annonc/mdi326; Pfeilschifter J, 1998, J BONE MINER RES, V13, P716, DOI 10.1359/jbmr.1998.13.4.716; Riethmuller G, 2001, SEMIN CANCER BIOL, V11, P307, DOI 10.1006/scbi.2001.0386; Bekker Pirow J, 2005, J Bone Miner Res, V20, P2275; Coleman RE, 2011, NEW ENGL J MED, V365, P1396, DOI 10.1056/NEJMoa1105195; Dunn LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006896; Gnant M, 2015, ANN ONCOL, V26, P313, DOI 10.1093/annonc/mdu544; He MF, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-80; Lipton Allan, 2011, Breast Cancer (Dove Med Press), V3, P1, DOI 10.2147/BCTT.S16774; Rogers Michael J., 2000, Cancer, V88, P2961, DOI 10.1002/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L; Vehmanen LK, 2014, ACTA ONCOL, V53, P75, DOI 10.3109/0284186X.2013.792992	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-6806	1573-7217		BREAST CANCER RES TR	Breast Cancer Res. Treat.	DEC	2015	154	3					521	531		10.1007/s10549-015-3638-2		11	Oncology	Oncology	CX4XY	WOS:000365705400008		
J	Webborn, N; Williams, A; McNamee, M; Bouchard, C; Pitsiladis, Y; Ahmetov, I; Ashley, E; Byrne, N; Camporesi, S; Collins, M; Dijkstra, P; Eynon, N; Fuku, N; Garton, FC; Hoppe, N; Holm, S; Kaye, J; Klissouras, V; Lucia, A; Maase, K; Moran, C; North, KN; Pigozzi, F; Wang, G				Webborn, Nick; Williams, Alun; McNamee, Mike; Bouchard, Claude; Pitsiladis, Yannis; Ahmetov, Ildus; Ashley, Euan; Byrne, Nuala; Camporesi, Silvia; Collins, Malcolm; Dijkstra, Paul; Eynon, Nir; Fuku, Noriyuki; Garton, Fleur C.; Hoppe, Nils; Holm, Soren; Kaye, Jane; Klissouras, Vassilis; Lucia, Alejandro; Maase, Kamiel; Moran, Colin; North, Kathryn N.; Pigozzi, Fabio; Wang, Guan			Direct-to-consumer genetic testing for predicting sports performance and talent identification: Consensus statement	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							OPEN FUTURE; GENOMICS; POWER	The general consensus among sport and exercise genetics researchers is that genetic tests have no role to play in talent identification or the individualised prescription of training to maximise performance. Despite the lack of evidence, recent years have witnessed the rise of an emerging market of direct-to-consumer marketing (DTC) tests that claim to be able to identify children's athletic talents. Targeted consumers include mainly coaches and parents. There is concern among the scientific community that the current level of knowledge is being misrepresented for commercial purposes. There remains a lack of universally accepted guidelines and legislation for DTC testing in relation to all forms of genetic testing and not just for talent identification. There is concern over the lack of clarity of information over which specific genes or variants are being tested and the almost universal lack of appropriate genetic counselling for the interpretation of the genetic data to consumers. Furthermore independent studies have identified issues relating to quality control by DTC laboratories with different results being reported from samples from the same individual. Consequently, in the current state of knowledge, no child or young athlete should be exposed to DTC genetic testing to define or alter training or for talent identification aimed at selecting gifted children or adolescents. Large scale collaborative projects, may help to develop a stronger scientific foundation on these issues in the future.	[Webborn, Nick] Univ Brighton, Ctr Sport & Exercise Sci & Med SESAME, Brighton BN2 4AT, E Sussex, England; [Williams, Alun] Manchester Metropolitan Univ, MMU Sports Genom Lab, Dept Exercise & Sport Sci, Crewe CW1 5DU, England; [McNamee, Mike] Swansea Univ, Coll Engn, Swansea, W Glam, Wales; [Bouchard, Claude] Pennington Biomed Res Ctr, Human Genom Lab, Baton Rouge, LA 70808 USA; [Pitsiladis, Yannis; Wang, Guan] Univ Brighton, FIMS Reference Collaborating Ctr Sports Med Antid, Eastbourne, England; [Ahmetov, Ildus] Volga Reg State Acad Phys Culture Sport & Tourism, Kazan, Russia; [Ashley, Euan] Stanford Univ, Ctr Inherited Cardiovasc Dis, Clin Genom Serv, Palo Alto, CA 94304 USA; [Byrne, Nuala] Bond Inst Hlth & Sport, Fac Hlth Sci & Med, Gold Coast, Australia; [Camporesi, Silvia] Kings Coll London, Dept Social Sci Hlth & Med, London WC2R 2LS, England; [Collins, Malcolm] Univ Cape Town, Dept Human Biol, ZA-7925 Cape Town, South Africa; [Dijkstra, Paul] Aspetar Qatar Orthopaed & Sports Med Hosp, Doha, Qatar; [Eynon, Nir] Victoria Univ, Inst Sport Exercise & Act Living, Melbourne, Vic 8001, Australia; [Fuku, Noriyuki] Juntendo Univ, Grad Sch Hlth & Sports Sci, Tokyo, Japan; [Garton, Fleur C.; North, Kathryn N.] Univ Melbourne, Murdoch Childrens Res Inst, Dept Paediat, Melbourne, Vic 3010, Australia; [Hoppe, Nils] Coram Chambers, London, England; [Holm, Soren] Univ Manchester, Sch Law, Manchester, Lancs, England; [Kaye, Jane] Univ Oxford, Ctr Hlth Law & Emerging Technol, Nuffield Dept Populat Hlth, Headington, England; [Klissouras, Vassilis] Univ Athens, Emeritus Ergophysiol, Athens, Greece; [Lucia, Alejandro] Univ Europea & Res Inst i 12, Madrid, Spain; [Maase, Kamiel] Netherlands Sports Confederat NOC NSF, Netherlands Olymp Comm, Elite Sport Unit, Utrecht, Netherlands; [Moran, Colin] Univ Stirling, Physiol Epigenet Res Grp, Stirling FK9 4LA, Scotland; [Pigozzi, Fabio] Univ Rome, Int Federat Sports Med, Rome, Italy	Williams, A (reprint author), Manchester Metropolitan Univ, MMU Sports Genom Lab, Dept Exercise & Sport Sci, Crewe Green Rd, Crewe CW1 5DU, England.	A.G.Williams@mmu.ac.uk	Bouchard, Claude/A-7637-2009				American College of Medicine Genetics Board of Directors, 2004, GENET MED, V6, P60, DOI DOI 10.1097/01.GIM.0000106164.59722.CE; Miah A, 2006, SPORT EDUC SOC, V11, P259, DOI 10.1080/13573320600813432; Su Pascal, 2013, Yale Journal of Biology and Medicine, V86, P359; Perusse L, 2013, MED SCI SPORT EXER, V45, P824, DOI 10.1249/MSS.0b013e31828b28a3; Moran CN, 2007, EUR J HUM GENET, V15, P88, DOI 10.1038/sj.ejhg.5201724; Bouchard C, 2011, EXERC SPORT SCI REV, V39, P212, DOI 10.1097/JES.0b013e31822643f6; Skirton H, 2012, CLIN GENET, V82, P210, DOI 10.1111/j.1399-0004.2012.01863.x; Caulfield T, 2012, ANNU REV MED, V63, P23, DOI 10.1146/annurev-med-062110-123753; Hughes DC, 2011, J SPORT SCI, V29, P1425, DOI 10.1080/02640414.2011.597773; Ahmetov II, 2011, EXP PHYSIOL, V96, P1302, DOI 10.1113/expphysiol.2011.060293; Botkin JR, 2015, AM J HUM GENET, V97, P6, DOI 10.1016/j.ajhg.2015.05.022; Dixon N, 2007, J PHILOS SPORT, V34, P147; Eynon N, 2013, SPORTS MED, V43, P803, DOI 10.1007/s40279-013-0059-4; Wang G, 2013, ADV GENET, V84, P123, DOI 10.1016/B978-0-12-407703-4.00004-9; Borry P, 2012, EUR J HUM GENET, V20, P715, DOI 10.1038/ejhg.2011.278; Hawkins AK, 2012, J GENET COUNS, V21, P367, DOI 10.1007/s10897-012-9488-8; Ayme S, 2013, EUR WORKSH GEN TEST; Caulfield T., 2011, J SCI COMMUN; Feinberg J, 1980, WHOSE CHILD CHILDREN, P124; Haddow J, 2004, HUMAN GENOME EPIDEMI, P217; Hauskeller C, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2317; Human Genetics Commission, 2010, LONDON HUM GENET COM, P1; Institute NHGR, REG GEN TESTS; Leighton J., 2011, PUBLIC HEALTH GENOM, V15, P11; Ma F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054685; United States Government Accountability Office, 2010, DIR TO CONS GEN TEST; Wetterstrand K., DNA SEQUENCING COSTS; Williams AG, 2014, SCI SPORT CURR TREND, V2, P3	28	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	DEC	2015	49	23					1486	1491		10.1136/bjsports-2015-095343		6	Sport Sciences	Sport Sciences	CX6FZ	WOS:000365797900004		
J	Sawada, T; Akazawa, Y; Narazaki, Y; Kubo, S; Nanamura, K				Sawada, Tsuyoshi; Akazawa, Yukari; Narazaki, Yu; Kubo, Shingo; Nanamura, Kazuaki			Synthesis and photochromic circular dichroism of 2,7-di-tert-butyl-10b, 10c-dimethyl-pyrazino[2,3-e]dihydropyrene	CANADIAN JOURNAL OF CHEMISTRY			English	Article						photochromism; planar chirality; circular dichroism; dihydropyrene	SWITCHES; DIMETHYLDIHYDROPYRENES; DIHYDROPYRENES; DERIVATIVES; CHIRALITY; SYSTEM	2,7-Di-tert-butyl-10b, 10c-dimethyl-pyrazino[2,3-e]dihydropyrene was prepared and its photochromic properties were studied. The open form of the molecule was separated into its constituent enantiomers by chiral HPLC. The absolute structures of the enantiomers were determined by using spectra predicted with time-dependent density functional theory. Photoswitchable circular dichroism properties of 2,7-di-tert-butyl-10b, 10c-dimethyl-pyrazino[2,3-e] dihydropyrene were observed, suggesting its potential for application in molecular devices.	[Sawada, Tsuyoshi; Kubo, Shingo; Nanamura, Kazuaki] Kagoshima Univ, Nat Sci Ctr Res & Educ, Kagoshima 8900065, Japan; [Sawada, Tsuyoshi] Kumamoto Inst Photoelect Organ Phoen, Higashi Ku, Kumamoto 8620901, Japan; [Akazawa, Yukari; Narazaki, Yu] Kumamoto Univ, Dept Appl Chem & Biochem, Kumamoto 8608555, Japan	Sawada, T (reprint author), Kagoshima Univ, Nat Sci Ctr Res & Educ, 1-21-40 Kohrimoto, Kagoshima 8900065, Japan.	sawada@gm.kagoshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven RD)	The authors thank Professor Hirotaka Ihara (Kumamoto University) for his support and advice about the HPLC analysis and CD spectroscopy. This work was partially supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven R&D).	Naito M, 2010, ANGEW CHEM INT EDIT, V49, P7006, DOI 10.1002/anie.201002552; Sawada T, 2013, TETRAHEDRON LETT, V54, P5963, DOI 10.1016/j.tetlet.2013.08.057; Bhattacharya S, 2006, J PHYS CHEM A, V110, P5665, DOI 10.1021/jp056556w; Kawasaki T, 2007, CHEM LETT, V36, P1048, DOI 10.1246/cl.2007.1048; Robinson SG, 2009, J ORG CHEM, V74, P6592, DOI 10.1021/jo901070y; Bohne C, 2011, J PHOTOCH PHOTOBIO C, V12, P126, DOI 10.1016/j.jphotochemrev.2011.08.001; Takeshita M, 2002, ANGEW CHEM INT EDIT, V41, P2156, DOI 10.1002/1521-3773(20020617)41:12<2156::AID-ANIE2156>3.0.CO;2-0; Nag K, 2002, BIOPHYS J, V82, P2041; Ikeda T, 2012, CHEM COMMUN, V48, P6025, DOI 10.1039/c2cc31512b; Mockus NV, 2008, ANGEW CHEM INT EDIT, V47, P1458, DOI 10.1002/anie.200703677; Irie M, 2000, CHEM REV, V100, P1683, DOI 10.1021/cr980068l; YAMATO T, 1995, TETRAHEDRON, V51, P9851, DOI 10.1016/0040-4020(95)00589-Z; Chifuku K, 2008, SYNLETT, P3153, DOI 10.1055/s-0028-1087363; Sheepwash MAL, 2002, J AM CHEM SOC, V124, P4693, DOI 10.1021/ja017229e; Sheepwash MAL, 2003, PHOTOCH PHOTOBIO SCI, V2, P104, DOI 10.1039/b208952a; Tsujioka T, 2010, PHOTOCH PHOTOBIO SCI, V9, P157, DOI 10.1039/b9pp00083f; Lee PHM, 2007, J AM CHEM SOC, V129, P6058, DOI 10.1021/ja067425r; Hecht S, 2005, SMALL, V1, P26, DOI 10.1002/smll.200400059; Sawada T, 2010, TETRAHEDRON LETT, V51, P4033, DOI 10.1016/j.tetlet.2010.05.092; Mitchell RH, 2004, ORG LETT, V6, P1729, DOI 10.1021/ol049590m; Frisch MJ, 2009, GAUSSIAN 09 REVISION; Gust D, 2006, CHEM COMMUN, P1169, DOI 10.1039/b514836k; Li YN, 2014, CHEM-EUR J, V20, P16286, DOI 10.1002/chem.201403705; Mitchell RH, 1999, EUR J ORG CHEM, P2695; Murphy RS, 1999, CHEM COMMUN, P2097; San Jose Benedict A, 2012, J Am Chem Soc, V134, P19795, DOI 10.1021/ja3086565	26	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-4042	1480-3291		CAN J CHEM	Can. J. Chem.	DEC	2015	93	12					1321	1325		10.1139/cjc-2014-0602		5	Chemistry, Multidisciplinary	Chemistry	CX3OT	WOS:000365609300003		
J	Nakata, K; Fujio, M; Siehl, HU; Tsuno, Y				Nakata, Kazuhide; Fujio, Mizue; Siehl, Hans-Ullrich; Tsuno, Yuho			Computational study of substituent effects on gas-phase stabilities of Meisenheimer complexes	CANADIAN JOURNAL OF CHEMISTRY			English	Article						substituent-effect analysis; Yukawa-Tsuno equation; DFT calculation; gas-phase stability; Meisenheimer complex	YUKAWA-TSUNO EQUATION; AB-INITIO MO; AROMATIC-SUBSTITUTION; BENZYLIC CATIONS; RESONANCE DEMAND; CARBOCATIONIC SYSTEMS; HAMMETT RELATIONSHIP; ACIDITIES; CONSTANTS; DENSITY	The total stabilization energies (TSEs) and anion stabilization energies (ASEs) of ring-substituted (X-) Meisenheimer complexes featuring two NO2 groups in the ring were determined using appropriate isodesmic reactions. The structures and energies of respective species were calculated at the B3LYP/6-311+ G(2d, p) level of theory. Ten series of substituent effects were examined by varying substituent Y, which is connected to the sp3 carbon of the ring. The substituent effects were successfully analyzed using an extended Yukawa-Tsuno equation, Delta E-X = rho(sigma(0) vertical bar r(-) Delta(sigma) over bar ((R) over bar) vertical bar s Delta(sigma) over bar (S)). The r(-) values for the TSEs were identical to those for the ASEs, whereas the s values for the TSEs were significantly different from those for the ASEs. This shows that the effect of neutral species contributes to the s values of the TSEs. The r(-) and s values for the ASEs of all Meisenheimer complexes were distributed in a narrow range because substituent Y was insulated from the pi-conjugation system. The r(-) values were large and the s values were small. This shows that the r(-) and s values were independent of each other and that the extended three-term Yukawa-Tsuno equation was intrinsic for substituent-effect analyses of anions. Although the variation was not substantial, the change in the r(-) values was clearly explained by the orbital interaction between substituent Y and the pi-conjugation system. The r-values exhibited a good correlation with the bond lengths between the ring and the 4-NO2 group among all Meisenheimer complexes and benzylic anions. These facts provide a physical meaning: the r(-) value is a parameter that reveals the degree of the additional pi interactions between the electron-withdrawing substituents and the pi-conjugation systems of the ring.	[Nakata, Kazuhide] Hosei Univ, Ctr Sci Res, Chiyoda Ku, Tokyo 1028160, Japan; [Fujio, Mizue; Tsuno, Yuho] Kyushu Univ, Inst Mat Chem & Engn, Higashi Ku, Fukuoka 8128581, Japan; [Siehl, Hans-Ullrich] Univ Ulm, Inst Organ Chem 1, D-89069 Ulm, Germany	Nakata, K (reprint author), Hosei Univ, Ctr Sci Res, Chiyoda Ku, 2-17-1 Fujimi, Tokyo 1028160, Japan.	nakata@hosei.ac.jp					Nakata K, 1996, J PHYS ORG CHEM, V9, P561, DOI 10.1002/(SICI)1099-1395(199608)9:8<561::AID-POC812>3.3.CO;2-F; Nakata K, 1996, J PHYS ORG CHEM, V9, P573, DOI 10.1002/(SICI)1099-1395(199608)9:8<573::AID-POC817>3.3.CO;2-U; DESTRO R, 1979, ACTA CRYSTALLOGR B, V35, P733, DOI 10.1107/S0567740879004593; Tsuno Y, 1999, ADV PHYS ORG CHEM, V32, P267, DOI 10.1016/S0065-3160(08)60009-X; Hammett LP, 1937, J AM CHEM SOC, V59, P96, DOI 10.1021/ja01280a022; BUNCEL E, 1995, CHEM REV, V95, P2261, DOI 10.1021/cr00039a001; Taft RW, 1960, J PHYS CHEM-US, V64, P1805, DOI 10.1021/j100841a003; Nakata K, 1998, J PHYS ORG CHEM, V11, P857, DOI 10.1002/(SICI)1099-1395(199812)11:12<857::AID-POC81>3.3.CO;2-T; [Anonymous], 2014, PURE APPL C IN PRESS; Tsuno Y, 1996, CHEM SOC REV, V25, P129, DOI 10.1039/cs9962500129; HIRAOKA K, 1987, J PHYS CHEM-US, V91, P5294, DOI 10.1021/j100304a032; Nakata K, 2010, J PHYS ORG CHEM, V23, P1057, DOI 10.1002/poc.1717; Chiavarino B, 2007, ANGEW CHEM INT EDIT, V46, P1995, DOI 10.1002/anie.200604630; Chiavarino B, 2013, J AM SOC MASS SPECTR, V24, P1603, DOI 10.1007/s13361-013-0703-0; YUKAWA Y, 1966, B CHEM SOC JPN, V39, P2274, DOI 10.1246/bcsj.39.2274; PAUL GJC, 1991, J AM CHEM SOC, V113, P1148, DOI 10.1021/ja00004a014; FUJIO M, 1981, J AM CHEM SOC, V103, P4017, DOI 10.1021/ja00404a008; Chiavarino B, 2009, CHEM-EUR J, V15, P8185, DOI 10.1002/chem.200900822; TERRIER F, 1982, CHEM REV, V82, P77, DOI 10.1021/cr00048a001; Nakata K, 2013, J PHYS ORG CHEM, V26, P115, DOI 10.1002/poc.2953; HOEFNAGEL AJ, 1976, J AM CHEM SOC, V98, P6194, DOI 10.1021/ja00436a021; Chiavarino B, 2013, INT J MASS SPECTROM, V354, P62, DOI 10.1016/j.ijms.2013.05.014; Nakata K, 2003, J PHYS ORG CHEM, V16, P323, DOI 10.1002/poc.621; BROWN HC, 1957, J AM CHEM SOC, V79, P1913, DOI 10.1021/ja01565a039; UEDA H, 1968, B CHEM SOC JPN, V41, P2866, DOI 10.1246/bcsj.41.2866; Nakata K, 2013, CHEMPLUSCHEM, V78, P1099, DOI 10.1002/cplu.201300167; TAFT RW, 1988, J AM CHEM SOC, V110, P1797, DOI 10.1021/ja00214a023; TAFT RW, 1983, PROG PHYS ORG CHEM, V14, P247, DOI 10.1002/9780470171936.ch6; DILLOW GW, 1988, J AM CHEM SOC, V110, P4877, DOI 10.1021/ja00223a001; HIRAOKA K, 1987, J CHEM PHYS, V86, P4102, DOI 10.1063/1.451920; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BROWN HC, 1958, J AM CHEM SOC, V80, P4979, DOI 10.1021/ja01551a055; FORESMAN JB, 1996, EXPLORING CHEM ELECT; Frisch M. J., 2010, GAUSSIAN 09 REVISION; Glendening E. D., 2013, NBO 6 0; Hammett L. P., 1970, PHYS ORGANIC CHEM; Koppel I. A., 2000, J CHEM SOC P2, P1125, DOI 10.1039/B001792M; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; MIEHLICH B, 1989, CHEM PHYS LETT, V157, P200, DOI 10.1016/0009-2614(89)87234-3; Nakata K., J PHYS ORG IN PRESS; Shorter J., 1978, CORRELATION ANAL CHE, DOI [10.1007/978-1-4615-8831-3_4, DOI 10.1007/978-1-4615-8831-3_4]; Siehl H.-U., 2009, JMDIFF LOCAL M UNPUB; Taft RW, 1987, PROG PHYS ORG CHEM, V16, P1, DOI 10.1002/9780470171950.ch1; Terrier F., 1991, NUCLEOPHILIC AROMATI; Terrier F., 2013, MODERN NUCLEOPHILIC, DOI [10.1002/9783527656141, DOI 10.1002/9783527656141]; Weinhold F., 2005, DISCOVERING CHEM NAT; Weinhold F., 2012, VALENCY BONDING NATU, DOI [10.1002/9781118229101, DOI 10.1002/9781118229101]; YUKAWA Y, 1959, B CHEM SOC JPN, V32, P971, DOI 10.1246/bcsj.32.971	48	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-4042	1480-3291		CAN J CHEM	Can. J. Chem.	DEC	2015	93	12					1327	1334		10.1139/cjc-2014-0582		8	Chemistry, Multidisciplinary	Chemistry	CX3OT	WOS:000365609300004		
J	Kon, H; Saito, H				Kon, Hirokazu; Saito, Hideki			Test of the temperature difference model predicting masting behavior	CANADIAN JOURNAL OF FOREST RESEARCH			English	Article						climate cue; Cryptomeria japonica; Delta T model; Japanese cedar; masting	SEED PRODUCTION; CLIMATE; REPRODUCTION; POLLEN; JAPAN; CUES; RESOURCES; DYNAMICS; ECOLOGY; FOREST	The differential temperature (Delta T) model, based on the assumption that masting plants respond to the difference in the temperatures during the growing seasons 1 and 2 years prior to seed production, has recently been proposed to explain the proximate factor of masting. In this study, we used a 28-year series of data on pollen cone and seed production in Cryptomeria japonica D. Don in Japan and compared several models based on temperatures and resources to test whether Delta T acts as a cue or is a proxy for resource limitation. Of all the models tested, models including Delta T, previous summer absolute temperature Tn-1, and reproduction in the previous year provided the best fit. The number of pollen cones and seeds produced was proportional to the difference in the mean daily maximum temperature during June to August between the preceding two years. In addition, to test whether the double mast events in consecutive years was less common than consecutive warm summers, we used our dataset and 12 datasets of pollen dispersal of 17 years or longer of C. japonica in Japan. Although consecutive warm summers occurred in 4.4% of pairs, double mast events occurred in 1.0%. The Delta T model was a considerably better predictor of the rare phenomenon of double mast events, which occur only after a specific sequence of cold-moderate-hot absolute summer temperatures. Thus, Delta T acts as cue for masting in C. japonica.	[Kon, Hirokazu] Hokkaido Res Org, Forestry Res Inst, Bibai, Hokkaido 0790198, Japan; [Saito, Hideki] Kyoto Prefectural Univ, Fac Agr, Sakyo Ku, Kyoto 6068522, Japan	Kon, H (reprint author), Hokkaido Res Org, Forestry Res Inst, Bibai, Hokkaido 0790198, Japan.	kon-hirokazu@hro.or.jp					Akamatsu S, 2010, B HYOGO PREFECTURAL, V1, P41; Smaill SJ, 2011, J ECOL, V99, P870, DOI 10.1111/j.1365-2745.2011.01803.x; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Schauber EM, 2002, ECOLOGY, V83, P1214, DOI 10.2307/3071937; Sakai S, 2006, AM J BOT, V93, P1134, DOI 10.3732/ajb.93.8.1134; Teranishi H, 2000, CLIMATE RES, V14, P65, DOI 10.3354/cr014065; Piovesan G, 2001, CAN J BOT, V79, P1039, DOI 10.1139/cjb-79-9-1039; Mooney KA, 2011, OECOLOGIA, V165, P651, DOI 10.1007/s00442-010-1742-x; Selas V, 2002, CAN J FOREST RES, V32, P217, DOI 10.1139/X01-192; Satake A, 2000, J THEOR BIOL, V203, P63, DOI 10.1006/jtbi.1999.1066; Saito Y, 2014, P JPN ACAD B-PHYS, V90, P203, DOI 10.2183/pjab.90.203; SILVERTOWN JW, 1980, BIOL J LINN SOC, V14, P235, DOI 10.1111/j.1095-8312.1980.tb00107.x; Moreira X, 2015, J ECOL, V103, P1317, DOI 10.1111/1365-2745.12434; SORK VL, 1993, ECOLOGY, V74, P528, DOI 10.2307/1939313; Shibata M, 2002, ECOLOGY, V83, P1727, DOI 10.2307/3071991; Pearse IS, 2014, OIKOS, V123, P179, DOI 10.1111/j.1600-0706.2013.00608.x; Tanentzap AJ, 2012, ECOLOGY, V93, P462, DOI 10.1890/11-1750.1; [Anonymous], OIKOS, V121, P1725, DOI [10.1111/j.1600-0706.2011.20399.x, DOI 10.1111/J.1600-0706.2011.20399.X]; Oka T, 2004, J WILDLIFE MANAGE, V68, P979, DOI 10.2193/0022-541X(2004)068[0979:RBCIBP]2.0.CO;2; Azegami Y, 2011, B NAGANO ENV CONSERV, V7, P57; Fujisaki Y, 2003, JPN J PALYNOL, V49, P59; Goto M, 2007, B HYOGO PREFECTURAL, V4, P58; Hayashi S, 2014, REPORT HYOGO PREFECT, V11, P3; Ito Yukiko, 2008, Allergol Int, V57, P321, DOI 10.2332/allergolint.O-07-520; Kobayashi S, 2006, SHINSHU J PUBLIC HLT, V1, P44; Nagao A, 1989, HDB FLOWERING, VVI, P247; Namba Hiroyuki, 2001, Allergology International, V50, P133, DOI 10.1046/j.1440-1592.2001.00216.x; Namba H, 1997, JPN J PALYNOL, V43, P87; Ogasawara H, 1998, JPN J PALYNOL, V44, P97; R Development Core Team, 2013, R LANG ENV STAT COMP; Sahashi N, 2008, JPN J PALYNOL, V54, P29; Sahashi N, 2002, ALLERGOLOGIE, V13, P80; Sahashi N, 2013, JPN J PALYNOL, V59, P35; Sahashi N, 2010, JPN J PALYNOL, V56, P45; Sahashi N, 2009, JPN J PALYNOL, V55, P39; Sahashi N, 2012, JPN J PALYNOL, V58, P25; Sahashi N, 2006, JPN J PALYNOL, V52, P53; Sahashi N, 2007, JPN J PALYNOL, V53, P53; Sahashi N, 2011, JPN J PALYNOL, V57, P25; Saito Y, 1996, JPN J PALYNOL, V42, P149; Satake A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3303; Shida T, 1998, JPN J PALYNOL, V44, P47; Sudo M, 2011, JPN J PALYNOL, V57, P17; Sudo M, 2007, JPN J PALYNOL, V53, P77; Taira Hideaki, 1998, Allergology International, V47, P297, DOI 10.1046/j.1440-1592.1998.00106.x; Takahashi Y, 1999, JPN J ALLERGOL, V48, P1217; Tanaka K, 2005, JPN J PALYNOL, V51, P13; Yamazaki F, 1979, JPN J ALLERGOL, V28, P732	48	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0045-5067	1208-6037		CAN J FOREST RES	Can. J. For. Res.	DEC	2015	45	12					1835	1844		10.1139/cjfr-2015-0118		10	Forestry	Forestry	CW9RJ	WOS:000365335600019		
J	Umezawa, S; Fujimori, M; Matsushima, E; Kinoshita, H; Uchitomi, Y				Umezawa, Shino; Fujimori, Maiko; Matsushima, Eisuke; Kinoshita, Hiroya; Uchitomi, Yosuke			Preferences of advanced cancer patients for communication on anticancer treatment cessation and the transition to palliative care	CANCER			English	Article						communication; empathy; life expectancy; neoplasms; palliative care; patient preference; physician-patient relations; prognosis; treatment failure	RECEIVING BAD-NEWS; INFORMATION; PROGNOSIS; FUTURE; HOPE; LIFE; DISCLOSURE; DIAGNOSIS; RESPONSES; ONCOLOGY	BACKGROUNDThe objective of this study was to clarify the communication preferences of patients with advanced cancer regarding discussions about ending anticancer treatment and transitioning to palliative care and to explore the variables associated with those preferences. METHODSParticipants were 106 Japanese patients with cancer who had been informed at least 1 week earlier about the cessation of their anticancer treatment. They completed a survey measuring their preferences for communication about ending anticancer treatment and transitioning to palliative care as well as their demographic characteristics. Medical records were also examined to investigate medical characteristics. RESULTSResults of the descriptive analysis indicated that patients strongly preferred their physicians to listen to their distress and concerns (96%), to assure them that their painful symptoms would be controlled (97.1%), and to explain the status of their illness and the physical symptoms that would likely occur in the future (95.1%). Multiple regression analyses identified the factors associated with these preferences: telling patients to prepare mentally and informing them of their expected life expectancy were associated with cancer site; sustaining hope was associated with cancer site and children; and empathic paternalism was associated with duration since cancer diagnosis. CONCLUSIONSThe majority of patients preferred their physicians to be realistic about their likely future and wanted to be reassured that their painful symptoms would be controlled. For patients with cancer at certain sites, those with children, and those more recently diagnosed, physicians should communicate carefully and actively by providing information on life expectancy and mental preparation, sustaining hope, and behaving with empathic paternalism. Cancer 2015;121:4240-4249. (c) 2015 American Cancer Society. The majority of patients with advanced cancer prefer physicians to be realistic about their likely future and want to be reassured that their painful symptoms will be controlled. For patients with cancer at certain sites, those with children, and those more recently diagnosed, physicians should communicate carefully and actively by providing information on life expectancy and mental preparation, sustaining hope, and behaving with empathic paternalism. See also pages 000-000.	[Umezawa, Shino; Matsushima, Eisuke] Tokyo Med & Dent Univ, Sect Liaison Psychiat & Palliat Med, Div Comprehens Patient Care, Grad Sch Med & Dent Sci, Tokyo, Japan; [Umezawa, Shino; Fujimori, Maiko; Kinoshita, Hiroya; Uchitomi, Yosuke] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Psychooncol Div, Chiba, Japan; [Fujimori, Maiko] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Ctr Suicide Prevent, Tokyo, Japan; [Kinoshita, Hiroya] Natl Canc Ctr Hosp East, Dept Palliat Med, Chiba, Japan; [Uchitomi, Yosuke] Natl Canc Ctr, Innovat Ctr Support Palliat & Psychosocial Care, Tokyo 104, Japan; [Uchitomi, Yosuke] Natl Canc Ctr, Psychooncol Div, Tokyo, Japan	Uchitomi, Y (reprint author), Natl Canc Ctr, Innovat Ctr Support Palliat & Psychosocial Care, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	yuchitom@ncc.go.jp			Japanese Government [H26-political-general-002]; Health and Labor Sciences Research grant from the Ministry of Health, Labor, and Welfare; Mental Health Okamoto Memorial Foundation	This study was supported by the Research for Promotion of Cancer Control Programs (H26-political-general-002) from the Japanese Government; a Health and Labor Sciences Research grant from the Ministry of Health, Labor, and Welfare; and a research grant from the Mental Health Okamoto Memorial Foundation.	Clayton JM, 2005, CANCER-AM CANCER SOC, V103, P1965, DOI 10.1002/cncr.21011; Hagerty RG, 2005, J CLIN ONCOL, V23, P1278, DOI 10.1200/JCO.2005.11.138; Clayton JM, 2008, PSYCHO-ONCOL, V17, P641, DOI 10.1002/pon.1288; Akechi T, 2004, J CLIN ONCOL, V22, P1957, DOI 10.1200/JCO.2004.08.149; Innes S, 2009, PALLIATIVE MED, V23, P29, DOI 10.1177/0269216308098799; Fujimori M, 2007, PSYCHO-ONCOL, V16, P573, DOI 10.1002/pon.1093; Clayton JM, 2005, SUPPORT CARE CANCER, V13, P733, DOI 10.1007/s00520-005-0789-4; Uchitomi Y, 1999, JPN J CLIN ONCOL, V29, P411, DOI 10.1093/jjco/29.9.411; Takayama T, 2001, SOC SCI MED, V53, P1335, DOI 10.1016/S0277-9536(00)00413-5; Uchitomi Y, 2001, CANCER, V92, P1926, DOI 10.1002/1097-0142(20011001)92:7<1926::AID-CNCR1711>3.0.CO;2-L; Fujimori M, 2007, PSYCHO-ONCOL, V16, P617, DOI 10.1002/pon.1102; Schofield P, 2006, PALLIATIVE MED, V20, P397, DOI 10.1191/0269216306pm1156oa; Hagerty RG, 2005, ANN ONCOL, V16, P1005, DOI 10.1093/annonc/mdi211; Schofield PE, 2003, ANN ONCOL, V14, P48, DOI 10.1093/annonc/mdg010; Hagerty RG, 2004, J CLIN ONCOL, V22, P1721, DOI 10.1200/JCO.2004.04.095; Roeland E, 2014, J PALLIAT MED, V17, P415, DOI 10.1089/jpm.2013.0408; Fujimori M, 2014, J CLIN ONCOL, V32, P2166, DOI 10.1200/JCO.2013.51.2756; Parker PA, 2001, J CLIN ONCOL, V19, P2049; Walling A, 2008, J CLIN ONCOL, V26, P3896, DOI 10.1200/JCO.2007.15.9509; Parker SM, 2007, J PAIN SYMPTOM MANAG, V34, P81, DOI 10.1016/j.jpaisymman.2006.09.035; Fujimori M, 2009, JPN J CLIN ONCOL, V39, P201, DOI 10.1093/jjco/hyn159; Back AL, 2008, CANCER-AM CANCER SOC, V113, P1897, DOI 10.1002/cncr.23653; Miyashita M, 2007, ANN ONCOL, V18, P1090, DOI 10.1093/annonc/mom068; Wenrich MD, 2001, ARCH INTERN MED, V161, P868, DOI 10.1001/archinte.161.6.868; Butow PN, 1997, ANN ONCOL, V8, P857, DOI 10.1023/A:1008284006045; Clayton Josephine M, 2007, Med J Aust, V186, pS83; Clayton JM, 2007, MED J AUSTRALIA, V186, pS83; Clayton JM, 2007, MED J AUSTRALIA, V186, pS79; Ichikura K, 2015, PALLIAT SUPPORT CARE, V13, P1623, DOI 10.1017/S147895151500005X; Japanese Ministry of Health and Welfare, 1995, FY 1994 REP SOC SURV	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0008-543X	1097-0142		CANCER-AM CANCER SOC	Cancer	DEC 1	2015	121	23					4240	4249		10.1002/cncr.29635		10	Oncology	Oncology	CX3TJ	WOS:000365621900020		
J	Toyokawa, G; Seto, T; Takenoyama, M; Ichinose, Y				Toyokawa, Gouji; Seto, Takashi; Takenoyama, Mitsuhiro; Ichinose, Yukito			Insights into brain metastasis in patients with ALK plus lung cancer: is the brain truly a sanctuary?	CANCER AND METASTASIS REVIEWS			English	Review						Non-small cell lungcancer; Anaplastic lymphoma kinase (ALK); Brain metastasis; ALK inhibitors	CENTRAL-NERVOUS-SYSTEM; POTENT ANTITUMOR-ACTIVITY; MULTICENTER PHASE-II; ADULT PATIENTS PTS; INHIBITOR ALECTINIB; OPEN-LABEL; NSCLC PATIENTS; SINGLE-ARM; POSITIVE NSCLC; CRIZOTINIB RESISTANCE	Anaplastic lymphoma kinase (ALK) has been identified to exert a potent transforming activity through its rearrangement in non-small cell lung cancer (NSCLC), and patients (pts) with ALK rearrangement can be treated more successfully with ALK inhibitors, such as crizotinib, alectinib, and ceritinib, than with chemotherapy. Despite the excellent efficacy of ALK inhibitors, resistance to these drugs is inevitably encountered in most ALK-rearranged pts. Cases of resistance are subtyped into three groups, i.e., systemic, oligo, and central nervous system (CNS) types, with the CNS being used to be considered a sanctuary. With regard to the management of CNS lesions in pts with ALK+ NSCLC, a growing body of evidence has gradually demonstrated the intracranial (IC) efficacy of ALK inhibitor (ALKi) in ALK+ NSCLC pts with brain metastases (BMs). Although the efficacy of crizotinib for the CNS lesions remains controversial, a recent retrospective investigation of ALK+ pts with BM enrolled in PROFILE 1005 and PROFILE 1007 demonstrated that crizotinib is associated with a high disease control rate for BM. However, BM comprises the most common site of progressive disease in pts with or without baseline BMs, which is a serious problem for crizotinib. Furthermore, alectinib can be used to achieve strong and long-lasting inhibitory effects on BM. In addition to alectinib, the IC efficacy of other next-generation ALK inhibitors, such as ceritinib, AP26113 and PF-06463922, has been demonstrated. In this article, we review the latest evidence regarding the BM and IC efficacy of ALK inhibitors in pts with ALK+ NSCLC.	[Toyokawa, Gouji; Seto, Takashi; Takenoyama, Mitsuhiro; Ichinose, Yukito] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Minami Ku, Fukuoka 8111395, Japan	Toyokawa, G (reprint author), Kyushu Natl Canc Ctr, Dept Thorac Oncol, Minami Ku, 3-1-1 Notame, Fukuoka 8111395, Japan.	gouji104kawa@gmail.com			JSPS KAKENHI [30627261]; Uehara Memorial Foundation (Japan)	This work was supported by Grant-in-Aid for Young Scientists (B) (JSPS KAKENHI Grant Number 30627261) and the Uehara Memorial Foundation (Japan).	Ajimizu Hitomi, 2015, Med Oncol, V32, P477, DOI 10.1007/s12032-014-0477-7; Doebele RC, 2012, CANCER-AM CANCER SOC, V118, P4502, DOI 10.1002/cncr.27409; Ou SHI, 2015, LUNG CANCER, V88, P355, DOI 10.1016/j.lungcan.2015.03.022; Iuchi T, 2013, LUNG CANCER, V82, P282, DOI 10.1016/j.lungcan.2013.08.016; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Gadgeel SM, 2014, LANCET ONCOL, V15, P1119, DOI 10.1016/S1470-2045(14)70362-6; Sekine A, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0228-9; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Costa DB, 2015, J CLIN ONCOL, V33, P1881, DOI 10.1200/JCO.2014.59.0539; Weickhardt AJ, 2012, J THORAC ONCOL, V7, P1807, DOI 10.1097/JTO.0b013e3182745948; [Anonymous], 2014, ANN ONCOL         S4, DOI DOI 10.1093/ANN0NC/MDU349.2; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Kim YH, 2013, J THORAC ONCOL, V8, pe85, DOI 10.1097/JTO.0b013e31829cebbb; Kodama T, 2014, CANCER LETT, V351, P215, DOI 10.1016/j.canlet.2014.05.020; Gainor JF, 2013, CLIN CANCER RES, V19, P4273, DOI 10.1158/1078-0432.CCR-13-0318; Seto T, 2013, LANCET ONCOL, V14, P590, DOI 10.1016/S1470-2045(13)70142-6; Barnholtz-Sloan JS, 2004, J CLIN ONCOL, V22, P2865, DOI 10.1200/JCO.2004.12.149; Arrieta O, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-119; Peled N, 2013, J THORAC ONCOL, V8, pe112, DOI 10.1097/JTO.0000000000000038; Heon S, 2012, CLIN CANCER RES, V18, P4406, DOI 10.1158/1078-0432.CCR-12-0357; Sperduto PW, 2012, J CLIN ONCOL, V30, P419, DOI 10.1200/JCO.2011.38.0527; Chun SG, 2012, CANCER BIOL THER, V13, P1376, DOI 10.4161/cbt.22255; Ou SHI, 2014, ANN ONCOL, V25, P415, DOI 10.1093/annonc/mdt572; Gainor JF, 2015, CLIN CANCER RES, V21, P2745, DOI 10.1158/1078-0432.CCR-14-3009; Ou SHI, 2015, ONCOLOGIST, V20, P224, DOI 10.1634/theoncologist.2014-0309; Shaw AT, 2014, NEW ENGL J MED, V370, P1189, DOI 10.1056/NEJMoa1311107; Bartels AL, 2009, NEUROBIOL AGING, V30, P1818, DOI 10.1016/j.neurobiolaging.2008.02.002; Friboulet L, 2014, CANCER DISCOV, V4, P662, DOI 10.1158/2159-8290.CD-13-0846; Zou HY, 2015, CANCER CELL, V28, P70, DOI 10.1016/j.ccell.2015.05.010; Gainor JF, 2013, J THORAC ONCOL, V8, P1570, DOI 10.1097/JTO.0000000000000029; Sakamoto H, 2011, CANCER CELL, V19, P679, DOI 10.1016/j.ccr.2011.04.004; Togashi Y, 2012, CANCER CHEMOTH PHARM, V70, P399, DOI 10.1007/s00280-012-1929-4; Omuro AMP, 2005, CANCER, V103, P2344, DOI 10.1002/cncr.21033; Takeda M, 2013, J THORAC ONCOL, V8, P654, DOI 10.1097/JTO.0b013e31828c28e7; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Schouten LJ, 2002, CANCER, V94, P2698, DOI 10.1002/cncr.10541; Kaneda H, 2013, J THORAC ONCOL, V8, pE32, DOI 10.1097/JTO.0b013e3182843771; Gandara DR, 2014, CLIN LUNG CANCER, V15, P1, DOI 10.1016/j.cllc.2013.10.001; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Costa DB, 2011, J CLIN ONCOL, V29, pE443, DOI 10.1200/JCO.2010.34.1313; Hanna NH, 2015, CANCER-AM CANCER SOC, V121, P2253, DOI 10.1002/cncr.29308; Arkenau HT, 2015, J CLIN ONCOL, V33; Camidge DR, 2015, J CLIN ONCOL, V33; Felip E, 2015, J CLIN ONCOL, V33; Gainor JF, 2015, J THORAC ONCOL, V10, P232, DOI 10.1097/JTO.0000000000000455; Gandhi L, 2015, J CLIN ONCOL, V33; Horn L., 2014, J CLIN ONCOL S, V32, p5s; Kinoshita Y., 2013, BMJ CASE REP, DOI [10.1136/bcr-2013-200867., DOI 10.1136/BCR-2013-200867, 10.1136/bcr-2013-200867]; Kodama T, 2014, MOL CANCER THER, V13, P2910, DOI 10.1158/1535-7163.MCT-14-0274; Kodama T, 2014, CANCER CHEMOTH PHARM, V74, P1023, DOI 10.1007/s00280-014-2578-6; Metro G, 2015, J THORAC ONCOL, V10, pE26, DOI 10.1097/JTO.0000000000000468; Mok T, 2015, J CLIN ONCOL, V33; Nanjo S, 2015, CANCER SCI, V106, P244, DOI 10.1111/cas.12600; Nieder C, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-19; Ohe Y, 2015, J CLIN ONCOL, V33; Ou SHI, 2015, J CLIN ONCOL, V33; Rangachari D, 2015, LUNG CANCER, V88, P108, DOI 10.1016/j.lungcan.2015.01.020; Seto T, 2014, ANN ONCOL         S4, V25, piv426; Shaw A., 2014, ANN ONCOL, V2, piv426, DOI [10.1093/annonc/mdu349., DOI 10.1093/ANNONC/MDU349]; Shaw AT, 2015, J CLIN ONCOL, V33; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI 10.1056/NEJMoa1408440; Zykadia C., 2014, US PRESCRIBING INFOR	62	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-7659	1573-7233		CANCER METAST REV	Cancer Metastasis Rev.	DEC	2015	34	4					797	805		10.1007/s10555-015-9592-y		9	Oncology	Oncology	CX4YB	WOS:000365705800016		
J	Peng, J; Hamanishi, J; Matsumura, N; Abiko, K; Murat, K; Baba, T; Yamaguchi, K; Horikawa, N; Hosoe, Y; Murphy, SK; Konishi, I; Mandai, M				Peng, Jin; Hamanishi, Junzo; Matsumura, Noriomi; Abiko, Kaoru; Murat, Kumuruz; Baba, Tsukasa; Yamaguchi, Ken; Horikawa, Naoki; Hosoe, Yuko; Murphy, Susan K.; Konishi, Ikuo; Mandai, Masaki			Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-kappa B to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer	CANCER RESEARCH			English	Article							MHC CLASS-I; GENE-EXPRESSION; SUPPRESSOR-CELLS; BREAST-CANCER; IMMUNOTHERAPY; IMMUNITY; PATHWAY; PD-L1; IDENTIFICATION; INHIBITION	Emerging evidence has highlighted the host immune system in modulating the patient response to chemotherapy, but the mechanism of this modulation remains unclear. The aim of this study was to analyze the effect of chemotherapy on antitumor immunity in the tumor microenvironment of ovarian cancer. Treatment of ovarian cancer cell lines with various chemotherapeutic agents resulted in upregulated expression of MHC class I and programmed cell death 1 ligand 1 (PD-L1) in a NF-kappa B-dependent manner and suppression of antigen-specific T-cell function in vitro. In a mouse model of ovarian cancer, treatment with paclitaxel increased CD8(+)T-cell infiltration into the tumor site, upregulated PD-L1 expression, and activated NF-kappa B signaling. In particular, tumor-bearing mice treated with a combination of paclitaxel and a PD-L1/PD-1 signal blockade survived longer than mice treated with paclitaxel alone. In summary, we found that chemotherapy induces local immune suppression in ovarian cancer through NF-kappa B-mediated PD-L1 upregulation. Thus, a combination of chemotherapy and immunotherapy targeting the PD-L1/PD-1 signaling axis may improve the antitumor response and offers a promising new treatment modality against ovarian cancer. (C) 2015 AACR.	[Peng, Jin; Hamanishi, Junzo; Matsumura, Noriomi; Abiko, Kaoru; Murat, Kumuruz; Baba, Tsukasa; Yamaguchi, Ken; Horikawa, Naoki; Hosoe, Yuko; Konishi, Ikuo] Kyoto Univ, Grad Sch Med, Dept Gynecol & Obstet, Kyoto 6068507, Japan; [Murphy, Susan K.] Duke Univ, Med Ctr, Div Gynecol Oncol, Dept Obstet & Gynecol, Durham, NC USA; [Mandai, Masaki] Kinki Univ, Dept Obstet & Gynecol, Osaka, Japan	Hamanishi, J (reprint author), Kyoto Univ, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawaharacho, Kyoto 6068507, Japan.	jnkhmns@kuhp.kyoto-u.ac.jp					Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Hong S, 2007, CANCER RES, V67, P9577, DOI 10.1158/0008-5472.CAN-07-1179; Carson WE, 2004, CLIN CANCER RES, V10, P3401, DOI 10.1158/1078-0432.CCR-1016-03; Nowak AK, 2003, CANCER RES, V63, P4490; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Hamanishi J, 2010, STEM CELLS, V28, P164, DOI 10.1002/stem.256; ISHIDA Y, 1992, EMBO J, V11, P3887; Ohtsukasa S, 2003, J CANCER RES CLIN, V129, P719, DOI 10.1007/s00432-003-0492-0; Korde LA, 2010, BREAST CANCER RES TR, V119, P685, DOI 10.1007/s10549-009-0651-3; Suzuki E, 2005, CLIN CANCER RES, V11, P6713, DOI 10.1158/1078-0432.CCR-05-0883; Liu JZ, 2007, BLOOD, V110, P296, DOI 10.1182/blood-2006-10-051482; Cho SJ, 2008, CANCER SCI, V99, P1117, DOI 10.1111/j.1349-7006.2008.00789.x; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Bukowski RM, 2007, SEMIN ONCOL, V34, pS1, DOI 10.1053/j.seminoncol.2007.03.012; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Mori S, 2008, CANCER RES, V68, P8525, DOI 10.1158/0008-5472.CAN-08-1329; Ogino S, 2011, NAT REV CLIN ONCOL, V8, P711, DOI 10.1038/nrclinonc.2011.122; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Abiko K, 2013, CLIN CANCER RES, V19, P1363, DOI 10.1158/1078-0432.CCR-12-2199; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Rubinfeld B, 2006, NAT BIOTECHNOL, V24, P205, DOI 10.1038/nbt1185; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Ahmed AA, 2007, CANCER CELL, V12, P514, DOI 10.1016/j.ccr.2007.11.014; Chen G, 2013, CANCER IMMUNOL IMMUN, V62, P203, DOI 10.1007/s00262-012-1388-0; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Fahy BN, 2004, J AM COLL SURGEONS, V198, P591, DOI 10.1016/j.jamcollsurg.2003.12.005; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Ghiringhelli F, 2004, EUR J IMMUNOL, V34, P336, DOI 10.1002/eji.200324181; Yamaguchi K, 2010, ONCOGENE, V29, P1741, DOI 10.1038/onc.2009.470; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Forloni M, 2010, CANCER RES, V70, P916, DOI 10.1158/0008-5472.CAN-09-2582; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Kandalaft LE, 2011, J CLIN ONCOL, V29, P925, DOI 10.1200/JCO.2009.27.2369; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Carlsson R., 2014, J IMMUNOL CLIN RES, V2, P1013; Chu Yiwei, 2006, J Immunother, V29, P367, DOI 10.1097/01.cji.0000199198.43587.ba; Denlinger Chadrick E, 2004, Semin Thorac Cardiovasc Surg, V16, P28, DOI 10.1053/j.semtcvs.2003.12.004; Ferlay J, 2013, IARC CANCERBASE, V11; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Hamanishi J, 2015, J CLIN ONCOL, V62, P3397; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Huang G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061602; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Konstantinopoulos PA, 2009, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-59; Taube JM, 2012, SCI TRANSL MED, V4, P127, DOI DOI 10.1126/SCITRANSLMED.3003689; Wan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032542	49	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	DEC 1	2015	75	23					5034	5045		10.1158/0008-5472.CAN-14-3098		12	Oncology	Oncology	CX3ML	WOS:000365603000005		
J	Heissig, B; Dhahri, D; Eiamboonsert, S; Salama, Y; Shimazu, H; Munakata, S; Hattori, K				Heissig, Beate; Dhahri, Douaa; Eiamboonsert, Salita; Salama, Yousef; Shimazu, Hiroshi; Munakata, Shinya; Hattori, Koichi			Role of mesenchymal stem cell-derived fibrinolytic factor in tissue regeneration and cancer progression	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Review						Plasmin; uPAR; uPA; Integrin; Cancer; Tissue-type plasminogen activator; Wound healing; MMP; Cancer; Microenvironment; Niche; Hematopoiesis; Chemokine; TGF-b; Colorectal cancer; Hypoxia	PLASMINOGEN-ACTIVATOR INHIBITOR-1; HUMAN UMBILICAL-CORD; HUMAN ADIPOSE-TISSUE; BONE-MARROW-CELLS; UROKINASE RECEPTOR; IN-VIVO; EXTRACELLULAR-MATRIX; PROGENITOR CELLS; HEMATOPOIETIC REGENERATION; MOLECULAR-MECHANISMS	Tissue regeneration during wound healing or cancer growth and progression depends on the establishment of a cellular microenvironment. Mesenchymal stem cells (MSC) are part of this cellular microenvironment, where they functionally modulate cell homing, angiogenesis, and immune modulation. MSC recruitment involves detachment of these cells from their niche, and finally MSC migration into their preferred niches; the wounded area, the tumor bed, and the BM, just to name a few. During this recruitment phase, focal proteolysis disrupts the extracellular matrix (ECM) architecture, breaks cell-matrix interactions with receptors, and integrins, and causes the release of bioactive fragments from ECM molecules. MSC produce a broad array of proteases, promoting remodeling of the surrounding ECM through proteolytic mechanisms. The fibrinolytic system, with its main player plasmin, plays a crucial role in cell migration, growth factor bioavailability, and the regulation of other protease systems during inflammation, tissue regeneration, and cancer. Key components of the fibrinolytic cascade, including the urokinase plasminogen activator receptor (uPAR) and plasminogen activator inhibitor-1 (PAI-1), are expressed in MSC. This review will introduce general functional properties of the fibrinolytic system, which go beyond its known function of fibrin clot dissolution (fibrinolysis). We will focus on the role of the fibrinolytic system for MSC biology, summarizing our current understanding of the role of the fibrinolytic system for MSC recruitment and the functional consequences for tissue regeneration and cancer. Aspects of MSC origin, maintenance, and the mechanisms by which these cells contribute to altered protease activity in the microenvironment under normal and pathological conditions will also be discussed.	[Heissig, Beate; Dhahri, Douaa; Eiamboonsert, Salita; Salama, Yousef] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Dynam,Minato Ku, Tokyo 1088639, Japan; [Shimazu, Hiroshi; Munakata, Shinya; Hattori, Koichi] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Regulat,Minato Ku, Tokyo 1088639, Japan; [Hattori, Koichi] Juntendo Univ, Sch Med, Ctr Genome & Regenerat Med, Bunkyo Ku, Tokyo 1138421, Japan; [Heissig, Beate] Juntendo Univ, Sch Med, Atopy Allergy Ctr, Bunkyo Ku, Tokyo 1138421, Japan	Heissig, B (reprint author), Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Dynam,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	b_heissig@yahoo.com			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT; Mitsubishi Pharma Research Foundation; Naito Grant; Program for Improvement of the Research Environment for Young Researchers - Special Coordination Funds for Promoting Science and Technology of the MEXT, Japan	We thank Stephanie C Napier for proofreading of the manuscript. This work was supported in part by grants from the Japan Society for the Promotion of Science and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (K.H.) Grant-in-Aid for Scientific Research on Priority Areas from the MEXT (K.H.), Mitsubishi Pharma Research Foundation (K.H), Naito Grant (B.H.), Grant-in-Aid for Scientific Research on Innovative Areas from the MEXT (B.H.), Program for Improvement of the Research Environment for Young Researchers funded by the Special Coordination Funds for Promoting Science and Technology of the MEXT, Japan (B.H.).	HEEB MJ, 1987, J BIOL CHEM, V262, P15813; Tsai MS, 2007, STEM CELLS, V25, P2511, DOI 10.1634/stemcells.2007-0023; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; Fietz T, 2006, BLOOD, V107, P3408, DOI 10.1182/blood-2005-08-3176; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; Lijnen HR, 2001, BBA-PROTEIN STRUCT M, V1547, P206, DOI 10.1016/S0167-4838(01)00186-8; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; LOSKUTOFF DJ, 1983, P NATL ACAD SCI-BIOL, V80, P2956, DOI 10.1073/pnas.80.10.2956; Kim JW, 2004, ANN HEMATOL, V83, P733, DOI 10.1007/s00277-004-0918-z; Copland IB, 2009, STEM CELLS, V27, P467, DOI 10.1634/stemcells.2008-0520; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Ma LJ, 2004, DIABETES, V53, P336, DOI 10.2337/diabetes.53.2.336; Selleri C, 2005, BLOOD, V105, P2198, DOI 10.1182/blood-2004-06-2424; Munakata S, 2015, GASTROENTEROLOGY, V148, P565, DOI 10.1053/j.gastro.2014.12.001; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Lijnen HR, 1998, THROMB HAEMOSTASIS, V79, P1171; Fadini GP, 2013, DIABETES CARE, V36, P943, DOI 10.2337/dc12-1084; De Boeck A, 2013, GUT, V62, P550, DOI 10.1136/gutjnl-2011-301393; Pulukuri SMK, 2010, MOL CANCER RES, V8, P1074, DOI 10.1158/1541-7786.MCR-09-0495; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Tamura Y, 2013, DIABETES, V62, P3170, DOI 10.2337/db12-1552; Lazarus HM, 1997, J HEMATOTHER, V6, P447; LATSINIK NV, 1970, J CELL PHYSIOL, V75, P163, DOI 10.1002/jcp.1040750205; ELLIS V, 1991, J BIOL CHEM, V266, P12752; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Tamama K, 2011, J CELL BIOCHEM, V112, P804, DOI 10.1002/jcb.22961; Shen Y, 2012, BLOOD, V119, P5879, DOI 10.1182/blood-2012-01-407825; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Song J, 2013, J IMMUNOL, V190, P401, DOI 10.4049/jimmunol.1202286; Houlihan DD, 2012, NAT PROTOC, V7, P2103, DOI 10.1038/nprot.2012.125; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; CLARK RAF, 1982, J INVEST DERMATOL, V79, P264, DOI 10.1111/1523-1747.ep12500075; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Shi XL, 2010, WORLD J GASTROENTERO, V16, P3674, DOI 10.3748/wjg.v16.i29.3674; Nykjaer A, 1997, EMBO J, V16, P2610, DOI 10.1093/emboj/16.10.2610; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Deng G, 1996, J CELL BIOL, V134, P1563, DOI 10.1083/jcb.134.6.1563; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Neuss S, 2010, CELLS TISSUES ORGANS, V191, P36, DOI 10.1159/000215579; Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405; Ishihara M, 2012, LEUKEMIA, V26, P332, DOI 10.1038/leu.2011.203; Brizzi MF, 2012, CURR OPIN CELL BIOL, V24, P645, DOI 10.1016/j.ceb.2012.07.001; Syrovets T, 2012, J LEUKOCYTE BIOL, V92, P509, DOI 10.1189/jlb.0212056; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Andolfo A, 2002, THROMB HAEMOSTASIS, V88, P298; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Heissig B, 2009, J CELL PHYSIOL, V221, P521, DOI 10.1002/jcp.21897; Vallabhaneni KC, 2011, CARDIOVASC RES, V90, P113, DOI 10.1093/cvr/cvq362; COLLEN D, 1991, BLOOD, V78, P3114; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Sturge J, 2003, J CELL BIOL, V162, P789, DOI 10.1083/job.200302124; Aguirre-Ghiso JA, 2001, MOL BIOL CELL, V12, P863; Zorio E, 2008, CURR MED CHEM, V15, P923, DOI 10.2174/092986708783955455; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; Kjoller L, 1997, EXP CELL RES, V232, P420, DOI 10.1006/excr.1997.3540; Carmeliet P, 1997, NAT GENET, V17, P439, DOI 10.1038/ng1297-439; Hu SL, 2012, J CELL BIOCHEM, V113, P1005, DOI 10.1002/jcb.23432; ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; Tashiro Y, 2012, BLOOD, V119, P6382, DOI 10.1182/blood-2011-12-399659; Pluskota E, 2003, BLOOD, V101, P1582, DOI 10.1182/blood-2002-06-1842; Daley GQ, 2008, CELL, V132, P544, DOI 10.1016/j.cell.2008.02.009; Gong YQ, 2011, ARTERIOSCL THROM VAS, V31, P2035, DOI 10.1161/ATVBAHA.111.229583; Fuchs H, 1996, INFECT IMMUN, V64, P4307; Yao Y, 2010, J BIOL CHEM, V285, P31509, DOI 10.1074/jbc.M110.124891; Lv FJ, 2014, STEM CELLS, V32, P1408, DOI 10.1002/stem.1681; Bajou K, 2001, J CELL BIOL, V152, P777, DOI 10.1083/jcb.152.4.777; KRUITHOF EKO, 1995, BLOOD, V86, P4007; HOYERHANSEN G, 1992, J BIOL CHEM, V267, P18224; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Shinagawa K, 2010, INT J CANCER, V127, P2323, DOI 10.1002/ijc.25440; Tjwa M, 2009, J CLIN INVEST, V119, P1008, DOI 10.1172/JCI36010; Czekay RP, 2003, J CELL BIOL, V160, P781, DOI 10.1083/jcb.200208117; Rifkin DB, 1999, APMIS, V107, P80; Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X; Fredriksson L, 2004, EMBO J, V23, P3793, DOI 10.1038/sj.emboj.7600397; Waltz DA, 1997, J CLIN INVEST, V100, P58, DOI 10.1172/JCI119521; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Syrovets T, 2004, CELL MOL LIFE SCI, V61, P873, DOI 10.1007/s00018-003-3348-5; Lin MT, 2008, J BIOL CHEM, V283, P15807, DOI 10.1074/jbc.M708933200; Heissig B, 2005, J EXP MED, V202, P739, DOI 10.1081/jem.20050959; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; NIELSEN LS, 1982, BIOCHEMISTRY-US, V21, P6410, DOI 10.1021/bi00268a014; Solberg H, 2001, J HISTOCHEM CYTOCHEM, V49, P237; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; SIER CFM, 1991, GASTROENTEROLOGY, V101, P1522; GALE RP, 1985, EXP HEMATOL, V13, P3; SCHLEEF RR, 1988, HAEMOSTASIS, V18, P328; PLOUG M, 1991, J BIOL CHEM, V266, P1926; Okumura Y, 2002, J BIOL CHEM, V277, P9395, DOI 10.1074/jbc.M111225200; Gutova M, 2008, STEM CELLS, V26, P1406, DOI 10.1634/stemcells.2008-0141; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rijken DC, 2009, J THROMB HAEMOST, V7, P4, DOI 10.1111/j.1538-7836.2008.03220.x; Heissig B, 2012, INT J HEMATOL, V95, P131, DOI 10.1007/s12185-012-1016-y; Aurich H, 2009, GUT, V58, P570, DOI 10.1136/gut.2008.154880; Ploplis VA, 1998, BLOOD, V91, P2005; Heissig B, 2007, CELL STEM CELL, V1, P658, DOI 10.1016/j.stem.2007.10.012; Mei JJ, 2012, J CLIN INVEST, V122, P974, DOI 10.1172/JCI60588; Loskutoff DJ, 1998, ARTERIOSCL THROM VAS, V18, P1; Okaji Y, 2012, EXP HEMATOL, V40, P143, DOI 10.1016/j.exphem.2011.10.008; Romer J, 1996, NAT MED, V2, P725, DOI 10.1038/nm0796-725a; Lijnen HR, 1998, BLOOD, V91, P2045; Menon LG, 2007, STEM CELLS, V25, P520, DOI 10.1634/stemcells.2006-0257; de Paulis A, 2004, J IMMUNOL, V173, P5739; Boulland JL, 2012, CELL TRANSPLANT, V21, P1743, DOI 10.3727/096368911X627598; Muller-Ehmsen J, 2006, J MOL CELL CARDIOL, V41, P876, DOI 10.1016/j.yjmcc.2006.07.023; Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005; Tjwa M, 2009, J CELL MOL MED, V13, P4587, DOI 10.1111/j.1582-4934.2008.00521.x; Hogan NM, 2013, BIOCHEM BIOPH RES CO, V435, P574, DOI 10.1016/j.bbrc.2013.05.013; Myohanen H, 2004, CELL MOL LIFE SCI, V61, P2840, DOI 10.1007/s00018-004-4230-9; Deryugina EI, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/564259; Basiouny Hend Shafik, 2013, International Journal of Stem Cells, V6, P12; Chandran VI, 2015, ONCOSCIENCE, V2, P207; Chiellini C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-26; Czekay R, 2011, INT J CELL BIOL, V2011, P1, DOI DOI 10.1155/2011/562481; da Silva ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Eggenhofer E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00297; Friedenstein A J, 1980, Haematol Blood Transfus, V25, P19; FRIEDENS.AJ, 1974, EXP HEMATOL, V2, P83; FRIEDENS.AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Herren T, 2003, FRONT BIOSCI, V8, pD1, DOI 10.2741/916; Hoogduijn MJ, 2014, STEM CELLS DEV, V23, P2328, DOI 10.1089/scd.2014.0269; Ibrahim A, 2014, STEM CELLS, V32, P946, DOI 10.1002/stem.1577; Lane SW, 2014, NAT BIOTECHNOL, V32, P795, DOI 10.1038/nbt.2978; Park Chae Woon, 2009, Int J Stem Cells, V2, P59; Santibanez JF, 2013, ISRN DERMATOL, V2013; Sato A, 2015, LEUKEMIA, V29, P145, DOI 10.1038/leu.2014.151; Schäffer Michael, 2002, Int J Low Extrem Wounds, V1, P104, DOI 10.1177/1534734602001002005	131	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	DEC	2015	72	24					4759	4770		10.1007/s00018-015-2035-7		12	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CW8AG	WOS:000365220200005		
J	Verma, K; Saito-Nakano, Y; Nozaki, T; Datta, S				Verma, Kuldeep; Saito-Nakano, Yumiko; Nozaki, Tomoyoshi; Datta, Sunando			Insights into endosomal maturation of human holo-transferrin in the enteric parasite Entamoeba histolytica: essential roles of Rab7A and Rab5 in biogenesis of giant early endocytic vacuoles	CELLULAR MICROBIOLOGY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; HUMAN ERYTHROCYTES; MYOSIN IB; IN-VITRO; GTPASE; IRON; PHAGOCYTOSIS; EVOLUTION; MEMBRANE; PROTEINS	The pathogenic amoeba Entamoeba histolytica is one of the causative agents of health hazards in tropical countries. It causes amoebic dysentery, colitis and liver abscesses in human. Iron is one of the essential nutritional resources for survival and chronic infection caused by the amoeba. The parasite has developed multiple ways to import, sequester and utilize iron from various iron-binding proteins from its host. In spite of its central role in pathogenesis, the mechanism of iron uptake by the parasite is largely unknown. Here, we carried out a systematic study to understand the role of some of the amoebic homologues of mammalian endocytic Rab GTPases (Rab5 and Rab21, Rab7A and Rab7B) in intracellular transport of human holo-transferrin by the parasite. Flow cytometry and quantitative microscopic image analysis revealed that Rab5 and Rab7A are required for the biogenesis of amoebic giant endocytic vacuoles (GEVs) and regulate the early phase of intracellular trafficking of transferrin. Rab7B is involved in the late phase, leading to the degradation of transferrin in the amoebic lysosome-like compartments. Using time-lapse fluorescence imaging in fixed trophozoites, we determined the kinetics of the vesicular transport of transferrin through Rab5-, Rab7A- and Rab7B-positive compartments. The involvement of Rab7A in the early phase of endocytosis by the parasite marks a significant divergence from its host in terms of spatiotemporal regulation by the Rab GTPases.	[Verma, Kuldeep; Datta, Sunando] Indian Inst Sci Educ & Res Bhopal, Dept Biol Sci, Bhopal, India; [Saito-Nakano, Yumiko; Nozaki, Tomoyoshi] Natl Inst Infect Dis, Dept Parasitol, Tokyo, Japan	Datta, S (reprint author), Indian Inst Sci Educ & Res Bhopal, Dept Biol Sci, Gas Rahat ITI Bldg, Bhopal, India.	sunando@iiserb.ac.in					Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Rupper A, 2001, MOL BIOL CELL, V12, P2813; Welter BH, 2009, EUKARYOT CELL, V8, P1014, DOI 10.1128/EC.00030-09; Meza I, 2004, CELL MOTIL CYTOSKEL, V59, P215, DOI 10.1002/cm.20038; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; HAMANN L, 1995, P NATL ACAD SCI USA, V92, P8975, DOI 10.1073/pnas.92.19.8975; Nakada-Tsukui K, 2005, MOL BIOL CELL, V16, P5294, DOI 10.1091/mbc.E05-04-0283; WEINBERG ED, 1974, SCIENCE, V184, P952, DOI 10.1126/science.184.4140.952; Marion S, 2004, J CELL SCI, V117, P3271, DOI 10.1242/jcs.01178; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Okada M, 2005, EUKARYOT CELL, V4, P827, DOI 10.1128/EC.4.4.827-831.2005; Klopper TH, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-71; Voigt H, 1999, J CELL SCI, V112, P1191; Vitelli R, 1997, J BIOL CHEM, V272, P4391; Bucci C, 2000, MOL BIOL CELL, V11, P467; Gunther T, 2011, MAGNESIUM RES, V24, P223, DOI 10.1684/mrh.2011.0297; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Collins TJ, 2007, BIOTECHNIQUES, V43, P25; GILLIN FD, 1980, EXP PARASITOL, V49, P328, DOI 10.1016/0014-4894(80)90069-7; Daro E, 1996, P NATL ACAD SCI USA, V93, P9559, DOI 10.1073/pnas.93.18.9559; Schlierf B, 2000, EXP CELL RES, V259, P257, DOI 10.1006/excr.2000.4947; Foret L, 2012, CURR BIOL, V22, P1381, DOI 10.1016/j.cub.2012.06.021; SMITH JM, 1982, ARCH INVEST MED, V13, P63; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; Hung CC, 2012, LANCET INFECT DIS, V12, P729, DOI 10.1016/S1473-3099(12)70147-0; Dacks JB, 2008, P NATL ACAD SCI USA, V105, P588, DOI 10.1073/pnas.0707318105; Sheff D, 2002, J CELL BIOL, V156, P797, DOI 10.1083/jcb.20111048; Lee J, 2008, KOREAN J PARASITOL, V46, P37, DOI 10.3347/kjp.2008.46.1.37; Singh MK, 2014, CURR BIOL, V24, P1383, DOI 10.1016/j.cub.2014.05.005; Mukhopadhyay A, 1997, J CELL BIOL, V136, P1227, DOI 10.1083/jcb.136.6.1227; Saito-Nakano Y, 2005, EXP PARASITOL, V110, P244, DOI 10.1016/j.exppara.2005.02.021; Nakada-Tsukui K, 2010, EXP PARASITOL, V126, P337, DOI 10.1016/j.exppara.2010.04.014; Welter BH, 2005, MOL BIOCHEM PARASIT, V140, P161, DOI 10.1016/j.molbiopara.2004.12.011; Saito-Nakano Y, 2007, CELL MICROBIOL, V9, P1796, DOI 10.1111/j.1462-5822.2007.00915.x; Doherty CP, 2007, J NUTR, V137, P1341; Espinosa A, 2009, J ANTIMICROB CHEMOTH, V63, P675, DOI 10.1093/jac/dkp015; Matsui T, 2011, TRAFFIC, V12, P1432, DOI 10.1111/j.1600-0854.2011.01240.x; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Reyes-Lopez M, 2011, MICROBIOL-SGM, V157, P209, DOI 10.1099/mic.0.040063-0; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Lopez-Soto F, 2009, INT J PARASITOL, V39, P417, DOI 10.1016/j.ijpara.2008.08.010; Saito-Nakano Y, 2004, J BIOL CHEM, V279, P49497, DOI 10.1074/jbc.M403987200; Nozaki T, 1998, MOL BIOCHEM PARASIT, V97, P33, DOI 10.1016/S0166-6851(98)00129-7; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; McGugan GC, 2003, MOL BIOCHEM PARASIT, V129, P137, DOI 10.1016/S0166-6851(03)00115-4; DIAMOND LS, 1978, ARCH INVEST MED, V9, P329; Lopez-Soto F, 2009, INFECT GENET EVOL, V9, P1038, DOI 10.1016/j.meegid.2009.05.018; WEINBERG ED, 1971, J INFECT DIS, V124, P401; Ralston KS, 2014, NATURE, V508, P526, DOI 10.1038/nature13242; KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715; Leon-Sicairos N, 2005, MICROBIOL-SGM, V151, P3859, DOI 10.1099/mic.0.28121-0; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Mitra BN, 2007, CELL MICROBIOL, V9, P2112, DOI 10.1111/j.1462-5822.2007.00941.x; Aslam S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003055; Boettner DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040008; Emmanuel M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004666; Hagiwara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087373; Hernandez-Cuevas NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107102; Leclerc EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017816; Mackiewicz P, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-101; Matsui T., 2011, CELL LOGIST, V1, P155; Perdomo D, 2015, J PROTEOMICS, V112, P125, DOI 10.1016/j.jprot.2014.07.034; Schmid SL, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022509; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.0020261; Somlata, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1199; Thibeaux R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003824; Traub LM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001037; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233	72	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-5814	1462-5822		CELL MICROBIOL	Cell Microbiol.	DEC	2015	17	12					1779	1796		10.1111/cmi.12470		18	Cell Biology; Microbiology	Cell Biology; Microbiology	CX3VD	WOS:000365626700006		
J	Nakayama, T; Uno, B				Nakayama, Tatsushi; Uno, Bunji			Importance of Proton-Coupled Electron Transfer from Natural Phenolic Compounds in Superoxide Scavenging	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						proton-coupled electron transfer; superoxide; natural phenolic compound; cyclic voltammetry; ESR spectrum	DNA STRAND BREAKS; ALPHA-TOCOPHEROL; VITAMIN-E; O-H; ELECTROCHEMICAL REDUCTION; TAXIFOLIN ANTIOXIDANTS; APROTIC-SOLVENTS; HUMAN-LEUKOCYTES; QUERCETIN; MECHANISM	The superoxide O-2(center dot-) scavenging reaction of (+)-catechin (Cat), quercetin (Que), rutin, and alpha-tocopherol (alpha-TOH) as natural phenolic compounds is investigated on the basis of electrochemical and ESR spectral measurements with the aid of density functional theory (DFT) calculations. Reversibility of the O-2/O-2(center dot-) redox couple is significantly affected by the presence of the phenolic compounds. The catechol moiety of Cat, Que, and rutin plays an essential role in concerted proton-coupled electron transfer (PCET) to HO2 center dot. derived from O-2(center dot-) to give H2O2 and the corresponding o-benzoquinone radical anions. On the other hand, the presence of alpha-TOH causes sequential electron and proton transfers to H-2(center dot) to give H2O2 and the alpha-tocopheroxyl radical. These electron transfers in the presence of the phenolic compounds are inferred from the ESR spectral measurements. The DFT calculation results suggest that the O-2(center dot-) scavenging reaction of the natural phenolic compounds proceeds efficiently with the one-step concerted PCET or sequential PCET mechanism.	[Nakayama, Tatsushi; Uno, Bunji] Gifu Pharmaceut Univ, Gifu 5011196, Japan	Uno, B (reprint author), Gifu Pharmaceut Univ, Gifu 5011196, Japan.	uno@gifu-pu.ac.jp			Japan Society for the Promotion of Science (JSPS) [25460039]	This work was supported by Grant-in-Aid for Scientific Research (C) Grant Number 25460039 from Japan Society for the Promotion of Science (JSPS). The authors would like to thank Mr. Yuki Mori for his experimental assistance.	Musialik M, 2005, ORG LETT, V7, P4951, DOI 10.1021/ol051962j; Kong L, 2005, J MOL STRUC-THEOCHEM, V716, P27, DOI 10.1016/j.theochem.2004.11.018; Trouillas P, 2006, FOOD CHEM, V97, P679, DOI 10.1016/j.foodchem.2005.05.042; Dhaouadi Z, 2009, J MOL STRUC-THEOCHEM, V904, P35, DOI 10.1016/j.theochem.2009.02.034; Foti MC, 2004, J ORG CHEM, V69, P2309, DOI 10.1021/jo035758q; Kozlowski D, 2007, J PHYS CHEM A, V111, P1138, DOI 10.1021/jp066496+; Anouar E, 2009, J PHYS CHEM A, V113, P13881, DOI 10.1021/jp906285b; SLABBERT NP, 1977, TETRAHEDRON, V33, P821, DOI 10.1016/0040-4020(77)80200-7; Cotelle N, 2005, J PHYS CHEM B, V109, P23720, DOI 10.1021/jp0550661; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Uno B, 2000, J ORG CHEM, V65, P1448, DOI 10.1021/jo991590q; NANNI EJ, 1980, J AM CHEM SOC, V102, P4481, DOI 10.1021/ja00533a029; Hammes-Schiffer S, 2015, J AM CHEM SOC, V137, P8860, DOI 10.1021/jacs.5b04087; ANDRIEUX CP, 1987, J AM CHEM SOC, V109, P3768, DOI 10.1021/ja00246a040; Russo N, 2000, J AGR FOOD CHEM, V48, P3232, DOI 10.1021/jf990469h; Trouillas P, 2008, J PHYS CHEM A, V112, P1054, DOI 10.1021/jp075814h; Nakayama T, 2010, CHEM LETT, V39, P162, DOI 10.1246/cl.2010.162; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; Priyadarsini KI, 2003, FREE RADICAL BIO MED, V35, P475, DOI 10.1016/S0891-5849(03)00325-3; Costentin C, 2008, CHEM REV, V108, P2145, DOI 10.1021/cr068065t; SOTIRIOU C, 1990, J ORG CHEM, V55, P2159, DOI 10.1021/jo00294a033; Foti MC, 2008, J ORG CHEM, V73, P9270, DOI 10.1021/jo8016555; Litwinienko G, 2007, ACCOUNTS CHEM RES, V40, P222, DOI 10.1021/ar0682029; Peressini S, 2002, J ELECTROANAL CHEM, V532, P295, DOI 10.1016/S0022-0728(02)00838-0; Malyszko J, 2006, J ELECTROANAL CHEM, V595, P136, DOI 10.1016/j.jelechem.2006.07.018; Mayer JM, 2004, BBA-BIOENERGETICS, V1655, P51, DOI 10.1016/j.bbabio.2003.07.002; Fukuhara K, 2003, CHEM RES TOXICOL, V16, P81, DOI 10.1021/tx025581f; Markovic JMD, 2014, RSC ADV, V4, P32228, DOI 10.1039/c4ra02577f; Williams LL, 2004, J AM CHEM SOC, V126, P12441, DOI 10.1021/ja046648j; Fiorucci S, 2004, CHEMPHYSCHEM, V5, P1726, DOI 10.1002/cphc.2004004186; SAWYER DT, 1982, ANAL CHEM, V54, P1720, DOI 10.1021/ac00248a014; BAGLEY AC, 1986, P NATL ACAD SCI USA, V83, P3189, DOI 10.1073/pnas.83.10.3189; Wright JS, 2001, J AM CHEM SOC, V123, P1173, DOI 10.1021/ja002455u; BIRNBOIM HC, 1985, P NATL ACAD SCI USA, V82, P6820, DOI 10.1073/pnas.82.20.6820; Leopoldini M, 2004, J PHYS CHEM A, V108, P92, DOI 10.1021/jp035901j; BIRNBOIM HC, 1986, CARCINOGENESIS, V7, P1511, DOI 10.1093/carcin/7.9.1511; Fiorucci S, 2007, J AGR FOOD CHEM, V55, P903, DOI 10.1021/jf061864s; FRIDOVICH I, 1986, ARCH BIOCHEM BIOPHYS, V247, P1, DOI 10.1016/0003-9861(86)90526-6; Frisch M. J., 2010, GAUSSIAN 09 REVISION; Halliwell B, 1999, MUTAT RES-GEN TOX EN, V443, P37, DOI 10.1016/S1383-5742(99)00009-5; Huynh M. H. V., 2007, J CHEM REV, V107, P5004; Inagaki T, 2014, J PHYS CHEM B, V118, P937, DOI 10.1021/jp410263f; KANO K, 1994, J CHEM SOC CHEM COMM, P593, DOI 10.1039/c39940000593; Leopoldini M, 2004, THEOR CHEM ACC, V111, P210, DOI 10.1007/s00214-003-0544-1; Lucarini M, 2004, CHEM-EUR J, V10, P933, DOI 10.1002/chem.200305311; Meo FD, 2013, J PHYS CHEM A, V117, P2082; Nakanishi I, 2001, CHEM LETT, P1152; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Vaganek A, 2014, COMPUT THEOR CHEM, V1050, P31, DOI 10.1016/j.comptc.2014.10.020	49	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	DEC	2015	63	12					967	973				7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CX4UD	WOS:000365694900001		
J	Shino, N; Uchida, T; Yoshida, M; Nomura, Y				Shino, Noriyuki; Uchida, Takahiro; Yoshida, Miyako; Nomura, Yasuo			Development and Assessment of a Nomogram to Propose the Initial Dosage Regimen of a Meropenem Infusion Based on Serum Creatinine and Age Using a Monte Carlo Simulation	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						meropenem; Monte Carlo simulation; serum creatinine; age; nomogram; elderly patient	DRUG; PHARMACODYNAMICS; ANTIBIOTICS; RESISTANCE	A conventional nomogram, based on serum creatinine (sCr) and age, was developed in order to determine the correct initial dosage regimen for meropenem (MEPM) infusions in elderly patients with severe community-acquired pneumonia (CAP), using a target minimum inhibitory concentration (MIC) of 2 mg/L. A correlation between age and actual bodyweight (BW) in a development cohort of 44 males and 45 females was performed by linear regression using the least-squares method (male: y=-0.4676x+80.281, R-2=0.4888; female: y=-0.4373x+77.502, R-2=0.3194). There were no significant differences between actual BW and the BW (e-BW) estimated using this equation in this cohort (male: e-BW 41.6 +/- 3.1 kg, BW 41.7 +/- 3.5 kg, p=0.93; female: e-BW 39.5 +/- 2.1 BW 39.5 +/- 3.7 kg, p=0.20). By integrating these equations using the Monte Carlo simulation method, a dosage regime was calculated which would have an 80% probability of maintaining plasma drug levels above the MIC for more than 40% of the time (>40%TAM), using only the age and sCr of individual patients. This relationship was summarized as a nomogram. The nomogram was validated using an independent validation cohort (n=28) of patients. An optimized dosage regimen could be predicted in 84 patients (94.4%) in the development cohort and 25 patients (89.3%) in the validation cohort. This nomogram may be a useful tool for clinicians and pharmacists in determining an initial MEPM regimen in elderly patients with severe CAP, based only on age and sCr.	[Shino, Noriyuki; Nomura, Yasuo] Pharm Saiseikai Chuwa Hosp, Sakurai, Nara 6330054, Japan; [Shino, Noriyuki; Uchida, Takahiro; Yoshida, Miyako] Mukogawa Womens Univ, Dept Clin Pharmaceut, Nishinomiya, Hyogo 6638179, Japan	Shino, N (reprint author), Pharm Saiseikai Chuwa Hosp, 232 Abe, Sakurai, Nara 6330054, Japan.	yakuzaibu@chuwa-hp.jp					Ana P. F. M., METHODS ESTIMATING B; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Gould IM, 2002, CURR OPIN INFECT DIS, V15, P395; Turnidge JD, 1998, CLIN INFECT DIS, V27, P10, DOI 10.1086/514622; Neuhauser MM, 2003, JAMA-J AM MED ASSOC, V289, P885, DOI 10.1001/jama.289.7.885; Rabito E. I., 2006, Revista de Nutrição, V19, P655, DOI 10.1590/S1415-52732006000600002; Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284; Ikawa K, 2010, J INFECT CHEMOTHER, V16, P25, DOI 10.1007/s10156-009-0022-3; Nicolau DP, 2008, EXPERT OPIN PHARMACO, V9, P23, DOI 10.1517/14656566.9.1.23; Drusano GL, 2004, NAT REV MICROBIOL, V2, P289, DOI 10.1038/nrmicro862; Niki Y, 2009, J INFECT CHEMOTHER, V15, P156, DOI 10.1007/s10156-009-0674-z; Gill J, 2007, NEPHROL DIAL TRANSPL, V22, P2894, DOI 10.1093/ndt/gfm289; CHUMLEA WC, 1988, J AM DIET ASSOC, V88, P564; WISEMAN LR, 1995, DRUGS, V50, P73; Nyman HA, 2011, PHARMACOTHERAPY, V31, P1130, DOI 10.1592/phco.31.11.1130; Baughman Robert P, 2009, J Intensive Care Med, V24, P230, DOI 10.1177/0885066609335660; Craig WA, 1998, CLIN INFECT DIS, V26, P11, DOI DOI 10.1086/516284]; Hawkey PM, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3236	18	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	DEC	2015	63	12					986	991				6	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CX4UD	WOS:000365694900003		
J	Doi, N; Sasai, Y; Yamauchi, Y; Adachi, T; Kuzuya, M; Kondo, S				Doi, Naoki; Sasai, Yasushi; Yamauchi, Yukinori; Adachi, Tetsuo; Kuzuya, Masayuki; Kondo, Shin-ichi			Development of Novel Polymeric Prodrugs Synthesized by Mechanochemical Solid-State Copolymerization of Hydroxyethylcellulose and Vinyl Monomers	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						polysaccharide; hydroxyethylcellulose; polymeric prodrug; mechanochemical solid-state copolymerization; drug release; 5-fluorouracil	ELECTRON-SPIN-RESONANCE; DRUG-RELEASE; MECHANORADICAL FORMATION; HYDROLYSIS; DELIVERY; DEXTRAN; NANOPARTICLES; MECHANOLYSIS; DERIVATIVES; CONJUGATE	Novel polymeric prodrugs were synthesized by mechanochemical solid-state copolymerization of hydroxyethylcellulose and the methacryloyloxy derivative of 5-fluorouracil (5-FU). Copolymerization was about 94% complete after 4h, and the polymeric prodrug was quantitatively obtained after 14h of reaction. The number average molecular weight (M-n) and polydispersity (H) of the polymeric prodrug were 39000 g/mol and 6.20, respectively. Mechanical fracturing of the polymer in a stainless steel twin-shell blender improved these properties (M-n=16000 g/mol and H=1.94). 5-FU was sustainably released from the polymeric prodrugs, and the rate was not affected by the molecular weight or molecular weight distribution of the prodrug under the experimental conditions used. These results suggest that novel polymeric prodrugs composed of a polysaccharide and a synthetic polymer can be fabricated by mechanochemical solid-state copolymerization under anaerobic conditions.	[Doi, Naoki; Sasai, Yasushi; Kondo, Shin-ichi] Gifu Pharmaceut Univ, Lab Pharmaceut Phys Chem, Gifu 5011196, Japan; [Yamauchi, Yukinori] Matsuyama Univ, Fac Pharmaceut Sci, Dept Pharmaceut Phys Chem, Matsuyama, Ehime 7908578, Japan; [Adachi, Tetsuo] Gifu Pharmaceut Univ, Lab Clin Pharmaceut, Gifu 5011196, Japan; [Kuzuya, Masayuki] Chubu Gakuin Univ, Fac Human Welf, Dept Hlth & Welf, Seki, Gifu 5013993, Japan	Kondo, S (reprint author), Gifu Pharmaceut Univ, Lab Pharmaceut Phys Chem, 1-25-4 Daigalcu Nishi, Gifu 5011196, Japan.	skondo@gifu-pu.ac.jp					Kondo S, 1998, CHEM PHARM BULL, V46, P1918; Kondo S, 2007, CHEM PHARM BULL, V55, P389, DOI 10.1248/cpb.55.389; Mahdavinia GR, 2004, POLYM ADVAN TECHNOL, V15, P173, DOI 10.1002/pat.408; Mitra S, 2001, J CONTROL RELEASE, V74, P317, DOI 10.1016/S0168-3659(01)00342-X; Kuzuya M, 1999, J PHYS CHEM B, V103, P8051, DOI 10.1021/jp984278d; Kondo S, 2000, YAKUGAKU ZASSHI, V120, P1337; KUZUYA M, 1992, J POLYM SCI POL PHYS, V30, P97, DOI 10.1002/polb.1992.090300110; Kondo SI, 1998, CHEM PHARM BULL, V46, P669; Kondo S, 2000, CHEM PHARM BULL, V48, P1882; Kondo S, 2002, CHEM PHARM BULL, V50, P1434, DOI 10.1248/cpb.50.1434; KUZUYA M, 1991, CHEM PHARM BULL, V39, P3018; JOHANSEN M, 1982, INT J PHARM, V13, P89, DOI 10.1016/0378-5173(82)90145-4; KUZUYA M, 1991, MACROMOLECULES, V24, P4047, DOI 10.1021/ma00014a013; KONDO S, 1994, CHEM PHARM BULL, V42, P768; Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002; Kondo SI, 2004, J POLYM SCI POL CHEM, V42, P4161, DOI 10.1002/pola.20245; Sasai Y, 2004, CHEM PHARM BULL, V52, P339, DOI 10.1248/cpb.52.339; Kondo S, 2005, CHEM PHARM BULL, V53, P863, DOI 10.1248/cpb.53.863; KUZUYA M, 1993, J PHYS CHEM-US, V97, P7800, DOI 10.1021/j100132a003; BUUR A, 1985, INT J PHARM, V24, P43, DOI 10.1016/0378-5173(85)90143-7; Dhaneshwar Suneela S., 2006, Indian Journal of Pharmaceutical Sciences, V68, P705; Haward R. N., 1970, AM MAT INT C PHYS NO, P513; Kondo S., 1994, DDS, V9, P315; Kondo S., 1998, CURRENT TRENDS POLYM, V3, P1; Maiti S., 2010, INT J PHARMTECH RES, V2, P1350; Mehvar Reza, 2003, Current Pharmaceutical Biotechnology, V4, P283, DOI 10.2174/1389201033489685; vanDijkWolthuis WNE, 1997, MACROMOLECULES, V30, P4639, DOI 10.1021/ma9704018; Zohuriaan-Mehr MJ, 2005, IRAN POLYM J, V14, P235	28	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	DEC	2015	63	12					992	997				6	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CX4UD	WOS:000365694900004		
J	Otake, K; Azukizawa, S; Takeda, S; Fukui, M; Kawahara, A; Kitao, T; Shirahase, H				Otake, Kazuya; Azukizawa, Satoru; Takeda, Shigemitsu; Fukui, Masaki; Kawahara, Arisa; Kitao, Tatsuya; Shirahase, Hiroaki			Novel 2,7-Substituted (S)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acids: Peroxisome Proliferator-Activated Receptor gamma Partial Agonists with Protein-Tyrosine Phosphatase 1B Inhibition	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						peroxisome proliferator-activated receptor gamma; partial agonist; diabetes; adverse effect; protein-tyrosine phosphatase 1B inhibitor; insulin resistance	ALPHA/GAMMA DUAL AGONISTS; TYPE-2 DIABETES-MELLITUS; PPAR-GAMMA; INSULIN-RESISTANCE; ALPHA AGONIST; THIAZOLIDINEDIONES; FENOFIBRATE; DISCOVERY; MICE; DERIVATIVES	A novel series of 2,7-substituted 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives were synthesized and biologically evaluated. (S)-2-(2-Furylacryloyl)-7-[2-(2-methylindane-2-yl)-5-methyloxazol-4-yl]methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid tert-butylamine salt (13jE) was identified as a potent human peroxisome proliferator-activated receptor gamma (PPAR gamma)-selective agonist (EC50=85nm) and human protein-tyrosine phosphatase 1B (PTP-1B) inhibitor (IC50=1.0 mu m). Compound 13jE partially activated PPAR gamma, but not PPAR alpha or PPAR delta, and antagonized farglitazar, a full PPAR gamma agonist. C-max after the oral administration of 13jE at 10 mg/kg was 28.6 mu g/mL (53 mu m) in male Sprague-Dawley (SD) rats. Repeated administration of 13jE and rosiglitazone for 14d at 10 mg/kg/d decreased plasma glucose and triglyceride levels significantly in male KK-A(y) mice. Rosiglitazone, but not 13jE, significantly increased the plasma volume and liver weight. In conclusion, 13jE showed stronger hypoglycemic and hypolipidemic effects and weaker hemodilution and hepatotoxic effects than rosiglitazone, suggesting that its safer efficacy may be due to its partial PPAR gamma agonism and PTP-1B inhibition.	[Otake, Kazuya; Azukizawa, Satoru; Takeda, Shigemitsu; Fukui, Masaki; Kawahara, Arisa; Kitao, Tatsuya; Shirahase, Hiroaki] Kyoto Pharmaceut Ind Co Ltd, Drug Discovery Res Dept, Nakagyo Ku, Kyoto 6048444, Japan	Shirahase, H (reprint author), Kyoto Pharmaceut Ind Co Ltd, Drug Discovery Res Dept, Nakagyo Ku, 38 Nishinokyo Tsukinowa Cho, Kyoto 6048444, Japan.	shirahase@kyoto-pham.co.jp					WILSON RJ, 1970, J CLIN PATHOL, V23, P286, DOI 10.1136/jcp.23.4.286; Pochetti G, 2007, J BIOL CHEM, V282, P17314, DOI 10.1074/jbc.M702316200; Fievet C, 2006, CURR OPIN PHARMACOL, V6, P606, DOI 10.1016/j.coph.2006.06.009; MULLER P, 1992, HELV CHIM ACTA, V75, P745, DOI 10.1002/hlca.19920750310; Taygerly JP, 2013, BIOORGAN MED CHEM, V21, P979, DOI 10.1016/j.bmc.2012.11.058; Staels B, 2005, CELL METAB, V2, P77, DOI 10.1016/j.cmet.2005.08.001; Koh KK, 2005, DIABETES CARE, V28, P1419, DOI 10.2337/diacare.28.6.1419; Bloomgarden ZT, 2005, DIABETES CARE, V28, P488, DOI 10.2337/diacare.28.2.488; Wrobel J, 1999, J MED CHEM, V42, P3199, DOI 10.1021/jm990260v; Lebovitz HE, 2001, RECENT PROG HORM RES, V56, P265, DOI 10.1210/rp.56.1.265; Otake K, 2011, CHEM PHARM BULL, V59, P876; SAREL S, 1956, J AM CHEM SOC, V78, P5416, DOI 10.1021/ja01601a068; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Yajima K, 2003, AM J PHYSIOL-ENDOC M, V284, pE966, DOI 10.1152/ajpendo.00149.2002; Cho N, 2008, CURR TOP MED CHEM, V8, P1483, DOI 10.2174/156802608786413474; Henke BR, 2004, J MED CHEM, V47, P4118, DOI 10.1021/jm030631e; Zungu M, 2006, MITOCHONDRION, V6, P315, DOI 10.1016/j.mito.2006.09.001; Rubenstrunk A, 2007, BBA-MOL CELL BIOL L, V1771, P1065, DOI 10.1016/j.bbalip.2007.02.003; Tack CJJ, 2006, NETH J MED, V64, P166; Otake K, 2011, CHEM PHARM BULL, V59, P1233; Ala PJ, 2006, J BIOL CHEM, V281, P38013, DOI 10.1074/jbc.M607913200; Chou CJ, 2002, J BIOL CHEM, V277, P24484, DOI 10.1074/jbc.M202449200; Ma ZK, 1997, TETRAHEDRON-ASYMMETR, V8, P883, DOI 10.1016/S0957-4166(97)00049-9; Otake K, 2012, BIOORGAN MED CHEM, V20, P1060, DOI 10.1016/j.bmc.2011.11.035; Hussein Z, 2004, MED J AUSTRALIA, V181, P536; Everett L, 2000, LIVER, V20, P191, DOI 10.1034/j.1600-0676.2000.020003191.x; Arasappan A, 2007, TETRAHEDRON LETT, V48, P6343, DOI 10.1016/j.tetlet.2007.07.002; Brooks DA, 2001, J MED CHEM, V44, P2061, DOI 10.1021/jm0155188; Thareja S, 2012, MED RES REV, V32, P459, DOI 10.1002/med.20219; Azukizawa S, 2008, CHEM PHARM BULL, V56, P335, DOI 10.1248/cpb.56.335; Kuwabara K, 2004, J PHARMACOL EXP THER, V309, P970, DOI 10.1124/jpet.103.064659; Lai DY, 2004, J ENVIRON SCI HEAL C, V22, P37, DOI 10.1081/GNC-120038005; JUDD DB, 1994, J MED CHEM, V37, P3108, DOI 10.1021/jm00045a016; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Chaput E, 2000, BIOCHEM BIOPH RES CO, V271, P445, DOI 10.1006/bbrc.2000.2647; Cornwell PD, 2004, MUTAT RES-FUND MOL M, V549, P131, DOI 10.1016/j.mrfmmm.2003.12.019; Augeri DJ, 2005, J MED CHEM, V48, P5025, DOI 10.1021/jm050261p; Krische D, 2000, WESTERN J MED, V173, P54, DOI 10.1136/ewjm.173.1.54; Kubo M, 2014, J PHARMACOL SCI, V124, P276, DOI 10.1254/jphs.13236FP	39	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	DEC	2015	63	12					998	1014				17	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CX4UD	WOS:000365694900005		
J	Ogata, F; Kawasaki, N				Ogata, Fumihiko; Kawasaki, Naohito			Adsorption of As(III) from Aqueous Solutions by Novel Fe-Mg Type Hydrotalcite	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						Fe-Mg hydrotalcite; arsenic(III); adsorption	LAYERED DOUBLE HYDROXIDES; ARSENIC REMOVAL; EXCHANGE PROPERTIES; ANION-EXCHANGE; ION-EXCHANGE; WATER; PHOSPHATE; GROUNDWATER; CONTAMINATION; EQUILIBRIUM	Morphological and chemical evaluation of Fe-Mg hydrotalcite (Fe-HT) was performed using scanning electron microscopy, X-ray diffraction analysis, and electron microanalysis for application as an adsorbent for water treatment. The adsorption of arsenic III (As(III)) on Fe-HT was evaluated via examination of the effect of the contact time and analysis of the adsorption isotherm. The amount of As(III) adsorbed increased slightly with increasing temperature. The results of the adsorption isotherm studies suggested that As(III) adsorption can be well described by both the Freundlich and Langmuir equations. The adsorption of As(III) on Fe-HT reached equilibrium within 24 h, and the adsorption kinetic data fit the pseudo-second-order kinetic model better than the pseudo-first-order model. The amount of As(III) present on the surface of Fe-HT increased after As(III) adsorption, and the crystalline structure of Fe-HT was maintained after adsorption of As(III). The (003) and (006) peaks in the X-ray diffraction patterns were attributed to basal reflections, and these peaks shifted from respective 2 theta values of 10.86 and 21.94 degrees to 11.12 and 22.52 degrees, indicating exchange of As(III) with chloride ions in Fe-HT with consequent narrowing of the inter-layer spacing. Collectively, these results suggest that Fe-HT is prospectively useful for the adsorption of As(III) from aqueous solutions.	[Ogata, Fumihiko; Kawasaki, Naohito] Kinki Univ, Fac Pharm, Higashiosaka, Osaka 5778502, Japan; [Kawasaki, Naohito] Kinki Univ, Antiaging Ctr, Higashiosaka, Osaka 5778502, Japan	Kawasaki, N (reprint author), Kinki Univ, Fac Pharm, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	kawasaki@phar.kindai.ac.jp			MEXT (Ministry of Education, Culture, Sports, Science and Technology) [S1411037]	MEXT (Ministry of Education, Culture, Sports, Science and Technology)-supported Program for the Strategic Research Foundation at Private Universities, 2014-2018 (S1411037).	Abe I., 1976, J JPN OIL CHEM SOC, V25, P145; Grover K, 2009, WATER RES, V43, P3884, DOI 10.1016/j.watres.2009.06.003; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; [Anonymous], 2012, J ENV CHEM ECOTOXICO, DOI DOI 10.5897/JECE11.013; Yan LG, 2015, J COLLOID INTERF SCI, V448, P508, DOI 10.1016/j.jcis.2015.02.048; Turk T, 2014, J IND ENG CHEM, V20, P732, DOI 10.1016/j.jiec.2013.06.002; Chakraborti D, 2003, ENVIRON HEALTH PERSP, V111, P1194, DOI 10.1289/ehp.5966; Ferreira OP, 2004, J SOLID STATE CHEM, V177, P3058, DOI 10.1016/j.jssc.2004.04.030; Benhima H, 2008, COLLOID SURFACE B, V61, P10, DOI 10.1016/j.colsurfb.2007.06.024; Ng JC, 2003, CHEMOSPHERE, V52, P1353, DOI 10.1016/S0045-6535(03)00470-3; Paikaray S, 2013, APPL CLAY SCI, V77-78, P33, DOI [10.1016/j.clay.2013.03.016, 10.1016/j.day.2013.03.016]; OOKUBO A, 1992, J PHARM SCI, V81, P1139, DOI 10.1002/jps.2600811120; Bulut E, 2008, J HAZARD MATER, V154, P613, DOI 10.1016/j.jhazmat.2007.10.071; Faria PCC, 2004, WATER RES, V38, P2043, DOI 10.1016/j.watres.2004.01.034; MIYATA S, 1983, CLAY CLAY MINER, V31, P305, DOI 10.1346/CCMN.1983.0310409; Bhattacharya P, 2003, J PHYS IV, V107, P173, DOI 10.1051/jp4:20030270; Redman AD, 2002, ENVIRON SCI TECHNOL, V36, P2889, DOI 10.1021/es0112808; Chetia M, 2012, CLEAN TECHNOL ENVIR, V14, P21, DOI 10.1007/s10098-011-0365-1; Palmer SJ, 2009, J COLLOID INTERF SCI, V329, P404, DOI 10.1016/j.jcis.2008.09.065; Veli S, 2007, J HAZARD MATER, V149, P226, DOI 10.1016/j.jhazmat.2007.04.109; CHEN CJ, 1992, BRIT J CANCER, V66, P888, DOI 10.1038/bjc.1992.380; Acharyya SK, 2007, ENVIRON GEOL, V52, P489, DOI 10.1007/s00254-006-0482-z; Liu R, 2009, WATER RES, V43, P1323, DOI 10.1016/j.watres.2008.12.030; Ogata F, 2006, J COLLOID INTERF SCI, V300, P88, DOI 10.1016/j.jcis.2006.03.026; Mukherjee A, 2006, J HEALTH POPUL NUTR, V24, P142; OOKUBO A, 1994, LANGMUIR, V10, P407, DOI 10.1021/la00014a013; Bhattacharya P, 2006, MANAGING ARSENIC IN THE ENVIRONMENT: FROM SOIL TO HUMAN HEALTH, P95; Yang L, 2005, IND ENG CHEM RES, V44, P6804, DOI 10.1021/ie049060u; OOKUBO A, 1993, LANGMUIR, V9, P1418, DOI 10.1021/la00029a042; Lakshmipathiraj P, 2006, J HAZARD MATER, V136, P281, DOI 10.1016/j.jhazmat.2005.12.015; CULLEN WR, 1989, CHEM REV, V89, P713, DOI 10.1021/cr00094a002; Huang WY, 2013, CHEM ENG J, V228, P679, DOI 10.1016/j.cej.2013.05.036; Morel-Desrosiers N, 2003, J MATER CHEM, V13, P2582, DOI 10.1039/b303953f; Altundogan HS, 2000, WASTE MANAGE, V20, P761; Qiu W, 2007, J HAZARD MATER, V148, P721, DOI 10.1016/j.jhazmat.2007.03.038; Turk T, 2009, J HAZARD MATER, V171, P665, DOI 10.1016/j.jhazmat.2009.06.052; Zhang W, 2004, MINER ENG, V17, P517, DOI 10.1016/j.mineng.2003.11.020; Seki Y, 2006, ADSORPTION, V12, P89, DOI 10.1007/s10450-006-0141-4; Kundu S, 2007, J HAZARD MATER, V142, P97, DOI 10.1016/j.jhazmat.2006.07.059; Ogata F, 2009, CHEM PHARM BULL, V57, P129; Das B, 2009, WATER QUAL EXPOS HEA, V1, P5, DOI 10.1007/s12403-008-0002-3; Hagihara Y., 2004, ANN DISASTER PREVE B, V47B, P15; Israeli Y., 2000, DALTON, V2000, P791; Jobbagy M, 2013, J COLLOID INTERF SCI, V393, P314, DOI 10.1016/j.jcis.2012.10.069; Murakami T., 2005, J SOC WATER ENV, V28, P269, DOI 10.2965/jswe.28.269; Nishida S., 2004, 14 INT C PROP WAST S; Paikaray S, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1560-y; Yanagita T., 2013, J JPN SOC WATER ENV, V36, P149	48	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	DEC	2015	63	12					1040	1046				7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CX4UD	WOS:000365694900008		
J	Kawakami, S; Matsunami, K; Otsuka, H; Inagaki, M; Takeda, Y; Kawahata, M; Yamaguchi, K				Kawakami, Susumu; Matsunami, Katsuyoshi; Otsuka, Hideaki; Inagaki, Masanori; Takeda, Yoshio; Kawahata, Masatoshi; Yamaguchi, Kentaro			Crotocascarins I-K: Crotofolane-Type Diterpenoids, Crotocascarin gamma, Isocrotofolane Glucoside and Phenolic Glycoside from the Leaves of Croton cascarilloides	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						Croton cascarilloides; Euphorbiaceae; crotocascarin; crotofolane; nor-crotofolane; isocrotofolane	PHORBOL ESTERS	From the 1-BuOH-soluble fraction of a methanol (MeOH) extract of the leaves of Croton cascarilloides, crotofolanes: crotocascarins I-K, nor-crotofolane: crotocascarin gamma, isocrotofolane glucoside and phenolic glycoside were isolated by a combination of various separation techniques. Their structures were elucidated mainly from the NMR spectroscopic evidence. The structure of crotocascarin K was first elucidated by spectroscopic analysis and then was confirmed by X-ray crystallographic analysis. Its absolute structure was finally determined by the modified Mosher's method. Isocrotofolane glucoside was found to possess a new skeleton, however, its absolute structure remains to be determined.	[Kawakami, Susumu; Otsuka, Hideaki; Inagaki, Masanori; Takeda, Yoshio] Yasuda Womens Univ, Fac Pharm, Dept Nat Prod Chem, Asaminami Ku, Hiroshima 7310153, Japan; [Matsunami, Katsuyoshi; Otsuka, Hideaki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmacognosy, Minami Ku, Hiroshima 7348553, Japan; [Kawahata, Masatoshi; Yamaguchi, Kentaro] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Kagawa 7692193, Japan	Otsuka, H (reprint author), Yasuda Womens Univ, Fac Pharm, Dept Nat Prod Chem, Asaminami Ku, 6-13-1 Yasuhigashi, Hiroshima 7310153, Japan.	otsuka-h@yasuda-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science [22590006, 23590130, 15H04651]; Research Foundation for Pharmaceutical Sciences; Takeda Science Foundation	The authors are grateful for access to the superconducting NMR instrument (JEOL JNM alpha-400) at the Analytical Center of Molecular Medicine of the Hiroshima University Faculty of Medicine, and an Applied Biosystem QSTAR XL system ESI (Nano Spray)-MS at the Analysis Center of Life Science of the Graduate School of Biomedical Sciences, Hiroshima University. This work was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Japan Society for the Promotion of Science (Nos. 22590006, 23590130 and 15H04651). Thanks are also due to the Research Foundation for Pharmaceutical Sciences and the Takeda Science Foundation for the financial support.	Ishii T, 1998, CARBOHYD RES, V313, P189, DOI 10.1016/S0008-6215(98)00262-6; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Fragoso-Serrano M, 2005, PLANTA MED, V71, P278, DOI 10.1055/s-2005-837831; BOHLMANN F, 1981, PHYTOCHEMISTRY, V20, P469, DOI 10.1016/S0031-9422(00)84168-0; HECKER E, 1967, NATURWISSENSCHAFTEN, V54, P282; SNATZKE G, 1968, ANGEW CHEM INT EDIT, V7, P14, DOI 10.1002/anie.196800141; INOSHIRI S, 1988, PHYTOCHEMISTRY, V27, P2869, DOI 10.1016/0031-9422(88)80678-2; Kawakami S, 2013, CHEM PHARM BULL, V61, P411; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; Hatushima S, 1975, FLORA RYUKYUS ADDED, P364; KASAI R, 1977, TETRAHEDRON LETT, P175; Sheldrick G. M., 1996, SADABS PROGRAM EMPIR; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; VANDUURE.BL, 1969, PROG EXP TUMOR RES, V11, P31	14	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	DEC	2015	63	12					1047	1054				8	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CX4UD	WOS:000365694900009		
J	Mise, R; Iwao, Y; Kimura, S; Osugi, Y; Noguchi, S; Itai, S				Mise, Ryohei; Iwao, Yasunori; Kimura, Shin-ichiro; Osugi, Yukiko; Noguchi, Shuji; Itai, Shigeru			Investigation of Physicochemical Drug Properties to Prepare Fine Globular Granules Composed of Only Drug Substance in Fluidized Bed Rotor Granulation	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						high drug-loading; globular fine granule; fluidized bed rotor granulation; wettability	PROCESSOR; FORMULATION; PARTICLES; SYSTEM	The effect of some drug properties (wettability and particle size distribution) on granule properties (mean particle size, particle size distribution, sphericity, and granule strength) were investigated in a high (>97%) drug-loading formulation using fluidized bed rotor granulation. Three drugs: acetaminophen (APAP); ibuprofen (IBU); and ethenzamide (ETZ) were used as model drugs based on their differences in wettability and particle size distribution. Granules with mean particle sizes of 100-200 mu m and a narrow particle size distribution (PSD) could be prepared regardless of the drug used. IBU and ETZ granules showed a higher sphericity than APAP granules, while APAP and ETZ granules exhibited higher granule strength than IBU. The relationship between drug and granule properties suggested that the wettability and the PSD of the drugs were critical parameters affecting sphericity and granule strength, respectively. Furthermore, the dissolution profiles of granules prepared with poorly water-soluble drugs (IBU and ETZ) showed a rapid release (80% release in 20 min) because of the improved wettability with granulation. The present study demonstrated for the first time that fluidized bed rotor granulation can prepare high drug-loaded (>97%) globular granules with a mean particle size of less than 200 mu m and the relationship between physicochemical drug properties and the properties of the granules obtained could be readily determined, indicating the potential for further application of this methodology to various drugs.	[Mise, Ryohei; Iwao, Yasunori; Osugi, Yukiko; Noguchi, Shuji; Itai, Shigeru] Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmaceut Engn, Suruga Ku, Shizuoka 4228526, Japan; [Kimura, Shin-ichiro] Kissei Pharmaceut Co Ltd, Pharmaceut Res & Dev, Matsumoto, Nagano 3998710, Japan	Itai, S (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmaceut Engn, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	s-itai@u-shizuoka-ken.ac.jp					Xu L, 2007, CHEM PHARM BULL, V55, P1545, DOI 10.1248/cpb.55.1545; Noguchi S, 2013, INT J PHARMACEUT, V445, P93, DOI 10.1016/j.ijpharm.2013.01.048; Shiino K, 2010, INT J PHARMACEUT, V395, P71, DOI 10.1016/j.ijpharm.2010.05.007; Hamashita T, 2007, CHEM PHARM BULL, V55, P1169, DOI 10.1248/cpb.55.1169; Kimura S, 2010, INT J PHARMACEUT, V391, P244, DOI 10.1016/j.ijpharm.2010.03.005; Cai LX, 2013, INT J PHARMACEUT, V441, P790, DOI 10.1016/j.ijpharm.2012.09.052; Iwao Y, 2015, CHEM PHARM BULL, V63, P95, DOI 10.1248/cpb.c14-00687; Kimura S, 2014, CHEM PHARM BULL, V62, P309; Suzuki Yoshio, 2011, Journal of the Vacuum Society of Japan, V54, DOI 10.3131/jvsj2.54.47; Uesugi K., 2012, P SOC PHOTO-OPT INS, V8506, DOI DOI 10.1117/12.929575	10	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	DEC	2015	63	12					1070	1075				6	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CX4UD	WOS:000365694900012		
J	Kishimoto, T				Kishimoto, Takeo			Entry into mitosis: a solution to the decades-long enigma of MPF	CHROMOSOMA			English	Review						Arpp19/Ensa; Cyclin B-Cdk1; Greatwall kinase; Mitosis; MPF; PP2A	MATURATION-PROMOTING FACTOR; PROTEIN PHOSPHATASE 2A; CELL-CYCLE CONTROL; GERMINAL VESICLE BREAKDOWN; NUCLEAR-ENVELOPE BREAKDOWN; XENOPUS EGG EXTRACTS; STARFISH OOCYTES; M-PHASE; GREATWALL KINASE; CYTOPLASMIC FACTOR	Maturation or M phase-promoting factor (MPF) is the universal inducer of M phase common to eukaryotic cells. MPF was originally defined as a transferable activity that can induce the G2/M phase transition in recipient cells. Today, however, MPF is assumed to describe an activity that exhibits its effect in donor cells, and furthermore, MPF is consistently equated with the kinase cyclin B-Cdk1. In some conditions, however, MPF, as originally defined, is undetectable even though cyclin B-Cdk1 is fully active. For over three decades, this inconsistency has remained a long-standing puzzle. The enigma is now resolved through the elucidation that MPF, defined as an activity that exhibits its effect in recipient cells, consists of at least two separate kinases, cyclin B-Cdk1 and Greatwall (Gwl). Involvement of Gwl in MPF can be explained by its contribution to the autoregulatory activation of cyclin B-Cdk1 and by its stabilization of phosphorylations on cyclin B-Cdk1 substrates, both of which are essential when MPF induces the G2/M phase transition in recipient cells. To accomplish these tasks, Gwl helps cyclin B-Cdk1 by suppressing protein phosphatase 2A (PP2A)-B55 that counteracts cyclin B-Cdk1. MPF, as originally defined, is thus not synonymous with cyclin B-Cdk1, but is instead a system consisting of both cyclin B-Cdk1 that directs mitotic entry and Gwl that suppresses the anti-cyclin B-Cdk1 phosphatase. The current view that MPF is a synonym for cyclin B-Cdk1 in donor cells is thus imprecise; instead, MPF is best regarded as the entire pathway involved in the autoregulatory activation of cyclin B-Cdk1, with specifics depending on the experimental system.	[Kishimoto, Takeo] Tokyo Inst Technol, Grad Sch Biosci, Lab Cell & Dev Biol, Yokohama, Kanagawa 2268501, Japan; [Kishimoto, Takeo] Ochanomizu Univ, Sci & Educ Ctr, Bunkyo Ku, Tokyo 1128610, Japan	Kishimoto, T (reprint author), Ochanomizu Univ, Sci & Educ Ctr, Bunkyo Ku, Ootsuka 2-1-1, Tokyo 1128610, Japan.	kishimoto.takeo@ocha.ac.jp			Ministry of Education, Science and Culture, Japan	This article is dedicated to both Marcel Doree and the late Andre Picard, who shared the nuclear factor problem with me over two decades. The author sincerely thanks many colleagues who worked on the MPF project for so many years, particularly E. Okumura, M. Hara, Y. Abe, and K. Tachibana. The author cordially thanks also Michael L. Goldberg for critical reading of, and invaluable suggestions on, the manuscript. This study was supported by grants-in-aid from the Ministry of Education, Science and Culture, Japan.	Alvarez-Fernandez M, 2013, P NATL ACAD SCI USA, V110, P17374, DOI 10.1073/pnas.1310745110; Qian JB, 2013, CURR OPIN CELL BIOL, V25, P697, DOI 10.1016/j.ceb.2013.06.005; KISHIMOTO T, 1986, EXP CELL RES, V163, P445, DOI 10.1016/0014-4827(86)90075-3; Yu JT, 2004, J CELL BIOL, V164, P487, DOI 10.1083/JCB.200310059; Vigneron S, 2011, MOL CELL BIOL, V31, P2262, DOI 10.1128/MCB.00753-10; Castilho PV, 2009, MOL BIOL CELL, V20, P4777, DOI 10.1091/mbc.E09-07-0643; DUNPHY WG, 1988, CELL, V54, P423, DOI 10.1016/0092-8674(88)90205-X; O'Farrell PH, 2001, TRENDS CELL BIOL, V11, P512, DOI 10.1016/S0962-8924(01)02142-0; WASSERMAN WJ, 1975, EXP CELL RES, V91, P381, DOI 10.1016/0014-4827(75)90118-4; Wang P, 2013, J CELL BIOL, V202, P277, DOI 10.1083/jcb.201211141; Kim MY, 2012, GENETICS, V191, P1181, DOI 10.1534/genetics.112.140574; Okumura E, 2002, NAT CELL BIOL, V4, P111, DOI 10.1038/ncb741; SMITH LD, 1971, DEV BIOL, V25, P232, DOI 10.1016/0012-1606(71)90029-7; Okano-Uchida T, 2003, EMBO J, V22, P5633, DOI 10.1093/emboj/cdg535; SUNKARA PS, 1979, P NATL ACAD SCI USA, V76, P2799, DOI 10.1073/pnas.76.6.2799; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Kishimoto T, 1996, TRENDS BIOCHEM SCI, V21, P35, DOI 10.1016/0968-0004(96)80885-1; TACHIBANA K, 1987, J CELL SCI, V88, P273; Yu JT, 2006, MOL CELL, V22, P83, DOI 10.1016/j.molcel.2006.02.022; Vigneron S, 2009, EMBO J, V28, P2786, DOI 10.1038/emboj.2009.228; DOREE M, 1982, EXP CELL RES, V139, P127, DOI 10.1016/0014-4827(82)90326-3; Abe Y, 2010, J CELL SCI, V123, P3978, DOI 10.1242/jcs.076315; MAYERJAEKEL RE, 1994, J CELL SCI, V107, P2609; Kishimoto T, 2011, MOL REPROD DEV, V78, P704, DOI 10.1002/mrd.21343; Haccard O, 2006, EMBO REP, V7, P321, DOI 10.1038/sj.embor.7400611; LOHKA MJ, 1988, P NATL ACAD SCI USA, V85, P3009, DOI 10.1073/pnas.85.9.3009; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; KISHIMOTO T, 1976, NATURE, V260, P321, DOI 10.1038/260321a0; PICARD A, 1984, DEV BIOL, V104, P357, DOI 10.1016/0012-1606(84)90091-5; KANATANI H, 1969, NATURE, V221, P273, DOI 10.1038/221273a0; KISHIMOTO T, 1988, DEV GROWTH DIFFER, V30, P105; GAUTIER J, 1990, CELL, V60, P487, DOI 10.1016/0092-8674(90)90599-A; Haccard O, 2006, CELL CYCLE, V5, P1152, DOI 10.4161/cc.5.11.2800; DRAETTA G, 1989, CELL, V56, P829, DOI 10.1016/0092-8674(89)90687-9; JOHNSON RT, 1970, NATURE, V226, P717, DOI 10.1038/226717a0; Iwashita J, 1998, P NATL ACAD SCI USA, V95, P4392, DOI 10.1073/pnas.95.8.4392; Blake-Hodek KA, 2012, MOL CELL BIOL, V32, P1337, DOI 10.1128/MCB.06525-11; Cundell MJ, 2013, MOL CELL, V52, P393, DOI 10.1016/j.molcel.2013.09.005; KISHIMOTO T, 1981, DEV BIOL, V81, P177, DOI 10.1016/0012-1606(81)90360-2; WU M, 1980, DEV BIOL, V79, P465, DOI 10.1016/0012-1606(80)90131-1; GERHART J, 1984, J CELL BIOL, V98, P1247, DOI 10.1083/jcb.98.4.1247; WEINTRAUB H, 1982, CR ACAD SCI III-VIE, V295, P787; LABBE JC, 1989, EMBO J, V8, P3053; Santos SDM, 2012, CELL, V149, P1500, DOI 10.1016/j.cell.2012.05.028; Lew DJ, 1996, CURR OPIN CELL BIOL, V8, P795, DOI 10.1016/S0955-0674(96)80080-9; Voets E, 2010, CELL CYCLE, V9, P3591, DOI 10.4161/cc.9.17.12832; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Hagting A, 1998, EMBO J, V17, P4127, DOI 10.1093/emboj/17.14.4127; GERHART J, 1985, CYTOBIOS, V43, P335; KISHIMOTO T, 1984, J EXP ZOOL, V231, P293, DOI 10.1002/jez.1402310215; PICARD A, 1991, J CELL BIOL, V115, P337, DOI 10.1083/jcb.115.2.337; Doree M, 2002, J CELL SCI, V115, P2461; WASSERMAN WJ, 1976, SCIENCE, V191, P1266, DOI 10.1126/science.1083070; MIAKELYE R, 1983, J CELL BIOL, V97, P81, DOI 10.1083/jcb.97.1.81; OOKATA K, 1992, EMBO J, V11, P1763; PICARD A, 1988, DEV BIOL, V128, P129, DOI 10.1016/0012-1606(88)90274-6; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Fung TK, 2007, MOL BIOL CELL, V18, P1861, DOI 10.1091/mbc.E06-12-1092; DUNPHY WG, 1988, CELL, V55, P925, DOI 10.1016/0092-8674(88)90234-6; Hunt T, 1989, CURR OPIN CELL BIOL, V1, P268, DOI 10.1016/0955-0674(89)90099-9; KISHIMOTO T, 1982, EXP CELL RES, V137, P121, DOI 10.1016/0014-4827(82)90014-3; WhiteCooper H, 1996, GENETICS, V144, P1097; REYNHOUT JK, 1974, DEV BIOL, V38, P394, DOI 10.1016/0012-1606(74)90016-5; ADLAKHA RC, 1985, EXP CELL RES, V160, P471, DOI 10.1016/0014-4827(85)90194-6; WASSERMAN WJ, 1978, J CELL BIOL, V78, pR15, DOI 10.1083/jcb.78.1.R15; Kishimoto T, 1999, DEV BIOL, V214, P1, DOI 10.1006/dbio.1999.9393; Kishimoto T, 2003, CURR OPIN CELL BIOL, V15, P654, DOI 10.1016/j.ceb.2003.10.010; Okumura E, 2014, J CELL BIOL, V204, P881, DOI 10.1083/jcb.201307160; SORENSEN RA, 1985, J CELL BIOL, V100, P1637, DOI 10.1083/jcb.100.5.1637; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Mochida S, 2014, FEBS J, V281, P1159, DOI 10.1111/febs.12685; Ferrell JE, 2009, FEBS LETT, V583, P3999, DOI 10.1016/j.febslet.2009.10.068; Tachibana K, 2000, P NATL ACAD SCI USA, V97, P14301, DOI 10.1073/pnas.97.26.14301; Gharbi-Ayachi A, 2010, SCIENCE, V330, P1673, DOI 10.1126/science.1197048; GAUTIER J, 1988, CELL, V54, P433, DOI 10.1016/0092-8674(88)90206-1; Mochida S, 2012, EMBO REP, V13, P197, DOI 10.1038/embor.2011.263; Archambault V, 2007, PLOS GENET, V3, P2163, DOI 10.1371/journal.pgen.0030200; Hara M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2062; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Okumura E, 1996, J CELL BIOL, V132, P125, DOI 10.1083/jcb.132.1.125; Pines J, 1991, Trends Cell Biol, V1, P117, DOI 10.1016/0962-8924(91)90116-Q; Rangone H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002225; Williams BC, 2014, ELIFE, V3, DOI 10.7554/eLife.01695; Zhao Yong, 2008, Mol Biol Cell, V19, P1317, DOI 10.1091/mbc.E07-11-1099	86	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-5915	1432-0886		CHROMOSOMA	Chromosoma	DEC	2015	124	4					417	428		10.1007/s00412-015-0508-y		12	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CX5OE	WOS:000365750700001		
J	Arroyo, M; Trimborn, M; Sanchez, A; Hirano, T; Neitzel, H; Marchal, JA				Arroyo, M.; Trimborn, M.; Sanchez, A.; Hirano, T.; Neitzel, H.; Marchal, J. A.			Chromosome structure deficiencies in MCPH1 syndrome	CHROMOSOMA			English	Article							DNA-DAMAGE RESPONSE; MOSAIC VARIEGATED ANEUPLOIDY; SISTER-CHROMATID COHESION; XENOPUS EGG EXTRACTS; DE-LANGE-SYNDROME; MITOTIC CHROMOSOME; METAPHASE CHROMOSOMES; TOPOISOMERASE-II; CONDENSIN-II; MENTAL-RETARDATION	Mutations in the MCPH1 gene result in primary microcephaly in combination with a unique cellular phenotype of defective chromosome condensation. MCPH1 patient cells display premature chromosome condensation in G2 phase of the cell cycle and delayed decondensation in early G1 phase, observable as an increased proportion of cells with prophase-like appearance. MCPH1 deficiency thus appears to uncouple the chromosome cycle from the coordinated series of events that take place during mitosis such as some phases of the centrosome cycle and nuclear envelope breakdown. Here, we provide a further characterization of the effects of MCPH1 loss-of-function on chromosome morphology. In comparison to healthy controls, chromosomes of MCPH1 patients are shorter and display a pronounced coiling of their central chromatid axes. In addition, a substantial fraction of metaphase chromosomes shows apparently unresolved chromatids with twisted appearance. The patient chromosomes also showed signs of defective centromeric cohesion, which become more apparent and pronounced after harsh hypotonic conditions. Taking together, the observed alterations indicate additional so far unknown functions of MCPH1 during chromosome shaping and dynamics.	[Arroyo, M.; Sanchez, A.; Marchal, J. A.] Univ Jaen, Dept Expt Biol, E-23071 Jaen, Spain; [Trimborn, M.; Neitzel, H.] Charite Virchow Klinikum Hosp, Inst Med Genet & Human Genet, Berlin, Germany; [Hirano, T.] RIKEN, Chromosome Dynam Lab, Wako, Saitama, Japan	Marchal, JA (reprint author), Univ Jaen, Dept Expt Biol, Paraje Las Lagunillas S-N, E-23071 Jaen, Spain.	jamaor@ujaen.es			Universidad de Jaen [UJA2011/12/36]; Junta de Andalucia (Funding program "Ayudas a grupos de investigacion") [BIO220]; Deutsche Forschungsgemeinschaft [NE531/5-3]	This work was supported by Universidad de Jaen (grant UJA2011/12/36), Junta de Andalucia (Funding program "Ayudas a grupos de investigacion", reference BIO220) and by Deutsche Forschungsgemeinschaft (grant NE531/5-3).	Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; SUMNER AT, 1991, CHROMOSOMA, V100, P410, DOI 10.1007/BF00337519; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Maeshima K, 2003, DEV CELL, V4, P467, DOI 10.1016/S1534-5807(03)00092-3; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; Callier P, 2005, AM J MED GENET A, V137A, P204, DOI 10.1002/ajmg.a.30783; Kimura K, 2001, J BIOL CHEM, V276, P5417, DOI 10.1074/jbc.C000873200; Tibelius A, 2009, J CELL BIOL, V185, P1149, DOI 10.1083/jcb.200810159; MacCallum DE, 2002, MOL BIOL CELL, V13, P25, DOI 10.1091/mbc.01-09-0441; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; Ikeuchi T, 2004, AM J MED GENET A, V127A, P128, DOI 10.1002/ajmg.a.20666; Peng G, 2009, NAT CELL BIOL, V11, P865, DOI 10.1038/ncb1895; Gimenez-Abian JF, 2005, CELL CYCLE, V4, P1558; Shintomi K, 2010, CHROMOSOMA, V119, P459, DOI 10.1007/s00412-010-0271-z; TOMKINS D, 1979, AM J MED GENET, V4, P17, DOI 10.1002/ajmg.1320040104; Ritchie K, 2008, J CELL BIOL, V180, P315, DOI 10.1083/jcb.200706083; Awad S, 2013, HUM MOL GENET, V22, P2200, DOI 10.1093/hmg/ddt072; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Trimborn M, 2006, CELL CYCLE, V5, P322, DOI 10.4161/cc.5.3.2412; GASSER SM, 1986, J MOL BIOL, V188, P613, DOI 10.1016/S0022-2836(86)80010-9; EARNSHAW WC, 1985, J CELL BIOL, V100, P1706, DOI 10.1083/jcb.100.5.1706; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Liu JL, 2008, ANNU REV GENOM HUM G, V9, P303, DOI 10.1146/annurev.genom.9.081307.164211; VERNOS I, 1995, CELL, V81, P117, DOI 10.1016/0092-8674(95)90376-3; Gerkes EH, 2010, EUR J MED GENET, V53, P40, DOI 10.1016/j.ejmg.2009.10.005; LAEMMLI UK, 1978, PHARMACOL REV, V30, P469; Neitzel H, 2002, AM J HUM GENET, V70, P1015, DOI 10.1086/339518; Singh N, 2012, P NATL ACAD SCI USA, V109, P14381, DOI 10.1073/pnas.1212366109; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003; EARNSHAW WC, 1983, J CELL BIOL, V96, P84, DOI 10.1083/jcb.96.1.84; Venkatesh T, 2014, EUR J CELL BIOL, V93, P98, DOI 10.1016/j.ejcb.2014.01.005; Gavvovidis I, 2010, CELL CYCLE, V9, P4893, DOI 10.4161/cc.9.24.14157; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Yamashita D, 2011, J CELL BIOL, V194, P841, DOI 10.1083/jcb.201106141; Kajii T, 1998, AM J MED GENET, V78, P245, DOI 10.1002/(SICI)1096-8628(19980707)78:3<245::AID-AJMG7>3.0.CO;2-O; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Shintomi K, 2011, GENE DEV, V25, P1464, DOI 10.1101/gad.2060311; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; GIMENEZABIAN JF, 1995, J CELL BIOL, V131, P7, DOI 10.1083/jcb.131.1.7; Kaur M, 2005, AM J MED GENET A, V138A, P27, DOI 10.1002/ajmg.a.30919; VANDENBERG DJ, 1993, AM J MED GENET, V47, P1104, DOI 10.1002/ajmg.1320470735; SAITOH N, 1994, J CELL BIOL, V127, P303, DOI 10.1083/jcb.127.2.303; WRAY W, 1970, EXP CELL RES, V59, P469, DOI 10.1016/0014-4827(70)90656-7; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Barbelanne M, 2014, BIOMED RES INT, DOI 10.1155/2014/547986; Gavvovidis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040387; Ghani-Kakhki M, 2012, MOL SYNDROMOL, V3, P6; Khan MA, 2014, HUM MOL GENET, V23, P5940, DOI 10.1093/hmg/ddu318; Liang Y, 2015, ONCOGENE, V34, P4368, DOI 10.1038/onc.2014.367; Mahmood S, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-39; STUBBLEF.E, 1971, CHROMOSOMA, V32, P262	59	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-5915	1432-0886		CHROMOSOMA	Chromosoma	DEC	2015	124	4					491	501		10.1007/s00412-015-0512-2		11	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CX5OE	WOS:000365750700006		
J	Matsubara, K; Uno, Y; Srikulnath, K; Seki, R; Nishida, C; Matsuda, Y				Matsubara, Kazumi; Uno, Yoshinobu; Srikulnath, Kornsorn; Seki, Risako; Nishida, Chizuko; Matsuda, Yoichi			Molecular cloning and characterization of satellite DNA sequences from constitutive heterochromatin of the habu snake (Protobothrops flavoviridis, Viperidae) and the Burmese python (Python bivittatus, Pythonidae)	CHROMOSOMA			English	Article							REPETITIVE DNA; SEX-CHROMOSOMES; CYTOGENETIC CHARACTERIZATION; CENTROMERIC HETEROCHROMATIN; MITOCHONDRIAL GENOMES; LACERTID LIZARDS; EVOLUTION; KARYOTYPES; MOUSE; MICROCHROMOSOMES	Highly repetitive DNA sequences of the centromeric heterochromatin provide valuable molecular cytogenetic markers for the investigation of genomic compartmentalization in the macrochromosomes and microchromosomes of sauropsids. Here, the relationship between centromeric heterochromatin and karyotype evolution was examined using cloned repetitive DNA sequences from two snake species, the habu snake (Protobothrops flavoviridis, Crotalinae, Viperidae) and Burmese python (Python bivittatus, Pythonidae). Three satellite DNA (stDNA) families were isolated from the heterochromatin of these snakes: 168-bp PFL-MspI from P. flavoviridis and 196-bp PBI-DdeI and 174-bp PBI-MspI from P. bivittatus. The PFL-MspI and PBI-DdeI sequences were localized to the centromeric regions of most chromosomes in the respective species, suggesting that the two sequences were the major components of the centromeric heterochromatin in these organisms. The PBI-MspI sequence was localized to the pericentromeric region of four chromosome pairs. The PFL-MspI and the PBI-DdeI sequences were conserved only in the genome of closely related species, Gloydius blomhoffii (Crotalinae) and Python molurus, respectively, although their locations on the chromosomes were slightly different. In contrast, the PBI-MspI sequence was also in the genomes of P. molurus and Boa constrictor (Boidae), and additionally localized to the centromeric regions of eight chromosome pairs in B. constrictor, suggesting that this sequence originated in the genome of a common ancestor of Pythonidae and Boidae, approximately 86 million years ago. The three stDNA sequences showed no genomic compartmentalization between the macrochromosomes and microchromosomes, suggesting that homogenization of the centromeric and/or pericentromeric stDNA sequences occurred in the macrochromosomes and microchromosomes of these snakes.	[Matsubara, Kazumi; Uno, Yoshinobu; Srikulnath, Kornsorn; Matsuda, Yoichi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Lab Anim Genet,Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Srikulnath, Kornsorn] Kasetsart Univ, Fac Sci, Dept Genet, Lab Anim Cytogenet & Comparat Genom, Bangkok 10900, Thailand; [Srikulnath, Kornsorn] Kasetsart Univ, Ctr Adv Studies Trop Nat Resources CASTNAR, NRU KU, Bangkok, Thailand; [Seki, Risako] Hokkaido Univ, Lab Anim Cytogenet, Biosyst Sci Course, Grad Sch Life Sci,Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Nishida, Chizuko] Hokkaido Univ, Fac Sci, Dept Biol Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Matsuda, Yoichi] Nagoya Univ, Grad Sch Bioagr Sci, Avian Biosci Res Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Matsubara, K (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Lab Anim Genet,Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	baramaty@nuagr1.agr.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23113004, 22370081]	This research was partially supported by Grants-in-Aid for Scientific Research on Innovative Areas (no. 23113004) and a Grant-in-Aid for Scientific Research (B) (no. 22370081) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	SINGH L, 1972, CHROMOSOMA, V38, P185, DOI 10.1007/BF00326193; Capriglione T, 1998, J MOL EVOL, V46, P240, DOI 10.1007/PL00006299; Srikulnath K, 2009, CYTOGENET GENOME RES, V125, P213, DOI 10.1159/000230005; Saifitdinova AF, 2001, GENOME, V44, P96, DOI 10.1139/gen-44-1-96; Ishishita S, 2014, CHROMOSOME RES, V22, P15, DOI 10.1007/s10577-014-9402-3; Schmidt T, 1998, TRENDS PLANT SCI, V3, P195, DOI 10.1016/S1360-1385(98)01223-0; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; TAKAGI N, 1974, CHROMOSOMA, V46, P91, DOI 10.1007/BF00332341; Chaiprasertsri N, 2013, J HERED, V104, P798, DOI 10.1093/jhered/est061; Kawagoshi T, 2012, CHROMOSOME RES, V20, P95, DOI 10.1007/s10577-011-9267-7; Yamada K, 2005, CHROMOSOME RES, V13, P33, DOI 10.1007/s10577-005-2351-0; Kawai A, 2007, CYTOGENET GENOME RES, V117, P92, DOI 10.1159/000103169; Ciobanu D, 2004, J EXP ZOOL PART B, V302B, P505, DOI 10.1002/jez.b.21014; Castoe TA, 2009, CYTOGENET GENOME RES, V127, P112, DOI 10.1159/000295342; Tanaka K, 2000, J HERED, V91, P412, DOI 10.1093/jhered/91.5.412; MATZKE MA, 1990, CHROMOSOMA, V99, P131, DOI 10.1007/BF01735329; Matsubara K, 2006, P NATL ACAD SCI USA, V103, P18190, DOI 10.1073/pnas.0605274103; Matsubara K, 2008, CHROMOSOME RES, V16, P1013, DOI 10.1007/s10577-008-1259-x; CAPRIGLIONE T, 1991, COMP BIOCHEM PHYS B, V100, P641, DOI 10.1016/0305-0491(91)90233-4; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; MATSUDA Y, 1995, ELECTROPHORESIS, V16, P261, DOI 10.1002/elps.1150160142; SINGH L, 1976, CHROMOSOMA, V57, P177, DOI 10.1007/BF00292916; BECAK W, 1969, CYTOGENETICS, V8, P247, DOI 10.1159/000130037; Yamada K, 2002, CHROMOSOME RES, V10, P513, DOI 10.1023/A:1020996431588; Yamada K, 2004, CHROMOSOMA, V112, P277, DOI 10.1007/s00412-003-0267-z; MATSUDA Y, 1992, CYTOGENET CELL GENET, V61, P282, DOI 10.1159/000133423; BELTERMAN RHR, 1984, GENETICA, V65, P39, DOI 10.1007/BF00056765; CAPRIGLIONE T, 1989, GENETICA, V79, P85, DOI 10.1007/BF00057925; BECAK W, 1964, CHROMOSOMA, V15, P606, DOI 10.1007/BF00319994; Kumazawa Y, 2007, GENE, V388, P19, DOI 10.1016/j.gene.2006.09.026; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; MATZKE AJM, 1992, CHROMOSOMA, V102, P9, DOI 10.1007/BF00352284; Csink AK, 1998, TRENDS GENET, V14, P200, DOI 10.1016/S0168-9525(98)01444-9; DEBOER LEM, 1984, GENETICA, V65, P89; Giovannotti M, 2009, CYTOGENET GENOME RES, V125, P272, DOI 10.1159/000235933; Yamada K, 2002, CYTOGENET GENOME RES, V98, P255, DOI 10.1159/000071044; SINGER MF, 1982, INT REV CYTOL, V76, P67, DOI 10.1016/S0074-7696(08)61789-1; Castoe TA, 2011, GENOME BIOL EVOL, V3, P641, DOI 10.1093/gbe/evr043; Capriglione T, 1994, CHROMOSOME RES, V2, P327, DOI 10.1007/BF01552726; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; JELINEK WR, 1982, ANNU REV BIOCHEM, V51, P813, DOI 10.1146/annurev.bi.51.070182.004121; Giovannotti M, 2014, J EXP ZOOL PART B, V322, P13, DOI 10.1002/jez.b.22530; Giovannotti N, 2013, AMPHIBIA-REPTILIA, V34, P401; Grechko VV, 2006, MOL BIOL, V40, P51, DOI 10.1134/S0026893306010092; Grechko V V, 2005, Dokl Biochem Biophys, V400, P44, DOI 10.1007/s10628-005-0029-3; OHNO S, 1972, BROOKHAVEN SYM BIOL, P366; Olmo E, 2005, CHROMOREP REPTILE CH; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; SAMBROOK J, 1989, MOL CLONING LAB MANU; Srikulnath K, 2014, CHROMOSOMA, V123, P563, DOI 10.1007/s00412-014-0467-8; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Uetz P., 2015, REPTILE DATABASE; Uno Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053027; Vidal Nicolas, 2009, P390	54	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-5915	1432-0886		CHROMOSOMA	Chromosoma	DEC	2015	124	4					529	539		10.1007/s00412-015-0529-6		11	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CX5OE	WOS:000365750700009		
J	Shimizu, N; Maekawa, M; Asai, S; Shimizu, Y				Shimizu, Nobuyoshi; Maekawa, Masahiko; Asai, Satoko; Shimizu, Yoshiko			Multicolor FISHs for simultaneous detection of genes and DNA segments on human chromosomes	CHROMOSOME RESEARCH			English	Review						multicolor FISH; BAC clones; numerical anomaly; fusion genes; trisomy 21	EPIDERMAL-GROWTH-FACTOR; SQUAMOUS-CELL CARCINOMAS; IN-SITU HYBRIDIZATION; EGF RECEPTOR GENE; PROGNOSTIC-SIGNIFICANCE; AMPLIFICATION; HYPERPRODUCTION; SEQUENCE; REGION; LOCUS	We have developed a convenient multicolor fluorescent in situ hybridization (FISH) (five-, four-, three-, and two-color FISHs) for detecting specific genes/DNA segments on the human chromosomes. As a foundation of multicolor FISH, we first isolated 80 bacterial artificial chromosome (BAC) probes that specifically detect the peri-centromeres (peri-CEN) and subtelomeres (subTEL) of 24 different human chromosomes (nos. 1 similar to 22, X, and Y) by screening our homemade BAC library (Keio BAC library) consisting of 200,000 clones. Five-color FISH was performed using human DNA segments specific for peri-CEN or subTEL, which were labeled with five different fluorescent dyes [7-diethylaminocoumarin (DEAC): blue, fluorescein isothiocyanate (FITC): green, rhodamine 6G (R6G): yellow, TexRed: red, and cyanine5 (Cy5): purple]. To observe FISH signals under a fluorescence microscope, five optic filters were carefully chosen to avoid overlapping fluorescence emission. Five-color FISH and four-color FISH enabled us to accurately examine the numerical anomaly of human chromosomes. Three-color FISH using two specific BAC clones, that distinguish 5' half of oncogene epidermal growth factor receptor (EGFR) from its 3' half, revealed the amplification and truncation of EGFR in EGFR-overproducing cancer cells. Moreover, two-color FISH readily detected a fusion gene in leukemia cells such as breakpoint cluster region (BCR)/Abelson murine leukemia viral oncogene homologue (ABL) on the Philadelphia (Ph') chromosome with interchromosomal translocation. Some other successful cases such as trisomy 21 of Down syndrome are presented. Potential applications of multicolor FISH will be discussed.	[Shimizu, Nobuyoshi; Maekawa, Masahiko; Asai, Satoko; Shimizu, Yoshiko] Keio Univ, Tsukuba, Ibaraki, Japan	Shimizu, N (reprint author), Keio Univ, Tsukuba, Ibaraki, Japan.	smzgsp@dmb.med.keio.ac.jp					Wang J, 1998, BIOCHEM BIOPH RES CO, V250, P704, DOI 10.1006/bbrc.1998.9392; OZAWA S, 1989, CANCER, V63, P2169, DOI 10.1002/1097-0142(19890601)63:11<2169::AID-CNCR2820631117>3.0.CO;2-W; Shindoh N, 1996, BIOCHEM BIOPH RES CO, V225, P92, DOI 10.1006/bbrc.1996.1135; GILL GN, 1985, SOMAT CELL MOLEC GEN, V11, P309, DOI 10.1007/BF01534689; Hattori M, 2000, NATURE, V405, P311; Asakawa S, 1997, GENE, V191, P69, DOI 10.1016/S0378-1119(97)00044-9; COX DR, 1990, CYTOGENET CELL GENET, V55, P235, DOI 10.1159/000133017; WANG Y, 1993, JPN J HUM GENET, V38, P399, DOI 10.1007/BF01907986; Funakoshi E, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-12; SHIMIZU N, 1994, JPN J CANCER RES, V85, P567; SHIMIZU N, 1984, SOMAT CELL MOLEC GEN, V10, P45, DOI 10.1007/BF01534472; KONDO I, 1983, CYTOGENET CELL GENET, V35, P9, DOI 10.1159/000131829; Okui M, 1999, GENOMICS, V62, P165, DOI 10.1006/geno.1999.5998; OZAWA S, 1987, INT J CANCER, V39, P333, DOI 10.1002/ijc.2910390311; Kitagawa Y, 1996, CLIN CANCER RES, V2, P909; Kawasaki K, 1997, GENOME RES, V7, P250, DOI 10.1101/gr.7.3.250; HUNTS J, 1985, JPN J CANCER RES, V76, P663; Kawasaki K, 2000, J EXP ZOOL, V288, P120, DOI 10.1002/1097-010X(20000815)288:2<120::AID-JEZ4>3.0.CO;2-I; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; KAWASAKI K, 1988, JPN J CANCER RES, V79, P1174; WANG YM, 1995, JPN J HUM GENET, V40, P243, DOI 10.1007/BF01876182; KAWASAKI K, 1995, GENOME RES, V5, P125, DOI 10.1101/gr.5.2.125; MERLINO GT, 1985, MOL CELL BIOL, V5, P1722; International Stem Cell Initiative, 2011, NAT BIOTECHNOL, V29, P1132; SHIMIZU N, 1980, P NATL ACAD SCI-BIOL, V77, P3600, DOI 10.1073/pnas.77.6.3600	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0967-3849	1573-6849		CHROMOSOME RES	Chromosome Res.	DEC	2015	23	4					649	662		10.1007/s10577-015-9473-9		14	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CX5OI	WOS:000365751100002		
J	Ishii, T; Sunamura, N; Matsumoto, A; Eltayeb, AE; Tsujimoto, H				Ishii, Takayoshi; Sunamura, Naohiro; Matsumoto, Ayaka; Eltayeb, Amin Elsadig; Tsujimoto, Hisashi			Preferential recruitment of the maternal centromere-specific histone H3 (CENH3) in oat (Avena sativa L.) x pearl millet (Pennisetum glaucum L.) hybrid embryos	CHROMOSOME RESEARCH			English	Article						oat; pearl millet; embryogenesis; centromere-specific histone H3 (CENH3); interspecific cross; chromosome elimination	UNIPARENTAL CHROMOSOME ELIMINATION; MAIZE CENTROMERES; FOLD DOMAIN; WHEAT; FERTILIZATION; ARABIDOPSIS; CROSSES; HYBRIDIZATION; VARIANT	Chromosome elimination occurs frequently in interspecific hybrids between distantly related species in Poaceae. However, chromosomes from both parents behave stably in a hybrid of female oat (Avena sativa L.) pollinated by pearl millet (Pennisetum glaucum L.). To analyze the chromosome behavior in this hybrid, we cloned the centromere-specific histone H3 (CENH3) genes of oat and pearl millet and produced a pearl millet-specific anti-CENH3 antibody. Application of this antibody together with a grass species common anti-CENH3 antibody revealed the dynamic CENH3 composition of the hybrid cells before and after fertilization. Despite co-expression of CENH3 genes encoded by oat and pearl millet, only an oat-type CENH3 was incorporated into the centromeres of both species in the hybrid embryo. Oat CENH3 enables a functional centromere in pearl millet chromosomes in an oat genetic background. Comparison of CENH3 genes among Poaceae species that show chromosome elimination in interspecific hybrids revealed that the loop 1 regions of oat and pearl millet CENH3 exhibit exceptionally high similarity.	[Ishii, Takayoshi; Matsumoto, Ayaka; Eltayeb, Amin Elsadig; Tsujimoto, Hisashi] Tottori Univ, Arid Land Res Ctr, Tottori 6800001, Japan; [Sunamura, Naohiro] Tottori Univ, Fac Med, Tottori 6838503, Japan	Tsujimoto, H (reprint author), Tottori Univ, Arid Land Res Ctr, Tottori 6800001, Japan.	tsujim@alrc.tottori-u.ac.jp					Ingouff M, 2010, CURR BIOL, V20, P2137, DOI 10.1016/j.cub.2010.11.012; Zhang H, 2012, CHROMOSOME RES, V20, P403, DOI 10.1007/s10577-012-9284-1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ravi M, 2010, GENETICS, V186, P461, DOI 10.1534/genetics.110.120337; RINES HW, 1990, CROP SCI, V30, P1073; Gernand D, 2005, PLANT CELL, V17, P2431, DOI 10.1105/tpc.105.034249; Ishii T, 2010, CHROMOSOME RES, V18, P821, DOI 10.1007/s10577-010-9158-3; LAURIE DA, 1986, CAN J GENET CYTOL, V28, P313; Ravi M, 2010, NATURE, V464, P615, DOI 10.1038/nature08842; Gassmann R, 2012, NATURE, V484, P534, DOI 10.1038/nature10973; Hirsch CD, 2009, MOL BIOL EVOL, V26, P2877, DOI 10.1093/molbev/msp208; LAURIE DA, 1988, PLANT BREEDING, V100, P73, DOI 10.1111/j.1439-0523.1988.tb00220.x; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; Houben A, 2011, PLANT CELL TISS ORG, V104, P321, DOI 10.1007/s11240-010-9856-8; Ishii T, 2013, PLANT REPROD, V26, P25, DOI 10.1007/s00497-012-0205-4; Jin WW, 2004, PLANT CELL, V16, P571, DOI 10.1105/tpc.018937; Nagaki K, 2009, CHROMOSOMA, V118, P249, DOI 10.1007/s00412-008-0193-1; Mochida K, 2004, GENOME, V47, P199, DOI 10.1139/G03-123; Sprunck S, 2005, PLANT J, V41, P660, DOI 10.1111/j.1365-313X.2005.02332.x; Vermaak D, 2002, MOL CELL BIOL, V22, P7553, DOI 10.1128/MCB.22.21.7553-7561.2002; Talbert PB, 2002, PLANT CELL, V14, P1053, DOI 10.1105/tpc.010425; Wang GX, 2011, CHROMOSOMA, V120, P353, DOI 10.1007/s00412-011-0315-z; LAURIE DA, 1989, GENOME, V32, P1063; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Maheshwari S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004970; Ravi M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002121; Sanei M, 2011, P NATL ACAD SCI USA, V108, pE498, DOI 10.1073/pnas.1103190108; Wang K, 2014, GENOME RES, V24, P107, DOI 10.1101/gr.160887.113	28	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0967-3849	1573-6849		CHROMOSOME RES	Chromosome Res.	DEC	2015	23	4					709	718		10.1007/s10577-015-9477-5		10	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CX5OI	WOS:000365751100005		
J	Hayashi-Takanaka, Y; Maehara, K; Harada, A; Umehara, T; Yokoyama, S; Obuse, C; Ohkawa, Y; Nozaki, N; Kimura, H				Hayashi-Takanaka, Yoko; Maehara, Kazumitsu; Harada, Akihito; Umehara, Takashi; Yokoyama, Shigeyuki; Obuse, Chikashi; Ohkawa, Yasuyuki; Nozaki, Naohito; Kimura, Hiroshi			Distribution of histone H4 modifications as revealed by a panel of specific monoclonal antibodies	CHROMOSOME RESEARCH			English	Article						Chromatin; Epigenetics; Histone modification; Monoclonal antibody	HUMAN GENOME; HUMAN-CELLS; DNA-DAMAGE; LYSINE 16; CHROMATIN SIGNATURES; 20 MONOMETHYLATION; ACETYLATION SITES; BREAST-CANCER; LIVING CELLS; METHYLATION	Post-translational histone modifications play a critical role in genome functions such as epigenetic gene regulation and genome maintenance. The tail of the histone H4 N-terminus contains several amino acids that can be acetylated and methylated. Some of these modifications are known to undergo drastic changes during the cell cycle. In this study, we generated a panel of mouse monoclonal antibodies against histone H4 modifications, including acetylation at K5, K8, K12, and K16, and different levels of methylation at K20. Their specificity was evaluated by ELISA and immunoblotting using synthetic peptide and recombinant proteins that harbor specific modifications or amino acid substitutions. Immunofluorescence confirmed the characteristic distributions of target modifications. An H4K5 acetylation (H4K5ac)-specific antibody CMA405 reacted with K5ac only when the neighboring K8 was unacetylated. This unique feature allowed us to detect newly assembled H4, which is diacetylated at K5 and K12, and distinguish it from hyperacetylated H4, where K5 and K8 are both acetylated. Chromatin immunoprecipiation combined with deep sequencing (ChIP-seq) revealed that acetylation of both H4K8 and H4K16 were enriched around transcription start sites. These extensively characterized and highly specific antibodies will be useful for future epigenetics and epigenome studies.	[Hayashi-Takanaka, Yoko; Kimura, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Hayashi-Takanaka, Yoko; Kimura, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Hayashi-Takanaka, Yoko; Ohkawa, Yasuyuki; Kimura, Hiroshi] JST, CREST, Kawaguchi, Saitama 3320012, Japan; [Maehara, Kazumitsu; Harada, Akihito; Ohkawa, Yasuyuki] Kyushu Univ, Fac Med, Dept Adv Med Initiat, Fukuoka 8128582, Japan; [Umehara, Takashi] RIKEN, Ctr Life Sci Technol, Yokohama, Kanagawa 2300045, Japan; [Yokoyama, Shigeyuki] RIKEN, Struct Biol Lab, Yokohama, Kanagawa 2300045, Japan; [Obuse, Chikashi] Hokkaido Univ, Sch Life Sci, Sapporo, Hokkaido 0010021, Japan; [Nozaki, Naohito] MAB Inst Inc, Sapporo, Hokkaido 0010021, Japan	Kimura, H (reprint author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	hkimura@bio.titech.ac.jp	Umehara, Takashi/N-5683-2015	Umehara, Takashi/0000-0003-3464-2960	New Energy and Industrial Technology Development Organization of Japan; Japan Society for the Promotion of Science [25116005, 26291071]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science fellowship; Naito Foundation	We thank Hitoshi Niwa (RIKEN CDB) for ZHBTc4 mouse embryonic stem cells and Timothy Stasevich (Colorado State University) for proofreading the manuscript. This work was supported by the New Energy and Industrial Technology Development Organization of Japan, grants-in-aid from the Japan Society for the Promotion of Science (25116005 and 26291071), and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan. Y.H.-T. was supported by a Japan Society for the Promotion of Science fellowship and by the Naito Foundation.	Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241; Kimura H, 2013, J HUM GENET, V58, P439, DOI 10.1038/jhg.2013.66; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Greeson NT, 2008, J BIOL CHEM, V283, P33168, DOI 10.1074/jbc.M806857200; Eberhart A, 2013, CHROMOSOME RES, V21, P535, DOI 10.1007/s10577-013-9375-7; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Eberhart A, 2012, CHROMOSOME RES, V20, P849, DOI 10.1007/s10577-012-9318-8; Mukai T, 2011, BIOCHEM BIOPH RES CO, V411, P757, DOI 10.1016/j.bbrc.2011.07.020; Barman HK, 2006, BIOCHEM BIOPH RES CO, V345, P1547, DOI 10.1016/j.bbrc.2006.05.079; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Chandra T, 2012, MOL CELL, V47, P203, DOI 10.1016/j.molcel.2012.06.010; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Hayashi-Takanaka Y, 2009, J CELL BIOL, V187, P781, DOI 10.1083/jcb.200904137; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Li XZ, 2010, MOL CELL BIOL, V30, P5335, DOI 10.1128/MCB.00350-10; Taylor GCA, 2013, GENOME RES, V23, P2053, DOI 10.1101/gr.155028.113; Johnson CA, 1998, NUCLEIC ACIDS RES, V26, P994, DOI 10.1093/nar/26.4.994; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Chang L, 1997, BIOCHEMISTRY-US, V36, P469, DOI 10.1021/bi962069i; Beck DB, 2012, GENE DEV, V26, P325, DOI 10.1101/gad.177444.111; Krishnan V, 2011, P NATL ACAD SCI USA, V108, P12325, DOI 10.1073/pnas.1102789108; Shinchi Y, 2015, EXP CELL RES, V334, P90, DOI 10.1016/j.yexcr.2015.03.010; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860; Wu SM, 2011, CELL CYCLE, V10, P68, DOI 10.4161/cc.10.1.14363; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Luger K, 1997, NATURE, V389, P251; Jorgensen S, 2013, NUCLEIC ACIDS RES, V41, P2797, DOI 10.1093/nar/gkt012; Sims JK, 2006, J BIOL CHEM, V281, P12760, DOI 10.1074/jbc.M513462200; Kimura H, 2006, J CELL BIOL, V175, P389, DOI 10.1083/jcb.200608001; Lang DN, 2013, PROTEOMICS, V13, P2989, DOI 10.1002/pmic.201200568; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Hayashi-Takanaka Y, 2011, NUCLEIC ACIDS RES, V39, P6475, DOI 10.1093/nar/gkr343; Hori T, 2014, DEV CELL, V29, P740, DOI 10.1016/j.devcel.2014.05.001; TURNER BM, 1989, FEBS LETT, V253, P141, DOI 10.1016/0014-5793(89)80947-0; Sinha D, 2010, J BIOL CHEM, V285, P16572, DOI 10.1074/jbc.M109.091298; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Kapoor-Vazirani P, 2014, J BIOL CHEM, V289, P7425, DOI 10.1074/jbc.M113.520783; Ma XJ, 1998, P NATL ACAD SCI USA, V95, P6693, DOI 10.1073/pnas.95.12.6693; Sasaki K, 2009, P NATL ACAD SCI USA, V106, P16257, DOI 10.1073/pnas.0902150106; TURNER BM, 1992, CELL, V69, P375, DOI 10.1016/0092-8674(92)90417-B; Taddei A, 1999, J CELL BIOL, V147, P1153, DOI 10.1083/jcb.147.6.1153; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; TURNER BM, 1991, J CELL SCI, V99, P13; Stasevich TJ, 2014, NATURE, V516, P272, DOI 10.1038/nature13714; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ejlassi-Lassallette A, 2011, MOL BIOL CELL, V22, P245, DOI 10.1091/mbc.E10-07-0633; Hayashi-Takanaka Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106271; Kimura H, 1994, J BIOL CHEM, V269, P21439, DOI [10.1074/jbc.271.35.21439, DOI 10.1074/JBC.271.35.21439]; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Rothbart SB, 2012, SCI REP-UK, V2, DOI 10.1038/srep00489; Yokoyama Y, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3681; Zheng YP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3203	65	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0967-3849	1573-6849		CHROMOSOME RES	Chromosome Res.	DEC	2015	23	4					753	766		10.1007/s10577-015-9486-4		14	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CX5OI	WOS:000365751100008		
J	Nakamura, T; Hara, M; Oshika, M; Tachibana, Y				Nakamura, Tetsu; Hara, Masayuki; Oshika, Miki; Tachibana, Yoshihiro			Impact of the winter North Atlantic Oscillation (NAO) on the Western Pacific (WP) pattern in the following winter through Arctic sea ice and ENSO. Part II: multi-model evaluation of the NAO-ENSO linkage	CLIMATE DYNAMICS			English	Article						ENSO; Multi-model ensemble analysis; NAO; WP	NINO-SOUTHERN-OSCILLATION; MADDEN-JULIAN OSCILLATION; EL-NINO; SURFACE TEMPERATURE; TROPICAL ATLANTIC; WIND BURSTS; GEOPOTENTIAL HEIGHT; SUMMER CLIMATE; IPCC AR4; VARIABILITY	A 1-year-lagged relationship between the North Atlantic Oscillation (NAO) in winter and El Nio/Southern Oscillation (ENSO) in the following year was examined with a multi-model ensemble analysis using Coupled Model Intercomparison Project phase 3 models. A coherency index was developed as a measure of the coherence between the NAO and ENSO in each model and used as a weighting factor in the ensemble model. Weighted multi-model ensemble means of the regressed field on the maximum covariance analysis coefficients between the surface pressure field in the North Atlantic (NAO field) and the sea surface temperature field in the equatorial Pacific (ENSO field) were explored. The results indicated that when the wintertime NAO was in its negative (positive) phase, anomalous atmospheric circulation associated with a large (small) Eurasian snow mass anomaly intensified (weakened) the Asian cold surge and the westerly wind burst (WWB) in the warm pool region. Intensification of the WWB initiates El Nio. A sensitivity experiment using an idealized dry general circulation model revealed that the atmospheric response to anomalous, near-surface cooling associated with an anomalous Eurasian snow mass induced higher surface pressure near the Tibetan plateau and thus intensified the Asian cold surge and WWB. Linear regression analyses applied to the reanalysis data strongly supported the model results. Our results therefore suggest an influence of the NAO on the initiation of El Nio via a process that involves Eurasian snow anomalies associated with the NAO phase.	[Nakamura, Tetsu] Natl Inst Polar Res, Tachikawa, Tokyo, Japan; [Nakamura, Tetsu] Hokkaido Univ, Sapporo, Hokkaido, Japan; [Hara, Masayuki] Japan Agcy Marine Earth Sci & Technol, Yokohama, Kanagawa, Japan; [Oshika, Miki; Tachibana, Yoshihiro] Mie Univ, Grad Sch Bioresources, Climate & Ecosyst Dynam Div, Tsu, Mie 514, Japan	Tachibana, Y (reprint author), Mie Univ, Grad Sch Bioresources, Climate & Ecosyst Dynam Div, Tsu, Mie 514, Japan.	tachi@bio.mie-u.ac.jp			"Green Network of Excellence" Program (GRENE Program) of the Arctic Climate Change Research Project; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)	We thank K. Yamazaki and J. Ukita for their useful discussions. We also thank three anonymous reviewers for their valuable remarks to improve the quality of the paper. We acknowledge the modeling groups, the Program for Climate Model Diagnosis and Intercomparison (PCMDI) and the WCRP's Working Group on Coupled Modeling (WGCM), for their roles in making available the WCRP CMIP3 multi-model dataset. Support of this dataset is provided by the Office of Science, U.S. Department of Energy. The NLBM we used was provided by M. Watanabe (Atmospheric and Ocean Research Institute, the University of Tokyo). This study was supported by the "Green Network of Excellence" Program (GRENE Program) of the Arctic Climate Change Research Project and Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through a Grant-in-Aid for Scientific Research in Innovative Areas 2205.	LAU NC, 1984, J ATMOS SCI, V41, P313, DOI 10.1175/1520-0469(1984)041<0313:TEFOTT>2.0.CO;2; Nakamura T, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031220; Nakamura T, 2006, GEOPHYS RES LETT, V33, DOI [10.1029/2006GL025719, 10.1029/2006GL026318]; BARNETT TP, 1989, J ATMOS SCI, V46, P661, DOI 10.1175/1520-0469(1989)046<0661:TEOESC>2.0.CO;2; Yu LA, 1998, GEOPHYS RES LETT, V25, P3537, DOI 10.1029/98GL02628; Ohba M, 2010, J CLIMATE, V23, P6051, DOI 10.1175/2010JCLI3608.1; Zavala-Garay J, 2005, J CLIMATE, V18, P2441, DOI 10.1175/JCLI3408.1; Yasui S, 2010, J CLIMATE, V23, P2093, DOI 10.1175/2009JCLI3323.1; Wang X, 2011, CLIM DYNAM, V37, P663, DOI 10.1007/s00382-010-0833-z; Ham YG, 2013, NAT GEOSCI, V6, P112, DOI [10.1038/ngeo1686, 10.1038/NGEO1686]; GIESE BS, 1990, J GEOPHYS RES-OCEANS, V95, P7289, DOI 10.1029/JC095iC05p07289; Chen SF, 2014, CLIM DYNAM, V42, P973, DOI 10.1007/s00382-012-1654-z; Stoner AMK, 2009, J CLIMATE, V22, P4348, DOI 10.1175/2009JCLI2577.1; Klein SA, 1999, J CLIMATE, V12, P917, DOI 10.1175/1520-0442(1999)012<0917:RSSTVD>2.0.CO;2; Scaife AA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023226; Cordero EC, 2006, ATMOS CHEM PHYS, V6, P5369; Hori ME, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018103; Kosaka Y, 2012, J CLIMATE, V25, P7574, DOI [10.1175/JCLI-D-12-00009.1, 10.1175/JCLI-D-12-00009.-1]; Cagnazzo C, 2009, J CLIMATE, V22, P1223, DOI 10.1175/2008JCLI2549.1; Yu LS, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001498; YASUNARI T, 1987, J METEOROL SOC JPN, V65, P81; Peings Y, 2010, CLIM DYNAM, V34, P643, DOI 10.1007/s00382-009-0565-0; GILL AE, 1980, Q J ROY METEOR SOC, V106, P447, DOI 10.1256/smsqj.44904; Hung MP, 2013, J CLIMATE, V26, P6185, DOI 10.1175/JCLI-D-12-00541.1; HOREL JD, 1981, MON WEATHER REV, V109, P813, DOI 10.1175/1520-0493(1981)109<0813:PSAPAW>2.0.CO;2; Takaya K, 2001, J ATMOS SCI, V58, P608, DOI 10.1175/1520-0469(2001)058<0608:AFOAPI>2.0.CO;2; Xie SP, 2009, J CLIMATE, V22, P730, DOI 10.1175/2008JCLI2544.1; YASUNARI T, 1991, J METEOROL SOC JPN, V69, P473; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; Cassou C, 2008, NATURE, V455, P523, DOI 10.1038/nature07286; Saravanan R, 2000, J CLIMATE, V13, P2177, DOI 10.1175/1520-0442(2000)013<2177:IBTAVA>2.0.CO;2; WALLACE JM, 1981, MON WEATHER REV, V109, P784, DOI 10.1175/1520-0493(1981)109<0784:TITGHF>2.0.CO;2; Seiki A, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015039; Lin JL, 2006, J CLIMATE, V19, P2665, DOI 10.1175/JCLI3735.1; Roesch A, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006473; LAU NC, 1991, J ATMOS SCI, V48, P2589, DOI 10.1175/1520-0469(1991)048<2589:VOTBAB>2.0.CO;2; Lin H, 2009, J CLIMATE, V22, P364, DOI 10.1175/2008JCLI2515.1; Chung C, 1999, J GEOPHYS RES, V16, P925; Enfield DB, 1997, J GEOPHYS RES-OCEANS, V102, P929, DOI 10.1029/96JC03296; Handorf D, 2012, TELLUS A, V64, DOI 10.3402/tellusa.v64i0.19777; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; KINDLE JC, 1995, J GEOPHYS RES-OCEANS, V100, P4893, DOI 10.1029/94JC02392; Matsuno T., 1966, J METEOR SOC JAPAN, V44, P25; Meehl GA, 2007, CLIMATE CHANGE 2007, P748; Oshika M, 2015, CLIM DYNAM, V45, P1355, DOI 10.1007/s00382-014-2384-1; PHILANDER SGH, 1985, J ATMOS SCI, V42, P2652, DOI 10.1175/1520-0469(1985)042<2652:ENALN>2.0.CO;2; Randall DA, 2007, CLIMATE CHANGE 2007, P590; Von Storch H., 1999, STAT ANAL CLIMATE RE	49	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-7575	1432-0894		CLIM DYNAM	Clim. Dyn.	DEC	2015	45	11-12					3547	3562		10.1007/s00382-015-2556-7		16	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CX0WU	WOS:000365418900035		
J	Poudel, A; Asahina, M; Fujinuma, Y; Yamanaka, Y; Katagiri, A; Araki, N; Hirano, S; Kuwabara, S				Poudel, Anupama; Asahina, Masato; Fujinuma, Yoshikatsu; Yamanaka, Yoshitaka; Katagiri, Akira; Araki, Nobuyuki; Hirano, Shigeki; Kuwabara, Satoshi			Skin sympathetic function in complex regional pain syndrome type 1	CLINICAL AUTONOMIC RESEARCH			English	Article						Complex regional pain syndrome; Sweating; Vasomotor system; Autonomic nervous system; Skin sympathetic function	GENE-RELATED PEPTIDE; SUBSTANCE-P; DYSTROPHY; NEUROPEPTIDES; SUDOMOTOR; NERVE; LIMBS; CRPS	Purpose Cutaneous sympathetic pathophysiology in complex regional pain syndrome type 1 (CRPS-1) is not yet completely understood. To evaluate cutaneous sympathetic dysfunction in CRPS-1, we evaluated sympathetic sweat response (SSwR) and skin vasomotor reflex (SkVR) in CRPS-1 patients. Methods We studied 10 CRPS-1 patients (age 41 +/- A 13 years; 5 females and 5 males; disease duration 20 +/- A 22 months) and 10 healthy subjects (age 44 +/- A 13 years; 3 females and 7 males). SkVRs and SSwRs to several sympathetic activating procedures were recorded on the palms of the CRPS-1 patients (affected side) and controls (right side). Results There were no significant differences in the baselines of sweat output and skin blood flow between the CRPS-1 and control groups. SSwR and SkVR amplitudes were significantly lower in the CRPS-1 group than in the control group. There was no significant correlation between disease duration and SSwR or SkVR amplitudes among the patients. Conclusions The reduced SSwRs and SkVRs in the affected limb of our CRPS-1 patients may reflect underlying damage to the sympathetic postganglionic fibres.	[Poudel, Anupama; Asahina, Masato; Fujinuma, Yoshikatsu; Yamanaka, Yoshitaka; Katagiri, Akira; Araki, Nobuyuki; Hirano, Shigeki; Kuwabara, Satoshi] Chiba Univ, Grad Sch Med, Dept Neurol, Chuo Ku, Chiba 2608670, Japan	Asahina, M (reprint author), Chiba Univ, Grad Sch Med, Dept Neurol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	anupamauprety@yahoo.com; asahina@faculty.chiba-u.jp					Schlereth T, 2006, J PHYSIOL-LONDON, V576, P823, DOI 10.1113/jphysiol.2006.116111; DRORY VE, 1995, J NEUROL SCI, V128, P92, DOI 10.1016/0022-510X(94)00210-F; Vetrugno R, 2003, CLIN AUTON RES, V13, P256, DOI 10.1007/s10286-003-0107-5; Asahina M, 2003, CLIN AUTON RES, V13, P91, DOI 10.1007/s10286-003-0072-z; Birklein F, 1997, PAIN, V69, P49, DOI 10.1016/S0304-3959(96)03242-3; Albrecht PJ, 2006, PAIN, V120, P244, DOI 10.1016/j.pain.2005.10.035; Kumazawa K, 1994, Clin Auton Res, V4, P319, DOI 10.1007/BF01821532; Bruehl S, 1999, PAIN, V81, P147, DOI 10.1016/S0304-3959(99)00011-1; BERG TJ, 1995, CLIN AUTON RES, V5, P159, DOI 10.1007/BF01826199; Schinkel C, 2006, CLIN J PAIN, V22, P235, DOI 10.1097/01.ajp.0000169669.70523.f0; Marinus J, 2011, LANCET NEUROL, V10, P637, DOI 10.1016/S1474-4422(11)70106-5; Birklein F, 2001, NEUROLOGY, V57, P2179; HARDEN RN, 1994, CLIN J PAIN, V10, P324, DOI 10.1097/00002508-199412000-00014; Clinchot DM, 1996, AM J PHYS MED REHAB, V75, P252, DOI 10.1097/00002060-199607000-00002; Wasner G, 1999, ARCH NEUROL-CHICAGO, V56, P613, DOI 10.1001/archneur.56.5.613; ROMMEL O, 1995, CLIN AUTON RES, V5, P205, DOI 10.1007/BF01824008; Zancanaro C, 1999, NEUROREPORT, V10, P2023, DOI 10.1097/00001756-199907130-00006; ISHIDAYAMAMOTO A, 1990, CELL TISSUE RES, V260, P621, DOI 10.1007/BF00297243; Akaogi Y, 2009, NEUROLOGY, V73, P59, DOI 10.1212/WNL.0b013e3181aae83c; Birklein F, 2008, NEUROSCI LETT, V437, P199, DOI 10.1016/j.neulet.2008.03.081; LINDH B, 1989, NEUROSCI LETT, V107, P1, DOI 10.1016/0304-3940(89)90781-7; van der Laan L, 1998, NEUROLOGY, V51, P20; Oklander AL, 2009, ANN NEUROL, V65, P629, DOI [10.1002/ana.21692, DOI 10.1002/ANA.21692]	23	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0959-9851	1619-1560		CLIN AUTON RES	Clin. Auton. Res.	DEC	2015	25	6					367	371		10.1007/s10286-015-0314-x		5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CX5LE	WOS:000365742300004		
J	Iwamoto, Y; Mitsudomi, T; Sakai, K; Yamanaka, T; Yoshioka, H; Takahama, M; Yoshimura, M; Yoshino, I; Takeda, M; Sugawara, S; Kawaguchi, T; Takahashi, T; Ohta, M; Ichinose, Y; Atagi, S; Okada, M; Saka, H; Nakagawa, K; Nakanishi, Y; Nishio, K				Iwamoto, Yasuo; Mitsudomi, Tetsuya; Sakai, Kazuko; Yamanaka, Takeharu; Yoshioka, Hiroshige; Takahama, Makoto; Yoshimura, Masahiro; Yoshino, Ichiro; Takeda, Masayuki; Sugawara, Shunichi; Kawaguchi, Tomoya; Takahashi, Toshiaki; Ohta, Mitsunori; Ichinose, Yukito; Atagi, Shinji; Okada, Morihito; Saka, Hideo; Nakagawa, Kazuhiko; Nakanishi, Yoichi; Nishio, Kazuto			Randomized Phase II Study of Adjuvant Chemotherapy with Long-term S-1 versus Cisplatin+S-1 in Completely Resected Stage II-IIIA Non-Small Cell Lung Cancer	CLINICAL CANCER RESEARCH			English	Article							VINORELBINE PLUS CISPLATIN; 5-FLUOROURACIL; EXPRESSION; EFFICACY; TEGAFUR; URACIL; TRIAL; TRANSFERASE	Purpose: The aims of this study were to evaluate the efficacy and safety of S-1 versus cisplatin (CDDP)+S-1 in patients with completely resected stage II and IIIA non-small cell lung cancer, and to identify predictive biomarkers whose expression in the tumors was significantly associated with patient outcome. Experimental Design: A total of 200 patients were randomly assigned to receive either S-1 (40 mg/m(2) twice per day) for 2 consecutive weeks repeated every 3 weeks for 1 year (S group) or CDDP (60 mg/m2) on day 1 plus oral S-1 (40 mg/m2 twice per day) for 2 consecutive weeks repeated every 3 weeks for four cycles (CS group) within 8 weeks after surgery. The primary endpoints were relapse-free survival (RFS) at 2 years and identification of predictive biomarkers whose expressions have been reported to be associated with CDDP or fluoropyrimidine sensitivity. Results: The RFS rate at 2 years was 65.6% (95% confidence intervals; CI, 55.3-74.0%) in the S group and 58.1% (95% CI, 47.7-67.2%) in the CS group. The only gene with interaction of P < 0.05 was uridine monophosphate synthase (UMPS; P = 0.0348). The benefit that members of the S group had over members of the CS group was higher expression of UMPS. In vitro and in vivo experiments confirmed that overexpression of UMPS enhanced the antitumor effect of fluoropyrimidine. Conclusions: Adjuvant S-1 monotherapy might be preferable to CDDP+S-1 for patients with completely resected NSCLC. UMPS expression may define a patient subset that would benefit from long-term postoperative S-1 monotherapy. (C) 2015 AACR.	[Iwamoto, Yasuo] Hiroshima City Hosp, Dept Med Oncol, Hiroshima, Japan; [Mitsudomi, Tetsuya] Kinki Univ, Fac Med, Dept Thorac Surg, Osakasayama, Japan; [Sakai, Kazuko; Nishio, Kazuto] Kinki Univ, Fac Med, Dept Genome Biol, Osakasayama, Japan; [Yamanaka, Takeharu] Yokohama City Univ, Dept Biostat, Yokohama, Kanagawa 232, Japan; [Yoshioka, Hiroshige] Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama, Japan; [Takahama, Makoto] Osaka City Gen Hosp, Dept Gen Thorac Surg, Osaka, Japan; [Yoshimura, Masahiro] Hyogo Canc Ctr, Dept Thorac Surg, Akashi, Hyogo, Japan; [Yoshino, Ichiro] Chiba Univ, Grad Sch Med, Dept Gen Thorac Surg, Chiba, Japan; [Takeda, Masayuki; Nakagawa, Kazuhiko] Kinki Univ, Fac Med, Dept Med Oncol, Osakasayama, Japan; [Sugawara, Shunichi] Sendai Kousei Hosp, Dept Pulm Med, Sendai, Miyagi, Japan; [Kawaguchi, Tomoya] Osaka City Univ, Grad Sch Med, Dept Resp Med, Osaka 558, Japan; [Takahashi, Toshiaki] Shizuoka Canc Ctr, Div Thorac Oncol, Shuntougun, Japan; [Ohta, Mitsunori] Osaka Prefectural Med Ctr Resp & Allerg Dis, Dept Thorac Surg, Habikino, Japan; [Ichinose, Yukito] Kyushu Natl Canc Ctr, Clin Res Inst, Fukuoka, Japan; [Atagi, Shinji] Kinki Chuo Chest Med Ctr, Dept Thorac Oncol, Sakai, Osaka, Japan; [Okada, Morihito] Hiroshima Univ, Grad Sch Med, Dept Surg Oncol, Hiroshima, Japan; [Saka, Hideo] Nagoya Med Ctr, Natl Hosp Org, Dept Med Oncol, Nagoya, Aichi, Japan; [Nakanishi, Yoichi] Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka 812, Japan	Mitsudomi, T (reprint author), Kinki Univ, Fac Med, Dept Thorac Surg, 377-2 Ohno Higashi, Osaka 5898511, Japan.	mitsudom@surg.med.kindai.ac.jp			West Japan Oncology Group	This work was supported by the West Japan Oncology Group.	Ichinose Y, 2004, CLIN CANCER RES, V10, P7860, DOI 10.1158/1078-0432.CCR-04-1200; Friboulet L, 2013, NEW ENGL J MED, V368, P1101, DOI [10.1056/NEJMoa1214271, 10.1056/oa1214271]; Nio Y, 2007, ONCOL REP, V18, P59; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Fukushima M, 1998, INT J ONCOL, V13, P693; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Takeda M, 2011, LUNG CANCER, V73, P103, DOI 10.1016/j.lungcan.2010.10.022; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc.1074; Nakano J, 2006, BRIT J CANCER, V95, P607, DOI 10.1038/sj.bjc.6603297; Wada H, 1996, J CLIN ONCOL, V14, P1048; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Hamada C, 2005, J CLIN ONCOL, V23, P4999, DOI 10.1200/JCO.2005.09.017; Sakamoto E, 2007, BIOCHEM BIOPH RES CO, V363, P216, DOI 10.1016/j.bbrc.2007.08.164; SKIPPER HE, 1970, CANCER CHEMOTH REP 1, V54, P431; Asamura H, 2008, J THORAC ONCOL, V3, P46, DOI 10.1097/JTO.0b013e31815e8577; Goto S, 1999, FREE RADICAL RES, V31, P549, DOI 10.1080/10715769900301121; Ichikawa W, 2006, CLIN CANCER RES, V12, P3928, DOI 10.1158/1078-0432.CCR-05-2665; WILKOFF LJ, 1967, J NATL CANCER I, V39, P965; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Kato H, 2004, NEW ENGL J MED, V350, P1713, DOI 10.1056/NEJMoa032792; Shirasaka T, 1996, CANCER RES, V56, P2602; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351; Katakami N, 2002, J CLIN ONCOL S, V30; Shimoyama M, 1973, SAISHIN IGAKU, V28, P1024; TATSUMI K, 1987, JPN J CANCER RES, V78, P748	25	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1078-0432	1557-3265		CLIN CANCER RES	Clin. Cancer Res.	DEC 1	2015	21	23					5245	5252		10.1158/1078-0432.CCR-14-3160		8	Oncology	Oncology	CX3MT	WOS:000365603800010		
J	Kobayashi, Y; Togashi, Y; Yatabe, Y; Mizuuchi, H; Jangchul, P; Kondo, C; Shimoji, M; Sato, K; Suda, K; Tomizawa, K; Takemoto, T; Hida, T; Nishio, K; Mitsudomi, T				Kobayashi, Yoshihisa; Togashi, Yosuke; Yatabe, Yasushi; Mizuuchi, Hiroshi; Jangchul, Park; Kondo, Chiaki; Shimoji, Masaki; Sato, Katsuaki; Suda, Kenichi; Tomizawa, Kenji; Takemoto, Toshiki; Hida, Toyoaki; Nishio, Kazuto; Mitsudomi, Tetsuya			EGFR Exon 18 Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib or Neratinib as Compared with First- or Third-Generation TKIs	CLINICAL CANCER RESEARCH			English	Article							RANDOMIZED PHASE-3 TRIAL; FACTOR-RECEPTOR GENE; 1ST-LINE TREATMENT; OPEN-LABEL; GEFITINIB TREATMENT; TREATMENT RESPONSE; GASTRIC-CANCER; ASIAN PATIENTS; INHIBITOR; ADENOCARCINOMA	Purpose: Lung cancers harboring common EGFR mutations respond to EGFR tyrosine kinase inhibitors (TKI), whereas exon 20 insertions (Ins20) are resistant to them. However, little is known about mutations in exon 18. Experimental Design: Mutational status of lung cancers between 2001 and 2015 was reviewed. Three representative mutations in exon 18, G719A, E709K, and exon 18 deletion (Del18: delE709_T710insD) were retrovirally introduced into Ba/F3 and NIH/3T3 cells. The 90% inhibitory concentrations (IC(90)s) of first-generation (1G; gefitinib and erlotinib), second-generation (2G; afatinib, dacomitinib, and neratinib), and third-generation TKIs (3G; AZD9291 and CO1686) were determined. Results: Among 1,402 EGFR mutations, Del19, L858R, and Ins20 were detected in 40%, 47%, and 4%, respectively. Exon 18 mutations, including G719X, E709X, and Del18, were present in 3.2%. Transfected Ba/F3 cells grew in the absence of IL3, and NIH/3T3 cells formed foci with marked pile-up, indicating their oncogenic abilities. IC(90)s of 1G and 3G TKIs in G719A, E709K, and Del18 were much higher than those in Del19 (by > 11-50-fold), whereas IC(90)s of afatinib were only 3- to 7-fold greater than those for Del19. Notably, cells transfected with G719A and E709K exhibited higher sensitivity to neratinib (by 5-25-fold) than those expressing Del19. Patients with lung cancers harboring G719X exhibited higher response rate to afatinib or neratinib (similar to 80%) than to 1G TKIs (35%-56%) by compilation of data in the literature. Conclusions: Lung cancers harboring exon 18 mutations should not be overlooked in clinical practice. These cases can be best treated with afatinib or neratinib, although the currently available in vitro diagnostic kits cannot detect all exon 18 mutations. (C) 2015 AACR.	[Kobayashi, Yoshihisa; Mizuuchi, Hiroshi; Shimoji, Masaki; Sato, Katsuaki; Suda, Kenichi; Tomizawa, Kenji; Takemoto, Toshiki; Mitsudomi, Tetsuya] Kinki Univ, Fac Med, Dept Thorac Surg, Osaka 5898511, Japan; [Togashi, Yosuke; Nishio, Kazuto] Kinki Univ, Fac Med, Dept Genome Biol, Osaka 5898511, Japan; [Yatabe, Yasushi; Kondo, Chiaki] Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi 464, Japan; [Mizuuchi, Hiroshi] Kitakyushu Municipal Med Ctr, Dept Thorac Surg, Kitakyushu, Fukuoka, Japan; [Jangchul, Park; Hida, Toyoaki] Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi 464, Japan; [Jangchul, Park] Nagoya City East Med Ctr, Dept Resp Med, Nagoya, Aichi, Japan	Mitsudomi, T (reprint author), Kinki Univ, Fac Med, Dept Thorac Surg, 377-2 Ohno Higashi, Osaka 5898511, Japan.	mitsudom@surg.med.kindai.ac.jp			Japan Society for the Promotion of Science; Uehara Memorial Foundation; Takeda Science Foundation; Boehringer-Ingelheim	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to Y. Kobayashi), Uehara Memorial Foundation, Takeda Science Foundation, and research grant from Boehringer-Ingelheim (to T. Mitsudomi).	Wu JY, 2008, CLIN CANCER RES, V14, P4877, DOI 10.1158/1078-0432.CCR-07-5123; Yatabe Y, 2006, J MOL DIAGN, V8, P335, DOI 10.2353/jmoldx.2006.050104; Janne PA, 2011, CLIN CANCER RES, V17, P1131, DOI 10.1158/1078-0432.CCR-10-1220; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Yatabe Y, 2011, J CLIN ONCOL, V29, P2972, DOI 10.1200/JCO.2010.33.3906; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Tanaka K, 2009, INT J CANCER, V124, P1072, DOI 10.1002/ijc.24065; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Chiu CH, 2015, J THORAC ONCOL, V10, P793, DOI 10.1097/JTO.0000000000000504; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Yang JCH, 2015, LANCET ONCOL, V16, P830, DOI 10.1016/S1470-2045(15)00026-1; Sequist LV, 2015, NEW ENGL J MED, V372, P1700, DOI 10.1056/NEJMoa1413654; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Wu JY, 2011, CLIN CANCER RES, V17, P3812, DOI 10.1158/1078-0432.CCR-10-3408; Ackerman A, 2012, J THORAC ONCOL, V7, pE19, DOI 10.1097/JTO.0b013e3182635ab4; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Sequist LV, 2010, J CLIN ONCOL, V28, P3076, DOI 10.1200/JCO.2009.27.9414; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Nakagawa K, 2003, ANN ONCOL, V14, P922, DOI 10.1093/annonc/mdg250; Yap TA, 2010, J CLIN ONCOL, V28, P3965, DOI 10.1200/JCO.2009.26.7278; Drilon A, 2015, CLIN CANC R IN PRESS; Gow CH, 2005, PLOS MED, V2, P924, DOI 10.1371/journal.pmed.0020269; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; HidalgoM Siu LL, 2001, J CLIN ONCOL, V19, P3267; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Shi Y, 2014, J THORAC ONCOL, V9, P154, DOI 10.1097/JTO.0000000000000033; Sogabe S, 2014, MOL CANCER THER, V13, P3098, DOI 10.1158/1535-7163.MCT-14-0429; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Yasuda H, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007205; Yatabe Y, 2015, J THORAC ONCOL, V10, P438, DOI 10.1097/JTO.0000000000000422	35	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1078-0432	1557-3265		CLIN CANCER RES	Clin. Cancer Res.	DEC 1	2015	21	23					5305	5313		10.1158/1078-0432.CCR-15-1046		9	Oncology	Oncology	CX3MT	WOS:000365603800016		
J	Sadahiro, S; Morita, S; Sasaki, K; Sakamoto, K; Ohge, H; Takahashi, T; Tsuchiya, T; Sato, T; Kondo, K; Ogata, Y; Masuko, H; Baba, H; Maeda, K; Hamada, M; Itabashi, M; Nishimura, G; Takahashi, K; Ikeda, M; Taguri, M; Kodaira, S				Sadahiro, Sotaro; Morita, Satoshi; Sasaki, Kazuaki; Sakamoto, Kazuhiro; Ohge, Hiroki; Takahashi, Takao; Tsuchiya, Takashi; Sato, Toshihiko; Kondo, Ken; Ogata, Yutaka; Masuko, Hiroyuki; Baba, Hideo; Maeda, Kiyoshi; Hamada, Madoka; Itabashi, Michio; Nishimura, Genichi; Takahashi, Keiichi; Ikeda, Masataka; Taguri, Masataka; Kodaira, Susumu			Treatment Rationale and Study Design for Clinical Trial on the Efficacy of UFT/LV for Stage II Colorectal Cancer With Risk Factors for Recurrence (JFMC46-1201)	CLINICAL COLORECTAL CANCER			English	Article						Adjuvant chemotherapy; High-risk stage II; Propensity score matching; Treatment duration; UFT/Leucovorin	TEGAFUR PLUS LEUCOVORIN; COLON-CANCER; INTRAVENOUS FLUOROURACIL; ADJUVANT CHEMOTHERAPY; ORAL URACIL; RECOMMENDATIONS; CELLS	Background: The usefulness of adjuvant chemotherapy for stage II colon cancer has not been established. Meanwhile, the presence of stage II colon cancer with high-risk factors for recurrence has been reported. To our knowledge, no prospective study of adjuvant chemotherapy for stage II colon cancer with high-risk factors has been implemented to date. Patients and Methods: This study is a prospective nonrandomized controlled study based on patients' selection of treatment option, including randomized therapeutic decision-making, to evaluate the usefulness of adjuvant chemotherapy with tegafur-uracil (UFT) with leucovorin (LV) for stage II colon cancer with high-risk factors for recurrence, compared with surgery alone. Five courses of UFT/LV therapy will be given as follows: UFT (300 mg/m(2)/d) with LV (75 mg/d) will be orally administered in 3 doses per day. Treatment will be received daily for 28 days, followed by a 7-day rest or will be received daily for 5 days, followed by a 2-day rest. For both regimens, 1 course will last 5 weeks, and 5 courses will be given. The primary end point is disease-free survival. A propensity score matching will be conducted based on 7 variables that represent risk factors to minimize selection bias in a comparison between the nonrandomized arms. For this nonrandomized comparison, a target sample size is set at 1200 (400 and 800 patients for the surgery alone and UFT/LV groups, respectively) and 1720 patients will be enrolled. In this study we aim to evaluate the therapeutic usefulness of adjuvant chemotherapy with UFT/LV for stage II colorectal cancer with risk factors for recurrence. (C) 2015 The Authors. Published by Elsevier Inc.	[Sadahiro, Sotaro] Tokai Univ, Dept Surg, Isehara, Kanagawa 2591193, Japan; [Morita, Satoshi] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan; [Sasaki, Kazuaki] Otaru Ekisaikai Hosp, Dept Surg, Otaru, Hokkaido, Japan; [Sakamoto, Kazuhiro] Juntendo Univ, Sch Med, Dept Coloproctol Surg, Tokyo 113, Japan; [Ohge, Hiroki] Hiroshima Univ Hosp, Dept Infect Dis, Hiroshima, Japan; [Takahashi, Takao] Gifu Univ, Sch Med, Dept Surg Oncol, Gifu 500, Japan; [Tsuchiya, Takashi] Sendai City Med Ctr, Dept Surg, Sendai, Miyagi, Japan; [Sato, Toshihiko] Yamagata Prefectural Cent Hosp, Dept Surg, Yamagata, Japan; [Kondo, Ken] Nagoya Med Ctr, Dept Surg, Nagoya, Aichi, Japan; [Ogata, Yutaka] Kurume Univ, Sch Med, Dept Surg, Fukuoka, Japan; [Masuko, Hiroyuki] Hokkaido Sapporo Kosei Hosp, Dept Surg, Sapporo, Hokkaido, Japan; [Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Gastroenterol Surg, Kumamoto, Japan; [Maeda, Kiyoshi] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan; [Hamada, Madoka] Kansai Med Univ, Hirakata Hosp, Dept Gastrointestinal Surg, Osaka, Japan; [Itabashi, Michio] Tokyo Womens Med Coll, Dept Surg 2, Tokyo 162, Japan; [Nishimura, Genichi] Japanese Red Cross Kanazawa Hosp, Dept Surg, Kanazawa, Ishikawa, Japan; [Takahashi, Keiichi] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Surg, Tokyo, Japan; [Ikeda, Masataka] Osaka Natl Hosp, Natl Hosp Org, Osaka, Japan; [Taguri, Masataka] Yokohama City Univ, Grad Sch Med, Dept Biostat, Yokohama, Kanagawa 232, Japan; [Kodaira, Susumu] Nerima Gen Hosp, Tokyo, Japan	Sadahiro, S (reprint author), Tokai Univ, Dept Surg, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	sadahiro@is.icc.u-tokai.ac.jp			Japanese Foundation for Multidisciplinary Treatment of Cancer (JFMC); Taiho Pharmaceutical Co Ltd, Japan [JFMC 46-1201]	This study was sponsored by the Japanese Foundation for Multidisciplinary Treatment of Cancer (JFMC) with funding from Taiho Pharmaceutical Co Ltd, Japan, under the research contract (JFMC 46-1201). The funding source has no role in the study design, data collection, analysis and interpretation, or decision to submit results for presentation or publication other than providing information on the efficacy and safety of UFT/LV. We thank Mitsuo Kusano, Ichinosuke Hyodo, and Junichi Sakamoto for their work on the Independent Data Monitoring Committee.	ANDRE T, 2004, NEW ENGL J MED, V350, P2343, DOI DOI 10.1056/NEJM0A032709; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Sadahiro S, 2007, ANN SURG ONCOL, V14, P1092, DOI 10.1245/s10434-006-9289-0; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Lembersky BC, 2006, J CLIN ONCOL, V24, P2059, DOI 10.1200/JCO.2005.04.7498; Peach G, 2010, BRIT J CANCER, V102, P1327, DOI 10.1038/sj.bjc.6605651; Shimada Y, 2014, EUR J CANCER, V50, P2231, DOI 10.1016/j.ejca.2014.05.025; Van Cutsem EJD, 2008, ANN ONCOL, V19, P29, DOI 10.1093/annonc/mdn077; Erlichman C, 1999, J CLIN ONCOL, V17, P1356; National Comprehensive Cancer Network, 2011, NCCN CLIN PRACT GUID; Sakamoto Junichi, 2004, J Clin Oncol, V22, P484	14	0	0	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1533-0028	1938-0674		CLIN COLORECTAL CANC	Clin. Colorectal Canc.	DEC	2015	14	4					277	280		10.1016/j.clcc.2015.05.004		4	Oncology	Oncology	CX3XX	WOS:000365633900008		
J	Tani, S; Nagao, K; Hirayama, A				Tani, Shigemasa; Nagao, Ken; Hirayama, Atsushi			Effect of Febuxostat, a Xanthine Oxidase Inhibitor, on Cardiovascular Risk in Hyperuricemic Patients with Hypertension: A Prospective, Open-label, Pilot Study	CLINICAL DRUG INVESTIGATION			English	Article							SERUM URIC-ACID; CHRONIC KIDNEY-DISEASE; RENIN-ANGIOTENSIN SYSTEM; BLOOD-PRESSURE; GLOMERULAR HYPERTENSION; MILD HYPERURICEMIA; INDEPENDENT MECHANISM; METABOLIC SYNDROME; RENAL-FUNCTION; ALLOPURINOL	Background and Objective There is growing evidence of an association between high uric acid (UA) levels and cardiovascular disease (CVD). We hypothesized that febuxostat, a xanthine oxidase inhibitor, may be associated with suppressing the renin-angiotensin-aldosterone system (RAAS) and improving renal function in hyperurecemic patients with hypertension. Methods We conducted a 6-month prospective study in which we randomized hypertensive hyperuricemic patients to either a febuxostat group (n = 30) or a control group (n = 30). The dose of febuxostat was adjusted to maintain the serum UA level at <6.0 mg/dL. Results In the febuxostat group, the plasma renin activity (PRA), plasma aldosterone concentration (PAC), and serum UA level significantly decreased by 33 % (p = 0.0012), 14 % (p = 0.001), and 29 % (p < 0.0001), respectively. The estimated glomerular filtration rate (eGFR) significantly increased by 5.5 % (p = 0.001). Similar changes were not observed in the control group. Furthermore, a significant correlation was observed between the percent changes in the serum UA levels and the percent changes in the PRA (r = 0.277, p = 0.033), PAC (r = 0.310, p = 0.016), serum blood urea nitrogen levels (r = 0.434, p = 0.0005), serum creatinine levels (r = 0.413, p = 0.002), and eGFR (r = -0.474, p = 0.0001). Conclusions These results support the hypothesis that febuxostat might not only reduce serum UA levels but also suppress RAAS and improve renal function in hyperuricemic patients with hypertension, possibly leading to prevention of CVD.	[Tani, Shigemasa] Nihon Univ Hosp, Dept Hlth, Planning Ctr, Chiyoda Ku, Tokyo 1018309, Japan; [Tani, Shigemasa; Nagao, Ken; Hirayama, Atsushi] Nihon Univ, Sch Med, Div Cardiol, Dept Med, Tokyo, Japan	Tani, S (reprint author), Nihon Univ Hosp, Dept Hlth, Planning Ctr, Chiyoda Ku, 1-6 Kanda Surugadai, Tokyo 1018309, Japan.	tani.shigemasa@nihon-u.ac.jp					Chen J, 2004, ANN INTERN MED, V140, P167; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Malik UZ, 2011, FREE RADICAL BIO MED, V51, P179, DOI 10.1016/j.freeradbiomed.2011.04.004; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feig DI, 2008, JAMA-J AM MED ASSOC, V300, P924, DOI 10.1001/jama.300.8.924; Maejima I, 2013, EMBO J, V32, P2336, DOI 10.1038/emboj.2013.171; Ripley E, 2009, AM HEART J, V157, pS7, DOI 10.1016/j.ahj.2009.04.008; GRUSKIN AB, 1985, AM J KIDNEY DIS, V6, P86; Ye P, 2013, CLIN THER, V35, P180, DOI 10.1016/j.clinthera.2012.12.011; Talaat KM, 2007, AM J NEPHROL, V27, P435, DOI 10.1159/000105142; Whelton A, 2011, JCR-J CLIN RHEUMATOL, V17, P7, DOI 10.1097/RHU.0b013e318204aab4; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; Sanchez-Lozada LG, 2005, KIDNEY INT, V67, P237, DOI 10.1111/j.1523-1755.2005.00074.x; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Alderman MH, 1999, HYPERTENSION, V34, P144; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d; SAITO I, 1978, J AM GERIATR SOC, V26, P241; Kanbay M, 2007, INT UROL NEPHROL, V39, P1227, DOI 10.1007/s11255-007-9253-3; Verdecchia P, 2000, HYPERTENSION, V36, P1072; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Hoieggen A, 2004, KIDNEY INT, V65, P1041, DOI 10.1111/j.1523-1755.2004.00484.x; Soltani Z, 2013, CURR HYPERTENS REP, V15, P175, DOI 10.1007/s11906-013-0344-5; Zhang JX, 2014, J CLIN HYPERTENS, V16, P569, DOI 10.1111/jch.12353; Cohn JN, 2003, CIRCULATION, V108, P1306, DOI 10.1161/01.CIR.0000091234.45664.62; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Franse LV, 2000, J HYPERTENS, V18, P1149, DOI 10.1097/00004872-200018080-00021; Noman A, 2010, LANCET, V375, P2161, DOI 10.1016/S0140-6736(10)60391-1; Herlitz LC, 2012, ARCH PATHOL LAB MED, V136, P713, DOI 10.5858/arpa.2011-0565-RA; Krishnan E, 2009, CIRC-HEART FAIL, V2, P556, DOI 10.1161/CIRCHEARTFAILURE.108.797662; Sanchez-Lozada LG, 2002, AM J PHYSIOL-RENAL, V283, pF1105, DOI 10.1152/ajprenal.00170.2002; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Aroor AR, 2013, METABOLISM, V62, P1543, DOI 10.1016/j.metabol.2013.07.001; Hosoya T, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-26; Sanchez-Lozada LG, 2007, AM J PHYSIOL-RENAL, V292, pF423, DOI 10.1152/ajprenal.00124.2006; Agodoa L, 2007, J HYPERTENS, V25, P951	35	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1173-2563	1179-1918		CLIN DRUG INVEST	Clin. Drug Invest.	DEC	2015	35	12					823	831		10.1007/s40261-015-0349-8		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX2TR	WOS:000365550200006		
J	Sugimura, T; Jounai, K; Ohshio, K; Tanaka, T; Suwa, M; Fujiwara, D				Sugimura, Tetsu; Jounai, Kenta; Ohshio, Konomi; Tanaka, Takaaki; Suwa, Masahiro; Fujiwara, Daisuke			Immunomodulatory effect of Lactococcus lactis JCM5805 on human plasmacytoid dendritic cells (vol 149, pg 509, 2013)	CLINICAL IMMUNOLOGY			English	Correction									[Sugimura, Tetsu; Ohshio, Konomi; Fujiwara, Daisuke] Kirin Co Ltd, Cent Labs Key Technol, Yokohama, Kanagawa, Japan; [Jounai, Kenta; Suwa, Masahiro] Koiwai Dairy Prod Co Ltd, Tech Dev Ctr, Saitama, Japan; [Tanaka, Takaaki] Koiwai Dairy Prod Co Ltd, Prod Dev Dept, Tokyo, Japan	Sugimura, T (reprint author), Kirin Co Ltd, Cent Labs Key Technol, Yokohama, Kanagawa, Japan.	Tetsu_Sugimura@kirin.co.jp					Sugimura T, 2013, CLIN IMMUNOL, V149, P509, DOI 10.1016/j.clim.2013.10.007	1	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1521-6616	1521-7035		CLIN IMMUNOL	Clin. Immunol.	DEC	2015	161	2					156	156		10.1016/j.clim.2015.08.011		1	Immunology	Immunology	CX6SL	WOS:000365831600014		
J	Chujo, D; Nguyen, TS; Foucat, E; Blankenship, D; Banchereau, J; Nepom, GT; Chaussabel, D; Ueno, H				Chujo, Daisuke; Nguyen, Thien-Son; Foucat, Emile; Blankenship, Derek; Banchereau, Jacques; Nepom, Gerald T.; Chaussabel, Damien; Ueno, Hideki			Adult-onset type 1 diabetes patients display decreased IGRP-specific Tr1 cells in blood	CLINICAL IMMUNOLOGY			English	Article						Type 1 diabetes; CD4 T cells; Islet antigens; Islet-specific glucose 6 phosphatase catalytic subunit-related protein; T regulatory type 1 (Tr1) cells	GLUTAMIC-ACID DECARBOXYLASE; CD4(+) T-CELLS; SUBUNIT-RELATED PROTEIN; PRESERVES C-PEPTIDE; CLASS-II TETRAMERS; AT-RISK SUBJECTS; PROINSULIN PEPTIDES; PERIPHERAL-BLOOD; INSULIN; IDENTIFICATION	The breakdown of immune tolerance against islet antigens causes type 1 diabetes (T1D). The antigens associated with adult-onset T1D (AT1D) remain largely undefined. It is possible that AT1D patients display a unique type of CD4(+) T cells specific for a certain islet antigen. Here we analyzed the cytokine production profiles of CD4(+) helper T (Th) cells that are specific for three islet antigens; GAD65, preproinsulin, and IGRP in patients with AT1D, juvenile-onset T1D (JT1D), and age-, gender- and human leukocyte antigen (HLA)-matched control adults. While IGRP-specific Th cells in AT1D patients were dominantly Th1 cells, IGRP-specific Th cells in control adults and JT1D patients were dominantly Th2 and T regulatory type 1 (Tr1) cells. Notably, the frequency of IGRP-specific Tr1 cells was significantly lower in AT1D patients than in control adults and JT1D patients. In conclusion, our study suggests that IGRP-specific Th cells play a unique pathogenic role in AT1D. (C) 2015 Elsevier Inc. All rights reserved.	[Chujo, Daisuke; Foucat, Emile; Blankenship, Derek; Banchereau, Jacques; Ueno, Hideki] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Chujo, Daisuke] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Nguyen, Thien-Son; Nepom, Gerald T.; Chaussabel, Damien] Benaroya Res Inst Virginia Mason, Seattle, WA USA	Ueno, H (reprint author), Baylor Inst Immunol Res, 3434 Live Oak, Dallas, TX 75204 USA.	HideKiU@baylorhealth.edu			Juvenile Diabetes Research Foundation; Baylor Health Care System	The authors thank Olivier Agouna-Deciat and Sandy Zurawski for their technical assistance with the Cytokine multiplex assay, and Nicolas Loof and Sebastien Coquery for their technical assistance with flow cytometry. This study was supported by funding from Juvenile Diabetes Research Foundation and Baylor Health Care System.	Vincent BG, 2010, J IMMUNOL, V184, P4196, DOI 10.4049/jimmunol.0903931; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Jarchum I, 2008, CLIN IMMUNOL, V127, P359, DOI 10.1016/j.clim.2008.01.015; Lohmann T, 1996, J AUTOIMMUN, V9, P385, DOI 10.1006/jaut.1996.0052; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Roep BO, 2011, CURR OPIN IMMUNOL, V23, P746, DOI 10.1016/j.coi.2011.10.001; Herman AE, 1999, J IMMUNOL, V163, P6275; Herold KC, 2013, DIABETES, V62, P3766, DOI 10.2337/db13-0345; Velthuis JH, 2010, DIABETES, V59, P1721, DOI 10.2337/db09-1486; Sorgjerd EP, 2012, DIABETOLOGIA, V55, P1310, DOI 10.1007/s00125-012-2463-y; VANDEWALLE CL, 1993, DIABETOLOGIA, V36, P1155, DOI 10.1007/BF00401060; Hawa MI, 2013, DIABETES CARE, V36, P908, DOI 10.2337/dc12-0931; Geluk A, 1998, DIABETES, V47, P1594, DOI 10.2337/diabetes.47.10.1594; Schloot NC, 2001, HUM IMMUNOL, V62, P299, DOI 10.1016/S0198-8859(01)00223-3; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Gianani R, 2005, IMMUNOL REV, V204, P232, DOI 10.1111/j.0105-2896.2005.00248.x; Mannering SI, 2005, J EXP MED, V202, P1191, DOI 10.1084/jem.20051251; Greenbaum CJ, 2012, DIABETES, V61, P2066, DOI 10.2337/db11-1538; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Astill TP, 2003, DIABETOLOGIA, V46, P496, DOI 10.1007/s00125-003-1070-3; Dang M, 2011, J IMMUNOL, V186, P6056, DOI 10.4049/jimmunol.1003815; Alleva DG, 2001, J CLIN INVEST, V107, P173, DOI 10.1172/JCI8525; Reijonen H, 2002, DIABETES, V51, P1375, DOI 10.2337/diabetes.51.5.1375; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Kent SC, 2005, NATURE, V435, P224, DOI 10.1038/nature03625; Sabbah E, 2000, DIABETES CARE, V23, P1326, DOI 10.2337/diacare.23.9.1326; Nepom GT, 2001, P NATL ACAD SCI USA, V98, P1763, DOI 10.1073/pnas.98.4.1763; Yang JB, 2006, J IMMUNOL, V176, P2781; Standifer NE, 2006, DIABETES, V55, P3061, DOI 10.2337/db06-0066; Gitelman SE, 2013, LANCET DIABETES ENDO, V1, P306, DOI 10.1016/S2213-8587(13)70065-2; Peakman M, 1999, J CLIN INVEST, V104, P1449, DOI 10.1172/JCI7936; Roep BO, 2003, DIABETOLOGIA, V46, P305, DOI 10.1007/s00125-003-1089-5; Naik RG, 2009, J CLIN ENDOCR METAB, V94, P4635, DOI 10.1210/jc.2009-1120; Reijonen H, 1999, J IMMUNOL, V163, P1674; Hagopian W, 2013, DIABETES, V62, P3901, DOI 10.2337/db13-0236; Mannering SI, 2009, CLIN EXP IMMUNOL, V156, P226, DOI 10.1111/j.1365-2249.2009.03907.x; Oeser JK, 2011, DIABETES, V60, P2922, DOI 10.2337/db11-0220; Reijonen H, 2004, DIABETES, V53, P1987, DOI 10.2337/diabetes.53.8.1987; Monti P, 2007, J IMMUNOL, V179, P5785; Harfouch-Hammoud E, 1999, DIABETES, V48, P1937, DOI 10.2337/diabetes.48.10.1937; Viglietta V, 2002, J CLIN INVEST, V109, P895, DOI 10.1172/JCI14114; Oling V, 2005, J AUTOIMMUN, V25, P235, DOI 10.1016/j.jaut.2005.09.018; Martinuzzi E, 2008, DIABETES, V57, P1312, DOI 10.2337/db07-1594; Borg H, 2002, Pediatr Diabetes, V3, P149, DOI 10.1034/j.1399-5448.2002.30305.x; Chujo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055595; Jasinski J M, 2005, Clin Dev Immunol, V12, P181, DOI 10.1080/17402520500078204; Ouyang Qin, 2006, Diabetes, V55, P3068, DOI 10.2337/db06-0065; Roep BO, 2014, NAT REV ENDOCRINOL, V10, P229, DOI 10.1038/nrendo.2014.2; Unger WWJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049213	50	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1521-6616	1521-7035		CLIN IMMUNOL	Clin. Immunol.	DEC	2015	161	2					270	277		10.1016/j.clim.2015.08.014		8	Immunology	Immunology	CX6SL	WOS:000365831600028		
J	Higuchi, T; Kawaguchi, Y; Takagi, K; Tochimoto, A; Ota, Y; Katsumata, Y; Ichida, H; Hanaoka, M; Kawasumi, H; Tochihara, M; Yamanaka, H				Higuchi, Tomoaki; Kawaguchi, Yasushi; Takagi, Kae; Tochimoto, Akiko; Ota, Yuko; Katsumata, Yasuhiro; Ichida, Hisae; Hanaoka, Masanori; Kawasumi, Hidenaga; Tochihara, Mari; Yamanaka, Hisashi			Sildenafil attenuates the fibrotic phenotype of skin fibroblasts in patients with systemic sclerosis	CLINICAL IMMUNOLOGY			English	Article						Sildenafil; Systemic sclerosis; Fibrosis; CGMP	NITRIC-OXIDE; SCLERODERMA FIBROBLASTS; NATRIURETIC PEPTIDE; KIDNEY FIBROSIS; DISEASE; MECHANISMS; HYPERTENSION; INHIBITION; ACTIVATION; DISABILITY	Systemic sclerosis (SSc) is a multi-organ fibrotic disease that affects the skin and various internal organs. Therapeutic strategies for tissue fibrosis have not been established; however, aberrantly activated fibroblasts in affected lesions are key targets for modulating fibrosis. Recently, increased intracellular cyclic GMP (cGMP) levels were demonstrated to improve fibrosis levels in various diseases. The purpose of this study was to assess the antifibrotic properties of cGMP in cultured fibroblasts from patients with SSc. The phosphodiesterase (PDE) 5 inhibitor sildenafil increased the intracellular cGMP levels in skin fibroblasts in a dose-dependent manner. Sildenafil treatment also significantly decreased the expression of several pro-fibrotic factors that were upregulated by TGF-beta 1 treatment in SSc skin fibroblasts. These inhibitory effects occurred via non-canonical TGF-beta signaling. Our findings revealed that sildenafil might be a novel strategy to treat tissue fibrosis and vasculopathy in SSc. (C) 2015 Elsevier Inc. All rights reserved.	[Higuchi, Tomoaki; Kawaguchi, Yasushi; Takagi, Kae; Tochimoto, Akiko; Ota, Yuko; Katsumata, Yasuhiro; Ichida, Hisae; Hanaoka, Masanori; Kawasumi, Hidenaga; Tochihara, Mari; Yamanaka, Hisashi] Tokyo Womens Med Univ, Inst Rheumatol, Shinjuku Ku, Tokyo 1620054, Japan	Kawaguchi, Y (reprint author), Tokyo Womens Med Univ, Inst Rheumatol, Shinjuku Ku, 10-22 Kawada Cho, Tokyo 1620054, Japan.	y-kawa@ior.twmu.ac.jp			Ministry of Health, Labour and Welfare, Japan	This work is supported by systemic sclerosis and mixed connective tissue disease research grants from the Ministry of Health, Labour and Welfare, Japan.	Reiff A, 2013, CLIN IMMUNOL, V149, P146, DOI 10.1016/j.clim.2013.07.005; Ihn H, 2005, J INVEST DERMATOL, V125, P247, DOI 10.1111/j.0022-202X.2005.23766.x; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Takagi K, 2003, CLIN EXP IMMUNOL, V134, P538, DOI 10.1046/j.1365-2249.2003.02320.x; GROZDOVA MD, 1984, ARTHRITIS RHEUM, V27, P1144, DOI 10.1002/art.1780271010; Shimizu K, 2007, CLIN EXP RHEUMATOL, V25, P281; Yamamoto T, 1998, J RHEUMATOL, V25, P314; Kass DA, 2010, P NATL ACAD SCI USA, V107, pE98, DOI 10.1073/pnas.1003889107; Ferrini MG, 2006, BJU INT, V97, P625, DOI 10.1111/j.1464-410X.2006.05955.x; Danieli E, 2005, CLIN RHEUMATOL, V24, P48, DOI 10.1007/s10067-004-0970-z; Elshamy HA, 2011, EUR J DERMATOL, V21, P686, DOI 10.1684/ejd.2011.1423; Ohicita M, 2012, J PHARMACOL SCI, V119, P302, DOI 10.1254/jphs.12R01CR; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; Asano Y, 2010, J DERMATOL, V37, P54, DOI 10.1111/j.1346-8138.2009.00758.x; Chen YL, 2008, ARTHRITIS RHEUM-US, V58, P577, DOI 10.1002/art.23146; Ota Y, 2013, CLIN IMMUNOL, V147, P71, DOI 10.1016/j.clim.2013.03.001; Schinner E, 2013, KIDNEY INT, V84, P1198, DOI 10.1038/ki.2013.219; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Takimoto E, 2012, CIRC J, V76, P1819, DOI 10.1253/circj.CJ-12-0664; Messner B, 2014, ARTERIOSCL THROM VAS, V34, P509, DOI 10.1161/ATVBAHA.113.300156; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Vandeput F, 2009, J PHARMACOL EXP THER, V330, P884, DOI 10.1124/jpet.109.154468; Jinnin M, 2010, J DERMATOL, V37, P11, DOI 10.1111/j.1346-8138.2009.00738.x; Moalem J, 2006, J SURG RES, V135, P38, DOI 10.1016/j.jss.2006.01.012; Matucci-Cerinic M, 2013, ARTHRITIS RHEUM-US, V65, P1953, DOI 10.1002/art.37988; Movsesian M, 2009, HEART FAIL REV, V14, P255, DOI 10.1007/s10741-008-9130-x; Prasad S, 2000, NEW ENGL J MED, V343, P1342, DOI 10.1056/NEJM200011023431814; Ioannidis JPA, 2005, AM J MED, V118, P2, DOI 10.1016/j.amjmed.2004.04.031; Varga J, 2009, NAT REV RHEUMATOL, V5, P200, DOI 10.1038/nrrheum.2009.26; Chau VQ, 2011, AM J PHYSIOL-HEART C, V300, pH2272, DOI 10.1152/ajpheart.00654.2010; Schinner E, 2015, INT J MOL SCI, V16, P2320, DOI 10.3390/ijms16022320; Klaiber M, 2010, BASIC RES CARDIOL, V105, P583, DOI 10.1007/s00395-010-0098-z; Wang YY, 2013, CLIN IMMUNOL, V149, P46, DOI 10.1016/j.clim.2013.06.006; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; Das A, 2006, J BIOL CHEM, V281, P38644, DOI 10.1074/jbc.M606142200; Cui WP, 2014, AM J PHYSIOL-RENAL, V306, pF996, DOI 10.1152/ajprenal.00657.2013; Kuwana M, 2003, J RHEUMATOL, V30, P1253; Beyer C, 2012, ANN RHEUM DIS, V71, P1019, DOI 10.1136/annrheumdis-2011-200862; Beyer C, ANN RHEUM DIS; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Geschka S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021853; Ihn Hironobu, 2005, Curr Rheumatol Rep, V7, P156, DOI 10.1007/s11926-005-0069-9; Lin CS, 2004, INT J IMPOT RES, V16, pS8, DOI 10.1038/sj.ijir.3901207; Panasyuk A.F., 1984, ARTHRITIS RHEUM, V27, P114; Ramani G.V., 2010, DRUG DES DEVEL THER, V25, P61	45	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1521-6616	1521-7035		CLIN IMMUNOL	Clin. Immunol.	DEC	2015	161	2					333	338		10.1016/j.clim.2015.09.010		6	Immunology	Immunology	CX6SL	WOS:000365831600037		
J	Nakazawa, Y; Kawai, T; Uchiyama, T; Goto, F; Watanabe, N; Maekawa, T; Ishiguro, A; Okuyama, T; Otsu, M; Yamada, M; Hershfield, MS; Ariga, T; Onodera, M				Nakazawa, Yumiko; Kawai, Toshinao; Uchiyama, Toru; Goto, Fumihiro; Watanabe, Nobuyuki; Maekawa, Takanobu; Ishiguro, Akira; Okuyama, Torayuki; Otsu, Makoto; Yamada, Masafumi; Hershfield, Michael S.; Ariga, Tadashi; Onodera, Masafumi			Effects of enzyme replacement therapy on immune function in ADA deficiency patient	CLINICAL IMMUNOLOGY			English	Letter						Adenosine deaminase deficiency; Severe combined immunodeficiency; Enzyme replacement therapy; PEG-ADA; Stem cell gene therapy; Immune reconstitution	ADENOSINE-DEAMINASE-DEFICIENCY; SEVERE COMBINED IMMUNODEFICIENCY; GENE-THERAPY; RECONSTITUTION		[Nakazawa, Yumiko; Kawai, Toshinao; Uchiyama, Toru; Goto, Fumihiro; Watanabe, Nobuyuki; Onodera, Masafumi] Natl Res Inst Child Hlth & Dev, Dept Human Genet, Tokyo, Japan; [Maekawa, Takanobu; Ishiguro, Akira] Natl Ctr Child Hlth & Dev, Dept Gen Pediat & Interdisciplinary Med, Tokyo 1578535, Japan; [Okuyama, Torayuki] Natl Ctr Child Hlth & Dev, Clin Lab Med, Tokyo 1578535, Japan; [Otsu, Makoto] Univ Tokyo, Ctr Stem Cell Biol & Regenerat Med, Tokyo 1138654, Japan; [Yamada, Masafumi; Ariga, Tadashi] Hokkaido Univ, Dept Pediat, Sapporo, Hokkaido 060, Japan; [Hershfield, Michael S.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27706 USA	Onodera, M (reprint author), Natl Ctr Child Hlth & Dev, Dept Human Genet, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	onodera-m@ncchd.go.jp					Brigida I, 2014, J ALLERGY CLIN IMMUN, V133, P799, DOI 10.1016/j.jaci.2013.12.1043; Gaspar HB, 2009, BLOOD, V114, P3524, DOI 10.1182/blood-2009-06-189209; Tangye SG, 2006, SEMIN IMMUNOL, V18, P305, DOI 10.1016/j.smim.2006.04.004; Otsu M, 2015, J CLIN IMMUNOL, V35, P384, DOI 10.1007/s10875-015-0157-1; Qasim W, 2009, GENE THER, V16, P1285, DOI 10.1038/gt.2009.127; Malacarne F, 2005, EUR J IMMUNOL, V35, P3376, DOI 10.1002/eji.200526248; Kohn DB, 2010, CLIN IMMUNOL, V135, P247, DOI 10.1016/j.clim.2009.12.003; Serana F, 2010, J IMMUNOL, V185, P7713, DOI 10.4049/jimmunol.1001770; Jawa V, 2013, CLIN IMMUNOL, V149, P534, DOI 10.1016/j.clim.2013.09.006; Aldrich MB, 2003, J IMMUNOL, V171, P5562; Liu P, 2009, CLIN IMMUNOL, V130, P162, DOI 10.1016/j.clim.2008.08.026; Chan B, 2005, CLIN IMMUNOL, V117, P133, DOI 10.1016/j.clim.2005.07.006; HERSHFIELD MS, 1987, NEW ENGL J MED, V316, P589, DOI 10.1056/NEJM198703053161005; Morinishi Y, 2009, J PEDIATR-US, V155, P829, DOI 10.1016/j.jpeds.2009.05.026	14	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1521-6616	1521-7035		CLIN IMMUNOL	Clin. Immunol.	DEC	2015	161	2					391	393		10.1016/j.clim.2015.06.011		3	Immunology	Immunology	CX6SL	WOS:000365831600045		
J	Hiramatsu, H; Sugiura, Y; Kamio, Y; Kamiya, M				Hiramatsu, H.; Sugiura, Y.; Kamio, Y.; Kamiya, M.			Transvenous Embolization of a Dural Arteriovenous Fistula Involving the Suboccipital Cavernous Sinus	CLINICAL NEURORADIOLOGY			English	Editorial Material									[Hiramatsu, H.; Kamio, Y.] Hamamatsu Univ Sch Med, Dept Neurosurg, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Sugiura, Y.] Seirei Mikatahara Hosp, Dept Endovasc Neurosurg, Hamamatsu, Shizuoka, Japan; [Kamiya, M.] Hamamatsu Univ Sch Med, Dept Radiol, Hamamatsu, Shizuoka 4313192, Japan	Hiramatsu, H (reprint author), Hamamatsu Univ Sch Med, Dept Neurosurg, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	jzt00467@nifty.com					Miyachi S, 2008, INTERV NEURORADIOL, V14, P303; Takahashi S, 2005, EUR RADIOL, V15, P1694, DOI 10.1007/s00330-004-2597-5; Ruiz DS, 2002, AM J NEURORADIOL, V23, P1500; Arnautovic KI, 1997, J NEUROSURG, V86, P252, DOI 10.3171/jns.1997.86.2.0252; Fisher E, 1938, ZENTRALBL NEUROCHIR, V3, P300; Geibprasert S, 2008, STROKE, V39, P2784; Osborn AG, 1999, DIAGNOSTIC CEREBRAL, P173; Sakuma I, 2004, CLIN RADIOL EXTRA, V59, P3, DOI 10.1016/S1477-6804(03)00032-3	8	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1869-1439	1869-1447		CLIN NEURORADIOL	Clin. Neuroradiol.	DEC	2015	25	4					419	422		10.1007/s00062-014-0356-9		4	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CX5TK	WOS:000365765200011		
J	Okubo, T; Kitano, H; Murou, M; Yoshinaga, K; Nakamuro, M; Tsuchida, A				Okubo, Tsuneo; Kitano, Hiromi; Murou, Masanobu; Yoshinaga, Kohji; Nakamuro, Masaaki; Tsuchida, Akira			(Drying structures of marine clay in the deionized aqueous suspension)	COLLOID AND POLYMER SCIENCE			English	Article						Drying pattern; Marine colloidal clay; Broad ring; Dissipative structure; Branch-like pattern	COLLOIDAL SILICA SPHERES; DISSIPATIVE CRYSTALLIZATION; EVAPORATING DROPLETS; DIFFERENT SIZES; LIQUID-FILMS; PARTICLES; MIXTURES; SEDIMENTATION; STABILITY; PATTERNS	Drying dissipative patterns during drying of marine colloidal (MC) clays were observed in the deionized aqueous suspension on a cover glass, a watch glass, and a Petri glass dish. Two kinds of broad rings (BR), i.e., BR of small particles at the outside edge and BR of large particles at the inner area from the edge, were observed. The size of the outside BR was the same as that of the initial suspension irrespective of colloidal concentration, whereas the size of the inner BR increased as colloidal concentration increased. Highly distorted multi-rings, i.e., branch-like or net-like patterns, appeared. Furthermore, no spoke lines formed except the areas at the outside edge of the dried film. These observations support the circular stacking of the anisotropic-shaped MC particles during the convectional flow process. The B type of solutes was deduced for MC from the drying patterns, where strong solute-substrate affinity especially for the small particles and weak inter-solute affinity coexist.	[Okubo, Tsuneo] Inst Colloidal Org, Uji, Kyoto 6110012, Japan; [Kitano, Hiromi; Murou, Masanobu] Toyama Univ, Grad Sch Sci & Engn, Dept Appl Chem, Toyama, Toyama 9308555, Japan; [Yoshinaga, Kohji; Nakamuro, Masaaki] Kyushu Inst Technol, Dept Appl Chem, Fukuoka 8048550, Japan; [Tsuchida, Akira] Gifu Univ, Grad Sch Engn, Dept Appl Chem, Gifu, Gifu 5011193, Japan	Okubo, T (reprint author), Inst Colloidal Org, Hatoyama 3-1-112, Uji, Kyoto 6110012, Japan.	okubotsu@ybb.ne.jp					Okubo T, 2009, COLLOID POLYM SCI, V287, P443, DOI 10.1007/s00396-008-1987-7; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; Maenosono S, 1999, LANGMUIR, V15, P957, DOI 10.1021/la980702q; Okubo T, 2013, COLLOID POLYM SCI, V291, P2599, DOI 10.1007/s00396-013-3009-7; Okubo T, 2009, COLLOID POLYM SCI, V287, P351, DOI 10.1007/s00396-008-1947-2; Kralchevsky PA, 2000, ADV COLLOID INTERFAC, V85, P145, DOI 10.1016/S0001-8686(99)00016-0; Okubo T, 2008, COLLOID POLYM SCI, V286, P385, DOI 10.1007/s00396-007-1778-6; JACOBS MB, 1965, SCIENCE, V149, P179, DOI 10.1126/science.149.3680.179; Okubo T, 2014, COLLOID POLYM SCI, V292, P1419, DOI 10.1007/s00396-014-3200-5; Hu H, 2005, LANGMUIR, V21, P3963, DOI 10.1021/la047528s; Yamaguchi T, 2005, COLLOID POLYM SCI, V283, P1123, DOI 10.1007/s00396-004-1258-1; BASSIN NJ, 1975, LIMNOL OCEANOGR, V20, P133; Routh AF, 1998, AICHE J, V44, P2088, DOI 10.1002/aic.690440916; Okubo T, 2009, COLLOID POLYM SCI, V287, P1435, DOI 10.1007/s00396-009-2110-4; Okubo T, 2009, COLLOID POLYM SCI, V287, P645, DOI 10.1007/s00396-009-2021-4; Okubo T, 2011, COLLOID SURFACE B, V87, P11, DOI 10.1016/j.colsurfb.2011.03.022; Okubo T, 2008, COLLOID POLYM SCI, V286, P941, DOI 10.1007/s00396-008-1852-8; Fischer BJ, 2002, LANGMUIR, V18, P60, DOI 10.1021/la015518a; Cachile M, 2002, LANGMUIR, V18, P7985, DOI 10.1021/la020231e; Deegan RD, 2000, PHYS REV E, V62, P756, DOI 10.1103/PhysRevE.62.756; Nikoobakht B, 2000, J PHYS CHEM B, V104, P8635, DOI 10.1021/jp001287p; Okubo T, 2010, COLLOID SURFACE B, V80, P193, DOI 10.1016/j.colsurfb.2010.06.004; Ung T, 2001, J PHYS CHEM B, V105, P3441, DOI 10.1021/jp003500n; ANDERSON DM, 1995, PHYS FLUIDS, V7, P248, DOI 10.1063/1.868623; PALMER HJ, 1976, J FLUID MECH, V75, P487, DOI 10.1017/S0022112076000347; Ball P, 1999, SELF MADE TAPESTRY P; Shahidzadeh-Bonn N, 2006, J FLUID MECH, V549, P307, DOI 10.1017/S0022112005008190; BURELBACH JP, 1988, J FLUID MECH, V195, P463, DOI 10.1017/S0022112088002484; Deegan RD, 2000, PHYS REV E, V61, P475, DOI 10.1103/PhysRevE.61.475; Gribbin G, 1999, ALMOST EVERYONES GUI; Nakaya U, 1947, MEMOIRS T TERADA; Nicolis G, 1977, SELF ORG NONEQUILIBR; Ohara PC, 1997, ANGEW CHEM, V109, P1120, DOI 10.1002/ange.19971091011; Okubo T, 2015, COLLOIDAL ORG; Russ JC, 1971, AM SOC TESTING MAT S, V485, ppp154; Terada T, 1934, SCI PAP I PHYS CHEM, V23, P173; Terada T, 1934, SCI PAP I PHYS CHEM, V27, P75; Vanderhoff JW, 1973, J POLYM SCI POLYM S, V41, P155	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	DEC	2015	293	12					3393	3401		10.1007/s00396-015-3740-3		9	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CX5ON	WOS:000365751600001		
J	Otsuka, Y; Ito, A; Matsumura, S; Takeuchi, M; Tanaka, H				Otsuka, Yuta; Ito, Akira; Matsumura, Saki; Takeuchi, Masaki; Tanaka, Hideji			Effect of hydroxypropyl cellulose and hydroxypropyl methylcellulose on carbamazepine polymorphic transformation; attenuated total reflectance-infrared spectroscopy and chemoinformatics analysis	COLLOID AND POLYMER SCIENCE			English	Article						Carbamazepine; Polymorphic transformation; Attenuated total reflectance-Fourier transform infrared spectroscopy; Multivariate curve resolution-alternating least squares; Two-dimensional correlation spectroscopic analysis	MULTIVARIATE CURVE RESOLUTION; SQUARES MCR-ALS; ANHYDROUS CARBAMAZEPINE; DIHYDRATE; KINETICS; STATE; SORPTION; SPECTRA; POWDER; RAMAN	The effect of hydroxypropyl cellulose (HPC) and hydroxypropyl methylcellulose (HPMC) on carbamazepine (CBZ) polymorphic transformation has been investigated by an attenuated total reflectance-infrared (ATR-IR) spectroscopy and chemoinformatics. CBZ anhydrate samples were each kneaded with 35.0 mu L of pure water, aqueous solution of 0.005 w/v% HPC, or that of 0.005 w/v% HPMC. Each paste was put on a germanium glass of an ATR accessory and was covered with a sheet of ParafilmA (R) at 20 +/- A 2 A degrees C. Measured IR spectra were analyzed by a multivariate curve resolution-alternating least squares (MCR-ALS) and a two-dimensional correlation spectroscopic analysis. Source vectors of MCR-ALS were assigned to CBZ anhydrate and dihydrate. Concentration data of MCR-ALS were evaluated for the kinetics of CBZ polymorphic transformation. The combination of ATR-IR spectroscopy and MCR-ALS is concluded to be useful for the elucidation of rapid polymorphic transformation in suspension. The transformation rate is delayed by HPC and HPMC.	[Otsuka, Yuta; Ito, Akira] Univ Tokushima, Grad Sch Pharmaceut Sci, Tokushima 7708505, Japan; [Matsumura, Saki] Univ Tokushima, Fac Pharmaceut Sci, Tokushima 7708505, Japan; [Takeuchi, Masaki; Tanaka, Hideji] Univ Tokushima, Inst Biomed Sci, Tokushima 7708505, Japan	Otsuka, Y (reprint author), Univ Tokushima, Grad Sch Pharmaceut Sci, I-78-1 Shomachi, Tokushima 7708505, Japan.	y.otsuka36156803@gmail.com					Stephenson GA, 1997, J PHARM SCI, V86, P1239, DOI 10.1021/js9701667; Kessler W, 2006, ANAL BIOANAL CHEM, V384, P1087, DOI 10.1007/s00216-005-0077-7; VADAS EB, 1991, PHARMACEUT RES, V8, P148, DOI 10.1023/A:1015871415925; Noda I, 2000, APPL SPECTROSC, V54, P994, DOI 10.1366/0003702001950472; YOUNG WWL, 1991, J PHARM SCI, V80, P496, DOI 10.1002/jps.2600800519; KONTNY MJ, 1985, J PHARM SCI, V74, P124, DOI 10.1002/jps.2600740204; Otsuka Y, 2013, COLLOID SURFACE B, V102, P931, DOI 10.1016/j.colsurfb.2012.07.049; Tauler R, 1995, CHEMOMETR INTELL LAB, V30, P133, DOI 10.1016/0169-7439(95)00047-X; Noda I, 1996, J PHYS CHEM-US, V100, P8674, DOI 10.1021/jp9534141; Gift AD, 2008, J PHARM SCI-US, V97, P5198, DOI 10.1002/jps.21379; Harris RK, 2005, ORG PROCESS RES DEV, V9, P902, DOI 10.1021/op0500990; NODA I, 1990, APPL SPECTROSC, V44, P550, DOI 10.1366/0003702904087398; Dubbini A, 2014, INT J PHARMACEUT, V473, P536, DOI 10.1016/j.ijpharm.2014.07.030; Himmelsbach D, 2009, VIB SPECTROSC, V51, P142, DOI 10.1016/j.vibspec.2009.03.004; Kirsch JD, 1999, J PHARMACEUT BIOMED, V19, P351, DOI 10.1016/S0731-7085(98)00132-0; Kobayashi Y, 2000, INT J PHARM, V193, P137, DOI 10.1016/S0378-5173(99)00315-4; Azzouz T, 2008, TALANTA, V74, P1201, DOI 10.1016/j.talanta.2007.08.024; Garrido M, 2008, ANAL BIOANAL CHEM, V390, P2059, DOI 10.1007/s00216-008-1955-6; NODA I, 1993, APPL SPECTROSC, V47, P1329, DOI 10.1366/0003702934067694; Muller M, 1996, J PHYS CHEM-US, V100, P10810, DOI 10.1021/jp9602843; Cassinelli WH, 2014, CATAL TODAY, V229, P114, DOI 10.1016/j.cattod.2013.10.077; Colthup N, 2012, INTRO INFRARED RAMAN, P1; Juan A., 2006, CRIT REV ANAL CHEM, V36, P163; Mayo DW, 2004, COURSE NOTES INTERPR, P169; Noda I, 2004, 2 DIMENSIONAL CORREL, P15; SURYANARAYANAN R, 1989, PHARMACEUT RES, V6, P1017, DOI 10.1023/A:1015970218980; TAULER R, 1995, J CHEMOMETR, V9, P31, DOI 10.1002/cem.1180090105; Van CL, 1983, J PHARM SCI, V72, P1394	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	DEC	2015	293	12					3471	3478		10.1007/s00396-015-3698-1		8	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CX5ON	WOS:000365751600009		
J	Nguele, R; Sasaki, K; Said-Al Salim, H; Sugai, Y				Nguele, Ronald; Sasaki, Kyuro; Said-Al Salim, Hikmat; Sugai, Yuichi			Physicochemical and microemulsion properties of dimeric quaternary ammonium salts with trimethylene spacer for enhanced oil recovery	COLLOID AND POLYMER SCIENCE			English	Article						Bis(quaternary ammonium halide); Surface properties; Microemulsion; Oil solubilization; Oil recovery	NONIONIC SURFACTANTS; INTERFACIAL-TENSIONS; CATIONIC SURFACTANTS; SULFATE SURFACTANTS; GEMINI SURFACTANTS; MASS-SPECTROMETRY; AQUEOUS-SOLUTION; PHASE-BEHAVIOR; WATER; FORMULATIONS	Dimeric surfactants, also termed as Gemini surfactants, are regarded as organic materials which have two hydrophilic head groups and two hydrophobic groups in the molecules linked together with a spacer. In this study, dimeric surfactants of quaternary ammonium bromide connected with a trimethylene spacer group (m-3-m) have been investigated as potential micellar solutions for enhanced oil recovery. Static surface tension, interfacial tension as well as optimal salinity characterized their physicochemical and microemulsion properties. Using modeled petroleum fluids, the critical micelle concentration (CMC) was found dependent not only of the chemical architecture of the surfactant but also of the composition in the liquid phase. The nature and/or the length of spacer group participates significantly to the spatial rearrangement of the dimeric surfactants which subsequently altered the surface properties. For the same spacer group, an ultralow interfacial tension was achieved. Encouraging oil solubilization was found for surfactants used with an effect pronounced for longer alkyl chain. Furthermore, both the effects and the presence of metallic divalent ions on the phase behavior were discussed.	[Nguele, Ronald; Sasaki, Kyuro; Sugai, Yuichi] Kyushu Univ, Resources Prod & Safety Engn Lab, Nishi Ku, Fukuoka 8190395, Japan; [Said-Al Salim, Hikmat] North Wing UCSI Univ, Dept Chem & Petr Engn, Kuala Lumpur 56000, Malaysia	Nguele, R (reprint author), Kyushu Univ, Resources Prod & Safety Engn Lab, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	nguele.ronald@mine.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)	The authors extend their gratitude towards Lion Ltd. for synthetizing and kindly supplying the surfactants used in this study. The authors would also like to acknowledge the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) for the support.	Harkins WD, 1919, J AM CHEM SOC, V41, P499, DOI 10.1021/ja01461a003; Iglauer S, 2014, INT J GREENH GAS CON, V22, P325, DOI 10.1016/j.ijggc.2014.01.006; Wu Y, 2010, TENSIDE SURFACT DET, V47, P152; Ab Rani MA, 2011, PHYS CHEM CHEM PHYS, V13, P16831, DOI 10.1039/c1cp21262a; Iglauer S, 2010, J PETROL SCI ENG, V71, P23, DOI 10.1016/j.petrol.2009.12.009; Iglauer S, 2009, COLLOID SURFACE A, V339, P48, DOI 10.1016/j.colsurfa.2009.01.015; Villa C, 2013, MATERIALS, V6, P1506, DOI 10.3390/ma6041506; Buse J, 2013, J CHROMATOGR A, V1294, P98, DOI 10.1016/j.chroma.2013.04.031; Aguila-Hernandez J, 2001, FLUID PHASE EQUILIBR, V185, P165, DOI 10.1016/S0378-3812(01)00467-8; DEVINSKY F, 1985, J COLLOID INTERF SCI, V105, P235, DOI 10.1016/0021-9797(85)90363-7; Zana R, 2002, ADV COLLOID INTERFAC, V97, P205, DOI 10.1016/S0001-8686(01)00069-0; ZANA R, 1991, LANGMUIR, V7, P1072, DOI 10.1021/la00054a008; Yoshimura T, 2003, J COLLOID INTERF SCI, V267, P167, DOI 10.1016/S0021-9797(03)00694-5; BUNTON CA, 1971, J ORG CHEM, V36, P2346, DOI 10.1021/jo00815a033; Yoshimura T, 2004, J COLLOID INTERF SCI, V272, P191, DOI 10.1016/j.jcis.2003.12.021; HUH C, 1979, J COLLOID INTERF SCI, V71, P408, DOI 10.1016/0021-9797(79)90249-2; HUGHES FA, 1970, J AM OIL CHEM SOC, V47, P162, DOI 10.1007/BF02638743; LANDO JL, 1967, J COLLOID INTERF SCI, V25, P526, DOI 10.1016/0021-9797(67)90064-1; Michel JC, 2001, EUR J SOIL SCI, V52, P459, DOI 10.1046/j.1365-2389.2001.00392.x; Wu Y, 2010, TENSIDE SURFACT DET, V47, P280; Magdassi S, 2003, COLLOID SURFACE A, V212, P1, DOI 10.1016/S0927-7757(02)00294-7; Jeirani Z, 2013, IND CROP PROD, V43, P15, DOI 10.1016/j.indcrop.2012.07.004; Santanna VC, 2009, J PETROL SCI ENG, V66, P117, DOI 10.1016/j.petrol.2009.01.009; LYON PA, 1984, ANAL CHEM, V56, P2278, DOI 10.1021/ac00277a004; Mata J, 2005, THERMOCHIM ACTA, V428, P147, DOI 10.1016/j.tca.2004.11.009; Bera A, 2012, J CHEM ENG DATA, V57, P1000, DOI 10.1021/je2013796; Bansal VK, 1978, J AM OIL CHEM SOC, V55, P67; Bertsch H, 1936, Patent No, Patent No. [2,049,758, 2049758]; Daley SJ, 2008, ORGANIC CHEM ORGANIC; Das S, 2013, J CHEM ENG DATA, V58, P2586, DOI 10.1021/je4004788; Davies J. T., 1961, INTERFACIAL PHENOMEN; Diamant H, 2003, GEMINI SURFACTANTS I, P16; Green DW, 1998, SOC PETROL ENG J, DOI [10.4236/oalib.1101437, DOI 10.4236/OALIB.1101437]; Holmberg K., 2003, SURFACTANTS POLYM AQ; Hua XY, 1991, J COLLOID INTERF SCI, V141, P180, DOI DOI 10.1016/0021-9797(91)90313-W; Iglauer S, 2004, S IMPR OIL REC; Kumar P, 1999, HDB MICROEMULSION SC; Onitsuka E, 2000, J JPN OIL CHEM SOC J, V49, P929; Pine S. H., 1970, ORG REACTIONS, V18, P403; Sekhon BS, 2004, RESONANCE, V42, P42; Shah DO, 1977, IMPROVED OIL RECOVER; Sheng JJ, 2011, MODERN CHEMICAL ENHANCED OIL RECOVERY: THEORY AND PRACTICE, P1; Shukla D., 2006, J OLEO SCI, V55, P381; Tarek A, 2007, EQUATIONS STATE PVT; Winsor PA, 1954, SOLVENT PROPERTIES A; Zana R, 2002, J COLLOID INTERF SCI, V248, P203, DOI 10.1006/jcis.2001.8104	46	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	DEC	2015	293	12					3487	3497		10.1007/s00396-015-3701-x		11	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CX5ON	WOS:000365751600011		
J	Feng, LL; Kobayashi, M; Adachi, Y				Feng, Lili; Kobayashi, Motoyoshi; Adachi, Yasuhisa			Initial stage dynamics of bridging flocculation of polystyrene latex particles with low charge density polycation in a mixing flow near the isoelectric point	COLLOID AND POLYMER SCIENCE			English	Article						Low charge density polyelectrolyte; Ionic strength; Bridging flocculation; Steric effect; Adsorption dynamics of polyelectrolyte; Reconformation of polymer at interface	CATIONIC POLYMERS; IONIC-STRENGTH; POLYELECTROLYTE ADSORPTION; TURBULENT COAGULATION; BROWNIAN FLOCCULATION; KINETICS; SPHERES; AGGREGATION; SUSPENSIONS; STABILITY	Dynamics of ortho-kintetic flocculation of PSL particles with long-chain polycation of low charge density was studied together with the adsorption process of polyelectrolyte near isoelectric point as a function of ionic strength. Within the range of investigation, the initial rate of flocculation was found to take the maximum value immediately after the onset of mixing, but the flocculation gradually slows down with the progress of adsorption. The initial rate of flocculation goes through the minimum as ionic strength increases. Without salt addition, the rate of flocculation is about three times faster than that of salt-induced rapid coagulation. With slightly increasing ionic strength the rate of flocculation slows down because of the reductions of the stiffness and the size of polymer coil in solution and also of the smooth rearrangement of adsorbed chains. The adsorption process monitored by the electrophoresis demonstrates that the zero mobility appears much earlier than the time predicted by collision process in the presence of salt (KCl 100 mM). This trend can be explained by the concept of electrokinetically stagnant layer and by smooth spreading of polyelectrolyte on the colloidal surface. The kinetics of adsorption is in good accordance with the change in the flocculation rate.	[Feng, Lili; Kobayashi, Motoyoshi; Adachi, Yasuhisa] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Feng, Lili] North China Univ Water Resources & Elect Power, Zhengzhou, Henan, Peoples R China	Adachi, Y (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	adachi.yasuhisa.gu@u.tsukuba.ac.jp			JSPS [A22248025, 15H04563]	This work is funded by a Grant-in-Aid for Scientific Research (A22248025 and 15H04563) from JSPS. We acknowledge Prof. M.A. Cohen Stuart for his helpful discussion on the electrophoresis data and Miss Y. Wu for her additional measurements of electrophoresis. L.F. expresses her thanks to the China Scholarship Council.	Becker AL, 2012, CURR OPIN COLLOID IN, V17, P90, DOI 10.1016/j.cocis.2011.10.001; RUEHRWEIN RA, 1952, SOIL SCI, V73, P485, DOI 10.1097/00010694-195206000-00007; SAFFMAN PG, 1956, J FLUID MECH, V1, P16, DOI 10.1017/S0022112056000020; Plunkett MA, 2003, LANGMUIR, V19, P4673, DOI 10.1021/la026569q; Somasundaran P, 1998, COLLOID SURFACE A, V133, P125, DOI 10.1016/S0927-7757(97)00128-3; Adachi Y, 2013, COLLOID SURFACE A, V435, P127, DOI 10.1016/j.colsurfa.2012.12.042; GREGORY J, 1973, J COLLOID INTERF SCI, V42, P448, DOI 10.1016/0021-9797(73)90311-1; ADACHI Y, 1994, J COLLOID INTERF SCI, V167, P346, DOI 10.1006/jcis.1994.1369; Santore MM, 2005, CURR OPIN COLLOID IN, V10, P176, DOI 10.1016/j.cocis.2005.05.005; Zhou Y, 2008, COLLOID SURFACE A, V331, P183, DOI 10.1016/j.colsurfa.2008.08.004; HIGASHITANI K, 1983, J CHEM ENG JPN, V16, P299, DOI 10.1252/jcej.16.299; GOODWIN JW, 1974, COLLOID POLYM SCI, V252, P464, DOI 10.1007/BF01554752; Adachi Y, 1996, COLLOID SURFACE A, V113, P229, DOI 10.1016/0927-7757(96)03649-7; Feng LL, 2014, COLLOID SURFACE A, V440, P155, DOI 10.1016/j.colsurfa.2012.09.023; DEWITT JA, 1992, LANGMUIR, V8, P788, DOI 10.1021/la00039a011; Ouali L, 1999, J COLLOID INTERF SCI, V215, P36, DOI 10.1006/jcis.1999.6183; Feng LL, 2014, COLLOID SURFACE A, V454, P128, DOI 10.1016/j.colsurfa.2014.03.103; Swerin A, 1996, COLLOID SURFACE A, V113, P25, DOI 10.1016/0927-7757(95)03506-0; Szilagyi I, 2014, SOFT MATTER, V10, P2479, DOI 10.1039/c3sm52132j; Aoki K, 2006, J COLLOID INTERF SCI, V300, P69, DOI 10.1016/j.jcis.2006.03.027; Bauer D, 1999, COLLOID SURFACE A, V156, P291, DOI 10.1016/S0927-7757(99)00081-3; GREGORY J, 1988, COLLOID SURFACE, V31, P231, DOI 10.1016/0166-6622(88)80196-3; ADACHI Y, 1994, J COLLOID INTERF SCI, V165, P310, DOI 10.1006/jcis.1994.1234; Lin W, 2006, LANGMUIR, V22, P1038, DOI 10.1021/la0522808; Popa I, 2010, J PHYS CHEM B, V114, P3170, DOI 10.1021/jp911482a; Kobayashi M, 2008, COLLOID POLYM SCI, V286, P935, DOI 10.1007/s00396-008-1851-9; ADACHI Y, 1995, ADV COLLOID INTERFAC, V56, P1, DOI 10.1016/0001-8686(94)00229-6; Popa I, 2010, PHYS CHEM CHEM PHYS, V12, P4863, DOI 10.1039/b925812d; Farrow JB, 1996, INT J MINER PROCESS, V46, P263, DOI 10.1016/0301-7516(95)00084-4; Kobayashi M, 2009, COLLOID SURFACE A, V347, P2, DOI 10.1016/j.colsurfa.2008.09.054; Petzold G, 2014, ADV POLYM SCI, V256, P25, DOI 10.1007/12_2012_205; Bolto B, 2007, WATER RES, V41, P2301, DOI 10.1016/j.watres.2007.03.012; Gregory J, 2011, ADV COLLOID INTERFAC, V169, P1, DOI 10.1016/j.cis.2011.06.004; Zhou Y, 2006, LANGMUIR, V22, P6775, DOI 10.1021/la060281+; Borkovec M, 2008, CURR OPIN COLLOID IN, V13, P429, DOI 10.1016/j.cocis.2008.02.006; Borkovec M, 2012, ADV COLLOID INTERFAC, V179, P85, DOI 10.1016/j.cis.2012.06.005; Adachi Y, 2015, COLLOID SURFACE A, V471, P38, DOI 10.1016/j.colsurfa.2015.02.011; PELSSERS EGM, 1990, J CHEM SOC FARADAY T, V86, P1355, DOI 10.1039/ft9908601355; BAKEEV KN, 1992, MACROMOLECULES, V25, P4249, DOI 10.1021/ma00043a003; VANDEVEN TGM, 1977, COLLOID POLYM SCI, V255, P468; ODIJK T, 1977, J POLYM SCI POL PHYS, V15, P477, DOI 10.1002/pol.1977.180150307; ELAISSARI A, 1991, J COLLOID INTERF SCI, V143, P343, DOI 10.1016/0021-9797(91)90268-D; Barany S, 2015, ADV COLLOID INTERFAC, V222, P58, DOI 10.1016/j.cis.2014.09.009; Bratby J, 2006, COAGULATION AND FLOCCULATION IN WATER AND WASTEWATER TREATMENT, 2ND EDITION, P1; Fleer G.R., 1993, POLYM INTERFACES; Netz RR, 2003, PHYS REP, V308, P1; Ohshima H, 2012, ELECT PHENOMENA INTE; Takuya S, 2015, THEORETICAL APPL MEC, V63, P133	48	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	DEC	2015	293	12					3585	3593		10.1007/s00396-015-3729-y		9	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CX5ON	WOS:000365751600021		
J	Yoshida, E				Yoshida, Eri			Giant vesicles comprised of mixed amphiphilic poly(methacrylic acid)-block-poly(methyl methacrylate-random-methacrylic acid) diblock copolymers	COLLOID AND POLYMER SCIENCE			English	Article						Giant vesicles; Mixed amphiphilic diblock copolymers; Poly(methacrylic acid)-block-poly(methyl methacrylate-random-methacrylic acid); Morphology	RANDOM BLOCK-COPOLYMERS; RANDOM-MATHACRYLIC ACID); MORPHOLOGY CONTROL; MEMBRANE; BILAYERS; SHAPE	The morphological changes in giant vesicles were investigated using mixed amphiphilic diblock copolymers consisting of poly(methacrylic acid)-block-poly(methyl methacrylate-random-methacrylic acid), PMAA-b-P(MMA-r-MAA). The mixed copolymers had the identical length of the hydrophobic P(MMA-r-MAA) block and different lengths of the hydrophilic PMAA block; long-length PMAA (PMAA-L) was about three times longer than short-length PMAA (PMAA-S). Large contorted vesicles formed by the copolymer containing PMAA-S were transformed into various elliptical and spherical vesicles, followed by worm-like vesicles as the ratio of the PMAA-L-containing copolymer increased. It was found that the vesicular morphology of the mixed copolymers was determined by the average length of the PMAA blocks contained in the mixed copolymers based on the comparison with the spherical vesicles formed only by the copolymer containing the middle length of the PMAA block.	[Yoshida, Eri] Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi 4418580, Japan	Yoshida, E (reprint author), Toyohashi Univ Technol, Dept Environm & Life Sci, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.	eyoshida@ens.tut.ac.jp			JSPS [25390003]	The author is thankful for a JSPS Grant-in-Aid for Scientific Research (Grant Number 25390003).	ANDERSON RGW, 1977, CELL, V10, P351, DOI 10.1016/0092-8674(77)90022-8; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Yoshida E, 2015, COLLOID POLYM SCI, V293, P249, DOI 10.1007/s00396-014-3403-9; Zhang LF, 1996, J AM CHEM SOC, V118, P3168, DOI 10.1021/ja953709s; ELGSAETER A, 1986, SCIENCE, V234, P1217, DOI 10.1126/science.3775380; SHEETZ MP, 1976, J CELL BIOL, V70, P193, DOI 10.1083/jcb.70.1.193; KOBAYASHI S, 1990, POLYM J, V22, P759, DOI 10.1295/polymj.22.759; Yoshida E, 2015, COLLOID POLYM SCI, V293, P2437, DOI 10.1007/s00396-015-3679-4; Austin JR, 2011, PLANT PHYSIOL, V155, P1601, DOI 10.1104/pp.110.170647; TANAKA T, 1980, PHYS REV LETT, V45, P1636, DOI 10.1103/PhysRevLett.45.1636; Yoshida E, 2015, COLLOID POLYM SCI, V293, P1835, DOI 10.1007/s00396-015-3577-9; Blanazs A, 2011, J AM CHEM SOC, V133, P16581, DOI 10.1021/ja206301a; Yoshida E, 2014, COLLOID POLYM SCI, V292, P763, DOI 10.1007/s00396-013-3154-z; Wan WM, 2010, POLYM CHEM-UK, V1, P1475, DOI 10.1039/c0py00124d; SELMAN GG, 1964, J CELL BIOL, V20, P175, DOI 10.1083/jcb.20.1.175; Yoshida E, 2015, COLLOID POLYM SCI, V293, P1841, DOI 10.1007/s00396-015-3600-1; ISRAELACHVILI JN, 1976, J CHEM SOC FARAD T 2, V72, P1525, DOI 10.1039/f29767201525; Dodonova SO, 2015, SCIENCE, V349, P195, DOI 10.1126/science.aab1121; Yoshida E, 2014, COLLOID POLYM SCI, V292, P1463, DOI 10.1007/s00396-014-3216-x; Yoshida E, 2013, COLLOID POLYM SCI, V291, P2733, DOI 10.1007/s00396-013-3056-0; Delaittre G, 2009, CHEM COMMUN, P2887, DOI 10.1039/b903040a; Sadava DE, 1993, CELL BIOL ORGANELLE, P130; Yoshida E, 2015, COLLOID POLYM SCI, V293, P1275, DOI 10.1007/s00396-015-3519-6; Yoshida E, 2014, COLLOID POLYM SCI, V292, P2555, DOI 10.1007/s00396-014-3297-6; Yoshida E, 2013, OPEN J POLYM CHEM, V3, P16; Yoshida E, 2015, SUPRAMOL CHEM, V27, P274, DOI 10.1080/10610278.2014.959014; Yoshida E, 2015, COLLOID POLYM SCI, V293, P649, DOI 10.1007/s00396-014-3482-7; Yoshida E, 2012, POLYM SCI, DOI 10.5402/2012/102186	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	DEC	2015	293	12					3641	3648		10.1007/s00396-015-3763-9		8	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CX5ON	WOS:000365751600027		
J	Ishigami, T; Kaneko, Y; Suga, K; Okamoto, Y; Umakoshi, H				Ishigami, Takaaki; Kaneko, Yoshinori; Suga, Keishi; Okamoto, Yukihiro; Umakoshi, Hiroshi			Homochiral oligomerization of L-histidine in the presence of liposome membranes	COLLOID AND POLYMER SCIENCE			English	Article						Liposome membrane; Enantioselective adsorption; Homochiral oligomerization; Histidine; Amino acids	AMINO-ACIDS; POLYMERIZATION; PEPTIDES; MICELLES; VESICLES; ORIGIN; LIFE; LONG	We report about a novel method for the homochiral oligomerization of l-amino acids in the presence of liposomes. For this homochiral oligomerization, we took advantage of the superior properties of liposomes as chiral adsorbent, concentrator of reacting molecules, and as effective reaction medium. Indeed, liposomes composed of l-phospholipids could enantioselectively bind and concentrate only l-histidine (l-His) on the liposome membrane, and not D-His, which was confirmed by UV measurements. Furthermore, we demonstrate that the liposomes enabled effective oligomerization of l-His on or in the liposome membrane, while the oligomerization of d-His in the liposome system-or in absence of liposomes-was less efficient. The experimental findings are supported by logP value calculations. These calculations indicate that activated intermediates locate in the center of the bilayer where they are protected from hydrolysis due to the hydrophobic environment of the liposome membrane. Therefore, the use of liposomes from l-phospholipids enables homochiral oligomerization and more efficient oligomerization of l-amino acids as compared to d-amino acids. Thus, our developed method could be used for the synthesis of homochiral polymers from racemic mixtures of monomers and may contribute to the understanding of prebiotic biopolymer formation.	[Ishigami, Takaaki; Kaneko, Yoshinori; Suga, Keishi; Okamoto, Yukihiro; Umakoshi, Hiroshi] Osaka Univ, Grad Sch Engn Sci, Div Chem Engn, Toyonaka, Osaka 5608531, Japan	Umakoshi, H (reprint author), Osaka Univ, Grad Sch Engn Sci, Div Chem Engn, 1-3 Machikaneyamacho, Toyonaka, Osaka 5608531, Japan.	B-ICE@cheng.es.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [13J03878]; Funding Program for Next Generation World-Leading Researchers of the Council for Science and Technology Policy (CSTP) [GR066]; JSPS [26249116, 25889039]; Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology of Japan [2306]	This research was supported by a Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for JSPS Fellows number 13J03878, the Funding Program for Next Generation World-Leading Researchers of the Council for Science and Technology Policy (CSTP) (GR066), a JSPS Grant-in-Aid for Scientific Research A (26249116), and a JSPS Grant-in-Aid for Research Activity Start-up (25889039). One of the authors (T.I.) expresses his gratitude for the Japan Society for the Promotion of Science (JSPS) scholarships. Furthermore, Y.O. acknowledges the Multidisciplinary Research Laboratory System in Osaka University and a Grant-in-Aid for Scientific Research on Innovative Areas "Nanomedicine Molecular Science" (No. 2306) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. All the authors also thank Mr. Makoto Nakata of Peptide Institute, Inc. for performing MALDI-TOF MS experiments.	WALDE P, 1994, J AM CHEM SOC, V116, P7541, DOI 10.1021/ja00096a010; Hitz T, 2001, MACROMOLECULES, V34, P2443, DOI 10.1021/ma001946w; Ferris JP, 1996, NATURE, V381, P59, DOI 10.1038/381059a0; Ishigami T, 2013, SOLVENT EXTR RES DEV, V20, P213; Kunishima M, 2005, ANGEW CHEM INT EDIT, V44, P7254, DOI 10.1002/anie.200502594; Blocher M, 1999, MACROMOLECULES, V32, P7332, DOI 10.1021/ma990917m; Rajamani S, 2008, ORIGINS LIFE EVOL B, V38, P57, DOI 10.1007/s11084-007-9113-2; Orgel LE, 1998, ORIGINS LIFE EVOL B, V28, P227, DOI 10.1023/A:1006595411403; Zepik HH, 2007, ORIGINS LIFE EVOL B, V37, P495, DOI 10.1007/s11084-007-9070-9; Blain JC, 2014, ANNU REV BIOCHEM, V83, P615, DOI 10.1146/annurev-biochem-080411-124036; Brandenburg A, 2004, INT J ASTROBIOL, V3, P209, DOI 10.1017/S1473550404001983; Luisi PL, 1999, CURR OPIN COLLOID IN, V4, P33, DOI 10.1016/S1359-0294(99)00012-6; BADA JL, 1995, NATURE, V374, P594, DOI 10.1038/374594a0; Walde P, 2014, CHEM COMMUN, V50, P10177, DOI 10.1039/c4cc02812k; Weissbuch I, 2009, ACCOUNTS CHEM RES, V42, P1128, DOI 10.1021/ar900033k; Tuan LQ, 2008, LANGMUIR, V24, P350, DOI 10.1021/la702690a; Yoshimoto M, 2007, LANGMUIR, V23, P9416, DOI 10.1021/la701277f; Brandenburg A, 2005, ORIGINS LIFE EVOL B, V35, P225, DOI 10.1007/s11084-005-0656-9; Sandars PGH, 2003, ORIGINS LIFE EVOL B, V33, P575, DOI 10.1023/A:1025705401769	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	DEC	2015	293	12					3649	3653		10.1007/s00396-015-3764-8		5	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CX5ON	WOS:000365751600028		
J	Wu, CT; Wu, YC; Koishi, M				Wu, C. T.; Wu, Youcai; Koishi, M.			A strain-morphed nonlocal meshfree method for the regularized particle simulation of elastic-damage induced strain localization problems	COMPUTATIONAL MECHANICS			English	Article						Meshfree; Nodal integration; Nonlocal; Stabilization; Regularization	CONFORMING NODAL INTEGRATION; FAILURE ANALYSIS; GALERKIN METHOD; SOLIDS; ELEMENT; DEFORMATION; STABILITY; MODEL	In this work, a strain-morphed nonlocal meshfree method is developed to overcome the computational challenges for the simulation of elastic-damage induced strain localization problem when the spatial domain integration is performed based on the background cells and Gaussian quadrature rule. The new method is established by introducing the decomposed strain fields from a meshfree strain smoothing to the penalized variational formulation. While the stabilization strain field circumvents the onerous zero-energy modes inherent in the direct nodal integration scheme, the regularization strain field aims to avoid the pathological localization of deformation in Galerkin meshfree solution using the weak-discontinuity approach. A strain morphing algorithm is introduced to couple the locality and non-locality of the decomposed strain approximations such that the continuity condition in the coupled strain field is met under the Galerkin meshfree framework using the direct nodal integration scheme. Three numerical benchmarks are examined to demonstrate the effectiveness and accuracy of the proposed method for the regularization of elastic-damage induced strain localization problems.	[Wu, C. T.] Livermore Software Technol Corp, Livermore, CA 94550 USA; [Wu, Youcai] Karagozian & Case, Glendale, CA 91203 USA; [Koishi, M.] Yokohama Rubber Co Ltd, Koishi Lab, Hiratsuka, Kanagawa 2548601, Japan	Wu, CT (reprint author), Livermore Software Technol Corp, Livermore, CA 94550 USA.	ctwu@lstc.com			Yokohama Rubber Co. Ltd.	The authors would like to thank Dr. John O. Hallquist of LSTC for his support to this research. The support from Yokohama Rubber Co. Ltd. to LSTC under the Yosemite Project is greatly acknowledged.	Dyka CT, 1997, INT J NUMER METH ENG, V40, P2325, DOI 10.1002/(SICI)1097-0207(19970715)40:13<2325::AID-NME161>3.0.CO;2-8; Li SF, 2000, INT J NUMER METH ENG, V48, P1285, DOI 10.1002/1097-0207(20000730)48:9<1285::AID-NME825>3.3.CO;2-8; BELYTSCHKO T, 1994, INT J NUMER METH ENG, V37, P229, DOI 10.1002/nme.1620370205; Wu CT, 2015, COMPUT METHOD APPL M, V291, P197, DOI 10.1016/j.cma.2015.03.003; Chen JS, 2000, INT J NUMER METH ENG, V47, P1303, DOI 10.1002/(SICI)1097-0207(20000310)47:7<1303::AID-NME826>3.3.CO;2-X; Silling SA, 2005, COMPUT STRUCT, V83, P1526, DOI 10.1016/j.compstruc.2004.11.026; Peerlings RHJ, 2002, EUR J MECH A-SOLID, V21, P175, DOI 10.1016/S0997-7538(02)01211-1; Sukumar N, 2004, INT J NUMER METH ENG, V61, P2159, DOI 10.1002/nme.1193; Wang DD, 2014, ENG ANAL BOUND ELEM, V42, P51, DOI 10.1016/j.enganabound.2013.09.001; Rabczuk T, 2004, COMPUT METHOD APPL M, V193, P1035, DOI 10.1016/j.cma.2003.12.005; Lian YP, 2015, COMPUT METHOD APPL M, V289, P291, DOI 10.1016/j.cma.2015.02.020; Belytschko T, 2000, INT J NUMER METH ENG, V48, P1359, DOI 10.1002/1097-0207(20000730)48:9<1359::AID-NME829>3.0.CO;2-U; Cardoso RPR, 2002, COMPUT METHOD APPL M, V191, P5177, DOI 10.1016/S0045-7825(02)00455-3; Lian YP, 2014, INT J IMPACT ENG, V70, P50, DOI 10.1016/j.ijimpeng.2014.03.008; Wang DD, 2013, COMPUT MECH, V51, P1013, DOI 10.1007/s00466-012-0784-9; Wu C, 2015, COMPUT MECH, V56, P19, DOI 10.1007/s00466-015-1153-2; Wu CT, 2013, COMPOS PART B-ENG, V45, P1397, DOI 10.1016/j.compositesb.2012.09.061; Chen JS, 2001, INT J NUMER METH ENG, V50, P435, DOI 10.1002/1097-0207(20010120)50:2<435::AID-NME32>3.0.CO;2-A; HILL R, 1958, J MECH PHYS SOLIDS, V6, P236, DOI 10.1016/0022-5096(58)90029-2; Wang DD, 2014, COMPUT MECH, V54, P689, DOI 10.1007/s00466-014-1022-4; Chen JS, 2004, COMPUT METHOD APPL M, V193, P2827, DOI 10.1016/j.cma.2003.12.057; SIMO JC, 1986, J APPL MECH-T ASME, V53, P51; [Anonymous], 2009, INTERACTION MULTISCA; Wang DD, 2013, INT J DAMAGE MECH, V22, P440, DOI 10.1177/1056789512455938; Wu CT, 2011, INT J NUMER METH ENG, V85, P693, DOI 10.1002/nme.2991; HILL R, 1962, J MECH PHYS SOLIDS, V10, P1, DOI 10.1016/0022-5096(62)90024-8; Bavzant ZP, 1984, J ENG MECH, V110, P1666; Bavzant ZP, 1998, FRACTURE SIZE EFFECT; Beissel S, 1996, COMPUT METHOD APPL M, V139, P49, DOI 10.1016/S0045-7825(96)01079-1; Chen JS, 1996, COMPUT METHOD APPL M, V139, P195, DOI 10.1016/S0045-7825(96)01083-3; Chen JS, 2013, INT J NUMER METHODS, V95, P361; DEBORST R, 1992, INT J NUMER METH ENG, V35, P521, DOI 10.1002/nme.1620350307; Hillman M, 2014, COMPUT PART MECH, V1, P245; LASRY D, 1988, INT J SOLIDS STRUCT, V24, P581, DOI 10.1016/0020-7683(88)90059-5; Li S, 2004, MESHFREE PARTICLE ME; LIU WK, 1995, INT J NUMER METH FL, V20, P1081, DOI 10.1002/fld.1650200824; Wu CT, 2014, 13 INT LS DYNA US C, P1; Wu YC, 2015, INT J IMPACT ENG, DOI [10.1016/j.ijimpeng.2015.03.013, DOI 10.1016/J.IJIMPENG.2015.03.013]; Wu YC, 2014, THEOR APPL FRACT MEC, V27, P89	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0178-7675	1432-0924		COMPUT MECH	Comput. Mech.	DEC	2015	56	6					1039	1054		10.1007/s00466-015-1217-3		16	Mathematics, Interdisciplinary Applications; Mechanics	Mathematics; Mechanics	CX4YJ	WOS:000365706600008		
J	Hurkamp, A; Tanaka, M; Kaliske, M				Huerkamp, Andre; Tanaka, Masato; Kaliske, Michael			Complex step derivative approximation of consistent tangent operators for viscoelasticity based on fractional calculus	COMPUTATIONAL MECHANICS			English	Article						Complex step derivative approximation; Algorithmic tangent moduli; Fractional time derivative; Large strain viscoelasticity; Nonlinear finite element simulation	TIME-DEPENDENT BEHAVIOR; NUMERICAL DIFFERENTIATION; STIFFNESS MATRICES; PLASTICITY; MODEL; FORMULATION; ELASTOMERS; MODULI	In this contribution, the convergence behaviour of simulations with nonlinear viscoelastic models for rubber-like materials using fractional derivatives is investigated. Based on the complex step derivative approximation, numerical approximation schemes for tangent operators on the local and global algorithmic level are analysed. Material models including fractional derivatives usually exhibit numerical difficulties, since the entire stress history of the material has to be considered for the current stress state. Non-classical methods can help to reduce the numerical effort, but the convergence behaviour is not perfect. In this paper, a classical and a non-classical fractional element based viscoelastic material formulation are analysed. The local and the global convergence rate using analytically and numerically derived tangents are investigated and compared to the convergence behaviour of a standard nonlinear viscoelastic model. Numerical examples on rubber materials are exploited, showing the performance of the proposed methods. It can be proven that the outlined numerical differentiation schemes improve the convergence rate, as well as reduce the computation time for the fractional element based material models.	[Huerkamp, Andre; Kaliske, Michael] Tech Univ Dresden, Fac Civil Engn, Inst Struct Anal, D-01062 Dresden, Germany; [Tanaka, Masato] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan	Kaliske, M (reprint author), Tech Univ Dresden, Fac Civil Engn, Inst Struct Anal, D-01062 Dresden, Germany.	michael.kaliske@tu-dresden.de					Tanaka M, 2015, COMPUT METHOD APPL M, V283, P22, DOI 10.1016/j.cma.2014.08.020; Bergstrom JS, 1998, J MECH PHYS SOLIDS, V46, P931, DOI 10.1016/S0022-5096(97)00075-6; Balzani D, 2015, COMPUT MECH, V55, P861, DOI 10.1007/s00466-015-1139-0; Tanaka M, 2014, COMPUT METHOD APPL M, V269, P454, DOI 10.1016/j.cma.2013.11.005; Zopf C, 2015, COMP MATER SCI, V98, P287, DOI 10.1016/j.commatsci.2014.11.012; Lai KL, 2008, J COMPUT APPL MATH, V219, P276, DOI 10.1016/j.cam.2007.07.026; Perez-Foguet A, 2000, INT J NUMER METH ENG, V48, P159, DOI 10.1002/(SICI)1097-0207(20000520)48:2<159::AID-NME871>3.0.CO;2-Y; Dal H, 2009, COMPUT MECH, V44, P809, DOI 10.1007/s00466-009-0407-2; KOELLER RC, 1984, J APPL MECH-T ASME, V51, P299; Kim S, 2011, COMPUT METHOD APPL M, V200, P403, DOI 10.1016/j.cma.2010.09.004; Bergstrom JS, 2000, MECH MATER, V32, P627, DOI 10.1016/S0167-6636(00)00028-4; Birk C, 2010, COMPUT MECH, V46, P721, DOI 10.1007/s00466-010-0510-4; BAGLEY RL, 1986, J RHEOL, V30, P133, DOI 10.1122/1.549887; Diethelm K, 2008, NUMER ALGORITHMS, V47, P361, DOI 10.1007/s11075-008-9193-8; Perez-Foguet A, 2000, COMPUT METHOD APPL M, V189, P277, DOI 10.1016/S0045-7825(99)00296-0; Miehe C, 1996, COMPUT METHOD APPL M, V134, P223, DOI 10.1016/0045-7825(96)01019-5; SIMO JC, 1992, COMPUT METHOD APPL M, V99, P61, DOI 10.1016/0045-7825(92)90123-2; Schmidt A, 2002, NONLINEAR DYNAM, V29, P37, DOI 10.1023/A:1016552503411; Martins JRRA, 2003, ACM T MATH SOFTWARE, V29, P245, DOI 10.1145/838250.838251; Zopf C, 2013, KGK-KAUT GUMMI KUNST, V66, P32; BAGLEY RL, 1983, AIAA J, V21, P741, DOI 10.2514/3.8142; Diethelm K, 2009, J VIB ACOUST, V131, P1; Holzapfel G.A., 2000, NONLINEAR SOLID MECH; Kaliske M, 1995, THESIS; Lyness J. N., 1967, SIAM J NUMER ANAL, V4, P202, DOI DOI 10.1137/0704019; Caputo M., 1971, Rivista del Nuovo Cimento, V1, DOI 10.1007/BF02820620; MIEHE C, 1994, INT J NUMER METH ENG, V37, P1981, DOI 10.1002/nme.1620371202; Muller S, 2012, COMPUT MECH, V51, P999; Sasagawa T, 2014, T JAPAN SOC COMPUT E, V2014; SIMO JC, 1985, COMPUT METHOD APPL M, V51, P177, DOI 10.1016/0045-7825(85)90033-7	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0178-7675	1432-0924		COMPUT MECH	Comput. Mech.	DEC	2015	56	6					1055	1071		10.1007/s00466-015-1218-2		17	Mathematics, Interdisciplinary Applications; Mechanics	Mathematics; Mechanics	CX4YJ	WOS:000365706600009		
J	Kuroda, M; Geng, Z; Sakakihara, M				Kuroda, Masahiro; Geng, Zhi; Sakakihara, Michio			Improving the vector acceleration for the EM algorithm using a re-starting procedure	COMPUTATIONAL STATISTICS			English	Article						The vector epsilon algorithm; The EM algorithm; Re-starting procedure; Acceleration of convergence	GAUSSIAN MIXTURE-MODELS; MAXIMUM-LIKELIHOOD; EPSILON-ALGORITHM; CONVERGENCE; VALUES	The expectation-maximization (EM) algorithm is a popular algorithm for finding maximum likelihood estimates from incomplete data. However, the EM algorithm converges slowly when the proportion of missing data is large. Although many acceleration algorithms have been proposed, they require complex calculations. Kuroda and Sakakihara (Comput Stat Data Anal 51:1549-1561, 2006) developed the -accelerated EM algorithm which only uses the sequence of estimates obtained by the EM algorithm to get an accelerated sequence for the EM sequence but does not change the original EM sequence. We find that the accelerated sequence often has larger values of the likelihood than the current estimate obtained by the EM algorithm. Thus, in this paper, we try to re-start the EM iterations using the accelerated sequence and then generate a new EM sequence that increases its speed of convergence. This algorithm has another advantage of simple implementation since it only uses the EM iterations and re-starts the iterations by an estimate with a larger likelihood. The re-starting algorithm called the R-accelerated EM algorithm can further improve the EM algorithm and the -accelerated EM algorithm in the sense of that it can reduces the number of iterations and computation time.	[Kuroda, Masahiro] Okayama Univ Sci, Dept Socioinformat, Okayama 7000005, Japan; [Geng, Zhi] Peking Univ, Sch Math Sci, LMAM, Beijing 100871, Peoples R China; [Sakakihara, Michio] Okayama Univ Sci, Dept Informat Sci, Okayama 7000005, Japan	Kuroda, M (reprint author), Okayama Univ Sci, Dept Socioinformat, 1-1 Ridaicho, Okayama 7000005, Japan.	kuroda@soci.ous.ac.jp			Japan Society for the Promotion of Science (JSPS) [24500353]	The authors would like to thank the editor and two referees for their valuable comments and helpful suggestions. This research is supported by the Japan Society for the Promotion of Science (JSPS), Grant-in-Aid for Scientific Research (C), No. 24500353.	Lin TI, 2009, J MULTIVARIATE ANAL, V100, P257, DOI 10.1016/j.jmva.2008.04.010; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1; Wang MF, 2008, COMPUTATION STAT, V23, P469, DOI 10.1007/s00180-007-0089-1; LAIRD N, 1987, J AM STAT ASSOC, V82, P97, DOI 10.2307/2289129; Pyne S, 2009, P NATL ACAD SCI USA, V106, P8519, DOI 10.1073/pnas.0903028106; JAMSHIDIAN M, 1993, J AM STAT ASSOC, V88, P221, DOI 10.2307/2290716; Lee G, 2012, COMPUT STAT DATA AN, V56, P2816, DOI 10.1016/j.csda.2012.03.003; Karlis D, 2003, COMPUT STAT DATA AN, V41, P577, DOI 10.1016/S0167-9473(02)00177-9; Lee G, 2011, J BIOMED INFORM, V44, P663, DOI 10.1016/j.jbi.2011.03.004; MENG XL, 1994, LINEAR ALGEBRA APPL, V199, P413, DOI 10.1016/0024-3795(94)90363-8; Jamshidian M, 1997, J ROY STAT SOC B MET, V59, P569, DOI 10.1111/1467-9868.00083; Kuroda M, 2006, COMPUT STAT DATA AN, V51, P1549, DOI 10.1016/j.csda.2006.05.004; Biernacki C, 2003, COMPUT STAT DATA AN, V41, P561, DOI 10.1016/S0167-9473(02)00163-9; Jones O, 2009, INTRO SCI PROGRAMMIN; LANGE K, 1995, STAT SINICA, V5, P1; Little R.J.A., 1987, STAT ANAL MISSING DA; LOUIS TA, 1982, J ROY STAT SOC B MET, V44, P226; McLachlan G., 2000, FINITE MIXTURE MODEL; R Development Core Team, 2013, R LANG ENV STAT COMP; Schafer J. L., 1997, ANAL INCOMPLETE MULT; Snedecor G W, 1967, STAT METHODS; Wynn P, 1962, MATH COMPUT, V16, P301	22	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0943-4062	1613-9658		COMPUTATION STAT	Comput. Stat.	DEC	2015	30	4					1051	1077		10.1007/s00180-015-0565-y		27	Statistics & Probability	Mathematics	CX5CZ	WOS:000365720500007		
J	Kurokochi, H; Nurtjahjaningsih, ILG; Sukartiningsih; Tan, EK; Asakawa, S; Saito, Y; Ide, Y				Kurokochi, Hiroyuki; Nurtjahjaningsih, I. L. G.; Sukartiningsih; Tan, Engkong; Asakawa, Shuichi; Saito, Yoko; Ide, Yuji			Development of polymorphic chloroplast DNA markers for the endangered tree Eusideroxylon zwageri through chloroplast isolation and next-generation sequencing	CONSERVATION GENETICS RESOURCES			English	Article						Eusideroxylon zwageri; Next-generation sequencing; Chloroplast DNA; Polymorphic markers; Phylogeography	MICROSATELLITE MARKERS; GENOME	Borneo ironwood (Eusideroxylon zwageri) is a tall tropical tree that is threatened by illegal logging and exploitation due to its economic value. In the present study, approximately 10,618 bp of E. zwageri chloroplast DNA were sequenced genome-wide and 16 polymorphic markers of chloroplast DNA were developed, using next-generation sequencing technology. In total, 26 nucleotide substitutions, 3 indels, 1 sequence inversion, and 1 mononucleotide repeat variation were detected in samples of 10 trees collected from 5 populations in Kalimantan, Indonesia. These markers are a powerful tool that may be used to describe the phylogeographical genetic structure of E. zwageri and will be essential for the conservation and management of this endangered tree.	[Kurokochi, Hiroyuki] Univ Tokyo, Asian Nat Environm Sci Ctr, Nishitokyo, Tokyo 1880002, Japan; [Nurtjahjaningsih, I. L. G.; Tan, Engkong; Asakawa, Shuichi; Saito, Yoko; Ide, Yuji] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Sukartiningsih] Mulawarman Univ, Fac Forestry, Samarinda 75119, East Kalimantan, Indonesia	Kurokochi, H (reprint author), Univ Tokyo, Asian Nat Environm Sci Ctr, 1-1-8 Midori Cho, Nishitokyo, Tokyo 1880002, Japan.	kurokochi@anesc.u-tokyo.ac.jp			JSPS [25304025]	This study was supported in part by a Grant-in-Aid for Scientific Research (B) from the JSPS to YI (No. 25304025).	Kurokochi H, 2014, CONSERV GENET RESOUR, V6, P593, DOI 10.1007/s12686-014-0148-1; PETIT RJ, 1993, THEOR APPL GENET, V87, P122, DOI 10.1007/BF00223755; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Kurokochi H, 2013, BOTANY, V91, P148, DOI 10.1139/cjb-2012-0159; SATO N, 1993, EMBO J, V12, P555; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; SHINOZAKI K, 1986, EMBO J, V5, P2043; Hall T, 2004, BIOEDIT VERSION 7 0; Kurokochi H, 2015, J FOREST RES-JPN, V20, P244, DOI 10.1007/s10310-014-0456-z; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Partomihardjo T, 1987, DUTA RIMBA, V13, P10; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Whitten AJ, 1987, ECOLOGY SUMATRA	14	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1877-7252	1877-7260		CONSERV GENET RESOUR	Conserv. Genet. Resour.	DEC	2015	7	4					845	850		10.1007/s12686-015-0485-8		6	Biodiversity Conservation; Genetics & Heredity	Biodiversity & Conservation; Genetics & Heredity	CX0XH	WOS:000365420200015		
J	Miura, O; Nishimura, T				Miura, Osamu; Nishimura, Tomohiro			Development and characterization of ten polymorphic microsatellite markers for the American mud snails Cerithideopsis californica	CONSERVATION GENETICS RESOURCES			English	Article						Microsatellite; Cerithideopsis californica; Invasive species		We describe ten polymorphic microsatellite markers in the American mud snail, Cerithideopsis californica which is declining after the invasion of an Asian mud snail. The number of alleles per locus ranged from 4 to 15. Expected heterozygosity ranged from 0.44 to 0.85. No loci deviated significantly from Hardy-Weinberg equilibrium and no significant linkage disequilibrium was detected after the correction for multiple testing. The set of markers described here will constitute efficient tools for the conservation genetic study of C. californica.	[Miura, Osamu; Nishimura, Tomohiro] Kochi Univ, Ctr Sci Res, Oceanog Sect, Nankoku, Kochi 7838502, Japan	Miura, O (reprint author), Kochi Univ, Ctr Sci Res, Oceanog Sect, 200 Monobe, Nankoku, Kochi 7838502, Japan.	miurao@kochi-u.ac.jp			Program to Disseminate Tenure Tracking System from the MEXT	We thank M. E. Torchin and S. Carmen for their field assistance and N. Sato for her laboratory assistance. H. Itoh and S. Kamimura provided useful information for the development of the microsatellite markers. Support was provided by Program to Disseminate Tenure Tracking System from the MEXT.	Blacket MJ, 2012, MOL ECOL RESOUR, V12, P456, DOI 10.1111/j.1755-0998.2011.03104.x; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Byers James E., 1999, Biological Invasions, V1, P339, DOI 10.1023/A:1010038001768; Meglecz E, 2014, MOL ECOL RESOUR, V14, P1302, DOI 10.1111/1755-0998.12271	5	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1877-7252	1877-7260		CONSERV GENET RESOUR	Conserv. Genet. Resour.	DEC	2015	7	4					879	880		10.1007/s12686-015-0494-7		2	Biodiversity Conservation; Genetics & Heredity	Biodiversity & Conservation; Genetics & Heredity	CX0XH	WOS:000365420200019		
J	Mogensen, KM; Robinson, MK; Casey, JD; Gunasekera, NS; Moromizato, T; Rawn, JD; Christopher, KB				Mogensen, Kris M.; Robinson, Malcolm K.; Casey, Jonathan D.; Gunasekera, Nicole S.; Moromizato, Takuhiro; Rawn, James D.; Christopher, Kenneth B.			Nutritional Status and Mortality in the Critically Ill	CRITICAL CARE MEDICINE			English	Article						critical illness; malnutrition; mortality; nutrition	DISEASE-RELATED MALNUTRITION; BODY-MASS INDEX; HOSPITALIZED-PATIENTS; CRITICAL-CARE; PARENTERAL-NUTRITION; SCREENING TOOL; UNITED-STATES; PREVALENCE; IMPACT; RISK	Objectives: The association between nutritional status and mortality in critically ill patients is unclear based on the current literature. To clarify this relation, we analyzed the association between nutrition and mortality in a large population of critically ill patients and hypothesized that mortality would be impacted by nutritional status. Design: Retrospective observational study. Setting: Single academic medical center. Patients Six thousand five hundred eighteen adults treated in medical and surgical ICUs between 2004 and 2011. Interventions: None. Measurements and Main Results: All cohort patients received a formal, in-person, standardized evaluation by a registered dietitian. The exposure of interest, malnutrition, was categorized as nonspecific malnutrition, protein-energy malnutrition, or well nourished and determined by data related to anthropometric measurements, biochemical indicators, clinical signs of malnutrition, malnutrition risk factors, and metabolic stress. The primary outcome was all-cause 30-day mortality determined by the Social Security Death Master File. Associations between nutrition groups and mortality were estimated by bivariable and multivariable logistic regression models. Adjusted odds ratios were estimated with inclusion of covariate terms thought to plausibly interact with both nutrition status and mortality. We used propensity score matching on baseline characteristics to reduce residual confounding of the nutrition status category assignment. In the cohort, nonspecific malnutrition was present in 56%, protein-energy malnutrition was present in 12%, and 32% were well nourished. The 30-day and 90-day mortality rates for the cohort were 19.1% and 26.6%, respectively. Nutritional status is a significant predictor of 30-day mortality following adjustment for age, gender, race, medical versus surgical patient type, Deyo-Charlson index, acute organ failure, vasopressor use, and sepsis: nonspecific malnutrition 30-day mortality odds ratio, 1.17 (95% CI, 1.01-1.37); protein-energy malnutrition 30-day mortality odds ratio, 2.10 (95% CI, 1.70-2.59), all relative to patients without malnutrition. In the matched cohort, the adjusted odds of 30-day mortality in the group of propensity score-matched patients with protein-energy malnutrition was two-fold greater than that of patients without malnutrition. Conclusion: In a large population of critically ill adults, an association exists between nutrition status and mortality.	[Mogensen, Kris M.] Brigham & Womens Hosp, Dept Nutr, Boston, MA 02115 USA; [Robinson, Malcolm K.; Rawn, James D.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Casey, Jonathan D.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Gunasekera, Nicole S.] Harvard Univ, Sch Med, Boston, MA USA; [Moromizato, Takuhiro] Okinawa Hokubu Prefectural Hosp, Dept Med, Okinawa, Japan; [Christopher, Kenneth B.] Brigham & Womens Hosp, Dept Med, Nathan E Hellman Mem Lab, Div Renal, Boston, MA 02115 USA	Christopher, KB (reprint author), Brigham & Womens Hosp, Dept Med, Nathan E Hellman Mem Lab, Div Renal, Boston, MA 02115 USA.	kbchristopher@partners.org			ThriveRx; International Symposium on Intensive Care and Emergency Medicine Faculty Member Honorarium; ASPEN Clinical Nutrition Week Faculty Honorarium	Ms. Mogensen received support from honoraria for speaking for the Massachusetts Dietetic Association and related Massachusetts Dietetic Association subchapters as well as honorarium for speaking at the Academy of Nutrition and Dietetics 2014 Food and Nutrition Conference and Expo (these are in the past, but there may be future speaking engagements), received consulting fees for Advisory Board membership from ThriveRx (home infusion company), received royalties for the publication/continuing education self-study course "Nutritional Support of the Critically Ill Adult" from Wolf Rinke Associates, and received honoraria for speaking at Clinical Nutrition Week in 2013, 2014, and 2015 from the American Society for Parenteral and Enteral Nutrition. Dr. Christopher received support from the International Symposium on Intensive Care and Emergency Medicine Faculty Member Honorarium and the ASPEN Clinical Nutrition Week Faculty Honorarium. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Zager S, 2011, CHEST, V139, P1368, DOI 10.1378/chest.10-2594; Tremblay A, 2003, CHEST, V123, P1202, DOI 10.1378/chest.123.4.1202; Kruizenga HM, 2003, CLIN NUTR, V22, P147, DOI 10.1054/clnu.2002.0611; Swails WS, 1996, J AM DIET ASSOC, V96, P370, DOI 10.1016/S0002-8223(96)00101-0; Schols AMWJ, 1998, AM J RESP CRIT CARE, V157, P1791; Dreyfus B, 2013, CANCER EPIDEMIOL, V37, P191, DOI 10.1016/j.canep.2012.11.001; Dvir D, 2006, CLIN NUTR, V25, P37, DOI 10.1016/j.clnu.2005.10.010; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Iwashyna TJ, 2014, MED CARE, V52, pE39, DOI 10.1097/MLR.0b013e318268ac86; Planas M, 2004, CLIN NUTR, V23, P1016, DOI 10.1016/j.clnu.2004.01.003; Phang PT, 1996, CAN J SURG, V39, P212; Caregaro L, 1996, AM J CLIN NUTR, V63, P602; Ferguson M, 1999, NUTRITION, V15, P458, DOI 10.1016/S0899-9007(99)00084-2; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Alberda C, 2009, INTENS CARE MED, V35, P1728, DOI 10.1007/s00134-009-1567-4; Robinson MK, 2003, JPEN-PARENTER ENTER, V27, P389, DOI 10.1177/0148607103027006389; White JV, 2012, J ACAD NUTR DIET, V112, P730, DOI 10.1016/j.jand.2012.03.012; Pirlich M, 2006, CLIN NUTR, V25, P563, DOI 10.1016/j.clnu.2006.03.005; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; Singh GK, 2003, AM J PUBLIC HEALTH, V93, P1137, DOI 10.2105/AJPH.93.7.1137; [Anonymous], 1991, N ENG J MED, V325, P525; Westergren A, 2008, J NUTR HEALTH AGING, V12, P39, DOI 10.1007/BF02982162; Kaiser MJ, 2010, J AM GERIATR SOC, V58, P1734, DOI 10.1111/j.1532-5415.2010.03016.x; Cartin-Ceba R, 2007, CRIT CARE MED, V35, P2420, DOI 10.1097/01.CCM.0000281856.78526.F4; SIMOPOULOS AP, 1986, ANNU REV PUBL HEALTH, V7, P481, DOI 10.1146/annurev.publhealth.7.1.481; O'Flynn J, 2005, CLIN NUTR, V24, P1078, DOI 10.1016/j.clnu.2005.08.012; Giner M, 1996, NUTRITION, V12, P23, DOI 10.1016/0899-9007(95)00015-1; CEDERHOLM T, 1995, AM J MED, V98, P67, DOI 10.1016/S0002-9343(99)80082-5; REILLY JJ, 1988, JPEN-PARENTER ENTER, V12, P371, DOI 10.1177/0148607188012004371; MCWHIRTER JP, 1994, BRIT MED J, V308, P945; THOMAS L, 1979, INTENS CARE MED, V5, P156, DOI 10.1007/BF01683201; [Anonymous], 2013, AC INP PROSP PAYM SY; Jordao AA, 2004, INT J OBESITY, V28, P1451, DOI 10.1038/sj.ijo.0802781; DOWEIKO JP, 1991, JPEN-PARENTER ENTER, V15, P476, DOI 10.1177/0148607191015004476; De Lima JJG, 1998, RENAL FAILURE, V20, P581, DOI 10.3109/08860229809045150; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90; Correia MITD, 2003, CLIN NUTR, V22, P235, DOI 10.1016/S0261-5614(02)00215-7; Jacobs DG, 2004, J TRAUMA, V57, P660, DOI 10.1097/01.TA.0000135348.48525.A0; Purtle SW, 2014, CRIT CARE MED, V42, P918, DOI 10.1097/CCM.0000000000000118; van Venrooij LMW, 2011, J AM DIET ASSOC, V111, P1924, DOI 10.1016/j.jada.2011.09.009; INGENBLEEK Y, 1985, INT J VITAM NUTR RES, V55, P91; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Kagansky N, 2005, AM J CLIN NUTR, V82, P784; Drahos J, 2013, ANN EPIDEMIOL, V23, P291, DOI 10.1016/j.annepidem.2013.02.005; Norman K, 2008, CLIN NUTR, V27, P5, DOI 10.1016/j.clnu.2007.10.007; Angus DC, 2001, CRIT CARE MED, V29, P1303, DOI 10.1097/00003246-200107000-00002; Kondrup J, 2002, CLIN NUTR, V21, P461, DOI 10.1054/clnu.2002.0585; Jensen GL, 2010, JPEN-PARENTER ENTER, V34, P156, DOI 10.1177/0148607110361910; Lawson JA, 2001, J RENAL NUTR, V11, P16, DOI 10.1053/jren.2001.19735; Kind AJH, 2014, ANN INTERN MED, V161, P765, DOI 10.7326/M13-2946; BUZBY GP, 1980, AM J SURG, V139, P160, DOI 10.1016/0002-9610(80)90246-9; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Rasmussen HH, 2004, CLIN NUTR, V23, P1009, DOI 10.1016/j.clnu.2004.01.001; Blackburn G L, 1977, JPEN J Parenter Enteral Nutr, V1, P11, DOI 10.1177/014860717700100111; DEMPSEY DT, 1988, AM J CLIN NUTR, V47, P352; FLEISCH A., 1951, HELVETICA MED ACTA, V18, P23; Horkan CM, 2015, CRIT CARE MED, V43, P354, DOI 10.1097/CCM.0000000000000706; Karkeck J, 1984, AM DIETETIC ASS RENA, V3, P6; Laporte M, 2001, J Nutr Health Aging, V5, P292; Robinson MK, 2015, CRIT CARE MED, V43, P87, DOI 10.1097/CCM.0000000000000602; Thickett DR, 2015, BMJ OPEN RESP RES, V2; Tolzman Casey, 2014, WMJ, V113, P139	64	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	DEC	2015	43	12					2605	2615		10.1097/CCM.0000000000001306		11	Critical Care Medicine	General & Internal Medicine	CX1VB	WOS:000365482600011		
J	Shimizu, I; Yoshida, Y; Minamino, T				Shimizu, Ippei; Yoshida, Yohko; Minamino, Tohru			Maintenance of Subcutaneous Fat Homeostasis Improves Systemic Metabolic Dysfunction in Obesity	DIABETES			English	Editorial Material							INSULIN-RESISTANCE; ADIPOSE-TISSUE; BROWN FAT		[Shimizu, Ippei; Yoshida, Yohko; Minamino, Tohru] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan; [Shimizu, Ippei; Yoshida, Yohko] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol Aging & Cell Biol, Niigata, Japan	Minamino, T (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan.	t_minamino@yahoo.co.jp					Sun K, 2012, P NATL ACAD SCI USA, V109, P5874, DOI 10.1073/pnas.1200447109; Shimizu I, 2014, CELL METAB, V20, P967, DOI 10.1016/j.cmet.2014.10.008; Karakasilioti I, 2013, CELL METAB, V18, P403, DOI 10.1016/j.cmet.2013.08.011; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Shimizu I, 2013, CELL METAB, V18, P491, DOI 10.1016/j.cmet.2013.09.001; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Nedergaard J, 2011, CELL METAB, V13, P238, DOI 10.1016/j.cmet.2011.02.009; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Shimizu I, 2014, J CLIN INVEST, V124, P2099, DOI 10.1172/JCI71643; Rejeski WJ, 2012, NEW ENGL J MED, V366, P1209, DOI 10.1056/NEJMoa1110294; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Liu Y, 2015, DIABETES, V64, P4061, DOI 10.2337/db15-0278	16	0	0	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0012-1797	1939-327X		DIABETES	Diabetes	DEC	2015	64	12					3984	3986		10.2337/dbi15-0013		3	Endocrinology & Metabolism	Endocrinology & Metabolism	CX8DN	WOS:000365932900004		
J	Sweetwyne, MT; Gruenwald, A; Niranjan, T; Nishinakamura, R; Strobl, LJ; Susztaki, K				Sweetwyne, Mariya T.; Gruenwald, Antje; Niranjan, Thiruvur; Nishinakamura, Ryuichi; Strobl, Lothar J.; Susztaki, Katalin			Notch1 and Notch2 in Podocytes Play Differential Roles During Diabetic Nephropathy Development	DIABETES			English	Article							ALAGILLE SYNDROME; EPITHELIAL-CELLS; ACTIVATION; EXPRESSION; PATHWAY; GLOMERULOSCLEROSIS; NEPHRIN; DISEASE; GROWTH; MICE	Notch pathway activation in podocytes has been shown to play an important role in diabetic kidney disease (DKD) development; however, the receptors and ligands involved in the process have not been identified. Here, we report that conditional deletion of Notch1 in podocytes using NPHS2(cre)Notch1(flox/flox) animals resulted in marked amelioration of DKD. On the contrary, podocytespecific genetic deletion of Notch2 had no effect on albuminuria and mesangial expansion. Notch1-null podocytes were protected from apoptosis and dedifferentiation in vitro, likely explaining the protective phenotype in vivo. Deletion of Notch1 in podocytes also resulted in an increase in Notch2 expression, indicating an interaction between the receptors. At the same time, transgenic overexpression of Notch2 in podocytes did not induce phenotypic changes, while constitutive expression of Notch1 caused rapid development of albuminuria and glomerulosclerosis. In summary, our studies indicate that Notchl plays a distinct (nonredundant) role in podocytes during DKD development.	[Sweetwyne, Mariya T.; Gruenwald, Antje; Niranjan, Thiruvur; Susztaki, Katalin] Univ Penn, Perelman Sch Med, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Nishinakamura, Ryuichi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Kidney Dev, Kumamoto, Japan; [Strobl, Lothar J.] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Dept Gene Vectors, Munich, Germany	Susztaki, K (reprint author), Univ Penn, Perelman Sch Med, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA.	ksusztak@mail.med.upenn.edu			National Institutes of Health [DK-076007S1, DK-076007]	This work was supported by National Institutes of Health grants DK-076007S1 to M.T.S. and DK-076007 to K.S.	Cohen MP, 2005, KIDNEY INT, V68, P1554, DOI 10.1111/j.1523-1755.2005.00567.x; Kumar PA, 2014, J PHYSIOL BIOCHEM, V70, P433, DOI 10.1007/s13105-014-0321-8; Graziani I, 2008, CANCER RES, V68, P9678, DOI 10.1158/0008-5472.CAN-08-0969; Lin CL, 2010, DIABETES, V59, P1915, DOI 10.2337/db09-0663; Ueno T, 2013, KIDNEY INT, V83, P1065, DOI 10.1038/ki.2013.48; Artero RD, 2001, DEVELOPMENT, V128, P4251; El Machhour F, 2015, J AM SOC NEPHROL, V26, P1561, DOI 10.1681/ASN.2013090968; Fujimura S, 2010, J AM SOC NEPHROL, V21, P803, DOI 10.1681/ASN.2009040353; Szabo C, 2006, DIABETES, V55, P3004, DOI 10.2337/db06-0147; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Kato H, 2012, SEMIN NEPHROL, V32, P350, DOI 10.1016/j.semnephrol.2012.06.006; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Kato H, 2011, J BIOL CHEM, V286, P26003, DOI 10.1074/jbc.M111.223164; Reidy K, 2014, J CLIN INVEST, V124, P2333, DOI 10.1172/JCI72271; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Waters AM, 2008, J AM SOC NEPHROL, V19, P1139, DOI 10.1681/ASN.2007050596; Krtil J, 2007, KIDNEY BLOOD PRESS R, V30, P162, DOI 10.1159/000102520; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Kamath BM, 2012, AM J MED GENET A, V158A, P85, DOI 10.1002/ajmg.a.34369; Kamath BM, 2012, J MED GENET, V49, P138, DOI 10.1136/jmedgenet-2011-100544; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Waters AM, 2012, J AM SOC NEPHROL, V23, P27, DOI 10.1681/ASN.2011010027; Ka SM, 2012, DIABETOLOGIA, V55, P509, DOI 10.1007/s00125-011-2364-5; Saleem MA, 2002, AM J PATHOL, V161, P1459, DOI 10.1016/S0002-9440(10)64421-5; Bonegio R, 2012, EXP CELL RES, V318, P986, DOI 10.1016/j.yexcr.2012.02.036; Matsui I, 2007, LAB INVEST, V87, P273, DOI 10.1038/labinvest.3700518; Saad S, 2010, INT J BIOCHEM CELL B, V42, P1115, DOI 10.1016/j.biocel.2010.03.016; Lan HY, 2012, CLIN EXP PHARMACOL P, V39, P731, DOI 10.1111/j.1440-1681.2011.05663.x; Sharma M, 2010, AIDS, V24, P2161, DOI 10.1097/QAD.0b013e32833dbc31; Djudjaj S, 2012, J PATHOL, V228, P286, DOI 10.1002/path.4076; Liu ZY, 2013, DEV CELL, V25, P585, DOI 10.1016/j.devcel.2013.05.022; Murea M, 2010, KIDNEY INT, V78, P514, DOI 10.1038/ki.2010.172; Chu D, 2011, ANN ONCOL, V22, P2440, DOI 10.1093/annonc/mdq776; Ilagan Maria Xenia G, 2007, Cell, V128, P1246; Ishikawa Y, 2008, ONCOGENE, V27, P6164; Lasagni L, 2010, STEM CELLS, V28, P1673, DOI 10.1002/stem.492; Schiffer M, 2000, Kidney Int Suppl, V77, pS45; Surendran K, 2010, J AM SOC NEPHROL, V21, P819; Takemoto M, 2002, AM J PATHOL, V161, P799; Tanaka E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4296; Xu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053654	44	0	0	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0012-1797	1939-327X		DIABETES	Diabetes	DEC	2015	64	12					4099	4111		10.2337/db15-0260		13	Endocrinology & Metabolism	Endocrinology & Metabolism	CX8DN	WOS:000365932900016		
J	Wu, B; Huang, JS; Fukuo, K; Suzuki, K; Yoshino, G; Kazumi, T				Wu, Bin; Huang, Jingshan; Fukuo, Keisuke; Suzuki, Kazuhisa; Yoshino, Gen; Kazumi, Tsutomu			Associations between C reactive protein and body fat mass distribution, adipokines, oxidative stress index and arterial	DIABETES-METABOLISM RESEARCH AND REVIEWS			English	Meeting Abstract	19th Scientific Meeting of the Chinese-Diabetes-Society	DEC 09-12, 2015	Suzhou, PEOPLES R CHINA	Chinese Diabet Soc					[Wu, Bin] Kunming Med Univ, Dept Endocrinol, Affiliated Hosp 1, Kunming, Peoples R China; [Wu, Bin; Fukuo, Keisuke; Suzuki, Kazuhisa; Kazumi, Tsutomu] Mukogawa Womens Univ, Open Res Ctr Studying Lifestyle Related Dis, Nishinomiya, Hyogo, Japan; [Fukuo, Keisuke; Suzuki, Kazuhisa; Kazumi, Tsutomu] Mukogawa Womens Univ, Sch Human Environm Sci, Dept Food Sci & Nutr, Nishinomiya, Hyogo, Japan; [Yoshino, Gen] Toho Univ, Omori Med Ctr, Dept Diabet & Endocrinol, Tokyo, Japan; [Huang, Jingshan] Univ S Alabama, Sch Comp, Mobile, AL 36688 USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1520-7560			DIABETES-METAB RES	Diabetes-Metab. Res. Rev.	DEC	2015	31			1		728	68	68				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CX5PQ	WOS:000365754800144		
J	Kato, F; Miura, G; Shirato, S; Sato, E; Yamamoto, S				Kato, Fusae; Miura, Gen; Shirato, Suguru; Sato, Eiju; Yamamoto, Shuichi			Correlation between N2 amplitude of multifocal ERGs and retinal sensitivity and retinal nerve fiber layer thickness in glaucomatous eyes	DOCUMENTA OPHTHALMOLOGICA			English	Article						Glaucoma; Multifocal ERG; N2; Retinal nerve fiber layer thickness	PHOTOPIC NEGATIVE RESPONSE; OPEN-ANGLE GLAUCOMA; FOCAL ELECTORETINOGRAMS; REGIONAL-VARIATIONS; GANGLION-CELLS; INNER RETINA; ELECTRORETINOGRAM; DAMAGE; TOPOGRAPHY; ATROPHY	To determine whether there are significant correlations between the N2 amplitude of the multifocal electroretinograms (mfERGs) and the retinal sensitivity and retinal nerve fiber layer (RNFL) thickness in glaucomatous and normal eyes. Thirty-eight glaucomatous and 11 normal eyes were studied. The mfERGs were elicited by red stimuli presented on a blue background. The responses from the central five elements within a 20A degrees stimulated area were analyzed. The retinal sensitivity was determined by Humphrey Field Analyzer and the RNFL thickness by spectral-domain optical coherence tomography. The correlations between the N2 amplitude and the retinal sensitivity and the RNFL thickness were calculated. The N2 amplitude was significantly smaller in the glaucomatous eyes than the normal eyes in all areas (P < 0.05). There was a significant correlation between the N2 amplitude and the retinal sensitivity (1/Lambert linear unit) of the HFA for the superior retina (r = 0.36, P = 0.01), for the central retina (r = 0.54, P < 0.0001), and for the inferior retina (r = 0.51, P = 0.0001). There were significant correlations between the N2 amplitude and the RNFL thicknesses in the superior retina (r = 0.49, P = 0.0003), the central retina (r = 0.79, P < 0.0001), and the inferior retina (r = 0.52, P = 0.0001) for both normal and glaucomatous eyes. These results indicate that the activity of the retinal ganglion cells contribute to the amplitude of the N2 of the mfERGs and thus can be used as an objective monitor of retinal ganglion cell function.	[Kato, Fusae; Miura, Gen; Shirato, Suguru; Sato, Eiju; Yamamoto, Shuichi] Chiba Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Chuo Ku, Chiba, Chiba 2608670, Japan	Miura, G (reprint author), Chiba Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Chuo Ku, Inohana 1-8-1, Chiba, Chiba 2608670, Japan.	gmiura2@chiba-u.jp					Anderson D. R., 1999, AUTOMATED STATIC PER; Kobayashi M, 2004, JPN J OPHTHALMOL, V48, P208, DOI 10.1007/s10384-004-0045-3; Rangaswamy NV, 2003, INVEST OPHTH VIS SCI, V44, P3233, DOI 10.1167/iovs.03-0009; Machida S, 2008, INVEST OPHTH VIS SCI, V49, P2201, DOI 10.1167/iovs.07-0887; Hood DC, 2007, INVEST OPHTH VIS SCI, V48, P3662, DOI 10.1167/iovs.06-1401; Rangaswamy NV, 2007, INVEST OPHTH VIS SCI, V48, P4818, DOI 10.1167/iovs.07-0218; Hood DC, 2000, INVEST OPHTH VIS SCI, V41, P1570; Hood DC, 2007, PROG RETIN EYE RES, V26, P688, DOI 10.1016/j.preteyeres.2007.08.001; Medeiros FA, 2012, INVEST OPHTH VIS SCI, V53, P6939, DOI 10.1167/iovs.12-10345; Pagliara MM, 2008, PROG BRAIN RES, V173, P139, DOI 10.1016/S0079-6123(08)01110-2; Viswanathan S, 2001, INVEST OPHTH VIS SCI, V42, P514; Hasegawa S, 2000, INVEST OPHTH VIS SCI, V41, P1597; QUIGLEY HA, 1989, AM J OPHTHALMOL, V107, P453; Hood DC, 1997, VISUAL NEUROSCI, V14, P533; Viswanathan S, 1999, INVEST OPHTH VIS SCI, V40, P1124; Rangaswamy NV, 2004, INVEST OPHTH VIS SCI, V45, P3827, DOI 10.1167/iovs.04-0458; Gotoh Y, 2004, ARCH OPHTHALMOL-CHIC, V122, P341, DOI 10.1001/archopht.122.3.341; Machida S, 2008, INVEST OPHTH VIS SCI, V49, P5636, DOI 10.1167/iovs.08-1946; Machida S, 2010, BRIT J OPHTHALMOL, V94, P202, DOI 10.1136/bjo.2009.161166; Nakamura H, 2011, AM J OPHTHALMOL, V151, P494, DOI 10.1016/j.ajo.2010.09.018; Machida S, 2011, J OPHTHALMOL, DOI 10.1155/2011/564131; Kondo M, 2008, INVEST OPHTH VIS SCI, V49, P3544, DOI 10.1167/iovs.08-1798; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; DRASDO N, 1989, VISION RES, V29, P985, DOI 10.1016/0042-6989(89)90113-2; Garway-Heath DF, 2000, OPHTHALMOLOGY, V113, P325; Kaneko M, 2014, CURR EYE RES, V40, P77; Machida S, 2015, CURR EYE RES, V40, P439, DOI 10.3109/02713683.2014.922196; Okano M, 1999, NIHON GANKA KIYO, V50, P443; QUIGLEY HA, 1982, ARCH OPHTHALMOL-CHIC, V100, P135; Rao A, 2015, BRIT J OPHTHALMOL, V99, P500, DOI 10.1136/bjophthalmol-2014-305323; Sakemi F, 2000, NIHON GANKA KIYO, V51, P573; Satomi A, 1997, NIHON GANKA KIYO, V48, P583; Xiaoli S, 2013, ISRN OPTHALMOL, V2011	33	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0012-4486	1573-2622		DOC OPHTHALMOL	Doc. Ophthalmol.	DEC	2015	131	3					197	206		10.1007/s10633-015-9519-5		10	Ophthalmology	Ophthalmology	CX5QM	WOS:000365757200005		
J	Kobayashi, S				Kobayashi, Shinji			On a Dynamic Model of Cooperative and Noncooperative R and D in Oligopoly with Spillovers	DYNAMIC GAMES AND APPLICATIONS			English	Article						R and D; Spillovers; Differential games; Stability	CAPITAL ACCUMULATION; COMPETITION; DUOPOLY; GAME	We developed a dynamic model of oligopoly in which firms' R and D investments accumulate as R and D capital and have spillover effects. We showed that there exists a symmetric stable open-loop Nash equilibrium for each of the differential games under noncooperative R and D and cooperative R and D. We then showed that for small spillovers, each firm's R and D investments are larger under R and D competition than under R and D cooperation. We further demonstrated that, in the limit, when the discount rate goes to zero, the stability condition for our dynamic game approaches the stability condition for the static two-stage game in d'Aspremont and Jacquemin (Am Econ Rev 78:1133-1137, 1988). However, we also showed that at the Markov perfect equilibrium, cooperative R and D investments are larger than noncooperative investments for all possible values of spillovers.	[Kobayashi, Shinji] Nihon Univ, Grad Sch Econ, Chiyoda Ku, Tokyo 1018360, Japan	Kobayashi, S (reprint author), Nihon Univ, Grad Sch Econ, Chiyoda Ku, 1-3-2 Misaki, Tokyo 1018360, Japan.	kobayashi.shinji@nihon-u.ac.jp			Nihon University	I would like to thank the editor Luca Lambertini and two anonymous referees for insightful comments and helpful suggestions. I am grateful to Jim Y. Jin for his helpful comments and conversations. I would also like to thank Mihkel Tombak for valuable comments on an earlier version of the paper. The usual disclaimer applies. I gratefully acknowledge financial support from Nihon University.	Cassiman B, 2002, AM ECON REV, V92, P1169, DOI 10.1257/00028280260344704; Amir R, 2000, INT J IND ORGAN, V18, P1013, DOI 10.1016/S0167-7187(00)00071-0; Amir R, 2003, GAME ECON BEHAV, V42, P183, DOI 10.1016/S0899-8256(02)00541-9; KAMIEN MI, 1992, AM ECON REV, V82, P1293; HENRIQUES I, 1990, AM ECON REV, V80, P638; Cellini R, 2008, J OPTIMIZ THEORY APP, V138, P17, DOI 10.1007/s10957-008-9432-0; REINGANUM JF, 1982, ECONOMETRICA, V50, P671, DOI 10.2307/1912607; Hinloopen J, 2003, J ECON, V80, P107, DOI 10.1007/s00712-003-0016-z; Petit ML, 1999, EUR ECON REV, V43, P185, DOI 10.1016/S0014-2921(97)00111-6; Amir R, 2008, INT J IND ORGAN, V26, P695, DOI 10.1016/j.ijindorg.2007.04.011; DEBONDT R, 1992, INT J IND ORGAN, V10, P35, DOI 10.1016/0167-7187(92)90046-2; Cellini R, 2009, J ECON DYN CONTROL, V33, P568, DOI 10.1016/j.jedc.2008.08.006; Cellini R, 1998, J ECON THEORY, V83, P145, DOI 10.1006/jeth.1998.2454; BERNSTEIN JI, 1989, REV ECON STUD, V56, P249, DOI 10.2307/2297460; Basar T, 1982, DYNAMIC NONCOOPERATI; Cohen W, 1989, HDB IND ORG, VII; DASPREMONT C, 1988, AM ECON REV, V78, P1133; Dockner E., 2000, DIFFERENTIAL GAMES E; Hinloopen J, 2000, RES EC, V54, P153, DOI 10.1006/reec.1999.0211; JAFFE AB, 1986, AM ECON REV, V76, P984; Kamien M, 1980, MARKET STRUCTURE INN; Kamien M.I., 1991, DYNAMIC OPTIMIZATION; Pakes A, 1979, 346 NBER; Reinganum J, 1989, HDB IND ORG, VI; Reinganum J, 1981, J ECON THEORY, V25, P11; REYNOLDS SS, 1987, INT ECON REV, V28, P69, DOI 10.2307/2526860; Starr A. W., 1969, Journal of Optimization Theory and Applications, V3, DOI 10.1007/BF00929443; SUZUMURA K, 1992, AM ECON REV, V82, P1307	28	0	0	SPRINGER BIRKHAUSER	NEW YORK	233 SPRING STREET, 6TH FLOOR, NEW YORK, NY 10013 USA	2153-0785	2153-0793		DYN GAMES APPL	Dyn. Games Appl.	DEC	2015	5	4			SI		599	619		10.1007/s13235-014-0117-z		21	Mathematics, Interdisciplinary Applications	Mathematics	CX5PU	WOS:000365755200009		
J	Sato, S; Kabeya, H; Yoshino, A; Sekine, W; Suzuki, K; Tamate, HB; Yamazaki, S; Chomel, BB; Maruyama, S				Sato, Shingo; Kabeya, Hidenori; Yoshino, Aika; Sekine, Wataru; Suzuki, Kazuo; Tamate, Hidetoshi B.; Yamazaki, Shouki; Chomel, Bruno B.; Maruyama, Soichi			Japanese Macaques (Macaca fuscata) as Natural Reservoir of Bartonella quintana	EMERGING INFECTIOUS DISEASES			English	Article							BACTERIA; MONKEYS	Bartonella quintana bacteremia was detected in 6 (13.3%) of 45 wild-caught Japanese macaques (Macaca fuscata). Multi-locus sequence typing of the isolates revealed that Japanese macaques were infected with a new and specific B. quintana sequence type. Free-ranging Japanese macaques thus represent another natural reservoir of B. quintana.	[Sato, Shingo] Nihon Univ, Dept Vet Med, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan; [Kabeya, Hidenori; Yoshino, Aika; Sekine, Wataru; Maruyama, Soichi] Nihon Univ, Fujisawa, Kanagawa 2520880, Japan; [Suzuki, Kazuo] Hikiiwa Pk Ctr, Tanabe, Japan; [Tamate, Hidetoshi B.] Yamagata Univ, Yamagata 990, Japan; [Yamazaki, Shouki] Japan Wildlife Res Ctr, Tokyo, Japan; [Chomel, Bruno B.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA	Maruyama, S (reprint author), Nihon Univ, Dept Vet Med, Coll Bioresource Sci, Lab Vet Publ Hlth, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	maruyama.soichi@nihon-u.ac.jp			Japan Society for the Promotion of Science Grant-in-Aid for Young Scientists (B) [26850188]; Strategic Research Base Development Program, International Research on Epidemiology of Zoonoses and Training for Young Researchers [S1491007]; Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported in part by the Japan Society for the Promotion of Science Grant-in-Aid for Young Scientists (B) grant no. 26850188, and the Strategic Research Base Development Program, International Research on Epidemiology of Zoonoses and Training for Young Researchers grant no. S1491007 by the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Maggi RG, 2013, J CLIN MICROBIOL, V51, P1408, DOI 10.1128/JCM.03019-12; O'Rourke LG, 2005, EMERG INFECT DIS, V11, P1931; Huang RT, 2011, EMERG INFECT DIS, V17, P1707, DOI 10.3201/eid1709.110133; Zhang P, 2004, P NATL ACAD SCI USA, V101, P13630, DOI 10.1073/pnas.0405284101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Li H, 2013, MOL ECOL, V22, P2118, DOI 10.1111/mec.12261; Foucault C, 2006, EMERG INFECT DIS, V12, P217; ROUX V, 1995, GENE, V156, P107, DOI 10.1016/0378-1119(94)00919-J; Kabeya H, 2011, J VET MED SCI, V73, P1561, DOI 10.1292/jvms.11-0134; Arvand M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009765; Bittar F, 2014, SCI REP-UK, V4, DOI 10.1038/srep07174; Deng HK, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-15; Fooden Jack, 2005, Fieldiana Zoology, V104, P1; NORMAN AF, 1995, J CLIN MICROBIOL, V33, P1797; Vayssier-Taussat M, 2009, VET RES, V40, P29	15	0	0	CENTERS  DISEASE CONTROL	ATLANTA	1600 CLIFTON RD, ATLANTA, GA 30333 USA	1080-6040	1080-6059		EMERG INFECT DIS	Emerg. Infect. Dis	DEC	2015	21	12					2168	2170		10.3201/eid2112.150632		3	Immunology; Infectious Diseases	Immunology; Infectious Diseases	CX1MT	WOS:000365461000011		
J	Nishiguchi, Y; Takano, K; Tanno, Y				Nishiguchi, Yuki; Takano, Keisuke; Tanno, Yoshihiko			Explicitly Guided Attentional Bias Modification Promotes Attentional Disengagement From Negative Stimuli	EMOTION			English	Article						attentional bias; negative information; attentional training; spatial attention; explicit instruction	IMPAIRED DISENGAGEMENT; SELECTIVE ATTENTION; ANXIETY DISORDER; VISUAL-ATTENTION; SOCIAL ANXIETY; DEPRESSION; INFORMATION; THREAT; VULNERABILITY; METAANALYSIS	Previous studies have shown that attentional bias modification (ABM) is effective in reducing negative attentional biases. However, the mechanisms underlying how ABM effectively reduces negative attentional biases are still unclear. In the present study, we conducted an ABM procedure that included a 3-day training session with a sample of nonclinical participants (N = 40) to investigate the effect of ABM on emotional and nonemotional attentional biases. Participants completed a modified dot-probe task with 2 different instructions (explicit or standard) during the training; their attentional biases were tested before and after the training. Only participants trained with explicit instructions showed a reduction in negative attentional biases in dot-probe task and an improvement in attentional disengagement from negative stimuli in gap-overlap task. On the other hand, attention toward nonemotional stimuli was only marginally improved by training with both explicit and standard instructions. These results indicate that explicit instructions may promote ABM training.	[Nishiguchi, Yuki; Tanno, Yoshihiko] Univ Tokyo, Grad Sch Arts & Sci, Tokyo 1538902, Japan; [Takano, Keisuke] Nihon Univ, Coll Humanities & Sci, Tokyo 102, Japan; [Takano, Keisuke] Univ Leuven, Ctr Psychol Learning & Expt Psychopathol, Leuven, Belgium	Nishiguchi, Y (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Cognit & Behav Sci, Tanno Lab,Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	ynishiguchi@beck.c.u-tokyo.ac.jp			Japan Society for the Promotion of Science [24-1573]	This research was supported by Japan Society for the Promotion of Science Grant 24-1573 awarded to Keisuke Takano.	Amir N, 2009, J ABNORM PSYCHOL, V118, P28, DOI 10.1037/a0012589; Hakamata Y, 2010, BIOL PSYCHIAT, V68, P982, DOI 10.1016/j.biopsych.2010.07.021; Koster EHW, 2005, EMOTION, V5, P446, DOI 10.1037/1528-3542.5.4.446; Amir N, 2009, J CONSULT CLIN PSYCH, V77, P961, DOI 10.1037/a0016685; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037//0096-3445.130.4.681; Krebs G, 2010, BEHAV RES THER, V48, P251, DOI 10.1016/j.brat.2009.10.009; Fan J, 2003, P NATL ACAD SCI USA, V100, P7406, DOI 10.1073/pnas.0732088100; Wells TT, 2010, COGNITION EMOTION, V24, P719, DOI 10.1080/02699930802652388; Peckham AD, 2010, DEPRESS ANXIETY, V27, P1135, DOI 10.1002/da.20755; Sanchez A, 2013, J ABNORM PSYCHOL, V122, P303, DOI 10.1037/a0031529; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Moriya J, 2009, COGNITION EMOTION, V23, P1090, DOI 10.1080/02699930802335018; Johnson DR, 2009, EMOTION, V9, P681, DOI 10.1037/a0017095; Compton RJ, 2000, COGNITION EMOTION, V14, P401, DOI 10.1080/026999300378897; MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107; Eldar S, 2010, PSYCHOL MED, V40, P667, DOI 10.1017/S0033291709990766; Kikuchi Y, 2011, J AUTISM DEV DISORD, V41, P629, DOI 10.1007/s10803-010-1082-z; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; De Raedt R, 2010, COGN AFFECT BEHAV NE, V10, P50, DOI 10.3758/CABN.10.1.50; Ouimet AJ, 2009, CLIN PSYCHOL REV, V29, P459, DOI 10.1016/j.cpr.2009.05.004; Schmidt NB, 2009, J ABNORM PSYCHOL, V118, P5, DOI 10.1037/a0013643; Hallion LS, 2011, PSYCHOL BULL, V137, P940, DOI 10.1037/a0024355; Beevers CG, 2003, COGNITIVE THER RES, V27, P619, DOI 10.1023/A:1026347610928; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037//0096-1523.18.4.1030; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037//0021-843X.95.1.15; FISCHER B, 1993, BEHAV BRAIN SCI, V16, P553; Baert S, 2010, J BEHAV THER EXP PSY, V41, P265, DOI 10.1016/j.jbtep.2010.02.004; Mathews A, 1997, TRENDS COGN SCI, V1, P340, DOI 10.1016/S1364-6613(97)01092-9; Wisco BE, 2009, CLIN PSYCHOL REV, V29, P382, DOI 10.1016/j.cpr.2009.03.003; Reeck C, 2012, J COGNITIVE NEUROSCI, V24, P1113, DOI 10.1162/jocn_a_00211; Koster EHW, 2011, CLIN PSYCHOL REV, V31, P138, DOI 10.1016/j.cpr.2010.08.005; Bar-Haim Y, 2010, J CHILD PSYCHOL PSYC, V51, P859, DOI 10.1111/j.1469-7610.2010.02251.x; Moriya J, 2011, J BEHAV THER EXP PSY, V42, P122, DOI 10.1016/j.jbtep.2010.08.001; Hertel PT, 2011, PERSPECT PSYCHOL SCI, V6, P521, DOI 10.1177/1745691611421205; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; POSNER MI, 1987, PSYCHOBIOLOGY, V15, P107; Ellenbogen MA, 2006, PSYCHONEUROENDOCRINO, V31, P373, DOI 10.1016/j.psyneuen.2005.09.001; Koster EHW, 2004, BEHAV RES THER, V42, P1183, DOI 10.1016/j.brat.2003.08.001; Beck A. T., 1967, DEPRESSION CAUSES TR; Cohen J, 2003, APPL MULTIPLE REGRES; Imae K., 1981, JAPANESE J ED PSYCHO, V29, P62; MACLEOD C, 1992, BEHAV RES THER, V30, P151; Matsumoto K., 2006, SOCIOENVIRONMENTAL S, V11, P203; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Shima S, 1985, CLIN PSYCHIATR, V27, P717; Spielberger C. D., 1970, STATE TRAIT ANXIETY	48	1	1	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1528-3542	1931-1516		EMOTION	Emotion	DEC	2015	15	6					731	740		10.1037/a0039117		10	Psychology, Experimental	Psychology	CX4WS	WOS:000365701700008		
J	Nozaki, Y				Nozaki, Yuki			Emotional Competence and Extrinsic Emotion Regulation Directed Toward an Ostracized Person	EMOTION			English	Article						emotional competence; emotional intelligence; extrinsic emotion regulation; ostracism; Cyberball	CONFLICT COMMUNICATION PATTERNS; RELATIONSHIP SATISFACTION; SOCIAL NEUROSCIENCE; INTELLIGENCE; SCALE; BEHAVIOR; EMPATHY; STRESS; OTHERS; METAANALYSIS	Positive interpersonal relationships hinge on individuals' competence in regulating others' emotions as well as their own. Nevertheless, little is known about the relationship between emotional competence and specific interpersonal behaviors. In particular, it is unclear which situations require emotional competence for extrinsic emotion regulation and whether emotionally competent individuals actually attempt to regulate others' emotions. To clarify these issues, the current investigation examined the relationship between emotional competence and extrinsic emotion regulation directed toward an ostracized person. The results of Study 1 (N = 39) indicated that interpersonal emotional competence (competence related to others' emotions) was positively associated with participants' efforts to relieve the ostracized person's sadness. In Study 2 (N = 120), this relationship was moderated by the ostracized person's emotional expression. In particular, participants with high interpersonal emotional competence were more likely to attempt to regulate the sadness of ostracized individuals who expressed neutral affect. In contrast, when the ostracized person expressed sadness, there were no significant relationships between high or low interpersonal emotional competence and extrinsic emotion regulation behavior. These results offer novel insight into how emotionally competent individuals use their competence to benefit others.	[Nozaki, Yuki] Kyoto Univ, Kyoto 6068501, Japan; [Nozaki, Yuki] Japan Soc Promot Sci, Tokyo, Japan	Nozaki, Y (reprint author), Kyoto Univ, Grad Sch Educ, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	yuki.nozaki.kt@gmail.com			 [13J05204]	The research reported here was supported by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) fellows (13J05204). I thank Satoko Kuwahara, Asuka Tamura, Minako Nakatani, and Saori Fuwa for their help with data collection.	Aiken L. S., 1991, MULTIPLE REGRESSION; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Nelis D, 2011, EMOTION, V11, P354, DOI 10.1037/a0021554; Crede M, 2012, J PERS SOC PSYCHOL, V102, P874, DOI 10.1037/a0027403; Cote S, 2011, PSYCHOL SCI, V22, P1073, DOI 10.1177/0956797611416251; Austin EJ, 2005, PERS INDIV DIFFER, V39, P403, DOI 10.1016/j.paid.2005.01.017; Zeidner M, 2008, EUR PSYCHOL, V13, P64, DOI 10.1027/1016-9040.13.1.64; DeWall CN, 2010, SOC PSYCHOL PERS SCI, V1, P168, DOI 10.1177/1948550610361387; Fleeson W, 2009, J PERS SOC PSYCHOL, V97, P1097, DOI 10.1037/a0016786; Niven K, 2012, HUM RELAT, V65, P777, DOI 10.1177/0018726712439909; JOSEPH S, 1994, PERS INDIV DIFFER, V16, P869, DOI 10.1016/0191-8869(94)90231-3; Petrides KV, 2003, EUR J PERSONALITY, V17, P39, DOI 10.1002/per.466; Masten CL, 2011, NEUROIMAGE, V55, P381, DOI 10.1016/j.neuroimage.2010.11.060; Smith L, 2008, PERS INDIV DIFFER, V44, P1314, DOI 10.1016/j.paid.2007.11.024; Spokas M, 2009, J BEHAV THER EXP PSY, V40, P283, DOI 10.1016/j.jbtep.2008.12.004; Schutte NS, 2001, J SOC PSYCHOL, V141, P523; Killen M, 2013, CHILD DEV, V84, P772, DOI 10.1111/cdev.12012; Ehrhart MG, 2009, PERS INDIV DIFFER, V47, P900, DOI 10.1016/j.paid.2009.07.012; Frederickson N, 2012, PERS INDIV DIFFER, V52, P323, DOI 10.1016/j.paid.2011.10.034; Wesselmann ED, 2013, SOC PSYCHOL PERS SCI, V4, P108, DOI 10.1177/1948550612443386; Petrides KV, 2007, BRIT J PSYCHOL, V98, P273, DOI 10.1348/00712606X120618; Gross JJ, 2013, EMOTION, V13, P359, DOI 10.1037/a0032135; Salovey P, 2002, PSYCHOL HEALTH, V17, P611, DOI 10.1080/08870440290025812; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Kotsou I, 2011, J APPL PSYCHOL, V96, P827, DOI 10.1037/a0023047; Decety J, 2006, THESCIENTIFICWORLDJO, V6, P1146, DOI 10.1100/tsw.2006.221; Mikolajczak M, 2007, PSYCHONEUROENDOCRINO, V32, P1000, DOI 10.1016/j.psyneuen.2007.07.009; Ching CM, 2014, J RES PERS, V48, P1, DOI 10.1016/j.jrp.2013.10.002; Schroder-Abe M, 2011, EUR J PERSONALITY, V25, P155, DOI 10.1002/per.818; Wesselmann ED, 2012, PERS INDIV DIFFER, V53, P580, DOI 10.1016/j.paid.2012.04.039; Mikolajczak M, 2009, INT J CLIN HLTH PSYC, V9, P455; Wesselmann ED, 2009, J EXP SOC PSYCHOL, V45, P1308, DOI 10.1016/j.jesp.2009.08.003; KING LA, 1990, J PERS SOC PSYCHOL, V58, P864, DOI 10.1037//0022-3514.58.5.864; Masuda T, 2008, J PERS SOC PSYCHOL, V94, P365, DOI 10.1037/0022-3514.94.3.365; Zaki J, 2013, EMOTION, V13, P803, DOI 10.1037/a0033839; Austin EJ, 2013, PERS INDIV DIFFER, V55, P834, DOI 10.1016/j.paid.2013.07.005; Austin EJ, 2004, PERS INDIV DIFFER, V36, P1855, DOI 10.1016/j.paid.2003.07.006; Smith L, 2008, PERS INDIV DIFFER, V45, P738, DOI 10.1016/j.paid.2008.07.023; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Austin EJ, 2014, PERS INDIV DIFFER, V65, P8, DOI 10.1016/j.paid.2014.01.060; Saklofske DH, 2003, PERS INDIV DIFFER, V34, P707, DOI 10.1016/S0191-8869(02)00056-9; Nozaki Y, 2013, PSYCHOLOGIA, V56, P167; Riem MME, 2013, PSYCHONEUROENDOCRINO, V38, P1418, DOI 10.1016/j.psyneuen.2012.12.023; Niven K, 2011, CURR PSYCHOL, V30, P53, DOI 10.1007/s12144-011-9099-9; Williams KD, 2007, ANNU REV PSYCHOL, V58, P425, DOI 10.1146/annurev.psych.58.110405.085641; Baroncelli A, 2014, J ADOLESCENCE, V37, P807, DOI 10.1016/j.adolescence.2014.05.009; Engen HG, 2013, CURR OPIN NEUROBIOL, V23, P275, DOI 10.1016/j.conb.2012.11.003; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Mikolajczak M, 2009, BRIT J PSYCHOL, V100, P699, DOI 10.1348/000712608X395522; Brasseur S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062635; Hodges S.D., 2001, J SOCIO-ECON, V30, P437, DOI DOI 10.1016/S1053-5357(01)00112-3; Koyasu M., 2015, ASSESSMENT; Nozaki Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077579; Malouff JM, 2014, AM J FAM THER, V42, P53, DOI 10.1080/01926187.2012.748549; Mayer J., 1997, EMOTIONAL DEV EMOTIO, P3; Mikolajczak M., 2009, ELCT J APPL PSYCHOL, V5, P25, DOI DOI 10.7790/EJAP.V5I2.175; Mikolajczak M., EMOTION IN PRESS; Oshio A., 2013, PSYCHOLOGY, V4, P924, DOI [10.4236/psych.2013.412133, DOI 10.4236/PSYCH.2013.412133]; Oshio A., 2012, JAPANESE J PERSONALI, V21, P40, DOI [10.2132/personality.21.40, DOI 10.2132/PERSONALITY.21.40]; Saarni C, 1999, DEV EMOTIONAL COMPET; Salovey P., 1990, IMAGINATION COGNITIO, V9, P185, DOI DOI 10.2190/DUGG-P24E-52WK-6CDG; Scherer K. R., 2007, SCI EMOTIONAL INTELL, P101; Sheeran P., 2002, EUROPEAN REV SOCIAL, V12, P1, DOI DOI 10.1080/14792772143000003; Suzuki T., 1986, JPN J SOC PSYCHIATRY, V9, P173	65	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1528-3542	1931-1516		EMOTION	Emotion	DEC	2015	15	6					763	774		10.1037/emo0000081		12	Psychology, Experimental	Psychology	CX4WS	WOS:000365701700012		
J	Murakami, M; Yoshimoto, T; Minami, I; Bouchi, R; Tsuchiya, K; Hashimoto, K; Izumiyama, H; Fujii, Y; Endo, T; Akashi, T; Nishimoto, K; Mukai, K; Kihara, K; Ogawa, Y				Murakami, Masanori; Yoshimoto, Takanobu; Minami, Isao; Bouchi, Ryotaro; Tsuchiya, Kyoichiro; Hashimoto, Koshi; Izumiyama, Hajime; Fujii, Yasuhisa; Endo, Takashi; Akashi, Takumi; Nishimoto, Koshiro; Mukai, Kuniaki; Kihara, Kazunori; Ogawa, Yoshihiro			A Novel Somatic Deletion Mutation of ATP2B3 in Aldosterone-Producing Adenoma	ENDOCRINE PATHOLOGY			English	Article						Primary aldosteronism; Aldosterone-producing adenoma; ATP2B3; CYP11B2	MONOCLONAL-ANTIBODIES; CHANNEL MUTATIONS; HYPERTENSION; ATP1A1; PREVALENCE; EXPRESSION; COMMON	Aldosterone-producing adenoma (APA) is a form of primary aldosteronism (PA). Recent studies suggested that somatic mutations in the KCNJ5, ATP1A1, ATP2B3, and CACNA1D genes are involved in the pathogenesis of APA. We report a case of a 62-year-old man diagnosed as PA with left adrenal mass. He underwent adrenalectomy for treatment. We identified a novel somatic deletion mutation in ATP2B3 in the adrenal tumor: c.1269_1274delTGTGCT which spans three codons (423-425) resulting in p.Val424_Leu425del. Immunohistochemical analysis revealed strong expression of aldosterone synthase (CYP11B2) in the tumor tissue, which is consistent with APA. Here, we identified a novel somatic deletion mutation in ATP2B3, which results in the amino acid sequences increasing intracellular calcium concentrations as reported previously, leading to increased aldosterone synthase (CYP11B2) expression and following excess aldosterone production in the APA cells. The novel ATP2B3 mutation detected in our case supports the pathogenic significance of the locus spanning the codon 424-426 of ATP2B3.	[Murakami, Masanori; Yoshimoto, Takanobu; Minami, Isao; Bouchi, Ryotaro; Tsuchiya, Kyoichiro; Hashimoto, Koshi; Izumiyama, Hajime; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Endocrinol & Metab, Bunkyo Ku, Tokyo 1138510, Japan; [Hashimoto, Koshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Preempt Med & Metab, Tokyo 1138510, Japan; [Izumiyama, Hajime] Tokyo Med & Dent Univ, Ctr Med Welf & Liaison Serv, Tokyo 1138510, Japan; [Fujii, Yasuhisa; Kihara, Kazunori] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Urol, Tokyo 1138510, Japan; [Endo, Takashi; Akashi, Takumi] Tokyo Med & Dent Univ, Dept Pathol, Tokyo 1138510, Japan; [Nishimoto, Koshiro] Tachikawa Hosp, Dept Urol, Tokyo 1900022, Japan; [Nishimoto, Koshiro; Mukai, Kuniaki] Keio Univ, Sch Med, Dept Biochem, Tokyo 1608582, Japan	Yoshimoto, T (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Endocrinol & Metab, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	tyoshimoto.mem@tmd.ac.jp			"Advancing Care of Primary Aldosteronism in Japan Study"-Japan Primary Aldosteronism Study (JPAS)-from the Japan Agency for Medical Research and development, AMED	The authors thank the members of the Molecular Endocrinology and Metabolism, Tokyo Medical and Dental University. This research is partially supported by the "Advancing Care of Primary Aldosteronism in Japan Study"-Japan Primary Aldosteronism Study (JPAS)-from the Japan Agency for Medical Research and development, AMED. We thank Mr. Shinya Sasai in the Department of Pathology, Tachikawa Hospital, for great assistance of immunohistochemistry; Dr. Takeshi Yamazaki in the Graduate School of Integrated Arts and Sciences, Hiroshima University, for giving us rabbit antihuman 3 beta HSD and CYP17 antibodies; as well as Dr. Celso E. Gomez-Sanchez in the University of Mississippi Medical Center for giving us excellent mouse monoclonal antihuman CYP11B2 and rat monoclonal antihuman CYP11B1 antibodies.	Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Nishimoto K, 2015, P NATL ACAD SCI USA, V112, pE4591, DOI 10.1073/pnas.1505529112; Fernandes-Rosa FL, 2014, HYPERTENSION, V64, P354, DOI 10.1161/HYPERTENSIONAHA.114.03419; Plouin PF, 2004, NEPHROL DIAL TRANSPL, V19, P774, DOI 10.1093/ndt/gfh112; Azizan EAB, 2013, NAT GENET, V45, P1055, DOI 10.1038/ng.2716; Nishimoto K, 2010, J CLIN ENDOCR METAB, V95, P2296, DOI 10.1210/jc.2009-2010; KAWAMOTO T, 1992, P NATL ACAD SCI USA, V89, P1458, DOI 10.1073/pnas.89.4.1458; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Nakamura Y, 2014, MOL CELL ENDOCRINOL, V392, P73, DOI 10.1016/j.mce.2014.05.002; Zennaro MC, 2012, HYPERTENSION, V60, P580, DOI 10.1161/HYPERTENSIONAHA.111.188250; Gomez-Sanchez CE, 2014, MOL CELL ENDOCRINOL, V383, P111, DOI 10.1016/j.mce.2013.11.022; Hannemann A, 2012, HORM METAB RES, V44, P157, DOI 10.1055/s-0031-1295438; Chao CT, 2013, ANN MED, V45, P375, DOI 10.3109/07853890.2013.785234; Howard B, 2014, J CLIN ENDOCR METAB, V99, pE536, DOI 10.1210/jc.2013-3495; Milliez P, 2005, J AM COLL CARDIOL, V45, P1243, DOI 10.1016/j.jacc.2005.01.015; Williams TA, 2014, HYPERTENSION, V63, P188, DOI 10.1161/HYPERTENSIONAHA.113.01733; Beuschlein F, 2013, NAT GENET, V45, P440, DOI 10.1038/ng.2550; Scholl UI, 2013, NAT GENET, V45, P1050, DOI 10.1038/ng.2695; Monticone S, 2015, MOL CELL ENDOCRINOL, V399, P311, DOI 10.1016/j.mce.2014.09.015; Murakami M, 2015, EUR J ENDOCRINOL; Zheng FF, 2015, HYPERTENSION, V65, P622, DOI 10.1161/HYPERTENSIONAHA.114.03346	21	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1046-3976	1559-0097		ENDOCR PATHOL	Endocr. Pathol.	DEC	2015	26	4					328	333		10.1007/s12022-015-9400-9		6	Endocrinology & Metabolism; Pathology	Endocrinology & Metabolism; Pathology	CX0XR	WOS:000365421300009		
J	Nishioka, H; Inoshita, N; Mete, O; Asa, SL; Hayashi, K; Takeshita, A; Fukuhara, N; Yamaguchi-Okada, M; Takeuchi, Y; Yamada, S				Nishioka, Hiroshi; Inoshita, Naoko; Mete, Ozgur; Asa, Sylvia L.; Hayashi, Kyohei; Takeshita, Akira; Fukuhara, Noriaki; Yamaguchi-Okada, Mitsuo; Takeuchi, Yasuhiro; Yamada, Shozo			The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas	ENDOCRINE PATHOLOGY			English	Article						Nonfunctioning pituitary adenomas; Silent adenomas; Transcription factors; Tpit; Pit-1; SF-1	SILENT CORTICOTROPH ADENOMAS; CLINICOPATHOLOGICAL CORRELATIONS; GLAND; PATHOLOGY; DISEASE; MARKER; TUMORS	Clinically nonfunctioning pituitary adenomas (NFAs) may be hormonally inactive tumors of differentiated cells, mainly not only gonadotroph adenomas (GAs) but also silent corticotroph adenomas (SCAs) and other differentiated silent adenomas. Recently, the use of transcription factors has been recommended to confirm cytodiffererentiation of these neoplasms. Our objective was to assess the clinical significance of the new classification system using transcription factors. Five hundred sixteen consecutive NFAs were studied retrospectively. They were initially classified based on hormone immunohistochemistry as follows: 119 hormone-negative adenomas (23.1 %), 300 GAs (58.1 %), 51 SCAs (9.9 %), and 46 other silent adenomas. The 119 hormone-negative adenomas were further evaluated for expression of transcription factors including steroidogenic factor-1 (SF-1), estrogen receptor-alpha (ER alpha), pituitary-specific transcription factor 1 (Pit-1), and t-box transcription factor (Tpit). One hundred thirteen of 119 (95 %) hormone-negative adenomas showed mutually exclusive lineage-specific differentiation as gonadotrophs (SF-1 positive), corticotrophs (Tpit positive), or somatotrophs/mammosomatotrophs/lactotrophs/thyrotrophs (Pit-1 positive) in 79 cases (66.4 %), 32 cases (26.9 %), and 2 cases, respectively. The 32 ACTH-negative and Tpit-positive adenomas had higher pro-opiomelanocortin mRNA expression levels compared with GAs (P = 0.0001) on quantitative real-time PCR. They showed a female preponderance (P < 0.0001) and were more frequently giant adenomas (P = 0.0028) associated with marked cavernous sinus invasion (P < 0.0001) compared with GAs. These clinical features were identical to those of the 51 ACTH-positive SCAs. Our results justify the complementary role of transcription factors in the precise classification of NFAs that can more accurately characterize biological behavior. Our data suggest that more than one quarter of hormone-negative adenomas are SCAs that share distinct clinicopathological features with ACTH-expressing SCAs.	[Nishioka, Hiroshi; Fukuhara, Noriaki; Yamaguchi-Okada, Mitsuo; Yamada, Shozo] Toranomon Gen Hosp, Dept Hypothalam & Pituitary Surg, Minato Ku, Tokyo 1058470, Japan; [Inoshita, Naoko] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan; [Mete, Ozgur; Asa, Sylvia L.] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada; [Hayashi, Kyohei; Takeshita, Akira; Takeuchi, Yasuhiro] Toranomon Gen Hosp, Dept Endocrinol, Tokyo, Japan; [Nishioka, Hiroshi; Inoshita, Naoko; Takeshita, Akira; Takeuchi, Yasuhiro; Yamada, Shozo] Okinaka Mem Inst Med Res, Tokyo, Japan	Nishioka, H (reprint author), Toranomon Gen Hosp, Dept Hypothalam & Pituitary Surg, Minato Ku, 2-2-2 Toranomon, Tokyo 1058470, Japan.	nishioka@tokyo-med.ac.jp			Okinaka Memorial Institute for Medical Research; JSPS KAKENHI [25460468]	This work was supported by the Okinaka Memorial Institute for Medical Research. This work was also supported in part by JSPS KAKENHI Grant Number 25460468.	Sano T, 2003, ENDOCR PATHOL, V14, P363, DOI 10.1385/EP:14:4:363; Du L, 2013, P NATL ACAD SCI USA, V110, P8555, DOI 10.1073/pnas.1306182110; KNOSP E, 1993, NEUROSURGERY, V33, P610; Mete O, 2012, BRAIN PATHOL, V22, P443, DOI 10.1111/j.1750-3639.2012.00599.x; Yamada S, 2007, NEUROSURGERY, V61, P580, DOI 10.1227/01.NEU.0000280049.93275.3C; Webb KM, 2003, NEUROSURGERY, V53, P1076, DOI 10.1227/01.NEU.0000088660.16904.F7; Sahli R, 2006, PATHOL RES PRACT, V202, P457, DOI 10.1016/j.prp.2006.01.007; Young WF, 1996, MAYO CLIN PROC, V71, P649; JAMESON JL, 1987, J CLIN INVEST, V80, P1472, DOI 10.1172/JCI113228; Al-Brahim NYY, 2006, J CLIN PATHOL, V59, P1245, DOI 10.1136/jcp.2005.031187; Tateno T, 2007, EUR J ENDOCRINOL, V157, P717, DOI 10.1530/EJE-07-0428; Scheithauer BW, 2000, NEUROSURGERY, V47, P723, DOI 10.1097/00006123-200009000-00039; Asa SL, 2008, ARCH PATHOL LAB MED, V132, P1231, DOI 10.1043/1543-2165(2008)132[1231:PPPWDT]2.0.CO;2; Nishioka H, 2012, ENDOCR PATHOL, V23, P151, DOI 10.1007/s12022-012-9208-9; YAMADA S, 1989, J CLIN ENDOCR METAB, V68, P73; HORVATH E, 1992, MICROSC RES TECHNIQ, V20, P107, DOI 10.1002/jemt.1070200202; KOVACS K, 1978, AM J MED, V64, P492, DOI 10.1016/0002-9343(78)90236-X; Raverot G, 2010, EUR J ENDOCRINOL, V163, P35, DOI 10.1530/EJE-10-0076; Cooper Odelia, 2010, Hormones & Cancer, V1, P80, DOI 10.1007/s12672-010-0014-x; Vallette-Kasic S, 2003, J CLIN ENDOCR METAB, V88, P3050, DOI 10.1210/jc.2002-021934; Asa SL, 2011, ATLAS TUMOR PATHOLOG; Baldeweg SE, 2005, BRIT J NEUROSURG, V19, P38, DOI 10.1080/02688690500081230; DeLellis RA, 2004, PATHOLOGY GENETICS T; Kovacs K, 1990, ENDOCR PATHOL, P17; Nishioka H, 2011, WORLD NEUROSURG, V77, P533	25	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1046-3976	1559-0097		ENDOCR PATHOL	Endocr. Pathol.	DEC	2015	26	4					349	355		10.1007/s12022-015-9398-z		7	Endocrinology & Metabolism; Pathology	Endocrinology & Metabolism; Pathology	CX0XR	WOS:000365421300012		
J	Luo, RL; Wang, SF; Wang, TY; Zhu, CY; Nomura, T; Akiyama, T				Luo, Ruilian; Wang, Shuangfeng; Wang, Tingyu; Zhu, Chunyu; Nomura, Takahiro; Akiyama, Tomohiro			Fabrication of paraffin@SiO2 shape-stabilized composite phase change material via chemical precipitation method for building energy conservation	ENERGY AND BUILDINGS			English	Article						Shape-stabilized composite phase change material (ss-CPCM); Chemical precipitation method; Sodium silicate precursor; Thermal properties; Building energy conservation	CHANGE MATERIALS PCMS; THERMAL-PROPERTIES; STORAGE; MICROCAPSULES; SILICA; WALLS; SHELL	A novel paraffin@SiO2 shape-stabilized composite phase change material (ss-CPCM) was fabricated by chemical precipitation process using sodium silicate precursor. Various techniques were used to characterize the as-prepared paraffin@SiO2 ss-CPCM so as to investigate its structure and thermal properties, including Fourier transforms infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscopy (SEM), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA) and thermal conductivity measurement. The SEM results show that the microstructures of the prepared ss-CPCM are some uniform submicron particles. The FUR and XRD results showed that there was no chemical interaction between paraffin and SiO2 matrix. The DSC analysis results indicated that the paraffin@SiO2 ss-CPCM achieved high encapsulation efficiency and desirable latent heat storage capability. The thermal conductivity of the composite was also significantly improved compared with pure paraffin. According to the TGA results and the thermal cycling tests, the prepared ss-CPCMs had a good thermal stability. The prepared paraffin@SiO2 ss-CPCM with enhanced heat transfer and phase change properties holds great promise for building energy conservation owing to the low cost of raw materials and the simple synthetic technique. (C) 2015 Elsevier B.V. All rights reserved.	[Luo, Ruilian; Wang, Shuangfeng; Wang, Tingyu] S China Univ Technol, Key Lab Enhanced Heat Transfer & Energy Conservat, Minist Educ, Guangzhou 510640, Guangdong, Peoples R China; [Zhu, Chunyu; Nomura, Takahiro; Akiyama, Tomohiro] Hokkaido Univ, Ctr Adv Res Energy Convers Mat, Sapporo, Hokkaido 0608628, Japan	Wang, SF (reprint author), S China Univ Technol, Key Lab Enhanced Heat Transfer & Energy Conservat, Minist Educ, Guangzhou 510640, Guangdong, Peoples R China.	sfwang@scut.edu.cn			Ministry of Science and Technology of China [2013DFG60080]; National Natural Science Foundation of China [51476059]	The authors gratefully acknowledge the financial support for this project from the International Cooperation and Exchange Program from the Ministry of Science and Technology of China (Grant No. 2013DFG60080) and the National Natural Science Foundation of China (Grant No. 51476059).	Kalnaes SE, 2015, ENERG BUILDINGS, V94, P150, DOI 10.1016/j.enbuild.2015.02.023; Silakhori M, 2014, ENERG CONVERS MANAGE, V80, P491, DOI 10.1016/j.enconman.2014.01.023; Zhao CY, 2011, RENEW SUST ENERG REV, V15, P3813, DOI 10.1016/j.rser.2011.07.019; Gu S, 2015, IND CROP PROD, V65, P1, DOI 10.1016/j.indcrop.2014.11.045; Gan LM, 1996, COLLOID SURFACE A, V110, P199, DOI 10.1016/0927-7757(95)03437-4; Jamekhorshid A, 2014, RENEW SUST ENERG REV, V31, P531, DOI 10.1016/j.rser.2013.12.033; Zhang YP, 2007, BUILD ENVIRON, V42, P2197, DOI 10.1016/j.buildenv.2006.07.023; Pielichowska K, 2014, PROG MATER SCI, V65, P67, DOI 10.1016/j.pmatsci.2014.03.005; Zhang XX, 2004, MATER CHEM PHYS, V88, P300, DOI 10.1016/j.matchemphys.2004.06.043; Zhang YL, 2011, SOL ENERG MAT SOL C, V95, P2726, DOI 10.1016/j.solmat.2011.02.015; Sari A, 2014, APPL ENERG, V136, P217, DOI 10.1016/j.apenergy.2014.09.047; Qi GQ, 2014, SOL ENERG MAT SOL C, V123, P171, DOI 10.1016/j.solmat.2014.01.024; Li BX, 2013, ACS SUSTAIN CHEM ENG, V1, P374, DOI 10.1021/sc300082m; Sharma A, 2009, RENEW SUST ENERG REV, V13, P318, DOI 10.1016/j.rser.2007.10.005; Jesionowski T, 2009, MATER CHEM PHYS, V113, P839, DOI 10.1016/j.matchemphys.2008.08.067; Jin Y, 2010, PARTICUOLOGY, V8, P588, DOI 10.1016/j.partic.2010.07.009; Shirin-Abadi AR, 2011, MACROMOLECULES, V44, P7405, DOI 10.1021/ma201509d; Zhang HZ, 2010, J COLLOID INTERF SCI, V343, P246, DOI 10.1016/j.jcis.2009.11.036; Kuznik F, 2011, RENEW SUST ENERG REV, V15, P379, DOI 10.1016/j.rser.2010.08.019; Zhou D, 2012, APPL ENERG, V92, P593, DOI 10.1016/j.apenergy.2011.08.025; Fang GY, 2010, CHEM ENG J, V163, P154, DOI 10.1016/j.cej.2010.07.054; Cabeza LF, 2007, ENERG BUILDINGS, V39, P113, DOI 10.1016/j.enbuild.2006.03.030; Sari A, 2008, MATER CHEM PHYS, V109, P459, DOI 10.1016/j.matchemphys.2007.12.016; Rao ZH, 2011, ENERG CONVERS MANAGE, V52, P3408, DOI 10.1016/j.enconman.2011.07.009; Qian TT, 2015, SOL ENERG MAT SOL C, V132, P29, DOI 10.1016/j.solmat.2014.08.017; Jesionowski T, 2002, POWDER TECHNOL, V127, P56, DOI 10.1016/S0032-5910(02)00093-1; Jiang X, 2015, APPL ENERG, V137, P731, DOI 10.1016/j.apenergy.2014.09.028; Ma YJ, 2011, IND CROP PROD, V33, P403, DOI 10.1016/j.indcrop.2010.11.001; Fang H., 2015, RENEW ENERG, V74, P689; [方玉堂 FANG Yutang], 2007, [化工学报, Journal of Chemical Industry and Engineering (China)], V58, P771; Huang J. F., 2005, MECH TECHNOLOGY SOL; Konukiu Y., 2014, APPL ENERG, V150, P335; Wang U., 2010, INT C MECH AUT CONTR, P1154; Zhang HZ, 2011, COLLOID SURFACE A, V389, P104, DOI 10.1016/j.colsurfa.2011.08.043	34	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0378-7788	1872-6178		ENERG BUILDINGS	Energy Build.	DEC 1	2015	108						373	380		10.1016/j.enbuild.2015.09.043		8	Construction & Building Technology; Energy & Fuels; Engineering, Civil	Construction & Building Technology; Energy & Fuels; Engineering	CX0CM	WOS:000365364500037		
J	Aliyu, AS; Evangeliou, N; Mousseau, TA; Wu, JW; Ramli, AT				Aliyu, Abubakar Sadiq; Evangeliou, Nikolaos; Mousseau, Timothy Alexander; Wu, Junwen; Ramli, Ahmad Termizi			An overview of current knowledge concerning the health and environmental consequences of the Fukushima Daiichi Nuclear Power Plant (FDNPP) accident	ENVIRONMENT INTERNATIONAL			English	Review						Biota; Human health; Fukushima nuclear accident; Radioactive contamination; Radioecology; Source term	AIRBORNE FISSION-PRODUCTS; RADIOLOGICAL IMPACT ASSESSMENT; SOURCE-TERM ESTIMATION; NORTH PACIFIC-OCEAN; LOW-DOSE RADIATION; REACTOR ACCIDENT; ATMOSPHERIC DISPERSION; RADIOACTIVE FALLOUT; CANCER-RISKS; CS-137 CONCENTRATION	Since 2011, the scientific community has worked to identify the exact transport and deposition patterns of radionuclides released from the accident at the Fukushima Daiichi Nuclear Power Plant (FDNPP) in Japan. Nevertheless, there still remain many unknowns concerning the health and environmental impacts of these radionuclides. The present paper reviews the current understanding of the FDNPP accident with respect to interactions of the released radionuclides with the environment and impacts on human and non-human biota. Here, we scrutinize existing literature and combine and interpret observations and modeling assessments derived after Fukushima. Finally, we discuss the behavior and applications of radionuclides that might be used as tracers of environmental processes. This review focuses on Cs-137 and I-131 releases derived from Fukushima. Published estimates suggest total release amounts of 12-36.7 PBq of Cs-137 and 150-160 PBq of I-131. Maximum estimated human mortality due to the Fukushima nuclear accident is 10,000 (due to all causes) and the maximum estimates for lifetime cancer mortality and morbidity are 1500 and 1800, respectively. Studies of plants and animals in the forests offukushima have recorded a range of physiological, developmental, morphological, and behavioral consequences of exposure to radioactivity. Some of the effects observed in the exposed populations include the following: hematological aberrations in Fukushima monkeys; genetic, developmental and morphological aberrations in a butterfly; declines in abundances of birds, butterflies and cicadas; aberrant growth forms in trees; and morphological abnormalities in aphids. These findings are discussed from the perspective of conservation biology. (C) 2015 Elsevier Ltd. All rights reserved.	[Aliyu, Abubakar Sadiq] Nasarawa State Univ Keffi, Dept Phys, Keffi, Nigeria; [Aliyu, Abubakar Sadiq; Ramli, Ahmad Termizi] Univ Teknol Malaysia, Dept Phys, Johor Baru 81310, Malaysia; [Evangeliou, Nikolaos] Norwegian Inst Air Res NILU, Dept Atmospher & Climate Res ATMOS, Kjeller, Norway; [Mousseau, Timothy Alexander] Univ S Carolina, Environm & Sustainabil Program, Columbia, SC 29208 USA; [Mousseau, Timothy Alexander] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Mousseau, Timothy Alexander] Chubu Univ, Fac Biotechnol, Kasugai, Aichi 487, Japan; [Wu, Junwen] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361005, Peoples R China	Aliyu, AS (reprint author), Nasarawa State Univ Keffi, Dept Phys, PMB 1022, Keffi, Nigeria.	abubakarsaliyu@nsuk.edu.ng			Research Management Center of the Universiti Teknologi Malaysia [Q.J130000.21A2.01E98]; Samuel Freeman Charitable Trust; University of South Carolina College of Arts Sciences	A.S. Aliyu wishes to acknowledge the support of the Research Management Center of the Universiti Teknologi Malaysia for its support through the Post Doc fellowship scheme under the project number (Q.J130000.21A2.01E98). Support for TAM has been provided by the Samuel Freeman Charitable Trust and the University of South Carolina College of Arts & Sciences. The authors are grateful to Elizabeth Farnsworth (of Mount Holyoke College, Massachusetts) for help with manuscript editing.	Aarkrog A, 1997, J ENVIRON RADIOACTIV, V34, P69, DOI 10.1016/0265-931X(96)00005-7; Aliyu A. S., 2014, ATMOSPHERIC DISPERSI; Aliyu A. S., 2015, RADIAT PROT DOSIM, V162, P238; Katata G, 2015, ATMOS CHEM PHYS, V15, P1029, DOI 10.5194/acp-15-1029-2015; Aoyama M, 2011, PROG OCEANOGR, V89, P7, DOI 10.1016/j.pocean.2010.12.003; Buesseler K, 2011, ENVIRON SCI TECHNOL, V45, P9931, DOI 10.1021/es202816c; Tuo F, 2013, APPL RADIAT ISOTOPES, V78, P77, DOI 10.1016/j.apradiso.2013.04.002; Thakur P, 2012, J ENVIRON MONITOR, V14, P1317, DOI 10.1039/c2em11011c; Tanaka TY, 2005, J METEOROL SOC JPN, V83A, P255, DOI 10.2151/jmsj.83A.255; Pittauerova D, 2011, J ENVIRON RADIOACTIV, V102, P877, DOI 10.1016/j.jenvrad.2011.06.003; Saunier O, 2013, ATMOS CHEM PHYS, V13, P11403, DOI 10.5194/acp-13-11403-2013; Hsu SC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049986; Moller AP, 2012, ENVIRON POLLUT, V164, P36, DOI 10.1016/j.envpol.2012.01.008; Barsanti M, 2012, J ENVIRON RADIOACTIV, V114, P126, DOI 10.1016/j.jenvrad.2011.12.020; Moller AP, 2011, ECOL INDIC, V11, P424, DOI 10.1016/j.ecolind.2010.06.013; Kaeriyama H, 2008, J ENVIRON RADIOACTIV, V99, P1838, DOI 10.1016/j.jenvrad.2008.08.006; Ohno T, 2014, J ANAL ATOM SPECTROM, V29, P347, DOI 10.1039/c3ja50291k; Carvalho FP, 2012, J ENVIRON RADIOACTIV, V114, P152, DOI 10.1016/j.jenvrad.2012.03.005; Tsumune D, 2012, J ENVIRON RADIOACTIV, V111, P100, DOI 10.1016/j.jenvrad.2011.10.007; Kritidis P, 2012, J ENVIRON RADIOACTIV, V114, P100, DOI 10.1016/j.jenvrad.2011.12.006; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; Yamashiro H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02850; Moller AP, 2006, TRENDS ECOL EVOL, V21, P200, DOI 10.1016/j.tree.2006.01.008; MacMullin S, 2012, J ENVIRON RADIOACTIV, V112, P165, DOI 10.1016/j.jenvrad.2012.01.026; Evangeliou N, 2015, J ENVIRON RADIOACTIV, V149, P164, DOI 10.1016/j.jenvrad.2015.07.024; Baeza A, 2012, J ENVIRON RADIOACTIV, V114, P138, DOI 10.1016/j.jenvrad.2012.03.001; Clemenza M, 2012, J ENVIRON RADIOACTIV, V114, P113, DOI 10.1016/j.jenvrad.2011.12.012; Hosoda M, 2013, ENVIRON INT, V61, P73, DOI 10.1016/j.envint.2013.09.013; Moller AP, 2007, BIOLOGY LETT, V3, P483, DOI 10.1098/rsbl.2007.0226; Brenner DJ, 2006, RADIAT ENVIRON BIOPH, V44, P253, DOI 10.1007/s00411-006-0029-4; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; MARZANO FN, 1994, MAR POLLUT BULL, V28, P244, DOI 10.1016/0025-326X(94)90100-7; Manolopoulou M, 2011, J ENVIRON RADIOACTIV, V102, P796, DOI 10.1016/j.jenvrad.2011.04.010; Kasamatsu F, 1997, MAR ECOL PROG SER, V160, P109, DOI 10.3354/meps160109; Evrard O, 2012, J ENVIRON RADIOACTIV, V114, P54, DOI 10.1016/j.jenvrad.2012.01.024; Kawamura H, 2011, J NUCL SCI TECHNOL, V48, P1349, DOI 10.3327/jnst.48.1349; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108; Bikit I, 2012, J ENVIRON RADIOACTIV, V114, P89, DOI 10.1016/j.jenvrad.2012.01.020; Hoffman FO, 2011, HEALTH PHYS, V101, P591, DOI 10.1097/HP.0b013e318225c2e1; Watanabe Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep13232; Winiarek V, 2014, ATMOS ENVIRON, V82, P268, DOI 10.1016/j.atmosenv.2013.10.017; Cosma C, 2012, J ENVIRON RADIOACTIV, V114, P94, DOI 10.1016/j.jenvrad.2011.11.020; Steinhauser G, 2013, ENVIRON SCI POLLUT R, V20, P2527, DOI 10.1007/s11356-012-1140-5; Galvan I, 2014, FUNCT ECOL, V28, P1387, DOI 10.1111/1365-2435.12283; Eidemuller M, 2010, RADIAT ENVIRON BIOPH, V49, P477, DOI 10.1007/s00411-010-0289-x; Katata G, 2012, J ENVIRON RADIOACTIV, V111, P2, DOI 10.1016/j.jenvrad.2011.09.011; Ishikawa T, 2014, ENVIRON SCI TECHNOL, V48, P2430, DOI 10.1021/es404691m; Evangeliou N, 2014, ENVIRON INT, V64, P17, DOI 10.1016/j.envint.2013.11.020; Mousseau TA, 2013, TREES-STRUCT FUNCT, V27, P1443, DOI 10.1007/s00468-013-0891-z; Kristiansen NI, 2012, ATMOS CHEM PHYS, V12, P10759, DOI 10.5194/acp-12-10759-2012; Kim CK, 2012, J ENVIRON RADIOACTIV, V111, P70, DOI 10.1016/j.jenvrad.2011.10.018; Moller AP, 2007, J APPL ECOL, V44, P909, DOI 10.1111/j.1365-2664.2007.01353.x; Burns PC, 2012, SCIENCE, V335, P1184, DOI 10.1126/science.1211285; Butler D, 2011, NATURE, V471, P555, DOI 10.1038/471555a; Knapinska-Skiba D, 2003, MAR POLLUT BULL, V46, P1558, DOI 10.1016/S0025-326X(03)00317-5; Lujaniene G, 2012, J ENVIRON RADIOACTIV, V114, P71, DOI 10.1016/j.jenvrad.2011.12.004; von Hippel FN, 2011, B ATOM SCI, V67, P27, DOI 10.1177/0096340211421588; du Bois PB, 2012, J ENVIRON RADIOACTIV, V114, P2, DOI 10.1016/j.jenvrad.2011.11.015; Long NQ, 2012, J ENVIRON RADIOACTIV, V111, P53, DOI 10.1016/j.jenvrad.2011.11.018; BUESSELER KO, 1991, DEEP-SEA RES, V38, pS725, DOI 10.1016/S0198-0149(10)80006-8; BOWEN VT, 1980, EARTH PLANET SC LETT, V49, P411, DOI 10.1016/0012-821X(80)90083-7; Almgren S, 2006, J ENVIRON RADIOACTIV, V91, P90, DOI 10.1016/j.jenvrad.2006.08.008; Hiyama A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00570; Chen J, 2013, RADIAT PROT DOSIM, V157, P1, DOI 10.1093/rpd/nct239; Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Povinec PP, 2012, J ENVIRON RADIOACTIV, V114, P81, DOI 10.1016/j.jenvrad.2012.05.008; Buesseler KO, 2012, P NATL ACAD SCI USA, V109, P5984, DOI 10.1073/pnas.1120794109; Beyea J, 2013, ENERG ENVIRON SCI, V6, P1042, DOI 10.1039/c2ee24183h; Hong GH, 2012, J RADIOL PROT, V32, P397, DOI 10.1088/0952-4746/32/4/397; Pham MK, 2012, J ENVIRON RADIOACTIV, V114, P131, DOI 10.1016/j.jenvrad.2012.01.010; Mierelski JW, 2014, ATMOS ENVIRON, V91, P137, DOI 10.1016/j.atmosenv.2014.03.065; Evangeliou N, 2013, ENVIRON SCI TECHNOL, V47, P5803, DOI 10.1021/es400372u; Oza RB, 2013, ANN NUCL ENERGY, V58, P95, DOI 10.1016/j.anucene.2013.03.016; Evangeliou N, 2013, ATMOS CHEM PHYS, V13, P7183, DOI 10.5194/acp-13-7183-2013; Ten Hoeve JE, 2012, ENERG ENVIRON SCI, V5, P8743, DOI 10.1039/c2ee22019a; Beresford NA, 2012, J ENVIRON RADIOACTIV, V114, P48, DOI 10.1016/j.jenvrad.2011.12.008; Terada H, 2012, J ENVIRON RADIOACTIV, V112, P141, DOI 10.1016/j.jenvrad.2012.05.023; Moller AP, 2013, ECOL INDIC, V24, P75, DOI 10.1016/j.ecolind.2012.06.001; Buesseler KO, 2012, SCIENCE, V338, P480, DOI 10.1126/science.1228250; Higgins K, 2001, P NATL ACAD SCI USA, V98, P2928, DOI 10.1073/pnas.031358898; Tubiana M, 2009, RADIOLOGY, V251, P13, DOI 10.1148/radiol.2511080671; Saegusa J, 2013, APPL RADIAT ISOTOPES, V77, P56, DOI 10.1016/j.apradiso.2013.02.018; Evangeliou N, 2014, SCI TOTAL ENVIRON, V500, P155, DOI 10.1016/j.scitotenv.2014.08.102; Cuttler JM, 2010, DOSE-RESPONSE, V8, P378, DOI 10.2203/dose-response.10-003.Cuttler; Lindahl P, 2010, MAR ENVIRON RES, V69, P73, DOI 10.1016/j.marenvres.2009.08.002; Wada T, 2013, J ENVIRON RADIOACTIV, V124, P246, DOI 10.1016/j.jenvrad.2013.05.008; Muramatsu Y, 2000, ENVIRON SCI TECHNOL, V34, P2913, DOI 10.1021/es0008968; Lujaniene G, 2013, APPL RADIAT ISOTOPES, V81, P330, DOI 10.1016/j.apradiso.2013.03.072; Leppanen AP, 2013, J ENVIRON RADIOACTIV, V126, P273, DOI 10.1016/j.jenvrad.2013.08.008; Lujaniene G, 2012, ATMOS ENVIRON, V61, P419, DOI 10.1016/j.atmosenv.2012.07.046; Christoudias T, 2013, ATMOS CHEM PHYS, V13, P1425, DOI 10.5194/acp-13-1425-2013; Perrot F, 2012, J ENVIRON RADIOACTIV, V114, P61, DOI 10.1016/j.jenvrad.2011.12.026; Nakanishi T, 2014, J ENVIRON RADIOACTIV, V128, P9, DOI 10.1016/j.jenvrad.2013.10.019; Moller AP, 2011, BIOL CONSERV, V144, P2787, DOI 10.1016/j.biocon.2011.08.009; Perianez R, 2013, J RADIOANAL NUCL CH, V298, P635, DOI 10.1007/s10967-013-2422-1; Leon JD, 2011, J ENVIRON RADIOACTIV, V102, P1032, DOI 10.1016/j.jenvrad.2011.06.005; Lozano RL, 2011, ENVIRON INT, V37, P1259, DOI 10.1016/j.envint.2011.06.001; Paatero J, 2012, J ENVIRON RADIOACTIV, V114, P41, DOI 10.1016/j.jenvrad.2011.12.027; Moller AP, 2009, J ORNITHOL, V150, P239, DOI 10.1007/s10336-008-0343-5; Aliyu AS, 2015, ATMOSFERA, V28, P13; Masson O, 2011, ENVIRON SCI TECHNOL, V45, P7670, DOI 10.1021/es2017158; Povinec PP, 2012, ENVIRON SCI TECHNOL, V46, P10356, DOI 10.1021/es301997c; Sinclair LE, 2011, J ENVIRON RADIOACTIV, V102, P1018, DOI 10.1016/j.jenvrad.2011.06.008; Huh CA, 2012, EARTH PLANET SC LETT, V319, P9, DOI 10.1016/j.epsl.2011.12.004; Chai TF, 2015, ATMOS ENVIRON, V106, P241, DOI 10.1016/j.atmosenv.2015.01.070; Bolsunovsky A, 2011, J ENVIRON RADIOACTIV, V102, P1062, DOI 10.1016/j.jenvrad.2011.06.007; Akahane Keiichi, 2012, Environmentalist, V32, P136, DOI 10.1007/s10669-011-9381-2; HOLM E, 1988, ENVIRON INT, V14, P363, DOI 10.1016/0160-4120(88)90016-5; Aoyama Michio, 2004, ScientificWorldJournal, V4, P200; Bonisoli-Alquati A. K., 2015, SCI REP, V9; Bucic E. H., 2011, EFFECTS RAD FUKUSHIM; Caffrey E. A., 2014, J ENV PROT; Carpenter J., 2012, 162 ARPANSA; Charette M. A., 2013, BIOGEOSCI DISCUSS, V9, P16139; Chen J., 2014, RAD PROT DOSIM; CIBTO, 2011, FUK REL MEAS CTBTO; Copplestone D., 2014, THE CONVERSATION; Draxler R., 2004, HYSPL PC TRAIN SEM; Draxler R. R., 1997, DESCRIPTION HYSPLIT4; Gamier-Laplace J, 2013, J ENVIRON RADIOACTIV, V121, P12, DOI DOI 10.1016/JJENVRAD2012.01.013; Gamier-Laplace J., 2011, ENVIRON SCI TECHNOL, V45, P5077; Gamier-Laplace J., 2015, SCI REP IN PRESS; Gungor E, 2014, RADIAT PROT DOSIM, V158, P195, DOI 10.1093/rpd/nct205; Harrison R., 1993, RADIOECOLOGY CHERNOB; Hayama S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068530; Hermosell L. G., 2013, BIOL LETT, V9; Hirose K, 2011, J ENVIRON RADIOACTIV, V111, P13, DOI DOI 10.1016/J; Homoki Z., 2013, RADIOPROTECTION, V48, pS117; Honda M.C., 2012, GEOCHEM J, V46, P9; IAEA, 1986, IAEA SAF SER; IAEA, 2004, SED DISTR COEFF CONC; INES, 2009, INT NUCL RAD EV SCAL; IPPNW, 2013, INF NUCL EN EN TRANS; IRSN, 2012, FUK ON YEAR LAT IN A; Isnard O., 2006, C3X NOUVELLE PLATEFO; Jilani A. B., 2009, ATMOSPHERIC DISPERSI; Johansen M. P., 2014, ENV SCI TECHNOL; Katata G, 2014, ATMOS CHEM PHYS DISC, V14, P14725, DOI [10.5194/acpd-14-14725-2014, DOI 10.5194/ACPD-14-14725-2014]; Kelley J. M., 1999, Science of the Total Environment, V237-238, P483, DOI 10.1016/S0048-9697(99)00160-6; Kozubov G., 2006, RAD BIOL RADIOECOL, V47, P204; Krey P., 1976, MASS ISOTOPIC COMPOS; Kumamoto Y, 2015, J ENVIRON RADIOACTIV, V140, P114, DOI 10.1016/j.jenvrad.2014.11.010; Marka J. C., 1993, SCI GLOBAL SECURITY, V4, P111, DOI 10.1080/08929889308426394; Marshall J., 1965, ATMOSPHERE OCEAN CLI; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Matsui S, 2015, ENVIRON POLLUT, V206, P159, DOI 10.1016/j.envpol.2015.06.013; MEXT, 2011, MON DAT IB PREF 15 1; Moller A. P., 2015, J ORNITHOL; Moller AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100296; Moller A. P., 2015, SCI REP; Moller A. P., 2015, J ORNITHOL IN PRESS; Moller AP, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-92; Mousseau TA, 2014, J HERED, V105, P704, DOI 10.1093/jhered/esu040; Murase K., 2015, SCI REP, V5; NEA, 2002, CHERN ASS RAD HLTH I; NERHJ, 2011, JAP GOV IAEA MIN C N; NRC, 2006, HLTH RISKS EXP LOW L; [NSCJ Japan NSCo], 2011, TRIAL EST EM RAD MAT; Ochiai K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05793; RJG, 2011, REP JAP GOV ACC TEPC; Rulik P., 2014, RAD PROT DOSIM; SCJ, 2014, REV MOD COMP TRANSP; Sin HS, 2014, SAINS MALAYS, V43, P1565; Smith JN, 2015, P NATL ACAD SCI USA, V112, P1310, DOI 10.1073/pnas.1412814112; Sorbjan Z., 1989, STRUCTURE ATMOSPHERI; Stallard B., 2014, NATURE WORLD NEWS; Steinhauser G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057760; Stepanova E., 2008, ENV HLTH, V7, P1; Stohl A., 2012, ATMOS CHEM PHYS DISC, V11, P28319; Takahashi J, 2015, J ENVIRON RADIOACTIV, V139, P351, DOI 10.1016/j.jenvrad.2014.07.004; Tokonami S., 2012, SCI REP, V2; Toyoshima K., 2011, REP SCI ENG SAGA U, V40, P1; Tronko T. D., 2014, THYROID, V24; UNSCEAR, 2000, SOURC EFF ION RAD; UNSCEAR, 2013, SOURC EFF ION RAD; UNSCEAR 2010, 2010, SUMM LOW DOS RAD EFF; Wetherbee G. A., 2012, FISSION PRODUCTS NAT; WHO, 2013, HLTH RISK ASS NUCL A; Wu JW, 2013, CHINESE SCI BULL, V58, P552, DOI 10.1007/s11434-012-5426-2; Yamana H., 2001, RADIOACTIVITY ENV; Zheng J., 2012, SCI REP, V2	182	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0160-4120	1873-6750		ENVIRON INT	Environ. Int.	DEC	2015	85						213	228		10.1016/j.envint.2015.09.020		16	Environmental Sciences	Environmental Sciences & Ecology	CX0CF	WOS:000365363800023		
J	Zhao, Y; Kato, S; Zhao, JN				Zhao, Yu; Kato, Shinsuke; Zhao, Jianing			Characteristics of particle coagulation in an underground parking lot	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Coagulation; Half-time; Particle size distribution; Ultrafine particle; Underground parking lot; Vehicle exhaust	EXHAUST PARTICULATE MATTER; BROWNIAN COAGULATION; SIZE DISTRIBUTIONS; ON-ROAD; NANOPARTICLE COAGULATION; LABORATORY EVALUATION; COMBUSTION AEROSOLS; DIESEL-ENGINE; TURBULENT; VEHICLE	Particles in vehicle exhaust plumes in underground parking lots have adverse health effects due to the enclosed environment in which they are released and the temperature difference between the tailpipe and ambient environment; at the same time, particle coagulation might be obvious near the tailpipe in an underground parking lot. In the present study, airflow and temperature fields were calculated using the Realizable k-epsilon model, and the Eulerian particle transport model was selected in the numerical simulation of particle concentration dispersion. Polydisperse thermal coagulation due to Brownian collisions was employed to calculate the particle coagulation. The results show that particle coagulation rate and half-time were significant within 1 m from the tailpipe. The variations in the particle coagulation rate and half-time were similar, but their directions were opposite. Air exhaust time was nearly four times longer than averaged half-time and 40 times longer than minimum half-time. The peak particle diameter increased approximately 1.43 times due to coagulation. A double particle concentration at the tailpipe caused the fourfold rise in the particle coagulation rate in the distance ranging less than 1 m from the tailpipe. An increase in exhaust velocity at the tailpipe could shorten the obvious range of particle coagulation along the centerline of the tailpipe from 1 to 0.8 m in the study.	[Zhao, Yu; Zhao, Jianing] Harbin Inst Technol, Sch Municipal & Environm Engn, Harbin 150090, Peoples R China; [Kato, Shinsuke] Univ Tokyo, Inst Ind Sci, Kato Lab, Meguro Ku, Tokyo 1538505, Japan; [Kato, Shinsuke] Univ Tokyo, Inst Ind Sci, Ooka Lab, Meguro Ku, Tokyo 1538505, Japan	Zhao, JN (reprint author), Harbin Inst Technol, Sch Municipal & Environm Engn, 73 Huanghe St, Harbin 150090, Peoples R China.	zhaojn@hit.edu.cn					Carpentieri M, 2011, ENVIRON POLLUT, V159, P685, DOI 10.1016/j.envpol.2010.11.041; SAFFMAN PG, 1956, J FLUID MECH, V1, P16, DOI 10.1017/S0022112056000020; Peters A, 2004, NEW ENGL J MED, V351, P1721, DOI 10.1056/NEJMoa040203; Garrick SC, 2006, J AEROSOL SCI, V37, P555, DOI 10.1016/j.jaerosci.2005.04.010; Ketzel M, 2004, ATMOS ENVIRON, V38, P2639, DOI 10.1016/j.atmosenv.2004.02.020; Ning Z, 2005, ATMOS ENVIRON, V39, P7880, DOI 10.1016/j.atmosenv.2005.09.020; Cheng Z, 2013, ATMOS ENVIRON, V65, P186, DOI 10.1016/j.atmosenv.2012.10.022; Uhrner U, 2007, ATMOS ENVIRON, V41, P7440, DOI 10.1016/j.atmosenv.2007.05.057; Kittelson DB, 1998, J AEROSOL SCI, V29, P575, DOI 10.1016/S0021-8502(97)10037-4; Park SH, 2002, AEROSOL SCI TECH, V36, P419, DOI 10.1080/027868202753571241; Li HR, 2014, CHEMOSPHERE, V94, P128, DOI 10.1016/j.chemosphere.2013.09.061; Harris SJ, 2001, J AEROSOL SCI, V32, P749, DOI 10.1016/S0021-8502(00)00111-7; McNabola A, 2009, TRANSPORT RES D-TR E, V14, P567, DOI 10.1016/j.trd.2009.08.003; Chan TL, 2010, J AEROSOL SCI, V41, P553, DOI 10.1016/j.jaerosci.2010.03.005; Nicolai T, 2003, EUR RESPIR J, V21, P956, DOI 10.1183/09031936.03.00041103; Miller SE, 2004, AEROSOL SCI TECH, V38, P79, DOI 10.1080/02786820490247669; Kim DH, 2002, J COLLOID INTERF SCI, V249, P96, DOI 10.1006/jcis.2002.8264; Fan L, 2007, J CHIN INST CHEM ENG, V38, P425, DOI 10.1016/j.jcice.2007.06.006; Kittelson DB, 2006, J AEROSOL SCI, V37, P913, DOI 10.1016/j.jaerosci.2005.08.005; Ristovski ZD, 2005, SCI TOTAL ENVIRON, V345, P93, DOI 10.1016/j.scitotenv.2004.10.021; Chan MY, 2004, BUILD ENVIRON, V39, P635, DOI 10.1016/j.buildenv.2003.10.009; Kim DS, 2006, J AEROSOL SCI, V37, P1781, DOI 10.1016/j.jaerosci.2006.07.001; Chan CK, 2008, ATMOS ENVIRON, V42, P1, DOI 10.1016/j.atmosenv.2007.09.003; Wong CP, 2003, ATMOS ENVIRON, V37, P4435, DOI 10.1016/S1352-2310(03)00571-5; Kinsey JS, 2007, ENVIRON SCI TECHNOL, V41, P4972, DOI 10.1021/es0625024; Jiang PZ, 2005, J AIR WASTE MANAGE, V55, P437; [Anonymous], 1975, TURBULENCE; Canagaratna MR, 2004, AEROSOL SCI TECH, V38, P555, DOI 10.1080/02786820490465504; LEE KW, 1984, AEROSOL SCI TECH, V3, P327, DOI 10.1080/02786828408959020; Mukherjee D, 2006, J AEROSOL SCI, V37, P1388, DOI 10.1016/j.jaerosci.2006.01.008; HUANG CM, 1970, J COLLOID INTERF SCI, V33, P529, DOI 10.1016/0021-9797(70)90004-4; Fruin SA, 2004, ATMOS ENVIRON, V38, P4123, DOI 10.1016/j.atmosenv.2004.04.026; Kleeman MJ, 2000, ENVIRON SCI TECHNOL, V34, P1132, DOI 10.1021/es981276y; Rusly E, 2005, INT J REFRIG, V28, P1092, DOI 10.1016/j.ijrefrig.2005.02.005; Liu YH, 2011, AEROSOL SCI TECH, V45, P1019, DOI 10.1080/02786826.2011.580021; Ristovski ZD, 2000, J AEROSOL SCI, V31, P403, DOI 10.1016/S0021-8502(99)00530-3; WAGNER PE, 1977, J CHEM PHYS, V66, P638, DOI 10.1063/1.433937; Kim DS, 2003, J AEROSOL SCI, V34, P859, DOI 10.1016/S0021-8502(03)00055-7; Kittelson DB, 2006, J AEROSOL SCI, V37, P931, DOI 10.1016/j.jaerosci.2005.08.008; ASHRAE, 2009, ASHRAE HDB FUND; CD-adapco, 2013, US GUID STAR CCM VER; [高继东 GAO Jidong], 2007, [燃烧科学与技术, Journal of Combustion Science and Technology], V13, P248; Hinds WC, 1982, AEROSOL TECHNOLOGY; Klot SV, 2002, EUR RESPIR J, V20, P691, DOI 10.1183/09031936.02.01402001; Maele KV, 2006, FIRE SAFETY J, V41, P122; Obaidullah M, 2012, INT J ENERGY ENV, V5, P508; SHIH TH, 1995, COMPUT FLUIDS, V24, P227, DOI 10.1016/0045-7930(94)00032-T; Tchen CM, 1947, THESIS; Zhai ZJ, 2007, HVAC&R RES, V13, P853, DOI 10.1080/10789669.2007.10391459	49	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	DEC	2015	22	23					18654	18668		10.1007/s11356-015-5590-4		15	Environmental Sciences	Environmental Sciences & Ecology	CX6MU	WOS:000365816000033		
J	Azuma, T; Ishiuchi, H; Inoyama, T; Teranishi, Y; Yamaoka, M; Sato, T; Mino, Y				Azuma, Takashi; Ishiuchi, Hirotaka; Inoyama, Tomomi; Teranishi, Yusuke; Yamaoka, Misato; Sato, Takaji; Mino, Yoshiki			Occurrence and fate of selected anticancer, antimicrobial, and psychotropic pharmaceuticals in an urban river in a subcatchment of the Yodo River basin, Japan	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Ozonation; PPCPs; Urban river; Sewage treatment plant; Solid-phase extraction; UPLC-MS/MS	PERSONAL CARE PRODUCTS; ENVIRONMENTAL RISK-ASSESSMENT; QUADRUPOLE MASS-SPECTROMETRY; WASTE-WATER; AQUATIC ENVIRONMENT; ANTIINFLUENZA DRUGS; SURFACE WATERS; TRANSFORMATION PRODUCTS; INFLUENZA OUTBREAK; CYTOSTATIC DRUGS	Pollution status of six anticancer agents in the river water and effluents of sewage treatment plants (STPs) in Japan was surveyed with comparative analysis of the levels of four microbial and one psychotropic pharmaceuticals widely used for therapeutic medication. The area of survey is located in the Kanzaki-Ai River basin which is a major subcatchment of the Yodo River basin and is centered on a highly populated area that includes the middle and downstream reaches of the Yodo River. Selected cancer agents were bicalutamide, capecitabine, cyclophosphamide, doxifluridine, tamoxifen, and tegafur. A combination of strong anion solid-phase extraction cartridge under pH 11 for adsorption and optimization of liquid chromatography-tandem mass spectroscopy (LC-MS/MS) system was necessary to ensure high recovery rates (63-124 % for river water and 52-115 % for STP effluent). The year-round survey of these compounds in four seasons showed that all anticancer compounds were detected at median concentrations ranged from not detected to 32 ng/L in the river water and from not detected to 245 ng/L in the effluents of sewage treatment plants not using ozonation. In the case of bicalutamide (an active antiandrogen used to treat prostate cancer), the maximum concentration detected was 254 ng/L in river water and 1032 ng/L in non-ozonated sewage treatment plant effluents. Based on the mass balance, sewage treatment plants were the primary sources of anticancer compounds as well as the other pharmaceuticals in the river, and the attenuation effect of the river water was small. Ozonation at sewage treatment plants was effective in removing these compounds. To the best of our knowledge, this study is the first to report the existence of bicalutamide, doxifluridine, and tegafur in the river environment.	[Azuma, Takashi; Ishiuchi, Hirotaka; Inoyama, Tomomi; Teranishi, Yusuke; Yamaoka, Misato; Sato, Takaji; Mino, Yoshiki] Osaka Univ Pharmaceut Sci, Takatsuki, Osaka 5691094, Japan	Azuma, T (reprint author), Osaka Univ Pharmaceut Sci, 4-20-1 Nasahara, Takatsuki, Osaka 5691094, Japan.	t.azuma@gly.oups.ac.jp			River Foundation	We thank the staff of the STPs for sampling the water. We acknowledge the River Foundation for the funding in the form of research and scholarships.	Agerstrand M, 2015, ENVIRON SCI TECHNOL, V49, P5336, DOI 10.1021/acs.est.5b00302; Kim IH, 2009, WATER SCI TECHNOL, V59, P945, DOI 10.2166/wst.2009.076; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Petrovic M, 2014, SCI TOTAL ENVIRON, V468, P415, DOI 10.1016/j.scitotenv.2013.08.079; Kumar V, 2011, ENVIRON POLLUT, V159, P2906, DOI 10.1016/j.envpol.2011.04.038; Ferrando-Climent L, 2013, ANAL BIOANAL CHEM, V405, P5937, DOI 10.1007/s00216-013-6794-4; Kosjek T, 2011, TRAC-TREND ANAL CHEM, V30, P1065, DOI 10.1016/j.trac.2011.04.007; Negreira N, 2014, SCI TOTAL ENVIRON, V497, P68, DOI 10.1016/j.scitotenv.2014.07.101; Antoniou MG, 2013, SCI TOTAL ENVIRON, V456, P42, DOI 10.1016/j.scitotenv.2013.03.072; Hanamoto S, 2013, ENVIRON SCI TECHNOL, V47, P13571, DOI 10.1021/es4035478; Azuma T, 2014, INT J ENVIRON AN CH, V94, P853, DOI 10.1080/03067319.2014.921290; Liu XJ, 2010, ANAL BIOANAL CHEM, V396, P2977, DOI 10.1007/s00216-010-3531-0; Nussbaumer S, 2011, TALANTA, V85, P2265, DOI 10.1016/j.talanta.2011.08.034; Narumiya M, 2013, J HAZARD MATER, V260, P305, DOI 10.1016/j.jhazmat.2013.05.032; Ferrando-Climent L, 2014, ENVIRON POLLUT, V193, P216, DOI 10.1016/j.envpol.2014.07.002; Okuda T, 2009, ENVIRON INT, V35, P815, DOI 10.1016/j.envint.2009.01.006; Adachi F, 2013, SCI TOTAL ENVIRON, V444, P508, DOI 10.1016/j.scitotenv.2012.11.077; Besse JP, 2012, ENVIRON INT, V39, P73, DOI 10.1016/j.envint.2011.10.002; Ashton D, 2004, SCI TOTAL ENVIRON, V333, P167, DOI 10.1016/j.scitotenv.2004.04.062; Schlusener MP, 2015, ENVIRON POLLUT, V196, P247, DOI 10.1016/j.envpol.2014.09.019; Martin J, 2011, J SEP SCI, V34, P3166, DOI 10.1002/jssc.201100461; Grabic R, 2012, TALANTA, V100, P183, DOI 10.1016/j.talanta.2012.08.032; Aristilde L, 2010, ENVIRON SCI TECHNOL, V44, P1444, DOI 10.1021/es902665n; Andreozzi R, 2003, CHEMOSPHERE, V50, P1319, DOI 10.1016/S0045-6535(02)00769-5; Nakada N, 2007, WATER SCI TECHNOL, V56, P133, DOI 10.2166/wst.2007.801; Kummerer K, 2009, CHEMOSPHERE, V75, P417, DOI 10.1016/j.chemosphere.2008.11.086; Carlsson C, 2006, SCI TOTAL ENVIRON, V364, P67, DOI 10.1016/j.scitotenv.2005.06.035; Ghosh GC, 2010, ENVIRON HEALTH PERSP, V118, P103, DOI 10.1289/ehp.0900930; Azuma T, 2012, ENVIRON SCI TECHNOL, V46, P12873, DOI 10.1021/es303203c; Lopez-Serna R, 2013, ENVIRON POLLUT, V174, P305, DOI 10.1016/j.envpol.2012.11.022; Azuma T, 2013, CHEMOSPHERE, V93, P1672, DOI 10.1016/j.chemosphere.2013.05.025; Kim I, 2009, J HAZARD MATER, V166, P1134, DOI 10.1016/j.jhazmat.2008.12.020; Ferrer I, 2010, J CHROMATOGR A, V1217, P5674, DOI 10.1016/j.chroma.2010.07.002; Toolaram AP, 2014, MUTAT RES-REV MUTAT, V760, P18, DOI 10.1016/j.mrrev.2014.02.001; Prasse C, 2010, ENVIRON SCI TECHNOL, V44, P1728, DOI 10.1021/es903216p; Booker V, 2014, SCI TOTAL ENVIRON, V473, P159, DOI 10.1016/j.scitotenv.2013.11.145; Loffler D, 2005, ENVIRON SCI TECHNOL, V39, P5209, DOI 10.1021/es0484146; Yamamoto H, 2009, WATER RES, V43, P351, DOI 10.1016/j.watres.2008.10.039; Cockshott ID, 2004, CLIN PHARMACOKINET, V43, P855, DOI 10.2165/00003088-200443130-00003; Komori K, 2013, ENVIRON MONIT ASSESS, V185, P4529, DOI 10.1007/s10661-012-2886-4; Patrolecco L, 2015, ENVIRON SCI POLLUT R, V22, P5864, DOI 10.1007/s11356-014-3765-z; Rabii FW, 2014, SCI TOTAL ENVIRON, V487, P792, DOI 10.1016/j.scitotenv.2013.12.050; Kumar V, 2009, CHEMOSPHERE, V77, P1440, DOI 10.1016/j.chemosphere.2009.08.052; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; Environment Canada, 2015, SCREEN ASS ETH 2 4 1, P1; Japan Meteorological Agency, WEATH STAT; Jiho, 2014, YAKUJI HDB; Lake Biwa-Yodo River Water Quality Preservation Organization Japan, 2012, BYQ LAK BIW YOD RIV, P1; Ministry of Health Labour and Welfare Japan, 2014, VIT STAT JAP, P1; Ministry of Health Labour and Welfare Japan, 2012, ANN REP STAT PROD PH; Ministry of Health Labour and Welfare Japan, 2013, VIS MED IND 2013, P1; Ministry of the Environment Japan, 2009, 3 MIN ENV JAP; Osaka Prefecture Japan, 2012, YOD RIV SYST RIV CON, P1; Social Welfare and Public Health in Tokyo, 2012, SUMM MED PRACT SURV, P1; Sun L, 2015, ECOTOXICOLOGICAL EFF, P47; Vasquez MI, 2014, J HAZARD MATER, V279, P169, DOI 10.1016/j.jhazmat.2014.06.069	56	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	DEC	2015	22	23					18676	18686		10.1007/s11356-015-5013-6		11	Environmental Sciences	Environmental Sciences & Ecology	CX6MU	WOS:000365816000035		
J	Liu, Z; Geng, Y; Wang, H; Sun, L; Ma, ZX; Tian, X; Yu, XM				Liu, Zhe; Geng, Yong; Wang, Hui; Sun, Lu; Ma, Zhixiao; Tian, Xu; Yu, Xiaoman			Emergy-based comparative analysis of energy intensity in different industrial systems	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Energy intensity; Emergy analysis; Industrial park; Primary energy	CIRCULAR ECONOMY; CHINA; SHENYANG; EVALUATE; INDEXES; PARK; SUSTAINABILITY; GROWTH; RATIOS; LEVEL	With the rapid economic development, energy consumption of China has been the second place in the world next to the USA. Usually, measuring energy consumption intensity or efficiency applies heat unit which is joule per gross domestic production (GDP) or coal equivalent per GDP. However, this measuring approach is only oriented by the conversion coefficient of heat combustion which does not match the real value of the materials during their formation in the ecological system. This study applied emergy analysis to evaluate the energy consumption intensity to fill this gap. Emergy analysis is considered as a bridge between ecological system and economic system, which can evaluate the contribution of ecological products and services as well as the load placed on environmental systems. In this study, emergy indicator for performing energy consumption intensity of primary energy was proposed. Industrial production is assumed as the main contributor of energy consumption compared to primary and tertiary industries. Therefore, this study validated this method by investigating the two industrial case studies which were Dalian Economic Development Area (DEDA) and Fuzhou economic and technological area (FETA), to comparatively study on their energy consumption intensity between the different kinds of industrial systems and investigate the reasons behind the differences. The results show that primary energy consumption (PEC) of DEDA was much higher than that of FETA during 2006 to 2010 and its primary energy consumption ratio (PECR) to total emergy involvement had a dramatically decline from year 2006 to 2010. In the same time, nonrenewable energy of PEC in DEDA was also much higher than that in FETA. The reason was that industrial structure of DEDA was mainly formed by heavy industries like petro-chemistry industry, manufacturing industries, and high energy-intensive industries. However, FETA was formed by electronic business, food industry, and light industries. Although the GDP of DEDA was much higher than that of FETA, its energy intensity was higher as well. Through the 5-year development, energy consumption intensity in DEDA made a significant reduction from 3.90E+16 seJ/$ to 1.84E+16 seJ/$, which was attributed by the improvement of industrial structure, construction of eco-industrial park and circular economic industrial park. The proposed emergy indicator for demonstrating energy consumption intensity overcame the weakness that the indicator was only transformed from the heat burning. Therefore, this study shows an optional way to measure energy consumption intensity from the perspective of material ecological contribution.	[Liu, Zhe; Geng, Yong; Tian, Xu; Yu, Xiaoman] Chinese Acad Sci, Key Lab Pollut Ecol & Environm Engn, Inst Appl Ecol, Shenyang 110016, Peoples R China; [Geng, Yong] Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, Shanghai 200240, Peoples R China; [Wang, Hui] Shenyang Univ, Key Lab Reg Environm & Ecoremediat, Minist Educ, Shenyang 110044, Peoples R China; [Sun, Lu] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Ma, Zhixiao] United Nations Univ, Inst Adv Study Sustainabil, Shibuya Ku, Tokyo 1508925, Japan; [Tian, Xu; Yu, Xiaoman] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Liu, Z (reprint author), Chinese Acad Sci, Key Lab Pollut Ecol & Environm Engn, Inst Appl Ecol, Shenyang 110016, Peoples R China.	liuzhe@iae.ac.cn; ygeng@sjtu.edu.cn			Natural Science Foundation of China [71325006, 71033004]	This work is supported by the Natural Science Foundation of China (71325006 and 71033004). Especially, we want to thank those anonymous reviewers for their valuable comments and contributions to the revised version of this paper.	Andresen N, 1999, EC AN HUSB NORD COUN, V303, P16; Geng Y, 2009, J IND ECOL, V13, P15, DOI 10.1111/j.1530-9290.2008.00071.x; Liu Z, 2014, ENVIRON SCI POLLUT R, V21, P10243, DOI 10.1007/s11356-014-2854-3; Liu Z, 2015, ENVIRON ENG SCI, V32, P193, DOI 10.1089/ees.2014.0003; Geng Y, 2010, SCI TOTAL ENVIRON, V408, P5273, DOI 10.1016/j.scitotenv.2010.07.081; Lou B, 2013, ENERG POLICY, V55, P217, DOI 10.1016/j.enpol.2012.12.009; Brown MT, 2011, ECOL MODEL, V222, P879, DOI 10.1016/j.ecolmodel.2010.11.006; Geng Y, 2013, J CLEAN PROD, V58, P82, DOI 10.1016/j.jclepro.2013.06.034; Pulselli RM, 2007, ENERG BUILDINGS, V39, P620, DOI 10.1016/j.enbuild.2006.10.004; Brown MT, 1997, ECOL ENG, V9, P51, DOI 10.1016/S0925-8574(97)00033-5; Zhang N, 2011, ENERGY, V36, P3639, DOI 10.1016/j.energy.2011.01.035; Brown MT, 2002, J CLEAN PROD, V10, P321, DOI 10.1016/S0959-6526(01)00043-9; Ulgiati S, 1995, ECOL ENG, V5, P519, DOI 10.1016/0925-8574(95)00043-7; Geng Y, 2009, WASTE MANAGE, V29, P996, DOI 10.1016/j.wasman.2008.06.036; Crompton P, 2005, ENERG ECON, V27, P195, DOI 10.1016/j.eneco.2004.10.006; Jorgensen SE, 2004, ECOL MODEL, V178, P11, DOI 10.1016/j.ecolmodel.2003.12.036; Liu ZX, 2014, SUSTAINABILITY-BASEL, V6, P3669, DOI 10.3390/su6063669; Geng Y, 2013, SCIENCE, V339, P1526, DOI 10.1126/science.1227059; Dong HJ, 2013, ENERG POLICY, V57, P298, DOI 10.1016/j.enpol.2013.01.057; Deng SH, 2014, ENERG SOURCE PART B, V9, P325, DOI 10.1080/15567249.2010.533330; Bargigli S, 2003, BIENN EM EV RES C 2; Brandt-Williams SL, 2002, HDB EMERGY EVALUATIO; Brown MT, 1991, TRANSFORMITIES WORKI; Brown MT, 2004, ENCY ENERGY, P329, DOI DOI 10.1016/B0-12-176480-X/00242-4; Brown MT, 2000, QUANTIFYING SUSTAINA, P695, DOI 10.1016/B978-012318860-1/50033-2; Brown MT, 2001, HDB EMERGY EVALUATIO; Buenfil A, 2001, THESIS U FLORIDA, P264; Buranakarn V, 1998, THESIS; Comar V, 2000, P 1 BIENN EM AN RES; De Boer IJM, 2001, P 2 INT WORKSH ADV E; Lei Shi, 2010, J CHINA UNIV GEOSCI, V10, P60; Liu Z, 2015, J CLEAN PROD, DOI [10.1016/j.jclepro.2015.04.132, DOI 10.1016/J.JCLEPRO.2015.04.132]; [Lu Hongfang 陆宏芳], 2003, [生态学报, Acta Ecologica Sinica], V23, P1363; Odell PR, 2004, WHY CARBON FUELS WIL; Odum H. T., 1996, ENV ACCOUNTING EMERG; Odum HT, 2000, INTRO GLOBAL BUDGET, P16; Ren JM, 2010, MEASURING SUSTAINABI; Sun XJ, 2014, INT J GREEN ENERGY, V11, P849, DOI 10.1080/15435075.2013.830261; Tilley DR, 1999, THESIS; UFL, 2008, U FLOR DAT EM AN NAT; Ulgiati S, 1993, TRENDS ECOLOGICAL PH, V2, P187; United Nations Industrial Development Organization (UNIDO), 1997, IND EST PRINC PRACT; Wesley WI, 2011, J IND ECOL, V15, P550	43	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	DEC	2015	22	23					18687	18698		10.1007/s11356-015-4957-x		12	Environmental Sciences	Environmental Sciences & Ecology	CX6MU	WOS:000365816000036		
J	Toublanc, N; Okagaki, T; Boyce, M; Chan, R; Mugitani, A; Watanabe, S; Yamamoto, K; Yoshida, K; Andreas, JO				Toublanc, Nathalie; Okagaki, Takuya; Boyce, Malcolm; Chan, Robert; Mugitani, Ayumi; Watanabe, Shikiko; Yamamoto, Katsumi; Yoshida, Katsumi; Andreas, Jens-Otto			Pharmacokinetics of the antiepileptic drug levetiracetam in healthy Japanese and Caucasian volunteers following intravenous administration	EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Levetiracetam; E-Keppra; Intravenous; Pharmacokinetics; Japanese; Caucasian	POOLED ANALYSIS; SAFETY PROFILE; INFUSION; BIOAVAILABILITY; TOLERABILITY; PLACEBO; TRIALS	The intravenous (iv) formulation of levetiracetam has been available in clinical practice worldwide for several years, but not in Japan. Two open-label studies were conducted: Study A evaluated the bioequivalence of iv and oral tablet formulations in healthy Japanese volunteers; and Study B subsequently compared the pharmacokinetics of iv levetiracetam in healthy Japanese and Caucasian volunteers. Study A had a randomised, two-way crossover design; a single 1,500 mg levetiracetam dose was administered as a 15-min iv infusion and as 3 x 500 mg oral tablets to Japanese volunteers. In Study B, 1,500 mg levetiracetam was administered as single and repeated 15-min iv infusions to Japanese and Caucasian volunteers. Overall, 26/27 volunteers completed Study A and 32/32 (16 Japanese; 16 Caucasian) completed Study B. In Study A, the point estimate and 90 % confidence interval (CI) for the geometric least squares mean (LSM) ratio (iv vs oral) were fully included within the acceptance range for bioequivalence (0.85-1.25) for the area under plasma concentration-time curve from 0 to last quantifiable observation (AUC(last) 0.97 [0.95, 0.99]), but not for the maximum plasma concentration (C (max) 1.64 [1.47, 1.83]). In Study B, after a single iv infusion, the point estimates (90 % CI) for the geometric LSM ratio (Japanese vs Caucasian) for body weight-normalised C (max) and AUC(last) were 1.21 (1.07, 1.36) and 0.97 (0.90, 1.04), respectively. Corresponding values after repeated iv infusions were C (max,ss) 1.01 (0.91, 1.12) and AUC(tau,ss) 0.89 (0.83, 0.96). Levetiracetam was well tolerated in both studies. Study A did not demonstrate the bioequivalence of single doses of levetiracetam 1,500 mg administered as an iv infusion and as oral tablets in healthy Japanese adults. Study B, however, showed that pharmacokinetic profiles were generally similar between Japanese and Caucasian adults after single and repeated iv infusions of levetiracetam 1,500 mg.	[Toublanc, Nathalie; Watanabe, Shikiko; Andreas, Jens-Otto] UCB Pharma, Braine Lalleud, Belgium; [Okagaki, Takuya; Chan, Robert; Yamamoto, Katsumi; Yoshida, Katsumi] UCB Pharma, Tokyo, Japan; [Boyce, Malcolm] Hammersmith Med Res, London, England; [Mugitani, Ayumi] Medical Co, LTA Sumida Hosp, Tokyo, Japan	Toublanc, N (reprint author), UCB Pharma, Braine Lalleud, Belgium.	Nathalie.Toublanc@ucb.com			UCB Pharma	This study was sponsored by UCB Pharma. UCB Pharma was involved in the design and conduct of the study, and collection, management and analysis of the data. The authors thank Azita Tofighy, Ph.D. (UCB Pharma) for review and coordination of manuscript preparation, Mieko Shirakawa (Medical Co. LTA Sumida Hospital, Tokyo, Japan) for clinical pharmacy support and critical review of the manuscript and Dr. Steven Warrington (Hammersmith Medicines Research, London, UK) for critical review of the manuscript. Ioana Edgeworth, Ph.D. and Jennifer Stewart, M.Sc. (QXV Communications, Macclesfield, UK) provided writing support, funded by UCB Pharma.	Toublanc N, 2014, DRUG METAB PHARMACOK, V29, P61, DOI 10.2133/dmpk.DMPK-13-RG-045; Patsalos PN, 2004, CLIN PHARMACOKINET, V43, P707, DOI 10.2165/00003088-200443110-00002; Pigeolet E, 2007, CLIN PHARMACOKINET, V46, P503, DOI 10.2165/00003088-200746060-00004; Weinstock A, 2013, J CHILD NEUROL, V28, P1423, DOI 10.1177/0883073813480241; Perucca E, 2003, EPILEPSY RES, V53, P47, DOI 10.1016/S0920-1211(02)00250-4; Harden C, 2001, EPILEPSIA, V42, P36, DOI 10.1046/j.1528-1157.2001.0420s4036.x; Ramael S, 2006, CLIN THER, V28, P734, DOI 10.1016/j.clinthera.2006.05.004; Ramael S, 2006, EPILEPSIA, V47, P1128, DOI 10.1111/j.1528-1167.2006.00586.x; Baulac M, 2007, EPILEPSIA, V48, P589, DOI 10.1111/j.1528-1167.2006.00959.x; SHAH VP, 1991, EUR J DRUG METAB PH, V16, P249; Gidal BE, 2005, EPILEPSY RES, V64, P1, DOI 10.1016/j.eplepsyres.2005.01.005; French J, 2001, EPILEPSY RES, V47, P77, DOI 10.1016/S0920-1211(01)00296-0; Inoue T, 2014, JPN J CLIN PSYCHOPHA, V17, P413	13	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0378-7966	2107-0180		EUR J DRUG METAB PH	Eur. J. Drug Metabol. Pharmacokinet.	DEC	2015	40	4					461	469		10.1007/s13318-014-0227-4		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX2GF	WOS:000365514000011		
J	Yamamoto, K; Yamamoto, T; Honjo, K; Ichioka, H; Oseko, F; Kishida, T; Mazda, O; Kanamura, N				Yamamoto, Kenta; Yamamoto, Toshiro; Honjo, Kenichi; Ichioka, Hiroaki; Oseko, Fumishige; Kishida, Tsunao; Mazda, Osam; Kanamura, Narisato			Electrical stimulation with periodic alternating intervals stimulates neuronal cells to produce neurotrophins and cytokines through activation of mitogen-activated protein kinase pathways	EUROPEAN JOURNAL OF ORAL SCIENCES			English	Article						electrical stimulation; mitogen-activated protein kinase; Neuro2a; neurotrophins; peripheral neuropathy	PERIPHERAL-NERVE INJURY; 3RD MOLAR REMOVAL; FUNCTIONAL RECOVERY; GROWTH-FACTOR; REGENERATION; RAT; HYPERSENSITIVITY; MANAGEMENT; VEGF; PAIN	Peripheral neuropathy is a representative complication of dental surgery. Electrical therapy, based on electrical stimulation with periodic alternating intervals (ES-PAI), may promote nerve regeneration after peripheral nerve injury in a non-invasive manner, potentially providing an effective therapy for neuropathy. This study aimed to analyze the molecular mechanisms underlying the nerve recovery stimulated by ES-PAI. In brief, ES-PAI was applied to a neuronal cell line, Neuro2A, at various intensities using the pulse generator apparatus, FREUDE. Cell viability, neurotrophin mRNA expression, and cytokine production were examined using a tetrazolium-based assay, real-time RT-PCR, and ELISA, respectively. Mitogen-activated protein kinase (MAPK) signaling was assessed using flow cytometry. It was found that ES-PAI increased the viability of cells and elevated expression of nerve growth factor (NGF) and neurotrophin-3 (NT-3); ESPAI also augmented vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) expression, which was restored by addition of p38 inhibitors. Phosphorylation of p38 and extracellular signal-regulated kinase 1/2 (ERK-1/2) was augmented by ES-PAI. Hence, ES-PAI may ameliorate peripheral neuropathy by promoting neuronal cell proliferation and production of neurogenic factors by activating p38 and ERK-1/2 pathways.	[Yamamoto, Kenta; Yamamoto, Toshiro; Honjo, Kenichi; Ichioka, Hiroaki; Oseko, Fumishige; Kanamura, Narisato] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dent Med, Kamigyo Ku, Kyoto 6028566, Japan; [Yamamoto, Kenta; Honjo, Kenichi; Kishida, Tsunao; Mazda, Osam] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Immunol, Kamigyo Ku, Kyoto 6028566, Japan	Yamamoto, K (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dent Med, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	fiori30@koto.kpu-m.ac.jp			Kyoto Prefectural University of Medicine; Techno Company; JSPS	Support for this research was provided by Kyoto Prefectural University of Medicine, Techno Company, and Grant-in-Aid for Young Scientists B from JSPS.	Alhassani AA, 2010, J ORAL IMPLANTOL, V36, P401, DOI 10.1563/AAID-JOI-D-09-00059; Widmann C, 1999, PHYSIOL REV, V79, P143; Huang JH, 2013, EUR J NEUROSCI, V38, P3691, DOI 10.1111/ejn.12370; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Obata K, 2004, J NEUROSCI, V24, P10211, DOI 10.1523/JNEUROSCI.3388-04.2004; Zheng LS, 2010, J NEUROSCI RES, V88, P1273, DOI 10.1002/jnr.22302; Yamamoto K, 2015, P NATL ACAD SCI USA, V112, P6152, DOI 10.1073/pnas.1420713112; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Johnson MI, 2011, EXPERT REV NEUROTHER, V11, P735, DOI [10.1586/ern.11.48, 10.1586/ERN.11.48]; Robert RC, 2005, J ORAL MAXIL SURG, V63, P732, DOI 10.1016/j.jams.2005.02.006; Pieber K, 2010, J REHABIL MED, V42, P289, DOI 10.2340/16501977-0554; Bagheri SC, 2010, J ORAL MAXIL SURG, V68, P2770, DOI 10.1016/j.joms.2010.05.065; Boyd JG, 2003, MOL NEUROBIOL, V27, P277, DOI 10.1385/MN:27:3:277; Conover JC, 1997, REV NEUROSCIENCE, V8, P13; Ljungberg C, 1999, NEUROSCI LETT, V262, P29, DOI 10.1016/S0304-3940(99)00040-3; Obata K, 2004, LIFE SCI, V74, P2643, DOI 10.1016/j.lfs.2004.01.007; KLEIN R, 1994, FASEB J, V8, P738; LeviMontalcini R, 1996, TRENDS NEUROSCI, V19, P514, DOI 10.1016/S0166-2236(96)10058-8; Segi-Nishida E, 2008, P NATL ACAD SCI USA, V105, P11352, DOI 10.1073/pnas.0710858105; Boffano P, 2012, OR SURG OR MED OR PA, V113, pE10, DOI 10.1016/j.tripleo.2011.06.034; Okada K, 2010, EXP NEUROL, V222, P191, DOI 10.1016/j.expneurol.2009.12.017; Sarina, 2013, BRAIN RES, V1490, P61, DOI 10.1016/j.brainres.2012.10.059; Saygili E, 2010, J MOL CELL CARDIOL, V49, P79, DOI 10.1016/j.yjmcc.2010.01.019; Shinjyo N, 2007, BIOCHEM BIOPH RES CO, V358, P130, DOI 10.1016/j.bbrc.2007.04.071; Chang KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018738; Nisiwaki K, 2002, JPN J REHABIL MED, V39, P257	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-8836	1600-0722		EUR J ORAL SCI	Eur. J. Oral Sci.	DEC	2015	123	6					403	408		10.1111/eos.12224		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CX5RJ	WOS:000365759800004		
J	van Strijp, AJP; Takatsuka, T; Sono, R; Iijima, Y				van Strijp, Augustinus J. P.; Takatsuka, Tsutomu; Sono, Ryohei; Iijima, Youichi			Inhibition of dentine collagen degradation by hesperidin: an in situ study	EUROPEAN JOURNAL OF ORAL SCIENCES			English	Article						collagen; degradation; dentine; flavonoid; hesperidin	GINGIVAL CREVICULAR FLUID; MATRIX METALLOPROTEINASES; BACTERIAL-COLONIZATION; ROOT CARIES; BONE SIALOPROTEIN; MMP INHIBITORS; VITRO; CHLORHEXIDINE; DEMINERALIZATION; REMINERALIZATION	Dentine caries is a process of demineralization and subsequent degradation of the collagenous matrix. Host-derived proteolytic enzymes, such as matrix metalloproteinases (MMPs), play a role in this process of dentine collagen degradation. Hampering this degradation retards the caries process. Dietary antioxidants, such as the flavonoid hesperidin, can inhibit the proteolytic activity of MMPs and act as natural stabilizers of collagen. The aim of this study was to investigate the anti-collagenolytic activity of hesperidin in an in situ model. A single-blind, split-mouth, in situ experiment was designed. Seventeen participants received two completely demineralized dentine specimens placed contralaterally in the buccal flanges of their partial prosthesis. During the 4-wk experimental period, the participants immersed the dentine specimens in a test solution [1,000 parts per million (p.p.m.) hesperidin] or a control solution (saline), twice daily for 3 min. After the in situ period, the specimens were retrieved and their collagen content was determined. A saliva sample was taken at the start and at the end of the experimental period, to assess collagenolytic activity. A significant protection of collagen, of 24%, was observed in the hesperidin-treated specimens compared with the control-treated specimens. No correlation was found between salivary collagenolytic activity and loss of collagen in the control-treated specimens. The results of this in situ study show that hesperidin could play a role in the preservation of dentine collagen matrix.	[van Strijp, Augustinus J. P.] Univ Amsterdam, Dept Cariol Endodontol Pedodontol, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands; [van Strijp, Augustinus J. P.] Vrije Univ Amsterdam, NL-1081 LA Amsterdam, Netherlands; [Takatsuka, Tsutomu; Sono, Ryohei] Sunstar, Osaka, Japan; [Iijima, Youichi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Hlth, Nagasaki 852, Japan	Vrije Univ Amsterdam, Univ Amsterdam, Dept Cariol Endodontol Pedodontol, Acad Ctr Dent Amsterdam ACTA, Gustav Mahlerlaan 3004, NL-1081 LA Amsterdam, Netherlands.	a.vstrijp@acta.nl			Sunstar, Osaka, Japan	This study was funded by an unconditional research grant from Sunstar, Osaka, Japan. No other conflicts of interest can be identified.	Kennedy S, 1998, J DENT RES, V77, P1515; Hebling J, 2005, J DENT RES, V84, P741; Chaussain-Miller C, 2006, J DENT RES, V85, P22; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; KLETER GA, 1994, J DENT RES, V73, P1523; Magalhaes AC, 2009, J DENT, V37, P994, DOI 10.1016/j.jdent.2009.08.007; Xie Q, 2008, J DENT, V36, P900, DOI 10.1016/j.jdent.2008.07.011; TENG YT, 1992, J PERIODONTAL RES, V27, P544, DOI 10.1111/j.1600-0765.1992.tb01830.x; Shimada Y, 2009, AUST DENT J, V54, P347, DOI 10.1111/j.1834-7819.2009.01161.x; Bedran-Russo AKB, 2009, J DENT RES, V88, P807, DOI 10.1177/0022034509342556; Toledano M, 2012, CARIES RES, V46, P201, DOI 10.1159/000337315; Boushell LW, 2011, CARIES RES, V45, P453, DOI 10.1159/000330601; Hiraishi N, 2013, DENT MATER, V29, P1048, DOI 10.1016/j.dental.2013.07.015; Tjaderhane L, 1998, J DENT RES, V77, P1622; Osorio R, 2011, EUR J ORAL SCI, V119, P79, DOI 10.1111/j.1600-0722.2010.00789.x; Hiraishi N, 2011, J DENT, V39, P391, DOI 10.1016/j.jdent.2011.03.002; Mazzoni A, 2011, J DENT, V39, P231, DOI 10.1016/j.jdent.2011.01.001; Bedran-Russo AKB, 2010, J BIOMED MATER RES B, V94B, P250, DOI 10.1002/jbm.b.31649; Pavan S, 2011, CARIES RES, V45, P443, DOI 10.1159/000330599; ELEY BM, 1992, J PERIODONTAL RES, V27, P62, DOI 10.1111/j.1600-0765.1992.tb02087.x; KLONT B, 1991, CARIES RES, V25, P39; Osorio R, 2011, J DENT, V39, P148, DOI 10.1016/j.jdent.2010.11.005; VOLPIN D, 1973, BIOCHEMISTRY-US, V12, P1452, DOI 10.1021/bi00731a028; Mazzoni A, 2007, J DENT RES, V86, P436; Kato MT, 2010, J DENT RES, V89, P468, DOI 10.1177/0022034510363248; Sulkala M, 2001, J DENT RES, V80, P1545; DAYAN D, 1983, ARCH ORAL BIOL, V28, P185, DOI 10.1016/0003-9969(83)90126-7; Simons D, 1999, LANCET, V353, P1761, DOI 10.1016/S0140-6736(99)01343-4; Griffin SO, 2004, J DENT RES, V83, P634; Sulkala M, 2007, ARCH ORAL BIOL, V52, P121, DOI 10.1016/j.archoralbio.2006.08.009; Chibinski ACR, 2014, CARIES RES, V48, P312, DOI 10.1159/000355302; Hedenbjork-Lager A, 2015, CARIES RES, V49, P1, DOI 10.1159/000360625; Islam S, 2014, DENT MATER, V30, P1205; Islam Sofiqul Md, 2012, Dent Mater J, V31, P362; Khaddam M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00425; Koide T, 1997, Dent Mater J, V16, P1; Scheffel DLS, 2014, DENT MATER, V30, P227, DOI 10.1016/j.dental.2013.11.007; tensCate JM, 1998, CARIES RES, V32, P141; van Strijp AJP, 2008, CARIES RES, V42, P460, DOI 10.1159/000170587; VANSTRIJP AJP, 1994, CARIES RES, V28, P21; van Strijp AJP, 2003, CARIES RES, V37, P58, DOI 10.1159/000068223; vanStrijp AJP, 1997, CARIES RES, V31, P349; vanStrijp AJP, 1997, EUR J ORAL SCI, V105, P27	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-8836	1600-0722		EUR J ORAL SCI	Eur. J. Oral Sci.	DEC	2015	123	6					447	452		10.1111/eos.12225		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CX5RJ	WOS:000365759800010		
J	Sato, T; Muroya, K; Hanakawa, J; Iwano, R; Asakura, Y; Tanaka, Y; Murayama, K; Ohtake, A; Hasegawa, T; Adachi, M				Sato, Takeshi; Muroya, Koji; Hanakawa, Junko; Iwano, Reiko; Asakura, Yumi; Tanaka, Yukichi; Murayama, Kei; Ohtake, Akira; Hasegawa, Tomonobu; Adachi, Masanori			Clinical manifestations and enzymatic activities of mitochondrial respiratory chain complexes in Pearson marrow-pancreas syndrome with 3-methylglutaconic aciduria: a case report and literature review	EUROPEAN JOURNAL OF PEDIATRICS			English	Review						Pearson marrow-pancreas syndrome; Mitochondrial respiratory chain complexes; 3-Methylglutaconic aciduria; Organic aciduria	ADRENAL INSUFFICIENCY; DNA REARRANGEMENTS; ORGANIC ACIDURIA; MTDNA DELETION; I DEFICIENCY; PATIENT; DISORDERS; CHILDREN; MYOPATHY; INFANT	Pearson marrow-pancreas syndrome (PS) is a rare mitochondrial disorder. Impaired mitochondrial respiratory chain complexes (MRCC) differ among individuals and organs, which accounts for variable clinical pictures. A subset of PS patients develop 3-methylglutaconic aciduria (3-MGA-uria), but the characteristic symptoms and impaired MRCC remain unknown. Our patient, a girl, developed pancytopenia, hyperlactatemia, steatorrhea, insulin-dependent diabetes mellitus, liver dysfunction, Fanconi syndrome, and 3-MGA-uria. She died from cerebral hemorrhage at 3 years of age. We identified a novel 5.4-kbp deletion of mitochondrial DNA. The enzymatic activities of MRCC I and IV were markedly reduced in the liver and muscle and mildly reduced in skin fibroblasts and the heart. To date, urine organic acid analysis has been performed on 29 PS patients, including our case. Eight patients had 3-MGA-uria, while only one patient did not. The remaining 20 patients were not reported to have 3-MGA-uria. In this paper, we included these 20 patients as PS patients without 3-MGA-uria. PS patients with and without 3-MGA-uria have similar manifestations. Only a few studies have examined the enzymatic activities of MRCC. Conclusion: No clinical characteristics distinguish between PS patients with and without 3-MGA-uria. The correlation between 3-MGA-uria and the enzymatic activities of MRCC remains to be elucidated.	[Sato, Takeshi; Muroya, Koji; Hanakawa, Junko; Iwano, Reiko; Asakura, Yumi; Adachi, Masanori] Kanagawa Childrens Med Ctr, Dept Endocrinol & Metab, Minami Ku, Yokohama, Kanagawa 2328555, Japan; [Tanaka, Yukichi] Kanagawa Childrens Med Ctr, Dept Pathol, Yokohama, Kanagawa 2328555, Japan; [Murayama, Kei] Chiba Childrens Hosp, Dept Metab, Midori Ku, Chiba, Chiba 2660007, Japan; [Ohtake, Akira] Saitama Med Univ, Dept Pediat, Fac Med, Moroyama, Saitama 3500495, Japan; [Sato, Takeshi; Hasegawa, Tomonobu] Keio Univ, Dept Pediat, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan	Muroya, K (reprint author), Kanagawa Childrens Med Ctr, Dept Endocrinol & Metab, Minami Ku, Mutsukawa 2-138-4, Yokohama, Kanagawa 2328555, Japan.	sato_tksjp@yahoo.co.jp; kmuroya@kcmc.jp; hanajun0624@yahoo.co.jp; rosso-nero1996sapporo@hotmail.co.jp; yumi79@mvb.biglobe.ne.jp; ytanaka@kcmc.jp; kmuraya@mri.biglobe.ne.jp; akira_oh@saitama-med.ac.jp; thaseg@a6.keio.jp; madachi@mars.sannet.ne.jp					Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482; Jacobs LJAM, 2004, J INHERIT METAB DIS, V27, P47, DOI 10.1023/B:BOLI.0000016601.49372.18; Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261; Kirby DM, 1999, NEUROLOGY, V52, P1255; Topaloglu R, 2008, TURKISH J PEDIATR, V50, P572; Lacbawan F, 2000, AM J MED GENET, V95, P266, DOI 10.1002/1096-8628(20001127)95:3<266::AID-AJMG13>3.0.CO;2-0; Murayama K, 2009, EUR J PEDIATR, V168, P297, DOI 10.1007/s00431-008-0753-7; Warris A, 1999, PEDIATR INFECT DIS J, V18, P739, DOI 10.1097/00006454-199908000-00023; Shimada M, 1999, HEPATO-GASTROENTEROL, V46, P401; NIAUDET P, 1994, PEDIATR NEPHROL, V8, P164; Manea EM, 2009, J PEDIAT HEMATOL ONC, V31, P947, DOI 10.1097/MPH.0b013e3181bbc4ef; Kleinle S, 1997, HUM GENET, V100, P643, DOI 10.1007/s004390050567; PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3; KAPSA R, 1994, J INHERIT METAB DIS, V17, P521, DOI 10.1007/BF00711584; JAKOBS C, 1991, EUR J PEDIATR, V150, P684, DOI 10.1007/BF02072635; GIBSON KM, 1992, J PEDIATR-US, V121, P940, DOI 10.1016/S0022-3476(05)80348-8; RIBES A, 1993, J INHERIT METAB DIS, V16, P537, DOI 10.1007/BF00711675; LICHTERKONECKI U, 1993, EUR J PEDIATR, V152, P378, DOI 10.1007/BF01956761; Tumino M, 2011, AM J MED GENET A, V155A, P3063, DOI 10.1002/ajmg.a.34288; SANO T, 1993, PEDIATR RES, V34, P105, DOI 10.1203/00006450-199307000-00024; SUPERTIFURGA A, 1993, EUR J PEDIATR, V152, P44, DOI 10.1007/BF02072515; Krahenbuhl S, 1999, J HEPATOL, V31, P550, DOI 10.1016/S0168-8278(99)80050-6; Krauch G, 2002, AM J MED GENET, V110, P57, DOI 10.1002/ajmg.10410; MULLERHOCKER J, 1991, VIRCHOWS ARCH A, V419, P355, DOI 10.1007/BF01606527; Knerr I, 2003, J PEDIAT HEMATOL ONC, V25, P948, DOI 10.1097/00043426-200312000-00008; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Atale A, 2009, EUR J MED GENET, V52, P23, DOI 10.1016/j.ejmg.2008.10.003; HOLME E, 1992, PEDIATR RES, V32, P731, DOI 10.1203/00006450-199212000-00022; Morel AS, 2009, EUR J PEDIATR, V168, P311, DOI 10.1007/s00431-008-0756-4; ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327; Crippa BL, 2015, AM J MED GENET A, V167, P621, DOI 10.1002/ajmg.a.36939; Williams TB, 2012, MOL GENET METAB, V106, P104, DOI 10.1016/j.ymgme.2012.01.018; Santorelli FM, 1996, NEUROLOGY, V47, P1320; ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881; Wortmann SB, 2013, J INHERIT METAB DIS, V36, P913, DOI 10.1007/s10545-012-9579-6; Bernier FP, 2002, NEUROLOGY, V59, P1406	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6199	1432-1076		EUR J PEDIATR	Eur. J. Pediatr.	DEC	2015	174	12					1593	1602		10.1007/s00431-015-2576-7		10	Pediatrics	Pediatrics	CX6BS	WOS:000365786800005		
J	Doi, T; Ohga, S; Ishimura, M; Takada, H; Ishii, K; Ihara, K; Nagai, H; Hara, T				Doi, Takehiko; Ohga, Shouichi; Ishimura, Masataka; Takada, Hidetoshi; Ishii, Kanako; Ihara, Kenji; Nagai, Hideyuki; Hara, Toshiro			Long-term liposteroid therapy for idiopathic pulmonary hemosiderosis (vol 172, pg 1475, 2013)	EUROPEAN JOURNAL OF PEDIATRICS			English	Correction									[Doi, Takehiko; Ohga, Shouichi; Ishimura, Masataka; Takada, Hidetoshi; Ishii, Kanako; Ihara, Kenji; Hara, Toshiro] Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Higashi Ku, Fukuoka 8128582, Japan; [Ohga, Shouichi] Kyushu Univ, Grad Sch Med Sci, Dept Perinatal & Pediat Med, Higashi Ku, Fukuoka 8128582, Japan; [Nagai, Hideyuki] Kyoto Yamashiro Gen Med Ctr, Div Pediat, Kizukawa, Kyoto 6190214, Japan	Ohga, S (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ohgas@pediatr.med.kyushu-u.ac.jp					Doi T, 2013, EUR J PEDIATR, V172, P1475, DOI 10.1007/s00431-013-2065-9	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6199	1432-1076		EUR J PEDIATR	Eur. J. Pediatr.	DEC	2015	174	12					1701	1701		10.1007/s00431-015-2638-x		1	Pediatrics	Pediatrics	CX6BS	WOS:000365786800022		
J	Inokuchi, H; Tojima, M; Mano, H; Ishikawa, Y; Ogata, N; Haga, N				Inokuchi, Haruhi; Tojima, Michio; Mano, Hiroshi; Ishikawa, Yuki; Ogata, Naoshi; Haga, Nobuhiko			Neck range of motion measurements using a new three-dimensional motion analysis system: validity and repeatability	EUROPEAN SPINE JOURNAL			English	Article						Neck; Range of motion; Motion analysis; Validity; Repeatability	PASSIVE CERVICAL RANGE; OF-MASS DISPLACEMENT; CRITERION VALIDITY; ACTIVE RANGE; SPINE; RELIABILITY; DEVICE; GONIOMETER; FLEXION; ZEBRIS	Neck movement is important for many activities of daily living (ADL). Neck disorders, such as cervical spondylosis and whiplash can limit neck movement and ADL. The cervical range of motion (CROM) device has been recently used to measure neck range of motion (ROM); however, this measurement includes trunk motion, and therefore does not represent a pure neck ROM measurement. The authors aimed to develop a new method to establish pure neck ROM measurements during flexion, extension, lateral bending, and rotation using a three-dimensional motion analysis system, VICON. Twelve healthy participants were recruited and neck ROMs during flexion, extension, lateral bending, and rotation were measured using VICON and the CROM device. Test-retest repeatability was assessed using interclass correlation coefficients (ICCs), standard error of measurement (SEM), and minimal detectable change (MDC). Validity between two measurements was evaluated using a determination coefficient and Pearson's correlation coefficient. ICCs of neck ROM measured using VICON and the CROM device were all at substantial or almost perfect levels [VICON: ICC(1,2) = 0.786-0.962, the CROM device: ICC(1,2) = 0.736-0.950]. Both SEMs and MDCs were low in all measurement directions (VICON: SEM = 1.3A degrees-4.5A degrees, MDC = 3.6A degrees-12.5A degrees; the CROM device: SEM = 2.2A degrees-3.9A degrees, MDC = 6.1A degrees-10.7A degrees). Determination coefficients (R (2)s) and Pearson's correlation coefficients (rs) between the two measurement methods were high (R (2) = 0.607-0.745, r = 0.779-0.863). VICON is a useful system to measure neck ROMs and evaluate the efficacy of interventions, such as surgery or physiotherapeutic exercise.	[Inokuchi, Haruhi; Tojima, Michio; Mano, Hiroshi; Haga, Nobuhiko] Univ Tokyo, Grad Sch Med, Dept Rehabil Med, Bunkyo Ku, Tokyo 1138655, Japan; [Tojima, Michio] Waseda Univ, Fac Sport Sci, Tokyo, Japan; [Ishikawa, Yuki; Ogata, Naoshi; Haga, Nobuhiko] Tokyo Univ Hosp, Dept Rehabil, Tokyo 113, Japan; [Ishikawa, Yuki] Univ Tokyo, Grad Sch Engn, Dept Precis Engn, Tokyo, Japan; [Ogata, Naoshi] Teikyo Univ, Dept Rehabil, Tokyo 173, Japan	Haga, N (reprint author), Univ Tokyo, Grad Sch Med, Dept Rehabil Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	hagan-reh@h.u-tokyo.ac.jp			JSPS KAKENHI [25282159]; Foundation for Total Health Promotion	This study was supported by a JSPS KAKENHI Grant-in-Aid for Exploratory Research (Grant Number 25282159) and by the Foundation for Total Health Promotion. The authors would like to thank Dr. Yasuo Nakahara for helpful discussions. The protocol was approved by the Institutional Review Board of the institution (No. 3996).	Haynes MJ, 2002, J MANIP PHYSIOL THER, V25, P579, DOI 10.1067/mmt.2002.128370; Ferrari A, 2008, GAIT POSTURE, V28, P207, DOI 10.1016/j.gaitpost.2007.11.009; Guo LY, 2012, J BACK MUSCULOSKELET, V25, P47, DOI 10.3233/BMR-2012-0309; Miller CP, 2010, SPINE, V35, P1271, DOI 10.1097/BRS.0b013e3181c0ddad; Assink N, 2005, J MANIP PHYSIOL THER, V28, P408, DOI 10.1016/j.jmpt.2005.06.009; Sterling M, 2004, SPINE, V29, P182, DOI 10.1097/01.BRS.0000105535.12598.AE; KUHLMAN KA, 1993, ARCH PHYS MED REHAB, V74, P1071, DOI 10.1016/0003-9993(93)90064-H; Bennett SE, 2002, J SPINAL DISORD TECH, V15, P307, DOI 10.1097/01.BSD.000002808085.69379.4B; YOUDAS JW, 1992, PHYS THER, V72, P770; Tousignant M, 2006, J ORTHOP SPORT PHYS, V36, P242; Bland JM, 2012, ANESTHESIOLOGY, V116, P182, DOI 10.1097/ALN.0b013e31823d7784; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Williams MA, 2010, J MANIP PHYSIOL THER, V33, P138, DOI 10.1016/j.jmpt.2009.12.009; Audette I, 2010, J ORTHOP SPORT PHYS, V40, P318, DOI 10.2519/jospt.2010.3180; Nagamoto Y, 2011, SPINE, V36, P778, DOI 10.1097/BRS.0b013e3181e218cb; Mannion AF, 2000, EUR SPINE J, V9, P379, DOI 10.1007/s005860000187; Machino M, 2012, SPINE, V37, pE1243, DOI 10.1097/BRS.0b013e3182659d3e; DVORAK J, 1992, SPINE, V17, pS393, DOI 10.1097/00007632-199210001-00009; Ferrario VF, 2002, J ORTHOPAED RES, V20, P122, DOI 10.1016/S0736-0266(01)00079-1; Malmstrom EM, 2003, SPINE, V28, pE433, DOI 10.1097/01.BRS.0000090840.45802.D4; Ordway NR, 1997, SPINE, V22, P501, DOI 10.1097/00007632-199703010-00007; Cagnie B, 2007, J MANIP PHYSIOL THER, V30, P450, DOI 10.1016/j.jmpt.2007.05.003; Miyazaki M, 2008, SPINE, V33, P187, DOI 10.1097/BRS.0b013e3181604501; Okada S, 2007, DYSPHAGIA, V22, P204, DOI 10.1007/s00455-006-9073-0; Tojima M, 2013, SPINE, V38, pE1327, DOI 10.1097/BRS.0b013e3182a0dbc5; Tousignant M, 2002, SPINE, V27, P812, DOI 10.1097/00007632-200204150-00007; LIND B, 1989, ARCH PHYS MED REHAB, V70, P692; Orendurff MS, 2004, J REHABIL RES DEV, V41, P829, DOI 10.1682/JRRD.2003.10.0150; Tousignant M, 2000, SPINE, V25, P324, DOI 10.1097/00007632-200002010-00011; Bible JE, 2010, J SPINAL DISORD TECH, V23, P15, DOI 10.1097/BSD.0b013e3181981632; Morphett AL, 2003, J MANIP PHYSIOL THER, V26, P152, DOI 10.1016/S0161-4754(02)54107-5; Kasch H, 2001, NEUROLOGY, V56, P1637; Beaton DE, 2001, J CLIN EPIDEMIOL, V54, P1204, DOI 10.1016/S0895-4356(01)00407-3; Stratford PW, 1997, PHYS THER, V77, P745; BUCK C A, 1959, Arch Phys Med Rehabil, V40, P390; Gutierrez-Farewik EM, 2006, HUM MOVEMENT SCI, V25, P238, DOI 10.1016/j.humov.2005.11.001	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	DEC	2015	24	12					2807	2815		10.1007/s00586-015-3913-2		9	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CX7IQ	WOS:000365875800014		
J	Nakamaru, K; Aizawa, J; Koyama, T; Nitta, O				Nakamaru, Koji; Aizawa, Junya; Koyama, Takayuki; Nitta, Osamu			Reliability, validity, and responsiveness of the Japanese version of the Patient-Specific Functional Scale in patients with neck pain	EUROPEAN SPINE JOURNAL			English	Article						Neck pain; The Patient-Specific Functional Scale; Cultural adaptation; Psychometric testing	STATUS QUESTIONNAIRES; DISABILITY INDEX; HEALTH; DYSFUNCTION; GUIDELINES	The aims of this study were to translate and culturally adapt the Patient-Specific Functional Scale (PSFS) and validate the Japanese version of the PSFS (PSFS-J) in outpatients with neck pain. The PSFS was translated and adapted into Japanese in accordance with the published guidelines. A total of 103 outpatients with neck pain were recruited for this study. Psychometric evaluation included test-retest reliability, convergent validity by comparing the PSFS-J to the Neck Disability Index (NDI), patient's global impression of change (PGIC), and responsiveness (unpaired t test, minimal detectable change). The intraclass correlation coefficient for test-retest reliability was 0.98 (95 % confidence interval = 0.95-0.99). The Pearson correlation coefficient with the NDI was -0.35. The Spearman correlation coefficient showed a strong relationship between the change score in the PSFS-J and PGIC (-0.70). The analysis of responsiveness was calculated with the unpaired t test showing a significant difference between the stable and improved patients (P < 0.01). The minimal detectable change was calculated as 0.64. The Japanese version of the PSFS is a valid, reliable, and responsive instrument to assess Japanese outpatients with neck pain.	[Nakamaru, Koji] Terashima Orthopaed Clin, Dept Rehabil Med, Nerima Ku, Tokyo 1780065, Japan; [Nakamaru, Koji; Nitta, Osamu] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Tokyo 158, Japan; [Aizawa, Junya] Tokyo Med & Dent Univ, Clin Ctr Sports Med & Sports Dent Sports Sci Org, Athlet Rehabil Sect, Tokyo, Japan; [Koyama, Takayuki] Nihon Univ, Dept Phys Educ, Tokyo, Japan	Nakamaru, K (reprint author), Terashima Orthopaed Clin, Dept Rehabil Med, Nerima Ku, 3-33-10 Nishiooizumi, Tokyo 1780065, Japan.	koji.nakamaru@nifty.com					Chatman AB, 1997, PHYS THER, V77, P820; Rosengren J, 2013, J HAND THER, V26, P53, DOI 10.1016/j.jht.2012.10.007; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Gross DP, 2008, ARCH PHYS MED REHAB, V89, P1294, DOI 10.1016/j.apmr.2007.11.040; Childs JD, 2008, J ORTHOP SPORT PHYS, V38, pA1, DOI 10.2519/jospt.2008.0303; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Wyrwich KW, 1999, J CLIN EPIDEMIOL, V52, P861, DOI 10.1016/S0895-4356(99)00071-2; Westaway MD, 1998, J ORTHOP SPORT PHYS, V27, P331; Cleland JA, 2006, SPINE, V31, P598, DOI 10.1097/01.brs.0000201241.90914.22; Young IA, 2009, PHYS THER, V89, P632, DOI 10.2522/ptj.20080283; Haldeman S, 2008, EUR SPINE J, V17, pS5, DOI 10.1007/s00586-008-0619-8; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Davidson M, 2002, PHYS THER, V82, P8; Fayers PM, 2007, QUALITY LIFE ASSESSM; Nakamaru K, 2012, SPINE, V32, pE1343; Ostelo RWJG, 2004, J CLIN EPIDEMIOL, V57, P268, DOI 10.1016/j.jclinepi.2003.09.005; Stratford P, 1995, PHYSIOTHER CAN, V47, P258; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	DEC	2015	24	12					2816	2820		10.1007/s00586-015-4236-z		5	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CX7IQ	WOS:000365875800015		
J	Kobayashi, R; Iizuka, H; Nishinome, M; Iizuka, Y; Yorifuji, H; Takagishi, K				Kobayashi, Ryoichi; Iizuka, Haku; Nishinome, Masahiro; Iizuka, Yoichi; Yorifuji, Hiroshi; Takagishi, Kenji			A cadaveric study of the cervical nerve roots and spinal segments	EUROPEAN SPINE JOURNAL			English	Article						Anatomy; Cervical nerve root; Spinal segment	INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; MICROSURGICAL ANATOMY; MOTOR; HYPERTROPHY; ROOTLETS	The purpose of this study was to anatomically measure the width of the cervical nerve root and spinal cord segment in addition to clarifying the anatomical characteristics of the cervical nerve root. We assessed 132 cervical nerve roots obtained from 11 cadavers. A total of 11 cervical spines from C3 to C8 were directly evaluated using digital calipers. The patients from whom the cadaveric specimens were obtained ranged from 79 to 90 years of age at the time of death. Four measurements were taken: the width at the entry of the spinal nerve in the vertebral foramen (WE), the maximum width of the spinal nerve (MW) and the length of the spinal segment on the ventral (LV) and dorsal rootlets (LD). The mean values of the WE from C3 to C8 were 5.5, 5.6, 6.0, 5.8, 4.8 and 4.3 mm, respectively. The value of C8 was significantly smaller than that of C3, C4, C5 and C6. The mean values of the MW from C3 to C8 were 5.6, 6.0, 6.4, 6.7, 6.3 and 6.0 mm, respectively. The mean values of the LV from C3 to C8 were 12.1, 12.5, 12.6, 12.7, 11.8 and 10.6 mm, respectively. The value of C8 was significantly narrower than that of C4, C5 and C6. The mean values of the LD from C3 to C8 were 12.1, 13.3, 13.6, 12.2, 11.0 and 10.6 mm, respectively. The value of C8 was significantly narrower than that of C4 and C5. We anatomically measured the width of cervical nerve roots and spinal segments. The spinal segment of C8 was significantly narrower than some of the roots located in the middle of the cervical spine, and this characteristic continued to the entry of the root in the vertebral foramen, although the difference disappeared at the maximum width point of the root.	[Kobayashi, Ryoichi; Iizuka, Haku; Nishinome, Masahiro; Iizuka, Yoichi; Takagishi, Kenji] Gunma Univ, Grad Sch Med, Dept Orthopaed Surg, Maebashi, Gumma 3718511, Japan; [Yorifuji, Hiroshi] Gunma Univ, Grad Sch Med, Dept Anat, Maebashi, Gunma 3718511, Japan	Iizuka, H (reprint author), Gunma Univ, Grad Sch Med, Dept Orthopaed Surg, 3-39-22 Showa, Maebashi, Gumma 3718511, Japan.	ihaku@gunma-u.ac.jp					Karatas A, 2005, ACTA NEUROCHIR, V147, P195, DOI 10.1007/s00701-004-0425-y; Tazawa KI, 2008, INTERNAL MED, V47, P2019, DOI 10.2169/internalmedicine.47.1272; KUBO Y, 1994, NEUROSURGERY, V34, P895; Heinemeyer O, 1999, ULTRASOUND MED BIOL, V25, P481, DOI 10.1016/S0301-5629(98)00187-2; Takeuchi M, 2014, SPINE, V39, pE944, DOI 10.1097/BRS.0000000000000407; SHINOMIYA K, 1994, SPINE, V19, P2501, DOI 10.1097/00007632-199411001-00002; Matsuoka N, 2004, J NEUROL SCI, V219, P15, DOI 10.1016/j.jns.2003.11.011; Chiba T, 2015, CLIN NEUROPHYSIOL, V126, P837, DOI 10.1016/j.clinph.2014.07.031	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	DEC	2015	24	12					2828	2831		10.1007/s00586-015-4070-3		4	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CX7IQ	WOS:000365875800017		
J	Ouchida, J; Yukawa, Y; Ito, K; Machino, M; Inoue, T; Tomita, K; Kato, F				Ouchida, Jun; Yukawa, Yasutsugu; Ito, Keigo; Machino, Masaaki; Inoue, Taro; Tomita, Keisuke; Kato, Fumihiko			Functional computed tomography scanning for evaluating fusion status after anterior cervical decompression fusion	EUROPEAN SPINE JOURNAL			English	Article						Anterior cervical fusion; Computed tomography; Functional CT scan; Pseudarthrosis; Radiographic assessment	PSEUDOARTHROSIS; DISKECTOMY; SPINE	Nonunion is a major complication of anterior cervical fusion that causes poor outcomes and occasionally requires additional operative intervention. The purpose of this study is to evaluate the accuracy of functional computed tomography (CT) scanning for determining fusion status after anterior cervical fusion by comparing with functional radiographs. The fusion status in 59 patients treated by anterior cervical fusion was assessed by functional radiography and functional CT scanning at 6 and 12 months after surgery. Fusion rates and clinical symptoms were evaluated. Fusion on functional radiography was defined as less than 2 mm of motion between adjacent spinous processes and a particular bony trabeculation on functional CT; fusion was defined as nonexistence of a clear zone or a gas pattern and a particular bone connection on reconstructed sagittal-view images. Functional radiographs demonstrated solid fusion in 83.9 % at 6 months and 91.1 % at 12 months postoperatively; functional CT showed solid fusion in 55.3 and 78.6 %, respectively. The fusion rate detected on functional CT images was significantly lower than that on functional radiographs at each period. At 6 months postoperatively, patients with incomplete union on functional CT were more likely to have neck pain than those who had complete union on functional CT. (46.2 vs 13.3 %, P < 0.05) Functional CT can detect nonunion more clearly than functional radiography. At 6 months postoperatively, patients with incomplete union on functional CT images were likely to have more neck pain. Functional CT may allow accurate detection of symptomatic nonunion after anterior cervical fusion.	[Ouchida, Jun; Yukawa, Yasutsugu; Ito, Keigo; Machino, Masaaki; Inoue, Taro; Tomita, Keisuke; Kato, Fumihiko] Japan Labor Hlth & Welf Org, Chubu Rosai Hosp, Dept Orthoped Surg, Minato Ku, Nagoya, Aichi 4558530, Japan	Ouchida, J (reprint author), Japan Labor Hlth & Welf Org, Chubu Rosai Hosp, Dept Orthoped Surg, Minato Ku, 1-10-6 Komei, Nagoya, Aichi 4558530, Japan.	orthochida@gmail.com					Ghiselli G, 2011, SPINE, V36, P463, DOI 10.1097/BRS.0b013e3181d7a81a; Watanabe S, 2012, EUR SPINE J, V21, P946, DOI 10.1007/s00586-011-2090-1; Yukawa Y, 2009, EUR SPINE J, V18, P911, DOI 10.1007/s00586-009-0949-1; Guo QF, 2011, EUR SPINE J, V20, P1539, DOI 10.1007/s00586-011-1735-4; Song KS, 2013, SPINE, V38, P2171, DOI 10.1097/BRS.0000000000000017; Fountas KN, 2007, SPINE, V32, P2310; Nakashima H, 2011, EUR SPINE J, V20, P1496, DOI 10.1007/s00586-011-1739-0; Fraser JF, 2007, J NEUROSURG-SPINE, V6, P298, DOI 10.3171/spi.2007.6.4.2; Epstein Nancy E, 2011, Surg Neurol Int, V2, P9, DOI 10.4103/2152-7806.76146; Phillips FM, 1997, SPINE, V22, P1585, DOI 10.1097/00007632-199707150-00012; Park DK, 2013, J SPINAL DISORD TECH, DOI [10.1097/BSD.0b013e31829a37ac, DOI 10.1097/BSD.OBO13E31829A37AC]	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	DEC	2015	24	12					2924	2929		10.1007/s00586-014-3722-z		6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CX7IQ	WOS:000365875800030		
J	Iizuka, H; Iizuka, Y; Mieda, T; Kobayashi, R; Nishinome, M; Ara, T; Sorimachi, Y; Nakajima, T; Takagishi, K				Iizuka, Haku; Iizuka, Yoichi; Mieda, Tokue; Kobayashi, Ryoichi; Nishinome, Masahiro; Ara, Tsuyoshi; Sorimachi, Yasunori; Nakajima, Takashi; Takagishi, Kenji			Retrospective review of 22 surgically treated adults with congenital anomalies of the upper cervical spine: a clinical and radiological review	EUROPEAN SPINE JOURNAL			English	Article						Upper cervical spine; Congenital anomaly; Clinical findings; Intramedullary high signal intensity	TRANSARTICULAR SCREW FIXATION; HIGH SIGNAL INTENSITY; RHEUMATOID-ARTHRITIS; OSSEOUS ANOMALIES; CRANIOVERTEBRAL JUNCTION; ATLANTOAXIAL SUBLUXATION; OS ODONTOIDEUM; MYELOPATHY; CLASSIFICATION; RELEVANCE	The purpose of this study was to clarify the characteristics of adult cases with instability due to upper cervical spine anomalies who needed fusion surgery regarding the clinical and radiological findings. Twenty-two consecutive patients with instability due to upper cervical spine anomaly in adult cases were reviewed. The congenital anomalies included idiopathic atlanto-axial subluxation in nine cases, os odontoideum in seven cases, occipitalization of the atlas in four cases, atlanto-occipital subluxation in one case and AAS with another anomaly in one case. We evaluated the severity of neurological symptoms before surgery and at the last follow-up. We also observed MR images before and 1 year after surgery. Before surgery, the 22 patients included seven Ranawat Grade I cases, ten Ranawat Grade II cases, and five Ranawat Grade IIIa cases. Regarding the neurological status after surgery, those included eighteen Ranawat Grade I cases, three Ranawat Grade II cases, and one Ranawat Grade IIIa case. Preoperative T2-weighted MR images demonstrated intramedullary high signal intensity (IHSI) in 12 cases. IHSI group did not include significantly more Ranawat Grade IIIa cases compared to the remaining 10 cases. In postoperative MR images (nine cases), the regression or disappearance of IHSI was demonstrated in only three cases. In adult cases with instability due to upper cervical spine anomalies, we acquired favorable clinical outcomes after surgery. Regarding the neurological severity before surgery, there was no relationship with the IHSI on T2-weighted MR image. Moreover, the regression or disappearance of IHSI after surgery was not frequently demonstrated.	[Iizuka, Haku; Iizuka, Yoichi; Mieda, Tokue; Kobayashi, Ryoichi; Nishinome, Masahiro; Ara, Tsuyoshi; Sorimachi, Yasunori; Nakajima, Takashi; Takagishi, Kenji] Gunma Univ, Dept Orthoped Surg, Grad Sch Med, Maebashi, Gumma 3718511, Japan	Iizuka, H (reprint author), Gunma Univ, Dept Orthoped Surg, Grad Sch Med, 3-39-22 Showa, Maebashi, Gumma 3718511, Japan.	ihaku@gunma-u.ac.jp					GROB D, 1991, J BONE JOINT SURG BR, V73, P972; Gholve PA, 2007, J BONE JOINT SURG AM, V89A, P571, DOI 10.2106/JBJS.F.00527; Yukawa Y, 2008, J NEUROSURG-SPINE, V8, P524, DOI 10.3171/SPI/2008/8/6/524; Nagaria J, 2009, SPINE, V34, P2880, DOI 10.1097/BRS.0b013e3181b4e218; HENSINGER RN, 1986, SPINE, V11, P323, DOI 10.1097/00007632-198605000-00006; Ding XJ, 2012, EUR SPINE J, V21, P1580, DOI 10.1007/s00586-012-2324-x; Goel A, 2004, SPINE, V29, pE520, DOI 10.1097/01.brs.0000144827.17054.35; Weng C, 2012, SPINE, V37, P1839, DOI 10.1097/BRS.0b013e3182578fd8; Cho YE, 2011, EUR SPINE J, V20, P2267, DOI 10.1007/s00586-011-1878-3; Kim IS, 2011, J CLIN NEUROSCI, V18, P481, DOI 10.1016/j.jocn.2010.07.114; RANAWAT CS, 1979, J BONE JOINT SURG AM, V61, P1003; Iizuka H, 2014, SPINE J, V14, P938, DOI 10.1016/j.spinee.2013.07.448; Iizuka H, 2013, EUR SPINE J, V22, P54, DOI 10.1007/s00586-012-2466-x; Guille JT, 2002, J BONE JOINT SURG AM, V84A, P277; FIELDING JW, 1980, J BONE JOINT SURG AM, V62, P376; ERBENGI A, 1994, ACTA NEUROCHIR, V127, P180, DOI 10.1007/BF01808763; GREENBER.AD, 1968, BRAIN, V91, P655, DOI 10.1093/brain/91.4.655; Magerl F., 1987, CERVICAL SPINE, V1, P322; Suri Ashish, 2003, Spine J, V3, P33, DOI 10.1016/S1529-9430(02)00448-5; YONE K, 1992, SPINE, V17, pS388, DOI 10.1097/00007632-199210001-00008	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	DEC	2015	24	12					2961	2966		10.1007/s00586-015-4207-4		6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CX7IQ	WOS:000365875800036		
J	Rachman, AN; Chung, TW; Yoshimoto, K; Yun, S				Rachman, Asep Nur; Chung, Tae Woong; Yoshimoto, Kazuo; Yun, Sukyoung			Direct simulation Monte Carlo method with a focal mechanism algorithm	EXPLORATION GEOPHYSICS			English	Article						direct simulation Monte Carlo (DSMC) method; focal mechanism; number of stations; receiver problem; seismic wave attenuation	SCATTERING SEISMIC ATTENUATION; S-WAVE; INTRINSIC ATTENUATION; SEISMOGRAM ENVELOPES; SOUTH-KOREA; SEPARATION; ENERGY; JAPAN; ABSORPTION; PENINSULA	To simulate the observation of the radiation pattern of an earthquake, the direct simulation Monte Carlo (DSMC) method is modified by implanting a focal mechanism algorithm. We compare the results of the modified DSMC method (DSMC-2) with those of the original DSMC method (DSMC-1). DSMC-2 shows more or similarly reliable results compared to those of DSMC-1, for events with 12 or more recorded stations, by weighting twice for hypocentral distance of less than 80km. Not only the number of stations, but also other factors such as rough topography, magnitude of event, and the analysis method influence the reliability of DSMC-2. The most reliable result by DSMC-2 is obtained by the best azimuthal coverage by the largest number of stations. The DSMC-2 method requires shorter time steps and a larger number of particles than those of DSMC-1 to capture a sufficient number of arrived particles in the small-sized receiver.	[Rachman, Asep Nur; Chung, Tae Woong] Sejong Univ, Dept Energy & Mineral Resources Engn, Seoul 143747, South Korea; [Yoshimoto, Kazuo] Yokohama City Univ, Grad Sch Nanobiosci, Dept Mat Syst Sci, Yokohama, Kanagawa 2360027, Japan; [Yun, Sukyoung] Korea Polar Res Inst, Inchon 406840, South Korea	Chung, TW (reprint author), Sejong Univ, Dept Energy & Mineral Resources Engn, Seoul 143747, South Korea.	chungtw@sejong.ac.kr			Center for Atmosphere Sciences and Earthquake Research (CATER) of Korea [CATER 2012-8010]	This research was supported by funds from CATER 2012-8010 provided by the Center for Atmosphere Sciences and Earthquake Research (CATER) of Korea.	Aki K., 1980, QUANTITATIVE SEISMOL; GELI L, 1988, B SEISMOL SOC AM, V78, P42; DAINTY AM, 1981, GEOPHYS RES LETT, V8, P1126, DOI 10.1029/GL008i011p01126; Bianco F, 2002, GEOPHYS J INT, V150, P10, DOI 10.1046/j.1365-246X.2002.01696.x; MITCHELL BJ, 1995, REV GEOPHYS, V33, P441, DOI 10.1029/95RG02074; Hoshiba M, 1997, PHYS EARTH PLANET IN, V104, P15, DOI 10.1016/S0031-9201(97)00055-1; Park JC, 2007, GEOPHYS J INT, V169, P1103, DOI 10.1111/j.1365-246X.2007.03321.x; Hong TK, 2012, TECTONOPHYSICS, V570, P102, DOI 10.1016/j.tecto.2012.08.034; Giampiccolo E, 2006, GEOPHYS J INT, V165, P211, DOI 10.1111/j.1365-246X.2006.02881.x; MITCHELL BJ, 1994, GEOPHYS J INT, V116, P468, DOI 10.1111/j.1365-246X.1994.tb01809.x; Rodgers AJ, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007707; Bianco F, 2005, GEOPHYS J INT, V161, P130, DOI 10.1111/j.1365-246X.2005.02555.x; SATO H, 1993, GEOPHYS J INT, V112, P141, DOI 10.1111/j.1365-246X.1993.tb01443.x; YOSHIMOTO K, 1993, GEOPHYS J INT, V114, P165, DOI 10.1111/j.1365-246X.1993.tb01476.x; Lee WS, 2010, B SEISMOL SOC AM, V100, P833, DOI 10.1785/0120090149; Chung TW, 2010, B SEISMOL SOC AM, V100, P3183, DOI 10.1785/0120100054; Yoshimoto K, 2000, J GEOPHYS RES-SOL EA, V105, P6153, DOI 10.1029/1999JB900437; Helffrich GR, 1997, GEOPHYS J INT, V131, P741, DOI 10.1111/j.1365-246X.1997.tb06609.x; FEHLER M, 1992, GEOPHYS J INT, V108, P787, DOI 10.1111/j.1365-246X.1992.tb03470.x; Asep N. R., 2014, B SEISMOLOGICAL SOC; Cerveny V., 1971, THEORY SEISMIC HEAD; Chung T. W., 2014, DISASTER ADV, V7, P7; Chung T. W., 2013, J KOREAN SOC EARTH E, V16, P293, DOI [10.7582/GGE.2013.16.4.293, DOI 10.7582/GGE.2013.16.4.293]; Feynman R. P., 1989, FEYNMAN LECT PHYS, V1; HOSHIBA M, 1991, PHYS EARTH PLANET IN, V67, P123, DOI 10.1016/0031-9201(91)90066-Q; Hoshiba M, 1991, PAP METEOROL GEOPHYS, V42, P65, DOI DOI 10.2467/MRIPAPERS.42.65; HOSHIBA M, 1993, J GEOPHYS RES-SOL EA, V98, P15809, DOI 10.1029/93JB00347; R Development Core Team, 2006, R LANGUAGE ENV STAT; Sato H, 2012, SEISMIC WAVE PROPAGA; Smith H., 1998, APPL REGRESSION ANAL; ZENG YH, 1991, J GEOPHYS RES-SOLID, V96, P607, DOI 10.1029/90JB02012	31	0	0	CSIRO PUBLISHING	CLAYTON	UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC 3168, AUSTRALIA	0812-3985	1834-7533		EXPLOR GEOPHYS	Explor. Geophys.	DEC	2015	46	4					371	380		10.1071/EG14116		10	Geochemistry & Geophysics	Geochemistry & Geophysics	CX4SL	WOS:000365690500007		
J	Speed, JS; Heimlich, JB; Hyndman, KA; Fox, BM; Patel, V; Yanagisawa, M; Pollock, JS; Titze, JM; Pollock, DM				Speed, Joshua S.; Heimlich, J. Brett; Hyndman, Kelly A.; Fox, Brandon M.; Patel, Vivek; Yanagisawa, Masashi; Pollock, Jennifer S.; Titze, Jens M.; Pollock, David M.			Endothelin-1 as a master regulator of whole-body Na+ homeostasis	FASEB JOURNAL			English	Article						skin; endothelium; vascular; inflammation	BLOOD-PRESSURE; MEDULLARY OSMOLALITY; HIGH-SALT; HYPERTENSION; SODIUM; EXPRESSION; INCREASES; RATS; PHYSIOLOGY; RECEPTOR	The current study was designed to determine whether vascular endothelial-derived endothelin-1 (ET-1) is important for skin Na+ buffering. In control mice (C57BL/6J), plasma Na+ and osmolarity were significantly elevated in animals on high-vs. low-salt (HS and LS, respectively) intake. The increased plasma Na+ and osmolarity were associated with increased ET-1 mRNA in vascular tissue. There was no detectable difference in skin Na+: H2O in HS fed mice (0.119 +/- 0.005 mM vs. 0.127 +/- 0.007 mM; LS vs. HS); however, skin Na+: H2O was significantly increased by blockade of the endothelin type A receptor with ABT-627 (0.116 +/- 0.006 mM vs. 0.137 +/- 0.007 mM; LS vs. HS; half-maximal inhibitory concentration, 0.055 nM). ET-1 peptide content in skin tissue was increasedinfloxed control animalsonHS(85.9 +/- 0.9 pg/mg vs. 106.4 +/- 6.8 pg/mg; P < 0.05), but not in vascular endothelial cell endothelin-1 knockout (VEET KO) mice (76.46 5.7 pg/mgvs. 65.7 +/- 7.9 pg/mg; LS vs. HS). VEET KO mice also had a significantly elevated skin Na+: H2O (0.113 +/- 0.007 mM vs. 0.137 +/- 0.005 mM; LS vs. HS; P < 0.05). Finally, ET-1 production was elevated in response to increasing extracellular osmolarity in cultured human endothelial cells. These data support the hypothesis that increased extrarenal vascular ET-1 production in response to HS intake is mediated by increased extracellular osmolarity and plays a critical role in regulating skin storage of Na+.	[Speed, Joshua S.; Hyndman, Kelly A.; Fox, Brandon M.; Patel, Vivek; Pollock, Jennifer S.; Pollock, David M.] Univ Alabama Birmingham, Div Nephrol, Dept Med, Cardiorenal Physiol & Med, Birmingham, AL 35233 USA; [Heimlich, J. Brett] Georgia Regents Univ, Dept Physiol, Augusta, GA USA; [Yanagisawa, Masashi] Univ Tsukuba, Ctr Behav Mol Genet, Tsukuba, Ibaraki, Japan; [Titze, Jens M.] Vanderbilt Univ, Dept Med, Nashville, TN USA	Pollock, DM (reprint author), Univ Alabama Birmingham, Div Nephrol, Dept Med, Cardiorenal Physiol & Med, Birmingham, AL 35233 USA.	dpollock@uab.edu			American Heart Association; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [T32 DK079337]; NIH National Heart, Lung, and Blood Institute [HL69999, HL95499]	ABT-627 was provided as a gift from AbbVie Inc. (North Chicago, IL, USA). This work was financially supported by a fellowship from the American Heart Association (to J.S.S.), an institutional training grant from U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK079337 to J.S.S.), and program project grants from the NIH National Heart, Lung, and Blood Institute (HL69999 and HL95499 to D.M.P. and J.S.P., respectively).	Kopp C, 2013, HYPERTENSION, V61, P635, DOI 10.1161/HYPERTENSIONAHA.111.00566; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Titze J, 2002, AM J PHYSIOL-RENAL, V283, pF134, DOI 10.1152/ajprenal.00323.2001; Suckling RJ, 2012, KIDNEY INT, V81, P407, DOI 10.1038/ki.2011.369; Herrera M, 2005, AM J PHYSIOL-RENAL, V288, pF58, DOI 10.1152/ajprenal.00209.2004; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Kisanuki YY, 2010, HYPERTENSION, V56, P121, DOI 10.1161/HYPERTENSIONAHA.109.138701; KOHAN DE, 1993, J CLIN INVEST, V91, P1235, DOI 10.1172/JCI116286; Cannon WB, 1929, PHYSIOL REV, V9, P399; Boesen EI, 2007, AM J PHYSIOL-RENAL, V292, pF185, DOI 10.1152/ajprenal.00021.2006; Kohan DE, 2011, PHYSIOL REV, V91, P1, DOI 10.1152/physrev.00060.2009; Tsai YH, 2006, EXP BIOL MED, V231, P813; Kohan DE, 2011, COMPR PHYSIOL, V1, P883, DOI 10.1002/cphy.c100039; Pollock DM, 2001, AM J PHYSIOL-RENAL, V281, pF144; Titze J, 2003, AM J PHYSIOL-RENAL, V285, pF1108, DOI 10.1152/ajprenal.00200.2003; Saleh MA, 2010, HYPERTENSION, V56, P942, DOI 10.1161/HYPERTENSIONAHA.110.156570; Titze J, 2010, CURR OPIN NEPHROL HY, V19, P385, DOI 10.1097/MNH.0b013e32833aeb3b; Sasser JM, 2002, AM J PHYSIOL-REG I, V283, pR243, DOI 10.1152/ajpregu.00086.2002; Titze J, 2009, SEMIN DIALYSIS, V22, P253, DOI 10.1111/j.1525-139X.2009.00569.x; Wiig H, 2013, J CLIN INVEST, V123, P2803, DOI 10.1172/JCI60113; Winn M, 1996, J MED CHEM, V39, P1039, DOI 10.1021/jm9505369; Machnik A, 2010, HYPERTENSION, V55, P755, DOI 10.1161/HYPERTENSIONAHA.109.143339; Hall JE, 2012, COMPR PHYSIOL, V2, P2393, DOI 10.1002/cphy.c110058; Dahlmann A, 2015, KIDNEY INT, V87, P434, DOI 10.1038/ki.2014.269; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Stuart D, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-166	26	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4937	4944		10.1096/fj.15-276584		8	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	WOS:000365523600019		
J	Gan, LN; Lei, S; Yu, J; Ma, HT; Yamamoto, Y; Suzuki, Y; Xu, GW; Zhang, ZG				Gan, Lina; Lei, Shan; Yu, Jian; Ma, Hongtao; Yamamoto, Yo; Suzuki, Yoshizo; Xu, Guangwen; Zhang, Zhanguo			Development of highly active coated monolith SCR catalyst with strong abrasion resistance for low-temperature application	FRONTIERS OF ENVIRONMENTAL SCIENCE & ENGINEERING			English	Article						coated monolith; low-temperature denitration; abrasion resistance; attrition	NO; NH3; REDUCTION	Monolith SCR catalysts coated with V2O5-WO3/TiO2 were prepared by varying binder and coating thickness. Comparing with a monolith extruded with 100% V2O5-WO3/TiO2 powder, a coated monolith with a catalyst-coating layer of 260 A mu m in thickness exhibited the similar initial NO (x) reduction activity at 250A degrees C. After 4 h abrasion (attrition) in an air stream containing 300 g center dot m(-3) fine sands (50-100 A mu m) at a superficial gas velocity of 10 m center dot s(-1), the catalyst still has the activity as a 100% molded monolith does in a 24-h activity test and it retains about 92% of its initial activity at 250A degrees C. Estimation of the equivalent durable hours at a fly ash concentration of 1.0 g center dot m(-3) in flue gas and a gas velocity of 5 m center dot s(-1) demonstrated that this coated monolith catalyst is capable of resisting abrasion for 13 months without losing more than 8% of its initial activity. The result suggests the great potential of the coated monolith for application to de-NO (x) of flue gases with low fly ash concentrations from, such as glass and ceramics manufacturing processes.	[Gan, Lina; Lei, Shan; Yu, Jian; Xu, Guangwen] Chinese Acad Sci, Inst Proc Engn, State Key Lab Multiphase Complex Syst, Beijing 100190, Peoples R China; [Gan, Lina] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Ma, Hongtao; Yamamoto, Yo] Meidensha Corp, Res & Dev Grp, Mat Res Labs, Mat Res Dept,Shinagawa Ku, Tokyo 1418565, Japan; [Suzuki, Yoshizo; Zhang, Zhanguo] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058569, Japan	Xu, GW (reprint author), Chinese Acad Sci, Inst Proc Engn, State Key Lab Multiphase Complex Syst, Beijing 100190, Peoples R China.	gwxu@ipe.ac.cn; z.zhang@aist.go.jp			International Science and Technology Cooperation Program of China [2013DFA51530]; National High Technology Research and Development Program of China [2010AA065004]; Strategic Priority Research Program of Chinese Academy of Sciences [XDA07030300]	The work was financially supported by the International Science and Technology Cooperation Program of China (2013DFA51530), National High Technology Research and Development Program of China (Grant No. 2010AA065004), and Strategic Priority Research Program of the Chinese Academy of Sciences (XDA07030300).	Yang J, 2013, CHEM ENG J, V230, P513, DOI 10.1016/j.cej.2013.06.114; Willi R, 1996, CHEM ENG SCI, V51, P2897, DOI 10.1016/0009-2509(96)00171-6; Garcia-Bordeje E, 2004, IND ENG CHEM RES, V43, P4073, DOI 10.1021/ie0498854; Lei ZG, 2011, ENVIRON SCI TECHNOL, V45, P3437, DOI 10.1021/es104156j; Chen L, 2009, J PHYS CHEM C, V113, P21177, DOI 10.1021/jp907109c; Yu J, 2010, APPL CATAL B-ENVIRON, V95, P160, DOI 10.1016/j.apcatb.2009.12.023; Zamaro JM, 2005, CATAL TODAY, V107-08, P86, DOI 10.1016/j.cattod.2005.07.066; Li JH, 2013, FRONT ENV SCI ENG, V7, P302, DOI 10.1007/s11783-013-0511-6; Su JH, 2008, IND ENG CHEM RES, V47, P4295, DOI 10.1021/ie800105p; Phil HH, 2008, APPL CATAL B-ENVIRON, V78, P301, DOI 10.1016/j.apcatb.2007.09.012; Matsumoto S, 1996, CATAL TODAY, V29, P43, DOI 10.1016/0920-5861(95)00259-6; Forzatti P, 2001, APPL CATAL A-GEN, V222, P221, DOI 10.1016/S0926-860X(01)00832-8; Liu ZM, 2006, CATAL REV, V48, P43, DOI 10.1080/01614940500439891; Krocher O, 2008, APPL CATAL B-ENVIRON, V77, P215, DOI 10.1016/j.apcatb.2007.04.021; General Administration of Quality Supervision Inspection and Quarantine of the People's Republic of China Standardization Administration of the People's Republic of China, 2007, GB T 17954 2007 EC O; Hao Jiming, 2007, Frontiers of Environmental Science and Engineering in China, V1, DOI 10.1007/s11783-007-0024-2; Klovsky J R, 1980, IND ENG CHEM PROD RD, V19, P218, DOI 10.1021/i360074a018; Moon L S, 2012, CHEM ENG SCI, V79, P177; Yamamoto S, 2013, International Patent, Patent No. [WO2013125137 (A1), 2013125137A1]; Yu J, 2010, China Patent, Patent No. [CN201010537130. 0, 2010105371300, 201010537130.0]; Yu J, 2011, China Patent, Patent No. [CN201210167211. 5, 2012101672115]	21	0	0	HIGHER EDUCATION PRESS	BEIJING	NO 4 DEWAI DAJIE, BEIJING 100120, PEOPLES R CHINA	2095-2201	2095-221X		FRONT ENV SCI ENG	Front. Env. Sci. Eng.	DEC	2015	9	6					979	987		10.1007/s11783-015-0824-8		9	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CW9HI	WOS:000365309400004		
J	Zhang, Q; Duan, FK; He, KB; Ma, YL; Li, HY; Kimoto, T; Zheng, AH				Zhang, Qian; Duan, Fengkui; He, Kebin; Ma, Yongliang; Li, Haiyan; Kimoto, Takashi; Zheng, Aihua			Organic nitrogen in PM2.5 in Beijing	FRONTIERS OF ENVIRONMENTAL SCIENCE & ENGINEERING			English	Article						organic nitrogen; N:C ratio; secondary; day and night variation; relative humidity (RH); acidity	MULTIPHASE CHEMISTRY; MASS-SPECTROMETRY; ALKYL NITRATES; CHINA; AEROSOLS; DEPOSITION; PARTICLES; SECONDARY; GLYOXAL; SPECIATION	Nitrogenous species, as important chemical components in PM2.5, include organic nitrogen (ON) and inorganic nitrogen (IN), both of which have potential effects on human health, climate change and visibility degradation. In this study, we analyzed total nitrogen (TN) by CHN Elemental analyzer and inorganic nitrogen by ion chromatography (IC) respectively to obtain ON by calculating the difference between TN and IN. The results show that the mean ON concentrations in winter and summer are both 2.86 mu g center dot m(-3), ten times higher than other places reported on average. ON contributes about 20%-30% to TN on average in both seasons, presenting higher contribution in summer. N:C ratios are much higher in summer than winter. ON sources or formation were strengthened by heavy PM2.5 pollution loads, especially sensitive to sulfate. ON concentrations are higher at night in the both seasons, however with distinguished day and night difference patterns influenced by relative humidity (RH) conditions. In winter, ON concentrations increase with RH on average through low RH values to high RH values. The variations are far larger than the ones caused by day and night difference. However in summer, day and night difference dominates the variations of ON concentrations at low RH values, and RH conditions promote ON concentrations increase significantly only at high RH values. Dust related source and anthropogenic emission related secondary source are identified as important sources for ON. At heavy pollution loads, ON sources are more of secondary formation, possibly strengthened by combination influence of RH and acidity increase.	[Zhang, Qian; Duan, Fengkui; He, Kebin; Ma, Yongliang; Li, Haiyan] Tsinghua Univ, State Key Joint Lab Environm Simulat & Pollut Con, Sch Environm, Beijing 100084, Peoples R China; [Zhang, Qian; Duan, Fengkui; He, Kebin; Ma, Yongliang; Li, Haiyan] Tsinghua Univ, State Environm Protect Key Lab Sources & Control, Beijing 100084, Peoples R China; [Kimoto, Takashi] Kimoto Elect Co Ltd, Tennouji Ku, Osaka 5430024, Japan; [Zheng, Aihua] Beijing Normal Univ, Anal & Testing Ctr, Beijing 100875, Peoples R China	Duan, FK (reprint author), Tsinghua Univ, State Key Joint Lab Environm Simulat & Pollut Con, Sch Environm, Beijing 100084, Peoples R China.	duanfk@tsinghua.edu.cn; hekb@tsinghua.edu.cn			National Science and Technology Support Program of China [2014BAC22B01]; National Natural Science Foundation of China [21107061, 21190054]; Fund of Japan International Cooperation Agency (JICA)	This work was supported by the National Science and Technology Support Program of China (No. 2014BAC22B01), the National Natural Science Foundation of China (Grant Nos. 21107061 and 21190054), and the Fund of Japan International Cooperation Agency (JICA). Authors also thank to Energy Saving and Pollution control Association of East Asia (ESPA), for their helps to the management of the field observation program.	Aiken AC, 2008, ENVIRON SCI TECHNOL, V42, P4478, DOI 10.1021/es703009q; Cape JN, 2011, ATMOS RES, V102, P30, DOI 10.1016/j.atmosres.2011.07.009; Miyazaki Y, 2014, J GEOPHYS RES-ATMOS, V119, P1440, DOI 10.1002/2013JD020713; Ervens B, 2010, ATMOS CHEM PHYS, V10, P8219, DOI 10.5194/acp-10-8219-2010; Nakamura T, 2006, ATMOS ENVIRON, V40, P7259, DOI 10.1016/j.atmosenv.2006.06.026; Neff JC, 2002, BIOGEOCHEMISTRY, V57, P99, DOI 10.1023/A:1015791622742; Zhang Q, 2003, ENVIRON SCI TECHNOL, V37, P3522, DOI 10.1021/es034114x; Rollins AW, 2012, SCIENCE, V337, P1210, DOI 10.1126/science.1221520; Kanakidou M, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004277; Ozel MZ, 2011, ENVIRON SCI TECHNOL, V45, P1497, DOI 10.1021/es102528g; Yang F, 2011, ATMOS CHEM PHYS, V11, P5207, DOI 10.5194/acp-11-5207-2011; De Haan DO, 2009, ENVIRON SCI TECHNOL, V43, P2818, DOI 10.1021/es803534f; Sun YL, 2013, ATMOS ENVIRON, V77, P927, DOI 10.1016/j.atmosenv.2013.06.019; Zhang Q, 2001, ATMOS ENVIRON, V35, P5629, DOI 10.1016/S1352-2310(01)00337-5; Rastogi N, 2011, ATMOS ENVIRON, V45, P6040, DOI 10.1016/j.atmosenv.2011.07.045; Wang XF, 2010, ENVIRON SCI TECHNOL, V44, P4441, DOI 10.1021/es1001117; Seitzinger SP, 1999, LIMNOL OCEANOGR, V44, P721; Ge XL, 2011, ATMOS ENVIRON, V45, P524, DOI 10.1016/j.atmosenv.2010.10.012; He KB, 2001, ATMOS ENVIRON, V35, P4959, DOI 10.1016/S1352-2310(01)00301-6; Bruns EA, 2010, ENVIRON SCI TECHNOL, V44, P1056, DOI 10.1021/es9029864; Duan FK, 2009, B ENVIRON CONTAM TOX, V82, P332, DOI 10.1007/s00128-008-9560-0; Cheng Y, 2014, SCI TOTAL ENVIRON, V468, P1103, DOI 10.1016/j.scitotenv.2013.08.084; Day DA, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000779; Zhang Y, 2008, ATMOS ENVIRON, V42, P1035, DOI 10.1016/j.atmosenv.2007.12.015; Lim YB, 2009, PHYS CHEM CHEM PHYS, V11, P8029, DOI 10.1039/b904333k; Cornell SE, 2011, ENVIRON POLLUT, V159, P2214, DOI 10.1016/j.envpol.2010.11.014; Day DA, 2003, J GEOPHYS RES, V108; Day DA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003685; Day DA, 2002, J GEOPHYS RES, V107; Fry JL, 2013, ATMOS CHEM PHYS, V13, P8585, DOI 10.5194/acp-13-8585-2013; Galloway MM, 2009, ATMOS CHEM PHYS, V9, P3331; Jickells T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0115; Miyazaki Y, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042483; Qiu C, 2013, PHYS CHEM CHEM PHYS, V15, P5738, DOI 10.1039/c3cp43446j; Rollins A W, 2010, THESIS; Russell KM, 2003, J GEOPHYS RES-ATMOS, V108; Russell KM, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003736; Shi JH, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013238; Walsh MP, 2014, FRONT ENV SCI ENG, V8, P1, DOI 10.1007/s11783-014-0634-4	39	0	0	HIGHER EDUCATION PRESS	BEIJING	NO 4 DEWAI DAJIE, BEIJING 100120, PEOPLES R CHINA	2095-2201	2095-221X		FRONT ENV SCI ENG	Front. Env. Sci. Eng.	DEC	2015	9	6					1004	1014		10.1007/s11783-015-0799-5		11	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CW9HI	WOS:000365309400007		
J	Ohashi, S; Miyamoto, S; Kikuchi, O; Goto, T; Amanuma, Y; Muto, M				Ohashi, Shinya; Miyamoto, Shin'ichi; Kikuchi, Osamu; Goto, Tomoyuki; Amanuma, Yusuke; Muto, Manabu			Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma	GASTROENTEROLOGY			English	Article						Acetaldehyde; Aldehyde Dehydrogenase 2; Genetic Polymorphism; Field Cancerization; Squamous Differentiation	GROWTH-FACTOR RECEPTOR; PHASE-III TRIAL; ENDOSCOPIC MUCOSAL RESECTION; CISPLATIN PLUS FLUOROURACIL; RANDOMIZED CONTROLLED-TRIAL; TO-MESENCHYMAL TRANSITION; UPPER AERODIGESTIVE TRACT; ZEB TRANSCRIPTION FACTORS; DEFINITIVE CHEMORADIOTHERAPY; ONCOLOGY-GROUP	Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive squamous cell carcinomas and is highly prevalent in Asia. Alcohol and its metabolite, acetaldehyde, are considered definite carcinogens for the esophagus. Polymorphisms in the aldehyde dehydrogenase 2 gene, which encodes an enzyme that eliminates acetaldehyde, have been associated with esophageal carcinogenesis. Studies of the mutagenic and carcinogenic effects of acetaldehyde support this observation. Several recent largescale comprehensive analyses of the genomic alterations in ESCC have shown a high frequency of mutations in genes such as TP53 and others that regulate the cell cycle or cell differentiation. Moreover, whole genome and whole exome sequencing studies have frequently detected somatic mutations, such as G:C -> A:T transitions or G:C -> C:G transversions, in ESCC tissues. Genomic instability, caused by abnormalities in the Fanconi anemia DNA repair pathway, is also considered a pathogenic mechanism of ESCC. Advances in diagnostic techniques such as magnifying endoscopy with narrow band imaging or positron emission tomography have increased the accuracy of diagnosis of ESCC. Updated guidelines from the National Comprehensive Cancer Network standardize the practice for the diagnosis and treatment of esophageal cancer. Patients with ESCC are treated endoscopically or with surgery, chemotherapy, or radiotherapy, based on tumor stage. Minimally invasive treatments help improve the quality of life of patients who undergo such treatments. We review recent developments in the diagnosis and treatment of ESCC and advances gained from basic and clinical research.	[Ohashi, Shinya; Amanuma, Yusuke; Muto, Manabu] Kyoto Univ, Grad Sch Med, Dept Therapeut Oncol, Kyoto 6068507, Japan; [Miyamoto, Shin'ichi; Kikuchi, Osamu; Goto, Tomoyuki] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto 6068507, Japan; [Ohashi, Shinya; Amanuma, Yusuke; Muto, Manabu] Kyoto Univ Hosp, Ctr Canc, Dept Clin Oncol, Kyoto 606, Japan	Muto, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Therapeut Oncol, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	mmuto@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [25460926]	Supported by Grant-in-Aid for Scientific Research (Japan Society for the Promotion of Science KAKENHI grant 25460926 to S.O.).	Adams Allie K, 2014, Cancers (Basel), V6, P1793, DOI 10.3390/cancers6031793; Ohtsu A, 1999, J CLIN ONCOL, V17, P2915; Bedenne L, 2007, J CLIN ONCOL, V25, P1160, DOI 10.1200/JCO.2005.04.7118; Swisher SG, 2002, J THORAC CARDIOV SUR, V123, P175, DOI 10.1067/mtc.2002.119070; Matsuo K, 2001, CARCINOGENESIS, V22, P913, DOI 10.1093/carcin/22.6.913; Ohashi S, 2010, CANCER RES, V70, P4174, DOI 10.1158/0008-5472.CAN-09-4614; Petrick JL, 2014, BRIT J CANCER, V110, P2369, DOI 10.1038/bjc.2014.96; Minsky BD, 2002, J CLIN ONCOL, V20, P1167, DOI 10.1200/JCO.20.5.1167; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Grugan KD, 2010, P NATL ACAD SCI USA, V107, P11026, DOI 10.1073/pnas.0914295107; Hong Y, 2005, CANCER RES, V65, P9582, DOI 10.1158/0008-5472.CAN-05-1460; Choi J, 2010, SURG ENDOSC, V24, P1380, DOI 10.1007/s00464-009-0783-x; Misra S, 2012, SURG ENDOSC, V26, P518, DOI 10.1007/s00464-011-1911-y; Kuszyk BS, 1996, AM J ROENTGENOL, V166, P91; van Vliet EPM, 2008, BRIT J CANCER, V98, P547, DOI 10.1038/sj.bjc.6604200; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; Seitz HK, 2006, BIOL CHEM, V387, P349, DOI 10.1515/BC.2006.047; van Lieshout EMM, 1999, CANCER RES, V59, P586; Smithers BM, 2007, DIS ESOPHAGUS, V20, P471, DOI 10.1111/j.1442-2050.2007.00701.x; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Wouters MWJM, 2012, CANCER-AM CANCER SOC, V118, P1754, DOI 10.1002/cncr.26383; Muto M, 2005, CARCINOGENESIS, V26, P1008, DOI 10.1093/carcin/bgi035; BLAZEBY JM, 1995, GUT, V37, P505, DOI 10.1136/gut.37.4.505; Akbari MR, 2008, ONCOGENE, V27, P1290, DOI 10.1038/sj.onc.1210739; Downey RJ, 2003, J CLIN ONCOL, V21, P428, DOI 10.1200/JCO.2003.04.013; Biere SSAY, 2012, LANCET, V379, P1887, DOI 10.1016/S0140-6736(12)60516-9; Thosani N, 2012, GASTROINTEST ENDOSC, V75, P242, DOI 10.1016/j.gie.2011.09.016; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; CASPERS RJL, 1988, RADIOTHER ONCOL, V12, P15, DOI 10.1016/0167-8140(88)90188-0; Muto M, 2002, CARCINOGENESIS, V23, P1759, DOI 10.1093/carcin/23.10.1759; FERON VJ, 1982, EUR J CANCER CLIN ON, V18, P13, DOI 10.1016/0277-5379(82)90020-7; Schiller W, 1933, SURG GYNECOL OBSTET, V56, P210; Shin JH, 2004, RADIOLOGY, V232, P252, DOI 10.1148/radiol.2321030733; Ishiguro S, 2009, CANCER LETT, V275, P240, DOI 10.1016/j.canlet.2008.10.020; Stahl M, 2005, J CLIN ONCOL, V23, P2310, DOI 10.1200/JCO.2005.00.034; Bosset JF, 1997, NEW ENGL J MED, V337, P161, DOI 10.1056/NEJM199707173370304; Ye T, 2013, ANN THORAC SURG, V96, P1933, DOI 10.1016/j.athoracsur.2013.06.050; MORI M, 1993, AM J GASTROENTEROL, V88, P701; Hardefeldt HA, 2014, EPIDEMIOL INFECT, V142, P1119, DOI 10.1017/S0950268814000016; van Westreenen HL, 2004, J CLIN ONCOL, V22, P3805, DOI 10.1200/JCO.2004.01.083; Zhang L, 2015, AM J HUM GENET, V96, P597, DOI 10.1016/j.ajhg.2015.02.017; Henderson S, 2014, CELL REP, V7, P1833, DOI 10.1016/j.celrep.2014.05.012; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Ninomiya I, 2014, WORLD J SURG, V38, P120, DOI 10.1007/s00268-013-2238-8; Hingorani M, 2011, CLIN ONCOL-UK, V23, P696, DOI 10.1016/j.clon.2011.05.005; Nozoe T, 2006, ONCOLOGY-BASEL, V71, P402, DOI 10.1159/000108611; Kurokawa Y, 2009, JPN J CLIN ONCOL, V39, P686, DOI 10.1093/jjco/hyp078; Salaspuro MP, 2003, CRIT REV CL LAB SCI, V40, P183, DOI 10.1080/713609333; Dutton SJ, 2014, LANCET ONCOL, V15, P894, DOI 10.1016/S1470-2045(14)70024-5; Li Y, 2014, GASTROENTEROLOGY, V146, P1701, DOI 10.1053/j.gastro.2014.02.029; Nakamura K, 2013, JPN J CLIN ONCOL, V43, P752, DOI 10.1093/jjco/hyt061; Muto M, 2002, GASTROINTEST ENDOSC, V56, P517, DOI 10.1067/mge.2002.128104; Muto M, 2010, J CLIN ONCOL, V28, P1566, DOI 10.1200/JCO.2009.25.4680; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Wu MT, 2002, BRIT J CANCER, V87, P529, DOI 10.1038/sj.bjc.6600499; Upton DC, 2006, CHEM RES TOXICOL, V19, P960, DOI 10.1021/tx060084a; Moaven O, 2010, CANCER EPIDEMIOL, V34, P285, DOI 10.1016/j.canep.2010.03.009; WOUTERSEN RA, 1986, TOXICOLOGY, V41, P213, DOI 10.1016/0300-483X(86)90201-5; Noori P, 2001, CARCINOGENESIS, V22, P1825, DOI 10.1093/carcin/22.11.1825; HELANDER A, 1991, MUTAT RES, V264, P103, DOI 10.1016/0165-7992(91)90124-M; Salaspuro VJ, 2006, CANCER EPIDEM BIOMAR, V15, P146, DOI 10.1158/1055-9965.EPI-05-0248; Natsuizaka M, 2010, CARCINOGENESIS, V31, P1344, DOI 10.1093/carcin/bgq108; Wu C, 2014, NAT GENET, V46, P1001, DOI 10.1038/ng.3064; Griffiths EA, 2012, SURG ENDOSC, V26, P2367, DOI 10.1007/s00464-012-2192-9; Ahrens TD, 2014, CELL TISSUE RES, V356, P643, DOI 10.1007/s00441-014-1876-y; Hiyama T, 2007, INT J CANCER, V121, P1643, DOI 10.1002/ijc.23044; GOEDDE HW, 1992, HUM GENET, V88, P344; Okawa T, 2007, GENE DEV, V21, P2788, DOI 10.1101/gad.1544507; SINGH NP, 1995, MUTAT RES-DNA REPAIR, V337, P9, DOI 10.1016/0921-8777(95)00006-6; Kodama M, 1998, SURGERY, V123, P432, DOI 10.1016/S0039-6060(98)70165-5; Nagpal K, 2010, SURG ENDOSC, V24, P1621, DOI 10.1007/s00464-009-0822-7; Ishikura S, 2003, J CLIN ONCOL, V21, P2697, DOI 10.1200/JCO.2003.03.055; Homann N, 1997, CARCINOGENESIS, V18, P1739, DOI 10.1093/carcin/18.9.1739; Yang CX, 2005, WORLD J GASTROENTERO, V11, P2531; Kataoka K, 2015, JPN J CLIN ONCOL, V45, P494, DOI 10.1093/jjco/hyv012; AJANI JA, 1994, J NATL CANCER I, V86, P1086, DOI 10.1093/jnci/86.14.1086; Theruvathu JA, 2005, NUCLEIC ACIDS RES, V33, P3513, DOI 10.1093/nar/gki661; Zhang WC, 2014, ANN THORAC SURG, V98, P513, DOI 10.1016/j.athoracsur.2014.03.015; Hara H, 2013, CANCER SCI, V104, P1455, DOI 10.1111/cas.12274; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; Pickens A, 2003, ANN THORAC SURG, V76, pS1367, DOI 10.1016/S0003-4975(03)01202-5; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Launoy G, 1998, INT J CANCER, V76, P7, DOI 10.1002/(SICI)1097-0215(19980330)76:1<7::AID-IJC2>3.0.CO;2-4; PICUS D, 1983, RADIOLOGY, V146, P433; Muto M, 2009, J GASTROEN HEPATOL, V24, P1333, DOI 10.1111/j.1440-1746.2009.05925.x; Ohashi S, 2011, CANCER RES, V71, P6836, DOI 10.1158/0008-5472.CAN-11-0846; Kato K, 2011, INT J RADIAT ONCOL, V81, P684, DOI 10.1016/j.ijrobp.2010.06.033; Bhatt A, 2015, AM J GASTROENTEROL, V110, P784, DOI 10.1038/ajg.2014.425; Muro K, 2004, ANN ONCOL, V15, P955, DOI 10.1093/annonc/mdh231; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; MARGER RS, 1993, CANCER, V72, P17, DOI 10.1002/1097-0142(19930701)72:1<17::AID-CNCR2820720105>3.0.CO;2-2; Merkow RP, 2012, ANN SURG ONCOL, V19, P357, DOI 10.1245/s10434-011-1945-3; Yang X, 2015, GENE, V556, P149, DOI 10.1016/j.gene.2014.11.049; Crosby T, 2013, LANCET ONCOL, V14, P627, DOI 10.1016/S1470-2045(13)70136-0; Shimizu Y, 2008, J GASTROEN HEPATOL, V23, P546, DOI 10.1111/j.1440-1746.2007.04990.x; Paget V, 2008, MUTAT RES-GEN TOX EN, V652, P12, DOI 10.1016/j.mrgentox.2007.11.010; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; HOFFMANN D, 1985, CANCER RES, V45, P935; Inoue H, 2015, ANN GASTROENTEROL, V28, P41; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Ishihara R, 2010, INT J RADIAT ONCOL, V76, P123, DOI 10.1016/j.ijrobp.2009.01.038; Ishida K, 2004, JPN J CLIN ONCOL, V34, P615, DOI 10.1093/jjco/hyh107; Levine MS, 1997, AM J ROENTGENOL, V168, P1423; Blaydon DC, 2012, AM J HUM GENET, V90, P340, DOI 10.1016/j.ajhg.2011.12.008; Uebelacker M, 2011, J AUTOM METHOD MANAG, DOI 10.1155/2011/907317; Bosetti C, 2008, INT J CANCER, V122, P1118, DOI 10.1002/ijc.23232; AlSarraf M, 1997, J CLIN ONCOL, V15, P277; Michaylira CZ, 2010, CANCER RES, V70, P5281, DOI 10.1158/0008-5472.CAN-10-0704; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Yano T, 2005, GASTROINTEST ENDOSC, V62, P31, DOI 10.1016/S0016-5107(05)00545-6; Long A, 2015, CARCINOGENESIS, V36, P598, DOI 10.1093/carcin/bgv025; Wei WQ, 2015, J CLIN ONCOL, V33, P1951, DOI 10.1200/JCO.2014.58.0423; Muto M, 2000, INT J CANCER, V88, P342, DOI 10.1002/1097-0215(20001101)88:3<342::AID-IJC4>3.3.CO;2-9; Saranovic D, 2005, DIS ESOPHAGUS, V18, P230, DOI 10.1111/j.1442-2050.2005.00484.x; TAKASHIMA S, 1991, AM J ROENTGENOL, V156, P297; Yano T, 2008, ENDOSCOPY, V40, P717, DOI 10.1055/s-2008-1077480; SUGIMACHI K, 1992, GASTROINTEST ENDOSC, V38, P657, DOI 10.1016/S0016-5107(92)70560-4; Sjoquist KM, 2011, LANCET ONCOL, V12, P681, DOI 10.1016/S1470-2045(11)70142-5; Gao ZH, 2014, ONCOL LETT, V7, P1118, DOI 10.3892/ol.2014.1881; Stein S, 2006, MUTAT RES-GEN TOX EN, V608, P1, DOI 10.1016/j.mrgentox.2006.01.009; Ando N, 2003, J CLIN ONCOL, V21, P4592, DOI 10.1200/JCO.2003.12.095; Nimura Y, 1997, CANCER, V80, P852, DOI 10.1002/(SICI)1097-0142(19970901)80:5<852::AID-CNCR4>3.0.CO;2-N; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Matsuda T, 1998, NUCLEIC ACIDS RES, V26, P1769, DOI 10.1093/nar/26.7.1769; Bar-Shalom R, 2005, EUR J NUCL MED MOL I, V32, P918, DOI 10.1007/s00259-005-1795-y; YOSHIDA A, 1984, P NATL ACAD SCI-BIOL, V81, P258, DOI 10.1073/pnas.81.1.258; Rustgi AK, 2014, NEW ENGL J MED, V371, P2499, DOI 10.1056/NEJMra1314530; Burtness B, 2005, J CLIN ONCOL, V23, P8646, DOI 10.1200/JCO.2005.02A646; Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469; Yokoyama A, 2010, ALCOHOL CLIN EXP RES, V34, P1246, DOI 10.1111/j.1530-0277.2010.01202.x; Ling Y, 2011, J CLIN PATHOL, V64, P246, DOI 10.1136/jcp.2010.082875; [Anonymous], 2015, NATL COMPREHENSIVE C; Maesawa C, 1996, CANCER RES, V56, P3875; Guo YL, 2007, PHARMACOGENET GENOM, V17, P197, DOI 10.1097/FPC.0b013e328010bda1; Waridel F, 1997, ONCOGENE, V14, P163, DOI 10.1038/sj.onc.1200812; Yukawa Y, 2014, AM J CANCER RES, V4, P279; Tu CH, 2011, DIS ESOPHAGUS, V24, P274, DOI 10.1111/j.1442-2050.2010.01141.x; Lecleire S, 2006, ALIMENT PHARM THERAP, V23, P1693, DOI 10.1111/j.1365-2036.2006.02946.x; Bartsch H, 2000, CANCER EPIDEM BIOMAR, V9, P3; Kalabis J, 2012, NAT PROTOC, V7, P235, DOI 10.1038/nprot.2011.437; Brooks PJ, 2014, ENVIRON MOL MUTAGEN, V55, P77, DOI 10.1002/em.21824; DIPAOLO JA, 1993, CRIT REV ONCOGENESIS, V4, P337; Goda K, 2009, DIS ESOPHAGUS, V22, P453, DOI 10.1111/j.1442-2050.2009.00942.x; Bosnian FT, 2010, WHO CLASSIFICATION T; Brooks PJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000050; Dai Y, 2014, COCHRANE DB SYST REV, V10; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; GARRO AJ, 1986, ALCOHOL CLIN EXP RES, V10, pS73, DOI 10.1111/j.1530-0277.1986.tb05184.x; HERSKOVIC A, 1992, NEW ENGL J MED, V326, P1593, DOI 10.1056/NEJM199206113262403; Hironaka S, 2014, CANCER SCI, V105, P1189, DOI 10.1111/cas.12486; Hoffmann D, 1997, J TOXICOL ENV HEALTH, V50, P307, DOI 10.1080/009841097160393; Homs MYV, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004063.pub2; Japan Esophageal Society, 2009, ESOPHAGUS, V6, P71, DOI DOI 10.1007/S10388-009-0193-0]; Kuwano H, 2015, ESOPHAGUS-TOKYO, V12, P1, DOI 10.1007/s10388-014-0465-1; Lindor NM, 2008, J NATL CANC I MONOGR, V2008, P1; Makuuchi H, 1997, DIG ENDOSC, V9, P110, DOI 10.1111/j.1443-1661.1997.tb00469.x; Matsubara Hisahiro, 2007, Ann Thorac Cardiovasc Surg, V13, P293; Muto Manabu, 2005, Clin Gastroenterol Hepatol, V3, pS16, DOI 10.1016/S1542-3565(05)00262-4; Pennathur A, 2009, ANN THORAC SURG, V87, P1054; Prabhu A, 2014, AM J GASTROENTEROL, V109, P821, DOI 10.1038/ajg.2014.71; Quint Leslie Eisenbud, 2008, Cancer Imaging, V8 Spec No A, pS33, DOI 10.1102/1470-7330.2008.9007; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Sobin LH, 2009, TNM CLASSIFICATION M, P66; Sureshbabu Waheeda, 2005, J Nucl Med Technol, V33, P156; Sureshbabu W, 2005, J NUCL MED TECHNOL, V33, P163; Taghavi N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-138; Zare M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-24	170	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	DEC	2015	149	7					1700	1715		10.1053/j.gastro.2015.08.054		16	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CX6JX	WOS:000365808100025		
J	Yoshimura, N; Watanabe, M; Motoya, S; Tominaga, K; Matsuoka, K; Iwakiri, R; Watanabe, K; Hibi, T				Yoshimura, Naoki; Watanabe, Mamoru; Motoya, Satoshi; Tominaga, Keiichi; Matsuoka, Katsuyoshi; Iwakiri, Ryuichi; Watanabe, Kenji; Hibi, Toshifumi		AJM300 Study Grp	Safety and Efficacy of AJM300, an Oral Antagonist of alpha 4 Integrin, in Induction Therapy for Patients With Active Ulcerative Colitis	GASTROENTEROLOGY			English	Article						Integrin; IBD; Randomized Clinical Trial; Lymphocyte Trafficking	PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; INFLAMMATORY-BOWEL-DISEASE; CELL-ADHESION MOLECULE-1; PLACEBO-CONTROLLED TRIAL; CROHNS-DISEASE; MULTIPLE-SCLEROSIS; MAINTENANCE THERAPY; CLINICAL-OUTCOMES; DOUBLE-BLIND; NATALIZUMAB	BACKGROUND & AIMS: AJM300 is an orally active small-molecule antagonist of the alpha 4 integrin subunit. We performed a randomized trial to investigate the efficacy and safety of AJM300 in patients with active ulcerative colitis (UC). METHODS: In a double-blind, placebo-controlled, phase 2a study, 102 patients with moderately active UC (Mayo Clinic scores of 6-10, endoscopic subscores >= 2, and rectal bleeding subscores >= 1) who had inadequate response or intolerance to mesalamine or corticosteroids were randomly assigned to receive AJM300 (960 mg) or placebo 3 times daily for 8 weeks. The primary end point was a clinical response at week 8, defined as a decrease in Mayo Clinic score of at least 3 points and a decrease of at least 30% from baseline, with a decrease in the rectal bleeding subscore of at least 1 point or an absolute rectal bleeding subscore of 0 or 1. RESULTS: Clinical response rates were 62.7% and 25.5% at week 8 in the AJM300 group and placebo group, respectively (odds ratio [OR] = 5.35; 95% confidence interval [CI]: 2.23-12.82; P = .0002). Rates of clinical remission (Mayo Clinic score <= 2 and no subscore > 1) were 23.5% and 3.9% in the AJM300 group and placebo groups, respectively (OR = 7.81; 95% CI: 1.64-37.24; P = .0099), and rates of mucosal healing (endoscopic subscores of 0 or 1) were 58.8% and 29.4% (OR = 4.65; 95% CI: 1.81-11.90; P = .0014). No serious adverse event, including progressive multifocal leukoencephalopathy, was observed, although more investigations are needed to confirm the safety profile of this drug. CONCLUSIONS: AJM300 was well tolerated and more effective than placebo in inducing clinical response, clinical remission, and mucosal healing in patients with moderately active UC.	[Yoshimura, Naoki] Tokyo Yamate Med Ctr, Tokyo, Japan; [Watanabe, Mamoru; Matsuoka, Katsuyoshi] Tokyo Med & Dent Univ, Tokyo 1138510, Japan; [Motoya, Satoshi] Sapporo Kosei Gen Hosp, Sapporo, Hokkaido, Japan; [Tominaga, Keiichi] Dokkyo Med Univ, Mibu, Tochigi, Japan; [Iwakiri, Ryuichi] Saga Univ, Saga 840, Japan; [Watanabe, Kenji] Osaka City Gen Hosp, Osaka, Japan; [Hibi, Toshifumi] Kitasato Univ, Kitasato Inst Hosp, Tokyo, Japan	Watanabe, M (reprint author), Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Bunkyo Ku, 5-45 Yushima,1 Chome, Tokyo 1138510, Japan.	mamoru.gast@tmd.ac.jp			Ajinomoto Pharmaceuticals Co., Ltd.	This study was sponsored and funded by Ajinomoto Pharmaceuticals Co., Ltd. The trial was designed, managed, and data housed and analyzed by Ajinomoto Pharmaceuticals Co., Ltd. in collaboration with investigators. The authors had full access to all the data.	Vermeire S, 2011, GUT, V60, P1068, DOI 10.1136/gut.2010.226548; Colombel JF, 2011, GASTROENTEROLOGY, V141, P1194, DOI 10.1053/j.gastro.2011.06.054; Miller DH, 2012, LANCET NEUROL, V11, P131, DOI 10.1016/S1474-4422(11)70299-X; Vermeire S, 2014, LANCET, V384, P309, DOI 10.1016/S0140-6736(14)60661-9; Sandborn WJ, 2005, NEW ENGL J MED, V353, P1912, DOI 10.1056/NEJMoa043335; Davenport RJ, 2007, DRUG DISCOV TODAY, V12, P569, DOI 10.1016/j.drudis.2007.05.001; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Arihiro S, 2002, PATHOL INT, V52, P367, DOI 10.1046/j.1440-1827.2002.01365.x; Kappos L, 2011, LANCET NEUROL, V10, P745, DOI 10.1016/S1474-4422(11)70149-1; Sandborn WJ, 2013, NEW ENGL J MED, V369, P711, DOI 10.1056/NEJMoa1215739; Lichtenstein GR, 2010, INFLAMM BOWEL DIS, V16, P338, DOI 10.1002/ibd.20997; Bloomgren G, 2012, NEW ENGL J MED, V366, P1870, DOI 10.1056/NEJMoa1107829; Nanda KS, 2013, AM J GASTROENTEROL, V108, P40, DOI 10.1038/ajg.2012.363; Parikh A, 2012, INFLAMM BOWEL DIS, V18, P1470, DOI 10.1002/ibd.21896; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Gonzalez-Amaro R, 2005, IMMUNOLOGY, V116, P289, DOI 10.1111/j.1365-2567.2005.02225.x; Eksteen B, 2008, INFLAMM BOWEL DIS, V14, P1298, DOI 10.1002/ibd.20453; Villablanca EJ, 2011, GASTROENTEROLOGY, V140, P1776, DOI 10.1053/j.gastro.2011.02.015; Briskin M, 1997, AM J PATHOL, V151, P97; Hijazi Y, 2004, J CLIN PHARMACOL, V44, P1368, DOI 10.1177/0091270004270147; Takazoe M, 2009, GASTROENTEROLOGY, V136, pA181; Feagan BG, 2013, NEW ENGL J MED, V369, P699, DOI 10.1056/NEJMoa1215734; RILEY SA, 1991, GUT, V32, P174, DOI 10.1136/gut.32.2.174; Targan SR, 2007, GASTROENTEROLOGY, V132, P1672, DOI 10.1053/j.gastro.2007.03.024; Bozic C, 2012, NEUROLOGY S1, V78; Chalkley JJ, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0408-6; Makino S, 2002, Patent application, Patent No. [WO02/16329, 0216329]; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Sugiura Toshihiko, 2013, J Crohns Colitis, V7, pe533, DOI 10.1016/j.crohns.2013.03.014	29	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	DEC	2015	149	7					1775	+		10.1053/j.gastro.2015.08.044		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CX6JX	WOS:000365808100031		
J	Lammers, WJ; Hirschfield, GM; Corpechot, C; Nevens, F; Lindor, KD; Janssen, HLA; Floreani, A; Ponsioen, CY; Mayo, MJ; Invernizzi, P; Battezzati, PM; Pares, A; Burroughs, AK; Mason, AL; Kowdley, KV; Kumagi, T; Harms, MH; Trivedi, PJ; Poupon, R; Cheung, A; Lleo, A; Caballeria, L; Hansen, BE; van Buuren, HR				Lammers, Willem J.; Hirschfield, Gideon M.; Corpechot, Christophe; Nevens, Frederik; Lindor, Keith D.; Janssen, Harry L. A.; Floreani, Annarosa; Ponsioen, Cyriel Y.; Mayo, Marlyn J.; Invernizzi, Pietro; Battezzati, Pier M.; Pares, Albert; Burroughs, Andrew K.; Mason, Andrew L.; Kowdley, Kris V.; Kumagi, Teru; Harms, Maren H.; Trivedi, Palak J.; Poupon, Raoul; Cheung, Angela; Lleo, Ana; Caballeria, Llorenc; Hansen, Bettina E.; van Buuren, Henk R.		Global PBC Study Grp	Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy	GASTROENTEROLOGY			English	Article						Cholestasis; Autoimmune Liver Disease; Prognosis; Predictive Factor	LIVER FIBROSIS PROGRESSION; BIOCHEMICAL RESPONSE; SERUM BILIRUBIN; HISTOLOGICAL PROGRESSION; END-POINTS; FOLLOW-UP; PROGNOSIS; MODEL; RECLASSIFICATION; SURVIVAL	BACKGROUND & AIMS: Approaches to risk stratification for patients with primary biliary cirrhosis (PBC) are limited, single-center based, and often dichotomous. We aimed to develop and validate a better model for determining prognoses of patients with PBC. METHODS: We performed an international, multicenter meta-analysis of 4119 patients with PBC treated with ursodeoxycholic acid at liver centers in 8 European and North American countries. Patients were randomly assigned to derivation (n = 2488 [60%]) and validation cohorts (n = 1631 [40%]). A risk score (GLOBE score) to predict transplantation-free survival was developed and validated with univariate and multivariable Cox regression analyses using clinical and biochemical variables obtained after 1 year of ursodeoxycholic acid therapy. Risk score outcomes were compared with the survival of age-, sex-, and calendar time-matched members of the general population. The prognostic ability of the GLOBE score was evaluated alongside those of the Barcelona, Paris-1, Rotterdam, Toronto, and Paris-2 criteria. RESULTS: Age (hazard ratio = 1.05; 95% confidence interval [CI]: 1.04-1.06; P<. 0001); levels of bilirubin (hazard ratio = 2.56; 95% CI: 2.22-2.95; P <.0001), albumin (hazard ratio = 0.10; 95% CI: 0.05-0.24; P <.0001), and alkaline phosphatase (hazard ratio = 1.40; 95% CI: 1.18-1.67; P = .0002); and platelet count (hazard ratio/10 units decrease = 0.97; 95% CI: 0.96-0.99; P <.0001) were all independently associated with death or liver transplantation (C-statistic derivation, 0.81; 95% CI: 0.79-0.83, and validation cohort, 0.82; 95% CI: 0.79-0.84). Patients with risk scores > 0.30 had significantly shorter times of transplant-free survival than matched healthy individuals (P <.0001). The GLOBE score identified patients who would survive for 5 years and 10 years (responders) with positive predictive values of 98% and 88%, respectively. Up to 22% and 21% of events and nonevents, respectively, 10 years after initiation of treatment were correctly reclassified in comparison with earlier proposed criteria. In subgroups of patients aged < 45, 45-52, 52-58, 58-66, and -66 years, age-specific GLOBE-score thresholds beyond which survival significantly deviated from matched healthy individuals were -0.52, 0.01, 0.60, 1.01 and 1.69, respectively. Transplant-free survival could still be accurately calculated by the GLOBE score with laboratory values collected at 2-5 years after treatment. CONCLUSIONS: We developed and validated scoring system (the GLOBE score) to predict transplant-free survival of ursodeoxycholic acid-treated patients with PBC. This score might be used to select strategies for treatment and care.	[Lammers, Willem J.; Harms, Maren H.; Hansen, Bettina E.; van Buuren, Henk R.] Erasmus Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Hirschfield, Gideon M.; Trivedi, Palak J.] Univ Birmingham, NIHR Biomed Res Unit, Birmingham, W Midlands, England; [Hirschfield, Gideon M.; Trivedi, Palak J.] Univ Birmingham, Liver Res Ctr, Birmingham, W Midlands, England; [Corpechot, Christophe; Poupon, Raoul] Hop St Antoine, Ctr Reference Malad Inflammatoires Voies Biliaire, AP HP, F-75571 Paris, France; [Nevens, Frederik] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Hepatol, Leuven, Belgium; [Lindor, Keith D.] Mayo Clin, Dept Gastroenterol & Hepatol, Rochester, MN USA; [Lindor, Keith D.] Arizona State Univ, Coll Hlth Solut, Phoenix, AZ USA; [Janssen, Harry L. A.; Cheung, Angela] Univ Hlth Network, Toronto Western & Gen Hosp, Liver Clin, Toronto, ON, Canada; [Floreani, Annarosa] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy; [Ponsioen, Cyriel Y.] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands; [Mayo, Marlyn J.] Univ Texas SW Med Ctr Dallas, Digest & Liver Dis, Dallas, TX 75390 USA; [Invernizzi, Pietro] Humanitas Clin & Res Ctr, Liver Unit, Rozzano, Italy; [Invernizzi, Pietro; Lleo, Ana] Humanitas Clin & Res Ctr, Ctr Autoimmune Liver Dis, Rozzano, Italy; [Battezzati, Pier M.] Univ Milan, Dept Hlth Sci, Milan, Italy; [Pares, Albert; Caballeria, Llorenc] Univ Barcelona, Liver Unit, Hosp Clin, CIBERehd,IDIBAPS, Barcelona, Spain; [Burroughs, Andrew K.] Royal Free Hosp, Sheila Sherlock Liver Ctr, London NW3 2QG, England; [Mason, Andrew L.] Univ Alberta, Divison Gastroenterol & Hepatol, Edmonton, AB, Canada; [Kowdley, Kris V.] Swedish Med Ctr, Liver Care Network & Organ Care Res, Seattle, WA USA; [Kumagi, Teru] Ehime Univ, Dept Gastroenterol & Metabol, Grad Sch Med, Matsuyama, Ehime 790, Japan	van Buuren, HR (reprint author), Erasmus MC, Univ Med Ctr, Dept Gastroenterol & Hepatol, S Gravendijkwal 230,Room Ha 203, NL-3015 CE Rotterdam, Netherlands.	h.vanbuuren@erasmusmc.nl	Burroughs, Andrew/C-5645-2009	Burroughs, Andrew/0000-0001-6527-457X	Intercept Pharmaceuticals; Zambon Nederland BV; Foundation for Liver and Gastrointestinal Research (a not-for-profit foundation) in Rotterdam, the Netherlands	This investigator-initiated study was supported by unrestricted grants from Intercept Pharmaceuticals and Zambon Nederland BV, and was funded by the Foundation for Liver and Gastrointestinal Research (a not-for-profit foundation) in Rotterdam, the Netherlands. The supporting parties had no influence on the study design, data collection and analyses, writing of the manuscript, or on the decision to submit the manuscript for publication.	Kumagi T, 2010, AM J GASTROENTEROL, V105, P2186, DOI 10.1038/ajg.2010.216; Selmi C, 2011, LANCET, V377, P1600, DOI 10.1016/S0140-6736(10)61965-4; Angulo P, 1999, LIVER, V19, P115, DOI 10.1111/j.1478-3231.1999.tb00020.x; Pares A, 2006, GASTROENTEROLOGY, V130, P715, DOI 10.1053/j.gastro.2005.12.029; Bonnand AM, 1999, HEPATOLOGY, V29, P39, DOI 10.1002/hep.510290140; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Trivedi PJ, 2014, J HEPATOL, V60, P1249, DOI 10.1016/j.jhep.2014.01.029; Momah N, 2012, LIVER INT, V32, P790, DOI 10.1111/j.1478-3231.2011.02678.x; Corpechot C, 2011, J HEPATOL, V55, P1361, DOI 10.1016/j.jhep.2011.02.031; Corpechot C, 2000, HEPATOLOGY, V32, P1196, DOI 10.1053/jhep.2000.20240; Krzeski P, 1999, HEPATOLOGY, V30, P865, DOI 10.1002/hep.510300415; DICKSON ER, 1989, HEPATOLOGY, V10, P1, DOI 10.1002/hep.1840100102; ter Borg PCJ, 2006, AM J GASTROENTEROL, V101, P2044, DOI 10.1111/j.1572-0241.2006.00699.x; CHRISTENSEN E, 1985, GASTROENTEROLOGY, V89, P1084; Corpechot C, 2012, HEPATOLOGY, V56, P198, DOI 10.1002/hep.25599; Poupon RE, 2003, J HEPATOL, V39, P12, DOI 10.1016/S0168-8278(03)00192-2; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; SHAPIRO JM, 1979, GUT, V20, P137, DOI 10.1136/gut.20.2.137; Leening MJG, 2014, ANN INTERN MED, V160, P122, DOI 10.7326/M13-1522; Patanwala I, 2013, J HEPATOL, V59, P327, DOI 10.1016/j.jhep.2013.04.010; Angulo P, 1999, HEPATOLOGY, V29, P644, DOI 10.1002/hep.510290301; ROLL J, 1983, NEW ENGL J MED, V308, P1, DOI 10.1056/NEJM198301063080101; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Kuiper EMM, 2009, GASTROENTEROLOGY, V136, P1281, DOI 10.1053/j.gastro.2009.01.003; Corpechot C, 2005, GASTROENTEROLOGY, V128, P297, DOI 10.1016/j.gastro.2004.11.009; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Corpechot C, 2008, HEPATOLOGY, V48, P871, DOI 10.1002/hep.22428; Carbone M, 2013, GASTROENTEROLOGY, V144, pe13; Carbone M, 2013, GASTROENTEROLOGY, V144, P560; Child C G, 1964, Major Probl Clin Surg, V1, P1; European Association for the Study of the Liver, 2009, J HEPATOL, V51, P237; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Joshita S, 2014, J HEPATOL, V61, P1443, DOI 10.1016/j.jhep.2014.07.036; Lammers WJ, 2014, GASTROENTEROLOGY, V147, P1338, DOI 10.1053/j.gastro.2014.08.029; Lammers WJ, 2013, HEPATOLOGY, V58, p249A; Little R.J.A., 1987, STAT ANAL MISSING DA; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-33; Steyerberg EW, 2009, CLIN PREDICTION MODE; Trivedi PJ, GUT	40	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	DEC	2015	149	7					1804	+		10.1053/j.gastro.2015.07.061		13	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CX6JX	WOS:000365808100034		
J	Khashab, MA; Levy, MJ; Itoi, T; Artifon, ELA				Khashab, Mouen A.; Levy, Michael J.; Itoi, Takao; Artifon, Everson L. A.			EUS-guided biliary drainage	GASTROINTESTINAL ENDOSCOPY			English	Review							INDWELLING DUODENAL STENT; APPOSING METAL STENT; FAILED ERCP; GALLBLADDER DRAINAGE; ADVERSE EVENTS; OBSTRUCTION; CHOLEDOCHODUODENOSTOMY; PLACEMENT; ACCESS; VIDEOS		[Khashab, Mouen A.] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; [Khashab, Mouen A.] Johns Hopkins Med Inst, Div Gastroenterol Hepatol, Baltimore, MD 21205 USA; [Levy, Michael J.] Mayo Clin, Dept Med, Rochester, MN USA; [Levy, Michael J.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Itoi, Takao] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan; [Artifon, Everson L. A.] Univ Sao Paulo, Dept Surg, BR-04107030 Sao Paulo, Brazil	Khashab, MA (reprint author), Johns Hopkins Univ Hosp, 1800 Orleans St,Zayed Tower,Suite 7125B, Baltimore, MD 21287 USA.						Artifon ELA, 2015, GASTROINTEST ENDOSC, V81, P950, DOI 10.1016/j.gie.2014.09.047; Maranki J, 2009, ENDOSCOPY, V41, P532, DOI 10.1055/s-0029-1214712; Itoi T, 2009, GASTROINTEST ENDOSC, V69, pS8, DOI 10.1016/j.gie.2008.11.003; Khashab MA, 2013, GASTROINTEST ENDOSC, V78, P734, DOI 10.1016/j.gie.2013.05.013; Shah JN, 2012, GASTROINTEST ENDOSC, V75, P56, DOI 10.1016/j.gie.2011.08.032; Fabbri C, 2011, ENDOSCOPY, V43, P438, DOI 10.1055/s-0030-1256097; Nguyen-Tang T, 2010, ENDOSCOPY, V42, P232, DOI 10.1055/s-0029-1243858; Artifon ELA, 2012, J CLIN GASTROENTEROL, V46, P768, DOI 10.1097/MCG.0b013e31825f264c; Kim YS, 2010, ENDOSCOPY, V42, P496, DOI 10.1055/s-0029-1244082; Itoi T, 2012, GASTROINTEST ENDOSC, V75, P870, DOI 10.1016/j.gie.2011.10.020; Henry WA, 2012, GASTROINTEST ENDOSC, V76, P1065, DOI 10.1016/j.gie.2011.09.046; Kumbhari V, 2015, GASTROINTEST ENDOSC, V81, P1015, DOI 10.1016/j.gie.2014.10.019; Park DH, 2011, GASTROINTEST ENDOSC, V74, P1276, DOI 10.1016/j.gie.2011.07.054; Gupta K, 2014, J CLIN GASTROENTEROL, V48, P80, DOI 10.1097/MCG.0b013e31828c6822; Dhir V, 2012, GASTROINTEST ENDOSC, V75, P354, DOI 10.1016/j.gie.2011.07.075; Komaki T, 2011, PANCREATOLOGY, V11, P47, DOI 10.1159/000323508; Park DH, 2013, GASTROINTEST ENDOSC, V78, P91, DOI 10.1016/j.gie.2013.01.042; Khashab MA, 2012, GASTROINTEST ENDOSC, V76, P209, DOI 10.1016/j.gie.2012.03.170; Park SJ, 2013, GASTROINTEST ENDOSC, V78, P374, DOI 10.1016/j.gie.2013.04.183; Hara K, 2011, AM J GASTROENTEROL, V106, P1239, DOI 10.1038/ajg.2011.84; Binmoeller KF, 2011, ENDOSCOPY, V43, P337, DOI 10.1055/s-0030-1256127; Giovannini M, 2001, ENDOSCOPY, V33, P898, DOI 10.1055/s-2001-17324; Mallery S, 2004, GASTROINTEST ENDOSC, V59, P100, DOI 10.1016/S0016-5107(03)02300-9; Voermans RP, 2011, GASTROINTEST ENDOSC, V74, P1285, DOI 10.1016/j.gie.2011.07.059; Khashab MA, 2013, GASTROINTEST ENDOSC, V78, P102, DOI 10.1016/j.gie.2013.03.004; Iwashita T, 2012, ENDOSCOPY, V44, P60, DOI 10.1055/s-0030-1256871; Cotton PB, 2010, GASTROINTEST ENDOSC, V71, P446, DOI 10.1016/j.gie.2009.10.027; Hara K, 2013, ENDOSCOPY, V45, P392, DOI 10.1055/s-0032-1326076; Saxena P, 2015, GASTROINTEST ENDOSC, V81, P1010, DOI 10.1016/j.gie.2014.06.038; Dhir V, 2014, DIGEST ENDOSC, V26, P430, DOI 10.1111/den.12153; Sharaiha RZ, 2012, GASTROINTEST ENDOSC, V76, P227, DOI 10.1016/j.gie.2012.01.044; Hamada T, 2014, DIGEST DIS SCI, V59, P1931, DOI 10.1007/s10620-014-3062-1; Kahaleh M, 2006, GASTROINTEST ENDOSC, V64, P52, DOI 10.1016/j.gie.2006.01.063; Artifon Everson L A, 2011, JOP, V12, P610; de la Serna-Higuera C, 2013, GASTROINTEST ENDOSC, V77, P303, DOI 10.1016/j.gie.2012.09.021; Dhir V, 2013, GASTROINTEST ENDOSC, V1, P103, DOI [10.1177/ 2050640613480145, DOI 10.1177/2050640613480145]; Khashab MA, 2015, DIGEST DIS SCI, V60, P557, DOI 10.1007/s10620-014-3300-6; Khashab Mouen A, 2014, Endoscopy, V46, P252, DOI 10.1055/s-0033-1359214; Savides TJ, 2009, GASTROINTEST ENDOSC, V69, pS3; Wiersema MJ, 1996, GASTROINTEST ENDOSC, V43, P102, DOI 10.1016/S0016-5107(06)80108-2	40	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	DEC	2015	82	6					993	1001		10.1016/j.gie.2015.06.043		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CX3GN	WOS:000365585000003		
J	Hanaoka, N; Ishihara, R; Takeuchi, Y; Suzuki, M; Otozai, S; Kida, K; Yoshii, T; Fujii, T; Yoshino, K; Sugawa, T; Kitamura, K; Kanemura, R; Koike, R; Uedo, N; Higashino, K; Akasaka, T; Yamashina, T; Kanesaka, T; Matsuura, N; Aoi, K; Yamasaki, Y; Hamada, K; Iishi, H; Tomita, Y				Hanaoka, Noboru; Ishihara, Ryu; Takeuchi, Yoji; Suzuki, Motoyuki; Otozai, Shinji; Kida, Kota; Yoshii, Tadashi; Fujii, Takashi; Yoshino, Kunitoshi; Sugawa, Toshimitsu; Kitamura, Koji; Kanemura, Ryo; Koike, Ryosuke; Uedo, Noriya; Higashino, Koji; Akasaka, Tomofumi; Yamashina, Takeshi; Kanesaka, Takashi; Matsuura, Noriko; Aoi, Kenji; Yamasaki, Yasushi; Hamada, Kenta; Iishi, Hiroyasu; Tomita, Yasuhiko			Endoscopic submucosal dissection as minimally invasive treatment for superficial pharyngeal cancer: a phase II study	GASTROINTESTINAL ENDOSCOPY			English	Article							SQUAMOUS-CELL CARCINOMA; EN-BLOC RESECTION; MUCOSAL RESECTION; HYPOPHARYNX; FEASIBILITY; OUTCOMES; RADIOTHERAPY; SURGERY	Background and Aims: Although endoscopic submucosal dissection (ESD) has been applied for superficial pharyngeal cancer, no prospective trials have been reported. To investigate the efficacy and safety of ESD for superficial pharyngeal cancer, we conducted a prospective phase II trial. Methods: Fifty-four patients with 73 lesions were enrolled from September 2010 to August 2014, and ESD was performed. The primary endpoint was the complete resection rate. Secondary endpoints were safety, recurrencefree survival, overall survival, and incidence of metachronous pharyngeal cancer. Results: Fifty-four patients had stage 0-III cancer: stage 0, n = 22; stage I, n = 14; stage II, n = 17; and stage III, n = 1. The en bloc resection rate was 100%, and the complete resection rate was 79.5% (58/73 lesions; 95% confidence interval, 68%-88%). No serious adverse events related to ESD were encountered. Four patients required nasogastric intubation and feeding. No patients required percutaneous endoscopic gastrostomy and tracheotomy. Swallowing, speech, and airway functions were preserved in all patients. One of the 54 patients died of an unrelated illness. Median follow-up was 27 months (range 6-55 months). Local cervical lymph node metastasis was observed in 1 patient, and the case was salvaged successfully with lymph node dissection. The 3-year overall and recurrence-free survival rates were 97.7% and 98.1%, respectively. Cumulative development of multiple cancers of the pharynx at 3 years was 18.4%. Conclusions: ESD appears to be a safe and effective minimally invasive treatment in patients with superficial pharyngeal cancer.	[Hanaoka, Noboru; Ishihara, Ryu; Takeuchi, Yoji; Uedo, Noriya; Higashino, Koji; Akasaka, Tomofumi; Yamashina, Takeshi; Kanesaka, Takashi; Matsuura, Noriko; Aoi, Kenji; Yamasaki, Yasushi; Hamada, Kenta; Iishi, Hiroyasu] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gastrointestinal Oncol, Osaka 5378511, Japan; [Suzuki, Motoyuki; Otozai, Shinji; Kida, Kota; Yoshii, Tadashi; Fujii, Takashi; Yoshino, Kunitoshi; Sugawa, Toshimitsu; Kitamura, Koji; Kanemura, Ryo; Koike, Ryosuke] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Otorhinolaryngol, Osaka 5378511, Japan; [Tomita, Yasuhiko] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Pathol, Osaka 5378511, Japan	Hanaoka, N (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gastrointestinal Oncol, Higashinari Ku, 1-3-3 Nakamichi, Osaka 5378511, Japan.						Iizuka T, 2009, ENDOSCOPY, V41, P113, DOI 10.1055/s-0028-1119453; Hanaoka N, 2013, HEAD NECK-J SCI SPEC, V35, P1248, DOI 10.1002/hed.23106; Katada C, 2010, ENDOSCOPY, V42, P185, DOI 10.1055/s-0029-1243963; Okada K, 2012, ENDOSCOPY, V44, P556, DOI 10.1055/s-0032-1309720; Eckel HE, 2001, OTOLARYNG HEAD NECK, V124, P561, DOI 10.1067/mhn.2991.115060; Shiotani A, 2010, ANN OTO RHINOL LARYN, V119, P225; Martin A, 2008, LARYNGOSCOPE, V118, P398, DOI 10.1097/MLG.0b013e31815aeda3; Cabanillas R, 2004, HEAD NECK-J SCI SPEC, V26, P653, DOI 10.1002/hed.20063; Nakamura K, 2006, INT J RADIAT ONCOL, V65, P1045, DOI 10.1016/j.ijrobp.2006.02.001; Kraus DH, 1997, OTOLARYNG HEAD NECK, V116, P637, DOI 10.1016/S0194-5998(97)70240-7; Muto M, 2011, GASTROINTEST ENDOSC, V74, P477, DOI 10.1016/j.gie.2011.04.027; Rabbani A, 2008, INT J RADIAT ONCOL, V72, P351, DOI 10.1016/j.ijrobp.2008.01.003; Kuwabara T, 2012, GASTROINTEST ENDOSC, V76, P1095, DOI 10.1016/j.gie.2012.07.032; Johansen LV, 2000, ACTA ONCOL, V39, P529; Imai K, 2013, GASTROINTEST ENDOSC, V78, P22, DOI 10.1016/j.gie.2013.01.047; Matsuba H, 2011, LARYNGOSCOPE, V121, P753, DOI 10.1002/lary.21553; Suzuki H, 2010, ENDOSCOPY, V42, P1, DOI 10.1055/s-0029-1243807; Wahlberg PCG, 1998, HEAD NECK-J SCI SPEC, V20, P714, DOI 10.1002/(SICI)1097-0347(199812)20:8<714::AID-HED9>3.0.CO;2-2; Barnes L, 2005, WHO CLASSIFICATION T; Hamilton SR, 2000, WHO CLASSIFICATION T, P9; Kawakubo H, 2010, STOMACH INTESTINE TO, V45, P265; Lorincz BB, 2014, HEAD NECK; Muto M, 2004, CANCER, V101, P1375, DOI 10.1002/cncr.20482; Muto M, 2010, J CLIN ONCOL, V20, P1566; Satake H, 2015, ENDOSCOPY, V47, P11, DOI 10.1055/s-0034-1378107; Sobin LH, 2010, TNM CLASSIFICATION M, P30	26	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	DEC	2015	82	6					1002	1008		10.1016/j.gie.2015.06.021		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CX3GN	WOS:000365585000004		
J	Kawasaki, K; Kurahara, K; Yanai, S; Oshiro, Y; Eizuka, M; Uesugi, N; Ishida, K; Nakamura, S; Fuchigami, T; Sugai, T; Matsumoto, T				Kawasaki, Keisuke; Kurahara, Koichi; Yanai, Shunichi; Oshiro, Yumi; Eizuka, Makoto; Uesugi, Noriyuki; Ishida, Kazuyuki; Nakamura, Shotaro; Fuchigami, Tadahiko; Sugai, Tamotsu; Matsumoto, Takayuki			Significance of a white opaque substance under magnifying narrow-band imaging colonoscopy for the diagnosis of colorectal epithelial neoplasms	GASTROINTESTINAL ENDOSCOPY			English	Article							CARCINOMA; ENDOSCOPY; INVASION; DEPTH; TUMORS	Background and Aims: The aim of this study was to examine the significance of a white opaque substance (WOS) found on magnifying narrow-band imaging (M-NBI) for the diagnosis of colorectal neoplastic lesions. Methods: We retrospectively reviewed colonoscopy records from 2006 to 2012 at our institution and identified cases of endoscopically or surgically resected colorectal epithelial neoplasms observed by M-NBI colonoscopy. The colonoscopic and histologic characteristics of the lesions were compared between WOS-positive and WOS-negative lesions. We further classified the WOS as regular or irregular and compared the histologic characteristics between the two types of lesions. Results: There were 105 WOS-positive lesions and 451 WOS-negative lesions. The former were subdivided into lesions with regular and irregular WOS. The incidence of high-grade dysplasia or carcinoma was significantly higher in WOS-positive lesions (61.9%) than in WOS-negative lesions (28.6%) (P < .05). Among the WOS-positive lesions, massive submucosal invasion was more frequent in lesions with irregular WOS (82.4%) than in those with regular WOS (1.4%) (P < .05). Among cancers with massive submucosal invasion, lymph node metastasis was more frequent in cancers with irregular WOS (17.4%) than in those with regular WOS or without the WOS (0%) (P < .05). Conclusions: A WOS in colorectal neoplasms may be an optical marker for high-grade dysplasia and cancer. An irregular WOS may be indicative of massive submucosal invasion and lymph node metastasis.	[Kawasaki, Keisuke; Yanai, Shunichi; Nakamura, Shotaro; Matsumoto, Takayuki] Iwate Med Univ, Dept Internal Med, Div Gastroenterol, Morioka, Iwate 0208505, Japan; [Kawasaki, Keisuke; Kurahara, Koichi; Fuchigami, Tadahiko] Matsuyama Red Cross Hosp, Div Gastroenterol, Fukuoka, Ehime, Japan; [Oshiro, Yumi] Matsuyama Red Cross Hosp, Dept Pathol, Fukuoka, Ehime, Japan; [Eizuka, Makoto; Uesugi, Noriyuki; Ishida, Kazuyuki; Sugai, Tamotsu] Iwate Med Univ, Dept Diagnost Pathol, Morioka, Iwate 0208505, Japan	Kawasaki, K (reprint author), Iwate Med Univ, Dept Internal Med, Div Gastroenterol, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.						Yao K, 2008, GASTROINTEST ENDOSC, V68, P574, DOI 10.1016/j.gie.2008.04.011; Kanao H, 2009, GASTROINTEST ENDOSC, V69, P631, DOI 10.1016/j.gie.2008.08.028; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Kitajima K, 2004, J GASTROENTEROL, V39, P534, DOI 10.1007/s00535-004-1339-4; Yoshimura N, 2010, HEPATO-GASTROENTEROL, V57, P462; Ueno H, 2002, HISTOPATHOLOGY, V40, P127, DOI 10.1046/j.1365-2559.2002.01324.x; Ueno H, 2004, GASTROENTEROLOGY, V127, P385, DOI 10.1053/S0016-5085(04)00717-6; Ueo T, 2013, DIGEST ENDOSC, V25, P147, DOI 10.1111/j.1443-1661.2012.01364.x; Ropert A, 1996, GASTROENTEROLOGY, V111, P289, DOI 10.1053/gast.1996.v111.pm8690193; Yao KS, 2012, DIGEST ENDOSC, V24, P419, DOI 10.1111/j.1443-1661.2012.01314.x; Wada Y, 2009, GASTROINTEST ENDOSC, V70, P522, DOI 10.1016/j.gie.2009.01.040; Hamilton SR, 2000, WHO CLASSIFICATION T, P103; Hisabe T, 2014, DIGEST DIS SCI, V59, P2544, DOI 10.1007/s10620-014-3204-5; Hisabe T., 2013, ANN GASTROENTEROL, V26, P45; Ikematsu H, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-33; Paris Workshop Participants, 2003, GASTROINTEST ENDOSC, V58, pS3; Vander Heiden Matthew G, 2009, Science, V324, P1029, DOI 10.1126/science.1160809; Yoshii S, 2014, DIG ENDOSC	18	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	DEC	2015	82	6					1097	1104		10.1016/j.gie.2015.06.023		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CX3GN	WOS:000365585000020		
J	Hashimoto, K; Suzuki, AM; Dos Santos, A; Desterke, C; Collino, A; Ghisletti, S; Braun, E; Bonetti, A; Fort, A; Qin, XY; Radaelli, E; Kaczkowski, B; Forrest, ARR; Kojima, S; Samue, D; Natoli, G; Buendia, MA; Faivre, J; Carninci, P				Hashimoto, Kosuke; Suzuki, Ana Maria; Dos Santos, Alexandre; Desterke, Christophe; Collino, Agnese; Ghisletti, Serena; Braun, Emilie; Bonetti, Alessandro; Fort, Alexandre; Qin, Xian-Yang; Radaelli, Enrico; Kaczkowski, Bogumil; Forrest, Alistair R. R.; Kojima, Soichi; Samue, Didier; Natoli, Gioacchino; Buendia, Marie Annick; Faivre, Jamila; Carninci, Piero			CAGE profiling of ncRNAs in hepatocellular carcinoma reveals widespread activation of retroviral LTR promoters in virus-induced tumors	GENOME RESEARCH			English	Article							LONG NONCODING RNAS; GENE-EXPRESSION; TRANSPOSABLE ELEMENTS; STEM-CELLS; CANCER; TRANSCRIPTION; LANDSCAPE; GENOME; PLURIPOTENCY; RETROTRANSPOSITION	An increasing number of noncoding RNAs (ncRNAs) have been implicated in various human diseases including cancer; however, the ncRNA transcriptome of hepatocellular carcinoma (HCC) is largely unexplored. We used CAGE to map transcription start sites across various types of human and mouse HCCs with emphasis on ncRNAs distant from protein-coding genes. Here, we report that retroviral LTR promoters, expressed in healthy tissues such as testis and placenta but not liver, are widely activated in liver tumors. Despite HCC heterogeneity, a subset of LTR-derived ncRNAs were more than 10-fold up-regulated in the vast majority of samples. HCCs with a high LTR activity mostly had a viral etiology, were less differentiated, and showed higher risk of recurrence. ChIP-seq data show that MYC and MAX are associated with ncRNA deregulation. Globally, CAGE enabled us to build a mammalian promoter map for HCC, which uncovers a new layer of complexity in HCC genomics.	[Hashimoto, Kosuke; Suzuki, Ana Maria; Bonetti, Alessandro; Fort, Alexandre; Kaczkowski, Bogumil; Forrest, Alistair R. R.; Carninci, Piero] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa 2300045, Japan; [Dos Santos, Alexandre; Desterke, Christophe; Braun, Emilie; Samue, Didier; Buendia, Marie Annick; Faivre, Jamila] Hop Paul Brousse, Hepatobiliary Ctr, INSERM, U1193, F-94800 Villejuif, France; [Dos Santos, Alexandre; Desterke, Christophe; Braun, Emilie; Samue, Didier; Buendia, Marie Annick; Faivre, Jamila] Univ Paris Saclay, Fac Med Le Kremlin Bicetre, F-94800 Villejuif, France; [Collino, Agnese; Ghisletti, Serena; Natoli, Gioacchino] IEO, Dept Expt Oncol, I-20139 Milan, Italy; [Qin, Xian-Yang; Kojima, Soichi] RIKEN, Ctr Life Sci Technol, Div Biofunct Dynam Imaging, Wako, Saitama 3510198, Japan; [Radaelli, Enrico] KU Leuven Ctr Human Genet, VIB Ctr Biol Dis, B-3000 Louvain, Belgium; [Faivre, Jamila] Hop Paul Brousse, AP HP, Pole Biol Med, F-94800 Villejuif, France	Carninci, P (reprint author), RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa 2300045, Japan.	jamila.faivre@inserm.fr; carninci@riken.jp			European Union's Seventh Framework Programme (FP7) [259743]; RIKEN Center; IEO; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); French National Institute of Cancer (INCa PAIR-HCC)	This work was supported by the European Union's Seventh Framework Programme (FP7) under grant agreement No. 259743 (MODHEP consortium) to the INSERM (D.S., M.A.B, J.F.), the RIKEN Center (K.H., A.M.S., P.C.), and IEO (A.C., S.G., G.N.), as well as a Research Grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) to the RIKEN Center for Life Science Technologies. The authors thank RIKEN GeNAS for the sequencing of the libraries. We also thank Professor Rene Adam, Professor Daniel Azoulay, Professor Daniel Cherqui, Professor Antonio Sa Cunha, Professor Catherine Guettier, and Dr. Eric Vibert (Centre Hepatobiliaire, Villejuif), and the Biological Resources Centres (AP-HP, Universite Paris-Sud, National Liver cancer biobanks network) for providing HCC specimens. J.F. acknowledges the support of the French National Institute of Cancer (INCa PAIR-HCC).	Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Lu XY, 2014, NAT STRUCT MOL BIOL, V21, P423, DOI 10.1038/nsmb.2799; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Mazur PK, 2014, NATURE, V510, P283, DOI 10.1038/nature13320; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Spizzo R, 2012, ONCOGENE, V31, P4577, DOI 10.1038/onc.2011.621; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gao W, 2014, HEPATOLOGY, V60, P576, DOI 10.1002/hep.26996; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Braconi C, 2011, P NATL ACAD SCI USA, V108, P786, DOI 10.1073/pnas.1011098108; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Petersen M, 2003, TRENDS BIOTECHNOL, V21, P74, DOI 10.1016/S0167-7799(02)00038-0; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Kovalskaya E, 2006, VIROLOGY, V346, P373, DOI 10.1016/j.virol.2005.11.007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Takahashi H, 2012, NAT PROTOC, V7, P542, DOI 10.1038/nprot.2012.005; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Capurro M, 2003, GASTROENTEROLOGY, V125, P89, DOI 10.1016/S0016-5085(03)00689-9; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Jia HL, 2007, CLIN CANCER RES, V13, P1133, DOI 10.1158/1078-0432.CCR-06-1025; Ohnuki M, 2014, P NATL ACAD SCI USA, V111, P12426, DOI 10.1073/pnas.1413299111; Severin J, 2014, NAT BIOTECHNOL, V32, P217, DOI 10.1038/nbt.2840; Xie MC, 2013, NAT GENET, V45, P836, DOI 10.1038/ng.2649; Lassmann T, 2009, BIOINFORMATICS, V25, P2839, DOI 10.1093/bioinformatics/btp527; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; Fort A, 2014, NAT GENET, V46, P558, DOI 10.1038/ng.2965; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Saeed AI, 2003, BIOTECHNIQUES, V34, P374; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; Hasegawa A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-144; Huang QC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026168; Iannelli F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4850; Jacques PE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003504; Kapitonov Vladimir V, 2008, Nat Rev Genet, V9, P411, DOI 10.1038/nrg2165-c1; Katzenellenbogen M, 2007, MOL CANCER RES, V5, P1159, DOI 10.1158/1541-7786.MCR-07-0172; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Santoni FA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-111; St Laurent G, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r73; Thoolen B, 2010, TOXICOL PATHOL, V38, p5S; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006	55	0	0	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	DEC	2015	25	12					1812	1824		10.1101/gr.191031.115		13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	CX6RZ	WOS:000365830400004		
J	Miyamoto, K; Iwakuma, M; Nakayama, T				Miyamoto, Keiko; Iwakuma, Miho; Nakayama, Takeo			Social capital and health: implication for health promotion by lay citizens in Japan	GLOBAL HEALTH PROMOTION			English	Article						healthy cities; healthy communities; health promotion; surveillance; Japan; social capital; social networks	SELF-RATED HEALTH; MULTILEVEL ANALYSIS; PUBLIC-HEALTH; OLDER-ADULTS; TRANSLATION; BOURDIEU; PLACE; MODEL	A non-profit organization was formed in 2009 by lay citizens of Nagahama, Japan in response to a community-based genome-epidemiologic study, the Nagahama Zero(0)-ji Prevention Cohort Project (N0PCP)'. This organization aims to promote health by taking advantage of citizens' social networks. The Ottawa Charter for Health Promotion affirms the importance of creating supportive environments and coordinating social relationships. Supportive environments (infrastructure) and social relationships (resources) work together as aspects of social capital. This study sought to examine the association between self-rated health and social capital, at both individual and neighborhood levels, and to discuss suitable health promotion strategies for local circumstances. A cross-sectional survey was conducted in 2011, using a self-administered postal questionnaire. Social capital indicators included aspects of support in the environment (social support, neighborhood connectedness, informal social controls, neighborhood trust, general trust, and attachment to place) and social relationships (number of activities; participation in neighborhood activities; participation in recreational activities; and social leverage regarding physical health, mental health, and acquisition of health information). Neighborhood-level social capital was calculated as the percentage of individuals in a neighborhood in the high social capital' category. At the individual level, participation in recreational activities, high general trust, and discussion regarding mental health problems with family members were associated with self-rated health positively, whereas discussion of mental health problems with acquaintances had a negative correlation. At the neighborhood level, a highly supportive environment did not contribute to good health, whereas aggregated attachment to place had a positive correlation. There were no significant inter-regional health differences. The results of this study suggest that health promotion activities should aim at promoting the formation of empathetic friendships through individual networks, based on bringing individuals who need support to compatible places. Attachment to place should be incorporated into activities as an important and effective tool.	[Miyamoto, Keiko; Iwakuma, Miho] Kyoto Univ, Sch Publ Hlth, Dept Med Commun, Kyoto 6068501, Japan; [Nakayama, Takeo] Kyoto Univ, Sch Publ Hlth, Dept Hlth Informat, Kyoto 6068501, Japan	Miyamoto, K (reprint author), Kyoto Univ, Sch Publ Hlth, Dept Med Commun, Kyoto 6068501, Japan.	miyamoto.keiko.87w@st.kyoto-u.ac.jp			'Nagahama Regional Open Genome Epidemiology Study' of Ristex in the Japan Science and Technology Agency	This project was supported in part by the 'Nagahama Regional Open Genome Epidemiology Study' of Ristex in the Japan Science and Technology Agency.	Wakefield SEL, 2005, SOC SCI MED, V60, P2819, DOI 10.1016/j.socscimed.2004.11.012; Kawachi I, 1999, AM J PUBLIC HEALTH, V89, P1187, DOI 10.2105/AJPH.89.8.1187; Hanibuchi T, 2012, HEALTH PLACE, V18, P229, DOI 10.1016/j.healthplace.2011.09.015; Aida J, 2009, SOC SCI MED, V69, P512, DOI 10.1016/j.socscimed.2009.06.003; Lasker RD, 2003, J URBAN HEALTH, V80, P14, DOI 10.1093/jurban/jtg014; Fujisawa Y, 2009, SOC SCI MED, V69, P500, DOI 10.1016/j.socscimed.2009.05.046; Gele AA, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-8; Carpiano RM, 2007, HEALTH PLACE, V13, P639, DOI 10.1016/j.healthplace.2006.09.001; Stephens C, 2008, SOC SCI MED, V66, P1174, DOI 10.1016/j.socscimed.2007.11.026; Melchior M, 2003, SOC SCI MED, V56, P1817, DOI 10.1016/S0277-9536(02)00181-8; Ichida Y, 2009, SOC SCI MED, V69, P489, DOI 10.1016/j.socscimed.2009.05.006; Murayama H, 2012, SOC SCI MED, V75, P2472, DOI 10.1016/j.socscimed.2012.09.027; Kondo N, 2007, SOC SCI MED, V64, P2311, DOI 10.1016/j.socscimed.2007.02.009; Hidalgo MC, 2001, J ENVIRON PSYCHOL, V21, P273, DOI 10.1006/jevp.2001.0221; Moore S, 2006, J EPIDEMIOL COMMUN H, V60, P729, DOI 10.1136/jech.2005.041848; Ziersch AM, 2005, SOC SCI MED, V61, P2119, DOI 10.1016/j.socscimed.2005.01.015; Moore S, 2005, AM J PUBLIC HEALTH, V95, P1330, DOI 10.2105/AJPH.2004.046094; Islam M Kamrul, 2006, Int J Equity Health, V5, P3, DOI 10.1186/1475-9276-5-3; Carpiano RM, 2006, SOC SCI MED, V62, P165, DOI 10.1016/j.socscimed.2005.05.020; Giordano GN, 2011, HEALTH PLACE, V17, P946, DOI 10.1016/j.healthplace.2011.04.004; Cabinet office Government Japan, 2006, WHIT PAP NAT LIF; Cabinet office Government of Japan, 2010, REG SURV LIF ELD; Cabinet office Government of Japan, 2002, SURV BEN CYCL RICH H; Hamano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013214; Hashimoto S, 2003, JAPANESE SOCIOLOGICA, V54, P49; Iwase T., 2010, J EPIDEMIOL COMMUNIT, V66, P557; Kawachi I., 2008, SOCIAL CAPITAL HLTH; Lin Nan, 2001, SOCIAL CAPITAL THEOR; Ministry of Internal Affairs and Communications Statistics Bureau, 2009, JAP NAT SURV FAM INC; Ministry of Internal Affairs and Communications Statistics Bureau, 2010, JAP NAT CENS SUBR BL; NPO, 2009, HLTH PROM ZER JI CLU; Putnam Robert D., 2000, BOWLING ALONE COLLAP; Ueshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012135; UNICEF, 2007, OV CHILD WELL BEING; World Health Organisation [WHO], 1986, OTT CHART HLTH PROM	35	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1757-9759	1757-9767		GLOB HEALTH PROMOT	Glob. Health Promot.	DEC	2015	22	4					5	19		10.1177/1757975914547547		15	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CX5JP	WOS:000365738200002		
J	Rina, M; Shiba, T; Takahashi, M; Hori, Y; Maeno, T				Rina, Muramatsu; Shiba, Tomoaki; Takahashi, Mao; Hori, Yuichi; Maeno, Takatoshi			Pulse waveform analysis of optic nerve head circulation for predicting carotid atherosclerotic changes	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Carotid intima-media thickness; Plaque score; Risk factor; Laser speckle flowgraphy; Ocular circulation	INTIMA-MEDIA THICKNESS; LASER SPECKLE FLOWGRAPHY; RISK-FACTORS; WALL THICKNESS; FAMILIAL HYPERCHOLESTEROLEMIA; ARTERY-DISEASE; PLAQUE SCORE; BLOOD-FLOW; POPULATION; DETERMINANTS	To evaluate the relationship between the parameters of pulse waveform analysis in the optic nerve head using laser speckle flowgraphy (LSFG) and intima-media thickness (IMT) and severity of carotid arterial plaque. Prospective and cross-sectional study. One hundred seventy-six subjects were studied. Mean IMT and plaque score obtained from high-resolution B-mode ultrasound were evaluated. If mean IMT was 1 mm or greater, abnormal carotid artery thickening was diagnosed; if the plaque score exceeded 10, severe atherosclerosis was diagnosed. Blowout time and blowout score, which are parameters of pulse waveform analysis using LSFG, were evaluated. Logistic regression analyses determined the independent factors for abnormal carotid artery thickening and severe atherosclerosis. The cutoff levels for abnormal carotid artery thickening and severe atherosclerosis were analyzed using a conventional receiver operating characteristic (ROC) curve. Logistic regression analysis showed that blowout time and body mass index contributed independently to abnormal carotid artery thickening, and blowout score contributed independently to severe atherosclerosis. The ROC curve showed that sensitivity and specificity of the blowout time and blowout score were equivalent to or greater than those of other factors. The cutoff level of the blowout time for abnormal carotid artery thickening was 46.4; the cutoff level of the blowout score for severe atherosclerosis was 71.8. Measurement of blowout time and blowout score in the optic nerve head by LSFG can be useful for evaluating mean IMT and plaque score, which are parameters of carotid atherosclerosis.	[Rina, Muramatsu; Maeno, Takatoshi] Toho Univ, Sakura Med Ctr, Dept Ophthalmol, Chiba 2748510, Japan; [Shiba, Tomoaki; Hori, Yuichi] Toho Univ, Sch Med, Dept Ophthalmol, Ota Ku, Tokyo 1438541, Japan; [Takahashi, Mao] Toho Univ, Sakura Med Ctr, Ctr Cardiovasc, Chiba 2748510, Japan	Shiba, T (reprint author), Toho Univ, Sch Med, Dept Ophthalmol, Ota Ku, 6-11-1 Omori Nishi, Tokyo 1438541, Japan.	tomoaki-s@med.toho-u.ac.jp					Aizawa Naoko, 2011, Clin Ophthalmol, V5, P1171, DOI 10.2147/OPTH.S22093; Touboul PJ, 2000, CIRCULATION, V102, P313; Sakaguchi M, 2003, ULTRASOUND MED BIOL, V29, P367, DOI 10.1016/S0301-5629(02)00743-3; Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; BOTS ML, 1992, HYPERTENSION, V19, P717; Isono H, 2003, ARCH OPHTHALMOL-CHIC, V121, P225; HEISS G, 1991, AM J EPIDEMIOL, V134, P250; Hillen T, 2000, J INTERN MED, V247, P679, DOI 10.1046/j.1365-2796.2000.00681.x; Pinto E, 2007, POSTGRAD MED J, V83, P109, DOI 10.1136/pgmj.2006.048371; GARIEPY J, 1995, ATHEROSCLEROSIS, V113, P141, DOI 10.1016/0021-9150(94)05436-M; Sun Y, 2002, ATHEROSCLEROSIS, V164, P89, DOI 10.1016/S0021-9150(02)00017-5; Chambless LE, 2000, AM J EPIDEMIOL, V151, P478; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; HOUGAKU H, 1994, STROKE, V25, P566; BOTS ML, 1993, ATHEROSCLEROSIS, V102, P99, DOI 10.1016/0021-9150(93)90088-C; FUJII H, 1994, MED BIOL ENG COMPUT, V32, P302, DOI 10.1007/BF02512526; WILLEIT J, 1993, ARTERIOSCLER THROMB, V13, P661; Smilde TJ, 2001, LANCET, V357, P577, DOI 10.1016/S0140-6736(00)04053-8; OLEARY DH, 1992, STROKE, V23, P1752; HANDA N, 1995, STROKE, V26, P1781; Lassila HC, 1997, STROKE, V28, P513; WENDELHAG I, 1992, ARTERIOSCLER THROMB, V12, P70; Nagaoka T, 2005, INVEST OPHTH VIS SCI, V46, P720, DOI 10.1167/iovs.04-0906; TAMAKI Y, 1995, EXP EYE RES, V60, P373, DOI 10.1016/S0014-4835(05)80094-6; Gnasso A, 1996, ATHEROSCLEROSIS, V119, P7, DOI 10.1016/0021-9150(95)05625-4; SALONEN R, 1991, J INTERN MED, V229, P225; Zureik M, 1999, STROKE, V30, P550; Shiba T, 2012, GRAEF ARCH CLIN EXP, V250, P1275, DOI 10.1007/s00417-012-1952-5; Shiba T, 2012, J ATHEROSCLER THROMB, V19, P999; Takiuchi S, 2004, J HUM HYPERTENS, V18, P17, DOI 10.1038/sj.jhh.1001628; YAMASAKI Y, 1994, DIABETES, V43, P634, DOI 10.2337/diabetes.43.5.634; BonithonKopp C, 1996, ARTERIOSCL THROM VAS, V16, P310; Shiba T, 2014, JOURNAL OF OPHTHALMO, V2014; Tsuda S, 2014, CURR EYE RES, V39, P1207, DOI 10.3109/02713683.2014.905608	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	DEC	2015	253	12					2285	2291		10.1007/s00417-015-3123-y		7	Ophthalmology	Ophthalmology	CX0ZV	WOS:000365426900028		
J	Matsuura, K				Matsuura, Kazuki			Long-term effects of intracameral moxifloxacin	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Letter									[Matsuura, Kazuki] Nojima Hosp, Kurayoshi City, Tottori 6820863, Japan	Matsuura, K (reprint author), Nojima Hosp, 2714-1 Sesaki Machi, Kurayoshi City, Tottori 6820863, Japan.	i-mnys2001@hb.tp1.jp					Matsuura K, 2013, GRAEF ARCH CLIN EXP, V251, P81, DOI 10.1007/s00417-012-2098-1	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	DEC	2015	253	12					2335	2336		10.1007/s00417-015-3074-3		2	Ophthalmology	Ophthalmology	CX0ZV	WOS:000365426900034		
J	Okamoto, M; Taira, K; Ito, R; Asai, F				Okamoto, M.; Taira, K.; Ito, R.; Asai, F.			Transcriptomic study of the rat pinworm Syphacia muris	HELMINTHOLOGIA			English	Article						Syphacia muris; transcriptome; Gene ontology analysis	OBVELATA-INFECTED MICE; WBN/KOB-LEPR(FA) RATS; PARASITE; GENERATION; RESPONSES; CELLS; ONSET	Syphacia muris is a ubiquitous nematode parasite and common contaminant of laboratory rats. Although S. muris infection is considered symptomless, it has some effects on the host's immunity and therefore can interfere with experimental settings and interrupt final results. However, the molecular mechanisms involved in the alteration within the host's immunity remain unclear because of the absence of information about mRNA expressed in this parasite. In this study we performed the transcriptome profiling of S. muris by next-generation sequencing. After de novo assembly and annotation, 14,821 contigs were found to have a sequence homology with any nematode sequence. Gene ontology analysis showed that the majority of the expressed genes are involved in cellular process, binding, and catalytic activity. Although the rate of expressed genes involved in the immune system was low, we found candidate genes that might be involved in the alteration within the host's immunity by regulating the host's innate immune response.	[Okamoto, M.; Ito, R.] Azabu Univ, Sch Vet Med, Lab Vet Immunol, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan; [Taira, K.] Azabu Univ, Sch Vet Med, Parasitol Lab, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan; [Asai, F.] Azabu Univ, Sch Vet Med, Lab Vet Pharmacol, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan	Okamoto, M (reprint author), Azabu Univ, Sch Vet Med, Lab Vet Immunol, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan.	m-okamoto@azabu-u.ac.jp			Azabu University	This study was supported by a research project grant awarded by Azabu University. We thank the members of Eurofins MWG Operon for technical supports.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bugarski D, 2006, PARASITOL INT, V55, P91, DOI 10.1016/j.parint.2005.10.005; Akimoto T, 2012, J VET MED SCI, V74, P65, DOI 10.1292/jvms.11-0168; Ilic V, 2010, PARASITOL INT, V59, P82, DOI 10.1016/j.parint.2009.10.011; Taira K, 2015, HELMINTHOLOGIA, V52, P58, DOI 10.1515/helmin-2015-0010; Young ND, 2010, BIOTECHNOL ADV, V28, P222, DOI 10.1016/j.biotechadv.2009.12.003; Sotillo J, 2012, PARASITOL INT, V61, P561, DOI 10.1016/j.parint.2012.05.004; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; STAHL W, 1961, SCIENCE, V133, P576, DOI 10.1126/science.133.3452.576-a; Baker DG, 1998, CLIN MICROBIOL REV, V11, P231; Michels C, 2006, INFECT IMMUN, V74, P5926, DOI 10.1128/IAI.00207-06; Agersborg SS, 2001, EUR J IMMUNOL, V31, P851, DOI 10.1002/1521-4141(200103)31:3<851::AID-IMMU851>3.0.CO;2-9; Ng HP, 2015, ARTERIOSCL THROM VAS, V35, P1101, DOI 10.1161/ATVBAHA.115.305290; Wang LC, 2013, PARASITOL RES, V112, P3193, DOI 10.1007/s00436-013-3495-z; Desjardins CA, 2013, NAT GENET, V45, P495, DOI 10.1038/ng.2585; Trelis M, 2013, INT J PARASITOL, V43, P453, DOI 10.1016/j.ijpara.2012.12.009; SATO Y, 1995, J PARASITOL, V81, P559, DOI 10.2307/3283853; Chevreux B, 1999, COMP SCI BIOL P GERM, V99, P45; ROCHE DIAGNOSTICS, 2009, GS FLX TITANIUM SERI	19	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0440-6605	1336-9083		HELMINTHOLOGIA	Helminthologia	DEC	2015	52	4					370	374		10.1515/helmin-2015-0059		5	Parasitology; Zoology	Parasitology; Zoology	CX6HC	WOS:000365800800013		
J	Briones, JCA; Papa, RDS; Cauyan, GA; Urabe, M				Briones, J. C. A.; Papa, R. D. S.; Cauyan, G. A.; Urabe, M.			The first report of three acanthocephalan parasite species isolated from Philippine fishes	HELMINTHOLOGIA			English	Article						Neoechinorhynchus; Bolbosoma; Rhadinorhynchus; fish parasites; Acanthocephala	POLYMORPHIDAE; NEOECHINORHYNCHIDAE; CYSTACANTHS; HOSTS; LAKE; KEY	Three acanthocephalan parasites, namely Neoechinorhynchus (Neoechinorhynchus) quinghaiensis, Rhadinorhynchus ganapatti, and Bolbosoma sp. are reported for the first time from Philippine fishes. N. (N.) quinghaiensis (Neoechinorhynchidae) may have been introduced into the country through the importation of carp species from China, where this parasite was first described and is presumed to be naturally occurring. The adult worms of R. ganapatti and the isolated cystacanth of Bolbosoma sp. represent the first record of parasites from both the family Rhadinorhynchidae and Polymorphidae in Philippine waters, respectively. These three new records encompass a third of all listed acanthocephalan parasites that have been reported in Philippine fish species to date, highlighting the need for more biodiversity-focused parasitology research, in light of potentially numerous more undocumented parasite species.	[Briones, J. C. A.; Papa, R. D. S.] Univ Santo Tomas, Grad Sch, Manila 1015, Philippines; [Briones, J. C. A.; Papa, R. D. S.; Cauyan, G. A.] Univ Santo Tomas, Dept Biol Sci, Manila 1015, Philippines; [Briones, J. C. A.; Papa, R. D. S.; Cauyan, G. A.] Univ Santo Tomas, Res Ctr Nat & Appl Sci, Manila 1015, Philippines; [Urabe, M.] Univ Shiga Prefecture, Sch Environm Sci, Dept Ecosyst Studies, Hikone 5228533, Japan	Briones, JCA (reprint author), Univ Santo Tomas, Grad Sch, Manila 1015, Philippines.	jonathancarlo@ymail.com			Commission on Higher Education of the Philippines under the Philippine Higher Education Research Network; University of Santo Tomas (CHED-PHERNet UST Project) [A-1]; US National Science Foundation; USAID under the Partnerships for Enhanced Engagement in Research (PEER) Science Grant [AID-OAA-A-11-00012]; Science Education Institute of the Department of Science and Technology (DOST-SEI) of the Philippines under the Accelerated Science and Technology Human Resource Development Program (ASTHRDP)	This study was mainly funded by the Commission on Higher Education of the Philippines under the Philippine Higher Education Research Network grant with the University of Santo Tomas as the member institution (CHED-PHERNet UST Project A-1) to RDSP and GAC, as one of the projects of the University of Santo Tomas as a member institution. The study was also partly funded by the US National Science Foundation and USAID (2014 - 2016) under the Partnerships for Enhanced Engagement in Research (PEER) Science Grant (Sponsor Grant Award No. AID-OAA-A-11-00012). JCB was funded by the Science Education Institute of the Department of Science and Technology (DOST-SEI) of the Philippines, as part of his scholarship grant under the Accelerated Science and Technology Human Resource Development Program (ASTHRDP). JCB is grateful for the opportunity to do joint-research work in the University of Shiga Prefecture, Japan. We would like to thank Dr. Takashi Iwaki and Dr. Kazuo Ogawa of the Meguro Parasitological Museum and Dr. Toshiaki Kuramochi of the National Museum of Science and Nature of Japan for graciously allowing us to study type specimens.	Amin Omar M., 2010, Neotropical Helminthology, V4, P81; de la Cruz CPP, 2012, ASIA LIFE SCI, V21, P287; Santos CP, 2008, ZOOTAXA, P1; Amin OM, 2011, ACTA PARASITOL, V56, P67, DOI 10.2478/s11686-011-0004-3; TUBANGUI MA, 1946, J PARASITOL, V32, P154, DOI 10.2307/3272590; Braicovich PE, 2005, ACTA PARASITOL, V50, P145; Papa Rey Donne S., 2011, Philippine Science Letters, V4, P1; AMIN OM, 1987, J PARASITOL, V73, P1216, DOI 10.2307/3282307; Masova S, 2013, FOLIA PARASIT, V60, P169; Sardella NH, 2005, SYST PARASITOL, V61, P143, DOI 10.1007/s11230-005-3131-0; Amin OM, 2002, SYST PARASITOL, V53, P1, DOI 10.1023/A:1019953421835; AMIN OM, 1995, J HELMINTHOL SOC W, V62, P249; Collette B, 1983, FAO FISH SYNOP, V2, P137; LIQING L., 1981, J FISH CHINA, V5, P295; REGIDOR S., 1990, S DIS AS AQ FISH HLT, P34; Tingbao Yang, 2001, Journal of Helminthology, V75, P93, DOI 10.1079/JOH200030; TUBANGUI M. A., 1937, PHILIPP J SCI, V62, P83; TUBANGTUI MARCOS A., 1933, PHILIPPINE JOUR SCI, V50, P115; Velasquez C. C., 1976, Fis. Res. J. Philippines., V1, P52; YAMAGUTI S., 1963, SYSTEMA HELMINTHUM A	20	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0440-6605	1336-9083		HELMINTHOLOGIA	Helminthologia	DEC	2015	52	4					384	389		10.1515/helmin-2015-0061		6	Parasitology; Zoology	Parasitology; Zoology	CX6HC	WOS:000365800800015		
J	Yamamoto, S; Kubota, T; Abe, T				Yamamoto, S.; Kubota, T.; Abe, T.			A rare case of mechanical bowel obstruction caused by mesh plug migration	HERNIA			English	Article						Mesh migration; Bowel obstruction; Hernia	RECURRENT INGUINAL-HERNIAS; REPAIR; HERNIOPLASTY	Tension-free hernia repair with a mesh plug is currently one of the most popular techniques for open inguinal hernioplasty. It is well tolerated by most patients and is associated with few complications. However, rare mesh migration has been reported. We describe a case of a 72-year-old man who had undergone inguinal hernioplasty with a mesh plug 2 years previously. He visited the emergency department complaining of vomiting. Strangulation ileus was suspected, and an emergency operation was performed. The mesh plug had migrated into the intra-peritoneal cavity, granulation tissue had formed around the plug, and the small intestine was involved in the granulation tissue. The small intestine was strangulated for more than 13 cm, and obstruction was present at this point.	[Yamamoto, S.; Kubota, T.; Abe, T.] Yokohama City Minato Red Cross Hosp, Dept Surg, Naka Ku, Yokohama, Kanagawa 2318682, Japan	Yamamoto, S (reprint author), Yokohama City Minato Red Cross Hosp, Dept Surg, Naka Ku, 3-12-1 Shinyamashita, Yokohama, Kanagawa 2318682, Japan.	shinya@rf.catv.ne.jp					Liang XA, 2008, CHINESE MED J-PEKING, V121, P183; Chuback JA, 2000, SURGERY, V127, P475, DOI 10.1067/msy.2000.104122; Ojo P, 2006, AM SURGEON, V72, P1210; Moorman ML, 2004, AM SURGEON, V70, P298; Millikan KW, 2001, AM SURGEON, V67, P285; Yilmaz I, 2013, HERNIA, V17, P267, DOI 10.1007/s10029-011-0867-0; ROBBINS AW, 1993, SURG CLIN N AM, V73, P501; Chen MJ, 2010, SURG TODAY, V40, P566, DOI 10.1007/s00595-009-4107-5; Benedetti M, 2005, Hernia, V9, P93, DOI 10.1007/s10029-004-0256-z; LICHTENS.IL, 1974, AM J SURG, V128, P439, DOI 10.1016/0002-9610(74)90189-5; SHULMAN AG, 1990, ARCH SURG-CHICAGO, V125, P265	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1265-4906	1248-9204		HERNIA	Hernia	DEC	2015	19	6					983	985		10.1007/s10029-014-1247-3		3	Surgery	Surgery	CX4ZL	WOS:000365709400018		
J	Hoshiai, S; Mori, K; Shiigai, M; Uchikawa, Y; Watanebe, A; Shiotani, S; Atake, S; Minami, M				Hoshiai, S.; Mori, K.; Shiigai, M.; Uchikawa, Y.; Watanebe, A.; Shiotani, S.; Atake, S.; Minami, M.			Reduction en masse of inguinal hernia: MDCT findings of two cases	HERNIA			English	Article						Hernia; Inguinal hernia; Reduction en masse; Atypical hernia; MDCT		Reduction en masse of inguinal hernia is an extremely rare complication arising from manual reduction of a hernia. The hernial content remaining in the hernia sac returns above the inguinal canal but remains in the abdominal wall. Accurate preoperative diagnosis of reduction en masse of inguinal hernia is challenging because the hernia appears to be reduced upon physical examination. We experienced two cases of reduction en masse. In both cases, multidetector row computed tomography revealed a closed loop obstruction near the inguinal fossa. In addition, we observed a continuous tract of the hernia sac to the inguinal canal and prominent peritoneal thickening suggestive of the hernia sac.	[Hoshiai, S.; Mori, K.; Shiigai, M.; Uchikawa, Y.; Watanebe, A.; Minami, M.] Univ Tsukuba Hosp, Dept Diagnost & Intervent Radiol, Tsukuba, Ibaraki, Japan; [Shiotani, S.] Tsukuba Med Ctr Hosp, Dept Radiol, Tsukuba, Ibaraki, Japan; [Atake, S.] Tsukuba Med Ctr Hosp, Dept Emergency Med, Tsukuba, Ibaraki, Japan	Hoshiai, S (reprint author), Univ Tsukuba Hosp, Dept Diagnost & Intervent Radiol, 2-1-1 Amakubo, Tsukuba, Ibaraki, Japan.	hoshiai@sb4.so-net.ne.jp					Bernie AM, 2012, J PEDIATR SURG, V47, pE19, DOI 10.1016/j.jpedsurg.2012.01.016; Wu CC, 2012, J GASTROINTEST SURG, V16, P1433, DOI 10.1007/s11605-012-1846-1; Sasaya T, 2001, ABDOM IMAGING, V26, P89, DOI 10.1007/s002610000134; PARVEY LS, 1974, AM J ROENTGENOL, V121, P252; Bay-Nielsen M, 2013, MANAGEMENT ABDOMINAL, P171; Cissé Mamadou, 2009, J Med Case Rep, V3, P9333, DOI 10.1186/1752-1947-3-9333; Hattori T, 2010, J JPN SURG ASS, V71, P2473; Kitami M, 2008, EUR J RADIOL EXTRA, V67, P111; Pearse HE, 1931, SURG GYNECOL OBSTET, V53, P822; Ponka JL, 1980, HERNIAS ABDOMINAL WA, P496; Ravikumar H, 2009, Biomed Imaging Interv J, V5, pe14, DOI 10.2349/biij.5.4.e14	11	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1265-4906	1248-9204		HERNIA	Hernia	DEC	2015	19	6					999	1003		10.1007/s10029-014-1217-9		5	Surgery	Surgery	CX4ZL	WOS:000365709400022		
J	Suzuki, Y; Katagiri, H; Yoshinaga, Y; Lefor, AT; Mizokami, K				Suzuki, Y.; Katagiri, H.; Yoshinaga, Y.; Lefor, A. T.; Mizokami, K.			Internal hernia caused by epiploic appendices successfully treated by single-incision laparoscopic surgery (SILS)	HERNIA			English	Article						Internal hernia; Epiploic appendix; Single-incision laparoscopic surgery (SILS); Small bowel obstruction	METAANALYSIS	Internal hernia is a rare and often overlooked cause of small bowel obstruction. We report a case of internal hernia with an orifice composed of epiploic fat, successfully diagnosed and treated by single-incision laparoscopic surgery. This is the second report of this type of internal hernia and the first reported case addressed laparoscopically. Although the use of laparoscopy for the treatment of small bowel obstruction is not firmly established today, it may be beneficial for both its diagnostic value and as a less invasive treatment.	[Suzuki, Y.; Katagiri, H.; Yoshinaga, Y.; Mizokami, K.] Noguchi Hideyo Mem Int Hosp, Dept Surg, Tokyo Bay Urayasu Ichikawa Med Ctr, Chiba 2790001, Japan; [Lefor, A. T.] Jichi Med Univ, Dept Surg, Shimotsuke, Tochigi 3290498, Japan	Katagiri, H (reprint author), Noguchi Hideyo Mem Int Hosp, Dept Surg, Tokyo Bay Urayasu Ichikawa Med Ctr, 3-4-32 Todaijima, Chiba 2790001, Japan.	x62h20k38@yahoo.co.jp					Szomstein S, 2006, WORLD J SURG, V30, P535, DOI 10.1007/s00268-005-7778-0; GHAHREMANI GG, 1984, SURG CLIN N AM, V64, P393; Pfluke JM, 2011, J AM COLL SURGEONS, V212, P113, DOI 10.1016/j.jamcollsurg.2010.09.008; Cai YL, 2013, WORLD J GASTROENTERO, V19, P5165, DOI 10.3748/wjg.v19.i31.5165; Salar O, 2013, HERNIA, V17, P373, DOI 10.1007/s10029-012-1023-1; NEWSOM BD, 1986, AM J SURG, V152, P279, DOI 10.1016/0002-9610(86)90258-8; Arezzo A, 2013, SURG ENDOSC, V27, P2293, DOI 10.1007/s00464-012-2763-9; Liu C H, 2004, Tech Coloproctol, V8, P106; Oneyama M, 2011, J JPN SURG ASS, V72, P3175; Townsend CM, 2012, SABISTON TXB SURG BI; Wheeless CR, 1969, J REPROD MED, V3, P65	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1265-4906	1248-9204		HERNIA	Hernia	DEC	2015	19	6					1011	1013		10.1007/s10029-014-1231-y		3	Surgery	Surgery	CX4ZL	WOS:000365709400024		
J	Sakauchi, H; Higashi, E; Shimizu, Y; Kojima, M; Asamitsu, Y; Kuwahara, S; Izumi, M; Kiyota, H				Sakauchi, Hiroyuki; Higashi, Emi; Shimizu, Yuko; Kojima, Mikiko; Asamitsu, Yuko; Kuwahara, Shigefumi; Izumi, Minoru; Kiyota, Hiromasa			Synthesis of the spiroacetal fragments of spirofungins A and B, antibiotics isolated from Streptomyces violaceusniger Tu 4113	HETEROCYCLIC COMMUNICATIONS			English	Article						acetylide; antibiotics; iodolactonization; selenolactonization; spiroacetalization; spirofungins A and B; Streptomyces violaceusniger Tu 4113; synthesis	STEREOCHEMISTRY; REASSIGNMENT; STRATEGY; CORE	The spiroacetal [C(9)-C(20)] fragments of spirofungins A and B, antibiotics isolated from Streptomyces violaceusniger Tu 4113, were prepared from a known bromo alcohol derived from (S)-citronellal, using thermodynamically controlled iodolactonization and spiroacetalization as the key steps.	[Sakauchi, Hiroyuki; Izumi, Minoru; Kiyota, Hiromasa] Okayama Univ, Grad Sch Environm & Life Sci, Kita Ku, Okayama 7008530, Japan; [Higashi, Emi; Shimizu, Yuko; Kojima, Mikiko; Asamitsu, Yuko; Kuwahara, Shigefumi] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan	Kiyota, H (reprint author), Okayama Univ, Grad Sch Environm & Life Sci, Kita Ku, 1-1-1 Tsushima Naka, Okayama 7008530, Japan.	kiyota@okayama-u.ac.jp			JSPS KAKENHI [17580092, 19580120, 22560112, 25450144]; Agricultural Chemical Research Foundation; Intelligent Cosmos Foundation; Naito Foundation	Financial support was provided by Grants-in-Aid from JSPS KAKENHI (No. 17580092, 19580120, 22560112 and 25450144). Support from the Agricultural Chemical Research Foundation, the Intelligent Cosmos Foundation and the Naito Foundation is gratefully acknowledged. Our thanks are also due to the Takasago International Corporation for the gift of (S)-citronellal.	Aldred M., 2005, LIQ CRYST, V3, P951; Dias LC, 2004, ORG LETT, V6, P2587, DOI 10.1021/ol0491078; La Cruz TE, 2005, ORG LETT, V7, P1873, DOI 10.1021/ol050589c; Ranganathan S, 2004, TETRAHEDRON, V60, P5273, DOI 10.1016/j.tet.2004.04.014; Shimizu T, 2005, ORG LETT, V7, P5573, DOI 10.1021/ol052039k; Shimizu Y, 2000, TETRAHEDRON LETT, V41, P3141, DOI 10.1016/S0040-4039(00)00371-3; Zanatta SD, 2004, ORG LETT, V6, P1041, DOI 10.1021/ol049873e; Neumaier J, 2011, SYNLETT, P187, DOI 10.1055/s-0030-1259287; Markowski T, 2011, EUR J ORG CHEM, P5894, DOI 10.1002/ejoc.201100758; [Anonymous], 1996, ORG REACTIONS; de Oliveira LG, 2006, TETRAHEDRON LETT, V47, P2413, DOI 10.1016/j.tetlet.2006.01.153; Marjanovic J, 2007, ANGEW CHEM INT EDIT, V46, P8854, DOI 10.1002/anie.200702440; El Sous M, 2006, ARKIVOC, P105; MORI K, 1982, TETRAHEDRON, V38, P3705, DOI 10.1016/0040-4020(82)80081-1; Crimmins MT, 2010, ORG LETT, V12, P4416, DOI 10.1021/ol101961c; Lynch JE, 2011, CHEM-EUR J, V17, P297, DOI 10.1002/chem.201002501; Shimizu T, 2008, BIOORG MED CHEM LETT, V18, P3756, DOI 10.1016/j.bmcl.2008.05.054; Holtzel A, 1998, J ANTIBIOT, V51, P699	18	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0793-0283	2191-0197		HETEROCYCL COMMUN	Heterocycl. Commun.	DEC	2015	21	6					337	343		10.1515/hc-2015-0193		7	Chemistry, Organic	Chemistry	CX6EU	WOS:000365794800003		
J	Sawada, T				Sawada, Takashi			Ultrastructural and immunocytochemical characterization of ameloblast-enamel adhesion at maturation stage in amelogenesis in Macaca fuscata tooth germ	HISTOCHEMISTRY AND CELL BIOLOGY			English	Article						Amelotin; Laminin 332; Immunoelectron microscopy; Maturation-stage ameloblasts; Basal lamina; Primate	BASEMENT-MEMBRANE; BASAL LAMINA; RAT INCISOR; AMELOTIN; PROTEIN; LOCALIZATION	Maturation-stage ameloblasts are firmly bound to the tooth enamel by a basal lamina-like structure. The mechanism underlying this adhesion, however, remains to be fully clarified. The goal of this study was to investigate the mechanism underlying adhesion between the basal lamina-like structure and the enamel in monkey tooth germ. High-resolution immunogold labeling was performed to localize amelotin and laminin 332 at the interface between ameloblasts and tooth enamel. Minute, electron-dense strands were observed on the enamel side of the lamina densa, extending into the degrading enamel matrix to produce a well-developed fibrous layer (lamina fibroreticularis). In un-demineralized tissue sections, mineral crystals smaller than those in the bulk of the enamel were observed adhering to these strands where they protruded into the surface enamel. Immunogold particles reactive for amelotin were preferentially localized on these strands in the fibrous layer. On the other hand, those for laminin 332 were localized solely in the lamina densa; none were observed in the fibrous layer. These results suggest that the fibrous layer of the basal lamina-like structure is partly composed of amelotin molecules, and that these molecules facilitate ameloblast-enamel adhesion by promoting mineralization of the fibrous layer during the maturation stage of amelogenesis.	[Sawada, Takashi] Tokyo Dent Coll, Dept Histol & Dev Biol, Chiyoda Ku, Tokyo 1010061, Japan	Sawada, T (reprint author), Tokyo Dent Coll, Dept Histol & Dev Biol, Chiyoda Ku, Misaki Cho 2-9-18, Tokyo 1010061, Japan.	sawada@tdc.ac.jp			JSPS KAKENHI [24592779]	This work was supported by JSPS KAKENHI Grant Number 24592779.	Al Kawas S, 2008, ARCH ORAL BIOL, V53, P310, DOI 10.1016/j.archoralbio.2007.10.008; LEBLOND CP, 1989, AM J ANAT, V185, P367, DOI 10.1002/aja.1001850403; Neves JD, 2012, HISTOCHEM CELL BIOL, V137, P329, DOI 10.1007/s00418-011-0901-4; INOUE S, 1989, INT REV CYTOL, V117, P57, DOI 10.1016/S0074-7696(08)61334-0; Yoshiba N, 1998, CELL TISSUE RES, V292, P143, DOI 10.1007/s004410051044; Abbarin N, 2015, J BONE MINER RES, V30, P775, DOI 10.1002/jbmr.2411; NANCI A, 1993, HISTOCHEMISTRY, V99, P321, DOI 10.1007/BF00269105; Sawada T, 2001, INT REV CYTOL, V207, P151; Moffatt P, 2008, J CELL BIOCHEM, V103, P941, DOI 10.1002/jcb.21465; Iwasaki K, 2005, J DENT RES, V84, P1127; McMillan JR, 2003, J HISTOCHEM CYTOCHEM, V51, P1299; Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100; Yamashita S, 2014, J HISTOCHEM CYTOCHEM, V62, P584, DOI 10.1369/0022155414537899; Sawada T, 2000, CALCIFIED TISSUE INT, V66, P277, DOI 10.1007/s002230010056; Somogyi-Ganss E, 2012, CELLS TISSUES ORGANS, V195, P535, DOI 10.1159/000329255; Moffatt P, 2006, BIOCHEM J, V399, P37, DOI 10.1042/BJ20060662; Kawasaki K., 2013, J ORAL BIOSCI, V55, P85; Lacruz RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035200; Moffatt P, 2014, CELL TISSUE RES, V358, P843, DOI 10.1007/s00441-014-1989-3; Nakayama Y, 2015, J DENT RES, V94, P697, DOI 10.1177/0022034514566214; TAKANO Y, 1979, ARCH HISTOL JAPON, V42, P11	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0948-6143	1432-119X		HISTOCHEM CELL BIOL	Histochem. Cell Biol.	DEC	2015	144	6					587	596		10.1007/s00418-015-1362-y		10	Cell Biology; Microscopy	Cell Biology; Microscopy	CX2GL	WOS:000365514900006		
J	Matsumoto, K; Chiba, Y; Fujihara, R; Kubo, H; Sakamoto, H; Ueno, M				Matsumoto, Koichi; Chiba, Yoichi; Fujihara, Ryuji; Kubo, Hiroyuki; Sakamoto, Haruhiko; Ueno, Masaki			Immunohistochemical analysis of transporters related to clearance of amyloid-beta peptides through blood-cerebrospinal fluid barrier in human brain	HISTOCHEMISTRY AND CELL BIOLOGY			English	Article						Amyloid-beta; Choroid plexus; Ependymal cell; Transporter	DENSITY-LIPOPROTEIN RECEPTOR; GLYCATION END-PRODUCTS; BINDING CASSETTE TRANSPORTERS; RESISTANCE-ASSOCIATED PROTEIN; B SCAVENGER RECEPTOR; CHOROID-PLEXUS; ALZHEIMERS-DISEASE; P-GLYCOPROTEIN; A-BETA; EFFLUX TRANSPORT	A large number of previous reports have focused on the transport of amyloid-beta peptides through cerebral endothelial cells via the blood-brain barrier, while fewer reports have mentioned the transport through the choroid plexus epithelium via the blood-cerebrospinal fluid barrier. Concrete roles of these two pathways remain to be clarified. In this study, we immunohistochemically examined the expression of transporters/receptors that are supposed to be related to the clearance of amyloid-beta peptides in the choroid plexus epithelium, the ventricular ependymal cells and the brain microvessels, using seven autopsied human brains. In the choroid plexus epithelium, immunoreactivity for low-density lipoprotein receptor (LDLR), LDLR-related protein 1 (LRP1), LRP2, formylpeptide receptor-like 1 (FPRL1), ATP-binding cassette (ABC) transporter-A1 (ABCA1), ABCC1 and ABCG4 was seen in 7 of 7 brains, while that for ABCB1, ABCG2, RAGE and CD36 was seen in 0-2 brains. In the ventricular ependymal cells, immunoreactivity for CD36, LDLR, LRP1, LRP2, FPRL1, ABCA1, ABCC1 and ABCG4 was seen in 6-7 brains, while that for ABCB1, ABCG2 and RAGE was seen in 0-1 brain. Immunoreactivity for insulin-degrading enzyme (IDE) was seen in three and four brains in the choroid plexus epithelium and the ventricular ependymal cells, respectively. In addition, immunoreactivity for LDLR, ABCB1 and ABCG2 was seen in over 40 % of the microvessels (all seven brains), and that for FPRL1, ABCA1, ABCC1 and RAGE was seen in over 5 % of the microvessels (4-6 brains), while that for CD36, IDE, LRP1, LRP2 and ABCG4 was seen in less than 5 % of the microvessels (0-2 brains). These findings may suggest that these multiple transporters/receptors and IDE expressed on the choroid plexus epithelium, ventricular ependymal cells and brain microvessels complementarily or cooperatively contribute to the clearance of amyloid-beta peptides from the brain.	[Matsumoto, Koichi; Chiba, Yoichi; Fujihara, Ryuji; Sakamoto, Haruhiko; Ueno, Masaki] Kagawa Univ, Dept Pathol & Host Def, Fac Med, Miki, Kagawa 7610793, Japan; [Fujihara, Ryuji] Kagawa Univ, Fac Med, Dept Orthopaed Surg, Miki, Kagawa 7610793, Japan; [Kubo, Hiroyuki] Kagawa Univ, Fac Med, Dept Pediat Surg, Miki, Kagawa 7610793, Japan	Ueno, M (reprint author), Kagawa Univ, Dept Pathol & Host Def, Fac Med, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	masaueno@med.kagawa-u.ac.jp			 [26430055]	This study was supported by a Grant-in-aid for Scientific Research (C) 26430055 (MU) for the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors thank Ms. M. Kawauchi and Ms. K. Yasutomi for technical and editorial assistance, respectively.	CULICAN SM, 1990, J NEUROSCI, V10, P684; Westerterp M, 2014, CIRC RES, V114, P157, DOI 10.1161/CIRCRESAHA.114.300738; Ueno M, 2000, ACTA NEUROPATHOL, V99, P385; Gazzin S, 2008, J COMP NEUROL, V510, P497, DOI 10.1002/cne.21808; Gosselet F, 2013, CURR ALZHEIMER RES, V10, P1015; Crossgrove JS, 2005, EXP BIOL MED, V230, P771; Liu Chong-Bin, 2014, Shengli Xuebao, V66, P158; Lam FC, 2001, J NEUROCHEM, V76, P1121, DOI 10.1046/j.1471-4159.2001.00113.x; Cui YH, 2002, J LEUKOCYTE BIOL, V72, P628; Akanuma SI, 2008, NEUROCHEM INT, V52, P956, DOI 10.1016/j.neuint.2007.12.002; KEEP RF, 1990, DEV BRAIN RES, V56, P47, DOI 10.1016/0165-3806(90)90163-S; Carro E, 2005, J NEUROSCI, V25, P10884, DOI 10.1523/JNEUROSCI.2909-05.2005; Steneberg P, 2015, J BIOL CHEM, V290, P19034, DOI 10.1074/jbc.M115.640292; Nishino JI, 1999, J PHARMACOL EXP THER, V290, P289; Ohashi R, 2004, TRENDS CARDIOVAS MED, V14, P187, DOI 10.1016/j.tcm.2004.04.002; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Gu HY, 2011, NEUROSCI LETT, V490, P16, DOI 10.1016/j.neulet.2010.12.017; Yazawa H, 2001, FASEB J, V15, P2454, DOI 10.1096/fj.01-0251com; Le YY, 2001, J NEUROSCI, V21; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; Narang VS, 2008, AM J PHYSIOL-CELL PH, V295, pC440, DOI 10.1152/ajpcell.00491.2007; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI14006; Abdulkarim Y, 2006, NEUROCHEM RES, V31, P839, DOI 10.1007/s11064-006-9084-0; Mueggler T, 2004, EUR J NEUROSCI, V20, P811, DOI 10.1111/j.1460-9568.2004.03534.x; Bradley MN, 2007, J CLIN INVEST, V117, P2337, DOI 10.1172/JCI31909; Maslinska D, 2011, FOLIA NEUROPATHOL, V49, P295; Crossgrove JS, 2007, BRAIN RES, V1138, P187, DOI 10.1016/j.brainres.2006.12.022; Iribarren P, 2005, IMMUNOL RES, V31, P165, DOI 10.1385/IR:31:3:165; Castellano JM, 2012, P NATL ACAD SCI USA, V109, P15502, DOI 10.1073/pnas.1206446109; Wijnholds J, 2000, J CLIN INVEST, V105, P279, DOI 10.1172/JCI8267; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Ueno M, 1997, ACTA NEUROPATHOL, V93, P233; Warren KE, 2000, CANCER CHEMOTH PHARM, V45, P207, DOI 10.1007/s002800050031; Behl M, 2010, NEUROTOXICOLOGY, V31, P524, DOI 10.1016/j.neuro.2010.05.004; Brandstatter A, 2010, ATHEROSCLEROSIS, V210, P474, DOI 10.1016/j.atherosclerosis.2009.12.013; Cirrito JR, 2005, J CLIN INVEST, V115, P3285, DOI 10.1172/JCI25247; Chan CYT, 2013, EUR J VASC ENDOVASC, V46, P549, DOI 10.1016/j.ejvs.2013.08.006; Sugiyama Y, 1999, J CONTROL RELEASE, V62, P179, DOI 10.1016/S0168-3659(99)00036-X; Gajera CR, 2010, J CELL SCI, V123, P1922, DOI 10.1242/jcs.065912; Fryer JD, 2005, J BIOL CHEM, V280, P25754, DOI 10.1074/jbc.M502143200; Hoffman WH, 2008, BRAIN RES, V1238, P154, DOI 10.1016/j.brainres.2008.08.041; ZHENG G, 1994, J HISTOCHEM CYTOCHEM, V42, P531; Rao VV, 1999, P NATL ACAD SCI USA, V96, P3900, DOI 10.1073/pnas.96.7.3900; Deane R, 2004, STROKE, V35, P2628, DOI 10.1161/01.STR.0000143452.85382.dl; Kanekiyo T, 2013, J NEUROSCI, V33, P19276, DOI 10.1523/JNEUROSCI.3487-13.2013; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; Caravaggio JW, 2013, CARDIOVASC PATHOL, V22, P458, DOI 10.1016/j.carpath.2013.03.006; Fujiyoshi M, 2007, J NEUROCHEM, V100, P968, DOI 10.1111/j.1471-4159.2006.04240.x; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Schmidt AM, 1999, CIRC RES, V84, P489; Strickland DK, 2014, ARTERIOSCL THROM VAS, V34, P487, DOI 10.1161/ATVBAHA.113.301924; Frassoni C, 2000, J COMP NEUROL, V428, P527, DOI 10.1002/1096-9861(20001218)428:3<527::AID-CNE9>3.0.CO;2-X; Tachikawa M, 2005, J NEUROCHEM, V95, P294, DOI 10.1111/j.1471-4159.2005.03369.x; Gubert F, 2009, BRAIN RES, V1258, P43, DOI 10.1016/j.brainres.2008.12.021; Xiong HQ, 2009, J NEUROSCI, V29, P5463, DOI 10.1523/JNEUROSCI.5103-08.2009; Fujiyoshi M, 2011, J NEUROCHEM, V118, P407, DOI 10.1111/j.1471-4159.2011.07311.x; Ruzali WAW, 2012, NEUROSCI LETT, V525, P123, DOI 10.1016/j.neulet.2012.07.065; Kanekiyo T, 2012, J NEUROSCI, V32, P16458, DOI 10.1523/JNEUROSCI.3987-12.2012; ElAli A, 2012, BRAIN PATHOL, V22, P175, DOI 10.1111/j.1750-3639.2011.00517.x; DAHL D, 1981, EUR J CELL BIOL, V24, P191; Ito S, 2010, J NEUROCHEM, V113, P1356, DOI 10.1111/j.1471-4159.2010.06708.x; Krohn M, 2011, J CLIN INVEST, V121, P3924, DOI 10.1172/JCI57867; Weller RO, 2008, BRAIN PATHOL, V18, P253, DOI 10.1111/j.1750-3639.2008.00133.x; Dietrich MO, 2008, NEUROBIOL AGING, V29, P902, DOI 10.1016/j.neurobiolaging.2007.01.008; MAY C, 1990, NEUROLOGY, V40, P500; Hammad SM, 1997, J BIOL CHEM, V272, P18644, DOI 10.1074/jbc.272.30.18644; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Herzig MC, 2006, BRAIN PATHOL, V16, P40, DOI 10.1111/j.1750-3639.2006.tb00560.x; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Ghersi-Egea JF, 2006, J CEREBR BLOOD F MET, V26, P1165, DOI 10.1038/sj.jcbfm.9600267; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001; Kakee A, 1996, J PHARMACOL EXP THER, V277, P1550; Cao DF, 2006, NEUROBIOL AGING, V27, P1632, DOI 10.1016/j.neurobiolaging.2005.09.011; Wilensky RL, 2007, CURR OPIN CARDIOL, V22, P545; GREENWALT DE, 1995, J CLIN INVEST, V96, P1382, DOI 10.1172/JCI118173; Do TM, 2012, J ALZHEIMERS DIS, V30, P155, DOI 10.3233/JAD-2012-112189; Silverberg GD, 2003, LANCET NEUROL, V2, P506, DOI 10.1016/S1474-4422(03)00487-3; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; BRETT J, 1993, AM J PATHOL, V143, P1699; Yamanaka M, 2012, J NEUROSCI, V32, P17321, DOI 10.1523/JNEUROSCI.1569-12.2012; Kim J, 2009, NEURON, V64, P632, DOI 10.1016/j.neuron.2009.11.013; Zlokovic BV, 2004, J NEUROCHEM, V89, P807, DOI 10.1111/j.1471-4159.2004.02385.x; Kounnas M Z, 1994, In Vivo, V8, P343; Basak JM, 2012, J BIOL CHEM, V287, P13959, DOI 10.1074/jbc.M111.288746; Abuznait AH, 2012, ACS CHEM NEUROSCI, V3, P820, DOI 10.1021/cn300077c; Tai LM, 2009, J CEREBR BLOOD F MET, V29, P1079, DOI 10.1038/jcbfm.2009.42; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Wilhelmus MMM, 2007, AM J PATHOL, V171, P1989, DOI 10.2353/ajpath.2007.070050; Chun JT, 1999, EXP NEUROL, V157, P194, DOI 10.1006/exnr.1999.7052; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Buerger K, 2009, EXP GERONTOL, V44, P579, DOI 10.1016/j.exger.2009.06.003; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Weller RO, 2009, ACTA NEUROPATHOL, V117, P1, DOI 10.1007/s00401-008-0457-0; Daood M, 2008, NEUROPEDIATRICS, V39, P211, DOI 10.1055/s-0028-1103272; Brinker Thomas, 2014, Fluids Barriers CNS, V11, P10, DOI 10.1186/2045-8118-11-10; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Johanson C, 2006, CEREBROSPINAL FLUID, V3, pS29, DOI 10.1186/1743-8454-3-S1-S29; Pascale Crissey L, 2011, Fluids Barriers CNS, V8, P21, DOI 10.1186/2045-8118-8-21; SZENTISTVANYI I, 1984, AM J PHYSIOL, V246, pF835; Ueno M, 2014, CURR MED CHEM, V21, P4085; Wildsmith KR, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt187; Behl Mamta, 2009, Cerebrospinal Fluid Res, V6, P11, DOI 10.1186/1743-8454-6-11; Zlokovic BV, 1996, P NATL ACAD SCI USA, V93, P4229, DOI 10.1073/pnas.93.9.4229	104	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0948-6143	1432-119X		HISTOCHEM CELL BIOL	Histochem. Cell Biol.	DEC	2015	144	6					597	611		10.1007/s00418-015-1366-7		15	Cell Biology; Microscopy	Cell Biology; Microscopy	CX2GL	WOS:000365514900007		
J	Satoh, T				Satoh, T.			Toxicology in AsiaPast, present, and future	HUMAN & EXPERIMENTAL TOXICOLOGY			English	Article						ASIATOX; toxicology; certification; ASIA; regional society		The Asian Society of Toxicology (ASIATOX), which consists of the seven national toxicology member societies of Japan, Korea, China, Taiwan, Thailand, Singapore, and Iran, now boasts of more than 3,000 members from a variety of industries, academia, and regulatory organizations. ASIATOX congresses are spaced three years apart and rotated among the member societies. In 1995, ASIATOX joined the International Union of Toxicology (IUTOX) as a regional society, and now serves as the scientific voice of toxicology in Asia under the IUTOX umbrella. Since its inauguration, the society has worked diligently to handle matters deemed essential to promoting the vision set fourth by its founders. Future perspectives of ASIATOX include the establishment of education and training programs, and the certification and accreditation of toxicologists. As the leading voice of toxicology in Asia, the society seeks to extend knowledge of toxicological issues to developing nations in Asia based on the following missions and goals: (1) to provide leadership as a worldwide scientific organization that objectively addresses global issues involving the toxicological sciences, (2) to broaden the geographical base of toxicology as a discipline and profession to all countries of the world, and (3) to pursue capacity building in toxicology, particularly in developing countries, while utilizing its global perspective and network to contribute to the enhancement of toxicology education and the career development of young toxicologists.	[Satoh, T.] Chiba Univ, Dept Pharmacol & Toxicol, Grad Sch Pharmaceut Sci, Chiba, Japan	Satoh, T (reprint author), Chiba Univ, Dept Pharmacol & Toxicol, Grad Sch Pharmaceut Sci, Chiba, Japan.	tetsuo.sastoh@cnc.jp						0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0960-3271	1477-0903		HUM EXP TOXICOL	Hum. Exp. Toxicol.	DEC	2015	34	12					1291	1296		10.1177/0960327115606334		6	Toxicology	Toxicology	CX5ME	WOS:000365745000013		
J	Komori, T; Kondo, S; Wakisaka, N; Nakanishi, Y; Nakanishi-Yagi, S; Tsuji, A; Endo, K; Murono, S; Yoshizaki, T				Komori, Takeshi; Kondo, Satoru; Wakisaka, Naohiro; Nakanishi, Yosuke; Nakanishi-Yagi, Sayaka; Tsuji, Akira; Endo, Kazuhira; Murono, Shigeyuki; Yoshizaki, Tomokazu			IL-18 is highly expressed in inflammatory infiltrates of submandibular glands in patients with immunoglobulin G4 related disease	HUMAN PATHOLOGY			English	Article						IgG4-RD; IL-18; Salivary glands; IL-13; IFN-gamma	REGULATORY IMMUNE-REACTIONS; IFN-GAMMA PRODUCTION; SJOGRENS-SYNDROME; MIKULICZS-DISEASE; TH1 CELLS; IGG4-RELATED DISEASE; T-CELLS; INTERLEUKIN-18; CYTOKINE; HYPERRESPONSIVENESS	Immunoglobulin (Ig) G4-related disease (IgG4-RD) is a new disease entity characterized by high serum IgG4 concentrations, infiltration of IgG4-positive plasmacytes, and fibrosis of various organs. Several groups have reported that IgG4-RD is a unique inflammatory disorder characterized by an immune reaction predominantly mediated by T helper (Th) 2 and regulatory T cells. Meanwhile, recent studies have demonstrated that interleukin (IL) 18 has a potential to trigger the production of Th2 cytokines by Th1 cells. We analyzed IL-18 expression in submandibular glands of patients with IgG4-RD (20 cases) and controls (19 cases) by immunohistochemical analysis and quantitative real-time reverse-transcription polymerase chain reaction. We found that IL-18 was highly expressed in submandibular glands of patients with IgG4-RD than in controls with both protein (P < .05, chi(2) test) and messenger RNA levels (P < .05, Mann-Whitney U test). In addition, the expression of IL-18 and IL-13 was correlated in submandibular glands of patients with IgG4-RD. Moreover, by analyzing dual immunofluorescence staining, a few numbers of cells were double positive for IL-13 and interferon gamma at the inflammatory infiltrates of submandibular glands of patients with IgG4-RD. These data suggest a possibility that IL-13 is produced by Thl cells. We speculated that IL-18 stimulates Thl cells producing Th2 cytokines and enhances the immune reaction of Th2 cytokines in pathogenesis of IgG4-RD. (C) 2015 Elsevier Inc. All rights reserved.	[Komori, Takeshi; Kondo, Satoru; Wakisaka, Naohiro; Nakanishi, Yosuke; Nakanishi-Yagi, Sayaka; Tsuji, Akira; Endo, Kazuhira; Murono, Shigeyuki; Yoshizaki, Tomokazu] Kanazawa Univ, Grad Sch Med Sci, Div Otolaryngol & Head & Neck Surg, Kanazawa, Ishikawa 9208640, Japan	Yoshizaki, T (reprint author), Kanazawa Univ, Grad Sch Med Sci, Div Otolaryngol Head & Neck Surg, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	tomoy@med.kanazawa-u.ac.jp			Ministry of Education, Science, Sports, Culture and Technology of Japan [A24689064, B23390396]	This study was supported by research grants from the Ministry of Education, Science, Sports, Culture and Technology of Japan (A24689064 for S. K. and B23390396 for T. Y.).	Aga M, 2014, HUM PATHOL, V4, P793; Aga M, 2013, AURIS NASUS LARYNX, V5, P514; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Sakai A, 2008, J IMMUNOL, V181, P2898; Miyake K, 2008, MOD RHEUMATOL, V18, P86, DOI 10.1007/s10165-007-0010-3; Yoshimoto T, 1998, J IMMUNOL, V161, P3400; Eriksson P, 2004, CLIN EXP IMMUNOL, V137, P617, DOI 10.1111/j.1365-2249.2004.02562.x; Pizarro TT, 1999, J IMMUNOL, V162, P6829; Nakanishi Kenji, 2010, Allergology International, V59, P137, DOI 10.2332/allergolint.10-RAI-0208; Sugimoto T, 2004, J EXP MED, V199, P535, DOI 10.1084/jem.20031368; Kudo-Tanaka E, 2009, MOD RHEUMATOL, V19, P691, DOI 10.1007/s10165-009-0214-9; Umehara H, 2012, MOD RHEUMATOL, V22, P1, DOI 10.1007/s10165-011-0508-6; Cameron LA, 1999, EUR RESPIR J, V14, P553, DOI 10.1034/j.1399-3003.1999.14c12.x; Bombardieri M, 2004, ARTHRITIS RES THER, V6, pR447, DOI 10.1186/ar1209; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Sugawara S, 2001, J IMMUNOL, V167, P6568; Terada M, 2006, P NATL ACAD SCI USA, V103, P8816, DOI 10.1073/pnas.0602900103; Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748; Renauld JC, 2001, J CLIN PATHOL, V54, P577, DOI 10.1136/jcp.54.8.577; Tanaka A, 2012, ARTHRITIS RHEUM-US, V64, P254, DOI 10.1002/art.33320; Huang TJ, 2001, J IMMUNOL, V166, P207; Maehara T, 2012, ANN RHEUM DIS, V71, P2011, DOI 10.1136/annrheumdis-2012-201477; Kohno K, 1997, J IMMUNOL, V158, P1541; Zen Y, 2007, HEPATOLOGY, V45, P1538, DOI 10.1002/hep.21697; Tsuboi H, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3924; Umehara H, 2012, MOD RHEUMATOL, V1, P21	26	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0046-8177	1532-8392		HUM PATHOL	Hum. Pathol.	DEC	2015	46	12					1850	1858		10.1016/j.humpath.2015.08.002		9	Pathology	Pathology	CX6UG	WOS:000365836600009		
J	Takizawa, N; Ohishi, Y; Hirahashi, M; Takahashi, S; Nakamura, K; Tanaka, M; Oki, E; Takayanagi, R; Oda, Y				Takizawa, Nobuyoshi; Ohishi, Yoshihiro; Hirahashi, Minako; Takahashi, Shunsuke; Nakamura, Kazuhiko; Tanaka, Masao; Oki, Eiji; Takayanagi, Ryoichi; Oda, Yoshinao			Molecular characteristics of colorectal neuroendocrine carcinoma; similarities with adenocarcinoma rather than neuroendocrine tumor	HUMAN PATHOLOGY			English	Article						Colorectal neuroendocrine carcinoma; Neuroendocrine tumor; Adenocarcinoma; Rb-p16 pathway; Molecular characteristics	ENDOCRINE TUMORS; GASTROINTESTINAL-TRACT; D1/RB PATHWAY; BETA-CATENIN; SMALL-CELL; PROTEIN; INSTABILITY; MUTATIONS; DISTINCT; CANCER	To further clarify the molecular features of colorectal neuroendocrine carcinomas (NECs), we immunohistochemically examined tumor samples from 25 NECs, including 9 small cell NECs (SCNECs) and 16 large cell NECs (LCNECs), 20 neuroendocrine tumors (NETs), and 21 poorly differentiated adenocarcinomas (PDCs) for the expression of several biomarkers (p53, beta-catenin, Bcl-2, Rb, p16, p21, cyclin D1, and cyclin E) and used sequencing analysis to identify gene alterations of TP53, APC, CTNNB1, KRAS, and BRAF. The frequencies of aberrant p53 expression (88%), beta-catenin nuclear expression (48%), and high expression of cyclin E (84%) were significantly higher in NECs than in NETs (0%, 5%, and 5%, P < .01, respectively). The immunohistochemical results of NECs and PDCs were similar. TP53, APC, KRAS, and BRAF gene mutations were variously detected in NECs and PDCs but not in any NETs. The frequencies of decreased expression of Rb (56%) and high expression of p16 (56%) and Bcl-2 (64%) were significantly higher in NECs than in PDCs (5%, 19%, and 5%, P < .05, respectively) or NETs (10%, 5%, and 5%, P <.01, respectively). Such immunohistochemical characteristics of NECs were more evident in SCNECs than in large cell NECs (P <.01). In conclusion, the molecular features of colorectal NECs are similar to those of adenocarcinomas and not to those of NETs. Decreased expression of Rb and high expression of p16 and Bcl-2 are characteristics of NECs, suggesting that Rb-p16 pathway disruption may contribute to the promotion of proliferative activity in colorectal NECs. SCNECs may be a prototype of NECs. (C) 2015 Elsevier Inc. All rights reserved.	[Takizawa, Nobuyoshi; Ohishi, Yoshihiro; Hirahashi, Minako; Takahashi, Shunsuke; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 8128582, Japan; [Nakamura, Kazuhiko; Takayanagi, Ryoichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 8128582, Japan; [Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 8128582, Japan; [Oki, Eiji] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan	Oda, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Pathol Sci,Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	oda@surgpath.med.kyushu-u.ac.jp					Pizzi S, 2008, ENDOCR-RELAT CANCER, V15, P1013, DOI 10.1677/ERC-07-0230; Bernick PE, 2004, DIS COLON RECTUM, V47, P163, DOI 10.1007/s10350-003-0038-1; Li AFY, 2008, AM J CLIN PATHOL, V130, P535, DOI 10.1309/TLLVXK9HVA89CHPE; Karkouche R, 2012, EUR J GASTROEN HEPAT, V24, P1430, DOI 10.1097/MEG.0b013e3283583c87; Rindi G, 2007, VIRCHOWS ARCH, V451, P757, DOI 10.1007/s00428-007-0452-1; Liu SZ, 2013, ONCOL LETT, V6, P1641, DOI 10.3892/ol.2013.1610; Vortmeyer AO, 1997, J NATL CANCER I, V89, P1448, DOI 10.1093/jnci/89.19.1448; Shia J, 2008, AM J SURG PATHOL, V32, P719, DOI 10.1097/PAS.0b013e318159371c; Stelow EB, 2006, AM J SURG PATHOL, V30, P1401, DOI 10.1097/01.pas.0000213272.15221.38; Yemelyanova A, 2011, MODERN PATHOL, V24, P1248, DOI 10.1038/modpathol.2011.85; Wick MR, 2005, AM J CLIN PATHOL, V123, P56, DOI 10.1309/1VFJ1C3LP52A4FP8; Jenkins MA, 2007, GASTROENTEROLOGY, V133, P48, DOI 10.1053/j.gastro.2007.04.044; Li YR, 2011, AM J SURG PATHOL, V35, P413, DOI 10.1097/PAS.0b013e3182093657; Fujimori M, 2001, CANCER RES, V61, P6656; Kim JT, 2013, CARCINOGENESIS, V34, P953, DOI 10.1093/carcin/bgt018; GASPARINI G, 1995, CLIN CANCER RES, V1, P189; Yachida S, 2012, AM J SURG PATHOL, V36, P173, DOI 10.1097/PAS.0b013e3182417d36; Beasley MB, 2003, HUM PATHOL, V34, P136, DOI 10.1053/hupa.2003.8; Cheng CC, 2008, J SOC COLON RECTAL S, V19, P87; Klimstra DS, 2010, WHO CLASSIFICATION T, P174; Rosa S La, 2012, AM J SURG PATHOL, V35, P601; Sobin LH, 2009, CLASSIFICATION MALIG; Zhou ZR, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-78	23	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0046-8177	1532-8392		HUM PATHOL	Hum. Pathol.	DEC	2015	46	12					1890	1900		10.1016/j.humpath.2015.08.006		11	Pathology	Pathology	CX6UG	WOS:000365836600013		
J	Miura, S; Hsu, LT; Chen, FY; Kamijo, S				Miura, Shunsuke; Hsu, Li-Ta; Chen, Feiyu; Kamijo, Shunsuke			GPS Error Correction With Pseudorange Evaluation Using Three-Dimensional Maps	IEEE TRANSACTIONS ON INTELLIGENT TRANSPORTATION SYSTEMS			English	Article						3-dimensional digital map; GNSS; GPS; non-line-of-sight (NLOS) propagation; ray tracing		The accuracy of the positions of a pedestrian is very important and useful information for the statistics, advertisement, and safety of different applications. Although the GPS chip in a smartphone is currently the most convenient device to obtain the positions, it still suffers from the effect of multipath and nonline-of-sight propagation in urban canyons. These reflections could greatly degrade the performance of a GPS receiver. This paper describes an approach to estimate a pedestrian position by the aid of a 3-D map and a ray-tracing method. The proposed approach first distributes the numbers of position candidates around a reference position. The weighting of the position candidates is evaluated based on the similarity between the simulated pseudorange and the observed pseudorange. Simulated pseudoranges are calculated using a ray-tracing simulation and a 3-D map. Finally, the proposed method was verified through field experiments in an urban canyon in Tokyo. According to the results, the proposed approach successfully estimates the reflection and direct paths so that the estimate appears very close to the ground truth, whereas the result of a commercial GPS receiver is far from the ground truth. The results show that the proposed method has a smaller error distance than the conventional method.	[Miura, Shunsuke; Hsu, Li-Ta; Chen, Feiyu; Kamijo, Shunsuke] Univ Tokyo, Tokyo 1538505, Japan	Miura, S (reprint author), Univ Tokyo, Tokyo 1538505, Japan.	miura@kmj.iis.u-tokyo.ac.jp; qmohsu@kmj.iis.u-tokyo.ac.jp; chen@kmj.iis.u-tokyo.ac.jp; kamijo@iis.u-tokyo.ac.jp			Strategic Information and Communications R&D Promotion Programme (SCOPE)	This work was supported in part by the Strategic Information and Communications R&D Promotion Programme (SCOPE). The Associate Editor for this paper was Q. Kong.	Meguro JI, 2009, IEEE T INTELL TRANSP, V10, P22, DOI 10.1109/TITS.2008.2011688; Pinana-Diaz C, 2011, IEEE INT C INTELL TR, P19, DOI 10.1109/ITSC.2011.6083042; Iwase T, 2013, GPS SOLUT, V17, P53, DOI 10.1007/s10291-012-0260-1; Iskander MF, 2002, IEEE T MICROW THEORY, V50, P662, DOI 10.1109/22.989951; Obst M, 2012, 2012 IEEE INTELLIGENT VEHICLES SYMPOSIUM (IV), P184, DOI 10.1109/IVS.2012.6232285; Groves PD, 2011, J NAVIGATION, V64, P417, DOI 10.1017/S0373463311000087; Wang L, 2013, NAVIGATION-US, V60, P195, DOI 10.1002/navi.38; Jiang ZY, 2014, GPS SOLUT, V18, P15, DOI 10.1007/s10291-012-0305-5; Bertoni H. L., 1999, RADIO PROPAGATION MO; Braasch M. S., 2001, P IEEE AER C BIG SKY, V3, P1309; Brown R. G., 1992, J I NAVIGATION, V39, P301; Fenton P. C., 2005, P ION GNSS 2005 LONG, P2178; Garin L., 1997, P 10 INT TECHN M SAT, P559; Groves PD, 2013, ARTECH HSE GNSS TECH, P1; Kaplan E. D., 2005, UNDERSTANDING GPS PR; Kubo N., 2005, P INT S GNSS GPS, P8; Lee Y. C., 2000, Navigation. Journal of the Institute of Navigation, V47; MacGougan G, 2002, GPS SOLUT, V6, P179; Marias J., 2005, IEEE T VEH TECHNOL, V54, P1697; Peyret F., 2012, P 19 ITS WORLD C VIE, VEU00077:1-EU00077:8; TOWNSEND B, 1994, PROCEEDINGS OF ION GPS-94: 7TH INTERNATIONAL TECHNICAL MEETING OF THE SATELLITE DIVISION OF THE INSTITUTE OF NAVIGATION, PTS 1 AND 2, P143; Townsend B. R., 1995, Navigation. Journal of the Institute of Navigation, V42; Van Dierendonck A. J., 1992, J I NAVIGATION, V39, P265; Wang L., 2014, J NAVIGAT, V68, P411; Wang L., 2013, INSIDE GNSS, P44; Yasuda A., 2001, IEICE T B J, VJ84-B, P2082	26	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1524-9050	1558-0016		IEEE T INTELL TRANSP	IEEE Trans. Intell. Transp. Syst.	DEC	2015	16	6								10.1109/TITS.2015.2432122		12	Engineering, Civil; Engineering, Electrical & Electronic; Transportation Science & Technology	Engineering; Transportation	CX8MS	WOS:000365958500012		
J	Katagiri, W; Osugi, M; Kinoshita, K; Hibi, H				Katagiri, Wataru; Osugi, Masashi; Kinoshita, Kazuhiko; Hibi, Hideharu			Conditioned Medium From Mesenchymal Stem Cells Enhances Early Bone Regeneration After Maxillary Sinus Floor Elevation in Rabbits	IMPLANT DENTISTRY			English	Article						bone regeneration; conditioned medium; maxillary sinus floor elevation; growth factor	GROWTH-FACTOR-BETA; AUTOGENOUS BONE; IGF-I; AUGMENTATION; MARROW; HYDROXYAPATITE; GRAFT	Purpose:Conditioned medium from stem cells contains growth factors and has a promising prospect for use in regenerative medicine. In this study, the effects of marrow-derived stem cell-conditioned medium (MSC-CM) on bone regeneration after maxillary sinus floor elevation were examined in rabbits.Materials and Methods:Rabbit bone marrow-derived stem cells (rMSCs) were cultured with MSC-CM for 48 hours, and their mobilization and proliferation were evaluated. Beta-tricalcium phosphate scaffolds were impregnated with MSC-CM and grafted in the rabbit maxillary sinus cavities. At 2, 4, and 8 weeks after transplantation, sections of the newly formed bone were evaluated histologically and by immunohistochemical staining.Results:MSC-CM increased the migration and proliferation of rMSCs and the early bone regeneration in rabbit sinus. Cell proliferation and vascularization were increased at 2 weeks after implantation of grafts impregnated with MSC-CM compared to controls, indicating that MSC-CM is effective at the early phase of bone regeneration.Conclusion:MSC-CM is a promising novel therapeutic agent to promote bone regeneration after maxillary sinus floor elevation.	[Katagiri, Wataru; Osugi, Masashi; Kinoshita, Kazuhiko; Hibi, Hideharu] Nagoya Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Nagoya, Aichi 4648601, Japan	Katagiri, W (reprint author), 65 Tsuruma Cho,Showa Ku, Nagoya, Aichi 4668550, Japan.	w-kat@med.nagoya-u.ac.jp	Hibi, Hideharu/E-4443-2015	Hibi, Hideharu/0000-0003-0248-7476	Ministry of Education, Culture, Sports, and Technology of Japan [23592883]	The authors thank Minoru Ueda and the members of the Department of Oral and Maxillofacial Surgery of Nagoya University Graduate School of Medicine for their help and contributions to the completion of this study. This work was supported in part by Grants-in-Aid for Scientific Research (B) (23592883) from the Ministry of Education, Culture, Sports, and Technology of Japan.	Katagiri W, 2013, INT J ORAL MAX IMPL, V28, P1009, DOI 10.11607/jomi.3036; Nakamura Y, 2007, STEM CELLS, V25, P612, DOI 10.1634/stemcells.2006-0168; Li Y, 2007, BIOCHEM BIOPH RES CO, V356, P780, DOI 10.1016/j.bbrc.2007.03.049; van den Bergh JPA, 2000, CLIN ORAL IMPLAN RES, V11, P487, DOI 10.1034/j.1600-0501.2000.011005487.x; Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635; Mangano C, 2003, INT J ORAL MAX IMPL, V18, P23; BOYNE PJ, 1980, J ORAL SURG, V38, P613; Osugi M, 2012, TISSUE ENG PT A, V18, P1479, DOI [10.1089/ten.TEA.2011.0325, 10.1089/ten.tea.2011.0325]; Kaigler D, 2003, TISSUE ENG, V9, P95, DOI 10.1089/107632703762687573; Yamada Y, 2013, STEM CELLS, V31, P572, DOI 10.1002/stem.1300; [Anonymous], 1998, CLIN ORTHOP S, DOI 10.1097/00003086-199810001-00014; Bettega G, 2009, TRANSFUSION, V49, P779, DOI 10.1111/j.1537-2995.2008.02036.x; Fowlkes JL, 2006, J BONE MINER RES, V21, P1359, DOI 10.1359/JBMR.060618; Yoon BS, 2010, STEM CELLS DEV, V19, P887, DOI 10.1089/scd.2009.0138; PFEILSCHIFTER J, 1990, J BONE MINER RES, V5, P825; Triplett RG, 2009, J ORAL MAXIL SURG, V67, P1947, DOI 10.1016/j.joms.2009.04.085; Watanabe K, 1999, ORAL SURG ORAL MED O, V88, P26, DOI 10.1016/S1079-2104(99)70189-7; SPENCER EM, 1991, BONE, V12, P21, DOI 10.1016/8756-3282(91)90050-S; Kitamura M, 2011, J DENT RES, V90, P35, DOI 10.1177/0022034510384616; Perin EC, 2009, CATHETER CARDIO INTE, V73, P281, DOI 10.1002/ccd.21807; Ide C, 2010, BRAIN RES, V1332, P32, DOI 10.1016/j.brainres.2010.03.043; Di Santo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005643; Handschel Jörg, 2009, Head Face Med, V5, P12, DOI 10.1186/1746-160X-5-12; Katsuyama H, 2011, ITI TREATMENT GUIDE, V5, P48; Nevins ML, 2011, COMPEND CONTIN ED DE, V32, P20	25	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1056-6163			IMPLANT DENT	Implant Dent.	DEC	2015	24	6					657	663		10.1097/ID.0000000000000335		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CX4XH	WOS:000365703300004		
J	Tanaka, H; Toyoshima, T; Atsuta, I; Ayukawa, Y; Sasaki, M; Matsushita, Y; Hiraoka, R; Koyano, K; Nakamura, S				Tanaka, Hideaki; Toyoshima, Takeshi; Atsuta, Ikiru; Ayukawa, Yasunori; Sasaki, Masanori; Matsushita, Yasuyuki; Hiraoka, Ryu; Koyano, Kiyoshi; Nakamura, Seiji			Additional Effects of Platelet-Rich Fibrin on Bone Regeneration in Sinus Augmentation With Deproteinized Bovine Bone Mineral: Preliminary Results	IMPLANT DENTISTRY			English	Article						sinus augmentation; deproteinized bovine bone mineral; platelet-rich fibrin; histology	BIO-OSS; HISTOMORPHOMETRIC EVALUATION; FLOOR ELEVATION; HUMANS; COMBINATION; BIO-OSS((R)); IMPLANTATION; SUBSTITUTE; MEMBRANES; CELLS	Purpose:Platelet-rich fibrin (PRF) has been reported to contribute to bone regeneration; however, little is known about details with deproteinized bovine bone mineral (DBBM). This study aims to evaluate additional effects of PRF on bone regeneration in sinus augmentation with DBBM.Materials and Methods:Sinus augmentations were made with DBBM/PRF mixture as lateral approach for 4 sinuses from 4 patients. Bone biopsies were obtained from posterior maxilla at the implant placements 7 or 10 months after sinus augmentations. Histological observations and histomorphometric analyses from augmented areas were performed.Results:The new bone formation was found around the DBBMs with very good contact while surfaces of DBBMs were partly resorbed. Osteoclasts recognized the DBBMs for remodeling, followed by new bone running. The histomorphometric analyses revealed that mean percentages of newly formed bone were 31.7 1.2%, 21.0 +/- 1.0%, 38.0 +/- 0.6%, and 47.0 +/- 0.6%, respectively (mean 34.5 +/- 5.7%).Conclusions:Additional effects of PRF could be found because of higher percentages of newly bone formation by DBBM/PRF mixture than those by DBBM individual in previous reports.	[Tanaka, Hideaki; Toyoshima, Takeshi; Nakamura, Seiji] Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Fukuoka 8128582, Japan; [Tanaka, Hideaki] Kyushu Univ Hosp, Regenerat Dent & Implant Ctr, Fukuoka, Japan; [Atsuta, Ikiru; Ayukawa, Yasunori; Matsushita, Yasuyuki; Koyano, Kiyoshi] Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Fukuoka 8128582, Japan; [Sasaki, Masanori; Matsushita, Yasuyuki; Hiraoka, Ryu; Koyano, Kiyoshi] Kyushu Univ Hosp, Regenerat Dent & Implant Ctr, Fukuoka, Japan	Toyoshima, T (reprint author), Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	takesea@dent.kyushu-u.ac.jp			Japanese Ministry of Education, Culture, Science, Sports and Technology of Japan [26861730, 25861955]	The work was supported by a Grant-in-Aid for scientific research from the Japanese Ministry of Education, Culture, Science, Sports and Technology of Japan (Nos. 26861730 and 25861955).	Tadjoedin ES, 2003, J CLIN PERIODONTOL, V30, P261, DOI 10.1034/j.1600-051X.2003.01099.x; Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x; Gassling V, 2013, J CRANIO MAXILL SURG, V41, P76, DOI 10.1016/j.jcms.2012.10.015; Orsini G, 2007, ORAL DIS, V13, P586, DOI 10.1111/j.1601-0825.2006.01343.x; Valentini P, 2000, INT J PERIODONT REST, V20, P245; Yildirim M, 2001, INT J ORAL MAX IMPL, V16, P23; Metzler P, 2012, J CRANIO MAXILL SURG, V40, P409, DOI 10.1016/j.jcms.2011.07.012; Lind M, 1998, ACTA ORTHOP SCAND, V69, P2; Artzi Z, 2001, J PERIODONTOL, V72, P152, DOI 10.1902/jop.2001.72.2.152; Bassil J, 2013, J ORAL IMPLANTOL, V39, P73, DOI 10.1563/AAID-JOI-D-11-00012; BOYNE PJ, 1980, J ORAL SURG, V38, P613; Gruber R, 2003, J ORTHOPAED RES, V21, P941, DOI 10.1016/S0736-0266(03)00053-6; Traini T, 2007, J PERIODONTOL, V78, P955, DOI 10.1902/jop.2007.060308; Cordaro L, 2003, CLIN ORAL IMPLAN RES, V14, P201, DOI 10.1034/j.1600-0501.2003.140210.x; Zhang Y, 2012, J CRANIO MAXILL SURG, V40, P321, DOI 10.1016/j.jcms.2011.04.020; Norton MR, 2003, CLIN ORAL IMPLAN RES, V14, P775, DOI 10.1046/j.0905-7161.2003.00952.x; Simion M, 2007, CLIN ORAL IMPLAN RES, V18, P620, DOI 10.1111/j.1600-0501.2007.01389.x; Inchingolo F, 2010, EUR REV MED PHARMACO, V14, P1075; Margolin MD, 1998, J PERIODONTOL, V69, P911; van den Bergh JPA, 1998, CLIN ORAL IMPLAN RES, V9, P429, DOI 10.1034/j.1600-0501.1996.090608.x; Valentini P, 1998, CLIN ORAL IMPLAN RES, V9, P59, DOI 10.1034/j.1600-0501.1998.090108.x; Sartori S, 2003, CLIN ORAL IMPLAN RES, V14, P369, DOI 10.1034/j.1600-0501.2003.140316.x; Avera SP, 1997, INT J ORAL MAX IMPL, V12, P88; Dohan DM, 2006, ORAL SURG ORAL MED O, V101, pe45; Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe37, DOI 10.1016/j.tripleo.2005.07.008; Froum Stuart J, 2005, Compend Contin Educ Dent, V26, P259; Froum S J, 1998, Int J Periodontics Restorative Dent, V18, P528; Hallman M, 2001, Clin Implant Dent Relat Res, V3, P87, DOI 10.1111/j.1708-8208.2001.tb00236.x; Kaufman Eliaz, 2003, J Esthet Restor Dent, V15, P272, DOI 10.1111/j.1708-8240.2003.tb00298.x; Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835	30	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1056-6163			IMPLANT DENT	Implant Dent.	DEC	2015	24	6					669	674		10.1097/ID.0000000000000306		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CX4XH	WOS:000365703300006		
J	Kuppusamy, M; Watanabe, H; Kasugai, S; Kuroda, S				Kuppusamy, Maheswari; Watanabe, Hiroshi; Kasugai, Shohei; Kuroda, Shinji			Effects of Abutment Removal and Reconnection on Inflammatory Cytokine Production Around Dental Implants	IMPLANT DENTISTRY			English	Article						cytokines; periimplant crevicular fluid; abutment	TUMOR-NECROSIS-FACTOR; IMMEDIATELY LOADED IMPLANTS; BONE-FORMATION INVITRO; FACTOR-ALPHA LEVELS; CREVICULAR FLUID; FOLLOW-UP; OSSEOINTEGRATED IMPLANTS; PERI-IMPLANTITIS; MARGINAL BONE; TNF-ALPHA	Objectives:The purpose of this study was to examine effects of abutment change on inflammatory cytokine production around implants. Materials and Methods:Ten partially edentulous patients with a mean age of 60 years were recruited and divided into 2 groups. External Branemark implants with anodic oxidized surface were installed and submerged in all patients. In the control group, the healing abutments were delivered at the second surgery, and they were removed more than 3 times till the final prosthesis delivery. In the test group, the final abutments were delivered at the second surgery. At different time points during the treatment, periimplant crevicular fluid was collected, and proinflammatory cytokines (interleukin-1 [IL-1] and tumor necrosis factor [TNF]-) were measured with enzyme-linked immunosorbent assay. The bone level was measured on the radiograms and clinical indices were also taken. Results:All implants were osseointegrated. In the test group, IL-1 level and probing depths were less in test group patients compared with the control group patients, whereas TNF- level and bone level were not different between the groups. Conclusion:Although TNF- and bone levels were not significantly different, delivering final abutment at the second surgery would induce less inflammation in the tissues around the implant.	[Kuppusamy, Maheswari; Kasugai, Shohei; Kuroda, Shinji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Implantol & Regenerat Dent Med, Tokyo 1138510, Japan; [Watanabe, Hiroshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral & Maxillofacial Radiol, Tokyo 1138510, Japan	Kuroda, S (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Implantol & Regenerat Dent Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	skuroda.mfc@tmd.ac.jp					Abrahamsson Ingemar, 2003, Clin Implant Dent Relat Res, V5, P82, DOI 10.1111/j.1708-8208.2003.tb00188.x; Akdis M, 2011, J ALLERGY CLIN IMMUN, V127; TATAKIS DN, 1988, CALCIFIED TISSUE INT, V42, P358, DOI 10.1007/BF02556353; Berglundh T, 1991, CLIN ORAL IMPLAN RES, V2, P81, DOI 10.1034/j.1600-0501.1991.020206.x; Canullo L, 2010, EUR J ORAL IMPLANTOL, V3, P285; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Schierano G, 2008, J CLIN PERIODONTOL, V35, P532, DOI 10.1111/j.1600-051X.2008.01224.x; DEWHIRST FE, 1985, J IMMUNOL, V135, P2562; Degidi M, 2011, CLIN ORAL IMPLAN RES, V22, P1303, DOI 10.1111/j.1600-0501.2010.02111.x; Ataoglu T, 2002, INT ENDOD J, V35, P181, DOI 10.1046/j.1365-2591.2002.00467.x; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Nowzari H, 2008, CLIN IMPLANT DENT R, V10, P166, DOI 10.1111/j.1708-8208.2007.00076.x; Ataoglu H, 2002, CLIN ORAL IMPLAN RES, V13, P470, DOI 10.1034/j.1600-0501.2002.130505.x; GOWEN M, 1983, NATURE, V306, P378, DOI 10.1038/306378a0; LORENZO JA, 1987, ENDOCRINOLOGY, V121, P1164; STASHENKO P, 1987, J BONE MINER RES, V2, P559; BEUTLER B, 1986, NATURE, V320, P584, DOI 10.1038/320584a0; Grandi T, 2012, EUR J ORAL IMPLANTOL, V5, P9; Romanos GE, 2010, J PERIODONTOL, V81, P70, DOI 10.1902/jop.2009.090364; Lazzara RJ, 2006, INT J PERIODONT REST, V26, P9; Cury PR, 2009, INT J ORAL MAX IMPL, V24, P1101; Petkovic AB, 2010, INT J ORAL MAX SURG, V39, P478, DOI 10.1016/j.ijom.2010.01.014; Lindquist LW, 1996, CLIN ORAL IMPLAN RES, V7, P329, DOI 10.1034/j.1600-0501.1996.070405.x; Murata M, 2002, CLIN ORAL IMPLAN RES, V13, P637, DOI 10.1034/j.1600-0501.2002.130610.x; STASHENKO P, 1987, J IMMUNOL, V138, P1464; BERTOLINI DR, 1986, NATURE, V319, P516, DOI 10.1038/319516a0; Abrahamsson I, 1999, J CLIN PERIODONTOL, V26, P600, DOI 10.1034/j.1600-051X.1999.260907.x; Nowzari H, 2012, CLIN IMPLANT DENT R, V14, P546, DOI 10.1111/j.1708-8208.2010.00299.x; Arango D.G., 2014, FRONT IMMUNOL, V7, P491; BILLINGHAM MEJ, 1987, BRIT MED BULL, V43, P350; Kao R T, 1995, Int J Oral Maxillofac Implants, V10, P696; Konttinen Yrjö T, 2006, Int J Periodontics Restorative Dent, V26, P135; Mombelli A, 1987, Oral Microbiol Immunol, V2, P145, DOI 10.1111/j.1399-302X.1987.tb00298.x; Panagakos F S, 1996, Int J Oral Maxillofac Implants, V11, P794; Rompen E, 2012, EUR J ORAL IMPLANTOL, V5, pS83	35	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1056-6163			IMPLANT DENT	Implant Dent.	DEC	2015	24	6					730	734		10.1097/ID.0000000000000330		5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CX4XH	WOS:000365703300015		
J	Hagiya, H; Otsuka, F				Hagiya, Hideharu; Otsuka, Fumio			Refractory chyluria due to filariasis	INFECTION			English	Editorial Material						Diethylcarbamazine; Filaria; Milky urine; Wuchereria bancrofti			[Hagiya, Hideharu; Otsuka, Fumio] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Med, Kita Ku, Okayama 7008558, Japan	Hagiya, H (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Med, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	e_dai_for_all@hotmail.com					Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; Hagiya H, 2014, INTERNAL MED, V53, P2001, DOI 10.2169/internalmedicine.53.2572; Goyal Neeraj Kumar, 2014, Indian J Urol, V30, P23, DOI 10.4103/0970-1591.124201	3	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0300-8126	1439-0973		INFECTION	Infection	DEC	2015	43	6					785	786		10.1007/s15010-015-0804-8		2	Infectious Diseases	Infectious Diseases	CX2FG	WOS:000365510700024		
J	Waddell, A; Vallance, JE; Moore, PD; Hummel, AT; Wu, D; Shanmukhappa, SK; Fei, L; Washington, MK; Minar, P; Coburn, LA; Nakae, S; Wilson, KT; Denson, LA; Hogan, SP; Rosen, MJ				Waddell, Amanda; Vallance, Jefferson E.; Moore, Preston D.; Hummel, Amy T.; Wu, David; Shanmukhappa, Shiva K.; Fei, Lin; Washington, M. Kay; Minar, Phillip; Coburn, Lori A.; Nakae, Susumu; Wilson, Keith T.; Denson, Lee A.; Hogan, Simon P.; Rosen, Michael J.			IL-33 Signaling Protects from Murine Oxazolone Colitis by Supporting Intestinal Epithelial Function	INFLAMMATORY BOWEL DISEASES			English	Article						ulcerative colitis; inflammatory bowel disease; interleukin-33; epithelial cells; oxazolone	T-CELL RESPONSES; AMELIORATES EXPERIMENTAL COLITIS; INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; ENDOGENOUS IL-33; TYPE-2 IMMUNITY; IN-VIVO; CYTOKINE; INTERLEUKIN-33; ALARMIN	Background:IL-33, a member of the IL-1 cytokine family that signals through ST2, is upregulated in ulcerative colitis (UC); however, the role of IL-33 in colitis remains unclear. IL-33 augments type 2 immune responses, which have been implicated in UC pathogenesis. We sought to determine the role of IL-33 signaling in oxazolone (OXA) colitis, a type 2 cytokine-mediated murine model of UC.Methods:Colon mucosal IL-33 expression was compared between pediatric and adult UC and non-IBD patients using immunohistochemistry and real-time PCR. OXA colitis was induced in WT, IL-33(-/-), and ST2(-/-) mice, and histopathology, cytokine levels, and goblet cells were assessed. Transepithelial resistance was measured across IL-33-treated T84 cell monolayers.Results:Colon mucosal IL-33 was increased in pediatric patients with active UC and in OXA colitis. IL-33(-/-) and ST2(-/-) OXA mice exhibited increased disease severity compared with WT OXA mice. OXA induced a mixed mucosal cytokine response, but few differences were observed between OXA WT and IL-33(-/-) or ST2(-/-) mice. Goblet cells were significantly decreased in IL-33(-/-) and ST2(-/-) OXA compared with WT OXA mice. IL-33 augmented transepithelial resistance in T84 cells, and this effect was blocked by the ERK1/2 inhibitor PD98,059.Conclusions:OXA colitis is exacerbated in IL-33(-/-) and ST2(-/-) mice. Increased mucosal IL-33 in human UC and murine colitis may be a homeostatic response to limit inflammation, potentially through effects on epithelial barrier function. Further investigation of IL-33 protective mechanisms would inform the development of novel therapeutic approaches.	[Waddell, Amanda; Vallance, Jefferson E.; Hummel, Amy T.; Minar, Phillip; Denson, Lee A.; Rosen, Michael J.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Moore, Preston D.; Rosen, Michael J.] Vanderbilt Univ, Med Ctr, Div Pediat Gastroenterol Hepatol & Nutr, Nashville, TN USA; [Wu, David; Hogan, Simon P.] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Shanmukhappa, Shiva K.] Cincinnati Childrens Hosp Med Ctr, Div Pathol & Lab Med, Cincinnati, OH 45229 USA; [Fei, Lin] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Washington, M. Kay; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Coburn, Lori A.; Wilson, Keith T.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA; [Coburn, Lori A.; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Div Gastroenterol Hepatol & Nutr, Nashville, TN USA; [Nakae, Susumu] Univ Tokyo, Inst Med Sci, Tokyo, Japan	Rosen, MJ (reprint author), Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, 3333 Burnet Ave,MLC 2010, Cincinnati, OH 45229 USA.	michael.rosen@cchmc.org			National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) [K23DK094832]; NIH [P30 DK078392, P30 DK058404, R01AT004821, 3R01AT004821-02S1, R01DK090119]; National Center for Advancing Translational Sciences of NIH [UL1TR000077]; NIH Child Health Research Career Development Award [K12HD028827]; NIH training grant [5T32DK007673]; Vanderbilt Physician Scientist Development Award; Veterans Affairs Career Development Award [1IK2BX002126-01]; CCFA Senior Research Award	Supported primarily by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) under Award Number K23DK094832 (to M.J.R.). Biostatistical, Pathology, and Protein Multiplexing Core Services performed through the Cincinnati Children's Hospital Medical Center Digestive Health Center supported by NIH P30 DK078392. Tissue Morphology Core Services performed through Vanderbilt University Medical Center's Digestive Disease Research Center supported by NIH grant P30 DK058404. Database services provided by the Center for Clinical and Translational Science and Training supported by the National Center for Advancing Translational Sciences of the NIH, under Award Number UL1TR000077. P. Minar was supported NIH Child Health Research Career Development Award under award Number K12HD028827. L. A. Coburn was supported by NIH training grant 5T32DK007673, a Vanderbilt Physician Scientist Development Award, and a Veterans Affairs Career Development Award 1IK2BX002126-01. Studies were also supported in part by NIH grants R01AT004821 and 3R01AT004821-02S1 to K. T. Wilson, and R01DK090119 and a CCFA Senior Research Award to SPH. Michael J. Rosen served on an advisory board for Abbvie, Inc. The remaining authors have no conflicts of interest to disclose.	Duan LH, 2012, MOL MED, V18, P753, DOI 10.2119/molmed.2011.00428; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Dai C, 2012, INT J MOL MED, V29, P202, DOI 10.3892/ijmm.2011.839; Allison J, 2008, CLIN GASTROENTEROL H, V6, P999, DOI 10.1016/j.cgh.2008.05.022; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Howe HS, 2005, RHEUMATOLOGY, V44, P51, DOI 10.1093/rheumatology/keh426; McSorley HJ, 2014, MUCOSAL IMMUNOL, V7, P1068, DOI 10.1038/mi.2013.123; Li J, 2014, J CLIN INVEST, V124, P3241, DOI 10.1172/JCI73742; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Kobori A, 2010, J GASTROENTEROL, V45, P999, DOI 10.1007/s00535-010-0245-1; Rosen MJ, 2013, J IMMUNOL, V190, P1849, DOI 10.4049/jimmunol.1201373; Beltran CJ, 2010, INFLAMM BOWEL DIS, V16, P1097, DOI 10.1002/ibd.21175; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Pei C, 2014, IMMUNOLOGY, V141, P9, DOI 10.1111/imm.12174; Kennedy RJ, 2000, BRIT J SURG, V87, P1346, DOI 10.1046/j.1365-2168.2000.01615.x; Bonilla WV, 2012, SCIENCE, V335, P984, DOI 10.1126/science.1215418; Iijima H, 2004, J EXP MED, V199, P471, DOI 10.1084/jem.20030437; Humphreys NE, 2008, J IMMUNOL, V180, P2443; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Yang ZH, 2013, AM J PHYSIOL-GASTR L, V304, pG381, DOI 10.1152/ajpgi.00357.2012; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; Louten J, 2011, INT IMMUNOL, V23, P307, DOI 10.1093/intimm/dxr006; Imaeda H, 2011, INT J MOL MED, V28, P573, DOI 10.3892/ijmm.2011.718; Schmitz H, 1999, GASTROENTEROLOGY, V116, P301, DOI 10.1016/S0016-5085(99)70126-5; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Sedhom MAK, 2013, GUT, V62, P1714, DOI 10.1136/gutjnl-2011-301785; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Sattler S, 2014, J AUTOIMMUN, V50, P107, DOI 10.1016/j.jaut.2014.01.032; Pastorelli L, 2010, P NATL ACAD SCI USA, V107, P8017, DOI 10.1073/pnas.0912678107; Hung LY, 2013, P NATL ACAD SCI USA, V110, P282, DOI 10.1073/pnas.1206587110; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Seidelin JB, 2010, IMMUNOL LETT, V128, P80, DOI 10.1016/j.imlet.2009.11.001; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; DHARMSATHAPHORN K, 1984, AM J PHYSIOL, V246, pG204; Forbes EE, 2008, J EXP MED, V205, P897, DOI 10.1084/jem.20071046; Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129; Bessa J, 2014, J AUTOIMMUN, V55, P33, DOI 10.1016/j.jaut.2014.02.012; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Groβ Philipp, 2012, Inflamm Bowel Dis, V18, P1900, DOI 10.1002/ibd.22900; Hardman CS, 2012, EUR J IMMUNOL, V43, P488; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Latiano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062144; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Seidelin JB, 2015, J GASTROENTEROL, V50, P180, DOI 10.1007/s00535-014-0982-7	49	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-0998	1536-4844		INFLAMM BOWEL DIS	Inflamm. Bowel Dis.	DEC	2015	21	12					2737	2746		10.1097/MIB.0000000000000532		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CX3IZ	WOS:000365593500001		
J	Hiejima, E; Nakase, H; Heike, T				Hiejima, Eitaro; Nakase, Hiroshi; Heike, Toshio			Reduced Numbers and Proapoptotic Features of Mucosal-associated Invariant T Cells as a Characteristic Finding in Patients with Inflammatory Bowel Disease Reply	INFLAMMATORY BOWEL DISEASES			English	Letter									[Hiejima, Eitaro; Nakase, Hiroshi; Heike, Toshio] Kyoto Univ, Grad Sch Med, Kyoto, Japan	Hiejima, E (reprint author), Kyoto Univ, Grad Sch Med, Kyoto, Japan.						Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Hinks TSC, 2015, J ALLERGY CLIN IMMUN, V136, P323, DOI 10.1016/j.jaci.2015.01.014; Hiejima E, 2015, INFLAMM BOWEL DIS, V21, P1529, DOI 10.1097/MIB.0000000000000397; Napier RJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00344	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-0998	1536-4844		INFLAMM BOWEL DIS	Inflamm. Bowel Dis.	DEC	2015	21	12					E30	E31		10.1097/MIB.0000000000000645		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CX3IY	WOS:000365593300002		
J	Enomoto, M; Watatani, Y				Enomoto, Masatoshi; Watatani, Yasuo			Strongly Irreducible Operators and Indecomposable Representations of Quivers on Infinite-Dimensional Hilbert Spaces	INTEGRAL EQUATIONS AND OPERATOR THEORY			English	Article						Strongly irreducible operators; quiver; indecomposable representation; Hilbert space	4 SUBSPACES; MODULES; SYSTEMS; GRAPHS	We study several classes of indecomposable representations of quivers on infinite-dimensional Hilbert spaces and their relation. Many examples are constructed using strongly irreducible operators. Some problems in operator theory are rephrased in terms of representations of quivers. We shall show two kinds of constructions of quite non-trivial indecomposable Hilbert representations (H, f) of the Kronecker quiver such that which is called transitive. One is a perturbation of a weighted shift operator by a rank-one operator. The other one is a modification of an unbounded operator used by Harrison,Radjavi and Rosenthal to provide a transitive lattice.	[Enomoto, Masatoshi] Koshien Univ, Inst Educ & Res, Takarazuka, Hyogo 6650006, Japan; [Watatani, Yasuo] Kyushu Univ, Dept Math Sci, Fukuoka 8190395, Japan	Watatani, Y (reprint author), Kyushu Univ, Dept Math Sci, Fukuoka 8190395, Japan.	enomotoma@hotmail.co.jp; watatani@math.kyushu-u.ac.jp			JSPS KAKENHI [23654053, 25287019]	This work was supported by JSPS KAKENHI Grant Number 23654053 and 25287019.	Enomoto M, 2007, INTEGR EQUAT OPER TH, V59, P149, DOI 10.1007/s00020-007-1512-2; FIXMAN U, 1964, T AM MATH SOC, V113, P424, DOI 10.2307/1994142; GABRIEL P, 1972, MANUSCRIPTA MATH, V6, P71, DOI 10.1007/BF01298413; Kruglyak SA, 2005, FUNCT ANAL APPL+, V39, P91, DOI 10.1007/s10688-005-0022-8; KAC VG, 1980, INVENT MATH, V56, P57, DOI 10.1007/BF01403155; HARRISON KJ, 1971, P AM MATH SOC, V28, P119, DOI 10.2307/2037768; Kruglyak SA, 2002, FUNCT ANAL APPL+, V36, P182, DOI 10.1023/A:1020193804109; DLAB V, 1976, MEM AM MATH SOC, V6, P1; Enomoto M, 2009, J FUNCT ANAL, V256, P959, DOI 10.1016/j.jfa.2008.12.011; OKOH F, 1986, LINEAR ALGEBRA APPL, V76, P165, DOI 10.1016/0024-3795(86)90221-1; DEAN AP, 1990, J ALGEBRA, V132, P50, DOI 10.1016/0021-8693(90)90251-I; Enomoto M, 2006, ADV MATH, V201, P263, DOI 10.1016/j.aim.2005.02.004; Ringel CP, 2000, TRENDS MATH, P1; Auslander M., 1976, ALGEBRA TOPOLOGY CAT, P1; Bernstein I. N., 1973, RUSS MATH SURV, V28, P17, DOI 10.1070/RM1973v028n02ABEH001526; Donovan P., 1973, CARLETON MATH LECT N, V5, P1; Gabriel P., 1997, REPRESENTATIONS FINI; Gelfand I. M., 1972, C MATH J BOLYAI, V5, P163; GILFEATH.F, 1972, INDIANA U MATH J, V22, P393, DOI 10.1512/iumj.1972.22.22032; Goodman F., 1989, COXETER GRAPHS TOWER, V14; Jiang C, 2006, STRUCTURE OF HILBERT SPACE OPERATORS, P1; Jiang C., 1998, STRONGLY IRREDUCIBLE; Krause H., 2000, INFINITE LENGTH MODU; Moskaleva Y.P., 2006, METHODS FUNCT ANAL T, V12, P57; Nazarova L.A., 1973, IZV AKAD NAUK SSSR M, V37, P752; Nazarova L.A., 1967, IZV AKAD NAUK SSSR M, V31, P1361; Radjavi H., 1973, INVARIANT SUBSPACES; Ringel C. M., 1979, S MATH I NAZ ALTA MA, V23, P321; Shields A., 1974, MATH SURVEYS, V13, P49	29	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0378-620X	1420-8989		INTEGR EQUAT OPER TH	Integr. Equ. Oper. Theory	DEC	2015	83	4					563	587		10.1007/s00020-015-2228-3		25	Mathematics	Mathematics	CX5PF	WOS:000365753600005		
J	Matsuda, T; Kido, T; Itoh, T; Saeki, H; Shigemi, S; Watanabe, K; Kido, T; Aono, S; Yamamoto, M; Matsuda, T; Mochizuki, T				Matsuda, Takuya; Kido, Teruhito; Itoh, Toshihide; Saeki, Hideyuki; Shigemi, Susumu; Watanabe, Kouki; Kido, Tomoyuki; Aono, Shoji; Yamamoto, Masaya; Matsuda, Takeshi; Mochizuki, Teruhito			Diagnostic accuracy of late iodine enhancement on cardiac computed tomography with a denoise filter for the evaluation of myocardial infarction	INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING			English	Article						Acute myocardial infarction; Cardiac computed tomography; Image postprocessing; Late iodine enhancement	CORONARY-ANGIOGRAPHY; CT; PREDICTION; VIABILITY; MRI	We evaluated the image quality and diagnostic performance of late iodine enhancement (LIE) in dual-source computed tomography (DSCT) with low kilo-voltage peak (kVp) images and a denoise filter for the detection of acute myocardial infarction (AMI) in comparison with late gadolinium enhancement (LGE) magnetic resonance imaging (MRI). The Hospital Ethics Committee approved the study protocol. Before discharge, 19 patients who received percutaneous coronary intervention after AMI underwent DSCT and 1.5 T MRI. Immediately after coronary computed tomography (CT) angiography, contrast medium was administered at a slow injection rate. LIE-CT scans were acquired via dual-energy CT and reconstructed as 100-, 140-kVp, and mixed images. An iterative three-dimensional edge-preserved smoothing filter was applied to the 100-kVp images to obtain denoised 100-kVp images. The mixed, 140-kVp, 100-kVp, and denoised 100-kVp images were assessed using contrast-to-noise ratio (CNR), and their diagnostic performance in comparison with MRI and infarcted volumes were evaluated. Three hundred four segments of 19 patients were evaluated. Fifty-three segments showed LGE in MRI. The median CNR of the mixed, 140-, 100-kVp and denoised 100-kVp images was 3.49, 1.21, 3.57, and 6.08, respectively. The median CNR was significantly higher in the denoised 100-kVp images than in the other three images (P < 0.05). The denoised 100-kVp images showed the highest diagnostic accuracy and sensitivity. The percentage of myocardium in the four CT image types was significantly correlated with the respective MRI findings. The use of a denoise filter with a low-kVp image can improve CNR, sensitivity, and accuracy in LIE-CT.	[Matsuda, Takuya; Kido, Teruhito; Mochizuki, Teruhito] Ehime Univ, Grad Sch Med, Dept Radiol, Toon, Ehime 7910295, Japan; [Itoh, Toshihide] Siemens Japan, Res & Collaborat, Shinagawa Ku, Tokyo, Japan; [Saeki, Hideyuki; Shigemi, Susumu; Watanabe, Kouki] Saiseikai Matsuyama Hosp, Dept Cardiol, Matsuyama, Ehime, Japan; [Kido, Tomoyuki; Aono, Shoji; Yamamoto, Masaya] Saiseikai Matsuyama Hosp, Dept Radiol, Matsuyama, Ehime, Japan; [Matsuda, Takeshi] Matsuyama Red Cross Hosp, Dept Radiol, Matsuyama, Ehime, Japan	Matsuda, T (reprint author), Ehime Univ, Grad Sch Med, Dept Radiol, Toon, Ehime 7910295, Japan.	tmatsuda.singing@gmail.com					Black MJ, 1998, IEEE T IMAGE PROCESS, V7, P421, DOI 10.1109/83.661192; Nieman K, 2008, RADIOLOGY, V247, P49, DOI 10.1148/radiol.2471070332; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Raff GL, 2005, J AM COLL CARDIOL, V46, P552, DOI 10.1016/j.jacc.2005.05.056; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Deseive S, 2011, INVEST RADIOL, V46, P450, DOI 10.1097/RLI.0b013e3182145b4f; Kim RJ, 1999, CIRCULATION, V100, P1992; Lardo AC, 2006, CIRCULATION, V113, P394, DOI 10.1161/CIRCULATIONAHA.105.521450; Koyama Y, 2005, RADIOLOGY, V235, P804, DOI 10.1148/radiol.2353030441; Beek AM, 2003, J AM COLL CARDIOL, V42, P895, DOI 10.1016/S0735-1097(03)00835-0; Brodoefel H, 2007, EUR RADIOL, V17, P475, DOI 10.1007/s00330-006-0334-y; Lee VS, 2004, RADIOLOGY, V230, P191, DOI 10.1148/radiol.2301030070; Wagner A, 2003, LANCET, V361, P374, DOI 10.1016/S0140-6736(03)12389-6; Kurobe Y, 2014, J CARDIOVASC COMPUT, V8, P289, DOI 10.1016/j.jcct.2014.06.004; Srichai Monvadi B, 2013, World J Radiol, V5, P295, DOI 10.4329/wjr.v5.i8.295; Wichmann JL, 2013, INVEST RADIOL, V48, P851, DOI 10.1097/RLI.0b013e31829d91a8	17	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1569-5794	1573-0743		INT J CARDIOVAS IMAG	Int. J. Cardiovasc. Imaging	DEC	2015	31			2			177	185		10.1007/s10554-015-0716-9		9	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CX1TQ	WOS:000365478900006		
J	Kidoh, M; Utsunomiya, D; Oda, S; Funama, Y; Yuki, H; Nakaura, T; Kai, N; Nozaki, T; Yamashita, Y				Kidoh, Masafumi; Utsunomiya, Daisuke; Oda, Seitaro; Funama, Yoshinori; Yuki, Hideaki; Nakaura, Takeshi; Kai, Noriyuki; Nozaki, Takeshi; Yamashita, Yasuyuki			Validity of the size-specific dose estimate in adults undergoing coronary CT angiography: comparison with the volume CT dose index	INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING			English	Article						Heart; Multi-detector computed tomography; Radiation doses; Adult	COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; ITERATIVE RECONSTRUCTION; IMAGE QUALITY; PEDIATRIC CT; BODY CT; APPENDICITIS	Size-specific dose estimate (SSDE) takes into account the patient size but remains to be fully validated for adult coronary computed tomography angiography (CCTA). We investigated the appropriateness of SSDE for accurate estimation of patient dose by comparing the SSDE and the volume CT dose index (CTDIvol) in adult CCTA. This prospective study received institutional review board approval, and informed consent was obtained from each patient. We enrolled 37 adults who underwent CCTA with a 320-row CT. High-sensitivity metal oxide semiconductor field effect transistor dosimeters were placed on the anterior chest. CTDIvol reported by the scanner based on a 32-cm phantom was recorded. We measured chest diameter to convert CTDIvol to SSDE. Using linear regression, we then correlated SSDE with the mean measured skin dose. We also performed linear regression analyses between the skin dose/CTDIvol and the body mass index (BMI), and the skin dose/SSDE and BMI. There was a strong linear correlation (r = 0.93, P < 0.001) between SSDE (mean 37 +/- A 22 mGy) and mean skin dose (mean 17.7 +/- A 10 mGy). There was a moderate negative correlation between the skin dose/CTDIvol and BMI (r = 0.45, P < 0.01). The skin dose/SSDE was not affected by BMI (r = 0.06, P > 0.76). SSDE yields a more accurate estimation of the radiation dose without estimation errors attributable to the body size of adult patients undergoing CCTA.	[Kidoh, Masafumi; Utsunomiya, Daisuke; Oda, Seitaro; Yuki, Hideaki; Nakaura, Takeshi; Kai, Noriyuki; Nozaki, Takeshi; Yamashita, Yasuyuki] Kumamoto Univ, Fac Life Sci, Dept Diagnost Radiol, Kumamoto 8608556, Japan; [Funama, Yoshinori] Kumamoto Univ, Fac Life Sci, Dept Med Phys, Kumamoto 8608556, Japan	Kidoh, M (reprint author), Kumamoto Univ, Fac Life Sci, Dept Diagnost Radiol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	masafkidoh@yahoo.co.jp					Westra SJ, 2014, J CARDIOVASC COMPUT, V8, P97, DOI 10.1016/j.jcct.2013.08.002; Huda W, 2007, AM J ROENTGENOL, V188, P540, DOI 10.2214/AJR.06.0101; Sharp NE, 2014, J PEDIATR SURG, V49, P1016, DOI 10.1016/j.jpedsurg.2014.01.042; Emigh B, 2013, PEDIATR RADIOL, V43, P1108, DOI 10.1007/s00247-013-2674-5; Huda W, 2010, PHYS MED BIOL, V55, P3675, DOI 10.1088/0031-9155/55/13/007; McCollough CH, 2011, RADIOLOGY, V259, P311, DOI 10.1148/radiol.11101800; Nakaura T, 2013, INT J CARDIOVAS IMAG, V29, P913, DOI 10.1007/s10554-012-0153-y; Brady SL, 2012, RADIOLOGY, V265, P832, DOI 10.1148/radiol.12120131; Moore BM, 2014, MED PHYS, V41, DOI 10.1118/1.4884227; Israel GM, 2010, AM J ROENTGENOL, V195, P1342, DOI 10.2214/AJR.09.3331; Huda W, 2010, AM J ROENTGENOL, V194, P874, DOI 10.2214/AJR.09.4032; Van der Molen AJ, 2012, PHYS MEDICA, V28, P319, DOI 10.1016/j.ejmp.2011.10.005; Elojeimy S, 2010, RADIAT PROT DOSIM, V141, P43, DOI 10.1093/rpd/ncq138; Bedayat A, 2012, INT J CARDIOVAS IMAG, V28, P381, DOI 10.1007/s10554-011-9814-5; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; Huda W, 2010, MED PHYS, V37, P842, DOI 10.1118/1.3298015; Candela-Juan C, 2014, EUR RADIOL, V24, P649, DOI 10.1007/s00330-013-3047-z; Smith EA, 2014, RADIOLOGY, V270, P526, DOI 10.1148/radiol.13130362; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Buchmann RF, 2014, J COMPUT ASSIST TOMO, V38, P786, DOI 10.1097/RCT.0000000000000122; Didier RA, 2015, PEDIATR RADIOL, V45, P181, DOI 10.1007/s00247-014-3109-7; Hoerger M, 2013, ZH UPDATED VERSION S; Imai R, 2015, PEDIATR RADIOL, V45, P345, DOI 10.1007/s00247-014-3189-4; Mahesh M, 2009, ARCH INTERN MED, V169, P2071, DOI DOI 10.1001/ARCHINTERNMED.2009.440; Oda S, 2015, J CARDIOVASC COMPUT, V9, P19, DOI 10.1016/j.jcct.2014.12.002; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037//0033-2909.87.2.245; Strauss KJ, 2014, PEDIATR RADIOL, V44, P450, DOI 10.1007/s00247-014-3104-z	27	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1569-5794	1573-0743		INT J CARDIOVAS IMAG	Int. J. Cardiovasc. Imaging	DEC	2015	31			2			205	211		10.1007/s10554-015-0782-z		7	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CX1TQ	WOS:000365478900009		
J	Kitayama, H; Tsuji, Y; Sugiyama, J; Doi, A; Kondo, T; Hirayama, M				Kitayama, Hiromitsu; Tsuji, Yasushi; Sugiyama, Junko; Doi, Ayako; Kondo, Tomohiro; Hirayama, Michiaki			Efficacy of palonosetron and 1-day dexamethasone in moderately emetogenic chemotherapy compared with fosaprepitant, granisetron, and dexamethasone: a prospective randomized crossover study	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Chemotherapy-induced nausea and vomiting; Moderately emetogenic chemotherapy; Palonosetron; 1-Day dexamethasone; Fosaprepitant; Granisetron	INDUCED NAUSEA; DOUBLE-BLIND; 5-HT3 RECEPTOR; PREVENTION; ANTIEMETICS; APREPITANT	Background Although palonosetron (PALO) and NK1 receptor antagonist both reduce chemotherapy-induced nausea and vomiting, no comparison trial in moderately emetogenic chemotherapy (MEC) had been reported. The purpose of this study was to find out which drug combinations are preferable for patients receiving MEC. Methods Chemotherapy-naive patients receiving MEC were randomized to two groups; group A first received PALO therapy [PALO plus 1-day dexamethasone (DEX)], and group B first received fosaprepitant (FAPR) therapy [FAPR, granisetron (GRAN), and DEX]. Patients were re-allocated to the other therapy, respectively, for the second cycle of chemotherapy. We administered intravenous PALO (0.75 mg) and DEX (9.9 mg) to the PALO therapy group, and FAPR (150 mg), DEX (4.95 mg), and GRAN (3 mg) to the FAPR therapy group, on Day 1. Complete response (CR) was the primary endpoint; complete control (CC), total control (CT), and the therapy chosen by the patients for their third and following cycles of antiemetic therapy were the secondary endpoints. We evaluated CR, CC, and TC in the acute phase, in the delayed phase, and over the whole period. Results A total of 35 patients and 70 cycles of therapy was evaluable for analysis. No significant difference was found at all evaluation points. Overall CR rates for PALO and FAPR therapy were 74 vs 69 % (P = 0.567), CC rates 66 vs 69 % (P = 0.521), and TC rates 46 vs 60 % (P = 0.235), respectively. Patients also showed no clear preference for their third and following cycles of chemotherapy, choosing both regimens almost equally often (PALO 10 vs FAPR 13). Conclusions PALO and 1-day DEX is almost equivalent to FAPR, GRAN, and DEX for MEC.	[Kitayama, Hiromitsu; Tsuji, Yasushi; Sugiyama, Junko; Doi, Ayako; Kondo, Tomohiro] Tonan Hosp, Dept Med Oncol, Chuo Ku, Sapporo, Hokkaido 0600001, Japan; [Hirayama, Michiaki] Tonan Hosp, Dept Gastroenterol Med, Sapporo, Hokkaido 0600001, Japan	Kitayama, H (reprint author), Tonan Hosp, Dept Med Oncol, Chuo Ku, Kita 1 Jo Nishi 6 Chome, Sapporo, Hokkaido 0600001, Japan.	m02032hk@jichi.ac.jp			Ono Pharmaceutical Co., Ltd.	All of the authors, except Yasushi Tusji, declare that they have no conflict of interest. Yasushi Tusji has received lecture fees from Ono Pharmaceutical Co., Ltd.	Takahashi T, 2011, CANCER CHEMOTH PHARM, V68, P653, DOI 10.1007/s00280-010-1519-2; Grunberg S, 2011, J CLIN ONCOL, V29, P1495, DOI 10.1200/JCO.2010.31.7859; Rapoport BL, 2010, SUPPORT CARE CANCER, V18, P423, DOI 10.1007/s00520-009-0680-9; Roila F, 2006, ANN ONCOL, V17, P20, DOI 10.1093/annonc/mdj078; Sun CC, 2005, SUPPORT CARE CANCER, V13, P219, DOI 10.1007/s00520-004-0710-6; Aapro MS, 2006, ANN ONCOL, V17, P1441, DOI 10.1093/annonc/mdl137; Aapro M, 2010, ANN ONCOL, V21, P1083, DOI 10.1093/annonc/mdp584; dos Santos LV, 2012, JNCI-J NATL CANCER I, V104, P1280, DOI 10.1093/jnci/djs335; Hesketh PJ, 2010, SUPPORT CARE CANCER, V18, P1171, DOI 10.1007/s00520-009-0737-9; Rojas C, 2008, ANESTH ANALG, V107, P469, DOI 10.1213/ane.0b013e318172fa74; Basch E, 2011, J CLIN ONCOL, V29, P4189, DOI 10.1200/JCO.2010.34.4614; Celio L, 2011, SUPPORT CARE CANCER, V19, P1217, DOI 10.1007/s00520-010-0941-7; Rojas C, 2010, J PHARMACOL EXP THER, V335, P362, DOI 10.1124/jpet.110.166181; Molassiotis A, 2007, J PAIN SYMPTOM MANAG, V34, P148, DOI 10.1016/j.jpainsymman.2006.10.018; Oo TH, 2005, NAT CLIN PRACT ONCOL, V2, P196, DOI 10.1038/ncponc0132; Ettinger DS, 2014, NCCN VERSION 2 2014; Gralla RJ, 2013, MASCC ESMO ANTIEMETI; Hesketh PJ, 2008, NEW ENGL J MED, V358, P2482, DOI 10.1056/NEJMra0706547; Huang JQ, 2004, CLIN RES REGUL AFF, V21, P191, DOI 10.1081/CRP-200049997	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	DEC	2015	20	6					1051	1056		10.1007/s10147-015-0823-6		6	Oncology	Oncology	CX5FS	WOS:000365728100001		
J	Osawa, M; Kudoh, S; Sakai, F; Endo, M; Hamaguchi, T; Ogino, Y; Yoneoka, M; Sakaguchi, M; Nishimoto, H; Gemma, A				Osawa, Masahiro; Kudoh, Shoji; Sakai, Fumikazu; Endo, Masahiro; Hamaguchi, Tetsuya; Ogino, Yumiko; Yoneoka, Miyo; Sakaguchi, Motonobu; Nishimoto, Hiroyuki; Gemma, Akihiko			Clinical features and risk factors of panitumumab-induced interstitial lung disease: a postmarketing all-case surveillance study	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Colorectal cancer; Interstitial lung disease; Panitumumab; Postmarketing surveillance; Risk factors	METASTATIC COLORECTAL-CANCER; PHASE-III TRIAL; JAPANESE PATIENTS; TARGETED THERAPIES; PULMONARY-FIBROSIS; MONOTHERAPY; FLUOROURACIL; ASSOCIATION; LEUCOVORIN; PNEUMONIA	Background Drug-induced interstitial lung disease (ILD) is one of the most serious adverse reactions associated with the molecularly targeted drugs. Panitumumab has been approved for advanced or recurrent colorectal cancer. Although there were no adverse reaction reports of ILD in panitumumab monotherapy, 4 cases in combination chemotherapy were reported prior to its approval in Japan in 2010. Several studies also reported that the incidence of drug-induced ILD was higher in Japan than in other countries. The clinical features of ILD and the associated risk factors therefore need investigation. Methods We analyzed the data from 3085 unresectable, advanced or recurrent colorectal cancer patients enrolled in a postmarketing all-case surveillance study of panitumumab in Japan. ILD case reports were assessed based on the clinical and radiologic findings by a committee of external experts. Multivariate analysis using Cox's hazard model identified the risk factors. Results ILD incidence (1.3 %) and mortality rates (51.3 %) were similar to those of patients receiving another anti-epidermal growth factor receptor (EGFR) monoclonal antibody in Japan. No specific onset timing was determined. Although panitumumab-specific ILD findings were not observed in computed tomography images or clinical practice, panitumumab can induce ILD with diffuse alveolar damage, as do the other anti-EGFR targeting drugs. A history/complication of ILD, male sex, poor general condition, and 65 years or older were identified as ILD risk factors, and no history of previous drug treatment was an apparent risk factor. Conclusion Panitumumab-induced ILD can occur at any time after initiation, and close and regular monitoring is needed.	[Osawa, Masahiro; Ogino, Yumiko; Yoneoka, Miyo; Sakaguchi, Motonobu; Nishimoto, Hiroyuki] Takeda Pharmaceut Co Ltd, Pharmacovigilance Dept, Chuo Ku, Osaka 5410046, Japan; [Kudoh, Shoji] Fukujuji Hosp, Kiyose, Japan; [Sakai, Fumikazu] Saitama Med Univ, Dept Diagnost Radiol, Saitama Int Med Ctr, Hidaka, Japan; [Endo, Masahiro] Shizuoka Canc Ctr, Div Diagnost Radiol, Shizuoka, Japan; [Hamaguchi, Tetsuya] Natl Canc Ctr, Dept Gastrointestinal Med Oncol, Tokyo, Japan; [Gemma, Akihiko] Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Tokyo 113, Japan	Osawa, M (reprint author), Takeda Pharmaceut Co Ltd, Pharmacovigilance Dept, Chuo Ku, 4-9 Hiranomachi 2 Chome, Osaka 5410046, Japan.	Vectibix_TakedaSafety@takeda.co.jp			Takeda Pharmaceutical Co., Ltd.	Akihiko Gemma, Shoji Kudoh, Fumikazu Sakai, Masahiro Endo, and Tetsuya Hamaguchi received consultancy fees from Takeda Pharmaceutical Co., Ltd. as members of the Vectibix ILD review subcommittee. Masahiro Osawa was an employee of Bayer Healthcare. Masahiro Osawa, Yumiko Ogino, Miyo Yoneoka, Motonobu Sakaguchi, and Hiroyuki Nishimoto are employees of Takeda Pharmaceutical Co., Ltd. The study was conducted by Takeda Pharmaceutical Co., Ltd. in conjunction with the Vectibix Appropriate Use/Vectibix Safety Evaluation Committees. Takeda Pharmaceutical Co., Ltd. funded, collected, and analyzed the data, and contributed to the interpretation of the study. Bell Medical Solutions, Inc. conducted statistical analysis.	Barber NA, 2011, TARGET ONCOL, V6, P235, DOI 10.1007/s11523-011-0199-0; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Muro K, 2009, JPN J CLIN ONCOL, V39, P321, DOI 10.1093/jjco/hyp016; Inoue A, 2003, LANCET, V361, P137, DOI 10.1016/S0140-6736(03)12190-3; Peeters M, 2010, J CLIN ONCOL, V28, P4706, DOI 10.1200/JCO.2009.27.6055; Weiner LM, 2008, CLIN CANCER RES, V14, P502, DOI 10.1158/1078-0432.CCR-07-1509; Siena S, 2007, BRIT J CANCER, V97, P1469, DOI 10.1038/sj.bjc.6604053; Gemma Akihiko, 2009, Journal of Nippon Medical School, V76, P4; Ishiguro M, 2012, JPN J CLIN ONCOL, V42, P287, DOI 10.1093/jjco/hys005; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Nakagawa K, 2012, J THORAC ONCOL, V7, P1296, DOI 10.1097/JTO.0b013e3182598abb; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Ando M, 2006, J CLIN ONCOL, V24, P2549, DOI 10.1200/JCO.2005.04.9866; Hecht JR, 2007, CANCER, V110, P980, DOI 10.1002/cncr.22915; Raghu G, 2004, BRIT J CANCER, V91, pS3, DOI 10.1038/sj.bjc.6602061; Yang XD, 2001, CRIT REV ONCOL HEMAT, V38, P17, DOI 10.1016/S1040-8428(00)00134-7; Boku N, 2014, JPN J CLIN ONCOL, V44, P214, DOI 10.1093/jjco/hyt196; Koo LC, 2005, PHARMACOEPIDEM DR S, V14, P775, DOI 10.1002/pds.1071; Saito Y, 2012, INT J CLIN ONCOL, V17, P534, DOI 10.1007/s10147-012-0494-5; Camus P, 2004, BRIT J CANCER, V91, pS18, DOI 10.1038/sj.bjc.6602063; Horiuchi-Yamamoto Y, 2013, INT J CLIN ONCOL, V18, P743, DOI 10.1007/s10147-012-0438-0; Kudoh S, 2008, AM J RESP CRIT CARE, V177, P1348, DOI 10.1164/rccm.200710-1501OC; Makris D, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-150; Mukai Harumi, 2011, Rinsho Ketsueki, V52, P1859; Noguchi S, 2014, BREAST CANCER-TOKYO, V21, P703, DOI 10.1007/s12282-013-0444-8; Satoh T, 2014, JPN J CLIN ONCOL, V44, P1032, DOI 10.1093/jjco/hyu128	28	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	DEC	2015	20	6					1063	1071		10.1007/s10147-015-0834-3		9	Oncology	Oncology	CX5FS	WOS:000365728100003		
J	Maeda, H; Kurokawa, T				Maeda, Hideki; Kurokawa, Tatsuo			Recent trends for drug lag in clinical development of oncology drugs in Japan: does the oncology drug lag still exist in Japan?	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Anticancer drug; Clinical development; Drug lag; Japan; Oncology; PMDA	ANTICANCER DRUGS; UNITED-STATES; APPROVAL; TRIALS; STRATEGIES; SYSTEM; DELAYS; TIME; US	Background This study exhaustively and historically investigated the status of drug lag for oncology drugs approved in Japan. Methods We comprehensively investigated oncology drugs approved in Japan between April 2001 and July 2014, using publicly available information. We also examined changes in the status of drug lag between Japan and the United States, as well as factors influencing drug lag. Results This study included 120 applications for approval of oncology drugs in Japan. The median difference over a 13-year period in the approval date between the United States and Japan was 875 days (29.2 months). This figure peaked in 2002, and showed a tendency to decline gradually each year thereafter. In 2014, the median approval lag was 281 days (9.4 months). Multiple regression analysis identified the following potential factors that reduce drug lag: "Japan's participation in global clinical trials"; "bridging strategies"; "designation of priority review in Japan"; and "molecularly targeted drugs". Conclusions From 2001 to 2014, molecularly targeted drugs emerged as the predominant oncology drug, and the method of development has changed from full development in Japan or bridging strategy to global simultaneous development by Japan's taking part in global clinical trials. In line with these changes, the drug lag between the United States and Japan has significantly reduced to less than 1 year.	[Maeda, Hideki; Kurokawa, Tatsuo] Keio Univ, Grad Sch Pharmaceut Sci, Div Drug Dev & Regulatory Sci, Minato Ku, Tokyo 1058512, Japan; [Maeda, Hideki] Astellas Pharma Inc, Clin Dev Dept, Global Dev, Oncol,Chuo Ku, Tokyo 1038411, Japan	Maeda, H (reprint author), Keio Univ, Grad Sch Pharmaceut Sci, Div Drug Dev & Regulatory Sci, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	hideki.maeda@astellas.com					Maeda H, 2015, J CLIN PHARMACOL, V55, P481, DOI 10.1002/jcph.458; Quan H, 2010, PHARM STAT, V9, P100, DOI 10.1002/pst.380; Shimazawa R, 2012, CLIN THER, V34, P2104, DOI 10.1016/j.clinthera.2012.09.004; Asano K, 2013, CLIN PHARMACOL THER, V94, P195, DOI 10.1038/clpt.2013.106; Ueno T, 2014, CLIN PHARMACOL THER, V95, P533, DOI 10.1038/clpt.2013.223; Shimazawa R, 2012, J CLIN PHARM THER, V37, P348, DOI 10.1111/j.1365-2710.2011.01311.x; Tanaka M, 2008, CLIN PHARMACOL THER, V84, P340, DOI 10.1038/sj.clpt.6100346; Tsuji K, 2010, J CLIN PHARM THER, V35, P289, DOI 10.1111/j.1365-2710.2009.01099.x; Ishiguro A, 2013, J HUM GENET, V58, P313, DOI 10.1038/jhg.2013.36; Uyama Y, 2005, CLIN PHARMACOL THER, V78, P102, DOI 10.1016/j.clpt.2005.04.001; Hartmann M, 2013, CRIT REV ONCOL HEMAT, V87, P112, DOI 10.1016/j.critrevonc.2013.01.004; Mendelsohn J, 2013, J CLIN ONCOL, V31, P1904, DOI 10.1200/JCO.2012.45.3605; Hirai Y, 2010, CLIN PHARMACOL THER, V87, P212, DOI 10.1038/clpt.2009.215; Boku N, 2010, JPN J CLIN ONCOL, V40, P183, DOI 10.1093/jjco/hyp171; Hirai Y, 2012, HEALTH POLICY, V104, P241, DOI 10.1016/j.healthpol.2011.11.008; Ito Y, 2013, ANN ONCOL, V24, P1297, DOI 10.1093/annonc/mdt020; Yonemori K, 2011, INVEST NEW DRUG, V29, P706, DOI 10.1007/s10637-011-9638-0; Molzon JA, 2011, CLIN PHARMACOL THER, V89, P503, DOI 10.1038/clpt.2011.10; COPPINGER PL, 1989, CLIN PHARMACOL THER, V46, P139; Maeda H, 2014, INVEST NEW DRUG, V32, P661, DOI 10.1007/s10637-014-0080-y; Gunjan S., 2010, JNCI-J NATL CANCER I, V102, P148; Honig PK, 2014, CLIN PHARMACOL THER, V95, P466, DOI 10.1038/clpt.2013.256; Maeda H, 2015, ANN ONCOL, V26, P211, DOI 10.1093/annonc/mdu500; Ministry of Health Labour and Welfare, 2007, BAS PRINC GLOB CLIN; Ministry of Health Labour and Welfare, 2012, GUID EST SAF 1 IN HU; Ministry of Health Labour and Welfare, 2005, REV GUID CLIN EV MET; Ohkawa K, 2014, J CLIN PHARM THER, V39, P649, DOI [10.1111/jcpt.12202, DOI 10.1111/JCPT.12202]; Shimura Hirohisa, 2014, Drug Discov Ther, V8, P57; Shoda EK, 2012, J CLIN PHARM THER, V37, P547; Tsuji K, 2008, NATURE, V32, P851; Wileman Harriet, 2010, Perspect Clin Res, V1, P51	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	DEC	2015	20	6					1072	1080		10.1007/s10147-015-0825-4		9	Oncology	Oncology	CX5FS	WOS:000365728100004		
J	Sakashita, T; Homma, A; Hatakeyama, H; Furusawa, J; Kano, S; Mizumachi, T; Iizuka, S; Onimaru, R; Tsuchiya, K; Yasuda, K; Shirato, H; Fukuda, S				Sakashita, Tomohiro; Homma, Akihiro; Hatakeyama, Hiromitsu; Furusawa, Jun; Kano, Satoshi; Mizumachi, Takatsugu; Iizuka, Satoshi; Onimaru, Rikiya; Tsuchiya, Kazuhiko; Yasuda, Koichi; Shirato, Hiroki; Fukuda, Satoshi			Clinical outcomes of weekly cisplatin chemoradiotherapy for patients with pyriform sinus cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Chemoradiation; Hypopharyngeal cancer; Laryngeal preservation	NECK-CANCER; CONCURRENT CHEMORADIOTHERAPY; HYPOPHARYNGEAL CARCINOMA; ORGAN PRESERVATION; RADIOTHERAPY; HEAD; INTERGROUP	Background Pyriform sinus squamous cell carcinoma (SCC) has one of the worst prognoses of all upper aerodigestive tract cancers. Improving clinical outcomes for patients with hypopharyngeal SCC has been particularly challenging for head and neck surgeons and oncologists. Methods We investigated 30 patients with pyriform sinus SCC to verify the effectiveness of weekly cisplatin chemotherapy with concurrent radiotherapy. Cisplatin was administered at a dose of 40 mg/m(2) on weeks 1, 2, 3, 5, 6, and 7 during definitive radiotherapy with the aim of preserving the larynx. Results All 30 patients achieved definitive radiotherapy at a median dose of 70 Gy (range 64-70 Gy). Cisplatin was administrated concomitantly a median of five times (range 2-6 times). Persistent or recurrent primary disease was observed in four patients (13 %). Persistent or recurrent nodal metastasis was observed in five patients (17 %). Nine salvage surgeries were performed for eight patients, of whom seven survived without any evidence of disease. Post-operative complications were observed in two patients (22 %). The 5-year overall survival and locoregional control rates were 87 and 96 %, respectively. The 5-year laryngeal preservation rate was 74 %. Conclusions The regimen of weekly cisplatin CRT may be effective for pyriform sinus SCC; however, there were problems with strong selection bias in the current study due to the large number of T2 patients. Salvage surgery was safe and was able to improve the survival rate. This chemoradiation regimen was considered successful in preserving laryngeal function.	[Sakashita, Tomohiro; Homma, Akihiro; Hatakeyama, Hiromitsu; Furusawa, Jun; Kano, Satoshi; Mizumachi, Takatsugu; Iizuka, Satoshi; Fukuda, Satoshi] Hokkaido Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Onimaru, Rikiya; Tsuchiya, Kazuhiko; Yasuda, Koichi; Shirato, Hiroki] Hokkaido Univ, Dept Radiol, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan	Homma, A (reprint author), Hokkaido Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	ak-homma@med.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26861352]; Health and Labour Sciences Research Grant for Clinical Cancer Research from Ministry of Health, Labour and Welfare of Japan [H26-141]; National Cancer Center Research and Development Fund of Japan [26-A-4]	This work was supported in part by a Grant-in-Aid for Young Scientists (B) Number 26861352 from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by a Health and Labour Sciences Research Grant for Clinical Cancer Research (H26-141) from the Ministry of Health, Labour and Welfare of Japan and the National Cancer Center Research and Development Fund (26-A-4) of Japan.	Prades JM, 2002, ARCH OTOLARYNGOL, V128, P384; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Tai SK, 2008, JPN J CLIN ONCOL, V38, P521, DOI 10.1093/jjco/hyn073; Machtay M, 2008, J CLIN ONCOL, V26, P3582, DOI 10.1200/JCO.2007.14.8841; Homma A, 2011, JPN J CLIN ONCOL, V41, P980, DOI 10.1093/jjco/hyr086; Lefebvre JL, 1996, J NATL CANCER I, V88, P890, DOI 10.1093/jnci/88.13.890; Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310; KOCH WM, 1995, ARCH OTOLARYNGOL, V121, P974; PINGREE TF, 1987, LARYNGOSCOPE, V97, P901; Adelstein DJ, 2003, J CLIN ONCOL, V21, P92, DOI 10.1200/JCO.2003.01.008; Yoon MS, 2008, ACTA OTO-LARYNGOL, V128, P590, DOI 10.1080/00016480701596021	11	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	DEC	2015	20	6					1081	1085		10.1007/s10147-015-0821-8		5	Oncology	Oncology	CX5FS	WOS:000365728100005		
J	Osako, T; Nishimura, R; Nishiyama, Y; Okumura, Y; Tashima, R; Nakano, M; Fujisue, M; Toyozumi, Y; Arima, N				Osako, Tomofumi; Nishimura, Reiki; Nishiyama, Yasuyuki; Okumura, Yasuhiro; Tashima, Rumiko; Nakano, Masahiro; Fujisue, Mamiko; Toyozumi, Yasuo; Arima, Nobuyuki			Efficacy of intraoperative entire-circumferential frozen section analysis of lumpectomy margins during breast-conserving surgery for breast cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Breast-conserving surgery; Lumpectomy margin; Intraoperative entire-circumferential frozen section analysis; Re-operation; Local recurrence	TOUCH PREPARATION CYTOLOGY; 20-YEAR FOLLOW-UP; CARCINOMA IN-SITU; LOCAL RECURRENCE; RADIATION-THERAPY; CONSERVATION THERAPY; STAGE-I; POSITIVE MARGINS; RE-EXCISION; DISTANT METASTASES	Intraoperative frozen section analysis of the surgical margins during breast-conserving surgery (BCS) for breast cancer can reliably achieve clear surgical margins and prevent re-operations. The aim of this study was to assess intraoperative entire-circumferential frozen section analysis (IEFSA) of the lumpectomy margins during BCS. A total of 1029 patients who underwent BCS with IEFSA between June 2007 and July 2013 were available for assessment. The inner surfaces of the shaved lumpectomy margins were examined as frozen sections during BCS. The margins were defined as positive when the cancer cells were present within 5 mm from the edge of the outermost margins of the specimens. Out of 1029 patients, 312 patients (30.3 %) had positive margins after the initial lumpectomy and underwent additional resections during BCS. Fourteen patients (1.4 %) underwent mastectomy following the results of additional resections during the first surgery. Of 1015 patients who completed BCS, 60 patients (5.9 %) were found to have positive margins in the final pathology. One patient (0.1 %) underwent re-operation after BCS while the residual diseases of the other 59 patients were judged to be minimal. Of the 312 patients who were judged to have positive margins after the initial lumpectomy with IEFSA, 53 patients (16.9 %) were found to have negative margins in the final pathology. At a median follow-up time of 54.1 months, one patient (0.1 %) had a recurrence of breast cancer in the preserved breast. IEFSA is useful for preventing the need for re-operation and local recurrence after BCS.	[Osako, Tomofumi; Nishimura, Reiki; Nishiyama, Yasuyuki; Okumura, Yasuhiro; Tashima, Rumiko; Nakano, Masahiro; Fujisue, Mamiko] Kumamoto City Hosp, Dept Breast & Endocrine Surg, Higashi Ku, Kumamoto 8628605, Japan; [Toyozumi, Yasuo; Arima, Nobuyuki] Kumamoto City Hosp, Dept Pathol, Higashi Ku, Kumamoto 8628605, Japan	Osako, T (reprint author), Kumamoto City Hosp, Dept Breast & Endocrine Surg, Higashi Ku, 1-1-60 Kotoh, Kumamoto 8628605, Japan.	tohsako630108@yahoo.co.jp					Freedman G, 1999, INT J RADIAT ONCOL, V44, P1005, DOI 10.1016/S0360-3016(99)00112-1; BURKE MF, 1995, INT J RADIAT ONCOL, V31, P295, DOI 10.1016/0360-3016(94)E0210-B; Chen K, 2012, ANN SURG ONCOL, V19, P3386, DOI 10.1245/s10434-012-2331-5; Singletary SE, 2002, AM J SURG, V184, P383, DOI 10.1016/S0002-9610(02)01012-7; Livi L, 2007, RADIOTHER ONCOL, V82, P287, DOI 10.1016/j.radonc.2006.11.009; Kreike B, 2008, INT J RADIAT ONCOL, V71, P1014, DOI 10.1016/j.ijrobp.2007.11.029; Whipp E, 2010, INT J RADIAT ONCOL, V76, P984, DOI 10.1016/j.ijrobp.2009.03.026; Demirci S, 2012, INT J RADIAT ONCOL, V83, P814, DOI 10.1016/j.ijrobp.2011.09.001; Talsma AK, 2011, EJSO-EUR J SURG ONC, V37, P357, DOI 10.1016/j.ejso.2011.01.008; Santiago RJ, 2004, INT J RADIAT ONCOL, V58, P233, DOI 10.1016/S0360-3016(03)01460-3; SMITT MC, 1995, CANCER, V76, P259, DOI 10.1002/1097-0142(19950715)76:2<259::AID-CNCR2820760216>3.0.CO;2-2; Park CC, 2000, J CLIN ONCOL, V18, P1668; Neuschatz AC, 2003, CANCER, V97, P30, DOI 10.1002/cncr.10981; Varghese P, 2008, EJSO-EUR J SURG ONC, V34, P369, DOI 10.1016/j.ejso.2007.04.008; Obedian E, 1999, INT J RADIAT ONCOL, V44, P997, DOI 10.1016/S0360-3016(99)00135-2; Valdes EK, 2007, ANN SURG ONCOL, V14, P1045, DOI 10.1245/s10434-006-9263-x; Kokubo M, 2000, AM J CLIN ONCOL-CANC, V23, P499, DOI 10.1097/00000421-200010000-00014; Aziz D, 2006, BREAST J, V12, P331, DOI 10.1111/j.1075-122X.2006.00271.x; Leong C, 2004, CANCER, V100, P1823, DOI 10.1002/cncr.20153; Kunos C, 2006, BREAST J, V12, P28, DOI 10.1111/j.1075-122X.2006.00181.x; Weng EY, 2000, CANCER, V88, P1643, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1643::AID-CNCR19>3.0.CO;2-O; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; Jacobson AF, 2008, AM J SURG, V196, P556, DOI 10.1016/j.amjsurg.2008.06.007; McBain CA, 2003, CLIN ONCOL-UK, V15, P25, DOI 10.1053/clon.2002.0165; Pierce LJ, 1997, INT J RADIAT ONCOL, V39, P921, DOI 10.1016/S0360-3016(97)00464-1; Houssami N, 2014, ANN SURG ONCOL, V21, P717, DOI 10.1245/s10434-014-3480-5; Lupe K, 2011, INT J RADIAT ONCOL, V81, pE561, DOI 10.1016/j.ijrobp.2011.02.021; Mirza NQ, 2002, ANN SURG ONCOL, V9, P256, DOI 10.1245/aso.2002.9.3.256; SCHNITT SJ, 1994, CANCER, V74, P1746, DOI 10.1002/1097-0142(19940915)74:6<1746::AID-CNCR2820740617>3.0.CO;2-Y; Jorns JM, 2012, AM J CLIN PATHOL, V138, P657, DOI 10.1309/AJCP4IEMXCJ1GDTS; Moore MM, 2001, ANN SURG, V233, P761, DOI 10.1097/00000658-200106000-00005; Smitt MC, 2003, INT J RADIAT ONCOL, V57, P979, DOI 10.1016/S0360-3016(03)00740-5; Groot G, 2011, J SURG ONCOL, V103, P212, DOI 10.1002/jso.21826; Olson TP, 2007, ANN SURG ONCOL, V14, P2953, DOI 10.1245/s10434-007-9437-1; Liau SS, 2010, ANN ROY COLL SURG, V92, P562, DOI 10.1308/003588410X12699663903476; Camp ER, 2005, J AM COLL SURGEONS, V201, P855, DOI 10.1016/j.jamcollsurg.2005.06.274; Ewertz M, 2008, ACTA ONCOL, V47, P682, DOI 10.1080/02841860802032769; Gage I, 1996, CANCER, V78, P1921, DOI 10.1002/(SICI)1097-0142(19961101)78:9<1921::AID-CNCR12>3.0.CO;2-#; Livi L, 2013, RADIOTHER ONCOL, V108, P273, DOI 10.1016/j.radonc.2013.02.009; Touboul E, 1999, INT J RADIAT ONCOL, V43, P25, DOI 10.1016/S0360-3016(98)00365-4; Moran MS, 2014, J CLIN ONCOL, V32, P1507, DOI 10.1200/JCO.2013.53.3935; Perez CA, 2003, CANCER J, V9, P442, DOI 10.1097/00130404-200311000-00003; Voogd AC, 2001, J CLIN ONCOL, V19, P1688; Cabioglu N, 2007, ANN SURG ONCOL, V14, P1458, DOI 10.1245/s10434-006-9236-0; Cao DF, 2005, AM J SURG PATHOL, V29, P1625, DOI 10.1097/01.pas.0000180448.08203.70; COX CE, 1991, ARCH SURG-CHICAGO, V126, P490; Chagpar A, 2003, AM J SURG, V186, P371, DOI 10.1016/S0002-99610(03)00264-2; Goldstein NS, 2003, AM J CLIN PATHOL, V120, P500, DOI 10.1309/8941VDAJMKY2GCLX; Bellon JR, 2005, J CLIN ONCOL, V23, P1934, DOI 10.1200/JCO.2005.04.032; Rahusen FD, 2002, ANN SURG ONCOL, V9, P994, DOI 10.1245/ASO.2002.04.009; D'Halluin F, 2009, BREAST, V18, P248, DOI 10.1016/j.breast.2009.05.002; Horiguchi J, 2002, ONCOL REP, V9, P1053; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; JACOBSON JA, 1995, NEW ENGL J MED, V332, P907, DOI 10.1056/NEJM199504063321402; Karasawa Kumiko, 2005, Breast Cancer, V12, P91, DOI 10.2325/jbcs.12.91; Karasawa Kumiko, 2003, Breast Cancer, V10, P341, DOI 10.1007/BF02967655; Kasumi F, 2006, BREAST J, V12, pS181, DOI 10.1111/j.1075-122X.2006.00332.x; SPIVACK B, 1994, ARCH SURG-CHICAGO, V129, P952; Spivack B, 1994, ARCH SURG-CHICAGO, V129, P956	59	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	DEC	2015	20	6					1093	1101		10.1007/s10147-015-0827-2		9	Oncology	Oncology	CX5FS	WOS:000365728100007		
J	Inoue, K; Kuroi, K; Shimizu, S; Rai, Y; Aogi, K; Masuda, N; Nakayama, T; Iwata, H; Nishimura, Y; Armour, A; Sasaki, Y				Inoue, Kenichi; Kuroi, Katsumasa; Shimizu, Satoru; Rai, Yoshiaki; Aogi, Kenjiro; Masuda, Norikazu; Nakayama, Takahiro; Iwata, Hiroji; Nishimura, Yuichiro; Armour, Alison; Sasaki, Yasutsuna			Safety, pharmacokinetics and efficacy findings in an open-label, single-arm study of weekly paclitaxel plus lapatinib as first-line therapy for Japanese women with HER2-positive metastatic breast cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Lapatinib; Paclitaxel; HER2; Metastatic breast cancer	BRAIN METASTASES; PHASE-III; TRASTUZUMAB; RECEPTOR; PLACEBO; TRIAL	Lapatinib is the human epidermal growth factor receptor 2 (HER2) targeting agent approved globally for HER2-positive metastatic breast cancer (MBC). The efficacy, safety and pharmacokinetics (PK) of lapatinib combined with paclitaxel (L+P) were investigated in this study, to establish clear evidence regarding the combination in Japanese patients. In this two-part, single-arm, open-label study, the tolerability of L+P as first-line treatment in Japanese patients with HER2-positive MBC was evaluated in six patients in the first part, and the safety, efficacy and PK were evaluated in a further six patients (making a total of twelve patients) in the second part. Eligible women were enrolled and received lapatinib 1500 mg once daily and paclitaxel 80 mg/m(2) weekly for at least 6 cycles. The only dose-limiting toxicity reported was Grade 3 diarrhea in one patient. The systemic exposure to maximum plasma concentration and area under the plasma concentration curve (AUC) for lapatinib, as well as the AUC of paclitaxel, were increased when combined. The most common adverse events (AEs) related to the study treatment were alopecia, diarrhea and decreased hemoglobin. The majority of drug-related AEs were Grade 1 or 2. The median overall survival was 35.6 months (95 % confidence interval 23.9, not reached). The response rate and clinical benefit rate were both 83 % (95 % confidence interval 51.6, 97.9). The L+P treatment was well tolerated in Japanese patients with HER2-positive MBC. Although the PK profiles of lapatinib and paclitaxel influenced each other, the magnitudes were not greatly different from those in non-Japanese patients.	[Inoue, Kenichi] Saitama Canc Ctr, Div Breast Oncol, Ina, Saitama 3620806, Japan; [Kuroi, Katsumasa] Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Breast Surg, Komagome Hosp, Tokyo, Japan; [Shimizu, Satoru] Kanagawa Canc Ctr, Dept Breast Oncol & Endocrine Surg, Yokohama, Kanagawa 2410815, Japan; [Rai, Yoshiaki] Sagara Hosp, Hakuaikai Med Corp, Kagoshima, Japan; [Aogi, Kenjiro] Natl Hosp Org, Dept Surg, Shikoku Canc Ctr, Matsuyama, Ehime, Japan; [Masuda, Norikazu] Osaka Natl Hosp, Natl Hosp Org, Dept Surg, Breast Oncol, Osaka, Japan; [Nakayama, Takahiro] Osaka Univ, Grad Sch Med, Dept Breast & Endocrine Surg, Osaka, Japan; [Nakayama, Takahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Breast & Endocrine Surg, Osaka, Japan; [Iwata, Hiroji] Aichi Canc Ctr Hosp, Dept Breast Oncol, Nagoya, Aichi 464, Japan; [Nishimura, Yuichiro] GlaxoSmithKline KK, Dev & Med Affairs Div, Tokyo, Japan; [Armour, Alison] GlaxoSmithKline, Res & Dev, Philadelphia, PA USA; [Sasaki, Yasutsuna] Saitama Med Univ, Dept Med Oncol, Int Med Ctr, Saitama, Japan; [Sasaki, Yasutsuna] Showa Univ Hosp, Div Med Oncol, Dept Med, Tokyo, Japan	Inoue, K (reprint author), Saitama Canc Ctr, Div Breast Oncol, 780 Komuro, Ina, Saitama 3620806, Japan.	ino@cancer-c.pref.saitama.jp			GlaxoSmithKline K.K.	We thank all the patients who participated in this study and their families; the investigators; medical nurses and research staffs at all the study centers. This study was fully funded and lapatinib was supplied by GlaxoSmithKline K.K.	Clayton AJ, 2004, BRIT J CANCER, V91, P639, DOI 10.1038/sj.bjc.6601970; Lin NU, 2007, CLIN CANCER RES, V13, P1648, DOI 10.1158/1078-0432.CCR-06-2478; Nielsen DL, 2013, BREAST, V22, P1, DOI 10.1016/j.breast.2012.09.008; Guan ZZ, 2013, J CLIN ONCOL, V31, P1947, DOI 10.1200/JCO.2011.40.5241; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Satoh T, 2014, J CLIN ONCOL, V32, P2039, DOI 10.1200/JCO.2013.53.6136; Di Leo A, 2008, J CLIN ONCOL, V26, P5544, DOI 10.1200/JCO.2008.16.2578; Lin NU, 2008, J CLIN ONCOL, V26, P1993, DOI 10.1200/JCO.2007.12.3588; Burstein HJ, 2005, NEW ENGL J MED, V353, P1652, DOI 10.1056/NEJMp058197; Yau T, 2006, ACTA ONCOL, V45, P196, DOI 10.1080/02841860500486630; Stemmler HJ, 2006, BREAST, V15, P219, DOI 10.1016/j.breast.2005.04.017; Bendell JC, 2003, CANCER, V97, P2972, DOI 10.1002/cncr.11436; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Giordano SH, 2014, J CLIN ONCOL, V32, P2078, DOI 10.1200/JCO.2013.54.0948; Gelmon KA, 2012, J CLIN ONCOL S, V30; Japanese Breast Cancer Society, 2013, EV BAS BREAST CANC D; Jones SF, 2004, J CLIN ONCOL, V22; National comprehensive cancer network, 2014, CLIN PRACT GUID ONC	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	DEC	2015	20	6					1102	1109		10.1007/s10147-015-0832-5		8	Oncology	Oncology	CX5FS	WOS:000365728100008		
